Psyllid ID: psy3166

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------23
Protein Sequence
MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ
Secondary Structure (PSIPRED)
cccccccccccEEEEcccccccccEEEEEEEccccccccccccccEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEccccccHHHHHHHHHHcccccccHHHHHcccccccccEEEEccccccccccccccEEccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEccccEEEEEEEccccccEEEEEEEcccccccccccccEEEEEEEccccccHHHHHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEccccccHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccccHHHcEEHHccccEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHccccccccccccHH
Coil and Loop (DISEMBL)
malscgypperlilgevlgqGEFGVVVKgllgdgptegasgQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNillssphvvkisdfglsediyeqnvfqngepseklpIRWLALESLVSNiytnksdvwSFGVVLWEIVTlganpyphiplcRIVHylstgyrmerpascneq
Flexible Loop (DISEMBL)
MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGanpyphipLCRIVHYLSTGYRMERPASCNEQ
Low Complexity Region (SEG)
MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ
Disordered region (IsUnstruct)
*****GYPPERLILGEVLGQGEFGVVVKGLLGDG*********AMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR**********
Disordered Region (DISOPRED)
*ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM*********
Disordered Region (DISEMBL)
MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ
Disordered Region (DISPRO)
MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	228	2.2.26 [Sep-21-2011]
P35546	1115	Proto-oncogene tyrosine-p	yes	N/A	0.947	0.193	0.411	7e-49
P07949	1114	Proto-oncogene tyrosine-p	yes	N/A	0.947	0.193	0.411	8e-49
Q91147	729	Fibroblast growth factor	N/A	N/A	0.942	0.294	0.376	5e-46
P21802	821	Fibroblast growth factor	no	N/A	0.942	0.261	0.376	1e-45
P18461	823	Fibroblast growth factor	no	N/A	0.942	0.261	0.376	1e-45
P21804	819	Fibroblast growth factor	no	N/A	0.938	0.261	0.377	1e-45
P11362	822	Fibroblast growth factor	no	N/A	0.938	0.260	0.374	2e-45
P16092	822	Fibroblast growth factor	no	N/A	0.938	0.260	0.374	2e-45
P21803	821	Fibroblast growth factor	no	N/A	0.942	0.261	0.372	4e-45
P22182	812	Fibroblast growth factor	N/A	N/A	0.929	0.261	0.369	4e-45

>sp|P35546|RET_MOUSE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Mus musculus GN=Ret PE=1 SV=2

 Score =  193 bits (491), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 110/267 (41%), Positives = 151/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 720 FPRKNLVLGKTLGEGEFGKVVKATAFR--LKGRAGYTT--VAVKMLKENASQSELRDLLS 775

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E NL+K V  H H++   G C +D  L L+VEY   G L+ +LR+               
Sbjct: 776 EFNLLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRDSRKIGPAYVSGGGSR 834

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 835 NSSSLDHPDERVLTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 894

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +   +   ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 895 GLSRDVYEEDSYVK-KSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 953

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 954 PGIPPERLFNLLKTGHRMERPDNCSEE 980

Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Act as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1

>sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3

 Score =  193 bits (491), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 110/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 719 FPRKNLVLGKTLGEGEFGKVVKATAFH--LKGRAGYTT--VAVKMLKENASPSELRDLLS 774

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 775 EFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 833

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 834 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 893

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 894 GLSRDVYEEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 952

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 953 PGIPPERLFNLLKTGHRMERPDNCSEE 979

Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Act as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q91147|FGFR2_NOTVI Fibroblast growth factor receptor 2 OS=Notophthalmus viridescens GN=FGFR2 PE=2 SV=1

 Score =  184 bits (467), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           YP E+L LG+ LG+G FG VV     G+  D P + A+      VAVKMLK +A  K   
Sbjct: 384 YPREKLTLGKPLGEGCFGQVVMAEAVGIDKDRPKDAAT------VAVKMLKDDATEKDLS 437

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 438 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRTRRPPGMEYSFD 497

Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 498 INRIPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTETNVMKIADFGLAR 557

Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 558 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 616

Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++P +C  +
Sbjct: 617 VEELFKLLKEGHRMDKPGNCTNE 639

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Notophthalmus viridescens (taxid: 8316)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P21802|FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1

 Score =  182 bits (463), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 476 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 529

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 530 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 589

Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 590 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 649

Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 650 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 708

Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 709 VEELFKLLKEGHRMDKPANCTNE 731

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus GN=FGFR2 PE=2 SV=1

 Score =  182 bits (463), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 478 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDRPKE------AVTVAVKMLKDDATEKDLS 531

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 532 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSFD 591

Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 592 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 651

Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 652 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 710

Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 711 VEELFKLLKEGHRMDKPANCTNE 733

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P21804|FGFR1_CHICK Fibroblast growth factor receptor 1 OS=Gallus gallus GN=FGFR1 PE=2 SV=1

 Score =  182 bits (463), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RLILG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 472 PRDRLILGKPLGEGCFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 525

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 526 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGMEYCYNP 585

Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 586 TRIPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 645

Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 646 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 704

Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 705 EELFKLLKEGHRMDKPSNCTNE 726

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and normal skeletogenesis. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol-1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by ubiquitination, internalization and degradation.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P11362|FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3

 Score =  182 bits (461), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 474 PRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 527

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 528 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNP 587

Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 588 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 647

Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 648 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 706

Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 707 EELFKLLKEGHRMDKPSNCTNE 728

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus GN=Fgfr1 PE=1 SV=2

 Score =  182 bits (461), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 474 PRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 527

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 528 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNP 587

Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 588 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 647

Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 648 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 706

Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 707 EELFKLLKEGHRMDKPSNCTNE 728

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P21803|FGFR2_MOUSE Fibroblast growth factor receptor 2 OS=Mus musculus GN=Fgfr2 PE=1 SV=4

 Score =  181 bits (459), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 476 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 529

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 530 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 589

Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 590 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 649

Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 650 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 708

Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++P +C  +
Sbjct: 709 VEELFKLLKEGHRMDKPTNCTNE 731

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P22182|FGFR1_XENLA Fibroblast growth factor receptor 1 OS=Xenopus laevis GN=fgfr1 PE=1 SV=1

 Score =  181 bits (459), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 96/260 (36%), Positives = 152/260 (58%), Gaps = 48/260 (18%)

Query: 10  ERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +RLILG+ LG+G FG VV     GL  + P +        +VAVKMLK++A  K     +
Sbjct: 470 DRLILGKPLGEGCFGQVVMAEAIGLDKEKPNK------VTKVAVKMLKSDASEKDLSDLI 523

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE-------------- 110
            E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR               
Sbjct: 524 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYTSKGNLREYLRARRPPAMEYCYNPTC 583

Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 +YL++ K +HRDLA RN+L++  +++KI+DFGL+ DI+
Sbjct: 584 VPDQLLSFKDLVSCAYQVARGMDYLASKKCIHRDLAARNVLVTEDNIMKIADFGLARDIH 643

Query: 149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR 208
             + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+  
Sbjct: 644 HIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPMEE 702

Query: 209 IVHYLSTGYRMERPASCNEQ 228
           +   L  G+RM++P +C  +
Sbjct: 703 LFKLLKEGHRMDKPTNCTNE 722

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and normal skeletogenesis. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol-1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by ubiquitination, internalization and degradation.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	228
334313883	1105	PREDICTED: LOW QUALITY PROTEIN: proto-on	0.947	0.195	0.419	2e-48
36009	899	retII [Homo sapiens]	0.947	0.240	0.411	2e-48
395501615	1362	PREDICTED: proto-oncogene tyrosine-prote	0.947	0.158	0.419	3e-48
5419753	1091	RET tyrosine kinase receptor [Homo sapie	0.951	0.198	0.411	6e-48
355782732	1068	Proto-oncogene tyrosine-protein kinase r	0.942	0.201	0.445	7e-48
444726194	1123	Proto-oncogene tyrosine-protein kinase r	0.947	0.192	0.415	8e-48
410975651	819	PREDICTED: proto-oncogene tyrosine-prote	0.947	0.263	0.415	9e-48
344293911	1116	PREDICTED: LOW QUALITY PROTEIN: proto-on	0.947	0.193	0.415	9e-48
46048747	1064	ret proto-oncogene precursor [Gallus gal	0.947	0.203	0.415	1e-47
71979961	776	HOOK3-RET fusion protein [Homo sapiens]	0.947	0.278	0.411	1e-47

>gi|334313883|ref|XP_003339960.1| PREDICTED: LOW QUALITY PROTEIN: proto-oncogene tyrosine-protein kinase receptor Ret-like [Monodelphis domestica]

 Score =  197 bits (502), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 112/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 710 FPRKNLVLGKTLGEGEFGKVVKATAFQ--LKGKAGYTT--VAVKMLKENASPSELRDLLS 765

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E NL+K V  H H++   G C +D  L L+VEY   G L+S+LRE               
Sbjct: 766 EFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGQSYMGGNGNR 824

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                         YL+  K+VHRDLA RN+L++    +KISDF
Sbjct: 825 NSSYLDNPDERALTMGDLISFAWQISRGMHYLAEMKLVHRDLAARNVLVAEGRKMKISDF 884

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 885 GLSRDVYEEDSYVKRSKG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 943

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TGYRMERP +C+E+
Sbjct: 944 PGIPPERLFNLLKTGYRMERPENCSEE 970

Source: Monodelphis domestica

Species: Monodelphis domestica

Genus: Monodelphis

Family: Didelphidae

Order: Didelphimorphia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|36009|emb|CAA33787.1| retII [Homo sapiens]

 Score =  197 bits (501), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 110/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 504 FPRKNLVLGKTLGEGEFGKVVKATAFH--LKGRAGYTT--VAVKMLKENASPSELRDLLS 559

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 560 EFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 618

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 619 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 678

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 679 GLSRDVYEEDSYVKRSQG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 737

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 738 PGIPPERLFNLLKTGHRMERPDNCSEE 764

Source: Homo sapiens

Species: Homo sapiens

Genus: Homo

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|395501615|ref|XP_003755187.1| PREDICTED: proto-oncogene tyrosine-protein kinase receptor Ret [Sarcophilus harrisii]

 Score =  197 bits (501), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 112/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7    YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
            +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 967  FPRKNLVLGKTLGEGEFGKVVKATAFR--LKGKAGYTT--VAVKMLKENASPSELKDLLS 1022

Query: 67   EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE-------------- 111
            E NL+K V  H H++   G C +D  L L+VEY   G L+S+LRE               
Sbjct: 1023 EFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGPSYMGGNGNR 1081

Query: 112  ------------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                          YL+  K+VHRDLA RN+L++    +KISDF
Sbjct: 1082 NSSYLDNPDERALTMGDLISFAWQISRGMHYLAEMKLVHRDLAARNVLVAEGRKMKISDF 1141

Query: 142  GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 1142 GLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 1200

Query: 202  PHIPLCRIVHYLSTGYRMERPASCNEQ 228
            P IP  R+ + L TGYRMERP +C+E+
Sbjct: 1201 PGIPPERLFNLLKTGYRMERPENCSEE 1227

Source: Sarcophilus harrisii

Species: Sarcophilus harrisii

Genus: Sarcophilus

Family: Dasyuridae

Order: Dasyuromorphia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|5419753|emb|CAB46483.1| RET tyrosine kinase receptor [Homo sapiens]

 Score =  196 bits (498), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 110/267 (41%), Positives = 150/267 (56%), Gaps = 50/267 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 695 FPRKNLVLGKTLGEGEFGKVVKATAFH--LKGRAGYTT--VAVKMLKENASPSELRDLLS 750

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 751 EFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 809

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 810 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 869

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 870 GLSRDVYEEDSYVKRSQVGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 929

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 930 PGIPPERLFNLLKTGHRMERPDNCSEE 956

Source: Homo sapiens

Species: Homo sapiens

Genus: Homo

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|355782732|gb|EHH64653.1| Proto-oncogene tyrosine-protein kinase receptor Ret, partial [Macaca fascicularis]

 Score =  196 bits (497), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 111/249 (44%), Positives = 151/249 (60%), Gaps = 34/249 (13%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 692 FPRKNLVLGKTLGEGEFGKVVKATAFR--LKGRAGYTT--VAVKMLKENASPSELRDLLS 747

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYC---------------------ALGDL 104
           E NL+K V  H H++   G C +D  L L+VEY                       +GDL
Sbjct: 748 EFNLLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLGSRNSSSLDHPDERALTMGDL 806

Query: 105 QSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
            S+  +     +YL+  K+VHRDLA RNIL++    +KISDFGLS D+YE++ +     S
Sbjct: 807 ISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR--S 864

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM 219
            ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP IP  R+ + L TG+RM
Sbjct: 865 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM 924

Query: 220 ERPASCNEQ 228
           ERP +C+E+
Sbjct: 925 ERPDNCSEE 933

Source: Macaca fascicularis

Species: Macaca fascicularis

Genus: Macaca

Family: Cercopithecidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|444726194|gb|ELW66734.1| Proto-oncogene tyrosine-protein kinase receptor Ret [Tupaia chinensis]

 Score =  196 bits (497), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 111/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 728 FPRKNLVLGKTLGEGEFGKVVKATAFR--LKGRAGYTT--VAVKMLKENASPSELRDLLS 783

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E NL+K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 784 EFNLLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYVGGGGSR 842

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RN+L++    +KISDF
Sbjct: 843 NSSSLEHPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 902

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 903 GLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 961

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TGYRMERP +C+E+
Sbjct: 962 PGIPPERLFNLLKTGYRMERPDNCSEE 988

Source: Tupaia chinensis

Species: Tupaia chinensis

Genus: Tupaia

Family: Tupaiidae

Order: Scandentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|410975651|ref|XP_003994244.1| PREDICTED: proto-oncogene tyrosine-protein kinase receptor Ret [Felis catus]

 Score =  196 bits (497), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 111/267 (41%), Positives = 149/267 (55%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 466 FPRKNLVLGKTLGEGEFGKVVKATAFR--LKGKAGYTT--VAVKMLKENASPSELRDLLS 521

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E NL+K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 522 EFNLLKQV-NHPHVIKLYGACSQDGPLFLIVEYAKYGSLRGFLRESRKAGPGYVGSGGSR 580

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                         YL+  K+VHRDLA RN+L++    +KISDF
Sbjct: 581 SSSYLDNPEERALTMGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDF 640

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 641 GLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 699

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TGYRMERP +C+E+
Sbjct: 700 PGIPPERLFNLLKTGYRMERPDNCSEE 726

Source: Felis catus

Species: Felis catus

Genus: Felis

Family: Felidae

Order: Carnivora

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|344293911|ref|XP_003418663.1| PREDICTED: LOW QUALITY PROTEIN: proto-oncogene tyrosine-protein kinase receptor Ret-like [Loxodonta africana]

 Score =  195 bits (496), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 111/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 721 FPRKNLVLGKTLGEGEFGKVVKATAFR--LKGKAGYTT--VAVKMLKENASPSELRDLLS 776

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E NL+K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 777 EFNLLKQV-NHPHVIKLHGACSQDGPLFLIVEYAKYGSLRGFLRESRKVGPSYVGSGGSR 835

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RN+L++    +KISDF
Sbjct: 836 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 895

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 896 GLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 954

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TGYRMERP +C+E+
Sbjct: 955 PGIPPERLFNLLKTGYRMERPDNCSEE 981

Source: Loxodonta africana

Species: Loxodonta africana

Genus: Loxodonta

Family: Elephantidae

Order: Proboscidea

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|46048747|ref|NP_990521.1| ret proto-oncogene precursor [Gallus gallus] gi|871042|emb|CAA90078.1| ret protein [Gallus gallus]

 Score =  195 bits (496), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 111/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 711 FPRKNLVLGKTLGEGEFGKVVKATAFR--LKGRAGYTT--VAVKMLKENASQSELRDLLS 766

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E NL+K V  H H++   G C +D  L L+VEY   G L+S+LRE               
Sbjct: 767 EFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGPSYVGSDGNR 825

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RN+L++    +KISDF
Sbjct: 826 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 885

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 886 GLSRDVYEEDSYVKRSKG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 944

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P I   R+ + L TGYRMERP +C+E+
Sbjct: 945 PGIAPERLFNLLKTGYRMERPENCSEE 971

Source: Gallus gallus

Species: Gallus gallus

Genus: Gallus

Family: Phasianidae

Order: Galliformes

Class: Aves

Phylum: Chordata

Superkingdom: Eukaryota

>gi|71979961|gb|AAZ57203.1| HOOK3-RET fusion protein [Homo sapiens]

 Score =  195 bits (496), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 110/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 381 FPRKNLVLGKTLGEGEFGKVVKATAFH--LKGRAGYTT--VAVKMLKENASPSELRDLLS 436

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 437 EFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 495

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 496 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 555

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 556 GLSRDVYEEDSYVKRSQG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 614

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 615 PGIPPERLFNLLKTGHRMERPDNCSEE 641

Source: Homo sapiens

Species: Homo sapiens

Genus: Homo

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	228
UNIPROTKB|F1PLF6	1109	RET "Uncharacterized protein"	0.557	0.114	0.526	5.7e-50
MGI|MGI:97902	1115	Ret "ret proto-oncogene" [Mus	0.557	0.113	0.526	1.2e-49
UNIPROTKB|G3V9H8	1115	Ret "Protein Ret" [Rattus norv	0.557	0.113	0.526	1.2e-49
UNIPROTKB|P07949	1114	RET "Proto-oncogene tyrosine-p	0.557	0.114	0.526	1.2e-49
UNIPROTKB|F1MS00	1113	RET "Uncharacterized protein"	0.552	0.113	0.518	1e-47
FB|FBgn0003733	923	tor "torso" [Drosophila melano	0.596	0.147	0.5	2e-47
UNIPROTKB|F1RG22	1122	RET "Uncharacterized protein"	0.557	0.113	0.511	2.7e-47
UNIPROTKB|H7C265	371	FGFR2 "Fibroblast growth facto	0.508	0.312	0.483	1.8e-46
UNIPROTKB|F1LQ69	371	Fgfr2 "Protein Fgfr2" [Rattus	0.508	0.312	0.474	4.7e-46
FB|FBgn0011829	1237	Ret "Ret oncogene" [Drosophila	0.504	0.092	0.525	1.5e-45

UNIPROTKB|F1PLF6 RET "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 371 (135.7 bits), Expect = 5.7e-50, Sum P(2) = 5.7e-50
 Identities = 70/133 (52%), Positives = 97/133 (72%)

Query:   101 LGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
             +GDL S+  +      YL+  K+VHRDLA RN+L++    +KISDFGLS D+YE++ +  
Sbjct:   843 MGDLISFAWQISRGMRYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 902

Query:   156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                  ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP IP  R+ + L T
Sbjct:   903 RSKG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 961

Query:   216 GYRMERPASCNEQ 228
             GYRMERP +C+E+
Sbjct:   962 GYRMERPDNCSEE 974

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

MGI|MGI:97902 Ret "ret proto-oncogene" [Mus musculus (taxid:10090)]

 Score = 370 (135.3 bits), Expect = 1.2e-49, Sum P(2) = 1.2e-49
 Identities = 70/133 (52%), Positives = 99/133 (74%)

Query:   101 LGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
             +GDL S+  +     +YL+  K+VHRDLA RNIL++    +KISDFGLS D+YE++ +  
Sbjct:   849 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 908

Query:   156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
              +   ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP IP  R+ + L T
Sbjct:   909 -KSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 967

Query:   216 GYRMERPASCNEQ 228
             G+RMERP +C+E+
Sbjct:   968 GHRMERPDNCSEE 980

GO:0000165 "MAPK cascade" evidence=IGI

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IMP

GO:0001755 "neural crest cell migration" evidence=IMP

GO:0001838 "embryonic epithelial tube formation" evidence=IGI;IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004714 "transmembrane receptor protein tyrosine kinase activity" evidence=TAS

GO:0005509 "calcium ion binding" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005887 "integral to plasma membrane" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0007155 "cell adhesion" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0007158 "neuron cell-cell adhesion" evidence=ISO;IDA

GO:0007165 "signal transduction" evidence=TAS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=IGI

GO:0007399 "nervous system development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=TAS

GO:0010008 "endosome membrane" evidence=ISO

GO:0010976 "positive regulation of neuron projection development" evidence=ISO

GO:0014042 "positive regulation of neuron maturation" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030155 "regulation of cell adhesion" evidence=ISO

GO:0030335 "positive regulation of cell migration" evidence=ISO

GO:0033619 "membrane protein proteolysis" evidence=ISO

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=ISO

GO:0035799 "ureter maturation" evidence=IMP

GO:0042551 "neuron maturation" evidence=IMP

GO:0045121 "membrane raft" evidence=ISO

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IMP

GO:0048265 "response to pain" evidence=IMP

GO:0048484 "enteric nervous system development" evidence=IMP

GO:0060384 "innervation" evidence=ISO

GO:0061146 "Peyer's patch morphogenesis" evidence=IMP

GO:0071300 "cellular response to retinoic acid" evidence=ISO

GO:0072300 "positive regulation of metanephric glomerulus development" evidence=IMP

GO:2001241 "positive regulation of extrinsic apoptotic signaling pathway in absence of ligand" evidence=ISO

UNIPROTKB|G3V9H8 Ret "Protein Ret" [Rattus norvegicus (taxid:10116)]

 Score = 370 (135.3 bits), Expect = 1.2e-49, Sum P(2) = 1.2e-49
 Identities = 70/133 (52%), Positives = 99/133 (74%)

Query:   101 LGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
             +GDL S+  +     +YL+  K+VHRDLA RNIL++    +KISDFGLS D+YE++ +  
Sbjct:   849 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 908

Query:   156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
              +   ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP IP  R+ + L T
Sbjct:   909 -KSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 967

Query:   216 GYRMERPASCNEQ 228
             G+RMERP +C+E+
Sbjct:   968 GHRMERPDNCSEE 980

GO:0000165 "MAPK cascade" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IEA

GO:0001755 "neural crest cell migration" evidence=IEA

GO:0001838 "embryonic epithelial tube formation" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005887 "integral to plasma membrane" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0007158 "neuron cell-cell adhesion" evidence=IEA

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=IEA

GO:0010008 "endosome membrane" evidence=IEA

GO:0010976 "positive regulation of neuron projection development" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0033619 "membrane protein proteolysis" evidence=IEA

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=IEA

GO:0035799 "ureter maturation" evidence=IEA

GO:0042551 "neuron maturation" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0048265 "response to pain" evidence=IEA

GO:0048484 "enteric nervous system development" evidence=IEA

GO:0061146 "Peyer's patch morphogenesis" evidence=IEA

GO:0071300 "cellular response to retinoic acid" evidence=IEA

GO:0072300 "positive regulation of metanephric glomerulus development" evidence=IEA

UNIPROTKB|P07949 RET "Proto-oncogene tyrosine-protein kinase receptor Ret" [Homo sapiens (taxid:9606)]

 Score = 369 (135.0 bits), Expect = 1.2e-49, Sum P(2) = 1.2e-49
 Identities = 70/133 (52%), Positives = 98/133 (73%)

Query:   101 LGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
             +GDL S+  +     +YL+  K+VHRDLA RNIL++    +KISDFGLS D+YE++ +  
Sbjct:   848 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 907

Query:   156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                  ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP IP  R+ + L T
Sbjct:   908 RSQG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 966

Query:   216 GYRMERPASCNEQ 228
             G+RMERP +C+E+
Sbjct:   967 GHRMERPDNCSEE 979

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004714 "transmembrane receptor protein tyrosine kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IEA

GO:0001755 "neural crest cell migration" evidence=IEA

GO:0001838 "embryonic epithelial tube formation" evidence=IEA

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=IEA

GO:0035799 "ureter maturation" evidence=IEA

GO:0042551 "neuron maturation" evidence=IEA

GO:0048484 "enteric nervous system development" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IDA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=ISS

GO:0072300 "positive regulation of metanephric glomerulus development" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0005887 "integral to plasma membrane" evidence=IDA

GO:0010008 "endosome membrane" evidence=IDA

GO:0030155 "regulation of cell adhesion" evidence=IDA

GO:2001241 "positive regulation of extrinsic apoptotic signaling pathway in absence of ligand" evidence=IMP;TAS

GO:0033619 "membrane protein proteolysis" evidence=IDA

GO:0048265 "response to pain" evidence=ISS

GO:0030335 "positive regulation of cell migration" evidence=IDA

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=IDA

GO:0061146 "Peyer's patch morphogenesis" evidence=ISS

GO:0097021 "lymphocyte migration into lymphoid organs" evidence=ISS

GO:0007158 "neuron cell-cell adhesion" evidence=IMP

GO:0004713 "protein tyrosine kinase activity" evidence=TAS

GO:0004872 "receptor activity" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0007497 "posterior midgut development" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0071300 "cellular response to retinoic acid" evidence=IMP

GO:0010976 "positive regulation of neuron projection development" evidence=IMP

UNIPROTKB|F1MS00 RET "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 357 (130.7 bits), Expect = 1.0e-47, Sum P(2) = 1.0e-47
 Identities = 69/133 (51%), Positives = 97/133 (72%)

Query:   101 LGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
             +GDL S+  +     +YL+  K+VHRDLA RN+L++    +KIS FGLS D+YE++ +  
Sbjct:   848 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKIS-FGLSRDVYEEDSYVK 906

Query:   156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                  ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP IP  R+ + L T
Sbjct:   907 RSKG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 965

Query:   216 GYRMERPASCNEQ 228
             GYRMERP +C+E+
Sbjct:   966 GYRMERPDNCSEE 978

GO:0072300 "positive regulation of metanephric glomerulus development" evidence=IEA

GO:0071300 "cellular response to retinoic acid" evidence=IEA

GO:0061146 "Peyer's patch morphogenesis" evidence=IEA

GO:0048484 "enteric nervous system development" evidence=IEA

GO:0048265 "response to pain" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0042551 "neuron maturation" evidence=IEA

GO:0035799 "ureter maturation" evidence=IEA

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=IEA

GO:0033619 "membrane protein proteolysis" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0010976 "positive regulation of neuron projection development" evidence=IEA

GO:0010008 "endosome membrane" evidence=IEA

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=IEA

GO:0007158 "neuron cell-cell adhesion" evidence=IEA

GO:0005887 "integral to plasma membrane" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0001838 "embryonic epithelial tube formation" evidence=IEA

GO:0001755 "neural crest cell migration" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

FB|FBgn0003733 tor "torso" [Drosophila melanogaster (taxid:7227)]

 Score = 365 (133.5 bits), Expect = 2.0e-47, Sum P(2) = 2.0e-47
 Identities = 69/138 (50%), Positives = 97/138 (70%)

Query:    93 RLVVEYCALGDL--QSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ 150
             R+ ++Y  L D+  Q  +  E+L+ NKVVHRDLA RN+L+S    +KI+DFGLS D+Y +
Sbjct:   710 RIPLKYADLLDIAQQVAVGMEFLAQNKVVHRDLAARNVLISVDRSIKIADFGLSRDVYHE 769

Query:   151 NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
             NV++    S KLPI+WLALESL   +YT++SDVWSFGV+L+EI TLG  PYP +    ++
Sbjct:   770 NVYRKSGGSGKLPIKWLALESLTHQVYTSQSDVWSFGVLLYEITTLGGMPYPSVSPSDLL 829

Query:   211 HYLSTGYRMERPASCNEQ 228
               L  G+RM+RP  C ++
Sbjct:   830 QLLRQGHRMKRPEGCTQE 847

GO:0007362 "terminal region determination" evidence=NAS;IMP

GO:0004714 "transmembrane receptor protein tyrosine kinase activity" evidence=ISS

GO:0030381 "chorion-containing eggshell pattern formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004713 "protein tyrosine kinase activity" evidence=NAS;IDA

GO:0001709 "cell fate determination" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0008293 "torso signaling pathway" evidence=NAS;TAS

GO:0008595 "anterior/posterior axis specification, embryo" evidence=TAS

GO:0007443 "Malpighian tubule morphogenesis" evidence=TAS

GO:0005886 "plasma membrane" evidence=NAS

GO:0007280 "pole cell migration" evidence=IMP

GO:0007369 "gastrulation" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0007552 "metamorphosis" evidence=IMP

UNIPROTKB|F1RG22 RET "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 353 (129.3 bits), Expect = 2.7e-47, Sum P(2) = 2.7e-47
 Identities = 68/133 (51%), Positives = 95/133 (71%)

Query:   101 LGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
             +GDL S+  +     +YL+  K+VHRDLA RN+L++    +KISDFGL    YE++ +  
Sbjct:   856 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRRMKISDFGLFPRCYEEDSYVK 915

Query:   156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                  ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP IP  R+ + L T
Sbjct:   916 RSKG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 974

Query:   216 GYRMERPASCNEQ 228
             GYRMERP +C+E+
Sbjct:   975 GYRMERPDNCSEE 987

GO:0072300 "positive regulation of metanephric glomerulus development" evidence=IEA

GO:0071300 "cellular response to retinoic acid" evidence=IEA

GO:0061146 "Peyer's patch morphogenesis" evidence=IEA

GO:0048484 "enteric nervous system development" evidence=IEA

GO:0048265 "response to pain" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0042551 "neuron maturation" evidence=IEA

GO:0035799 "ureter maturation" evidence=IEA

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=IEA

GO:0033619 "membrane protein proteolysis" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0010976 "positive regulation of neuron projection development" evidence=IEA

GO:0010008 "endosome membrane" evidence=IEA

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=IEA

GO:0007158 "neuron cell-cell adhesion" evidence=IEA

GO:0005887 "integral to plasma membrane" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0001838 "embryonic epithelial tube formation" evidence=IEA

GO:0001755 "neural crest cell migration" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

UNIPROTKB|H7C265 FGFR2 "Fibroblast growth factor receptor 2" [Homo sapiens (taxid:9606)]

 Score = 321 (118.1 bits), Expect = 1.8e-46, Sum P(2) = 1.8e-46
 Identities = 57/118 (48%), Positives = 88/118 (74%)

Query:   111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
             EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ DI   + ++    + +LP++W+A E
Sbjct:   207 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPE 265

Query:   171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC-NE 227
             +L   +YT++SDVWSFGV++WEI TLG +PYP IP+  +   L  G+RM++PA+C NE
Sbjct:   266 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNE 323

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1LQ69 Fgfr2 "Protein Fgfr2" [Rattus norvegicus (taxid:10116)]

 Score = 317 (116.6 bits), Expect = 4.7e-46, Sum P(2) = 4.7e-46
 Identities = 56/118 (47%), Positives = 87/118 (73%)

Query:   111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
             EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ DI   + ++    + +LP++W+A E
Sbjct:   207 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPE 265

Query:   171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC-NE 227
             +L   +YT++SDVWSFGV++WEI TLG +PYP IP+  +   L  G+RM++P +C NE
Sbjct:   266 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPTNCTNE 323

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

FB|FBgn0011829 Ret "Ret oncogene" [Drosophila melanogaster (taxid:7227)]

 Score = 345 (126.5 bits), Expect = 1.5e-45, Sum P(2) = 1.5e-45
 Identities = 61/116 (52%), Positives = 86/116 (74%)

Query:   112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
             YLS  K+VHRDLA RN+LL+   + KISDFGL+ D+YE + +      +++P++W+A ES
Sbjct:   903 YLSELKLVHRDLAARNVLLADGKICKISDFGLTRDVYEDDAYLK-RSRDRVPVKWMAPES 961

Query:   172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE 227
             L  ++YT+KSDVWSFGV+ WE++TLGA+PYP I    +   L TGYRM+RP +C+E
Sbjct:   962 LADHVYTSKSDVWSFGVLCWELITLGASPYPGIAPQNLWSLLKTGYRMDRPENCSE 1017

GO:0004714 "transmembrane receptor protein tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;NAS

GO:0007165 "signal transduction" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=NAS

GO:0005887 "integral to plasma membrane" evidence=ISS;IDA

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.10	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	228
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-93
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-93
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-93
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-92
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-73
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-68
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-61
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-60
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-60
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-59
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-58
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-58
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-56
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-54
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-54
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-53
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-52
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-51
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-51
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-51
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-51
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-50
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-49
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-49
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-49
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-49
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-47
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-47
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-46
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-46
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-46
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-46
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-45
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-45
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-45
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-44
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-44
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-44
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-43
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-43
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-42
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-42
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-42
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-42
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-41
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-41
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-41
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-40
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-39
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-39
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-39
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-39
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-38
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-38
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-38
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-38
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-38
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-37
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-37
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-37
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-37
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-37
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-36
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-35
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-35
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-35
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-35
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-34
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-34
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-33
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-33
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-33
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-32
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-32
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-32
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-31
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-31
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-30
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-30
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-30
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-29
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-29
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-29
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-28
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-28
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-25
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-25
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-20
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-17
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-16
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-16
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-16
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-15
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-15
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-15
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-11
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-07
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.001
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.001
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.001
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.001
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	0.001
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.003

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  273 bits (701), Expect = 3e-93
 Identities = 104/243 (42%), Positives = 137/243 (56%), Gaps = 38/243 (15%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG+G FG V KG L     +        EVAVK LK +A  +    FLKE  +MK +G
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKT------TEVAVKTLKEDASEEERKDFLKEARVMKKLG 54

Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------------ 110
            H ++V  +G C ++E L LV+EY   GDL  YLR+                        
Sbjct: 55  -HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL++ K VHRDLA RN L+    VVKISDFGLS D+Y+ + ++      KLPIR
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIR 172

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W+A ESL   I+T+KSDVWSFGV+LWEI TLGA PYP +    ++ YL  GYR+ +P  C
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYC 232

Query: 226 NEQ 228
            ++
Sbjct: 233 PDE 235

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  273 bits (700), Expect = 4e-93
 Identities = 102/236 (43%), Positives = 140/236 (59%), Gaps = 30/236 (12%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           L LG+ LG+G FG V KG L     +G  G+  +EVAVK LK +A  +  ++FL+E  +M
Sbjct: 1   LTLGKKLGEGAFGEVYKGKL-----KGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIM 55

Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           + +  H ++V  +G C ++E L +V+EY   GDL SYLR+                    
Sbjct: 56  RKL-DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            EYL +   +HRDLA RN L+    VVKISDFGLS D+Y+ +     +   KLPIRW+A 
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY--YRKRGGKLPIRWMAP 172

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           ESL    +T+KSDVWSFGV+LWEI TLG  PYP +    ++ YL  GYR+ +P +C
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC 228

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  272 bits (698), Expect = 7e-93
 Identities = 101/237 (42%), Positives = 138/237 (58%), Gaps = 31/237 (13%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           L LG+ LG+G FG V KG L     +G      +EVAVK LK +A  +  ++FL+E  +M
Sbjct: 1   LTLGKKLGEGAFGEVYKGTL-----KGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIM 55

Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           + +  H +IV  +G C ++E L +V+EY   GDL  YLR+                    
Sbjct: 56  RKL-DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
             EYL +   +HRDLA RN L+    VVKISDFGLS D+Y+ + ++      KLPIRW+A
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK--GGKLPIRWMA 172

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ESL    +T+KSDVWSFGV+LWEI TLG  PYP +    ++ YL  GYR+ +P +C
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC 229

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  272 bits (697), Expect = 1e-92
 Identities = 102/236 (43%), Positives = 135/236 (57%), Gaps = 29/236 (12%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           L LG+ LG+G FG V KG L     +G       +VAVK LK  A  +  ++FL+E ++M
Sbjct: 1   LELGKKLGEGAFGEVYKGTL-----KGDGEGTETKVAVKTLKEGASEEEREEFLEEASIM 55

Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K +  H +IV  +G C + E L +V EY   GDL  +LR+                    
Sbjct: 56  KKL-SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            EYL +   VHRDLA RN L++   VVKISDFGLS DIYE + ++      KLPI+W+A 
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG-GGKLPIKWMAP 173

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           ESL    +T+KSDVWSFGV+LWEI TLG  PYP +    ++  L  GYR+ RP +C
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENC 229

Length = 258

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  223 bits (570), Expect = 5e-73
 Identities = 101/259 (38%), Positives = 148/259 (57%), Gaps = 50/259 (19%)

Query: 8   PPERLILGEVLGQGEFGVVVKG-LLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P +RL LG+ LG+G FG VVK   +G              VAVKMLK +A  K     + 
Sbjct: 10  PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNET-----STVAVKMLKDDATEKDLSDLVS 64

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E+ +MK +GKH +I++ +G C ++  L +VVEY A G+L+ +LR                
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                E+L++ K +HRDLA RN+L++  HV+KI+DFGL+ DI+ 
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184

Query: 150 QNVFQ---NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
            + ++   NG    +LP++W+A E+L   +YT++SDVWSFGV+LWEI TLG +PYP IP+
Sbjct: 185 IDYYRKTTNG----RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240

Query: 207 CRIVHYLSTGYRMERPASC 225
             +   L  GYRME+P +C
Sbjct: 241 EELFKLLKEGYRMEKPQNC 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  212 bits (540), Expect = 1e-68
 Identities = 108/263 (41%), Positives = 144/263 (54%), Gaps = 51/263 (19%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
            L+LG+ LG+GEFG VVK                  VAVKMLK NA +      L E NL
Sbjct: 1   NLVLGKTLGEGEFGKVVKAT----AFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNL 56

Query: 71  MKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------- 110
           +K V  H H++   G C +D  L L+VEY   G L+S+LRE                   
Sbjct: 57  LKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115

Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    +YL+  K+VHRDLA RN+L++    +KISDFGLS 
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPYP I 
Sbjct: 176 DVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234

Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
             R+ + L TGYRMERP +C+E+
Sbjct: 235 PERLFNLLKTGYRMERPENCSEE 257

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  194 bits (494), Expect = 2e-61
 Identities = 88/243 (36%), Positives = 136/243 (55%), Gaps = 33/243 (13%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P   L  G+ LG G FG VV+    G   +      A M+VAVKMLK  A +   +  +
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKS-----DAVMKVAVKMLKPTAHSSEREALM 86

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE-------------- 110
            E+ +M  +G H++IV+ +G C     + ++ EYC  GDL ++LR               
Sbjct: 87  SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEK 161
                    +L++   +HRDLA RN+LL+   +VKI DFGL+ DI  + N    G  + +
Sbjct: 147 SYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG--NAR 204

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRME 220
           LP++W+A ES+ + +YT +SDVWS+G++LWEI +LG+NPYP +P+  +    +  GYRM 
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264

Query: 221 RPA 223
           +P 
Sbjct: 265 QPE 267

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  189 bits (483), Expect = 2e-60
 Identities = 90/241 (37%), Positives = 123/241 (51%), Gaps = 43/241 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + L LG  +G+GEFG V+ G                +VAVK LK   D+     FL E
Sbjct: 4   NSKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKD--DSTAAQAFLAE 50

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  + +H ++V  +G   +   L +V EY A G L  YLR                 
Sbjct: 51  ASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL 109

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                 EYL     VHRDLA RN+L+S   V K+SDFGL+++         G+ S KLP+
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA------SQGQDSGKLPV 163

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V ++  GYRME P  
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223

Query: 225 C 225
           C
Sbjct: 224 C 224

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  190 bits (484), Expect = 3e-60
 Identities = 90/252 (35%), Positives = 130/252 (51%), Gaps = 37/252 (14%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E++ L   LGQG FG+V +GL          G+    VA+K +  NA  +   +FL E
Sbjct: 4   PREKITLIRELGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNE 59

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE--------------- 111
            ++MK+   H H+V  +G     +  LVV E  A GDL+SYLR                 
Sbjct: 60  ASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 112 ---------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG 156
                          YL+  K VHRDLA RN +++    VKI DFG++ DIYE + ++ G
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP+RW+A ESL   ++T KSDVWSFGVVLWE+ TL   PY  +    ++ ++  G
Sbjct: 179 GKG-LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237

Query: 217 YRMERPASCNEQ 228
             ++ P +C ++
Sbjct: 238 GHLDLPENCPDK 249

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  187 bits (477), Expect = 6e-59
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  + P          +VAVKMLK++A  K    
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNR------VTKVAVKMLKSDATEKDLSD 69

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR             
Sbjct: 70  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP 129

Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 190 IHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248

Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 249 EELFKLLKEGHRMDKPSNCTNE 270

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  187 bits (475), Expect = 1e-58
 Identities = 97/263 (36%), Positives = 152/263 (57%), Gaps = 48/263 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +  ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 12  FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKE------AVTVAVKMLKDDATEKDLS 65

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 66  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125

Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           D+   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 186 DVNNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244

Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 245 VEELFKLLKEGHRMDKPANCTNE 267

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  186 bits (474), Expect = 2e-58
 Identities = 95/266 (35%), Positives = 154/266 (57%), Gaps = 54/266 (20%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P +RL+LG+ LG+G FG VV+    G+    P +  +      VAVKMLK NA  K   
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVT------VAVKMLKDNATDKDLA 62

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ LMK +GKH +I++ +G C ++  L ++VEY A G+L+ +LR            
Sbjct: 63  DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL + + +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 146 DIYEQNVFQ---NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            +++ + ++   NG    +LP++W+A E+L   +YT++SDVWSFG+++WEI TLG +PYP
Sbjct: 183 GVHDIDYYKKTSNG----RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238

Query: 203 HIPLCRIVHYLSTGYRMERPASCNEQ 228
            IP+  +   L  G+RM++P++C  +
Sbjct: 239 GIPVEELFKLLREGHRMDKPSNCTHE 264

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  182 bits (464), Expect = 1e-56
 Identities = 97/259 (37%), Positives = 150/259 (57%), Gaps = 48/259 (18%)

Query: 11  RLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           RL LG+ LG+G FG VV     G+  D P +       + VAVKMLK +A  K     + 
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNK------PVTVAVKMLKDDATDKDLSDLVS 66

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR                
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D++ 
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI 209
            + ++    + +LP++W+A E+L   +YT++SDVWSFGV+LWEI TLG +PYP IP+  +
Sbjct: 187 IDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245

Query: 210 VHYLSTGYRMERPASCNEQ 228
              L  G+RM++PA+C  +
Sbjct: 246 FKLLKEGHRMDKPANCTHE 264

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  175 bits (444), Expect = 2e-54
 Identities = 87/248 (35%), Positives = 132/248 (53%), Gaps = 42/248 (16%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT-YDKFLKEINL 70
           L LG++LG+GEFG V++G L     +G+  +    VAVK +K +    +  ++FL E   
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQ--DDGSQLK----VAVKTMKLDIHTYSEIEEFLSEAAC 54

Query: 71  MKDVGKHDHIVSFIGCCYKDELR-------LVVEYCALGDLQSYLRE------------- 110
           MKD   H +++  IG C++           +++ +   GDL S+L               
Sbjct: 55  MKDF-DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ 113

Query: 111 -------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                        EYLSN   +HRDLA RN +L     V ++DFGLS+ IY  + ++ G 
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173

Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY 217
            + K+P++W+A+ESL   +YT+KSDVW+FGV +WEI T G  PYP +    I  YL  G 
Sbjct: 174 IA-KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232

Query: 218 RMERPASC 225
           R+++P  C
Sbjct: 233 RLKQPEDC 240

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  173 bits (440), Expect = 7e-54
 Identities = 92/234 (39%), Positives = 128/234 (54%), Gaps = 31/234 (13%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
            V+G+G FG V  G L D      S    +  AVK L    D +  ++FLKE  +MKD  
Sbjct: 1   RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF- 53

Query: 76  KHDHIVSFIGCCYKDE-LRLVV-EYCALGDLQSYLREE---------------------Y 112
            H +++S +G C   E   LVV  Y   GDL++++R E                     Y
Sbjct: 54  SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKLPIRWLALES 171
           L++ K VHRDLA RN +L     VK++DFGL+ DIY++  +  +     KLP++W+ALES
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           L +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P  C
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC 227

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  171 bits (435), Expect = 5e-53
 Identities = 88/244 (36%), Positives = 129/244 (52%), Gaps = 38/244 (15%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G FG V +G   D       G   + VAVK L+  A  +   +FLKE +LM +   H
Sbjct: 3   LGSGAFGEVYEGTATD---ILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NH 58

Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE------------------------- 111
            +IV  +G C  +E   +++E    GDL SYLR+                          
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 112 --YLSNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
             YL     +HRDLA RN L+S        VVKI DFGL+ DIY+ + ++  E    LP+
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK-EGEGLLPV 177

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           RW+A ESL+   +T +SDVWSFGV++WEI+TLG  PYP +    ++ +++ G R+++P +
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237

Query: 225 CNEQ 228
           C ++
Sbjct: 238 CPDK 241

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  170 bits (432), Expect = 2e-52
 Identities = 87/241 (36%), Positives = 126/241 (52%), Gaps = 38/241 (15%)

Query: 11  RLILGEVLGQGEFGVVVKGL---LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
            L   +VLG G FG V KG+    G+           + VA+K+L+     K   + L E
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGEK--------VKIPVAIKVLREETSPKANKEILDE 59

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +M  V  H H+V  +G C   +++L+ +   LG L  Y+R                  
Sbjct: 60  AYVMASVD-HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118

Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPI 164
                YL   ++VHRDLA RN+L+ +P  VKI+DFGL++  D+ E+     G    K+PI
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG---KVPI 175

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W+ALES++  IYT+KSDVWS+GV +WE++T GA PY  IP   I   L  G R+ +P  
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235

Query: 225 C 225
           C
Sbjct: 236 C 236

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  167 bits (425), Expect = 1e-51
 Identities = 83/230 (36%), Positives = 116/230 (50%), Gaps = 31/230 (13%)

Query: 18  LGQGEFGVVVKG--LLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           LG G FG VVKG  L+  G          +EVAVK LK    A    +FL+E ++M  + 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKE--------VEVAVKTLKQEHIAAGKKEFLREASVMAQL- 53

Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE--------------------YLSN 115
            H  IV  IG C  + L LV+E   LG L  YL++                     YL +
Sbjct: 54  DHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN 175
              VHRDLA RN+LL + H  KISDFG+S  +   + +     + + P++W A E +   
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 176 IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            +++KSDVWS+GV LWE  + GA PY  +    ++  L +G R+ RP  C
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEEC 223

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  168 bits (427), Expect = 1e-51
 Identities = 80/249 (32%), Positives = 120/249 (48%), Gaps = 50/249 (20%)

Query: 18  LGQGEFGVVVKG---LLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           LG+G FG V       LGD   E        +VAVK L  + + +    F +EI +++ +
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGE--------QVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 75  GKHDHIVSFIGCCYKD---ELRLVVEYCALGDLQSYLRE--------------------- 110
             H++IV + G C K     LRL++EY   G L+ YL+                      
Sbjct: 64  -DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +YL + + +HRDLA RNIL+ S  +VKISDFGL++ + E   +   +   + PI W A E
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP--------------LCRIVHYLSTG 216
            L ++ +++ SDVWSFGV L+E+ T G                      + R++  L  G
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 217 YRMERPASC 225
            R+ RP SC
Sbjct: 243 ERLPRPPSC 251

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  167 bits (423), Expect = 4e-51
 Identities = 90/251 (35%), Positives = 134/251 (53%), Gaps = 42/251 (16%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT-YDKFLKEINL 70
             LG +LG+GEFG V +  L    +E  S Q   +VAVKMLKA+  + +  ++FL+E   
Sbjct: 1   FTLGRMLGKGEFGSVREAQL---KSEDGSFQ---KVAVKMLKADIFSSSDIEEFLREAAC 54

Query: 71  MKDVGKHDHIVSFIGCCYKDELR-------LVVEYCALGDLQSYLRE------------- 110
           MK+   H +++  IG   +   +       +++ +   GDL ++L               
Sbjct: 55  MKEF-DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQ 113

Query: 111 -------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                        EYLS+   +HRDLA RN +L+    V ++DFGLS+ IY  + ++ G 
Sbjct: 114 TLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY 217
            S KLP++WLALESL  N+YT  SDVW+FGV +WEI+T G  PY  +    I +YL  G 
Sbjct: 174 AS-KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232

Query: 218 RMERPASCNEQ 228
           R+++P  C E 
Sbjct: 233 RLKQPPDCLED 243

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  166 bits (423), Expect = 7e-51
 Identities = 82/267 (30%), Positives = 129/267 (48%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVV-------KGLLGDGPTEGASGQAAMEVAVKMLKANADAK 59
           +P + L   E LG+G+FG V        +        E  +  A + VAVK+L+ +A   
Sbjct: 2   FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61

Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------- 110
             + FLKE+ ++  +    +I   +G C  D  L +++EY   GDL  +L++        
Sbjct: 62  AREDFLKEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 111 -----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
                                   YL +   VHRDLATRN L+   + +KI+DFG+S ++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 148 YEQNVFQ-NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG-ANPYPHIP 205
           Y  + ++  G     LPIRW+A ES++   +T KSDVW+FGV LWEI+TL    PY H+ 
Sbjct: 181 YSSDYYRVQGRAP--LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 206 LCRIVHYLSTGYR-------MERPASC 225
             +++      +R       + RP +C
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNC 265

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  164 bits (416), Expect = 4e-50
 Identities = 83/249 (33%), Positives = 125/249 (50%), Gaps = 37/249 (14%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +GL      +       ++VAVK L  +   +    FL E
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGD----AVELQVAVKTLPESCSEQDESDFLME 59

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE--------------- 111
             +M     H +IV  IG  ++   R ++ E  A GDL+S+LRE                
Sbjct: 60  ALIMSKF-NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 112 ------------YLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                       YL  N  +HRD+A RN LL+      V KI+DFG++ DIY  + ++ G
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
             +  LPI+W+  E+ +  I+T+K+DVWSFGV+LWEI +LG  PYP      ++ +++ G
Sbjct: 179 GRA-MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237

Query: 217 YRMERPASC 225
            R++ P  C
Sbjct: 238 GRLDPPKGC 246

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  162 bits (413), Expect = 1e-49
 Identities = 84/253 (33%), Positives = 118/253 (46%), Gaps = 41/253 (16%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + ++L   LG+G FG V  G                 VAVK LK  A       F +E
Sbjct: 3   QRDTIVLKRELGEGAFGKVFLGEC----YHLEPENDKELVAVKTLKETASNDARKDFERE 58

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------- 110
             L+ +   H++IV F G C + D   +V EY   GDL  +LR                 
Sbjct: 59  AELLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 111 ------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV 152
                              YL++   VHRDLATRN L+    VVKI DFG+S D+Y  + 
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177

Query: 153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY 212
           ++ G     LPIRW+  ES++   +T +SDVWSFGVVLWEI T G  P+  +    ++  
Sbjct: 178 YRVGG-HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236

Query: 213 LSTGYRMERPASC 225
           ++ G  ++RP +C
Sbjct: 237 ITQGRLLQRPRTC 249

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  162 bits (412), Expect = 2e-49
 Identities = 80/237 (33%), Positives = 126/237 (53%), Gaps = 30/237 (12%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E + LG  +G+G+FG V +G+      E       + VAVK  K        +KFL+E  
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENE------KIAVAVKTCKNCTSPSVREKFLQEAY 59

Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
           +M+    H HIV  IG   ++ + +V+E   LG+L+SYL+                    
Sbjct: 60  IMRQF-DHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SSP  VK+ DFGLS  + +++ ++  +   KLPI+W+A
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK--GKLPIKWMA 176

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+ LG  P+  +    ++  +  G R+  P +C
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC 233

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  162 bits (411), Expect = 2e-49
 Identities = 90/235 (38%), Positives = 122/235 (51%), Gaps = 45/235 (19%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +MK++ KH
Sbjct: 14  LGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI-KH 61

Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLS 114
            ++V  +G C ++    ++ E+   G+L  YLRE                      EYL 
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRWLALE 170
               +HRDLA RN L+   H+VK++DFGLS     D Y            K PI+W A E
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPE 175

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           SL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L  GYRMERP  C
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC 230

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  160 bits (406), Expect = 9e-49
 Identities = 87/248 (35%), Positives = 120/248 (48%), Gaps = 46/248 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LG G+FG V  G   +G T+         VAVK LK    +     FL+E
Sbjct: 4   PRESLKLERKLGAGQFGEVWMGTW-NGTTK---------VAVKTLKPGTMSPE--AFLQE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE--------------- 111
             +MK + +HD +V     C ++E + +V EY + G L  +L+                 
Sbjct: 52  AQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110

Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
                  YL +   +HRDLA RNIL+    V KI+DFGL+    +D Y            
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE------GA 164

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME 220
           K PI+W A E+     +T KSDVWSFG++L EIVT G  PYP +    ++  +  GYRM 
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP 224

Query: 221 RPASCNEQ 228
           RP +C E+
Sbjct: 225 RPPNCPEE 232

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  158 bits (400), Expect = 1e-47
 Identities = 91/266 (34%), Positives = 125/266 (46%), Gaps = 57/266 (21%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           YP   +     +GQG FG V +    GLL          +    VAVKMLK  A A    
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLL--------PYEPFTMVAVKMLKEEASADMQA 53

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------- 111
            F +E  LM +   H +IV  +G C   + + L+ EY A GDL  +LR            
Sbjct: 54  DFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112

Query: 112 --------------------------------YLSNNKVVHRDLATRNILLSSPHVVKIS 139
                                           YLS  K VHRDLATRN L+    VVKI+
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172

Query: 140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN 199
           DFGLS +IY  + ++  E ++ +PIRW+  ES+  N YT +SDVW++GVVLWEI + G  
Sbjct: 173 DFGLSRNIYSADYYKASE-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231

Query: 200 PYPHIPLCRIVHYLSTGYRMERPASC 225
           PY  +    +++Y+  G  +  P +C
Sbjct: 232 PYYGMAHEEVIYYVRDGNVLSCPDNC 257

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  156 bits (395), Expect = 7e-47
 Identities = 87/224 (38%), Positives = 118/224 (52%), Gaps = 45/224 (20%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+G FG V KG L  GP E  S  +   VA+K LK NA+ K   +F +E  LM D+ 
Sbjct: 11  EELGEGAFGKVYKGEL-TGPNERLSATS---VAIKTLKENAEPKVQQEFRQEAELMSDL- 65

Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------------ 110
           +H +IV  +G C K++   ++ EY A GDL  +L                          
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                       EYLS++  VHRDLA RN L+     VKISDFGLS DIY  + ++    
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR--VQ 183

Query: 159 SEK-LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           S+  LP+RW+  E+++   +T +SD+WSFGVVLWEI + G  PY
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  154 bits (391), Expect = 1e-46
 Identities = 87/238 (36%), Positives = 131/238 (55%), Gaps = 43/238 (18%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ++L LGE++G+GEFG V++G          +GQ   +VAVK +K +  A+    FL+E  
Sbjct: 6   QKLTLGEIIGEGEFGAVLQG--------EYTGQ---KVAVKNIKCDVTAQA---FLEETA 51

Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE------------------- 110
           +M  +  H ++V  +G    + L +V+E  + G+L ++LR                    
Sbjct: 52  VMTKL-HHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVA 110

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
              EYL + K+VHRDLA RNIL+S   V K+SDFGL+       V   G  + KLP++W 
Sbjct: 111 EGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR------VGSMGVDNSKLPVKWT 164

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           A E+L    +++KSDVWS+GV+LWE+ + G  PYP + L  +   +  GYRME P  C
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC 222

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  154 bits (391), Expect = 2e-46
 Identities = 85/248 (34%), Positives = 128/248 (51%), Gaps = 43/248 (17%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT-YDKFLKEINL 70
           L LG+ LG+GEFG V++G L           + ++VAVK +K     ++  + FL E   
Sbjct: 1   LALGKTLGEGEFGSVMEGQLN-------QDDSILKVAVKTMKIAICTRSEMEDFLSEAVC 53

Query: 71  MKDVGKHDHIVSFIGCCYKDELR-------LVVEYCALGDLQSYLR-------------- 109
           MK+   H +++  IG C +           +++ +   GDL S+L               
Sbjct: 54  MKEF-DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112

Query: 110 ------------EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                        EYLS+   +HRDLA RN +L+    V ++DFGLS+ IY  + ++ G 
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172

Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY 217
            + K+P++W+A+ESL   +YT KSDVWSFGV +WEI T G  PYP +    I  YL  G 
Sbjct: 173 IA-KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231

Query: 218 RMERPASC 225
           R+++P  C
Sbjct: 232 RLKQPPDC 239

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  154 bits (390), Expect = 4e-46
 Identities = 86/259 (33%), Positives = 134/259 (51%), Gaps = 54/259 (20%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           E +   +V+G+G FG V++ ++  DG          M  A+KMLK  A    +  F  E+
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDG--------LKMNAAIKMLKEFASENDHRDFAGEL 53

Query: 69  NLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----------------- 110
            ++  +G H +I++ +G C  +  L + +EY   G+L  +LR+                 
Sbjct: 54  EVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113

Query: 111 -------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS--EDIYE 149
                              +YLS  + +HRDLA RN+L+      KI+DFGLS  E++Y 
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI 209
           +          +LP+RW+A+ESL  ++YT KSDVWSFGV+LWEIV+LG  PY  +    +
Sbjct: 174 KKTMG------RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227

Query: 210 VHYLSTGYRMERPASCNEQ 228
              L  GYRME+P +C+++
Sbjct: 228 YEKLPQGYRMEKPRNCDDE 246

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  153 bits (389), Expect = 4e-46
 Identities = 83/246 (33%), Positives = 120/246 (48%), Gaps = 42/246 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
            P  + + +V+G GEFG V +G L         G+  ++VA+K LKA +  K    FL E
Sbjct: 2   DPSYVTIEKVIGGGEFGEVCRGRLK------LPGKKEIDVAIKTLKAGSSDKQRLDFLTE 55

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M     H +I+   G   K   + ++ EY   G L  +LRE                
Sbjct: 56  ASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG 114

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS------EDIYEQNVFQNGEPS 159
                +YLS    VHRDLA RNIL++S  V K+SDFGLS      E  Y           
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-------G 167

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM 219
            K+PIRW A E++    +T+ SDVWSFG+V+WE+++ G  PY  +    ++  +  GYR+
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL 227

Query: 220 ERPASC 225
             P  C
Sbjct: 228 PPPMDC 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  151 bits (383), Expect = 2e-45
 Identities = 80/234 (34%), Positives = 122/234 (52%), Gaps = 34/234 (14%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E +G+G FG V KG+L              EVAVK  ++        KFL+E  ++K   
Sbjct: 1   EKIGKGNFGDVYKGVLKGN----------TEVAVKTCRSTLPPDLKRKFLQEAEILKQY- 49

Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYL 113
            H +IV  IG C + + + +V+E    G L ++LR+                     EYL
Sbjct: 50  DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            +   +HRDLA RN L+   +V+KISDFG+S +  E  ++   +  +++PI+W A E+L 
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE 227
              YT++SDVWS+G++LWE  +LG  PYP +   +    + +GYRM  P  C E
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  150 bits (381), Expect = 4e-45
 Identities = 81/246 (32%), Positives = 122/246 (49%), Gaps = 45/246 (18%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + LG G+FGVV  G            +  ++VA+KM++  A ++  D F++E 
Sbjct: 3   PSELTFLKELGSGQFGVVHLGKW----------RGKIDVAIKMIREGAMSE--DDFIEEA 50

Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M  +  H ++V   G C K   + +V EY A G L +YLRE                 
Sbjct: 51  KVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV 109

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKL 162
               EYL +N  +HRDLA RN L+   +VVK+SDFGL+    +D Y  +         K 
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ------GTKF 163

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W   E    + +++KSDVWSFGV++WE+ + G  PY       +V  +S GYR+ RP
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP 223

Query: 223 ASCNEQ 228
                +
Sbjct: 224 KLAPTE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  150 bits (379), Expect = 7e-45
 Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 45/240 (18%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           + L L + +G+GEFG V   +LGD            +VAVK +K +A A+    FL E +
Sbjct: 6   KELKLLQTIGKGEFGDV---MLGD--------YRGNKVAVKCIKNDATAQA---FLAEAS 51

Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           +M  + +H ++V  +G   +++  L +V EY A G L  YLR                  
Sbjct: 52  VMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++        + + + KLP++
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVK 164

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P  C
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 224

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  150 bits (380), Expect = 1e-44
 Identities = 90/252 (35%), Positives = 131/252 (51%), Gaps = 37/252 (14%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNE 59

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
            ++MK    H H+V  +G   K +  LVV E  A GDL+SYLR                 
Sbjct: 60  ASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118

Query: 111 --------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG 156
                          YL+  K VHRDLA RN +++    VKI DFG++ DIYE + ++ G
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G
Sbjct: 179 GKG-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237

Query: 217 YRMERPASCNEQ 228
             +++P +C E+
Sbjct: 238 GYLDQPDNCPER 249

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  147 bits (373), Expect = 7e-44
 Identities = 83/253 (32%), Positives = 132/253 (52%), Gaps = 54/253 (21%)

Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +V+G+G FG V+K  +  DG          M+ A+K +K  A    +  F  E+ ++  +
Sbjct: 1   DVIGEGNFGQVLKARIKKDG--------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 52

Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----------------------- 110
           G H +I++ +G C  +  L L +EY   G+L  +LR+                       
Sbjct: 53  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112

Query: 111 -------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS--EDIYEQNVFQN 155
                        +YLS  + +HRDLA RNIL+   +V KI+DFGLS  +++Y +     
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 171

Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                +LP+RW+A+ESL  ++YT  SDVWS+GV+LWEIV+LG  PY  +    +   L  
Sbjct: 172 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226

Query: 216 GYRMERPASCNEQ 228
           GYR+E+P +C+++
Sbjct: 227 GYRLEKPLNCDDE 239

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  147 bits (373), Expect = 7e-44
 Identities = 80/235 (34%), Positives = 115/235 (48%), Gaps = 30/235 (12%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG G FGVV +G          SG   + VAVK LK++  +   D FLKE  +M  + 
Sbjct: 1   KKLGDGSFGVVRRG------EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL- 53

Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE----------------------YL 113
            H++++   G      L +V E   LG L   LR++                      YL
Sbjct: 54  DHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            + + +HRDLA RNILL+S   VKI DFGL   + +       E   K+P  W A ESL 
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL-STGYRMERPASCNE 227
           +  +++ SDVW FGV LWE+ T G  P+  +   +I+  +   G R+ERP +C +
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ 228

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  146 bits (371), Expect = 1e-43
 Identities = 78/245 (31%), Positives = 117/245 (47%), Gaps = 46/245 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E   L   LG G FG V +GL  +           + VA+K+LK++ D      F KE
Sbjct: 4   PREEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSD-DLLKQQDFQKE 52

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
           +  +K + +H H++S    C   E + ++ E    G L ++LR                 
Sbjct: 53  VQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
                  YL     +HRDLA RNIL+    V K++DFGL+    ED+Y  +        +
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-------DK 164

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME 220
           K+P +W A E+     ++ KSDVWSFG++L+E+ T G  PYP +    +   ++ GYRM 
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP 224

Query: 221 RPASC 225
            PA C
Sbjct: 225 CPAKC 229

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  146 bits (370), Expect = 3e-43
 Identities = 86/253 (33%), Positives = 129/253 (50%), Gaps = 45/253 (17%)

Query: 8   PPERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
             E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPE--------TRVAIKTVNEAASMRERIE 55

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------ 110
           FL E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR             
Sbjct: 56  FLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 111 ------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV 152
                              YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + 
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Query: 153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY 212
           ++ G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ +
Sbjct: 175 YRKGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233

Query: 213 LSTGYRMERPASC 225
           +  G  +++P +C
Sbjct: 234 VMEGGLLDKPDNC 246

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  144 bits (364), Expect = 2e-42
 Identities = 80/239 (33%), Positives = 113/239 (47%), Gaps = 48/239 (20%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLKEINLMKDVGK 76
           LG G+FG V +GL  +             VAVK LK    D K    FL E  +MK + +
Sbjct: 14  LGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTMDPK---DFLAEAQIMKKL-R 59

Query: 77  HDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE----------------------YL 113
           H  ++     C  +E + +V E    G L  YL+                        YL
Sbjct: 60  HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRWLAL 169
                +HRDLA RN+L+   ++ K++DFGL+    EDIYE           K PI+W A 
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE------AREGAKFPIKWTAP 173

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
           E+ + N ++ KSDVWSFG++L EIVT G  PYP +    ++  +  GYRM  P  C ++
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE 232

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  145 bits (367), Expect = 2e-42
 Identities = 83/253 (32%), Positives = 133/253 (52%), Gaps = 54/253 (21%)

Query: 16  EVLGQGEFGVVVKGLL-GDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +V+G+G FG V+K  +  DG          M+ A+K +K  A    +  F  E+ ++  +
Sbjct: 13  DVIGEGNFGQVLKARIKKDG--------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64

Query: 75  GKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE----------------------- 110
           G H +I++ +G C ++  L L +EY   G+L  +LR+                       
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 111 -------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS--EDIYEQNVFQN 155
                        +YLS  + +HRDLA RNIL+   +V KI+DFGLS  +++Y +     
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 183

Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                +LP+RW+A+ESL  ++YT  SDVWS+GV+LWEIV+LG  PY  +    +   L  
Sbjct: 184 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238

Query: 216 GYRMERPASCNEQ 228
           GYR+E+P +C+++
Sbjct: 239 GYRLEKPLNCDDE 251

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  143 bits (362), Expect = 5e-42
 Identities = 78/250 (31%), Positives = 126/250 (50%), Gaps = 37/250 (14%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            +R+ L ++L +G FG +  G+L D            EV VK +K +A        L+E 
Sbjct: 5   RDRVTLSDLLQEGTFGRIFYGILID-----EKPGKEEEVFVKTVKDHASEIQVTLLLQES 59

Query: 69  NLMKDVGKHDHIVSFIGCCYKD-ELRLVVE-YCALGDLQSYLRE---------------- 110
            L+  +  H +I+  +  C +D E   V+  Y   G+L+ +L++                
Sbjct: 60  CLLYGL-SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118

Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL    V+H+D+A RN ++     VKI+D  LS D++  +    G+ 
Sbjct: 119 LVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD- 177

Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
           +E  P++W+ALESLV+  Y++ SDVWSFGV+LWE++TLG  PY  I    +  YL  GYR
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237

Query: 219 MERPASCNEQ 228
           + +P +C ++
Sbjct: 238 LAQPINCPDE 247

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  142 bits (360), Expect = 9e-42
 Identities = 86/233 (36%), Positives = 123/233 (52%), Gaps = 34/233 (14%)

Query: 17  VLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           VLG G FG V KG+ + DG          + VA+K+L+ N   K   + L E  +M  VG
Sbjct: 14  VLGSGAFGTVYKGIWIPDGE------NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
              ++   +G C    ++LV +    G L  Y+RE                      YL 
Sbjct: 68  S-PYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126

Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPIRWLALESL 172
             ++VHRDLA RN+L+ SP+ VKI+DFGL+   DI E     +G    K+PI+W+ALES+
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG---KVPIKWMALESI 183

Query: 173 VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +   +T++SDVWS+GV +WE++T GA PY  IP   I   L  G R+ +P  C
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPIC 236

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  142 bits (360), Expect = 2e-41
 Identities = 81/232 (34%), Positives = 122/232 (52%), Gaps = 30/232 (12%)

Query: 16  EVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +VLG G FG V KGL + +G       +  + VA+K L+     K   + L E  +M  V
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 75  GKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YL 113
             + H+   +G C    ++L+ +    G L  Y+RE                      YL
Sbjct: 67  -DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
              ++VHRDLA RN+L+ +P  VKI+DFGL++ +       + E   K+PI+W+ALES++
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE-GGKVPIKWMALESIL 184

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
             IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 236

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  141 bits (357), Expect = 4e-41
 Identities = 87/236 (36%), Positives = 129/236 (54%), Gaps = 45/236 (19%)

Query: 7   YPPERLILGEVLGQGEFGVV----VKGL---LGDGPTEGASGQAAMEVAVKMLKANADAK 59
           +P ++L L E LG+G+FG V     +GL   LG+G  E   GQ  + VAVKML+A+    
Sbjct: 2   FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPE-FDGQPVL-VAVKMLRADVTKT 59

Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYL--RE------ 110
             + FLKEI +M  + K+ +I+  +G C  D+ L ++ EY   GDL  +L  RE      
Sbjct: 60  ARNDFLKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT 118

Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   +YL++   VHRDLATRN L+ + + +KI+DFG+S +
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178

Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL-GANPY 201
           +Y  + ++  +    LPIRW+A ES++   +T  SDVW+FGV LWE+ TL    PY
Sbjct: 179 LYSGDYYRI-QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  140 bits (354), Expect = 4e-41
 Identities = 78/229 (34%), Positives = 115/229 (50%), Gaps = 29/229 (12%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG+           ++   VAVK+LK +  D    D+ L+E N+M+ +  
Sbjct: 3   LGSGNFGTVKKGMY-------KMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-D 54

Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  +L++                    +YL   
Sbjct: 55  NPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114

Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   + +G RME P  C
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRC 223

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  139 bits (353), Expect = 8e-41
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 40/213 (18%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E LG+G FG V          +  +G+    VA+K++K     K  ++ L+EI ++K 
Sbjct: 3   ILEKLGEGSFGKVYLA------RDKKTGK---LVAIKVIKKKKIKKDRERILREIKILKK 53

Query: 74  VGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------EY 112
           + KH +IV        +D+L LV+EYC  GDL   L++                    EY
Sbjct: 54  L-KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEY 112

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLALE 170
           L +  +VHRDL   NILL     VK++DFGL+  +          G P       ++A E
Sbjct: 113 LHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE------YMAPE 166

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            L+   Y    D+WS GV+L+E++T G  P+P 
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLT-GKPPFPG 198

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  137 bits (347), Expect = 9e-40
 Identities = 90/254 (35%), Positives = 121/254 (47%), Gaps = 51/254 (20%)

Query: 12  LILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           ++L   LG+G FG V       LL +        Q  M VAVK LK  A       F +E
Sbjct: 7   IVLKWELGEGAFGKVFLAECHNLLPE--------QDKMLVAVKALK-EASESARQDFQRE 57

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE--------------- 111
             L+  V +H HIV F G C +   L +V EY   GDL  +LR                 
Sbjct: 58  AELLT-VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116

Query: 112 --------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
                               YL++   VHRDLATRN L+    VVKI DFG+S DIY  +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Query: 152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH 211
            ++ G  +  LPIRW+  ES++   +T +SD+WSFGVVLWEI T G  P+  +     + 
Sbjct: 177 YYRVGGRT-MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235

Query: 212 YLSTGYRMERPASC 225
            ++ G  +ERP +C
Sbjct: 236 CITQGRELERPRTC 249

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  136 bits (343), Expect = 3e-39
 Identities = 82/243 (33%), Positives = 122/243 (50%), Gaps = 37/243 (15%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  +   +V+G GEFG V +G+L         G+  + VA+K LK     K    FL E 
Sbjct: 4   PSHITKQKVIGAGEFGEVFRGILK------MPGRKEVAVAIKTLKPGYTEKQRQDFLSEA 57

Query: 69  NLMKDVGKHDHIVSFIGCC--YKDELRLVVEYCALGDLQSYLRE---------------- 110
           ++M     H +I+   G    +K  + ++ EY   G L  YLR+                
Sbjct: 58  SIMGQFS-HHNIIRLEGVVTKFKPAM-IITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPSEKL 162
                +YLS+   VHRDLA RNIL++S    K+SDFGLS   ED  E     +G    K+
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG---KI 172

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           PIRW A E++    +T+ SDVWSFG+V+WE+++ G  PY  +    ++  ++ G+R+  P
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP 232

Query: 223 ASC 225
             C
Sbjct: 233 MDC 235

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  136 bits (343), Expect = 3e-39
 Identities = 75/241 (31%), Positives = 127/241 (52%), Gaps = 34/241 (14%)

Query: 9   PERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
              L   ++LG G FG V KG+ + +G +        + VA+K ++  +  +T+ +    
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDS------IKIPVAIKTIQDRSGRQTFQEITDH 59

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
           +  M  +  H +IV  +G C    L+LV +   LG L  ++R+                 
Sbjct: 60  MLAMGSL-DHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118

Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY--EQNVFQNGEPSEKLPI 164
                YL  +++VHR+LA RNILL S  +V+I+DFG+++ +Y  ++  F +     K PI
Sbjct: 119 AKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS---EHKTPI 175

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W+ALES++   YT++SDVWS+GV +WE+++ GA PY  +    +   L  G R+ +P  
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI 235

Query: 225 C 225
           C
Sbjct: 236 C 236

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  135 bits (342), Expect = 6e-39
 Identities = 88/255 (34%), Positives = 127/255 (49%), Gaps = 46/255 (18%)

Query: 12  LILGEVLGQGEFG-VVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           ++L   LG+G FG V +       PT+       M VAVK LK    A   D F +E  L
Sbjct: 7   IVLKRELGEGAFGKVFLAECYNLSPTKDK-----MLVAVKALKDPTLAARKD-FQREAEL 60

Query: 71  MKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE------------------ 111
           + ++ +H+HIV F G C   D L +V EY   GDL  +LR                    
Sbjct: 61  LTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 112 ------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF 153
                             YL++   VHRDLATRN L+ +  +VKI DFG+S D+Y  + +
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL 213
           + G  +  LPIRW+  ES++   +T +SDVWSFGV+LWEI T G  P+  +    ++  +
Sbjct: 180 RVGGHT-MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238

Query: 214 STGYRMERPASCNEQ 228
           + G  +ERP  C ++
Sbjct: 239 TQGRVLERPRVCPKE 253

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  133 bits (337), Expect = 7e-39
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 37/200 (18%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V          +         VA+K++K    +   ++ L+EI ++K +  H
Sbjct: 1   LGEGGFGTVYLARDKKTGKK---------VAIKIIKKEDSSSLLEELLREIEILKKL-NH 50

Query: 78  DHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------------EYLSN 115
            +IV   G    ++ L LV+EYC  G L+  L+E                     EYL +
Sbjct: 51  PNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS 110

Query: 116 NKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           N ++HRDL   NILL S    VK++DFGLS+ +           +      ++A E L+ 
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK---TIVGTPAYMAPEVLLG 167

Query: 175 NI-YTNKSDVWSFGVVLWEI 193
              Y+ KSD+WS GV+L+E+
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  134 bits (338), Expect = 1e-38
 Identities = 81/246 (32%), Positives = 124/246 (50%), Gaps = 45/246 (18%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 3   PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 50

Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M  +  H+ +V   G C K   + +V EY + G L +YLRE                 
Sbjct: 51  KVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV 109

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKL 162
                YL + + +HRDLA RN L+     VK+SDFGLS    +D Y  +V        K 
Sbjct: 110 CEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV------GSKF 163

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P+RW   E L+ + +++KSDVW+FGV++WE+ +LG  PY        V  +S G R+ RP
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223

Query: 223 ASCNEQ 228
              +E+
Sbjct: 224 HLASEK 229

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  134 bits (339), Expect = 2e-38
 Identities = 80/232 (34%), Positives = 120/232 (51%), Gaps = 30/232 (12%)

Query: 16  EVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +VLG G FG V KG+ + +G T        + VA+K+L      K   +F+ E  +M  +
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGET------VKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 75  GKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YL 113
             H H+V  +G C    ++LV +    G L  Y+ E                      YL
Sbjct: 67  -DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
              ++VHRDLA RN+L+ SP+ VKI+DFGL+  + E +  +      K+PI+W+ALE + 
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
              +T++SDVWS+GV +WE++T G  PY  IP   I   L  G R+ +P  C
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 236

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  133 bits (336), Expect = 3e-38
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 37/229 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P   L     LG+GEFG V                    V VK L+   D     +F +
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKA----KGIEEEGGETLVLVKALQKTKDENLQSEFRR 57

Query: 67  EINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------- 110
           E+++ + +  H ++V  +G C   +   +++EY  LGDL+ +LR                
Sbjct: 58  ELDMFRKL-SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 111 --------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG 156
                         ++LSN + VHRDLA RN L+SS   VK+S   LS+D+Y    ++  
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176

Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
                +P+RWLA E++  + ++ KSDVWSFGV++WE+ T G  P+  + 
Sbjct: 177 N--ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  133 bits (336), Expect = 4e-38
 Identities = 86/251 (34%), Positives = 127/251 (50%), Gaps = 41/251 (16%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L   LG+G FG V      +   E    Q  + VAVK LK  +D    D F +E  L+
Sbjct: 7   IVLKRELGEGAFGKVFLAECYNLCPE----QDKILVAVKTLKDASDNARKD-FHREAELL 61

Query: 72  KDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE------------------- 111
            ++ +H+HIV F G C + D L +V EY   GDL  +LR                     
Sbjct: 62  TNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 112 --------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                         YL++   VHRDLATRN L+    +VKI DFG+S D+Y  + ++ G 
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY 217
            +  LPIRW+  ES++   +T +SDVWS GVVLWEI T G  P+  +    ++  ++ G 
Sbjct: 181 HT-MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239

Query: 218 RMERPASCNEQ 228
            ++RP +C ++
Sbjct: 240 VLQRPRTCPKE 250

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  133 bits (335), Expect = 7e-38
 Identities = 81/238 (34%), Positives = 123/238 (51%), Gaps = 42/238 (17%)

Query: 7   YPPERLILGEVLGQGEFGVV----VKGL---LGDGPTEGASGQAAMEVAVKMLKANADAK 59
           +P +RL   E LG+G+FG V     +G+   +    +   SG   + VAVKML+ +A+  
Sbjct: 2   FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61

Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYL-REE------ 111
             + FLKEI +M  + K  +I+  +  C   + L ++ EY   GDL  +L R E      
Sbjct: 62  ARNDFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120

Query: 112 ------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
                                   YLS+   VHRDLATRN L+   + +KI+DFG+S ++
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL-GANPYPHI 204
           Y  + ++  +    LPIRW++ ES++   +T  SDVW+FGV LWEI+TL    PY  +
Sbjct: 181 YSGDYYRI-QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  131 bits (330), Expect = 1e-37
 Identities = 80/235 (34%), Positives = 119/235 (50%), Gaps = 35/235 (14%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E+LG+G FG V KG L D             VAVK  K +   +   KFL E  ++K   
Sbjct: 1   ELLGKGNFGEVFKGTLKD----------KTPVAVKTCKEDLPQELKIKFLSEARILKQY- 49

Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------------YL 113
            H +IV  IG C + + + +V+E    GD  S+LR++                     YL
Sbjct: 50  DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            +   +HRDLA RN L+   +V+KISDFG+S    E +   +    +++PI+W A E+L 
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALN 167

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
              Y+++SDVWS+G++LWE  +LG  PYP +   +    +  GYRM  P  C + 
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD 222

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  131 bits (330), Expect = 1e-37
 Identities = 71/232 (30%), Positives = 117/232 (50%), Gaps = 29/232 (12%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G FG V KG+           +  ++VA+K+LK   +    D+ ++E  +M  +  +
Sbjct: 3   LGSGNFGCVKKGVY-------KMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DN 54

Query: 78  DHIVSFIGCCYKDELRLVVEYCALGDLQSYL---REE------------------YLSNN 116
            +IV  IG C  + L LV+E  + G L  +L   ++E                  YL   
Sbjct: 55  PYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114

Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +   + +     + K P++W A E +    
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
           ++++SDVWS+G+ +WE  + G  PY  +    ++ ++  G R++ PA C  +
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPE 226

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  132 bits (334), Expect = 3e-37
 Identities = 64/132 (48%), Positives = 86/132 (65%), Gaps = 15/132 (11%)

Query: 101 LGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-NVFQ 154
           L DL SY  +     E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY+  +  +
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231

Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL----CRIV 210
            G    +LP++W+A ES+   +YT +SDVWSFGV+LWEI +LGA+PYP + +    CR  
Sbjct: 232 KG--DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR-- 287

Query: 211 HYLSTGYRMERP 222
             L  G RM  P
Sbjct: 288 -RLKEGTRMRAP 298

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  130 bits (329), Expect = 4e-37
 Identities = 88/257 (34%), Positives = 130/257 (50%), Gaps = 49/257 (19%)

Query: 10  ER-LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           ER L   + LG+G FG V   L    P +  +G+    VAVK L+ +      D F +EI
Sbjct: 3   ERHLKFIQQLGKGNFGSV--ELCRYDPLQDNTGEV---VAVKKLQHSTAEHLRD-FEREI 56

Query: 69  NLMKDVGKHDHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE--------------- 110
            ++K + +HD+IV + G CY   +  LRLV+EY   G L+ YL++               
Sbjct: 57  EILKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS 115

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLP 163
                 EYL + + VHRDLATRNIL+ S + VKI DFGL++ +  ++  ++  EP E  P
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-P 174

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCR 208
           I W A ESL  + ++  SDVWSFGVVL+E+ T               +G +    + +  
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 209 IVHYLSTGYRMERPASC 225
           ++  L    R+  P  C
Sbjct: 235 LIELLKNNGRLPAPPGC 251

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  129 bits (326), Expect = 9e-37
 Identities = 85/244 (34%), Positives = 123/244 (50%), Gaps = 39/244 (15%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
              + + +V+G GEFG V  G L         G+  + VA+K LKA    K    FL E 
Sbjct: 3   ASCIKIEKVIGAGEFGEVCSGRLK------LPGKREIPVAIKTLKAGYTEKQRRDFLSEA 56

Query: 69  NLMKDVGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           ++M   G+ DH  I+   G   K + + +V EY   G L ++LR+               
Sbjct: 57  SIM---GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPSEK 161
                 +YLS+   VHRDLA RNIL++S  V K+SDFGLS   ED  E      G    K
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG---K 170

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER 221
           +PIRW A E++    +T+ SDVWS+G+V+WE+++ G  PY  +    ++  +  GYR+  
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230

Query: 222 PASC 225
           P  C
Sbjct: 231 PMDC 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  128 bits (324), Expect = 1e-36
 Identities = 77/235 (32%), Positives = 117/235 (49%), Gaps = 33/235 (14%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E +G+G FG V  G L    T          VAVK  +         KFL+E  ++K   
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQY- 50

Query: 76  KHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE---------------------YL 113
            H +IV  IG C  K  + +V+E    GD  ++LR E                     YL
Sbjct: 51  SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            +   +HRDLA RN L++  +V+KISDFG+S +  E  V+ +    +++P++W A E+L 
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
              Y+++SDVWSFG++LWE  +LGA PY ++   +    +  G R+  P  C + 
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDA 224

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (320), Expect = 7e-36
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 36/219 (16%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEIN 69
               GE+LG+G FG V   L  D      +G+    +AVK ++ +    +  +   +EI 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKD------TGE---LMAVKSVELSGDSEEELEALEREIR 51

Query: 70  LMKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQS---------------YLRE- 110
           ++  + +H +IV + G    +E   L + +EY + G L S               Y R+ 
Sbjct: 52  ILSSL-QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI 110

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL +N +VHRD+   NIL+ S  VVK++DFG ++ +        G  S +    W
Sbjct: 111 LEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTGSVRGTPYW 169

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           +A E +    Y   +D+WS G  + E+ T G  P+  + 
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELG 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  126 bits (319), Expect = 8e-36
 Identities = 80/243 (32%), Positives = 117/243 (48%), Gaps = 37/243 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V  G                +VA+K LK  +   + + FL E
Sbjct: 4   PRETLKLVKKLGAGQFGEVWMGYY----------NGHTKVAIKSLKQGS--MSPEAFLAE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 52  ANLMKQL-QHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110

Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  + E N +   E + K PI+
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGA-KFPIK 168

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNC 228

Query: 226 NEQ 228
            E+
Sbjct: 229 PEE 231

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  126 bits (318), Expect = 1e-35
 Identities = 74/221 (33%), Positives = 101/221 (45%), Gaps = 45/221 (20%)

Query: 12  LILGEVLGQGEFGVVVKG-LLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLKEIN 69
             L   LG G FG V K    G G            VAVK+LK  +  +K      +EI 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTG----------KIVAVKILKKRSEKSKKDQTARREIR 50

Query: 70  LMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------ 110
           +++ +  H +IV  I     KD L LV+EYC  GDL  YL                    
Sbjct: 51  ILRRL-SHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILR 109

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIR 165
             EYL +N ++HRDL   NILL    VVKI+DFGL++ + + +       G P       
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTP------W 163

Query: 166 WLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           ++A E L+    Y  K DVWS GV+L+E++T G  P+    
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLT-GKPPFSGEN 203

Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  125 bits (316), Expect = 2e-35
 Identities = 83/244 (34%), Positives = 123/244 (50%), Gaps = 38/244 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E + L + LG G+FG V  G   +          + +VAVK LK      +   FL+E
Sbjct: 4   PRESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGT--MSVQAFLEE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE--------------- 111
            NLMK + +HD +V       K+E + ++ EY A G L  +L+ +               
Sbjct: 52  ANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  Y+     +HRDL   N+L+S   + KI+DFGL+  I E N +   E + K PI
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGA-KFPI 168

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A E++    +T KSDVWSFG++L+EIVT G  PYP +    ++  L  GYRM R  +
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228

Query: 225 CNEQ 228
           C ++
Sbjct: 229 CPDE 232

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  125 bits (315), Expect = 2e-35
 Identities = 82/243 (33%), Positives = 123/243 (50%), Gaps = 37/243 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V            A+     +VAVK +K  +   + + FL E
Sbjct: 4   PRESLKLEKKLGAGQFGEVWM----------ATYNKHTKVAVKTMKPGS--MSVEAFLAE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
            N+MK + +HD +V       K+ + ++ E+ A G L  +L+ +                
Sbjct: 52  ANVMKTL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110

Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S+  V KI+DFGL+  + E N +   E + K PI+
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGA-KFPIK 168

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 228

Query: 226 NEQ 228
            E+
Sbjct: 229 PEE 231

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  124 bits (314), Expect = 6e-35
 Identities = 80/240 (33%), Positives = 121/240 (50%), Gaps = 43/240 (17%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           EV+G GEFG V +G L         G+  + VA+K LK+    K    FL E ++M   G
Sbjct: 10  EVIGAGEFGEVCRGRLK------LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM---G 60

Query: 76  KHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------E 111
           + DH  I+   G   K   + ++ E+   G L S+LR+                     +
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE------KLPIR 165
           YLS    VHRDLA RNIL++S  V K+SDFGLS  + +       +P+       K+PIR
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT----SDPTYTSSLGGKIPIR 176

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T+ SDVWS+G+V+WE+++ G  PY  +    +++ +   YR+  P  C
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  124 bits (313), Expect = 3e-34
 Identities = 58/114 (50%), Positives = 79/114 (69%), Gaps = 4/114 (3%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-NVFQNGEPSEKLPIRWLAL 169
           E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY+  +  + G  S +LP++W+A 
Sbjct: 188 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG--SARLPLKWMAP 245

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR-IVHYLSTGYRMERP 222
           ES+   +YT +SDVWSFGV+LWEI +LGA+PYP + +       L  G RM  P
Sbjct: 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP 299

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  121 bits (306), Expect = 6e-34
 Identities = 78/237 (32%), Positives = 119/237 (50%), Gaps = 39/237 (16%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + LG G+FGVV  G            +A ++VA+K    N  A + + F++E 
Sbjct: 3   PSELTFMKELGSGQFGVVHLG----------KWRAQIKVAIK--AINEGAMSEEDFIEEA 50

Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M  +  H  +V   G C + + L +V E+   G L +YLR+                 
Sbjct: 51  KVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDV 109

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE-QNVFQNGEPSEKLPIR 165
               EYL  N  +HRDLA RN L+SS  VVK+SDFG++  + + +    +G    K P++
Sbjct: 110 CEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA---KFPVK 166

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           W   E    + Y++KSDVWSFGV++WE+ T G  P+       +V  +S G+R+ RP
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  121 bits (306), Expect = 1e-33
 Identities = 79/247 (31%), Positives = 119/247 (48%), Gaps = 44/247 (17%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
            VLG+G FG V   L    P    +G+    VAVK LK     +    + KEIN++K + 
Sbjct: 10  RVLGEGHFGKVS--LYCYDPANDGTGEM---VAVKTLKRECGQQNTSGWKKEINILKTL- 63

Query: 76  KHDHIVSFIGCCYK---DELRLVVEYCALGDLQSYLRE-------------------EYL 113
            H++IV + GCC +     L+L++EY  LG L+ YL +                    YL
Sbjct: 64  YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYL 123

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            +   +HRDLA RN+LL +  +VKI DFGL++ + E + +         P+ W A+E L 
Sbjct: 124 HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP---------------LCRIVHYLSTGYR 218
            N ++  SDVWSFGV L+E++T   +     P               + R++  L  G R
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242

Query: 219 MERPASC 225
           +  P +C
Sbjct: 243 LPCPKNC 249

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  120 bits (302), Expect = 2e-33
 Identities = 69/241 (28%), Positives = 117/241 (48%), Gaps = 37/241 (15%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L L + +G G+FG+V  G                +VA+K ++  A ++  + F++E 
Sbjct: 3   PSELTLVQEIGSGQFGLVWLG----------YWLEKRKVAIKTIREGAMSE--EDFIEEA 50

Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------- 111
            +M  +  H  +V   G C +   + LV E+   G L  YLR +                
Sbjct: 51  QVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV 109

Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL ++ V+HRDLA RN L+    VVK+SDFG++  + +           K P++W
Sbjct: 110 CEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 167

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  ++ G+R+ +P   +
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLAS 227

Query: 227 E 227
           +
Sbjct: 228 Q 228

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  119 bits (301), Expect = 4e-33
 Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 44/213 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E +G+G FG V K           +G+   EVA+K++K  +  K  +K + EI ++K 
Sbjct: 4   ILEKIGKGGFGEVYKA------RHKRTGK---EVAIKVIKLESKEK-KEKIINEIQILKK 53

Query: 74  VGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------------E 111
             KH +IV + G    KDEL +V+E+C+ G L+  L+                      E
Sbjct: 54  C-KHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLA 168
           YL +N ++HRD+   NILL+S   VK+ DFGLS  +      +N   G P       W+A
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPY------WMA 165

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E +    Y  K+D+WS G+   E+   G  PY
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAE-GKPPY 197

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score =  121 bits (304), Expect = 7e-33
 Identities = 58/117 (49%), Positives = 81/117 (69%), Gaps = 10/117 (8%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-NVFQNGEPSEKLPIRWLAL 169
           E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY+  +  + G+   +LP++W+A 
Sbjct: 193 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA--RLPLKWMAP 250

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL----CRIVHYLSTGYRMERP 222
           E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +    CR    L  G RM  P
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR---RLKEGTRMRAP 304

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score =  121 bits (304), Expect = 1e-32
 Identities = 56/120 (46%), Positives = 80/120 (66%), Gaps = 4/120 (3%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLAL 169
           E+L++   VHRDLA RN+L+    +VKI DFGL+ DI  + N    G  S  LP++W+A 
Sbjct: 253 EFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFLPLKWMAP 310

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY-LSTGYRMERPASCNEQ 228
           ES+ +N+YT  SDVWSFG++LWEI TLG  PYP +P+    +  +  GYRM +PA  +++
Sbjct: 311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDE 370

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score =  117 bits (294), Expect = 5e-32
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 42/218 (19%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G G FG V+ G       E   G +   V VK L+A+A       FL+E+   +++  H
Sbjct: 3   IGNGWFGKVLLG-------EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NH 54

Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE------------------------- 111
            +++  +G C +     LV+E+C LGDL++YLR                           
Sbjct: 55  PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA--- 168
           +L     +H DLA RN  L++   VKI D+GL+ + Y ++ +   +    +P+RWLA   
Sbjct: 115 WLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD-CHAVPLRWLAPEL 173

Query: 169 LESLVSNIY----TNKSDVWSFGVVLWEIVTLGANPYP 202
           +E    ++     T KS++WS GV +WE+ T    PYP
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  117 bits (293), Expect = 7e-32
 Identities = 74/223 (33%), Positives = 112/223 (50%), Gaps = 43/223 (19%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+  FG V KG L  G   G   QA   VA+K LK  A+    ++F  E  +M+   
Sbjct: 11  EELGEDRFGKVYKGHLF-GTAPGEQTQA---VAIKTLKDKAEGPLREEFKHEA-MMRSRL 65

Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYL-------------------------- 108
           +H +IV  +G   K++ L ++  YC+  DL  +L                          
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 109 ----------REEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                       E+LS++ VVH+DLATRN+L+     VKISD GL  ++Y  + ++    
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           S  LPIRW++ E+++   ++  SD+WS+GVVLWE+ + G  PY
Sbjct: 186 S-LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  116 bits (293), Expect = 1e-31
 Identities = 78/275 (28%), Positives = 127/275 (46%), Gaps = 59/275 (21%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQ--------AAMEVAVKMLKANADA 58
           +P   L+  E LG+G+FG V    +   P +  + Q          + VAVK+L+ +A+ 
Sbjct: 2   FPRGHLLFKEKLGEGQFGEVHLCEV-VNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60

Query: 59  KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------- 110
              + FLKE+ ++  + K  +I+  +G C  ++ L ++ EY   GDL  +L         
Sbjct: 61  NARNDFLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119

Query: 111 --------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKI 138
                                           +YLS+   VHRDLATRN L+     +KI
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179

Query: 139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL-G 197
           +DFG+S ++Y  + ++  +    LPIRW+A E ++   +T  SDVW+FGV LWEI+ L  
Sbjct: 180 ADFGMSRNLYAGDYYRI-QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238

Query: 198 ANPYPHIPLCRIVHYLSTGYR-------MERPASC 225
             PY  +   +++      +R       + RP  C
Sbjct: 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPC 273

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  113 bits (285), Expect = 8e-31
 Identities = 80/240 (33%), Positives = 117/240 (48%), Gaps = 37/240 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V  G   +G T+         VAVK LK      + + FL+E
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTW-NGNTK---------VAVKTLKPGT--MSPESFLEE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
             +MK + +HD +V       ++ + +V EY + G L  +L++                 
Sbjct: 52  AQIMKKL-RHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     +HRDL + NIL+    V KI+DFGL+  I E N +       K PI+
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI-EDNEY-TARQGAKFPIK 168

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+VT G  PYP +    ++  +  GYRM  P  C
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC 228

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score =  115 bits (290), Expect = 1e-30
 Identities = 49/114 (42%), Positives = 76/114 (66%), Gaps = 4/114 (3%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY-EQNVFQNGEPSEKLPIRWLAL 169
           ++L++   +HRD+A RN+LL+   V KI DFGL+ DI  + N    G  + +LP++W+A 
Sbjct: 226 DFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG--NARLPVKWMAP 283

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRMERP 222
           ES+   +YT +SDVWS+G++LWEI +LG +PYP I +  +    +  GY+M RP
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP 337

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  114 bits (287), Expect = 3e-30
 Identities = 58/140 (41%), Positives = 87/140 (62%), Gaps = 14/140 (10%)

Query: 90  DELRLVVEYCALGDLQSYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS 144
           DEL L  E     DL S+  +      +L++   +HRDLA RNILL+   + KI DFGL+
Sbjct: 207 DELALDTE-----DLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261

Query: 145 EDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            DI  + N    G  + +LP++W+A ES+ + +YT +SDVWS+G++LWEI +LG++PYP 
Sbjct: 262 RDIRNDSNYVVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319

Query: 204 IPL-CRIVHYLSTGYRMERP 222
           +P+  +    +  GYRM  P
Sbjct: 320 MPVDSKFYKMIKEGYRMLSP 339

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score =  115 bits (288), Expect = 4e-30
 Identities = 53/114 (46%), Positives = 77/114 (67%), Gaps = 4/114 (3%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLAL 169
           E+L++   VHRDLA RN+LL+   +VKI DFGL+ DI ++ N    G  S  LP++W+A 
Sbjct: 251 EFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAP 308

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRMERP 222
           ES+  N+YT  SDVWS+G++LWEI +LG  PYP + +     + + +GYRM +P
Sbjct: 309 ESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP 362

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  111 bits (279), Expect = 1e-29
 Identities = 73/224 (32%), Positives = 112/224 (50%), Gaps = 45/224 (20%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+  FG + KG L     +      A  VA+K LK   + + + +F +E +LM ++ 
Sbjct: 11  EELGECAFGKIYKGHLYLPGMD-----HAQLVAIKTLKDINNPQQWGEFQQEASLMAEL- 64

Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYL-------------------------- 108
            H +IV  +G   +++ + ++ EY   GDL  +L                          
Sbjct: 65  HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 109 -----------REEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                        EYLS++  VH+DLA RNIL+     VKISD GLS +IY  + ++  +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV-Q 183

Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           P   LPIRW+  E+++   +++ SD+WSFGVVLWEI + G  PY
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  110 bits (275), Expect = 2e-29
 Identities = 79/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +     +VA+K LK        + FL+E
Sbjct: 4   PRESLRLDVKLGQGCFGEVWMG----------TWNGTTKVAIKTLKPGT--MMPEAFLQE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
             +MK + +HD +V       ++ + +V E+   G L  +L+E                 
Sbjct: 52  AQIMKKL-RHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     +HRDL   NIL+    V KI+DFGL+  I E N +       K PI+
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEY-TARQGAKFPIK 168

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+VT G  PYP +    ++  +  GYRM  P  C
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC 228

Query: 226 NE 227
            E
Sbjct: 229 PE 230

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (275), Expect = 3e-29
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 45/223 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E   + E LG+G +G V K +  +      +GQ    VA+K++    D     + +KE
Sbjct: 1   PEEVFDILEKLGEGSYGSVYKAIHKE------TGQ---VVAIKVVPVEED---LQEIIKE 48

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALG---DL----QSYLREE-------- 111
           I+++K      +IV + G  +K+ +L +V+EYC  G   D+       L EE        
Sbjct: 49  ISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107

Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKL 162
                 YL +NK +HRD+   NILL+     K++DFG+S  + +    +N   G P    
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF--- 164

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
              W+A E +    Y NK+D+WS G+   E+   G  PY  I 
Sbjct: 165 ---WMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIH 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score =  109 bits (273), Expect = 5e-29
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 44/220 (20%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G G FG V+ G       E  SG    +V VK L+ +A  +   KFL+E    + + +H
Sbjct: 3   IGNGWFGKVILG-------EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QH 54

Query: 78  DHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE------------------------- 111
            +++  +G C +     LV+E+C LGDL+ YLR                           
Sbjct: 55  SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +L  N  +H DLA RN LL++   VKI D+GLS + Y+++ +   +    +P+RW+A E 
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD-QLWVPLRWIAPE- 172

Query: 172 LVSNIYTN--------KSDVWSFGVVLWEIVTLGANPYPH 203
           LV  ++ N        +S+VWS GV +WE+  LG+ PY H
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  108 bits (272), Expect = 1e-28
 Identities = 76/249 (30%), Positives = 119/249 (47%), Gaps = 44/249 (17%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    P    +G+   +VAVK LK  +         KEI +++++  H
Sbjct: 12  LGEGHFGKV--ELCRYDPEGDNTGE---QVAVKSLKPESGGNHIADLKKEIEILRNL-YH 65

Query: 78  DHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE---------------------EYL 113
           ++IV + G C +D    ++L++E+   G L+ YL                       +YL
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            + + VHRDLA RN+L+ S H VKI DFGL++ I     +   +     P+ W A E L+
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYP--------------HIPLCRIVHYLSTGYRM 219
            + +   SDVWSFGV L+E++T   +                  + + R+V  L  G R+
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 220 ERPASCNEQ 228
            RP +C E+
Sbjct: 246 PRPPNCPEE 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  107 bits (268), Expect = 3e-28
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK      + + FL+E
Sbjct: 4   PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGT--MSPEAFLQE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 52  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110

Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 168

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 228

Query: 226 NE 227
            E
Sbjct: 229 PE 230

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  103 bits (258), Expect = 8e-27
 Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 33/232 (14%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           +LG G FG + +G L          +  + VA+  L+A    K    FL E   +     
Sbjct: 12  ILGTGRFGELCRGCLK------LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-D 64

Query: 77  HDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------------EYLS 114
           H +IV   G   + + + +V EY + G L S+LR+                     +YLS
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124

Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFG-LSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
               VH+ LA   +L++S  V KIS F  L ED  E  ++     S K P+ W A E++ 
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA-IYTT--MSGKSPVLWAAPEAIQ 181

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            + +++ SDVWSFG+V+WE+++ G  PY  +    ++  +  G+R+  P +C
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNC 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  101 bits (254), Expect = 4e-26
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 49/212 (23%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDV 74
           + +G+G FG V            + G+      +K +  +N   K  +  L E+ ++K +
Sbjct: 6   KQIGKGSFGKVYLV------RRKSDGK---LYVLKEIDLSNMSEKEREDALNEVKILKKL 56

Query: 75  GKHDHIVSFIGC-CYKDELRLVVEYCALGDLQS----------YLREE------------ 111
             H +I+ +      K +L +V+EY   GDL               EE            
Sbjct: 57  -NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 112 --YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN----GEPSEKLPIR 165
             YL + K++HRD+  +NI L+S  +VK+ DFG+S+ +    V       G P       
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPY------ 168

Query: 166 WLALESLVSNI-YTNKSDVWSFGVVLWEIVTL 196
           +L+ E L  N  Y  KSD+WS G VL+E+ TL
Sbjct: 169 YLSPE-LCQNKPYNYKSDIWSLGCVLYELCTL 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  100 bits (252), Expect = 1e-25
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 44/211 (20%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E +G+G  G V K       T+ A+G+   EVA+K ++     K  +  + EI +MKD  
Sbjct: 25  EKIGEGASGEVYKA------TDRATGK---EVAIKKMRLRKQNK--ELIINEILIMKDC- 72

Query: 76  KHDHIVSFIGC-CYKDELRLVVEYCALGDL-------QSYLRE--------------EYL 113
           KH +IV +       DEL +V+EY   G L          + E              EYL
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLALE 170
            +  V+HRD+ + NILLS    VK++DFG +  + ++   +N   G P       W+A E
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY------WMAPE 186

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +    Y  K D+WS G++  E+   G  PY
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAE-GEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 2e-25
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 46/229 (20%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEIN 69
              LG+++G+G FGVV KGL  +      +G     VA+K +       +     ++EI+
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLE------TGDF---VAIKQISLEKIKEEALKSIMQEID 51

Query: 70  LMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQS---------------YLRE--- 110
           L+K++ KH +IV +IG     D L +++EY   G L+                Y+ +   
Sbjct: 52  LLKNL-KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ 110

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIR 165
              YL    V+HRD+   NIL +   VVK++DFG++  + + +       G P       
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY------ 164

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY----PHIPLCRIV 210
           W+A E +  +  +  SD+WS G  + E++T G  PY    P   L RIV
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIV 212

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 98.4 bits (245), Expect = 6e-25
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 41/219 (18%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G G FG V+         E  +      V VK LKANA +K  ++FL++ +  + + +H
Sbjct: 3   IGNGWFGKVLLS-------EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYR-ILQH 54

Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE------------------------Y 112
            +I+  +G C +     LV EYC LGDL+SYL +E                        +
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE-- 170
           +  +  +H DLA RN  L+S   VK+ D+G+    Y+++  +  E  + +P+RWLA E  
Sbjct: 115 MHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET-EDDKCVPLRWLAPELV 173

Query: 171 -----SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
                 L++   T  S+VW+ GV LWE+    A PY H+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.9 bits (236), Expect = 1e-23
 Identities = 65/248 (26%), Positives = 120/248 (48%), Gaps = 39/248 (15%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQ--AAMEVAVKMLKANAD---AKTYDKFL 65
           + I G ++G G FG V  G+        +SG+  A  +V +  + A++        D   
Sbjct: 1   KWIKGALIGSGSFGSVYLGM------NASSGELMAVKQVELPSVSASSKDRKRSMLDALA 54

Query: 66  KEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQ---------------SYLR 109
           +EI L+K++ +H++IV ++G     D L + +EY   G +                +++R
Sbjct: 55  REIALLKEL-QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR 113

Query: 110 E-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG----EPSE 160
           +      YL N  ++HRD+   NIL+ +   +KISDFG+S+ + E N          PS 
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSL 172

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME 220
           +  + W+A E +    YT K+D+WS G ++ E++T G +P+P     + +  +      E
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGENASPE 231

Query: 221 RPASCNEQ 228
            P++ + +
Sbjct: 232 IPSNISSE 239

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 8e-23
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 58/221 (26%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P     L EV+G+G +G V K                  VA+K++    D +  ++  +E
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIEDEE--EEIKEE 52

Query: 68  INLMKDVGKHDHIVSFIGCCYK-------DELRLVVEYCALG------------------ 102
            N+++    H +I +F G   K       D+L LV+E C  G                  
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE 112

Query: 103 DLQSY-LRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED----IYEQNV 152
           +  +Y LRE      YL  NKV+HRD+  +NILL+    VK+ DFG+S      +  +N 
Sbjct: 113 EWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 153 FQNGEPSEKLPIRWLALESLVSN-----IYTNKSDVWSFGV 188
           F  G P       W+A E +  +      Y  +SDVWS G+
Sbjct: 173 FI-GTPY------WMAPEVIACDEQPDASYDARSDVWSLGI 206

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.2 bits (221), Expect = 2e-21
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 37/229 (16%)

Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           GEVLG+G +G V  GL   G        A  +V +      A  K Y+K  +E++L+K +
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQL-----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 75  GKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYL 113
            KH +IV ++G C  D  + + +E+   G + S L                       YL
Sbjct: 60  -KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL------PIRWL 167
            NN VVHRD+   N++L    ++K+ DFG +  +    V  +G  S  L      P  W+
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL--AWVGLHGTHSNMLKSMHGTPY-WM 175

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
           A E +  + Y  KSD+WS G  ++E+ T G  P   +     + Y+   
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFYIGAH 223

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.5 bits (215), Expect = 3e-20
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 49/213 (23%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LK 66
           R   G+ LG+G + VV K        +  +G+    VA+K +K     +  D      L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKA------RDKETGR---IVAIKKIKLGERKEAKDGINFTALR 51

Query: 67  EINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYC---------------ALGDLQSYLRE 110
           EI L++++ KH +I+  +    +K  + LV E+                   D++SY+  
Sbjct: 52  EIKLLQEL-KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLM 110

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP-- 163
                EYL +N ++HRDL   N+L++S  V+K++DFGL+           G P+ K+   
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF--------GSPNRKMTHQ 162

Query: 164 --IRWL-ALESLV-SNIYTNKSDVWSFGVVLWE 192
              RW  A E L  +  Y    D+WS G +  E
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 86.3 bits (212), Expect = 8e-20
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 46/223 (20%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDKFLKEINL 70
            +   LG+G FG V                    VA+K+L  K  + +K  ++FL+EI +
Sbjct: 3   RILRKLGEGSFGEVYLARD------------RKLVALKVLAKKLESKSKEVERFLREIQI 50

Query: 71  MKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------- 110
           +  +    +IV        +  L LV+EY   G L+  L++                   
Sbjct: 51  LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110

Query: 111 ----EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYEQNVFQNGEPSEKLPI- 164
               EYL +  ++HRD+   NILL     VVK+ DFGL++ + +     +        + 
Sbjct: 111 LSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 165 --RWLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPYP 202
              ++A E L+       ++ SD+WS G+ L+E++T G  P+ 
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFE 212

Length = 384

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 2e-19
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 35/207 (16%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK----EIN 69
            G++LGQG FG V   L  D  T         E+AVK +  + D+    K +     EI 
Sbjct: 6   RGKLLGQGAFGRVY--LCYDVDT-------GRELAVKQVPFDPDSPETKKEVNALECEIQ 56

Query: 70  LMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------ 110
           L+K++ +H+ IV + GC   DE L + +EY   G ++  L+                   
Sbjct: 57  LLKNL-QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE 115

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
             EYL +N +VHRD+   NIL  S   VK+ DFG S+ +        G  S      W++
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVT 195
            E +    Y  K+DVWS G  + E++T
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 81.1 bits (201), Expect = 2e-18
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 54/218 (24%)

Query: 16  EVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKD 73
           E +G+G FG V K     DG            +  K +   N   K   + + E+N++++
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKI----------LVWKEIDYGNMTEKEKQQLVSEVNILRE 55

Query: 74  VGKHDHIVSFIGCCY---KDELRLVVEYCALGDLQS----------YLREEYL------- 113
           + KH +IV +           L +V+EYC  GDL            Y+ EE++       
Sbjct: 56  L-KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 114 ------------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEP 158
                         N V+HRDL   NI L + + VK+ DFGL++ +   + F     G P
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP 174

Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
               P      E L    Y  KSD+WS G +++E+  L
Sbjct: 175 YYMSP------EQLNHMSYDEKSDIWSLGCLIYELCAL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.8 bits (200), Expect = 2e-18
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 29/177 (16%)

Query: 47  VAVKML-KANADAK-TYDKFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGD 103
            A+K++ KA+   K   D+ L E +++    +  ++V        K  L LV+EY   GD
Sbjct: 21  YAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79

Query: 104 LQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           L S L                      EYL +N ++HRDL   NIL+ S   +K++DFGL
Sbjct: 80  LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGL 139

Query: 144 SE-DIYEQNVFQNGEPSEKLPI----RWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           S+  +  + +  N +  E   I     ++A E ++   ++   D WS G +L+E + 
Sbjct: 140 SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 79.9 bits (198), Expect = 5e-18
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 54/218 (24%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           VLGQG  GVV K      PT    G+     A+K +  + D +   + L+E+  ++   +
Sbjct: 8   VLGQGSSGVVYKVR--HKPT----GK---IYALKKIHVDGDEEFRKQLLRELKTLRS-CE 57

Query: 77  HDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYL-S 114
             ++V   G  YK+ E+ +V+EY   G L   L++                    +YL +
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE---------PSEKLPIR 165
              ++HRD+   N+L++S   VKI+DFG+S+ + E  + Q            P       
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSP------- 169

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
               E +    Y+  +D+WS G+ L E   LG  P+  
Sbjct: 170 ----ERIQGESYSYAADIWSLGLTLLECA-LGKFPFLP 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.4 bits (196), Expect = 7e-18
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 35/210 (16%)

Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL-KEINLMKD 73
           GE+LG G FG V +GL  D       G       V +       +   K L +EI L+  
Sbjct: 5   GELLGSGSFGSVYEGLNLD------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK 58

Query: 74  VGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EY 112
           + +H +IV ++G   +++ L + +E    G L   L++                    EY
Sbjct: 59  L-QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L +   VHRD+   NIL+ +  VVK++DFG++    +Q V  +   S K    W+A E +
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMA----KQVVEFSFAKSFKGSPYWMAPEVI 173

Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGANPY 201
                Y   +D+WS G  + E+ T G  P+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMAT-GKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 2e-17
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 42/213 (19%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E +G+G FG V K        +  + Q    VA+K++         +   +EI  +    
Sbjct: 7   ECIGKGSFGEVYKA------IDKRTNQ---VVAIKVIDLEEAEDEIEDIQQEIQFLSQC- 56

Query: 76  KHDHIVSFIGCCYKD-ELRLVVEYCALG---DLQSY-----------LRE-----EYLSN 115
           +  +I  + G   K  +L +++EYC  G   DL              LRE     EYL  
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEKLPIRWLALES 171
              +HRD+   NILLS    VK++DFG    L+  + ++N F  G P       W+A E 
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPF------WMAPEV 169

Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           +  + Y  K+D+WS G+   E+   G  P   +
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAK-GEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 77.9 bits (193), Expect = 3e-17
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 64/217 (29%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA----KTYDKFLKEINLM 71
           E LG+G +GVV K        +  +G+    VA+K ++ + +      T    L+EI+L+
Sbjct: 5   EKLGEGTYGVVYKA------RDKKTGE---IVALKKIRLDNEEEGIPSTA---LREISLL 52

Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH +IV  +   + +  L LV EYC + DL+ YL +                    
Sbjct: 53  KEL-KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRG 110

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR---- 165
             Y  +++++HRDL  +NIL++   V+K++DFGL+                 +P+R    
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF-------------GIPLRTYTH 157

Query: 166 -----W-LALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
                W  A E L+ S  Y+   D+WS G +  E++T
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-17
 Identities = 52/222 (23%), Positives = 99/222 (44%), Gaps = 44/222 (19%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E++G+G +G V +G          +G+    VA+K++  +          +E+ L+  + 
Sbjct: 7   ELIGRGAYGAVYRGK------HVPTGRV---VALKIINLDTPDDDVSDIQREVALLSQLR 57

Query: 76  KHD--HIVSFIGCCYKD-ELRLVVEYCALGDLQSYLR----EE---------------YL 113
           +    +I  + G   K   L +++EY   G +++ ++     E               Y+
Sbjct: 58  QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYI 117

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN----GEPSEKLPIRWLAL 169
               V+HRD+   NIL+++   VK+ DFG++  +  QN  +     G P       W+A 
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRSTFVGTPY------WMAP 170

Query: 170 ESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
           E +     Y  K+D+WS G+ ++E+ T G  PY  +   R +
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAM 211

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 4e-17
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 50/212 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K             +  +  A K+++  ++ +  D F+ EI+++ 
Sbjct: 9   IIGE-LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELED-FMVEIDILS 57

Query: 73  DVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE--------------------- 110
           +  KH +IV       Y+++L +++E+C  G L S + E                     
Sbjct: 58  EC-KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEAL 116

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
            +L ++KV+HRDL   NILL+    VK++DFG+S      + +++ F  G P       W
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTP------YW 169

Query: 167 LALESLV-----SNIYTNKSDVWSFGVVLWEI 193
           +A E +       N Y  K+D+WS G+ L E+
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 77.2 bits (191), Expect = 6e-17
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 55/226 (24%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML---KANADAKTYDKFL-KEI 68
             G+++G+G F  VV         E  + +   E A+K+L   +   + K     + KE+
Sbjct: 4   KFGKIIGEGSFSTVVLA------KEKETNK---EYAIKILDKRQLIKEKKVKYVKIEKEV 54

Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE---------------- 110
             +  +  H  I+      ++DE  L  V+EY   G+L  Y+R+                
Sbjct: 55  --LTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI 111

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG--------EP 158
               EYL +  ++HRDL   NILL     +KI+DFG ++ +   +  ++           
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 159 SEKLPIR---------WLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
            EK   R         +++ E L        SD+W+ G ++++++T
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.1 bits (189), Expect = 7e-17
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 41/236 (17%)

Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V          + A+GQ   EVA+K +      K  +
Sbjct: 12  VSIGDPKKKYTRYEKIGQGASGTVFTA------IDVATGQ---EVAIKQINLQKQPKK-E 61

Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +MK++ K+ +IV+F+      DEL +V+EY A G L   + E           
Sbjct: 62  LIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV 120

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   E+L  N+V+HRD+ + N+LL     VK++DFG    I  +   ++   G P 
Sbjct: 121 CRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E+V  G  PY +    R ++ ++T
Sbjct: 181 ------WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIAT 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 8e-17
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 47/214 (21%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E   L + +G G +G V K        + A+G+    VA+K++K       ++   +E
Sbjct: 1   PQEDYELIQRIGSGTYGDVYKA------RDIATGEL---VAIKVIKLEPG-DDFEIIQQE 50

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQ---------------SYL-RE 110
           I+++K+  +H +IV++ G   + D+L +V+EYC  G LQ               +Y+ RE
Sbjct: 51  ISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEK 161
                 YL     +HRD+   NILL+    VK++DFG    L+  I ++  F  G P   
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTP--- 165

Query: 162 LPIRWLALESLVSNI---YTNKSDVWSFGVVLWE 192
               W+A E         Y  K D+W+ G+   E
Sbjct: 166 ---YWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.9 bits (189), Expect = 9e-17
 Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 41/222 (18%)

Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V          + A+GQ   EVA+K +      K  +
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTA------IDVATGQ---EVAIKQMNLQQQPKK-E 61

Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  KH +IV+++      DEL +V+EY A G L   + E           
Sbjct: 62  LIINEILVMRE-NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 120

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY-EQNVFQN--GEPS 159
                   E+L +N+V+HRD+ + NILL     VK++DFG    I  EQ+      G P 
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                 W+A E +    Y  K D+WS G++  E+V  G  PY
Sbjct: 181 ------WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 77.4 bits (190), Expect = 1e-16
 Identities = 44/113 (38%), Positives = 64/113 (56%), Gaps = 10/113 (8%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGAS-GQAAMEVAVKMLKANADAKTYDKFL 65
           +P + L+LG +LG G FG VV     +G   G S  Q  M+VAVKMLK  A +      +
Sbjct: 34  FPRDGLVLGRILGSGAFGKVV-----EGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALM 88

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYL---REEYLS 114
            E+ +M  +G H +IV+ +G C K   + ++ EYC  GDL +YL   R+ +LS
Sbjct: 89  SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLS 141

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 42/215 (19%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
            +   +G+G FGVV K +        A  Q  +           + +  ++ + E  ++ 
Sbjct: 3   EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--------KMNRREREEAIDEARVLA 54

Query: 73  DVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE-------------------- 111
            +    +I+ +        +L +V+EY   GDL   L+ +                    
Sbjct: 55  KL-DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG 113

Query: 112 --YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRW 166
             +L + K++HRD+ + N+ L +   VKI D G+++ + +   F N   G P       +
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY------Y 167

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           L+ E      Y  KSDVW+ GVVL+E  T G +P+
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 76.4 bits (188), Expect = 3e-16
 Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 7/107 (6%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P + L  G+ LG G FG VV+    G G  +       + VAVKMLKA+A     +  +
Sbjct: 35  FPRDNLQFGKTLGAGAFGKVVEATAFGLGKED-----NVLRVAVKMLKASAHTDEREALM 89

Query: 66  KEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE 111
            E+ ++  +G+H +IV+ +G C +   + ++ EYC  GDL ++LR++
Sbjct: 90  SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.5 bits (185), Expect = 3e-16
 Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 41/236 (17%)

Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V   +      + A+GQ   EVA+K +      K  +
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAI------DIATGQ---EVAIKQMNLQQQPKK-E 61

Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E           
Sbjct: 62  LIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 120

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   ++L +N+V+HRD+ + NILL     VK++DFG    I  +   ++   G P 
Sbjct: 121 CRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E+V  G  PY +    R ++ ++T
Sbjct: 181 ------WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIAT 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.6 bits (186), Expect = 3e-16
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 51/229 (22%)

Query: 1   MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT 60
           + +  G P   L     +G+G  G+V         T+ ++G+   +VAVK +      + 
Sbjct: 10  LVVDPGDPRSYLDNFVKIGEGSTGIVCIA------TDKSTGR---QVAVKKMDLRKQQRR 60

Query: 61  YDKFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDL-----QSYLREE--- 111
              F  E+ +M+D  +H +IV         DEL +V+E+   G L      + + EE   
Sbjct: 61  ELLF-NEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA 118

Query: 112 -----------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                      +L    V+HRD+ + +ILL+S   VK+SDFG              + S+
Sbjct: 119 TVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC-----------AQVSK 167

Query: 161 KLPIR--------WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++P R        W+A E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.1 bits (184), Expect = 4e-16
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 41/236 (17%)

Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V   +      + A+GQ   EVA++ +      K  +
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAM------DVATGQ---EVAIRQMNLQQQPKK-E 62

Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E           
Sbjct: 63  LIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   E+L +N+V+HRD+ + NILL     VK++DFG    I  +   ++   G P 
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E++  G  PY +    R ++ ++T
Sbjct: 182 ------WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIAT 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.4 bits (183), Expect = 5e-16
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 49/218 (22%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK---- 66
           + + GE++G+G +G V   L         +G+    +AVK ++  A         +    
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVT------TGEM---MAVKQVELPATIAGRHDSRQKDMV 52

Query: 67  -----EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLR-----EE---- 111
                EI  +KD+  H +IV ++G    +E L + +EY   G + S LR     EE    
Sbjct: 53  KALRSEIETLKDL-DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR 111

Query: 112 -----------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL---SEDIYEQNVFQNGE 157
                      YL +  ++HRDL   N+L+ +  + KISDFG+   S+DIY+    QN  
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN--DQNM- 168

Query: 158 PSEKLPIRWLALE--SLVSNIYTNKSDVWSFGVVLWEI 193
            S +  + W+A E     S  Y+ K D+WS G V+ E+
Sbjct: 169 -SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 74.3 bits (183), Expect = 5e-16
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 47/213 (22%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
            LG G  GVV K L         +G+    +AVK ++   +     + L+E++++     
Sbjct: 8   ELGAGNSGVVSKVL------HRPTGKI---MAVKTIRLEINEAIQKQILRELDILHKC-N 57

Query: 77  HDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYL- 113
             +IV F G  Y + ++ + +EY   G L   L+E                      YL 
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRWLAL 169
             +K++HRD+   NIL++S   +K+ DFG+S      + +  V   G  S      ++A 
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSS------YMAP 168

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E +  N Y+ KSD+WS G+ L E+ T G  PYP
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.7 bits (181), Expect = 9e-16
 Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 44/242 (18%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAA-MEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           LGQG F  + KG+L         G    + V +K+L +  D +    F +  +LM  +  
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS--DHRDSLAFFETASLMSQL-S 59

Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLSN 115
           H H+V   G C +DE  +V EY   G L  +L  E                     YL +
Sbjct: 60  HKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 116 NKVVHRDLATRNILL-------SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
            K+VH ++  +NIL+            +K+SD G         V    E  E++P  W+A
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-----IPITVLSREERVERIP--WIA 172

Query: 169 LE---SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            E   +  +++    +D WSFG  L EI + G  P   +       +    +R+  P  C
Sbjct: 173 PECIRNGQASLTIA-ADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMP-DC 230

Query: 226 NE 227
            E
Sbjct: 231 AE 232

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 74.3 bits (182), Expect = 1e-15
 Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 7/103 (6%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGAS-GQAAMEVAVKMLKANADAKTYDKFLK 66
           P + L+LG  LG G FG VV     +    G S  Q+ M+VAVKMLK+ A +      + 
Sbjct: 35  PRDNLVLGRTLGSGAFGRVV-----EATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMS 89

Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYL 108
           E+ +M  +G H +IV+ +G C K   + ++ EYC  GDL  YL
Sbjct: 90  ELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 56/210 (26%)

Query: 37  EGASG--------QAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY 88
           EGA G           M  A+K +  + +     + L+E+ + K   K  +IV + G   
Sbjct: 11  EGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFL 69

Query: 89  KD---ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHR 121
            +    + + +EYC  G L S  ++                         YL + K++HR
Sbjct: 70  DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR 129

Query: 122 DLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR------WLALESLVSN 175
           D+   NILL+    VK+ DFG+S           GE    L         ++A E +   
Sbjct: 130 DIKPSNILLTRKGQVKLCDFGVS-----------GELVNSLAGTFTGTSFYMAPERIQGK 178

Query: 176 IYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
            Y+  SDVWS G+ L E+     N +P  P
Sbjct: 179 PYSITSDVWSLGLTLLEVAQ---NRFPFPP 205

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 60/186 (32%), Positives = 89/186 (47%), Gaps = 30/186 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + AS +    VAVKMLK  A A  Y   + 
Sbjct: 4   FPRDRLKLGKPLGRGAFGKVIQAS-AFGIEKSASCRT---VAVKMLKEGATASEYKALMT 59

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYL---REEYLSNNKVVHR 121
           E+ ++  +G H ++V+ +G C K    L ++VEYC  G+L +YL   RE +        R
Sbjct: 60  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY-----R 114

Query: 122 DLATRNILLSSPHVVKI----------SDF-GLSEDIYEQNVFQNGEPSE--KLPIRWLA 168
           + +TR   +      K           S   G  ED    +V ++ E  E  K P   L 
Sbjct: 115 NKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP---LT 171

Query: 169 LESLVS 174
           LE L+S
Sbjct: 172 LEDLIS 177

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 66/230 (28%), Positives = 94/230 (40%), Gaps = 61/230 (26%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK---MLKANADAKTYDKFLKEINL 70
           L EV+G G   VV   +               +VA+K   + K        D+  KE+  
Sbjct: 5   LIEVIGVGATAVVYAAICLPN---------NEKVAIKRIDLEKCQTS---VDELRKEVQA 52

Query: 71  MKDVGKHDHIV----SFIGCCYKDELRLVVEYCALG---DLQSY---------------L 108
           M     H ++V    SF+     DEL LV+ Y + G   D+                  L
Sbjct: 53  MSQC-NHPNVVKYYTSFV---VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108

Query: 109 RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN-------G 156
           +E     EYL +N  +HRD+   NILL     VKI+DFG+S  + +             G
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168

Query: 157 EPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
            P       W+A E +   + Y  K+D+WSFG+   E+ T GA PY   P
Sbjct: 169 TPC------WMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYP 211

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (178), Expect = 2e-15
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 37/214 (17%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK-- 66
           P    LG++LG+G FG V   L  D  T         E+AVK +  + D++   K +   
Sbjct: 1   PVNWRLGKLLGRGAFGEVY--LCYDADT-------GRELAVKQVPFDPDSQETSKEVNAL 51

Query: 67  --EINLMKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE----------- 110
             EI L+K++ +HD IV + GC    E   L + VEY   G ++  L+            
Sbjct: 52  ECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110

Query: 111 ---------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                     YL +N +VHRD+   NIL  S   VK+ DFG S+ I    +   G  S  
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
               W++ E +    Y  K+DVWS    + E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.1 bits (176), Expect = 4e-15
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 57/225 (25%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L E++G G +G V KG          +GQ A   A+K++    D +  ++  +EIN++K 
Sbjct: 10  LVELVGNGTYGQVYKG------RHVKTGQLA---AIKVMDVTGDEE--EEIKQEINMLKK 58

Query: 74  VGKHDHIVSFIGCCYK-------DELRLVVEYCALGDLQ--------SYLREEY------ 112
              H +I ++ G   K       D+L LV+E+C  G +         + L+EE+      
Sbjct: 59  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118

Query: 113 --------LSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
                   L  +KV+HRD+  +N+LL+    VK+ DFG+S      +  +N F  G P  
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY- 176

Query: 161 KLPIRWLALESLVSN-----IYTNKSDVWSFGVVLWEIVTLGANP 200
                W+A E +  +      Y  KSD+WS G+   E+   GA P
Sbjct: 177 -----WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 72.6 bits (178), Expect = 5e-15
 Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 33/181 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P  RL  G+ LG G FG VV+    GL            AAM VAVKMLK +A     +
Sbjct: 32  FPRNRLSFGKTLGAGAFGKVVEATAYGLF--------KSDAAMTVAVKMLKPSAHLTERE 83

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREEYLSNNKVVHR 121
             + E+ ++  +G H +IV+ +G C      LV+ EYC  GDL ++LR +          
Sbjct: 84  ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK---------- 133

Query: 122 DLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKS 181
               R+  +   H         +E    +N+    E S      ++ ++  VS +   K+
Sbjct: 134 ----RDSFICPKH------EDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA 183

Query: 182 D 182
           D
Sbjct: 184 D 184

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 71.4 bits (176), Expect = 5e-15
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 51/224 (22%)

Query: 18  LGQGEFGVV--VKGLLGDGPTEGASGQA-AMEVAVK--MLKANADAKTYDKFLKEINLMK 72
           LG+G FG V  V+        +  +G+  AM+V  K  ++K      T    L E N++ 
Sbjct: 1   LGKGSFGKVLLVR--------KKDTGKLYAMKVLKKKKIIKRKEVEHT----LTERNILS 48

Query: 73  DVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE-------------------- 110
            +  H  IV      ++ E +L  V+EY   G+L S+L +                    
Sbjct: 49  RI-NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLAL 106

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWL 167
           EYL +  +++RDL   NILL +   +K++DFGL++++  +    N   G P       +L
Sbjct: 107 EYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE------YL 160

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH 211
           A E L+   Y    D WS GV+L+E++T G  P+       I  
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPFYAEDRKEIYE 203

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 71.3 bits (175), Expect = 5e-15
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 53/211 (25%)

Query: 18  LGQGEFGVVVK-GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           LG+G +G V K   L D         A  EV +  +            + EI ++  V  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQF-----YALKEVDLGSMSQKEREDA----VNEIRILASV-N 57

Query: 77  HDHIVSF-----IGCCYKDELRLVVEYCALGDLQSYLRE--------------------- 110
           H +I+S+      G     +L +V+EY   GDL   + +                     
Sbjct: 58  HPNIISYKEAFLDGN----KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF--QNGEPSEKLPIR 165
              + L   K++HRDL + NILL +  +VKI D G+S+ + ++N+   Q G P       
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQIGTPH------ 166

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           ++A E      Y+ KSD+WS G +L+E+ T 
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 72.3 bits (177), Expect = 6e-15
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 6/105 (5%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+VLG G FG VV+     G  + +S      VAVKMLK  A A  +   + 
Sbjct: 4   FPRDRLRLGKVLGHGAFGKVVEASAF-GIDKKSSCNT---VAVKMLKEGATASEHKALMS 59

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLR 109
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L ++LR
Sbjct: 60  ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLR 104

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.0 bits (175), Expect = 1e-14
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 54/215 (25%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-----LKEI 68
           + + LG G FG V             +G+    VA+K +K     K +  +     L+E+
Sbjct: 3   VIKQLGDGTFGSVYLA------RNKETGEL---VAIKKMK-----KKFYSWEECMNLREV 48

Query: 69  NLMKDVGKHDHIV----SFIGCCYKDELRLVVEYC----------------ALGDLQSYL 108
             ++ + +H +IV     F      DEL  V EY                 +   ++S +
Sbjct: 49  KSLRKLNEHPNIVKLKEVFR---ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSII 105

Query: 109 RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
            +      ++  +   HRDL   N+L+S P VVKI+DFGL+ +I  +  +     ++ + 
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-----TDYVS 160

Query: 164 IRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVTL 196
            RW  A E L+ S  Y++  D+W+ G ++ E+ TL
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.6 bits (173), Expect = 1e-14
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 52/221 (23%)

Query: 16  EVLGQGEFGVVVKGL---LGDGPTEGASGQA-AMEVAVKMLKANADAKTY-DKFLKEINL 70
           E LGQG F  + KG+   +GD       G+    EV +K+L  +   + Y + F +  ++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDY------GELHKTEVLLKVL--DKSHRNYSESFFEAASM 52

Query: 71  MKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------- 110
           M  +  H H+V   G C   DE  +V EY   G L +YL++                   
Sbjct: 53  MSQL-SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAW 111

Query: 111 --EYLSNNKVVHRDLATRNILL--------SSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
              +L +  + H ++  +N+LL         +P  +K+SD G+S  +  + +       E
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILL-----E 166

Query: 161 KLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANP 200
           ++P  W+  E +      +  +D WSFG  LWEI + G  P
Sbjct: 167 RIP--WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.2 bits (172), Expect = 2e-14
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 41/206 (19%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+G +  V KG          +      VA+K +  +A+  T    ++EI+LMK++ 
Sbjct: 6   EKLGEGTYATVYKGR---------NRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL- 55

Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-----------------------E 111
           KH++IV      + +++L LV EY    DL+ Y+                          
Sbjct: 56  KHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALE 170
           +   N+V+HRDL  +N+L++    +K++DFGL+       N F N    E + + + A +
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN----EVVTLWYRAPD 170

Query: 171 SLV-SNIYTNKSDVWSFGVVLWEIVT 195
            L+ S  Y+   D+WS G ++ E++T
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.6 bits (170), Expect = 3e-14
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 57/225 (25%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L EV+G G +G V KG          +GQ A   A+K++    D +  ++   EIN++K 
Sbjct: 20  LVEVVGNGTYGQVYKG------RHVKTGQLA---AIKVMDVTEDEE--EEIKLEINMLKK 68

Query: 74  VGKHDHIVSFIGCCYK-------DELRLVVEYCALG----------------DLQSYLRE 110
              H +I ++ G   K       D+L LV+E+C  G                D  +Y+  
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 111 E------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
           E      +L  +KV+HRD+  +N+LL+    VK+ DFG+S      +  +N F  G P  
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY- 186

Query: 161 KLPIRWLALESLVSN-----IYTNKSDVWSFGVVLWEIVTLGANP 200
                W+A E +  +      Y  +SD+WS G+   E+   GA P
Sbjct: 187 -----WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE-GAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 69.3 bits (169), Expect = 3e-14
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 37/214 (17%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK-- 66
           P    LG++LGQG FG V   L  D  T         E+AVK ++ + ++    K +   
Sbjct: 1   PTNWRLGKLLGQGAFGRVY--LCYDADT-------GRELAVKQVQFDPESPETSKEVNAL 51

Query: 67  --EINLMKDVGKHDHIVSFIGCC---YKDELRLVVEYCALGDLQSYLRE----------- 110
             EI L+K++  H+ IV + GC     +  L + +E+   G ++  L+            
Sbjct: 52  ECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK 110

Query: 111 ---------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                     YL +N +VHRD+   NIL  S   VK+ DFG S+ +    +   G  S  
Sbjct: 111 YTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
               W++ E +    Y  K+D+WS G  + E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 69.3 bits (169), Expect = 5e-14
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 45/211 (21%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E +G+G +G V K L         +G  A   AVK+L    D    ++   E N++K + 
Sbjct: 24  ETIGKGTYGKVFKVL------NKKNGSKA---AVKILDPIHDID--EEIEAEYNILKALS 72

Query: 76  KHDHIVSFIGCCYK------DELRLVVEYCALGDL----QSYLRE--------------- 110
            H ++V F G  YK      D+L LV+E C  G +    + +L+                
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKL 162
                ++L  NK +HRD+   NILL++   VK+ DFG+S  +    + +N   G P    
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
           P   +A E  + + Y  + DVWS G+   E+
Sbjct: 193 P-EVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 9e-14
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 38/203 (18%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDVGK 76
           +G+G +GVV K        +  +G+    VA+K +K   +++   K  L+EI L+K++  
Sbjct: 7   IGEGTYGVVYKA------RDKLTGEI---VAIKKIKLRFESEGIPKTALREIKLLKEL-N 56

Query: 77  HDHIVSFIGCCY-KDELRLVVEYC---------------ALGDLQSYLRE-----EYLSN 115
           H +I+  +     K +L LV E+                    ++SYL +      +  +
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-ALESLV- 173
           + ++HRDL   N+L+++  V+K++DFGL+              +  +  RW  A E L+ 
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY----THYVVTRWYRAPELLLG 172

Query: 174 SNIYTNKSDVWSFGVVLWEIVTL 196
              Y+   D+WS G +  E+++ 
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 68.3 bits (167), Expect = 1e-13
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 46/213 (21%)

Query: 9   PERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT--YDKFL 65
           PE+L      +G G FG V          +  + +    VA+K +  +       +   +
Sbjct: 13  PEKLFTDLREIGHGSFGAVYFA------RDVRTNEV---VAIKKMSYSGKQSNEKWQDII 63

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYCALGD-------LQSYLRE------- 110
           KE+  ++ + +H + + + GC  ++    LV+EYC LG         +  L+E       
Sbjct: 64  KEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAIC 121

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                   YL +++ +HRD+   NILL+ P  VK++DFG +  +   N F  G P     
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-GTPY---- 176

Query: 164 IRWLALESLVS---NIYTNKSDVWSFGVVLWEI 193
             W+A E +++     Y  K DVWS G+   E+
Sbjct: 177 --WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 54/213 (25%)

Query: 18  LGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLK--ANADAKTYDKFLKEINLMKDV 74
           +G+G+F VV K + L DG            VA+K ++     DAK     LKEI+L+K +
Sbjct: 10  IGKGQFSVVYKAICLLDGRV----------VALKKVQIFEMMDAKARQDCLKEIDLLKQL 59

Query: 75  GKHDHIV----SFIGCCYKDELRLVVEYCALGDLQSYLRE-------------------- 110
             H +++    SFI     +EL +V+E    GDL   ++                     
Sbjct: 60  -DHPNVIKYLASFI---ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLP 163
               E++ + +++HRD+   N+ +++  VVK+ D GL      +    +   G P    P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
                 E +  N Y  KSD+WS G +L+E+  L
Sbjct: 176 ------ERIHENGYNFKSDIWSLGCLLYEMAAL 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.0 bits (163), Expect = 2e-13
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 37/208 (17%)

Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK----EINL 70
           G++LGQG FG V   L  D  T         E+A K ++ + ++    K +     EI L
Sbjct: 7   GKLLGQGAFGRVY--LCYDVDT-------GRELAAKQVQFDPESPETSKEVSALECEIQL 57

Query: 71  MKDVGKHDHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE----------------- 110
           +K++ +H+ IV + GC     +  L + +EY   G ++  L+                  
Sbjct: 58  LKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL 116

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               YL +N +VHRD+   NIL  S   VK+ DFG S+ +    +   G  S      W+
Sbjct: 117 EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           + E +    Y  K+DVWS G  + E++T
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 67.0 bits (163), Expect = 2e-13
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 39/209 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     E +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 2   PEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQE 52

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGD--------------LQSYLRE-- 110
           I ++       ++  + G   KD +L +++EY   G               + + LRE  
Sbjct: 53  ITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 111

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF----- 166

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEI 193
            W+A E +  + Y +K+D+WS G+   E+
Sbjct: 167 -WMAPEVIKQSAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 55/212 (25%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEINLMK 72
           +   +G+G  G+V K        +  +G+    VA+K +     +    ++ L+EI  ++
Sbjct: 4   ILGRIGEGAHGIVFKA------KDRETGET---VALKKVALRRLEGGIPNQALREIKALQ 54

Query: 73  DVGKHDHIVSFI------GCCYKDELRLVVEYCALGDLQSYLREE--------------- 111
              +H ++V  +               LV+EY    DL   LR+E               
Sbjct: 55  AC-QHPYVVKLLDVFPHGSGFV-----LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRM 107

Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP---SEKL 162
                 Y+  N ++HRDL   N+L+S+  V+KI+DFGL+       +F   EP   S ++
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR------LFSEEEPRLYSHQV 161

Query: 163 PIRWL-ALESLV-SNIYTNKSDVWSFGVVLWE 192
             RW  A E L  +  Y    D+W+ G +  E
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.8 bits (163), Expect = 3e-13
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 55/220 (25%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK----FLKEINLM 71
           E LG G FG V K    +    G +  A  E+ V       D +  DK     + E+ ++
Sbjct: 6   EHLGSGAFGCVYKVRKKNN---GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 72  KDVGKHDHIVSFIGCCYK-----DELRLV---VEYCALGDLQSYLREE------------ 111
           K+  +H +IV +    YK     D L +V   +E   LG+  + L+E+            
Sbjct: 63  KEQLRHPNIVRY----YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 112 ---------YLSNNK-VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                    YL   K +VHRDL   NI+L     V I+DFGL++        Q   P  K
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--------QKQ-PESK 169

Query: 162 LP-----IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           L      I +   E + +  Y  K+DVW+FG +L+++ TL
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.2 bits (164), Expect = 3e-13
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 41/205 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLM 71
           +GE LG G FG V             +G+     A+K LK       K      +E +++
Sbjct: 22  MGETLGTGSFGRVRIAKHK------GTGEY---YAIKCLKKREILKMKQVQHVAQEKSIL 72

Query: 72  KDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE------------------- 110
            ++  H  IV+ + C ++DE R+  ++E+   G+L ++LR+                   
Sbjct: 73  MEL-SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA 130

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            EYL +  +++RDL   N+LL +   VK++DFG ++ + ++     G P       +LA 
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTP------EYLAP 184

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIV 194
           E + S  +    D W+ GV+L+E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 66.4 bits (163), Expect = 5e-13
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 45/207 (21%)

Query: 14  LGEVLGQGEFGVV--VKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEIN 69
             + LG G FG V  V+           SG+     A+K+L        K  +  L E  
Sbjct: 5   FIKTLGTGSFGRVMLVR--------HKGSGKY---YALKILSKAKIVKLKQVEHVLNEKR 53

Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           +++ + +H  +V+  G  ++D+  L LV+EY   G+L S+LR+                 
Sbjct: 54  ILQSI-RHPFLVNLYGS-FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
              EYL +  +V+RDL   N+LL S   +KI+DFG ++ +  +     G P       +L
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE------YL 165

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E ++S  Y    D W+ G++++E++
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 7e-13
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 31/177 (17%)

Query: 48  AVKML-KANADAKTYDKFLK-EINLMKDVGKHDHIVS-FIGCCYKDELRLVVEYCALGDL 104
           A+K+L K++  AK     +K E  +M   G+  ++   +     KD L LV+EY   GD 
Sbjct: 25  AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84

Query: 105 QS---------------YLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS 144
            S               Y+ E     E L    ++HRD+   N+L+     +K++DFGLS
Sbjct: 85  ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144

Query: 145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +  E   F  G P       +LA E+++       SD WS G V++E +  G  P+
Sbjct: 145 RNGLENKKF-VGTPD------YLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 7   YPPERLILGEVLGQGEFGVVVKG-LLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P +RL LG+ LG+G FG V++    G   T          VAVKMLK  A    +   +
Sbjct: 4   FPRDRLKLGKPLGRGAFGQVIEADAFGIDKT-----ATCRTVAVKMLKEGATHSEHRALM 58

Query: 66  KEINLMKDVGKHDHIVSFIGCCYK--DELRLVVEYCALGDLQSYLREE 111
            E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR +
Sbjct: 59  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 65.3 bits (159), Expect = 1e-12
 Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 37/181 (20%)

Query: 47  VAVKMLK-----ANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCA 100
           +AVK +      ++   +  +   KEI LM  +  H HI+  +G  C      L VE+ A
Sbjct: 28  MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNLFVEWMA 86

Query: 101 LGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILL-SSPHVVKIS 139
            G +   L +                     YL  N+++HRD+   N+L+ S+   ++I+
Sbjct: 87  GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIA 146

Query: 140 DFG----LSEDIYEQNVFQNGEPSEKL-PIRWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
           DFG    L+        FQ     + L  I ++A E L    Y    DVWS G V+ E+ 
Sbjct: 147 DFGAAARLAAKGTGAGEFQ----GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202

Query: 195 T 195
           T
Sbjct: 203 T 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 37/204 (18%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDV 74
            V+G+G +GVV+K          A+G+    VA+K  K + D +   K  L+E+ +++ +
Sbjct: 7   GVVGEGAYGVVLKC------RNKATGEI---VAIKKFKESEDDEDVKKTALREVKVLRQL 57

Query: 75  GKHDHIVSFIGCC-YKDELRLVVEYCA---LGDLQSY---LREE--------------YL 113
            +H++IV+       K  L LV EY     L  L++    L  +              Y 
Sbjct: 58  -RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-ALESL 172
            ++ ++HRD+   NIL+S   V+K+ DFG +  +  +        ++ +  RW  A E L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP---ASPLTDYVATRWYRAPELL 173

Query: 173 VSNI-YTNKSDVWSFGVVLWEIVT 195
           V +  Y    DVW+ G ++ E++ 
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.0 bits (158), Expect = 1e-12
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 46/219 (21%)

Query: 3   LSCGYPPERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--K 59
           L     PE + +G   +G G FG V         T   + +    VAVK +  +     +
Sbjct: 13  LFYKDDPEEIFVGLHEIGHGSFGAVYFA------TNSHTNEV---VAVKKMSYSGKQTNE 63

Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE------- 111
            +   +KE+  ++ + KH + + + GC  K+    LV+EYC LG     L          
Sbjct: 64  KWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEV 121

Query: 112 --------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                         YL ++ ++HRD+   NILL+ P  VK++DFG +      N F  G 
Sbjct: 122 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-GT 180

Query: 158 PSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEI 193
           P       W+A E +++     Y  K DVWS G+   E+
Sbjct: 181 PY------WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.7 bits (157), Expect = 2e-12
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 50/215 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K           + +  +  A K++   ++ +  D ++ EI+++ 
Sbjct: 9   IIGE-LGDGAFGKVYKA---------QNKETGVLAAAKVIDTKSEEELED-YMVEIDILA 57

Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------- 110
               H +IV  +   Y ++ L +++E+CA G + + + E                     
Sbjct: 58  SC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
            YL  NK++HRDL   NIL +    +K++DFG+S      I  ++ F  G P       W
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY------W 169

Query: 167 LALESLVSNI-----YTNKSDVWSFGVVLWEIVTL 196
           +A E ++        Y  K+DVWS G+ L E+  +
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI 204

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 60/226 (26%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           LGE +G+G FG V K L         SG     +AVK +++  D K   + L +++++  
Sbjct: 9   LGE-IGRGAFGTVNKMLHKP------SGT---IMAVKRIRSTVDEKEQKRLLMDLDVVMR 58

Query: 74  VGKHDHIVSFIGCCYKD-------EL---------RLV---------------VEYCALG 102
                +IV F G  +++       EL         + V               +    + 
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 103 DLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPS 159
            L +YL+EE     K++HRD+   NILL     +K+ DFG+S    D   +       P 
Sbjct: 119 AL-NYLKEEL----KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP- 172

Query: 160 EKLPIRWLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPYP 202
                 ++A E +  +    Y  +SDVWS G+ L+E+ T G  PYP
Sbjct: 173 ------YMAPERIDPSARDGYDVRSDVWSLGITLYEVAT-GKFPYP 211

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 64.7 bits (157), Expect = 2e-12
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 41/226 (18%)

Query: 9   PERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           PE L    E +G+G FG V KG+           +    VA+K++         +   +E
Sbjct: 2   PEELFTKLERIGKGSFGEVYKGI---------DNRTKEVVAIKIIDLEEAEDEIEDIQQE 52

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGD--------------LQSYLRE-- 110
           I ++       +I  + G   K  +L +++EY   G               + + LRE  
Sbjct: 53  ITVLSQCDS-PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL 111

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + + +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF----- 166

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
            W+A E +  + Y  K+D+WS G+   E+   G  P   +   R++
Sbjct: 167 -WMAPEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVL 210

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 64.2 bits (156), Expect = 2e-12
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 42/208 (20%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + +G+G FG   K  L    ++  S    ++  + + K     K   K  KE+ L+  + 
Sbjct: 6   KKIGEGSFG---KIYLAKAKSD--SEHCVIK-EIDLTKMPVKEKEASK--KEVILLAKM- 56

Query: 76  KHDHIVSFIGCCYKD-ELRLVVEYCALGDL----------------------QSYLREEY 112
           KH +IV+F     ++  L +V+EYC  GDL                      Q  L  ++
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116

Query: 113 LSNNKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLA 168
           + + K++HRD+ ++NI LS    V K+ DFG++  + +         G P       +L+
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY------YLS 170

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTL 196
            E   +  Y NK+D+WS G VL+E+ TL
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTL 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 3e-12
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 39/209 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     E +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 2   PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------- 110
           I ++       ++  + G   K  +L +++EY   G     LR                 
Sbjct: 53  ITVLSQCDS-PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL 111

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF----- 166

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEI 193
            W+A E +  + Y +K+D+WS G+   E+
Sbjct: 167 -WMAPEVIQQSAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 52/216 (24%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDV 74
            ++G+G +G+V+K    +      +GQ    VA+K    + D K   K  ++EI ++K +
Sbjct: 7   GLVGEGSYGMVMKCKHKE------TGQI---VAIKKFLESEDDKMVKKIAMREIRMLKQL 57

Query: 75  GKHDHIVSFIGCC-YKDELRLVVEY---CALGDLQSY----------------LRE-EYL 113
            +H+++V+ I     K  L LV E+     L DL+ Y                LR  E+ 
Sbjct: 58  -RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSE------DIYEQNVFQNGEPSEKLPIRWL 167
            ++ ++HRD+   NIL+S   VVK+ DFG +       ++Y   V            RW 
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV----------ATRWY 166

Query: 168 -ALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY 201
            A E LV +  Y    D+W+ G ++ E++T    P 
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLT--GEPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 64.3 bits (157), Expect = 3e-12
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 47/215 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKFLKEINLM 71
           VLG+G FG V   LL +    G         A+K LK     A  + ++     K I   
Sbjct: 6   VLGRGHFGKV---LLAEYKKTGEL------YAIKALKKGDIIARDEVESL-MCEKRIFET 55

Query: 72  KDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLREE------------------ 111
            +  +H  +V+    C++ E  +  V+EY A GDL  ++  +                  
Sbjct: 56  ANSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGL 114

Query: 112 -YLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
            YL  NK+V+RDL   N+LL +   VKI+DFGL  E +   +      G P       +L
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTP------EFL 168

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           A E L    YT   D W  GV+++E++ +G +P+P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEML-VGESPFP 202

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.9 bits (155), Expect = 4e-12
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 51/233 (21%)

Query: 1   MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT 60
           + +S G P E L     +G+G  G+V         TE  +G+   +VAVK +      + 
Sbjct: 13  LVVSPGDPREYLDSFIKIGEGSTGIVCIA------TEKHTGK---QVAVKKMDLRKQQRR 63

Query: 61  YDKFLKEINLMKDVGKHDHIVS-FIGCCYKDELRLVVEYC---ALGDLQSYLR--EE--- 111
            +    E+ +M+D   H+++V  +      DEL +V+E+    AL D+ ++ R  EE   
Sbjct: 64  -ELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA 121

Query: 112 -----------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                      YL N  V+HRD+ + +ILL+S   +K+SDFG    +           S+
Sbjct: 122 TVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-----------SK 170

Query: 161 KLPIR--------WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           ++P R        W+A E +    Y  + D+WS G+++ E++  G  PY + P
Sbjct: 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.5 bits (154), Expect = 5e-12
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 45/223 (20%)

Query: 4   SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           S G P +   + E +G+G +G V K       T    G  A   AVK+L   +D    ++
Sbjct: 16  SLGDPTDTWEIIETIGKGTYGKVYK------VTNKKDGSLA---AVKILDPISDVD--EE 64

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD------ELRLVVEYCALGDLQSYLRE------- 110
              E N+++ +  H ++V F G  YK       +L LV+E C  G +   ++        
Sbjct: 65  IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 111 -----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF 153
                            ++L NN+++HRD+   NILL++   VK+ DFG+S  +    + 
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 154 QN---GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
           +N   G P    P   +A E      Y  + DVWS G+   E+
Sbjct: 185 RNTSVGTPFWMAP-EVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.7 bits (153), Expect = 8e-12
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 39/179 (21%)

Query: 47  VAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE----LRLVVEYCALG 102
            A+K +K +  +      L+EI  ++ +  H +I+  I   + D     L LV E   L 
Sbjct: 27  YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLF-DRKTGRLALVFE---LM 82

Query: 103 DLQSYL----REEYLSNNKV-------------------VHRDLATRNILLSSPHVVKIS 139
           D+  Y     R+  L   +V                    HRD+   NIL+    + K++
Sbjct: 83  DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDIL-KLA 141

Query: 140 DFGLSEDIYEQNVFQNGEPSEKLPIRWL-ALESLVSN-IYTNKSDVWSFGVVLWEIVTL 196
           DFG    IY +  +     +E +  RW  A E L+++  Y  K D+W+ G V +EI++L
Sbjct: 142 DFGSCRGIYSKPPY-----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL 195

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 46/214 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           VLG+G FG V   LL       A  +   E+ AVK+LK +        +  + E  ++  
Sbjct: 2   VLGKGSFGKV---LL-------AELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLAL 51

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDL----QSYLR--EE-------------- 111
            GKH  +   +  C+  KD L  V+EY   GDL    Q   R  E               
Sbjct: 52  AGKHPFLTQ-LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQ 110

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           +L    +++RDL   N+LL S   +KI+DFG+  E I          G P       ++A
Sbjct: 111 FLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD------YIA 164

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            E L    Y    D W+ GV+L+E++  G +P+ 
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEML-AGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.0 bits (150), Expect = 2e-11
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 48/223 (21%)

Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           LS   P E   L + +G G +G V K           +G+ A   A+K++K     + + 
Sbjct: 2   LSRRNPQEDFELIQRIGSGTYGDVYKA------RNVNTGELA---AIKVIKLEP-GEDFA 51

Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQ--------------SY 107
              +EI +MKD  KH +IV++ G    +D+L + +E+C  G LQ              +Y
Sbjct: 52  VVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY 110

Query: 108 LREE------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEP 158
           +  E      YL +   +HRD+   NILL+    VK++DFG+S  I      +    G P
Sbjct: 111 VSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170

Query: 159 SEKLPIRWLALESLVSNI-----YTNKSDVWSFGVVLWEIVTL 196
                  W+A E  V+ +     Y    D+W+ G+   E+  L
Sbjct: 171 Y------WMAPE--VAAVERKGGYNQLCDIWAVGITAIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.0 bits (150), Expect = 2e-11
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 59/216 (27%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V          E  SG+   +VAVKM+      +  +    E+ +M+D  +H
Sbjct: 29  IGEGSTGIVCIA------REKHSGR---QVAVKMMDLRKQQRR-ELLFNEVVIMRDY-QH 77

Query: 78  DHIVSFIGCCYK-----DELRLVVEYC---ALGDLQSYLR--EE--------------YL 113
            ++V      YK     +EL +++E+    AL D+ S  R  EE              YL
Sbjct: 78  QNVVEM----YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYL 133

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-------- 165
            +  V+HRD+ + +ILL+    VK+SDFG    I           S+ +P R        
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-----------SKDVPKRKSLVGTPY 182

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           W+A E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 46/220 (20%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           V+G+G FG   + LL        S Q      +++ K+++  +   K   E  L+  + K
Sbjct: 7   VVGEGSFG---RALL---VQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKM-K 56

Query: 77  HDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE----------------------YL 113
           H +IV+F      D  L +V+EYC  GDL   ++ +                      ++
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLALE 170
              +V+HRD+ ++NI L+    VK+ DFG +  +     +     G P    P  W  + 
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLG----ANPYPHIPL 206
                 Y NKSD+WS G +L+E+ TL     AN + ++ L
Sbjct: 177 ------YNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 61.4 bits (149), Expect = 2e-11
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 60/204 (29%)

Query: 37  EGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK-----------DVG-----KHDHI 80
           EG+ G+A +      +K+  D K Y   +KEIN+ K           +V      KH +I
Sbjct: 10  EGSFGKAIL------VKSKEDGKQY--VIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 81  VSF------IGCCYKDELRLVVEYCALGDL----------------------QSYLREEY 112
           V +       G  Y     +V++YC  GDL                      Q  L  ++
Sbjct: 62  VQYQESFEENGNLY-----IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKH 116

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           + + K++HRD+ ++NI L+    +K+ DFG++  +   +  +        P  +L+ E  
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPY-YLSPEIC 173

Query: 173 VSNIYTNKSDVWSFGVVLWEIVTL 196
            +  Y NKSD+W+ G VL+E+ TL
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTL 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 40/210 (19%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K           + +     A K+++  ++ +  D ++ EI ++ 
Sbjct: 16  IIGE-LGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELED-YMVEIEILA 64

Query: 73  DVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------- 110
               H +IV  +G  Y D +L +++E+C  G + + + E                     
Sbjct: 65  TC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEAL 123

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
           +YL + K++HRDL   N+LL+    +K++DFG+S    + +  ++ F  G P    P   
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAP-EV 181

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           +  E++    Y  K+D+WS G+ L E+  +
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMAQI 211

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 60.4 bits (147), Expect = 5e-11
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 41/217 (18%)

Query: 14  LGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLM 71
            G  +G G FG V   + L  G            +AVK ++  + D KT  +   E+ ++
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGEL----------MAVKEIRIQDNDPKTIKEIADEMKVL 53

Query: 72  KDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE-------------------- 110
           + + KH ++V + G   +++++ + +EYC+ G L+  L                      
Sbjct: 54  ELL-KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGL 112

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN--VFQNGEPSEKLPIRWLA 168
            YL ++ +VHRD+   NI L    V+K+ DFG +  +      + +  +     P  ++A
Sbjct: 113 AYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA-YMA 171

Query: 169 LESLVSNIYTNK---SDVWSFGVVLWEIVTLGANPYP 202
            E +           +D+WS G V+ E+ T G  P+ 
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWS 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.3 bits (147), Expect = 6e-11
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 47/208 (22%)

Query: 18  LGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDVG 75
           +G+G +G V K   L  G            VA+K ++   ++       L+EI L+K + 
Sbjct: 7   IGEGAYGTVYKARDLNTGRF----------VALKKVRVPLSEEGIPLSTLREIALLKQLE 56

Query: 76  KHDH--IVSFIGCCYKDE------LRLVVEYCALGDLQSYLRE----------------- 110
             +H  IV  +  C+         L LV E+    DL +YL +                 
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                ++L ++++VHRDL  +NIL++S   VKI+DFGL+  IY    F+    S  + + 
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYS---FEMALTSVVVTLW 171

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEI 193
           + A E L+ + Y    D+WS G +  E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.0 bits (145), Expect = 6e-11
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 35/173 (20%)

Query: 57  DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----- 110
           DAK     +KEI+L+K +  H +++ +     +D EL +V+E    GDL   ++      
Sbjct: 42  DAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 100

Query: 111 -------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
                              E++ + +V+HRD+   N+ +++  VVK+ D GL      + 
Sbjct: 101 RLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160

Query: 152 VFQN---GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +   G P       +++ E +  N Y  KSD+WS G +L+E+  L +  Y
Sbjct: 161 TAAHSLVGTPY------YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 59.8 bits (145), Expect = 7e-11
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 35/203 (17%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           VLG+G FG           TE  S     EV +  L      K     L EI ++  + +
Sbjct: 7   VLGKGAFGEATLYR----RTEDDSLVVWKEVNLTRL----SEKERRDALNEIVILSLL-Q 57

Query: 77  HDHIVSFIGCCYKDELRLV-VEYCALGDL--------QSYLREE--------------YL 113
           H +I+++      D   L+ +EY   G L             EE              Y+
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
               ++HRD+ T NI L+   ++K+ DFG+S+ +  +  +   E     P  +++ E   
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTPY-YMSPELCQ 174

Query: 174 SNIYTNKSDVWSFGVVLWEIVTL 196
              Y  KSD+W+ G VL+E++TL
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTL 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 60.0 bits (145), Expect = 7e-11
 Identities = 66/248 (26%), Positives = 103/248 (41%), Gaps = 49/248 (19%)

Query: 16  EVLGQGEFGVVVKGLL---GDGPTEGASGQAAMEVAVKMLKANADAKTYD---KFLKEIN 69
           E LG+G    +  G+L    D   +G S +  ++V +K+L    D    D    F +  +
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL----DPSHRDISLAFFETAS 56

Query: 70  LMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE----------------- 111
           +M+ V  H HIV   G C +D E  +V E+   G L  ++  +                 
Sbjct: 57  MMRQV-SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115

Query: 112 ----YLSNNKVVHRDLATRNILLSSPHV-------VKISDFGLSEDIYEQNVFQNGEPSE 160
               YL +  +VH ++ T+NILL+   +       +K+SD G+        V    E  E
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-----ITVLSRQECVE 170

Query: 161 KLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM 219
           ++P  W+A E +  S   +  +D WSFG  LWEI   G  P     L     +      +
Sbjct: 171 RIP--WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML 228

Query: 220 ERPASCNE 227
             P SC E
Sbjct: 229 VTP-SCKE 235

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.3 bits (147), Expect = 7e-11
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 54/213 (25%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF---------LKEI 68
           LG+G +G+V K +  D  T+         VA+K        K +D F          +EI
Sbjct: 15  LGKGAYGIVWKAI--DRRTK-------EVVALK--------KIFDAFRNATDAQRTFREI 57

Query: 69  NLMKDVGKHDHIVSFIGCCYKDE----LRLVVEYCALGDLQSYLR----EE--------- 111
             ++++G H +IV  +    K E    + LV EY    DL + +R    E+         
Sbjct: 58  MFLQELGDHPNIVKLLNV-IKAENDKDIYLVFEY-METDLHAVIRANILEDVHKRYIMYQ 115

Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE-QNVFQNGEPSEKLPI 164
                 Y+ +  V+HRDL   NILL+S   VK++DFGL+  + E +   +N   ++ +  
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 165 RWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
           RW  A E L+ S  YT   D+WS G +L E++ 
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 9e-11
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 35/173 (20%)

Query: 57  DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----- 110
           DAK     +KEI+L+K +  H +++ ++    +D EL +V+E    GDL   ++      
Sbjct: 42  DAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK 100

Query: 111 -------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
                              E++ + +V+HRD+   N+ +++  VVK+ D GL      + 
Sbjct: 101 RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160

Query: 152 VFQN---GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +   G P       +++ E +  N Y  KSD+WS G +L+E+  L +  Y
Sbjct: 161 TAAHSLVGTPY------YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 47/209 (22%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK---FLKEINLMKD 73
           V+G+G FG+V                    V +K +    +  T D+      E  ++K 
Sbjct: 7   VVGRGAFGIVHLCRRKA---------DQKLVIIKQI--PVEQMTKDERLAAQNECQVLKL 55

Query: 74  VGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE--------------------- 111
           +  H +I+ +     +D+ L +V+EY   G L  Y+++                      
Sbjct: 56  L-SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114

Query: 112 -YLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
            ++    ++HRDL T+NILL     VVKI DFG+S+ +  ++      G P       ++
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPC------YI 168

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           + E      Y  KSD+W+ G VL+E+ +L
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASL 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 66/236 (27%), Positives = 99/236 (41%), Gaps = 53/236 (22%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY--DKFLKEINLMKDVG 75
           LGQG +G+V            A       VA+K +  N  +K     + L+E+ L++   
Sbjct: 8   LGQGAYGIVCS-------ARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFR 59

Query: 76  KHDHIVSFIGCCYK---------DELRLVVEYC------------ALGD--LQSYLRE-- 110
            H +I     C Y          +EL L  E               L D   QS++ +  
Sbjct: 60  GHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
              +Y+ +  V+HRDL   N+L+++   +KI DFGL+    E      G  +E +  RW 
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 168 -ALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANP------YPHIPLCRIVHYLST 215
            A E ++S   YT   DVWS G +L E+  LG  P      Y    L +I+  L T
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAEL--LGRKPVFKGKDYVD-QLNQILQVLGT 228

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 46/213 (21%)

Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT--YDKF 64
           PE+L   L E+ G G FG V      D  T          VA+K +  +       +   
Sbjct: 23  PEKLFTDLREI-GHGSFGAVY--FARDVRTNEV-------VAIKKMSYSGKQSNEKWQDI 72

Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYC--ALGDL----QSYLRE------- 110
           +KE+  ++ + KH + + + GC  ++    LV+EYC  +  DL    +  L+E       
Sbjct: 73  IKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT 131

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                   YL ++ ++HRD+   NILL+ P  VK++DFG +      N F  G P     
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-GTP----- 185

Query: 164 IRWLALESLVS---NIYTNKSDVWSFGVVLWEI 193
             W+A E +++     Y  K DVWS G+   E+
Sbjct: 186 -YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 58/233 (24%)

Query: 10  ERLI-LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF---- 64
           ER I  G  LG+G +G V K        +  +G+    VA+K +K    +    K     
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAY------DTLTGK---IVAIKKVKIIEISNDVTKDRQLV 58

Query: 65  ---------LKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQS------YL 108
                    L+E+ +M ++ KH++I+  +      D + LV++  A  DL+        L
Sbjct: 59  GMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRL 116

Query: 109 REEY--------------LSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQ 150
            E                L     +HRDL+  NI ++S  + KI+DFGL+       Y  
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 151 NVF--QNGEPSEKLPIRWLAL-----ESLV-SNIYTNKSDVWSFGVVLWEIVT 195
            +   +  +  E++  + + L     E L+ +  Y    D+WS G +  E++T
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 34/173 (19%)

Query: 47  VAVKMLKANADA--KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYC--AL 101
           VA+K +  +     + +   +KE+  ++ + +H + + + GC  ++    LV+EYC  + 
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSA 101

Query: 102 GDL----QSYLRE--------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
            DL    +  L+E               YL ++ ++HRD+   NILLS P +VK+ DFG 
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 161

Query: 144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEI 193
           +  +   N F  G P       W+A E +++     Y  K DVWS G+   E+
Sbjct: 162 ASIMAPANXFV-GTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 42/208 (20%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  G V K        +       M  A K++   A +    + L+E+ +M +  + 
Sbjct: 13  LGAGNGGSVSK-------VKHIPTGTVM--AKKVVHIGAKSSVRKQILRELQIMHEC-RS 62

Query: 78  DHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE--------------------EYLSN- 115
            +IVSF G    ++ + + +E+   G L    ++                     YL N 
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLALESLV 173
           ++++HRD+   NIL++S   +K+ DFG+S ++     + F            +++ E + 
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST-------YMSPERIQ 175

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              YT KSDVWS G+ + E+  LG  P+
Sbjct: 176 GGKYTVKSDVWSLGISIIELA-LGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 30/150 (20%)

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE-------------- 110
           E  ++K+V  H  I+        D+  L +++EY   G+L SYLR               
Sbjct: 51  EKRVLKEV-SHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                 EYL + ++V+RDL   NILL     +K++DFG ++ + ++     G P      
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE----- 163

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
            +LA E + S  +    D W+ G++++E++
Sbjct: 164 -YLAPEVIQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-10
 Identities = 65/264 (24%), Positives = 103/264 (39%), Gaps = 85/264 (32%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEI 68
           I G + G+G +G V K    +G           E A+K  K   D + Y        +EI
Sbjct: 4   IEGCI-GRGTYGRVYKAKRKNGKDGK-------EYAIKKFKG--DKEQYTGISQSACREI 53

Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR---LVVEYCA--LGDLQSYLREE------------ 111
            L++++ KH+++VS +    +   +   L+ +Y    L  +  + R+             
Sbjct: 54  ALLREL-KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 112 ----------YLSNNKVVHRDLATRNILLSSPH----VVKISDFGLSEDIYEQNVFQNGE 157
                     YL +N V+HRDL   NIL+        VVKI D GL+       +F    
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR------LFNA-- 164

Query: 158 PSEKLPIRWLA-LESLVSNI-------------YTNKSDVWSFGVVLWEIVTL------- 196
                P++ LA L+ +V  I             YT   D+W+ G +  E++TL       
Sbjct: 165 -----PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219

Query: 197 -----GANPYPHIPLCRIVHYLST 215
                 +NP+    L RI   L T
Sbjct: 220 EAKIKKSNPFQRDQLERIFEVLGT 243

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 57.6 bits (140), Expect = 6e-10
 Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 40/168 (23%)

Query: 65  LKEINLMKDVGKHDHIVSFIGC---CYKDELRLVVEYCALGDLQSYLRE----------- 110
           ++EI L++ + +H +IV          K  + +V EY    DL   L             
Sbjct: 46  IREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIK 103

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                     +YL +N ++HRD+   NIL+++  V+K++DFGL+              S 
Sbjct: 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSA 156

Query: 161 KLPIRWLAL-----ESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
               R + L     E L+ +  Y  + D+WS G +L E+   G   + 
Sbjct: 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQ 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 57.3 bits (138), Expect = 7e-10
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 43/215 (20%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPT-EGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           R IL + LG+G FG V   L+ D         +   E+ V  L  N   +      +E  
Sbjct: 1   RYILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQ 54

Query: 70  LMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE------------------ 110
           L+  +  H  IV F      +D   ++ EYC   DL   L E                  
Sbjct: 55  LLSKL-DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGEPSEK 161
                  Y+   +++HRDL  +NI L + +++KI DFG+S  +    +      G P   
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTP--- 169

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
               +++ E+L    Y +KSD+WS G +L+E+  L
Sbjct: 170 ---YYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 56.8 bits (137), Expect = 9e-10
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 42/212 (19%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           VLG+G +G+V                  + +A+K +    D++      +EI L   + K
Sbjct: 15  VLGKGTYGIVYAA---------RDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYL-K 63

Query: 77  HDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE-----------------------Y 112
           H +IV ++G   +    ++ +E    G L + LR +                       Y
Sbjct: 64  HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 113 LSNNKVVHRDLATRNILLSS-PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           L +N++VHRD+   N+L+++   VVKISDFG S+ +   N       +    ++++A E 
Sbjct: 124 LHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE---TFTGTLQYMAPEV 180

Query: 172 LVSNI--YTNKSDVWSFGVVLWEIVTLGANPY 201
           +      Y   +D+WS G  + E+ T G  P+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMAT-GKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 41/212 (19%)

Query: 16  EVLGQGEFGVV--VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF--LKEINLM 71
           +VLGQG FG V  V+ + G       +GQ     A+K+LK  A  K  D+     E +++
Sbjct: 2   KVLGQGSFGKVFLVRKITGPD-----AGQL---YAMKVLK-KATLKVRDRVRTKMERDIL 52

Query: 72  KDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL---------------QSYLRE---- 110
            +V  H  IV  +   ++ E  L L++++   GDL               + YL E    
Sbjct: 53  AEVN-HPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 110

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            ++L +  +++RDL   NILL     +K++DFGLS++  +    +    S    + ++A 
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EKKAYSFCGTVEYMAP 167

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    +T  +D WSFGV+++E++T G+ P+
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLT-GSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 46/214 (21%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV- 74
           +VLG+G FG V   LL +   +G         AVK LK   D    D  ++   + K V 
Sbjct: 1   KVLGKGSFGKV---LLAELKGKGEY------FAVKALKK--DVVLIDDDVECTMVEKRVL 49

Query: 75  --GKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLRE-------------------- 110
                +  ++ + C +  K+ L  V+E+   GDL  ++++                    
Sbjct: 50  ALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGL 109

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           ++L +  +++RDL   N++L     +KI+DFG+  E+++  N      G P       ++
Sbjct: 110 QFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPD------YI 163

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    YT   D WSFGV+L+E++ +G +P+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEML-IGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 40/204 (19%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQA-AMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           ++LG+G FG V+         E ASG+  AM++  K +    D   +   L E  ++K+ 
Sbjct: 1   KLLGKGTFGKVIL------VREKASGKYYAMKILKKEVIIAKDEVAHT--LTESRVLKNT 52

Query: 75  GKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE--------------------YL 113
            +H  + S       KD L  V+EY   G+L  +L  E                    YL
Sbjct: 53  -RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYL 111

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALE 170
            + K+V+RDL   N++L     +KI+DFGL  E I +    +   G P       +LA E
Sbjct: 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP------EYLAPE 165

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIV 194
            L  N Y    D W  GVV++E++
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 60/216 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDV 74
           E +G+G +GVV KG          +GQ    VA+K ++  + +       ++EI+L+K++
Sbjct: 6   EKIGEGTYGVVYKG------RNKKTGQI---VAMKKIRLESEEEGVPSTAIREISLLKEL 56

Query: 75  GKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYL----REEYLS--------------- 114
            +H +IV       ++  L L+ E+ ++ DL+ YL    + +Y+                
Sbjct: 57  -QHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 115 ----NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR----- 165
               + +V+HRDL  +N+L+ +  V+K++DFGL+                 +P+R     
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-------------GIPVRVYTHE 161

Query: 166 ----WL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
               W  A E L+ S  Y+   D+WS G +  E+ T
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 40/158 (25%)

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE---------- 110
           + L+E N       H  IV      +KD+  + +++EYC  G+L + LR+          
Sbjct: 45  EILEECN-------HPFIVKLY-RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR 96

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                     EYL N  +++RDL   N+LL S   VK+ DFG ++ +       +G+ + 
Sbjct: 97  FYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK------SGQKTW 150

Query: 161 KL---PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                P  ++A E +++  Y    D WS G++L+E++T
Sbjct: 151 TFCGTP-EYVAPEIILNKGYDFSVDYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 25/131 (19%)

Query: 90  DELRLVVEYCALGDLQSYLRE---------EY---------------LSNNKVVHRDLAT 125
           D+L L++EY + GDL   +++         EY               + + K++HRDL +
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197

Query: 126 RNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWS 185
            NI L    ++K+ DFG S+  Y  +V  +   S      +LA E      Y+ K+D+WS
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256

Query: 186 FGVVLWEIVTL 196
            GV+L+E++TL
Sbjct: 257 LGVILYELLTL 267

Length = 478

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 41/215 (19%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY-DKFLKE 67
             R      +G+G +G+V        PT    G    +VA+K +    + +T+  + L+E
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSAT--HKPT----GV---KVAIKKISP-FEHQTFCQRTLRE 53

Query: 68  INLMKDVGKHDHIVSF------IGCCYKDELRLVVEYCALGDLQSYLREEYLSNN----- 116
           I +++   KH++I+              +++ +V E     DL   ++ ++LSN+     
Sbjct: 54  IKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYF 111

Query: 117 --------------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                          V+HRDL   N+LL++   +KI DFGL+  I +      G  +E +
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTEYV 170

Query: 163 PIRWL-ALE-SLVSNIYTNKSDVWSFGVVLWEIVT 195
             RW  A E  L S  YT   D+WS G +L E+++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 40/157 (25%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD-KFLKEINLMKDVGK 76
           +GQG FG V K           + Q    VA+K +    + + +    L+EI +++ + K
Sbjct: 20  IGQGTFGEVFKA------RHKKTKQI---VALKKVLMENEKEGFPITALREIKILQLL-K 69

Query: 77  HDHIVSFIGCC---------YKDELRLVVEYCA---------------LGDLQSYLRE-- 110
           H+++V+ I  C         YK    LV E+C                L +++  ++   
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS 144
               Y+  NK++HRD+   NIL++   ++K++DFGL+
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 37/204 (18%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLM 71
           +LG V+G+G +GVV+K             +    VA+K  K +  + +  +  L+E+ ++
Sbjct: 5   VLG-VVGEGAYGVVLKC---------RHKETKEIVAIKKFKDSEENEEVKETTLRELKML 54

Query: 72  KDVGKHDHIVSFIGCCYK-DELRLVVEYC--------------ALGD-LQSYLRE----- 110
           + + K ++IV       +  +L LV EY                  + ++SY+ +     
Sbjct: 55  RTL-KQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI 113

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-AL 169
            +   N +VHRD+   N+L+S   V+K+ DFG + ++ E +   N   +E +  RW  + 
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS---NANYTEYVATRWYRSP 170

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEI 193
           E L+   Y    D+WS G +L E+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 55.6 bits (135), Expect = 3e-09
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 51/213 (23%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-----DAKTYDKFLKEINLM 71
            +G G +GVV   +  D  T         +VA+K + +N      DAK   + L+EI L+
Sbjct: 7   PIGSGAYGVVCSAV--DKRTG-------RKVAIKKI-SNVFDDLIDAK---RILREIKLL 53

Query: 72  KDVGKHDHIVSFI-------GCCYKDELRLVVEYCALGDLQSYLREE------------- 111
           + + +H++I+  +          + D + +V E     DL   ++               
Sbjct: 54  RHL-RHENIIGLLDILRPPSPEDFND-VYIVTEL-METDLHKVIKSPQPLTDDHIQYFLY 110

Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL +  V+HRDL   NIL++S   +KI DFGL+  +      + G  +E +  
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK-GFLTEYVVT 169

Query: 165 RWL-ALE-SLVSNIYTNKSDVWSFGVVLWEIVT 195
           RW  A E  L S+ YT   D+WS G +  E++T
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 33/148 (22%)

Query: 76  KHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLREE---------------------- 111
           KH +IV++      ++  L +V+ +C  GDL   L+E+                      
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLA 168
           YL    ++HRDL T+N+ L+  +++K+ D G++  +  Q    +   G P       +++
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY------YMS 170

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTL 196
            E   +  Y  KSDVW+ G  ++E+ TL
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATL 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 55.5 bits (134), Expect = 3e-09
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 51/217 (23%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           LGE LG G  GVV K L         SG   + +A K++         ++ ++E+ ++ +
Sbjct: 6   LGE-LGAGNGGVVTKVL------HRPSG---LIMARKLIHLEIKPAIRNQIIRELKVLHE 55

Query: 74  VGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SY 107
                +IV F G  Y D E+ + +E+   G L                          +Y
Sbjct: 56  C-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114

Query: 108 LREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIR 165
           LRE++    K++HRD+   NIL++S   +K+ DFG+S  + +   N F  G  S      
Sbjct: 115 LREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRS------ 163

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           +++ E L    YT +SD+WS G+ L E+   G  P P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAI-GRYPIP 199

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.5 bits (131), Expect = 6e-09
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 46/223 (20%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E  +L E LG+G +G V K L    PT        + +A+K ++   D   +++ + E++
Sbjct: 2   EIEVLDE-LGKGNYGSVYKVL--HRPT-------GVTMAMKEIRLELDESKFNQIIMELD 51

Query: 70  LMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQS---------------------- 106
           ++       +IV F G  + +  + + +EY   G L                        
Sbjct: 52  ILHKAVS-PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA 110

Query: 107 ------YLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN-GEPS 159
                 +L+EE+     ++HRD+   N+L++    VK+ DFG+S ++       N G  S
Sbjct: 111 VVKGLKFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS 166

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
              P R  +     +  YT +SDVWS G+ + E+  LG  PYP
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM-ALGRYPYP 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 54.4 bits (131), Expect = 7e-09
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 47/209 (22%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY-DKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 6   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 56

Query: 75  GKHDHIVSFIGCCYKD-ELRLVVEY-----------CALGDL-----QSYLRE-----EY 112
             H +IV  +   + + +L LV E+             L  +     +SYL +      +
Sbjct: 57  -NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP-----SEKLPIRWL 167
             +++V+HRDL  +N+L+++   +K++DFGL+           G P      E + + + 
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--------GVPVRTYTHEVVTLWYR 167

Query: 168 ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
           A E L+    Y+   D+WS G +  E+VT
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.3 bits (131), Expect = 8e-09
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 38/202 (18%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDVGK 76
           +G+G +GVV K    +      +GQ    VA+K    + D     K  L+EI ++K + K
Sbjct: 9   IGEGSYGVVFKCRNRE------TGQI---VAIKKFVESEDDPVIKKIALREIRMLKQL-K 58

Query: 77  HDHIVSFIGCC-YKDELRLVVEYC---ALGDL-----------------QSYLREEYLSN 115
           H ++V+ I     K +L LV EYC    L +L                 Q+     +   
Sbjct: 59  HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-ALESLVS 174
           +  +HRD+   NIL++    +K+ DFG +  +         + ++ +  RW  A E LV 
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTG----PGDDYTDYVATRWYRAPELLVG 174

Query: 175 NI-YTNKSDVWSFGVVLWEIVT 195
           +  Y    DVW+ G V  E++T
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.4 bits (131), Expect = 8e-09
 Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 30/136 (22%)

Query: 89  KDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNI 128
           K+ L  V+EY   GDL  +++                     ++L    +++RDL   N+
Sbjct: 68  KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNV 127

Query: 129 LLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTNKSDVWS 185
           LL     +KI+DFG+  E++  +       G P       ++A E L    Y    D WS
Sbjct: 128 LLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD------YIAPEILKGQKYNESVDWWS 181

Query: 186 FGVVLWEIVTLGANPY 201
           FGV+L+E++ +G +P+
Sbjct: 182 FGVLLYEML-IGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 30/83 (36%), Positives = 50/83 (60%), Gaps = 4/83 (4%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           ++L +++VVHRDL  +NIL++S   +K++DFGL+  IY    FQ    S  + + + A E
Sbjct: 124 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYS---FQMALTSVVVTLWYRAPE 179

Query: 171 SLVSNIYTNKSDVWSFGVVLWEI 193
            L+ + Y    D+WS G +  E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 48/162 (29%)

Query: 80  IVSFIGCCY--KDELRLVVEYCALGDLQSYLRE--------------------EYLSNNK 117
           +VS   C +  K  L +V+EY   GD  + L+                     EYL N  
Sbjct: 63  VVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSE--------DIYEQNV------FQN----GEPS 159
           +VHRDL   N+L++S   +K++DFGLS+        ++YE ++      F +    G P 
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP- 180

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                 ++A E ++   Y    D W+ G++L+E + +G  P+
Sbjct: 181 -----EYIAPEVILRQGYGKPVDWWAMGIILYEFL-VGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 64/216 (29%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           ++LG+G FG V+  L+     E A+G+     A+K+LK            KE+ + KD  
Sbjct: 1   KLLGKGTFGKVI--LV----REKATGKY---YAMKILK------------KEVIIAKDEV 39

Query: 76  KHDHIVSFI--GCCY------------KDELRLVVEYCALGDLQSYLREE---------- 111
            H    S +     +             D L  V+EY   G+L  +L  E          
Sbjct: 40  AHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 99

Query: 112 ----------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEP 158
                     YL +  VV+RDL   N++L     +KI+DFGL  E I +    +   G P
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159

Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
                  +LA E L  N Y    D W  GVV++E++
Sbjct: 160 ------EYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 67/260 (25%), Positives = 99/260 (38%), Gaps = 65/260 (25%)

Query: 18  LGQGEFGVVVKGLL---------------GDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           LGQG    +  G L                D   EG +    + V +K+L    D    D
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVL----DPSHRD 58

Query: 63  ---KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE------- 111
               F +  +LM  V  H H+    G C +  E  +V E+   G L   LR+E       
Sbjct: 59  IALAFFETASLMSQV-SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVA 117

Query: 112 --------------YLSNNKVVHRDLATRNILL--------SSPHVVKISDFGLSEDIYE 149
                         YL +  +VH ++  +NILL        +SP  +K+SD G+S     
Sbjct: 118 WKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP-FIKLSDPGVS----- 171

Query: 150 QNVFQNGEPSEKLPIRWLALESL--VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC 207
                  E  E++P  W+A E +   +++ T  +D WSFG  L EI   G  P       
Sbjct: 172 FTALSREERVERIP--WIAPECVPGGNSLST-AADKWSFGTTLLEICFDGEVPLKERTPS 228

Query: 208 RIVHYLSTGYRMERPASCNE 227
               +    +R+  P SC E
Sbjct: 229 EKERFYEKKHRLPEP-SCKE 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 30/136 (22%)

Query: 89  KDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNI 128
           K+ L  V+EY   GDL  +++                     ++L +  +V+RDL   NI
Sbjct: 68  KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNI 127

Query: 129 LLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLALESLVSNIYTNKSDVWS 185
           LL +   +KI+DFG+ ++    +       G P       ++A E L+   Y    D WS
Sbjct: 128 LLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD------YIAPEILLGQKYNTSVDWWS 181

Query: 186 FGVVLWEIVTLGANPY 201
           FGV+L+E++ +G +P+
Sbjct: 182 FGVLLYEML-IGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 7/112 (6%)

Query: 87  CY-KDELRLVVEYCALGDLQ-SYLRE-EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           CY   +  + +  C +  ++ S LR  +YL  N+++HRD+   NI ++ P  V + DFG 
Sbjct: 171 CYLAAKRNIAI--CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA 228

Query: 144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           +   +  ++  N        I   A E L  + Y    D+WS G+VL+E+ T
Sbjct: 229 A--CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 46/216 (21%)

Query: 18  LGQGEFGVVVKGLL--GDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKD 73
           LG G FG V+       D P           VA+K  + +     K  D    E  ++  
Sbjct: 38  LGTGSFGRVILATYKNEDFPP----------VAIKRFEKSKIIKQKQVDHVFSERKILNY 87

Query: 74  VGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE--------------------E 111
           +  H   V+  G  +KDE  L LV+E+   G+  ++LR                     E
Sbjct: 88  I-NHPFCVNLYGS-FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           YL +  +V+RDL   N+LL     +K++DFG ++ +  +     G P       ++A E 
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTP------EYIAPEI 199

Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANP-YPHIPL 206
           L++  +   +D W+ G+ ++EI+ +G  P Y + PL
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEIL-VGCPPFYANEPL 234

Length = 340

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E  I  E LG+G +  V KG          S      VA+K ++   +       ++E++
Sbjct: 6   ETYIKLEKLGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVS 56

Query: 70  LMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------ 110
           L+KD+ KH +IV+     + D+ L LV EY    DL+ Y+ +                  
Sbjct: 57  LLKDL-KHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQIL 114

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               Y    KV+HRDL  +N+L++    +K++DFGL+     ++V      +E + + + 
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171

Query: 168 ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             + L+ S+ Y+ + D+W  G + +E+ +
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.9 bits (124), Expect = 4e-08
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 51/216 (23%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V         T  +SG+    VAVK +      +  +    E+ +M+D  +H
Sbjct: 28  IGEGSTGIVCIA------TVKSSGKL---VAVKKMDLRKQQRR-ELLFNEVVIMRDY-QH 76

Query: 78  DHIVSFIGC-CYKDELRLVVEYC---ALGDLQSYLR--EEYLSN--------------NK 117
           +++V         DEL +V+E+    AL D+ ++ R  EE ++                 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136

Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--------WLAL 169
           V+HRD+ + +ILL+    VK+SDFG    +           S+++P R        W+A 
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKSLVGTPYWMAP 185

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           E +    Y  + D+WS G+++ E+V  G  PY + P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.1 bits (125), Expect = 5e-08
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEINLMKDVG 75
           VLG+G +G V +     G   G     AM+V  K  +  N     + K   E N+++ V 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKI--FAMKVLKKATIVRNQKDTAHTK--AERNILEAV- 57

Query: 76  KHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYL-RE-------------------EYLS 114
           KH  IV  I       +L L++EY + G+L  +L RE                   E+L 
Sbjct: 58  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALES 171
              +++RDL   NILL +   VK++DFGL  E I+E  V     G       I ++A E 
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGT------IEYMAPEI 171

Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           L+ + +    D WS G ++++++T GA P+
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLT-GAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 35/159 (22%)

Query: 65  LKEINLMKDVGKHDH--IVSFIGCC------YKDELRLVVEYCALGDLQSYLRE------ 110
           ++E+ L+K +   DH  IV  +  C       + ++ LV E+    DL++YL +      
Sbjct: 47  VREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGL 105

Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                           ++L  N +VHRDL   NIL++S   VK++DFGL+  IY     Q
Sbjct: 106 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYS---CQ 161

Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
                  + + + A E L+ + Y    D+WS G +  E+
Sbjct: 162 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 46/193 (23%)

Query: 46  EVAVKMLK--ANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK--DEL-RLVV--EY 98
           EV ++  K          D    EI  ++ +   ++I+   G      D+L RL +  EY
Sbjct: 45  EVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILEY 103

Query: 99  CALGDLQSYLREE----------------------YLSNNKVVHRDLATRNILLSSPHVV 136
           C  G L+  L +E                      Y   NK  +++L + + L++  + +
Sbjct: 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKL 162

Query: 137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES--LVSNI---YTNKSDVWSFGVVLW 191
           KI   GL E I     F+N        + ++   S  ++++I   YT K D++S GVVLW
Sbjct: 163 KIICHGL-EKILSSPPFKN--------VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213

Query: 192 EIVTLGANPYPHI 204
           EI T G  P+ ++
Sbjct: 214 EIFT-GKIPFENL 225

Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.0 bits (124), Expect = 6e-08
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 13  LGAGNGGVVFK--VSHKPS-------GLIMARKLIHLEIKPAIRNQIIRELQVLHECNS- 62

Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 123 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 171

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEM-AIGRYPIP 203

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.5 bits (124), Expect = 7e-08
 Identities = 53/225 (23%), Positives = 86/225 (38%), Gaps = 57/225 (25%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEIN 69
           +   LG+G FG V K        +  +G+    VA+K +    + K  D F    L+EI 
Sbjct: 12  ILGKLGEGTFGEVYKAR------QIKTGRV---VALKKI-LMHNEK--DGFPITALREIK 59

Query: 70  LMKDVGKHDHIVSFI--------------GCCYKDELRLVVEYCAL----------GDLQ 105
           ++K + KH ++V  I              G  Y     +  +   L            ++
Sbjct: 60  ILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118

Query: 106 SYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
            Y+ +      YL  N ++HRD+   NIL+ +  ++KI+DFGL+   Y+           
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPNPKGGGG 177

Query: 161 KLP--------IRWLALESLVSNI--YTNKSDVWSFGVVLWEIVT 195
                       RW     L+     YT   D+W  G V  E+ T
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.5 bits (123), Expect = 7e-08
 Identities = 41/129 (31%), Positives = 58/129 (44%), Gaps = 29/129 (22%)

Query: 89  KDELRLVVEYCALGDLQSYL-RE-------------------EYLSNNKVVHRDLATRNI 128
            D L  V+EY   G+L  +L RE                   EYL +  VV+RD+   N+
Sbjct: 67  HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 126

Query: 129 LLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTNKSDVWS 185
           +L     +KI+DFGL  E I +    +   G P       +LA E L  N Y    D W 
Sbjct: 127 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTP------EYLAPEVLEDNDYGRAVDWWG 180

Query: 186 FGVVLWEIV 194
            GVV++E++
Sbjct: 181 LGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 8e-08
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 60/222 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAME-VAVKMLKANADAKTYDKF-LKEINLMKD 73
           E +G+G +G V K          A  +   E VA+K ++ + D +      L+EI L+K+
Sbjct: 6   EKIGEGTYGTVFK----------AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE 55

Query: 74  VGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------E 111
           + KH +IV      + D +L LV EYC   DL+ Y                         
Sbjct: 56  L-KHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +  ++ V+HRDL  +N+L++    +K++DFGL+              +  +P+R  + E 
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-------------AFGIPVRCYSAEV 160

Query: 172 LV-----------SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           +            + +Y+   D+WS G +  E+   G   +P
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.2 bits (122), Expect = 9e-08
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 37/201 (18%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G +  V KG          S      VA+K ++   +       ++E++L+K++ KH
Sbjct: 13  LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KH 62

Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSN 115
            +IV+     + +  L LV EY    DL+ YL                        Y   
Sbjct: 63  ANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-S 174
            K++HRDL  +N+L++    +K++DFGL+     ++V      +E + + +   + L+ S
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGS 178

Query: 175 NIYTNKSDVWSFGVVLWEIVT 195
             Y+   D+W  G +L+E+ T
Sbjct: 179 TEYSTPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 51.3 bits (123), Expect = 9e-08
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 48/214 (22%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANADAKTYDKFLKEINLMKDV- 74
           VLG+G FG V+           A  +   E+ A+K+LK   D    D  ++   + K V 
Sbjct: 7   VLGKGSFGKVML----------AERKGTDELYAIKILKK--DVIIQDDDVECTMVEKRVL 54

Query: 75  --GKHDHIVSFIGCCYK--DELRLVVEYCALGDLQSYLREE------------------- 111
                   ++ +  C++  D L  V+EY   GDL  ++++                    
Sbjct: 55  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 112 -YLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
            +L +  +++RDL   N++L +   +KI+DFG+  E+I+     +   G P       ++
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD------YI 168

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E +    Y    D W+FGV+L+E++  G  P+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 51.2 bits (122), Expect = 9e-08
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 42/209 (20%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 13  LGAGNGGVVTK--VQHKPS-------GLIMARKLIHLEIKPAIRNQIIRELQVLHECNS- 62

Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE--------------------YL-SN 115
            +IV F G  Y D E+ + +E+   G L   L+E                     YL   
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLALESLV 173
           ++++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ E L 
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSPERLQ 175

Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
              Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEL-AIGRYPIP 203

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 37/201 (18%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G +  V KG          S      VA+K ++   +       ++E++L+KD+ KH
Sbjct: 14  LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KH 63

Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSN 115
            +IV+     + ++ L LV EY    DL+ YL +                      Y   
Sbjct: 64  ANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122

Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-S 174
            KV+HRDL  +N+L++    +K++DFGL+     +++      +E + + +   + L+ S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGS 179

Query: 175 NIYTNKSDVWSFGVVLWEIVT 195
             Y+ + D+W  G + +E+ T
Sbjct: 180 TDYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 46/214 (21%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMK 72
           +VLG+G FG V+           A  +   EV A+K+LK +        D  + E  ++ 
Sbjct: 1   KVLGKGSFGKVML----------AELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA 50

Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDL---------------QSYLRE----- 110
              KH  + + + CC+  KD L  V+EY   GDL               + Y  E     
Sbjct: 51  LAAKHPFLTA-LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
            +L  + V++RDL   NILL +    K++DFG+  E I          G P       ++
Sbjct: 110 MFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD------YI 163

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D W+ GV+++E++  G  P+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMA-GQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 14/97 (14%)

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRWL 167
           YL + K++HRD+   N+L+++   VK+ DFG+S      I +  V  N          ++
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA---------YM 160

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           A E +    Y   SDVWS G+   E+  LG  PYP I
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMEL-ALGRFPYPQI 196

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 39/176 (22%)

Query: 47  VAVKMLKANADAKTYDKFL---KEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALG 102
           VAVK  K N D+ + +      +EI   + + +H +I+ ++       EL +V    A G
Sbjct: 28  VAVK--KINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYG 84

Query: 103 DLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD 140
             +  L+                       +Y+ +   +HR +   +ILLS    V +S 
Sbjct: 85  SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSG 144

Query: 141 FGLSEDIYEQN-----VFQNGEPSEK-LPIRWLALESLVSNI--YTNKSDVWSFGV 188
              S  + +       V    + S K LP  WL+ E L  N+  Y  KSD++S G+
Sbjct: 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLP--WLSPEVLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 60/229 (26%), Positives = 91/229 (39%), Gaps = 67/229 (29%)

Query: 17  VLGQGEFGVV--VKGLLGDGPTEGASGQA-AMEVAVK--MLKANADAKTYDKFLKEINLM 71
           V+G+G FG V  V+        +  +GQ  AM+V  K  M+K N  A        E +++
Sbjct: 8   VIGRGAFGEVWLVR--------DKDTGQVYAMKVLRKSDMIKRNQIA----HVRAERDIL 55

Query: 72  KDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYL------REE------------ 111
            D      IV      ++DE  L LV+EY   GDL + L       EE            
Sbjct: 56  AD-ADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113

Query: 112 --YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-------YEQNVFQNGEPSEKL 162
              +     +HRD+   NIL+ +   +K++DFGL + +       Y  N   N    + +
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 163 PIRW-------------------LALESLVSNIYTNKSDVWSFGVVLWE 192
            +R                    +A E L    Y  + D WS GV+L+E
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 54/226 (23%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDKFLKEIN-LMK 72
           +V+G+G FG V   LL     +G         AVK+L  K   + K     + E N L+K
Sbjct: 1   KVIGKGSFGKV---LLAKRKLDGKC------YAVKVLQKKIVLNRKEQKHIMAERNVLLK 51

Query: 73  DVGKHDHIVSFIGCCYK----DELRLVVEYCALGDLQSYLREE----------------- 111
           +V KH  +V   G  Y     ++L  V+++   G+L  +L+ E                 
Sbjct: 52  NV-KHPFLV---GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIAS 107

Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED---IYEQNVFQNGEPSEKLPIR 165
              YL +  +V+RDL   NILL S   V ++DFGL ++     +      G P       
Sbjct: 108 ALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP------E 161

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH 211
           +LA E +    Y N  D W  G VL+E++  G  P+     CR V 
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPF----YCRDVA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 44/213 (20%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEIN-LMK 72
           +V+G+G FG V   LL     E          AVK+L+  A  K  ++   + E N L+K
Sbjct: 1   KVIGKGSFGKV---LLARHKAE------EKFYAVKVLQKKAILKKKEEKHIMSERNVLLK 51

Query: 73  DVGKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE-------------------- 111
           +V KH  +V         D+L  V++Y   G+L  +L+ E                    
Sbjct: 52  NV-KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 110

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLA 168
           YL +  +V+RDL   NILL S   + ++DFGL ++  E N   +   G P       +LA
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP------EYLA 164

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E L    Y    D W  G VL+E++  G  P+
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 59/215 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY-DKFLKEINLMKDV 74
           E +G+G +GVV K        +  +G+    VA+K ++   + +      ++EI+L+K++
Sbjct: 5   EKIGEGTYGVVYKAR------DKLTGEI---VALKKIRLETEDEGVPSTAIREISLLKEL 55

Query: 75  GKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLR------------EEYLS------- 114
             H +IV  +   + + +L LV E+  L DL+ Y+             + YL        
Sbjct: 56  -NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 115 ---NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR------ 165
              +++V+HRDL  +N+L+     +K++DFGL+              +  +P+R      
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-------------AFGVPVRTYTHEV 160

Query: 166 ---WL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
              W  A E L+ S  Y+   D+WS G +  E+V 
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 106 SYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLP 163
            YL+E++     V+HRD+   NILL +   VK+ DFG+S  + +        G  +   P
Sbjct: 128 HYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAP 183

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R +         Y  ++DVWS G+ L E+ T G  PY 
Sbjct: 184 ER-IDPPDPNPK-YDIRADVWSLGISLVELAT-GQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 104 LQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN------GE 157
           +Q  L   ++ +  ++HRD+ + NILL S  +VK+ DFG S+ +Y   V  +      G 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDDVGRTFCGT 208

Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           P    P  W          Y+ K+D++S GV+L+E++TL
Sbjct: 209 PYYVAPEIWRRKP------YSKKADMFSLGVLLYELLTL 241

Length = 496

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 15/95 (15%)

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE---KLPIRWLA 168
           YL   +++HRD+ T NI ++    V I D G ++       F    P+       +   A
Sbjct: 172 YLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------FPVVAPAFLGLAGTVETNA 224

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            E L  + Y +K+D+WS G+VL+E++      YP 
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLA-----YPS 254

Length = 357

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 4/88 (4%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
           +Y+ +  V+HRDL   N+ +++   V+KI DFGL+  I + +    G  SE L  +W   
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGLVTKWYRS 186

Query: 170 ESLV--SNIYTNKSDVWSFGVVLWEIVT 195
             L+   N YT   D+W+ G +  E++T
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLT 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 50.0 bits (120), Expect = 2e-07
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 47/211 (22%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKEINLMKDV 74
           E +G G +GVV   +      +  SG+   +VA+K +    D  T  K  L+E+ +++  
Sbjct: 11  ENIGSGAYGVVCSAI------DTRSGK---KVAIKKIPHAFDVPTLAKRTLRELKILRHF 61

Query: 75  GKHDHIVSFIGCCYKDELRLVVE-----YCALGDLQSYLRE------------------- 110
            KHD+I++      +D LR         Y  +  ++S L                     
Sbjct: 62  -KHDNIIAI-----RDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +Y+ +  V+HRDL   N+L++    ++I DFG++  +           +E +  R
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 166 WL-ALESLVS-NIYTNKSDVWSFGVVLWEIV 194
           W  A E L+S   YT   D+WS G +  E++
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 14/90 (15%)

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP----IRWL 167
           +L +N ++HRDL T N+LL++  ++KI DFGL+         + G P +         W 
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR--------EYGSPLKPYTQLVVTLWY 172

Query: 168 -ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
            A E L+    Y+   D+WS G +  E++T
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.6 bits (118), Expect = 4e-07
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 44/218 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINL 70
           L +VLG G +G V       G   G         A+K+L+  A    AKT +    E N+
Sbjct: 4   LLKVLGTGAYGKVFLVRKVTGHDTGKL------YAMKVLQKAALVQKAKTVEHTRTERNV 57

Query: 71  MKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------------- 110
           ++ V +   +V+       + +L L+++Y + G++ ++L +                   
Sbjct: 58  LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA 117

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PI 164
            E+L    +V+RD+   NILL S   V ++DFGLS++          E  E+       I
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-------EEKERTYSFCGTI 170

Query: 165 RWLALESLVSNIYTNKS-DVWSFGVVLWEIVTLGANPY 201
            ++A E +       K+ D WS G++++E++T GA+P+
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLT-GASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 48.9 bits (117), Expect = 4e-07
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 9/94 (9%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQ-NGEPSEKLPIRWLA 168
           EYL +  ++HRD+   NILL     V I+DF ++  +  +      +G P       ++A
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG------YMA 167

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            E L    Y+   D WS GV  +E +  G  PY 
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 43/205 (20%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEIN-LMKD 73
           V+G+G FG V   LL     +G         AVK+L+  A  K  ++   + E N L+K+
Sbjct: 2   VIGKGSFGKV---LLAKHKADGKF------YAVKVLQKKAILKKKEQKHIMAERNVLLKN 52

Query: 74  VGKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE--------------------Y 112
           V KH  +V         D+L  V++Y   G+L  +L+ E                    Y
Sbjct: 53  V-KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLAL 169
           L +  +++RDL   NILL S   V ++DFGL  E I          G P       +LA 
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP------EYLAP 165

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIV 194
           E L    Y    D W  G VL+E++
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 48.6 bits (116), Expect = 6e-07
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 49/222 (22%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           L + E LG+G +GVV K  +   PT          +AVK ++A  +++   + L ++++ 
Sbjct: 3   LEVIEELGRGAYGVVDK--MRHVPTGTI-------MAVKRIRATVNSQEQKRLLMDLDIS 53

Query: 72  KDVGKHDHIVSFIGCCYKD----------------------ELRLVVEYCALGDLQ-SYL 108
                  + V+F G  +++                      +  L +    LG +  S +
Sbjct: 54  MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113

Query: 109 RE-EYL-SNNKVVHRDLATRNILLSSPHVVKISDFGLSE---DIYEQNVFQNGEPSEKLP 163
           +  EYL S   V+HRD+   N+L++    VK+ DFG+S    D   + +    +P     
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----- 168

Query: 164 IRWLALESLVSNI----YTNKSDVWSFGVVLWEIVTLGANPY 201
             ++A E +   +    Y  KSDVWS G+ + E+ T G  PY
Sbjct: 169 --YMAPERINPELNQKGYDVKSDVWSLGITMIELAT-GRFPY 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.8 bits (116), Expect = 7e-07
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 49/209 (23%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDKFLKEIN-LMK 72
           +V+G+G FG V   LL    ++G+        AVK+L  K     K  +  + E N L+K
Sbjct: 1   KVIGKGSFGKV---LLAKRKSDGSF------YAVKVLQKKTILKKKEQNHIMAERNVLLK 51

Query: 73  DVGKHDHIVSFIGCCYK----DELRLVVEYCALGDLQSYLREE----------------- 111
           ++ KH  +V   G  Y     ++L  V++Y   G+L  +L+ E                 
Sbjct: 52  NL-KHPFLV---GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVAS 107

Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIR 165
              YL +  +++RDL   NILL S   V ++DFGL ++  E     +   G P       
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP------E 161

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIV 194
           +LA E L    Y    D W  G VL+E++
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.3 bits (115), Expect = 8e-07
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 50/211 (23%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDV 74
           E +G+G +GVV K    D  T          +A+K ++    D       ++EI+L+K++
Sbjct: 8   EKIGEGTYGVVYKA--RDRVTNET-------IALKKIRLEQEDEGVPSTAIREISLLKEM 58

Query: 75  GKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQ-----------------SYLRE-----E 111
            +H +IV      + ++ L LV EY  L DL+                 +YL +      
Sbjct: 59  -QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 112 YLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEP-----SEKLPIR 165
           Y  +++V+HRDL  +N+L+    + +K++DFGL+           G P      E + + 
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--------GIPVRTFTHEVVTLW 168

Query: 166 WLALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
           + A E L+ S  Y+   D+WS G +  E+V 
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.5 bits (115), Expect = 8e-07
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 44/212 (20%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANADAKTYDK--FLKEINLMKD 73
           VLG+G FG V+           A  +   E+ A+K+LK +   +  D    + E  ++  
Sbjct: 7   VLGKGSFGKVML----------AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL 56

Query: 74  VGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE--------------------Y 112
            GK   +     C    D L  V+EY   GDL   +++                     +
Sbjct: 57  SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFF 116

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLAL 169
           L +  +++RDL   N++L S   +KI+DFG+  E++++    +   G P       ++A 
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD------YIAP 170

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    Y    D W+FGV+L+E++  G  P+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 34/152 (22%)

Query: 74  VGKHDHIVSFIGCCY----KDELRLVVEYCALGDLQS---------------YLREEYLS 114
             K + +V  +   Y     + L L +EY   GD ++               Y+ E + +
Sbjct: 57  TTKSEWLVKLL---YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA 113

Query: 115 NNKV-----VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            + +     +HRDL   N L+ +   +K++DFGLS+ I        G P       ++A 
Sbjct: 114 VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD------YMAP 167

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E L    Y    D WS G +L+E +  G  P+
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 55/220 (25%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML----KANADAK-TYDK 63
           P+R      +G G +G V                   +VA+K L    ++   AK TY  
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFDTKTG---------RKVAIKKLSRPFQSAIHAKRTY-- 62

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKDELR-------LVVEYCALGDLQSYLREEYLSNN 116
             +E+ L+K +  H++++  +                LV       DL + ++ + LS++
Sbjct: 63  --RELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDD 118

Query: 117 KV-------------------VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
            +                   +HRDL   NI ++    +KI DFGL+          + E
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH-------TDDE 171

Query: 158 PSEKLPIRW-LALESLVSNI-YTNKSDVWSFGVVLWEIVT 195
            +  +  RW  A E +++ + Y    D+WS G ++ E++T
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 39/183 (21%)

Query: 48  AVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-----DELRLVVEYCALG 102
           A+K++  N +     +  +EI +++DV  H ++V     C+       E+++++E+   G
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVK----CHDMFDHNGEIQVLLEFMDGG 157

Query: 103 DL-------QSYLRE---------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
            L       + +L +          YL    +VHRD+   N+L++S   VKI+DFG+S  
Sbjct: 158 SLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR- 216

Query: 147 IYEQNVFQNGEP--SEKLPIRWLALESLVSNIYTNK-----SDVWSFGVVLWEIVTLGAN 199
           I  Q +    +P  S    I +++ E + +++          D+WS GV + E   LG  
Sbjct: 217 ILAQTM----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY-LGRF 271

Query: 200 PYP 202
           P+ 
Sbjct: 272 PFG 274

Length = 353

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 44/216 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P     L + +G G +G V K           +G+ A   AVK++K       +    +E
Sbjct: 7   PQHDYELIQRVGSGTYGDVYKA------RNLHTGELA---AVKIIKLEP-GDDFSLIQQE 56

Query: 68  INLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQ--------------SYLREE- 111
           I ++K+  KH +IV++ G    +++L + +EYC  G LQ              +Y+  E 
Sbjct: 57  IFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRET 115

Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLP 163
                YL +   +HRD+   NILL+    VK++DFG++  I      +    G P     
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY---- 171

Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTL 196
             W+A E      +  Y    D+W+ G+   E+  L
Sbjct: 172 --WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 33/151 (21%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG+G +  V KG          S      VA+K ++   +       ++E +L+KD+ 
Sbjct: 11  DKLGEGSYATVYKGR---------SKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL- 60

Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYL 113
           KH +IV+     +  + L LV EY    DL+ Y+ +                      Y 
Sbjct: 61  KHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLS 144
              +V+HRDL  +N+L+S    +K++DFGL+
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 9/93 (9%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLA 168
           E+L   ++V+RDL   N+LL     V+ISD GL+ ++      +   G P       ++A
Sbjct: 109 EHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG------YMA 162

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E L   +Y    D ++ G  L+E++  G +P+
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 40/161 (24%)

Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELR---LVVEYCALGDLQSYLRE----------- 110
           L+EI L+ ++ +H +IV          L    LV+EYC   DL S L             
Sbjct: 54  LREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVK 111

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP-- 158
                     +YL  N ++HRDL   N+LL+    +KI+DFGL+           G P  
Sbjct: 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY--------GLPAK 163

Query: 159 --SEKLPIRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             + K+   W  A E L+    YT   D+W+ G +L E++ 
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.0 bits (111), Expect = 3e-06
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 35/183 (19%)

Query: 44  AMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCAL 101
           AM+V  K L    D +  D    E ++ +    H  +V  +  C++ E RL  V+EY   
Sbjct: 24  AMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNG 80

Query: 102 GDL------QSYLREE--------------YLSNNKVVHRDLATRNILLSSPHVVKISDF 141
           GDL      Q  L EE              YL    +++RDL   N+LL S   +K++D+
Sbjct: 81  GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 140

Query: 142 GLSEDIYEQNVFQN---GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA 198
           G+ ++        +   G P+      ++A E L    Y    D W+ GV+++E++  G 
Sbjct: 141 GMCKEGLRPGDTTSTFCGTPN------YIAPEILRGEDYGFSVDWWALGVLMFEMMA-GR 193

Query: 199 NPY 201
           +P+
Sbjct: 194 SPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.0 bits (111), Expect = 3e-06
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 38/210 (18%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+G +  V KG          S      VA+K+++   +  T    ++E +L+K + 
Sbjct: 11  EKLGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL- 60

Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE---------------------YL 113
           KH +IV      + K+ L LV EY    DL  Y+ +                      Y+
Sbjct: 61  KHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
               ++HRDL  +N+L+S    +K++DFGL+     ++V  +   +E + + +   + L+
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 174 -SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            S  Y+   D+W  G +  E++  G   +P
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQ-GVAAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E+L    +V+RDL   NILL +   + + DFGLS+     N   N          +LA E
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT---EYLAPE 166

Query: 171 SLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY 201
            L+    YT   D WS GV+++E+   G +P+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 6/86 (6%)

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-ALE 170
           Y+ +  V+HRDL   N+LL++   +KI DFGL+    E+  F     +E +  RW  A E
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM----TEYVVTRWYRAPE 178

Query: 171 SLVS-NIYTNKSDVWSFGVVLWEIVT 195
            L++ + YT   DVWS G +  E++ 
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLG 204

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.5 bits (110), Expect = 3e-06
 Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 37/202 (18%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+G +  V KG+         +GQ    VA+K++    +       ++E +L+K + 
Sbjct: 11  EKLGEGSYATVYKGI------SRINGQL---VALKVISMKTEEGVPFTAIREASLLKGL- 60

Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE---------------------YL 113
           KH +IV      + K+ L  V EY    DL  Y+ +                      Y+
Sbjct: 61  KHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
               ++HRDL  +N+L+S    +K++DFGL+     +++      SE + + +   + L+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 174 -SNIYTNKSDVWSFGVVLWEIV 194
            +  Y++  D+W  G +  E++
Sbjct: 177 GATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (110), Expect = 4e-06
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 12/95 (12%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPIRW 166
           E L    V++RDL   NILL     + + DFGL +    D  + N F  G P       +
Sbjct: 107 ENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-CGTP------EY 159

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           LA E L+ + YT   D W+ GV+L+E++T G  P+
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 46.7 bits (110), Expect = 4e-06
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 59/188 (31%)

Query: 67  EINLMKDVGKHDHIVSFIGCCYK---DELRLVVEYCALGDLQSYLREEYL---------- 113
           E+N+M+++ KH +IV +I         +L +++E+C  GDL   +++ Y           
Sbjct: 62  EVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120

Query: 114 ---------------------SNNKVVHRDLATRNILLSS-----------------PHV 135
                                +  +V+HRDL  +NI LS+                   +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 136 VKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
            KI DFGLS++I  +++  +  G P    P   L L    S  Y +KSD+W+ G +++E+
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSP--ELLLHETKS--YDDKSDMWALGCIIYEL 236

Query: 194 VTLGANPY 201
            + G  P+
Sbjct: 237 CS-GKTPF 243

Length = 1021

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 46.0 bits (109), Expect = 6e-06
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 44/213 (20%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD--KFLKEINLMKD 73
            VLG+G FG V+   L +      SG+     AVK+LK +   +  D    + E  ++  
Sbjct: 1   RVLGKGSFGKVMLARLKE------SGRL---YAVKVLKKDVILQDDDVECTMTEKRILSL 51

Query: 74  VGKHDHIVSFIGCCYK--DELRLVVEYCALGDLQSYLREE-------------------- 111
              H  +     CC++  D L  V+E+   GDL  ++++                     
Sbjct: 52  ARNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALM 110

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLA 168
           +L +  +++RDL   N+LL      K++DFG+  E I+         G P       ++A
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD------YIA 164

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E L   +Y    D W+ GV+L+E++  G  P+
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 41/129 (31%), Positives = 56/129 (43%), Gaps = 30/129 (23%)

Query: 90  DELRLVVEYCALGDLQSYLREE--------------------YL-SNNKVVHRDLATRNI 128
           D L  V+EY   G+L  +L  E                    YL S   VV+RDL   N+
Sbjct: 68  DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127

Query: 129 LLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTNKSDVWS 185
           +L     +KI+DFGL  E I +    +   G P       +LA E L  N Y    D W 
Sbjct: 128 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP------EYLAPEVLEDNDYGRAVDWWG 181

Query: 186 FGVVLWEIV 194
            GVV++E++
Sbjct: 182 LGVVMYEMM 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.8 bits (108), Expect = 7e-06
 Identities = 35/140 (25%), Positives = 64/140 (45%), Gaps = 32/140 (22%)

Query: 87  CYK--DELRLVVEYCALGDLQSYLREE--------------------YLSNNKVVHRDLA 124
           C++  D L  V+EY   GDL  ++++                     +L    +++RDL 
Sbjct: 69  CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLK 128

Query: 125 TRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTNKS 181
             N++L S   +KI+DFG+  E + +    +   G P       ++A E +    Y    
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD------YIAPEIIAYQPYGKSV 182

Query: 182 DVWSFGVVLWEIVTLGANPY 201
           D W++GV+L+E++  G  P+
Sbjct: 183 DWWAYGVLLYEMLA-GQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 7e-06
 Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 20/71 (28%)

Query: 94  LVVEYCALGDLQS------YLREE--------------YLSNNKVVHRDLATRNILLSSP 133
           LV+EY   GD++S      Y  EE              YL  + ++HRDL   N+L+S+ 
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE 140

Query: 134 HVVKISDFGLS 144
             +K++DFGLS
Sbjct: 141 GHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 46/192 (23%), Positives = 75/192 (39%), Gaps = 46/192 (23%)

Query: 42  QAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI--GCCYKDELRLVVE 97
               EVA+K+L+ +A  +     +F +E  L   +  H +IV+ +  G      L  V E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLDSGEAPPGLLFAVFE 59

Query: 98  YCALGDLQSYLREE--------------------YLSNNKVVHRDLATRNILLSS----P 133
           Y     L+  L  +                       N  +VHRDL  +NI++S     P
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119

Query: 134 HVVKISDFGLS------EDIYEQNVFQNGE----PSEKLPIRWLALESLVSNIYTNKSDV 183
           H  K+ DFG+        D     + +  E    P+   P      E L     T  SD+
Sbjct: 120 H-AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP------EQLRGEPVTPNSDL 172

Query: 184 WSFGVVLWEIVT 195
           +++G++  E +T
Sbjct: 173 YAWGLIFLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 5/91 (5%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E L   ++V+RDL   NILL     ++ISD GL+  + E    +    +    + ++A E
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT----VGYMAPE 171

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            + +  YT   D W+ G +L+E++  G +P+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIA-GQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 9e-06
 Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 13/88 (14%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP------I 164
           +Y+    ++HRD+ T N+L++ P  + + DFG +        F  G  S          +
Sbjct: 274 DYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA-------CFARGSWSTPFHYGIAGTV 326

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWE 192
              A E L  + YT   D+WS G+V++E
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 51/157 (32%)

Query: 94  LVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILL- 130
           LV++YC  G+L   L+                       EYL    +V+RDL   NILL 
Sbjct: 78  LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137

Query: 131 SSPHVVKISDFGLS-----EDIYEQNVFQNGEPS---EKLPIR----------------- 165
            S H++ +SDF LS     E        + G        +P                   
Sbjct: 138 ESGHIM-LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTE 196

Query: 166 -WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +  + + +  D W+ G++L+E++  G  P+
Sbjct: 197 EYIAPEVISGDGHGSAVDWWTLGILLYEML-YGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 14/103 (13%)

Query: 99  CALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
           C L DLQ   RE      ++V+RDL   NILL     ++ISD GL+  I E    +    
Sbjct: 113 CGLEDLQ---RE------RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVG 163

Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +    + ++A E + +  YT   D W  G +++E++  G +P+
Sbjct: 164 T----VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 18/111 (16%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS-----EKLPIR 165
           +Y+    V HRDL  +NIL ++   +KI DFGL+       V  N  P+     + +  R
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLAR------VAFNDTPTAIFWTDYVATR 170

Query: 166 WLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL 213
           W     L  +    YT   D+WS G +  E++T      P  P   +VH L
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT----GKPLFPGKNVVHQL 217

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 27/86 (31%), Positives = 38/86 (44%), Gaps = 9/86 (10%)

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEKLPIRWL 167
           YL    ++HRD+ T NI L  P    + DFG    L         +      E      L
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEI 193
           AL+      Y  K+D+WS G+VL+E+
Sbjct: 260 ALDP-----YCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 29/135 (21%)

Query: 91  ELRLVVEYCALGDLQSYL--RE------------------EYLSNNKVVHRDLATRNILL 130
           +L L+++Y   G+L ++L  RE                  ++L    +++RD+   NILL
Sbjct: 79  KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138

Query: 131 SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--PIRWLALESLV--SNIYTNKSDVWSF 186
            S   V ++DFGLS++     + +  E +      I ++A E +   S  +    D WS 
Sbjct: 139 DSEGHVVLTDFGLSKEF----LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194

Query: 187 GVVLWEIVTLGANPY 201
           GV+ +E++T GA+P+
Sbjct: 195 GVLTFELLT-GASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 30/113 (26%), Positives = 52/113 (46%), Gaps = 30/113 (26%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR----- 165
           EY+ +  V+HRDL   NILL     V I D+G +       +F+  E  + L I      
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-------IFKKLEEEDLLDIDVDERN 179

Query: 166 -----------------WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                            ++A E L+    +  +D+++ GV+L++++TL + PY
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL-SFPY 231

Length = 932

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 41/217 (18%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA---DAKTYDKFLKEIN 69
           L +VLG G +G V             SG  + ++ A+K+LK       AKT +    E  
Sbjct: 4   LLKVLGTGAYGKVFL-------VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQ 56

Query: 70  LMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------------ 110
           +++ + +   +V+       D +L L+++Y   G+L ++L +                  
Sbjct: 57  VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--PIRW 166
             E+L    +++RD+   NILL S   V ++DFGLS++ +E  V    E +      I +
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV----ERAYSFCGTIEY 172

Query: 167 LALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPY 201
           +A + +      +    D WS GV+++E++T GA+P+
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 3e-05
 Identities = 29/116 (25%), Positives = 52/116 (44%), Gaps = 20/116 (17%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL- 169
           EY+ + K++HRD+   NI L+    + + DFG +        F+     E     W+   
Sbjct: 281 EYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA------MPFEK--EREAFDYGWVGTV 332

Query: 170 -----ESLVSNIYTNKSDVWSFGVVLWEIVT-----LGAN-PYPHIPLCRIVHYLS 214
                E L  + Y   +D+WS G++L ++++     +G     P   L +I+  LS
Sbjct: 333 ATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLS 388

Length = 501

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.4 bits (102), Expect = 3e-05
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 5/91 (5%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E L     V+RDL   NILL     ++ISD GL+  I E    +    +    + ++A E
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT----VGYMAPE 171

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            L +  YT   D W  G +++E++  G +P+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIE-GQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 36/179 (20%), Positives = 66/179 (36%), Gaps = 63/179 (35%)

Query: 86  CCYKDE--LRLVVEYCALGDLQSYL-REEYLSNN-------------------KVVHRDL 123
             ++DE  L L++EY   GD+ + L +++  +                       +HRD+
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127

Query: 124 ATRNILLSSPHVVKISDFGLS-------EDIYEQNVFQNGEPSEKLPIR----------- 165
              N+LL +   +K+SDFGL           + + +      +    I            
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187

Query: 166 -----------------WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC 207
                            ++A E  +   Y  + D WS GV+++E++ +G   YP  P C
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML-VG---YP--PFC 240

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 9/93 (9%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--PIRWLA 168
           E L   ++V+RDL   NILL     ++ISD GL+ +I        GE        + ++A
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI------PEGETIRGRVGTVGYMA 169

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E + +  YT   D W  G +++E++  G +P+
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 36/143 (25%)

Query: 89  KDELRLVVEYCALGDLQS----------------YLREEYLSNNKV-----VHRDLATRN 127
           KD L LV+EY   GDL S                YL E  L+ + V     VHRD+   N
Sbjct: 73  KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN 132

Query: 128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI---RWLALESLVS-NIYTNKS-- 181
           +L+     +K++DFG +  +       N   + KLP+    ++A E L + N     +  
Sbjct: 133 VLIDRTGHIKLADFGSAARLT-----ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187

Query: 182 ---DVWSFGVVLWEIVTLGANPY 201
              D WS GV+ +E++  G +P+
Sbjct: 188 VECDWWSLGVIAYEMI-YGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 5e-05
 Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 47/207 (22%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKEINLMKDVGK 76
           +G G +G V   L           +   +VA+K L     ++ + K   +E+ L+K + K
Sbjct: 23  VGSGAYGTVCSAL---------DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-K 72

Query: 77  HDHIVSFIGCCYKDE-------LRLVVEYCALGDLQSYLREEYLSNNKV----------- 118
           H++++  +     D          LV+ +    DL   ++ E LS +++           
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 119 --------VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
                   +HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-------TDSEMTGYVVTRWYRAP 184

Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G ++ E++T
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLT 211

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 47/214 (21%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY-DKFLKEINLMKDV 74
           E +G+G +G V K        +  +G+    VA+K  +   D +      L+EI+L++ +
Sbjct: 7   EKIGEGTYGKVYKA------RDKNTGKL---VALKKTRLEMDEEGIPPTALREISLLQML 57

Query: 75  GKHDHIVSFIGCCYKDE------LRLVVEYCALGDLQSYLREEYLSNNK----------- 117
            +  +IV  +   + +E      L LV EY    DL+ ++        +           
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 118 --------------VVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                         V+HRDL  +N+L+     ++KI+D GL       ++       E +
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---SIPVKSYTHEIV 173

Query: 163 PIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
            + + A E L+ S  Y+   D+WS G +  E+  
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.8 bits (101), Expect = 6e-05
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 17/91 (18%)

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR------ 165
           YL +  ++HRD+   N+L++S  V+KI DFGL+         +  EP E   +       
Sbjct: 118 YLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA---------RVEEPDESKHMTQEVVTQ 168

Query: 166 -WLALESLV-SNIYTNKSDVWSFGVVLWEIV 194
            + A E L+ S  YT+  D+WS G +  E++
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 32/140 (22%)

Query: 87  CYKDELRL--VVEYCALGDL------QSYLREE--------------YLSNNKVVHRDLA 124
           C++ E RL  V+E+ + GDL      Q  L EE              +L    +++RDL 
Sbjct: 64  CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLK 123

Query: 125 TRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTNKS 181
             N+LL +   +K++D+G+  E I   +      G P+      ++A E L    Y    
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN------YIAPEILRGEDYGFSV 177

Query: 182 DVWSFGVVLWEIVTLGANPY 201
           D W+ GV+++E++  G +P+
Sbjct: 178 DWWALGVLMFEMMA-GRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 9/87 (10%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE-QNVFQN--GEPSEKLPIRWL 167
           E+L   ++++RDL   N+LL +   V+ISD GL+ ++ + Q+  +   G P       ++
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG------FM 164

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L    Y    D ++ GV L+E++
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 37/140 (26%), Positives = 64/140 (45%), Gaps = 32/140 (22%)

Query: 87  CYKDELRL--VVEYCALGDL------QSYLREE--------------YLSNNKVVHRDLA 124
           C++   RL  V+EY   GDL      Q  L EE              +L    +++RDL 
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLK 123

Query: 125 TRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTNKS 181
             N+LL +   +K++D+G+  E +   +      G P+      ++A E L    Y    
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN------YIAPEILRGEEYGFSV 177

Query: 182 DVWSFGVVLWEIVTLGANPY 201
           D W+ GV+++E++  G +P+
Sbjct: 178 DWWALGVLMFEMMA-GRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 40.7 bits (95), Expect = 3e-04
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 17/145 (11%)

Query: 59  KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKV 118
            T DK    ++LM     H H+ S  G   + E+R       LG        E++ N  V
Sbjct: 67  HTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILG-------LEHMHNRFV 118

Query: 119 VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-WLALESLVSNI- 176
           V+RDL   NILL     V+ISD GL+ D      F   +P   +    ++A E L   + 
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASVGTHGYMAPEVLQKGVA 172

Query: 177 YTNKSDVWSFGVVLWEIVTLGANPY 201
           Y + +D +S G +L++++  G +P+
Sbjct: 173 YDSSADWFSLGCMLFKLLR-GHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 53/165 (32%)

Query: 89  KDELRLVVEYCALGDL---------------QSYLREEYLSNNKV-----VHRDLATRNI 128
           K  L L++E+   GD+               Q Y+ E  L+ + +     +HRD+   N+
Sbjct: 73  KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132

Query: 129 LLSSPHVVKISDFGLSEDIYEQN----------------VFQNGEPSEKLPI-------- 164
           LL S   VK+SDFGL   + + +                 FQN     K           
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192

Query: 165 --------RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                    ++A E  +   Y    D WS GV+++E++ +G  P+
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 3e-04
 Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 61/173 (35%)

Query: 89  KDELRLVVEYCALGDLQS---------------YLRE-----EYLSNNKVVHRDLATRNI 128
           KD L  V++Y   GD+ S               Y+ E     E +     +HRD+   NI
Sbjct: 73  KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132

Query: 129 LLSSPHVVKISDFGLSEDI---YEQNVFQNG--------EPS--------------EKLP 163
           L+     +K++DFGL       ++   +Q G        EPS              E+  
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192

Query: 164 IR---------------WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            R               ++A E L+   YT   D WS GV+L+E++ +G  P+
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML-VGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 66/244 (27%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           LG ++G G FGVV + +  D          + +VA+K +  +   K      +E+ +MK+
Sbjct: 70  LGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDPQYKN-----RELLIMKN 115

Query: 74  VGKHDHIV-----SFIGCCYKDE----LRLVVEYCA--------------------LGDL 104
           +  H +I+      +  C  K+E    L +V+E+                      L  L
Sbjct: 116 L-NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL 174

Query: 105 QSYL---REEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
            SY       Y+ +  + HRDL  +N+L+  + H +K+ DFG +     +N+        
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA-----KNLLAGQRSVS 229

Query: 161 KLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-------LCRIVH 211
            +  R+     L+  +  YT   D+WS G ++ E++ LG   YP          L RI+ 
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-LG---YPIFSGQSSVDQLVRIIQ 285

Query: 212 YLST 215
            L T
Sbjct: 286 VLGT 289

Length = 440

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 17/144 (11%)

Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREEYLSNNKVV 119
           T DK    ++LM     H H+ S  G   + E+R       LG        E++ N  VV
Sbjct: 68  TPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILG-------LEHMHNRFVV 119

Query: 120 HRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-WLALESLVSNI-Y 177
           +RDL   NILL     V+ISD GL+ D      F   +P   +    ++A E L     Y
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASVGTHGYMAPEVLQKGTAY 173

Query: 178 TNKSDVWSFGVVLWEIVTLGANPY 201
            + +D +S G +L++++  G +P+
Sbjct: 174 DSSADWFSLGCMLFKLLR-GHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 26/94 (27%), Positives = 52/94 (55%), Gaps = 10/94 (10%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-AL 169
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+    +       E +  +  RW  A 
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-------EMTGYVATRWYRAP 186

Query: 170 ESLVSNIYTNKS-DVWSFGVVLWEIVTLGANPYP 202
           E +++ ++ N++ D+WS G ++ E++T G   +P
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFP 219

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 43/196 (21%)

Query: 46  EVAVKMLKANADAKTYDKFLKEINLMKD-------------VGKHDHIVSFIGCCYKDE- 91
           EVAV  LK NAD     K L +  ++K              V   +  ++ +   ++DE 
Sbjct: 16  EVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74

Query: 92  -LRLVVEYCALGDLQS----------------YLREEYLSNNKV-----VHRDLATRNIL 129
            L LV++Y   GDL +                YL E  ++ + V     VHRD+   NIL
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134

Query: 130 LSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWS 185
           +     ++++DFG    L ED   Q+    G P    P    A+E      Y  + D WS
Sbjct: 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK-YGPECDWWS 193

Query: 186 FGVVLWEIVTLGANPY 201
            GV ++E++  G  P+
Sbjct: 194 LGVCMYEML-YGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 39.7 bits (92), Expect = 7e-04
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 39/230 (16%)

Query: 18  LGQGEFGVVVKGLLGDGPTE-----------GASGQAAMEVAV-KMLKANADAKTYDKFL 65
           +G+G +G V K    DG  E           G S  A  E+A+ + LK          FL
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 66  ----KEINLMKDVGKHD--HIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--EYLSNNK 117
               +++ L+ D  +HD  HI+ F      ++  + +    +  L   + +   YL  N 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 118 VVHRDLATRNILL--SSPH--VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
           V+HRDL   NIL+    P    VKI+D G +  ++   +    +    +   W     L+
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELL 187

Query: 174 --SNIYTNKSDVWSFGVVLWEIVT------------LGANPYPHIPLCRI 209
             +  YT   D+W+ G +  E++T              +NP+ H  L RI
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.6 bits (92), Expect = 7e-04
 Identities = 41/177 (23%), Positives = 67/177 (37%), Gaps = 65/177 (36%)

Query: 89  KDELRLVVEYCALGDLQS---------------YLRE-----EYLSNNKVVHRDLATRNI 128
           KD L  V++Y   GD+ S               Y+ E     E +     +HRD+   NI
Sbjct: 73  KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132

Query: 129 LLSSPHVVKISDFGLSEDI---YEQNVFQNGE--------------------------PS 159
           L+     +K++DFGL       ++   +Q+G+                          P 
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192

Query: 160 EKLPIR---------------WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E+   R               ++A E L+   YT   D WS GV+L+E++ +G  P+
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML-VGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.3 bits (91), Expect = 0.001
 Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 61/245 (24%)

Query: 18  LGQGEFGVVVKGLLGDGPTE-----------GASGQAAMEVAV-------------KMLK 53
           +G+G +G V K    DG  +           G S  A  E+A+             K+  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 54  ANADAKTYDKFLKEINLMKDVGKHD--HIVSFIGCCYKDELRLVVEYCALGDLQSYLRE- 110
           ++AD K +        L+ D  +HD  HI+ F      ++  + +     G ++S L + 
Sbjct: 69  SHADRKVW--------LLFDYAEHDLWHIIKFHRASKANKKPVQLPR---GMVKSLLYQI 117

Query: 111 ----EYLSNNKVVHRDLATRNILL--SSPH--VVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                YL  N V+HRDL   NIL+    P    VKI+D G +  ++   +    +    +
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVV 176

Query: 163 PIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVT------------LGANPYPHIPLCR 208
              W     L+  +  YT   D+W+ G +  E++T              +NPY H  L R
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236

Query: 209 IVHYL 213
           I + +
Sbjct: 237 IFNVM 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 39.0 bits (91), Expect = 0.001
 Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 19/94 (20%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNG------EPSEK 161
            Y      +HRD+   NILL++   +K++DFGL+  +Y   E   + N        P E 
Sbjct: 130 NYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYTNKVITLWYRPPEL 188

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           L         L    Y    DVWS G +L E+ T
Sbjct: 189 L---------LGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 24/87 (27%), Positives = 49/87 (56%), Gaps = 9/87 (10%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-AL 169
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW  A 
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH-------ADAEMTGYVVTRWYRAP 183

Query: 170 ESLVSNIYTNKS-DVWSFGVVLWEIVT 195
           E +++ ++ N++ D+WS G ++ E++T
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 53/165 (32%)

Query: 89  KDELRLVVEYCALGDL---------------QSYLREEYLSNNKV-----VHRDLATRNI 128
           K  L L++E+   GD+               Q Y+ E  L+ + +     +HRD+   N+
Sbjct: 73  KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132

Query: 129 LLSSPHVVKISDFGLSEDI-------YEQNV---------FQNGEPSEKLPI-------- 164
           LL +   VK+SDFGL   +       + +N+         FQN     K           
Sbjct: 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192

Query: 165 --------RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                    ++A E  +   Y    D WS GV+++E++ +G  P+
Sbjct: 193 AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 29/141 (20%)

Query: 88  YKDE--LRLVVEYCALGDLQS----------------YLREEYLSNNKV-----VHRDLA 124
           ++DE  L LV++Y   GDL +                Y+ E  L+ + +     VHRD+ 
Sbjct: 70  FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129

Query: 125 TRNILLSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNK 180
             N+LL     ++++DFG    +++D   Q+    G P    P    A+E  +   Y  +
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK-YGPE 188

Query: 181 SDVWSFGVVLWEIVTLGANPY 201
            D WS GV ++E++  G  P+
Sbjct: 189 CDWWSLGVCMYEML-YGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 23/84 (27%), Positives = 42/84 (50%), Gaps = 4/84 (4%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           ++L +  ++HRDL   NI++ S   +KI DFGL+       +     P   +   + A E
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP-YVVTRYYRAPE 195

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIV 194
            ++   Y    D+WS G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 38.7 bits (90), Expect = 0.001
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 48/204 (23%)

Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML----KANADAK-TYDKFLKEINLMK 72
           +G G FG+V          +  +GQ    VA+K +         AK TY    +E+ L+K
Sbjct: 18  VGMGAFGLVCSA------RDQLTGQN---VAIKKIMKPFSTPVLAKRTY----RELKLLK 64

Query: 73  DVGKHDHIVSF--IGCCYKDELRLVVEYCALGDLQSYLRE-------------------E 111
            + +H++I+S   I     +++  V E     DL   L                     +
Sbjct: 65  HL-RHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLK 122

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           Y+ +  VVHRDL   NIL++    +KI DFGL+     Q+    G  S +    + A E 
Sbjct: 123 YVHSAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRY---YRAPEI 176

Query: 172 LVS-NIYTNKSDVWSFGVVLWEIV 194
           +++   Y  + D+WS G +  E++
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 6/85 (7%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-AL 169
           ++L +  ++HRDL   NI++ S   +KI DFGL+     +    N   +  +  R+  A 
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTACTNFMMTPYVVTRYYRAP 191

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIV 194
           E ++   Y    D+WS G ++ E+V
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 37.6 bits (88), Expect = 0.002
 Identities = 21/62 (33%), Positives = 30/62 (48%), Gaps = 13/62 (20%)

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----------DIY--EQNVFQNGEPSE 160
           L    +VH DL T NI+LS   +  I DFGL E          D++  E+ +    E +E
Sbjct: 108 LHKAGIVHGDLTTSNIILSGGRIYFI-DFGLGEFSDEVEDKAVDLHVLERALESTHEKAE 166

Query: 161 KL 162
           +L
Sbjct: 167 EL 168

Length = 204

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 36/145 (24%)

Query: 86  CCYKDE--LRLVVEYCALGDL--------------QSYLREEYLSNNKV-----VHRDLA 124
           C ++D+  L +V+EY   GDL              + Y  E  L+ + +     +HRD+ 
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169

Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQN----GEPSEKLPIRWLALESLVSN----I 176
             N+LL     +K++DFG    + E  + +     G P       +++ E L S      
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD------YISPEVLKSQGGDGY 223

Query: 177 YTNKSDVWSFGVVLWEIVTLGANPY 201
           Y  + D WS GV L+E++ +G  P+
Sbjct: 224 YGRECDWWSVGVFLFEML-VGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	228
KOG0598|consensus	357		100.0
KOG0595|consensus	429		100.0
KOG0197|consensus	468		100.0
KOG0581|consensus	364		100.0
KOG0592|consensus	604		100.0
KOG0616|consensus	355		100.0
KOG0605|consensus	550		100.0
KOG0615|consensus	475		100.0
KOG0192|consensus	362		100.0
KOG0575|consensus	592		100.0
KOG0591|consensus	375		100.0
KOG0694|consensus	694		100.0
KOG1026|consensus	774		100.0
KOG0583|consensus	370		100.0
KOG0582|consensus	516		100.0
KOG1095|consensus	1025		100.0
KOG0593|consensus	396		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0597|consensus	808		100.0
KOG0611|consensus	668		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0194|consensus	474		100.0
KOG0198|consensus	313		100.0
KOG0193|consensus	678		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0659|consensus	318		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0600|consensus	560		100.0
KOG0610|consensus	459		100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0588|consensus	786		100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0585|consensus	576		100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0196|consensus	996		100.0
KOG4257|consensus	974		100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0578|consensus	550		100.0
KOG4721|consensus	904		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0580|consensus	281		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0663|consensus	419		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0199|consensus	1039		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0033|consensus	355		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0667|consensus	586		100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG4278|consensus	1157		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0661|consensus	538		100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0690|consensus	516		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0589|consensus	426		100.0
KOG0032|consensus	382		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0201|consensus	467		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0696|consensus	683		100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0594|consensus	323		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG4250|consensus	732		100.0
KOG0658|consensus	364		100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG4717|consensus	864		100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0607|consensus	463		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0660|consensus	359		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0612|consensus	1317		100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0586|consensus	596		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0599|consensus	411		100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG1187|consensus	361		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0986|consensus	591		100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG1989|consensus	738		100.0
KOG0200|consensus	609		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4279|consensus	1226		100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4645|consensus	1509		100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0584|consensus	632		100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0608|consensus	1034		100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0695|consensus	593		100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0596|consensus	677		100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0983|consensus	391		100.0
KOG1094|consensus	807		100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG1025|consensus	1177		100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0614|consensus	732		100.0
KOG0579|consensus	1187		100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0574|consensus	502		100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG1006|consensus	361		100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
KOG0984|consensus	282		99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
KOG0577|consensus	948		99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
KOG0604|consensus	400		99.98
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.98
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.98
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
PHA03209	357	serine/threonine kinase US3; Provisional	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
KOG2345|consensus	302		99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG0662|consensus	292		99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
KOG4236|consensus	888		99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG0587|consensus	953		99.97
KOG1024|consensus	563		99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG0603|consensus	612		99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
KOG1035|consensus	1351		99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0671|consensus	415		99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
KOG2052|consensus	513		99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
KOG0666|consensus	438		99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
KOG0668|consensus	338		99.96
KOG0669|consensus	376		99.96
KOG3653|consensus	534		99.96
KOG1152|consensus	772		99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1151|consensus	775		99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG0665|consensus	369		99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
KOG1027|consensus	903		99.94
KOG0664|consensus	449		99.94
KOG0670|consensus	752		99.93
KOG1167|consensus	418		99.92
KOG0576|consensus	829		99.92
KOG1345|consensus	378		99.92
KOG1165|consensus	449		99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1163|consensus	341		99.91
KOG1290|consensus	590		99.91
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
KOG0195|consensus	448		99.87
KOG1164|consensus	322		99.86
KOG0603|consensus	612		99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG4158|consensus	598		99.8
KOG0606|consensus	1205		99.8
PLN00181	793	protein SPA1-RELATED; Provisional	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
KOG1166|consensus	974		99.73
KOG0590|consensus	601		99.72
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
smart00090	237	RIO RIO-like kinase.	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
KOG1240|consensus	1431		99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.5
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.46
KOG0590|consensus	601		99.46
KOG1023|consensus	484		99.45
KOG1033|consensus	516		99.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.2
KOG0606|consensus	1205		99.17
KOG0601|consensus	524		99.02
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.99
KOG3087|consensus	229		98.92
KOG1243|consensus	690		98.77
KOG0601|consensus	524		98.76
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.73
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.48
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.36
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.3
KOG1266|consensus	458		98.14
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.13
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.08
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.99
KOG3741|consensus	655		97.9
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.78
PF01636	239	APH: Phosphotransferase enzyme family This family	97.71
KOG2137|consensus	700		97.65
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.55
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.5
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.46
PRK09902	216	hypothetical protein; Provisional	97.37
COG4248	637	Uncharacterized protein with protein kinase and he	97.35
KOG0576|consensus	829		97.32
KOG1235|consensus	538		97.2
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.12
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.0
PLN02876	822	acyl-CoA dehydrogenase	96.94
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.84
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.8
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.73
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.32
PLN02756	418	S-methyl-5-thioribose kinase	96.21
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.19
PRK12396	409	5-methylribose kinase; Reviewed	96.11
PLN02236	344	choline kinase	96.04
PRK05231	319	homoserine kinase; Provisional	96.03
KOG1093|consensus	725		95.69
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	95.68
KOG2268|consensus	465		94.03
KOG1826|consensus	2724		93.28
KOG1033|consensus	516		92.86
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	92.49
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	92.29
PRK10593	297	hypothetical protein; Provisional	92.11
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.77
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	91.48
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	91.16
PRK10271	188	thiK thiamine kinase; Provisional	91.09
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	90.93
KOG1236|consensus	565		90.79
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	89.82
KOG2270|consensus	520		88.65
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	88.59
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	87.9
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	87.18
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	86.52
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	86.09
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	85.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	84.91
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	84.52
PRK06148	1013	hypothetical protein; Provisional	81.96

>KOG0598|consensus

Probab=100.00  E-value=3.1e-48  Score=306.65  Aligned_cols=206  Identities=27%  Similarity=0.416  Sum_probs=179.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+++|+++++||+|+||+|+.++.         +.+++.||+|.+++..  ......+...|..+|.++ +||+|+.++
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk---------~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~   91 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRK---------KDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLI   91 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEE---------cccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeE
Confidence            5678999999999999999999984         4566789999998663  233466788999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..|++. .+|+|+||++||.|+..|++                    .|||++||+||||||+|||++..|+++|+|||+
T Consensus        92 ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen   92 YSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             EecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecccc
Confidence            999875 49999999999999998875                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.......   ...+.+||+.|||||++....|+..+|+||+|+++|+|++ |..||.+.+..++.+++.++..+..|.
T Consensus       172 ~k~~~~~~~---~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~-G~pPF~~~~~~~~~~~I~~~k~~~~p~  247 (357)
T KOG0598|consen  172 CKEDLKDGD---ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLT-GKPPFYAEDVKKMYDKILKGKLPLPPG  247 (357)
T ss_pred             chhcccCCC---ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhh-CCCCCcCccHHHHHHHHhcCcCCCCCc
Confidence            985544432   2345799999999999999999999999999999999999 999999999999999999996565555


Q ss_pred             CCC
Q psy3166         224 SCN  226 (228)
Q Consensus       224 ~~~  226 (228)
                      .++
T Consensus       248 ~ls  250 (357)
T KOG0598|consen  248 YLS  250 (357)
T ss_pred             cCC
Confidence            444

>KOG0595|consensus

Probab=100.00  E-value=1.4e-47  Score=306.02  Aligned_cols=197  Identities=33%  Similarity=0.603  Sum_probs=172.8

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      -..+|++.+.||.|+|++||+|++         +.++..||||.+.... ..+.++.+..|+.+|+.+ +|||||.++++
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h---------~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~   77 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRH---------KKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDC   77 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEe---------ccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEE
Confidence            346899999999999999999984         4444679999987553 666777889999999999 89999999999


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC------CcEEEe
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP------HVVKIS  139 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~------~~~kl~  139 (228)
                      +..+ .+++|||||.||+|.+|++.                    ++||+++|+||||||+|||+...      -.+||+
T Consensus        78 ~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   78 IEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             EecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence            8764 48899999999999999876                    69999999999999999999864      469999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      |||+++.+.+...    ..+.+|++.|||||++....|+.|+|+||+|+++|+|++ |..||...+..|++.+++++...
T Consensus       158 DFGfAR~L~~~~~----a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~~eL~~~~~k~~~~  232 (429)
T KOG0595|consen  158 DFGFARFLQPGSM----AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT-GKPPFDAETPKELLLYIKKGNEI  232 (429)
T ss_pred             ccchhhhCCchhH----HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHHHhccccc
Confidence            9999998865432    235789999999999999999999999999999999999 99999999999999998887544

>KOG0197|consensus

Probab=100.00  E-value=2.2e-47  Score=314.09  Aligned_cols=210  Identities=41%  Similarity=0.756  Sum_probs=185.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++++.+++.+.||+|.||+||.|.+.+..          .||+|.++....  ..+.|.+|+++|++| +|+|||++
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~----------~vavk~ik~~~m--~~~~f~~Ea~iMk~L-~H~~lV~l  266 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGST----------KVAVKTIKEGSM--SPEAFLREAQIMKKL-RHEKLVKL  266 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCCC----------cccceEEecccc--ChhHHHHHHHHHHhC-cccCeEEE
Confidence            56788888999999999999999999987754          389999876522  225788999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++..+. ++|||||++.|+|.+||+.                      .||.++++|||||...|||++.+..+||+|
T Consensus       267 ~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsD  346 (468)
T KOG0197|consen  267 YGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISD  346 (468)
T ss_pred             EEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcc
Confidence            99998855 9999999999999999985                      599999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||+++.+ .+..+.. .....-++.|+|||++....++.++||||||+++||+.|+|..||.++++.++++++++|+|+|
T Consensus       347 FGLAr~~-~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp  424 (468)
T KOG0197|consen  347 FGLARLI-GDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP  424 (468)
T ss_pred             ccccccc-CCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence            9999943 3333322 2233446789999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q psy3166         221 RPASCNEQ  228 (228)
Q Consensus       221 ~p~~~~~~  228 (228)
                      +|++||++
T Consensus       425 ~P~~CP~~  432 (468)
T KOG0197|consen  425 RPEGCPDE  432 (468)
T ss_pred             CCCCCCHH
Confidence            99999985

>KOG0581|consensus

Probab=100.00  E-value=2.8e-45  Score=290.06  Aligned_cols=206  Identities=27%  Similarity=0.436  Sum_probs=183.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++++....||+|..|+|||++         |+.+++.+|+|.+..+.....+.++.+|++++++. +||+||.+++.
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~---------Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~yga  145 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVR---------HKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGA  145 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEE---------EcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEE
Confidence            445588889999999999999998         55666789999998787888889999999999999 99999999999


Q ss_pred             EEcCc--eEEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          87 CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        87 ~~~~~--~~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      |+.+.  +.++||||.+|+|.+.+..                    .|||+ ++|+||||||+|+|++.+|.+||+|||.
T Consensus       146 F~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  146 FYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             EEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccc
Confidence            98754  8899999999999998874                    69995 9999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI-----PLCRIVHYLSTGYR  218 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~-----~~~~~~~~~~~~~~  218 (228)
                      ++.+.++.     ..+..||..||+||.+.+..|+.++||||||+.++||.+ |+.||...     +.-+++..+..+.+
T Consensus       226 S~~lvnS~-----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~-GrfP~~~~~~~~~~~~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  226 SGILVNSI-----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI-GRFPYPPPNPPYLDIFELLCAIVDEPP  299 (364)
T ss_pred             cHHhhhhh-----cccccccccccChhhhcCCcCCcccceecccHHHHHHhh-CCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence            98765542     345788999999999999999999999999999999998 99999874     55688889999988


Q ss_pred             CCCCCC-CCCC
Q psy3166         219 MERPAS-CNEQ  228 (228)
Q Consensus       219 ~~~p~~-~~~~  228 (228)
                      |..|.+ +++|
T Consensus       300 P~lP~~~fS~e  310 (364)
T KOG0581|consen  300 PRLPEGEFSPE  310 (364)
T ss_pred             CCCCcccCCHH
Confidence            888987 7765

>KOG0592|consensus

Probab=100.00  E-value=4.6e-45  Score=300.32  Aligned_cols=209  Identities=26%  Similarity=0.430  Sum_probs=180.8

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+.+|.+++.||+|+|++|++|+         ++.+++.||+|++.+..  +......+..|-.+|.+|.+||.|++++.
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~---------~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~  141 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAR---------EKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF  141 (604)
T ss_pred             ChhhcchhheeccccceeEEEee---------ecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE
Confidence            46899999999999999999998         55577789999997552  11222346689999999999999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .|++.. +|+|+||+++|+|.+++..                    +|||++||+||||||+|||++.+++++|+|||-+
T Consensus       142 TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  142 TFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             EeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccc
Confidence            888754 9999999999999999876                    7999999999999999999999999999999999


Q ss_pred             ccccccccc------c----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         145 EDIYEQNVF------Q----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       145 ~~~~~~~~~------~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      +.+.+....      .    ....+..||..|.+||++.....++.+|+|+|||++|+|+. |.+||.+....-+.++|+
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla-G~PPFra~NeyliFqkI~  300 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA-GQPPFRAANEYLIFQKIQ  300 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc-CCCCCccccHHHHHHHHH
Confidence            877654221      1    12256889999999999999999999999999999999999 999999999898999999


Q ss_pred             cCCCCCCCCCCCC
Q psy3166         215 TGYRMERPASCNE  227 (228)
Q Consensus       215 ~~~~~~~p~~~~~  227 (228)
                      .. .+++|++.|+
T Consensus       301 ~l-~y~fp~~fp~  312 (604)
T KOG0592|consen  301 AL-DYEFPEGFPE  312 (604)
T ss_pred             Hh-cccCCCCCCH
Confidence            87 8888888775

>KOG0616|consensus

Probab=100.00  E-value=1.4e-44  Score=278.31  Aligned_cols=203  Identities=28%  Similarity=0.435  Sum_probs=178.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ...++|++.+.||.|+||.|-+++         ++.++.-||+|.+++..  +.+..++..+|..+|+.+ .||+++.++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr---------~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~  110 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVR---------EKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLY  110 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEE---------EccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEE
Confidence            566789999999999999999988         44455679999998663  334456788999999999 899999999


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +.+.+ +++++||||.+||.|+.+++.                    +|||+++|++|||||+|||++++|.+||+|||+
T Consensus       111 ~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  111 GTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             EeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccc
Confidence            88766 558999999999999999876                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.....      .-+.+||+.|+|||++.+.+|+.++|+||||+++|||+. |.+||....+..+.+++.++ ....|.
T Consensus       191 AK~v~~r------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla-G~pPF~~~~~~~iY~KI~~~-~v~fP~  262 (355)
T KOG0616|consen  191 AKRVSGR------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA-GYPPFYDDNPIQIYEKILEG-KVKFPS  262 (355)
T ss_pred             eEEecCc------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc-CCCCCcCCChHHHHHHHHhC-cccCCc
Confidence            9865443      335789999999999999999999999999999999999 99999999999999999999 788886


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      ...+
T Consensus       263 ~fs~  266 (355)
T KOG0616|consen  263 YFSS  266 (355)
T ss_pred             ccCH
Confidence            6543

>KOG0605|consensus

Probab=100.00  E-value=1.4e-44  Score=297.18  Aligned_cols=210  Identities=23%  Similarity=0.369  Sum_probs=174.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      -+..++|+++..||+|+||.||+|+.         +.|+..+|+|+++++.  .......+..|-.+|... +.|+||++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarK---------k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKL  206 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARK---------KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKL  206 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEE---------ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEE
Confidence            35678999999999999999999984         4456689999998763  223346778899999997 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +..|++.. +||||||++||++..+|..                    +-+|+.|++||||||+|+|||.+|++||+|||
T Consensus       207 yYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  207 YYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             EEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccc
Confidence            99998754 8999999999999887654                    57999999999999999999999999999999


Q ss_pred             Ccccccccc---------------------cccC-----------------------CCCCCCCcceeecccccccCCCC
Q psy3166         143 LSEDIYEQN---------------------VFQN-----------------------GEPSEKLPIRWLALESLVSNIYT  178 (228)
Q Consensus       143 ~~~~~~~~~---------------------~~~~-----------------------~~~~~~~~~~~~~Pe~~~~~~~~  178 (228)
                      ++..+....                     .+..                       ...+..||+-|+|||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            985432200                     0000                       01267889999999999999999


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCC
Q psy3166         179 NKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY-RMERPASCN  226 (228)
Q Consensus       179 ~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~-~~~~p~~~~  226 (228)
                      ..+|+|||||++||||. |.+||.+.++.++++++.+-. ....|...+
T Consensus       367 ~~cDwWSLG~ImyEmLv-GyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~  414 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLV-GYPPFCSETPQETYRKIVNWRETLKFPEEVD  414 (550)
T ss_pred             ccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhhhccCCCcCc
Confidence            99999999999999998 999999999999999988742 345565443

>KOG0615|consensus

Probab=100.00  E-value=1.2e-45  Score=295.09  Aligned_cols=195  Identities=28%  Similarity=0.444  Sum_probs=163.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHH------HHHHHHHHHHHHHhcCCCCceEEe
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK------TYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.|.+.+.||+|+||.|-+|.         .+.+++.||+|++++.....      ......+|+++|++| +|||||++
T Consensus       172 d~yii~~~LGsGafg~Vkla~---------e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~  241 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAY---------EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRI  241 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEE---------EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEE
Confidence            467899999999999999988         55677789999997542111      122356999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC---CcEEEe
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP---HVVKIS  139 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~---~~~kl~  139 (228)
                      +++|.... .|+||||+.||+|++++..                    .|||++||+||||||+|||+..+   ..+||+
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEec
Confidence            99997754 6999999999999998754                    69999999999999999999876   689999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR-IVHYLST  215 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~---~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~-~~~~~~~  215 (228)
                      |||+++......    ...+.+||+.|.|||++.+..   +..+.|+||+||++|-|+| |.+||++..... +.+++.+
T Consensus       322 DFGlAK~~g~~s----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs-G~pPFS~~~~~~sl~eQI~~  396 (475)
T KOG0615|consen  322 DFGLAKVSGEGS----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS-GYPPFSEEYTDPSLKEQILK  396 (475)
T ss_pred             ccchhhccccce----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec-cCCCcccccCCccHHHHHhc
Confidence            999999765432    245689999999999999775   3447899999999999999 999999977766 7888998


Q ss_pred             CCCCC
Q psy3166         216 GYRME  220 (228)
Q Consensus       216 ~~~~~  220 (228)
                      | ++.
T Consensus       397 G-~y~  400 (475)
T KOG0615|consen  397 G-RYA  400 (475)
T ss_pred             C-ccc
Confidence            8 443

>KOG0192|consensus

Probab=100.00  E-value=2.6e-43  Score=289.01  Aligned_cols=210  Identities=36%  Similarity=0.614  Sum_probs=179.7

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      ..|.++...+.+.+.||+|+||+||+|.|++..          .||+|.+.... .......+.+|+.+|+++ +||||+
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~----------~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV  102 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD----------VVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIV  102 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeCCce----------eEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCee
Confidence            346788888999999999999999999987754          28999997653 233367899999999999 999999


Q ss_pred             EeeeEEEcCc--eEEEEecCCCCcHHHHHHH----------------------hcccCCC-CcccCCCCCCEeecCCC-c
Q psy3166          82 SFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------------EYLSNNK-VVHRDLATRNILLSSPH-V  135 (228)
Q Consensus        82 ~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~-i~H~~lk~~nil~~~~~-~  135 (228)
                      +++|++....  ..+||||+++|+|.+++..                      +|||+++ |+||||||+|+|++.++ +
T Consensus       103 ~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~  182 (362)
T KOG0192|consen  103 QFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT  182 (362)
T ss_pred             eEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE
Confidence            9999998764  8999999999999999843                      5999999 99999999999999997 9


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY-  212 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~-  212 (228)
                      +||+|||+++......   .......||..|||||++.  +..|+.++|+||||+++|||+| |..||.+.....+... 
T Consensus       183 ~KI~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t-~~~Pf~~~~~~~~~~~v  258 (362)
T KOG0192|consen  183 LKIADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT-GEIPFEDLAPVQVASAV  258 (362)
T ss_pred             EEECCCccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            9999999997554321   2223367889999999999  6689999999999999999999 9999999988666444 


Q ss_pred             HHcCCCCCCCCCCCC
Q psy3166         213 LSTGYRMERPASCNE  227 (228)
Q Consensus       213 ~~~~~~~~~p~~~~~  227 (228)
                      +..+.|+++|..||+
T Consensus       259 ~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  259 VVGGLRPPIPKECPP  273 (362)
T ss_pred             HhcCCCCCCCccCCH
Confidence            568999999998886

>KOG0575|consensus

Probab=100.00  E-value=2.8e-43  Score=293.41  Aligned_cols=203  Identities=26%  Similarity=0.432  Sum_probs=178.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .+|+..+.||+|||+.||.++         +..++..||+|.+.+..  +...+++..+|+++.+.| +|||||+++++|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~---------~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~F   87 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEAR---------DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFF   87 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEE---------EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEe
Confidence            569999999999999999988         45566679999997652  455678899999999999 999999999999


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+.+ +|+|.|+|..++|..+++.                    .|||+++|+|||||..|++++.+..+||.|||++..
T Consensus        88 EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeee
Confidence            8755 8999999999999998874                    699999999999999999999999999999999987


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      +....   .+..+.+||+.|.|||++....++..+||||+||++|.|+. |++||...+..+++.++... ...+|..++
T Consensus       168 le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~-G~PPFetk~vkety~~Ik~~-~Y~~P~~ls  242 (592)
T KOG0575|consen  168 LEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV-GRPPFETKTVKETYNKIKLN-EYSMPSHLS  242 (592)
T ss_pred             ecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh-CCCCcccchHHHHHHHHHhc-CcccccccC
Confidence            65432   23456899999999999999999999999999999999998 99999999999999998887 777776655


Q ss_pred             C
Q psy3166         227 E  227 (228)
Q Consensus       227 ~  227 (228)
                      .
T Consensus       243 ~  243 (592)
T KOG0575|consen  243 A  243 (592)
T ss_pred             H
Confidence            4

>KOG0591|consensus

Probab=100.00  E-value=1.1e-44  Score=277.50  Aligned_cols=201  Identities=29%  Similarity=0.451  Sum_probs=174.7

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..+|+++++||.|+||+||++.         ...++..+|.|.++-. .+.+.+++...|+.+|+.| +||||+++++.
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~---------~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~   86 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQ---------CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAH   86 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEee---------eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHH
Confidence            45679999999999999999987         5566778999998744 3556778899999999999 99999999984


Q ss_pred             -EEc-Cc-eEEEEecCCCCcHHHHHHH------------------------hcccC--CC--CcccCCCCCCEeecCCCc
Q psy3166          87 -CYK-DE-LRLVVEYCALGDLQSYLRE------------------------EYLSN--NK--VVHRDLATRNILLSSPHV  135 (228)
Q Consensus        87 -~~~-~~-~~lv~e~~~~~~L~~~l~~------------------------~~lh~--~~--i~H~~lk~~nil~~~~~~  135 (228)
                       +.. .+ ++++||+|.+|+|.+.++.                        .++|.  .+  |+||||||.||+++.+|.
T Consensus        87 ~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   87 SFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             hhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence             433 33 7899999999999988764                        47887  44  889999999999999999


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +||.|||+++.+.....+   ..+..||+.||+||.+...+|+.++|+||+||++|||+. =..||.+..-.+++.++.+
T Consensus       167 vKLGDfGL~r~l~s~~tf---A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca-L~~PF~g~n~~~L~~KI~q  242 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSKTTF---AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA-LQSPFYGDNLLSLCKKIEQ  242 (375)
T ss_pred             eeeccchhHhHhcchhHH---HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh-cCCCcccccHHHHHHHHHc
Confidence            999999999987666444   346789999999999999999999999999999999999 8899999988999999999


Q ss_pred             CCCCCCC
Q psy3166         216 GYRMERP  222 (228)
Q Consensus       216 ~~~~~~p  222 (228)
                      |.-++.|
T Consensus       243 gd~~~~p  249 (375)
T KOG0591|consen  243 GDYPPLP  249 (375)
T ss_pred             CCCCCCc
Confidence            9777788

>KOG0694|consensus

Probab=100.00  E-value=3.2e-42  Score=290.36  Aligned_cols=206  Identities=28%  Similarity=0.452  Sum_probs=174.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +..++|+++++||+|+||+|+++..         +.+++.||||.+++..  .....+..+.|.+++.-..+||+++.++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~---------k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~  435 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAEL---------KGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLF  435 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEE---------cCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecc
Confidence            4567999999999999999999884         4455679999998773  2334577889999999997899999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .+|++. .+|.||||+.||++....+.                   +|||++||++||||.+|||+|..|++||+|||++
T Consensus       436 ~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  436 SCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             cccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccc
Confidence            999875 48999999999996543221                   7999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +.-....   ...++.+||+.|+|||++.+..|+...||||||+++|||+. |..||++.+..|+.+.|..- .+.-|..
T Consensus       516 Ke~m~~g---~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEee~FdsI~~d-~~~yP~~  590 (694)
T KOG0694|consen  516 KEGMGQG---DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF  590 (694)
T ss_pred             cccCCCC---CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCc
Confidence            8654332   34567899999999999999999999999999999999998 99999999999999988775 4444544


Q ss_pred             CC
Q psy3166         225 CN  226 (228)
Q Consensus       225 ~~  226 (228)
                      ++
T Consensus       591 ls  592 (694)
T KOG0694|consen  591 LS  592 (694)
T ss_pred             cc
Confidence            44

>KOG1026|consensus

Probab=100.00  E-value=5.2e-42  Score=295.30  Aligned_cols=217  Identities=41%  Similarity=0.718  Sum_probs=192.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .|++.+.++.+.||+|.||+||+|...+-.    -.+....||||.++.....+.+++|.+|+++|..+ +|||||+++|
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlG  556 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLL----PGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLG  556 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCC----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEE
Confidence            478889999999999999999999865433    23455679999999887887889999999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH----------------------------------hcccCCCCcccCCCCCCEee
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE----------------------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                      +|..++ +++|+||+..|||.+||..                                  .||-++.++||||-+.|+|+
T Consensus       557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV  636 (774)
T ss_pred             EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence            998766 8999999999999999875                                  58889999999999999999


Q ss_pred             cCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy3166         131 SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV  210 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~  210 (228)
                      .....|||+|||+++.+-....+..+. ...-+++||+||.+..+.+++++||||+|+++||+.|+|..||.+.++.|++
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~-~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRG-NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccC-CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            999999999999998765554443322 2345689999999999999999999999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCCCCC
Q psy3166         211 HYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       211 ~~~~~~~~~~~p~~~~~~  228 (228)
                      +.+.+|.-+++|++||.+
T Consensus       716 e~i~~g~lL~~Pe~CP~~  733 (774)
T KOG1026|consen  716 ECIRAGQLLSCPENCPTE  733 (774)
T ss_pred             HHHHcCCcccCCCCCCHH
Confidence            999999999999999974

>KOG0583|consensus

Probab=100.00  E-value=6.2e-41  Score=276.95  Aligned_cols=204  Identities=28%  Similarity=0.466  Sum_probs=173.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ...++|++.+.||+|+||+|+.|.         +..++..||+|+++...    .....+.+.+|+.+++++..||||++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~---------~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~   84 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAK---------HRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIR   84 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEee---------eccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeE
Confidence            456799999999999999999997         44555689999876531    11234566689999999955999999


Q ss_pred             eeeEEEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC-CcEEEee
Q psy3166          83 FIGCCYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP-HVVKISD  140 (228)
Q Consensus        83 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~-~~~kl~d  140 (228)
                      +++++.. ..+++||||+.||+|++++.+                    +|||++||+||||||+|+|++.+ +.+||+|
T Consensus        85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   85 LLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             EEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEec
Confidence            9999876 448999999999999999875                    69999999999999999999999 9999999


Q ss_pred             ccCccccc-ccccccCCCCCCCCcceeecccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         141 FGLSEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNI-YT-NKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       141 fg~~~~~~-~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~-~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ||++.... ..    ......+||+.|+|||++.+.. |+ .++|+||+|+++|.|++ |..||.......+..++.++ 
T Consensus       165 FG~s~~~~~~~----~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~-G~~PF~d~~~~~l~~ki~~~-  238 (370)
T KOG0583|consen  165 FGLSAISPGED----GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC-GRLPFDDSNVPNLYRKIRKG-  238 (370)
T ss_pred             cccccccCCCC----CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCccHHHHHHHHhcC-
Confidence            99998652 22    2234578999999999999877 75 78999999999999999 99999998888888888888 


Q ss_pred             CCCCCCCC
Q psy3166         218 RMERPASC  225 (228)
Q Consensus       218 ~~~~p~~~  225 (228)
                      ...+|..+
T Consensus       239 ~~~~p~~~  246 (370)
T KOG0583|consen  239 EFKIPSYL  246 (370)
T ss_pred             CccCCCCc
Confidence            88888876

>KOG0582|consensus

Probab=100.00  E-value=1.6e-40  Score=268.07  Aligned_cols=208  Identities=27%  Similarity=0.413  Sum_probs=176.5

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..|....++|++.++||.|..+.||+|+..         -++..||||++...........+.+|++.|+.+ +||||++
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~---------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~   88 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCI---------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVT   88 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeec---------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcce
Confidence            457788999999999999999999999843         344579999997664444567888999999999 9999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++..|..+ .+|+||.|+.+|++.+.+..                      .|||++|-+|||+|+.||||+.+|.+||+
T Consensus        89 ~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen   89 YHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             EEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEc
Confidence            99988765 59999999999999998775                      69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCC-CCCCCcceeeccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         140 DFGLSEDIYEQNVFQNGE-PSEKLPIRWLALESLVS--NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~-~~~~~~~~~~~Pe~~~~--~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |||.+..+..++...... ....|++.|||||++..  ..|+.|+||||||++..|+.+ |..||+.+++.+++.+-.++
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~-G~aPf~k~pPmkvLl~tLqn  247 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH-GHAPFSKYPPMKVLLLTLQN  247 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc-CCCCcccCChHHHHHHHhcC
Confidence            999988776655322222 55688999999999653  359999999999999999998 99999999999997776666


Q ss_pred             CCCCCC
Q psy3166         217 YRMERP  222 (228)
Q Consensus       217 ~~~~~p  222 (228)
                       .||+|
T Consensus       248 -~pp~~  252 (516)
T KOG0582|consen  248 -DPPTL  252 (516)
T ss_pred             -CCCCc
Confidence             44443

>KOG1095|consensus

Probab=100.00  E-value=2.2e-40  Score=294.10  Aligned_cols=216  Identities=44%  Similarity=0.769  Sum_probs=190.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+++++.++.+.||+|.||+||.|....-....    ....||+|.++.....+...+|++|..+|+++ +||||++++|
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liG  762 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIG  762 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEE
Confidence            478899999999999999999999976544211    13459999999888888889999999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH---------------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE---------------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      ++.... .++++|||.+|+|..||++                           +||++++++||||...|+|++.+..+|
T Consensus       763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence            988754 7789999999999999987                           699999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      |.|||+++++.....+..... ..-+..|||||.+....++.++||||||+++||++|+|..||.+.++.+++..+.+|.
T Consensus       843 IaDFGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGE-AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG  921 (1025)
T ss_pred             EcccchhHhhhhchheeccCc-cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence            999999997766554433222 2335689999999999999999999999999999999999999999999999888888


Q ss_pred             CCCCCCCCCC
Q psy3166         218 RMERPASCNE  227 (228)
Q Consensus       218 ~~~~p~~~~~  227 (228)
                      |++.|..||+
T Consensus       922 RL~~P~~CP~  931 (1025)
T KOG1095|consen  922 RLDPPSYCPE  931 (1025)
T ss_pred             ccCCCCCCCh
Confidence            9999999996

>KOG0593|consensus

Probab=100.00  E-value=2.3e-41  Score=261.52  Aligned_cols=190  Identities=27%  Similarity=0.471  Sum_probs=156.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +.|+.+.++|+|+||+|++|+         ++.|++.||||++..+.. +...+-+++|+++|+.+ +|+|+|.++++|-
T Consensus         2 ekYE~LgkvGEGSYGvV~KCr---------nk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFr   71 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCR---------NKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFR   71 (396)
T ss_pred             cHHhhhhccccCcceEEEEec---------cCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHH
Confidence            478889999999999999998         677888999999976644 55556688999999999 9999999999986


Q ss_pred             c-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 K-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      . ..+++|+|||.. ++.+-+..                     .|+|+++++||||||+|||+.++|.+||+|||+++.
T Consensus        72 rkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~  150 (396)
T KOG0593|consen   72 RKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFART  150 (396)
T ss_pred             hcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHh
Confidence            6 459999999966 44333332                     699999999999999999999999999999999987


Q ss_pred             ccc-cccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         147 IYE-QNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~-~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +.. ...++.    -..|.=|.|||.+.+ ..|+++.||||+||++.||++ |.+-|++.++-..+..+++
T Consensus       151 L~~pgd~YTD----YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~k  216 (396)
T KOG0593|consen  151 LSAPGDNYTD----YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIRK  216 (396)
T ss_pred             hcCCcchhhh----hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHHH
Confidence            763 223322    223444789999998 579999999999999999999 9999999877655555444

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-39  Score=268.89  Aligned_cols=218  Identities=43%  Similarity=0.810  Sum_probs=173.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||+|.+....    ...++..||+|.++..........+.+|+.++.++.+||||++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~   77 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLL   77 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEE
Confidence            7789999999999999999999999753321    223445699999976544445567889999999998899999999


Q ss_pred             eEEEcC--ceEEEEecCCCCcHHHHHHH----------------------------------------------------
Q psy3166          85 GCCYKD--ELRLVVEYCALGDLQSYLRE----------------------------------------------------  110 (228)
Q Consensus        85 ~~~~~~--~~~lv~e~~~~~~L~~~l~~----------------------------------------------------  110 (228)
                      +++...  .++++|||+++|+|.+++..                                                    
T Consensus        78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (338)
T cd05102          78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST  157 (338)
T ss_pred             eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence            987653  37899999999999877641                                                    


Q ss_pred             ------------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCC
Q psy3166         111 ------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE  160 (228)
Q Consensus       111 ------------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (228)
                                                    .|||+++|+||||||+||+++.++.+||+|||+++.+....... .....
T Consensus       158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~  236 (338)
T cd05102         158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGSA  236 (338)
T ss_pred             ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh-cccCC
Confidence                                          58999999999999999999999999999999987543322111 11223


Q ss_pred             CCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCC
Q psy3166         161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       161 ~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .++..|+|||++....++.++|+|||||++|+|++.|..||.+.... ++...+..+.++..|..+++
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATP  304 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCH
Confidence            44567999999988889999999999999999997699999886544 34566777767766776654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597|consensus

Probab=100.00  E-value=7.5e-41  Score=276.87  Aligned_cols=192  Identities=29%  Similarity=0.505  Sum_probs=168.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|-+.+.||+|+||.||||+         .+.+.+.||+|.+.+.. ..+....+.+|+++++++ +||||+.++++|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgr---------rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfE   71 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGR---------RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFE   71 (808)
T ss_pred             cchhHHHHhcCCccceeeecc---------cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhc
Confidence            578899999999999999998         66677789999997653 445667788999999999 9999999999987


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .. .+++|.|||.| +|..++..                    .|||+++|+|||+||.|||++..|++|++|||+++.+
T Consensus        72 t~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   72 TSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             ccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence            64 58999999977 99998875                    5999999999999999999999999999999999877


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .....   -.....||+.|||||...+.+|+..+|+||+||++|||.+ |.+||......++...|...
T Consensus       151 ~~~t~---vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~-G~PPF~a~si~~Lv~~I~~d  215 (808)
T KOG0597|consen  151 STNTS---VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV-GQPPFYARSITQLVKSILKD  215 (808)
T ss_pred             ccCce---eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc-CCCCchHHHHHHHHHHHhcC
Confidence            65432   1235678999999999999999999999999999999999 99999998888888777765

>KOG0611|consensus

Probab=100.00  E-value=2.3e-40  Score=265.16  Aligned_cols=193  Identities=31%  Similarity=0.524  Sum_probs=171.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .+|++.+.||.|+||+|-+|.         +...++.||||.++++.  ..+....+.+|+++|+.| +||||++++++|
T Consensus        53 HRyE~~etLGkGTYGKVk~A~---------e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVF  122 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAY---------EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVF  122 (668)
T ss_pred             hHHHHHHHhcCCcccceeehh---------hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhh
Confidence            589999999999999999987         44566679999998663  445667889999999999 999999999999


Q ss_pred             Ec-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+ +.+++||||+.+|.|++|+.+                    -|+|.++++|||||.+|||+|+++.+||+|||++..
T Consensus       123 ENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  123 ENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             cCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhh
Confidence            76 558999999999999999886                    499999999999999999999999999999999987


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      +...+..    ++.+|++.|.+||++.+.+| ++..|.||||+++|.+.. |..||.+.+...++.++..|.
T Consensus       203 y~~~kfL----qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVy-GtMPFDG~Dhk~lvrQIs~Ga  269 (668)
T KOG0611|consen  203 YADKKFL----QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVY-GTMPFDGRDHKRLVRQISRGA  269 (668)
T ss_pred             hccccHH----HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhh-cccccCCchHHHHHHHhhccc
Confidence            7665443    35788899999999999988 577999999999999997 999999999999999999873

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.7e-39  Score=265.67  Aligned_cols=204  Identities=22%  Similarity=0.319  Sum_probs=164.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||+||++..         ..+++.||+|.++...  .......+.+|+.++.++ +||||+++++.+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~   70 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQK---------KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSF   70 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence            5899999999999999999974         3445579999987542  122335677899999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .... +++||||+++|+|.+++..                    .|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          71 QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             ecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            7654 8899999999999998764                    699999999999999999999999999999999865


Q ss_pred             ccccccc--------------------------------cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHH
Q psy3166         147 IYEQNVF--------------------------------QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV  194 (228)
Q Consensus       147 ~~~~~~~--------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~  194 (228)
                      +......                                ........||..|+|||++.+..++.++|+|||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4221000                                00012346889999999999888999999999999999999


Q ss_pred             hCCCCCCCCCCHHHHHHHHHcC-CCCCCCCC
Q psy3166         195 TLGANPYPHIPLCRIVHYLSTG-YRMERPAS  224 (228)
Q Consensus       195 t~g~~pf~~~~~~~~~~~~~~~-~~~~~p~~  224 (228)
                      + |..||.+.+..+...++... ..+..|+.
T Consensus       231 ~-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  260 (363)
T cd05628         231 I-GYPPFCSETPQETYKKVMNWKETLIFPPE  260 (363)
T ss_pred             h-CCCCCCCCCHHHHHHHHHcCcCcccCCCc
Confidence            9 99999998888888777663 23444543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0194|consensus

Probab=100.00  E-value=1.1e-39  Score=272.00  Aligned_cols=216  Identities=41%  Similarity=0.680  Sum_probs=180.6

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      +|.+.-++-.+.+.||+|+||+||+|++......     ....||+|..+..  ........+++|.++|+.+ +||||+
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVV  224 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVV  224 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEE
Confidence            4666667777889999999999999998654320     1222899998752  3456677899999999999 999999


Q ss_pred             EeeeEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          82 SFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        82 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +++|+....+ ++++||+|+||+|.++|+.                     +|||+++++||||-..|+|+..++.+||+
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence            9999987765 8899999999999999986                     69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL-STGYR  218 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~-~~~~~  218 (228)
                      |||++..-.   .+........-+..|+|||.+....|+.++||||||+++||+.+.|..||.++...++.+++ .+++|
T Consensus       305 DFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  305 DFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR  381 (474)
T ss_pred             ccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence            999986332   11111111234578999999999999999999999999999999999999999999999998 88999


Q ss_pred             CCCCCCCCCC
Q psy3166         219 MERPASCNEQ  228 (228)
Q Consensus       219 ~~~p~~~~~~  228 (228)
                      ++.|..+|.+
T Consensus       382 ~~~~~~~p~~  391 (474)
T KOG0194|consen  382 MPIPSKTPKE  391 (474)
T ss_pred             CCCCCCCHHH
Confidence            9999988753

>KOG0198|consensus

Probab=100.00  E-value=1.2e-39  Score=260.61  Aligned_cols=208  Identities=25%  Similarity=0.438  Sum_probs=165.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ..+++..+.||+|+||.||++...         +++...|+|.+....... .+.+.+|+.+|+++ +|||||++++...
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~---------~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l-~~p~IV~~~G~~~   84 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNK---------KTGELMAVKSVELEDSPT-SESLEREIRILSRL-NHPNIVQYYGSSS   84 (313)
T ss_pred             cchhhhhccccCccceEEEEEEec---------CCCcceeeeeeecccchh-HHHHHHHHHHHHhC-CCCCEEeeCCccc
Confidence            456889999999999999999843         335568999987653333 56788999999999 6999999999632


Q ss_pred             -cC--ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC-CCcEEEeeccC
Q psy3166          89 -KD--ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS-PHVVKISDFGL  143 (228)
Q Consensus        89 -~~--~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~dfg~  143 (228)
                       ..  .++++|||+++|+|.+++..                     .|||++||+|+||||+|||++. ++.+||+|||.
T Consensus        85 ~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   85 SRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             cccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcc
Confidence             23  47799999999999998774                     6999999999999999999999 79999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHH-HHHHHcCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPH-IPLCRI-VHYLSTGYRME  220 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~-~~~~~~-~~~~~~~~~~~  220 (228)
                      ++................||+.|||||++..+ ...+++|+||+||++.||+| |..||.. ....+. ........-|+
T Consensus       165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T-g~~PW~~~~~~~~~~~~ig~~~~~P~  243 (313)
T KOG0198|consen  165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT-GKPPWSEFFEEAEALLLIGREDSLPE  243 (313)
T ss_pred             ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC-CCCcchhhcchHHHHHHHhccCCCCC
Confidence            87655322222334567889999999999853 33458999999999999999 9999998 444444 33344454567


Q ss_pred             CCCCCCCC
Q psy3166         221 RPASCNEQ  228 (228)
Q Consensus       221 ~p~~~~~~  228 (228)
                      +|..+|+|
T Consensus       244 ip~~ls~~  251 (313)
T KOG0198|consen  244 IPDSLSDE  251 (313)
T ss_pred             CCcccCHH
Confidence            88888764

>KOG0193|consensus

Probab=100.00  E-value=4.5e-40  Score=273.91  Aligned_cols=204  Identities=31%  Similarity=0.599  Sum_probs=174.0

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .|.|+.+...+...||+|.||+||+|+|.++            ||||.+.... .++..+.|.+|+.+|++- +|.||+.
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlL  452 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------------VAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILL  452 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccccc------------eEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhhee
Confidence            4889999999999999999999999998663            9999998664 455678899999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +.|++....+-+|..+|.|.+|+.+++.                     .|||.++|+|||||..||++..+++|||.||
T Consensus       453 FMG~~~~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  453 FMGACMNPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             eehhhcCCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecc
Confidence            9999999888999999999999998764                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      |++..-..+.. ........|...|||||++.   ..+|++.+||||||+++|||+| |..||.....+.++.++..|+.
T Consensus       533 GLatvk~~w~g-~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt-g~lPysi~~~dqIifmVGrG~l  610 (678)
T KOG0193|consen  533 GLATVKTRWSG-EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT-GELPYSIQNRDQIIFMVGRGYL  610 (678)
T ss_pred             cceeeeeeecc-ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh-CcCCcCCCChhheEEEeccccc
Confidence            99753222211 12233456677899999987   4468999999999999999999 9999997666777888888877


Q ss_pred             CCCC
Q psy3166         219 MERP  222 (228)
Q Consensus       219 ~~~p  222 (228)
                      ++.+
T Consensus       611 ~pd~  614 (678)
T KOG0193|consen  611 MPDL  614 (678)
T ss_pred             Cccc
Confidence            6654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1e-38  Score=262.21  Aligned_cols=203  Identities=26%  Similarity=0.438  Sum_probs=169.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ....++|++.+.||+|+||.||+|++..         +++.||+|.++...  .......+.+|+.+++++ +||||+++
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~   83 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNM   83 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcE
Confidence            4456799999999999999999998543         44579999986442  223345678999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++.+..+. .+++|||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||
T Consensus        84 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         84 MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             EEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeecc
Confidence            99887654 8899999999999988754                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++......      .....|+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+.+..+ +++.|
T Consensus       164 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~-~~~~p  235 (329)
T PTZ00263        164 FAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIYEKILAG-RLKFP  235 (329)
T ss_pred             CceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CcCCC
Confidence            98754322      123467888999999998889999999999999999999 99999998887778887776 56666


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      ..++
T Consensus       236 ~~~~  239 (329)
T PTZ00263        236 NWFD  239 (329)
T ss_pred             CCCC
Confidence            6554

>KOG0659|consensus

Probab=100.00  E-value=4e-39  Score=244.89  Aligned_cols=200  Identities=27%  Similarity=0.425  Sum_probs=163.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|.-.+++|+|.||.||+|+         +.++++.||+|+++... .......+.+|+..|+.+ +|+||+.+.++|.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~---------d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~   71 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKAR---------DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFP   71 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEE---------ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhcc
Confidence            578899999999999999998         66677889999998552 222345678999999999 9999999999987


Q ss_pred             c-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 K-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      . +++.+|+||++. +|...++.                     .|||++.|+|||+||.|+|++.+|.+||+|||+++.
T Consensus        72 ~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   72 HKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             CCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhc
Confidence            6 558899999954 88777654                     699999999999999999999999999999999987


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +.......   .....|.=|.|||.+.+. .|+...|+||.||++.||+- |.+.|++.++-+.+..+-....+|.|+.
T Consensus       151 f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll-r~P~fpG~sDidQL~~If~~LGTP~~~~  225 (318)
T KOG0659|consen  151 FGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL-RVPFFPGDSDIDQLSKIFRALGTPTPDQ  225 (318)
T ss_pred             cCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc-cCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence            76543211   111334457899999865 58999999999999999996 9999999888777777666556665543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=257.60  Aligned_cols=199  Identities=26%  Similarity=0.400  Sum_probs=165.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|...         .++..||+|.++...  .......+.+|+.+++++ +||||+++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   70 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR---------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTE   70 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhh
Confidence            47999999999999999999843         345579999986432  223345678899999999 999999999887


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. ++++|||+++++|.+++..                    .|||++||+||||||+||+++.++.+||+|||++..
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          71 HDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             ccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            6644 7899999999999988754                    699999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ....      .....|+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+.+..+ +++.|..++
T Consensus       151 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  222 (291)
T cd05612         151 LRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAG-KLEFPRHLD  222 (291)
T ss_pred             ccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CcCCCccCC
Confidence            4321      123457788999999998889999999999999999999 99999998888888777776 555665544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0600|consensus

Probab=100.00  E-value=3e-39  Score=264.11  Aligned_cols=193  Identities=25%  Similarity=0.370  Sum_probs=159.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .+.|+.++.||+|+||.||+|+         +..+++.||+|++..+. ......-..+||.+|++| +||||+++.+..
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr---------~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eiv  185 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKAR---------DLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIV  185 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEee---------ecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEE
Confidence            4568889999999999999988         67788899999987542 344445567999999999 999999999988


Q ss_pred             EcC---ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          88 YKD---ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        88 ~~~---~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +..   .+|+|+||+.. +|.-++..                     +|||++||+|||||.+||||+.+|.+||+|||+
T Consensus       186 t~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  186 TSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             EecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccc
Confidence            764   59999999965 55544332                     799999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ++++.....  ...+++..|.=|.+||.+.+. .|+++.|+||.||++.||+. |.+.|++.+.-+.++.|-+
T Consensus       265 Ar~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQl~kIfk  334 (560)
T KOG0600|consen  265 ARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL-GKPILQGRTEVEQLHKIFK  334 (560)
T ss_pred             eeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc-CCCCcCCccHHHHHHHHHH
Confidence            986644321  113345556668999999865 59999999999999999998 9999999988887777554

>KOG0610|consensus

Probab=100.00  E-value=1.2e-38  Score=255.18  Aligned_cols=207  Identities=24%  Similarity=0.317  Sum_probs=171.6

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..+.|++++.||+|.-|+||+++.+++.         ..+|+|.+.+..  ......++..|.+||+++ +||.++.+
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~---------~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTL  142 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTN---------CLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTL  142 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCC---------ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchh
Confidence            355678999999999999999999966543         469999998663  234456778899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      +..|..+. .+++||||+||+|...++.                      +|||-.||+.|||||+|||+-++|++.|+|
T Consensus       143 Ya~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  143 YASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             hheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeee
Confidence            99998876 6899999999999887764                      699999999999999999999999999999


Q ss_pred             ccCcccccc------c--------------------------c-c-------------------c-cCCCCCCCCcceee
Q psy3166         141 FGLSEDIYE------Q--------------------------N-V-------------------F-QNGEPSEKLPIRWL  167 (228)
Q Consensus       141 fg~~~~~~~------~--------------------------~-~-------------------~-~~~~~~~~~~~~~~  167 (228)
                      |.++.....      .                          . .                   . ..+..+..||..|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            998532210      0                          0 0                   0 01123567788999


Q ss_pred             cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       168 ~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      |||++.+...+.++|||+||+++|||+. |..||.+.+..+++..+... .+..|..
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLy-G~TPFKG~~~~~Tl~NIv~~-~l~Fp~~  357 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLY-GTTPFKGSNNKETLRNIVGQ-PLKFPEE  357 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHh-CCCCcCCCCchhhHHHHhcC-CCcCCCC
Confidence            9999999999999999999999999997 99999999999999988776 5666543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-37  Score=248.70  Aligned_cols=212  Identities=30%  Similarity=0.579  Sum_probs=174.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||+|.+...      ......||+|.++..........+.+|+.++.++ +||||++++++
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~   74 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLP------SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGV   74 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecC------CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEE
Confidence            5678999999999999999999976432      2345579999998765555556788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+ ..++||||+++++|.+++..                     +|||+++++||||||+||+++.++.++++|||..
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          75 ITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             EecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence            8764 48899999999999988754                     5899999999999999999999999999999986


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      .........  ......++..|+|||.+....++.++|+|||||++|++++.|..||...+..++.+.+..+.+++.|..
T Consensus       155 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (266)
T cd05064         155 QEDKSEAIY--TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRN  232 (266)
T ss_pred             ccccccchh--cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCC
Confidence            543221111  111223356799999998888999999999999999987569999999988888888888888888888


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      ||.
T Consensus       233 ~~~  235 (266)
T cd05064         233 CPN  235 (266)
T ss_pred             CCH
Confidence            774

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0588|consensus

Probab=100.00  E-value=7.1e-39  Score=269.12  Aligned_cols=204  Identities=26%  Similarity=0.428  Sum_probs=176.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ..-|++++.||.|+-|.|.+|+         +..|++..|||++.+..  .......+.+|+.+|+-+ .||||+.++++
T Consensus        11 iGpwkLgkTLG~Gstg~vrlak---------h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydV   80 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAK---------HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDV   80 (786)
T ss_pred             ccceeccccccCCCCceehhhh---------cccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeee
Confidence            4568999999999999999986         77888899999986542  222234677999999999 99999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.+.. +|+|+||+++|.|++++.+                    .|+|..+|+|||+||+|+|++..+.+||+|||++.
T Consensus        81 we~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   81 WENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMAS  160 (786)
T ss_pred             eccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceee
Confidence            98754 8999999999999999865                    69999999999999999999998889999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      .-.+....    .+.+|+++|.+||++.+..| +.++||||.|+++|.|+| |+.||.+...+.++.++..| -.++|..
T Consensus       161 Le~~gklL----eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt-G~LPFdDdNir~LLlKV~~G-~f~MPs~  234 (786)
T KOG0588|consen  161 LEVPGKLL----ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT-GKLPFDDDNIRVLLLKVQRG-VFEMPSN  234 (786)
T ss_pred             cccCCccc----cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh-CCCCCCCccHHHHHHHHHcC-cccCCCc
Confidence            54444332    34689999999999999887 478999999999999999 99999999999999999999 8899988


Q ss_pred             CCCC
Q psy3166         225 CNEQ  228 (228)
Q Consensus       225 ~~~~  228 (228)
                      .|+|
T Consensus       235 Is~e  238 (786)
T KOG0588|consen  235 ISSE  238 (786)
T ss_pred             CCHH
Confidence            8764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-38  Score=259.57  Aligned_cols=205  Identities=24%  Similarity=0.392  Sum_probs=167.9

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..+..++|++.+.||+|+||.||+|....+.        ...||+|.+....  .......+.+|+.+++.+ +||||++
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~   95 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNED--------FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVN   95 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCC--------CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcc
Confidence            4567789999999999999999999754322        2359999886432  223345678899999999 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++.... .+++|||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DF  175 (340)
T PTZ00426         96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDF  175 (340)
T ss_pred             eEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecC
Confidence            999987755 7899999999999988754                    5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++..+...      .....||..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+...+.+.+..+ ....
T Consensus       176 G~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~  247 (340)
T PTZ00426        176 GFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV-GCPPFYANEPLLIYQKILEG-IIYF  247 (340)
T ss_pred             CCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Confidence            998754221      123467888999999988888999999999999999999 99999998877777777776 3444


Q ss_pred             CCCCC
Q psy3166         222 PASCN  226 (228)
Q Consensus       222 p~~~~  226 (228)
                      |..++
T Consensus       248 p~~~~  252 (340)
T PTZ00426        248 PKFLD  252 (340)
T ss_pred             CCCCC
Confidence            54444

>KOG0585|consensus

Probab=100.00  E-value=2.9e-38  Score=256.78  Aligned_cols=204  Identities=27%  Similarity=0.433  Sum_probs=162.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHH-------------HHHHHHHHHHHHHhcC
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-------------TYDKFLKEINLMKDVG   75 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~   75 (228)
                      .++|++.+.||+|.||+|.+|+         +..+++.||+|++.+.....             ..++..+|+.+|+++ 
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar---------~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-  165 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLAR---------DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-  165 (576)
T ss_pred             hhheehhhhhcCCccceEEEEe---------ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-
Confidence            4689999999999999999998         55566789999986442111             124788999999999 


Q ss_pred             CCCceEEeeeEEEc---CceEEEEecCCCCcHHH---------------HHHH-----hcccCCCCcccCCCCCCEeecC
Q psy3166          76 KHDHIVSFIGCCYK---DELRLVVEYCALGDLQS---------------YLRE-----EYLSNNKVVHRDLATRNILLSS  132 (228)
Q Consensus        76 ~h~ni~~~~~~~~~---~~~~lv~e~~~~~~L~~---------------~l~~-----~~lh~~~i~H~~lk~~nil~~~  132 (228)
                      +|||||+++++..+   +.+|+|+|||..|.+..               ++..     +|||.+||+||||||+|+|++.
T Consensus       166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence            99999999998754   55999999998775431               2221     7999999999999999999999


Q ss_pred             CCcEEEeeccCccccccccc--ccCCCCCCCCcceeecccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         133 PHVVKISDFGLSEDIYEQNV--FQNGEPSEKLPIRWLALESLVSNI----YTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      +|++||+|||.+........  .........||+.|+|||.+..+.    .+.+.||||+|+++|.|+- |..||.+...
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf-G~~PF~~~~~  324 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF-GQLPFFDDFE  324 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh-ccCCcccchH
Confidence            99999999999875522110  001112368899999999988632    3578899999999999997 9999999888


Q ss_pred             HHHHHHHHcCCCCCCCCC
Q psy3166         207 CRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       207 ~~~~~~~~~~~~~~~p~~  224 (228)
                      .++..+|.+. ++.+|+.
T Consensus       325 ~~l~~KIvn~-pL~fP~~  341 (576)
T KOG0585|consen  325 LELFDKIVND-PLEFPEN  341 (576)
T ss_pred             HHHHHHHhcC-cccCCCc
Confidence            8889998887 7777764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-37  Score=253.00  Aligned_cols=214  Identities=37%  Similarity=0.702  Sum_probs=176.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +...+|++.+.||+|+||.||+|.+..+.     ......||+|.++........+.+.+|+.+++.+ +||||++++++
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~   77 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGI   77 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCC-----CccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEE
Confidence            56789999999999999999999865432     1223458999987655555667788999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..+..++++|++++|+|.+++..                     .|||+++|+||||||+||+++.++.+||+|||+++
T Consensus        78 ~~~~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          78 CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             EcCCCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence            988888899999999999988754                     69999999999999999999999999999999997


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+........ .....++..|++||.+....++.++|+||||+++|+|++.|..||.+.+..++.+.+..+.+++.|..|
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd05108         158 LLGADEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  236 (316)
T ss_pred             cccCCCccee-ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Confidence            6543321111 112233567999999988889999999999999999997799999998888877778888888877776


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      +.
T Consensus       237 ~~  238 (316)
T cd05108         237 TI  238 (316)
T ss_pred             CH
Confidence            53

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0196|consensus

Probab=100.00  E-value=7.5e-39  Score=272.92  Aligned_cols=215  Identities=37%  Similarity=0.656  Sum_probs=189.3

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .|++....+.++||.|.||+|++|+++.-+      +....||||.++.....+.+..|+.|..||-++ +||||+.+.+
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pg------kre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEG  697 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPG------KREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEG  697 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCC------CcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEE
Confidence            588889999999999999999999986643      344569999999887777788999999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +.+... +-+|.||+++|+|..||++                     +||.+++.+||||...|||++++-.+|++|||+
T Consensus       698 VVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL  777 (996)
T KOG0196|consen  698 VVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL  777 (996)
T ss_pred             EEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence            998877 5578899999999999987                     699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.+.++.........-..+++|.|||.+....++.++|+||+|+++||.+++|+-||=.+++.+++..+++|+|+|.|-
T Consensus       778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm  857 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM  857 (996)
T ss_pred             eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence            99775553111111112235789999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      +||.
T Consensus       858 DCP~  861 (996)
T KOG0196|consen  858 DCPA  861 (996)
T ss_pred             CCcH
Confidence            9994

>KOG4257|consensus

Probab=100.00  E-value=8e-39  Score=267.44  Aligned_cols=213  Identities=38%  Similarity=0.748  Sum_probs=187.5

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +.++..++.+.||.|-||.||+|....-.     ++.+-.||||..+.++.+...+.|++|..+|+.+ +||||++++|+
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv  459 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGV  459 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeee
Confidence            44555566789999999999999864421     2333459999999888887889999999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.....++|||+++-|.|..|++.                     .|||+.+++||||...|||+.+...+||.|||+++
T Consensus       460 ~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  460 CVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence            999999999999999999999986                     59999999999999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+.....+...  ...-++-||+||.+.-..++.++|+|=||+++||++++|..||++..+..++-.+++|.|+|+|++|
T Consensus       540 ~~ed~~yYkaS--~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC  617 (974)
T KOG4257|consen  540 YLEDDAYYKAS--RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC  617 (974)
T ss_pred             hccccchhhcc--ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence            87665544321  2233567999999998899999999999999999999999999999999999999999999999999


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      ||
T Consensus       618 Pp  619 (974)
T KOG4257|consen  618 PP  619 (974)
T ss_pred             Ch
Confidence            97

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.8e-37  Score=259.08  Aligned_cols=219  Identities=39%  Similarity=0.765  Sum_probs=173.9

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..|.++.++|++.+.||+|+||.||+|.+....    +..++..||+|.++........+.+.+|+.++..+.+||||++
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~  103 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLF----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVN  103 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccc----cCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceee
Confidence            457788999999999999999999999753321    2345567999998755444445678899999999978999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------------------------------------
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------------------------------------  110 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------------------------------------  110 (228)
                      +++++... ..+++|||+++|+|.+++.+                                                   
T Consensus       104 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  183 (375)
T cd05104         104 LLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA  183 (375)
T ss_pred             eeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence            99988764 47899999999999877631                                                   


Q ss_pred             --------------------------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166         111 --------------------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus       111 --------------------------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                                                                  .|||+++|+||||||+||+++.++.+||+|||++..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~  263 (375)
T cd05104         184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD  263 (375)
T ss_pred             ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence                                                        589999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~~~~~~~~p~~~  225 (228)
                      ........ ......++..|+|||++.+..++.++|+|||||++|+|++.|..||..... .+..+.+..+.++..|..+
T Consensus       264 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (375)
T cd05104         264 IRNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECA  342 (375)
T ss_pred             ccCccccc-ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCC
Confidence            53332111 111233456799999999888999999999999999999878999988654 4556667777777766655


Q ss_pred             C
Q psy3166         226 N  226 (228)
Q Consensus       226 ~  226 (228)
                      |
T Consensus       343 ~  343 (375)
T cd05104         343 P  343 (375)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-37  Score=260.75  Aligned_cols=195  Identities=23%  Similarity=0.345  Sum_probs=157.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ..|++.+.||+|+||+||+|+.         ..++..||+|.+....  .......+.+|+.+++++ +||||+++++.+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~   70 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACK---------VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSF   70 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEE
Confidence            3689999999999999999984         3445579999986542  223345678899999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .... +++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.++|+|||++..
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          71 QDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            7644 8899999999999988754                    699999999999999999999999999999998753


Q ss_pred             cccccc---c-----------------------------------------cCCCCCCCCcceeecccccccCCCCchhh
Q psy3166         147 IYEQNV---F-----------------------------------------QNGEPSEKLPIRWLALESLVSNIYTNKSD  182 (228)
Q Consensus       147 ~~~~~~---~-----------------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D  182 (228)
                      +.....   .                                         ........||..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            311000   0                                         00012346888999999998888999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         183 VWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       183 iwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +|||||++|+|++ |..||...+..+....+..
T Consensus       231 iwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~  262 (381)
T cd05626         231 WWSVGVILFEMLV-GQPPFLAPTPTETQLKVIN  262 (381)
T ss_pred             eeehhhHHHHHHh-CCCCCcCCCHHHHHHHHHc
Confidence            9999999999999 9999998877666555443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-37  Score=259.25  Aligned_cols=219  Identities=37%  Similarity=0.763  Sum_probs=172.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|+++.++|++.+.||+|+||.||+|++....    ...+...||+|.++..........+.+|+.+++.+.+|+||+++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLG----KEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCC----cccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeE
Confidence            47788999999999999999999999864433    22344569999997665455566788999999999789999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------------------------------------
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------------------------------------  110 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------------------------------------  110 (228)
                      ++.+... ..+++|||+++|+|.+++..                                                    
T Consensus       108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            9988764 48899999999999887520                                                    


Q ss_pred             --------------------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166         111 --------------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus       111 --------------------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                                                            .|||+++|+||||||+||+++.++.++|+|||++..+.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                                                  589999999999999999999999999999999875433221


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~~~~~~~~~p~~~~~  227 (228)
                      ... .....++..|+|||++....++.++|+|||||++|+|++.|..||........ ...+..+.++..|..+|+
T Consensus       268 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (374)
T cd05106         268 YVV-KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPP  342 (374)
T ss_pred             eee-ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCH
Confidence            111 11223455799999998888999999999999999999769999988655443 444555666666665553

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.1e-37  Score=257.79  Aligned_cols=218  Identities=41%  Similarity=0.812  Sum_probs=174.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |+++.++|++.+.||+|+||.||+|.+....    .......||+|.++........+.+.+|+.+|+++..||||++++
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLS----RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccC----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            6789999999999999999999999864432    223445799999976555555677899999999995599999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH-----------------------------------------------------
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE-----------------------------------------------------  110 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~-----------------------------------------------------  110 (228)
                      +++... ..++||||+++|+|.+++..                                                     
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            998764 48899999999999876521                                                     


Q ss_pred             ---------------------------------------------------------------hcccCCCCcccCCCCCC
Q psy3166         111 ---------------------------------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus       111 ---------------------------------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                                                                                     .|||+++|+|+||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                                           58999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      |+++.++.+||+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++.|..||......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999999999999998754332211 11122345667999999988889999999999999999997689999886544


Q ss_pred             -HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 -RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 -~~~~~~~~~~~~~~p~~~~~  227 (228)
                       .+...+..+.+++.|..+|+
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~  367 (400)
T cd05105         347 STFYNKIKSGYRMAKPDHATQ  367 (400)
T ss_pred             HHHHHHHhcCCCCCCCccCCH
Confidence             44566777777777777764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-37  Score=254.19  Aligned_cols=202  Identities=24%  Similarity=0.380  Sum_probs=163.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +|++.+.||+|+||.||+|+..         .++..||+|.+++..  ..........|..++..+.+|++|+++.+++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            5899999999999999999843         344579999987542  12223456678888888867999999998887


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .. .+++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||++...
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            64 48899999999999888753                    6999999999999999999999999999999998643


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      .....   ......|++.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+.+..+ ....|..++
T Consensus       152 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  225 (323)
T cd05616         152 MWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEH-NVAYPKSMS  225 (323)
T ss_pred             CCCCC---ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCcCC
Confidence            22211   1223567888999999998889999999999999999999 99999998888888877765 445555544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0578|consensus

Probab=100.00  E-value=8.6e-39  Score=264.69  Aligned_cols=209  Identities=29%  Similarity=0.459  Sum_probs=171.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ..+-|...|.-...||+|..|.||.++         ...++..||+|++....- ...+-+++|+.+|+.. +|+|||.+
T Consensus       267 ~~~dP~~~y~~~~kigqgaSG~vy~A~---------~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~-~H~NiVnf  335 (550)
T KOG0578|consen  267 SQGDPRSKYTDFKKIGQGATGGVYVAR---------KISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDL-HHPNIVNF  335 (550)
T ss_pred             cCCChhhhhcchhhhccccccceeeee---------eccCCceEEEEEEEeccC-CchhhhHHHHHHHHhc-cchHHHHH
Confidence            456788899999999999999999988         444555699999875532 2345678999999999 99999999


Q ss_pred             eeEEE-cCceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCY-KDELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++.+. .+++++||||+.||+|.+.+..                   .|||.+||+|||||.+|||+..+|.+||+|||+
T Consensus       336 l~Sylv~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGF  415 (550)
T KOG0578|consen  336 LDSYLVGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGF  415 (550)
T ss_pred             HHHhcccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeee
Confidence            98764 4669999999999999987653                   699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER--  221 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~--  221 (228)
                      +..+.....   -+....||+-|||||++....|+++.||||||+++.||+. |++||-..++-..+..+....+|++  
T Consensus       416 caqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve-GEPPYlnE~PlrAlyLIa~ng~P~lk~  491 (550)
T KOG0578|consen  416 CAQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPKLKN  491 (550)
T ss_pred             eeccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhc-CCCCccCCChHHHHHHHhhcCCCCcCC
Confidence            976655432   3456889999999999999999999999999999999998 9999876544444444444435553  


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |+.+++
T Consensus       492 ~~klS~  497 (550)
T KOG0578|consen  492 PEKLSP  497 (550)
T ss_pred             ccccCH
Confidence            555543

>KOG4721|consensus

Probab=100.00  E-value=2.9e-39  Score=267.74  Aligned_cols=198  Identities=35%  Similarity=0.630  Sum_probs=170.7

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.||.+...-++-||+|+.|.||+|+.++.           .||||+++.-        -..+|.=|++| +||||+.+.
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~ne-----------tVAVKKV~el--------kETdIKHLRkL-kH~NII~Fk  178 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLHNE-----------TVAVKKVREL--------KETDIKHLRKL-KHPNIITFK  178 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeeccCc-----------eehhHHHhhh--------hhhhHHHHHhc-cCcceeeEe
Confidence            778888888889999999999999997664           4999987521        12467888999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++|.... +++|||||+.|.|+..|+.                    +|||.+.|+|||||.-||||..+..+||+|||.
T Consensus       179 GVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  179 GVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             eeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence            9999877 6799999999999998875                    799999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYRMERP  222 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~-~~~~~~p  222 (228)
                      ++.+.+..    ..-+..||..|||||++...+.+.|.||||||+++|||+| |..||...+.+.++.-+.. -..++.|
T Consensus       259 S~e~~~~S----TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT-~EiPYkdVdssAIIwGVGsNsL~LpvP  333 (904)
T KOG4721|consen  259 SKELSDKS----TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT-GEIPYKDVDSSAIIWGVGSNSLHLPVP  333 (904)
T ss_pred             hHhhhhhh----hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh-cCCCccccchheeEEeccCCcccccCc
Confidence            98765542    1345789999999999999999999999999999999999 9999999887777665443 4456788


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..||+
T Consensus       334 stcP~  338 (904)
T KOG4721|consen  334 STCPD  338 (904)
T ss_pred             ccCch
Confidence            88885

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-37  Score=253.29  Aligned_cols=202  Identities=24%  Similarity=0.379  Sum_probs=162.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +|++.+.||+|+||.||+|...         .++..||+|.++...  .......+..|..++..+.+|++|+.+++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            5899999999999999999843         344579999987542  22334567789999999955667888888876


Q ss_pred             c-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 K-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      . +.+++||||+++++|.+++..                    .|||+++|+||||||+|||++.++.++|+|||++...
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            5 448899999999999887753                    6999999999999999999999999999999988643


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ....   .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+..+.+... ++..|..++
T Consensus       152 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  225 (324)
T cd05587         152 IFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQSIMEH-NVSYPKSLS  225 (324)
T ss_pred             CCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Confidence            2111   11223457888999999998889999999999999999999 99999998888888777765 555565554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=258.91  Aligned_cols=196  Identities=21%  Similarity=0.342  Sum_probs=160.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||+||+|+.         ..++..||+|.++...  .......+.+|+.++..+ +||||+++++.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~   70 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQK---------KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSF   70 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEE
Confidence            4799999999999999999984         3445579999987542  223345577899999999 899999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. +++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.++|+|||++..
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          71 QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             EcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            7655 8899999999999998754                    699999999999999999999999999999999865


Q ss_pred             cccccccc-----------------------------------CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHH
Q psy3166         147 IYEQNVFQ-----------------------------------NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLW  191 (228)
Q Consensus       147 ~~~~~~~~-----------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~  191 (228)
                      +.......                                   .......||+.|+|||++....++.++|+|||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            42211000                                   0011245888999999998888999999999999999


Q ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         192 EIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       192 ~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +|++ |..||.+.+..+....+...
T Consensus       231 el~~-G~~Pf~~~~~~~~~~~i~~~  254 (364)
T cd05599         231 EMLV-GYPPFCSDNPQETYRKIINW  254 (364)
T ss_pred             Hhhc-CCCCCCCCCHHHHHHHHHcC
Confidence            9999 99999998887777766653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-37  Score=260.41  Aligned_cols=195  Identities=23%  Similarity=0.323  Sum_probs=157.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||+||+|+.         ..++..||+|.+....  .......+.+|+.+++++ +||||+++++.+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~   70 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARK---------VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSF   70 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEE
Confidence            3699999999999999999984         3445579999986542  223345678899999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. +++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||++..
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          71 QDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            7654 8899999999999988753                    699999999999999999999999999999998753


Q ss_pred             ccccccc--------------------------------------------cCCCCCCCCcceeecccccccCCCCchhh
Q psy3166         147 IYEQNVF--------------------------------------------QNGEPSEKLPIRWLALESLVSNIYTNKSD  182 (228)
Q Consensus       147 ~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D  182 (228)
                      +......                                            ........||..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            2110000                                            00011246788999999999888999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         183 VWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       183 iwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +||+||++|+|++ |..||.+.+..+....+..
T Consensus       231 iwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~  262 (382)
T cd05625         231 WWSVGVILYEMLV-GQPPFLAQTPLETQMKVIN  262 (382)
T ss_pred             EEechHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Confidence            9999999999999 9999999887776666554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0580|consensus

Probab=100.00  E-value=1.1e-38  Score=239.21  Aligned_cols=203  Identities=25%  Similarity=0.413  Sum_probs=174.6

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ..++|++.+.||.|-||.||.|+.+.         +...||+|.+-+..  ......++.+|+++-+.| +||||+++++
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~   89 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYG   89 (281)
T ss_pred             chhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhh
Confidence            45799999999999999999998544         44469999975442  222345788999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +|.+.. +|+++||++.|+++..|++                      .|+|.++++||||||+|+|++..+.+|++|||
T Consensus        90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence            998755 8999999999999999884                      59999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      .+-.-.     .+.....+||.-|++||+..+..++...|+|++|++.||++. |.+||.+....++.+++.+. +...|
T Consensus       170 wsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv-g~ppFes~~~~etYkrI~k~-~~~~p  242 (281)
T KOG0580|consen  170 WSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV-GLPPFESQSHSETYKRIRKV-DLKFP  242 (281)
T ss_pred             ceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh-cCCchhhhhhHHHHHHHHHc-cccCC
Confidence            875322     234567899999999999999999999999999999999998 99999999999999999987 77777


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      +.++.
T Consensus       243 ~~is~  247 (281)
T KOG0580|consen  243 STISG  247 (281)
T ss_pred             cccCh
Confidence            77654

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=260.32  Aligned_cols=195  Identities=24%  Similarity=0.328  Sum_probs=158.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||+||++..         ..++..||+|.+....  .......+.+|+++++++ +||||+++++++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~   70 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQK---------KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSF   70 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence            4799999999999999999874         3445579999886432  223345678899999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. +++||||+++|+|.+++..                    .|||++||+||||||+|||++.++.++|+|||+++.
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          71 QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             EcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            7755 8899999999999988753                    699999999999999999999999999999999853


Q ss_pred             cccccc------------ccC--------------------------------CCCCCCCcceeecccccccCCCCchhh
Q psy3166         147 IYEQNV------------FQN--------------------------------GEPSEKLPIRWLALESLVSNIYTNKSD  182 (228)
Q Consensus       147 ~~~~~~------------~~~--------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D  182 (228)
                      +.....            ...                                ......||..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            321100            000                                001245888999999998888999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         183 VWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       183 iwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +||+||++|+|++ |..||.+.+..+....+..
T Consensus       231 iwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~  262 (377)
T cd05629         231 WWSLGAIMFECLI-GWPPFCSENSHETYRKIIN  262 (377)
T ss_pred             eEecchhhhhhhc-CCCCCCCCCHHHHHHHHHc
Confidence            9999999999999 9999998887777666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.3e-37  Score=246.52  Aligned_cols=217  Identities=40%  Similarity=0.698  Sum_probs=178.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +++.++|++.+.||+|+||.||+|......    .......||+|.++..........+.+|+.++.++ +||||+++++
T Consensus         1 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~   75 (283)
T cd05048           1 EIPLSAVRFLEELGEGAFGKVYKGELTGPN----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLG   75 (283)
T ss_pred             CCChHHcchhhcccCccCCcEEEEEEecCC----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEE
Confidence            467789999999999999999999865543    12344579999987665555567788999999999 9999999999


Q ss_pred             EEEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCCE
Q psy3166          86 CCYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        86 ~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~ni  128 (228)
                      ++... ..+++|||+++++|.+++..                                    .|||+++++|+||||+||
T Consensus        76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni  155 (283)
T cd05048          76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC  155 (283)
T ss_pred             EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceE
Confidence            88664 47899999999999887642                                    589999999999999999


Q ss_pred             eecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         129 LLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      ++++++.++|+|||++......... .......++..|+|||.+....++.++|+|||||++|+|++.|..||.+....+
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE  234 (283)
T ss_pred             EEcCCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999998754332211 111223446679999999888899999999999999999977999999988888


Q ss_pred             HHHHHHcCCCCCCCCCCCCC
Q psy3166         209 IVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       209 ~~~~~~~~~~~~~p~~~~~~  228 (228)
                      +...+.++.+++.|..||++
T Consensus       235 ~~~~i~~~~~~~~~~~~~~~  254 (283)
T cd05048         235 VIEMIRSRQLLPCPEDCPAR  254 (283)
T ss_pred             HHHHHHcCCcCCCcccCCHH
Confidence            98889888888888888753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0663|consensus

Probab=100.00  E-value=3.1e-38  Score=246.96  Aligned_cols=191  Identities=27%  Similarity=0.395  Sum_probs=156.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .+.|+.+..|++|+||+||+|+         ++.++..||+|+++... ....-.-.++|+.+|.+. +|||||.+.++.
T Consensus        75 v~efe~lnrI~EGtyGiVYRak---------dk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVV  144 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAK---------DKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVV  144 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEec---------cCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEE
Confidence            3578899999999999999987         77888899999997542 122223568999999999 899999999987


Q ss_pred             Ec---CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          88 YK---DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        88 ~~---~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..   +.+|+|||||.. +|...+..                     +|||.+.|+||||||+|+|+...|.+||+|||+
T Consensus       145 vG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  145 VGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             eccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccch
Confidence            65   459999999966 66665543                     799999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ++.+.....   ..+....|.=|.|||.+.+. .|+++.|+||+||++.||++ +.+-|++.+....++++-
T Consensus       224 AR~ygsp~k---~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQl~~If  291 (419)
T KOG0663|consen  224 AREYGSPLK---PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQLDKIF  291 (419)
T ss_pred             hhhhcCCcc---cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCchHHHHHHHH
Confidence            987755421   12234445568899999866 49999999999999999999 999999987766666543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-37  Score=255.49  Aligned_cols=197  Identities=25%  Similarity=0.386  Sum_probs=159.0

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||++..         ..++..||+|.++...  .......+.+|+.+++++ +||||+++.+.+..+. +
T Consensus         1 ~~lG~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~   70 (323)
T cd05571           1 KLLGKGTFGKVILVRE---------KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRL   70 (323)
T ss_pred             CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEE
Confidence            4699999999999984         3445579999987542  223345677899999999 9999999998887654 8


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +++|||+++++|.+++..                    .|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        71 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          71 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            899999999999887653                    69999999999999999999999999999999986432211 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                        .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++...+..+ .+..|..+++
T Consensus       150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~  220 (323)
T cd05571         150 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-EIRFPRTLSP  220 (323)
T ss_pred             --CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCH
Confidence              11223467889999999998889999999999999999999 99999988777776666655 4556655543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-37  Score=253.99  Aligned_cols=217  Identities=43%  Similarity=0.822  Sum_probs=171.7

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.+|.++|++.+.||+|+||.||+|......    +..+++.||+|+++..........+..|+.++.++.+|+||++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~   77 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLL   77 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhhee
Confidence            8999999999999999999999998754322    334567899999875544444566788999999997899999999


Q ss_pred             eEEEc--CceEEEEecCCCCcHHHHHHH----------------------------------------------------
Q psy3166          85 GCCYK--DELRLVVEYCALGDLQSYLRE----------------------------------------------------  110 (228)
Q Consensus        85 ~~~~~--~~~~lv~e~~~~~~L~~~l~~----------------------------------------------------  110 (228)
                      +++..  ..++++|||+++++|.+++..                                                    
T Consensus        78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (337)
T cd05054          78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE  157 (337)
T ss_pred             eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence            98765  347899999999999877620                                                    


Q ss_pred             -----------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCC
Q psy3166         111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK  161 (228)
Q Consensus       111 -----------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  161 (228)
                                                   .|||+++|+||||||+||+++.++.++|+|||++..+....... ......
T Consensus       158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~-~~~~~~  236 (337)
T cd05054         158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDAR  236 (337)
T ss_pred             cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh-hccCCC
Confidence                                         68999999999999999999999999999999987653322111 112234


Q ss_pred             CcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCC
Q psy3166         162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYLSTGYRMERPASCN  226 (228)
Q Consensus       162 ~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~~~~~~~~~p~~~~  226 (228)
                      ++..|+|||++.+..++.++|+||+||++|+|++.|..||.+....+. ...+..+.++..|..++
T Consensus       237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (337)
T cd05054         237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT  302 (337)
T ss_pred             CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence            456799999999989999999999999999999769999987554443 44566666666665544

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=261.68  Aligned_cols=210  Identities=23%  Similarity=0.325  Sum_probs=172.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ....++|++.+.||+|+||+||+|+.         ..++..||+|.++... .......+.+|+.++..+ +|+|++++.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~   97 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKR---------VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCH   97 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEE---------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEee
Confidence            35668999999999999999999974         3345579999986542 344456778899999999 999999998


Q ss_pred             eEEEcC---------ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeec
Q psy3166          85 GCCYKD---------ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLS  131 (228)
Q Consensus        85 ~~~~~~---------~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~  131 (228)
                      +.+...         .++++|||+++|+|.+++..                        .|+|+++|+||||||+|||++
T Consensus        98 ~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~  177 (496)
T PTZ00283         98 EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC  177 (496)
T ss_pred             cceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe
Confidence            766421         15789999999999987753                        599999999999999999999


Q ss_pred             CCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         132 SPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      .++.+||+|||+++.+..... ........||..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt-G~~Pf~~~~~~~~~~  255 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMH  255 (496)
T ss_pred             CCCCEEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence            999999999999875433211 111234567889999999998889999999999999999999 999999988888888


Q ss_pred             HHHcCCCCCCCCCCCC
Q psy3166         212 YLSTGYRMERPASCNE  227 (228)
Q Consensus       212 ~~~~~~~~~~p~~~~~  227 (228)
                      .+..+...+.|..+|+
T Consensus       256 ~~~~~~~~~~~~~~~~  271 (496)
T PTZ00283        256 KTLAGRYDPLPPSISP  271 (496)
T ss_pred             HHhcCCCCCCCCCCCH
Confidence            8888877778877765

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2e-37  Score=257.45  Aligned_cols=204  Identities=21%  Similarity=0.325  Sum_probs=163.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||++...         .++..||+|.++...  .......+.+|+.++..+ +||||+++++.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~   70 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK---------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSF   70 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence            47999999999999999999843         345579999986432  223345677899999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. +++||||+++|+|.+++..                    .|||++||+||||||+||+++.++.++|+|||++..
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          71 QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            7654 8899999999999998754                    699999999999999999999999999999998764


Q ss_pred             ccccccc--------------------------------cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHH
Q psy3166         147 IYEQNVF--------------------------------QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV  194 (228)
Q Consensus       147 ~~~~~~~--------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~  194 (228)
                      +......                                ........||..|+|||++.+..++.++|+|||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            3211000                                00011346888999999999888999999999999999999


Q ss_pred             hCCCCCCCCCCHHHHHHHHHcC-CCCCCCCC
Q psy3166         195 TLGANPYPHIPLCRIVHYLSTG-YRMERPAS  224 (228)
Q Consensus       195 t~g~~pf~~~~~~~~~~~~~~~-~~~~~p~~  224 (228)
                      + |..||.+.+..+....+... .....|..
T Consensus       231 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  260 (360)
T cd05627         231 I-GYPPFCSETPQETYRKVMNWKETLVFPPE  260 (360)
T ss_pred             c-CCCCCCCCCHHHHHHHHHcCCCceecCCC
Confidence            9 99999998888877776653 23344443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0199|consensus

Probab=100.00  E-value=2.2e-38  Score=267.50  Aligned_cols=216  Identities=38%  Similarity=0.675  Sum_probs=191.2

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +-|+.++.++.+.||+|+||.|++|.|..-+      .....||||.++.........+|++|+.+|.+| +|+|+++++
T Consensus       105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLy  177 (1039)
T KOG0199|consen  105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLY  177 (1039)
T ss_pred             eeccHHHHHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEe
Confidence            3478888899999999999999999997733      233469999998776666788999999999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      |+..+..+-+|||+++.|+|.+.|..                      .||..++++||||-..|+|+.....+||+|||
T Consensus       178 GvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  178 GVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             eeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence            99888778899999999999998875                      59999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +.+.+........-...+...+.|-|||.+....++.++|+|++|+++|||+|+|+.||-+.....+++++.+++|+++|
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP  337 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC
Confidence            99877665444333334555678999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      +.||+
T Consensus       338 k~cse  342 (1039)
T KOG0199|consen  338 KYCSE  342 (1039)
T ss_pred             CCChH
Confidence            99986

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.7e-37  Score=246.60  Aligned_cols=192  Identities=27%  Similarity=0.473  Sum_probs=154.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|+..         .++..||+|.++..........+.+|+++++++ +||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~   73 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIH   73 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEc
Confidence            468999999999999999999843         344579999987543333334667899999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ... .+++||++.+ +|.+++..                     .|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        74 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          74 TERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             CCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence            654 7899999975 88877643                     699999999999999999999999999999999864


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .....   .......++..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+.+..+..
T Consensus       153 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  218 (288)
T cd07871         153 KSVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEELHLIFR  218 (288)
T ss_pred             ccCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            32211   11123456778999998875 458899999999999999999 9999999887776665544

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0033|consensus

Probab=100.00  E-value=1e-38  Score=240.59  Aligned_cols=193  Identities=26%  Similarity=0.459  Sum_probs=164.8

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.++||+|.|+.|+++.         ++.+++.+|+|++..+ ......+.+.+|+++.+.| +||||+.+.+.+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~---------~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti   79 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCV---------HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI   79 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHH---------hccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhh
Confidence            3678999999999999999987         6667778999998644 2233457788999999999 999999999987


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC---CcEEEeeccC
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGL  143 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~---~~~kl~dfg~  143 (228)
                      .... .|+|+|++.|++|..-+..                    +|+|.++|+|||+||+|+++.+.   .-+||+|||+
T Consensus        80 ~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   80 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             cccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccce
Confidence            7655 7899999999998653321                    79999999999999999999763   3699999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +..+... .   ......||+.||+||++...+|+.++|||+.|+++|-++. |.+||.+.+...+.+++.+|
T Consensus       160 Ai~l~~g-~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~-G~~PF~~~~~~rlye~I~~g  227 (355)
T KOG0033|consen  160 AIEVNDG-E---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYEQIKAG  227 (355)
T ss_pred             EEEeCCc-c---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhcc
Confidence            9877632 1   2345788999999999999999999999999999999999 99999999999999998886

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-37  Score=259.38  Aligned_cols=195  Identities=23%  Similarity=0.312  Sum_probs=157.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+++.         ..++..||+|.+....  .......+.+|+.+|+++ +||||+++++.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~   70 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRK---------VDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSF   70 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEE---------CCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence            4799999999999999999984         3445679999986432  112235677899999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..++ +++||||+++|+|.+++..                    .|||+++|+||||||+||+++.++.++|+|||++..
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          71 QDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            7654 8899999999999998754                    699999999999999999999999999999998743


Q ss_pred             cccccc----------------------------------------ccCCCCCCCCcceeecccccccCCCCchhhHHHH
Q psy3166         147 IYEQNV----------------------------------------FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSF  186 (228)
Q Consensus       147 ~~~~~~----------------------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwsl  186 (228)
                      +.....                                        .........||..|+|||++.+..++.++|+||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            210000                                        0000113468889999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         187 GVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       187 g~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ||++|+|++ |..||.+....+....+..
T Consensus       231 Gvilyell~-G~~Pf~~~~~~~~~~~i~~  258 (376)
T cd05598         231 GVILYEMLV-GQPPFLADTPAETQLKVIN  258 (376)
T ss_pred             cceeeehhh-CCCCCCCCCHHHHHHHHhc
Confidence            999999999 9999999877766655544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.6e-37  Score=250.90  Aligned_cols=202  Identities=23%  Similarity=0.366  Sum_probs=162.6

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +|++.+.||+|+||.||+|..         ..++..||+|.++...  .......+..|..++..+.+|++|+++.+++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAER---------KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            478899999999999999984         3445579999987542  12233456778899988866788999988876


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .. .+++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            64 48899999999999988754                    6999999999999999999999999999999998643


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      .....   ......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+... ....|..++
T Consensus       152 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  225 (323)
T cd05615         152 MVDGV---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSIMEH-NVSYPKSLS  225 (323)
T ss_pred             CCCCc---cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCC
Confidence            22211   1223457888999999998889999999999999999999 99999998888787777765 445555554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=241.89  Aligned_cols=217  Identities=40%  Similarity=0.724  Sum_probs=178.8

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||+|......    ...+...||+|.+...........+.+|+++++.+ +||||++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   75 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLL   75 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccC----CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEE
Confidence            6789999999999999999999999876543    12345679999987665555556788999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH------------------------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE------------------------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      +++..+. .+++|||+++++|.+++..                              .|||+++++|+||||+||+++.+
T Consensus        76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~  155 (277)
T cd05032          76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED  155 (277)
T ss_pred             EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence            9876644 8899999999999987631                              68999999999999999999999


Q ss_pred             CcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +.++|+|||+++.+....... ......++..|+|||.+....++.++|+|||||++|+++|.|..||.+.+..+....+
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             CCEEECCcccchhhccCcccc-cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            999999999987554432211 1123345667999999988888999999999999999997789999998888888888


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      ..+..++.|..+|.
T Consensus       235 ~~~~~~~~~~~~~~  248 (277)
T cd05032         235 IDGGHLDLPENCPD  248 (277)
T ss_pred             hcCCCCCCCCCCCH
Confidence            88777777877754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.8e-37  Score=250.99  Aligned_cols=198  Identities=25%  Similarity=0.386  Sum_probs=158.4

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ce
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-EL   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~   92 (228)
                      +.||+|+||+||+|...         .++..||+|.++...  ..........|..++..+.+||||+++++++..+ .+
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELK---------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            47999999999999853         344569999987542  1223345566777777666899999999988664 48


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||++....... 
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-  150 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-  150 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence            899999999999888754                    69999999999999999999999999999999987443221 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                        .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++...+... ++..|..+++
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~  221 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI-GQSPFHGEDEDELFDSILND-RPHFPRWISK  221 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCH
Confidence              11223567889999999988889999999999999999999 99999998888887777665 5666665553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=251.27  Aligned_cols=195  Identities=25%  Similarity=0.359  Sum_probs=158.9

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      ||+|+||.||+|+..         .++..||+|.++...  .......+.+|+.++.++ +||||+++++.+... ..++
T Consensus         1 lg~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l   70 (312)
T cd05585           1 IGKGSFGKVMQVRKR---------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYL   70 (312)
T ss_pred             CCcCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEE
Confidence            699999999999843         345579999986432  223345677899999999 999999999888664 4889


Q ss_pred             EEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ  154 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (228)
                      +|||+++++|.+++..                    .|||+++|+||||||+||+++.++.++|+|||+++......   
T Consensus        71 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---  147 (312)
T cd05585          71 VLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---  147 (312)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC---
Confidence            9999999999988753                    69999999999999999999999999999999987432221   


Q ss_pred             CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       155 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+..+.+..+ ....|..+++
T Consensus       148 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~  218 (312)
T cd05585         148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEMYRKILQE-PLRFPDGFDR  218 (312)
T ss_pred             CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHh-CCCCcCCCCHHHHHHHHHcC-CCCCCCcCCH
Confidence            11223467888999999998889999999999999999999 99999998888777777665 5566666554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.7e-37  Score=256.66  Aligned_cols=205  Identities=23%  Similarity=0.346  Sum_probs=163.7

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||.||+++..         .++..+|+|.+++..  .......+.+|+.+++.+ +||||+++
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~  108 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHK---------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQL  108 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeE
Confidence            355689999999999999999999853         344579999986431  122234577899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++.+..+. +++||||+++|+|.+++..                   .|||+++|+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence            99887655 8899999999999988754                   699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI----YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YR  218 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~-~~  218 (228)
                      +..+......  ......||..|+|||++....    ++.++|+||+||++|+|++ |..||.+.+..+....+... ..
T Consensus       189 a~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~-G~~Pf~~~~~~~~~~~i~~~~~~  265 (370)
T cd05621         189 CMKMDETGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV-GDTPFYADSLVGTYSKIMDHKNS  265 (370)
T ss_pred             ceecccCCce--ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCcc
Confidence            8755332211  122456888999999987542    7789999999999999999 99999998877776666553 23


Q ss_pred             CCCCC
Q psy3166         219 MERPA  223 (228)
Q Consensus       219 ~~~p~  223 (228)
                      +..|.
T Consensus       266 ~~~p~  270 (370)
T cd05621         266 LNFPE  270 (370)
T ss_pred             cCCCC
Confidence            44454

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.7e-37  Score=251.29  Aligned_cols=197  Identities=25%  Similarity=0.391  Sum_probs=157.6

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ce
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-EL   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~   92 (228)
                      +.||+|+||.||++..         ..++..||+|.++...  .......+.+|+.+++++ +||||+++++.+..+ .+
T Consensus         1 ~~lG~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~   70 (323)
T cd05595           1 KLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRL   70 (323)
T ss_pred             CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEE
Confidence            4699999999999984         3345579999987542  223345677899999999 999999999888664 48


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||++||+||||||+|||++.++.+||+|||++........
T Consensus        71 ~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          71 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            899999999999887654                    699999999999999999999999999999998864322111


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                         ......|+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+....+..+ ....|..+++
T Consensus       151 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~  220 (323)
T cd05595         151 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPRTLSP  220 (323)
T ss_pred             ---ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCH
Confidence               1123457888999999988889999999999999999999 99999988777776666554 4445555543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0667|consensus

Probab=100.00  E-value=2.1e-37  Score=260.46  Aligned_cols=191  Identities=28%  Similarity=0.383  Sum_probs=159.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC-----ceEEeee
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD-----HIVSFIG   85 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~-----ni~~~~~   85 (228)
                      +|++++.||+|+||.|.+|.         +..|++.||||+++..  .....+...|+.+|+.|++|.     |+|++++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~---------d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAY---------DHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             EEEEEEEecccccceeEEEE---------ecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            78999999999999999998         6667778999999865  344567788999999996443     9999999


Q ss_pred             EEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC--CCcEEEee
Q psy3166          86 CCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS--PHVVKISD  140 (228)
Q Consensus        86 ~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~--~~~~kl~d  140 (228)
                      +|... .+|+|+|++ ..+|.++++.                      .+||+.+|+|+||||+|||+..  +..+||+|
T Consensus       256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence            99764 589999998 5599999886                      5899999999999999999985  45899999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||.+........      .-..+.-|.|||++.+.+|+.+.|||||||++.||.+ |.+-|++.+..+.+..|.+...+|
T Consensus       335 FGSSc~~~q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t-G~PLfpG~ne~DQl~~I~e~lG~P  407 (586)
T KOG0667|consen  335 FGSSCFESQRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFT-GEPLFPGDNEYDQLARIIEVLGLP  407 (586)
T ss_pred             cccccccCCcce------eeeeccccccchhhccCCCCCccceeehhhhHHhHhc-CccccCCCCHHHHHHHHHHHhCCC
Confidence            998864332211      1223445899999999999999999999999999999 999999998888888877754444

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=258.57  Aligned_cols=206  Identities=24%  Similarity=0.362  Sum_probs=168.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ..|.+.+.||+|++|.||+|....+        .+..||+|.+.... ......+.+|+.+|+.+ +||||+++++.+..
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~  136 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLND-ERQAAYARSELHCLAAC-DHFGIVKHFDDFKS  136 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEE
Confidence            3499999999999999999974332        13468888765442 33345677899999999 99999999999876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      + ..++||||+++|+|.+++..                        .|+|+++|+||||||+|||++.++.+||+|||++
T Consensus       137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            4 48899999999999876542                        5899999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ..+...... .......||..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++...+..+...+.|..
T Consensus       217 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  294 (478)
T PTZ00267        217 KQYSDSVSL-DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT-LHRPFKGPSQREIMQQVLYGKYDPFPCP  294 (478)
T ss_pred             eecCCcccc-ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            755332211 11233567889999999988889999999999999999999 9999999888888888888877777766


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +++
T Consensus       295 ~s~  297 (478)
T PTZ00267        295 VSS  297 (478)
T ss_pred             CCH
Confidence            654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-37  Score=251.81  Aligned_cols=189  Identities=26%  Similarity=0.396  Sum_probs=159.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|++.         .++..||+|.++...  .......+.+|+.++..+ +||||+++++.+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~   70 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK---------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAF   70 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEE
Confidence            47999999999999999999854         344579999987542  122345678899999999 899999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. .+++|||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          71 QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            7654 8899999999999998754                    699999999999999999999999999999999864


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ...      ......|+..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+..
T Consensus       151 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  212 (333)
T cd05600         151 IVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENLKY  212 (333)
T ss_pred             ccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh-CCCCCCCCCHHHHHHHHHh
Confidence            432      1234567888999999998889999999999999999999 9999999887777666554

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.9e-37  Score=251.25  Aligned_cols=201  Identities=27%  Similarity=0.459  Sum_probs=159.9

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHH---HhcCCCCceEEeeeE
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLM---KDVGKHDHIVSFIGC   86 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~~h~ni~~~~~~   86 (228)
                      |++.+.||+|+||.||+|...         .++..||+|.++...  .....+.+.+|+.++   +++ +||||++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~   70 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK---------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFAC   70 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeE
Confidence            788999999999999999843         345579999987542  122334566666655   455 79999999998


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      +.... .++||||+++++|..++..                   .|||+++++||||||+||+++.++.+||+|||++..
T Consensus        71 ~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          71 FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            87644 8899999999999877653                   699999999999999999999999999999998764


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      .....   .......|+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++...+..+ .+..|..+|
T Consensus       151 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~  225 (324)
T cd05589         151 GMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRFLS  225 (324)
T ss_pred             CCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCC
Confidence            32211   11234567889999999988889999999999999999999 99999998888887777766 444565554


Q ss_pred             C
Q psy3166         227 E  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       226 ~  226 (324)
T cd05589         226 R  226 (324)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.4e-36  Score=242.11  Aligned_cols=217  Identities=40%  Similarity=0.701  Sum_probs=175.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.+..++|++.+.||+|+||.||+|..+...    .......||+|.++..........+.+|+.+++++ +||||++++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~   75 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLL   75 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEE
Confidence            7889999999999999999999998754321    11234469999887554444455678899999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      +++... ..+++|||+++|+|.+++..                              .|||+++++|+||||+||+++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~  155 (288)
T cd05061          76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence            987654 48899999999999998742                              58999999999999999999999


Q ss_pred             CcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +.++|+|||++..+....... ......++..|++||.+.+..++.++|+|||||++|+|++.|..||.+.+..++...+
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             CcEEECcCCcccccccccccc-ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999987543322211 1122334567999999988889999999999999999998678999998888888888


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      ..+..++.|..+|+
T Consensus       235 ~~~~~~~~~~~~~~  248 (288)
T cd05061         235 MDGGYLDQPDNCPE  248 (288)
T ss_pred             HcCCCCCCCCCCCH
Confidence            77777777777654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.6e-37  Score=255.71  Aligned_cols=199  Identities=23%  Similarity=0.348  Sum_probs=161.9

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..+..++|++.+.||+|+||.||+++.         ..++..||+|.+....  .......+.+|+.+++.+ +||||++
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~  107 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRH---------KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQ  107 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEE---------CCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCe
Confidence            356678999999999999999999984         4455679999986431  122234567899999999 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++.+..+. .+++|||+++|+|.+++..                   .|||+++|+||||||+||+++.++.+||+|||
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999887655 7899999999999988754                   69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN----IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~----~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ++..+......  ......||+.|+|||++...    .++.++|+||+||++|+|++ |..||.+.+.......+...
T Consensus       188 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~  262 (371)
T cd05622         188 TCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIMNH  262 (371)
T ss_pred             ceeEcCcCCcc--cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Confidence            98755332211  12245688899999998753    27889999999999999999 99999998877777776654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.1e-36  Score=241.52  Aligned_cols=214  Identities=35%  Similarity=0.627  Sum_probs=174.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.++|++.+.||+|+||+||+|.+...     +......+|+|.+...........+.+|+.+++++ +||||++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~   75 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLP-----GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGV   75 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecC-----CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Confidence            5678999999999999999999985332     22344579999987655555556788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH-------------------------------------hcccCCCCcccCCCCCCE
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE-------------------------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~-------------------------------------~~lh~~~i~H~~lk~~ni  128 (228)
                      +..+ ..+++|||+++++|.+++..                                     .|||+++++|+||||+||
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ni  155 (283)
T cd05090          76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNI  155 (283)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceE
Confidence            7664 48899999999999888730                                     699999999999999999


Q ss_pred             eecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         129 LLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      +++.++.+||+|||++......... .......++..|++||.+.+..++.++|+||||+++|+|++.|..||.+.+..+
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         156 LIGEQLHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             EEcCCCcEEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999998755332211 112233445679999999888899999999999999999987999999888888


Q ss_pred             HHHHHHcCCCCCCCCCCCC
Q psy3166         209 IVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       209 ~~~~~~~~~~~~~p~~~~~  227 (228)
                      +.+.+.....++.|..+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~  253 (283)
T cd05090         235 VIEMVRKRQLLPCSEDCPP  253 (283)
T ss_pred             HHHHHHcCCcCCCCCCCCH
Confidence            8888888877888887764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.2e-36  Score=240.76  Aligned_cols=217  Identities=36%  Similarity=0.701  Sum_probs=174.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.+..++|++.+.||+|+||.||+|.+.+..    .......||+|.++..........+.+|+.+++.+ +||||++++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~   75 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLL   75 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCC----CCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEE
Confidence            6678899999999999999999999865432    12344569999886554444556788999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      +++..+ ..+++|||+++++|.+++..                              .|||+++++|+||||+||+++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  155 (277)
T ss_pred             EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence            988654 47899999999999887642                              58999999999999999999999


Q ss_pred             CcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +.++|+|||++..+........ .....++..|+|||.+....++.++|+||||+++|+|++.|..||.+.+..+....+
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             CCEEECCCCCccccCCcceeec-CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999865433222111 112344667999999988889999999999999999998568999998887778777


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      .++..++.|..+|+
T Consensus       235 ~~~~~~~~~~~~~~  248 (277)
T cd05062         235 MEGGLLDKPDNCPD  248 (277)
T ss_pred             HcCCcCCCCCCCCH
Confidence            77766777777664

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-36  Score=240.53  Aligned_cols=214  Identities=36%  Similarity=0.644  Sum_probs=172.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||+|.+....      .....+|+|.++..........+.+|+.+++++ +||||++++++
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   73 (267)
T cd05066           1 IDASCIKIEKVIGAGEFGEVCSGRLKLPG------KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGV   73 (267)
T ss_pred             CCHHHeEeeeeecccCCCceEEEEEecCC------CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Confidence            45789999999999999999999854322      223458999987655455566788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+ ..+++|||+++++|.+++..                     .+||+++++|+||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          74 VTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence            8654 47899999999999988754                     5899999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ..+..............++..|++||.+....++.++|+||||+++|++++.|..||...+..+....+..+.+++.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMD  233 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCC
Confidence            76543221111111122245799999998888999999999999999988669999999888888888888888887777


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +|+
T Consensus       234 ~~~  236 (267)
T cd05066         234 CPA  236 (267)
T ss_pred             CCH
Confidence            764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4278|consensus

Probab=100.00  E-value=1.6e-37  Score=259.89  Aligned_cols=210  Identities=40%  Similarity=0.765  Sum_probs=186.4

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.+.+.+.+..++||-|.||.||.|.|+..+         ..||||.++.+.-  ....|+.|..+|+.+ +|||++++
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkys---------lTvAVKtLKEDtM--eveEFLkEAAvMKei-kHpNLVqL  328 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---------LTVAVKTLKEDTM--EVEEFLKEAAVMKEI-KHPNLVQL  328 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccc---------eeeehhhhhhcch--hHHHHHHHHHHHHhh-cCccHHHH
Confidence            57788889999999999999999999976654         4699999986632  246899999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      +++|+... +|+|.||+..|+|.+||++                      .||..++++||||-..|+|+..+..+|++|
T Consensus       329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeec
Confidence            99998754 8999999999999999987                      699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||+++.+..+....+.  ....++-|.|||.+..+.++-++|+|+||+++||+.|+|-.||.+.+..+++..+++|+|+.
T Consensus       409 FGLsRlMtgDTYTAHA--GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  409 FGLSRLMTGDTYTAHA--GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD  486 (1157)
T ss_pred             cchhhhhcCCceeccc--CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence            9999987665433322  23345679999999988899999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .|++||+
T Consensus       487 ~PeGCPp  493 (1157)
T KOG4278|consen  487 GPEGCPP  493 (1157)
T ss_pred             CCCCCCH
Confidence            9999997

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3e-36  Score=239.34  Aligned_cols=204  Identities=34%  Similarity=0.698  Sum_probs=167.1

Q ss_pred             eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEEEE
Q psy3166          17 VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV   96 (228)
Q Consensus        17 ~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~lv~   96 (228)
                      .||+|+||.||+|.++..       ..+..||+|.+.........+.+.+|+.+++++ +||||+++++++..+..+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEAEALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcCCCeEEEE
Confidence            489999999999976432       123358999987665555556788999999999 999999999988777789999


Q ss_pred             ecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccC
Q psy3166          97 EYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN  155 (228)
Q Consensus        97 e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (228)
                      ||+++++|.+++..                     .|||+++++|+||||+||+++.++.+||+|||++...........
T Consensus        74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99999999998753                     699999999999999999999999999999999875433322111


Q ss_pred             CCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q psy3166         156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       156 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~  228 (228)
                      ......++..|++||.+....++.++|+||||+++|++++.|..||.+....++...+..+.+++.|..++++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPE  226 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            1112223457999999888888999999999999999996599999999888888889999888888888753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.8e-37  Score=249.87  Aligned_cols=201  Identities=28%  Similarity=0.416  Sum_probs=161.3

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE   91 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   91 (228)
                      ++.||+|+||.||+++...+      ...++.||+|.++...   .......+.+|+.+|+.+ +||||+++++.+..+.
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~   73 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTG------ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGG   73 (323)
T ss_pred             CceeeecCCeEEEEEEEccc------CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCC
Confidence            36899999999999985332      2355679999986432   122334567899999999 9999999998887644


Q ss_pred             -eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccc
Q psy3166          92 -LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        92 -~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~  150 (228)
                       ++++|||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          74 KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             eEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence             8899999999999888753                    6899999999999999999999999999999998643222


Q ss_pred             ccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         151 NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ..   ......|+..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+..+ +.+.|..+++
T Consensus       154 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~  225 (323)
T cd05584         154 GT---VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT-GAPPFTAENRKKTIDKILKG-KLNLPPYLTP  225 (323)
T ss_pred             CC---cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCH
Confidence            11   1223467888999999988888999999999999999999 99999998877777777776 5566665553

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-36  Score=239.09  Aligned_cols=213  Identities=38%  Similarity=0.684  Sum_probs=174.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +.+++|++.+.||+|+||.||+|.+....      .+...||+|.++..........+.+|+.+++++ +||||+++++.
T Consensus         1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   73 (266)
T cd05033           1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPG------KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGV   73 (266)
T ss_pred             CChHHceeeeEecCCccceEEEEEEccCC------CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEE
Confidence            46789999999999999999999875431      233469999987665555567788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+ ..+++||++++++|.+++..                     .|||+++|+|+||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          74 VTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             EecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchh
Confidence            7664 47899999999999998753                     5999999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ..+........ .....++..|++||.+....++.++|+||||+++|+|++.|..||...+..++...+..+.+++.|..
T Consensus       154 ~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (266)
T cd05033         154 RRLEDSEATYT-TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMD  232 (266)
T ss_pred             hccccccccee-ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            76542111111 11123356799999998888899999999999999999779999999888888888888888887777


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +|+
T Consensus       233 ~~~  235 (266)
T cd05033         233 CPS  235 (266)
T ss_pred             CCH
Confidence            664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.6e-37  Score=251.02  Aligned_cols=196  Identities=27%  Similarity=0.406  Sum_probs=157.5

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||++..         ..++..||+|.+....  .......+.+|+.+++.+ +||||+++.+.+..+. +
T Consensus         1 ~~lG~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~   70 (328)
T cd05593           1 KLLGKGTFGKVILVRE---------KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRL   70 (328)
T ss_pred             CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEE
Confidence            4699999999999984         3445579999987542  223345678899999999 9999999998887654 8


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||+++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        71 ~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          71 CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            899999999999887653                    69999999999999999999999999999999986432211 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                        .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||...+..++.+.+..+ ....|..++
T Consensus       150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~  219 (328)
T cd05593         150 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-DIKFPRTLS  219 (328)
T ss_pred             --cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhh-CCCCCCCCCHHHHHHHhccC-CccCCCCCC
Confidence              11223457888999999988889999999999999999999 99999988777776666544 445555554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0661|consensus

Probab=100.00  E-value=4.6e-38  Score=255.56  Aligned_cols=193  Identities=23%  Similarity=0.366  Sum_probs=156.4

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      --++|.+.+.||.|+||.||+|+         .++++..||||++++......--.-++|+..|+++..||||+++++++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~---------~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi   78 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAK---------SKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI   78 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEee---------ecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence            34789999999999999999987         556667799999987744332233568999999995599999999998


Q ss_pred             EcC--ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          88 YKD--ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        88 ~~~--~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .+.  .+++||||+. .+|++.++.                     +|+|.+|+.|||+||+|||+..+..+||+|||++
T Consensus        79 ~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   79 RDNDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             hccCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccc
Confidence            653  4899999994 488888765                     6999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +.+....-++.    -..|.=|.|||++. +..|+.+.|+||+||+++|+.+ =++-|+|.+.-..+.++..
T Consensus       158 Rev~SkpPYTe----YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s-LrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  158 REVRSKPPYTE----YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS-LRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             cccccCCCcch----hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH-hcccCCCCcHHHHHHHHHH
Confidence            98755543332    22233468999987 4568999999999999999999 7788999766555555554

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-36  Score=253.43  Aligned_cols=199  Identities=24%  Similarity=0.353  Sum_probs=161.5

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      +.+..++|++.+.||+|+||.||++..         ..++..||+|.++...  .......+.+|+.+++.+ +||||++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~  107 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRH---------KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQ  107 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcce
Confidence            456778999999999999999999884         3445579999986431  122234567899999999 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++++..+. +++||||+++|+|.+++..                   .|||+++|+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             EEEEEecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecc
Confidence            998887655 8899999999999988754                   69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN----IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~----~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ++..+......  ......|++.|+|||++...    .++.++|+|||||++|+|++ |..||.+.+.......+...
T Consensus       188 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~  262 (370)
T cd05596         188 TCMKMDANGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIMDH  262 (370)
T ss_pred             ceeeccCCCcc--cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh-CCCCcCCCCHHHHHHHHHcC
Confidence            98754332211  11235678899999998643    37889999999999999999 99999998877776766654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.5e-36  Score=238.78  Aligned_cols=204  Identities=38%  Similarity=0.702  Sum_probs=167.3

Q ss_pred             eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEEE
Q psy3166          17 VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLV   95 (228)
Q Consensus        17 ~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~lv   95 (228)
                      .||+|+||.||+|.++.       ..++..+|+|.++.... ....+.+.+|+.+++++ +||||+++++++..+..+++
T Consensus         2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEAESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCcEEE
Confidence            68999999999987532       23445699999875533 33456788999999999 99999999998877778999


Q ss_pred             EecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccC
Q psy3166          96 VEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN  155 (228)
Q Consensus        96 ~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (228)
                      ||++++++|.+++..                    .|+|+++++|+||||.||+++.++.++|+|||++..+........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999999988754                    699999999999999999999999999999999876543322111


Q ss_pred             CCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q psy3166         156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       156 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~  228 (228)
                      ......++..|+|||.+....++.++|+|||||++|+|++.|..||......++.+.+.++.+++.|..+|++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPE  226 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            1122233567999999887788899999999999999997699999998888899999999888888888753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-36  Score=249.26  Aligned_cols=197  Identities=23%  Similarity=0.383  Sum_probs=158.8

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||+|...         .++..||+|.++...  .......+..|..++..+.+||||+++++++.... +
T Consensus         1 ~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLK---------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            46999999999999843         345579999986442  12234566788888888768999999999887654 8


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.++|+|||++........
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             EEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            899999999999887753                    699999999999999999999999999999999864322211


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                         ......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+..+ .+..|..++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~  220 (320)
T cd05590         152 ---TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILND-EVVYPTWLS  220 (320)
T ss_pred             ---cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCC
Confidence               1223567889999999988889999999999999999999 99999998888888887765 444555444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.6e-36  Score=239.42  Aligned_cols=209  Identities=41%  Similarity=0.786  Sum_probs=173.7

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |+++..+|++.+.||+|+||.||+|.+..         .+..||+|.++.+.  .....+.+|+++++++ +||||++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~   68 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT--MEVEEFLKEAAVMKEI-KHPNLVQLL   68 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc--hHHHHHHHHHHHHHhC-CCCChhheE
Confidence            78899999999999999999999998543         34469999887542  2345688899999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++..+ .++++|||+++++|.+++..                      .|||+++++|+||||+||++++++.++|+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df  148 (263)
T cd05052          69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF  148 (263)
T ss_pred             EEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCC
Confidence            987664 47899999999999998753                      5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.........  ......++..|++||.+.+..++.++|+|||||++|+|++.|..||.+.+..+....+..+.+++.
T Consensus       149 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (263)
T cd05052         149 GLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER  226 (263)
T ss_pred             ccccccccceee--ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence            998754332111  111223345799999998888999999999999999999768999999888888888888888888


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |.++|+
T Consensus       227 ~~~~~~  232 (263)
T cd05052         227 PEGCPP  232 (263)
T ss_pred             CCCCCH
Confidence            888775

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.7e-36  Score=250.64  Aligned_cols=219  Identities=42%  Similarity=0.819  Sum_probs=176.0

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|+++.++|.+.+.||+|+||.||+|++++..    ....+..||+|.++........+.+.+|+.+|.++..||||+++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~  106 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL  106 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence            58899999999999999999999999976532    23445679999998654444456788999999999459999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------------------------------------
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------------------------------------  110 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------------------------------------  110 (228)
                      ++.+... ..+++|||+++|+|.+++..                                                    
T Consensus       107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            9988764 48899999999999888731                                                    


Q ss_pred             ------------------------------------------------------------------hcccCCCCcccCCC
Q psy3166         111 ------------------------------------------------------------------EYLSNNKVVHRDLA  124 (228)
Q Consensus       111 ------------------------------------------------------------------~~lh~~~i~H~~lk  124 (228)
                                                                                        .|||+++++|||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk  266 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA  266 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence                                                                              48999999999999


Q ss_pred             CCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       125 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      |+||+++.++.++|+|||+++.+....... ......++..|++||.+....++.++|+||||+++|+|++.|..||...
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999987543322111 1122345678999999988889999999999999999998688999886


Q ss_pred             CHHHH-HHHHHcCCCCCCCCCCCC
Q psy3166         205 PLCRI-VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       205 ~~~~~-~~~~~~~~~~~~p~~~~~  227 (228)
                      ...+. ...+..+.+++.|..+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~p~~~~~  369 (401)
T cd05107         346 PMNEQFYNAIKRGYRMAKPAHASD  369 (401)
T ss_pred             CchHHHHHHHHcCCCCCCCCCCCH
Confidence            66554 455666777777776654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.3e-36  Score=238.51  Aligned_cols=208  Identities=36%  Similarity=0.618  Sum_probs=170.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||+|.+.++.          .||+|.++....  ....+.+|+++++++ +||||++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----------~valK~~~~~~~--~~~~~~~E~~~l~~l-~~~~i~~~~   67 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTT----------RVAIKTLKPGTM--SPEAFLQEAQVMKKL-RHEKLVQLY   67 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCc----------eEEEEecccCcc--CHHHHHHHHHHHHhC-CCCCcceEE
Confidence            6789999999999999999999999754322          389999875422  224678899999999 899999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +.+..+..+++||++++++|.+++..                      .|+|+++++|+||||+||+++.++.++|+|||
T Consensus        68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg  147 (262)
T cd05071          68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  147 (262)
T ss_pred             EEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCC
Confidence            98777778999999999999988753                      58999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      .+..+......  ......++..|++||......++.++|+||||+++|+|++.|..||.+....++...+..+.+++.+
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (262)
T cd05071         148 LARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP  225 (262)
T ss_pred             ceeeccccccc--cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCc
Confidence            98654332211  1112344567999999888889999999999999999998788999998888888888777776666


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       226 ~~~~~  230 (262)
T cd05071         226 PECPE  230 (262)
T ss_pred             cccCH
Confidence            55553

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.9e-36  Score=240.35  Aligned_cols=213  Identities=34%  Similarity=0.637  Sum_probs=172.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||+||+|.+..++.     .....+++|.+...........+..|+..+.++ +||||++++++
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~   77 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGD-----SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGI   77 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCC-----ceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEE
Confidence            456789999999999999999998754321     223358888886544444445677888899999 99999999998


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.....++++|++++|+|.+++..                     .|||+++++|+||||+||+++.++.+||+|||+++
T Consensus        78 ~~~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          78 CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             ECCCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence            877778899999999999998753                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      ........ .......++..|++||.+.+..++.++|+||||+++|++++.|..||.+.+..++.+.+.++.+++.|..|
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (279)
T cd05111         158 LLYPDDKK-YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC  236 (279)
T ss_pred             eccCCCcc-cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCC
Confidence            54332211 11122345667999999988889999999999999999997799999998888888888888888888776


Q ss_pred             C
Q psy3166         226 N  226 (228)
Q Consensus       226 ~  226 (228)
                      +
T Consensus       237 ~  237 (279)
T cd05111         237 T  237 (279)
T ss_pred             C
Confidence            5

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.9e-36  Score=241.78  Aligned_cols=205  Identities=35%  Similarity=0.673  Sum_probs=161.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCC-------CCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCc
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTE-------GASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDH   79 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~n   79 (228)
                      ++.++|++.+.||+|+||.||+|.++.+...       .....++..||+|.+...........+.+|+.++.++ +|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCC
Confidence            5778999999999999999999987554311       1123345579999987654455566788999999999 9999


Q ss_pred             eEEeeeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------------------------hcccCCCCc
Q psy3166          80 IVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------------------------EYLSNNKVV  119 (228)
Q Consensus        80 i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------------------------~~lh~~~i~  119 (228)
                      |+++++++... ..+++|||+++++|.+++..                                       .|||+++|+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            99999988764 48899999999999876521                                       689999999


Q ss_pred             ccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q psy3166         120 HRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT-LGA  198 (228)
Q Consensus       120 H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t-~g~  198 (228)
                      |+||||+||+++.++.+||+|||++..+....... ......++..|+|||++....++.++|+||||+++|+|++ .+.
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999987543322111 1112334667999999988889999999999999999986 256


Q ss_pred             CCCCCCCHHHHHHHH
Q psy3166         199 NPYPHIPLCRIVHYL  213 (228)
Q Consensus       199 ~pf~~~~~~~~~~~~  213 (228)
                      .||...+..++...+
T Consensus       240 ~p~~~~~~~~~~~~~  254 (304)
T cd05096         240 QPYGELTDEQVIENA  254 (304)
T ss_pred             CCCCcCCHHHHHHHH
Confidence            889887776655443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-36  Score=249.45  Aligned_cols=197  Identities=25%  Similarity=0.386  Sum_probs=158.2

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||+|...         .++..||+|.++...  .......+..|.+++..+.+||||+++++++.... .
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELK---------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            46999999999999843         344579999987542  12233456788899887768999999999987654 8


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.++|+|||++........
T Consensus        72 ~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            899999999999887653                    699999999999999999999999999999998864322211


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                         ......|+..|+|||++.+..++.++|+||+||++|+|++ |..||...+..++.+.+..+ .+..|..++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~  220 (321)
T cd05591         152 ---TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESILHD-DVLYPVWLS  220 (321)
T ss_pred             ---cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Confidence               1223457888999999988889999999999999999999 99999998888888877776 344454443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.3e-36  Score=239.32  Aligned_cols=214  Identities=37%  Similarity=0.678  Sum_probs=174.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||+||+|.+..+..     .....||+|.++..........+.+|+.+++.+ +||||+.++++
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~   77 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGE-----NVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGI   77 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCC-----ccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEE
Confidence            456899999999999999999998654321     223458999987665555566788999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.....++++|++++|+|.+++..                     .|||+++|+|+||||+||++++++.+||+|||+++
T Consensus        78 ~~~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          78 CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EcCCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence            888788899999999999988754                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+........ .....++..|++||......++.++|+|||||++|+|++.|..||......++...+..+.+++.|..+
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (279)
T cd05109         158 LLDIDETEYH-ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPIC  236 (279)
T ss_pred             ecccccceee-cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccC
Confidence            5533221111 112233567999999988889999999999999999998799999988877788788888777777666


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      ++
T Consensus       237 ~~  238 (279)
T cd05109         237 TI  238 (279)
T ss_pred             CH
Confidence            54

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.3e-36  Score=238.07  Aligned_cols=208  Identities=38%  Similarity=0.686  Sum_probs=171.5

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.|+.++|++.+.||+|+||.||+|....+          ..||+|.+....  ...+.+.+|+.+++++ +|+||++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~----------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~   67 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNS----------TKVAVKTLKPGT--MSVQAFLEEANLMKTL-QHDKLVRLY   67 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCC----------ceEEEEEccCCc--hhHHHHHHHHHHHHhC-CCCCeeeEE
Confidence            789999999999999999999999975332          248999876542  2346788999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +.+..+. .+++||++++++|.+++..                      .|||+++++|+||||+||+++.++.++|+||
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCC
Confidence            8876644 7899999999999988753                      5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.........  ......++..|+|||.+....++.++|+||||+++|+|+|.|..||.+.+..+....+..+.+.+.
T Consensus       148 g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05072         148 GLARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR  225 (261)
T ss_pred             ccceecCCCcee--ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            998755332211  111233456799999998888899999999999999999779999999888888888888877777


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      +..+|.
T Consensus       226 ~~~~~~  231 (261)
T cd05072         226 MENCPD  231 (261)
T ss_pred             CCCCCH
Confidence            666653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0690|consensus

Probab=100.00  E-value=5.8e-38  Score=245.20  Aligned_cols=207  Identities=26%  Similarity=0.388  Sum_probs=174.5

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +--++|..+++||+|+||+|.+++         .+.+++.||+|++++..  .......-+.|-++|+.. .||++..+.
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~r---------EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LK  234 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCR---------EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLK  234 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEe---------ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhh
Confidence            345688999999999999999998         45566789999998662  223345567899999999 999999998


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..|+. +.+|.||||+.||.|+-.|+.                    .|||+++|+.||+|.+|.|++++|++||+|||+
T Consensus       235 YsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGL  314 (516)
T KOG0690|consen  235 YSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGL  314 (516)
T ss_pred             hhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeeccc
Confidence            88865 569999999999999876654                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.-....   ......+||+.|+|||++....|+.+.|+|.+|+++|||++ |+.||...+...+...+..+ ....|.
T Consensus       315 CKE~I~~g---~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC-GRLPFyn~dh~kLFeLIl~e-d~kFPr  389 (516)
T KOG0690|consen  315 CKEEIKYG---DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC-GRLPFYNKDHEKLFELILME-DLKFPR  389 (516)
T ss_pred             chhccccc---ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHh-ccCcccccchhHHHHHHHhh-hccCCc
Confidence            98543332   33456899999999999999999999999999999999999 99999998877777776665 667777


Q ss_pred             CCCCC
Q psy3166         224 SCNEQ  228 (228)
Q Consensus       224 ~~~~~  228 (228)
                      .+++|
T Consensus       390 ~ls~e  394 (516)
T KOG0690|consen  390 TLSPE  394 (516)
T ss_pred             cCCHH
Confidence            77664

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-36  Score=242.39  Aligned_cols=181  Identities=27%  Similarity=0.379  Sum_probs=149.0

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .|++.+.||+|+||+||+|...         .++..||+|.+.....  ......+.+|+.+++++ +|+|++.+.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~   70 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYE   70 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEe---------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEc
Confidence            3788999999999999999843         3445799998864421  12234567899999999 9999999998886


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+ ..+++|||+++|+|.+++..                      .|||+++|+||||||+||+++.++.++|+|||++.
T Consensus        71 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  150 (285)
T cd05631          71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV  150 (285)
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence            64 48899999999999876532                      69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      .+.....    .....|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+...
T Consensus       151 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~  206 (285)
T cd05631         151 QIPEGET----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRKE  206 (285)
T ss_pred             EcCCCCe----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHh-CCCCCCCCCc
Confidence            5432211    123467888999999998889999999999999999999 9999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-36  Score=247.63  Aligned_cols=206  Identities=26%  Similarity=0.353  Sum_probs=159.1

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +|++.+.||+|+||.||+++...      +..++..||+|.++...   .......+..|+.++.++.+||||+.+++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT------GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc------cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            58999999999999999987533      33456779999986431   2223456778999999997799999999888


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. ++++|||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            7654 7899999999999988753                    699999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLSTGYRMER  221 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~----~~~~~~~~~~~~~~~~  221 (228)
                      ......  .......|+..|+|||++.+. .++.++|+|||||++|+|++ |..||....    ..++...+... .++.
T Consensus       155 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~  230 (332)
T cd05614         155 FLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT-GASPFTLEGERNTQSEVSRRILKC-DPPF  230 (332)
T ss_pred             ccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc-CCCCCCCCCCCCCHHHHHHHHhcC-CCCC
Confidence            432211  112234678899999998765 47889999999999999999 999996532    23344444443 4555


Q ss_pred             CCCCC
Q psy3166         222 PASCN  226 (228)
Q Consensus       222 p~~~~  226 (228)
                      |..++
T Consensus       231 ~~~~~  235 (332)
T cd05614         231 PSFIG  235 (332)
T ss_pred             CCCCC
Confidence            55444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-36  Score=247.57  Aligned_cols=217  Identities=41%  Similarity=0.788  Sum_probs=171.9

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||+||+|.+.+..    +..+++.||+|.++.+........+.+|+.++.++.+||||++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~   77 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   77 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhc
Confidence            7889999999999999999999999854322    334566799999976544444567889999999997899999999


Q ss_pred             eEEEc--CceEEEEecCCCCcHHHHHHH----------------------------------------------------
Q psy3166          85 GCCYK--DELRLVVEYCALGDLQSYLRE----------------------------------------------------  110 (228)
Q Consensus        85 ~~~~~--~~~~lv~e~~~~~~L~~~l~~----------------------------------------------------  110 (228)
                      +++..  ..++++|||+++|+|.+++..                                                    
T Consensus        78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (343)
T cd05103          78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS  157 (343)
T ss_pred             ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence            98754  347899999999999877531                                                    


Q ss_pred             -----------------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccC
Q psy3166         111 -----------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN  155 (228)
Q Consensus       111 -----------------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (228)
                                                         .|||+++|+||||||+||+++.++.++|+|||++...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  237 (343)
T cd05103         158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR  237 (343)
T ss_pred             cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence                                               589999999999999999999999999999999875433221111


Q ss_pred             CCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCC
Q psy3166         156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       156 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~~~~~~~~~~~~p~~~~  226 (228)
                       .....++..|++||.+.+..++.++|+||||+++|+|++.|..||...... ++...+.++.+++.|..++
T Consensus       238 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (343)
T cd05103         238 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT  308 (343)
T ss_pred             -cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCC
Confidence             112234567999999988889999999999999999997699999886543 4556677777777776554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.2e-35  Score=241.63  Aligned_cols=220  Identities=43%  Similarity=0.840  Sum_probs=174.9

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|.+.+.||+|+||.||++...+...  ........+|+|.++..........+.+|+.+++++.+||||++++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            56778999999999999999999998643221  0122345699999876544444567888999999997899999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++..+ ..+++|||+++++|.+++..                                    .|||+++++|+||||+|
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  170 (307)
T cd05098          91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN  170 (307)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence            988664 48899999999999888741                                    58999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      |+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+|||||++|+|++.|..||.+.+..
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999999999999999986543221111 1111223457999999988889999999999999999997688999988888


Q ss_pred             HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ++...+..+.+++.|..++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~  269 (307)
T cd05098         250 ELFKLLKEGHRMDKPSNCTN  269 (307)
T ss_pred             HHHHHHHcCCCCCCCCcCCH
Confidence            88888888888888877664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0589|consensus

Probab=100.00  E-value=2.3e-37  Score=253.88  Aligned_cols=203  Identities=25%  Similarity=0.429  Sum_probs=175.1

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|+.++.+|+|+||.++.++         ++..+..|++|.+.... ....+..+.+|+.+++++ .||||+.+.+.|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvr---------hk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~   72 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVR---------HKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSF   72 (426)
T ss_pred             cchhhhhhhcCccccchhhhhh---------hccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccch
Confidence            4689999999999999999877         44455579999986442 333445788999999999 999999999999


Q ss_pred             EcCc--eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          88 YKDE--LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        88 ~~~~--~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..+.  ++++|+||.||++.+.+.+                      +|||+++|+|||||+.||++.+++.++|.|||+
T Consensus        73 ~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   73 EEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             hcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhh
Confidence            7654  7899999999999998775                      699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.+.....   ...+..||+.|++||.+.+.+|+.++|+|||||++|||++ -+.+|.+.+-.++..++..+.-.|.|.
T Consensus       153 aK~l~~~~~---~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~-lk~aF~a~~m~~Li~ki~~~~~~Plp~  228 (426)
T KOG0589|consen  153 AKILNPEDS---LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT-LKPAFKASNMSELILKINRGLYSPLPS  228 (426)
T ss_pred             hhhcCCchh---hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh-cccccCccchHHHHHHHhhccCCCCCc
Confidence            998766542   2346789999999999999999999999999999999999 889999999999999988886666665


Q ss_pred             CC
Q psy3166         224 SC  225 (228)
Q Consensus       224 ~~  225 (228)
                      ..
T Consensus       229 ~y  230 (426)
T KOG0589|consen  229 MY  230 (426)
T ss_pred             cc
Confidence            43

>KOG0032|consensus

Probab=100.00  E-value=3.5e-36  Score=248.85  Aligned_cols=193  Identities=30%  Similarity=0.453  Sum_probs=165.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ..|++.+.||+|.||.||+++         ++.++..+|+|.+++...  ......+.+|+++|+++..||||+.+.+++
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~---------~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~  105 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCR---------EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF  105 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEE---------ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            479999999999999999998         444566899999976532  224467889999999995599999999998


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCC----CcEEEeeccC
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSP----HVVKISDFGL  143 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~----~~~kl~dfg~  143 (228)
                      ... .+++|||++.||.|++.+..                   .|||+.|++|||+||+|+|+...    +.+|++|||+
T Consensus       106 e~~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  106 EDPDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EcCCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            765 48899999999999998654                   69999999999999999999753    4799999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +......    ......+||+.|+|||++....|+..+|+||+|+++|.|++ |..||.+.+..+....+..+
T Consensus       186 a~~~~~~----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~~~~~~~i~~~  253 (382)
T KOG0032|consen  186 AKFIKPG----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS-GVPPFWGETEFEIFLAILRG  253 (382)
T ss_pred             ceEccCC----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh-CCCCCcCCChhHHHHHHHcC
Confidence            9866542    22345788999999999998999999999999999999999 99999999988888888887

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-35  Score=244.54  Aligned_cols=190  Identities=26%  Similarity=0.441  Sum_probs=160.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||+++..         .++..+|+|.+..........++.+|+++++++ +||||++++++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   71 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGA   71 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEE
Confidence            56789999999999999999999843         344569999987665555667889999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCC-CCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNN-KVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~-~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+ ..+++|||+++++|.+++..                    .|||++ +|+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  151 (331)
T cd06649          72 FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (331)
T ss_pred             EEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence            8664 48899999999999998754                    589986 6999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ..+....     .....++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..++...
T Consensus       152 ~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~  213 (331)
T cd06649         152 GQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI-GRYPIPPPDAKELEAI  213 (331)
T ss_pred             ccccccc-----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            6543221     123457788999999998889999999999999999999 9999988777665443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.1e-36  Score=236.67  Aligned_cols=208  Identities=38%  Similarity=0.654  Sum_probs=173.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.|+.++|++.++||+|+||.||+|..+.          +..||+|.+......  ..++.+|+.+++++ +|+|+++++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~----------~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~   67 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNG----------HTKVAIKSLKQGSMS--PEAFLAEANLMKQL-QHPRLVRLY   67 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCC----------CceEEEEEecCCCCc--HHHHHHHHHHHHhc-CCcCeeeEE
Confidence            78999999999999999999999987433          235999988754332  35788999999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++..+..+++||++++++|.+++..                      .|||+.+++|+||||+||++++++.++|+|||
T Consensus        68 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          68 AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             EEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCc
Confidence            98877778999999999999988643                      69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++.........  ......++..|++||++....++.++|+||||+++|++++.|..||.+.+..+....+..+.+++.|
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05067         148 LARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP  225 (260)
T ss_pred             ceeecCCCCcc--cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Confidence            98654322111  1112334567999999988888999999999999999997699999998888888888888888877


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|.
T Consensus       226 ~~~~~  230 (260)
T cd05067         226 DNCPE  230 (260)
T ss_pred             CCCCH
Confidence            77664

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.3e-36  Score=239.47  Aligned_cols=215  Identities=38%  Similarity=0.679  Sum_probs=174.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|.+.+.||+|+||.||+|......    .......||+|.++..........+.+|+++++++ +|+||++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~   76 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGV   76 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeE
Confidence            45678999999999999999999864432    22345579999987665555567889999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH----------------------------------hcccCCCCcccCCCCCCEeec
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE----------------------------------EYLSNNKVVHRDLATRNILLS  131 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~----------------------------------~~lh~~~i~H~~lk~~nil~~  131 (228)
                      +... ..+++|||+++++|.+++..                                  .+||+++++|+||||+||+++
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~  156 (280)
T cd05049          77 CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG  156 (280)
T ss_pred             EecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence            8764 48899999999999887641                                  589999999999999999999


Q ss_pred             CCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         132 SPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      .++.++|+|||++........... .....++..|+|||++.+..++.++|+||||+++|+|++.|..||.+.+..+...
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CCCeEEECCcccceecccCcceec-CCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999875433221111 1122345679999999988899999999999999999977999999988888888


Q ss_pred             HHHcCCCCCCCCCCCC
Q psy3166         212 YLSTGYRMERPASCNE  227 (228)
Q Consensus       212 ~~~~~~~~~~p~~~~~  227 (228)
                      .+..+..++.|..+|.
T Consensus       236 ~~~~~~~~~~~~~~~~  251 (280)
T cd05049         236 CITQGRLLQRPRTCPS  251 (280)
T ss_pred             HHHcCCcCCCCCCCCH
Confidence            8888766666666553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-35  Score=236.77  Aligned_cols=212  Identities=37%  Similarity=0.715  Sum_probs=176.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.++|.+.+.||+|+||.||+|.+....      .....+|+|...........+.+.+|+.+++++ +||||++++++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   75 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGV   75 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEE
Confidence            56788999999999999999999864431      122358999887665455567888999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.....+++||++++++|.+++..                     .|+|+++++|+||||+||+++.++.++|+|||++.
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          76 ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             EcCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceee
Confidence            888888999999999999998764                     68999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      ..........  ....++..|+|||.+....++.++|+||||++++++++.|..||.+.+..+....+.++.+++.|.++
T Consensus       156 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05056         156 YLEDESYYKA--SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC  233 (270)
T ss_pred             ecccccceec--CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            5543322211  12233456999999888888999999999999999986699999998888888888898888888888


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      |+
T Consensus       234 ~~  235 (270)
T cd05056         234 PP  235 (270)
T ss_pred             CH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.9e-36  Score=247.84  Aligned_cols=202  Identities=23%  Similarity=0.364  Sum_probs=160.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+++..         .+++.||+|.+....  .......+.+|..++..+ +|+||+++++.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~   70 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK---------HTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAF   70 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence            58999999999999999999843         344569999986431  222334567888999888 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ...+ .++||||+++|+|.+++..                     .|+|+++|+||||||+||+++.++.+||+|||++.
T Consensus        71 ~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          71 QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence            7655 7899999999999998754                     58999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeeccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVS-----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRM  219 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~-~~~  219 (228)
                      .+.......  .....|+..|+|||++..     ..++.++|+||+|+++|+|++ |..||...+..+....+... .+.
T Consensus       151 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  227 (331)
T cd05624         151 KMNQDGTVQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHEERF  227 (331)
T ss_pred             eccCCCcee--eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh-CCCCccCCCHHHHHHHHHcCCCcc
Confidence            554332111  123467889999998875     457789999999999999999 99999988777776666543 344


Q ss_pred             CCCCC
Q psy3166         220 ERPAS  224 (228)
Q Consensus       220 ~~p~~  224 (228)
                      +.|..
T Consensus       228 ~~p~~  232 (331)
T cd05624         228 QFPSH  232 (331)
T ss_pred             cCCCc
Confidence            44443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4e-36  Score=245.54  Aligned_cols=197  Identities=25%  Similarity=0.367  Sum_probs=156.3

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||+||+|...         .++..||+|.++....  .........|..++....+||||+++++++.... +
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            47999999999999843         3445699999875421  1223456678888877669999999999887644 7


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +++|||+++|+|.+++..                    .|||+++|+||||||+||+++.++.++|+|||++....... 
T Consensus        72 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-  150 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence            899999999999988754                    69999999999999999999999999999999986432211 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                        .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+... .+..|..++
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  220 (316)
T cd05619         151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI-GQSPFHGHDEEELFQSIRMD-NPCYPRWLT  220 (316)
T ss_pred             --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCC
Confidence              11123457788999999988889999999999999999999 99999998888887777665 344454443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.3e-36  Score=240.81  Aligned_cols=215  Identities=33%  Similarity=0.610  Sum_probs=175.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +...+|++.+.||+|+||+||+|....+.    ....+..||+|.++..........+.+|+.+++.+ +||||++++++
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~   76 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTA----PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGV   76 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCC----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEE
Confidence            45668999999999999999999865543    23345679999998665555556788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCCEe
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRNIL  129 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~nil  129 (228)
                      +... ..++++||+++++|.+++..                                    .|+|+++|+||||||+||+
T Consensus        77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil  156 (283)
T cd05091          77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL  156 (283)
T ss_pred             EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence            8664 47899999999999888630                                    6999999999999999999


Q ss_pred             ecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         130 LSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       130 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ++.++.+||+|||+++.+...... .......++..|+|||.+....++.++|+||+||++|+|++.|..||.+....++
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  235 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  235 (283)
T ss_pred             ecCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999998754332211 1112234456799999998888899999999999999999878899999888888


Q ss_pred             HHHHHcCCCCCCCCCCCC
Q psy3166         210 VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       210 ~~~~~~~~~~~~p~~~~~  227 (228)
                      .+.+..+...+.|.+||+
T Consensus       236 ~~~i~~~~~~~~~~~~~~  253 (283)
T cd05091         236 IEMIRNRQVLPCPDDCPA  253 (283)
T ss_pred             HHHHHcCCcCCCCCCCCH
Confidence            989988888888888875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-36  Score=246.04  Aligned_cols=197  Identities=25%  Similarity=0.355  Sum_probs=156.8

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||+|...         .++..||+|.++....  .........|..++....+||||+++++.+..++ +
T Consensus         1 ~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            47999999999999843         3455799999875421  1223456678888877669999999999887654 7


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.++|+|||+++...... 
T Consensus        72 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-  150 (316)
T ss_pred             EEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence            899999999999887654                    69999999999999999999999999999999886321111 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                        .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+..+ .+..|..++
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~  220 (316)
T cd05620         151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI-GQSPFHGDDEDELFESIRVD-TPHYPRWIT  220 (316)
T ss_pred             --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCC
Confidence              11223567888999999998889999999999999999999 99999998888777777665 445555443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0201|consensus

Probab=100.00  E-value=7.8e-38  Score=252.09  Aligned_cols=196  Identities=26%  Similarity=0.496  Sum_probs=167.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .+...|+.++.||+|.||.||+|.         +..+++.||+|++.........+...+|+.+|..+ +++||.++++.
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~---------d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygs   79 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAI---------DNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGS   79 (467)
T ss_pred             Ccccccccchhccccccceeeeee---------eccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhh
Confidence            456678888999999999999997         56677789999998765555567788999999999 89999999998


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..+. ++++|||+.||++.+.++.                    .|||.++.+|||||+.||++...|.+||+|||++.
T Consensus        80 yl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~  159 (467)
T KOG0201|consen   80 YLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAG  159 (467)
T ss_pred             eeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceee
Confidence            87755 8999999999999988764                    69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .+......   .....||+-|||||++.+..|+.++||||||++.+||.+ |.+||...++..++-.+-+.
T Consensus       160 ql~~~~~r---r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~-GePP~s~~hPmrvlflIpk~  226 (467)
T KOG0201|consen  160 QLTNTVKR---RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAK-GEPPHSKLHPMRVLFLIPKS  226 (467)
T ss_pred             eeechhhc---cccccccccccchhhhccccccchhhhhhhhHHHHHHhc-CCCCCcccCcceEEEeccCC
Confidence            66544322   256889999999999998899999999999999999999 99999998875544333333

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9e-36  Score=245.20  Aligned_cols=186  Identities=27%  Similarity=0.433  Sum_probs=148.1

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||+|+.         ..++..||+|.++... ......++.+|+.+++++ +||||+++++++..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~   70 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAID---------THTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP   70 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEE---------CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEec
Confidence            689999999999999999984         3445579999886432 222335678999999999 99999999988753


Q ss_pred             C------ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          90 D------ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        90 ~------~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .      .++++|||+. ++|.+++..                    .|||+++|+||||||+|||++.++.+||+|||+
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          71 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             cCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence            2      3789999995 688887653                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeeccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVS--NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      ++................++..|+|||++.+  ..++.++|+|||||++|+|++ |..||.+.+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t-g~~pf~~~~~~~  215 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH  215 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Confidence            8754322111111223467788999999865  568899999999999999999 999998765443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-35  Score=235.38  Aligned_cols=213  Identities=36%  Similarity=0.631  Sum_probs=171.9

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ...+|++.+.||+|+||.||+|.+....      .....||+|.++..........+..|+.+++++ +||||+++.+++
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~   74 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVV   74 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCC------CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEE
Confidence            4568999999999999999999865532      223469999987665555567889999999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..+. .+++|||+++++|.+++..                     .|||+++++|+||||+||+++.++.++|+|||++.
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          75 TKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             CCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccc
Confidence            6644 7899999999999988753                     68999999999999999999999999999999886


Q ss_pred             cccccccccCCCCCC--CCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSE--KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~--~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ...............  ..+..|++||.+....++.++|+||+||++|++++.|..||...+..++...+....+.+.|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  234 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM  234 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcc
Confidence            543322111001111  123469999999888899999999999999998866999999988888888888777777777


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .+|+
T Consensus       235 ~~~~  238 (269)
T cd05065         235 DCPT  238 (269)
T ss_pred             cCCH
Confidence            7764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-36  Score=248.73  Aligned_cols=197  Identities=25%  Similarity=0.395  Sum_probs=157.1

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||++..         ..++..||+|.++...  .......+.+|++++..+ +||||+++.+.+.... +
T Consensus         1 ~~lG~G~~g~V~~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~   70 (325)
T cd05594           1 KLLGKGTFGKVILVKE---------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRL   70 (325)
T ss_pred             CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEE
Confidence            4699999999999874         3455679999987542  222345667899999999 9999999998876644 8


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      ++||||+++++|.+++..                    .|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus        71 ~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          71 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            899999999999887653                    69997 799999999999999999999999999986432221


Q ss_pred             cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       152 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .   ......|+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+..+ ....|..+++
T Consensus       151 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  221 (325)
T cd05594         151 A---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-EIRFPRTLSP  221 (325)
T ss_pred             c---ccccccCCcccCCHHHHccCCCCCccccccccceeeeecc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCH
Confidence            1   1123457889999999988889999999999999999999 99999988777676666554 4555655543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-35  Score=235.76  Aligned_cols=208  Identities=37%  Similarity=0.636  Sum_probs=171.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||+|....+.          .+|+|.++.....  ...+.+|+.+++++ +|+|+++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~----------~~~~k~~~~~~~~--~~~~~~E~~~l~~l-~~~~i~~~~   67 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNT----------KVAVKTLKPGTMS--PESFLEEAQIMKKL-RHDKLVQLY   67 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCc----------eeEEEEecCCCCC--HHHHHHHHHHHHhc-CCCceEEEE
Confidence            6789999999999999999999999754322          4899988754332  35678999999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++.....+++||++++++|.+++..                      .|||+++++|+||||+||+++.++.++|+|||
T Consensus        68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg  147 (260)
T cd05070          68 AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFG  147 (260)
T ss_pred             eEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCce
Confidence            98877778999999999999988742                      58999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++..+......  ......++..|+|||......++.++|+||||+++|+|++.|..||.+.+..+....+..+.+++.|
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05070         148 LARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP  225 (260)
T ss_pred             eeeeccCcccc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            98754332111  1112234557999999888888999999999999999998688999998888888888888777777


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|.
T Consensus       226 ~~~~~  230 (260)
T cd05070         226 QDCPI  230 (260)
T ss_pred             CcCCH
Confidence            66653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-35  Score=233.93  Aligned_cols=205  Identities=37%  Similarity=0.683  Sum_probs=167.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +++++|++.+.||+|+||.||++.+..+          ..+|+|.+......  ..++.+|+.+++++ +||||++++++
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~----------~~~a~K~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~   67 (256)
T cd05114           1 INPSELTFMKELGSGQFGVVHLGKWRAQ----------IKVAIKAINEGAMS--EEDFIEEAKVMMKL-SHPKLVQLYGV   67 (256)
T ss_pred             CCHHHcEEeeEecCCcCceEEEEEeccC----------ceEEEEecccCCcc--HHHHHHHHHHHHHC-CCCCceeEEEE
Confidence            4678999999999999999999976432          24899987644322  35678899999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+ ..+++|||+++|+|.+++..                     .|||+++++|+||+|+||+++.++.++|+|||.+
T Consensus        68 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~  147 (256)
T cd05114          68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT  147 (256)
T ss_pred             EccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCc
Confidence            7664 48899999999999988753                     5899999999999999999999999999999988


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ..........  .....++..|+|||.+....++.++|+||||+++|+|++.|..||...+..+....+..+.++..|..
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  225 (256)
T cd05114         148 RYVLDDEYTS--SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL  225 (256)
T ss_pred             cccCCCceec--cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence            7543322111  11223445799999998888899999999999999999868999999888888888888877776654


Q ss_pred             CC
Q psy3166         225 CN  226 (228)
Q Consensus       225 ~~  226 (228)
                      .+
T Consensus       226 ~~  227 (256)
T cd05114         226 AS  227 (256)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.9e-35  Score=240.21  Aligned_cols=220  Identities=41%  Similarity=0.845  Sum_probs=176.2

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |-++.++|.+.+.||+|+||.||++...+...  ........+|+|.++..........+.+|+.+++++.+||||++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLL   84 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence            56888999999999999999999997543221  1123445689999876544555667889999999996799999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++.... .+++|||+++++|.+++..                                    .|||++|++|+||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            9887644 7899999999999887731                                    58999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      |+++.++.+||+|||+++.......... .....++..|++||.+....++.++|+||||+++|+|++.|..||.+.+..
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKK-TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccc-cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999875533221111 111223356999999988889999999999999999998789999998888


Q ss_pred             HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ++...+..+.+++.|..+|.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~  263 (314)
T cd05099         244 ELFKLLREGHRMDKPSNCTH  263 (314)
T ss_pred             HHHHHHHcCCCCCCCCCCCH
Confidence            88888888887787877764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.5e-36  Score=246.57  Aligned_cols=174  Identities=24%  Similarity=0.449  Sum_probs=143.8

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||++...         .++..||+|.++...  .......+..|..++.++.+||||+++++++.... +
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELK---------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            47999999999999843         345579999987542  22334567789999999878999999999887644 8


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +++|||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        72 ~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  150 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-  150 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence            899999999999887653                    69999999999999999999999999999999986422211 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                        .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~  197 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFD  197 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH-CCCCcc
Confidence              11223467888999999998889999999999999999999 999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.7e-36  Score=246.72  Aligned_cols=194  Identities=24%  Similarity=0.374  Sum_probs=156.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||++....         ++..+|+|.+.+..  .......+.+|+.++..+ +|+||+++++.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~   70 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAF   70 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEE
Confidence            579999999999999999998543         34569999986421  122234567889999998 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .... +++||||+++|+|.+++..                     .|||+++|+||||||+||+++.++.++|+|||++.
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             ecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence            7644 8899999999999998854                     58999999999999999999999999999999986


Q ss_pred             cccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .+......  ......|+..|+|||++.     ...++.++|+|||||++|+|++ |..||...+..+...++...
T Consensus       151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~  223 (332)
T cd05623         151 KLMEDGTV--QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNH  223 (332)
T ss_pred             ecccCCcc--eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc-CCCCCCCCCHHHHHHHHhCC
Confidence            54332211  112346788999999886     2357889999999999999999 99999998887777776654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-35  Score=238.67  Aligned_cols=221  Identities=42%  Similarity=0.828  Sum_probs=177.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.+..++|.+.+.||+|+||.||+|+......  ........||+|.++..........+.+|+.+++.+.+||||+++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhe
Confidence            467888999999999999999999997532111  012334569999987554445556788999999999789999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCC
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      ++++.... .+++|||+++++|.+++..                                    .|||++|++|+||||+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence            99887644 7899999999999887642                                    5899999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ||+++.++.++|+|||++..+....... ......++..|+|||++.+..++.++|+||||+++|+|++.|..||.+.+.
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccc-cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999999987554322111 112233456799999998888999999999999999999878899999988


Q ss_pred             HHHHHHHHcCCCCCCCCCCCC
Q psy3166         207 CRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       207 ~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .++...+..+.++..|..++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~  266 (304)
T cd05101         246 EELFKLLKEGHRMDKPANCTN  266 (304)
T ss_pred             HHHHHHHHcCCcCCCCCCCCH
Confidence            888888888888777777764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-35  Score=238.29  Aligned_cols=219  Identities=45%  Similarity=0.866  Sum_probs=177.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||++.......    ......+|+|.++.....+....+.+|+++++++.+|+||+++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~   81 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL   81 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            467889999999999999999999998654331    1333568999987654445556788999999999789999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      ++++..+ .++++|||+++++|.+++..                                    .|||+++|+|+||||+
T Consensus        82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~  161 (293)
T cd05053          82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR  161 (293)
T ss_pred             EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence            9988664 48899999999999988741                                    6899999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ||+++.++.++|+|||++..+........ .....++..|++||.+.+..++.++|+|||||++|++++.|..||.+...
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceec-cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            99999999999999999875533221111 11123345799999988888999999999999999999779999999888


Q ss_pred             HHHHHHHHcCCCCCCCCCCCC
Q psy3166         207 CRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       207 ~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .++.+.+..+.+++.|..++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~  261 (293)
T cd05053         241 EELFKLLKEGYRMEKPQNCTQ  261 (293)
T ss_pred             HHHHHHHHcCCcCCCCCCCCH
Confidence            888888888888887776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-35  Score=236.74  Aligned_cols=217  Identities=37%  Similarity=0.714  Sum_probs=172.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+..++|.+.+.||+|+||.||+|.+....    ...+...||+|.+...........+.+|+.+++++ +|+||++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~   75 (277)
T cd05036           1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRD----GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLI   75 (277)
T ss_pred             CCCCHHHcEeeeECCCCCCCcEEEEEEecCC----CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEE
Confidence            3567789999999999999999999865421    11245569999887555555556788999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH---------------------------hcccCCCCcccCCCCCCEeecCCC--
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE---------------------------EYLSNNKVVHRDLATRNILLSSPH--  134 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------------~~lh~~~i~H~~lk~~nil~~~~~--  134 (228)
                      +++... ..+++|||+++++|.+++..                           .|||+++++|+||||+||+++.++  
T Consensus        76 ~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             EEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCC
Confidence            987654 47899999999999987642                           589999999999999999998754  


Q ss_pred             -cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         135 -VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       135 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                       .+||+|||+++.+........ ......+..|++||++.+..++.++|+|||||++|+|++.|..||++.+..++...+
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~  234 (277)
T cd05036         156 RVAKIADFGMARDIYRASYYRK-GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV  234 (277)
T ss_pred             cceEeccCccccccCCccceec-CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             699999999875532221111 112233457999999988889999999999999999997699999998888888777


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      ....+.+.|..+|.
T Consensus       235 ~~~~~~~~~~~~~~  248 (277)
T cd05036         235 TGGGRLDPPKGCPG  248 (277)
T ss_pred             HcCCcCCCCCCCCH
Confidence            77777777777664

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=250.18  Aligned_cols=195  Identities=25%  Similarity=0.369  Sum_probs=160.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|+.         ..++..||+|.++...  .......+.+|+.++..+ +||||+++++.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~   70 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRD---------KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSF   70 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEE---------CCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhhe
Confidence            4799999999999999999984         3345679999987542  112345678899999999 999999999888


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. .++||||+++++|.+++..                    .|||++||+||||||+||+++.++.++|+|||++..
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          71 QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             ecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            7644 8899999999999988754                    699999999999999999999999999999999875


Q ss_pred             cccccc--------------------------ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy3166         147 IYEQNV--------------------------FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANP  200 (228)
Q Consensus       147 ~~~~~~--------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~p  200 (228)
                      +.....                          .........|+..|+|||++.+..++.++|+|||||++|+|++ |..|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc-CCCC
Confidence            533220                          0011223567889999999998889999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHc
Q psy3166         201 YPHIPLCRIVHYLST  215 (228)
Q Consensus       201 f~~~~~~~~~~~~~~  215 (228)
                      |......+...++..
T Consensus       230 f~~~~~~~~~~~i~~  244 (350)
T cd05573         230 FYSDTLQETYNKIIN  244 (350)
T ss_pred             CCCCCHHHHHHHHhc
Confidence            999887777666655

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-36  Score=244.71  Aligned_cols=193  Identities=22%  Similarity=0.357  Sum_probs=155.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||+||+++..         .++..||+|.+++..  .......+.+|+.++..+ +|+||+.+++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~   70 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK---------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAF   70 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEE
Confidence            58999999999999999999843         344579999986431  222345577899999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..+. +++||||+++++|.+++..                     +|||+++|+||||||+|||++.++.++|+|||++.
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence            7654 8899999999999988753                     58999999999999999999999999999999986


Q ss_pred             cccccccccCCCCCCCCcceeeccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVS-----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .+......  ......|+..|+|||++..     ..++.++|+||+||++|+|++ |..||.+....+....+..
T Consensus       151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05597         151 RLLADGTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMN  222 (331)
T ss_pred             ecCCCCCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh-CCCCCCCCCHHHHHHHHHc
Confidence            54332211  1112457888999999863     346789999999999999999 9999998777766666544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-35  Score=238.27  Aligned_cols=203  Identities=22%  Similarity=0.354  Sum_probs=164.9

Q ss_pred             CCCCCceeee--eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           6 GYPPERLILG--EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         6 ~~~~~~~~~~--~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .|+++++...  ..||+|+++.||+|...           ++.||+|.++...  .....+.+.+|+.+|+++ +||||+
T Consensus        14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv   81 (283)
T PHA02988         14 CIESDDIDKYTSVLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNIL   81 (283)
T ss_pred             ecCHHHcCCCCCeEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEE
Confidence            4677777766  78999999999999853           3459999987542  222346778999999999 999999


Q ss_pred             EeeeEEEc-----CceEEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCCc
Q psy3166          82 SFIGCCYK-----DELRLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        82 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~~  135 (228)
                      ++++++..     ..++++|||+++|+|.+++..                    .|+|+ .+++||||||+||+++.++.
T Consensus        82 ~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~  161 (283)
T PHA02988         82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK  161 (283)
T ss_pred             EEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc
Confidence            99998765     247899999999999998764                    58997 48999999999999999999


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeeccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS--NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +||+|||+++.+....      ....++..|+|||.+.+  ..++.++|+|||||++|+|++ |..||.+.+..++...+
T Consensus       162 ~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~-g~~Pf~~~~~~~~~~~i  234 (283)
T PHA02988        162 LKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLI  234 (283)
T ss_pred             EEEcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            9999999987543221      12356678999999875  568999999999999999999 99999998888877665


Q ss_pred             H-cCCCCCCCCCCCC
Q psy3166         214 S-TGYRMERPASCNE  227 (228)
Q Consensus       214 ~-~~~~~~~p~~~~~  227 (228)
                      . .+.+++.|..||+
T Consensus       235 ~~~~~~~~~~~~~~~  249 (283)
T PHA02988        235 INKNNSLKLPLDCPL  249 (283)
T ss_pred             HhcCCCCCCCCcCcH
Confidence            4 4567777767765

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.9e-35  Score=233.39  Aligned_cols=214  Identities=36%  Similarity=0.654  Sum_probs=171.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      |..++|+..+.||+|+||.||+|+....+      .....+|+|.++........+.+.+|+++++++ +|||++++.++
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   74 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPG------RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGV   74 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCC------CCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEE
Confidence            55679999999999999999999865422      123358999987664455567788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +... ..+++||++++++|.+++..                     .|||+++++|+||||+||+++.++.++++|||++
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          75 VTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             EccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence            8664 47899999999999888753                     6899999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ..................+..|++||++....++.++|+||||+++|+|++.|..||...+..++...+..+.+.+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  234 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMD  234 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCC
Confidence            65533221111111122245699999998888899999999999999998769999988888888888888877777766


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +|.
T Consensus       235 ~~~  237 (268)
T cd05063         235 CPS  237 (268)
T ss_pred             CCH
Confidence            653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4e-35  Score=232.44  Aligned_cols=202  Identities=43%  Similarity=0.773  Sum_probs=168.8

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||++...+           ..+|+|.++...   ..+.+.+|+.+++++ +|+|+++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----------~~~~~k~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~   65 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRG-----------NKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQLL   65 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcC-----------CcEEEEEeCCCc---hHHHHHHHHHHHHhC-CCCCeeeEE
Confidence            78889999999999999999999986532           348999886442   235678899999999 999999999


Q ss_pred             eEEEc--CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          85 GCCYK--DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        85 ~~~~~--~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      +++..  ...++++||+++++|.+++.+                      .|||+++++|+||||+||+++.++.+||+|
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~d  145 (256)
T cd05082          66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSD  145 (256)
T ss_pred             EEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecC
Confidence            87643  347899999999999988753                      599999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||++.......      ....++..|++||++....++.++|+|||||++|+|++.|..||...+..++...+.++.+++
T Consensus       146 fg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd05082         146 FGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD  219 (256)
T ss_pred             CccceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            99886432211      122334579999999888889999999999999999976999999988888888888888877


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .|..+|+
T Consensus       220 ~~~~~~~  226 (256)
T cd05082         220 APDGCPP  226 (256)
T ss_pred             CCCCCCH
Confidence            7777765

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-35  Score=233.40  Aligned_cols=208  Identities=37%  Similarity=0.649  Sum_probs=169.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|++|.||+|....+          ..||+|.++....  ..+.+.+|+++++++ +||||++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~----------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~   67 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNT----------TPVAVKTLKPGTM--DPKDFLAEAQIMKKL-RHPKLIQLY   67 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCC----------eEEEEEeeCCCcc--cHHHHHHHHHHHHHC-CCCCcccee
Confidence            678899999999999999999999874332          3599999875432  235678899999999 899999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++...+ .+++||++++++|.+++..                      .+||+++++|+||||+||+++.++.++|+||
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~df  147 (261)
T cd05068          68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADF  147 (261)
T ss_pred             EEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCc
Confidence            9876644 7899999999999988743                      5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |+++........  .......+..|++||.+....++.++|+||||+++|+|++.|..||.+.+..++...+....+++.
T Consensus       148 g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05068         148 GLARVIKEDIYE--AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC  225 (261)
T ss_pred             ceEEEccCCccc--ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            998765422111  111122235799999998888899999999999999999879999999888888888888777777


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       226 ~~~~~~  231 (261)
T cd05068         226 PPGCPK  231 (261)
T ss_pred             CCcCCH
Confidence            766653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-35  Score=232.48  Aligned_cols=205  Identities=40%  Similarity=0.709  Sum_probs=167.8

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLV   95 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~lv   95 (228)
                      +.||+|+||.||+|.+....      .....+|+|.++..........+.+|+++++++ +|||++++++++..+..+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKGEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcCCceEEE
Confidence            47999999999999864432      123469999988665444456788999999999 99999999998877778999


Q ss_pred             EecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccC
Q psy3166          96 VEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN  155 (228)
Q Consensus        96 ~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (228)
                      ||++++++|.+++..                    .|||+++++|+||||+||+++.++.++|+|||++..+........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999999998754                    699999999999999999999999999999999876543322211


Q ss_pred             CCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       156 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ......++..|++||.+.+..++.++|+||||+++|+|++.|..||...+..++...+..+.+++.|..+|+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ  225 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCH
Confidence            112222345799999998888999999999999999999769999999888888888888888888877764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-35  Score=243.29  Aligned_cols=197  Identities=26%  Similarity=0.405  Sum_probs=157.6

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ce
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-EL   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~   92 (228)
                      +.||+|+||+||++...         .++..||+|.+++..  .......+..|..++..+.+||||+++++++... .+
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELK---------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            46999999999999843         344579999987542  1223455678889998887899999999988664 48


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +++|||+++++|.+++..                    .|||+++|+|+||||+||+++.++.++|+|||++....... 
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  150 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-  150 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence            899999999999887654                    69999999999999999999999999999999886422211 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                        .......++..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++...+... .+..|..++
T Consensus       151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  220 (318)
T cd05570         151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQSILED-EVRYPRWLS  220 (318)
T ss_pred             --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcC-CCCCCCcCC
Confidence              11123457788999999998889999999999999999999 99999988877777776655 445555554

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-36  Score=245.17  Aligned_cols=196  Identities=28%  Similarity=0.415  Sum_probs=153.6

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHH-HHHhcCCCCceEEeeeEEEcC-c
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEIN-LMKDVGKHDHIVSFIGCCYKD-E   91 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~~h~ni~~~~~~~~~~-~   91 (228)
                      +.||+|+||+||+|+.         ..++..||+|.+....  .......+..|.. +++.+ +||||+++++.+... .
T Consensus         1 ~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~   70 (323)
T cd05575           1 KVIGKGSFGKVLLAKH---------KADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADK   70 (323)
T ss_pred             CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCE
Confidence            4799999999999984         3445579999986432  1122334555555 45667 999999999888664 4


Q ss_pred             eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          92 LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      .+++|||+++++|.+++..                    .|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        71 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          71 LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            8899999999999887654                    69999999999999999999999999999999986432221


Q ss_pred             cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       152 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                         .......|+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++...+..+ ....+.+++
T Consensus       151 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  220 (323)
T cd05575         151 ---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNILNK-PLRLKPNIS  220 (323)
T ss_pred             ---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Confidence               11223467889999999998889999999999999999999 99999998888777777665 344444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-35  Score=239.59  Aligned_cols=183  Identities=27%  Similarity=0.461  Sum_probs=147.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|+..         .++..||+|.++..........+.+|+.+++++ +||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~   73 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK---------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIH   73 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC---------CCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEe
Confidence            478999999999999999999843         345579999987553333334567899999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+. .++||||+. ++|.+++..                     .|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        74 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          74 TKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             cCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence            654 789999995 577666543                     699999999999999999999999999999998864


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      .....   .......++..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+..+
T Consensus       153 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  209 (303)
T cd07869         153 KSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ-GVAAFPGMKD  209 (303)
T ss_pred             ccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCcc
Confidence            32211   11223456778999998875 457889999999999999999 9999988543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0696|consensus

Probab=100.00  E-value=6.3e-37  Score=245.95  Aligned_cols=207  Identities=25%  Similarity=0.377  Sum_probs=173.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      -|...+|.++.+||.|+||+|.++.         .+.+...||||+++++..  ....+.-+.|-++|....+.|.++++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLae---------rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~ql  415 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAE---------RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQL  415 (683)
T ss_pred             ceeecccceEEEeccCccceeeeec---------ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHH
Confidence            3666789999999999999999986         556677899999986621  11223456688888877778999999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +.+|+. +.+|.||||+.||+|.-.+++                    -+||++||+.||||.+|++++..|++||+|||
T Consensus       416 HScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG  495 (683)
T KOG0696|consen  416 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG  495 (683)
T ss_pred             HHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence            998876 779999999999999888776                    48999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++.-.-...   ...+.+||+.|+|||++...+|+..+|+||+|+++|||+. |+.||.+.+..|+.+.+.+- ...-|
T Consensus       496 mcKEni~~~~---TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla-GQpPFdGeDE~elF~aI~eh-nvsyP  570 (683)
T KOG0696|consen  496 MCKENIFDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQAIMEH-NVSYP  570 (683)
T ss_pred             cccccccCCc---ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHc-cCcCc
Confidence            9874322221   2345789999999999999999999999999999999999 99999999999999888776 55566


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      .+++
T Consensus       571 KslS  574 (683)
T KOG0696|consen  571 KSLS  574 (683)
T ss_pred             cccc
Confidence            6554

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.6e-35  Score=232.71  Aligned_cols=207  Identities=37%  Similarity=0.629  Sum_probs=169.9

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++...||+|++|.||++.+..+.          .+|+|.+.....  ....+.+|+++++++ +|||+++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~----------~~~lK~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~   67 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTT----------KVAIKTLKPGTM--MPEAFLQEAQIMKKL-RHDKLVPLY   67 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCc----------eEEEEEcccCCc--cHHHHHHHHHHHHhC-CCCCeeeEE
Confidence            6788899999999999999999999754422          389998765432  235678899999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++..+..+++|||+++++|.+++..                      .|||+++++|+||||+||+++.++.++|+|||
T Consensus        68 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg  147 (260)
T cd05069          68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFG  147 (260)
T ss_pred             EEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCc
Confidence            98877778999999999999988753                      58999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++..+......  ......++..|++||...+..++.++|+||||+++|+|++.|..||.+....+....+..+.+++.|
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05069         148 LARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP  225 (260)
T ss_pred             cceEccCCccc--ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            98654332111  1112334567999999888888999999999999999997689999998888888888887777777


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      .+.|
T Consensus       226 ~~~~  229 (260)
T cd05069         226 QGCP  229 (260)
T ss_pred             cccC
Confidence            6555

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0594|consensus

Probab=100.00  E-value=3.8e-36  Score=237.55  Aligned_cols=199  Identities=27%  Similarity=0.408  Sum_probs=155.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCc-eEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDH-IVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~n-i~~~~~~   86 (228)
                      ...|+..++||+|+||+||+|+         ++.+++.||+|.+...... ..-....+|+.+|+++ +|+| |+.+.++
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar---------~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv   79 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKAR---------SKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDV   79 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEE---------EecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEee
Confidence            3457778889999999999998         5556678999998755331 1223467899999999 9999 9999999


Q ss_pred             EEcC-------ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          87 CYKD-------ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        87 ~~~~-------~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      +...       .+++|+||+. -+|.+++..                        .|||+++|+||||||+|+|++++|.
T Consensus        80 ~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   80 IHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             eeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc
Confidence            8653       4779999984 355555432                        7999999999999999999999999


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      +||+|||+++...-..   .......+|.-|.|||++.+. .|++..|+||+||++.||++ +..-|.+....+.+.++-
T Consensus       159 lKlaDFGlAra~~ip~---~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~If  234 (323)
T KOG0594|consen  159 LKLADFGLARAFSIPM---RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFRIF  234 (323)
T ss_pred             EeeeccchHHHhcCCc---ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Confidence            9999999998554221   112234556668999999876 69999999999999999999 999999987766655554


Q ss_pred             cCCCCCCC
Q psy3166         215 TGYRMERP  222 (228)
Q Consensus       215 ~~~~~~~p  222 (228)
                      +...+|..
T Consensus       235 ~~lGtP~e  242 (323)
T KOG0594|consen  235 RLLGTPNE  242 (323)
T ss_pred             HHcCCCCc
Confidence            44344433

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.4e-35  Score=235.31  Aligned_cols=214  Identities=38%  Similarity=0.697  Sum_probs=172.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      |..++|.+.+.||+|+||+||++......    ...+...+|+|.+.... ......+.+|+++++++ +|||++++.++
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   75 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDAS-DNARKDFHREAELLTNL-QHEHIVKFYGV   75 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhC-CCCCcceEEEE
Confidence            56789999999999999999998754322    22344568999887543 33456788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------------------hcccCCCCcccCCCCCCEeecC
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------------------EYLSNNKVVHRDLATRNILLSS  132 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------------------~~lh~~~i~H~~lk~~nil~~~  132 (228)
                      +... ..+++|||+++++|.+++..                                 .|||+++++||||||+||+++.
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~  155 (288)
T cd05093          76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  155 (288)
T ss_pred             EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            8764 47899999999999888741                                 5899999999999999999999


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ++.++|+|||++........... .....++..|+|||.+.+..++.++|+|||||++|+|++.|..||.+....++...
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~  234 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  234 (288)
T ss_pred             CCcEEeccCCccccccCCceeec-CCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999875433221111 11233456799999998888999999999999999999768999999888888888


Q ss_pred             HHcCCCCCCCCCCCC
Q psy3166         213 LSTGYRMERPASCNE  227 (228)
Q Consensus       213 ~~~~~~~~~p~~~~~  227 (228)
                      +..+..++.|..+|+
T Consensus       235 i~~~~~~~~~~~~~~  249 (288)
T cd05093         235 ITQGRVLQRPRTCPK  249 (288)
T ss_pred             HHcCCcCCCCCCCCH
Confidence            888877666666653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4250|consensus

Probab=100.00  E-value=8.1e-37  Score=258.53  Aligned_cols=191  Identities=30%  Similarity=0.475  Sum_probs=158.5

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-   89 (228)
                      .+...+.||+|+||.||+|+         ++.+++.||||.++.....+..++..+|+++|+++ +|+|||+++++-.+ 
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgr---------nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~   83 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGR---------NKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETK   83 (732)
T ss_pred             ceeehhhhcCCccceeeeec---------ccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCcc
Confidence            34677899999999999998         67788889999998765556667888999999999 79999999987543 


Q ss_pred             ------CceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecC--CC--cE
Q psy3166          90 ------DELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSS--PH--VV  136 (228)
Q Consensus        90 ------~~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~--~~--~~  136 (228)
                            +.-.++||||+||+|...+++                       .|||++||+||||||.||++-.  +|  .-
T Consensus        84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence                  235789999999999999875                       6999999999999999999743  34  47


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL----CRIVH  211 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~----~~~~~  211 (228)
                      ||+|||.++.+.+...    ..+..||..|++||..- .+.|+.-+|.|||||++|++.| |..||-....    .++..
T Consensus       164 KLtDfG~Arel~d~s~----~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT-G~lPF~p~~~pk~~~~~~~  238 (732)
T KOG4250|consen  164 KLTDFGAARELDDNSL----FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT-GELPFIPFGGPKNNKEIMW  238 (732)
T ss_pred             eeecccccccCCCCCe----eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc-cCCCCCcCCCccccchhhh
Confidence            8999999998876653    34689999999999998 4778888999999999999999 9999966433    34554


Q ss_pred             HHHcC
Q psy3166         212 YLSTG  216 (228)
Q Consensus       212 ~~~~~  216 (228)
                      .+..+
T Consensus       239 ~~~tk  243 (732)
T KOG4250|consen  239 HIITK  243 (732)
T ss_pred             hhhcc
Confidence            44433

>KOG0658|consensus

Probab=100.00  E-value=1.8e-36  Score=239.70  Aligned_cols=188  Identities=27%  Similarity=0.399  Sum_probs=147.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-   89 (228)
                      .|+-.+++|+|+||.||+|...++         ...||||+...+...+     .+|+++|+++ +||||+++..+|.. 
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~---------~~~vAIKKv~~d~r~k-----nrEl~im~~l-~HpNIV~L~~~f~~~   89 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRET---------EEEVAIKKVLQDKRYK-----NRELQIMRKL-DHPNIVRLLYFFSSS   89 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCC---------CceeEEEEecCCCCcC-----cHHHHHHHhc-CCcCeeeEEEEEEec
Confidence            367789999999999999986554         3469999987553322     3799999999 99999999988754 


Q ss_pred             --C-ceE--EEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCC-CcEEEe
Q psy3166          90 --D-ELR--LVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSP-HVVKIS  139 (228)
Q Consensus        90 --~-~~~--lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~-~~~kl~  139 (228)
                        . .+|  +||||+|. +|.++++.                        .|||+.||+||||||+|+|+|.+ |.+||+
T Consensus        90 ~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen   90 TESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             CCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEec
Confidence              2 334  79999966 88888773                        69999999999999999999974 999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      |||-++.+......    .+-..|.-|.|||.+.+. .|+.+.|+||.||++.||+- |.+-|++.+....+..+-+...
T Consensus       169 DFGSAK~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~-g~plFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  169 DFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK-GQPLFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             cCCcceeeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc-CCcccCCCCHHHHHHHHHHHhC
Confidence            99999866433110    111223457899998865 59999999999999999997 9999999887666555544333


Q ss_pred             C
Q psy3166         219 M  219 (228)
Q Consensus       219 ~  219 (228)
                      +
T Consensus       244 ~  244 (364)
T KOG0658|consen  244 T  244 (364)
T ss_pred             C
Confidence            3

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-35  Score=234.20  Aligned_cols=213  Identities=39%  Similarity=0.734  Sum_probs=175.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +...+|++.+.||+|+||.||+|.+..+.     ......+|+|.++..........+.+|+.++.++ +|||+++++++
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   77 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEG-----EKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGI   77 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCC-----CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Confidence            56789999999999999999999865432     1223468999887665555567788999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.....++++||+++++|.+++.+                     .|||+++++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          78 CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EecCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence            888889999999999999998754                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+........ .....++..|++||.+....++.++|+||||+++|++++.|..||.+.+..++.+.+.++...+.|..+
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (279)
T cd05057         158 LLDVDEKEYH-AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPIC  236 (279)
T ss_pred             cccCccccee-cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Confidence            5543221111 111223457999999888888999999999999999997799999998888888888888777777766


Q ss_pred             C
Q psy3166         226 N  226 (228)
Q Consensus       226 ~  226 (228)
                      +
T Consensus       237 ~  237 (279)
T cd05057         237 T  237 (279)
T ss_pred             C
Confidence            5

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=233.05  Aligned_cols=206  Identities=38%  Similarity=0.706  Sum_probs=167.8

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      |++.+|++.+.||+|+||.||++.++..          ..+|+|.+..+...  ...+.+|+++++++ +||||++++++
T Consensus         1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~----------~~~~iK~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~   67 (256)
T cd05059           1 IDPSELTFLKELGSGQFGVVHLGKWRGK----------IDVAIKMIREGAMS--EDDFIEEAKVMMKL-SHPNLVQLYGV   67 (256)
T ss_pred             CChHHcchhhhhccCCCceEEEeEecCC----------ccEEEEEeccCCCC--HHHHHHHHHHHHhC-CCCCEEEEEEE
Confidence            4678899999999999999999975432          24899988654322  24677899999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +... ..+++||++++++|.+++..                     .|||+++++|+||||+||+++.++.+||+|||++
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~  147 (256)
T cd05059          68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA  147 (256)
T ss_pred             EcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccc
Confidence            7654 47899999999999988743                     5899999999999999999999999999999988


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +.........  .....++..|++||.+.+..++.++|+||||+++|+|++.|..||...+..+....+..+.+++.|..
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd05059         148 RYVLDDQYTS--SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL  225 (256)
T ss_pred             eecccccccc--cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence            7543321111  11122345699999998888999999999999999999868999999888888888888888888877


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +|+
T Consensus       226 ~~~  228 (256)
T cd05059         226 APT  228 (256)
T ss_pred             CCH
Confidence            664

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-35  Score=238.22  Aligned_cols=199  Identities=24%  Similarity=0.373  Sum_probs=153.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcC--CCCceEEeeeE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVG--KHDHIVSFIGC   86 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--~h~ni~~~~~~   86 (228)
                      ++|++.+.||+|+||+||+|+...        ..+..||+|.++.... ........+|+.+++.+.  +||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC--------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            479999999999999999998522        2234689998864422 112234556777777663  69999999998


Q ss_pred             EEc------CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          87 CYK------DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        87 ~~~------~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      +..      ..++++||++. ++|.+++..                      .|||+++|+||||||+||+++.++.++|
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEE
Confidence            742      34789999996 578777643                      6999999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      +|||++......    .......++..|+|||.+....++.++|+||+||++|+|++ |..||.+....+.+..+.....
T Consensus       152 ~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~i~~~~~  226 (290)
T cd07862         152 ADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIG  226 (290)
T ss_pred             ccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHHHhC
Confidence            999998754322    11223456788999999988889999999999999999999 9999999877777666655434


Q ss_pred             CCCC
Q psy3166         219 MERP  222 (228)
Q Consensus       219 ~~~p  222 (228)
                      .+.|
T Consensus       227 ~~~~  230 (290)
T cd07862         227 LPGE  230 (290)
T ss_pred             CCCh
Confidence            4333

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4717|consensus

Probab=100.00  E-value=2.3e-36  Score=248.33  Aligned_cols=200  Identities=27%  Similarity=0.437  Sum_probs=170.9

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      =|.+.+.||+|.|++|-+|+         +-.++.+||||++++.. ......++++|+++|+.+ +|||||+++++...
T Consensus        19 LYDLekTlG~GHFAVVKLAr---------HVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDT   88 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLAR---------HVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDT   88 (864)
T ss_pred             eehhhhhhcCCceehhhhhh---------hhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcc
Confidence            47788999999999998876         66788899999998663 344556889999999999 99999999998754


Q ss_pred             -CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeec-CCCcEEEeeccCccc
Q psy3166          90 -DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSED  146 (228)
Q Consensus        90 -~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~-~~~~~kl~dfg~~~~  146 (228)
                       ..+|+|+|+=.+|+|++|+-.                     .|+|+..++||||||+|+++- +-|.+||.|||++..
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence             569999999999999999743                     599999999999999999865 579999999999876


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      +.+....    ...+|+..|.|||++.+..|+ ++.||||||+++|-+.+ |+.||+.-.+.|.+-+++.+ ++..|.-+
T Consensus       169 f~PG~kL----~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC-Gq~PFqeANDSETLTmImDC-KYtvPshv  242 (864)
T KOG4717|consen  169 FQPGKKL----TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC-GQPPFQEANDSETLTMIMDC-KYTVPSHV  242 (864)
T ss_pred             CCCcchh----hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh-CCCccccccchhhhhhhhcc-cccCchhh
Confidence            6554332    346788899999999999886 67899999999999888 99999999999999999988 77777554


Q ss_pred             C
Q psy3166         226 N  226 (228)
Q Consensus       226 ~  226 (228)
                      +
T Consensus       243 S  243 (864)
T KOG4717|consen  243 S  243 (864)
T ss_pred             h
Confidence            4

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.4e-35  Score=236.62  Aligned_cols=219  Identities=39%  Similarity=0.804  Sum_probs=172.3

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..|.+..++|.+.+.||+|+||.||++......    .......+|+|.++........+.+.+|+.+++++.+||||++
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~  103 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLS----KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVN  103 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCC----CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcce
Confidence            467888899999999999999999998753321    2344557999998765444555678899999999977999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +++.+... ..+++|||+++++|.+++..                      .|||+++|+|+||||+||+++.++.++++
T Consensus       104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEEC
Confidence            99987654 48899999999999988753                      58999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYLSTGYR  218 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~~~~~~  218 (228)
                      |||++..+........ .....++..|++||.+....++.++|+||+|+++|+|++.|..||.+....+. ...+..+.+
T Consensus       184 dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~  262 (302)
T cd05055         184 DFGLARDIMNDSNYVV-KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR  262 (302)
T ss_pred             CCcccccccCCCceee-cCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence            9999875543321111 11223456799999998888999999999999999999779999988665544 444555656


Q ss_pred             CCCCCCCC
Q psy3166         219 MERPASCN  226 (228)
Q Consensus       219 ~~~p~~~~  226 (228)
                      +..|...+
T Consensus       263 ~~~~~~~~  270 (302)
T cd05055         263 MAQPEHAP  270 (302)
T ss_pred             CCCCCCCC
Confidence            55554443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-35  Score=234.94  Aligned_cols=208  Identities=39%  Similarity=0.702  Sum_probs=170.4

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-Cc
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DE   91 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~   91 (228)
                      ++.+.||+|.||.||+|.+..     .....+..|+||.++..........+.+|++.++++ +||||+++++++.. +.
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~   75 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEP   75 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSS
T ss_pred             EEeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccccccc
Confidence            578899999999999999864     134556779999997655555578899999999999 99999999999985 44


Q ss_pred             eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          92 LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      .++|+||+++|+|.+++..                      .|||+++++|++|+++||+++.++.+||+|||+......
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            8899999999999998875                      599999999999999999999999999999999876522


Q ss_pred             cccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .... ...........|+|||.+....++.++||||||+++||+++.|..||...+..++..++.++.+++.|..||.
T Consensus       156 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (259)
T PF07714_consen  156 KSKY-KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPK  232 (259)
T ss_dssp             SSSE-EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBH
T ss_pred             cccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhH
Confidence            2111 1112234456799999998888999999999999999999967899999999999999999999999888874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.6e-36  Score=244.17  Aligned_cols=195  Identities=29%  Similarity=0.413  Sum_probs=151.7

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHH-HHHhcCCCCceEEeeeEEEcC-c
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEIN-LMKDVGKHDHIVSFIGCCYKD-E   91 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~~h~ni~~~~~~~~~~-~   91 (228)
                      +.||+|+||+||+|+..         .++..||+|.+.....  ......+..|.. +++.+ +||||+++++.+... .
T Consensus         1 ~~lg~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~   70 (325)
T cd05602           1 KVIGKGSFGKVLLARHK---------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK   70 (325)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCe
Confidence            47999999999999843         3445699999864321  122234444544 45667 999999999988664 4


Q ss_pred             eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          92 LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      .+++|||+++++|.+++..                    .|||++||+||||||+||+++.++.++|+|||+++......
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          71 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            8899999999999887753                    68999999999999999999999999999999986432221


Q ss_pred             cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       152 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                         .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+....+... ....+..+
T Consensus       151 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  219 (325)
T cd05602         151 ---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNK-PLQLKPNI  219 (325)
T ss_pred             ---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc-CCCCCCCCCHHHHHHHHHhC-CcCCCCCC
Confidence               11223567889999999998889999999999999999999 99999998887777776654 33333333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0607|consensus

Probab=100.00  E-value=2.7e-36  Score=235.19  Aligned_cols=200  Identities=28%  Similarity=0.461  Sum_probs=163.7

Q ss_pred             eeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      |++. +.||+|+|+.|--+.         +..++..||||++.+. ....+.++++|++++.....|+||++++++|.++
T Consensus        79 YkLt~e~LGeGAyasVqtcv---------~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCV---------SIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHhHHHHhcCccceeeeeee---------eeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3444 689999999998776         6678888999999877 5677889999999999999999999999999875


Q ss_pred             c-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC---cEEEeeccCccc
Q psy3166          91 E-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSED  146 (228)
Q Consensus        91 ~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~---~~kl~dfg~~~~  146 (228)
                      . +|+|||-+.||+|.+.+.+                    .|||.+||.|||+||+|||-...+   -+||+||.+...
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            5 8999999999999988765                    699999999999999999986543   599999998754


Q ss_pred             cccccc----ccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------H
Q psy3166         147 IYEQNV----FQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL----------C  207 (228)
Q Consensus       147 ~~~~~~----~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~----------~  207 (228)
                      +.....    .+....+..|+..|||||+..     ...|+.++|.||||+++|-|++ |..||.++.+          +
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh-CCCCccCccCCcCCccCCCcc
Confidence            433322    223344567888999999775     3458999999999999999999 9999998754          2


Q ss_pred             -----HHHHHHHcCCCCCCCC
Q psy3166         208 -----RIVHYLSTGYRMERPA  223 (228)
Q Consensus       208 -----~~~~~~~~~~~~~~p~  223 (228)
                           .+.+.|.+| .+++|+
T Consensus       308 r~CQ~~LFesIQEG-kYeFPd  327 (463)
T KOG0607|consen  308 RVCQNKLFESIQEG-KYEFPD  327 (463)
T ss_pred             HHHHHHHHHHHhcc-CCcCCh
Confidence                 334567777 788875

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-35  Score=242.91  Aligned_cols=198  Identities=22%  Similarity=0.378  Sum_probs=153.5

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ce
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-EL   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~   92 (228)
                      +.||+|+||+||+|....         ++..||+|.++...  .......+..|..++.++.+||||+.+++++... .+
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            479999999999998433         44569999987542  2233456778999999987899999999988664 48


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-  150 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-  150 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence            899999999999887643                    69999999999999999999999999999999886422211 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI------PLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~------~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                        .......|+..|+|||++.+..++.++|+|||||++|+|++ |..||...      ...+...+.....+.+.|..++
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  227 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS  227 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh-CCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC
Confidence              11223567888999999998889999999999999999999 99999642      2223333333333555665554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.9e-35  Score=235.82  Aligned_cols=208  Identities=39%  Similarity=0.780  Sum_probs=166.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +++|++.+.||+|+||.||+|....++.       ...+++|.++........+.+.+|+.++.++.+||||+++++++.
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   73 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGL-------KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE   73 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCC-------cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence            4789999999999999999998644321       123688887744344445678899999999977999999999886


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCCEeec
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRNILLS  131 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~nil~~  131 (228)
                      .. ..++++||+++++|.+++..                                    .|||+++++|+||||+||+++
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~  153 (297)
T cd05089          74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG  153 (297)
T ss_pred             cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC
Confidence            64 48899999999999887631                                    689999999999999999999


Q ss_pred             CCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         132 SPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      .++.+||+|||++......  ..  ......+..|++||+..+..++.++|+|||||++|+|++.|..||.+.+..++..
T Consensus       154 ~~~~~kl~dfg~~~~~~~~--~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~  229 (297)
T cd05089         154 ENLASKIADFGLSRGEEVY--VK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE  229 (297)
T ss_pred             CCCeEEECCcCCCccccce--ec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999987532111  00  1112224469999999888899999999999999999966999999988888888


Q ss_pred             HHHcCCCCCCCCCCCC
Q psy3166         212 YLSTGYRMERPASCNE  227 (228)
Q Consensus       212 ~~~~~~~~~~p~~~~~  227 (228)
                      .+..+.+++.|..+++
T Consensus       230 ~~~~~~~~~~~~~~~~  245 (297)
T cd05089         230 KLPQGYRMEKPRNCDD  245 (297)
T ss_pred             HHhcCCCCCCCCCCCH
Confidence            8888877777776664

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.6e-35  Score=239.07  Aligned_cols=221  Identities=43%  Similarity=0.817  Sum_probs=177.0

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.+...+|++.+.||+|+||.||+|...+....  .......||+|.++..........+.+|+++++++.+||||+++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKD--KPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCc--cCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            3678888999999999999999999986432210  11233468999887654555567788999999999789999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCC
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      ++++..+. .++++||+++++|.+++..                                    .|||++|++|+||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            99887654 7899999999999888641                                    5899999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ||+++.++.+||+|||++.......... ......++..|++||++.+..++.++|+||||+++|+|++.|..||.+.+.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccc-cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999987553322111 111223345799999998888999999999999999999878999999988


Q ss_pred             HHHHHHHHcCCCCCCCCCCCC
Q psy3166         207 CRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       207 ~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .+....+..+.+++.|..++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~  263 (334)
T cd05100         243 EELFKLLKEGHRMDKPANCTH  263 (334)
T ss_pred             HHHHHHHHcCCCCCCCCCCCH
Confidence            888888888888887776653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=246.48  Aligned_cols=207  Identities=24%  Similarity=0.355  Sum_probs=157.6

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ....++|++.+.||+|+||.||+|++.         .+++.||+|.+...........+.+|+++++++ +|+||+++++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  139 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHR---------PTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHD  139 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEEC---------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeee
Confidence            344678999999999999999999843         344579999987665555567788999999999 9999999999


Q ss_pred             EEEcC-ceEEEEecCCCCcHHHHHH-----------H-----hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          86 CCYKD-ELRLVVEYCALGDLQSYLR-----------E-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        86 ~~~~~-~~~lv~e~~~~~~L~~~l~-----------~-----~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      ++..+ .++++|||+.+++|.+...           +     .|||+++|+||||||+|||++.++.+||+|||++..+.
T Consensus       140 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EeccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            88664 4889999999988854311           1     79999999999999999999999999999999987543


Q ss_pred             ccccccCCCCCCCCcceeeccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVS-----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC---RIVHYLSTGYRME  220 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~---~~~~~~~~~~~~~  220 (228)
                      ....   ......|+..|++||++..     ...+.++|||||||++|+|++ |..||......   .....+.....++
T Consensus       220 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  295 (353)
T PLN00034        220 QTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL-GRFPFGVGRQGDWASLMCAICMSQPPE  295 (353)
T ss_pred             cccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHHHHhccCCCC
Confidence            2211   1123467888999998743     224568999999999999999 99999743322   2233333444444


Q ss_pred             CCCCCC
Q psy3166         221 RPASCN  226 (228)
Q Consensus       221 ~p~~~~  226 (228)
                      .|..++
T Consensus       296 ~~~~~~  301 (353)
T PLN00034        296 APATAS  301 (353)
T ss_pred             CCCccC
Confidence            554444

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-35  Score=243.63  Aligned_cols=174  Identities=25%  Similarity=0.463  Sum_probs=143.3

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ce
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-EL   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~   92 (228)
                      +.||+|+||+||+++..         .++..||+|.++...  .......+.+|+.++.++.+||||+++++++... ..
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK---------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            47999999999999843         344579999987542  2333456778898888877899999999988664 48


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        72 ~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-  150 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  150 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence            899999999999887653                    69999999999999999999999999999999986432211 


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                        .......|+..|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~  197 (329)
T cd05618         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFD  197 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh-CCCCCc
Confidence              11223567888999999998889999999999999999999 999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.7e-36  Score=245.87  Aligned_cols=200  Identities=27%  Similarity=0.385  Sum_probs=160.9

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LR   93 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~   93 (228)
                      +.||+|+||.||+++...      +..++..||+|.++... .........+|+++++++ +||||+++++.+..+. .+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~   74 (318)
T cd05582           2 KVLGQGSFGKVFLVRKIT------GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLY   74 (318)
T ss_pred             ceeeeCCCEEEEEEEEec------cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEE
Confidence            679999999999987422      23456679999987542 222344567899999999 9999999999887654 88


Q ss_pred             EEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc
Q psy3166          94 LVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF  153 (228)
Q Consensus        94 lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (228)
                      +||||+++++|.+++..                    .|||+++|+||||||+||+++.++.++|+|||++.......  
T Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            99999999999888753                    69999999999999999999999999999999986543221  


Q ss_pred             cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       154 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                       .......|+..|++||.+....++.++|+|||||++|+|++ |..||...+..+....+.+. ....|..+++
T Consensus       153 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~i~~~-~~~~p~~~~~  223 (318)
T cd05582         153 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMILKA-KLGMPQFLSP  223 (318)
T ss_pred             -CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeecc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCH
Confidence             11223467888999999988888999999999999999999 99999998887777777665 4556665543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-35  Score=242.95  Aligned_cols=195  Identities=28%  Similarity=0.428  Sum_probs=152.8

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHH-HHHhcCCCCceEEeeeEEEcC-c
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEIN-LMKDVGKHDHIVSFIGCCYKD-E   91 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~~h~ni~~~~~~~~~~-~   91 (228)
                      +.||+|+||.||+|+..         .++..||+|.+....  .......+..|.. +++.+ +||||+++++.+... .
T Consensus         1 ~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~   70 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK---------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEK   70 (321)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCE
Confidence            47999999999999843         344579999986432  1222334555554 56677 999999999887664 4


Q ss_pred             eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          92 LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      .+++|||+++++|.+.+..                    .|||+++|+||||||+||+++.++.+||+|||++.......
T Consensus        71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          71 LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            8899999999999877643                    69999999999999999999999999999999886432211


Q ss_pred             cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       152 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                         .......|+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++...+..+ +.+.|...
T Consensus       151 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  219 (321)
T cd05603         151 ---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDVSQMYDNILHK-PLQLPGGK  219 (321)
T ss_pred             ---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Confidence               11223467888999999988889999999999999999999 99999998877777776665 45555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.7e-35  Score=239.99  Aligned_cols=188  Identities=26%  Similarity=0.436  Sum_probs=157.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||++.+.         .++..+|+|.++..........+.+|+++++++ +||||++++++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   71 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGA   71 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEE
Confidence            56789999999999999999999854         344568999887654555566788999999999 89999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCC-CCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNN-KVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~-~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+. .+++|||+++++|.+++..                    .|||++ +++|+||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~  151 (333)
T cd06650          72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (333)
T ss_pred             EEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence            87654 8899999999999998754                    589975 7999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV  210 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~  210 (228)
                      ..+...     ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..++.
T Consensus       152 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~  211 (333)
T cd06650         152 GQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI-GRYPIPPPDAKELE  211 (333)
T ss_pred             hhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcchhHHH
Confidence            644221     1123456778999999988889999999999999999999 99999887655443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.4e-36  Score=245.27  Aligned_cols=194  Identities=23%  Similarity=0.341  Sum_probs=157.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||+||+++.         ..++..||+|.++...  .......+.+|+.+++.+ +||||+++++.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~   70 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVRE---------KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAF   70 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEE
Confidence            4799999999999999999984         3445579999987542  122345677899999988 999999999888


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..+. .++||||+++++|.+++..                     .|||+++|+||||||+||+++.++.+||+|||++.
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          71 QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             ecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence            7644 8899999999999998754                     58999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLV------SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~------~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .+......  ......++..|+|||++.      ...++.++|+|||||++|+|++ |..||...+..+...++...
T Consensus       151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~  224 (330)
T cd05601         151 RLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMNF  224 (330)
T ss_pred             ECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc-CCCCCCCCCHHHHHHHHHcC
Confidence            55432211  112245778899999986      3457789999999999999999 99999988777776666554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-35  Score=243.65  Aligned_cols=187  Identities=28%  Similarity=0.426  Sum_probs=149.8

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHH-HHhcCCCCceEEeeeEEEcC-c
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINL-MKDVGKHDHIVSFIGCCYKD-E   91 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~-l~~l~~h~ni~~~~~~~~~~-~   91 (228)
                      +.||+|+||+||+|+.         ..++..||+|.+....  .......+..|..+ ++.+ +||||+++++.+..+ .
T Consensus         1 ~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~   70 (325)
T cd05604           1 KVIGKGSFGKVLLAKR---------KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEK   70 (325)
T ss_pred             CceeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCE
Confidence            4699999999999984         3445579999986442  12233445556554 5567 999999999887664 4


Q ss_pred             eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          92 LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      .+++|||+++++|..++..                    .|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          71 LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            8899999999999887653                    69999999999999999999999999999999986432211


Q ss_pred             cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       152 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                         .......|+..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+..+
T Consensus       151 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~~~~~  211 (325)
T cd05604         151 ---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPFYCRDVAEMYDNILHK  211 (325)
T ss_pred             ---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc-CCCCCCCCCHHHHHHHHHcC
Confidence               11233567888999999998889999999999999999999 99999998888887777665

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.8e-35  Score=236.90  Aligned_cols=211  Identities=38%  Similarity=0.736  Sum_probs=166.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||.||+|.+..+.       ....+|+|.++..........+.+|+.++.++.+||||+++++
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~   75 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG   75 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            355679999999999999999999864422       1223688877644344445678889999999988999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCCE
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~ni  128 (228)
                      ++..+. .+++|||+++++|.+++..                                    +|||++|++||||||+||
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Ni  155 (303)
T cd05088          76 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  155 (303)
T ss_pred             EECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence            887644 8899999999999887741                                    689999999999999999


Q ss_pred             eecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         129 LLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      +++.++.++|+|||++......    ........+..|++||.+....++.++|+||||+++|+|+|.|..||.+.+..+
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  231 (303)
T cd05088         156 LVGENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  231 (303)
T ss_pred             EecCCCcEEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence            9999999999999988532111    001112234569999998888889999999999999999976999999888777


Q ss_pred             HHHHHHcCCCCCCCCCCCC
Q psy3166         209 IVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       209 ~~~~~~~~~~~~~p~~~~~  227 (228)
                      ....+..+.+++.|..+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~  250 (303)
T cd05088         232 LYEKLPQGYRLEKPLNCDD  250 (303)
T ss_pred             HHHHHhcCCcCCCCCCCCH
Confidence            7777777766766666554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=230.30  Aligned_cols=208  Identities=40%  Similarity=0.691  Sum_probs=171.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||+|...++          ..+|+|.+.....  ....+.+|+.+++++ +|+|+++++
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~----------~~~~vK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~   67 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGT----------TKVAVKTLKPGTM--SPEAFLQEAQIMKKL-RHDKLVQLY   67 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCC----------ceEEEEEecCCcc--CHHHHHHHHHHHhhC-CCCCEeeee
Confidence            678999999999999999999999975432          3489998875432  235678899999999 899999999


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++.. ...+++||++++++|.+++..                      .|||+++++|+||||+||+++.++.++|+||
T Consensus        68 ~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~  147 (261)
T cd05034          68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADF  147 (261)
T ss_pred             eeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcc
Confidence            98876 458899999999999888743                      5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++..+.......  ......+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+.....+.+..+.+++.
T Consensus       148 g~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05034         148 GLARLIEDDEYTA--REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR  225 (261)
T ss_pred             ccceeccchhhhh--hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9987553321111  11122345699999998888899999999999999999879999999888888888888878888


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       226 ~~~~~~  231 (261)
T cd05034         226 PPNCPE  231 (261)
T ss_pred             CCCCCH
Confidence            877764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0660|consensus

Probab=100.00  E-value=1.2e-35  Score=234.68  Aligned_cols=199  Identities=25%  Similarity=0.421  Sum_probs=159.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ..|...+.||.|+||.|..+.         ++.++..||+|++... ...-..++.++|+.+|+++ +|+||+.+.+++.
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~---------~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~   91 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAK---------DKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFR   91 (359)
T ss_pred             ceecccccccCcceeeEEEEE---------EcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecc
Confidence            456668999999999999987         5556678999998744 3344567889999999999 8999999999986


Q ss_pred             c------CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          89 K------DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        89 ~------~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      .      ..+|+|+|++ +.+|.+.++.                    +|+|+.+++||||||.|++++.++.+|++|||
T Consensus        92 p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccc
Confidence            5      2389999999 5578777664                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      +++..... ......+.-..|.=|.|||.+. ...|+...||||+||++.||++ |++-|.+.+.-+.++.+..-..+|.
T Consensus       171 LAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  171 LARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc-CCCCCCCCchHHHHHHHHHhcCCCC
Confidence            99876543 1111122334455578999886 4569999999999999999999 9999999887767766666444443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.3e-35  Score=236.66  Aligned_cols=191  Identities=25%  Similarity=0.415  Sum_probs=153.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++... .......+.+|+.+++++ +||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   70 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK---------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFR   70 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEe
Confidence            47999999999999999999854         344569999987542 223345678899999999 9999999999886


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .+. .++||||++++++..+...                    .|||+++|+|+||||+||+++.++.+||+|||++..+
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          71 RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             cCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            644 8899999988766544321                    6999999999999999999999999999999998754


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      .....  .......++..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+....+
T Consensus       151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~pf~~~~~~~~~~~~  213 (287)
T cd07848         151 SEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD-GQPLFPGESEIDQLFTI  213 (287)
T ss_pred             ccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            32211  11123456778999999988889999999999999999999 99999987765544433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-34  Score=229.27  Aligned_cols=207  Identities=38%  Similarity=0.666  Sum_probs=170.3

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |+++.++|++.+.||+|+||.||++......          .+|+|.+...  ......+.+|+++++++ +|+|++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~----------~~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~   67 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPG--SMSVEAFLAEANVMKTL-QHDKLVKLH   67 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCc----------cEEEEecCCC--hhHHHHHHHHHHHHHhc-CCCCcceEE
Confidence            7899999999999999999999999754322          3899987644  22345788899999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +.+.....+++|||+++++|.+++..                      .|||+.+++|+||+|+||+++.++.++|+|||
T Consensus        68 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             EEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCc
Confidence            98877778999999999999988753                      69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      .+..+......  ......++..|++||++....++.++|+||||+++|++++.|..||.+.+.......+..+..++.+
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05073         148 LARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP  225 (260)
T ss_pred             ceeeccCCCcc--cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc
Confidence            88654332111  1112334567999999988888999999999999999997689999998887778878888777766


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      ...|
T Consensus       226 ~~~~  229 (260)
T cd05073         226 ENCP  229 (260)
T ss_pred             ccCC
Confidence            6554

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-34  Score=228.47  Aligned_cols=201  Identities=36%  Similarity=0.676  Sum_probs=161.6

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      +.||+|+||.||+|....         ++..+|+|.............+.+|+++++++ +||||+++.+++.... .++
T Consensus         1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   70 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYI   70 (252)
T ss_pred             CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEE
Confidence            468999999999998533         34569999876554455556788999999999 9999999999887644 789


Q ss_pred             EEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF  153 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (228)
                      +|||+++++|.+++..                     .|||+++++|+||||+||+++.++.++|+|||++........ 
T Consensus        71 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  149 (252)
T cd05084          71 VMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-  149 (252)
T ss_pred             EEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc-
Confidence            9999999999988753                     589999999999999999999999999999999864432211 


Q ss_pred             cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       154 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .........+..|++||.+.+..++.++|+||||+++|+|++.|..||...+..+....+....+.+.|..+|+
T Consensus       150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (252)
T cd05084         150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPD  223 (252)
T ss_pred             cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCH
Confidence            11111122345699999998888999999999999999999768999988887777777777777777776654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.3e-34  Score=232.45  Aligned_cols=214  Identities=38%  Similarity=0.699  Sum_probs=171.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.++|.+.+.||+|+||.||+|......    .......+++|.++... ......+.+|+++++++ +||||+++.++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   75 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLS----PTKDKMLVAVKALKDPT-LAARKDFQREAELLTNL-QHEHIVKFYGV   75 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccC----CCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcC-CCCCcceEEEE
Confidence            56788999999999999999999754432    22344568899886542 33345688999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCCEe
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRNIL  129 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~nil  129 (228)
                      +... ..+++|||+++++|.+++..                                    .|||+++|+|+||||+||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  155 (291)
T cd05094          76 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL  155 (291)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEE
Confidence            8764 48899999999999988731                                    5899999999999999999


Q ss_pred             ecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         130 LSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       130 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ++.++.++|+|||++.......... ......++..|++||.+.+..++.++|+||||+++|+|+|.|..||...+..+.
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  234 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV  234 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceee-cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999987543322111 112234567799999998888999999999999999999779999999888888


Q ss_pred             HHHHHcCCCCCCCCCCCC
Q psy3166         210 VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       210 ~~~~~~~~~~~~p~~~~~  227 (228)
                      .+.+..+..++.|..+|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~  252 (291)
T cd05094         235 IECITQGRVLERPRVCPK  252 (291)
T ss_pred             HHHHhCCCCCCCCccCCH
Confidence            888888877776666653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-34  Score=232.41  Aligned_cols=214  Identities=40%  Similarity=0.689  Sum_probs=172.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|.+.+.||+|+||.||++......    ...++..+|+|.++.. .......+.+|+++++++ +|+||++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   75 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLL----PEQDKMLVAVKALKEA-SESARQDFQREAELLTVL-QHQHIVRFYGV   75 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCC----CCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcC-CCCCCceEEEE
Confidence            46688999999999999999998754321    2234556899987654 334456788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH-----------------------------------hcccCCCCcccCCCCCCEee
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE-----------------------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~-----------------------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                      +... ..+++|||+++++|.+++..                                   .|||+++++|+||||+||++
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~  155 (280)
T cd05092          76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV  155 (280)
T ss_pred             EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence            8764 47899999999999877631                                   59999999999999999999


Q ss_pred             cCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy3166         131 SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV  210 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~  210 (228)
                      +.++.++|+|||++........... .....++..|++||.+....++.++|+|||||++|+|++.|..||......+..
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  234 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI  234 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeec-CCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            9999999999999865433221111 112234567999999988889999999999999999998789999888888888


Q ss_pred             HHHHcCCCCCCCCCCCC
Q psy3166         211 HYLSTGYRMERPASCNE  227 (228)
Q Consensus       211 ~~~~~~~~~~~p~~~~~  227 (228)
                      +.+..+.+++.|..+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~  251 (280)
T cd05092         235 ECITQGRELERPRTCPP  251 (280)
T ss_pred             HHHHcCccCCCCCCCCH
Confidence            88888878888877765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0612|consensus

Probab=100.00  E-value=4.6e-37  Score=270.45  Aligned_cols=204  Identities=24%  Similarity=0.342  Sum_probs=170.3

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+.+++|+++++||+|+||+|..++         ++.+++.||+|++++-  .+......|+.|-.+|..- +.+.|+.+
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr---------~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~L  140 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVR---------HKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQL  140 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEE---------eeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHH
Confidence            4678999999999999999999988         5556667999999753  1233446788899999887 78999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +..|+++. +|+||||++||+|...+..                    .-+|+.|.|||||||+|||++..|++||+|||
T Consensus       141 hyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  141 HYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             HHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccch
Confidence            98888754 8999999999999888765                    46899999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeeccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-G  216 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~-~  216 (228)
                      .+-.+..++.-  ......||+-|.+||++..     +.|++-+||||+|+++|||+. |..||...+..+++-+|+. .
T Consensus       221 sClkm~~dG~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly-G~TPFYadslveTY~KIm~hk  297 (1317)
T KOG0612|consen  221 SCLKMDADGTV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY-GETPFYADSLVETYGKIMNHK  297 (1317)
T ss_pred             hHHhcCCCCcE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc-CCCcchHHHHHHHHHHHhchh
Confidence            88666544322  2345789999999999972     458899999999999999997 9999999988888888776 4


Q ss_pred             CCCCCC
Q psy3166         217 YRMERP  222 (228)
Q Consensus       217 ~~~~~p  222 (228)
                      ....+|
T Consensus       298 ~~l~FP  303 (1317)
T KOG0612|consen  298 ESLSFP  303 (1317)
T ss_pred             hhcCCC
Confidence            455666

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=234.66  Aligned_cols=182  Identities=27%  Similarity=0.370  Sum_probs=149.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .|++.+.||+|+||+||++...         .++..||+|.+.....  ......+.+|+.+++++ +||||+++++.+.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   70 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYE   70 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeec
Confidence            4889999999999999998843         3445799999865421  22234567899999999 9999999999876


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+ ..+++|||+++++|.+++..                      .|||+++++|+||||+||+++.++.++|+|||++.
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05605          71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             CCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence            54 48899999999999877632                      68999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      .+.....    .....++..|++||.+.+..++.++|+||+|+++|+|++ |..||.+.+..
T Consensus       151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~-g~~pf~~~~~~  207 (285)
T cd05605         151 EIPEGET----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEK  207 (285)
T ss_pred             ecCCCCc----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHH-CCCCCCCCchh
Confidence            5432211    123467788999999988888999999999999999999 99999886553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8e-35  Score=242.21  Aligned_cols=195  Identities=22%  Similarity=0.316  Sum_probs=156.1

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||++..         ..++..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~   92 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVF   92 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEE---------CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceee
Confidence            57999999999999999999984         3445579999987542 233345678899999999 999999999887


Q ss_pred             EcC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          88 YKD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        88 ~~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ...       ..++||||+.+ +|.+.+..                  .|||+++|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875          93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cccccccccCeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            532       36899999965 56554432                  69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      ++.......    ......++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+......
T Consensus       172 ~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  243 (364)
T cd07875         172 LARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQLGT  243 (364)
T ss_pred             CccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCC
Confidence            987543221    1123456778999999998889999999999999999999 99999998877666655544333

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-34  Score=229.40  Aligned_cols=205  Identities=38%  Similarity=0.699  Sum_probs=166.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +++++|++.+.||+|+||.||++.+.+.          ..+|+|.++....  ....+.+|+.+++++ +||||++++++
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~----------~~~aik~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~   67 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQ----------YDVAIKMIKEGSM--SEDEFIEEAKVMMKL-SHEKLVQLYGV   67 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecCC----------CcEEEEEcCCCcc--cHHHHHHHHHHHhcC-CCCCeeeEEEE
Confidence            4678999999999999999999975432          1389998875432  235688999999999 89999999998


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +.... .+++|||+++++|.+++..                     .|||+++++|+||||+||+++.++.+||+|||.+
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~  147 (256)
T cd05113          68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS  147 (256)
T ss_pred             EccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccc
Confidence            86544 7899999999999988753                     5899999999999999999999999999999988


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +........  ......++..|++||...+..++.++|+||||+++|+|++.|..||......++...+..+.+++.|..
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd05113         148 RYVLDDEYT--SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHL  225 (256)
T ss_pred             eecCCCcee--ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCC
Confidence            754332211  111223456799999998888899999999999999999779999998888888888888877766654


Q ss_pred             CC
Q psy3166         225 CN  226 (228)
Q Consensus       225 ~~  226 (228)
                      .+
T Consensus       226 ~~  227 (256)
T cd05113         226 AS  227 (256)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-34  Score=240.42  Aligned_cols=186  Identities=24%  Similarity=0.348  Sum_probs=150.0

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      -.++|++.+.||+|+||.||++..         ..++..||+|.++... .......+.+|+.+++.+ +||||++++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~   88 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFD---------TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNV   88 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEE---------cCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeee
Confidence            357999999999999999999984         3455679999986542 233345678899999999 99999999998


Q ss_pred             EEcC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          87 CYKD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        87 ~~~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +...       .++++|||+.+ ++.+.+..                  .|||++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          89 FTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             eccCCCccccceeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecC
Confidence            7542       36899999965 45444321                  6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      |++.......    ......++..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+....
T Consensus       168 g~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~  230 (359)
T cd07876         168 GLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQ  230 (359)
T ss_pred             CCccccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence            9986432221    1223456778999999998889999999999999999999 9999998765443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-34  Score=232.67  Aligned_cols=211  Identities=51%  Similarity=0.919  Sum_probs=169.5

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      +|++.+.||+|+||.||+|......    .......+++|.++.........++.+|+.+++.+ +||||+++++.+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLK----GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCC----CCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC
Confidence            5889999999999999999864322    12233458999887665555556788999999999 999999999987664


Q ss_pred             c-eEEEEecCCCCcHHHHHHH--------------------------------------------hcccCCCCcccCCCC
Q psy3166          91 E-LRLVVEYCALGDLQSYLRE--------------------------------------------EYLSNNKVVHRDLAT  125 (228)
Q Consensus        91 ~-~~lv~e~~~~~~L~~~l~~--------------------------------------------~~lh~~~i~H~~lk~  125 (228)
                      . .++++||+.+++|.+++..                                            .|||+++++|+||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp  155 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA  155 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence            4 7899999999999887531                                            689999999999999


Q ss_pred             CCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         126 RNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +||+++.++.++|+|||++..+........ .....++..|++||.+.+..++.++|+||||+++++|++.|..||.+..
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhc-ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999999875433222111 1123345679999998888899999999999999999987999999988


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCC
Q psy3166         206 LCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       206 ~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ..++.+.+..+.+++.|..++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~  256 (290)
T cd05045         235 PERLFNLLKTGYRMERPENCSE  256 (290)
T ss_pred             HHHHHHHHhCCCCCCCCCCCCH
Confidence            8888888888888887877654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-34  Score=234.00  Aligned_cols=213  Identities=37%  Similarity=0.686  Sum_probs=171.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|+..+.||+|+||.||+|.+..+..     .....+|+|.+...........+.+|+.+++++ +||||+++++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~   77 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGE-----TVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGV   77 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCC-----cceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEE
Confidence            345789999999999999999998654332     123458999887655554455688999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.....++++|++++|+|.+++..                     .|||+++|+|+||||+||+++.++.+||+|||++.
T Consensus        78 ~~~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          78 CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             EcCCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence            887778899999999999988653                     68999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+....... ......++..|++||.+.+..++.++|+||||+++|++++.|..||.+....++...+..+.+++.|..+
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd05110         158 LLEGDEKEY-NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC  236 (303)
T ss_pred             cccCccccc-ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence            553322111 1112334567999999988889999999999999999997799999998877777778888777776655


Q ss_pred             C
Q psy3166         226 N  226 (228)
Q Consensus       226 ~  226 (228)
                      +
T Consensus       237 ~  237 (303)
T cd05110         237 T  237 (303)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-34  Score=229.15  Aligned_cols=202  Identities=25%  Similarity=0.411  Sum_probs=166.9

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      +|++.+.||+|+||.||++...         .++..+|+|.++........+.+.+|+.+++++ +|+|++++.+.+..+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   70 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV---------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEAD   70 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc---------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC
Confidence            5899999999999999999743         345579999986544444556778899999999 999999999988764


Q ss_pred             c-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          91 E-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        91 ~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      . ++++|||+++++|.+++..                      .+||+++|+|+||||+||+++.++.++++|||.+..+
T Consensus        71 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          71 GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence            4 8899999999999887643                      6999999999999999999999999999999998654


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ......   .....++..|+|||++.+..++.++|+||+|+++|+|++ |..||...+.......+..+...+.|..++
T Consensus       151 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (255)
T cd08219         151 TSPGAY---ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGSYKPLPSHYS  225 (255)
T ss_pred             cccccc---cccccCCccccCHHHHccCCcCchhhhhhhchhheehhh-ccCCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence            332211   122346677999999988889999999999999999999 999999888777788888887777776655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-34  Score=227.54  Aligned_cols=203  Identities=43%  Similarity=0.786  Sum_probs=170.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||+|...           ++.||+|.++....  ..+++.+|+.+++++ +|+|+++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~   66 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST--AAQAFLAEASVMTTL-RHPNLVQLL   66 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh--HHHHHHHHHHHHHhc-CCcceeeeE
Confidence            5688899999999999999999998743           24599999875533  456788999999999 999999999


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++.. +..+++||++++++|.+++..                      .|||+++++|+||||+||+++.++.++|+||
T Consensus        67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~  146 (256)
T cd05039          67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDF  146 (256)
T ss_pred             EEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccc
Confidence            98875 458899999999999998753                      5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |.+........      ....+..|++||.+....++.++|+||||++++++++.|..||...+..++...+..+.+++.
T Consensus       147 g~~~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05039         147 GLAKEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA  220 (256)
T ss_pred             ccccccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            99875522111      122345699999998888899999999999999999769999999888888888888877777


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       221 ~~~~~~  226 (256)
T cd05039         221 PEGCPP  226 (256)
T ss_pred             ccCCCH
Confidence            776664

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-34  Score=231.22  Aligned_cols=187  Identities=37%  Similarity=0.651  Sum_probs=149.5

Q ss_pred             ce-eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RL-ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~-~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +| ++.+.||+|+||+||++.....     ...++..||+|.++..........+.+|+++++++ +||||+++.+++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   77 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSE   77 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec
Confidence            44 8999999999999998765332     23455679999987654444556788999999999 99999999998754


Q ss_pred             C---ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 D---ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 ~---~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .   .++++|||+++++|.+++..                   .|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            2   37899999999999988754                   6999999999999999999999999999999998755


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      ..............++..|++||.+....++.++|+||||+++|+|++ |..||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~  213 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSP  213 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHh-CCCCCCCC
Confidence            332211111112234556999999988888999999999999999999 99998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-34  Score=257.37  Aligned_cols=189  Identities=24%  Similarity=0.343  Sum_probs=154.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|..         ..+++.||+|.+....  ......++.+|+++++++ +||||+++++++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d---------~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~   71 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYD---------PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSIC   71 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEE---------CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEE
Confidence            6899999999999999999984         3445579999987542  334456788999999999 999999999988


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH-------------------------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE-------------------------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~-------------------------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      ..+ ..+++|||++|++|.+++..                               .|||++||+||||||+||+++.++.
T Consensus        72 ~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~  151 (932)
T PRK13184         72 SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE  151 (932)
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC
Confidence            664 47899999999999887641                               5999999999999999999999999


Q ss_pred             EEEeeccCccccccccc-------------c--cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy3166         136 VKISDFGLSEDIYEQNV-------------F--QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANP  200 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~-------------~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~p  200 (228)
                      ++|+|||++........             .  ........||..|+|||.+.+..++.++|+||+||++|+|+| |..|
T Consensus       152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT-G~~P  230 (932)
T PRK13184        152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSFP  230 (932)
T ss_pred             EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH-CCCC
Confidence            99999999875521100             0  001112457889999999998889999999999999999999 9999


Q ss_pred             CCCCCHHHH
Q psy3166         201 YPHIPLCRI  209 (228)
Q Consensus       201 f~~~~~~~~  209 (228)
                      |...+..++
T Consensus       231 F~~~~~~ki  239 (932)
T PRK13184        231 YRRKKGRKI  239 (932)
T ss_pred             CCCcchhhh
Confidence            988655444

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.5e-34  Score=229.90  Aligned_cols=215  Identities=34%  Similarity=0.659  Sum_probs=174.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||.||+|.+....     ......|++|.++..........+.+|+.+++++ +|||++++++
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~   75 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILH   75 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence            367889999999999999999999865421     1234569999987665556667788999999999 9999999999


Q ss_pred             EEEc--CceEEEEecCCCCcHHHHHHH----------------------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          86 CCYK--DELRLVVEYCALGDLQSYLRE----------------------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        86 ~~~~--~~~~lv~e~~~~~~L~~~l~~----------------------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      ++..  ...+++++++++++|.+++..                            .|||+++++|+||||+||+++.++.
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc
Confidence            8765  447899999999999888642                            5899999999999999999999999


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +||+|||+++.+....... ......++..|+|||++....++.++|+||||+++|++++.|..||...+..++...+..
T Consensus       156 ~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  234 (280)
T cd05043         156 VKITDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD  234 (280)
T ss_pred             EEECCCCCcccccCCceEE-eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence            9999999987553322111 111234456799999998888999999999999999999879999999888888888888


Q ss_pred             CCCCCCCCCCCC
Q psy3166         216 GYRMERPASCNE  227 (228)
Q Consensus       216 ~~~~~~p~~~~~  227 (228)
                      +.+++.+..+|+
T Consensus       235 ~~~~~~~~~~~~  246 (280)
T cd05043         235 GYRLAQPINCPD  246 (280)
T ss_pred             CCCCCCCCcCCH
Confidence            877777776664

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-34  Score=228.90  Aligned_cols=208  Identities=41%  Similarity=0.807  Sum_probs=166.4

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      |.+.+.||+|+||.||+|......      .+...||+|.++... .......+.+|+++++.+ +||||+++++.+...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   73 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDD------GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEA   73 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCC------CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccC
Confidence            578899999999999999864422      234569999987543 233456788999999999 999999999887542


Q ss_pred             c-------eEEEEecCCCCcHHHHHHH--------------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          91 E-------LRLVVEYCALGDLQSYLRE--------------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        91 ~-------~~lv~e~~~~~~L~~~l~~--------------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      .       .++++||+++++|.+++..                          .|||+++++|+||||+||++++++.+|
T Consensus        74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEE
Confidence            2       5799999999999877621                          699999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      |+|||+++.+....... .......+..|++||.+....++.++|+|||||++|+|++.|..||.+....++.+.+..+.
T Consensus       154 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  232 (273)
T cd05035         154 VADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN  232 (273)
T ss_pred             ECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999987554332211 11112334579999999888899999999999999999987899999988888888888887


Q ss_pred             CCCCCCCCCC
Q psy3166         218 RMERPASCNE  227 (228)
Q Consensus       218 ~~~~p~~~~~  227 (228)
                      .++.|..+++
T Consensus       233 ~~~~~~~~~~  242 (273)
T cd05035         233 RLKQPEDCLD  242 (273)
T ss_pred             CCCCCcCCCH
Confidence            8878877764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.9e-34  Score=231.39  Aligned_cols=215  Identities=40%  Similarity=0.711  Sum_probs=173.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.++|++...||+|+||.||++......    ...++..||+|.++..........+.+|+.+++++ +|||+++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~   76 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGV   76 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccC----CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEE
Confidence            56789999999999999999999864311    22345579999987665555556788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH------------------------------------------hcccCCCCcccCC
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE------------------------------------------EYLSNNKVVHRDL  123 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------------~~lh~~~i~H~~l  123 (228)
                      +..+ ..++++|++++++|.+++..                                          .|+|+++++|+||
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl  156 (288)
T cd05050          77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL  156 (288)
T ss_pred             EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            7664 48899999999999888741                                          5899999999999


Q ss_pred             CCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         124 ATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       124 k~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      ||+||+++.++.++|+|||++.......... .......+..|+|||.+.+..++.++|+|||||++|+|++.|..||.+
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999886443222111 111223345699999998888999999999999999999768899998


Q ss_pred             CCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         204 IPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ....++...+..+..++.|..+|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~  259 (288)
T cd05050         236 MAHEEVIYYVRDGNVLSCPDNCPL  259 (288)
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCCH
Confidence            888888888888877777777664

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-34  Score=226.83  Aligned_cols=202  Identities=24%  Similarity=0.403  Sum_probs=167.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|++|.||++....         ++..|++|.+... ........+.+|+++++++ +|||++++++.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   70 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD   70 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc
Confidence            58899999999999999998543         3456999988643 2344556788999999999 99999999998876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      +. .+++|||+++++|.+++..                      .|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEccccccee
Confidence            54 8899999999999988754                      589999999999999999999999999999998875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      +......   .....++..|++||+.....++.++|+||||+++++|++ |..||...+..+....+..+..++.+..++
T Consensus       151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (256)
T cd08529         151 LSDNTNF---ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPFDANNQGALILKIIRGVFPPVSQMYS  226 (256)
T ss_pred             ccCccch---hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            5433221   122346677999999998888999999999999999999 999999988777788888887777766554

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.2e-35  Score=231.11  Aligned_cols=207  Identities=37%  Similarity=0.699  Sum_probs=171.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .-+..+|++.+.||+|+||.||+|....          +..+|+|.+.... ......+.+|+++++.+ +||||+++++
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~   69 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDD-LLKQQDFQKEVQALKRL-RHKHLISLFA   69 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccc-hhhHHHHHHHHHHHhcC-CCcchhheee
Confidence            3456789999999999999999998544          2358999987553 23346788899999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++.... .+++|||+++++|.+++..                      .|||+++++|+||+|+||+++.++.++|+|||
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             eEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEcccc
Confidence            876644 7899999999999998753                      68999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++.........   .....++..|++||......++.++|+||||+++|+|++.|..||...+..++...+..+.+++.|
T Consensus       150 ~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  226 (261)
T cd05148         150 LARLIKEDVYL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP  226 (261)
T ss_pred             chhhcCCcccc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC
Confidence            98754332111   112344567999999988888999999999999999997689999998888888888888888888


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       227 ~~~~~  231 (261)
T cd05148         227 AKCPQ  231 (261)
T ss_pred             CCCCH
Confidence            77764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=227.29  Aligned_cols=208  Identities=30%  Similarity=0.480  Sum_probs=162.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC----HHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD----AKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +++|++.+.||+|++|.||++..         ..++..+|+|.+.....    ......+.+|+++++++ +||||++++
T Consensus         1 ~~~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~   70 (263)
T cd06625           1 PTNWRRGKLLGQGAFGRVYLCYD---------VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYY   70 (263)
T ss_pred             CCcccccceecCCCceEEEEEEE---------cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeE
Confidence            36899999999999999999974         33445799998764321    12235678899999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++... ..++++|++++++|.+++..                    .|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          71 GCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            988664 47899999999999887653                    689999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY-LSTGYRMERP  222 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~-~~~~~~~~~p  222 (228)
                      +..+..............++..|+|||.+.+..++.++|+||+|+++|++++ |..||......+.... .....+++.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTNPQLP  229 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh-CCCCccccchHHHHHHHhccCCCCCCC
Confidence            8654332111111123445678999999998888999999999999999999 9999988766555444 3334455566


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      +.+++
T Consensus       230 ~~~~~  234 (263)
T cd06625         230 SHVSP  234 (263)
T ss_pred             ccCCH
Confidence            66553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0586|consensus

Probab=100.00  E-value=1.8e-35  Score=246.95  Aligned_cols=204  Identities=29%  Similarity=0.448  Sum_probs=172.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ...|.+...||+|.|++|.+++         +..++..||+|.+++.. +...++.+.+|+++|+.| +||||++++++.
T Consensus        55 vg~y~i~~tig~g~f~~V~La~---------~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~  124 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLAR---------HILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVI  124 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeE---------ecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeee
Confidence            3578999999999999999998         55566789999998774 444556789999999999 999999999998


Q ss_pred             E-cCceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 Y-KDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~-~~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      . ...+|+||||+.+|.+++|+..                    +|||++.|+|||||++|++++.+..+||+|||++..
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccccee
Confidence            6 4679999999999999999875                    699999999999999999999999999999999987


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERPAS  224 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~-~~~~~p~~  224 (228)
                      +....    -..+.+|++.|.|||++.+..| .+.+|+|++|+++|.|++ |..||.+.+..++.+++..| .|.+.+-+
T Consensus       205 ~~~~~----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~-GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms  279 (596)
T KOG0586|consen  205 FDYGL----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE-GSLPFDGQNLKELRPRVLRGKYRIPFYMS  279 (596)
T ss_pred             ecccc----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee-cccccCCcccccccchheeeeecccceee
Confidence            65332    2345678889999999998876 478999999999999998 99999999988887775554 44455444


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      |.+
T Consensus       280 ~dc  282 (596)
T KOG0586|consen  280 CDC  282 (596)
T ss_pred             chh
Confidence            443

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-34  Score=239.69  Aligned_cols=188  Identities=24%  Similarity=0.322  Sum_probs=151.4

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      -.++|++.+.||+|+||.||++..         ..++..||+|.++... .......+.+|+.+++.+ +||||++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~   84 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNV   84 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEe---------cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeee
Confidence            357999999999999999999873         3455679999987542 233446778899999999 99999999998


Q ss_pred             EEcC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          87 CYKD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        87 ~~~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +...       ..+++|||+.+ ++.+.+..                  .|||++||+||||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          85 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             eeccccccccceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeC
Confidence            7542       36899999965 55554322                  6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      |++.......    ......++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus       164 g~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  228 (355)
T cd07874         164 GLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWN  228 (355)
T ss_pred             cccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            9987543221    1223456788999999988889999999999999999999 999999876554433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-34  Score=235.63  Aligned_cols=192  Identities=28%  Similarity=0.478  Sum_probs=152.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|+..         .++..||+|.++..........+.+|+++++++ +||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVH   74 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEec---------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEe
Confidence            468999999999999999999843         344569999987543333334567899999999 9999999999886


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+ ..+++|||+.+ +|.+++..                     .|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          75 TDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             eCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence            54 48899999975 77776542                     699999999999999999999999999999999864


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ......   ......++..|+|||.+.+ ..++.++|+||+||++|+|+| |..||.+.+..+....+.+
T Consensus       154 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  219 (309)
T cd07872         154 KSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS-GRPLFPGSTVEDELHLIFR  219 (309)
T ss_pred             cCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence            322211   1122345678999998865 457889999999999999999 9999998777665554433

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.1e-34  Score=226.69  Aligned_cols=205  Identities=43%  Similarity=0.809  Sum_probs=161.4

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc--CceE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK--DELR   93 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~--~~~~   93 (228)
                      +.||+|+||.||+|.+....      .....+|+|.+...........+.+|+.+++.+ +|||++++++++..  +..+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   73 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPL   73 (262)
T ss_pred             CcccccCCceEEEEEEecCC------CceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcE
Confidence            46899999999999864321      234569999986544445567788999999999 99999999997653  3378


Q ss_pred             EEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          94 LVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        94 lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++|||+++++|.+++..                     .|||+++++|+||||+||+++.++.+||+|||++..+.....
T Consensus        74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999999999998753                     699999999999999999999999999999999865432211


Q ss_pred             cc-CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         153 FQ-NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       153 ~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .. .......++..|+|||......++.++|+||||+++|+|++.|..||......++...+..+.+++.|..+|+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD  229 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCH
Confidence            11 1111234456799999998888999999999999999999856778888888788878888877777766653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-34  Score=227.05  Aligned_cols=202  Identities=41%  Similarity=0.761  Sum_probs=167.7

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |=++.++|++.+.||+|+||.||++..           .+..+|+|..+...   ....+.+|+.+++++ +|||+++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~-~~~~i~~~~   65 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV---TAQAFLEETAVMTKL-HHKNLVRLL   65 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc---hHHHHHHHHHHHHhC-CCCCcCeEE
Confidence            345678999999999999999998753           23358999886542   235678899999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++..+..+++|||+++++|.+++..                      .|+|+++++|+||||+||+++.++.++|+|||
T Consensus        66 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg  145 (254)
T cd05083          66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFG  145 (254)
T ss_pred             EEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCc
Confidence            99888889999999999999988753                      58999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++......      ......+..|++||.+....++.++|+||||+++|+|++.|..||...+..+....+.++.+++.|
T Consensus       146 ~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  219 (254)
T cd05083         146 LARVGSMG------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP  219 (254)
T ss_pred             cceecccc------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCC
Confidence            88643211      111223456999999988889999999999999999997699999998888888888888888777


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      .++|+
T Consensus       220 ~~~~~  224 (254)
T cd05083         220 EGCPA  224 (254)
T ss_pred             CcCCH
Confidence            76664

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-34  Score=231.88  Aligned_cols=174  Identities=26%  Similarity=0.377  Sum_probs=142.0

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      ||+|+||+||++..         ..++..||+|.+.....  ......+..|+.+++++ +|+||+++.+++..+ ..++
T Consensus         1 lg~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~l   70 (280)
T cd05608           1 LGKGGFGEVSACQM---------RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCL   70 (280)
T ss_pred             CCCCCceeEEEEEE---------ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEE
Confidence            69999999999874         33455799999864421  12234567899999999 999999999887664 4889


Q ss_pred             EEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccc
Q psy3166          95 VVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~  150 (228)
                      +|||+++|+|.+++..                        .|||+++|+||||||+||+++.++.++|+|||++..+...
T Consensus        71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            9999999999876521                        6999999999999999999999999999999998654332


Q ss_pred             ccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         151 NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      ..   ......++..|+|||++.+..++.++|+||+||++|+|++ |..||....
T Consensus       151 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~  201 (280)
T cd05608         151 QS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA-ARGPFRARG  201 (280)
T ss_pred             Cc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Confidence            11   1123456788999999998889999999999999999999 999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.3e-34  Score=227.76  Aligned_cols=207  Identities=41%  Similarity=0.790  Sum_probs=164.5

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-   89 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-   89 (228)
                      |.+.+.||+|+||.||+|.+....       ....+|+|.++... .......+.+|+.+++++ +||||+++++.+.. 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   72 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQT   72 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccC
Confidence            357789999999999999864432       12358999887542 344456788899999999 99999999987642 


Q ss_pred             ------CceEEEEecCCCCcHHHHHHH--------------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          90 ------DELRLVVEYCALGDLQSYLRE--------------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        90 ------~~~~lv~e~~~~~~L~~~l~~--------------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                            ...+++|||+++++|.+++..                          .|||+++|+||||||+||+++.++.++
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  152 (272)
T cd05075          73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC  152 (272)
T ss_pred             CcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEE
Confidence                  126789999999999877521                          699999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      |+|||++..+....... ......++..|++||......++.++|+||||+++|+|++.|..||.+.+..++..++.++.
T Consensus       153 l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  231 (272)
T cd05075         153 VADFGLSKKIYNGDYYR-QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN  231 (272)
T ss_pred             ECCCCcccccCccccee-cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999987654332211 11223445679999999888899999999999999999986789999988888888888888


Q ss_pred             CCCCCCCCCC
Q psy3166         218 RMERPASCNE  227 (228)
Q Consensus       218 ~~~~p~~~~~  227 (228)
                      +++.|..+++
T Consensus       232 ~~~~~~~~~~  241 (272)
T cd05075         232 RLKQPPDCLD  241 (272)
T ss_pred             CCCCCCCCCH
Confidence            7777766653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0599|consensus

Probab=100.00  E-value=9.4e-36  Score=227.88  Aligned_cols=193  Identities=27%  Similarity=0.449  Sum_probs=161.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-------CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-------DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..|.-.+.||.|..+.|.++.+         +.++..+|+|++....       ..+-++.-.+|+.+|+++..||+|++
T Consensus        17 ~~y~pkeilgrgvss~vrRci~---------k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~   87 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIH---------KETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID   87 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhh---------cccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            3566778999999999999884         4455578999985321       12234556789999999999999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +.+++.++. +++|+|.++.|.|+|++.+                    .|+|.++|+||||||+|||++.+..++|+||
T Consensus        88 l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   88 LQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             eeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecc
Confidence            999988766 6899999999999999876                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN------IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      |++..+......    ...+||++|+|||.+.+.      .|+...|+||+|+++|.++. |.+||-+....-++..+++
T Consensus       168 GFa~~l~~GekL----relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFwHRkQmlMLR~Ime  242 (411)
T KOG0599|consen  168 GFACQLEPGEKL----RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFWHRKQMLMLRMIME  242 (411)
T ss_pred             ceeeccCCchhH----HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc-CCCchhHHHHHHHHHHHHh
Confidence            999876554333    247899999999988743      47888999999999999999 9999988766666777887


Q ss_pred             C
Q psy3166         216 G  216 (228)
Q Consensus       216 ~  216 (228)
                      |
T Consensus       243 G  243 (411)
T KOG0599|consen  243 G  243 (411)
T ss_pred             c
Confidence            7

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.8e-34  Score=226.49  Aligned_cols=195  Identities=30%  Similarity=0.492  Sum_probs=155.2

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC----CCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN----ADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+|++.+.||+|+||.||++...         .++..||+|.+...    ........+.+|+++++++ +||||++++
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~   70 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDA---------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYY   70 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEc---------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEE
Confidence            478999999999999999999843         34457999987532    1223445778899999999 999999999


Q ss_pred             eEEEcC---ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYKD---ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~~---~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++...   .++++|||+++++|.+++..                    .|||+++++|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Df  150 (265)
T cd06652          71 GCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDF  150 (265)
T ss_pred             eEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcC
Confidence            987652   37799999999999988754                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      |++.................++..|+|||.+....++.++|+||||+++|+|++ |..||...+.......+.
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~  222 (265)
T cd06652         151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIA  222 (265)
T ss_pred             ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh-CCCCCCccchHHHHHHHh
Confidence            988644322111112223456778999999988788999999999999999999 999998876554444433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG1187|consensus

Probab=100.00  E-value=5.7e-35  Score=240.95  Aligned_cols=177  Identities=36%  Similarity=0.581  Sum_probs=146.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|.-...||+|+||.||+|...++          ..||||.++...... ...|.+|+.++.++ +|||+++++|+|..
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~----------~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG----------TVVAVKRLSSNSGQG-EREFLNEVEILSRL-RHPNLVKLLGYCLE  142 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC----------CEEEEEEecCCCCcc-hhHHHHHHHHHhcC-CCcCcccEEEEEec
Confidence            3555567999999999999987664          249999887654432 34599999999999 79999999999987


Q ss_pred             Cc--eEEEEecCCCCcHHHHHHH----------------------hcccCCC---CcccCCCCCCEeecCCCcEEEeecc
Q psy3166          90 DE--LRLVVEYCALGDLQSYLRE----------------------EYLSNNK---VVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        90 ~~--~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~---i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ..  .++|+||+++|+|.++|..                      .|||...   |+|||||++|||+|.+..+||+|||
T Consensus       143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG  222 (361)
T KOG1187|consen  143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG  222 (361)
T ss_pred             CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence            54  8999999999999988643                      5999854   9999999999999999999999999


Q ss_pred             Ccccccc-cccccCCCCCC-CCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         143 LSEDIYE-QNVFQNGEPSE-KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       143 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      +++.... ...    .... .||.+|++||+...+..+.++||||||+++.|++| |+.+...
T Consensus       223 La~~~~~~~~~----~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit-gr~~~d~  280 (361)
T KOG1187|consen  223 LAKLGPEGDTS----VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT-GRKAVDQ  280 (361)
T ss_pred             CcccCCccccc----eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh-CCcccCC
Confidence            9965432 111    1111 78889999999998889999999999999999999 9988765

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.5e-34  Score=230.08  Aligned_cols=199  Identities=28%  Similarity=0.462  Sum_probs=163.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||++.+..         .++.+|+|.+....  .......+.+|+++++++ +||||+++++++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   70 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSF   70 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEE
Confidence            479999999999999999998533         44579999886442  223346688999999999 899999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. .+++|||+++++|.+++..                    .|||+++++|+||+|.||+++.++.++|+|||++..
T Consensus        71 ~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          71 QDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             EcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            7654 7899999999999988754                    689999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ....      .....++..|++||.+.+...+.++|+||||+++|+|++ |..||...+..+..+.+..+ .++.|...+
T Consensus       151 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  222 (290)
T cd05580         151 VKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDDNPIQIYEKILEG-KVRFPSFFS  222 (290)
T ss_pred             cCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CccCCccCC
Confidence            4332      223456778999999888788889999999999999999 99999887766666666654 556665554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0986|consensus

Probab=100.00  E-value=1.5e-35  Score=239.84  Aligned_cols=186  Identities=28%  Similarity=0.379  Sum_probs=156.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+.-+.|+.-++||.|+||+|+-+..+.         |++.||.|.+.+..-  .+--...++|.++|.++ +-++||.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVsl  250 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSL  250 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEE
Confidence            4556788999999999999999988544         556899999865521  12224578899999999 88999999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ...|.+ +.+++|+..+.||+|.-.+.+                      ++||+++|+.||+||+|||+|..|+++|+|
T Consensus       251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             eeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeec
Confidence            888765 569999999999998654432                      699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      +|++-.+......    ..+.||.+|||||++....|+..+|+||+||++|+|+. |+.||.....
T Consensus       331 LGLAvei~~g~~~----~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~-G~sPFr~~Ke  391 (591)
T KOG0986|consen  331 LGLAVEIPEGKPI----RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA-GHSPFRQRKE  391 (591)
T ss_pred             cceEEecCCCCcc----ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc-ccCchhhhhh
Confidence            9999877665322    34688999999999999999999999999999999998 9999987543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-34  Score=223.89  Aligned_cols=199  Identities=40%  Similarity=0.712  Sum_probs=161.8

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      +.||+|+||.||+|....          +..+|+|.++..........+.+|+++++++ +||||+++.+++... ..++
T Consensus         1 ~~ig~g~~g~vy~~~~~~----------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   69 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD----------KTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYI   69 (250)
T ss_pred             CccCCCCCceEEEEEecC----------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEE
Confidence            468999999999997433          2358999987665555556788999999999 999999999988764 4789


Q ss_pred             EEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF  153 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (228)
                      +|||+++++|.+++..                     .|+|+++++|+||+|+||+++.++.++|+|||++.........
T Consensus        70 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          70 VMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            9999999999988753                     5899999999999999999999999999999988643222111


Q ss_pred             cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       154 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .  .....++..|++||++....++.++|+||||+++|++++.|..||.+....+....+..+.++..|..+|+
T Consensus       150 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (250)
T cd05085         150 S--SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD  221 (250)
T ss_pred             c--CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            1  11123345699999998888899999999999999999779999999888888888888888877776654

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.5e-34  Score=242.96  Aligned_cols=186  Identities=24%  Similarity=0.450  Sum_probs=145.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .+.++|++.+.||+|+||.||+|+..         .++..||+|.+.....     ...+|+.+|+.+ +||||+++.++
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l-~h~niv~l~~~  127 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICI---------DTSEKVAIKKVLQDPQ-----YKNRELLIMKNL-NHINIIFLKDY  127 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEecCcc-----hHHHHHHHHHhc-CCCCCcceeee
Confidence            35578999999999999999999843         3445799998854321     234699999999 99999999887


Q ss_pred             EEcC---------ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          87 CYKD---------ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        87 ~~~~---------~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      +...         .++++|||+++ ++.+++..                        .|||+++|+||||||+|||++.+
T Consensus       128 ~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~  206 (440)
T PTZ00036        128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN  206 (440)
T ss_pred             EeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCC
Confidence            6431         15689999975 66554431                        69999999999999999999976


Q ss_pred             C-cEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         134 H-VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       134 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      + .+||+|||+++.+....    ......++..|+|||++.+. .++.++|+||+||++|+|++ |..||.+.+..+.+.
T Consensus       207 ~~~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~  281 (440)
T PTZ00036        207 THTLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLV  281 (440)
T ss_pred             CCceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Confidence            4 79999999997553321    11234567789999988754 58999999999999999999 999999877665544


Q ss_pred             HH
Q psy3166         212 YL  213 (228)
Q Consensus       212 ~~  213 (228)
                      ++
T Consensus       282 ~i  283 (440)
T PTZ00036        282 RI  283 (440)
T ss_pred             HH
Confidence            43

>KOG1989|consensus

Probab=100.00  E-value=1e-34  Score=250.98  Aligned_cols=187  Identities=26%  Similarity=0.411  Sum_probs=151.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +...++++.+.|.+|||+.||.|...+..         ..||+|++-.. +....+.+.+|+++|+.|..|+|||.+++.
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~---------~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGG---------KKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCC---------ceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            45667889999999999999999865432         46999998766 566778899999999999889999999994


Q ss_pred             E-Ec-------CceEEEEecCCCCcHHHHHHH----------------------hcccCCC--CcccCCCCCCEeecCCC
Q psy3166          87 C-YK-------DELRLVVEYCALGDLQSYLRE----------------------EYLSNNK--VVHRDLATRNILLSSPH  134 (228)
Q Consensus        87 ~-~~-------~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~--i~H~~lk~~nil~~~~~  134 (228)
                      . ..       .++.|+||||+||.|-|+++.                      .+||...  |+|||||.+|+||..+|
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence            2 11       236789999999999999885                      5899887  99999999999999999


Q ss_pred             cEEEeeccCccccccccccc------CCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         135 VVKISDFGLSEDIYEQNVFQ------NGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      ..||||||-+..........      ...-...+|+.|.+||++.   +.+++.|+|||||||++|.|+- ...||.+-
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy-~t~PFe~s  261 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY-FTTPFEES  261 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH-hCCCcCcC
Confidence            99999999775332211000      0112456788999999987   5679999999999999999996 88888664

>KOG0200|consensus

Probab=100.00  E-value=3.1e-34  Score=251.59  Aligned_cols=223  Identities=44%  Similarity=0.833  Sum_probs=188.2

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.+++.+.+.||+|.||.|++|...+-....  ......||||.++........+.+..|+.+|+.+..|+||+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            58899999999999999999999999865443211  2235679999998776666778899999999999999999999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCC
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      .+++.. +.+++++||+..|+|.+|++.                                    +||+++.++||||-..
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999887 448899999999999988753                                    5889999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-  205 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~-  205 (228)
                      |||+..+..+|++|||+++.......+........-+..|||||.+....|+.++|+||||+++||+.|+|..||.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999998655544332111111145679999999998899999999999999999999999999976 


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCC
Q psy3166         206 LCRIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       206 ~~~~~~~~~~~~~~~~p~~~~~~  228 (228)
                      ..++.+.+..|.|++.|..|++|
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~e  550 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDE  550 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHH
Confidence            77888899999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-34  Score=240.02  Aligned_cols=177  Identities=24%  Similarity=0.363  Sum_probs=145.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ++...+|++.+.||+|+||.||+|.         +..+++.||+|....       ..+.+|+++++++ +||||+++++
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~---------d~~~~~~vaiK~~~~-------~~~~~E~~il~~l-~HpnIv~~~~  150 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACI---------DNKTCEHVVIKAGQR-------GGTATEAHILRAI-NHPSIIQLKG  150 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEE---------ECCCCCEEEEechhh-------hhhHHHHHHHHhC-CCCCCCCEeE
Confidence            5667889999999999999999998         444556799996532       3456899999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ++..+. .++++|++. ++|.+++..                    .|||+++|+||||||+||+++.++.++|+|||++
T Consensus       151 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        151 TFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             EEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            886544 789999985 678777643                    6999999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      .......  ........||..|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus       230 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~  285 (391)
T PHA03212        230 CFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT-CHDSLFE  285 (391)
T ss_pred             ccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH-CCCCcCC
Confidence            6432211  111223467889999999998889999999999999999999 9877654

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-33  Score=225.67  Aligned_cols=194  Identities=33%  Similarity=0.634  Sum_probs=149.1

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      +.||+|+||+||+|....+       .....+++|.+...........+.+|+.+++.+ +||||+++++.+... ..++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~l   72 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLL   72 (269)
T ss_pred             CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEE
Confidence            3689999999999974332       123358999876554445556788999999999 999999999988754 4889


Q ss_pred             EEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          95 VVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      +|||+++|+|.+++..                         .|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccccccc
Confidence            9999999999987643                         689999999999999999999999999999998764322


Q ss_pred             cccccCCCCCCCCcceeeccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVS-------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      ...... .....++..|+|||++..       ..++.++|+||+||++|+|++.|..||....+.+..........
T Consensus       153 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  227 (269)
T cd05042         153 EDYYIT-KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD  227 (269)
T ss_pred             chheec-cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence            211111 122344567999998743       34678999999999999999867899998877666555444333

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-34  Score=228.03  Aligned_cols=201  Identities=26%  Similarity=0.473  Sum_probs=165.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|++|.||+|...         .++..||+|.+...........+.+|+++++.+ +|+|++++.+.+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   70 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK---------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLK   70 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC---------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEE
Confidence            47899999999999999999843         345579999987554333445678899999999 89999999998776


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      +. .++++|++++++|.+++..                   .|||+++++|+||+|+||+++.++.++|+|||++..+..
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          71 GSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             CCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            54 7899999999999988764                   589999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ..   .......++..|++||.+.+..++.++|+||||+++|+|+| |..||...+..+....+..+..+..+..
T Consensus       151 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  221 (274)
T cd06609         151 TM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLFLIPKNNPPSLEGN  221 (274)
T ss_pred             cc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccCchHHHHHHhhhcCCCCCccc
Confidence            21   11223455677999999988889999999999999999999 9999988777777777777766655544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-33  Score=222.72  Aligned_cols=202  Identities=24%  Similarity=0.408  Sum_probs=162.5

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||.|++|.||++....         +++.||+|.+.... .......+.+|+++++++ +|+|++++.+.+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEG   70 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecC
Confidence            58999999999999999988433         34469999986542 233445678899999999 99999999987754


Q ss_pred             -C-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          90 -D-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        90 -~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                       + .+++++|++++++|.+++..                      .++|+++++|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~  150 (257)
T cd08223          71 EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR  150 (257)
T ss_pred             CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceE
Confidence             3 37899999999999888743                      58999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+....   .......++..|+|||...+..++.++|+||+|+++++|++ |..||...+.......+..+..++.|...
T Consensus       151 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (257)
T cd08223         151 VLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGKLPPMPKDY  226 (257)
T ss_pred             EecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCcccc
Confidence            553221   11223456778999999988888999999999999999999 99999988777777677777655555444


Q ss_pred             C
Q psy3166         226 N  226 (228)
Q Consensus       226 ~  226 (228)
                      +
T Consensus       227 ~  227 (257)
T cd08223         227 S  227 (257)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=224.53  Aligned_cols=207  Identities=30%  Similarity=0.481  Sum_probs=161.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC----CCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN----ADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+|++.+.||+|+||.||+|..         ..++..||+|.+...    ........+.+|+.+++++ +|+||+++.
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~   70 (264)
T cd06653           1 PVNWRLGKLLGRGAFGEVYLCYD---------ADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYY   70 (264)
T ss_pred             CCceeeeeeEccCCCeEEEEEEE---------cCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEE
Confidence            46899999999999999999984         334557999987432    1233445788899999999 999999999


Q ss_pred             eEEEcC---ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYKD---ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~~---~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +.+...   .+++++|++++++|.+++..                    .|||+++++|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~df  150 (264)
T cd06653          71 GCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDF  150 (264)
T ss_pred             EEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcc
Confidence            987653   37899999999999887653                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS-TGYRME  220 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~-~~~~~~  220 (228)
                      |++.................++..|++||.+.+..++.++|+|||||+++++++ |..||...+..+...++. ...++.
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  229 (264)
T cd06653         151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFKIATQPTKPM  229 (264)
T ss_pred             ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCccCHHHHHHHHHcCCCCCC
Confidence            998754221110111122456778999999988778899999999999999999 999998876665544433 344455


Q ss_pred             CCCCCC
Q psy3166         221 RPASCN  226 (228)
Q Consensus       221 ~p~~~~  226 (228)
                      .|...+
T Consensus       230 ~p~~~~  235 (264)
T cd06653         230 LPDGVS  235 (264)
T ss_pred             CCcccC
Confidence            666654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.6e-34  Score=228.29  Aligned_cols=180  Identities=27%  Similarity=0.399  Sum_probs=148.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .|++.+.||+|+||.||++.+.         .+++.||+|.+....  .......+.+|+.+++++ +|+|++.+.+.+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~   70 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYE   70 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEc---------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEe
Confidence            4788899999999999999844         345579999886542  122234567899999999 9999999998876


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+ ..+++|||+++++|.+++..                      .|||+++|+|+||||+||+++.++.++|+|||++.
T Consensus        71 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05630          71 TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV  150 (285)
T ss_pred             cCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeecccee
Confidence            54 47899999999999887642                      68999999999999999999999999999999886


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      .......    .....|+..|+|||++.+..++.++|+||+|+++|+|++ |..||....
T Consensus       151 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~  205 (285)
T cd05630         151 HVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK  205 (285)
T ss_pred             ecCCCcc----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCC
Confidence            4432211    123467888999999988889999999999999999999 999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.8e-33  Score=226.62  Aligned_cols=204  Identities=38%  Similarity=0.691  Sum_probs=159.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCC-------CCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCc
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEG-------ASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDH   79 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~n   79 (228)
                      +|.++|++.+.||+|+||.||++.+.+.....       ........+|+|.+..........++.+|+.+++++ +|+|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   80 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPN   80 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCC
Confidence            57789999999999999999998754422100       122344568999987665555567888999999999 9999


Q ss_pred             eEEeeeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------------------hcccCCCCcccCCCCCC
Q psy3166          80 IVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        80 i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      |+++++++..+ ..+++||++++++|.+++..                               .|||+++++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            99999988664 48899999999999887642                               58999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT-LGANPYPHIPL  206 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t-~g~~pf~~~~~  206 (228)
                      |+++.++.++|+|||++..+........ .....++..|++||......++.++|+|||||++|+|++ .|..||...+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRI-QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceec-cCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999999875433221111 111233567999998888889999999999999999997 26789988776


Q ss_pred             HHHHHH
Q psy3166         207 CRIVHY  212 (228)
Q Consensus       207 ~~~~~~  212 (228)
                      .+....
T Consensus       240 ~~~~~~  245 (296)
T cd05095         240 EQVIEN  245 (296)
T ss_pred             HHHHHH
Confidence            665543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-33  Score=223.02  Aligned_cols=204  Identities=39%  Similarity=0.691  Sum_probs=161.9

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLV   95 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~lv   95 (228)
                      +.||+|++|.||+|.+...      ......||+|.++..........+.+|+++++++ +||||+++++.+.....+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLTHPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecC------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcCCeEEEE
Confidence            4689999999999986442      1233358999987664435567888999999999 99999999998877668899


Q ss_pred             EecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc
Q psy3166          96 VEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF  153 (228)
Q Consensus        96 ~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (228)
                      +|++++++|.+++..                      .|||+++++|+||+|+||+++.++.+||+|||++..+......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            999999999988643                      5899999999999999999999999999999998765432211


Q ss_pred             cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Q psy3166         154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS-TGYRMERPASCN  226 (228)
Q Consensus       154 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~-~~~~~~~p~~~~  226 (228)
                      ........++..|++||.+....++.++|+|||||++|+|++.|..||...+..+..+.+. .....+.|..+|
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACP  227 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCC
Confidence            1111223456679999999888899999999999999999977999998887777766555 344555565554

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-33  Score=227.19  Aligned_cols=173  Identities=24%  Similarity=0.336  Sum_probs=140.5

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--HHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      ||+|+||.||+++.         ..++..||+|.+......  ........|+++++++ +||||+++.+.+..+. .++
T Consensus         1 lg~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~l   70 (277)
T cd05607           1 LGKGGFGEVCAVQV---------KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCL   70 (277)
T ss_pred             CCCCCceEEEEEEE---------ccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEE
Confidence            69999999999884         334557999988643211  1223456799999999 9999999998887654 789


Q ss_pred             EEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +|||+++++|.+++..                      .|||+++++|+||||+||+++.++.++|+|||++..+.....
T Consensus        71 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          71 VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             EEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence            9999999999876532                      699999999999999999999999999999999865433211


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      .    ....++..|+|||++.+..++.++|+||+||++|+|++ |..||....
T Consensus       151 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~p~~~~~  198 (277)
T cd05607         151 I----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHK  198 (277)
T ss_pred             e----eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCc
Confidence            1    12456778999999988889999999999999999999 999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-33  Score=226.76  Aligned_cols=206  Identities=37%  Similarity=0.667  Sum_probs=160.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCC-----CCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCce
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPT-----EGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHI   80 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni   80 (228)
                      .++.++|++.+.||+|+||.||+++.++...     ..........||+|.++..........+.+|+++++++ +|+|+
T Consensus         1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i   79 (295)
T cd05097           1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNI   79 (295)
T ss_pred             CCchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCc
Confidence            3677899999999999999999988654321     01122334458999987654455566788999999999 99999


Q ss_pred             EEeeeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------------------hcccCCCCcccCCCCCC
Q psy3166          81 VSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        81 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++++++..+ ..+++|||+++++|.+++..                                .|||+++++|+||||+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            9999988664 48899999999999887631                                58999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT-LGANPYPHIPL  206 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t-~g~~pf~~~~~  206 (228)
                      |+++.++.+||+|||++..+....... ......++..|+|||......++.++|+||||+++|+|++ .|..||...+.
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCccee-ccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999986543322111 1122334567999999988889999999999999999987 25678888776


Q ss_pred             HHHHHHH
Q psy3166         207 CRIVHYL  213 (228)
Q Consensus       207 ~~~~~~~  213 (228)
                      .++...+
T Consensus       239 ~~~~~~~  245 (295)
T cd05097         239 EQVIENT  245 (295)
T ss_pred             HHHHHHH
Confidence            6655443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.9e-33  Score=224.13  Aligned_cols=206  Identities=29%  Similarity=0.465  Sum_probs=159.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+|+..+.||+|+||.||++..         ..++..||+|.+....    ..+....+.+|+.+++++ +||||++++
T Consensus         1 ~~~~~~~~~lg~g~~g~vy~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~   70 (266)
T cd06651           1 PINWRRGKLLGQGAFGRVYLCYD---------VDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYY   70 (266)
T ss_pred             CCCccccceecCCCCEEEEEEEE---------cCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEE
Confidence            35899999999999999999974         3345579999875431    223345678899999999 999999999


Q ss_pred             eEEEc---CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYK---DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~---~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++..   ..+++++|++++++|.+++..                    .|||+++++|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          71 GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             EEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccC
Confidence            98764   337899999999999988753                    6899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS-TGYRME  220 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~-~~~~~~  220 (228)
                      |++..+..............++..|+|||.+....++.++|+||+||++|++++ |..||...+..+...++. ....+.
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  229 (266)
T cd06651         151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEAMAAIFKIATQPTNPQ  229 (266)
T ss_pred             CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH-CCCCccccchHHHHHHHhcCCCCCC
Confidence            998654321111111122346778999999988888999999999999999999 999998876655544433 333444


Q ss_pred             CCCCC
Q psy3166         221 RPASC  225 (228)
Q Consensus       221 ~p~~~  225 (228)
                      .|..+
T Consensus       230 ~~~~~  234 (266)
T cd06651         230 LPSHI  234 (266)
T ss_pred             Cchhc
Confidence            45443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-33  Score=224.65  Aligned_cols=201  Identities=40%  Similarity=0.784  Sum_probs=159.5

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      +.||+|+||.||+|....+..       ...+++|.++........+.+.+|++++.++.+||||+++++++.... .++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCC-------eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            368999999999998654321       124788887754444455678899999999988999999999887654 789


Q ss_pred             EEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          95 VVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      +|||+++++|.+++..                                    +|||+++++|+||||+||+++.++.+||
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence            9999999999887631                                    6899999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      +|||++......    ........+..|++||++....++.++|+||||+++|+|++.|..||.+.+..+..+.+..+.+
T Consensus       154 ~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  229 (270)
T cd05047         154 ADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  229 (270)
T ss_pred             CCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence            999987522111    0111122345699999998888899999999999999999669999998888888888888777


Q ss_pred             CCCCCCCCC
Q psy3166         219 MERPASCNE  227 (228)
Q Consensus       219 ~~~p~~~~~  227 (228)
                      ++.|..++.
T Consensus       230 ~~~~~~~~~  238 (270)
T cd05047         230 LEKPLNCDD  238 (270)
T ss_pred             CCCCCcCCH
Confidence            777766553

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-33  Score=228.93  Aligned_cols=192  Identities=28%  Similarity=0.483  Sum_probs=152.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|+..         .++..||+|.++..........+.+|+.+++++ +||||+++++++.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~   74 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIH   74 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEc---------CCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEe
Confidence            468999999999999999999843         344579999986543333334567899999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ... .+++|||++ ++|.+++..                     .|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          75 TEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             cCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            654 789999996 478776543                     699999999999999999999999999999998864


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ......   ......++..|++||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+..
T Consensus       154 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~~f~~~~~~~~~~~~~~  219 (301)
T cd07873         154 KSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST-GRPLFPGSTVEEQLHFIFR  219 (301)
T ss_pred             cCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            322211   11123456779999988654 47889999999999999999 9999998877666554443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.1e-33  Score=220.73  Aligned_cols=202  Identities=23%  Similarity=0.338  Sum_probs=165.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|+..+.||+|+||.||.++..         .++..+++|.+.... ......++.+|+++++++ +|+||+++++++..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~   70 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT---------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD   70 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc---------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec
Confidence            6899999999999999998743         344569999876542 344456788999999999 99999999999876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .. .+++|||+++++|.+++..                      .|||+.+++|+||+|+||+++.++.+||+|||++..
T Consensus        71 ~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            54 7899999999999988753                      589999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ......   ......++..|.+||...+..++.++|+||+|+++++|++ |..||......+....+..+...+.+..++
T Consensus       151 ~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (256)
T cd08221         151 LGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-LKRTFDATNPLNLVVKIVQGNYTPVVSVYS  226 (256)
T ss_pred             cccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            433221   1223456778999999887778889999999999999999 999999988888888877776666655444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=237.99  Aligned_cols=186  Identities=28%  Similarity=0.390  Sum_probs=147.5

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcC--CCCceEEeeeEEEcCc-e
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVG--KHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~--~h~ni~~~~~~~~~~~-~   92 (228)
                      ||+|+||+||+|+.         ..++..||+|.+....  ..........|..++.+..  +||||+.+++.+..+. .
T Consensus         1 lG~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRK---------KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEE---------CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            69999999999984         4455679999986432  1122334556777776654  7999999999887644 8


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +++|||+++++|.+++..                    .|||+++|+||||||+|||++.++.++|+|||++....... 
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-  150 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-  150 (330)
T ss_pred             EEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence            899999999999887653                    69999999999999999999999999999999986432221 


Q ss_pred             ccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                        .......|+..|+|||++.+. .++.++|+||+||++|+|++ |..||.+.+..+..+.+..+
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~  212 (330)
T cd05586         151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPFYAEDTQQMYRNIAFG  212 (330)
T ss_pred             --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc-CCCCCCCCCHHHHHHHHHcC
Confidence              112235678899999998754 47889999999999999999 99999998877777777665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-33  Score=221.36  Aligned_cols=204  Identities=50%  Similarity=0.881  Sum_probs=168.2

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      +.||+|+||.||+|......      ..+..|++|.++..........+.+|+.+++++ +|+|++++++++..+ ..++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEE
Confidence            46899999999999865421      234569999998665444457788999999999 799999999988764 4889


Q ss_pred             EEecCCCCcHHHHHHH-----------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          95 VVEYCALGDLQSYLRE-----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~-----------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +|||+++++|.+++..                             .+||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence            9999999999988742                             58999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      ........ .......++..|+|||.+....++.++|+||+|+++|+|++.|..||...+..++.+.+..+.+++.|..+
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd00192         154 DVYDDDYY-RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYC  232 (262)
T ss_pred             cccccccc-ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            65443211 11223445678999999988888999999999999999998569999999888889898888888888887


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      |+
T Consensus       233 ~~  234 (262)
T cd00192         233 PD  234 (262)
T ss_pred             Ch
Confidence            65

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-33  Score=227.38  Aligned_cols=188  Identities=26%  Similarity=0.395  Sum_probs=146.9

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcC--CCCceEEeeeEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVG--KHDHIVSFIGCC   87 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--~h~ni~~~~~~~   87 (228)
                      +|++.+.||+|+||+||+|+.         ..+++.||+|.++.... ........+|+.+++++.  +||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARD---------PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEE---------CCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            589999999999999999984         44556799998864321 111234556777777653  699999999987


Q ss_pred             Ec------CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          88 YK------DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        88 ~~------~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ..      ...+++||++++ +|.+++..                      .|+|++|++|+||||+||+++.++.+||+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~  150 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLA  150 (288)
T ss_pred             ccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEC
Confidence            53      237899999975 77776543                      69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      |||++........    .....++..|+|||++.+..++.++|+||+||++|+|++ |..||.+........++
T Consensus       151 dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~~f~~~~~~~~~~~~  219 (288)
T cd07863         151 DFGLARIYSCQMA----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKI  219 (288)
T ss_pred             ccCccccccCccc----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh-CCcCcCCCCHHHHHHHH
Confidence            9999875432211    123456778999999988889999999999999999998 99999887666555443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-33  Score=226.18  Aligned_cols=203  Identities=25%  Similarity=0.465  Sum_probs=163.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ...|+..+.||+|+||.||+|.+.         .++..||+|.++..........+.+|+.+++++ +|||++++.+.+.
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   72 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDN---------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYL   72 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEc---------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE
Confidence            356888999999999999999843         344579999987654445556788999999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      .+. .+++||++++++|.+++..                   .++|+++++|+||+|+||+++.++.++++|||++..+.
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          73 KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             ECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            655 8899999999999988753                   68999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      ....   ......++..|++||.+.+..++.++|+||||+++|+|++ |..||...+.......+..+.++..+..+
T Consensus       153 ~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (277)
T cd06640         153 DTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK-GEPPNSDMHPMRVLFLIPKNNPPTLTGEF  225 (277)
T ss_pred             CCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH-CCCCCCCcChHhHhhhhhcCCCCCCchhh
Confidence            3221   1122345667999999988888999999999999999999 99999987776666555555444444333

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.9e-33  Score=224.70  Aligned_cols=183  Identities=27%  Similarity=0.358  Sum_probs=149.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .|+..+.||+|+||+||++.+.         .+++.||+|.+....  .......+.+|+++++++ +|+|++.+.+.+.
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~   70 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYE   70 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEe
Confidence            3788899999999999999843         345579999986542  122234567899999999 9999999988876


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+ ..+++|||+++++|.+++..                      .|||+++|+||||||+||+++.++.++|+|||++.
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~  150 (285)
T cd05632          71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             cCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcce
Confidence            65 47899999999999876632                      69999999999999999999999999999999886


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      .......    .....++..|+|||++.+..++.++|+||+|+++|+|++ |..||.......
T Consensus       151 ~~~~~~~----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~P~~~~~~~~  208 (285)
T cd05632         151 KIPEGES----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKV  208 (285)
T ss_pred             ecCCCCc----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            4322211    123467788999999988889999999999999999999 999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.8e-33  Score=222.28  Aligned_cols=199  Identities=25%  Similarity=0.431  Sum_probs=159.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++..  ........+.+|+++++++ +|||++++++.+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   71 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL---------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSF   71 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe---------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeE
Confidence            68999999999999999999843         34457999987542  2344456788999999999 999999999987


Q ss_pred             Ec-CceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          88 YK-DELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        88 ~~-~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      .. +..++++||+++++|.+++..                        .|||+++++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          72 IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccc
Confidence            65 457899999999999877631                        69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP--LCRIVHYLSTGYRME  220 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~--~~~~~~~~~~~~~~~  220 (228)
                      ++..+......   .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||....  ..++.+.+..+..++
T Consensus       152 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T cd08228         152 LGRFFSSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLFSLCQKIEQCDYPP  227 (267)
T ss_pred             cceeccchhHH---HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc-CCCCCccccccHHHHHHHHhcCCCCC
Confidence            88755332211   122456678999999988888999999999999999999 999986643  245566666665555


Q ss_pred             CC
Q psy3166         221 RP  222 (228)
Q Consensus       221 ~p  222 (228)
                      .|
T Consensus       228 ~~  229 (267)
T cd08228         228 LP  229 (267)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.9e-33  Score=219.84  Aligned_cols=205  Identities=34%  Similarity=0.679  Sum_probs=165.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +++.+|++.+.||+|+||.||++.+..          +..+|+|.++.....  ...+.+|+++++++ +|||+++++++
T Consensus         1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~   67 (256)
T cd05112           1 IHPSELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAMS--EEDFIEEAQVMMKL-SHPKLVQLYGV   67 (256)
T ss_pred             CChhHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCCC--HHHHHHHHHHHHhC-CCCCeeeEEEE
Confidence            467899999999999999999987532          224899988754322  24678899999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +... ..++++||+++++|.+++..                     .+||+++++|+||||+||+++.++.++|+|||++
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~  147 (256)
T cd05112          68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT  147 (256)
T ss_pred             EccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcce
Confidence            7654 47899999999999888753                     5899999999999999999999999999999988


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ........  .......++..|++||.+.+..++.++|+||+|+++|+|++.|..||......++.+.+.++.++..|..
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd05112         148 RFVLDDQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL  225 (256)
T ss_pred             eecccCcc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCC
Confidence            65432211  1111223456799999998888899999999999999999779999999888888888888777666654


Q ss_pred             CC
Q psy3166         225 CN  226 (228)
Q Consensus       225 ~~  226 (228)
                      .+
T Consensus       226 ~~  227 (256)
T cd05112         226 AS  227 (256)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-33  Score=221.95  Aligned_cols=206  Identities=29%  Similarity=0.574  Sum_probs=162.2

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--------HHHHHHHHHHHHHHhcCCCCceEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--------KTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      +|++...||+|++|.||+|...         ..+..+|+|.+......        +....+.+|+.+++++ +||||++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~   70 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA---------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQ   70 (267)
T ss_pred             CccccceeecCCCeEEEEEEec---------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeee
Confidence            5788999999999999999843         33456999987643211        1234677899999999 9999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +.+++... ..++++||+++++|.+++..                    .|||+++++|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          71 YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEeccc
Confidence            99987664 47899999999999888754                    6899999999999999999999999999999


Q ss_pred             cCccccccccccc---CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         142 GLSEDIYEQNVFQ---NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       142 g~~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      |.++.........   .......++..|++||.+.+..++.++|+||+|+++|+|++ |..||...+.......+....+
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  229 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGENAS  229 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh-CCCCCCCccHHHHHHHHhccCC
Confidence            9987554221111   11122346678999999988888999999999999999999 9999998776666666666656


Q ss_pred             CCCCCCCCC
Q psy3166         219 MERPASCNE  227 (228)
Q Consensus       219 ~~~p~~~~~  227 (228)
                      +..|..+|.
T Consensus       230 ~~~~~~~~~  238 (267)
T cd06628         230 PEIPSNISS  238 (267)
T ss_pred             CcCCcccCH
Confidence            666666543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.7e-33  Score=222.54  Aligned_cols=188  Identities=40%  Similarity=0.650  Sum_probs=148.4

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ...+|++.+.||+|+||.||++.....     +..++..||+|.++... ......+.+|+++++++ +||||+++.+++
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~   74 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPL-----QDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSL-QHDNIVKYKGVC   74 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCC-----cCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhC-CCCCeeEEEEEE
Confidence            346899999999999999999875321     33455679999987543 33446788999999999 999999999976


Q ss_pred             Ec---CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          88 YK---DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        88 ~~---~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..   ..+++++||+++++|.+++..                     .|||++|++|+||||+||+++.++.++|+|||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence            53   347899999999999998753                     699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      +..+..............++..|++||...+..++.++|+||||+++++|++ |..|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-~~~~~~~  213 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCS  213 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhh-cCCcCCC
Confidence            8755332211111111223345899999988889999999999999999998 7666543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.6e-33  Score=224.98  Aligned_cols=192  Identities=30%  Similarity=0.511  Sum_probs=157.4

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ++.+-+..+|++.+.||+|+||.||+|...         .++..||+|.+...... ....+.+|+.+++.+ +|+|+++
T Consensus        13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~-~h~~v~~   81 (296)
T cd06654          13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQP-KKELIINEILVMREN-KNPNIVN   81 (296)
T ss_pred             cccCCcccceeeEEEecCCCCeEEEEEEEC---------CCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhC-CCCCEee
Confidence            455778899999999999999999999843         33446999988755332 246678899999999 9999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +.+.+..+ ..++||||+++++|.+++..                   .|||+++|+|+||||+||+++.++.++|+|||
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             EEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccc
Confidence            99987654 58899999999999988754                   69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ++........   ......++..|++||.+.+..++.++|+|||||++|+|++ |..||........
T Consensus       162 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~-g~~pf~~~~~~~~  224 (296)
T cd06654         162 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRA  224 (296)
T ss_pred             cchhcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHh
Confidence            8764322211   1122456678999999988888899999999999999999 9999988765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.3e-33  Score=224.22  Aligned_cols=208  Identities=37%  Similarity=0.677  Sum_probs=165.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCC-------CCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTE-------GASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD   78 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~   78 (228)
                      +++.++|++.+.||+|+||.||+|.....+..       ..+......||+|.+...........+.+|++++.++ +||
T Consensus         1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~   79 (296)
T cd05051           1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDP   79 (296)
T ss_pred             CCchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCC
Confidence            35678999999999999999999987654321       1233445678999988665555567788999999999 999


Q ss_pred             ceEEeeeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------------------hcccCCCCcccCCCCC
Q psy3166          79 HIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        79 ni~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      ||+++++++..+ ..+++||++++++|.+++..                               .|||+++++|+||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            999999988764 48899999999999887632                               5899999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCC
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL-GANPYPHIP  205 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~-g~~pf~~~~  205 (228)
                      ||+++.++.++|+|||++.......... ......++..|++||.+....++.++|+|||||++|+|++. |..||...+
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCccee-ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            9999999999999999987543322111 11223445679999999887899999999999999999873 568898877


Q ss_pred             HHHHHHHHHc
Q psy3166         206 LCRIVHYLST  215 (228)
Q Consensus       206 ~~~~~~~~~~  215 (228)
                      ..++.+.+..
T Consensus       239 ~~~~~~~~~~  248 (296)
T cd05051         239 DQQVIENAGH  248 (296)
T ss_pred             hHHHHHHHHh
Confidence            7776665544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-33  Score=225.29  Aligned_cols=185  Identities=35%  Similarity=0.603  Sum_probs=149.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      .-|++.+.||+|+||.||++.....     +..++..||+|.++..........+.+|+++++++ +|||++++.+++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   77 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTE   77 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccC-----CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEec
Confidence            4568999999999999999975432     33456679999987665555566788999999999 99999999998765


Q ss_pred             C---ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          90 D---ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        90 ~---~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .   ..+++|||+++++|.+++..                     .|+|++|++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          78 DGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence            3   37899999999999998753                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY  201 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf  201 (228)
                      .+..............++..|+|||++.+..++.++|+||||+++|+|++ +..|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt-~~~~~  212 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-YCDSE  212 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc-CCCCC
Confidence            65433221111122345567999999888888999999999999999998 76553

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-33  Score=235.36  Aligned_cols=189  Identities=24%  Similarity=0.367  Sum_probs=149.5

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||++..         ..++..||+|.+.... ......++.+|+.+++.+ +||||+++++++..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~   70 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTD---------PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQP   70 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEE---------CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecC
Confidence            578999999999999999984         3345579999986542 233446788999999999 99999999998865


Q ss_pred             C------ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          90 D------ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        90 ~------~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .      ..++++||+. ++|.+.+..                    .|||+++++||||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          71 PHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             CCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccc
Confidence            3      4789999986 467665432                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +........  .......++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.+..+....+
T Consensus       150 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i  217 (372)
T cd07853         150 ARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG-RRILFQAQSPIQQLDLI  217 (372)
T ss_pred             eeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence            864322211  111223456789999998764 47889999999999999999 99999987766555444

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4279|consensus

Probab=100.00  E-value=2.3e-35  Score=249.50  Aligned_cols=196  Identities=27%  Similarity=0.470  Sum_probs=159.0

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      -+||.|+||+||-|+         +..+...+|||-+.... .+..+...+|+.+.++| .|.|||+++|.+..+. +-+
T Consensus       581 vVLGKGTYG~VYA~R---------D~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kI  649 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAAR---------DMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKI  649 (1226)
T ss_pred             EEeecCceeEEEeec---------cccceeEEEeeeccccc-chhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEE
Confidence            489999999999988         56666779999987553 34456788999999999 9999999999987666 458


Q ss_pred             EEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecC-CCcEEEeeccCccccccc
Q psy3166          95 VVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSS-PHVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~dfg~~~~~~~~  150 (228)
                      +||..+||+|.+.+..                       .|||++.|+|||||-+|+|++. .|.+||+|||.++-+-.-
T Consensus       650 FMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  650 FMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             EeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            8999999999999875                       6999999999999999999997 699999999988754322


Q ss_pred             ccccCCCCCCCCcceeecccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH-HHcCCCCCCCCCCC
Q psy3166         151 NVFQNGEPSEKLPIRWLALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHY-LSTGYRMERPASCN  226 (228)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~-~~~~~~~~~p~~~~  226 (228)
                         +....+..||..|||||++..++  |+.++|||||||++-||.| |++||-.+..... .-+ -+-..-|++|++++
T Consensus       730 ---nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT-GrPPF~ElgspqAAMFkVGmyKvHP~iPeels  805 (1226)
T KOG4279|consen  730 ---NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT-GRPPFVELGSPQAAMFKVGMYKVHPPIPEELS  805 (1226)
T ss_pred             ---CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc-CCCCeeecCChhHhhhhhcceecCCCCcHHHH
Confidence               22334577899999999999664  8999999999999999999 9999988654433 323 33355677776654

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.4e-33  Score=221.57  Aligned_cols=213  Identities=34%  Similarity=0.631  Sum_probs=167.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.++|++.+.||+|+||.||+|+.+...    .......+++|.+...........+.+|+++++++ +|+|+++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   76 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIE----EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGL   76 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCC----cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEE
Confidence            56789999999999999999999976543    22344568999887654444567788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH-----------------------------hcccCCCCcccCCCCCCEeecCCCcE
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE-----------------------------EYLSNNKVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~-----------------------------~~lh~~~i~H~~lk~~nil~~~~~~~  136 (228)
                      +... ..+++||++++++|.+++..                             .|||+++|+|+||||+||+++.++.+
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          77 CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             ECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence            7664 47899999999999988642                             58999999999999999999999999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +++|||++.........  ......++..|++||.+....++.++|+||||+++|++++.|..||.......+...+..+
T Consensus       157 ~l~~~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~  234 (275)
T cd05046         157 KVSLLSLSKDVYNSEYY--KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG  234 (275)
T ss_pred             EEcccccccccCccccc--ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence            99999987643222111  1122345667999999887778899999999999999998688999887777777766654


Q ss_pred             CC-CCCCCCCC
Q psy3166         217 YR-MERPASCN  226 (228)
Q Consensus       217 ~~-~~~p~~~~  226 (228)
                      .. .+.+..+|
T Consensus       235 ~~~~~~~~~~~  245 (275)
T cd05046         235 KLELPVPEGCP  245 (275)
T ss_pred             CcCCCCCCCCC
Confidence            32 23344444

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4645|consensus

Probab=100.00  E-value=5.1e-36  Score=266.84  Aligned_cols=207  Identities=26%  Similarity=0.454  Sum_probs=171.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++.-...||.|.||.||-|.         +..++...|+|-++.... .+....+.+|..+|..+ +|||+++++++-..
T Consensus      1236 rWqrg~~Ig~G~fG~VYtav---------N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAV---------NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVH 1305 (1509)
T ss_pred             eeccccccCCcceeeeEEee---------cCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeec
Confidence            34455789999999999987         555666789998875432 33345677899999999 99999999999766


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      + .+++.||||.+|+|.+.+..                    .|||+.|||||||||.||+++.+|.+|+.|||-+..+.
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            4 48899999999999998764                    69999999999999999999999999999999987765


Q ss_pred             ccc-cccCCCCCCCCcceeecccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCC
Q psy3166         149 EQN-VFQNGEPSEKLPIRWLALESLVSN---IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIVHYLSTGYRMERPA  223 (228)
Q Consensus       149 ~~~-~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~~~~~~~~~~~~p~  223 (228)
                      ++. ..........||+.|||||++.+.   +...++||||+||++.||+| |+-||..+++. .+.-++..|..|++|+
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t-GkrPW~~~dne~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT-GKRPWAELDNEWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec-CCCchhhccchhHHHhHHhccCCCCCch
Confidence            553 222334567899999999999854   46678999999999999999 99999998775 4566799999999999


Q ss_pred             CCCCC
Q psy3166         224 SCNEQ  228 (228)
Q Consensus       224 ~~~~~  228 (228)
                      +++.|
T Consensus      1465 ~ls~~ 1469 (1509)
T KOG4645|consen 1465 RLSSE 1469 (1509)
T ss_pred             hhhHh
Confidence            87754

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.1e-33  Score=219.56  Aligned_cols=208  Identities=48%  Similarity=0.886  Sum_probs=170.4

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-C
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-D   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~   90 (228)
                      +++.+.||+|+||.||++.+.....     .....+|+|.++..........+..|+.+++.+ +|+||+++++++.. +
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   74 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEE   74 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCC
Confidence            4678899999999999998655321     234569999997665444556788999999999 99999999998876 4


Q ss_pred             ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          91 ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      ..+++||++++++|.+++..                      .+||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            48899999999999887643                      58999999999999999999999999999999987554


Q ss_pred             ccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ........  ...++..|++||.+....++.++|+||+|+++++|++.|..||...+..++.+.+..+.+++.|..+|.
T Consensus       155 ~~~~~~~~--~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T smart00219      155 DDDYYKKK--GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPP  231 (258)
T ss_pred             cccccccc--cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCH
Confidence            43222211  123566799999998778899999999999999999878999999888888888888888888877654

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=225.75  Aligned_cols=197  Identities=28%  Similarity=0.483  Sum_probs=159.5

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      |.++|++.+.||+|+||.||++....         ++..+|+|.++.. .....+.+.+|+.+++++ +||||+++.+.+
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   71 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIE-SEEELEDFMVEIDILSEC-KHPNIVGLYEAY   71 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhC-CCCceeEEEEEE
Confidence            56789999999999999999998533         3456999998754 334456788999999999 899999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..+. .+++|||+++++|.+++..                     .|||+++|+|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             ecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccch
Confidence            7644 7899999999999888653                     59999999999999999999999999999999875


Q ss_pred             cccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      ......   .......++..|++||.+.     ...++.++|+||+|+++|+|++ |..||...+..+....+..+.++
T Consensus       152 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  226 (280)
T cd06611         152 KNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ-MEPPHHELNPMRVLLKILKSEPP  226 (280)
T ss_pred             hhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh-CCCCcccCCHHHHHHHHhcCCCC
Confidence            432211   1112235677899999875     2346778999999999999999 99999998877777777766443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-33  Score=249.13  Aligned_cols=196  Identities=27%  Similarity=0.489  Sum_probs=153.9

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ....++|++.+.||+|+||+||+|..         ..++..+|+|.+... ........+..|+.+|++| +||||++++
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkd---------k~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~   78 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKH---------KRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYI   78 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEE---------CCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEE
Confidence            35567999999999999999999984         344557899988754 2344456788999999999 999999999


Q ss_pred             eEEEc---CceEEEEecCCCCcHHHHHHH------------------------hcccCC-------CCcccCCCCCCEee
Q psy3166          85 GCCYK---DELRLVVEYCALGDLQSYLRE------------------------EYLSNN-------KVVHRDLATRNILL  130 (228)
Q Consensus        85 ~~~~~---~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~-------~i~H~~lk~~nil~  130 (228)
                      ++|..   ..+++||||+++++|.+++..                        .|||+.       +|+|+||||+|||+
T Consensus        79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence            98754   238899999999999887743                        589984       49999999999999


Q ss_pred             cC-----------------CCcEEEeeccCcccccccccccCCCCCCCCcceeeccccccc--CCCCchhhHHHHHHHHH
Q psy3166         131 SS-----------------PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS--NIYTNKSDVWSFGVVLW  191 (228)
Q Consensus       131 ~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Diwslg~~~~  191 (228)
                      +.                 .+.+||+|||++..+.....    .....+++.|+|||++..  ..++.++|||||||++|
T Consensus       159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY  234 (1021)
T PTZ00266        159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY  234 (1021)
T ss_pred             ecCccccccccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence            64                 23589999999875432211    123467889999999864  34788999999999999


Q ss_pred             HHHhCCCCCCCCCCHHH-HHHHHHcC
Q psy3166         192 EIVTLGANPYPHIPLCR-IVHYLSTG  216 (228)
Q Consensus       192 ~l~t~g~~pf~~~~~~~-~~~~~~~~  216 (228)
                      +|++ |..||...+... +...+..+
T Consensus       235 ELLT-Gk~PF~~~~~~~qli~~lk~~  259 (1021)
T PTZ00266        235 ELCS-GKTPFHKANNFSQLISELKRG  259 (1021)
T ss_pred             HHHH-CCCCCCcCCcHHHHHHHHhcC
Confidence            9999 999998755443 34444444

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.7e-33  Score=222.56  Aligned_cols=207  Identities=42%  Similarity=0.784  Sum_probs=163.2

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      +.||+|+||.||+|.......   ....+..+|+|.+...........+.+|+++++++ +||||+++.+++..+ ..++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEE
Confidence            368999999999998644221   12233568999887554444456788999999999 999999999987654 4889


Q ss_pred             EEecCCCCcHHHHHHH---------------------------hcccCCCCcccCCCCCCEeecCCC-----cEEEeecc
Q psy3166          95 VVEYCALGDLQSYLRE---------------------------EYLSNNKVVHRDLATRNILLSSPH-----VVKISDFG  142 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~---------------------------~~lh~~~i~H~~lk~~nil~~~~~-----~~kl~dfg  142 (228)
                      +||++++++|.+++..                           .|||+++++|+||+|+||+++.++     .++++|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999999988742                           589999999999999999999877     89999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++..+........ .....++..|++||.+....++.++|+||||+++|+|++.|..||......+....+..+.++..|
T Consensus       157 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05044         157 LARDIYKSDYYRK-EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP  235 (269)
T ss_pred             ccccccccccccc-CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc
Confidence            9875533221111 112334567999999988889999999999999999997799999988888888888777777777


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       236 ~~~~~  240 (269)
T cd05044         236 ENCPD  240 (269)
T ss_pred             ccchH
Confidence            66653

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0584|consensus

Probab=100.00  E-value=4e-34  Score=239.44  Aligned_cols=205  Identities=26%  Similarity=0.447  Sum_probs=167.3

Q ss_pred             CCCCce-eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERL-ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~-~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .|..+| ++..+||+|+|-+||+|.+..++.++++      -.+|.-+....+..++++.+|+.+|+.| +||||+++++
T Consensus        36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAW------nqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~  108 (632)
T KOG0584|consen   36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAW------NQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYD  108 (632)
T ss_pred             CCCCceeehhhhcccccceeeeeccccccchhhHH------HHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeee
Confidence            455677 7889999999999999986665554433      2233333334566778999999999999 9999999999


Q ss_pred             EEEcCc---eEEEEecCCCCcHHHHHHH--------------------hcccCCC--CcccCCCCCCEeecC-CCcEEEe
Q psy3166          86 CCYKDE---LRLVVEYCALGDLQSYLRE--------------------EYLSNNK--VVHRDLATRNILLSS-PHVVKIS  139 (228)
Q Consensus        86 ~~~~~~---~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~--i~H~~lk~~nil~~~-~~~~kl~  139 (228)
                      +|.+..   +-+|.|++.+|+|..|+++                    .|||++.  |+|||||.+||+++. -|.+||.
T Consensus       109 SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  109 SWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             heecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence            987632   6689999999999999876                    6999985  999999999999986 5899999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYR  218 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~~~~~  218 (228)
                      |+|++..+....     .....||+.|||||+.. ..|+...||||||.+++||.| +.+||+...+ -+++.++..|.+
T Consensus       189 DLGLAtl~r~s~-----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT-~eYPYsEC~n~AQIYKKV~SGiK  261 (632)
T KOG0584|consen  189 DLGLATLLRKSH-----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT-SEYPYSECTNPAQIYKKVTSGIK  261 (632)
T ss_pred             chhHHHHhhccc-----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh-ccCChhhhCCHHHHHHHHHcCCC
Confidence            999998654331     23478999999999887 569999999999999999999 9999999655 467888999988


Q ss_pred             CCCCCCC
Q psy3166         219 MERPASC  225 (228)
Q Consensus       219 ~~~p~~~  225 (228)
                      |....++
T Consensus       262 P~sl~kV  268 (632)
T KOG0584|consen  262 PAALSKV  268 (632)
T ss_pred             HHHhhcc
Confidence            7654443

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-32  Score=222.78  Aligned_cols=197  Identities=27%  Similarity=0.473  Sum_probs=155.8

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .|.++|++.+.||+|+||.||+|...         .++..+++|.+... .......+.+|+.+++.+ +|||++++.+.
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   77 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNK---------ETGALAAAKVIETK-SEEELEDYMVEIEILATC-NHPYIVKLLGA   77 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEEC---------CCCceEEEEEeccC-CHHHHHHHHHHHHHHHhC-CCCcEeeeEEE
Confidence            45577999999999999999999743         34456999998754 344456788899999999 89999999998


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+. .+++|||+++++|..++.+                     .|||+++++|+||||+||+++.++.++|+|||++
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  157 (292)
T cd06644          78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS  157 (292)
T ss_pred             EEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence            76544 8899999999999876542                     6899999999999999999999999999999987


Q ss_pred             ccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      .......   .......++..|++||.+.     ...++.++|+|||||++|+|++ |..||...+..+...++....+
T Consensus       158 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  232 (292)
T cd06644         158 AKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEP  232 (292)
T ss_pred             eeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc-CCCCCccccHHHHHHHHhcCCC
Confidence            6432211   1112234566799999885     3346788999999999999999 9999988766655555555433

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-32  Score=224.29  Aligned_cols=196  Identities=22%  Similarity=0.337  Sum_probs=157.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||++..         ..++..|++|.++....  ......+.+|+++++.+ +||||+++++.+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~   70 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRH---------KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSF   70 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEE---------CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEE
Confidence            4799999999999999999884         34455799998875532  23345677899999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. .+++|||+++++|.+++..                    .|+|+++++|+||||+||+++.++.++|+|||+++.
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          71 ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            7655 7899999999999988754                    699999999999999999999999999999998763


Q ss_pred             cccccc------------ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         147 IYEQNV------------FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       147 ~~~~~~------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ......            .........++..|++||.+....++.++|+||||+++|+|++ |..||.+.+..++.++..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~-g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence            111000            0001112345677999999988888999999999999999999 999999888887777766


Q ss_pred             cC
Q psy3166         215 TG  216 (228)
Q Consensus       215 ~~  216 (228)
                      .+
T Consensus       230 ~~  231 (305)
T cd05609         230 SD  231 (305)
T ss_pred             hc
Confidence            54

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.7e-33  Score=223.59  Aligned_cols=197  Identities=31%  Similarity=0.512  Sum_probs=159.4

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ..|-+..+|++.+.||+|++|.||++..         ..+++.|++|.+...... ....+.+|+.+++.+ +|||++++
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~---------~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~   81 (296)
T cd06655          13 SIGDPKKKYTRYEKIGQGASGTVFTAID---------VATGQEVAIKQINLQKQP-KKELIINEILVMKEL-KNPNIVNF   81 (296)
T ss_pred             hcCCCcceEEEEEEEecCCCeEEEEEEE---------cCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhc-CCCceeee
Confidence            3466778999999999999999999974         344557999988654322 245678899999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .+.+..+ ..++++||+++++|.+++..                   .|||+++++|+||||+||+++.++.++|+|||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~  161 (296)
T cd06655          82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF  161 (296)
T ss_pred             eeeEecCceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence            9988764 48899999999999887654                   689999999999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +..+.....   ......++..|++||.+.+..++.++|+|||||++|+|++ |..||...+..+....+..
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~llt-g~~pf~~~~~~~~~~~~~~  229 (296)
T cd06655         162 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIAT  229 (296)
T ss_pred             chhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Confidence            765433211   1122356678999999988888999999999999999999 9999988766554444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-33  Score=225.17  Aligned_cols=179  Identities=26%  Similarity=0.475  Sum_probs=149.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|..         ..++..||+|.+..+........+.+|+++++++ +||||+++++.+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~   70 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFV   70 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEE---------cCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEE
Confidence            4789999999999999999984         3445579999987654455556788999999999 99999999998876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH----------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~----------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++ .+++|||+++++|..+...                .|||+++|+|+||||+||+++.++.++|+|||++..+...  
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          71 ENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            44 7899999999988654221                7999999999999999999999999999999998754322  


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                         ......++..|++||++.+..++.++|+||||+++|+|++ |..||...
T Consensus       149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~  196 (279)
T cd06619         149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL-GRFPYPQI  196 (279)
T ss_pred             ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh-CCCCchhh
Confidence               1123456778999999998889999999999999999999 99999653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.8e-33  Score=221.34  Aligned_cols=203  Identities=24%  Similarity=0.463  Sum_probs=163.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +-|++.+.||+|+||.||+|...         ..+..||+|.............+.+|+.+++++ +||||+++++.+..
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   73 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK   73 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEEC---------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe
Confidence            45788899999999999999743         334569999886554444456788999999999 99999999998876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      +. .+++|||+++++|.+++..                   .+||+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        74 ~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          74 DTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            54 8899999999999988753                   589999999999999999999999999999998865433


Q ss_pred             cccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ...   ......++..|++||.+....++.++|+||+||++|+|++ |..||...........+..+.++..+..+|
T Consensus       154 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (277)
T cd06641         154 TQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPHSELHPMKVLFLIPKNNPPTLEGNYS  226 (277)
T ss_pred             chh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCccchHHHHHHHhcCCCCCCCcccC
Confidence            211   1122345667999999887778899999999999999999 999999877766666666665555555444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-33  Score=233.20  Aligned_cols=190  Identities=23%  Similarity=0.394  Sum_probs=151.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      |.++ ++|++.+.||+|+||.||+|..         ..++..||+|.+..... ......+.+|+.+++++ +||||+++
T Consensus        11 ~~~~-~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~   79 (343)
T cd07878          11 WEVP-ERYQNLTPVGSGAYGSVCSAYD---------TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGL   79 (343)
T ss_pred             hhhh-hhhhhheecccCCCeEEEEEEE---------CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhh
Confidence            4443 7899999999999999999974         34455799999875422 22345677899999999 99999999


Q ss_pred             eeEEEc-------CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          84 IGCCYK-------DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        84 ~~~~~~-------~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      ++++..       ...+++++++ +++|.+++..                   .|||+++|+||||||+||+++.++.+|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          80 LDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             hhhhcccccccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEE
Confidence            987743       2367888887 7788776542                   699999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      |+|||++......      .....++..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+....+
T Consensus       159 l~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~  228 (343)
T cd07878         159 ILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK-GKALFPGNDYIDQLKRI  228 (343)
T ss_pred             EcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            9999998754321      123456778999999876 458889999999999999999 99999887655544443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.8e-33  Score=237.66  Aligned_cols=189  Identities=21%  Similarity=0.324  Sum_probs=145.3

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC-----CCCceEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG-----KHDHIVS   82 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~   82 (228)
                      ..++|++.+.||+|+||+||+|..         ..++..||+|+++...  ........|+++++.+.     +|.+++.
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~---------~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWD---------RKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEE---------cCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            347899999999999999999984         3445679999986431  22234456777777661     3456888


Q ss_pred             eeeEEEcC--ceEEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCC-----
Q psy3166          83 FIGCCYKD--ELRLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPH-----  134 (228)
Q Consensus        83 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~-----  134 (228)
                      +.+++...  .++++|+++ +++|.+++..                    .|||+ .||+||||||+|||++..+     
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence            88887653  378888887 6678776643                    69997 5999999999999998765     


Q ss_pred             -----------cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         135 -----------VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       135 -----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                                 .+||+|||.+....      .......||..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~  347 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT-GKLLYDT  347 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh-CCCCCCC
Confidence                       49999999875321      11234567889999999999899999999999999999999 9999998


Q ss_pred             CCHHHHHHHHHc
Q psy3166         204 IPLCRIVHYLST  215 (228)
Q Consensus       204 ~~~~~~~~~~~~  215 (228)
                      .+..+.+..+.+
T Consensus       348 ~~~~~~~~~i~~  359 (467)
T PTZ00284        348 HDNLEHLHLMEK  359 (467)
T ss_pred             CChHHHHHHHHH
Confidence            877666555443

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-32  Score=219.58  Aligned_cols=188  Identities=36%  Similarity=0.682  Sum_probs=147.1

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      +.||+|+||.||+|.+...       .+...+|+|.++..........+.+|+.+++++ +||||+++++.+... ..++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l   72 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLL   72 (269)
T ss_pred             CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEE
Confidence            3689999999999975332       233458999887665444556788899999999 999999999987654 4789


Q ss_pred             EEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          95 VVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      +|||+++|+|.+++..                         .|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999999887642                         589999999999999999999999999999998864322


Q ss_pred             cccccCCCCCCCCcceeecccccccC-------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVSN-------IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~~-------~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ..... ......++..|+|||++...       .++.++|+||||+++|+|++.|..||......+....
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  221 (269)
T cd05087         153 EDYYV-TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY  221 (269)
T ss_pred             cceee-cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence            22111 11224456779999988632       2577999999999999999559999988776665443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.4e-33  Score=225.82  Aligned_cols=183  Identities=28%  Similarity=0.469  Sum_probs=152.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||++...         .++..+|+|.++.........++.+|+++++++ +||||+++++.+..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~   70 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR---------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS   70 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc---------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee
Confidence            47999999999999999999743         344568999887655555566788999999999 99999999998876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      + ..+++|||+++++|.+++..                    .|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus        71 ~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          71 DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            4 48899999999999998754                    68997 58999999999999999999999999988644


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      ...     ......++..|++||.+.+..++.++|+||||+++|+|++ |..||...+...
T Consensus       151 ~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~  205 (308)
T cd06615         151 IDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI-GRYPIPPPDAKE  205 (308)
T ss_pred             ccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCcchhh
Confidence            222     1123456778999999887778899999999999999999 999997655433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-32  Score=217.59  Aligned_cols=200  Identities=40%  Similarity=0.738  Sum_probs=161.1

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      +.||+|+||.||++....          ++.||+|.++..........+.+|+++++++ +|+||+++++++.... .++
T Consensus         1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   69 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYI   69 (251)
T ss_pred             CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEE
Confidence            468999999999997533          3459999987665555567788999999999 9999999999877644 789


Q ss_pred             EEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF  153 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (228)
                      +||++++++|.+++..                     .|||+++++|+||+|+||+++.++.++|+|||++....... .
T Consensus        70 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  148 (251)
T cd05041          70 VMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI-Y  148 (251)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc-c
Confidence            9999999999888743                     58999999999999999999999999999999886442211 1


Q ss_pred             cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       154 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .........+..|++||.+.+..++.++|+||||+++|+|+|.|..||...........+....+++.|..+|.
T Consensus       149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (251)
T cd05041         149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE  222 (251)
T ss_pred             eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence            11111122345699999988888999999999999999999868899999887777777877777777776654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-33  Score=225.90  Aligned_cols=202  Identities=24%  Similarity=0.452  Sum_probs=161.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +.|+..+.||+|+||.||+|.+.         .++..||+|.++..........+.+|+.+++++ +||||+++.+.+..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   73 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDN---------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK   73 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEc---------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc
Confidence            45778889999999999999743         334569999987554444556788999999999 89999999998766


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      +. .++|+||+++++|.+++..                   .|||+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          74 GTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            44 8899999999999887643                   699999999999999999999999999999999865433


Q ss_pred             cccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      ...   ......++..|++||.+.+..++.++|+||||+++++|++ |..||......+....+..+.++..+..+
T Consensus       154 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (277)
T cd06642         154 TQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVLFLIPKNSPPTLEGQY  225 (277)
T ss_pred             cch---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh-CCCCCcccchhhHHhhhhcCCCCCCCccc
Confidence            211   1122345677999999988888999999999999999999 99999877666666555555444444433

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-32  Score=219.05  Aligned_cols=200  Identities=26%  Similarity=0.455  Sum_probs=160.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|...         .++..||+|.++..  ........+.+|+++++++ +|+|++++++.+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~   71 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL---------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASF   71 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc---------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeee
Confidence            58999999999999999999853         34456999987642  2233456788999999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ..++ .+++|||+++++|.+++..                        .|||++|++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             ecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccc
Confidence            7654 7899999999999887642                        58999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP--LCRIVHYLSTGYRME  220 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~--~~~~~~~~~~~~~~~  220 (228)
                      ++..+.....   ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||....  ..++...+..+..++
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T cd08224         152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEKCDYPP  227 (267)
T ss_pred             eeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH-CCCCcccCCccHHHHHhhhhcCCCCC
Confidence            8865433211   1122345667999999988888999999999999999999 999996543  334556666666666


Q ss_pred             CCC
Q psy3166         221 RPA  223 (228)
Q Consensus       221 ~p~  223 (228)
                      .|.
T Consensus       228 ~~~  230 (267)
T cd08224         228 LPA  230 (267)
T ss_pred             CCh
Confidence            654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0608|consensus

Probab=100.00  E-value=9.5e-34  Score=237.59  Aligned_cols=196  Identities=23%  Similarity=0.342  Sum_probs=158.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ++-.-|.-++.||-|+||+|.+++.-         .|+..||+|.+.+.+.  ......+..|..||..- +++.||+++
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~Kv---------DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLy  695 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKV---------DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLY  695 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeec---------chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEE
Confidence            45566788899999999999998843         3455799999976632  22234567899999998 999999999


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..|++ +++|+||+|.+||++..+|-+                    ++.|..|++||||||+|||||.+|++||+|||+
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccc
Confidence            99887 569999999999999887643                    689999999999999999999999999999999


Q ss_pred             cccc---cccccccC------------------------------------CCCCCCCcceeecccccccCCCCchhhHH
Q psy3166         144 SEDI---YEQNVFQN------------------------------------GEPSEKLPIRWLALESLVSNIYTNKSDVW  184 (228)
Q Consensus       144 ~~~~---~~~~~~~~------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Diw  184 (228)
                      +..+   .++..+..                                    ...+..||..|+|||++....|+..+|+|
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww  855 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW  855 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence            7533   11111000                                    12356788999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         185 SFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       185 slg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      |.|+++|||+- |.+||-..++-+...++
T Consensus       856 s~gvil~em~~-g~~pf~~~tp~~tq~kv  883 (1034)
T KOG0608|consen  856 SVGVILYEMLV-GQPPFLADTPGETQYKV  883 (1034)
T ss_pred             HhhHHHHHHhh-CCCCccCCCCCcceeee
Confidence            99999999997 99999887776655443

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.8e-33  Score=224.98  Aligned_cols=188  Identities=31%  Similarity=0.512  Sum_probs=154.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.+-+.++|++.+.||+|+||.||++..         ..++..||+|.+..+... ..+.+.+|+.+++.+ +|+|++++
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~-~h~~i~~~   81 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAID---------IATGQEVAIKQMNLQQQP-KKELIINEILVMREN-KNPNIVNY   81 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEE---------CCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhC-CCCCEeeE
Confidence            4456678999999999999999999984         334457999998755332 235678899999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++.+..+ ..+++|||+++++|.+++.+                   .|||+.+++|+||||+||+++.++.++|+|||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~  161 (297)
T cd06656          82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  161 (297)
T ss_pred             EEEEecCCEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence            9988764 48899999999999988753                   689999999999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      +........   ......++..|++||.+.+..++.++|+||+|+++|++++ |..||.+.+.
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~t-g~~pf~~~~~  220 (297)
T cd06656         162 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENP  220 (297)
T ss_pred             ceEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCc
Confidence            865432211   1122356678999999988888999999999999999999 9999977544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-33  Score=224.97  Aligned_cols=201  Identities=25%  Similarity=0.491  Sum_probs=157.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||++.+..         ++..||+|.++..........+.+|+.+++++ +||||+++++.+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~   70 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI   70 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec
Confidence            478999999999999999998543         34569999887554444556788999999999 99999999998766


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH-----------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE-----------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      + ..+++|||+++++|.+++..                       .|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            4 48899999999999887643                       58996 59999999999999999999999999988


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSN------IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY---LST  215 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~---~~~  215 (228)
                      ..+....     .....++..|++||.+.+.      .++.++|+||+||++|+|++ |..||...+.......   +..
T Consensus       151 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  224 (286)
T cd06622         151 GNLVASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPPETYANIFAQLSAIVD  224 (286)
T ss_pred             ccccCCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHh-CCCCCCCcchhhHHHHHHHHhh
Confidence            6442221     1223456679999988543      24788999999999999999 9999987655554433   344


Q ss_pred             CCCCCCCCCCC
Q psy3166         216 GYRMERPASCN  226 (228)
Q Consensus       216 ~~~~~~p~~~~  226 (228)
                      +.+++.|..++
T Consensus       225 ~~~~~~~~~~~  235 (286)
T cd06622         225 GDPPTLPSGYS  235 (286)
T ss_pred             cCCCCCCcccC
Confidence            54555555544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0695|consensus

Probab=100.00  E-value=8.6e-34  Score=222.96  Aligned_cols=187  Identities=23%  Similarity=0.404  Sum_probs=160.0

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCce
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHI   80 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni   80 (228)
                      ++|++..++|.++.+||+|+|++|..++         .+.|++.||+|++++..  ..+.......|..++..-++||++
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~---------~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pfl  313 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVR---------LKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFL  313 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhhee---------hcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeE
Confidence            6889999999999999999999999987         56677889999998652  233445566788888888899999


Q ss_pred             EEeeeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          81 VSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        81 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +-++.+|+.. .++.|.||.+||+|.-.+++                    +|||++||+.||||.+|+|++..|++||+
T Consensus       314 vglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghiklt  393 (593)
T KOG0695|consen  314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLT  393 (593)
T ss_pred             EehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeec
Confidence            9999988764 48899999999998644433                    79999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      |+|.++.-.....   ..++.+||+.|.|||.+.+..|....|+|++|++++||+. |+.||.
T Consensus       394 dygmcke~l~~gd---~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemma-grspfd  452 (593)
T KOG0695|consen  394 DYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFD  452 (593)
T ss_pred             ccchhhcCCCCCc---ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHc-CCCCcc
Confidence            9999875444332   3456889999999999999999999999999999999999 999995

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-32  Score=217.14  Aligned_cols=202  Identities=25%  Similarity=0.371  Sum_probs=164.1

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||++...         .++..+|+|.+.... .......+.+|+++++++ +|||++++++.+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~   70 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK---------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE   70 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec
Confidence            5899999999999999998843         345579999886542 334456788999999999 99999999988765


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCC-CcEEEeeccCcc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGLSE  145 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~-~~~kl~dfg~~~  145 (228)
                      +. .+++||++++++|.+++..                      .|||+++++|+||+|+||+++.+ +.++|+|||.+.
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            44 7899999999999988753                      68999999999999999999864 568999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .......    .....++..|++||.+.+..++.++|+||+|+++++|++ |..||...+.......+..+...+.|.++
T Consensus       151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd08220         151 ILSSKSK----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS-LKRAFEAANLPALVLKIMSGTFAPISDRY  225 (256)
T ss_pred             ecCCCcc----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh-CCCCcccCchHHHHHHHHhcCCCCCCCCc
Confidence            5533211    112345678999999988888899999999999999999 99999988777777777776666677666


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      ++
T Consensus       226 ~~  227 (256)
T cd08220         226 SP  227 (256)
T ss_pred             CH
Confidence            54

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=216.85  Aligned_cols=192  Identities=29%  Similarity=0.481  Sum_probs=156.2

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      |.++|++.+.||+|+||.||+|....         ++..+++|.+...... ....+.+|+++++++ +|||++++++.+
T Consensus         1 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~-~h~~i~~~~~~~   69 (262)
T cd06613           1 PQEDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGD-DFEIIQQEISMLKEC-RHPNIVAYFGSY   69 (262)
T ss_pred             CccceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchh-hHHHHHHHHHHHHhC-CCCChhceEEEE
Confidence            57899999999999999999998533         3446999998755322 456788999999999 999999999987


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ... .++++||++++++|.+++..                     .|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        70 ~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          70 LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccch
Confidence            654 48899999999999987643                     58999999999999999999999999999999886


Q ss_pred             cccccccccCCCCCCCCcceeecccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSN---IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ......   .......++..|++||.+...   .++.++|+||+|+++|+|++ |..||...+..+....+.
T Consensus       150 ~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t-g~~p~~~~~~~~~~~~~~  217 (262)
T cd06613         150 QLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE-LQPPMFDLHPMRALFLIS  217 (262)
T ss_pred             hhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence            543321   111234566779999998766   78889999999999999999 999998877655544433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0596|consensus

Probab=100.00  E-value=1.5e-33  Score=233.07  Aligned_cols=197  Identities=27%  Similarity=0.380  Sum_probs=155.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccc-cCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +....|++++.||+||.++||+++-.+..          .||+|++. ...+.+...-+.+|+..|.+|.+|.+|+++++
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~----------iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D  427 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ----------IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD  427 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCc----------chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence            56678999999999999999998744333          38887765 33566777889999999999999999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +-..+. +|+|||+= ..+|.+.|++                     ++.|+.||+|.||||.|+|+.+ |.+||+|||+
T Consensus       428 YEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGI  505 (677)
T KOG0596|consen  428 YEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGI  505 (677)
T ss_pred             eeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeech
Confidence            866544 88999963 4577777664                     6899999999999999999985 8899999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI-----------YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-----------~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      +..+..+....-. -+-.||+.||+||.+....           .++++||||+||++|+|+. |..||....  ...++
T Consensus       506 A~aI~~DTTsI~k-dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY-gktPf~~~~--n~~aK  581 (677)
T KOG0596|consen  506 ANAIQPDTTSIVK-DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY-GKTPFGQII--NQIAK  581 (677)
T ss_pred             hcccCccccceee-ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh-cCCchHHHH--HHHHH
Confidence            9877665432222 2357899999999887332           5678999999999999997 999998853  33444


Q ss_pred             HHcCCCC
Q psy3166         213 LSTGYRM  219 (228)
Q Consensus       213 ~~~~~~~  219 (228)
                      +.....|
T Consensus       582 l~aI~~P  588 (677)
T KOG0596|consen  582 LHAITDP  588 (677)
T ss_pred             HHhhcCC
Confidence            4444444

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=223.63  Aligned_cols=195  Identities=24%  Similarity=0.345  Sum_probs=157.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--HHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--KTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|++|.||+|....         ++..||+|.+......  .....+.+|+++++++ +||||+++++.+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   70 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASF   70 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeee
Confidence            479999999999999999998433         4457999998765322  2456788999999999 899999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ..+. .+++||++.+++|.+++..                      .|||+++++|+||||+||+++.++.++|+|||++
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~  150 (316)
T cd05574          71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS  150 (316)
T ss_pred             ecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchh
Confidence            6654 7899999999999988753                      6999999999999999999999999999999987


Q ss_pred             cccccccccc--------------------------CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCC
Q psy3166         145 EDIYEQNVFQ--------------------------NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA  198 (228)
Q Consensus       145 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~  198 (228)
                      ..........                          .......|+..|++||++.+..++.++|+||||+++|+|++ |.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~-g~  229 (316)
T cd05574         151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY-GT  229 (316)
T ss_pred             hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh-CC
Confidence            6432211000                          00112356778999999988888999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHHc
Q psy3166         199 NPYPHIPLCRIVHYLST  215 (228)
Q Consensus       199 ~pf~~~~~~~~~~~~~~  215 (228)
                      .||.+.+..+....+..
T Consensus       230 ~pf~~~~~~~~~~~~~~  246 (316)
T cd05574         230 TPFKGSNRDETFSNILK  246 (316)
T ss_pred             CCCCCCchHHHHHHHhc
Confidence            99998877666555443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-32  Score=217.52  Aligned_cols=203  Identities=22%  Similarity=0.396  Sum_probs=165.6

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||++...         ..+..||+|.+... ........+.+|+.+++++ +||||+++.+.+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK---------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE   70 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc---------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC
Confidence            5899999999999999998843         34456999988643 2334456788999999999 99999999998866


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ++ .++++||+++++|.+++..                      .|||+++++|+||+|+||+++.++.++++|||++..
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            54 7899999999999887643                      589999999999999999999999999999998864


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      .......   .....++..|++||.+.+..++.++|+||||+++++|++ |..||......+....+..+..++.|..++
T Consensus       151 ~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (256)
T cd08218         151 LNSTVEL---ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLKIIRGSYPPVSSHYS  226 (256)
T ss_pred             cCcchhh---hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc-CCCCccCCCHHHHHHHHhcCCCCCCcccCC
Confidence            4322111   112345667999999988888899999999999999999 999999888888888888887777776665


Q ss_pred             C
Q psy3166         227 E  227 (228)
Q Consensus       227 ~  227 (228)
                      .
T Consensus       227 ~  227 (256)
T cd08218         227 Y  227 (256)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-32  Score=218.01  Aligned_cols=204  Identities=31%  Similarity=0.561  Sum_probs=157.6

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-----CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-----DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +|++.+.||+|+||.||+|...+          +..+|+|.++...     ......++.+|+++++++ +|+||+++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~----------~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~   69 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLG   69 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC----------CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEee
Confidence            58889999999999999987432          3458999876432     122335678899999999 8999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ++.... .++++||+++++|.+++..                    .|||+.+|+|+||+|+||++++++.++|+|||++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          70 TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            987654 7899999999999998754                    6899999999999999999999999999999988


Q ss_pred             cccccccc---ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCC
Q psy3166         145 EDIYEQNV---FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG--YRM  219 (228)
Q Consensus       145 ~~~~~~~~---~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~--~~~  219 (228)
                      ........   .........++..|++||++.+..++.++|+||+|+++|+|++ |..||...+..+....+...  ..+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  228 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFYIGAHRGLMP  228 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh-CCCccccCChHHHHHHhhhccCCCC
Confidence            65422111   1111223456778999999988888999999999999999999 99999887655444443332  233


Q ss_pred             CCCCCCC
Q psy3166         220 ERPASCN  226 (228)
Q Consensus       220 ~~p~~~~  226 (228)
                      +.|..++
T Consensus       229 ~~~~~~~  235 (265)
T cd06631         229 RLPDSFS  235 (265)
T ss_pred             CCCCCCC
Confidence            4454443

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.7e-32  Score=217.89  Aligned_cols=192  Identities=34%  Similarity=0.610  Sum_probs=148.4

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      +.||+|+||+||++......       ....+++|.++..........+.+|+.+++.+ +||||+++++.+... ..++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~l   72 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLL   72 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEE
Confidence            36999999999998753322       12236777776554445567889999999999 999999999988764 4789


Q ss_pred             EEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccc
Q psy3166          95 VVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~  150 (228)
                      +|||+++++|.+++.+                        .|||+++++|+||||+||+++.++.++|+|||++......
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            9999999999988753                        6899999999999999999999999999999987532211


Q ss_pred             ccccCCCCCCCCcceeeccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         151 NVFQNGEPSEKLPIRWLALESLVS-------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .. ........++..|++||++..       ..++.++|+||||+++|+|++.|..||...+..+....+.++
T Consensus       153 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  224 (268)
T cd05086         153 DY-IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD  224 (268)
T ss_pred             hh-hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh
Confidence            11 111223456778999998753       235678999999999999998578899888877776665444

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.7e-33  Score=221.33  Aligned_cols=191  Identities=29%  Similarity=0.445  Sum_probs=153.5

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +...+.++|++.+.||+|+||.||+|..         ..++..||+|.++.... .....+.+|+.+++.+ +||||+++
T Consensus         3 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l-~h~~ii~~   71 (267)
T cd06645           3 SRRNPQEDFELIQRIGSGTYGDVYKARN---------VNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDC-KHSNIVAY   71 (267)
T ss_pred             cccCcHHHHHHHHHhCCCCCeEEEEEEE---------cCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhC-CCCCeeeE
Confidence            3455667999999999999999999974         33445799999875532 2334577899999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++.+..+ ..+++|||+++++|.+++..                    .|||+++++|+||||+||+++.++.++|+|||
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             EEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcce
Confidence            9987664 48899999999999988653                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ++..+....   .......++..|+|||++.   ...++.++|+||+||++|+|++ |..||......+.
T Consensus       152 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~-~~~p~~~~~~~~~  217 (267)
T cd06645         152 VSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRA  217 (267)
T ss_pred             eeeEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc-CCCCcccccchhh
Confidence            986543221   1122346678899999874   4457889999999999999999 9999876554433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0983|consensus

Probab=100.00  E-value=8.1e-34  Score=217.22  Aligned_cols=200  Identities=23%  Similarity=0.349  Sum_probs=159.4

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +.++++++..||+|+-|.||+++.+         .++...|||.+..+.+.+...+++..+.++.+-.+.|.||+.+++|
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~r---------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF  160 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFR---------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF  160 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEc---------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence            4456677789999999999999844         4556799999999888888899999999888775689999999999


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hccc-CCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLS-NNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh-~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ..+. +++.||.+. ..+...+..                     .||- .++|+|||+||+|||+|..|.+||+|||++
T Consensus       161 i~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  161 ITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             eeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence            7654 788888873 233333332                     3554 458999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSN---IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRME  220 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~~~~~~~  220 (228)
                      ..+.++...+    -..|.+.|||||.+...   .|+-++|+||||++++|+.| |..||.+.+. -+++-++.+.++|-
T Consensus       240 GrlvdSkAht----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT-g~yPy~~c~tdFe~ltkvln~ePP~  314 (391)
T KOG0983|consen  240 GRLVDSKAHT----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT-GQYPYKGCKTDFEVLTKVLNEEPPL  314 (391)
T ss_pred             ceeecccccc----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc-ccCCCCCCCccHHHHHHHHhcCCCC
Confidence            8776665433    24567789999998743   58899999999999999999 9999999544 57788888865544


Q ss_pred             CC
Q psy3166         221 RP  222 (228)
Q Consensus       221 ~p  222 (228)
                      .|
T Consensus       315 L~  316 (391)
T KOG0983|consen  315 LP  316 (391)
T ss_pred             CC
Confidence            44

>KOG1094|consensus

Probab=100.00  E-value=1.8e-33  Score=233.92  Aligned_cols=210  Identities=38%  Similarity=0.740  Sum_probs=174.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+|++.+.+.++||+|-||+|-+|...+          ..+||+|.++..+....+..|..|+.+|.++ +||||+.+++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvG  602 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLG  602 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEe
Confidence            4889999999999999999999997544          3569999999887777778999999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +|..++ +++++||+.+|+|.+|+..                      .||.+.+++|||+.+.|+|++.++++||+|||
T Consensus       603 VC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  603 VCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             eeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcc
Confidence            998765 8899999999999999875                      59999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHcCCCC--
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT-LGANPYPHIPLCRIVHYLSTGYRM--  219 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t-~g~~pf~~~~~~~~~~~~~~~~~~--  219 (228)
                      .++-+-....+.- ..-..-+++|||+|.+.-+.+++++|+|+||+++||+++ +...||+.+++..+.+....-.+.  
T Consensus       683 msR~lysg~yy~v-qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  683 MSRNLYSGDYYRV-QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG  761 (807)
T ss_pred             cccccccCCceee-ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence            9874433222211 111233578999999999999999999999999999854 278999999998887766554443  


Q ss_pred             -----CCCCCCCC
Q psy3166         220 -----ERPASCNE  227 (228)
Q Consensus       220 -----~~p~~~~~  227 (228)
                           ++|.-||.
T Consensus       762 ~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  762 RQVVLSRPPACPQ  774 (807)
T ss_pred             cceeccCCCcCcH
Confidence                 35566653

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-32  Score=215.79  Aligned_cols=202  Identities=26%  Similarity=0.431  Sum_probs=164.6

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||++..         ..++..+|+|.++.+. .....+++..|+++++++ +|||++++++.+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRR---------KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIID   70 (265)
T ss_pred             CceeeeeeccCCCeEEEEeee---------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeec
Confidence            589999999999999999874         3344569999886542 344556788999999999 99999999987753


Q ss_pred             ---CceEEEEecCCCCcHHHHHHH------------------------hccc-----CCCCcccCCCCCCEeecCCCcEE
Q psy3166          90 ---DELRLVVEYCALGDLQSYLRE------------------------EYLS-----NNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        90 ---~~~~lv~e~~~~~~L~~~l~~------------------------~~lh-----~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                         ...++++||+++++|.+++..                        .++|     +.+++|+||+|+||+++.++.++
T Consensus        71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence               237899999999999887642                        5899     89999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      |+|||++.........   .....++..|++||.+....++.++|+||||+++++|++ |..||...+..++.+.+..+.
T Consensus       151 l~d~g~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  226 (265)
T cd08217         151 LGDFGLAKILGHDSSF---AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARNQLQLASKIKEGK  226 (265)
T ss_pred             EecccccccccCCccc---ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH-CCCcccCcCHHHHHHHHhcCC
Confidence            9999998765433211   112346678999999988888999999999999999999 999999988777778888876


Q ss_pred             CCCCCCCCC
Q psy3166         218 RMERPASCN  226 (228)
Q Consensus       218 ~~~~p~~~~  226 (228)
                      .++.|...+
T Consensus       227 ~~~~~~~~~  235 (265)
T cd08217         227 FRRIPYRYS  235 (265)
T ss_pred             CCCCccccC
Confidence            666665554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-32  Score=220.40  Aligned_cols=196  Identities=27%  Similarity=0.475  Sum_probs=155.2

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .+-|++.+.||+|+||.||++....         ++..+++|.+.... ......+.+|+++++.+ +|||++++++.+.
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~   72 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKS-EEELEDYMVEIDILASC-DHPNIVKLLDAFY   72 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHC-CCCCeeeEEEEEe
Confidence            3456899999999999999998543         44568888886543 34456788899999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+. .++++||+++++|..++..                     .|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus        73 ~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             eCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence            654 7899999999999876542                     699999999999999999999999999999999864


Q ss_pred             ccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      .....   .......++..|++||++.     ...++.++|+||+||++|+|++ |..||...+..+....+....++
T Consensus       153 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~  226 (282)
T cd06643         153 NTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPP  226 (282)
T ss_pred             ccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc-CCCCccccCHHHHHHHHhhcCCC
Confidence            43221   1122345677899999874     3346789999999999999999 99999988776665555554333

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.9e-32  Score=216.06  Aligned_cols=196  Identities=29%  Similarity=0.450  Sum_probs=158.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|....         ++..+|+|.+...........+.+|+.+++.+ +|+|++++.+.+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV   70 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee
Confidence            579999999999999999998533         34469999987554344557788999999999 99999999988766


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ++ .++++|++++++|.+++..                       .+||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~  150 (267)
T cd06610          71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA  150 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence            54 7899999999999888743                       58999999999999999999999999999999987


Q ss_pred             ccccccccc-CCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         146 DIYEQNVFQ-NGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       146 ~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .+....... .......++..|++||.+... .++.++|+||||+++++|++ |..||...+..+........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~  222 (267)
T cd06610         151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVLMLTLQN  222 (267)
T ss_pred             HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh-CCCCccccChhhhHHHHhcC
Confidence            554432211 112234567789999998766 68889999999999999999 99999887766655554444

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-33  Score=223.06  Aligned_cols=184  Identities=27%  Similarity=0.452  Sum_probs=152.5

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||+||++....         ++..||+|.+..........++.+|+++++.+ +||||+++++.
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   71 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGA   71 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeee
Confidence            345789999999999999999998433         34568999876554445567788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +... ..++++||+++++|.+++..                    .|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          72 FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             EecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            8764 48899999999999887653                    58996 58999999999999999999999999987


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ......     ......++..|++||++....++.++|+||+||++|++++ |..||.....
T Consensus       152 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~  207 (284)
T cd06620         152 GELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNI  207 (284)
T ss_pred             cchhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh-CCCCCcccch
Confidence            643221     1123456778999999888888999999999999999999 9999987544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.4e-32  Score=217.40  Aligned_cols=207  Identities=41%  Similarity=0.774  Sum_probs=161.1

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      |++.+.||+|+||.||+|.+...      ..++..+|+|.++.+. .....+++.+|+++++++ +||||+++++++...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   73 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE------DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRS   73 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc------CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccC
Confidence            67788999999999999986442      2345679999987553 334456788999999999 999999999987532


Q ss_pred             c-------eEEEEecCCCCcHHHHHHH--------------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          91 E-------LRLVVEYCALGDLQSYLRE--------------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        91 ~-------~~lv~e~~~~~~L~~~l~~--------------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      .       .+++++|+.+++|.+++..                          .|||+++|+|+||||+||+++.++.++
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEE
Confidence            1       3578899999998776521                          699999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      |+|||++.......... ......++..|++||.+....++.++|+|||||++|+|++.|..||.+.+..+....+..+.
T Consensus       154 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  232 (273)
T cd05074         154 VADFGLSKKIYSGDYYR-QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN  232 (273)
T ss_pred             ECcccccccccCCccee-cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999987543322111 11122344578999999888889999999999999999987899999888777777777776


Q ss_pred             CCCCCCCCC
Q psy3166         218 RMERPASCN  226 (228)
Q Consensus       218 ~~~~p~~~~  226 (228)
                      .+..+..++
T Consensus       233 ~~~~~~~~~  241 (273)
T cd05074         233 RLKQPPDCL  241 (273)
T ss_pred             cCCCCCCCC
Confidence            666555444

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-32  Score=220.22  Aligned_cols=212  Identities=37%  Similarity=0.649  Sum_probs=163.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||++.+....     ..++..+|+|.++..........+.+|+++++++ +|+||+++.+++.
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~   76 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCE   76 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeee
Confidence            467889999999999999999864321     2355679999987664444456788999999999 9999999998876


Q ss_pred             c---CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          89 K---DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        89 ~---~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .   ...+++|||+++++|.+++..                     .|||+++++|+||||+||+++.++.++|+|||.+
T Consensus        77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          77 KPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             cCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            5   247899999999999988753                     6899999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------------HH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC---------------RI  209 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~---------------~~  209 (228)
                      .................++..|++||......++.++|+||||+++++|++ |..||......               .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeec-cCCCcccccchhccccccccccccHHHH
Confidence            765432221111112233446899999988888999999999999999999 99998764322               22


Q ss_pred             HHHHHcCCCCCCCCCCCC
Q psy3166         210 VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       210 ~~~~~~~~~~~~p~~~~~  227 (228)
                      ...+....+.+.|..||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~  253 (284)
T cd05038         236 LELLKEGERLPRPPSCPD  253 (284)
T ss_pred             HHHHHcCCcCCCCccCCH
Confidence            344455555565666653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-32  Score=218.61  Aligned_cols=190  Identities=30%  Similarity=0.539  Sum_probs=151.5

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +.++|++.+.||+|+||.||+|...         .+++.||+|.+......  ...+.+|+.+++++.+|+|++++.+.+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~   72 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAF   72 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEc---------CCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence            4567999999999999999999853         34457999998654322  346778999999987799999999987


Q ss_pred             Ec-------CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          88 YK-------DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        88 ~~-------~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      ..       ...+++|||+++++|.+++..                      .|||+++|+|+|++|+||+++.++.++|
T Consensus        73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             eecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEE
Confidence            53       237899999999999987653                      5899999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      +|||++.......   .......++..|++||++.     ...++.++|+||+||++|+|++ |..||...+.......
T Consensus       153 ~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~-g~~p~~~~~~~~~~~~  227 (272)
T cd06637         153 VDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALFL  227 (272)
T ss_pred             ccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHH
Confidence            9999986542211   1122345677899999886     2357889999999999999999 9999987665444333

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG1025|consensus

Probab=100.00  E-value=6.7e-34  Score=243.98  Aligned_cols=207  Identities=40%  Similarity=0.717  Sum_probs=179.0

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceE
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELR   93 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   93 (228)
                      -.++||+|+||+||+|.|-...     .+.+-+||+|.+......+..+.++.|.-+|.++ +|||++++++++..+.+-
T Consensus       700 k~kvLGsgAfGtV~kGiw~Peg-----e~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~~q  773 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEG-----ENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLSTLQ  773 (1177)
T ss_pred             hhceeccccceeEEeeeEecCC-----ceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccchHH
Confidence            4479999999999999984432     2344469999987776666678899999999999 999999999999988888


Q ss_pred             EEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          94 LVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        94 lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +|.+|++.|+|.+|+++                     .|||+++++||||...|+|+.+...+|+.|||+++.+..+..
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999999876                     699999999999999999999999999999999987655432


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ... .......+-|||-|.+....|+.++||||||+++||++|.|..||.+.+..|+-..+++|.|++.|+.|+.
T Consensus       854 ey~-~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  854 EYS-APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             ccc-ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccH
Confidence            211 11223345699999999889999999999999999999999999999999999999999999999999985

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-32  Score=216.64  Aligned_cols=180  Identities=34%  Similarity=0.579  Sum_probs=149.3

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHH-HHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT-YDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      |++.+.||+|+||+||++..         ..++..||+|.+........ .....+|+.+++++ +||||+++.+++...
T Consensus         1 y~~~~~lg~G~~g~v~~~~~---------~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~   70 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKN---------KKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDD   70 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEE---------TTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEES
T ss_pred             CEEeEEEEeCCCEEEEEEEE---------CCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccc
Confidence            78999999999999999984         44555799999986643322 22345699999999 999999999998764


Q ss_pred             -ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          91 -ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        91 -~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                       ..+++||++++++|.+++..                    .+||+++++|+||||+||+++.++.++|+|||.+.....
T Consensus        71 ~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   71 NYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             SEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence             47899999999999998873                    599999999999999999999999999999999864311


Q ss_pred             cccccCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      ..   .......++..|+|||... ...++.++|+||+|+++++|++ |..||....
T Consensus       151 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~p~~~~~  203 (260)
T PF00069_consen  151 NN---ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT-GKLPFEESN  203 (260)
T ss_dssp             TT---SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH-SSSSSTTSS
T ss_pred             cc---cccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            11   1123355677899999988 7778999999999999999999 999999873

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-32  Score=214.94  Aligned_cols=201  Identities=30%  Similarity=0.484  Sum_probs=159.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +|+..+.||+|++|+||+|....         .+..|++|.+....    ..+....+.+|+++++++ +|+||+++.+.
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   70 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGT   70 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeee
Confidence            57888999999999999998532         34469999876432    123446788999999999 99999999998


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..+. .++++||+++++|.+++..                    .|||+.+++|+||+|+||+++.++.+||+|||++.
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          71 EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             EecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence            87644 7899999999999988754                    58999999999999999999999999999999886


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYRMERPA  223 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~-~~~~~~p~  223 (228)
                      ......    ......++..|++||.+.... ++.++|+||+|+++|+|++ |..||......+....+.. ...+..|.
T Consensus       151 ~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (258)
T cd06632         151 QVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAVFKIGRSKELPPIPD  225 (258)
T ss_pred             eccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcccCcHHHHHHHHHhcccCCCcCC
Confidence            543322    122345677899999987666 8889999999999999999 9999988766555555444 44455565


Q ss_pred             CCC
Q psy3166         224 SCN  226 (228)
Q Consensus       224 ~~~  226 (228)
                      .++
T Consensus       226 ~~~  228 (258)
T cd06632         226 HLS  228 (258)
T ss_pred             CcC
Confidence            554

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-32  Score=219.20  Aligned_cols=199  Identities=25%  Similarity=0.438  Sum_probs=157.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||++...         .++..+|+|.+....  .......+.+|+.+++.+ +||||+++++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~   71 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASF   71 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec---------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhhee
Confidence            57999999999999999999843         344569999876432  233446788999999999 999999999988


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ..+ ..+++||++++++|.+++..                        .|||+++++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          72 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcch
Confidence            764 47899999999999887642                        69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL--CRIVHYLSTGYRME  220 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~--~~~~~~~~~~~~~~  220 (228)
                      ++..+......   .....++..|++||.+.+..++.++|+||||+++|+|++ |..||.+...  .+..+.+.....++
T Consensus       152 ~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T cd08229         152 LGRFFSSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCDYPP  227 (267)
T ss_pred             hhhccccCCcc---cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh-CCCCcccccchHHHHhhhhhcCCCCC
Confidence            87654332211   122356678999999988888999999999999999999 9999976533  34455565554444


Q ss_pred             CC
Q psy3166         221 RP  222 (228)
Q Consensus       221 ~p  222 (228)
                      .|
T Consensus       228 ~~  229 (267)
T cd08229         228 LP  229 (267)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-32  Score=224.40  Aligned_cols=177  Identities=26%  Similarity=0.403  Sum_probs=136.5

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc---Cc
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK---DE   91 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~---~~   91 (228)
                      ...||+|+||+||+|+....       .++..||+|.+.....   ...+.+|+.+++++ +||||+++.+++..   ..
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~   74 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI---SMSACREIALLREL-KHPNVISLQKVFLSHADRK   74 (317)
T ss_pred             ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC---cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcE
Confidence            46899999999999985332       2345699999865422   23466899999999 99999999998754   23


Q ss_pred             eEEEEecCCCCcHHHHHHH-----------------------------hcccCCCCcccCCCCCCEee----cCCCcEEE
Q psy3166          92 LRLVVEYCALGDLQSYLRE-----------------------------EYLSNNKVVHRDLATRNILL----SSPHVVKI  138 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~-----------------------------~~lh~~~i~H~~lk~~nil~----~~~~~~kl  138 (228)
                      ++++||++.+ +|.+++..                             .|||+++|+||||||+|||+    +.++.+||
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07868          75 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence            7899999854 66555421                             69999999999999999999    45678999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      +|||++..+..............+|..|+|||++.+. .++.++|+||+||++|+|++ |..||...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~  219 (317)
T cd07868         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR  219 (317)
T ss_pred             eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh-CCCCccCC
Confidence            9999987553322111122335667889999998764 57889999999999999999 99999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-31  Score=216.67  Aligned_cols=198  Identities=28%  Similarity=0.494  Sum_probs=156.1

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.+-+.++|++.+.||+|+||.||++...         .++..+|+|.+.....  ....+.+|+.++.++.+|||++++
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~---------~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNK---------KDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEE
Confidence            34567789999999999999999999843         3445699998864422  234567899999998789999999


Q ss_pred             eeEEEc------CceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          84 IGCCYK------DELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        84 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      ++++..      +..++++||+++++|.+++..                        .|||+++++|+||||+||+++.+
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~  164 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence            998753      237899999999999887642                        58999999999999999999999


Q ss_pred             CcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI-----YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-----~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      +.++|+|||++..+......   .....++..|++||.+....     ++.++|+||+||++|+|++ |..||...+..+
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~-g~~p~~~~~~~~  240 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD-GDPPLFDMHPVK  240 (291)
T ss_pred             CCEEEeecccchhccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh-CCCCCCCCcHHH
Confidence            99999999988754332111   12235667899999876432     5789999999999999999 999999877655


Q ss_pred             HHHHHHcC
Q psy3166         209 IVHYLSTG  216 (228)
Q Consensus       209 ~~~~~~~~  216 (228)
                      ....+.+.
T Consensus       241 ~~~~~~~~  248 (291)
T cd06639         241 TLFKIPRN  248 (291)
T ss_pred             HHHHHhcC
Confidence            55555444

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1e-32  Score=218.77  Aligned_cols=200  Identities=26%  Similarity=0.392  Sum_probs=159.6

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +|++.+.||+|+||.||+|...         .++..||+|.+....  .......+.+|+++++++ +||||+++++.+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   70 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQ   70 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhc
Confidence            5899999999999999999843         345579999986542  223456788999999999 9999999998876


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .+ ..++++||+.+++|.+++..                    .|||+++++|+||+|+||++++++.++|+|||++...
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          71 DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             CCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            54 48899999999999988754                    6899999999999999999999999999999988654


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL---CRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~---~~~~~~~~~~~~~~~p~~  224 (228)
                      ....    ......++..|++||.+....++.++|+||+|+++|+|++ |..||...+.   .++.+.... .+...|..
T Consensus       151 ~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  224 (258)
T cd05578         151 TPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRGHSRTIRDQIRAKQET-ADVLYPAT  224 (258)
T ss_pred             CCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh-CCCCCCCCCccHHHHHHHHhcc-ccccCccc
Confidence            3321    1123456677999999988888999999999999999999 9999998763   333333332 34555655


Q ss_pred             CC
Q psy3166         225 CN  226 (228)
Q Consensus       225 ~~  226 (228)
                      +|
T Consensus       225 ~~  226 (258)
T cd05578         225 WS  226 (258)
T ss_pred             Cc
Confidence            55

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-32  Score=230.38  Aligned_cols=180  Identities=23%  Similarity=0.295  Sum_probs=145.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ..+|++.+.||+|+||.||++...+       ..++..||+|.+....      ...+|+++|+++ +||||+++++.+.
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~~------~~~~E~~il~~l-~h~~iv~~~~~~~  156 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGGK------TPGREIDILKTI-SHRAIINLIHAYR  156 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEeccccc------cHHHHHHHHHhc-CCCCccceeeeEe
Confidence            4579999999999999999987432       2345569999876431      235799999999 9999999998876


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .. ..+++||++. ++|.+++..                    .|||+++|+||||||+|||++.++.++|+|||++..+
T Consensus       157 ~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        157 WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             eCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            54 4789999985 578777643                    6999999999999999999999999999999998654


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      ...... .......||..|+|||++....++.++|+||+||++|+|++ |..||.+..
T Consensus       236 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~  291 (392)
T PHA03207        236 DAHPDT-PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV-KNVTLFGKQ  291 (392)
T ss_pred             Cccccc-ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence            332111 11123467889999999998889999999999999999999 999997754

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-32  Score=220.93  Aligned_cols=193  Identities=32%  Similarity=0.512  Sum_probs=156.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.|.+.++|++.+.||+|+||.||++...         .++..||+|.+..... ...+.+.+|+.+++++ +|||++++
T Consensus        13 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~hp~i~~~   81 (293)
T cd06647          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDV---------ATGQEVAIKQMNLQQQ-PKKELIINEILVMREN-KHPNIVNY   81 (293)
T ss_pred             eccCchhhceeeeEecCCCCeEEEEEEEc---------CCCCEEEEEEeccccc-hHHHHHHHHHHHHhhc-CCCCeeeh
Confidence            35677889999999999999999999743         3344699998864422 2346678899999999 89999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++.+..+ ..++|+||+++++|.+++..                   .|||+++++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             hheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcc
Confidence            9988664 48899999999999988754                   689999999999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      +........   ......++..|++||.+....++.++|+||||+++|++++ |..||...+..+...
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~-g~~pf~~~~~~~~~~  225 (293)
T cd06647         162 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALY  225 (293)
T ss_pred             eeccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhee
Confidence            764433221   1122456677999999988788899999999999999999 999998766544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.6e-32  Score=217.27  Aligned_cols=198  Identities=25%  Similarity=0.432  Sum_probs=149.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||++.+.         .++..||+|.++.........++..|+..+.+..+|||++++++.+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHV---------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEc---------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            47999999999999999999843         445679999987654333344566677765555499999999998865


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH------------------------hcccCC-CCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE------------------------EYLSNN-KVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~-~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      + .++++|||++ ++|.+++..                        .|||++ +++|+||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            4 4889999996 577665532                        699997 999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeeccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVS----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-LCRIVHYLSTGYR  218 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~-~~~~~~~~~~~~~  218 (228)
                      +..+....    ......++..|++||.+.+    ..++.++|+||+||++|+|++ |..||.... ..+.......+..
T Consensus       151 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  225 (283)
T cd06617         151 SGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT-GRFPYDSWKTPFQQLKQVVEEPS  225 (283)
T ss_pred             cccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh-CCCCCCccccCHHHHHHHHhcCC
Confidence            87543221    1122345677999998864    346789999999999999999 999997643 2344444445545


Q ss_pred             CCCC
Q psy3166         219 MERP  222 (228)
Q Consensus       219 ~~~p  222 (228)
                      +..|
T Consensus       226 ~~~~  229 (283)
T cd06617         226 PQLP  229 (283)
T ss_pred             CCCC
Confidence            5444

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-31  Score=213.06  Aligned_cols=201  Identities=27%  Similarity=0.453  Sum_probs=162.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|++|.||+|...         .++..|++|.+...........+.+|+..+.++ +|+|++++.+.+..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK---------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYK   70 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc---------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcc
Confidence            47899999999999999999843         345579999987665444557788999999999 89999999998876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      + ..++++||+++++|.+++..                    .|+|+ ++++|+||+|+||+++.++.++|+|||.+..+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          71 EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            4 48899999999999998763                    69999 99999999999999999999999999988755


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI---PLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~---~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ......   .....++..|++||.+....++.++|+||||+++|+|++ |..||...   ...+....+.....+..+..
T Consensus       151 ~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (264)
T cd06623         151 ENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL-GKFPFLPPGQPSFFELMQAICDGPPPSLPAE  226 (264)
T ss_pred             ccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCccccccCHHHHHHHHhcCCCCCCCcc
Confidence            332211   112345667999999988888999999999999999999 99999887   33445555555544444444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.6e-32  Score=217.56  Aligned_cols=188  Identities=28%  Similarity=0.435  Sum_probs=150.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ..+.++|++.+.||+|+||.||+|...         .++..||+|.+..... .....+.+|+.+++++ +||||+++++
T Consensus         5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~-~h~~ii~~~~   73 (267)
T cd06646           5 RNPQHDYELIQRVGSGTYGDVYKARNL---------HTGELAAVKIIKLEPG-DDFSLIQQEIFMVKEC-KHCNIVAYFG   73 (267)
T ss_pred             cCchhhcchhheeecCCCeEEEEEEEC---------CCCeEEEEEEEecCcc-chHHHHHHHHHHHHhc-CCCCeeeeeE
Confidence            346678999999999999999999843         3445699998864422 2234577899999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .+..+. .+++|||+++++|.+++..                    +|||+++|+|+|++|+||+++.++.++|+|||++
T Consensus        74 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccc
Confidence            886644 7899999999999987643                    6999999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      ..+....   .......++..|++||.+.   ...++.++|+||+||++|+|++ |..||......+
T Consensus       154 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~-g~~p~~~~~~~~  216 (267)
T cd06646         154 AKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMR  216 (267)
T ss_pred             eeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhh
Confidence            7543221   1112345667899999875   3346789999999999999999 999997655443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.5e-32  Score=214.23  Aligned_cols=203  Identities=27%  Similarity=0.473  Sum_probs=159.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|.+.+.||+|+||.||++....         .+..|++|.++.+.. ......+.+|+++++++ +|+||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~   70 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH   70 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec
Confidence            68999999999999999998433         344699999876533 24567788999999999 99999999998765


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      . ..++++||+++++|.+++..                    .|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          71 REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             CCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            4 47899999999999988754                    69999999999999999999999999999999987554


Q ss_pred             ccccccCC-CCCCCCcceeecccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCC
Q psy3166         149 EQNVFQNG-EPSEKLPIRWLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRMERPA  223 (228)
Q Consensus       149 ~~~~~~~~-~~~~~~~~~~~~Pe~~~~~~---~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~~~~~~~~p~  223 (228)
                      ........ .....++..|++||.+....   ++.++|+||||++++++++ |..||...+. ......+..+.++..|.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  229 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDNEFQIMFHVGAGHKPPIPD  229 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh-CCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence            33221111 11234567899999988665   7889999999999999999 9999987633 33344455555555554


Q ss_pred             C
Q psy3166         224 S  224 (228)
Q Consensus       224 ~  224 (228)
                      .
T Consensus       230 ~  230 (264)
T cd06626         230 S  230 (264)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=224.16  Aligned_cols=187  Identities=24%  Similarity=0.396  Sum_probs=147.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|...         .++..||+|.++.........++.+|+.+++++ +||||+++++++..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~   74 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHK---------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRP   74 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEc---------CCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeec
Confidence            68999999999999999999843         345579999986543344456678899999999 89999999987643


Q ss_pred             C------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          90 D------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        90 ~------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .      ..++++|++.+ ++.+.+..                   .+||+++|+|+||||+||+++.++.++|+|||++
T Consensus        75 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          75 PSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             ccccccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence            2      36899999964 77665442                   6899999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      .................++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~-G~~~f~~~~~~~  217 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPLFPGKDYLH  217 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            754332211111223456778999998754 457889999999999999999 999998765433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.6e-32  Score=216.89  Aligned_cols=196  Identities=30%  Similarity=0.509  Sum_probs=153.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      .+...++|++.+.||+|+||.||++...         .++..+|+|.++....  ....+.+|+.+++++.+||||++++
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~   81 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNK---------KNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFY   81 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEEC---------CCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeee
Confidence            3557789999999999999999999843         3445699998764322  2245678999999996799999999


Q ss_pred             eEEEc------CceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCC
Q psy3166          85 GCCYK------DELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPH  134 (228)
Q Consensus        85 ~~~~~------~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~  134 (228)
                      +++..      +..+++|||+++++|.+++..                        .|||+++++|+||||+||+++.++
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~  161 (286)
T cd06638          82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC
Confidence            98742      237899999999999876531                        589999999999999999999999


Q ss_pred             cEEEeeccCcccccccccccCCCCCCCCcceeeccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         135 VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      .++|+|||++..+.....   ......++..|+|||++..     ..++.++|+||+||++|+|++ |..||......+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~-g~~p~~~~~~~~~  237 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD-GDPPLADLHPMRA  237 (286)
T ss_pred             CEEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc-CCCCCCCCchhHH
Confidence            999999999875432211   1122356778999998753     347889999999999999999 9999988765444


Q ss_pred             HHHHHc
Q psy3166         210 VHYLST  215 (228)
Q Consensus       210 ~~~~~~  215 (228)
                      ...+..
T Consensus       238 ~~~~~~  243 (286)
T cd06638         238 LFKIPR  243 (286)
T ss_pred             Hhhccc
Confidence            433333

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.8e-32  Score=218.07  Aligned_cols=199  Identities=30%  Similarity=0.512  Sum_probs=159.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||++...         .+++.+|+|.+..........++.+|+++++++ +||||+++++.+..
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~   70 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYN   70 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeec
Confidence            47889999999999999999853         344569999987665555567788999999999 79999999998766


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      +. .++++|++++++|.+++..                     .|+|+ .+++|+||+|+||+++.++.++|+|||.+..
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          71 NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence            54 7899999999999988753                     68999 9999999999999999999999999998865


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-----LCRIVHYLSTGYRMER  221 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~-----~~~~~~~~~~~~~~~~  221 (228)
                      +.....     ....++..|++||.+.+..++.++|+||+|+++++|++ |..||....     ..+..+.+..+..+..
T Consensus       151 ~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (265)
T cd06605         151 LVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYPPENDPPDGIFELLQYIVNEPPPRL  224 (265)
T ss_pred             hHHHHh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHHHhcCCCCCC
Confidence            432211     11456678999999988889999999999999999999 999997652     2344455555545444


Q ss_pred             CCC
Q psy3166         222 PAS  224 (228)
Q Consensus       222 p~~  224 (228)
                      |..
T Consensus       225 ~~~  227 (265)
T cd06605         225 PSG  227 (265)
T ss_pred             Chh
Confidence            443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-32  Score=218.22  Aligned_cols=182  Identities=27%  Similarity=0.477  Sum_probs=144.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|++|.||+|..+         .++..||+|.+...........+.+|+++++++ +|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~   73 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSK---------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIH   73 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEc---------CCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEe
Confidence            368999999999999999999843         334569999986543222223466899999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+. .++||||+++ +|.+++..                     .|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          74 TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             cCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence            654 7899999975 88877643                     699999999999999999999999999999998753


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      .....   .......++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+..
T Consensus       153 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~  208 (291)
T cd07844         153 KSVPS---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT-GRPLFPGST  208 (291)
T ss_pred             cCCCC---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCc
Confidence            32111   11112234667999998875 457889999999999999999 999997765

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-32  Score=217.16  Aligned_cols=193  Identities=24%  Similarity=0.508  Sum_probs=154.2

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC--CCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG--KHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--~h~ni~~~~~~~~   88 (228)
                      .|++.+.||+|+||.||+|.+.         .++..||+|.++.+........+.+|+.+++++.  .|||++++.+.+.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV---------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc---------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence            5888999999999999999853         3445799999876544444567788999999994  3999999999886


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      .+. .+++|||+++++|.+++..                   .|||+.+|+|+||+|+||+++.++.++|+|||++....
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            654 7899999999999888654                   68999999999999999999999999999999887554


Q ss_pred             ccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ....   ......++..|+|||.+... .++.++|+||||+++|+|++ |..||...+.......+...
T Consensus       153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~  217 (277)
T cd06917         153 QNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAMMLIPKS  217 (277)
T ss_pred             CCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh-CCCCCCCCChhhhhhccccC
Confidence            3321   11223567789999988754 46889999999999999999 99999887655444433333

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0614|consensus

Probab=100.00  E-value=4.9e-34  Score=234.01  Aligned_cols=206  Identities=25%  Similarity=0.398  Sum_probs=173.7

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .....++++....||-|+||.|=++...+.         ...+|+|++++..  ..+..+.+..|-.+|... +.|.|++
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvr  484 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVR  484 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHH
Confidence            356677889999999999999998764322         2258999998653  334456788999999999 8999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++..|-++. +|++||-|-||.|...++.                    .|||++||+.|||||+|.+++.+|.+||.||
T Consensus       485 LYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDF  564 (732)
T KOG0614|consen  485 LYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDF  564 (732)
T ss_pred             HHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeeh
Confidence            998776655 7899999999999988765                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM-E  220 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~-~  220 (228)
                      |+++.+......    -+.+||+.|.|||++.....+.++|.||||+++||+++ |.+||++.++..+.+.+.+|... .
T Consensus       565 GFAKki~~g~KT----wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~-G~pPFs~~dpmktYn~ILkGid~i~  639 (732)
T KOG0614|consen  565 GFAKKIGSGRKT----WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT-GSPPFSGVDPMKTYNLILKGIDKIE  639 (732)
T ss_pred             hhHHHhccCCce----eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHhhhhhhh
Confidence            999877554322    24789999999999999999999999999999999999 99999999999999999998654 3


Q ss_pred             CCCCC
Q psy3166         221 RPASC  225 (228)
Q Consensus       221 ~p~~~  225 (228)
                      .|...
T Consensus       640 ~Pr~I  644 (732)
T KOG0614|consen  640 FPRRI  644 (732)
T ss_pred             ccccc
Confidence            55443

>KOG0579|consensus

Probab=100.00  E-value=7.3e-34  Score=238.48  Aligned_cols=198  Identities=24%  Similarity=0.472  Sum_probs=164.2

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE-
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC-   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~-   87 (228)
                      .+-|+|+..||.|+||+||+|.         .+.++...|.|.+... ..+.+++++-|+++|... +||+|+++++.| 
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~---------nket~~lAAaKvIetk-seEELEDylVEIeILa~C-dHP~ivkLl~ayy   99 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAV---------NKETKLLAAAKVIETK-SEEELEDYLVEIEILAEC-DHPVIVKLLSAYY   99 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhh---------cccchhhhhhhhhccc-chhHHhhhhhhhhhhhcC-CChHHHHHHHHHh
Confidence            3445889999999999999987         4455556678887654 345678999999999999 899999999875 


Q ss_pred             EcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      +.+.++++.|||+||.+...+-+                     +|||+++|+|||||.-|||+..+|.++|+|||.+..
T Consensus       100 ~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  100 FENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             ccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc
Confidence            45679999999999988766543                     799999999999999999999999999999998753


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS-----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      ....   ....-+..||+.|||||+..+     .+|+.++||||||+++.+|.. +.+|-+...++.++-++.+-.+|..
T Consensus       180 n~~t---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnpMRVllKiaKSePPTL  255 (1187)
T KOG0579|consen  180 NKST---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPPTL  255 (1187)
T ss_pred             chhH---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc-cCCCccccchHHHHHHHhhcCCCcc
Confidence            2211   122346789999999998763     469999999999999999998 9999999999999888888766653

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.4e-32  Score=217.15  Aligned_cols=191  Identities=26%  Similarity=0.396  Sum_probs=153.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||+|.+..         ++..||+|.+..... ......+.+|+.+++++ +|||++++++++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~   70 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH   70 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec
Confidence            58999999999999999998533         345699999875532 33446788999999999 89999999998876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      +. .++|+|++ +++|.+++..                     .|||+++++|+||||+||+++.++.++|+|||.+...
T Consensus        71 ~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          71 GSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             CCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            54 78999999 9999987643                     6899999999999999999999999999999988755


Q ss_pred             cccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .....  .......++..|++||.+... .++.++|+||+|+++++|++ |..||.+.++.+....+..
T Consensus       150 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~~  215 (286)
T cd07832         150 SEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN-GSPLFPGENDIEQLAIVFR  215 (286)
T ss_pred             cCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc-CCcCcCCCCHHHHHHHHHH
Confidence            33221  112234567789999988654 46889999999999999999 9888988776665554443

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-32  Score=222.09  Aligned_cols=198  Identities=27%  Similarity=0.460  Sum_probs=158.2

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.+-+.+.|.....||+|+||.||++...         .++..||+|.+.... ......+.+|+.+++++ +|+|++++
T Consensus        16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~ii~~   84 (292)
T cd06658          16 SPGDPREYLDSFIKIGEGSTGIVCIATEK---------HTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDY-HHENVVDM   84 (292)
T ss_pred             ccCchHHHHhhhhcccCCCCeEEEEEEEC---------CCCCEEEEEEEecch-HHHHHHHHHHHHHHHhC-CCCcHHHH
Confidence            34455677777889999999999998743         344569999886442 33446688999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++.+..+ ..+++|||+++++|.+++..                   .|||+++|+|+||||+||+++.++.++|+|||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~  164 (292)
T cd06658          85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF  164 (292)
T ss_pred             HHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcc
Confidence            9887664 47899999999999887643                   699999999999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +.......   .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+...
T Consensus       165 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~  233 (292)
T cd06658         165 CAQVSKEV---PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMRRIRDN  233 (292)
T ss_pred             hhhccccc---ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence            86442221   11122456778999999988888999999999999999999 99999887766655555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-31  Score=213.73  Aligned_cols=191  Identities=28%  Similarity=0.498  Sum_probs=154.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|+..+.||.|++|.||++...         .++..+|+|.+..........++.+|+++++++ +||||+++++++..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   70 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLK---------NTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLD   70 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEEC---------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEc
Confidence            47999999999999999999853         345679999987654444556788999999999 89999999998754


Q ss_pred             ---CceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          90 ---DELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        90 ---~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                         +.++++|||+++++|.+++..                        .|||+.+++|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          71 ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             cCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecc
Confidence               247899999999999877542                        58999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI-----PLCRIVHYLSTG  216 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~-----~~~~~~~~~~~~  216 (228)
                      ++.......     .....++..|++||.+.+..++.++|+||+|+++|+|++ |..||...     ...+....+...
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd06621         151 VSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ-NRFPFPPEGEPPLGPIELLSYIVNM  223 (287)
T ss_pred             ccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcccCCCCChHHHHHHHhcC
Confidence            976443221     112345667999999988889999999999999999999 99999765     223444444443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0574|consensus

Probab=100.00  E-value=3.4e-35  Score=227.73  Aligned_cols=186  Identities=29%  Similarity=0.576  Sum_probs=160.6

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      |.+.|.+..+||+|+||.|+++.         ++++++.+|+|++....   .++.+..|+.+|.+. +.|+|+++++.+
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAI---------H~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC-~S~yVVKYYGSY   97 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAI---------HRESGHVLAIKKVPVDT---DLQEIIKEISIMQQC-KSKYVVKYYGSY   97 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHH---------HhccCcEEEEEecCccc---hHHHHHHHHHHHHHc-CCchhhhhhhhh
Confidence            44567889999999999999976         67777889999987553   346778999999999 999999999987


Q ss_pred             Ec-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +. ..+++|||||..|++.+.++.                     +|||...-+|||||.-|||++.+|..||+|||.+.
T Consensus        98 FK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAG  177 (502)
T KOG0574|consen   98 FKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAG  177 (502)
T ss_pred             ccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccc
Confidence            65 569999999999999987653                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV  210 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~  210 (228)
                      .+-+....   .....||+-|||||++..-.|+.++||||||++..||.. |++||.+.++...+
T Consensus       178 QLTDTMAK---RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE-G~PPYsDIHPMRAI  238 (502)
T KOG0574|consen  178 QLTDTMAK---RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE-GRPPYSDIHPMRAI  238 (502)
T ss_pred             hhhhhHHh---hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc-CCCCccccccccee
Confidence            65444332   346789999999999999999999999999999999998 99999998766444

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.6e-32  Score=216.54  Aligned_cols=196  Identities=29%  Similarity=0.511  Sum_probs=154.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .-+.+.|++.+.||+|+||.||+|...         .++..+|+|.+....  .....+..|+.+++++.+|+|++++++
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~   80 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYG   80 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEee
Confidence            356789999999999999999999853         344569999876442  233567789999999878999999999


Q ss_pred             EEEc-------CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcE
Q psy3166          86 CCYK-------DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        86 ~~~~-------~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~  136 (228)
                      ++..       +..+++|||+++++|.+++..                      .|||+++|+|+|++|+||+++.++.+
T Consensus        81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence            8742       347899999999999887753                      69999999999999999999999999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      +|+|||++.......   .......++..|+|||.+.     ...++.++|+||||+++|+|++ |..||......+...
T Consensus       161 ~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~  236 (282)
T cd06636         161 KLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE-GAPPLCDMHPMRALF  236 (282)
T ss_pred             EEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh-CCCCccccCHHhhhh
Confidence            999999876442211   1122345677899999875     2347789999999999999999 999998766554444


Q ss_pred             HHHcC
Q psy3166         212 YLSTG  216 (228)
Q Consensus       212 ~~~~~  216 (228)
                      .+...
T Consensus       237 ~~~~~  241 (282)
T cd06636         237 LIPRN  241 (282)
T ss_pred             hHhhC
Confidence            44433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-31  Score=220.18  Aligned_cols=190  Identities=22%  Similarity=0.327  Sum_probs=146.6

Q ss_pred             eeeeeeee--cCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          14 LGEVLGQG--EFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        14 ~~~~ig~g--~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      ++++||+|  +|++||++.         +..++..||+|.++... .......+.+|+.+++.+ +||||+++++++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~   71 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLAR---------YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD   71 (327)
T ss_pred             hhhhccccccceEEEEEEe---------ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC
Confidence            57889999  678999987         44455679999987542 334445677899999999 999999999988765


Q ss_pred             c-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          91 E-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        91 ~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      + .++||||+++++|.+++..                      .|||+++|+||||||+||+++.++.+++.||+.....
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            4 8899999999999888642                      6999999999999999999999999999999865332


Q ss_pred             cccccc----cCCCCCCCCcceeeccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         148 YEQNVF----QNGEPSEKLPIRWLALESLVS--NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       148 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ......    ........++..|+|||++.+  ..++.++|+||+||++|+|++ |..||.............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  223 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLLEKL  223 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchhHHHHHHh
Confidence            211100    001112234566999999875  358899999999999999999 999998876555444333

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.6e-32  Score=216.12  Aligned_cols=189  Identities=26%  Similarity=0.407  Sum_probs=150.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.+.... .....+.+.+|+.+++++ +|||++++.+++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~   70 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR---------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFR   70 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC---------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEe
Confidence            57999999999999999999853         344569999876442 222334577899999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .+. .+++|||++++++..++..                    .|||+++++|+||||+||++++++.++|+|||++..+
T Consensus        71 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          71 RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             eCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            654 7899999998888776532                    6999999999999999999999999999999998755


Q ss_pred             cccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ......   .....++..|++||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..+....
T Consensus       151 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~-g~~p~~~~~~~~~~~~  212 (286)
T cd07847         151 TGPGDD---YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT-GQPLWPGKSDVDQLYL  212 (286)
T ss_pred             CCCccc---ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence            332211   112345567999999875 457889999999999999999 9999998776555443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG1006|consensus

Probab=100.00  E-value=2.7e-34  Score=218.90  Aligned_cols=201  Identities=26%  Similarity=0.390  Sum_probs=160.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.+..++++-+..||.|+||+|+|-+         ++.+++..|||+++.....+.+++++.|.+...+-.+.|||++++
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~---------hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKML---------HKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhh---------cCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            34556677777899999999999976         677778899999987766677889999999888877899999999


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH-------------------------hccc-CCCCcccCCCCCCEeecCCCcEE
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE-------------------------EYLS-NNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~-------------------------~~lh-~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      |..+. +..++.||++ ..+|..+...                         +||- ...|+|||+||+|||++..|.+|
T Consensus       130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence            98665 5688999998 4466554322                         3554 34799999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLS  214 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~  214 (228)
                      |+|||++..+.++...+    -..|...|||||.+...  .|+-++|+||||+++||+.| |..||.+.+. -+.+.++.
T Consensus       209 LCDFGIcGqLv~SiAkT----~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAt-G~fPyr~w~svfeql~~Vv  283 (361)
T KOG1006|consen  209 LCDFGICGQLVDSIAKT----VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVAT-GNFPYRKWDSVFEQLCQVV  283 (361)
T ss_pred             eecccchHhHHHHHHhh----hccCCccccChhccCCccCCcchhhhhhhhcceEeeeec-CCCCcchHHHHHHHHHHHH
Confidence            99999987665554332    23455669999998743  58999999999999999999 9999999654 45566777


Q ss_pred             cCCCCC
Q psy3166         215 TGYRME  220 (228)
Q Consensus       215 ~~~~~~  220 (228)
                      .|..|.
T Consensus       284 ~gdpp~  289 (361)
T KOG1006|consen  284 IGDPPI  289 (361)
T ss_pred             cCCCCe
Confidence            775443

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.4e-32  Score=212.76  Aligned_cols=185  Identities=32%  Similarity=0.592  Sum_probs=153.6

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      |.++|++.+.||+|+||.||+|.+..         .+..+++|.++....   .+.+.+|+++++++ +|||++++.+.+
T Consensus         1 ~~~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l-~~~~i~~~~~~~   67 (256)
T cd06612           1 PEEVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED---LQEIIKEISILKQC-DSPYIVKYYGSY   67 (256)
T ss_pred             CcccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH---HHHHHHHHHHHHhC-CCCcEeeeeeee
Confidence            56899999999999999999998544         334699999865422   56788999999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..+. .++++|++++++|.+++..                     .|||+.+++|+|++|+||+++.++.++|+|||++.
T Consensus        68 ~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             ecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccch
Confidence            7654 7899999999999988753                     68999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      .......   ......++..|++||.+.+..++.++|+||||+++|+|++ |..||...+..+.
T Consensus       148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~-g~~p~~~~~~~~~  207 (256)
T cd06612         148 QLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIHPMRA  207 (256)
T ss_pred             hcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCcchhhh
Confidence            5433211   1122345678999999988888999999999999999999 9999987655443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=2.5e-31  Score=214.52  Aligned_cols=183  Identities=26%  Similarity=0.455  Sum_probs=144.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|...         .++..||+|.++..........+.+|+.+++.+ +|+||+++.+++.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~   73 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISR---------INGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIH   73 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEc---------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEe
Confidence            478999999999999999999843         334469999987553333234567899999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+. .++++|++. +++.+++..                     .|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  152 (291)
T cd07870          74 TKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA  152 (291)
T ss_pred             cCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence            654 789999995 566555432                     689999999999999999999999999999998864


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ......   ......++..|++||.+.+. .++.++|+||||+++|+|++ |..||.+.+.
T Consensus       153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~f~~~~~  209 (291)
T cd07870         153 KSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ-GQPAFPGVSD  209 (291)
T ss_pred             cCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCchh
Confidence            322111   11223456789999988754 47889999999999999999 9999987543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=8.9e-32  Score=219.58  Aligned_cols=177  Identities=26%  Similarity=0.403  Sum_probs=136.5

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc---Cc
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK---DE   91 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~---~~   91 (228)
                      ...||+|+||+||+|....+       .+...||+|.++....   ...+.+|+.+++++ +||||+++.+++..   ..
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~   74 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI---SMSACREIALLREL-KHPNVIALQKVFLSHSDRK   74 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC---cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCe
Confidence            36899999999999985432       2345699998865422   23567899999999 99999999998753   34


Q ss_pred             eEEEEecCCCCcHHHHHHH-----------------------------hcccCCCCcccCCCCCCEee----cCCCcEEE
Q psy3166          92 LRLVVEYCALGDLQSYLRE-----------------------------EYLSNNKVVHRDLATRNILL----SSPHVVKI  138 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~-----------------------------~~lh~~~i~H~~lk~~nil~----~~~~~~kl  138 (228)
                      .++++||+.+ +|.+++..                             .|||+++|+||||||+||++    +.++.+||
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          75 VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence            7899999864 66555421                             69999999999999999999    45678999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      +|||++..+..............++..|+|||++.+. .++.++|+||+||++|+|+| |..||...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t-g~~~f~~~  219 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR  219 (317)
T ss_pred             eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh-CCCCcccc
Confidence            9999987553322111122334567789999998764 47899999999999999999 99999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0984|consensus

Probab=99.98  E-value=1.1e-32  Score=203.27  Aligned_cols=203  Identities=26%  Similarity=0.412  Sum_probs=164.2

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .++.+++.-+..||+|+||.|-+.+         +.+.+...|+|.+....+.+.+.+.++|+.+..+-...|.++.+++
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmr---------h~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyG  112 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMR---------HIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYG  112 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhhee---------eccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence            4667777788899999999988766         6667778999999888778888889999998887768999999999


Q ss_pred             EEE-cCceEEEEecCCCCcHHHHHHH------------------------hcccCC-CCcccCCCCCCEeecCCCcEEEe
Q psy3166          86 CCY-KDELRLVVEYCALGDLQSYLRE------------------------EYLSNN-KVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        86 ~~~-~~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~-~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ... ...+++.||.+ ..+|..|-.+                        .|||++ .++|||+||+||||+..|++|++
T Consensus       113 a~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  113 ALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             hhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEc
Confidence            755 46799999998 4477666443                        588876 79999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeeccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS----NIYTNKSDVWSFGVVLWEIVTLGANPYPHI-PLCRIVHYLS  214 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~-~~~~~~~~~~  214 (228)
                      |||++..+.++...+    ...|+-.|||||.+..    ..|+.++|+||||+++.||.+ ++.||... ++-+.+.++.
T Consensus       192 DFGIsG~L~dSiAkt----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~-lr~PY~~w~tpF~qLkqvV  266 (282)
T KOG0984|consen  192 DFGISGYLVDSIAKT----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI-LRFPYESWGTPFQQLKQVV  266 (282)
T ss_pred             ccccceeehhhhHHH----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh-ccccccccCCHHHHHHHHh
Confidence            999998776654332    1234446999998863    368999999999999999999 99999884 5556688887


Q ss_pred             cCCCCCCCC
Q psy3166         215 TGYRMERPA  223 (228)
Q Consensus       215 ~~~~~~~p~  223 (228)
                      +.-.|..|.
T Consensus       267 eep~P~Lp~  275 (282)
T KOG0984|consen  267 EEPSPQLPA  275 (282)
T ss_pred             cCCCCCCcc
Confidence            775555553

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=1.6e-31  Score=221.59  Aligned_cols=188  Identities=23%  Similarity=0.345  Sum_probs=150.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|..         ..++..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   84 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYD---------TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVF   84 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEE---------CCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeee
Confidence            47899999999999999999984         3445579999986432 333445677899999999 999999999987


Q ss_pred             EcC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          88 YKD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        88 ~~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ...       ..+++||++.+ +|.+.+..                  .|||++|++|+||||+||+++.++.++|+|||
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             ccCCCccccCcEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            542       36899999954 67665432                  69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ++........    .....++..|+|||.+.+..++.++|+||+||++|+|++ |..||...+.......
T Consensus       164 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~  228 (353)
T cd07850         164 LARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GTVLFPGTDHIDQWNK  228 (353)
T ss_pred             cceeCCCCCC----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence            9875432211    122345678999999988889999999999999999999 9999988765444433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=1.9e-31  Score=212.02  Aligned_cols=194  Identities=26%  Similarity=0.445  Sum_probs=154.8

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      ||.|++|.||+++...         ++..+|+|.+....  .......+.+|+.+++++ +||||+++.+.+..+. .++
T Consensus         1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   70 (262)
T cd05572           1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYM   70 (262)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEE
Confidence            6899999999998533         44579999986543  223446788999999999 9999999999876654 889


Q ss_pred             EEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ  154 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (228)
                      ++||+++++|.+++..                    .|+|+++++|+||+|+||+++.++.++|+|||++.......   
T Consensus        71 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          71 LMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             EEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            9999999999988754                    68999999999999999999999999999999987553321   


Q ss_pred             CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-CCCCCCCCCCC
Q psy3166         155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP--LCRIVHYLST-GYRMERPASCN  226 (228)
Q Consensus       155 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~--~~~~~~~~~~-~~~~~~p~~~~  226 (228)
                       ......++..|++||.+....++.++|+||+|+++|+|++ |..||....  ..+..+.+.. ...++.|..++
T Consensus       148 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (262)
T cd05572         148 -KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYNDILKGNGKLEFPNYID  220 (262)
T ss_pred             -ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh-CCCCcCCCCCCHHHHHHHHhccCCCCCCCcccC
Confidence             1122345667999999888788999999999999999999 999998876  5555555553 33555666554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=1.5e-31  Score=211.88  Aligned_cols=196  Identities=29%  Similarity=0.497  Sum_probs=150.1

Q ss_pred             eeeeeecCceEEEeeecCCCCC-CCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTE-GASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~l   94 (228)
                      +.||+|+||.||+|....+... .........+++|.+......  ...+.+|+.+++++ +||||+++++++.....++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQL-SHKHLVKLYGVCVRDENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcC-CCcchhheeeEEecCCcEE
Confidence            4689999999999997654311 011223345788877654322  46788999999999 9999999999887767899


Q ss_pred             EEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCC-------cEEEeeccCccc
Q psy3166          95 VVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPH-------VVKISDFGLSED  146 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~-------~~kl~dfg~~~~  146 (228)
                      +|||+++++|.+++..                     .|||+++|+|+||||+||+++.++       .++|+|||++..
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~  157 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT  157 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence            9999999999988764                     689999999999999999999877       799999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      ....       ....++..|++||++...  .++.++|+||||+++|++++.|..||...+..+.........+.+.
T Consensus       158 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  227 (259)
T cd05037         158 VLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM  227 (259)
T ss_pred             cccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC
Confidence            4321       123344569999998876  6889999999999999999855888888765554444443333333

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0577|consensus

Probab=99.98  E-value=1.9e-33  Score=234.23  Aligned_cols=195  Identities=25%  Similarity=0.446  Sum_probs=159.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ...|.=++.||.|+||.||-|+         +..+...||||+++-+.  ..+.++++..|+..|.++ .|||++.+.++
T Consensus        25 Eklf~dLrEIGHGSFGAVYfAr---------d~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgC   94 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGC   94 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEee---------ccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccce
Confidence            3446667899999999999988         44555679999987442  345578899999999999 99999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +.... .++|||||-| +-.|.+..                     .|||+.+.+|||||.-|||+...|.|||.|||-+
T Consensus        95 yLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen   95 YLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             eeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccch
Confidence            87755 7899999954 55554432                     6999999999999999999999999999999987


Q ss_pred             ccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      ....+       ..+..||+.|||||++.   .+.|+.++||||||++..|+.. ..+|+..|..+..+-.|.....|..
T Consensus       174 si~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE-RkPPlFnMNAMSALYHIAQNesPtL  245 (948)
T KOG0577|consen  174 SIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPTL  245 (948)
T ss_pred             hhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhh-cCCCccCchHHHHHHHHHhcCCCCC
Confidence            64433       34578899999999987   4579999999999999999998 9999998888777666655545544


Q ss_pred             C
Q psy3166         222 P  222 (228)
Q Consensus       222 p  222 (228)
                      +
T Consensus       246 q  246 (948)
T KOG0577|consen  246 Q  246 (948)
T ss_pred             C
Confidence            3

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=3.4e-32  Score=220.49  Aligned_cols=196  Identities=27%  Similarity=0.443  Sum_probs=156.9

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +-+...|+....||+|+||.||++...         ..+..||+|.++.... .....+.+|+.++..+ +|||++++++
T Consensus        17 ~~~~~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~hp~i~~~~~   85 (297)
T cd06659          17 GDPRSLLENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDY-QHQNVVEMYK   85 (297)
T ss_pred             ccchhhHHhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEeccc-chHHHHHHHHHHHHhC-CCCchhhhhh
Confidence            334566777789999999999998743         3445699999865422 2345678899999999 9999999999


Q ss_pred             EEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          86 CCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        86 ~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+..+ ..++++||+++++|.+++..                   .|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~  165 (297)
T cd06659          86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA  165 (297)
T ss_pred             heeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence            87654 48899999999999887643                   68999999999999999999999999999999886


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .+.....   ......++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+....+...
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~  232 (297)
T cd06659         166 QISKDVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDS  232 (297)
T ss_pred             hcccccc---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc
Confidence            4432211   1123456778999999988888999999999999999999 99999887766666555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0604|consensus

Probab=99.98  E-value=6.9e-33  Score=214.34  Aligned_cols=192  Identities=28%  Similarity=0.446  Sum_probs=155.6

Q ss_pred             Cceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++. ++||-|-.|+|..+.         ++.|++++|+|.+.-.      ..+.+|+++.-+.+.|||||.+++++.
T Consensus        61 edY~is~qvLG~GinGkV~~C~---------~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVye  125 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCV---------HKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYE  125 (400)
T ss_pred             hhheehhhhhccccCCceEEEE---------eccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhh
Confidence            456444 799999999999998         5667778999998532      455689998888889999999999985


Q ss_pred             c---Cc--eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC---CCcEEE
Q psy3166          89 K---DE--LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS---PHVVKI  138 (228)
Q Consensus        89 ~---~~--~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~---~~~~kl  138 (228)
                      +   +.  +.+|||.+.||.|++.+++                      .|||+.+|.||||||+|+|...   +..+||
T Consensus       126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence            4   22  6689999999999999876                      6999999999999999999975   558999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR----IVHYLS  214 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~----~~~~~~  214 (228)
                      +|||+++.-...    ....+.+.|+-|.|||++-...|+..+|+||+|+++|-|++ |.+||-+.+...    +..+++
T Consensus       206 tDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC-GyPPFYS~hg~aispgMk~rI~  280 (400)
T KOG0604|consen  206 TDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKRRIR  280 (400)
T ss_pred             cccccccccCCC----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc-CCCcccccCCccCChhHHhHhh
Confidence            999999854332    22345677888999999998889999999999999999998 999998876532    344566


Q ss_pred             cCCCCCCC
Q psy3166         215 TGYRMERP  222 (228)
Q Consensus       215 ~~~~~~~p  222 (228)
                      .| ..++|
T Consensus       281 ~g-qy~FP  287 (400)
T KOG0604|consen  281 TG-QYEFP  287 (400)
T ss_pred             cc-CccCC
Confidence            66 55555

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.98  E-value=2.1e-31  Score=214.16  Aligned_cols=182  Identities=27%  Similarity=0.457  Sum_probs=144.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|++|.||+|...         .++..||+|.++.... ......+.+|+.+++++ +|||++++++.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   70 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK---------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ   70 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC---------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee
Confidence            5899999999999999999843         3445799998864422 22234677899999999 89999999999876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      + ..+++|||++ ++|.+++..                       .|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  149 (285)
T cd07861          71 ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR  149 (285)
T ss_pred             CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECccccee
Confidence            4 4889999997 577766532                       69999999999999999999999999999999986


Q ss_pred             cccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      ......   .......++..|+|||.+.+. .++.++|+|||||++|+|+| |..||.+.+..
T Consensus       150 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~~~~~~~~~  208 (285)
T cd07861         150 AFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEI  208 (285)
T ss_pred             ecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH-CCCCCCCCCHH
Confidence            443221   111123446679999988654 46889999999999999999 99999876554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.98  E-value=1.8e-31  Score=214.36  Aligned_cols=189  Identities=29%  Similarity=0.464  Sum_probs=150.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      +|++.+.||+|++|.||+|+..         .++..||+|.++..........+.+|+.+++++ +|||++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   70 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR---------TTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTE   70 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC---------CCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeC
Confidence            5899999999999999999843         345579999987654333345667899999999 999999999998764


Q ss_pred             -ceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          91 -ELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        91 -~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                       ..+++|||+++ +|.+++..                       .|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        71 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~  149 (284)
T cd07836          71 NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA  149 (284)
T ss_pred             CcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence             47899999975 77776542                       699999999999999999999999999999998864


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ......   ......++..|++||++.+. .++.++|+||+|+++|+|++ |..||.+.+..+...++.
T Consensus       150 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~  214 (284)
T cd07836         150 FGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLKIF  214 (284)
T ss_pred             hcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Confidence            432211   11223456679999988654 46889999999999999999 999999877666555443

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.7e-31  Score=212.03  Aligned_cols=194  Identities=30%  Similarity=0.518  Sum_probs=154.2

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +.++|++.+.||+|++|.||+|....         ++..+++|.+.....  ...++.+|+.+++++.+|+||+++++++
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~   72 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAF   72 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEE
Confidence            56899999999999999999998533         345699998875432  3357889999999997799999999988


Q ss_pred             EcCc-------eEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcE
Q psy3166          88 YKDE-------LRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        88 ~~~~-------~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~  136 (228)
                      ....       .+++|||+++++|.+++..                        .|||+++++|+||+|+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             EecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeE
Confidence            5432       7899999999998877542                        58999999999999999999999999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-----IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      +|+|||.+.......   .......++..|+|||.+...     .++.++|+||+|+++|+|++ |..||..........
T Consensus       153 ~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~  228 (275)
T cd06608         153 KLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD-GKPPLCDMHPMRALF  228 (275)
T ss_pred             EECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh-CCCCccccchHHHHH
Confidence            999999886443221   112234567789999987532     36778999999999999999 999998766555555


Q ss_pred             HHHcC
Q psy3166         212 YLSTG  216 (228)
Q Consensus       212 ~~~~~  216 (228)
                      ++.++
T Consensus       229 ~~~~~  233 (275)
T cd06608         229 KIPRN  233 (275)
T ss_pred             Hhhcc
Confidence            55544

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=2.2e-31  Score=210.48  Aligned_cols=200  Identities=27%  Similarity=0.424  Sum_probs=163.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||++...         .++..+++|.+.... .......+.+|+++++++ +|+||+++.+++..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL---------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLD   70 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC---------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhcc
Confidence            5899999999999999998743         344569999987542 334456678899999999 89999999988766


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      + ..++++|++++++|.+++..                        .+||++|++|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccch
Confidence            4 47899999999999887643                        5899999999999999999999999999999988


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ......     ......++..|++||.+.+..++.++|+||+|+++++|++ |..||...+..++...+..+..++.|.+
T Consensus       151 ~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd08530         151 KVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT-FAPPFEARSMQDLRYKVQRGKYPPIPPI  224 (256)
T ss_pred             hhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCchh
Confidence            755333     1112345677999999988888889999999999999999 9999999888877777777766666655


Q ss_pred             CC
Q psy3166         225 CN  226 (228)
Q Consensus       225 ~~  226 (228)
                      .+
T Consensus       225 ~~  226 (256)
T cd08530         225 YS  226 (256)
T ss_pred             hC
Confidence            44

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=5e-31  Score=211.32  Aligned_cols=191  Identities=28%  Similarity=0.429  Sum_probs=143.5

Q ss_pred             eeeeecCceEEEeeecCCCCC---------------CCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166          17 VLGQGEFGVVVKGLLGDGPTE---------------GASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus        17 ~ig~g~~~~V~~~~~~~~~~~---------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .||+|+||.||+|....+...               ..+......|++|.+.... ......+.+|..+++.+ +||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l-~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQV-SHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcC-CCCCee
Confidence            699999999999986432210               1122334568899886442 23345678889999999 999999


Q ss_pred             EeeeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCC-----
Q psy3166          82 SFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPH-----  134 (228)
Q Consensus        82 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~-----  134 (228)
                      ++++++..+ ..++||||+++++|.+++..                     .|||+++|+||||||+||+++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999998764 47899999999999888753                     699999999999999999997643     


Q ss_pred             --cEEEeeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         135 --VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       135 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                        .++++|||++......       ....++..|++||.+.. ..++.++|+||||+++|+++..|..||......+...
T Consensus       160 ~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             cceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence              4899999987532211       12344567999998865 4578999999999999999543999998876665544


Q ss_pred             HHHcC
Q psy3166         212 YLSTG  216 (228)
Q Consensus       212 ~~~~~  216 (228)
                      .....
T Consensus       233 ~~~~~  237 (274)
T cd05076         233 FYEKK  237 (274)
T ss_pred             HHHhc
Confidence            44433

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=3.1e-31  Score=213.87  Aligned_cols=206  Identities=27%  Similarity=0.371  Sum_probs=155.6

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +|++.+.||+|+||.||++.....      ..++..||+|.++...   .....+.+.+|+.+++++.+|+||+.+.+.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~------~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG------HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC------CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            588999999999999999875332      2345679999986532   1223456778999999997799999999888


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. .++++||+++++|.+++..                    .|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            7655 7899999999999998754                    689999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLSTGYRME  220 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Diwslg~~~~~l~t~g~~pf~~~~----~~~~~~~~~~~~~~~  220 (228)
                      .......  ......++..|++||.+...  .++.++|+||||+++|+|++ |..||....    ..++.+.+... .++
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~  230 (290)
T cd05613         155 FHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPFTVDGEKNSQAEISRRILKS-EPP  230 (290)
T ss_pred             ccccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc-CCCCCCcCCccccHHHHHHHhhcc-CCC
Confidence            4332111  11223466789999998753  46788999999999999999 999996432    23334444443 344


Q ss_pred             CCCCCC
Q psy3166         221 RPASCN  226 (228)
Q Consensus       221 ~p~~~~  226 (228)
                      .|..++
T Consensus       231 ~~~~~~  236 (290)
T cd05613         231 YPQEMS  236 (290)
T ss_pred             CCccCC
Confidence            454443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.98  E-value=4.4e-31  Score=212.77  Aligned_cols=195  Identities=27%  Similarity=0.446  Sum_probs=156.9

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +..+|.-...||+|++|.||++....         .+..+++|.++... ....+.+.+|+.+++++ +|||++++++.+
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~   85 (285)
T cd06648          17 PRSYLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRK-QQRRELLFNEVVIMRDY-QHPNIVEMYSSY   85 (285)
T ss_pred             chHhhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccc-hhHHHHHHHHHHHHHHc-CCCChheEEEEE
Confidence            34567777899999999999998433         34469999876442 23345678899999999 999999999987


Q ss_pred             Ec-CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          88 YK-DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        88 ~~-~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .. +..++++||+++++|.+++..                   .+||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus        86 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          86 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EcCCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            65 458899999999999987643                   6999999999999999999999999999999987644


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ....   .......++..|++||...+..++.++|+||+|+++|+|++ |..||...+..+..+++..+.
T Consensus       166 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~  231 (285)
T cd06648         166 SKEV---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKRIRDNL  231 (285)
T ss_pred             ccCC---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHhcC
Confidence            3221   11122456778999999988888999999999999999999 999998877666666666653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.5e-31  Score=206.53  Aligned_cols=203  Identities=29%  Similarity=0.517  Sum_probs=163.5

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|++|.||++....         .+..|++|.+..... ......+.+|+++++++ +|||++++.+++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIET   70 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEe
Confidence            58899999999999999998433         344699999875532 24456788999999999 99999999998766


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      .. .++++|++++++|.+++..                    .+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          71 SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            44 7899999999999887653                    58999999999999999999999999999999987553


Q ss_pred             ccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .....   .....++..|++||......++.++|+|++|+++++|++ |..||...+..+..........++.|..+++
T Consensus       151 ~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (254)
T cd06627         151 DVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQDDHPPLPEGISP  225 (254)
T ss_pred             CCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhccCCCCCCCCCCH
Confidence            32211   123456678999999887778889999999999999999 9999988776666666555556666666543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=1.3e-31  Score=222.38  Aligned_cols=173  Identities=23%  Similarity=0.334  Sum_probs=139.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ..+|++.+.||+|+||.||+|....         ++..||+|.....       ....|+.+++++ +||||+++++++.
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~  127 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG-------TTLIEAMLLQNV-NHPSVIRMKDTLV  127 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc-------ccHHHHHHHHhC-CCCCCcChhheEE
Confidence            3579999999999999999998543         3446899975433       224689999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ... .+++||++. ++|.+++..                     .|||+++|+||||||+||+++.++.++|+|||++..
T Consensus       128 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        128 SGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             eCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            655 789999985 578777643                     699999999999999999999999999999999864


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      .....    ......|+..|+|||++.+..++.++|+|||||++|+|++.+..+|..
T Consensus       207 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        207 PVVAP----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             cccCc----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            32211    112345778899999999888999999999999999999855555554

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.3e-31  Score=211.96  Aligned_cols=184  Identities=28%  Similarity=0.457  Sum_probs=147.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-----HHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-----AKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +|+..+.||+|+||.||++..         ..++..+|+|.++....     ......+.+|+.+++++ +|+|++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~   70 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARD---------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLG   70 (268)
T ss_pred             CccccceecCcCceEEEEEEE---------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhc
Confidence            578889999999999999874         33445799998864321     12346788999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC-cEEEeeccC
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGL  143 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~dfg~  143 (228)
                      ++...+ .++++||+++++|.+++.+                    .|||+++++|+||+|+||+++.++ .++|+|||.
T Consensus        71 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          71 ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            987644 7899999999999988754                    699999999999999999998775 699999999


Q ss_pred             ccccccccccc-CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         144 SEDIYEQNVFQ-NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       144 ~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +..+....... .......++..|++||.+.+..++.++|+||+|+++++|++ |..||....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  212 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAEK  212 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Confidence            86554321110 11122356678999999988888999999999999999999 999997544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=6.6e-31  Score=209.98  Aligned_cols=190  Identities=29%  Similarity=0.502  Sum_probs=149.0

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC---------HHHHHHHHHHHHHHHhcCCCCceE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD---------AKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      +|.+.+.||+|+||.||+|...         .++..+|+|.++....         ....+.+.+|+.+++++ +|||++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~   71 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV---------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIV   71 (272)
T ss_pred             ceeecceecccCceEEEEEeec---------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcc
Confidence            5889999999999999999743         3445699998753211         11234567899999999 999999


Q ss_pred             EeeeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          82 SFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        82 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++++... ..+++|||+++++|.+++..                    .|||+++++|+||+|+||+++.++.++++|
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          72 QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             eEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEee
Confidence            999987664 47899999999999988654                    689999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ||++........ ........++..|++||.+....  ++.++|+||+|++++++++ |..||......+....
T Consensus       152 ~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~  223 (272)
T cd06629         152 FGISKKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPWSDEEAIAAMFK  223 (272)
T ss_pred             cccccccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh-CCCCCcCcchHHHHHH
Confidence            998864322110 11122345677899999987654  7889999999999999999 9999987665544433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=4e-31  Score=214.81  Aligned_cols=202  Identities=24%  Similarity=0.377  Sum_probs=154.7

Q ss_pred             CccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCce
Q psy3166           2 ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHI   80 (228)
Q Consensus         2 ~~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni   80 (228)
                      |.+++-+.++|++.+.||+|+||.||+|...         .++..||+|.+...... .....+.+|+++++++ +||||
T Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i   73 (310)
T cd07865           4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHK---------KTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENV   73 (310)
T ss_pred             cCcccchhhheEEEEEeecCCCEEEEEEEEC---------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCc
Confidence            4567778889999999999999999999843         34567999988644221 2223456899999999 99999


Q ss_pred             EEeeeEEEcC---------ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEee
Q psy3166          81 VSFIGCCYKD---------ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        81 ~~~~~~~~~~---------~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                      +++++++...         ..+++|||+.+ +|.+.+..                     .|||+++++|+||||+||++
T Consensus        74 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~  152 (310)
T cd07865          74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI  152 (310)
T ss_pred             cceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999987542         25899999964 66665432                     69999999999999999999


Q ss_pred             cCCCcEEEeeccCcccccccccc-cCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         131 SSPHVVKISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      +.++.++|+|||++..+...... ........++..|+|||.+.+.. ++.++|+||+|+++|+|++ |..||.+.+...
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t-~~~~~~~~~~~~  231 (310)
T cd07865         153 TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQH  231 (310)
T ss_pred             CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            99999999999998755332111 11112334567799999886543 6889999999999999999 999998877665


Q ss_pred             HHHHHHc
Q psy3166         209 IVHYLST  215 (228)
Q Consensus       209 ~~~~~~~  215 (228)
                      ....+..
T Consensus       232 ~~~~~~~  238 (310)
T cd07865         232 QLTLISQ  238 (310)
T ss_pred             HHHHHHH
Confidence            5444333

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=3.2e-31  Score=209.80  Aligned_cols=202  Identities=27%  Similarity=0.462  Sum_probs=159.9

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||++....         .+..+|+|.+.... .......+.+|+++++++ +|+|++++++.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~   70 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE   70 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc
Confidence            58999999999999999998543         33458999886532 123345677899999999 99999999998766


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCC-cEEEeeccCcc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSE  145 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~dfg~~~  145 (228)
                      +. .++++||+++++|.+++..                      .|||+++++|+||+|+||+++.++ .++|+|||.+.
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccch
Confidence            54 7899999999999887643                      689999999999999999999875 57999999887


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      ........   .....++..|+|||......++.++|+||||+++++|++ |..||......+...++..+...+.+...
T Consensus       151 ~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (257)
T cd08225         151 QLNDSMEL---AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-LKHPFEGNNLHQLVLKICQGYFAPISPNF  226 (257)
T ss_pred             hccCCccc---ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhcccCCCCCCCC
Confidence            55332211   112346778999999888888999999999999999999 99999887777676666666555555443


Q ss_pred             C
Q psy3166         226 N  226 (228)
Q Consensus       226 ~  226 (228)
                      +
T Consensus       227 ~  227 (257)
T cd08225         227 S  227 (257)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=3.2e-31  Score=212.96  Aligned_cols=195  Identities=26%  Similarity=0.357  Sum_probs=142.4

Q ss_pred             eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhc--CCCCceEEeeeEEEc-Cc
Q psy3166          17 VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDV--GKHDHIVSFIGCCYK-DE   91 (228)
Q Consensus        17 ~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l--~~h~ni~~~~~~~~~-~~   91 (228)
                      .||+|+||.||++...         .++..+|+|.+.....  ........+|..+++.+  .+|||++.+.+.+.. +.
T Consensus         1 ~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEEC---------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            4899999999998843         3445799998865421  11122334444433332  279999999988765 45


Q ss_pred             eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          92 LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      .++||||+++++|.+++..                    .|||+++|+|+||||+||+++.++.++|+|||++.......
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            8899999999999888653                    69999999999999999999999999999999886442221


Q ss_pred             cccCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCC
Q psy3166         152 VFQNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL--CRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       152 ~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~--~~~~~~~~~~~~~~~p~~~~  226 (228)
                           .....++..|++||.+. +..++.++|+||+||++|+|++ |..||.....  .+.........+...|..++
T Consensus       152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (279)
T cd05633         152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS  223 (279)
T ss_pred             -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcCCCCCcCHHHHHHHhhcCCcCCccccC
Confidence                 12245678899999886 3557899999999999999999 9999976432  22333333333445555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.6e-31  Score=230.55  Aligned_cols=187  Identities=20%  Similarity=0.315  Sum_probs=137.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCC------ccccee----eeeeccccCCCHHHHHHHHHHHHHHHhcCCCCc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGAS------GQAAME----VAVKMLKANADAKTYDKFLKEINLMKDVGKHDH   79 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~------~~~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~n   79 (228)
                      ++|++.+.||+|+||+||+|..+........      ...+..    ++.|.++.  .......+.+|+.+|+++ +|||
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~Ei~il~~l-~Hpn  224 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA--GSRAAIQLENEILALGRL-NHEN  224 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc--chHHHHHHHHHHHHHHhC-CCCC
Confidence            5799999999999999999876542211000      000011    11222221  123345678999999999 9999


Q ss_pred             eEEeeeEEEcCc-eEEEEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          80 IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        80 i~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      |+++++++.... .+++++++. +++.+++..                         .|||+++|+||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            999999987644 788888874 455554321                         69999999999999999999999


Q ss_pred             CcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCC
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA-NPYPH  203 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~-~pf~~  203 (228)
                      +.+||+|||++..+......  ......|+..|++||++.+..++.++|||||||++|+|++ |. .||..
T Consensus       304 ~~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-~~~~p~~~  371 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREA--FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS-HDFCPIGD  371 (501)
T ss_pred             CCEEEEeCCCceecCccccc--ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH-CCCCCccC
Confidence            99999999998765432211  1123467888999999998889999999999999999999 65 55644

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=3.9e-31  Score=215.26  Aligned_cols=194  Identities=26%  Similarity=0.413  Sum_probs=152.5

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+.++|++.+.||+|+||.||+|...         .++..||+|.++.... ........+|+.+++++ +|+|++++.+
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~   73 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDT---------TSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKE   73 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEE
Confidence            35679999999999999999999843         3445799999864422 11123456799999999 9999999999


Q ss_pred             EEEcC---ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          86 CCYKD---ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        86 ~~~~~---~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++...   ..+++||++.+ +|.+++..                     .|||+++++|+||||+||+++.++.++|+||
T Consensus        74 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             EEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcc
Confidence            88653   37899999964 66665442                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      |++........   ......++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||...+..+.+..+..
T Consensus       153 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~~f~~~~~~~~~~~~~~  223 (309)
T cd07845         153 GLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA-HKPLLPGKSEIEQLDLIIQ  223 (309)
T ss_pred             ceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            99875533211   1112233567999998865 457889999999999999999 9999999888777766554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=4.6e-31  Score=212.38  Aligned_cols=189  Identities=25%  Similarity=0.421  Sum_probs=151.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|....         ++..||+|.++... .......+.+|+++++++ +|+||+++.+++.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   70 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFR   70 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEE
Confidence            479999999999999999998543         34579999987542 233346788999999999 8999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .+. .++++||++++.+..+...                    .|||+++++|+|++|+||+++.++.++|+|||++...
T Consensus        71 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          71 RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             ECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            644 8899999988776654432                    6999999999999999999999999999999998755


Q ss_pred             cccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      .....  .......++..|++||++... .++.++|+||+|+++|+|++ |..||.+....+...
T Consensus       151 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~  212 (288)
T cd07833         151 RARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD-GEPLFPGDSDIDQLY  212 (288)
T ss_pred             CCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            43321  011223456679999999877 78899999999999999999 999998866554433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.2e-30  Score=212.34  Aligned_cols=195  Identities=25%  Similarity=0.440  Sum_probs=153.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ..+.++|++.+.||+|+||.||+|....         .+..||+|.+....  .......+.+|+.+++++ +|||++++
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~   80 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEY   80 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEE
Confidence            5677889999999999999999998533         34579999886432  233445688999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      .+++..+ ..++++||+.+ ++.+++..                     .|||+++++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~df  159 (307)
T cd06607          81 KGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADF  159 (307)
T ss_pred             EEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeec
Confidence            9998764 47899999964 55555432                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      |++......       ....++..|+|||++.   ...++.++|+||||+++|+|++ |..||...+.......+....+
T Consensus       160 g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  231 (307)
T cd06607         160 GSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNDS  231 (307)
T ss_pred             CcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCC
Confidence            988643221       1234566799999874   3457889999999999999999 9999988766555444444433


Q ss_pred             C
Q psy3166         219 M  219 (228)
Q Consensus       219 ~  219 (228)
                      +
T Consensus       232 ~  232 (307)
T cd06607         232 P  232 (307)
T ss_pred             C
Confidence            3

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.5e-31  Score=226.33  Aligned_cols=173  Identities=23%  Similarity=0.301  Sum_probs=139.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ...|.+.+.||+|+||.||++....         ++..||+|....       ..+.+|+++|+++ +|+||+++++++.
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~-------~~~~~E~~iL~~L-~HpnIv~l~~~~~  230 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY-------ASSVHEARLLRRL-SHPAVLALLDVRV  230 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc-------cCHHHHHHHHHHC-CCCCCCcEEEEEE
Confidence            3479999999999999999998543         445799996432       2345799999999 9999999999876


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+ ..+++||++. ++|.+++..                     .|||++||+||||||+|||++.++.++|+|||+++.
T Consensus       231 ~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        231 VGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             ECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            54 4789999984 578777643                     699999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY  201 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf  201 (228)
                      +...... .......||..|++||++.+..++.++|+|||||++|||++ |..|+
T Consensus       310 ~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~-g~~~l  362 (461)
T PHA03211        310 ARGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV-HTASL  362 (461)
T ss_pred             ccccccc-ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHH-cCCCc
Confidence            4322111 11123467889999999998889999999999999999998 66543

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=9.4e-31  Score=208.76  Aligned_cols=199  Identities=25%  Similarity=0.414  Sum_probs=156.1

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC---------CCHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN---------ADAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .|++.+.||+|+||.||++.+..+        .+..+|+|.+...         .......++.+|+.++.+..+|||++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~   72 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV   72 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence            488899999999999999986442        2346899987532         12233456778888887644999999


Q ss_pred             EeeeEEEcCc-eEEEEecCCCCcHHHHHHH------------------------hcccC-CCCcccCCCCCCEeecCCCc
Q psy3166          82 SFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------------EYLSN-NKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        82 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------~~lh~-~~i~H~~lk~~nil~~~~~~  135 (228)
                      ++++.+..+. .+++|||+++++|.+++..                        .|||+ .+++|+||+|+||+++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc
Confidence            9999887644 7899999999999877532                        58996 78999999999999999999


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ++|+|||.+.......    ......++..|++||.+.+..++.++|+||||+++|+|++ |..||...........+..
T Consensus       153 ~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~  227 (269)
T cd08528         153 VTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVE  227 (269)
T ss_pred             EEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh-CCCcccccCHHHHHHHHhh
Confidence            9999999987543322    1223456778999999988888999999999999999999 9999988776666666665


Q ss_pred             CCCCCCC
Q psy3166         216 GYRMERP  222 (228)
Q Consensus       216 ~~~~~~p  222 (228)
                      +...+.+
T Consensus       228 ~~~~~~~  234 (269)
T cd08528         228 AVYEPLP  234 (269)
T ss_pred             ccCCcCC
Confidence            5444443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1.2e-30  Score=208.15  Aligned_cols=184  Identities=28%  Similarity=0.488  Sum_probs=145.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..+++.....||+|+||.||+|.+..         ++..||+|.+.... ....+.+.+|+.+++++ +|+||+++.++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~   73 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERD-SRYVQPLHEEIALHSYL-KHRNIVQYLGS   73 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCC-HHHHHHHHHHHHHHHhc-CCCCeeeeeee
Confidence            344555566799999999999998433         34569999876543 33446788999999999 99999999998


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecC-CCcEEEeec
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSS-PHVVKISDF  141 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~df  141 (228)
                      +..+. .++++|++++++|.+++..                       .|||+++|+|+||||+||+++. ++.++|+||
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             eccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecc
Confidence            76654 7899999999999987653                       5899999999999999999986 679999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      |.+..+.....   ......++..|++||.+....  ++.++|+||+|+++|+|++ |..||....
T Consensus       154 g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~-g~~p~~~~~  215 (268)
T cd06624         154 GTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELG  215 (268)
T ss_pred             hhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh-CCCCCcccc
Confidence            98865432211   112234567899999986543  7889999999999999999 999997654

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=1.8e-31  Score=214.53  Aligned_cols=188  Identities=27%  Similarity=0.482  Sum_probs=144.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||+|+..         .++..+|+|.++..... .....+.+|+.+++++ +|||++++++++..
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~---------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~   70 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS   70 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC---------CCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc
Confidence            5899999999999999999843         34457999988644222 2224567899999999 99999999998866


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .. .++++||+.+ +|.+++..                     .|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus        71 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          71 DKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             CCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            44 7899999964 77766542                     6999999999999999999999999999999998754


Q ss_pred             cccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANP-YPHIPLCRIVHYL  213 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~p-f~~~~~~~~~~~~  213 (228)
                      .....   ......++..|+|||.+.+. .++.++|+||+||++|+|+| |..| |.+.+..+.++.+
T Consensus       150 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~  213 (284)
T cd07839         150 GIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRI  213 (284)
T ss_pred             CCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHh-cCCCCcCCCCHHHHHHHH
Confidence            32211   11223456779999988764 46889999999999999999 7777 4555544444443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.6e-31  Score=207.72  Aligned_cols=184  Identities=24%  Similarity=0.348  Sum_probs=146.3

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-e
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-L   92 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~   92 (228)
                      +.||+|+||.||+|...         ..+..||+|.++....  .........|..++....+|+|++++++.+..+. .
T Consensus         2 ~~l~~g~~~~v~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKR---------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEec---------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            57999999999999843         3445699999865421  1112234455555555548999999999987654 7


Q ss_pred             EEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          93 RLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      ++++||+++++|.+++..                    .|||+.+++|+||+|+||+++.++.++|+|||++.....   
T Consensus        73 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  149 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---  149 (260)
T ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence            899999999999988754                    699999999999999999999999999999998764322   


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                          .....++..|++||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+..+
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  208 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSR  208 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhc
Confidence                122345667999999888778899999999999999999 99999988877776666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=9.5e-31  Score=206.72  Aligned_cols=203  Identities=26%  Similarity=0.413  Sum_probs=166.1

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|.+.+.||+|+||.||++...         .++..+++|.+..... ......+.+|+++++.+ +|||++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~   70 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK---------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEE   70 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc---------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEec
Confidence            5899999999999999999853         3445799999875532 34456788999999999 89999999998766


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      + ..++++|++++++|.+++..                        .+||+++++|+||+|+||+++.++.++|+|||.+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccce
Confidence            4 47899999999999887653                        5899999999999999999999999999999988


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      ........   ......++..|++||......++.++|+||+|+++++|++ |..||...+..++..........+.|..
T Consensus       151 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (258)
T cd08215         151 KVLSSTVD---LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT-LKHPFEGENLLELALKILKGQYPPIPSQ  226 (258)
T ss_pred             eecccCcc---eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc-CCCCCCCCcHHHHHHHHhcCCCCCCCCC
Confidence            65433221   1122356677999999888888999999999999999998 9999998887888888777766677766


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      ++.
T Consensus       227 ~~~  229 (258)
T cd08215         227 YSS  229 (258)
T ss_pred             CCH
Confidence            553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG2345|consensus

Probab=99.97  E-value=2.6e-32  Score=206.01  Aligned_cols=186  Identities=22%  Similarity=0.341  Sum_probs=149.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .|+.++|++.+.+|+|||+.|+++.         +..+++.||+|++.-.. .+..+..++|++..+++ +|||++++.+
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~---------~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf-~s~~vl~l~d   85 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVK---------GLSTGHLYALKKILCHS-QEDIEEALREIDNHRKF-NSPNVLRLVD   85 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeec---------ccCcccchhhheeeccc-hHHHHHHHHHHHHHHhh-CCcchHHHHH
Confidence            5788999999999999999999976         44566789999986543 45667889999999999 9999999987


Q ss_pred             EEEc------CceEEEEecCCCCcHHHHHHH------------------------hcccCCC--CcccCCCCCCEeecCC
Q psy3166          86 CCYK------DELRLVVEYCALGDLQSYLRE------------------------EYLSNNK--VVHRDLATRNILLSSP  133 (228)
Q Consensus        86 ~~~~------~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~--i~H~~lk~~nil~~~~  133 (228)
                      ....      ...|+++.|...|+|.+.+..                        +++|+..  .+||||||.||++...
T Consensus        86 h~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~  165 (302)
T KOG2345|consen   86 HQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS  165 (302)
T ss_pred             HHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC
Confidence            6421      238999999999999998875                        6899998  9999999999999999


Q ss_pred             CcEEEeeccCccccccccccc------CCCCCCCCcceeecccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQ------NGEPSEKLPIRWLALESLVSN---IYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      +.++++|||-+........-.      ........|..|.|||.+..+   ..+.++|||||||++|.|+- |..||..
T Consensus       166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf-~~sPfe~  243 (302)
T KOG2345|consen  166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF-GESPFER  243 (302)
T ss_pred             CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH-cCCcchH
Confidence            999999999765332211000      011223446779999988744   46789999999999999997 9999864

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=5.1e-31  Score=211.37  Aligned_cols=174  Identities=27%  Similarity=0.375  Sum_probs=140.8

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRL   94 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~l   94 (228)
                      ||+|+||+||++....         +++.||+|.+..+..  ......+..|+.+++++ +||||+++.+.+... ..++
T Consensus         1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l   70 (277)
T cd05577           1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCL   70 (277)
T ss_pred             CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEE
Confidence            6899999999987433         445699998864321  12234567899999999 899999999888664 4889


Q ss_pred             EEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV  152 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (228)
                      +|||+++++|.+++..                      .|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus        71 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  150 (277)
T cd05577          71 VMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK  150 (277)
T ss_pred             EEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence            9999999999887653                      589999999999999999999999999999998865433211


Q ss_pred             ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       153 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                          .....++..|++||++.+..++.++|+||+|+++|+|++ |..||.....
T Consensus       151 ----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~  199 (277)
T cd05577         151 ----IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKE  199 (277)
T ss_pred             ----cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhh-CCCCCCCCcc
Confidence                122345667999999988888999999999999999999 9999977543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2e-30  Score=206.45  Aligned_cols=185  Identities=30%  Similarity=0.541  Sum_probs=140.9

Q ss_pred             eeeeeecCceEEEeeecCCCCC---CCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-c
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTE---GASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-E   91 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~   91 (228)
                      +.||+|+||.||+|.+......   .........+++|.+.... ......+.+|+.+++.+ +||||+++++++..+ .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCC
Confidence            4689999999999986432210   0011234458888876542 23345678889999999 999999999988764 4


Q ss_pred             eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCc-------EEEeeccC
Q psy3166          92 LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHV-------VKISDFGL  143 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~-------~kl~dfg~  143 (228)
                      .+++|||+++++|..++..                     .|||+++|+||||||+||+++.++.       ++++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            7899999999998887653                     6999999999999999999986653       89999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      +......       ....++..|+|||.+. ...++.++|+||||+++|+|++.|..||......+.
T Consensus       159 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~  218 (262)
T cd05077         159 PITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK  218 (262)
T ss_pred             CccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence            7643221       1234566799999886 456888999999999999998548999987655444

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=4.9e-31  Score=212.45  Aligned_cols=183  Identities=29%  Similarity=0.519  Sum_probs=144.2

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +.++|+..+.||+|+||.||++...         .++..+|+|.+...........+.+|+.++.++.+|+||+++++++
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~   72 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHK---------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL   72 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEEC---------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE
Confidence            4568888999999999999998843         3445799999876544455567889999999995699999999987


Q ss_pred             EcC-ceEEEEecCCCCcHHHH---HHH----------------------hcccC-CCCcccCCCCCCEeecCCCcEEEee
Q psy3166          88 YKD-ELRLVVEYCALGDLQSY---LRE----------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~---l~~----------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ... ..+++||++.. ++.++   +..                      .|||+ .+++||||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~d  151 (288)
T cd06616          73 FREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCD  151 (288)
T ss_pred             ecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEee
Confidence            654 47899999854 43332   110                      58987 4999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN---IYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      ||++........    .....++..|++||.+...   .++.++|+||+|+++|+|++ |..||....
T Consensus       152 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  214 (288)
T cd06616         152 FGISGQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT-GKFPYPKWN  214 (288)
T ss_pred             cchhHHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh-CCCCchhcc
Confidence            999865433211    1123456779999998765   58899999999999999999 999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=9.5e-31  Score=211.39  Aligned_cols=188  Identities=25%  Similarity=0.362  Sum_probs=145.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|.+.         .++..||+|.++..... .....+.+|+.+++++.+||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK---------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC---------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            47999999999999999999853         34457999987654221 123467789999999977899999998875


Q ss_pred             cCc------eEEEEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecC-CCcE
Q psy3166          89 KDE------LRLVVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSS-PHVV  136 (228)
Q Consensus        89 ~~~------~~lv~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~-~~~~  136 (228)
                      ...      .+++|||+++ +|.+++..                         .|||+++|+|+||+|+||+++. ++.+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~  150 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL  150 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeE
Confidence            432      6899999975 77766531                         6999999999999999999998 8899


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      +|+|||++..+....   .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+...
T Consensus       151 kl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~  222 (295)
T cd07837         151 KIADLGLGRAFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLL  222 (295)
T ss_pred             EEeecccceecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Confidence            999999886442211   11112234567999998865 457889999999999999999 999998876655443

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=6.8e-31  Score=217.17  Aligned_cols=189  Identities=23%  Similarity=0.413  Sum_probs=147.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .-.++|++.+.||+|+||.||++..         ..++..||+|.++... .......+.+|+.+++++ +||||+++.+
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~   83 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFD---------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD   83 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEE---------cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceee
Confidence            3458899999999999999999974         3345579999987542 223345677899999999 9999999998


Q ss_pred             EEEcC-------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          86 CCYKD-------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        86 ~~~~~-------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++...       ..+++++++ +++|.+.+..                   .|||+++|+|+||||+||+++.++.++|+
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEe
Confidence            87532       256777766 7788765432                   69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      |||++......      .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||...+.......+
T Consensus       163 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         163 DFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             ccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence            99988643221      122345667999998765 457889999999999999999 99999876655544443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=4.1e-31  Score=212.57  Aligned_cols=186  Identities=25%  Similarity=0.425  Sum_probs=148.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|.+..         +++.||+|.+...... .....+.+|+++++++ +||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   70 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFR   70 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcc
Confidence            479999999999999999998543         3456999987654322 2345677899999999 9999999999887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .+. .++++||+++++|.++...                    .|||+++++|+|++|+||++++++.++|+|||++..+
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          71 RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             cCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            654 7899999998888766432                    6999999999999999999999999999999988654


Q ss_pred             cccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ......   .....++..|++||++.+. .++.++|+||||+++|+|++ |..||...+..+.
T Consensus       151 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~-g~~~~~~~~~~~~  209 (286)
T cd07846         151 AAPGEV---YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQ  209 (286)
T ss_pred             cCCccc---cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc-CCCCCCCCchHHH
Confidence            332211   1123456779999988753 46788999999999999999 9999987665443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=1.1e-30  Score=209.47  Aligned_cols=186  Identities=24%  Similarity=0.422  Sum_probs=145.7

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-   90 (228)
                      |++.+.||+|+||.||+|...         .++..||+|.++............+|+.++.++.+|+|++++++++..+ 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR---------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             CceEeeccccccceEEEEEEc---------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            678999999999999999843         3445699999875433222334567999999996699999999988654 


Q ss_pred             --ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          91 --ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        91 --~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                        ..+++|||+++ ++.+++..                     .|||+++++|+||+|+||+++. +.++|+|||++..+
T Consensus        72 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          72 TGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             CCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence              47899999964 77766543                     5899999999999999999999 99999999998755


Q ss_pred             cccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      ......    ....++..|++||.+.. ..++.++|+||+||++|+|++ |..||++.+..+....+
T Consensus       150 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~-~~~p~~~~~~~~~~~~~  211 (282)
T cd07831         150 YSKPPY----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKI  211 (282)
T ss_pred             ccCCCc----CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc-CCcCCCCCCHHHHHHHH
Confidence            332211    12345667999997654 456889999999999999999 99999987766554443

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=9.2e-31  Score=211.85  Aligned_cols=188  Identities=28%  Similarity=0.425  Sum_probs=148.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH----HHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA----KTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +|++.+.||+|+||.||+|....         ++..||+|.++.....    .....+..|+++++++ +|+||++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~   70 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDV   70 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhhe
Confidence            58899999999999999998433         3457999998755322    2234567899999999 89999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +... ..++||||+ +++|.+++..                     .|||+++++|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          71 FGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             eecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceee
Confidence            8764 478999999 8899888753                     5899999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      ........   ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+...++
T Consensus       150 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~-g~~~~~~~~~~~~~~~~  215 (298)
T cd07841         150 RSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKI  215 (298)
T ss_pred             eeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc-CCccccCCccHHHHHHH
Confidence            75433211   1112334567999998864 457889999999999999999 98888876665544444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=8.6e-31  Score=215.60  Aligned_cols=201  Identities=25%  Similarity=0.379  Sum_probs=152.0

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHH-------------HHHHHHHHHH
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-------------TYDKFLKEIN   69 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~e~~   69 (228)
                      ++..+..+...+.+.||+|+||+||+|...         ..+..||+|.++......             ....+.+|++
T Consensus         2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   72 (335)
T PTZ00024          2 MSFSISERYIQKGAHLGEGTYGKVEKAYDT---------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK   72 (335)
T ss_pred             CccccccchhhhhhcccCCCceeEEEEEEC---------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHH
Confidence            345555444456788999999999999843         344579999886442211             0124678999


Q ss_pred             HHHhcCCCCceEEeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCE
Q psy3166          70 LMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        70 ~l~~l~~h~ni~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~ni  128 (228)
                      +++++ +|+||+++++++.... .+++||++. ++|.+++..                    .|||+++++|+||+|+||
T Consensus        73 ~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~ni  150 (335)
T PTZ00024         73 IMNEI-KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANI  150 (335)
T ss_pred             HHHhC-CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHe
Confidence            99999 9999999999887654 789999996 588877643                    689999999999999999


Q ss_pred             eecCCCcEEEeeccCccccccccc-----------ccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhC
Q psy3166         129 LLSSPHVVKISDFGLSEDIYEQNV-----------FQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTL  196 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~  196 (228)
                      +++.++.++|+|||.+........           .........++..|++||.+.+. .++.++|+||+||++|+|++ 
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t-  229 (335)
T PTZ00024        151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-  229 (335)
T ss_pred             EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh-
Confidence            999999999999998875541110           01111223446679999988754 46889999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHc
Q psy3166         197 GANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       197 g~~pf~~~~~~~~~~~~~~  215 (228)
                      |..||.+.+..+....+..
T Consensus       230 g~~p~~~~~~~~~~~~i~~  248 (335)
T PTZ00024        230 GKPLFPGENEIDQLGRIFE  248 (335)
T ss_pred             CCCCCCCCCHHHHHHHHHH
Confidence            9999998877666554433

>KOG0662|consensus

Probab=99.97  E-value=7.6e-32  Score=195.27  Aligned_cols=191  Identities=26%  Similarity=0.452  Sum_probs=152.1

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|.-.++||+|+||+||+|+         ..++.+.||+|.+..+..+ ..-...++|+-+|+.+ .|.||++++++...
T Consensus         3 ~ydkmekigegtygtvfkar---------n~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs   72 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKAR---------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS   72 (292)
T ss_pred             chHHHHhhcCCcceeeEecc---------cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc
Confidence            45556899999999999987         5556678999998766433 2335678999999999 99999999998876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      ++ +.+|+|+| ..+|-.|+..                     .|+|++++.|||+||.|.+|+.+|.+|++|||+++.+
T Consensus        73 dkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   73 DKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             CceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence            55 88999999 4466666543                     5899999999999999999999999999999999866


Q ss_pred             cccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .......   +....|.-|.+|.++.+. .|++..|+||.||++.|+..-|.+-|++.+....+.++-.
T Consensus       152 gipvrcy---saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~  217 (292)
T KOG0662|consen  152 GIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_pred             CCceEee---eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence            4432211   112334457788888865 4899999999999999999889999999887766665443

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=5.9e-31  Score=208.94  Aligned_cols=185  Identities=28%  Similarity=0.530  Sum_probs=142.7

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELRL   94 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~l   94 (228)
                      +.||+|+||.||+|........  .......+|+|.+.... ....+.+.+|+.+++.+ +|||++++++++.. +..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccc--cccccchhhHHhhcchh-HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence            4689999999999986543210  12234458888876442 33445778899999999 99999999998876 45889


Q ss_pred             EEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCc--------EEEeeccCcc
Q psy3166          95 VVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHV--------VKISDFGLSE  145 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~--------~kl~dfg~~~  145 (228)
                      +|||+++|+|.+++..                     .|||+++|+||||||+||+++.++.        ++++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999998753                     6999999999999999999987654        7999999876


Q ss_pred             cccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLG-ANPYPHIPLCRIVHY  212 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g-~~pf~~~~~~~~~~~  212 (228)
                      .....       ....++..|++||++.+. .++.++|+||||+++|+|++ | ..||...+..+....
T Consensus       157 ~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~~~~~~~~~~~~~~~  217 (258)
T cd05078         157 TVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS-GGDKPLSALDSQKKLQF  217 (258)
T ss_pred             ccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc-CCCCChhhccHHHHHHH
Confidence            44322       123455679999998864 47889999999999999999 7 577777665554433

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG4236|consensus

Probab=99.97  E-value=2.4e-32  Score=225.29  Aligned_cols=182  Identities=29%  Similarity=0.457  Sum_probs=148.9

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELR   93 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~   93 (228)
                      ++||+|.||+||-|.         +..+++.||||.+++-. ..+.-.+..+|+.+|..+ +||-|+.+.-.|.. +.++
T Consensus       570 evLGSGQFG~VYgg~---------hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGK---------HRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVF  639 (888)
T ss_pred             hhccCCcceeeecce---------ecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEE
Confidence            689999999999887         66677789999997653 223335778899999999 99999998777755 5589


Q ss_pred             EEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCC---CcEEEeeccCccccc
Q psy3166          94 LVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIY  148 (228)
Q Consensus        94 lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~---~~~kl~dfg~~~~~~  148 (228)
                      +|||-+ .|++.+.+-.                      .|||.++|+|+||||+|+|+.+.   -++||+|||+++.+.
T Consensus       640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            999988 5566555432                      69999999999999999999863   389999999999876


Q ss_pred             ccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +...    ..+..||+.|+|||++..+.|+...|+||+|+++|--++ |-.||...  .++-.++.+
T Consensus       719 EksF----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS-GTFPFNEd--EdIndQIQN  778 (888)
T KOG4236|consen  719 EKSF----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS-GTFPFNED--EDINDQIQN  778 (888)
T ss_pred             hhhh----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec-ccccCCCc--cchhHHhhc
Confidence            6532    235789999999999999999999999999999999999 99999874  334444444

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.6e-30  Score=209.41  Aligned_cols=198  Identities=32%  Similarity=0.499  Sum_probs=159.3

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +-+.+.|++...||+|++|.||++....         .+..+++|.++....  ....+.+|+++++++ +|+|++++++
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~   82 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ--NKELIINEILIMKDC-KHPNIVDYYD   82 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch--hHHHHHHHHHHHHHC-CCCCeeEEEE
Confidence            4567789999999999999999998543         344699999876533  346678899999999 9999999999


Q ss_pred             EEEc-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          86 CCYK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        86 ~~~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .+.. +..++++||+++++|.+++..                     .|||++|++|+|++|+||+++.++.++|+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccch
Confidence            8765 448899999999999998764                     589999999999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      +........   ......++..|++||.+.+..++.++|+||||+++|+|++ |..||....+......+.....+
T Consensus       163 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06614         163 AAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE-GEPPYLREPPLRALFLITTKGIP  234 (286)
T ss_pred             hhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Confidence            754332211   1122345667999999888888999999999999999999 99999887766555555444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.9e-31  Score=217.09  Aligned_cols=193  Identities=26%  Similarity=0.437  Sum_probs=154.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|++|.||+|...         .++..||+|.+..... ....+.+.+|+.+++.+ +||||+++.+++..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK---------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRP   70 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC---------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcc
Confidence            6899999999999999999843         3345799999875432 33446788999999999 89999999998765


Q ss_pred             C------ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          90 D------ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        90 ~------~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .      ..+++|+|++ ++|.+++..                    .+||++||+|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          71 PSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            3      4789999997 477776543                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +.................++..|++||.+.+. .++.++|+||+|+++|+|++ |..||.+.+..+....+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~  221 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQLNLIVE  221 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHH
Confidence            87554332111112234556679999999877 78899999999999999999 9999999887666555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=6.8e-31  Score=210.32  Aligned_cols=206  Identities=24%  Similarity=0.406  Sum_probs=160.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||++....         ++..||+|.+....  .......+.+|..+++++.+||||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            579999999999999999998543         44569999886532  2233456778999999993499999999987


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+ ..+++||++++++|.+++..                    .+||+.+++|+|++|+||+++.++.++|+|||++..
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence            664 48899999999999988764                    689999999999999999999999999999998865


Q ss_pred             ccccccc-----------------cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         147 IYEQNVF-----------------QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       147 ~~~~~~~-----------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      .......                 ........++..|++||......++.++|+||+|++++++++ |..||...+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~  230 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGSNEYLT  230 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCccHHHH
Confidence            4332210                 011122345678999999888778899999999999999999 9999998876555


Q ss_pred             HHHHHcCCCCCCCCCCC
Q psy3166         210 VHYLSTGYRMERPASCN  226 (228)
Q Consensus       210 ~~~~~~~~~~~~p~~~~  226 (228)
                      .+.+... ....|...|
T Consensus       231 ~~~~~~~-~~~~~~~~~  246 (280)
T cd05581         231 FQKILKL-EYSFPPNFP  246 (280)
T ss_pred             HHHHHhc-CCCCCCccC
Confidence            5555433 334444443

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=3.4e-30  Score=210.61  Aligned_cols=195  Identities=25%  Similarity=0.439  Sum_probs=153.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      .+.+.|...+.||+|+||.||++....         ++..+|+|.+....  .......+.+|+++++++ +|||++++.
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~   91 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYK   91 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEE
Confidence            345668899999999999999998533         34469999886432  223345688899999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++..+. .+++|||+++ ++.+.+..                     .|||+++++|+||+|+||+++.++.++|+|||
T Consensus        92 ~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg  170 (317)
T cd06635          92 GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG  170 (317)
T ss_pred             EEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCC
Confidence            9887654 7899999975 66655432                     69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      ++.....       .....++..|++||.+.   ...++.++|+||||+++|+|++ |..||......+....+.....+
T Consensus       171 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~  242 (317)
T cd06635         171 SASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP  242 (317)
T ss_pred             CccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhccCC
Confidence            8764322       12245667799999874   3457889999999999999999 99999887766666655554443


Q ss_pred             C
Q psy3166         220 E  220 (228)
Q Consensus       220 ~  220 (228)
                      +
T Consensus       243 ~  243 (317)
T cd06635         243 T  243 (317)
T ss_pred             C
Confidence            3

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1.2e-30  Score=210.28  Aligned_cols=206  Identities=27%  Similarity=0.364  Sum_probs=155.6

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +|++.+.||+|+||.||++.....      ...+..||+|.++...   .......+.+|+.++.++.+||||+++.+.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~------~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG------HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc------ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence            588999999999999999875432      2344569999886432   1233456788999999997799999999887


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. .++||||+++++|.+++..                    .|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            6654 7899999999999887643                    689999999999999999999999999999998865


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLSTGYRME  220 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Diwslg~~~~~l~t~g~~pf~~~~----~~~~~~~~~~~~~~~  220 (228)
                      +......  ......++..|++||...+..  .+.++|+||+|+++|+|++ |..||....    ..++.+.+... .++
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~  230 (288)
T cd05583         155 FLAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT-GASPFTVDGEQNSQSEISRRILKS-KPP  230 (288)
T ss_pred             ccccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh-CCCCcccCcccchHHHHHHHHHcc-CCC
Confidence            4333211  112234667899999987654  6789999999999999999 999996432    23333333333 344


Q ss_pred             CCCCCC
Q psy3166         221 RPASCN  226 (228)
Q Consensus       221 ~p~~~~  226 (228)
                      .|..++
T Consensus       231 ~~~~~~  236 (288)
T cd05583         231 FPKTMS  236 (288)
T ss_pred             CCcccC
Confidence            555444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.5e-30  Score=208.85  Aligned_cols=194  Identities=25%  Similarity=0.334  Sum_probs=143.0

Q ss_pred             eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--HHHHHHHHHHH---HHHhcCCCCceEEeeeEEEcC-
Q psy3166          17 VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--KTYDKFLKEIN---LMKDVGKHDHIVSFIGCCYKD-   90 (228)
Q Consensus        17 ~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~---~l~~l~~h~ni~~~~~~~~~~-   90 (228)
                      .||+|+||.||++..         ..+++.||+|.+......  ........|..   .++.. +||||+.+.+.+... 
T Consensus         1 ~ig~g~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~   70 (278)
T cd05606           1 IIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPD   70 (278)
T ss_pred             CcccCCCeEEEEEEE---------ecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCC
Confidence            489999999999874         334557999988654211  11122333433   34444 799999999888764 


Q ss_pred             ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccc
Q psy3166          91 ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~  150 (228)
                      ..+++|||+++++|.+++..                    .|||+++++|+||||+||+++.++.++|+|||++..+...
T Consensus        71 ~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          71 KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            47899999999999887743                    6899999999999999999999999999999998644322


Q ss_pred             ccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCC
Q psy3166         151 NVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL--CRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~--~~~~~~~~~~~~~~~p~~~~  226 (228)
                      .     .....++..|++||.+.+. .++.++|+||+|+++|+|++ |..||.....  .+.........+++.|..++
T Consensus       151 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (278)
T cd05606         151 K-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  223 (278)
T ss_pred             C-----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCccchHHHHHHhhccCCCCCCcCC
Confidence            1     1234577889999998754 57889999999999999999 9999987632  22233333444556665554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=6e-31  Score=212.53  Aligned_cols=191  Identities=26%  Similarity=0.381  Sum_probs=150.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|...         .++..+|+|.++..... .....+.+|+.++.++ +||||+++.+++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~   73 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDK---------KTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVV   73 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEEC---------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEE
Confidence            358999999999999999999853         33456999998754322 2223567899999999 899999999987


Q ss_pred             Ec---CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          88 YK---DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        88 ~~---~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..   +..++++||+++ +|.+++..                     .|||+++++|+||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          74 VGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             EecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence            65   348899999974 77776543                     699999999999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      +..+.....   ......++..|++||.+.+. .++.++|+||+|+++++|++ |..||...+..+...++.
T Consensus       153 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~  220 (293)
T cd07843         153 AREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLNKIF  220 (293)
T ss_pred             eeeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Confidence            875543211   11223456679999988754 36889999999999999999 999999887766655543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=3.8e-30  Score=207.91  Aligned_cols=188  Identities=26%  Similarity=0.439  Sum_probs=146.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|++|.||+|..         ..+++.||+|.+..... ......+.+|+++++++ +|||++++++++.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   71 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARD---------RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVH   71 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEe---------cCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEe
Confidence            5899999999999999999984         33455799998865422 22234577899999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC-CCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS-PHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~dfg~~  144 (228)
                      .+. .++||||+++ +|.+++..                      +|||+++++|+||+|+||+++. ++.+||+|||++
T Consensus        72 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~  150 (294)
T PLN00009         72 SEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA  150 (294)
T ss_pred             cCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence            644 7899999954 66665432                      6999999999999999999985 567999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ........   ......++..|++||++.+. .++.++|+||+|+++|+|+| |..||...+..+...+
T Consensus       151 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t-g~~pf~~~~~~~~~~~  215 (294)
T PLN00009        151 RAFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFK  215 (294)
T ss_pred             cccCCCcc---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            64432211   11123446679999988653 57889999999999999999 9999988766544443

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=4.8e-30  Score=201.87  Aligned_cols=190  Identities=33%  Similarity=0.614  Sum_probs=155.0

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      +|++.+.||+|++|.||++....         .+..+++|.+..... .....+.+|+++++++ +|+|++++.+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   69 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESK-EKKEKIINEIQILKKC-KHPNIVKYYGSYLKK   69 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccch-hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC
Confidence            58899999999999999998543         344699999875533 3456788999999999 899999999988665


Q ss_pred             c-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          91 E-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        91 ~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      . .++++|++++++|.+++..                     .+||+++++|+||+|+||+++.++.++|+|||.+....
T Consensus        70 ~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          70 DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            4 7899999999999987643                     68999999999999999999999999999999886553


Q ss_pred             ccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ....    .....++..|++||.+.+..++.++|+||+|+++++|++ |..||...+..+........
T Consensus       150 ~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  212 (253)
T cd05122         150 DTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-GKPPYSELPPMKALFKIATN  212 (253)
T ss_pred             cccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhc
Confidence            3221    123455667999999988778899999999999999999 99999887655554444433

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=1.1e-30  Score=209.97  Aligned_cols=184  Identities=26%  Similarity=0.457  Sum_probs=144.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|++|.||+|+..         .++..||+|.++.... ......+.+|+++++++ +||||+++.+++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   70 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT   70 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC---------CCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc
Confidence            5899999999999999999843         3445799998865432 22234678899999999 99999999998766


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      + ..+++|||+. ++|.+++..                      .|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          71 ENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             CCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            4 4789999995 567666532                      699999999999999999999999999999998864


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      +.....   ......++..|++||.+.+.. ++.++|+||||+++|+|+| |..||.+.+..+.
T Consensus       150 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~  209 (284)
T cd07860         150 FGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ  209 (284)
T ss_pred             cccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH
Confidence            432211   111223456799999887544 5788999999999999999 9999988665444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.1e-30  Score=215.61  Aligned_cols=192  Identities=25%  Similarity=0.394  Sum_probs=147.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ..+|++.+.||+|+||.||+|..         ..++..||+|.+..... .....+.+|+++++++ +||||+++++.+.
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~---------~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~   72 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVD---------SDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRL-DHDNIVKVYEVLG   72 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEE---------CCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhc-CCCcchhhHhhhc
Confidence            47999999999999999999984         34555799998865432 3345678899999999 9999999987654


Q ss_pred             cC---------------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecC-C
Q psy3166          89 KD---------------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSS-P  133 (228)
Q Consensus        89 ~~---------------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~-~  133 (228)
                      ..               ..++++||++ ++|.+++..                   +|||++|++|+||||+||+++. +
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~  151 (342)
T cd07854          73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED  151 (342)
T ss_pred             ccccccccccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC
Confidence            32               3689999996 488776643                   6999999999999999999985 5


Q ss_pred             CcEEEeeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      +.++++|||++..+..............++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+....+....
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~~~~  230 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKPLFAGAHELEQMQL  230 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            67899999998654322111111122345667999998754 457889999999999999999 9999988766555444


Q ss_pred             H
Q psy3166         213 L  213 (228)
Q Consensus       213 ~  213 (228)
                      +
T Consensus       231 ~  231 (342)
T cd07854         231 I  231 (342)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0587|consensus

Probab=99.97  E-value=7.4e-31  Score=226.65  Aligned_cols=193  Identities=29%  Similarity=0.521  Sum_probs=161.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ..|.+-|++.++||.|.+|.||+++         +..+++..|+|++......  .+....|.++|+.+.+|||++.+++
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k---------~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg   83 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGR---------HVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYG   83 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEe---------eeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEE
Confidence            4577889999999999999999988         5556667899998765332  2455678899999989999999999


Q ss_pred             EEE------cCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          86 CCY------KDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        86 ~~~------~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      ++.      .+++++|||||.+|+..|.++.                      .+||.+.++|||+|-.|||+..++.+|
T Consensus        84 ~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   84 AFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEE
Confidence            874      3669999999999999998764                      689999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI-----YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-----~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      |.|||++..+-..   ..+.....||+.|||||++.+..     |+..+|+||||++..||.- |.+|+.++.+...+-.
T Consensus       164 LvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad-G~PPl~DmHPmraLF~  239 (953)
T KOG0587|consen  164 LVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE-GAPPLCDMHPMRALFL  239 (953)
T ss_pred             Eeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC-CCCCccCcchhhhhcc
Confidence            9999998754222   34455678899999999998553     6788999999999999998 9999999887766543


Q ss_pred             H
Q psy3166         213 L  213 (228)
Q Consensus       213 ~  213 (228)
                      +
T Consensus       240 I  240 (953)
T KOG0587|consen  240 I  240 (953)
T ss_pred             C
Confidence            3

>KOG1024|consensus

Probab=99.97  E-value=3.3e-31  Score=211.65  Aligned_cols=216  Identities=33%  Similarity=0.634  Sum_probs=182.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..+++++...+-+|+||.||.|.|+++.    .....+.|-+|.++....+-....++.|.-.|..+ +|||+.++.++
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEd----t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V  355 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREED----TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGV  355 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccC----CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEE
Confidence            45677888899999999999999987643    33444557788887666665566788899899889 89999999998


Q ss_pred             EEcC--ceEEEEecCCCCcHHHHHHH----------------------------hcccCCCCcccCCCCCCEeecCCCcE
Q psy3166          87 CYKD--ELRLVVEYCALGDLQSYLRE----------------------------EYLSNNKVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        87 ~~~~--~~~lv~e~~~~~~L~~~l~~----------------------------~~lh~~~i~H~~lk~~nil~~~~~~~  136 (228)
                      +..+  ..++++.+..-|+|-.|+..                            .|||++|++|.||...|++|+..-++
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence            7653  35677788888999999873                            69999999999999999999999999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ||+|=.+++++.+.....-+. ....+..||+||.+....|+.++|+||||+++|||+|.|..||...++.|+..++..|
T Consensus       436 kltDsaLSRDLFP~DYhcLGD-nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGD-NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCC-CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            999999998876654332222 2334567999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCC
Q psy3166         217 YRMERPASCNEQ  228 (228)
Q Consensus       217 ~~~~~p~~~~~~  228 (228)
                      +|+..|.+||+|
T Consensus       515 yRlaQP~NCPDe  526 (563)
T KOG1024|consen  515 YRLAQPFNCPDE  526 (563)
T ss_pred             ceecCCCCCcHH
Confidence            999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.9e-30  Score=207.24  Aligned_cols=175  Identities=19%  Similarity=0.286  Sum_probs=137.8

Q ss_pred             Cceeeeeee--eeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVL--GQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~i--g~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.+  |+|+||.||++..         +.++..+|+|.++......      .|+.....+.+|||++++++.+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKH---------KPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEE---------cCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEE
Confidence            456666655  9999999999984         3344568999886432111      1233333333799999999988


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC-cEEEeeccCcc
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSE  145 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~dfg~~~  145 (228)
                      ... ..+++|||+++++|.+++..                    .|||+.+++|+||+|+||+++.++ .++|+|||++.
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            664 48899999999999998765                    699999999999999999999988 99999999886


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      .....       ....++..|+|||++.+..++.++|+||+|+++|+|++ |..||......
T Consensus       159 ~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~  212 (267)
T PHA03390        159 IIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT-GKHPFKEDEDE  212 (267)
T ss_pred             ecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCcc
Confidence            54322       12346678999999988889999999999999999999 99999865443

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1.1e-30  Score=207.28  Aligned_cols=196  Identities=27%  Similarity=0.426  Sum_probs=155.1

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      ||+|+||.||++....         ++..+++|.+.....  ......+.+|+++++++ +|||++++.+.+..+. .++
T Consensus         1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   70 (265)
T cd05579           1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYL   70 (265)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEE
Confidence            6899999999998543         345799999865422  23446788899999999 8999999998876644 789


Q ss_pred             EEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc-
Q psy3166          95 VVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF-  153 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-  153 (228)
                      ++|++++++|.+++..                    .|||+++++|+||+|+||+++.++.++|+|||++......... 
T Consensus        71 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          71 VMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            9999999999887754                    6999999999999999999999999999999987643222110 


Q ss_pred             ----cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         154 ----QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       154 ----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                          ........++..|++||.......+.++|+||||++++++++ |..||...+..+....+..+ ..+.|..+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  224 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNG-KIEWPEDV  224 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CcCCCccc
Confidence                001123345667999999988778889999999999999999 99999988888887777765 45555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.2e-30  Score=212.97  Aligned_cols=187  Identities=24%  Similarity=0.403  Sum_probs=148.7

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      -.++|++.+.||+|+||.||++..         ..++..||+|.+.... .......+.+|+.+++++ +||||+++.++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   82 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALD---------RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDV   82 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEE---------CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeee
Confidence            357899999999999999999874         3345579999886432 233445678999999999 99999999998


Q ss_pred             EEcC-------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          87 CYKD-------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        87 ~~~~-------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      +..+       .++++|+++ +++|.+++..                   .|||++||+|+||||+||+++.++.++|+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ecCCccccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEee
Confidence            7643       257999998 6688776542                   699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ||++......      .....++..|++||.+.+ ..++.++|+||+|+++|++++ |..||.+.+.......
T Consensus       162 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~  227 (343)
T cd07880         162 FGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT-GKPLFKGHDHLDQLME  227 (343)
T ss_pred             cccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            9988643221      122345667999998875 347889999999999999999 9999988765444333

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=4.7e-31  Score=217.14  Aligned_cols=188  Identities=23%  Similarity=0.391  Sum_probs=148.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|..         ..++..||+|.+.... .......+.+|+.+|+++ +||||+++.+++.
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~---------~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   74 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAID---------TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILR   74 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEE---------cCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhcc
Confidence            7899999999999999999984         3445579999987542 223345677899999999 8999999998764


Q ss_pred             c-----CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          89 K-----DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        89 ~-----~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .     ...+++|||+. ++|.+++..                    .|||+++|+|+||||+||+++.++.+||+|||+
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          75 PPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             ccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccc
Confidence            2     34789999995 578777642                    699999999999999999999999999999999


Q ss_pred             ccccccccccc-CCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         144 SEDIYEQNVFQ-NGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       144 ~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      +.......... .......++..|++||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~~~~~  220 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG-RRQLFPGKNYVHQ  220 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc-CCCccCCCChHHH
Confidence            87554332111 11123356778999998865 457889999999999999999 9999988765443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.6e-30  Score=210.24  Aligned_cols=190  Identities=26%  Similarity=0.434  Sum_probs=152.3

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-   90 (228)
                      |.....||+|+||.||++...         .++..||+|.+... .......+.+|+.+++++ +|+|++++++.+..+ 
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   90 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVK---------SSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGD   90 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEc---------CCCeEEEEEEeccc-chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCC
Confidence            344568999999999998743         34557999987643 233456788999999999 899999999988664 


Q ss_pred             ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          91 ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      ..+++|||+++++|.+++..                   .|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          91 ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             EEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            48899999999999887643                   69999999999999999999999999999999876443221


Q ss_pred             cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       152 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                         .......++..|++||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+..+
T Consensus       171 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t-g~~p~~~~~~~~~~~~~~~~  231 (292)
T cd06657         171 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDN  231 (292)
T ss_pred             ---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Confidence               11123456778999999887778999999999999999999 99999887766665555544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=5.1e-30  Score=207.49  Aligned_cols=191  Identities=14%  Similarity=0.235  Sum_probs=135.2

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHH----------HHHHHHHHHHHhcC
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY----------DKFLKEINLMKDVG   75 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~   75 (228)
                      .+..++|++.+.||+|+||+||+|.+.++..      ....+|+|...........          .....+...+..+ 
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-   80 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-   80 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-
Confidence            3567899999999999999999998655421      1223566654322111000          1112233445566 


Q ss_pred             CCCceEEeeeEEEcCc-----eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEee
Q psy3166          76 KHDHIVSFIGCCYKDE-----LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        76 ~h~ni~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                      +|+|++.+++......     .+++++.+.. ++.+.+..                    .|||+++|+||||||+|||+
T Consensus        81 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill  159 (294)
T PHA02882         81 DHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV  159 (294)
T ss_pred             CCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            8999999998754322     3566776533 33333221                    69999999999999999999


Q ss_pred             cCCCcEEEeeccCcccccccccc----cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         131 SSPHVVKISDFGLSEDIYEQNVF----QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +.++.++|+|||+++.+......    ........||..|+|||+..+..++.++|+||+||++++|++ |..||.+..
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~-g~~P~~~~~  237 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG-IKLPWKGFG  237 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCccc
Confidence            99999999999998765432111    111223467889999999998889999999999999999999 999998873

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=6.6e-30  Score=206.86  Aligned_cols=203  Identities=23%  Similarity=0.342  Sum_probs=153.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.+..++|++.+.||+|+||+||+|.+..         ++..||+|.++..........+.+|+.++.+..+||||+++
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~   79 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKC   79 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhh
Confidence            466788999999999999999999998543         34579999987654444455667788877777579999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccC-CCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++..+. .+++||++.+ ++.+.+..                     .|||+ .+|+|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          80 YGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             heeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECc
Confidence            99987654 8899999854 55443321                     69997 5999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI----YTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLST  215 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~~  215 (228)
                      ||++..+......    ....++..|++||.+....    ++.++|+||||+++|+|++ |..||..... .+...++..
T Consensus       159 fg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~  233 (296)
T cd06618         159 FGISGRLVDSKAK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEVLTKILQ  233 (296)
T ss_pred             cccchhccCCCcc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh-CCCCCCcchhHHHHHHHHhc
Confidence            9998654322111    1224556799999987543    7889999999999999999 9999976433 344555554


Q ss_pred             CCCCCC
Q psy3166         216 GYRMER  221 (228)
Q Consensus       216 ~~~~~~  221 (228)
                      ...+..
T Consensus       234 ~~~~~~  239 (296)
T cd06618         234 EEPPSL  239 (296)
T ss_pred             CCCCCC
Confidence            433333

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.3e-30  Score=213.75  Aligned_cols=192  Identities=22%  Similarity=0.406  Sum_probs=148.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      |.+ .++|.+...||+|+||.||+|..         ..++..||+|.++... .......+.+|+.+++++ +||||+++
T Consensus        11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~   79 (342)
T cd07879          11 WEL-PERYTSLKQVGSGAYGSVCSAID---------KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGL   79 (342)
T ss_pred             hcc-ccceEEEEEeeecCCeEEEEEEe---------CCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccch
Confidence            344 36899999999999999999984         3445579999886542 222334677899999999 99999999


Q ss_pred             eeEEEcC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          84 IGCCYKD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        84 ~~~~~~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      .+++...       ..++++|++.. +|.+++..                  .|||+++++||||||+||+++.++.++|
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          80 LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             hheecccccCCCCceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence            9987542       35899999854 66554321                  6999999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +|||++......      .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+.......+..
T Consensus       159 ~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~-g~~pf~~~~~~~~~~~~~~  229 (342)
T cd07879         159 LDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILK  229 (342)
T ss_pred             eeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            999998643211      122345667999999875 457889999999999999999 9999998765544444433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0603|consensus

Probab=99.97  E-value=3.2e-31  Score=222.65  Aligned_cols=187  Identities=32%  Similarity=0.448  Sum_probs=154.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .+.|++...+|.|+|+.|-.+.         +..+++..++|++.....     +..+|+.++.+..+|||++++.+++.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~---------~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~  386 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCE---------SSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYE  386 (612)
T ss_pred             chhhccccccCCCCccceeeee---------ccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceec
Confidence            5788999999999999999887         555666799999975522     22367888888889999999999987


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEee-cCCCcEEEeeccCcccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILL-SSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~-~~~~~~kl~dfg~~~~~  147 (228)
                      .+ +.++|||.+.|+.+.+.+..                   .|||++|++|||+||+|||+ ++.++++|+|||.++..
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            65 48999999999888776543                   69999999999999999999 58899999999998754


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIVHYLSTG  216 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~~~~~~~  216 (228)
                      ...      ....+.|..|.|||++....|+.++||||||+++|+|++ |..||...+.. ++..++..+
T Consensus       467 ~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~~ei~~~i~~~  529 (612)
T KOG0603|consen  467 ERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT-GRTLFAAHPAGIEIHTRIQMP  529 (612)
T ss_pred             chh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCccccCCchHHHHHhhcCC
Confidence            332      223466778999999998889999999999999999999 99999886666 666666555

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.9e-30  Score=213.82  Aligned_cols=185  Identities=25%  Similarity=0.438  Sum_probs=146.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+++.         ..++..||+|.++... .......+.+|+.+++++ +|+||+++.+++.
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~   74 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKN---------SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMP   74 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEe---------cCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHhee
Confidence            5799999999999999999984         3455679999986532 222345667899999999 9999999998775


Q ss_pred             cC------ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          89 KD------ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        89 ~~------~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ..      ..++++||+. ++|.+++..                    .|||+++++|+||||+||+++.++.++|+|||
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCc
Confidence            32      3789999995 578776643                    68999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ++.........   .....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+.
T Consensus       154 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  217 (337)
T cd07858         154 LARTTSEKGDF---MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKDYVHQ  217 (337)
T ss_pred             cccccCCCccc---ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Confidence            98754332111   122345677999998764 458889999999999999998 9999987654433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1035|consensus

Probab=99.97  E-value=2.2e-31  Score=236.37  Aligned_cols=193  Identities=32%  Similarity=0.532  Sum_probs=147.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      .+|+.+..||+||||.||+++         ++-.++.||||++.............+|+.+|.+| +|||||.++..|..
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVR---------NKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVR---------NKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVE  548 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEe---------ecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhc
Confidence            567888999999999999998         55566779999997665555667889999999999 99999999865421


Q ss_pred             C-------------------------------------------------------------------------------
Q psy3166          90 D-------------------------------------------------------------------------------   90 (228)
Q Consensus        90 ~-------------------------------------------------------------------------------   90 (228)
                      .                                                                               
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence            0                                                                               


Q ss_pred             -----------------------------------------ceEEEEecCCCCcHHHHHHH-------------------
Q psy3166          91 -----------------------------------------ELRLVVEYCALGDLQSYLRE-------------------  110 (228)
Q Consensus        91 -----------------------------------------~~~lv~e~~~~~~L~~~l~~-------------------  110 (228)
                                                               -+|+-||||+..++.+++.+                   
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILE  708 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHH
Confidence                                                     02344555555444444432                   


Q ss_pred             --hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc------c-----cc----cccCCCCCCCCcceeecccccc
Q psy3166         111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY------E-----QN----VFQNGEPSEKLPIRWLALESLV  173 (228)
Q Consensus       111 --~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~------~-----~~----~~~~~~~~~~~~~~~~~Pe~~~  173 (228)
                        .|+|++||+||||||.||+++.++.|||.|||+++...      .     +.    ......++..||.-|+|||.+.
T Consensus       709 GLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  709 GLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence              49999999999999999999999999999999987621      0     00    0011244678899999999988


Q ss_pred             cC---CCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcC
Q psy3166         174 SN---IYTNKSDVWSFGVVLWEIVTLGANPYPH-IPLCRIVHYLSTG  216 (228)
Q Consensus       174 ~~---~~~~~~Diwslg~~~~~l~t~g~~pf~~-~~~~~~~~~~~~~  216 (228)
                      +.   .|+.|+|+||+|++++||+.    ||.. |.--.++..++++
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g  831 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKG  831 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccC
Confidence            55   49999999999999999997    7755 4444456666655

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=3.3e-30  Score=208.87  Aligned_cols=194  Identities=24%  Similarity=0.371  Sum_probs=148.6

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ..++|++.+.||+|+||.||+|....         ++..||+|.++.... ......+.+|+++++++ +|||+++++++
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~   74 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEI   74 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeehe
Confidence            35689999999999999999998533         345699999865422 22234567899999999 99999999988


Q ss_pred             EEcC-----------ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCC
Q psy3166          87 CYKD-----------ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPH  134 (228)
Q Consensus        87 ~~~~-----------~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~  134 (228)
                      +...           .+++++||+++ ++.+++..                     .|||+++|+|+||+|+||+++.++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~  153 (302)
T cd07864          75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            7542           47899999976 55554432                     699999999999999999999999


Q ss_pred             cEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         135 VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      .+||+|||++..+.....  .......++..|++||.+.+. .++.++|+||+||++++|++ |..||......+.+..+
T Consensus       154 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~-g~~~~~~~~~~~~~~~~  230 (302)
T cd07864         154 QIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELI  230 (302)
T ss_pred             cEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence            999999998875433221  001112345679999987643 46889999999999999999 99999887665555444


Q ss_pred             Hc
Q psy3166         214 ST  215 (228)
Q Consensus       214 ~~  215 (228)
                      .+
T Consensus       231 ~~  232 (302)
T cd07864         231 SR  232 (302)
T ss_pred             HH
Confidence            44

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-30  Score=210.78  Aligned_cols=186  Identities=27%  Similarity=0.419  Sum_probs=144.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +|++.+.||+|+||.||+|.....       ..+..||+|.+....  .........+|+.+++++ +||||+++++++.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   72 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFL   72 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEe
Confidence            588999999999999999985431       145579999987632  122235667899999999 9999999999987


Q ss_pred             cC---ceEEEEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecC----CCcE
Q psy3166          89 KD---ELRLVVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSS----PHVV  136 (228)
Q Consensus        89 ~~---~~~lv~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~----~~~~  136 (228)
                      ..   .+++|||++++ ++.+.+..                         .|||+++|+|+||||+||+++.    ++.+
T Consensus        73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          73 EHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             CCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceE
Confidence            64   37899999965 55444321                         6999999999999999999999    8999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ||+|||++..+..............++..|+|||.+.+. .++.++|+||||+++++|++ |..||.+...
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~  221 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREA  221 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-cCCCCcCCcc
Confidence            999999987543322111112234556779999987754 47889999999999999999 9999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.2e-30  Score=213.36  Aligned_cols=192  Identities=28%  Similarity=0.462  Sum_probs=149.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|...         .++..+|+|.+... ........+.+|+.+++++.+||||+++++++.
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDR---------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEc---------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            67999999999999999999843         34456999987543 222334556789999999988999999999875


Q ss_pred             cC---ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KD---ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~---~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..   ..+++||+++ ++|.+++..                   .|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          78 AENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             cCCCceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            42   3789999996 488776543                   689999999999999999999999999999999875


Q ss_pred             cccccccc--CCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         147 IYEQNVFQ--NGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       147 ~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      +.......  .......++..|++||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t-g~~pf~~~~~~~~~~~  224 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL-GKPLFPGTSTLNQLEK  224 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence            53332110  11112345778999998764 457889999999999999999 9999988766554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=2.1e-30  Score=205.77  Aligned_cols=201  Identities=27%  Similarity=0.454  Sum_probs=153.9

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccc---cC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK---AN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~---~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +|.+.+.||+|+||+||++.+....         ..+++|.++   .. .......++.+|+.+++++ +||||+++++.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   70 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAV---------AEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHAS   70 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCC---------CcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHH
Confidence            5899999999999999998854332         224444433   22 1222334567899999999 99999999988


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +... ..++++||+++++|.+++..                        .|||+++++|+|++|+||+++. +.++|+||
T Consensus        71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeeccc
Confidence            7654 47899999999999876642                        6899999999999999999975 66999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.........   .....++..|++||......++.++|+||+|+++++|++ |..||......+....+..+..+..
T Consensus       150 g~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd08222         150 GVSRLLMGSCDL---ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFLSVVLRIVEGPTPSL  225 (260)
T ss_pred             CceeecCCCccc---ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcCCCCCC
Confidence            988654332211   112345667999999887778889999999999999999 9999988776666777767766666


Q ss_pred             CCCCC
Q psy3166         222 PASCN  226 (228)
Q Consensus       222 p~~~~  226 (228)
                      |..+|
T Consensus       226 ~~~~~  230 (260)
T cd08222         226 PETYS  230 (260)
T ss_pred             cchhc
Confidence            65554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671|consensus

Probab=99.97  E-value=7.1e-32  Score=214.45  Aligned_cols=194  Identities=25%  Similarity=0.376  Sum_probs=156.1

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC-----ceEEe
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD-----HIVSF   83 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~-----ni~~~   83 (228)
                      ..+|++.+.+|+|+||.|..+.++.         ++..||+|+++.-  .+.++..+-|+++|.++..+.     -++++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            5789999999999999999988544         3557999999754  455677888999999994332     46777


Q ss_pred             eeEE-EcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC--------
Q psy3166          84 IGCC-YKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS--------  132 (228)
Q Consensus        84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~--------  132 (228)
                      .++| +.+..++|+|.+ |.++.+|+.+                      .+||+.+++|.||||+|||+.+        
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence            6766 456799999988 6689999875                      5999999999999999999842        


Q ss_pred             ------------CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy3166         133 ------------PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANP  200 (228)
Q Consensus       133 ------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~p  200 (228)
                                  +-.++|+|||-+..-....      +....|..|.|||++.+.+++.++|+||+||++.|+.| |..-
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt-G~~L  308 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT-GETL  308 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec-ccee
Confidence                        1248899999887443321      33556778999999999999999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHcCCCCCCC
Q psy3166         201 YPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       201 f~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      |++.++.|-++.++.... |+|
T Consensus       309 FqtHen~EHLaMMerIlG-p~P  329 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILG-PIP  329 (415)
T ss_pred             cccCCcHHHHHHHHHhhC-CCc
Confidence            999999988777666533 444

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2.6e-30  Score=210.15  Aligned_cols=194  Identities=25%  Similarity=0.360  Sum_probs=146.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|.+..         ++..+|+|.+.... .......+.+|+++++++ +||||+++++.+
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   76 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMA   76 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhhe
Confidence            5799999999999999999998433         34569999875432 122223567899999999 999999999876


Q ss_pred             EcC---------ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          88 YKD---------ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        88 ~~~---------~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      ...         .++++++|+.+ ++.+.+..                     .|||+++|+|+||||+||++++++.++
T Consensus        77 ~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~  155 (311)
T cd07866          77 VERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK  155 (311)
T ss_pred             ecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence            431         26899999864 55544321                     699999999999999999999999999


Q ss_pred             EeeccCcccccccccccC--------CCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQN--------GEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      |+|||++...........        ......++..|+|||.+.+. .++.++|+||+|+++|+|++ |..||.+.+...
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~-g~~~~~~~~~~~  234 (311)
T cd07866         156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKSDID  234 (311)
T ss_pred             ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            999998865432211100        01122345679999987654 47889999999999999999 999999877765


Q ss_pred             HHHHHH
Q psy3166         209 IVHYLS  214 (228)
Q Consensus       209 ~~~~~~  214 (228)
                      ..+.+.
T Consensus       235 ~~~~~~  240 (311)
T cd07866         235 QLHLIF  240 (311)
T ss_pred             HHHHHH
Confidence            555443

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.1e-29  Score=208.55  Aligned_cols=180  Identities=26%  Similarity=0.403  Sum_probs=145.2

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||++..         ..++..||+|.+.... .......+.+|+.+++++ +|||++++.+++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~   78 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARD---------QLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIF   78 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEE---------CCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeE
Confidence            46899999999999999999984         3455579999876432 222345677899999999 999999999988


Q ss_pred             Ec--CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YK--DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~--~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..  ...++++|++ +++|.+++..                   .|||+++|+|+||+|+||+++.++.++|+|||.+..
T Consensus        79 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          79 ISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             ecCCCcEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            65  3478999998 5578776643                   689999999999999999999999999999998864


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ....      .....++..|++||.+.+ ..++.++|+||+|+++|+|++ |..||.+...
T Consensus       158 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~~f~~~~~  211 (328)
T cd07856         158 QDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE-GKPLFPGKDH  211 (328)
T ss_pred             cCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh-CCCCCCCCCH
Confidence            3221      112344567999998765 468899999999999999999 9999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=8.1e-30  Score=209.64  Aligned_cols=193  Identities=26%  Similarity=0.367  Sum_probs=147.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|++.+.||+|+||.||+++...+.       .+..||+|.++... .....+.+.+|+.+++++.+||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            5899999999999999999854331       14469999886432 222345678899999999679999999986432


Q ss_pred             -----CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          90 -----DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        90 -----~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                           ..++++++++. ++|.+++..                    .|||++||+|+||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence                 23678888875 578777642                    6999999999999999999999999999999998


Q ss_pred             cccccccccc-CCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         145 EDIYEQNVFQ-NGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       145 ~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ..+....... .......++..|++||...+ ..++.++|+||+|+++|+|++ |..||...+..+....
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~-g~~pf~~~~~~~~~~~  221 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG-RKPVFKGKDYVDQLNQ  221 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCcCCCCCCHHHHHHH
Confidence            7554322111 11123456778999998765 457899999999999999999 9999988665444443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=7.2e-30  Score=205.07  Aligned_cols=190  Identities=24%  Similarity=0.393  Sum_probs=150.2

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      |++.+.||+|+||.||+|....         ++..+|+|.+.... .......+.+|+++++++ +|+|++++.+++...
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   70 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSK   70 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecC
Confidence            6789999999999999998543         34579999997653 233345677899999999 899999999988765


Q ss_pred             ---ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          91 ---ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        91 ---~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                         ..++++||+++ +|.+++..                     .|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        71 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~  149 (287)
T cd07840          71 GKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARP  149 (287)
T ss_pred             CCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceee
Confidence               48899999964 77766532                     689999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ......  .......++..|++||.+.+ ..++.++|+||||+++++|++ |..||...+....+..+..
T Consensus       150 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-~~~p~~~~~~~~~~~~~~~  216 (287)
T cd07840         150 YTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEKIFE  216 (287)
T ss_pred             ccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence            543321  01122344667999998765 357889999999999999999 9999998776655555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1.9e-29  Score=199.26  Aligned_cols=204  Identities=30%  Similarity=0.517  Sum_probs=159.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +|...+.||+|++|.||+|....         ++..+++|.+..... ......+.+|+.+++++ +||||+++.+.+..
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   70 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERD   70 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEec
Confidence            58889999999999999998543         445699999875532 34456788999999999 89999999998876


Q ss_pred             C---ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          90 D---ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        90 ~---~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .   ..++++|++++++|.+++..                    .|||+.+++|+|++|+||+++.++.++|+|||.+..
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          71 EEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             CCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            5   47899999999999988754                    699999999999999999999999999999998875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-LCRIVHYLST-GYRMERPAS  224 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~-~~~~~~~~~~-~~~~~~p~~  224 (228)
                      ....... .......++..|++||.......+.++|+||||+++++|++ |..||.... .......+.. ...++.|..
T Consensus       151 ~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd06606         151 LGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAALYKIGSSGEPPEIPEH  228 (260)
T ss_pred             ccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHhccccCCCcCCCcc
Confidence            5433211 01223456678999999988878999999999999999999 999998865 2223333332 334445555


Q ss_pred             CC
Q psy3166         225 CN  226 (228)
Q Consensus       225 ~~  226 (228)
                      +|
T Consensus       229 ~~  230 (260)
T cd06606         229 LS  230 (260)
T ss_pred             cC
Confidence            43

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-29  Score=200.14  Aligned_cols=195  Identities=31%  Similarity=0.440  Sum_probs=156.3

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRL   94 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~l   94 (228)
                      ||+|+||.||++....         .+..+|+|.+.....  ......+..|+.+++++ +|||++++++.+..+. .++
T Consensus         1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   70 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYL   70 (250)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEE
Confidence            6899999999998533         344699998865422  22345678899999999 8999999998876654 789


Q ss_pred             EEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ  154 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (228)
                      +||++++++|.+++..                    .|+|+.+++|+||+|+||+++.++.++|+|||.+........  
T Consensus        71 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--  148 (250)
T cd05123          71 VLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--  148 (250)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--
Confidence            9999999999988754                    589999999999999999999999999999998865433211  


Q ss_pred             CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       155 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                       ......++..|++||...+...+.++|+||||+++|++++ |..||...+..+..+.+... +.+.|...|+
T Consensus       149 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  218 (250)
T cd05123         149 -RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPFYAEDRKEIYEKILKD-PLRFPEFLSP  218 (250)
T ss_pred             -cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCH
Confidence             1123445667999999988778889999999999999999 99999888776667776663 5667766543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=1.3e-29  Score=208.10  Aligned_cols=187  Identities=20%  Similarity=0.324  Sum_probs=143.1

Q ss_pred             eeeeeee--cCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc
Q psy3166          15 GEVLGQG--EFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE   91 (228)
Q Consensus        15 ~~~ig~g--~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   91 (228)
                      ...||+|  +|++||++.         +..+++.||+|.+.... .....+.+.+|+.+++.+ +||||+++++++..+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~   72 (328)
T cd08226           3 QVEIGRGFCNLTSVYLAR---------HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGS   72 (328)
T ss_pred             HHHhCCcccCceeEEEEE---------EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCC
Confidence            3567777  889999987         44455679999987543 344456788899999889 9999999999987654


Q ss_pred             -eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          92 -LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        92 -~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                       .++++||+.++++.+++..                      +|||+++++||||||+||+++.++.+++.||+......
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~  152 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV  152 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence             7899999999999888753                      69999999999999999999999999999997543221


Q ss_pred             cccccc----CCCCCCCCcceeecccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         149 EQNVFQ----NGEPSEKLPIRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       149 ~~~~~~----~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ......    .......++..|++||++.+.  .++.++|+||+||++|+|++ |..||......+....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  221 (328)
T cd08226         153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT-GRVPFQDMLRTQMLLQ  221 (328)
T ss_pred             ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcChHHHHHH
Confidence            111000    001111234569999998764  47889999999999999999 9999988766554433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1e-29  Score=206.98  Aligned_cols=195  Identities=25%  Similarity=0.460  Sum_probs=152.5

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      .+.+.|...+.||+|+||.||+|+...         ++..+|+|.+...  .......++.+|+++++++ +|+|++++.
T Consensus        12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~   81 (308)
T cd06634          12 DPEKLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYR   81 (308)
T ss_pred             CcHHHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEE
Confidence            455678888999999999999998533         3456999987642  2233445678899999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++.... .++++||+. +++.+.+..                     .|||+++++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          82 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             EEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcc
Confidence            9877654 789999996 466665432                     68999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      ++......       ....++..|+|||.+.   ...++.++|+|||||++|+|++ |..||......+....+..+..+
T Consensus       161 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06634         161 SASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP  232 (308)
T ss_pred             cceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc-CCCCCccccHHHHHHHHhhcCCC
Confidence            88654322       1234566799999875   3457889999999999999999 99999887766665555555444


Q ss_pred             C
Q psy3166         220 E  220 (228)
Q Consensus       220 ~  220 (228)
                      .
T Consensus       233 ~  233 (308)
T cd06634         233 A  233 (308)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG2052|consensus

Probab=99.97  E-value=2.1e-30  Score=209.63  Aligned_cols=179  Identities=30%  Similarity=0.558  Sum_probs=141.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHh--cCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD--VGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~~h~ni~~~~~~~   87 (228)
                      .+..+.+.||+|.||+||+|+|+++.           ||||++...+.    ..+.+|.++.+.  | +|+||+.+++..
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~-----------VAVKiF~srdE----~SWfrEtEIYqTvmL-RHENILgFIaaD  274 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGED-----------VAVKIFSSRDE----RSWFRETEIYQTVML-RHENILGFIAAD  274 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCc-----------eEEEEecccch----hhhhhHHHHHHHHHh-ccchhhhhhhcc
Confidence            56789999999999999999998865           99999975422    346677777765  5 999999998876


Q ss_pred             EcC-----ceEEEEecCCCCcHHHHHHH-------------------hcccC--------CCCcccCCCCCCEeecCCCc
Q psy3166          88 YKD-----ELRLVVEYCALGDLQSYLRE-------------------EYLSN--------NKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        88 ~~~-----~~~lv~e~~~~~~L~~~l~~-------------------~~lh~--------~~i~H~~lk~~nil~~~~~~  135 (228)
                      ..+     ++++|.+|.+.|+|+|||.+                   .|||.        -.|.|||||..|||+.+++.
T Consensus       275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             ccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence            543     38999999999999999986                   47773        24999999999999999999


Q ss_pred             EEEeeccCccccccc-ccccCCCCCCCCcceeecccccccCC----C--CchhhHHHHHHHHHHHHhC---------CCC
Q psy3166         136 VKISDFGLSEDIYEQ-NVFQNGEPSEKLPIRWLALESLVSNI----Y--TNKSDVWSFGVVLWEIVTL---------GAN  199 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~-~~~~~~~~~~~~~~~~~~Pe~~~~~~----~--~~~~Diwslg~~~~~l~t~---------g~~  199 (228)
                      +-|+|+|++--.... +...-....+.||-+|||||++....    +  -..+||||||.++||+..+         -..
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            999999998433222 22223455688999999999998543    1  2468999999999998652         157


Q ss_pred             CCCCC
Q psy3166         200 PYPHI  204 (228)
Q Consensus       200 pf~~~  204 (228)
                      ||.+.
T Consensus       435 Pyyd~  439 (513)
T KOG2052|consen  435 PYYDV  439 (513)
T ss_pred             CcccC
Confidence            77653

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=5.2e-29  Score=203.31  Aligned_cols=190  Identities=27%  Similarity=0.477  Sum_probs=147.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +.|...+.||+|+||+||+|...         .++..|++|.+....  .......+.+|+++++++ +|||++++.+++
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   90 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNS---------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCY   90 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEE
Confidence            34567788999999999999843         344579999886432  223345678899999999 999999999988


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..+. .+++|||+.+ ++.+++..                     .|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~  169 (313)
T cd06633          91 LKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS  169 (313)
T ss_pred             EeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCc
Confidence            7655 7899999964 66655432                     69999999999999999999999999999999875


Q ss_pred             cccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      ....       .....++..|++||.+.   ...++.++|+||||+++|+|++ |..||...........+.....
T Consensus       170 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~  237 (313)
T cd06633         170 KSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNDS  237 (313)
T ss_pred             ccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Confidence            3211       12345667799999874   3457889999999999999999 9999988776555555444433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0666|consensus

Probab=99.97  E-value=4.8e-31  Score=205.24  Aligned_cols=186  Identities=26%  Similarity=0.377  Sum_probs=145.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ..|++...||+|+||.||+|.-.++.    + ..++.+|+|+++...+ ......+-+|+.+++.+ +|||++.+-.++.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n----~-kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl   97 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTN----D-KRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFL   97 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCC----c-ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHh
Confidence            46889999999999999999644432    1 1244699999975522 22335567899999999 9999999998876


Q ss_pred             c--CceEEEEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecCC----CcEE
Q psy3166          89 K--DELRLVVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSSP----HVVK  137 (228)
Q Consensus        89 ~--~~~~lv~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~~----~~~k  137 (228)
                      .  ..+++++||++. +|.+.++-                         .|||++=|+||||||.|||+..+    |.+|
T Consensus        98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen   98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence            5  448999999976 77776542                         69999999999999999999766    8999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      |.|||+++.+.+.-...-.......|+=|.|||.+.+. .|+++.|+||+||++.||+| -++-|.+
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt-l~PlF~g  242 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT-LEPLFKG  242 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc-cCccccc
Confidence            99999998765542222122235557778999999876 48899999999999999998 6665655

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.1e-30  Score=210.28  Aligned_cols=190  Identities=23%  Similarity=0.392  Sum_probs=150.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++...||+|++|.||+|+...         ++..||+|.+.... .......+.+|+.+++++ +|||++++.+++
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   83 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVF   83 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHh
Confidence            5789999999999999999998533         44569999886542 223345677899999999 999999998876


Q ss_pred             EcC-------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          88 YKD-------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        88 ~~~-------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ...       ..++++|++ +++|.+++..                   .|||++||+|+||+|+||+++.++.++|+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence            542       278999998 6688877543                   6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |++......      .....++..|++||.+... .++.++|+||+|+++|+|++ |..||.+....+....+...
T Consensus       163 g~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~  231 (343)
T cd07851         163 GLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GKTLFPGSDHIDQLKRIMNL  231 (343)
T ss_pred             ccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Confidence            998754221      1223456679999987653 57889999999999999999 99999887776665555443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-29  Score=203.02  Aligned_cols=183  Identities=27%  Similarity=0.443  Sum_probs=143.9

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      |++.+.||+|++|.||+|....         ++..||+|.+...... .....+.+|+++++++ +|||++++++++..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~   70 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSE   70 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccC
Confidence            6788999999999999998433         4456999988654322 2234577899999999 899999999988764


Q ss_pred             c-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          91 E-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        91 ~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      . .++++||++ ++|.+++..                      +|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus        71 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          71 NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            4 789999995 578877643                      6899999999999999999999999999999998644


Q ss_pred             cccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      .....   ......++..|+|||++.+. .++.++|+||+|+++|+|++ |..||...+....
T Consensus       150 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  208 (283)
T cd07835         150 GVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQ  208 (283)
T ss_pred             CCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence            22211   11122346679999987654 46889999999999999999 9999988765443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-29  Score=202.57  Aligned_cols=186  Identities=24%  Similarity=0.401  Sum_probs=147.8

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-   89 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-   89 (228)
                      |++.+.||+|++|.||+|..         ...+..+++|.++.... ......+.+|+++++++ +|+|++++++++.. 
T Consensus         1 y~~~~~i~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   70 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARD---------KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHK   70 (283)
T ss_pred             CccceeeecCCCceEEEEEc---------CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccC
Confidence            56788999999999999984         33445699998865432 23345778899999999 89999999998765 


Q ss_pred             CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          90 DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      +..++++||+++ ++.+++..                     .|||+++++|+||+|+||+++.++.++|+|||.+....
T Consensus        71 ~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          71 GDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             CCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            448899999965 77766543                     68999999999999999999999999999999886554


Q ss_pred             ccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ....   ......++..|++||.+.+. .++.++|+||+|+++|+|++ |..||.+.+..+...+
T Consensus       150 ~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~  210 (283)
T cd05118         150 SPVR---PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFK  210 (283)
T ss_pred             CCcc---cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            4321   11123455679999998866 68889999999999999999 9999988776554443

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=2e-29  Score=205.52  Aligned_cols=165  Identities=24%  Similarity=0.420  Sum_probs=131.8

Q ss_pred             cceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEEEEecCCCCcHHHHHHH----------
Q psy3166          43 AAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------  110 (228)
Q Consensus        43 ~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~----------  110 (228)
                      +++.||+|.++.. ........+.+|+++++++ +|+||+++++++..+. .+++|||+++++|.+++..          
T Consensus        24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~  102 (314)
T cd08216          24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA  102 (314)
T ss_pred             CCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHH
Confidence            5567999998755 3445556788999999999 8999999999887644 7899999999999888753          


Q ss_pred             ------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc----cCCCCCCCCcceeeccccccc
Q psy3166         111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF----QNGEPSEKLPIRWLALESLVS  174 (228)
Q Consensus       111 ------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~  174 (228)
                                  +|||+++|+|+||||+||+++.++.++++||+.+..+......    ........++..|++||.+..
T Consensus       103 ~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  182 (314)
T cd08216         103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ  182 (314)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcC
Confidence                        6999999999999999999999999999999987644322111    111122344567999999875


Q ss_pred             C--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         175 N--IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       175 ~--~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      .  .++.++|+||+||++++|++ |..||...+....
T Consensus       183 ~~~~~~~~~Diws~G~il~el~~-g~~pf~~~~~~~~  218 (314)
T cd08216         183 NLQGYNEKSDIYSVGITACELAN-GHVPFKDMPATQM  218 (314)
T ss_pred             CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence            3  47889999999999999999 9999988665443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=4.6e-29  Score=200.50  Aligned_cols=188  Identities=28%  Similarity=0.413  Sum_probs=147.1

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcC--CCCceEEeeeEEE
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVG--KHDHIVSFIGCCY   88 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--~h~ni~~~~~~~~   88 (228)
                      |++.+.||+|+||.||+|.++.         ++..||+|.++.... ......+.+|+.+++++.  +|||++++.+++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6789999999999999998543         345699999874422 222334567888877763  5999999999986


Q ss_pred             cC-c-----eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          89 KD-E-----LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        89 ~~-~-----~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      .. .     .+++||++.+ +|.+++..                      .|||+++++|+|++|+||+++.++.++|+|
T Consensus        72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~d  150 (287)
T cd07838          72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIAD  150 (287)
T ss_pred             eccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEec
Confidence            53 2     7899999864 77776543                      699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ||.+.........    ....++..|++||.+.+..++.++|+||+||++|+|++ |..||.+....+...++.
T Consensus       151 fg~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~-~~~~~~~~~~~~~~~~~~  219 (287)
T cd07838         151 FGLARIYSFEMAL----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIF  219 (287)
T ss_pred             cCcceeccCCccc----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHh-CCCcccCCChHHHHHHHH
Confidence            9988654322111    12235667999999988888999999999999999999 999999887766655543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-29  Score=202.08  Aligned_cols=186  Identities=26%  Similarity=0.405  Sum_probs=146.1

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-   90 (228)
                      |++.+.||+|++|+||+|....         ++..|++|.+.............+|+..+.++.+|+|++++++++..+ 
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            6788999999999999998543         344699998865533222334567999999993399999999987664 


Q ss_pred             ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          91 ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      ..+++||++ +++|.+++..                      .|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            488999999 7788776643                      68999999999999999999999999999999987543


Q ss_pred             ccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      .....    ....++..|+|||++.. ..++.++|+||||+++++|++ |..||......+...+
T Consensus       151 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~-g~~~~~~~~~~~~~~~  210 (283)
T cd07830         151 SRPPY----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLYK  210 (283)
T ss_pred             CCCCc----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHh-CCCccCCCChHHHHHH
Confidence            32211    12345667999998854 347889999999999999999 9999988765544433

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.3e-28  Score=218.84  Aligned_cols=127  Identities=29%  Similarity=0.444  Sum_probs=108.1

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .++|.+.+.||+|+||+||+|.+.         .++..||+|.++...  .......+..|+.++..+ +||||+++++.
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~   72 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKK---------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYS   72 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEE
Confidence            368999999999999999999854         344579999986542  233446778899999999 99999999988


Q ss_pred             EEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.. +.+++||||+.+++|.+++..                    .|||+++|+||||||+|||++.++.++|+|||+++
T Consensus        73 ~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            765 448899999999999988753                    69999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=4.7e-29  Score=199.97  Aligned_cols=188  Identities=30%  Similarity=0.496  Sum_probs=148.9

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      |++.+.||+|++|.||+|..         ..++..+|+|.+.... .......+..|+.+++++ +|+|++++.+++...
T Consensus         1 y~~~~~ig~g~~~~vy~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   70 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARD---------KKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTE   70 (282)
T ss_pred             CeeehcccccCcceEEEeee---------cCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcC
Confidence            67788999999999999874         3345679999987653 223345677899999999 899999999987664


Q ss_pred             -ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          91 -ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        91 -~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                       ..++++|+++ ++|.+++..                     .+||+++|+|+||+|+||+++.++.++|+|||.+....
T Consensus        71 ~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          71 RKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             CceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence             5889999997 488887643                     69999999999999999999999999999999887543


Q ss_pred             ccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      .....   ......+..|+|||.+... .++.++|+||||++++++++ |..||.+.+..+.+.++.
T Consensus       150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~  212 (282)
T cd07829         150 IPLRT---YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT-GKPLFPGDSEIDQLFKIF  212 (282)
T ss_pred             CCccc---cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHH
Confidence            32111   1122334569999998766 68889999999999999999 999998877665555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0668|consensus

Probab=99.96  E-value=5.4e-30  Score=191.90  Aligned_cols=190  Identities=19%  Similarity=0.373  Sum_probs=148.9

Q ss_pred             CccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           2 ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         2 ~~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .+.|| ..++|++.+.+|+|-|++||.|+         ....+.++++|+++.    -....+.+|+.+|..|..||||+
T Consensus        31 ~i~wg-~~ddYeivrk~GRGKYSEVFeg~---------~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi   96 (338)
T KOG0668|consen   31 VIDWG-NQDDYEIVRKVGRGKYSEVFEGI---------NITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNII   96 (338)
T ss_pred             eeecc-ccchHHHHHHHcCccHhhHhccc---------ccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCee
Confidence            35677 67899999999999999999987         444556799999863    23456789999999998899999


Q ss_pred             EeeeEEEc---CceEEEEecCCCCcHHHHHH------------H-----hcccCCCCcccCCCCCCEeecC-CCcEEEee
Q psy3166          82 SFIGCCYK---DELRLVVEYCALGDLQSYLR------------E-----EYLSNNKVVHRDLATRNILLSS-PHVVKISD  140 (228)
Q Consensus        82 ~~~~~~~~---~~~~lv~e~~~~~~L~~~l~------------~-----~~lh~~~i~H~~lk~~nil~~~-~~~~kl~d  140 (228)
                      +++++..+   ....+++|+..+.+..+...            +     .|+|++||+|||+||.|++|+. .-.++|+|
T Consensus        97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen   97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             ehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeee
Confidence            99998754   23568899987765543321            1     7999999999999999999996 45899999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCC-CCCCCHHHHH
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANP-YPHIPLCRIV  210 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~p-f~~~~~~~~~  210 (228)
                      .|++.+..+...++.+..    +.-|..||.+..- .|+...|+|||||++..|+- ...| |.+.++...+
T Consensus       177 WGLAEFYHp~~eYnVRVA----SRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF-rkepFFhG~dN~DQL  243 (338)
T KOG0668|consen  177 WGLAEFYHPGKEYNVRVA----SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQL  243 (338)
T ss_pred             cchHhhcCCCceeeeeee----hhhcCCchheeechhccccHHHHHHHHHHHHHHh-ccCcccCCCCCHHHH
Confidence            999998877766654333    3346799988744 47888999999999999997 5555 5666665443

>KOG0669|consensus

Probab=99.96  E-value=2.5e-31  Score=201.55  Aligned_cols=196  Identities=26%  Similarity=0.431  Sum_probs=151.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccc-cCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +..+.|+-...||+|.||+||+|+         ++++++.||+|++- .+.+...-....+|+.+|..| .|+|++.+.+
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr---------~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliE   83 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKAR---------SKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIE   83 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHh---------hcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHH
Confidence            345667778899999999999987         56666779997753 222222235678999999999 9999999988


Q ss_pred             EEEc---------CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          86 CCYK---------DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        86 ~~~~---------~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      +|..         ..+++||.+|+. +|.-.+..                     .|+|.+.|+|||+|+.|+||+.+|.
T Consensus        84 ic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi  162 (376)
T KOG0669|consen   84 ICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI  162 (376)
T ss_pred             HHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce
Confidence            7632         238899999965 55444332                     6999999999999999999999999


Q ss_pred             EEEeeccCcccccccc-cccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         136 VKISDFGLSEDIYEQN-VFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +||+|||+++.+.... ...++.+.+..|.-|.+||.+.+. .|+++.|+|+.||++.+|+| ++.-+++.+....++.+
T Consensus       163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt-rspimqgnteqqql~~I  241 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT-RSPIMQGNTEQQQLHLI  241 (376)
T ss_pred             EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc-cCccccCChHHHHHHHH
Confidence            9999999997665432 222333445556678999999876 48899999999999999999 99999998776655544


Q ss_pred             H
Q psy3166         214 S  214 (228)
Q Consensus       214 ~  214 (228)
                      .
T Consensus       242 s  242 (376)
T KOG0669|consen  242 S  242 (376)
T ss_pred             H
Confidence            3

>KOG3653|consensus

Probab=99.96  E-value=5.9e-29  Score=202.54  Aligned_cols=201  Identities=31%  Similarity=0.491  Sum_probs=151.8

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC-CCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG-KHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~h~ni~~~~~   85 (228)
                      ......++.+.||+|.||.||+|.+.+           +.||||++.    .+..+.+..|.++++... .|+||+++++
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~~-----------~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~  271 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLDN-----------RLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIG  271 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhccC-----------ceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhc
Confidence            344566788999999999999987644           469999985    445577888888887642 7999999987


Q ss_pred             EEEc-----CceEEEEecCCCCcHHHHHHH-------------------hcccC---------CCCcccCCCCCCEeecC
Q psy3166          86 CCYK-----DELRLVVEYCALGDLQSYLRE-------------------EYLSN---------NKVVHRDLATRNILLSS  132 (228)
Q Consensus        86 ~~~~-----~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~---------~~i~H~~lk~~nil~~~  132 (228)
                      .-..     -++++|++|.+.|+|.+||..                   .|||+         ..|+|||||..|||+.+
T Consensus       272 ~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~  351 (534)
T KOG3653|consen  272 AEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN  351 (534)
T ss_pred             hhccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence            6432     248899999999999999876                   58885         35999999999999999


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCC-CC-----chhhHHHHHHHHHHHHhC------C---
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI-YT-----NKSDVWSFGVVLWEIVTL------G---  197 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~-----~~~Diwslg~~~~~l~t~------g---  197 (228)
                      ++++.|+|||++..+....... ....-.||.+|||||++.+.. ..     .+.||||+|.++|||+++      |   
T Consensus       352 DlTccIaDFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  352 DLTCCIADFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             CCcEEeeccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            9999999999997665433222 222367899999999997653 22     358999999999999883      2   


Q ss_pred             --CCCCC-----CCCHHHHHHH-HHcCCCCCCCC
Q psy3166         198 --ANPYP-----HIPLCRIVHY-LSTGYRMERPA  223 (228)
Q Consensus       198 --~~pf~-----~~~~~~~~~~-~~~~~~~~~p~  223 (228)
                        ..||.     +++..++... +++..||.+|.
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~  464 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD  464 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChh
Confidence              23343     2233455444 56677888774

>KOG1152|consensus

Probab=99.96  E-value=7.6e-30  Score=212.12  Aligned_cols=178  Identities=24%  Similarity=0.374  Sum_probs=142.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHH-----HHHHHHHHHHHHhcC--CCCce
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKT-----YDKFLKEINLMKDVG--KHDHI   80 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~-----~~~~~~e~~~l~~l~--~h~ni   80 (228)
                      .+|...+.+|+|+||.|+.|.+         +.....|++|.+.+..  .+.+     +-..-.|+++|.+|.  .|+||
T Consensus       561 s~yttlq~lG~GAyGkV~lai~---------K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIH---------KENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             ccceeeeeccccccceEEEeee---------cccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            4689999999999999999984         3345679999987542  1111     112446999999993  29999


Q ss_pred             EEeeeEEEcCc-eEEEEecC-CCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          81 VSFIGCCYKDE-LRLVVEYC-ALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        81 ~~~~~~~~~~~-~~lv~e~~-~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      ++++++|.++. +|++||-. ++-+|++++..                    ++||++||+|||||-+|++++.+|.+||
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEE
Confidence            99999998866 56778775 56789998753                    6999999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      +|||-+.......     --...||..|.|||++.+..| +..-|||++|+++|.+.. ..+||-
T Consensus       712 idfgsaa~~ksgp-----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy-kenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY-KENPYY  770 (772)
T ss_pred             eeccchhhhcCCC-----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe-ccCCCc
Confidence            9999876442221     123678889999999998887 556799999999999986 889875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=3e-28  Score=191.24  Aligned_cols=160  Identities=21%  Similarity=0.262  Sum_probs=127.2

Q ss_pred             ecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-ceEEEEecC
Q psy3166          21 GEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYC   99 (228)
Q Consensus        21 g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-~~~lv~e~~   99 (228)
                      |.++.||+++         +..+++.||+|.++...      ...+|...+... .|||++++++++... ..+++|||+
T Consensus         4 g~~~~v~~~~---------~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~   67 (237)
T cd05576           4 GVIDKVLLVM---------DTRTQQTFILKGLRKSS------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHA   67 (237)
T ss_pred             cccceEEEEE---------EccCCcEEEEEeecchh------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecC
Confidence            7899999998         44555679999987542      122344444455 799999999987764 488999999


Q ss_pred             CCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCC
Q psy3166         100 ALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS  159 (228)
Q Consensus       100 ~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  159 (228)
                      ++++|.+++..                    .|||+++++|+||||+||+++.++.++++|||.+..+...      ...
T Consensus        68 ~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~  141 (237)
T cd05576          68 EGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDG  141 (237)
T ss_pred             CCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------ccc
Confidence            99999887643                    6899999999999999999999999999999977543221      112


Q ss_pred             CCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       160 ~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      ..++..|++||......++.++|+||+|+++|+|++ |..||..
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~~~~~  184 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLT-GKTLVEC  184 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHH-Ccchhhc
Confidence            233456999999887788999999999999999999 9887654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.3e-27  Score=183.67  Aligned_cols=198  Identities=37%  Similarity=0.538  Sum_probs=156.4

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-   90 (228)
                      |.+.+.||+|+++.||++....         ++..+|+|.+...........+.+|++.+.++ +|+|++++++.+..+ 
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   70 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPE   70 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCC
Confidence            5678999999999999998543         34569999987654332456788899999999 999999999987664 


Q ss_pred             ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          91 ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      ..++++|++++++|.+++..                     .++|+++++|+|++|.|++++.++.++|+|||.+..+..
T Consensus        71 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       71 PLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             ceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            47899999999899888643                     589999999999999999999999999999998875543


Q ss_pred             cccccCCCCCCCCcceeeccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHH-HHHHHHHcCCCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESL-VSNIYTNKSDVWSFGVVLWEIVTLGANPYPH-IPLC-RIVHYLSTGYRMERP  222 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~-~~~~-~~~~~~~~~~~~~~p  222 (228)
                      ...  .......++..|++||.. ....++.++|+|++|+++++|++ |..||.. ..+. ++.+.+..+..++.|
T Consensus       151 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (225)
T smart00221      151 DLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW-GPEPFSGEGEFTSLLSDVWSFGVPLLWE  223 (225)
T ss_pred             ccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH-CCCCccccchhHHHHHHHHhcCCccccc
Confidence            210  011223445679999988 55567789999999999999999 9999988 4444 667778877444433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1151|consensus

Probab=99.95  E-value=3.9e-29  Score=202.91  Aligned_cols=203  Identities=29%  Similarity=0.448  Sum_probs=154.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH------HHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA------KTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ++|-+++.||.|+|++||+|.         +....+-||+|+-..+...      .....+.+|.++.+.| +||.||++
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAF---------Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKl  532 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAF---------DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKL  532 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhc---------ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeee
Confidence            578899999999999999987         4555556899986544221      1234677899999999 99999999


Q ss_pred             eeEEEc--CceEEEEecCCCCcHHHHHHH--------------------hcccCC--CCcccCCCCCCEeecC---CCcE
Q psy3166          84 IGCCYK--DELRLVVEYCALGDLQSYLRE--------------------EYLSNN--KVVHRDLATRNILLSS---PHVV  136 (228)
Q Consensus        84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~--~i~H~~lk~~nil~~~---~~~~  136 (228)
                      +++|.-  +.+|-|+|||+|.+|.-||++                    .||.+.  .|+|-||||-|||+..   .|.+
T Consensus       533 YDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             eeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence            999854  458999999999999888875                    477665  5999999999999864   5789


Q ss_pred             EEeeccCcccccccccc-c---CCCCCCCCcceeecccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HH
Q psy3166         137 KISDFGLSEDIYEQNVF-Q---NGEPSEKLPIRWLALESLVSN----IYTNKSDVWSFGVVLWEIVTLGANPYPHIP-LC  207 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~-~---~~~~~~~~~~~~~~Pe~~~~~----~~~~~~Diwslg~~~~~l~t~g~~pf~~~~-~~  207 (228)
                      ||+|||+++.+.....- .   ...+...||.-|++||++.-+    .++.+.||||+|+++|.++. |+.||...- ..
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY-GrKPFGhnqsQQ  691 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY-GRKPFGHNQSQQ  691 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc-cCCCCCCchhHH
Confidence            99999999877543211 0   123345677778999988733    37889999999999999997 999997743 33


Q ss_pred             HHHHH--HHcCCCCCCCC
Q psy3166         208 RIVHY--LSTGYRMERPA  223 (228)
Q Consensus       208 ~~~~~--~~~~~~~~~p~  223 (228)
                      .+++.  +.+.+-..+|.
T Consensus       692 dILqeNTIlkAtEVqFP~  709 (775)
T KOG1151|consen  692 DILQENTILKATEVQFPP  709 (775)
T ss_pred             HHHhhhchhcceeccCCC
Confidence            44442  55555555553

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=8.9e-28  Score=222.21  Aligned_cols=169  Identities=25%  Similarity=0.389  Sum_probs=134.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      .+.....||+|+||+||+|...         ..+..||+|.++.....     ...|++.++++ +||||+++++++...
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~-----~~~~~~~l~~l-~HpnIv~~~~~~~~~  755 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSI---------KNGMQFVVKEINDVNSI-----PSSEIADMGKL-QHPNIVKLIGLCRSE  755 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEEC---------CCCcEEEEEEccCCccc-----cHHHHHHHhhC-CCCCcceEEEEEEcC
Confidence            3556678999999999999843         33456999988643221     12468889999 999999999998764


Q ss_pred             c-eEEEEecCCCCcHHHHHHH-----------------hccc---CCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          91 E-LRLVVEYCALGDLQSYLRE-----------------EYLS---NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        91 ~-~~lv~e~~~~~~L~~~l~~-----------------~~lh---~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      . .++||||+++|+|.+++..                 .|||   +.+|+|||+||+||+++.++..++. ++.......
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            4 7899999999999998753                 6999   6799999999999999988877765 554432111


Q ss_pred             cccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                             .....++..|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus       835 -------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t-g~~p~~~  880 (968)
T PLN00113        835 -------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT-GKSPADA  880 (968)
T ss_pred             -------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHh-CCCCCCc
Confidence                   112356778999999998889999999999999999999 9999854

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=6.3e-27  Score=203.90  Aligned_cols=184  Identities=22%  Similarity=0.312  Sum_probs=123.9

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +....++|++.+.||+|+||.||+|++..+..     ..+..||+|.+......+   ....+  .+.+. .+.++..+.
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~e---~~~~e--~l~~~-~~~~~~~~~  195 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAVE---IWMNE--RVRRA-CPNSCADFV  195 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchhH---HHHHH--HHHhh-chhhHHHHH
Confidence            45677899999999999999999999655421     225579999876432211   11111  11111 122222111


Q ss_pred             eE-------EEcCceEEEEecCCCCcHHHHHHH----------------------------------------hcccCCC
Q psy3166          85 GC-------CYKDELRLVVEYCALGDLQSYLRE----------------------------------------EYLSNNK  117 (228)
Q Consensus        85 ~~-------~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------~~lh~~~  117 (228)
                      ..       ......++++||+.+++|.+++..                                        .|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g  275 (566)
T PLN03225        196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG  275 (566)
T ss_pred             HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence            11       123458899999999998776531                                        5899999


Q ss_pred             CcccCCCCCCEeecC-CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC---------------------
Q psy3166         118 VVHRDLATRNILLSS-PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN---------------------  175 (228)
Q Consensus       118 i~H~~lk~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------------------  175 (228)
                      |+||||||+|||++. ++.+||+|||+++.+.....  .......+++.|+|||.+...                     
T Consensus       276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~  353 (566)
T PLN03225        276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ  353 (566)
T ss_pred             EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence            999999999999986 57999999999975432211  112335667789999965422                     


Q ss_pred             -CCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         176 -IYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       176 -~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                       .++.++||||+||++|+|++ +..|+.
T Consensus       354 ~~~~~k~DVwSlGviL~el~~-~~~~~~  380 (566)
T PLN03225        354 LNLPDRFDIYSAGLIFLQMAF-PNLRSD  380 (566)
T ss_pred             ccCCCCcccHHHHHHHHHHHh-CcCCCc
Confidence             13345699999999999998 765543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3e-26  Score=195.77  Aligned_cols=193  Identities=24%  Similarity=0.342  Sum_probs=133.9

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCC-------CCCcccceeeeeeccccCCCHHHHH--------------HH
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTE-------GASGQAAMEVAVKMLKANADAKTYD--------------KF   64 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~--------------~~   64 (228)
                      ..+.++|++.++||+|+||+||+|........       ......++.||+|.+..... ...+              ..
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchh
Confidence            45678999999999999999999975332210       01223445699999864321 1111              23


Q ss_pred             HHHHHHHHhcCCCCce-----EEeeeEEE---------cCceEEEEecCCCCcHHHHHHH--------------------
Q psy3166          65 LKEINLMKDVGKHDHI-----VSFIGCCY---------KDELRLVVEYCALGDLQSYLRE--------------------  110 (228)
Q Consensus        65 ~~e~~~l~~l~~h~ni-----~~~~~~~~---------~~~~~lv~e~~~~~~L~~~l~~--------------------  110 (228)
                      ..|+.++.++ +|.++     +.+.+++.         .+..++|+||+++++|.+++..                    
T Consensus       220 ~vE~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        220 MVEAYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             HHHHHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            3467777777 44433     45555543         2457899999999999877631                    


Q ss_pred             ------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCccee
Q psy3166         111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW  166 (228)
Q Consensus       111 ------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~  166 (228)
                                              .|+|+++|+||||||+||+++.++.+||+|||++..+.......  .....+++.|
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y  376 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRY  376 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcce
Confidence                                    58999999999999999999999999999999986543221111  1112336789


Q ss_pred             ecccccccCC--------------------C--CchhhHHHHHHHHHHHHhCCCC-CCCC
Q psy3166         167 LALESLVSNI--------------------Y--TNKSDVWSFGVVLWEIVTLGAN-PYPH  203 (228)
Q Consensus       167 ~~Pe~~~~~~--------------------~--~~~~Diwslg~~~~~l~t~g~~-pf~~  203 (228)
                      ++||.+....                    +  ..+.|+||+||++++|++ |.. ||..
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~-~~l~p~~~  435 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV-PELRPVAN  435 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh-CCCCCccc
Confidence            9999875322                    1  124699999999999998 764 7754

>KOG0665|consensus

Probab=99.94  E-value=1.5e-27  Score=186.08  Aligned_cols=183  Identities=25%  Similarity=0.362  Sum_probs=143.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .+|.-+..+|.|.- .|..+.         +.-++..||+|.+.... ......++.+|..++..+ .|+|+++++.+|+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~---------D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ft   85 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAF---------DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFT   85 (369)
T ss_pred             eeeeeecccCCCCc-eEEecc---------hhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccC
Confidence            46666777887776 455433         55566779999876542 334456788999999999 9999999999987


Q ss_pred             cC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          89 KD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        89 ~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..       ++|+|||++ ..+|.+.+..                  +|||+.||+||||||+||++..++.+||.|||+
T Consensus        86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   86 PQKTLEEFQEVYLVMELM-DANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             ccccHHHHHhHHHHHHhh-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchh
Confidence            63       378999999 4467666543                  799999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      +..-...    ...+.-..+.-|.|||++.+..+...+||||+||++.||++ |..-|++.+.-..
T Consensus       165 ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~-~~Vlf~g~d~idQ  225 (369)
T KOG0665|consen  165 ARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL-GTVLFPGKDHIDQ  225 (369)
T ss_pred             hcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh-ceEEecCchHHHH
Confidence            8632211    12233444566899999999999999999999999999998 9999998655333

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=4.9e-26  Score=177.74  Aligned_cols=184  Identities=34%  Similarity=0.528  Sum_probs=147.1

Q ss_pred             cCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceEEEEecCC
Q psy3166          22 EFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCA  100 (228)
Q Consensus        22 ~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~lv~e~~~  100 (228)
                      +||.||+|....         ++..+++|.+...........+.+|++.++++ +|+|++++.+.+.. ...++++|+++
T Consensus         1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~   70 (244)
T smart00220        1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCD   70 (244)
T ss_pred             CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCC
Confidence            588999998543         34569999987654333256788999999999 99999999998876 45789999999


Q ss_pred             CCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCC
Q psy3166         101 LGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE  160 (228)
Q Consensus       101 ~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (228)
                      +++|.+++..                    .+||+.+++|+||+|.||+++.++.++++|||.+.......    .....
T Consensus        71 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~  146 (244)
T smart00220       71 GGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTF  146 (244)
T ss_pred             CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccc
Confidence            9899988643                    58999999999999999999999999999999987554321    12234


Q ss_pred             CCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC
Q psy3166         161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH-IPLCRIVHYLSTGYRME  220 (228)
Q Consensus       161 ~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~-~~~~~~~~~~~~~~~~~  220 (228)
                      .++..|++||......++.++|+|++|++++++++ |..||.. .+...+.+.+.++....
T Consensus       147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~  206 (244)
T smart00220      147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT-GKPPFPGDDQLLELFKKIGKPKPPF  206 (244)
T ss_pred             cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCC
Confidence            45667999999987788899999999999999999 9999988 55455566666554443

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027|consensus

Probab=99.94  E-value=3e-27  Score=203.58  Aligned_cols=175  Identities=32%  Similarity=0.481  Sum_probs=143.2

Q ss_pred             eeeeeecCc-eEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eE
Q psy3166          16 EVLGQGEFG-VVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LR   93 (228)
Q Consensus        16 ~~ig~g~~~-~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~   93 (228)
                      +.+|.|+-| .||+|..+++           .||||.+-..    ....+.+|+++|..-..||||+++++.-.+++ .|
T Consensus       515 eilG~Gs~Gt~Vf~G~ye~R-----------~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y  579 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYEGR-----------EVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY  579 (903)
T ss_pred             HHcccCCCCcEEEEEeeCCc-----------eehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence            578888887 5899886554           4999998543    23456789999999989999999998766555 78


Q ss_pred             EEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecC---CC--cEEEeeccCc
Q psy3166          94 LVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSS---PH--VVKISDFGLS  144 (228)
Q Consensus        94 lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~---~~--~~kl~dfg~~  144 (228)
                      +..|.|. .+|++++..                        .+||+.+|+||||||.||||..   ++  .++|+|||++
T Consensus       580 IalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  580 IALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             EEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            8999994 488887653                        5999999999999999999986   33  6889999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      +.+........+.....||.+|+|||.+....-..++||+|+||++|+.++.|.-||.+.-.
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~  720 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE  720 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence            98876654444466778899999999999888788999999999999999977999987543

>KOG0664|consensus

Probab=99.94  E-value=1.9e-28  Score=188.06  Aligned_cols=188  Identities=23%  Similarity=0.422  Sum_probs=141.0

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      .+=.+.||=|+||+||-+.         +...++.||+|++..- .+-....++.+|+.+|.-+ +|.|++..+++....
T Consensus        55 i~PDRPIGYGAFGVVWsVT---------DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPp  124 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVT---------DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPA  124 (449)
T ss_pred             CCCCCcccccceeEEEecc---------CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCC
Confidence            3445799999999999876         5666678999987533 2233456789999999999 999999999887553


Q ss_pred             ------ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          91 ------ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        91 ------~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                            ++|++.|+++. +|...+..                    +|||+.+|.||||||-|.|++++..+||+|||++
T Consensus       125 h~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  125 NPSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             CchHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccc
Confidence                  24556666533 44332211                    7999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +........  ..+....|..|.|||.+.+. .|+.+.||||+||++.|++. .+.-|+.-.+-+.++.+
T Consensus       204 Rvee~d~~~--hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg-RrILFQAq~PiqQL~lI  270 (449)
T KOG0664|consen  204 RTWDQRDRL--NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ-RKILFQAAGPIEQLQMI  270 (449)
T ss_pred             cccchhhhh--hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh-hhhhhhccChHHHHHHH
Confidence            855332211  11222334568999999876 48999999999999999997 77888876665555443

>KOG0670|consensus

Probab=99.93  E-value=1.6e-27  Score=196.46  Aligned_cols=189  Identities=24%  Similarity=0.359  Sum_probs=149.2

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCC-----CCceEEe
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK-----HDHIVSF   83 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~ni~~~   83 (228)
                      -.+|.+....|+|-|++|.+|++         ...+..||||++..+...  ...-+.|+++|++|..     .-+++.+
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D---------~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARD---------QARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             cceeEEEeccccceeeeeeeccc---------cCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            46889999999999999999884         334447999999877433  2445789999999942     2377787


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecC-CCcEEE
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSS-PHVVKI  138 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl  138 (228)
                      +..|.. +.+|+|+|.+ .-+|.+.|+.                       .+|-..||+|.||||+|||++. ...+||
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence            766654 5699999987 4577777664                       4677889999999999999986 568999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ||||-+.....+.+.     +-..+.-|.|||++.+.+|+...|+||+||++||+.| |..-|++.++-.++...+.
T Consensus       579 CDfGSA~~~~eneit-----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYt-GkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  579 CDFGSASFASENEIT-----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYT-GKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             ccCcccccccccccc-----HHHHHHhccCcceeecCcccCCccceeeceeeEEeec-cceecCCCCcHHHHHHHHH
Confidence            999988765544321     1222345899999999999999999999999999999 9999999988877665444

>KOG1167|consensus

Probab=99.92  E-value=3.7e-26  Score=183.89  Aligned_cols=185  Identities=23%  Similarity=0.377  Sum_probs=146.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +.|.+.++||+|+|++||++.+...      ....+.||+|.+.....+   .++..|+++|..+..+.||+.+.+++..
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            5678899999999999999885441      124567999998766444   5688999999999999999999998754


Q ss_pred             -CceEEEEecCCCCcHHHHHHH-----------------hcccCCCCcccCCCCCCEeecC-CCcEEEeeccCccccccc
Q psy3166          90 -DELRLVVEYCALGDLQSYLRE-----------------EYLSNNKVVHRDLATRNILLSS-PHVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        90 -~~~~lv~e~~~~~~L~~~l~~-----------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~dfg~~~~~~~~  150 (228)
                       +++.+|+||.+..+..++...                 .++|.+||+|||+||.|+|.+. .+.-.|+|||++......
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence             669999999998877766543                 6899999999999999999986 578889999997621000


Q ss_pred             c-------------cc---------------------c-------CCCCCCCCcceeecccccccC-CCCchhhHHHHHH
Q psy3166         151 N-------------VF---------------------Q-------NGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGV  188 (228)
Q Consensus       151 ~-------------~~---------------------~-------~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~  188 (228)
                      .             ..                     .       .....+.||++|.|||++... ..+++.|+||.|+
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV  266 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence            0             00                     0       012256789999999999854 4788999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q psy3166         189 VLWEIVTLGANPYPHI  204 (228)
Q Consensus       189 ~~~~l~t~g~~pf~~~  204 (228)
                      ++..+++ +..||...
T Consensus       267 I~Lslls-~~~PFf~a  281 (418)
T KOG1167|consen  267 ILLSLLS-RRYPFFKA  281 (418)
T ss_pred             eeehhhc-cccccccC
Confidence            9999999 88887553

>KOG0576|consensus

Probab=99.92  E-value=1.3e-26  Score=195.70  Aligned_cols=188  Identities=29%  Similarity=0.487  Sum_probs=150.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      -|.++|+++.++|+|+||.|||++         ++.++...|+|.++...... ..-..+|+-+++.. +||||+.+++.
T Consensus        12 nP~ddyellqrvgsgTygdvyKaR---------d~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc-~h~nivay~gs   80 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKAR---------DKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDC-RHPNIVAYFGS   80 (829)
T ss_pred             CCccchhheeeecCCcccchhhhc---------ccccCchhhheeeeccCCcc-ccccccceeeeecC-CCcChHHHHhh
Confidence            577899999999999999999987         66777788999987542211 12344688888888 99999999998


Q ss_pred             EEc-CceEEEEecCCCCcHHHHH------HH--------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYK-DELRLVVEYCALGDLQSYL------RE--------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~-~~~~lv~e~~~~~~L~~~l------~~--------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.. +.++++||||.+|+|++--      .+              .|||++|-+|||||-.||++...|.+|+.|||.+.
T Consensus        81 ylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   81 YLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             hhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchh
Confidence            765 5699999999999998742      11              79999999999999999999999999999999886


Q ss_pred             cccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      .+....   .-..+..||+.|||||+..   ...|+..+|+|++|+...|+.. =+.|-....+...
T Consensus       161 qitati---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e-Lqpplfdlhpmr~  223 (829)
T KOG0576|consen  161 QITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE-LQPPLFDLHPMRA  223 (829)
T ss_pred             hhhhhh---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh-cCCcccccchHHH
Confidence            553322   2345688999999999875   5569999999999999999876 5566444444433

>KOG1345|consensus

Probab=99.92  E-value=1.2e-26  Score=177.80  Aligned_cols=178  Identities=24%  Similarity=0.447  Sum_probs=135.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE-
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC-   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~-   87 (228)
                      .+.|.+.+.+|+|.||.+.++.         |++++..+++|.+.+.  ......|.+|.----.|+.|.||+.-+++. 
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~e---------Hr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAE---------HRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeee---------ccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            3678899999999999999987         5666678999998754  344577888887766777899999988764 


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecC--CCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSS--PHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~--~~~~kl~dfg~~~  145 (228)
                      +... ++.++||+|.|+|.+-+..                   .|+|+++++|||||.+||||-.  .-.+||+|||+..
T Consensus        92 qt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   92 QTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             hcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence            3333 5688999999999875321                   6999999999999999999854  3479999999876


Q ss_pred             cccccccccCCCCCCCCcceeecccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSN-----IYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      ........      ...+..|-+||.....     ..++..|+|.||++++.++| |..||+..
T Consensus       172 k~g~tV~~------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt-G~~PWQka  228 (378)
T KOG1345|consen  172 KVGTTVKY------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT-GKFPWQKA  228 (378)
T ss_pred             ccCceehh------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec-CCCcchhh
Confidence            33222111      1112235677765421     24677899999999999999 99999863

>KOG1165|consensus

Probab=99.92  E-value=1.7e-24  Score=170.16  Aligned_cols=193  Identities=19%  Similarity=0.319  Sum_probs=154.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      -.|++.++||+|+||+.+.|.         ....++.||||.-......   .++.-|.+..+.|...+.|.+++.+...
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~---------Nl~nne~VAIKfEPrkS~A---PQLrdEYr~YKlL~g~~GIP~vYYFGqe   95 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGK---------NLYNNEPVAIKFEPRKSEA---PQLRDEYRTYKLLGGTEGIPQVYYFGQE   95 (449)
T ss_pred             ccceeccccccCcceeeeccc---------ccccCceEEEEeccccCCc---chHHHHHHHHHHHcCCCCCCceeeeccc
Confidence            469999999999999999986         5667788999987544322   3456788899988788999998876665


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCC-----cEEEeecc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPH-----VVKISDFG  142 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~-----~~kl~dfg  142 (228)
                      +. ..+|+|++ |.+|.|.+.-                     +++|++.++.|||||+|+||...+     .+.++|||
T Consensus        96 G~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen   96 GKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             cchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence            54 56889988 7788877543                     799999999999999999998643     68899999


Q ss_pred             Ccccccccc----cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc
Q psy3166         143 LSEDIYEQN----VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL---CRIVHYLST  215 (228)
Q Consensus       143 ~~~~~~~~~----~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~---~~~~~~~~~  215 (228)
                      +++...+..    +......+..||.+||+-....+...+.+.|+-|+|-++++.+. |..||++...   .+-.++|..
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLR-GsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhcc-CCCccccccCcchHHHHHHhcc
Confidence            998775543    22345667899999999999999889999999999988888886 9999999654   444555544


Q ss_pred             C
Q psy3166         216 G  216 (228)
Q Consensus       216 ~  216 (228)
                      .
T Consensus       254 ~  254 (449)
T KOG1165|consen  254 T  254 (449)
T ss_pred             c
Confidence            4

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.3e-24  Score=177.29  Aligned_cols=156  Identities=19%  Similarity=0.195  Sum_probs=115.5

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----CHHHHHHHHHHHHHHHhcCCCCceEE-
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----DAKTYDKFLKEINLMKDVGKHDHIVS-   82 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~ni~~-   82 (228)
                      -.++|++.+.||+|+||+||+|.....        ++..+|+|.+....    .......+.+|+++|+++ +|+|++. 
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~   86 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQ   86 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcE
Confidence            356899999999999999999985331        23347998865321    233345688999999999 8999884 


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHH--------HH-----hcccCCCCcccCC-CCCCEeecCCCcEEEeeccCccccc
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYL--------RE-----EYLSNNKVVHRDL-ATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l--------~~-----~~lh~~~i~H~~l-k~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      +++   .+..+++|||++|++|....        .+     .|||++||+|||| ||+|||++.++.++|+|||+++.+.
T Consensus        87 l~~---~~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         87 LLA---TGKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             EEE---cCCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            443   25689999999999886421        11     6999999999999 9999999999999999999998664


Q ss_pred             ccccccC-----CCCCCCCcceeecccccccC
Q psy3166         149 EQNVFQN-----GEPSEKLPIRWLALESLVSN  175 (228)
Q Consensus       149 ~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~  175 (228)
                      .......     ......++..|++||.+...
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            4321111     11234556678999988743

>KOG1163|consensus

Probab=99.91  E-value=3e-24  Score=162.19  Aligned_cols=189  Identities=20%  Similarity=0.259  Sum_probs=144.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +-...|++.+.||+|+||.+|.|.         +...+..||+|.-+.....   .+..-|..+...|+.-.-|..+..+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~---------~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y   79 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGI---------SITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHY   79 (341)
T ss_pred             eeccceEEEEeecCCchhheeeee---------eccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhh
Confidence            567899999999999999999987         5556668999997755332   3566788888888444555555555


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC---CCcEEEeec
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS---PHVVKISDF  141 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~---~~~~kl~df  141 (228)
                      ..... ..+||+++ |.+|.+.++-                     +|+|.++++||||||+|+|+.-   ..++.++||
T Consensus        80 ~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   80 GTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             ccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence            44433 67999988 7788776542                     7999999999999999999874   457899999


Q ss_pred             cCcccccccc----cccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         142 GLSEDIYEQN----VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       142 g~~~~~~~~~----~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      |+++.+.+..    +.........||.+|.+-....+...+.+.|+-|+|-++.+... |..||++.....-
T Consensus       159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnr-G~LPWQglka~tk  229 (341)
T KOG1163|consen  159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNR-GSLPWQGLKAATK  229 (341)
T ss_pred             cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeec-CCCcccccchhhH
Confidence            9998665432    22234556788999988777666678889999999977776675 9999999765433

>KOG1290|consensus

Probab=99.91  E-value=1.4e-23  Score=171.87  Aligned_cols=112  Identities=25%  Similarity=0.386  Sum_probs=91.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCC-------Cc
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH-------DH   79 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h-------~n   79 (228)
                      +...+|.+.++||.|.|++||+|.         +.+..+.||+|+.+..  ....+..+-||.+|++++.+       .+
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLaw---------Dtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAW---------DTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEe---------eccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            345799999999999999999987         6666678999998754  34456778899999998643       38


Q ss_pred             eEEeeeEEEc-----CceEEEEecCCCCcHHHHHHH----------------------hcccCC-CCcccCCCCCCEee
Q psy3166          80 IVSFIGCCYK-----DELRLVVEYCALGDLQSYLRE----------------------EYLSNN-KVVHRDLATRNILL  130 (228)
Q Consensus        80 i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~-~i~H~~lk~~nil~  130 (228)
                      ||++++.|..     ..+++|+|++ |-+|..++..                      .|||.+ ||+|.||||+|||+
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            9999998854     2388999998 6577777654                      699975 99999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=5.3e-22  Score=151.28  Aligned_cols=163  Identities=37%  Similarity=0.645  Sum_probs=131.2

Q ss_pred             eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceEEEE
Q psy3166          18 LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELRLVV   96 (228)
Q Consensus        18 ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~lv~   96 (228)
                      ||+|.+|.||++...+         .+..+++|.+...........+.+|++.++.+ .|++++++.+.+.. ...++++
T Consensus         1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~   70 (215)
T cd00180           1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVM   70 (215)
T ss_pred             CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEE
Confidence            6899999999998543         34569999987664332346788999999999 89999999998876 4578999


Q ss_pred             ecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC-CCcEEEeeccCccccccccccc
Q psy3166          97 EYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS-PHVVKISDFGLSEDIYEQNVFQ  154 (228)
Q Consensus        97 e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~  154 (228)
                      |++++++|.+++..                     .+||+++++|+|++|.||+++. .+.++|+||+.+........  
T Consensus        71 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--  148 (215)
T cd00180          71 EYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--  148 (215)
T ss_pred             ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence            99998999988642                     5899999999999999999999 89999999998865433211  


Q ss_pred             CCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHH
Q psy3166         155 NGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEI  193 (228)
Q Consensus       155 ~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l  193 (228)
                       ......+...|++||..... ..+.+.|+|++|++++++
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence             01123345568999988776 678899999999999988

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0195|consensus

Probab=99.87  E-value=6.9e-23  Score=157.60  Aligned_cols=201  Identities=21%  Similarity=0.402  Sum_probs=159.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ||+-.++.+..+|.+...|+.|+|+|.+..           +++|++.... ......+|.+|..-|+-+ .||||+.++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgnd-----------ivakil~vr~~t~risrdfneefp~lrif-shpnilpvl  253 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGND-----------IVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVL  253 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCcc-----------hhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhh
Confidence            678888889999999999999999987654           5667776442 333445788899888888 999999999


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH----------------------hcccCCC--CcccCCCCCCEeecCCCcEEEe
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE----------------------EYLSNNK--VVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~--i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +.+++ .++.++..|++-|+|+..+++                      .|||+..  |.-..+...+++++.+.+.+|.
T Consensus       254 gacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  254 GACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             hhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence            99976 458899999999999999886                      5888764  4445688889999998877755


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHc
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYT---NKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYLST  215 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~---~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~~~  215 (228)
                      --.        ..+......+..++.|++||.++..+-+   .++|+|||++++||+-| ...||...++.|+ .....+
T Consensus       334 mad--------~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t-revpfadlspmecgmkiale  404 (448)
T KOG0195|consen  334 MAD--------TKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT-REVPFADLSPMECGMKIALE  404 (448)
T ss_pred             ccc--------ceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc-cccccccCCchhhhhhhhhc
Confidence            211        1122233456667889999999877643   46899999999999999 9999999999999 666888


Q ss_pred             CCCCCCCCCCCC
Q psy3166         216 GYRMERPASCNE  227 (228)
Q Consensus       216 ~~~~~~p~~~~~  227 (228)
                      |.|+.+|++.++
T Consensus       405 glrv~ippgis~  416 (448)
T KOG0195|consen  405 GLRVHIPPGISR  416 (448)
T ss_pred             cccccCCCCccH
Confidence            999999988753

>KOG1164|consensus

Probab=99.86  E-value=5.4e-21  Score=156.65  Aligned_cols=185  Identities=20%  Similarity=0.290  Sum_probs=140.0

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCC---CCceEEeeeEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK---HDHIVSFIGCC   87 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~---h~ni~~~~~~~   87 (228)
                      +|++.+.||+|+||.||++....+.        ...+|+|........... .+..|..++..+..   -+++..+.+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G   89 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHG   89 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence            8999999999999999999854432        345888887654222211 45678888888842   25788888777


Q ss_pred             E-cC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCC-----CcEEE
Q psy3166          88 Y-KD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSP-----HVVKI  138 (228)
Q Consensus        88 ~-~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~-----~~~kl  138 (228)
                      . .. ..++||+.+ |.+|.+....                      +++|+.|++||||||+|+++...     ..+.|
T Consensus        90 ~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   90 RSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             cCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence            3 43 367888877 7788886642                      68999999999999999999864     46999


Q ss_pred             eeccCcc--ccc-cccc-ccCC---CCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         139 SDFGLSE--DIY-EQNV-FQNG---EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       139 ~dfg~~~--~~~-~~~~-~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      +|||+++  .+. .... ....   .....||..|.++.+..+...+.+.|+||++-++.++.. |..||++...
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~-g~LPW~~~~~  242 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK-GSLPWEALEM  242 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc-CCCCCccccc
Confidence            9999997  322 2211 1111   234558999999999888889999999999999999998 9999988654

>KOG0603|consensus

Probab=99.85  E-value=5.2e-23  Score=173.44  Aligned_cols=185  Identities=25%  Similarity=0.369  Sum_probs=145.5

Q ss_pred             eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceEE
Q psy3166          17 VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELRL   94 (228)
Q Consensus        17 ~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~l   94 (228)
                      ++|+|+||.|++++.-+      ....+..||+|..++.. ..........|..++..+.+||.++++...++. ...++
T Consensus         1 vlg~g~~gkvfLvrk~~------g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAG------GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhc------cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            37899999999887433      33455568998886542 222222445688888888679999999988876 45899


Q ss_pred             EEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccccc
Q psy3166          95 VVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ  154 (228)
Q Consensus        95 v~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (228)
                      ++++..+|++...+..                    +++|+.+|++||+|++||+++.+|++++.|||+++.......  
T Consensus        75 ~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             hhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            9999999888765443                    799999999999999999999999999999999986654432  


Q ss_pred             CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       155 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                           .+|+..|||||++.  .....+|+||||++.++|+| |..||.+    ++..+|.+. .+..|
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~fellt-g~~pf~~----~~~~~Il~~-~~~~p  207 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLT-GTLPFGG----DTMKRILKA-ELEMP  207 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhh-CCCCCch----HHHHHHhhh-ccCCc
Confidence                 27788899999988  45668899999999999999 9999998    566666664 33444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=4.5e-21  Score=147.77  Aligned_cols=159  Identities=14%  Similarity=0.094  Sum_probs=117.1

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHH------HHHHHHHHHhcCCCCc
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDK------FLKEINLMKDVGKHDH   79 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~------~~~e~~~l~~l~~h~n   79 (228)
                      -.++|++.+.+|.|+||.||++.. +          +..+|+|.+.....  ....+.      +.+|+..+.++ .|++
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~----------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~G   96 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-D----------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEG   96 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-C----------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCC
Confidence            357899999999999999998642 1          22499999975432  222222      56899999999 9999


Q ss_pred             eEEeeeEEEc---------CceEEEEecCCCCcHHHHHH-------H-----hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          80 IVSFIGCCYK---------DELRLVVEYCALGDLQSYLR-------E-----EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        80 i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~-------~-----~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      |......+..         ...+++|||++|.+|.+...       +     ..+|+.|++|+|++|.||+++.+| +++
T Consensus        97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359         97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            9999877542         24789999999999977532       1     689999999999999999999988 999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHH
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV  194 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~  194 (228)
                      +|||.........               ..........|+.++|+|+||+++....
T Consensus       176 iDfg~~~~~~e~~---------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRK---------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchh---------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            9999765321110               0111233444677899999998765443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=4.4e-19  Score=143.47  Aligned_cols=191  Identities=29%  Similarity=0.488  Sum_probs=151.2

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHH--HHHHHHHHHHHHHhcCCCC-ceEEeeeEEE
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKEINLMKDVGKHD-HIVSFIGCCY   88 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~h~-ni~~~~~~~~   88 (228)
                      |.+...||.|+|+.||++...            ..+++|.+.......  ....+.+|+.++..+ .|+ +++.+.+.+.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~   68 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQ   68 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEe
Confidence            788999999999999998754            358889887654332  467788999999999 555 8999999886


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecCCC-cEEEeeccC
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGL  143 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~dfg~  143 (228)
                      ... .+++++++.++++.+++..                       .++|+.+++|||+||+||+++..+ .++++|||.
T Consensus        69 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~  148 (384)
T COG0515          69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL  148 (384)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence            655 5899999999998866552                       489999999999999999999988 799999999


Q ss_pred             cccccccccccC---CCCCCCCcceeeccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Q psy3166         144 SEDIYEQNVFQN---GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL----CRIVHYL  213 (228)
Q Consensus       144 ~~~~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~---~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~----~~~~~~~  213 (228)
                      +...........   ......++..|++||.+..   ..++...|+|++|++++++++ |..||.....    ......+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~  227 (384)
T COG0515         149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKNSSATSQTLKII  227 (384)
T ss_pred             ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccccHHHHHHHH
Confidence            874433321110   2345677888999999987   567889999999999999998 9999888763    4455555


Q ss_pred             HcC
Q psy3166         214 STG  216 (228)
Q Consensus       214 ~~~  216 (228)
                      ...
T Consensus       228 ~~~  230 (384)
T COG0515         228 LEL  230 (384)
T ss_pred             Hhc
Confidence            444

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.7e-19  Score=135.50  Aligned_cols=176  Identities=14%  Similarity=0.055  Sum_probs=119.4

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH---HHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA---KTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      -+...|++|+||+|+.+..           .+.+++.+.++.....   .....+.+|+++|++|.+|++++.++++   
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---   70 (218)
T ss_pred             ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence            3567899999999997542           2234777766654321   1123577899999999767889998875   


Q ss_pred             CceEEEEecCCCCcHHHHHHH-------------hcccCCCCcccCC-CCCCEeecCCCcEEEeeccCcccccccccc--
Q psy3166          90 DELRLVVEYCALGDLQSYLRE-------------EYLSNNKVVHRDL-ATRNILLSSPHVVKISDFGLSEDIYEQNVF--  153 (228)
Q Consensus        90 ~~~~lv~e~~~~~~L~~~l~~-------------~~lh~~~i~H~~l-k~~nil~~~~~~~kl~dfg~~~~~~~~~~~--  153 (228)
                      +..+++|+|+.|.+|.+....             .++|++||+|||| ||+|||++.++.++|+|||++.........  
T Consensus        71 ~~~~lvmeyI~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         71 DGRHLDRSYLAGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             cCEEEEEeeecCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            457899999999888754321             6899999999999 799999999999999999998743322210  


Q ss_pred             --cCC------CCCCCCcceeecccccccC-CCC-chhhHHHHHHHHHHHHhCCCCC-CCC
Q psy3166         154 --QNG------EPSEKLPIRWLALESLVSN-IYT-NKSDVWSFGVVLWEIVTLGANP-YPH  203 (228)
Q Consensus       154 --~~~------~~~~~~~~~~~~Pe~~~~~-~~~-~~~Diwslg~~~~~l~t~g~~p-f~~  203 (228)
                        ...      ..-..++..++.|+...-. ..+ ...++.+.|+-+|.++| +..| |++
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~-~~~~~~~~  210 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT-RRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh-ccCCcccc
Confidence              000      0001122334444422211 123 45678899999999999 6555 443

>KOG4158|consensus

Probab=99.80  E-value=9.3e-20  Score=146.88  Aligned_cols=220  Identities=21%  Similarity=0.312  Sum_probs=141.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCC--------------------------CCCcccceeeeeeccc---cCC
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTE--------------------------GASGQAAMEVAVKMLK---ANA   56 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~--------------------------~~~~~~~~~vavK~~~---~~~   56 (228)
                      ++..++|++.+.||+|+.+.||-++..+.+..                          ..-....-+.|+|.+-   .++
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            35567899999999999999999998652211                          0000112234566542   111


Q ss_pred             CHH-HHHHHHHHHH--------------HHH-------hcCCCCceEEeeeEEEc-------------------------
Q psy3166          57 DAK-TYDKFLKEIN--------------LMK-------DVGKHDHIVSFIGCCYK-------------------------   89 (228)
Q Consensus        57 ~~~-~~~~~~~e~~--------------~l~-------~l~~h~ni~~~~~~~~~-------------------------   89 (228)
                      ... ......+|..              ..+       +|-.||||+.+.+.|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence            111 1122222221              111       23479999999987632                         


Q ss_pred             ---CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecC--CC--cEEEeeccC
Q psy3166          90 ---DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSS--PH--VVKISDFGL  143 (228)
Q Consensus        90 ---~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~--~~--~~kl~dfg~  143 (228)
                         ..+|+||.-.. .+|.+|+..                   .|||++|+.|||+|.+|||+.-  ++  ++.++|||.
T Consensus       313 g~~~tlylvMkrY~-~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC  391 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYR-QTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC  391 (598)
T ss_pred             CCCceEEEehhcch-hhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence               13788886663 488888754                   6999999999999999999853  33  688999996


Q ss_pred             ccccccc--cc-ccCCCCCCCCcceeecccccccCC-----C-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH
Q psy3166         144 SEDIYEQ--NV-FQNGEPSEKLPIRWLALESLVSNI-----Y-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYL  213 (228)
Q Consensus       144 ~~~~~~~--~~-~~~~~~~~~~~~~~~~Pe~~~~~~-----~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~  213 (228)
                      +-.-...  .. +........|-...||||+....+     . ..++|.|+.|.+.||+++ -.+||-+....-+ ....
T Consensus       392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg-~~NPFY~rGem~L~~r~Y  470 (598)
T KOG4158|consen  392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFG-RSNPFYKRGEMLLDTRTY  470 (598)
T ss_pred             eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhc-cCCcccccchheechhhh
Confidence            5321111  11 111122344455679999886332     1 258999999999999998 8899987443333 3346


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      ++-..|+.|+.||+
T Consensus       471 qe~qLPalp~~vpp  484 (598)
T KOG4158|consen  471 QESQLPALPSRVPP  484 (598)
T ss_pred             hhhhCCCCcccCCh
Confidence            77778999999997

>KOG0606|consensus

Probab=99.80  E-value=1.1e-19  Score=160.83  Aligned_cols=180  Identities=22%  Similarity=0.332  Sum_probs=132.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|..++.|..|+||.||.++         |+.+++.+|+|+-+.+...       +-  ++... .+|+++   +-| 
T Consensus        82 e~df~~IklisngAygavylvr---------h~~trqrfa~kiNkq~lil-------Rn--ilt~a-~npfvv---gDc-  138 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVR---------HKETRQRFAMKINKQNLIL-------RN--ILTFA-GNPFVV---GDC-  138 (1205)
T ss_pred             ccccceeEeeccCCCCceeeee---------ccccccchhhcccccchhh-------hc--ccccc-CCccee---chh-
Confidence            4689999999999999999987         6667778898554332111       11  33333 566665   111 


Q ss_pred             cCceEEEEecCCCCcHHHHHHHhcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccc------------cccCC
Q psy3166          89 KDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN------------VFQNG  156 (228)
Q Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~------------~~~~~  156 (228)
                       ...   +..+..-.+.-.++.+|+|+-||+|||+||+|.+|..-|++|+.|||+.+......            .....
T Consensus       139 -~tl---lk~~g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~  214 (1205)
T KOG0606|consen  139 -ATL---LKNIGPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQ  214 (1205)
T ss_pred             -hhh---cccCCCCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhh
Confidence             001   11111111111577799999999999999999999999999999999876432211            11124


Q ss_pred             CCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       157 ~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ....+||+.|.|||++....|+..+|||++|+++|+.+- |..||.+.++.|++.++..-
T Consensus       215 dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLV-gcvpffGdtpeelfg~visd  273 (1205)
T KOG0606|consen  215 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFGQVISD  273 (1205)
T ss_pred             hccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhe-eeeeccCCCHHHHHhhhhhh
Confidence            557899999999999999999999999999999999997 99999999999998776543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.79  E-value=3.2e-20  Score=168.58  Aligned_cols=124  Identities=17%  Similarity=0.156  Sum_probs=86.6

Q ss_pred             CceEEeeeEEE-------c-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCE
Q psy3166          78 DHIVSFIGCCY-------K-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        78 ~ni~~~~~~~~-------~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~ni  128 (228)
                      +||..+.+.+.       . ..++.++|++ +++|.+++..                     .|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            46666666551       1 2356677876 6689888843                     699999999999999999


Q ss_pred             eecCCCc-------------------EEEeeccCccccccccc--c-----------cCCCCCCCCcceeecccccccCC
Q psy3166         129 LLSSPHV-------------------VKISDFGLSEDIYEQNV--F-----------QNGEPSEKLPIRWLALESLVSNI  176 (228)
Q Consensus       129 l~~~~~~-------------------~kl~dfg~~~~~~~~~~--~-----------~~~~~~~~~~~~~~~Pe~~~~~~  176 (228)
                      |++..+.                   +|++|||+++.......  .           ........+|..|+|||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9965444                   55555555532110000  0           00001134677799999999888


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         177 YTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       177 ~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      ++.++|||||||++|||++ |..|+..
T Consensus       192 ~~~~sDVwSlGviL~ELl~-~~~~~~~  217 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFC-PVSSREE  217 (793)
T ss_pred             CCchhhhhhHHHHHHHHhh-CCCchhh
Confidence            9999999999999999999 8888754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=2.6e-19  Score=135.81  Aligned_cols=118  Identities=20%  Similarity=0.171  Sum_probs=84.1

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HH------------------------HHHHHHHHH
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KT------------------------YDKFLKEIN   69 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~e~~   69 (228)
                      ...||+|++|.||+|...          +++.||+|.++..... ..                        ......|.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05147           2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR   71 (190)
T ss_pred             CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence            468999999999999742          4557999998754210 00                        112345999


Q ss_pred             HHHhcCCCCceEEeeeEEEcCceEEEEecCCCCcHHHHH-HH-------------------hcc-cCCCCcccCCCCCCE
Q psy3166          70 LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYL-RE-------------------EYL-SNNKVVHRDLATRNI  128 (228)
Q Consensus        70 ~l~~l~~h~ni~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~-------------------~~l-h~~~i~H~~lk~~ni  128 (228)
                      ++.++ .++++..... ......++||||++++++.... ..                   .++ |+.||+||||||+||
T Consensus        72 ~l~~l-~~~~v~~p~~-~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NI  149 (190)
T cd05147          72 NLKRL-VTAGIPCPEP-ILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNL  149 (190)
T ss_pred             HHHHH-HHCCCCCCcE-EEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            99999 6666533222 2223348999999887654331 11                   577 799999999999999


Q ss_pred             eecCCCcEEEeeccCcc
Q psy3166         129 LLSSPHVVKISDFGLSE  145 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~  145 (228)
                      +++ ++.++|+|||++.
T Consensus       150 li~-~~~v~LiDFG~a~  165 (190)
T cd05147         150 LYH-DGKLYIIDVSQSV  165 (190)
T ss_pred             EEE-CCcEEEEEccccc
Confidence            998 4789999999885

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=1.7e-18  Score=132.71  Aligned_cols=119  Identities=17%  Similarity=0.230  Sum_probs=90.6

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC----CCCceEEeeeEEE
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG----KHDHIVSFIGCCY   88 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~----~h~ni~~~~~~~~   88 (228)
                      .-.+.||+|+|+.||.  ++         .+.. .++|++..... .....+.+|+.+++.+.    +||||+++++++.
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp---------~~~~-k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~e   71 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HP---------EDAQ-RCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVE   71 (210)
T ss_pred             CCcceecCCCceEEEE--CC---------CCcC-eEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEE
Confidence            4457899999999995  22         2222 36888765422 23456889999999994    4799999999987


Q ss_pred             cCc----eE-EEEec--CCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCC----CcEEEe
Q psy3166          89 KDE----LR-LVVEY--CALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSP----HVVKIS  139 (228)
Q Consensus        89 ~~~----~~-lv~e~--~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~----~~~kl~  139 (228)
                      ++.    ++ +|+||  +.+++|.+++++                  +|||+++|+||||||+|||++..    ..++|+
T Consensus        72 t~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         72 TDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             eCCCCeEEEEEEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            753    34 78999  557899888753                  69999999999999999999743    379999


Q ss_pred             eccCc
Q psy3166         140 DFGLS  144 (228)
Q Consensus       140 dfg~~  144 (228)
                      |++.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95433

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=2.4e-18  Score=130.67  Aligned_cols=121  Identities=21%  Similarity=0.222  Sum_probs=87.9

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----------------------H--HHHHHHHHH
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----------------------K--TYDKFLKEI   68 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------------~--~~~~~~~e~   68 (228)
                      +...||+|++|.||+|...          +++.||+|.++.....                       .  .......|.
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05145           1 INGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF   70 (190)
T ss_pred             CCceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence            3578999999999999742          4457999998754210                       0  012345789


Q ss_pred             HHHHhcCCCCceEEeeeEEEcCceEEEEecCCCCcHHHH-HHH-------------------hcccC-CCCcccCCCCCC
Q psy3166          69 NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSY-LRE-------------------EYLSN-NKVVHRDLATRN  127 (228)
Q Consensus        69 ~~l~~l~~h~ni~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~-------------------~~lh~-~~i~H~~lk~~n  127 (228)
                      +.+.++ .++++.....+... ..+++|||++++++... +..                   .++|+ +||+||||||+|
T Consensus        71 ~~l~~l-~~~~i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          71 RNLKRL-YEAGVPVPEPILLK-KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             HHHHHH-HhCCCCCceEEEec-CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            999999 78876443333222 35899999988754322 221                   58999 999999999999


Q ss_pred             EeecCCCcEEEeeccCcccc
Q psy3166         128 ILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~  147 (228)
                      |+++ ++.++|+|||++..+
T Consensus       149 Ill~-~~~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CCCEEEEEcccceec
Confidence            9998 789999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=6e-18  Score=134.24  Aligned_cols=187  Identities=23%  Similarity=0.342  Sum_probs=113.5

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCC----
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGK----   76 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~----   76 (228)
                      +..+-+...+.....||.|++++||.+.         +.+|++.+|+|+......  ....+++.+|.-....+..    
T Consensus         5 S~~~~~~r~l~~~~~i~~g~~~~v~~v~---------d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p   75 (288)
T PF14531_consen    5 SELGQRPRTLVRGRIIGKGGFSIVFEVT---------DVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNP   75 (288)
T ss_dssp             ESSS--EEEEEEEEEEEEETTEEEEEEE---------ETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SH
T ss_pred             ccCCCCceEEEEccccccCCceEEEEEE---------EccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCH
Confidence            3455566678888999999999999998         566777899999753322  2234455555533333211    


Q ss_pred             -----CCceEEeeeEE---------EcC---------ceEEEEecCCCCcHHHHHHH-----------------------
Q psy3166          77 -----HDHIVSFIGCC---------YKD---------ELRLVVEYCALGDLQSYLRE-----------------------  110 (228)
Q Consensus        77 -----h~ni~~~~~~~---------~~~---------~~~lv~e~~~~~~L~~~l~~-----------------------  110 (228)
                           |-.++.-++..         ...         +.+++|+-+ .++|.+++..                       
T Consensus        76 ~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~  154 (288)
T PF14531_consen   76 KEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQM  154 (288)
T ss_dssp             HHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHH
T ss_pred             HHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHH
Confidence                 11122112211         111         235566666 5588776542                       


Q ss_pred             ----hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC--------CCC
Q psy3166         111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN--------IYT  178 (228)
Q Consensus       111 ----~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--------~~~  178 (228)
                          .+||..|++|+||+|+|++++++|.+.|.||+...-.......      ...+..|.+||.....        .++
T Consensus       155 I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~------~~~~~~~~PPe~~~~~~~~~~~~~~~t  228 (288)
T PF14531_consen  155 IRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC------SEFPVAFTPPELESCAGQFGQNNAPYT  228 (288)
T ss_dssp             HHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG------GGS-TTTS-HHHHHHHTSCHHSEEEE-
T ss_pred             HHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec------cCCCcccCChhhhhhhcccCcccceee
Confidence                5899999999999999999999999999999865422221110      1112347788866532        367


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         179 NKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       179 ~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      .+.|.|++|+++|.+++ +..||.....
T Consensus       229 ~~~DaW~LG~~ly~lWC-~~lPf~~~~~  255 (288)
T PF14531_consen  229 FATDAWQLGITLYSLWC-GRLPFGLSSP  255 (288)
T ss_dssp             HHHHHHHHHHHHHHHHH-SS-STCCCGG
T ss_pred             eccCHHHHHHHHHHHHH-ccCCCCCCCc
Confidence            88999999999999999 9999987643

>KOG1166|consensus

Probab=99.73  E-value=8e-18  Score=150.85  Aligned_cols=175  Identities=20%  Similarity=0.259  Sum_probs=126.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCC---CCceEEe
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK---HDHIVSF   83 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~---h~ni~~~   83 (228)
                      .-.+.|.|.+.||+|+||.||+|...+          ++.||+|.-+.....+..    ==.+++.|| +   -+.|..+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~WEfY----I~~q~~~RL-k~~~~~~~~~~  759 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPWEFY----ICLQVMERL-KPQMLPSIMHI  759 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCceeee----ehHHHHHhh-chhhhcchHHH
Confidence            456788999999999999999997432          567999998765433221    112344444 2   1223333


Q ss_pred             eeE-EEcCceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecC-------CCc
Q psy3166          84 IGC-CYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSS-------PHV  135 (228)
Q Consensus        84 ~~~-~~~~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~-------~~~  135 (228)
                      ... .+.+.-++++||.+.|+|.++++.                    ++||..+|+|+||||+|+|+-.       ..-
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence            222 244667899999999999998874                    6899999999999999999953       235


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCC
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA  198 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~  198 (228)
                      ++|+|||.+-++..-..- ..-....+|-.+-++|+..+.+++..+|.+.++.+++.|+- |.
T Consensus       840 l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF-G~  900 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF-GK  900 (974)
T ss_pred             eEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH-HH
Confidence            999999998654321100 01123455677899999999999999999999999999986 63

>KOG0590|consensus

Probab=99.72  E-value=1.3e-18  Score=151.99  Aligned_cols=186  Identities=24%  Similarity=0.335  Sum_probs=129.2

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC-
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD-   90 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~-   90 (228)
                      .....+|.|++|.|+.+........    ...+.+++| ....... .....+..|..+-.++ +|||++......+.. 
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~----~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKS----FPEKEFRVR-VKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEID  394 (601)
T ss_pred             CccceeeecccCceEEEEecCCCcc----chhhhhhcc-cCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcc
Confidence            5678999999997776553332211    111122322 1111111 1112255677777778 999997776655443 


Q ss_pred             ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccc
Q psy3166          91 ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~  150 (228)
                      ...-.||||++ +|+.++..                    +|+|+.||.|||+|++|+++..+|.+|++|||.+..+...
T Consensus       395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            23334999999 98887654                    6999999999999999999999999999999987544322


Q ss_pred             ccc-cCCCCCCCCcceeecccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         151 NVF-QNGEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       151 ~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      -.. ........|+..|+|||++....|++ ..|+||.|+++..|.+ |+.||.-...
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~-~~~~Wk~a~~  530 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL-GRFPWKVAKK  530 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec-CCCccccccc
Confidence            110 11223466777899999999998876 4799999999999998 9999976543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.71  E-value=2.9e-17  Score=122.90  Aligned_cols=89  Identities=25%  Similarity=0.355  Sum_probs=70.6

Q ss_pred             hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHH
Q psy3166         111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVL  190 (228)
Q Consensus       111 ~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~  190 (228)
                      .|||+++      ||+||+++.++.+++  ||.+......        ...++..|+|||++.+..++.++|||||||++
T Consensus        31 ~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il   94 (176)
T smart00750       31 RELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITL   94 (176)
T ss_pred             HHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cCCCcccccChHHhcCCCCcchhhHHHHHHHH
Confidence            6888887      999999999999998  9987644221        12567889999999998999999999999999


Q ss_pred             HHHHhCCCCCCCCCCH-HHHHHHHHcC
Q psy3166         191 WEIVTLGANPYPHIPL-CRIVHYLSTG  216 (228)
Q Consensus       191 ~~l~t~g~~pf~~~~~-~~~~~~~~~~  216 (228)
                      |+|++ |..||..... ......+..+
T Consensus        95 ~ellt-g~~p~~~~~~~~~~~~~~~~~  120 (176)
T smart00750       95 YEALD-YELPYNEERELSAILEILLNG  120 (176)
T ss_pred             HHHHh-CCCCccccchhcHHHHHHHHH
Confidence            99999 9999976533 3334444433

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=3.9e-16  Score=120.27  Aligned_cols=118  Identities=19%  Similarity=0.262  Sum_probs=90.9

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--H-----HHHHHHHHHHHHHHhcCCCCceEEeeeEE-
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--A-----KTYDKFLKEINLMKDVGKHDHIVSFIGCC-   87 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~-   87 (228)
                      +.||+|++|.||+|.+.+           ..+++|.......  .     ....++.+|+.++..+ .|+++.....++ 
T Consensus         2 ~~l~~G~~~~vy~~~~~~-----------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~   69 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG-----------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFV   69 (211)
T ss_pred             cccccCceEEEEEEeeCC-----------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEE
Confidence            579999999999997532           2488887543211  1     1224567899999999 788776555444 


Q ss_pred             EcCceEEEEecCCCCcHHHHHHH----------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDELRLVVEYCALGDLQSYLRE----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~----------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+..+++|||++|++|.+.+..                .++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        70 ~~~~~~lv~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         70 DPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCCCEEEEEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            34557899999999999877642                589999999999999999999 78899999998763

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=3.2e-16  Score=136.68  Aligned_cols=122  Identities=21%  Similarity=0.291  Sum_probs=92.4

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeecc-ccC-C-----CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KAN-A-----DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~-~~~-~-----~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |...+.||+|+||+||++.+.+..           +++|.. .+. .     ......++.+|+++++++ +|++++...
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~-----------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~  402 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRD-----------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPV  402 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCcc-----------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeE
Confidence            345789999999999998864432           233321 111 0     112235678899999999 888887765


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+... ...+++|||+++++|.+++..            .++|+.+++|||+||+||++ .++.++|+|||+++.
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            54443 457899999999999988742            69999999999999999999 578899999999864

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=1.4e-16  Score=124.72  Aligned_cols=123  Identities=22%  Similarity=0.162  Sum_probs=89.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC---------------------HH--HHHHHHH
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD---------------------AK--TYDKFLK   66 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------------------~~--~~~~~~~   66 (228)
                      .-|++.+.||+|++|.||+|.+        +..++..||+|.++....                     ..  ....+..
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK   99 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence            3578999999999999999972        112345699999864321                     00  1123567


Q ss_pred             HHHHHHhcCCCC--ceEEeeeEEEcCceEEEEecCCCCcHHHHHH---------------H-----hcccCCC-CcccCC
Q psy3166          67 EINLMKDVGKHD--HIVSFIGCCYKDELRLVVEYCALGDLQSYLR---------------E-----EYLSNNK-VVHRDL  123 (228)
Q Consensus        67 e~~~l~~l~~h~--ni~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---------------~-----~~lh~~~-i~H~~l  123 (228)
                      |+.+++++ .+.  .+..+++   ....++|||++++.++.....               +     .++|++| ++|+|+
T Consensus       100 E~~~L~~L-~~~~i~~p~~~~---~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Di  175 (237)
T smart00090      100 EFRNLQRL-YEAGVPVPKPIA---WRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDL  175 (237)
T ss_pred             HHHHHHHH-HhcCCCCCeeeE---ecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCC
Confidence            99999999 442  2333333   234689999998877644321               1     6899999 999999


Q ss_pred             CCCCEeecCCCcEEEeeccCcc
Q psy3166         124 ATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       124 k~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ||+||+++ ++.++|+|||.+.
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~  196 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSV  196 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhh
Confidence            99999999 8899999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=9.3e-16  Score=117.17  Aligned_cols=116  Identities=20%  Similarity=0.308  Sum_probs=87.1

Q ss_pred             eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-C------HHHHHHHHHHHHHHHhcCCCCce--EEeeeEE
Q psy3166          17 VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-D------AKTYDKFLKEINLMKDVGKHDHI--VSFIGCC   87 (228)
Q Consensus        17 ~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~------~~~~~~~~~e~~~l~~l~~h~ni--~~~~~~~   87 (228)
                      .||+|+||.||+|.+.+           ..+++|...... .      .....++.+|++++..+ .|+++  ..++. .
T Consensus         1 ~ig~G~~~~vy~~~~~~-----------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~-~   67 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG-----------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYD-V   67 (199)
T ss_pred             CCCCCceEEEEEeecCC-----------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEE-E
Confidence            48999999999997433           248888754321 1      11234567899999999 66643  33332 2


Q ss_pred             EcCceEEEEecCCCCcHHHHHHH-------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDELRLVVEYCALGDLQSYLRE-------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~-------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+..+++||+++|++|.+.+..             .++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        68 ~~~~~~lv~e~~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        68 DPDNKTIVMEYIEGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCCCEEEEEEECCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            34557899999999999876533             589999999999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=3.5e-16  Score=119.57  Aligned_cols=121  Identities=21%  Similarity=0.180  Sum_probs=90.7

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH---------------------HHHHHHHHHHH
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA---------------------KTYDKFLKEIN   69 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~   69 (228)
                      .|.+.+.||+|+||.||++...          ++..||+|.+......                     ........|..
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   85 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA   85 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence            3788899999999999999743          3346999976532100                     11123567888


Q ss_pred             HHHhcCCCCc--eEEeeeEEEcCceEEEEecCCCCcHHHHHH-H-------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          70 LMKDVGKHDH--IVSFIGCCYKDELRLVVEYCALGDLQSYLR-E-------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        70 ~l~~l~~h~n--i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~-------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      ++..+ .+++  +....+   ....+++|||+++++|.+... .             .++|+.+++|+||+|.||+++.+
T Consensus        86 ~l~~l-~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          86 ALKAL-YEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             HHHHH-HHcCCCCCceee---cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence            88888 6663  333332   345689999999988766543 1             58999999999999999999999


Q ss_pred             CcEEEeeccCcc
Q psy3166         134 HVVKISDFGLSE  145 (228)
Q Consensus       134 ~~~kl~dfg~~~  145 (228)
                      +.++|+|||.+.
T Consensus       162 ~~~~liDfg~~~  173 (198)
T cd05144         162 EKIYIIDWPQMV  173 (198)
T ss_pred             CcEEEEECCccc
Confidence            999999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1240|consensus

Probab=99.61  E-value=8.9e-17  Score=143.25  Aligned_cols=177  Identities=25%  Similarity=0.306  Sum_probs=122.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH---HHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA---KTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++...+.+|++.|=+|.+|+++++-           |.+|.+-+....   ....+.+.|++ .. +.++||++.+--+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-----------vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~   90 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-----------VVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVL   90 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-----------EEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHH
Confidence            6778899999999999999876653           788887544322   22334455565 33 44899999986554


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. .|+|=+|.. .+|+|++..                    ..+|..||.|+|||.+|||+.+=+++.|+||.-.+.
T Consensus        91 ~t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   91 VTDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HhhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC
Confidence            4443 344445553 377776543                    579999999999999999999999999999985432


Q ss_pred             c--cccc--ccc-CCCCCCCCcceeecccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         147 I--YEQN--VFQ-NGEPSEKLPIRWLALESLVSNI-----------YTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       147 ~--~~~~--~~~-~~~~~~~~~~~~~~Pe~~~~~~-----------~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      .  ..++  .+. .-.+++.. .+|.|||.+....           ..++-||+|+||++.|+++.|.+||.
T Consensus       170 tYLPeDNPadf~fFFDTSrRR-tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRR-TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             ccCCCCCcccceEEEecCCce-eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            1  1111  110 00111111 2699999887521           45678999999999999998899985

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=5.8e-14  Score=110.21  Aligned_cols=118  Identities=19%  Similarity=0.208  Sum_probs=86.8

Q ss_pred             eeee-eecCceEEEeeecCCCCCCCCcccceeeeeeccccCC------------CHHHHHHHHHHHHHHHhcCCCCce--
Q psy3166          16 EVLG-QGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA------------DAKTYDKFLKEINLMKDVGKHDHI--   80 (228)
Q Consensus        16 ~~ig-~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~~h~ni--   80 (228)
                      ..|| .|+.|+||.+...+           ..+++|.+....            ......++.+|++++.++ .|+++  
T Consensus        37 ~~lg~~~g~gtv~~v~~~~-----------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~v  104 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPG-----------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPV  104 (239)
T ss_pred             ceeecCCCCccEEEEEeCC-----------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCC
Confidence            5687 78899999876532           247887764321            012235678899999999 77664  


Q ss_pred             EEeeeEEEc-Cc----eEEEEecCCC-CcHHHHHHH---------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          81 VSFIGCCYK-DE----LRLVVEYCAL-GDLQSYLRE---------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        81 ~~~~~~~~~-~~----~~lv~e~~~~-~~L~~~l~~---------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +..++.... ..    .++|||++++ .+|.+++..               .++|++||+|+||||.|||++.++.++|+
T Consensus       105 P~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        105 PRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             ceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence            555554322 11    3599999987 688877543               68999999999999999999998999999


Q ss_pred             eccCcc
Q psy3166         140 DFGLSE  145 (228)
Q Consensus       140 dfg~~~  145 (228)
                      |||.+.
T Consensus       185 Dfg~~~  190 (239)
T PRK01723        185 DFDRGE  190 (239)
T ss_pred             ECCCcc
Confidence            999775

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.50  E-value=6e-14  Score=106.06  Aligned_cols=117  Identities=26%  Similarity=0.237  Sum_probs=79.4

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHH----------------------HHHHHHHHH
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYD----------------------KFLKEINLM   71 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~----------------------~~~~e~~~l   71 (228)
                      .+.||+|+||.||+|...          .+..||+|.+...... ....                      ....|.+.+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l   71 (187)
T cd05119           2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL   71 (187)
T ss_pred             CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence            568999999999999743          3446999987643211 0001                      113466666


Q ss_pred             HhcCCC-CceEEeeeEEEcCceEEEEecCCC-----CcHHHHHH-H-------------hcccC-CCCcccCCCCCCEee
Q psy3166          72 KDVGKH-DHIVSFIGCCYKDELRLVVEYCAL-----GDLQSYLR-E-------------EYLSN-NKVVHRDLATRNILL  130 (228)
Q Consensus        72 ~~l~~h-~ni~~~~~~~~~~~~~lv~e~~~~-----~~L~~~l~-~-------------~~lh~-~~i~H~~lk~~nil~  130 (228)
                      .++..+ -.+.+.++   ....+++||++++     .+|.+... .             .++|. .+|+|+|+||+||++
T Consensus        72 ~~l~~~~~~~~~~~~---~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          72 KRLYEAGVPVPKPID---LNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             HHHHHcCCCCCceEe---cCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence            666222 12333332   2346899999988     33433322 1             68999 999999999999999


Q ss_pred             cCCCcEEEeeccCcc
Q psy3166         131 SSPHVVKISDFGLSE  145 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~  145 (228)
                      + ++.++++|||.+.
T Consensus       149 ~-~~~~~liDfg~a~  162 (187)
T cd05119         149 D-DGKVYIIDVPQAV  162 (187)
T ss_pred             E-CCcEEEEECcccc
Confidence            9 8999999999875

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.46  E-value=4.2e-13  Score=97.20  Aligned_cols=118  Identities=15%  Similarity=0.121  Sum_probs=90.1

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCC-CceEEeeeEEEc-Cc
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH-DHIVSFIGCCYK-DE   91 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h-~ni~~~~~~~~~-~~   91 (228)
                      +.+.||+|.++.||++...+           ..+++|.......   ...+..|...+..+.++ .++++++..... +.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-----------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~   67 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-----------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGW   67 (155)
T ss_pred             cceecccccccceEEEEecC-----------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc
Confidence            45789999999999988533           2489998865533   35677899999999434 588887776544 34


Q ss_pred             eEEEEecCCCCcHHH-----HHH---H-----hcccCC---CCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          92 LRLVVEYCALGDLQS-----YLR---E-----EYLSNN---KVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~-----~l~---~-----~~lh~~---~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+++||+++++++..     ...   .     ..+|..   +++|+|++|.|+++++.+.++++||+.+.
T Consensus        68 ~~~v~e~~~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          68 SYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             cEEEEEecCCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            789999998876642     111   1     567774   79999999999999998999999999764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590|consensus

Probab=99.46  E-value=6.5e-15  Score=128.94  Aligned_cols=189  Identities=25%  Similarity=0.349  Sum_probs=142.3

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +-..|.+.+.||+|+|+.|-......        .....+|.|.+.... ......+...|..+-+.+..|.|++.+++.
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~--------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~   89 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSR--------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP   89 (601)
T ss_pred             ccccccccccccccccchhhhhhhcC--------CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc
Confidence            36678999999999999988754322        233346777765442 222234445677777777559999999988


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHH-HH---------------------hccc-CCCCcccCCCCCCEeecCCC-cEEEeec
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYL-RE---------------------EYLS-NNKVVHRDLATRNILLSSPH-VVKISDF  141 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l-~~---------------------~~lh-~~~i~H~~lk~~nil~~~~~-~~kl~df  141 (228)
                      ....+ .++++++..++++++.+ ..                     .|+| ..++.|+|+||+|.+++.++ .+++.||
T Consensus        90 ~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   90 SSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             cCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCc
Confidence            76654 56788888888888776 21                     6999 99999999999999999999 9999999


Q ss_pred             cCcccccc-cccccCCCCCCCC-cceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         142 GLSEDIYE-QNVFQNGEPSEKL-PIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       142 g~~~~~~~-~~~~~~~~~~~~~-~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      |++..+.. .+.. .......| ++.|++||...+. ...+..|+||.|+++..+++ |..||.....
T Consensus       170 ~~At~~~~~~g~~-~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~-g~~p~~~~~~  235 (601)
T KOG0590|consen  170 GLATAYRNKNGAE-RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT-GELPWDFPSR  235 (601)
T ss_pred             hhhccccccCCcc-eeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc-CCCCcccccc
Confidence            99976655 3222 22233455 7889999999874 45678999999999999999 9999876543

>KOG1023|consensus

Probab=99.45  E-value=1.2e-13  Score=116.71  Aligned_cols=148  Identities=29%  Similarity=0.526  Sum_probs=111.5

Q ss_pred             HhcCCCCceEEeeeEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCC-cccCCCCCCE
Q psy3166          72 KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKV-VHRDLATRNI  128 (228)
Q Consensus        72 ~~l~~h~ni~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i-~H~~lk~~ni  128 (228)
                      +.+ .|.|+.++.+.+..+. .++|.+||..|+|++.+..                     .|+|.-.| .|+.++..|+
T Consensus         2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            456 8999999999987654 7789999999999998765                     68998766 8999999999


Q ss_pred             eecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCC-------CCchhhHHHHHHHHHHHHhCCCCCC
Q psy3166         129 LLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI-------YTNKSDVWSFGVVLWEIVTLGANPY  201 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-------~~~~~Diwslg~~~~~l~t~g~~pf  201 (228)
                      +++.+..+||+|||+.......... ...........|.|||.+....       -+.++|+||||++++|+++ ..-||
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~-r~~~~  158 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF-RSGPF  158 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh-ccCcc
Confidence            9999999999999987644221000 1111112234689999887531       3567999999999999998 88999


Q ss_pred             CC----CCHHHHHHHHHc-CCCCCCC
Q psy3166         202 PH----IPLCRIVHYLST-GYRMERP  222 (228)
Q Consensus       202 ~~----~~~~~~~~~~~~-~~~~~~p  222 (228)
                      ..    .+..|+..++.+ +..+.+|
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP  184 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRP  184 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCc
Confidence            76    233578778777 5444455

>KOG1033|consensus

Probab=99.38  E-value=1.3e-13  Score=115.10  Aligned_cols=131  Identities=24%  Similarity=0.429  Sum_probs=96.3

Q ss_pred             eEEEEecCCCCcHHHHHHH----------------hcccC----CCCcccCCCCCCEeecCCCcEEEeeccCcccccccc
Q psy3166          92 LRLVVEYCALGDLQSYLRE----------------EYLSN----NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN  151 (228)
Q Consensus        92 ~~lv~e~~~~~~L~~~l~~----------------~~lh~----~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~  151 (228)
                      +++.|++|...+|.+++..                ..+-.    ++.+|+|+||.||++..+..+||.|||+........
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~  410 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDE  410 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecccCC
Confidence            6789999999999999863                01111    889999999999999999999999999976443322


Q ss_pred             c---ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh----------------CCCCC--CCCCCHH--H
Q psy3166         152 V---FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT----------------LGANP--YPHIPLC--R  208 (228)
Q Consensus       152 ~---~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t----------------~g~~p--f~~~~~~--~  208 (228)
                      .   .....+.-.||..||+||.+.+..|+.++||||||++++|++.                .|..|  |-...+.  .
T Consensus       411 ~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d~p~e~~  490 (516)
T KOG1033|consen  411 TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQDYPEEYT  490 (516)
T ss_pred             cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhcCcHHHH
Confidence            0   0112234567888999999999999999999999999999987                25555  3333333  3


Q ss_pred             HHHHHHcCCCCCCC
Q psy3166         209 IVHYLSTGYRMERP  222 (228)
Q Consensus       209 ~~~~~~~~~~~~~p  222 (228)
                      +++++....+..+|
T Consensus       491 ll~~lls~~p~~RP  504 (516)
T KOG1033|consen  491 LLQQLLSPSPEERP  504 (516)
T ss_pred             HHHHhcCCCcccCc
Confidence            46666665555555

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.34  E-value=4.2e-12  Score=107.92  Aligned_cols=123  Identities=23%  Similarity=0.240  Sum_probs=84.9

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHH----------------------------------
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY----------------------------------   61 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------   61 (228)
                      +.||+|++|.||+|+.+++          +.||||+.+.+......                                  
T Consensus       123 ~plasaSigQVh~A~l~~G----------~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~  192 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDG----------KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK  192 (437)
T ss_pred             cceeeeehhheEEEEecCC----------CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence            5799999999999986543          35999998654211100                                  


Q ss_pred             -----HHHHHHHHHHHhcC---CCCceEEeeeEE--EcCceEEEEecCCCCcHHHHHHH-------------------hc
Q psy3166          62 -----DKFLKEINLMKDVG---KHDHIVSFIGCC--YKDELRLVVEYCALGDLQSYLRE-------------------EY  112 (228)
Q Consensus        62 -----~~~~~e~~~l~~l~---~h~ni~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~-------------------~~  112 (228)
                           -++.+|...+.++.   .+.+-+.+..++  ..+..+++|||++|++|.+....                   ..
T Consensus       193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQ  272 (437)
T ss_pred             HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence                 01333444444442   222333333333  23457899999999888765421                   35


Q ss_pred             ccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166         113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus       113 lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      +|..|++|+|++|.||++..++.++++|||++..+.
T Consensus       273 l~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       273 VLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            789999999999999999999999999999987553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=3.2e-11  Score=104.19  Aligned_cols=128  Identities=19%  Similarity=0.215  Sum_probs=86.7

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH---------------------------------
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA---------------------------------   58 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------   58 (228)
                      |+. +.||+|++|.|++|+.++         +++.||||..+.+...                                 
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            454 789999999999998654         3456999998754211                                 


Q ss_pred             HHHH------HHHHHHHHHHhcC---CCCceEEeeeEE--EcCceEEEEecCCCCcHHHH--HHH---------------
Q psy3166          59 KTYD------KFLKEINLMKDVG---KHDHIVSFIGCC--YKDELRLVVEYCALGDLQSY--LRE---------------  110 (228)
Q Consensus        59 ~~~~------~~~~e~~~l~~l~---~h~ni~~~~~~~--~~~~~~lv~e~~~~~~L~~~--l~~---------------  110 (228)
                      +...      ++.+|...+.++.   .+.+.+.+..++  .+...+++|||+.|+.+.+.  +..               
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence            0011      1233444444442   233344444443  24567899999999998764  221               


Q ss_pred             --hcccCCCCcccCCCCCCEeecCCC----cEEEeeccCcccccc
Q psy3166         111 --EYLSNNKVVHRDLATRNILLSSPH----VVKISDFGLSEDIYE  149 (228)
Q Consensus       111 --~~lh~~~i~H~~lk~~nil~~~~~----~~kl~dfg~~~~~~~  149 (228)
                        ..+...|++|+|++|.||+++.++    .++++|||+...+..
T Consensus       272 ~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence              234578999999999999999887    999999998875533

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.20  E-value=9.1e-11  Score=87.10  Aligned_cols=116  Identities=15%  Similarity=0.077  Sum_probs=82.1

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEE
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL   94 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~l   94 (228)
                      .+.|+.|.++.||++...           +..|++|........  ......|..+++.+.+...+.+++.. ..+..++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYF-DPETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeE
Confidence            467889999999998743           235999987644221  22456788888888333334445443 3334679


Q ss_pred             EEecCCCCcHHHH-------HHH-----hcccCCCC-----cccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          95 VVEYCALGDLQSY-------LRE-----EYLSNNKV-----VHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        95 v~e~~~~~~L~~~-------l~~-----~~lh~~~i-----~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      |||+++|.++.+.       +.+     ..||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        69 v~e~i~G~~l~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          69 ITEFIEGSELLTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EEEecCCCccccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9999998877531       111     57898875     9999999999999 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606|consensus

Probab=99.17  E-value=1.3e-11  Score=110.55  Aligned_cols=199  Identities=20%  Similarity=0.242  Sum_probs=139.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +..+.+.+.+.+.+|.++.++.+.....+         ...+.+.......  ....+...++-.++... .+|.++...
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sg---------h~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~  870 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSG---------HTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSF  870 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccc---------cccchhhhccchhhccccccccCCccCccccC-CCCceeccc
Confidence            46678888889999999999987644333         2234443322110  00111222333343333 556666554


Q ss_pred             eEEEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..+.. ...+++++++.+++|...++.                    ++||...+.|+|++|.|.++..++..++.+|+.
T Consensus       871 ~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  871 PSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccc
Confidence            44333 458899999988888887654                    799999899999999999999999999999983


Q ss_pred             ccccccc---c-c--------------------cc----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh
Q psy3166         144 SEDIYEQ---N-V--------------------FQ----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT  195 (228)
Q Consensus       144 ~~~~~~~---~-~--------------------~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t  195 (228)
                      .......   . .                    ..    .......++..|.+||...+......+|+|++|+++++.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            2211000   0 0                    00    01234566788999999999888899999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHHcC
Q psy3166         196 LGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       196 ~g~~pf~~~~~~~~~~~~~~~  216 (228)
                       |.+||....+..+.+.+.++
T Consensus      1031 -g~pp~na~tpq~~f~ni~~~ 1050 (1205)
T KOG0606|consen 1031 -GIPPFNAETPQQIFENILNR 1050 (1205)
T ss_pred             -CCCCCCCcchhhhhhccccC
Confidence             99999999999888887776

>KOG0601|consensus

Probab=99.02  E-value=4.8e-10  Score=95.27  Aligned_cols=177  Identities=27%  Similarity=0.304  Sum_probs=128.0

Q ss_pred             Cceeeeeeeee--ecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          10 ERLILGEVLGQ--GEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        10 ~~~~~~~~ig~--g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ..+-+.+.+|.  |.+|.||.++..+       ......+|+|.-+... .+....+-++|+...+++..|+|.++.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            34557789999  9999999987522       2334468888754432 223334556788888899889999997777


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecCC-CcEEEe
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSSP-HVVKIS  139 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~~-~~~kl~  139 (228)
                      +..+. .++-.|.+ +.+|+++...                         .++|...++|.|+||+||++..+ ..+++.
T Consensus       187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  187 WEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence            77655 56666666 5678777543                         47999999999999999999999 789999


Q ss_pred             eccCcccccccccccCC--CCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh
Q psy3166         140 DFGLSEDIYEQNVFQNG--EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT  195 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t  195 (228)
                      ||++...+.........  .....+-..|++||...+ .+....|++++|.+..+...
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l  322 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAIL  322 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHh
Confidence            99998766554321110  011134446999997654 47888999999988888766

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=3.4e-09  Score=78.32  Aligned_cols=117  Identities=23%  Similarity=0.254  Sum_probs=79.6

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeecc-ccCC-CH-----HHHHHHHHHHHHHHhcCCC-CceEEeeeEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANA-DA-----KTYDKFLKEINLMKDVGKH-DHIVSFIGCC   87 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~-~~~~-~~-----~~~~~~~~e~~~l~~l~~h-~ni~~~~~~~   87 (228)
                      ..+++|+=+.++.+.+-+.           .+.+|.- ++.- .+     -...+..+|..++.+.... -++..+++ +
T Consensus         2 ~~i~~GAEa~i~~~~~~g~-----------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d-v   69 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGL-----------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD-V   69 (204)
T ss_pred             chhhCCcceeEEeeeccCc-----------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE-E
Confidence            3567787788887643221           2444432 1111 11     1234567899999887332 23444433 3


Q ss_pred             EcCceEEEEecCCCCcHHHHHHH-------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDELRLVVEYCALGDLQSYLRE-------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~-------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..++..++|||.+|..|.+.+..             .-||..||+|+||.++||++...+ +.++|||++.
T Consensus        70 D~~~~~I~me~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          70 DPDNGLIVMEYIEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             cCCCCEEEEEEeCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            45667899999999888877765             469999999999999999998765 9999999986

>KOG3087|consensus

Probab=98.92  E-value=1.4e-08  Score=75.07  Aligned_cols=121  Identities=22%  Similarity=0.259  Sum_probs=81.6

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeec-cccC----C--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKM-LKAN----A--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~-~~~~----~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ....|-||+=+.|+++.+.+..           +.+|. +.+.    .  ..-...+..+|.+.|.++.----.++..-+
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~-----------~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEA-----------AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF   79 (229)
T ss_pred             cceeeeccceeeEeeeccCCce-----------eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence            5678889999999998765432           44443 2211    1  112345677899988886222112222222


Q ss_pred             EEcCceEEEEecCCC-CcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCC---cEEEee
Q psy3166          87 CYKDELRLVVEYCAL-GDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPH---VVKISD  140 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~-~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~---~~kl~d  140 (228)
                      +....-++.|||..| .++.+++.+                      .-||.++|+|+||.++||++.+++   .+.++|
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEe
Confidence            344557789999976 467777765                      469999999999999999998754   458999


Q ss_pred             ccCcc
Q psy3166         141 FGLSE  145 (228)
Q Consensus       141 fg~~~  145 (228)
                      ||++.
T Consensus       160 fgls~  164 (229)
T KOG3087|consen  160 FGLSS  164 (229)
T ss_pred             ecchh
Confidence            99875

>KOG1243|consensus

Probab=98.77  E-value=4.7e-08  Score=84.60  Aligned_cols=147  Identities=19%  Similarity=0.292  Sum_probs=100.4

Q ss_pred             cccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceEEEEecCCCCcHHHHHHH---------
Q psy3166          41 GQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------  110 (228)
Q Consensus        41 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---------  110 (228)
                      +..+.+|.+...+.... .......+.+.-|+.+ +||||+++++.+.. +.+|+|.|=+.  .|..++++         
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~~~v~~G  109 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGKEEVCLG  109 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHHHHHHHH
Confidence            34445677777765433 4445677888899999 99999999988765 45899998763  33333333         


Q ss_pred             --------hccc-CCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchh
Q psy3166         111 --------EYLS-NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKS  181 (228)
Q Consensus       111 --------~~lh-~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~  181 (228)
                              .||| +.+++|+++.-+.++++..|.-||.+|.++........   .......-..|..|+.+....  -..
T Consensus       110 l~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  110 LFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc--cch
Confidence                    5897 66899999999999999999999999997642211110   001111112355565444332  236


Q ss_pred             hHHHHHHHHHHHHhCC
Q psy3166         182 DVWSFGVVLWEIVTLG  197 (228)
Q Consensus       182 Diwslg~~~~~l~t~g  197 (228)
                      |.|-|||++++++. |
T Consensus       185 D~~~Lg~li~el~n-g  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFN-G  199 (690)
T ss_pred             hhhhHHHHHHHHhC-c
Confidence            99999999999997 7

>KOG0601|consensus

Probab=98.76  E-value=7.5e-09  Score=88.15  Aligned_cols=175  Identities=21%  Similarity=0.166  Sum_probs=122.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ....+|-+...||.+.|+.|+....+        ...+..|++|-+.+... .......+.|+.+.-.+..|.+++.+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r--------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKR--------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeec--------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            34567788899999999999987643        23344699998876532 2223345567777777778888988877


Q ss_pred             EEEc-CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC-CcEEEeeccC
Q psy3166          86 CCYK-DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGL  143 (228)
Q Consensus        86 ~~~~-~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~-~~~kl~dfg~  143 (228)
                      .|.. ++.++-.|||.++++...+..                    .++|++.++|+|++|+||++..+ +..++.||+.
T Consensus       334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  334 SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccc
Confidence            6654 557788899988887655432                    58999999999999999999986 7788899987


Q ss_pred             cccccccccccCCCCCCCCcceee-cccccc-cCCCCchhhHHHHHHHHHHHHh
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT  195 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~-~Pe~~~-~~~~~~~~Diwslg~~~~~l~t  195 (228)
                      ..-+.-..     . .......++ ..|.+. ...+..++|+++||..+.+.++
T Consensus       414 ~t~~~~~~-----~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~  461 (524)
T KOG0601|consen  414 WTRLAFSS-----G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAIT  461 (524)
T ss_pred             ccccceec-----c-cccccccccccchhhcccccccccccccccccccccccc
Confidence            65221110     0 011112234 244444 4567889999999998888887

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.73  E-value=2.9e-08  Score=75.25  Aligned_cols=123  Identities=21%  Similarity=0.204  Sum_probs=77.5

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-----------------------CHH--HHHHHHHHHHH
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-----------------------DAK--TYDKFLKEINL   70 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----------------------~~~--~~~~~~~e~~~   70 (228)
                      ..||.|-=+.||.|....+..   ....+..+|+|+.+...                       .+.  ......+|...
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~   79 (197)
T cd05146           3 GCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHN   79 (197)
T ss_pred             CccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHH
Confidence            467888888899987432100   00123358888854210                       001  11123479999


Q ss_pred             HHhcCCC-CceEEeeeEEEcCceEEEEecCCCC-----cHHHH----------HHH-----hcc-cCCCCcccCCCCCCE
Q psy3166          71 MKDVGKH-DHIVSFIGCCYKDELRLVVEYCALG-----DLQSY----------LRE-----EYL-SNNKVVHRDLATRNI  128 (228)
Q Consensus        71 l~~l~~h-~ni~~~~~~~~~~~~~lv~e~~~~~-----~L~~~----------l~~-----~~l-h~~~i~H~~lk~~ni  128 (228)
                      |+++... -++...+.+   ...+++|||+.+.     .|.+.          +.+     ..+ |+.|++|+|+++.||
T Consensus        80 L~rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          80 LKRMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            9998443 456666543   5678999999653     12111          111     234 899999999999999


Q ss_pred             eecCCCcEEEeeccCcc
Q psy3166         129 LLSSPHVVKISDFGLSE  145 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~  145 (228)
                      ++. ++.+.++||+.+-
T Consensus       157 L~~-~~~v~iIDF~qav  172 (197)
T cd05146         157 LWH-DGKVWFIDVSQSV  172 (197)
T ss_pred             EEE-CCcEEEEECCCce
Confidence            997 4779999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.48  E-value=1.3e-06  Score=69.76  Aligned_cols=83  Identities=16%  Similarity=0.112  Sum_probs=58.3

Q ss_pred             HHHHHHHHHHhcCC----CCceEEeeeEEE---cCceEEEEecCCCC-cHHHHHHH----------------------hc
Q psy3166          63 KFLKEINLMKDVGK----HDHIVSFIGCCY---KDELRLVVEYCALG-DLQSYLRE----------------------EY  112 (228)
Q Consensus        63 ~~~~e~~~l~~l~~----h~ni~~~~~~~~---~~~~~lv~e~~~~~-~L~~~l~~----------------------~~  112 (228)
                      .+.+|...+.++..    -|.++-+.....   ....++|+|++++. +|.+++..                      .-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            36788888877622    233333321111   12367999999875 78777531                      47


Q ss_pred             ccCCCCcccCCCCCCEeecC-------CCcEEEeeccCcc
Q psy3166         113 LSNNKVVHRDLATRNILLSS-------PHVVKISDFGLSE  145 (228)
Q Consensus       113 lh~~~i~H~~lk~~nil~~~-------~~~~kl~dfg~~~  145 (228)
                      ||+.||+|+|+++.|||++.       ...+.++||+.+.
T Consensus       154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99999999999999999975       4579999999774

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.36  E-value=1.2e-06  Score=67.53  Aligned_cols=81  Identities=11%  Similarity=0.102  Sum_probs=54.5

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCC-CceEEeeeEEEcC----
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH-DHIVSFIGCCYKD----   90 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h-~ni~~~~~~~~~~----   90 (228)
                      +.|+.|..+.||++...+          +..+++|.............+.+|.++++.+..+ .++.+++.+....    
T Consensus         4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            578999999999987533          2348999876543212234677899999998432 3456666554432    


Q ss_pred             ceEEEEecCCCCcHHH
Q psy3166          91 ELRLVVEYCALGDLQS  106 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~  106 (228)
                      ..+++||+++|.++.+
T Consensus        74 ~~~~v~e~i~G~~l~~   89 (223)
T cd05154          74 TPFYVMERVDGRVLRD   89 (223)
T ss_pred             CceEEEEEeCCEecCC
Confidence            4679999998776543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.30  E-value=1.6e-06  Score=65.41  Aligned_cols=81  Identities=26%  Similarity=0.267  Sum_probs=53.0

Q ss_pred             HHHHHHHHHHHHhcCCCC-ceEEeeeEEEcCceEEEEecCC--CCcHHHHHH-------------H------hcccCCCC
Q psy3166          61 YDKFLKEINLMKDVGKHD-HIVSFIGCCYKDELRLVVEYCA--LGDLQSYLR-------------E------EYLSNNKV  118 (228)
Q Consensus        61 ~~~~~~e~~~l~~l~~h~-ni~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~-------------~------~~lh~~~i  118 (228)
                      .....+|.+.|.++.... ++.+.+.+   ...++||||+.  |..+.....             +      ..+|..||
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~---~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~gi  128 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDY---NRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGI  128 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEE---ETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTE
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEE---eCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCc
Confidence            345678999999995442 56666543   35679999997  433322111             1      35789999


Q ss_pred             cccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         119 VHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       119 ~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +|+|+.+.||++..+ .+.++|||.+.
T Consensus       129 vHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen  129 VHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             EESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             eecCCChhhEEeecc-eEEEEecCcce
Confidence            999999999999987 89999999764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1266|consensus

Probab=98.14  E-value=2.7e-06  Score=68.38  Aligned_cols=123  Identities=20%  Similarity=0.350  Sum_probs=83.9

Q ss_pred             HHhcCCCCceEEeeeEEEcC------ceEEEEecCCCCcHHHHHHH------------------------hcccCCC--C
Q psy3166          71 MKDVGKHDHIVSFIGCCYKD------ELRLVVEYCALGDLQSYLRE------------------------EYLSNNK--V  118 (228)
Q Consensus        71 l~~l~~h~ni~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~--i  118 (228)
                      |..+ .|.|+++++.++.+.      ...++.||+..|++.+||++                        .|||+-.  |
T Consensus       121 llql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  121 LLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            3344 689999998887552      36788899999999999986                        5899764  8


Q ss_pred             cccCCCCCCEeecCCCcEEEeeccCccccccccccc-C-CCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHh
Q psy3166         119 VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-N-GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT  195 (228)
Q Consensus       119 ~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t  195 (228)
                      +|+++..+.|++..+|.+|+.--. ........... . ...-..+-++|.+||.=.-..-+.++|||+||....+|.-
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999988854221 11111110000 0 1111122345777876554455678999999999999976

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.13  E-value=1.8e-05  Score=60.80  Aligned_cols=125  Identities=15%  Similarity=0.138  Sum_probs=74.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHH--HH------HHHHHHHHHhcCC--CC
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY--DK------FLKEINLMKDVGK--HD   78 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~l~~--h~   78 (228)
                      ..+|.+.+++-......|.+....+           ..+.+|..........+  ..      ..+.+..+.++..  -.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~~-----------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEIDG-----------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEECC-----------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            3567777777777766666654322           34888887654322111  11      1223333333311  11


Q ss_pred             ceEEeeeEE------EcCceEEEEecCCCCcHHHH----------HHH--hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          79 HIVSFIGCC------YKDELRLVVEYCALGDLQSY----------LRE--EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        79 ni~~~~~~~------~~~~~~lv~e~~~~~~L~~~----------l~~--~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ....++-+.      .....+++|||++|..|.+.          +.+  ..+|+.|+.|+|..|.|+++..++ ++++|
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence            222211111      22346689999998766542          112  679999999999999999988544 99999


Q ss_pred             ccCcc
Q psy3166         141 FGLSE  145 (228)
Q Consensus       141 fg~~~  145 (228)
                      ++..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.08  E-value=1.4e-05  Score=61.32  Aligned_cols=84  Identities=17%  Similarity=0.175  Sum_probs=59.4

Q ss_pred             HHHHHHHHHHHhcCCC-CceEEeeeEEEc-----CceEEEEecCCCC-cHHHHHHH--------------------hccc
Q psy3166          62 DKFLKEINLMKDVGKH-DHIVSFIGCCYK-----DELRLVVEYCALG-DLQSYLRE--------------------EYLS  114 (228)
Q Consensus        62 ~~~~~e~~~l~~l~~h-~ni~~~~~~~~~-----~~~~lv~e~~~~~-~L~~~l~~--------------------~~lh  114 (228)
                      .++.+|...+.++... =.++....+...     ...++|+|.+++. +|.+++..                    .-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            4567788777766321 122333333322     2357899999874 68887653                    4699


Q ss_pred             CCCCcccCCCCCCEeecCCC---cEEEeeccCcc
Q psy3166         115 NNKVVHRDLATRNILLSSPH---VVKISDFGLSE  145 (228)
Q Consensus       115 ~~~i~H~~lk~~nil~~~~~---~~kl~dfg~~~  145 (228)
                      ++||+|+|+++.|||+..++   .+.++||+.+.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            99999999999999999877   89999999765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.99  E-value=1.7e-05  Score=58.54  Aligned_cols=116  Identities=21%  Similarity=0.186  Sum_probs=78.8

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCce
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDEL   92 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   92 (228)
                      ...+.||.|++|.||+|.+++.           .+|+|.-..++..   ..+..|.++|..+..-.-..+++.   -+..
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~-----------~~a~Kvrr~ds~r---~~l~kEakiLeil~g~~~~p~vy~---yg~~   87 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG-----------EVALKVRRRDSPR---RNLEKEAKILEILAGEGVTPEVYF---YGED   87 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc-----------eEEEEEecCCcch---hhHHHHHHHHHHhhhcCCCceEEE---echh
Confidence            4557899999999999987664           3888886655433   456679999888832222233332   2334


Q ss_pred             EEEEecCCCCcHHHHHHH------------h-cccCCCCcccCCC-CCCEeecCCCcEEEeeccCcc
Q psy3166          93 RLVVEYCALGDLQSYLRE------------E-YLSNNKVVHRDLA-TRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        93 ~lv~e~~~~~~L~~~l~~------------~-~lh~~~i~H~~lk-~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ++.|||+.|-.|.+.-..            . -|-..||-|..+. |.+.++..++.+.|+||.-+.
T Consensus        88 ~i~me~i~G~~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhcCcchhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            455999988777665431            2 2445688888764 666777777799999999775

>KOG3741|consensus

Probab=97.90  E-value=8.6e-05  Score=63.33  Aligned_cols=152  Identities=20%  Similarity=0.256  Sum_probs=101.8

Q ss_pred             ceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-----CceEEEEec
Q psy3166          24 GVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-----DELRLVVEY   98 (228)
Q Consensus        24 ~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-----~~~~lv~e~   98 (228)
                      .+.|++.         +..++..|.+|++... ..........-++.++++ .|+|++++.++|..     ..+++|++|
T Consensus       290 ~Ttyk~~---------s~~DG~~YvLkRlhg~-r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDY  358 (655)
T KOG3741|consen  290 ITTYKAT---------SNVDGNAYVLKRLHGD-RDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDY  358 (655)
T ss_pred             ceeEeee---------eccCCceeeeeeeccc-cccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEec
Confidence            4677776         4455567999998422 111111222347788899 99999999998863     237899999


Q ss_pred             CCC-CcHHHHH-HH----------------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          99 CAL-GDLQSYL-RE----------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        99 ~~~-~~L~~~l-~~----------------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      .|+ ++|.++- ..                                  .++|+.|+.-+-|.+.+|++..+..++++.-|
T Consensus       359 yP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  359 YPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccc
Confidence            875 5676642 11                                  57999999999999999999998888888777


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG-ANPYPHIPLC  207 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g-~~pf~~~~~~  207 (228)
                      ....+....               .  +.+..   -.+-|.-.||.++..|.| | ...+....+.
T Consensus       439 i~Dvl~~d~---------------~--~~le~---~Qq~D~~~lG~ll~aLAt-~~~ns~~~d~~~  483 (655)
T KOG3741|consen  439 IMDVLQEDP---------------T--EPLES---QQQNDLRDLGLLLLALAT-GTENSNRTDSTQ  483 (655)
T ss_pred             ceeeecCCC---------------C--cchhH---HhhhhHHHHHHHHHHHhh-cccccccccchH
Confidence            654332221               0  11111   124588899999999998 5 4555554433

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.83  E-value=8.6e-05  Score=64.40  Aligned_cols=123  Identities=20%  Similarity=0.249  Sum_probs=81.6

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHH---------------------------------H
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY---------------------------------D   62 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------~   62 (228)
                      ..|+.++-|.|++|++++          ++.||||+...+......                                 +
T Consensus       131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            678899999999999765          346999997654221110                                 0


Q ss_pred             ------HHHHHHHHHHhcC---CCCceEEeeeEE--EcCceEEEEecCCCCcHHHHH--HH-----------------hc
Q psy3166          63 ------KFLKEINLMKDVG---KHDHIVSFIGCC--YKDELRLVVEYCALGDLQSYL--RE-----------------EY  112 (228)
Q Consensus        63 ------~~~~e~~~l~~l~---~h~ni~~~~~~~--~~~~~~lv~e~~~~~~L~~~l--~~-----------------~~  112 (228)
                            ++.+|...+.++.   +...-+.+-.++  .++.-.++|||+.|-.+.+..  ..                 +.
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q  280 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQ  280 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence                  1222333333331   222233333443  346688999999987776652  22                 22


Q ss_pred             ccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166         113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus       113 lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      +-..|+.|.|..|-||++..+|.+-+.|||+...+.
T Consensus       281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            334789999999999999999999999999876543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.78  E-value=2.6e-05  Score=61.41  Aligned_cols=118  Identities=20%  Similarity=0.196  Sum_probs=78.8

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC----------C---------C--HHHHHHHHHHHHHH
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN----------A---------D--AKTYDKFLKEINLM   71 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~----------~---------~--~~~~~~~~~e~~~l   71 (228)
                      .+...||-|-=+.||.|..+++.          ++|+|.=+..          .         .  ..++..+.+|.+.|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~----------~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L  163 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGR----------KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL  163 (304)
T ss_pred             hhccccccCccceEEEEECCCCC----------EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence            46688999999999999754332          4777763211          0         0  11234567899999


Q ss_pred             HhcCCC-CceEEeeeEEEcCceEEEEecCCCCcHHHHH--HH-------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          72 KDVGKH-DHIVSFIGCCYKDELRLVVEYCALGDLQSYL--RE-------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        72 ~~l~~h-~ni~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~-------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      .+|... -.|...+   ..+...++||+..|..|...-  .+             .-.-..|++|+|+++=||+++.+|.
T Consensus       164 ~~L~~~G~~VP~P~---~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         164 QRLYPEGVKVPKPI---AWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             HHhhhcCCCCCCcc---ccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence            999333 2344333   334567899998776554332  11             1112789999999999999999999


Q ss_pred             EEEeeccC
Q psy3166         136 VKISDFGL  143 (228)
Q Consensus       136 ~kl~dfg~  143 (228)
                      +.++||=-
T Consensus       241 ~~vIDwPQ  248 (304)
T COG0478         241 IVVIDWPQ  248 (304)
T ss_pred             EEEEeCcc
Confidence            99999853

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.71  E-value=0.00025  Score=54.84  Aligned_cols=117  Identities=21%  Similarity=0.259  Sum_probs=74.2

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC-ceEEeeeEEEc----
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD-HIVSFIGCCYK----   89 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~-ni~~~~~~~~~----   89 (228)
                      .+.++.|..+.||+....++           .+++|.....   .....+.+|..+++.+.++. .+..++.....    
T Consensus         2 i~~l~~G~~n~~~~v~~~~~-----------~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~   67 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDG-----------RYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN   67 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTS-----------EEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET
T ss_pred             CccCCCCCeeeEEEEEECCc-----------EEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc
Confidence            46899999999999874332           4899986533   34456678888888874442 35555553322    


Q ss_pred             CceEEEEecCCCCcHHH----------------HHHH-------------------------------------------
Q psy3166          90 DELRLVVEYCALGDLQS----------------YLRE-------------------------------------------  110 (228)
Q Consensus        90 ~~~~lv~e~~~~~~L~~----------------~l~~-------------------------------------------  110 (228)
                      ...+++|++++|.++..                .+.+                                           
T Consensus        68 ~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (239)
T PF01636_consen   68 GFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEE  147 (239)
T ss_dssp             SEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHH
T ss_pred             ccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHH
Confidence            22578999998887776                0110                                           


Q ss_pred             ----------hcc---cCCCCcccCCCCCCEeec-CCCcEEEeeccCcc
Q psy3166         111 ----------EYL---SNNKVVHRDLATRNILLS-SPHVVKISDFGLSE  145 (228)
Q Consensus       111 ----------~~l---h~~~i~H~~lk~~nil~~-~~~~~kl~dfg~~~  145 (228)
                                ..+   ....++|+|+.|.||+++ +++.+-++||+.+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  148 LEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                      011   234589999999999999 56667899998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG2137|consensus

Probab=97.65  E-value=1.1e-05  Score=70.54  Aligned_cols=93  Identities=24%  Similarity=0.367  Sum_probs=65.2

Q ss_pred             hcccCC-CCcccCCCCCCEeecCCCcEEEeeccCccccccccccc-----CCCCCC-CCcceeecccccccCCCCchhhH
Q psy3166         111 EYLSNN-KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-----NGEPSE-KLPIRWLALESLVSNIYTNKSDV  183 (228)
Q Consensus       111 ~~lh~~-~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~-~~~~~~~~Pe~~~~~~~~~~~Di  183 (228)
                      .|+|.. +++|++|.|++|.++..+..|+..|+.+........+.     ...+.. .-...|.+||++....-+.++|+
T Consensus       113 ~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~  192 (700)
T KOG2137|consen  113 AFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDV  192 (700)
T ss_pred             hhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccccccc
Confidence            477865 79999999999999999999999999764332211111     111111 11235899999998778889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCC
Q psy3166         184 WSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       184 wslg~~~~~l~t~g~~pf~~  203 (228)
                      +|+|+++|.+...|..-+..
T Consensus       193 fSlG~li~~i~~~gk~i~~a  212 (700)
T KOG2137|consen  193 FSLGVLIYTIYNGGKSIIAA  212 (700)
T ss_pred             eeeeeEEEEEecCCcchhhc
Confidence            99999999887424433433

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.55  E-value=0.0014  Score=49.91  Aligned_cols=115  Identities=26%  Similarity=0.426  Sum_probs=76.0

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---------------CHHHHHHHHHHHHHHHhc----
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---------------DAKTYDKFLKEINLMKDV----   74 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l----   74 (228)
                      -...||+|+.-.||.  ++..+          ...||+.....               ......+..+|+.-...+    
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp----------~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~   72 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDP----------NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRR   72 (199)
T ss_pred             CCcccccCCCceEEE--CCCCC----------CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhcc
Confidence            346899999999996  22211          25777776443               001123455666655555    


Q ss_pred             -CCCCceEEeeeEEEcCc-eEEEEecCC------CCcHHHHHHH---------------hcccCCCCcccCCCCCCEeec
Q psy3166          75 -GKHDHIVSFIGCCYKDE-LRLVVEYCA------LGDLQSYLRE---------------EYLSNNKVVHRDLATRNILLS  131 (228)
Q Consensus        75 -~~h~ni~~~~~~~~~~~-~~lv~e~~~------~~~L~~~l~~---------------~~lh~~~i~H~~lk~~nil~~  131 (228)
                       ..+.+|.+++|+..++. .-+|+|...      .-+|.+++.+               ++|-+.+|+.+|++|.||++.
T Consensus        73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence             14789999999887654 556666642      3467888764               578889999999999999997


Q ss_pred             CC--C--cEEEee
Q psy3166         132 SP--H--VVKISD  140 (228)
Q Consensus       132 ~~--~--~~kl~d  140 (228)
                      ..  +  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            53  2  466665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.50  E-value=0.0012  Score=55.75  Aligned_cols=79  Identities=19%  Similarity=0.112  Sum_probs=51.6

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-----C-CHHHHHHHHHHHHHHHhcCCC--CceEEeeeE
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-----A-DAKTYDKFLKEINLMKDVGKH--DHIVSFIGC   86 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~~e~~~l~~l~~h--~ni~~~~~~   86 (228)
                      .+.||.|.++.||++...++         ++.+.||+-..-     . .+....+...|.+.|..+..+  .++++++.+
T Consensus        31 ~~elggGn~N~VyrV~~~~g---------~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~  101 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEG---------GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY  101 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCC---------CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence            46899999999999875332         124888985311     1 122345677788888876433  456776654


Q ss_pred             EEcCceEEEEecCCCCc
Q psy3166          87 CYKDELRLVVEYCALGD  103 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~  103 (228)
                       ..+..++|||++++..
T Consensus       102 -D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 -DEELAVTVMEDLSDHK  117 (401)
T ss_pred             -CCCCCEEEEecCCCcc
Confidence             3344689999987643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.46  E-value=0.002  Score=50.27  Aligned_cols=113  Identities=15%  Similarity=0.162  Sum_probs=72.5

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC-ceEEeeeEEEcC-ceE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD-HIVSFIGCCYKD-ELR   93 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~-ni~~~~~~~~~~-~~~   93 (228)
                      ..||+|..+.||+..             +..+++|........   ....+|.++++.+.... .+.+.+.+.... ...
T Consensus         7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~g   70 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLG   70 (226)
T ss_pred             eeecCCCCcceeEec-------------CCCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeee
Confidence            678999999999831             113678887654322   34578999988873332 245555554433 356


Q ss_pred             EEEecCCCCc-HHH--------------HHHH-----------------------------------------hccc---
Q psy3166          94 LVVEYCALGD-LQS--------------YLRE-----------------------------------------EYLS---  114 (228)
Q Consensus        94 lv~e~~~~~~-L~~--------------~l~~-----------------------------------------~~lh---  114 (228)
                      ++||++.|.+ +..              .+.+                                         .+|.   
T Consensus        71 lv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~  150 (226)
T TIGR02172        71 LIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP  150 (226)
T ss_pred             eeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence            8999998863 111              1111                                         0111   


Q ss_pred             -CCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         115 -NNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       115 -~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                       ...++|+|+.|.|++++..+ +.++||+.+.
T Consensus       151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence             12357999999999999877 9999998653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=97.37  E-value=0.001  Score=50.94  Aligned_cols=85  Identities=13%  Similarity=0.084  Sum_probs=58.4

Q ss_pred             HHHHHHHHHHHHhcCCC-CceEEeeeEE-E-c---CceEEEEecCCC-CcHHHHHHH----------------------h
Q psy3166          61 YDKFLKEINLMKDVGKH-DHIVSFIGCC-Y-K---DELRLVVEYCAL-GDLQSYLRE----------------------E  111 (228)
Q Consensus        61 ~~~~~~e~~~l~~l~~h-~ni~~~~~~~-~-~---~~~~lv~e~~~~-~~L~~~l~~----------------------~  111 (228)
                      ...+.+|+..+.++... -.+.+..... . .   ..-++|+|-+.+ -+|.+++.+                      .
T Consensus        63 ~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia  142 (216)
T PRK09902         63 RPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFK  142 (216)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHH
Confidence            35678899988887322 1244433111 1 1   125688886643 467666532                      4


Q ss_pred             cccCCCCcccCCCCCCEeecCCCc--EEEeeccCcc
Q psy3166         112 YLSNNKVVHRDLATRNILLSSPHV--VKISDFGLSE  145 (228)
Q Consensus       112 ~lh~~~i~H~~lk~~nil~~~~~~--~kl~dfg~~~  145 (228)
                      -||+.|+.|+|+-+.||+++..+.  +.++||..++
T Consensus       143 ~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        143 KMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            799999999999999999986666  9999998654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.35  E-value=0.00045  Score=57.83  Aligned_cols=90  Identities=17%  Similarity=0.149  Sum_probs=66.3

Q ss_pred             hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHH
Q psy3166         111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWS  185 (228)
Q Consensus       111 ~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diws  185 (228)
                      .-||..|-+-+|+.++|+|+.+++.+.|.|=.-.....+...+    .+..|...|.+||.-.     +..-+...|.+.
T Consensus       131 A~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~----~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FG  206 (637)
T COG4248         131 ATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLH----LCPVGVSEFTPPELQTLPSFVGFERTANHDNFG  206 (637)
T ss_pred             HHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceE----ecccCccccCCHHHhccccccccCCCccccchh
Confidence            3589999888999999999999999999875533222122222    1346677899999544     223456789999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q psy3166         186 FGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       186 lg~~~~~l~t~g~~pf~~~  204 (228)
                      ||+++++++-.|.-||++.
T Consensus       207 LavLiF~lL~ggrHPysGI  225 (637)
T COG4248         207 LAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             HHHHHHHHHhcCCCCCCcc
Confidence            9999999987469999885

>KOG0576|consensus

Probab=97.32  E-value=5.1e-05  Score=66.19  Aligned_cols=165  Identities=20%  Similarity=0.196  Sum_probs=104.5

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCc-eEEeeeEEEcC
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDH-IVSFIGCCYKD   90 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~n-i~~~~~~~~~~   90 (228)
                      +...+..+.+++++++|.+.-.         +...+ .+.+...      .....++++|.++ +||| .+..++.+...
T Consensus       244 s~~fh~fvK~altknpKkRpta---------eklL~-h~fvs~~------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E  306 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTA---------EKLLQ-HPFVSQT------LSRRLAIELLDKV-NNPNPVVRYLEDYDGE  306 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCCh---------hhhee-ceeeccc------hhhHHHHHHHHHc-cCCCCcccccccCCcc
Confidence            3455677889999999876322         11122 3333322      2234588999999 9999 55444443333


Q ss_pred             -ceEEEEecCCCC-cH-----------HHHH-----HH-----hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          91 -ELRLVVEYCALG-DL-----------QSYL-----RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        91 -~~~lv~e~~~~~-~L-----------~~~l-----~~-----~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                       ...+.++++.++ +.           .++-     ..     +++|+.--+|+|    ||+..+ +..++.+|+....+
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence             366888888665 11           1110     00     567766556777    555544 67888999987655


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      ....    ......++..|++||+...+.+..+.|.|+++.-..+|.- |..|-..
T Consensus       382 ~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap-~~pPr~~  432 (829)
T KOG0576|consen  382 TRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP-GLPPRSS  432 (829)
T ss_pred             Cccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC-CCCCCCC
Confidence            3332    1234567788999999999999999999999976666654 6555433

>KOG1235|consensus

Probab=97.20  E-value=0.002  Score=56.11  Aligned_cols=123  Identities=21%  Similarity=0.234  Sum_probs=77.0

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHH------------------------------HH---
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT------------------------------YD---   62 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------------~~---   62 (228)
                      +.||..+.|.|++|+.+++.          .||||.-+.......                              ..   
T Consensus       167 ~piaaASlaQVhrA~L~~G~----------~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~  236 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGE----------DVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP  236 (538)
T ss_pred             chhhhcchhheEEEEecCCC----------EEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence            68999999999999987643          599998654321110                              01   


Q ss_pred             ---HHHHHHHHHHhcC---CCCc---eEEeeeEE--EcCceEEEEecCCCCcHHHH--HHH-----------------hc
Q psy3166          63 ---KFLKEINLMKDVG---KHDH---IVSFIGCC--YKDELRLVVEYCALGDLQSY--LRE-----------------EY  112 (228)
Q Consensus        63 ---~~~~e~~~l~~l~---~h~n---i~~~~~~~--~~~~~~lv~e~~~~~~L~~~--l~~-----------------~~  112 (228)
                         +|.+|.+...+..   .|-+   -+.+..++  .+....++|||+.|..+.|.  +.+                 ..
T Consensus       237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q  316 (538)
T KOG1235|consen  237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ  316 (538)
T ss_pred             hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH
Confidence               1222332222211   3334   12233333  33567899999988765443  332                 23


Q ss_pred             ccCCCCcccCCCCCCEeecC----CCcEEEeeccCccccc
Q psy3166         113 LSNNKVVHRDLATRNILLSS----PHVVKISDFGLSEDIY  148 (228)
Q Consensus       113 lh~~~i~H~~lk~~nil~~~----~~~~kl~dfg~~~~~~  148 (228)
                      +-..|++|.|=.|-||++.+    ++.+.+.|||+...+.
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            33568999999999999984    5689999999876543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.12  E-value=0.0047  Score=48.51  Aligned_cols=75  Identities=8%  Similarity=-0.018  Sum_probs=47.4

Q ss_pred             eeeeecC-ceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceEE
Q psy3166          17 VLGQGEF-GVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELRL   94 (228)
Q Consensus        17 ~ig~g~~-~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~l   94 (228)
                      .|..|.+ +.||+....+           ..+.+|......    .....+|+.+++.+.++--+.+++.+... +.-++
T Consensus         5 ~~~~g~~~~~v~~~~~~~-----------~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   69 (244)
T cd05150           5 RVTEGQSGATVYRLDGKN-----------PGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWL   69 (244)
T ss_pred             ecCCCCCcCeEEEEcCCC-----------CcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEE
Confidence            3445555 6889875322           247788765432    23456788888888555456666665544 34688


Q ss_pred             EEecCCCCcHHH
Q psy3166          95 VVEYCALGDLQS  106 (228)
Q Consensus        95 v~e~~~~~~L~~  106 (228)
                      +|++++|.++.+
T Consensus        70 v~e~i~G~~l~~   81 (244)
T cd05150          70 LTSAVPGVPAAA   81 (244)
T ss_pred             EEEeeCCccHhH
Confidence            999998876653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.00  E-value=0.01  Score=45.27  Aligned_cols=118  Identities=22%  Similarity=0.297  Sum_probs=79.4

Q ss_pred             CceeeeeeeeeecC-ceEEEeeecCCCCCCCCcccceeeeeeccc---cCC--------C--H-------HHHHHHHHHH
Q psy3166          10 ERLILGEVLGQGEF-GVVVKGLLGDGPTEGASGQAAMEVAVKMLK---ANA--------D--A-------KTYDKFLKEI   68 (228)
Q Consensus        10 ~~~~~~~~ig~g~~-~~V~~~~~~~~~~~~~~~~~~~~vavK~~~---~~~--------~--~-------~~~~~~~~e~   68 (228)
                      .+++.++.||.|.- |.||++...+           ..||+|.++   ...        .  .       .....|..|-
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g-----------~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC  105 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDG-----------RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC  105 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECC-----------eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence            68899999999999 9999988644           359999932   110        0  0       1123467788


Q ss_pred             HHHHhcCC--CCce--EEeeeEEEcC---------------c----eEEEEecCCCCc------HHHHHHH-hcccCCCC
Q psy3166          69 NLMKDVGK--HDHI--VSFIGCCYKD---------------E----LRLVVEYCALGD------LQSYLRE-EYLSNNKV  118 (228)
Q Consensus        69 ~~l~~l~~--h~ni--~~~~~~~~~~---------------~----~~lv~e~~~~~~------L~~~l~~-~~lh~~~i  118 (228)
                      +...+|..  +..+  ++++|+..-+               .    .-+|.||.+...      +.+.++. ..+|..||
T Consensus       106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI  185 (207)
T PF13095_consen  106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGI  185 (207)
T ss_pred             HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCe
Confidence            77777632  3344  8888886211               1    247889986544      2222222 57899999


Q ss_pred             cccCCCCCCEeecCCCcEEEeeccC
Q psy3166         119 VHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus       119 ~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +-+|+++.|..   +  -+|+|||.
T Consensus       186 ~~~Dv~~~ny~---~--G~lvDfs~  205 (207)
T PF13095_consen  186 VPRDVKPRNYR---G--GKLVDFSS  205 (207)
T ss_pred             eeccCcccccc---C--CEEEeccc
Confidence            99999999986   2  37889874

>PLN02876 acyl-CoA dehydrogenase

Probab=96.94  E-value=0.014  Score=54.27  Aligned_cols=82  Identities=12%  Similarity=0.190  Sum_probs=52.5

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCce--EEeeeEEEc---
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHI--VSFIGCCYK---   89 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni--~~~~~~~~~---   89 (228)
                      .+.++.|.++.+|+.....+.       ....+++|+............+.+|.++|+.+..|+++  .+++.++.+   
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            466788999999987653321       11247777754332222234577899999999445554  666666544   


Q ss_pred             -CceEEEEecCCCCc
Q psy3166          90 -DELRLVVEYCALGD  103 (228)
Q Consensus        90 -~~~~lv~e~~~~~~  103 (228)
                       +..|+|||+++|..
T Consensus       116 ~G~~flVME~v~G~~  130 (822)
T PLN02876        116 IGTAFYIMEYLEGRI  130 (822)
T ss_pred             CCCceEEEEecCCcc
Confidence             34789999997653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.84  E-value=0.0051  Score=51.07  Aligned_cols=77  Identities=17%  Similarity=0.138  Sum_probs=47.1

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccc----c-C-CCHHHHHHHHHHHHHHHhcCCC-C-ceEEeeeEE
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK----A-N-ADAKTYDKFLKEINLMKDVGKH-D-HIVSFIGCC   87 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~----~-~-~~~~~~~~~~~e~~~l~~l~~h-~-ni~~~~~~~   87 (228)
                      +.||.|....||++..+++         +..++||+-.    . . ..+....+..-|...|+..... | .+++++. +
T Consensus         1 ~EigdGnlN~VfrV~~~~g---------~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~   70 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEG---------DRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F   70 (370)
T ss_pred             CcCCCCceEEEEEEEcCCC---------CeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E
Confidence            3689999999999874321         1248888743    1 1 2233445666788888776432 3 4555543 3


Q ss_pred             EcCceEEEEecCCCC
Q psy3166          88 YKDELRLVVEYCALG  102 (228)
Q Consensus        88 ~~~~~~lv~e~~~~~  102 (228)
                      ......++||+++..
T Consensus        71 D~e~~~~vMEdL~~~   85 (370)
T TIGR01767        71 DTEMAVTVMEDLSHH   85 (370)
T ss_pred             ccccceehHhhCccc
Confidence            444456889998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.80  E-value=0.011  Score=46.38  Aligned_cols=116  Identities=22%  Similarity=0.193  Sum_probs=69.6

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC---------------------HHHH--HHHHHHHHHHH
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD---------------------AKTY--DKFLKEINLMK   72 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------------------~~~~--~~~~~e~~~l~   72 (228)
                      ..|++|-=+.||+|.-.          .+..+|+|+.+....                     ....  .....|...|+
T Consensus        54 g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~  123 (268)
T COG1718          54 GCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK  123 (268)
T ss_pred             eeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            35555666689997632          234589999764311                     0111  12346777787


Q ss_pred             hcCC-CCceEEeeeEEEcCceEEEEecCCCC-----cHHHH-------------HHH---hcccCCCCcccCCCCCCEee
Q psy3166          73 DVGK-HDHIVSFIGCCYKDELRLVVEYCALG-----DLQSY-------------LRE---EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        73 ~l~~-h~ni~~~~~~~~~~~~~lv~e~~~~~-----~L~~~-------------l~~---~~lh~~~i~H~~lk~~nil~  130 (228)
                      ++.. +-.+.+-+.   ..+..++|||+...     .|.+.             +-+   ..++..+++|+||+.=|||+
T Consensus       124 R~~eAGVrvP~Pi~---~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~  200 (268)
T COG1718         124 RAYEAGVRVPEPIA---FRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV  200 (268)
T ss_pred             HHHHcCCCCCCcee---ecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence            7632 122222222   23467889987432     12221             000   34556899999999999999


Q ss_pred             cCCCcEEEeeccCcc
Q psy3166         131 SSPHVVKISDFGLSE  145 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~  145 (228)
                      . ++.+.++|++-+-
T Consensus       201 ~-~~~p~iID~~QaV  214 (268)
T COG1718         201 H-DGEPYIIDVSQAV  214 (268)
T ss_pred             E-CCeEEEEECcccc
Confidence            9 8889999999664

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.73  E-value=0.0081  Score=46.83  Aligned_cols=77  Identities=16%  Similarity=0.081  Sum_probs=44.1

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEE
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL   94 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~l   94 (228)
                      .+.|..|-...+|+....++        ....|.+|.......  ......+|..+++.+..+...++++....   -.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~~~   69 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ---NGL   69 (235)
T ss_pred             EEEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC---CcE
Confidence            35677777789998753210        123488887653311  11233468888888854444555544322   236


Q ss_pred             EEecCCCCcH
Q psy3166          95 VVEYCALGDL  104 (228)
Q Consensus        95 v~e~~~~~~L  104 (228)
                      +|||++|.++
T Consensus        70 l~e~i~G~~l   79 (235)
T cd05157          70 IYEFIPGRTL   79 (235)
T ss_pred             EEEeeCCCcC
Confidence            8888876554

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.32  E-value=0.031  Score=44.26  Aligned_cols=28  Identities=18%  Similarity=0.402  Sum_probs=24.6

Q ss_pred             CCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         117 KVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       117 ~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .++|+|+.|.||+++.++ +.++||+.+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            478999999999999877 7899999764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.21  E-value=0.029  Score=47.51  Aligned_cols=76  Identities=13%  Similarity=0.103  Sum_probs=48.1

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccc-----cCC-CHHHHHHHHHHHHHHHhcCC--CCceEEeee
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANA-DAKTYDKFLKEINLMKDVGK--HDHIVSFIG   85 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~-----~~~-~~~~~~~~~~e~~~l~~l~~--h~ni~~~~~   85 (228)
                      -.+.||.|....||+....+           ..+.||+-.     .+. .+....+...|...|+.+..  ..++.+++.
T Consensus        36 ~~~eiggGn~N~VyrV~~~~-----------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~  104 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSS-----------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYH  104 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCC-----------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEE
Confidence            36788999999999976422           137888754     111 12234455566777776632  246777776


Q ss_pred             EEEcCceEEEEecCCC
Q psy3166          86 CCYKDELRLVVEYCAL  101 (228)
Q Consensus        86 ~~~~~~~~lv~e~~~~  101 (228)
                      ++. +..+++||++++
T Consensus       105 ~de-d~~vlvME~L~~  119 (418)
T PLN02756        105 FDR-TMALIGMRYLEP  119 (418)
T ss_pred             ECC-CCCEEEEeecCC
Confidence            554 446678999966

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.19  E-value=0.035  Score=44.86  Aligned_cols=30  Identities=27%  Similarity=0.438  Sum_probs=26.0

Q ss_pred             CCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         116 NKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+++|+|+.|.|++++.++.+-|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            468999999999999987777899998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.11  E-value=0.011  Score=49.71  Aligned_cols=77  Identities=12%  Similarity=-0.002  Sum_probs=48.7

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccc----cC-CCHHHHHHHHHHHHHHHhcCCC-C-ceEEeeeEE
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK----AN-ADAKTYDKFLKEINLMKDVGKH-D-HIVSFIGCC   87 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~----~~-~~~~~~~~~~~e~~~l~~l~~h-~-ni~~~~~~~   87 (228)
                      .+.||.|.-.-||++...++         +..++||+-.    .. ..+-...+..-|.+.|+..... | .+++++. +
T Consensus        34 ~~eigdGnlN~VfrV~~~~~---------~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~  103 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQK---------NISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F  103 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCC---------CceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E
Confidence            67889999999999875321         1237888742    22 2344556777788888876432 3 4555554 3


Q ss_pred             EcCceEEEEecCCC
Q psy3166          88 YKDELRLVVEYCAL  101 (228)
Q Consensus        88 ~~~~~~lv~e~~~~  101 (228)
                      ......+|||+++.
T Consensus       104 D~e~~~~vMEdL~~  117 (409)
T PRK12396        104 DSVMNCCVMEDLSD  117 (409)
T ss_pred             CcHHhhHHHHhCcc
Confidence            33445678888854

>PLN02236 choline kinase

Probab=96.04  E-value=0.053  Score=45.05  Aligned_cols=127  Identities=19%  Similarity=0.213  Sum_probs=74.5

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +.+...+. .+..|-...+|++...+..     ......|.+|.......  ......+|..+++.+..+.--.++++.+
T Consensus        35 ~~~~~~i~-~l~gGlTN~~y~v~~~~~~-----~~~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~  106 (344)
T PLN02236         35 DDEALQVI-PLKGAMTNEVFQIKWPTKE-----GNLGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRF  106 (344)
T ss_pred             CcCcEEEE-EcCCcccceeEEEEeCCCC-----CCCCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEE
Confidence            34445555 4444777789987643321     11234688888754421  1122356888888875554455555555


Q ss_pred             EcCceEEEEecCCCCcHHHH----------H----HH-------------------h-----------------------
Q psy3166          88 YKDELRLVVEYCALGDLQSY----------L----RE-------------------E-----------------------  111 (228)
Q Consensus        88 ~~~~~~lv~e~~~~~~L~~~----------l----~~-------------------~-----------------------  111 (228)
                      ..+   .+.+|+++.++..-          +    ++                   .                       
T Consensus       107 ~~g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~  183 (344)
T PLN02236        107 PNG---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE  183 (344)
T ss_pred             CCc---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence            333   45666655443210          0    00                   0                       


Q ss_pred             --------cc----cCCCCcccCCCCCCEeecC-CCcEEEeeccCcc
Q psy3166         112 --------YL----SNNKVVHRDLATRNILLSS-PHVVKISDFGLSE  145 (228)
Q Consensus       112 --------~l----h~~~i~H~~lk~~nil~~~-~~~~kl~dfg~~~  145 (228)
                              .+    +...++|+|+++.||+++. ++.+.++||..+.
T Consensus       184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                    01    1234789999999999986 4789999999875

>PRK05231 homoserine kinase; Provisional

Probab=96.03  E-value=0.15  Score=41.76  Aligned_cols=30  Identities=27%  Similarity=0.413  Sum_probs=25.4

Q ss_pred             CCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         116 NKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+++|+|+.+.||+++.+...-++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            479999999999999966556799999763

>KOG1093|consensus

Probab=95.69  E-value=0.049  Score=47.33  Aligned_cols=117  Identities=21%  Similarity=0.344  Sum_probs=72.0

Q ss_pred             HHHHHHHHHHHhcCCCCceEEeeeEEEc--CceEEEEecCCCCcHHHHHHHhcccCCC-CcccCCCCCCEeecCCCcEEE
Q psy3166          62 DKFLKEINLMKDVGKHDHIVSFIGCCYK--DELRLVVEYCALGDLQSYLREEYLSNNK-VVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        62 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~lh~~~-i~H~~lk~~nil~~~~~~~kl  138 (228)
                      .+.+-..+.++.+ .|+|..++.++...  ...++|+|++ +-++.+.+....+-.-. ..|+ .-+.|++       ..
T Consensus        27 ~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~~~~-~~~~~~~-------~~   96 (725)
T KOG1093|consen   27 IQILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLLAHG-VLHLNII-------YI   96 (725)
T ss_pred             HHHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhcccc-cceehhh-------hc
Confidence            4555677888899 99999999887644  3377899998 66899887664322211 1222 1111221       11


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +|     .+..                +. |     ....+++|||++|.++.++.- |..-|...+..+.+..+.+-
T Consensus        97 td-----~~~t----------------~~-~-----~~~~pKsdVwsl~~i~~el~L-~~~l~~~~~~s~~l~~i~k~  146 (725)
T KOG1093|consen   97 TD-----HFLT----------------KY-P-----SPIGPKSDVWSLGFIILELYL-GISLEAELTESEYLEILLKY  146 (725)
T ss_pred             cc-----cccc----------------cC-C-----CCCCcchhhhhHHHHHHHHHH-hhHHHHHHHHHHHHHHHHHh
Confidence            22     0000                00 1     012258999999999999886 88777777777776665553

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=95.68  E-value=0.017  Score=43.73  Aligned_cols=77  Identities=22%  Similarity=0.302  Sum_probs=54.6

Q ss_pred             HHHHHHHhcCCCCceEEeeeEEEcCceEEEEecCCCCcH-------HHHHHH----------------hcccC---CCCc
Q psy3166          66 KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDL-------QSYLRE----------------EYLSN---NKVV  119 (228)
Q Consensus        66 ~e~~~l~~l~~h~ni~~~~~~~~~~~~~lv~e~~~~~~L-------~~~l~~----------------~~lh~---~~i~  119 (228)
                      .|.-+|+.+.+.+++++++|+|   ..+++.|+...+++       .+++..                .+++.   ..+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C---G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~   84 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC---GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY   84 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC---CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence            4778888885557999999987   34567788875533       333221                22322   2366


Q ss_pred             ccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         120 HRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       120 H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      -.|++++|+.+..++.+|++|.....
T Consensus        85 lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   85 LCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EeecchHHeEEeCCCcEEEEechhcc
Confidence            68999999999999999999999653

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268|consensus

Probab=94.03  E-value=0.025  Score=46.37  Aligned_cols=120  Identities=18%  Similarity=0.168  Sum_probs=78.0

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeecc----------ccC---------CCHH--HHHHHHHHHH
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML----------KAN---------ADAK--TYDKFLKEIN   69 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~----------~~~---------~~~~--~~~~~~~e~~   69 (228)
                      .+.+...||-|-=+-||.+-.+.+.          +.++|.=          +.+         ....  ++-.+.+|..
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~----------~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa  162 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGN----------PLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA  162 (465)
T ss_pred             hhhhccccccccccceEEEecCCCC----------chhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence            3456678888888889988755433          2444431          111         0111  2234567999


Q ss_pred             HHHhcCCCCceEEeeeEEEcCceEEEEecCCCCcHHHHHHH--------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          70 LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        70 ~l~~l~~h~ni~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      .|+.|..|..=|+  ..+..+..++|||++.+-.|.+.-..              --|..+|++|+|..-=||++..++.
T Consensus       163 fmkaL~e~gfpVP--kpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  163 FMKALYERGFPVP--KPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             HHHHHHHcCCCCC--CcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence            9998865543322  22334556788888877666543211              2466789999999999999999999


Q ss_pred             EEEeecc
Q psy3166         136 VKISDFG  142 (228)
Q Consensus       136 ~kl~dfg  142 (228)
                      ++++||=
T Consensus       241 i~vIDFP  247 (465)
T KOG2268|consen  241 IVVIDFP  247 (465)
T ss_pred             EEEeech
Confidence            9999996

>KOG1826|consensus

Probab=93.28  E-value=0.013  Score=56.86  Aligned_cols=135  Identities=17%  Similarity=0.101  Sum_probs=89.9

Q ss_pred             HHHHHHHHHHHhcCCCCceEEeeeEEEc---CceEEEEecCCCCcHHHHHHH------------------------hccc
Q psy3166          62 DKFLKEINLMKDVGKHDHIVSFIGCCYK---DELRLVVEYCALGDLQSYLRE------------------------EYLS  114 (228)
Q Consensus        62 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~------------------------~~lh  114 (228)
                      +....|..-++.. .|+++...+.-..+   ...+..++++..|.+++.+-.                        +-+|
T Consensus      1274 emll~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1274 EMLLSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             Hhhhhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            3344555555556 78888877655433   336778888888888876543                        1112


Q ss_pred             C-----CCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHH
Q psy3166         115 N-----NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVV  189 (228)
Q Consensus       115 ~-----~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~  189 (228)
                      .     +--+|+++|+.|.+|..+..+++.++|+.+.-.....+.   ....+++-|+.++....-.++.++|+|..++.
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~---Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF---GLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhh---hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence            1     124689999999999999999999999987222222221   12344455677776666667777999999999


Q ss_pred             HHHHHhCCCCCC
Q psy3166         190 LWEIVTLGANPY  201 (228)
Q Consensus       190 ~~~l~t~g~~pf  201 (228)
                      +|.+.. |..+|
T Consensus      1430 ly~rs~-~n~~f 1440 (2724)
T KOG1826|consen 1430 LYLRSD-GNAYF 1440 (2724)
T ss_pred             HHHHhc-ccHHH
Confidence            888765 65544

>KOG1033|consensus

Probab=92.86  E-value=0.032  Score=47.89  Aligned_cols=70  Identities=23%  Similarity=0.419  Sum_probs=55.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++++..+.+|.|+||+|+.+...         ...-.+|||.+..........+..+|..-+.++ .|++++.+...|..
T Consensus        49 ~~~e~~~~~~~~g~~~~~~~~n~---------~d~~~~avkritlkn~e~s~~rvl~~~~s~a~f-eh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   49 NDFEPGQCLGRGGFGVVFSAQNK---------ADENKYAVKRITLKNREESRSRVLREVSSLAEF-EHPGIKRYFHAWYE  118 (516)
T ss_pred             ccccccccccccCccccCCcccc---------ccchhhHHHHhcccchhhhhhhhhccccchhhh-cccchhhheeceec
Confidence            46788899999999999976532         222358999997776667777888999999999 99999999887754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=92.49  E-value=1.1  Score=36.41  Aligned_cols=75  Identities=17%  Similarity=0.131  Sum_probs=41.6

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC--CCCceEEeeeEEEc-
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG--KHDHIVSFIGCCYK-   89 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--~h~ni~~~~~~~~~-   89 (228)
                      +-.+.++-|....+|+...           .+..+.+|.-...    ....+..|..-|+.|.  ..-.+.+++.+... 
T Consensus        20 ~~~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~   84 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLDT-----------DGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD   84 (288)
T ss_dssp             -EEEEE--SSSSEEEEEET-----------TS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S
T ss_pred             eeeEecCCCChhheEEEEC-----------CCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            3456788888899998651           2234888876522    1245667888777773  33456777766543 


Q ss_pred             CceEEEEecCCCC
Q psy3166          90 DELRLVVEYCALG  102 (228)
Q Consensus        90 ~~~~lv~e~~~~~  102 (228)
                      +.-++++|+++.+
T Consensus        85 ~~~fLlle~l~~~   97 (288)
T PF03881_consen   85 DDAFLLLEFLEMG   97 (288)
T ss_dssp             SCCEEEEE-----
T ss_pred             CCceEEEEeecCC
Confidence            4468999998654

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=92.29  E-value=0.11  Score=42.05  Aligned_cols=29  Identities=34%  Similarity=0.535  Sum_probs=25.6

Q ss_pred             CCcccCCCCCCEeecCC----CcEEEeeccCcc
Q psy3166         117 KVVHRDLATRNILLSSP----HVVKISDFGLSE  145 (228)
Q Consensus       117 ~i~H~~lk~~nil~~~~----~~~kl~dfg~~~  145 (228)
                      .++|+|+.+.||+++.+    +.+.++||+.+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            46899999999999975    789999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=92.11  E-value=0.77  Score=37.33  Aligned_cols=79  Identities=10%  Similarity=0.007  Sum_probs=52.7

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCC--CceEEeeeEEEc
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH--DHIVSFIGCCYK   89 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h--~ni~~~~~~~~~   89 (228)
                      ..-.+.||.|..+.||+....++           .+.+|..+....   ...+..|...|+.+..+  -.+.++++.+..
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-----------~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~   81 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-----------NPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTH   81 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-----------CEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEecc
Confidence            34557899999999998642221           266676432111   24677899999988554  367777776532


Q ss_pred             ----CceEEEEecCCCCcH
Q psy3166          90 ----DELRLVVEYCALGDL  104 (228)
Q Consensus        90 ----~~~~lv~e~~~~~~L  104 (228)
                          +.-++|||++.+.++
T Consensus        82 ~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         82 EQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             CCcCCCeEEEEeccCCEec
Confidence                447899999987654

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.77  E-value=0.1  Score=39.98  Aligned_cols=29  Identities=34%  Similarity=0.491  Sum_probs=20.2

Q ss_pred             CCcccCCCCCCEee-cCCCcEEEeeccCcc
Q psy3166         117 KVVHRDLATRNILL-SSPHVVKISDFGLSE  145 (228)
Q Consensus       117 ~i~H~~lk~~nil~-~~~~~~kl~dfg~~~  145 (228)
                      -+.|+|+.+.||++ ..++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            46799999999999 778999999999874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=91.48  E-value=0.19  Score=40.91  Aligned_cols=30  Identities=30%  Similarity=0.444  Sum_probs=26.5

Q ss_pred             CCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         116 NKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+++|+|+.+.|++++.++...++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            579999999999999988767899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=91.16  E-value=1.4  Score=34.44  Aligned_cols=77  Identities=14%  Similarity=0.250  Sum_probs=49.3

Q ss_pred             HHHHHHHHHHHhcCCCCceEEeeeEEEcCceEEEEecCCCCcH--HHHHHH-----hccc--CCCCcccCCCCCCEeecC
Q psy3166          62 DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDL--QSYLRE-----EYLS--NNKVVHRDLATRNILLSS  132 (228)
Q Consensus        62 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~lv~e~~~~~~L--~~~l~~-----~~lh--~~~i~H~~lk~~nil~~~  132 (228)
                      .-+..+.+++.++  | -|+++.-- ..-.+-++.|.|.....  ..++-.     .-.|  ..+.+|+|..|+||+-++
T Consensus       103 ~~y~nky~v~Arm--h-GilrL~ND-n~~~yGvIlE~Cy~~~i~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~  178 (308)
T PF07387_consen  103 ALYFNKYRVFARM--H-GILRLKND-NNYKYGVILERCYKIKINFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDK  178 (308)
T ss_pred             hhhhhhhhHHHHh--h-heeEeecC-CCceeEEEEeeccCcccchhHHHHHhHHHHHHhhccCCCeecCCCChhheeecC
Confidence            3456788888877  2 24554411 11224478888743221  222211     2345  457899999999999999


Q ss_pred             CCcEEEeecc
Q psy3166         133 PHVVKISDFG  142 (228)
Q Consensus       133 ~~~~kl~dfg  142 (228)
                      .|.+||.|-+
T Consensus       179 ~G~lKlVDP~  188 (308)
T PF07387_consen  179 FGYLKLVDPV  188 (308)
T ss_pred             CCCEEecChh
Confidence            9999999977

The function of this family is unknown.

>PRK10271 thiK thiamine kinase; Provisional

Probab=91.09  E-value=0.22  Score=37.58  Aligned_cols=28  Identities=18%  Similarity=0.374  Sum_probs=24.4

Q ss_pred             CCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         117 KVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       117 ~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      -.+|+|+.|.|+++..++ ++++|++.+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            357999999999988777 8999999875

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=90.93  E-value=0.21  Score=40.03  Aligned_cols=30  Identities=23%  Similarity=0.289  Sum_probs=27.2

Q ss_pred             CCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         116 NKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .-++|+|+.|+|++.+..+.+.|+||..+.
T Consensus       153 ~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         153 LVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             eeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            357899999999999999999999999875

>KOG1236|consensus

Probab=90.79  E-value=0.23  Score=42.10  Aligned_cols=40  Identities=25%  Similarity=0.291  Sum_probs=28.4

Q ss_pred             eeeeeecCceEEEeeecCCCCC------CCCcccceeeeeeccccC
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTE------GASGQAAMEVAVKMLKAN   55 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~------~~~~~~~~~vavK~~~~~   55 (228)
                      ..||+|+-+.||+|..+..-.+      ..++...+.+|+|..+.+
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~  240 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPN  240 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCcc
Confidence            4799999999999986532221      223556677999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=89.82  E-value=0.29  Score=38.18  Aligned_cols=28  Identities=32%  Similarity=0.482  Sum_probs=23.5

Q ss_pred             CcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         118 VVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       118 i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ++|+|+.+.|++++..+..-++||+.+.
T Consensus       166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         166 WFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             EEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            7899999999999876555699999653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2270|consensus

Probab=88.65  E-value=1.1  Score=37.75  Aligned_cols=118  Identities=20%  Similarity=0.264  Sum_probs=71.2

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-----------------------CCHHHHH--HHHHHH
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-----------------------ADAKTYD--KFLKEI   68 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~--~~~~e~   68 (228)
                      +...|..|-=+.||-+....+.          .+|||+.+.+                       .++....  .+..|+
T Consensus       148 inGCiSTGKEANVYHat~~dG~----------~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~  217 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGS----------EFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM  217 (520)
T ss_pred             cccccccCccceeEeeecCCCc----------eEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence            4456667777789988644433          3899886532                       1122222  345688


Q ss_pred             HHHHhcCCCCceEEeeeEEEcCceEEEEecCCCC-----cHH----------HHHHH------hcccCCCCcccCCCCCC
Q psy3166          69 NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALG-----DLQ----------SYLRE------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        69 ~~l~~l~~h~ni~~~~~~~~~~~~~lv~e~~~~~-----~L~----------~~l~~------~~lh~~~i~H~~lk~~n  127 (228)
                      +.|+++ +..- +++..-..-.+.+|||+|+...     -|-          .+...      ...+..+++|-||+==|
T Consensus       218 RNLkRl-~~aG-IP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  218 RNLKRL-NNAG-IPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             HHHHHH-HhcC-CCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            899998 4333 2333333334567899998421     111          11110      23456789999999889


Q ss_pred             EeecCCCcEEEeeccCc
Q psy3166         128 ILLSSPHVVKISDFGLS  144 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~  144 (228)
                      +|+. +|.+.++|.+-+
T Consensus       296 ~Lyh-dG~lyiIDVSQS  311 (520)
T KOG2270|consen  296 LLYH-DGKLYIIDVSQS  311 (520)
T ss_pred             heEE-CCEEEEEEcccc
Confidence            8876 478999998865

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=88.59  E-value=0.4  Score=38.92  Aligned_cols=28  Identities=36%  Similarity=0.510  Sum_probs=24.6

Q ss_pred             CCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166         116 NKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .+++|+|+.+.|++++. +.+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            57899999999999987 66889999965

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=87.90  E-value=0.43  Score=33.15  Aligned_cols=45  Identities=24%  Similarity=0.412  Sum_probs=31.5

Q ss_pred             eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhc
Q psy3166          16 EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV   74 (228)
Q Consensus        16 ~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l   74 (228)
                      ..||+|+.|.|++|+++++          +.||||..+.+    ....+...+.+++.+
T Consensus        17 ~PlasASiaQVh~a~l~~g----------~~VaVKV~rP~----i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKDG----------EEVAVKVQRPG----IEEQIEADLRILRRL   61 (119)
T ss_pred             chhhheehhhheeeeeccc----------chhhhhhcchH----HHHHHHHHHHHHHHH
Confidence            5899999999999987553          35999998644    233444555555543

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=87.18  E-value=0.37  Score=39.35  Aligned_cols=29  Identities=17%  Similarity=0.212  Sum_probs=26.4

Q ss_pred             CCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         117 KVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       117 ~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +++|+|+.++|++++.++.+-++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            69999999999999998889999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=86.52  E-value=0.61  Score=35.37  Aligned_cols=32  Identities=34%  Similarity=0.404  Sum_probs=25.5

Q ss_pred             cCCCCcccCCCCCCEeecCCC-----cEEEeeccCcc
Q psy3166         114 SNNKVVHRDLATRNILLSSPH-----VVKISDFGLSE  145 (228)
Q Consensus       114 h~~~i~H~~lk~~nil~~~~~-----~~kl~dfg~~~  145 (228)
                      +...++|+|+.+.|+++..++     .+.++||..+.
T Consensus       118 ~~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      118 EFNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             CceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            345689999999999997543     58899998664

subfamily of choline kinases

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=86.09  E-value=0.6  Score=37.53  Aligned_cols=29  Identities=28%  Similarity=0.400  Sum_probs=23.8

Q ss_pred             CCcccCCCCCCEeecCCCcE-EEeeccCcc
Q psy3166         117 KVVHRDLATRNILLSSPHVV-KISDFGLSE  145 (228)
Q Consensus       117 ~i~H~~lk~~nil~~~~~~~-kl~dfg~~~  145 (228)
                      .++|+|+.+.|++++.++.+ -|+|++.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            47999999999999975554 599999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=85.61  E-value=0.51  Score=39.16  Aligned_cols=16  Identities=38%  Similarity=0.565  Sum_probs=13.9

Q ss_pred             CCCcccCCCCCCEeec
Q psy3166         116 NKVVHRDLATRNILLS  131 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~  131 (228)
                      ...+|-||||+|||+-
T Consensus       298 ~nF~H~DLKPdNILiF  313 (434)
T PF05445_consen  298 TNFLHVDLKPDNILIF  313 (434)
T ss_pred             ceeeecccCcCcEEEe
Confidence            4588999999999984

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=84.91  E-value=0.63  Score=39.03  Aligned_cols=27  Identities=41%  Similarity=0.578  Sum_probs=25.3

Q ss_pred             CcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         118 VVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       118 i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .-|||+...||||+ .|.+.|+||.+++
T Consensus       343 fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         343 FEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             cccccccccceeee-cCceEEEEeeeee
Confidence            56999999999999 8999999999987

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=84.52  E-value=0.77  Score=37.94  Aligned_cols=28  Identities=25%  Similarity=0.427  Sum_probs=24.5

Q ss_pred             CcccCCCCCCEeecC-CCcEEEeeccCcc
Q psy3166         118 VVHRDLATRNILLSS-PHVVKISDFGLSE  145 (228)
Q Consensus       118 i~H~~lk~~nil~~~-~~~~kl~dfg~~~  145 (228)
                      +.|+|+.+.||+++. ++.++++||+.+.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            579999999999975 5789999999874

>PRK06148 hypothetical protein; Provisional

Probab=81.96  E-value=1.2  Score=42.65  Aligned_cols=29  Identities=31%  Similarity=0.551  Sum_probs=24.5

Q ss_pred             CCCcccCCCCCCEeecCCC--cEE-EeeccCc
Q psy3166         116 NKVVHRDLATRNILLSSPH--VVK-ISDFGLS  144 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~--~~k-l~dfg~~  144 (228)
                      ++++|+|+.+.||+++.++  .+. |+|||-+
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa  234 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDA  234 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccc
Confidence            4689999999999999765  566 9999964

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	228
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-50
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-50
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-49
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-48
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-47
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-47
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-47
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-47
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-47
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-47
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-47
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-47
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-47
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-47
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-47
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-47
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-47
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-47
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-47
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-47
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-47
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-46
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-46
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-46
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-46
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-40
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-39
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-39
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-39
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-39
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-39
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-39
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-39
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-39
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-38
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-38
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-38
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-38
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-38
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-38
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-38
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-38
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-38
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-37
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-37
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-37
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-37
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-37
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-37
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-37
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-37
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-37
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-37
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-37
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-37
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-37
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-37
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-36
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-36
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-36
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-36
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-36
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-36
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-36
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-36
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-36
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-36
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-36
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-36
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-36
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-36
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-36
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-36
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-36
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-36
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-36
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-36
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-36
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-36
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-36
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-36
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-36
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-36
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-36
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-36
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-36
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-36
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-36
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-35
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-35
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-35
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-35
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-35
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-35
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-35
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-35
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-35
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-35
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-35
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-35
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-35
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-35
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-35
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-35
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-35
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-35
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-35
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-35
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-35
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-35
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-34
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-34
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-34
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-34
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-34
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-34
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-34
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-34
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-34
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-34
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-34
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-34
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-34
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-34
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-34
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-34
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-34
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-34
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-34
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-34
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-34
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-34
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-34
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-34
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-34
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-34
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-34
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-34
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-34
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-34
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-33
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-33
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-33
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-33
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-33
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-33
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-33
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-33
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-33
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-33
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-33
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-33
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-32
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-32
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-32
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-32
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-32
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-32
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-32
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-32
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-32
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-32
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-32
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-32
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-31
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-31
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-31
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-31
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-31
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-31
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-31
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-31
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-31
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-31
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-31
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-31
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-31
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-31
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-31
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-31
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-31
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-31
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-31
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-31
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-31
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-30
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-30
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-30
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-30
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-30
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-30
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-30
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-30
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-29
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-29
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-29
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-29
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-29
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-29
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-29
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-29
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-29
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-29
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-29
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-29
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-29
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-29
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-29
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-29
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-29
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-29
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-29
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-29
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-29
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-29
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-29
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-29
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-29
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-29
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-29
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-29
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-29
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-28
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-28
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-28
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-28
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-28
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-28
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-28
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-28
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-28
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-28
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-28
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-28
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-28
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-28
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-28
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-28
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-28
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-28
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-28
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-28
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-28
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-28
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-28
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-28
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-27
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-27
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-27
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-27
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-27
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-27
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-27
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-27
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-27
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-27
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-27
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-27
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-27
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-27
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-27
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-27
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-27
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-26
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-26
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-26
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-26
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-26
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-26
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-26
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-26
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-26
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-26
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-26
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-26
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-26
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-26
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-26
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-26
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-26
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-26
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-26
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-26
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-25
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-25
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-25
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-25
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-25
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-24
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-24
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-24
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-24
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-24
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-24
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-24
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-24
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-24
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-24
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-24
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-24
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-24
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-24
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-24
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-24
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-24
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-24
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-24
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-24
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-24
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-24
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-24
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-23
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-23
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-23
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-23
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-22
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-15
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-14
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-10
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-05
3soa_A	444	Full-Length Human Camkii Length = 444		4e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-04

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  195 bits (495), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 110/267 (41%), Positives = 150/267 (56%), Gaps = 51/267 (19%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFH--LKGRAGYTT--VAVKMLKENASPSELRDLLS 75
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 76  EFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 195 GLSRDVYEEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEE 280

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  193 bits (490), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 110/267 (41%), Positives = 149/267 (55%), Gaps = 51/267 (19%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFH--LKGRAGYTT--VAVKMLKENASPSELRDLLS 75
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 76  EFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++         ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 195 GLSRDVYEEDSXVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEE 280

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  191 bits (485), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 109/267 (40%), Positives = 148/267 (55%), Gaps = 51/267 (19%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK        +G +G     VAVKMLK NA        L 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFH--LKGRAGYTT--VAVKMLKENASPSELRDLLS 75
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 76  EFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+   +VHRDLA RNIL++    +KISDF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDF 194
Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++         ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 195 GLSRDVYEEDSXVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEE 280

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  187 bits (474), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 100/263 (38%), Positives = 154/263 (58%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++N   + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDYYKNTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  184 bits (466), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I+  +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  184 bits (466), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V++I+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  183 bits (465), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 131
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 252 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 311 VEELFKLLKEGHRMDKPANCTNE 333

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  183 bits (465), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 79
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 139
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 200 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNE 280

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  183 bits (465), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 79
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNP 139
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 200 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNE 280

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  183 bits (465), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 19  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 72
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 73  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 132
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 133 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 193 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 251
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 252 EELFKLLKEGHRMDKPSNCTNE 273

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  183 bits (464), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 15  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 68
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 69  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 128
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 129 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 189 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 247
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 248 EELFKLLKEGHRMDKPSNCTNE 269

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  183 bits (464), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 24  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 77
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 78  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 137
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 138 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 198 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 256
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 257 VEELFKLLKEGHRMDKPANCTNE 279

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  183 bits (464), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   +  +    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDXXKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  183 bits (464), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 18  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 71
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 72  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 131
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 132 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 192 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 250
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 251 EELFKLLKEGHRMDKPSNCTNE 272

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 67  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 120
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 241 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 300 EELFKLLKEGHRMDKPSNCTNE 321

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   +  +    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDXXKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 79
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNP 139
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 200 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNE 280

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  +   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEEDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 153/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 64
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 65  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNP 124
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 185 IHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNE 265

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  183 bits (464), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 21  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 74
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 75  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 134
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 135 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 195 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 253
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 254 VEELFKLLKEGHRMDKPANCTNE 276

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++V Y + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 152/262 (58%), Gaps = 48/262 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           P +RL+LG+ LG+G FG VV     GL  D P          +VAVKMLK++A  K    
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR------VTKVAVKMLKSDATEKDLSD 79
Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE------------ 110
            + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+             
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNP 139
Query: 111 ------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED 146
                                   EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ D
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           I+  +  +    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+
Sbjct: 200 IHHIDXXKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 207 CRIVHYLSTGYRMERPASCNEQ 228
             +   L  G+RM++P++C  +
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNE 280

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  182 bits (461), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 85
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++V Y + G+L+ YLR            
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYD 145
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 206 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNE 287

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 152/263 (57%), Gaps = 48/263 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P ++L LG+ LG+G FG VV     G+  D P E      A+ VAVKMLK +A  K   
Sbjct: 19  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE------AVTVAVKMLKDDATEKDLS 72
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR            
Sbjct: 73  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 132
Query: 111 -------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                                    EYL++ K +HRDL  RN+L++  +V+KI+DFGL+ 
Sbjct: 133 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192
Query: 146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           DI   + ++    + +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP
Sbjct: 193 DINNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 251
Query: 206 LCRIVHYLSTGYRMERPASCNEQ 228
           +  +   L  G+RM++PA+C  +
Sbjct: 252 VEELFKLLKEGHRMDKPANCTNE 274

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 137/272 (50%), Gaps = 52/272 (19%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           L   +P E L  G+VLG G FG V+          G S    ++VAVKMLK  AD+   +
Sbjct: 38  LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVS----IQVAVKMLKEKADSSERE 93
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE----------- 110
             + E+ +M  +G H++IV+ +G C     + L+ EYC  GDL +YLR            
Sbjct: 94  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 111 --------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKI 138
                                           E+L     VHRDLA RN+L++   VVKI
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 213
Query: 139 SDFGLSEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG 197
            DFGL+ DI  + N    G  + +LP++W+A ESL   IYT KSDVWS+G++LWEI +LG
Sbjct: 214 CDFGLARDIMSDSNYVVRG--NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 198 ANPYPHIPL-CRIVHYLSTGYRMERPASCNEQ 228
            NPYP IP+       +  G++M++P    E+
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEE 303

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 140/251 (55%), Gaps = 41/251 (16%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P   L  G+ LG G FG VV+    G G  +     A ++VAVKMLK+ A A   +  +
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKED-----AVLKVAVKMLKSTAHADEKEALM 89
Query: 66  KEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE------------- 111
            E+ +M  +G+H++IV+ +G C +   + ++ EYC  GDL ++LR +             
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 112 -----------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY-EQNVF 153
                            +L++   +HRD+A RN+LL++ HV KI DFGL+ DI  + N  
Sbjct: 150 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHY 212
             G  + +LP++W+A ES+   +YT +SDVWS+G++LWEI +LG NPYP I +  +    
Sbjct: 210 VKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 267
Query: 213 LSTGYRMERPA 223
           +  GY+M +PA
Sbjct: 268 VKDGYQMAQPA 278

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 140/251 (55%), Gaps = 41/251 (16%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P   L  G+ LG G FG VV+    G G  +     A ++VAVKMLK+ A A   +  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKED-----AVLKVAVKMLKSTAHADEKEALM 97
Query: 66  KEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE------------- 111
            E+ +M  +G+H++IV+ +G C +   + ++ EYC  GDL ++LR +             
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 112 -----------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY-EQNVF 153
                            +L++   +HRD+A RN+LL++ HV KI DFGL+ DI  + N  
Sbjct: 158 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHY 212
             G  + +LP++W+A ES+   +YT +SDVWS+G++LWEI +LG NPYP I +  +    
Sbjct: 218 VKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 275
Query: 213 LSTGYRMERPA 223
           +  GY+M +PA
Sbjct: 276 VKDGYQMAQPA 286

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  157 bits (397), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/255 (37%), Positives = 142/255 (55%), Gaps = 48/255 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 24  FPRDRLNLGKPLGRGAFGQVIEAD-AFGIDKTATXRT---VAVKMLKEGATHSEHRALMS 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 111 ------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-N 151
                             E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY+  +
Sbjct: 140 FLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL----C 207
             + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +    C
Sbjct: 200 YVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 257
Query: 208 RIVHYLSTGYRMERP 222
           R    L  G RM  P
Sbjct: 258 R---RLKEGTRMRAP 269

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 93/252 (36%), Positives = 140/252 (55%), Gaps = 42/252 (16%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 24  FPRDRLNLGKPLGRGAFGQVIEAD-AFGIDKTATXRT---VAVKMLKEGATHSEHRALMS 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 111 ------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-N 151
                             E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY+  +
Sbjct: 140 FLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD 199
Query: 152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIV 210
             + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +     
Sbjct: 200 YVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFX 257
Query: 211 HYLSTGYRMERP 222
             L  G RM  P
Sbjct: 258 RRLKEGTRMRAP 269

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  156 bits (395), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 140/255 (54%), Gaps = 45/255 (17%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P   L  G+ LG G FG VV+    G G  +     A ++VAVKMLK+ A A   +  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKED-----AVLKVAVKMLKSTAHADEKEALM 97
Query: 66  KEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE------------- 111
            E+ +M  +G+H++IV+ +G C +   + ++ EYC  GDL ++LR +             
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 112 ---------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY-E 149
                                +L++   +HRD+A RN+LL++ HV KI DFGL+ DI  +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CR 208
            N    G  + +LP++W+A ES+   +YT +SDVWS+G++LWEI +LG NPYP I +  +
Sbjct: 218 SNYIVKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 209 IVHYLSTGYRMERPA 223
               +  GY+M +PA
Sbjct: 276 FYKLVKDGYQMAQPA 290

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  156 bits (395), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 140/255 (54%), Gaps = 45/255 (17%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P   L  G+ LG G FG VV+    G G  +     A ++VAVKMLK+ A A   +  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKED-----AVLKVAVKMLKSTAHADEKEALM 97
Query: 66  KEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE------------- 111
            E+ +M  +G+H++IV+ +G C +   + ++ EYC  GDL ++LR +             
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 112 ---------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY-E 149
                                +L++   +HRD+A RN+LL++ HV KI DFGL+ DI  +
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CR 208
            N    G  + +LP++W+A ES+   +YT +SDVWS+G++LWEI +LG NPYP I +  +
Sbjct: 218 SNYIVKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 209 IVHYLSTGYRMERPA 223
               +  GY+M +PA
Sbjct: 276 FYKLVKDGYQMAQPA 290

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  156 bits (394), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/259 (36%), Positives = 142/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 200 KDPDXVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 258 EEFCR---RLKEGTRMRAP 273

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  156 bits (394), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/259 (36%), Positives = 142/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 61  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 116
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 117 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 237 KDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 295 EEFCR---RLKEGTRMRAP 310

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/259 (36%), Positives = 142/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 26  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 81
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 201
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 202 KDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 259
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 260 EEFCR---RLKEGTRMRAP 275

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/259 (36%), Positives = 142/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 200 KDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 258 EEFCR---RLKEGTRMRAP 273

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  155 bits (391), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/257 (34%), Positives = 140/257 (54%), Gaps = 47/257 (18%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P   L  G+ LG G FG VV+    G G  +     A ++VAVKMLK+ A A   +  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKED-----AVLKVAVKMLKSTAHADEKEALM 97
Query: 66  KEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE------------- 111
            E+ +M  +G+H++IV+ +G C +   + ++ EYC  GDL ++LR +             
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 112 -----------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                  +L++   +HRD+A RN+LL++ HV KI DFGL+ DI 
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 149 -EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
            + N    G  + +LP++W+A ES+   +YT +SDVWS+G++LWEI +LG NPYP I + 
Sbjct: 218 NDSNYIVKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 275
Query: 207 CRIVHYLSTGYRMERPA 223
            +    +  GY+M +PA
Sbjct: 276 SKFYKLVKDGYQMAQPA 292

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 141/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 70
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++ E+C  G+L +YLR               
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 191 KDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 249 EEFCR---RLKEGTRMRAP 264

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  154 bits (390), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 141/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 70
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++ E+C  G+L +YLR               
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 191 KDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 249 EEFCR---RLKEGTRMRAP 264

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  154 bits (389), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 141/257 (54%), Gaps = 50/257 (19%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 26  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATXRT---VAVKMLKEGATHSEHRALMS 81
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 111 --------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ 150
                               E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI + 
Sbjct: 142 KDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 151 -NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL--- 206
            +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +   
Sbjct: 202 PDXVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 207 -CRIVHYLSTGYRMERP 222
            CR    L  G RM  P
Sbjct: 260 FCR---RLKEGTRMRAP 273

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 141/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 70
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI 
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 191 KDPDXVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 249 EEFCR---RLKEGTRMRAP 264

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  153 bits (387), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 141/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 200 KDPDXVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 258 EEFCR---RLKEGTRMRAP 273

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  153 bits (386), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 94/258 (36%), Positives = 141/258 (54%), Gaps = 51/258 (19%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 25  FPRDRLNLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 80
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 81  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDL 140
Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 150 Q-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-- 206
             +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +  
Sbjct: 201 DPDXVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 207 --CRIVHYLSTGYRMERP 222
             CR    L  G RM  P
Sbjct: 259 EFCR---RLKEGTRMRAP 273

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 140/264 (53%), Gaps = 54/264 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           +P   L  G+ LG G FG VV+    G G  +     A ++VAVKMLK+ A A   +  +
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKED-----AVLKVAVKMLKSTAHADEKEALM 82
Query: 66  KEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLREE------------- 111
            E+ +M  +G+H++IV+ +G C +   + ++ EYC  GDL ++LR +             
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 112 ------------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                         +L++   +HRD+A RN+LL++ HV KI DF
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 142 GLSEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANP 200
           GL+ DI  + N    G  + +LP++W+A ES+   +YT +SDVWS+G++LWEI +LG NP
Sbjct: 203 GLARDIMNDSNYIVKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 260
Query: 201 YPHIPL-CRIVHYLSTGYRMERPA 223
           YP I +  +    +  GY+M +PA
Sbjct: 261 YPGILVNSKFYKLVKDGYQMAQPA 284

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  152 bits (384), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 80
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 81  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 140 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259
Query: 223 ASC 225
             C
Sbjct: 260 EYC 262

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  152 bits (384), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 26  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 80  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 138
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 139 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 198
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 258
Query: 223 ASC 225
             C
Sbjct: 259 EYC 261

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  152 bits (384), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 80
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 81  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 140 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259
Query: 223 ASC 225
             C
Sbjct: 260 EYC 262

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  152 bits (384), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 19  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 72
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 73  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 131
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 132 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 191
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 251
Query: 223 ASC 225
             C
Sbjct: 252 EYC 254

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  152 bits (384), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 45  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 98
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 99  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 157
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 158 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 217
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 277
Query: 223 ASC 225
             C
Sbjct: 278 EYC 280

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  152 bits (384), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 46  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 99
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 100 EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 158
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 159 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 218
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 278
Query: 223 ASC 225
             C
Sbjct: 279 EYC 281

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 24  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 77
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 78  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 136
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 137 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 196
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256
Query: 223 ASC 225
             C
Sbjct: 257 EYC 259

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/259 (35%), Positives = 140/259 (54%), Gaps = 52/259 (20%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + 
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRT---VAVKMLKEGATHSEHRALMS 70
Query: 67  EINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++ E+C  G+L +YLR               
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI 
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 149 EQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL- 206
           +  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + + 
Sbjct: 191 KDPDXVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 207 ---CRIVHYLSTGYRMERP 222
              CR    L  G RM  P
Sbjct: 249 EEFCR---RLKEGTRMRAP 264

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 25  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 78
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 79  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 137
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 138 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 197
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 257
Query: 223 ASC 225
             C
Sbjct: 258 EYC 260

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 22  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 75
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 76  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +  + +   KL
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254
Query: 223 ASC 225
             C
Sbjct: 255 EYC 257

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 88/250 (35%), Positives = 138/250 (55%), Gaps = 41/250 (16%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLKEINL 70
           LILG++LG+GEFG V++G L     +G S    ++VAVK +K  N+  +  ++FL E   
Sbjct: 36  LILGKILGEGEFGSVMEGNLKQ--EDGTS----LKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 71  MKDVGKHDHIVSFIGCCYKDELR------LVVEYCALGDLQSYLR--------------- 109
           MKD   H +++  +G C +   +      +++ +   GDL +YL                
Sbjct: 90  MKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 110 -----------EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                       EYLSN   +HRDLA RN +L     V ++DFGLS+ IY  + ++ G  
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI 208
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
           + K+P++W+A+ESL   +YT+KSDVW+FGV +WEI T G  PYP +    +  YL  G+R
Sbjct: 209 A-KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267
Query: 219 MERPASCNEQ 228
           +++P  C ++
Sbjct: 268 LKQPEDCLDE 277

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/243 (37%), Positives = 130/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 26  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 80  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 138
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   KL
Sbjct: 139 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKL 198
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 258
Query: 223 ASC 225
             C
Sbjct: 259 EYC 261

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 92/257 (35%), Positives = 136/257 (52%), Gaps = 46/257 (17%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLG--DGPTEGASGQAAMEVAVKMLKANADAKT-YDKF 64
           P ++  LG +LG+GEFG V +  L   DG        + ++VAVKMLKA+  A +  ++F
Sbjct: 21  PEQQFTLGRMLGKGEFGSVREAQLKQEDG--------SFVKVAVKMLKADIIASSDIEEF 72
Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELR-------LVVEYCALGDLQSYLRE------- 110
           L+E   MK+   H H+   +G   +   +       +++ +   GDL ++L         
Sbjct: 73  LREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 111 -------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
                              EYLS+   +HRDLA RN +L+    V ++DFGLS  IY  +
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH 211
            ++ G  S KLP++WLALESL  N+YT  SDVW+FGV +WEI+T G  PY  I    I +
Sbjct: 192 YYRQGCAS-KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
Query: 212 YLSTGYRMERPASCNEQ 228
           YL  G R+++P  C E+
Sbjct: 251 YLIGGNRLKQPPECMEE 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 126/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 15  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    +++E+   G+L  YLRE                    
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 176
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 225 CNEQ 228
           C E+
Sbjct: 237 CPEK 240

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/243 (37%), Positives = 130/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 139
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 140 EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   +L++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   KL
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318
Query: 223 ASC 225
             C
Sbjct: 319 EYC 321

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 126/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 20  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    +++E+   G+L  YLRE                    
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 181
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 241
Query: 225 CNEQ 228
           C E+
Sbjct: 242 CPEK 245

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/238 (37%), Positives = 124/238 (52%), Gaps = 45/238 (18%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +MK++ KH
Sbjct: 21  LGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI-KH 68
Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLS 114
            ++V  +G C ++    +++E+   G+L  YLRE                      EYL 
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPIRWLALE 170
               +HRDLA RN L+   H+VK++DFGLS     D Y            K PI+W A E
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPE 182
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
           SL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  C E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/243 (37%), Positives = 130/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 80
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 81  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   +L++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   KL
Sbjct: 140 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259
Query: 223 ASC 225
             C
Sbjct: 260 EYC 262

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  149 bits (375), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/243 (37%), Positives = 130/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 28  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 81
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 82  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 140
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   +L++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   KL
Sbjct: 141 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 200
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 260
Query: 223 ASC 225
             C
Sbjct: 261 EYC 263

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  149 bits (375), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/243 (37%), Positives = 130/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 32  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 85
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 86  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 144
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   +L++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   KL
Sbjct: 145 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 204
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 264
Query: 223 ASC 225
             C
Sbjct: 265 EYC 267

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  149 bits (375), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/243 (37%), Positives = 130/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 25  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 78
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 79  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 137
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   +L++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   KL
Sbjct: 138 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 197
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 257
Query: 223 ASC 225
             C
Sbjct: 258 EYC 260

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  149 bits (375), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/243 (37%), Positives = 130/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D      +    +  AVK L    D     +FL 
Sbjct: 27  PSSLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLT 80
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 81  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   +L++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   KL
Sbjct: 140 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259
Query: 223 ASC 225
             C
Sbjct: 260 EYC 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 20  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 181
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 241
Query: 225 CNEQ 228
           C E+
Sbjct: 242 CPEK 245

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 125/240 (52%), Gaps = 37/240 (15%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 16  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 64
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    +++E+   G+L  YLRE                    
Sbjct: 65  KEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
             EYL     +HRDLA RN L+   H+VK++DFGLS  +             K PI+W A
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTA 181
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
            ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  C E+
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 241

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 20  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 181
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 241
Query: 225 CNEQ 228
           C E+
Sbjct: 242 CPEK 245

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 15  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 176
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 225 CNEQ 228
           C E+
Sbjct: 237 CPEK 240

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 20  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 181
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 241
Query: 225 CNEQ 228
           C E+
Sbjct: 242 CPEK 245

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 17  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 65
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 66  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 178
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 238
Query: 225 CNEQ 228
           C E+
Sbjct: 239 CPEK 242

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 17  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 65
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 66  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 178
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 238
Query: 225 CNEQ 228
           C E+
Sbjct: 239 CPEK 242

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 19  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 67
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 68  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 180
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240
Query: 225 CNEQ 228
           C E+
Sbjct: 241 CPEK 244

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 28  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 76
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 77  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 189
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 190 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 249
Query: 225 CNEQ 228
           C E+
Sbjct: 250 CPEK 253

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 15  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 176
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 225 CNEQ 228
           C E+
Sbjct: 237 CPEK 240

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 15  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 176
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 225 CNEQ 228
           C E+
Sbjct: 237 CPEK 240

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 16  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 64
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 65  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAPAGAKFPI 177
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 237
Query: 225 CNEQ 228
           C E+
Sbjct: 238 CPEK 241

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 15  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAHAGAKFPI 176
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 225 CNEQ 228
           C E+
Sbjct: 237 CPEK 240

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 17  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 65
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 66  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HRDLA RN L+   H+VK++DFGLS     D Y            K PI
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------TAPAGAKFPI 178
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 238
Query: 225 CNEQ 228
           C E+
Sbjct: 239 CPEK 242

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  147 bits (372), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 124/240 (51%), Gaps = 37/240 (15%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 20  ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
             EYL     +HRDLA RN L+   H+VK++DFGLS  +             K PI+W A
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTA 185
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
            ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  C E+
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 91/235 (38%), Positives = 121/235 (51%), Gaps = 45/235 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G++G V  G+           + ++ VAVK LK   D    ++FLKE  +MK++ KH
Sbjct: 40  LGGGQYGEVYVGVWK---------KYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI-KH 87
Query: 78  DHIVSFIG-CCYKDELRLVVEYCALGDLQSYLRE----------------------EYLS 114
            ++V  +G C  +    +V EY   G+L  YLRE                      EYL 
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE 147
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPIRWLALE 170
               +HRDLA RN L+   HVVK++DFGLS     D Y            K PI+W A E
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPE 201
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           SL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L  GYRME+P  C
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGC 256

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  146 bits (369), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 88/234 (37%), Positives = 121/234 (51%), Gaps = 37/234 (15%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G+FG V          EG   + ++ VAVK LK   D    ++FLKE  +MK++ KH
Sbjct: 19  LGGGQFGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI-KH 66
Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLS 114
            ++V  +G C ++    ++ E+   G+L  YLRE                      EYL 
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
               +HRDLA RN L+   H+VK++DFGLS  +             K PI+W A ESL  
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTAPESLAY 184
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
           N ++ KSDVW+FGV+LWEI T G +PYP I   ++   L   YRMERP  C E+
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEK 238

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  146 bits (369), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 135/261 (51%), Gaps = 55/261 (21%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P  RL  G+ LG G FG VV+    GL+           AAM VAVKMLK +A     +
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLI--------KSDAAMTVAVKMLKPSAHLTERE 71
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE---------- 111
             + E+ ++  +G H +IV+ +G C      LV+ EYC  GDL ++LR +          
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 112 ----------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
                                       +L++   +HRDLA RNILL+   + KI DFGL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 144 SEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           + DI  + N    G  + +LP++W+A ES+ + +YT +SDVWS+G+ LWE+ +LG++PYP
Sbjct: 192 ARDIKNDSNYVVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 203 HIPL-CRIVHYLSTGYRMERP 222
            +P+  +    +  G+RM  P
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSP 270

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  146 bits (369), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 135/261 (51%), Gaps = 55/261 (21%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P  RL  G+ LG G FG VV+    GL+           AAM VAVKMLK +A     +
Sbjct: 36  FPRNRLSFGKTLGAGAFGKVVEATAYGLI--------KSDAAMTVAVKMLKPSAHLTERE 87
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE---------- 111
             + E+ ++  +G H +IV+ +G C      LV+ EYC  GDL ++LR +          
Sbjct: 88  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 147
Query: 112 ----------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
                                       +L++   +HRDLA RNILL+   + KI DFGL
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 207
Query: 144 SEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           + DI  + N    G  + +LP++W+A ES+ + +YT +SDVWS+G+ LWE+ +LG++PYP
Sbjct: 208 ARDIKNDSNYVVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 265
Query: 203 HIPL-CRIVHYLSTGYRMERP 222
            +P+  +    +  G+RM  P
Sbjct: 266 GMPVDSKFYKMIKEGFRMLSP 286

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  146 bits (369), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 89/244 (36%), Positives = 126/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 222 ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 270
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 271 KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HR+LA RN L+   H+VK++DFGLS     D Y  +         K PI
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------GAKFPI 383
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443
Query: 225 CNEQ 228
           C E+
Sbjct: 444 CPEK 447

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  146 bits (369), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 89/244 (36%), Positives = 126/244 (51%), Gaps = 45/244 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +   LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +M
Sbjct: 261 ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 309
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH ++V  +G C ++    ++ E+   G+L  YLRE                    
Sbjct: 310 KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE----DIYEQNVFQNGEPSEKLPI 164
             EYL     +HR+LA RN L+   H+VK++DFGLS     D Y  +         K PI
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------GAKFPI 422
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 423 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 482
Query: 225 CNEQ 228
           C E+
Sbjct: 483 CPEK 486

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/234 (37%), Positives = 122/234 (52%), Gaps = 37/234 (15%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +MK++ KH
Sbjct: 19  LGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI-KH 66
Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLS 114
            ++V  +G C ++    +++E+   G+L  YLRE                      EYL 
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
               +HRDLA RN L+   H+VK++DFGLS  +             K PI+W A ESL  
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTAPESLAY 184
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
           N ++ KSDVW+FGV+LWEI T G +PYP I   ++   L   YRMERP  C E+
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEK 238

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/234 (37%), Positives = 123/234 (52%), Gaps = 37/234 (15%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G++G V          EG   + ++ VAVK LK   D    ++FLKE  +MK++ KH
Sbjct: 19  LGGGQYGEVY---------EGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI-KH 66
Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLS 114
            ++V  +G C ++    ++ E+   G+L  YLRE                      EYL 
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
               +HRDLA RN L+   H+VK++DFGLS  +   + F       K PI+W A ESL  
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTF-TAHAGAKFPIKWTAPESLAY 184
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
           N ++ KSDVW+FGV+LWEI T G +PYP I   ++   L   YRMERP  C E+
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEK 238

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 89/243 (36%), Positives = 129/243 (53%), Gaps = 33/243 (13%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           P  LI    EV+G+G FG V  G L D   +       +  AVK L    D     +FL 
Sbjct: 28  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK------KIHCAVKSLNRITDIGEVSQFLT 81
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------- 111
           E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E             
Sbjct: 82  EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 140
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEKL 162
                   +L++ K VHRDLA RN +L     VK++DFGL+ D+ ++     + +   KL
Sbjct: 141 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL 200
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 260
Query: 223 ASC 225
             C
Sbjct: 261 EYC 263

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 135/261 (51%), Gaps = 55/261 (21%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P  RL  G+ LG G FG VV+    GL+           AAM VAVKMLK +A     +
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLI--------KSDAAMTVAVKMLKPSAHLTERE 94
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE---------- 111
             + E+ ++  +G H +IV+ +G C      LV+ EYC  GDL ++LR +          
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 112 ----------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
                                       +L++   +HRDLA RNILL+   + KI DFGL
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 214
Query: 144 SEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           + DI  + N    G  + +LP++W+A ES+ + +YT +SDVWS+G+ LWE+ +LG++PYP
Sbjct: 215 ARDIKNDSNYVVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 272
Query: 203 HIPL-CRIVHYLSTGYRMERP 222
            +P+  +    +  G+RM  P
Sbjct: 273 GMPVDSKFYKMIKEGFRMLSP 293

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 135/261 (51%), Gaps = 55/261 (21%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P  RL  G+ LG G FG VV+    GL+           AAM VAVKMLK +A     +
Sbjct: 38  FPRNRLSFGKTLGAGAFGKVVEATAYGLI--------KSDAAMTVAVKMLKPSAHLTERE 89
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE---------- 111
             + E+ ++  +G H +IV+ +G C      LV+ EYC  GDL ++LR +          
Sbjct: 90  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 149
Query: 112 ----------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
                                       +L++   +HRDLA RNILL+   + KI DFGL
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 209
Query: 144 SEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           + DI  + N    G  + +LP++W+A ES+ + +YT +SDVWS+G+ LWE+ +LG++PYP
Sbjct: 210 ARDIKNDSNYVVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 267
Query: 203 HIPL-CRIVHYLSTGYRMERP 222
            +P+  +    +  G+RM  P
Sbjct: 268 GMPVDSKFYKMIKEGFRMLSP 288

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/250 (36%), Positives = 131/250 (52%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 72  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHRDLA RN +++    VKI DFG++ DIYE + ++ G  
Sbjct: 131 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 191 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 249
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 250 LDQPDNCPER 259

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/250 (36%), Positives = 131/250 (52%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHRDLA RN +++    VKI DFG++ DIYE + ++ G  
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 191
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 192 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 251 LDQPDNCPER 260

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/250 (36%), Positives = 130/250 (52%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHRDLA RN +++    VKI DFG++ DIYE   ++ G  
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGK 191
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 192 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 251 LDQPDNCPER 260

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  144 bits (362), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 131/250 (52%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 18  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 74  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 132
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHR+LA RN +++    VKI DFG++ DIYE + ++ G  
Sbjct: 133 MIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 193 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 251
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 252 LDQPDNCPER 261

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  144 bits (362), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 131/250 (52%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHR+LA RN +++    VKI DFG++ DIYE + ++ G  
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 191
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 192 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 251 LDQPDNCPER 260

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  143 bits (361), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 133/253 (52%), Gaps = 54/253 (21%)
Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +V+G+G FG V+K  +  DG          M+ A+K +K  A    +  F  E+ ++  +
Sbjct: 31  DVIGEGNFGQVLKARIKKDG--------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 75  GKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE----------------------- 110
           G H +I++ +G C ++  L L +EY   G+L  +LR+                       
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 111 -------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS--EDIYEQNVFQN 155
                        +YLS  + +HRDLA RNIL+   +V KI+DFGLS  +++Y +     
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 201
Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                +LP+RW+A+ESL  ++YT  SDVWS+GV+LWEIV+LG  PY  +    +   L  
Sbjct: 202 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256
Query: 216 GYRMERPASCNEQ 228
           GYR+E+P +C+++
Sbjct: 257 GYRLEKPLNCDDE 269

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 16  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 67
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 68  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 187 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 245
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 246 EGGLLDKPDNC 256

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 15  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 66
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 67  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 126 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 186 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 244
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 245 EGGLLDKPDNC 255

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEP--------ETRVAIKTVNEAASMRERIEFL 63
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 64  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 183 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 241
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 242 EGGLLDKPDNC 252

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 76
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 77  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 196 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 255 EGGLLDKPDNC 265

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 69
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 70  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 189 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 247
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 248 EGGLLDKPDNC 258

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 133/253 (52%), Gaps = 54/253 (21%)
Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +V+G+G FG V+K  +  DG          M+ A+K +K  A    +  F  E+ ++  +
Sbjct: 21  DVIGEGNFGQVLKARIKKDG--------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 72
Query: 75  GKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE----------------------- 110
           G H +I++ +G C ++  L L +EY   G+L  +LR+                       
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 111 -------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS--EDIYEQNVFQN 155
                        +YLS  + +HRDLA RNIL+   +V KI+DFGLS  +++Y +     
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 191
Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                +LP+RW+A+ESL  ++YT  SDVWS+GV+LWEIV+LG  PY  +    +   L  
Sbjct: 192 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 246
Query: 216 GYRMERPASCNEQ 228
           GYR+E+P +C+++
Sbjct: 247 GYRLEKPLNCDDE 259

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 134/261 (51%), Gaps = 55/261 (21%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +P  RL  G+ LG G FG VV+    GL+           AAM VAVKMLK +A     +
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLI--------KSDAAMTVAVKMLKPSAHLTERE 94
Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE---------- 111
             + E+ ++  +G H +IV+ +G C      LV+ EYC  GDL ++LR +          
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 112 ----------------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
                                       +L++   +HRDLA RNILL+   + KI DFGL
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 214
Query: 144 SEDIY-EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           +  I  + N    G  + +LP++W+A ES+ + +YT +SDVWS+G+ LWE+ +LG++PYP
Sbjct: 215 ARHIKNDSNYVVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 272
Query: 203 HIPL-CRIVHYLSTGYRMERP 222
            +P+  +    +  G+RM  P
Sbjct: 273 GMPVDSKFYKMIKEGFRMLSP 293

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 70
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 71  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 190 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 248
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 249 EGGLLDKPDNC 259

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 69
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 70  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 189 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 247
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 248 EGGLLDKPDNC 258

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 76
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 77  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 196 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 255 EGGLLDKPDNC 265

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 129/251 (51%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 47  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 98
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 99  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 218 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 276
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 277 EGGLLDKPDNC 287

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 45/240 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           + L L + +G+GEFG V   +LGD            +VAVK +K +A A+    FL E +
Sbjct: 21  KELKLLQTIGKGEFGDV---MLGD--------YRGNKVAVKCIKNDATAQA---FLAEAS 66
Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           +M  + +H ++V  +G   +++  L +V EY A G L  YLR                  
Sbjct: 67  VMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++        + + + KLP++
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVK 179
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P  C
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 239

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 124/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 22  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 75
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 194
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 128/251 (50%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEP--------ETRVAIKTVNEAASMRERIEFL 63
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 64  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN  ++    VKI DFG++ DIYE + ++
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 183 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 241
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 242 EGGLLDKPDNC 252

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 21  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 74
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 193
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 85/246 (34%), Positives = 129/246 (52%), Gaps = 33/246 (13%)
Query: 8   PPERLIL--GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           P ER++     V+G+G FGVV  G   D        Q  ++ A+K L    + +  + FL
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFL 70
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE------------- 110
           +E  LM+ +  H ++++ IG     E    +++ Y   GDL  ++R              
Sbjct: 71  REGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEK 161
                   EYL+  K VHRDLA RN +L     VK++DFGL+ DI ++  +        +
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER 221
           LP++W ALESL +  +T KSDVWSFGV+LWE++T GA PY HI    + H+L+ G R+ +
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ 249
Query: 222 PASCNE 227
           P  C +
Sbjct: 250 PEYCPD 255

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 45/240 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           + L L + +G+GEFG V   +LGD            +VAVK +K +A A+    FL E +
Sbjct: 193 KELKLLQTIGKGEFGDV---MLGD--------YRGNKVAVKCIKNDATAQA---FLAEAS 238
Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           +M  + +H ++V  +G   +++  L +V EY A G L  YLR                  
Sbjct: 239 VMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++        + + + KLP++
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVK 351
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P  C
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 411

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 133/253 (52%), Gaps = 54/253 (21%)
Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +V+G+G FG V+K  +  DG          M+ A+K +K  A    +  F  E+ ++  +
Sbjct: 28  DVIGEGNFGQVLKARIKKDG--------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 79
Query: 75  GKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE----------------------- 110
           G H +I++ +G C ++  L L +EY   G+L  +LR+                       
Sbjct: 80  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 111 -------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS--EDIYEQNVFQN 155
                        +YLS  + +HR+LA RNIL+   +V KI+DFGLS  +++Y +     
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 198
Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                +LP+RW+A+ESL  ++YT  SDVWS+GV+LWEIV+LG  PY  +    +   L  
Sbjct: 199 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 253
Query: 216 GYRMERPASCNEQ 228
           GYR+E+P +C+++
Sbjct: 254 GYRLEKPLNCDDE 266

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 129/250 (51%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHRDLA RN +++    VKI DFG++ DI E +  + G  
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGK 191
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 192 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 251 LDQPDNCPER 260

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 45/240 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           + L L + +G+GEFG V   +LGD            +VAVK +K +A A+    FL E +
Sbjct: 12  KELKLLQTIGKGEFGDV---MLGD--------YRGNKVAVKCIKNDATAQA---FLAEAS 57
Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           +M  + +H ++V  +G   +++  L +V EY A G L  YLR                  
Sbjct: 58  VMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 116
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++        + + + KLP++
Sbjct: 117 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVK 170
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P  C
Sbjct: 171 WTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 230

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 129/250 (51%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 14  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 70  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 128
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHRDLA RN +++    VKI DFG++ DI E +  + G  
Sbjct: 129 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGK 188
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 189 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 247
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 248 LDQPDNCPER 257

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 45/240 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           + L L + +G+GEFG V   +LGD            +VAVK +K +A A+    FL E +
Sbjct: 6   KELKLLQTIGKGEFGDV---MLGD--------YRGNKVAVKCIKNDATAQA---FLAEAS 51
Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           +M  + +H ++V  +G   +++  L +V EY A G L  YLR                  
Sbjct: 52  VMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++        + + + KLP++
Sbjct: 111 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVK 164
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P  C
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 129/250 (51%), Gaps = 37/250 (14%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E++ L   LGQG FG+V +G   D       G+A   VAVK +  +A  +   +FL E +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------ 110
           +MK    H H+V  +G   K +  LVV E  A GDL+SYLR                   
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL+  K VHRDLA RN +++    VKI DFG++ DI E +  + G  
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGK 191
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR 218
              LP+RW+A ESL   ++T  SD+WSFGVVLWEI +L   PY  +   +++ ++  G  
Sbjct: 192 G-LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 219 MERPASCNEQ 228
           +++P +C E+
Sbjct: 251 LDQPDNCPER 260

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 124/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 24  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 77
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 196
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 124/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 23  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 76
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 195
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 124/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 25  KVLGSGAFGTVYKGLWI---PEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 78
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 197
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 28  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 81
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 200
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  140 bits (354), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 23  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 76
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 195
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  140 bits (354), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 124/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 21  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 76  -NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 193
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  140 bits (354), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 124/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 22  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 77  -NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 194
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  140 bits (354), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 27  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 80
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 81  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 141 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 199
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 200 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 251

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 24  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 77
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 196
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 24  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 77
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 196
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 46  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 99
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 100 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 160 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 218
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 219 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 21  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 76  -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 193
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 31  KVLGSGAFGTVYKGLWI---PEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 86  -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 145 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 203
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 204 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 255

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 21  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 76  -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 193
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 24  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 77
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 196
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  140 bits (353), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 18  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 71
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 72  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 132 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 190
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 191 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 242

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  140 bits (353), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 15  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 70  -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 187
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  140 bits (353), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 85/235 (36%), Positives = 125/235 (53%), Gaps = 34/235 (14%)
Query: 16  EVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +VLG G FG V KG+ + DG          + VA+K+L+ N   K   + L E  +M  V
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGEN------VKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 75  GKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           G   ++   +G C    ++LV +    G L  ++RE                      YL
Sbjct: 77  GSP-YVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL 135
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPIRWLALES 171
            + ++VHRDLA RN+L+ SP+ VKI+DFGL+   DI E     +G    K+PI+W+ALES
Sbjct: 136 EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG---KVPIKWMALES 192
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
           ++   +T++SDVWS+GV +WE++T GA PY  IP   I   L  G R+ +P  C 
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICT 247

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 127/251 (50%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--------TRVAIKTVNEAASMRERIEFL 70
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 71  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DI E +  +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 190 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 248
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 249 EGGLLDKPDNC 259

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 127/251 (50%), Gaps = 45/251 (17%)
Query: 10  ERLILGEVLGQGEFGVV----VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           E++ +   LGQG FG+V     KG++ D P           VA+K +   A  +   +FL
Sbjct: 10  EKITMSRELGQGSFGMVYEGVAKGVVKDEP--------ETRVAIKTVNEAASMRERIEFL 61
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE-------------- 110
            E ++MK+   H H+V  +G   + +  LV+ E    GDL+SYLR               
Sbjct: 62  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                            YL+ NK VHRDLA RN +++    VKI DFG++ DI E +  +
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS 214
            G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++ 
Sbjct: 181 KGGKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 239
Query: 215 TGYRMERPASC 225
            G  +++P +C
Sbjct: 240 EGGLLDKPDNC 250

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 23  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 76
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFG ++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GGKVPIKWMALESILH 195
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 23  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 76
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFG ++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GGKVPIKWMALESILH 195
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 25  KVLGSGAFGTVYKGLWI---PEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 80  -NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFG ++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GGKVPIKWMALESILH 197
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 122/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VL  G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 28  KVLSSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 81
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 200
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VL  G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 28  KVLSSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 81
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+++    G L  Y+RE                      YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 200
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 122/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 28  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 81
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFG ++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GGKVPIKWMALESILH 200
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 122/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 23  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV- 76
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFG ++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GGKVPIKWMALESILH 195
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 122/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+  L+     K   + L E  +M  V 
Sbjct: 55  KVLGSGAFGTVYKGLWI---PEGE--KVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 110 -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 169 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 227
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 228 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 279

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 122/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 21  KVLGSGAFGTVYKGLW---IPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 76  -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFG ++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GGKVPIKWMALESILH 193
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 122/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VL  G FG V KGL      EG   +  + VA+K L+     K   + L E  +M  V 
Sbjct: 21  KVLSSGAFGTVYKGLWI---PEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            + H+   +G C    ++L+ +    G L  Y+RE                      YL 
Sbjct: 76  -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
           + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES++ 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILH 193
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 123/235 (52%), Gaps = 34/235 (14%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G GEFG V KG+L     + +SG+  + VA+K LKA    K    FL E  +M    
Sbjct: 50  KVIGAGEFGEVYKGML-----KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 76  KHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE---------------------YL 113
            H+ I+   G   K   + ++ EY   G L  +LRE+                     YL
Sbjct: 105 HHN-IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPSEKLPIRWLALE 170
           +N   VHRDLA RNIL++S  V K+SDFGLS   ED  E     +G    K+PIRW A E
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG---KIPIRWTAPE 220
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           ++    +T+ SDVWSFG+V+WE++T G  PY  +    ++  ++ G+R+  P  C
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 275

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 80/233 (34%), Positives = 120/233 (51%), Gaps = 30/233 (12%)
Query: 16  EVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +VLG G FG V KG+ + +G T        + VA+K+L      K   +F+ E  +M  +
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGET------VKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 75  GKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YL 113
             H H+V  +G C    ++LV +    G L  Y+ E                      YL
Sbjct: 98  -DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 156
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
              ++VHRDLA RN+L+ SP+ VKI+DFGL+  + E +  +      K+PI+W+ALE + 
Sbjct: 157 EERRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              +T++SDVWS+GV +WE++T G  PY  IP   I   L  G R+ +P  C 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 268

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  134 bits (336), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 80/233 (34%), Positives = 120/233 (51%), Gaps = 30/233 (12%)
Query: 16  EVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +VLG G FG V KG+ + +G T        + VA+K+L      K   +F+ E  +M  +
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGET------VKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 75  GKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YL 113
             H H+V  +G C    ++LV +    G L  Y+ E                      YL
Sbjct: 75  -DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
              ++VHRDLA RN+L+ SP+ VKI+DFGL+  + E +  +      K+PI+W+ALE + 
Sbjct: 134 EERRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              +T++SDVWS+GV +WE++T G  PY  IP   I   L  G R+ +P  C 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 245

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  134 bits (336), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 122/237 (51%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    AM VA+K  K        +KFL+E  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYM------SPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 64  TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS   Y ++         KLPI+W+A
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTXXKASKGKLPIKWMA 180
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  134 bits (336), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    AM VA+K  K        +KFL+E  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYM------SPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 64  TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 180
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  133 bits (335), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 127/249 (51%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 29  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 85  ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG+++DIY  + ++ G
Sbjct: 144 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKG 203
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 204 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 263 GRMDPPKNC 271

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  133 bits (335), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    AM VA+K  K        +KFL+E  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYM------SPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 444 TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG--KLPIKWMA 560
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  133 bits (334), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 127/249 (51%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 43  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 98
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++  +  H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 99  ALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 158 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 218 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 277 GRMDPPKNC 285

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  133 bits (334), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    AM VA+K  K        +KFL+E  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYM------SPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 64  TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+S+   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 180
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 127/249 (51%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 29  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++  +  H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 85  ALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 144 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 203
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 204 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 263 GRMDPPKNC 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  133 bits (334), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 127/255 (49%), Gaps = 46/255 (18%)
Query: 12  LILGEVLGQGEFG-VVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           ++L   LG+G FG V +       PT+       M VAVK LK    A   D F +E  L
Sbjct: 17  IVLKRELGEGAFGKVFLAECYNLSPTKDK-----MLVAVKALKDPTLAARKD-FQREAEL 70
Query: 71  MKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE------------------ 111
           + ++ +H+HIV F G C   D L +V EY   GDL  +LR                    
Sbjct: 71  LTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 112 ------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF 153
                             YL++   VHRDLATRN L+ +  +VKI DFG+S D+Y  + +
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL 213
           + G  +  LPIRW+  ES++   +T +SDVWSFGV+LWEI T G  P+  +    ++  +
Sbjct: 190 RVGGHT-MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 214 STGYRMERPASCNEQ 228
           + G  +ERP  C ++
Sbjct: 249 TQGRVLERPRVCPKE 263

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  133 bits (334), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 20  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 75
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 76  ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 134
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 135 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 194
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 195 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 253
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 254 GRMDPPKNC 262

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    AM VA+K  K        +KFL+E  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYM------SPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 444 TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+S+   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG--KLPIKWMA 560
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 45  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 100
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 101 ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 159
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 160 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 219
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 220 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 278
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 279 GRMDPPKNC 287

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 43  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 98
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLV-VEYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R + +E  A GDL+S+LRE                
Sbjct: 99  ALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 158 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 218 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 277 GRMDPPKNC 285

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 55  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 110
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 111 ALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 169
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 170 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 229
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 230 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 288
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 289 GRMDPPKNC 297

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 35  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 90
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 91  ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 149
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 150 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 209
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 210 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 268
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 269 GRMDPPKNC 277

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 29  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 85  ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 144 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 203
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 204 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 263 GRMDPPKNC 271

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    A+ VA+K  K        +KFL+E  
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 67  TMRQF-DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 126 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 183
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    A+ VA+K  K        +KFL+E  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 69  TMRQF-DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 185
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 28  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLV-VEYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R + +E  A GDL+S+LRE                
Sbjct: 84  ALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 203 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 262 GRMDPPKNC 270

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 28  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 84  ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 203 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 262 GRMDPPKNC 270

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 127/251 (50%), Gaps = 41/251 (16%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L   LG+G FG V      +   E    Q  + VAVK LK  +D    D F +E  L+
Sbjct: 15  IVLKRELGEGAFGKVFLAECYNLCPE----QDKILVAVKTLKDASDNARKD-FHREAELL 69
Query: 72  KDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE------------------- 111
            ++ +H+HIV F G C + D L +V EY   GDL  +LR                     
Sbjct: 70  TNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 112 --------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                         YL++   VHRDLATRN L+    +VKI DFG+S D+Y  + ++ G 
Sbjct: 129 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY 217
            +  LPIRW+  ES++   +T +SDVWS GVVLWEI T G  P+  +    ++  ++ G 
Sbjct: 189 HT-MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247
Query: 218 RMERPASCNEQ 228
            ++RP +C ++
Sbjct: 248 VLQRPRTCPQE 258

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    A+ VA+K  K        +KFL+E  
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 92  TMRQF-DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 150
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 151 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 208
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 265

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    A+ VA+K  K        +KFL+E  
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 66  TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 125 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 182
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 239

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  132 bits (332), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 125/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 69  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 124
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 125 ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY    ++ G
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 244 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 303 GRMDPPKNC 311

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  132 bits (332), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 125/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 46  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVCSEQDELDFLME 101
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 102 ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 160
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY    ++ G
Sbjct: 161 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 220
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 221 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 279
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 280 GRMDPPKNC 288

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    A+ VA+K  K        +KFL+E  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 61  TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 177
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 122/250 (48%), Gaps = 43/250 (17%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L   LG+G FG V      +   E    Q  M VAVK LK  +++   D F +E  L+
Sbjct: 43  IVLKWELGEGAFGKVFLAECHNLLPE----QDKMLVAVKALKEASESARQD-FQREAELL 97
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE------------------- 111
             + +H HIV F G C +   L +V EY   GDL  +LR                     
Sbjct: 98  TML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 112 ----------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
                           YL+    VHRDLATRN L+    VVKI DFG+S DIY  + ++ 
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216
Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
           G  +  LPIRW+  ES++   +T +SDVWSFGVVLWEI T G  P+  +     +  ++ 
Sbjct: 217 GGRT-MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 216 GYRMERPASC 225
           G  +ERP +C
Sbjct: 276 GRELERPRAC 285

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 124/237 (52%), Gaps = 30/237 (12%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           ER+ LG  +G+G+FG V +G+        +    A+ VA+K  K        +KFL+E  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYM------SPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE------------------ 111
            M+    H HIV  IG   ++ + +++E C LG+L+S+L+                    
Sbjct: 64  TMRQFD-HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 112 ---YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W+A
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMA 180
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 122/250 (48%), Gaps = 43/250 (17%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L   LG+G FG V      +   E    Q  M VAVK LK  +++   D F +E  L+
Sbjct: 20  IVLKWELGEGAFGKVFLAECHNLLPE----QDKMLVAVKALKEASESARQD-FQREAELL 74
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE------------------- 111
             + +H HIV F G C +   L +V EY   GDL  +LR                     
Sbjct: 75  TML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 133
Query: 112 ----------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
                           YL+    VHRDLATRN L+    VVKI DFG+S DIY  + ++ 
Sbjct: 134 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 193
Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
           G  +  LPIRW+  ES++   +T +SDVWSFGVVLWEI T G  P+  +     +  ++ 
Sbjct: 194 GGRT-MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 252
Query: 216 GYRMERPASC 225
           G  +ERP +C
Sbjct: 253 GRELERPRAC 262

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 122/250 (48%), Gaps = 43/250 (17%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L   LG+G FG V      +   E    Q  M VAVK LK  +++   D F +E  L+
Sbjct: 14  IVLKWELGEGAFGKVFLAECHNLLPE----QDKMLVAVKALKEASESARQD-FQREAELL 68
Query: 72  KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE------------------- 111
             + +H HIV F G C +   L +V EY   GDL  +LR                     
Sbjct: 69  TML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 127
Query: 112 ----------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
                           YL+    VHRDLATRN L+    VVKI DFG+S DIY  + ++ 
Sbjct: 128 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 187
Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
           G  +  LPIRW+  ES++   +T +SDVWSFGVVLWEI T G  P+  +     +  ++ 
Sbjct: 188 GGRT-MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 246
Query: 216 GYRMERPASC 225
           G  +ERP +C
Sbjct: 247 GRELERPRAC 256

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 126/249 (50%), Gaps = 37/249 (14%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P + + L   LG G FG V +G +   P +     + ++VAVK L      +    FL E
Sbjct: 43  PRKNITLIRGLGHGAFGEVYEGQVSGMPND----PSPLQVAVKTLPEVYSEQDELDFLME 98
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             ++     H +IV  IG   +   R ++ E  A GDL+S+LRE                
Sbjct: 99  ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 111 -----------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNG 156
                      +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ G
Sbjct: 158 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++G
Sbjct: 218 G-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276
Query: 217 YRMERPASC 225
            RM+ P +C
Sbjct: 277 GRMDPPKNC 285

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  127 bits (320), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 126/242 (52%), Gaps = 37/242 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 23  PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 70
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                 
Sbjct: 71  KVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL + + +HRDLA RN L++   VVK+SDFGLS  + +    +      K P+RW
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--ETSSVGSKFPVRW 187
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   +
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247
Query: 227 EQ 228
           E+
Sbjct: 248 EK 249

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  127 bits (319), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 121/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KG+      EG S    + V +K+++  +  +++      +  +  + 
Sbjct: 19  KVLGSGVFGTVHKGVW---IPEGES--IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL- 72
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            H HIV  +G C    L+LV +Y  LG L  ++R+                      YL 
Sbjct: 73  DHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
            + +VHR+LA RN+LL SP  V+++DFG++ D+   +  Q      K PI+W+ALES+  
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVA-DLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
             YT++SDVWS+GV +WE++T GA PY  + L  +   L  G R+ +P  C 
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 243

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  127 bits (318), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 121/232 (52%), Gaps = 28/232 (12%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +VLG G FG V KG+      EG S    + V +K+++  +  +++      +  +  + 
Sbjct: 37  KVLGSGVFGTVHKGVW---IPEGES--IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL- 90
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------------YLS 114
            H HIV  +G C    L+LV +Y  LG L  ++R+                      YL 
Sbjct: 91  DHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 150
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS 174
            + +VHR+LA RN+LL SP  V+++DFG++ D+   +  Q      K PI+W+ALES+  
Sbjct: 151 EHGMVHRNLAARNVLLKSPSQVQVADFGVA-DLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
             YT++SDVWS+GV +WE++T GA PY  + L  +   L  G R+ +P  C 
Sbjct: 210 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  127 bits (318), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 125/242 (51%), Gaps = 37/242 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 8   PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 55
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                 
Sbjct: 56  KVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL + + +HRDLA RN L++   VVK+SDFGLS  + +           K P+RW
Sbjct: 115 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSRGSKFPVRW 172
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   +
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 232
Query: 227 EQ 228
           E+
Sbjct: 233 EK 234

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  127 bits (318), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 81/238 (34%), Positives = 122/238 (51%), Gaps = 33/238 (13%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E L+LGE +G+G FG V  G L    T          VAVK  +         KFL+E  
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTL---------VAVKSCRETLPPDLKAKFLQEAR 164
Query: 70  LMKDVGKHDHIVSFIG-CCYKDELRLVVEYCALGDLQSYLREE----------------- 111
           ++K    H +IV  IG C  K  + +V+E    GD  ++LR E                 
Sbjct: 165 ILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 112 ----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               YL +   +HRDLA RN L++  +V+KISDFG+S +  +  V+       ++P++W 
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWT 282
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           A E+L    Y+++SDVWSFG++LWE  +LGA+PYP++   +   ++  G R+  P  C
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC 340

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  126 bits (317), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 125/242 (51%), Gaps = 37/242 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 14  PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 61
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                 
Sbjct: 62  KVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 120
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL + + +HRDLA RN L++   VVK+SDFGLS  + +           K P+RW
Sbjct: 121 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRW 178
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   +
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 238
Query: 227 EQ 228
           E+
Sbjct: 239 EK 240

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  126 bits (317), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 128/246 (52%), Gaps = 45/246 (18%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 23  PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 70
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                 
Sbjct: 71  KVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKL 162
               EYL + + +HRDLA RN L++   VVK+SDFGLS    +D Y  +V        K 
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV------GSKF 183
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           P+RW   E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 243
Query: 223 ASCNEQ 228
              +E+
Sbjct: 244 HLASEK 249

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  126 bits (317), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 125/242 (51%), Gaps = 37/242 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 3   PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 50
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                 
Sbjct: 51  KVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL + + +HRDLA RN L++   VVK+SDFGLS  + +           K P+RW
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRW 167
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   +
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227
Query: 227 EQ 228
           E+
Sbjct: 228 EK 229

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 125/242 (51%), Gaps = 37/242 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 8   PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 55
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                 
Sbjct: 56  KVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL + + +HRDLA RN L++   VVK+SDFGLS  + +           K P+RW
Sbjct: 115 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRW 172
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   +
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 232
Query: 227 EQ 228
           E+
Sbjct: 233 EK 234

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 125/242 (51%), Gaps = 37/242 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E 
Sbjct: 7   PKDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIKEGSMSE--DEFIEEA 54
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                 
Sbjct: 55  KVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 113
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL + + +HRDLA RN L++   VVK+SDFGLS  + +           K P+RW
Sbjct: 114 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRW 171
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   +
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 231
Query: 227 EQ 228
           E+
Sbjct: 232 EK 233

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  125 bits (315), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 124/268 (46%), Gaps = 59/268 (22%)
Query: 7   YPPERLILGEVLGQGEFGVVVK----GLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           YP   +     +G+G FG V +    GLL   P           VAVKMLK  A A    
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT--------MVAVKMLKEEASADMQA 95
Query: 63  KFLKEINLMKDVGKHDHIVSFIG-CCYKDELRLVVEYCALGDLQSYLRE----------- 110
            F +E  LM +   + +IV  +G C     + L+ EY A GDL  +LR            
Sbjct: 96  DFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154
Query: 111 ---------------------------------EYLSNNKVVHRDLATRNILLSSPHVVK 137
                                             YLS  K VHRDLATRN L+    VVK
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 214
Query: 138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG 197
           I+DFGLS +IY  + ++  + ++ +PIRW+  ES+  N YT +SDVW++GVVLWEI + G
Sbjct: 215 IADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273
Query: 198 ANPYPHIPLCRIVHYLSTGYRMERPASC 225
             PY  +    +++Y+  G  +  P +C
Sbjct: 274 LQPYYGMAHEEVIYYVRDGNILACPENC 301

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/238 (34%), Positives = 122/238 (51%), Gaps = 33/238 (13%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E L+LGE +G+G FG V  G L    T          VAVK  +         KFL+E  
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTL---------VAVKSCRETLPPDLKAKFLQEAR 164
Query: 70  LMKDVGKHDHIVSFIG-CCYKDELRLVVEYCALGDLQSYLREE----------------- 111
           ++K    H +IV  IG C  K  + +V+E    GD  ++LR E                 
Sbjct: 165 ILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 112 ----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               YL +   +HRDLA RN L++  +V+KISDFG+S +  +     +G    ++P++W 
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGG-LRQVPVKWT 282
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           A E+L    Y+++SDVWSFG++LWE  +LGA+PYP++   +   ++  G R+  P  C
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC 340

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/238 (33%), Positives = 119/238 (50%), Gaps = 33/238 (13%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + +  V+G GEFG V  G L         G+  + VA+K LK     K    FL E ++M
Sbjct: 24  ITIERVIGAGEFGEVCSGRLK------LPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 72  KDVGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------ 110
              G+ DH  I+   G   K + + +V EY   G L ++L++                  
Sbjct: 78  ---GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGIS 134
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
              +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW 
Sbjct: 135 AGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           A E++    +T+ SDVWS+G+V+WE+V+ G  PY  +    ++  +  GYR+  P  C
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDC 252

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  125 bits (313), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/243 (33%), Positives = 122/243 (50%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V            A+     +VAVK +K  +   + + FL E
Sbjct: 13  PRESLKLEKKLGAGQFGEVWM----------ATYNKHTKVAVKTMKPGS--MSVEAFLAE 60
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
            N+MK + +HD +V       K+ + ++ E+ A G L  +L+ +                
Sbjct: 61  ANVMKTL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 119
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S+  V KI+DFGL+  + E N +   E   K PI+
Sbjct: 120 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTARE-GAKFPIK 177
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 178 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 237
Query: 226 NEQ 228
            E+
Sbjct: 238 PEE 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  125 bits (313), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/243 (33%), Positives = 123/243 (50%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V            A+     +VAVK +K  +   + + FL E
Sbjct: 186 PRESLKLEKKLGAGQFGEVWM----------ATYNKHTKVAVKTMKPGS--MSVEAFLAE 233
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
            N+MK + +HD +V       K+ + ++ E+ A G L  +L+ +                
Sbjct: 234 ANVMKTL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S+  V KI+DFGL+  + E N +   E + K PI+
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGA-KFPIK 350
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 410
Query: 226 NEQ 228
            E+
Sbjct: 411 PEE 413

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 121/238 (50%), Gaps = 30/238 (12%)
Query: 10  ERLILGEV-LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           + L++ ++ LG G FG V +G+           +  ++VA+K+LK   +    ++ ++E 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVY-------RMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYL---REE-------------- 111
            +M  +  + +IV  IG C  + L LV+E    G L  +L   REE              
Sbjct: 62  QIMHQLD-NPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 112 ----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               YL     VHRDLA RN+LL + H  KISDFGLS+ +   + +     + K P++W 
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           A E +    ++++SDVWS+GV +WE ++ G  PY  +    ++ ++  G RME P  C
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 79/234 (33%), Positives = 118/234 (50%), Gaps = 33/234 (14%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G GEFG V  G L         G+  + VA+K LKA    K    FL E ++M   G
Sbjct: 35  KVIGVGEFGEVCSGRLK------VPGKREICVAIKTLKAGYTDKQRRDFLSEASIM---G 85
Query: 76  KHDH--IVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------------E 111
           + DH  I+   G   K   + ++ EY   G L ++LR+                     +
Sbjct: 86  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           YLS+   VHRDLA RNIL++S  V K+SDFG+S  + +           K+PIRW A E+
Sbjct: 146 YLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +    +T+ SDVWS+G+V+WE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDC 259

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 125/250 (50%), Gaps = 31/250 (12%)
Query: 2   ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAK 59
           +L+C    + L L E LG G FGVV +G   D P    SG+  + VAVK LK +  +  +
Sbjct: 10  SLTCLIGEKDLRLLEKLGDGSFGVVRRGEW-DAP----SGKT-VSVAVKCLKPDVLSQPE 63
Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE-------- 111
             D F++E+N M  +  H +++   G      +++V E   LG L   LR+         
Sbjct: 64  AMDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 112 -------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     + 
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE 182
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GY 217
             K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G 
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
Query: 218 RMERPASCNE 227
           R+ RP  C +
Sbjct: 243 RLPRPEDCPQ 252

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  124 bits (310), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  124 bits (310), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 118/239 (49%), Gaps = 33/239 (13%)
Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           R+ + +++G G+ G V  G L         GQ  + VA+K LKA    +    FL E ++
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLR------VPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 71  MKDVGKHDH--IVSFIGCCYKDELRLVV-EYCALGDLQSYLRE----------------- 110
           M   G+ DH  I+   G   +  L ++V EY   G L ++LR                  
Sbjct: 104 M---GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YLS+   VHRDLA RN+L+ S  V K+SDFGLS  + +           K+PIRW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRW 220
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            A E++    +++ SDVWSFGVV+WE++  G  PY ++    ++  +  GYR+  P  C
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC 279

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  123 bits (309), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 20  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 71
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 72  -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 246

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 37  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 88
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 89  -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 125/250 (50%), Gaps = 31/250 (12%)
Query: 2   ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAK 59
           +L+C    + L L E LG G FGVV +G   D P    SG+  + VAVK LK +  +  +
Sbjct: 4   SLTCLIGEKDLRLLEKLGDGSFGVVRRGEW-DAP----SGKT-VSVAVKCLKPDVLSQPE 57
Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE-------- 111
             D F++E+N M  +  H +++   G      +++V E   LG L   LR+         
Sbjct: 58  AMDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 116
Query: 112 -------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     + 
Sbjct: 117 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GY 217
             K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G 
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 236
Query: 218 RMERPASCNE 227
           R+ RP  C +
Sbjct: 237 RLPRPEDCPQ 246

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 79/234 (33%), Positives = 118/234 (50%), Gaps = 33/234 (14%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G GEFG V  G L         G+  + VA+K LKA    K    FL E ++M   G
Sbjct: 20  KVIGVGEFGEVCSGRLK------VPGKREICVAIKTLKAGYTDKQRRDFLSEASIM---G 70
Query: 76  KHDH--IVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------------E 111
           + DH  I+   G   K   + ++ EY   G L ++LR+                     +
Sbjct: 71  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           YLS+   VHRDLA RNIL++S  V K+SDFG+S  + +           K+PIRW A E+
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +    +T+ SDVWS+G+V+WE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDC 244

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 125/250 (50%), Gaps = 31/250 (12%)
Query: 2   ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAK 59
           +L+C    + L L E LG G FGVV +G   D P    SG+  + VAVK LK +  +  +
Sbjct: 10  SLTCLIGEKDLRLLEKLGDGSFGVVRRGEW-DAP----SGKT-VSVAVKCLKPDVLSQPE 63
Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE-------- 111
             D F++E+N M  +  H +++   G      +++V E   LG L   LR+         
Sbjct: 64  AMDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 112 -------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     + 
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GY 217
             K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G 
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
Query: 218 RMERPASCNE 227
           R+ RP  C +
Sbjct: 243 RLPRPEDCPQ 252

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 79/234 (33%), Positives = 118/234 (50%), Gaps = 33/234 (14%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G GEFG V  G L         G+  + VA+K LKA    K    FL E ++M   G
Sbjct: 14  KVIGVGEFGEVCSGRLK------VPGKREICVAIKTLKAGYTDKQRRDFLSEASIM---G 64
Query: 76  KHDH--IVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------------E 111
           + DH  I+   G   K   + ++ EY   G L ++LR+                     +
Sbjct: 65  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           YLS+   VHRDLA RNIL++S  V K+SDFG+S  + +           K+PIRW A E+
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +    +T+ SDVWS+G+V+WE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDC 238

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 47  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 98
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 99  -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 273

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 125/250 (50%), Gaps = 31/250 (12%)
Query: 2   ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAK 59
           +L+C    + L L E LG G FGVV +G   D P    SG+  + VAVK LK +  +  +
Sbjct: 4   SLTCLIGEKDLRLLEKLGDGSFGVVRRGEW-DAP----SGKT-VSVAVKCLKPDVLSQPE 57
Query: 60  TYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE-------- 111
             D F++E+N M  +  H +++   G      +++V E   LG L   LR+         
Sbjct: 58  AMDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 116
Query: 112 -------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     + 
Sbjct: 117 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GY 217
             K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G 
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 236
Query: 218 RMERPASCNE 227
           R+ RP  C +
Sbjct: 237 RLPRPEDCPQ 246

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 124/249 (49%), Gaps = 31/249 (12%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKT 60
           L+C    + L L E LG G FGVV +G   D P    SG+  + VAVK LK +  +  + 
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEW-DAP----SGKT-VSVAVKCLKPDVLSQPEA 54
Query: 61  YDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE--------- 111
            D F++E+N M  +  H +++   G      +++V E   LG L   LR+          
Sbjct: 55  MDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 113
Query: 112 ------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
                       YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     +  
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 173
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYR 218
            K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G R
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233
Query: 219 MERPASCNE 227
           + RP  C +
Sbjct: 234 LPRPEDCPQ 242

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 121/238 (50%), Gaps = 30/238 (12%)
Query: 10  ERLILGEV-LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           + L++ ++ LG G FG V +G+           +  ++VA+K+LK   +    ++ ++E 
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVY-------RMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYL---REE-------------- 111
            +M  +  + +IV  IG C  + L LV+E    G L  +L   REE              
Sbjct: 388 QIMHQL-DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 112 ----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               YL     VHR+LA RN+LL + H  KISDFGLS+ +   + +     + K P++W 
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           A E +    ++++SDVWS+GV +WE ++ G  PY  +    ++ ++  G RME P  C
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 564

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  123 bits (308), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 121/241 (50%), Gaps = 30/241 (12%)
Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           G   E ++L  +LG+G FG V +G+  +   E       + VAVK  K +      +KF+
Sbjct: 8   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGE------KINVAVKTCKKDCTLDNKEKFM 61
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE-------------- 111
            E  +MK++  H HIV  IG   ++   +++E    G+L  YL                 
Sbjct: 62  SEAVIMKNLD-HPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL +   VHRD+A RNIL++SP  VK+ DFGLS  I +++ ++      +LPI
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPI 178
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W++ ES+    +T  SDVW F V +WEI++ G  P+  +    ++  L  G R+ +P  
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 238
Query: 225 C 225
           C
Sbjct: 239 C 239

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  123 bits (308), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 121/241 (50%), Gaps = 30/241 (12%)
Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           G   E ++L  +LG+G FG V +G+  +   E       + VAVK  K +      +KF+
Sbjct: 20  GIAREDVVLNRILGEGFFGEVYEGVYTNHKGE------KINVAVKTCKKDCTLDNKEKFM 73
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE-------------- 111
            E  +MK++  H HIV  IG   ++   +++E    G+L  YL                 
Sbjct: 74  SEAVIMKNLD-HPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 132
Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL +   VHRD+A RNIL++SP  VK+ DFGLS  I +++ ++      +LPI
Sbjct: 133 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPI 190
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W++ ES+    +T  SDVW F V +WEI++ G  P+  +    ++  L  G R+ +P  
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 250
Query: 225 C 225
           C
Sbjct: 251 C 251

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  123 bits (308), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 121/241 (50%), Gaps = 30/241 (12%)
Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           G   E ++L  +LG+G FG V +G+  +   E       + VAVK  K +      +KF+
Sbjct: 4   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGE------KINVAVKTCKKDCTLDNKEKFM 57
Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE-------------- 111
            E  +MK++  H HIV  IG   ++   +++E    G+L  YL                 
Sbjct: 58  SEAVIMKNLD-HPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 116
Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL +   VHRD+A RNIL++SP  VK+ DFGLS  I +++ ++      +LPI
Sbjct: 117 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPI 174
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W++ ES+    +T  SDVW F V +WEI++ G  P+  +    ++  L  G R+ +P  
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 234
Query: 225 C 225
           C
Sbjct: 235 C 235

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 118/239 (49%), Gaps = 33/239 (13%)
Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           R+ + +++G G+ G V  G L         GQ  + VA+K LKA    +    FL E ++
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLR------VPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 71  MKDVGKHDH--IVSFIGCCYKDELRLVV-EYCALGDLQSYLRE----------------- 110
           M   G+ DH  I+   G   +  L ++V EY   G L ++LR                  
Sbjct: 104 M---GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YLS+   VHRDLA RN+L+ S  V K+SDFGLS  + +           K+PIRW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            A E++    +++ SDVWSFGVV+WE++  G  PY ++    ++  +  GYR+  P  C
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC 279

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 124/249 (49%), Gaps = 31/249 (12%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKT 60
           L+C    + L L E LG G FGVV +G   D P    SG+  + VAVK LK +  +  + 
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEW-DAP----SGKT-VSVAVKCLKPDVLSQPEA 54
Query: 61  YDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE--------- 111
            D F++E+N M  +  H +++   G      +++V E   LG L   LR+          
Sbjct: 55  MDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 113
Query: 112 ------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
                       YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     +  
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYR 218
            K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G R
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233
Query: 219 MERPASCNE 227
           + RP  C +
Sbjct: 234 LPRPEDCPQ 242

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 124/249 (49%), Gaps = 31/249 (12%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKT 60
           L+C    + L L E LG G FGVV +G   D P    SG+  + VAVK LK +  +  + 
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEW-DAP----SGKT-VSVAVKCLKPDVLSQPEA 54
Query: 61  YDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE--------- 111
            D F++E+N M  +  H +++   G      +++V E   LG L   LR+          
Sbjct: 55  MDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 113
Query: 112 ------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
                       YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     +  
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYR 218
            K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G R
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233
Query: 219 MERPASCNE 227
           + RP  C +
Sbjct: 234 LPRPEDCPQ 242

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGL+  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 377 LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 428
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 429 NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 488
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 597

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 378 LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 429
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 430 NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 489
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 550 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 598

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V EY   G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGL   + +           K+PIRW + 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 25  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 76
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 77  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 245

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V E    G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 19  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 70
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 71  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 239

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 13  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 64
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 65  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 124
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 185 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 233

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 35  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD- 86
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 87  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 255

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 35  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD- 86
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 87  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 255

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 15  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 66
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 67  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 123/244 (50%), Gaps = 38/244 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E + L + LG G+FG V  G   +          + +VAVK LK      +   FL+E
Sbjct: 11  PRESIKLVKRLGAGQFGEVWMGYYNN----------STKVAVKTLKPGT--MSVQAFLEE 58
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE--------------- 111
            NLMK + +HD +V       ++E + ++ EY A G L  +L+ +               
Sbjct: 59  ANLMKTL-QHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  Y+     +HRDL   N+L+S   + KI+DFGL+  I E N +   E + K PI
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGA-KFPI 175
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A E++    +T KSDVWSFG++L+EIVT G  PYP      ++  LS GYRM R  +
Sbjct: 176 KWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVEN 235
Query: 225 CNEQ 228
           C ++
Sbjct: 236 CPDE 239

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 33  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 84
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 85  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 144
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++W A E +    
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 205 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 253

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 20  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 71
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V E    G L S+LR+                    
Sbjct: 72  -GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 246

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  120 bits (301), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 86/243 (35%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 6   PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 53
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 54  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 112
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I E N +   E + K PI+
Sbjct: 113 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGA-KFPIK 170
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 171 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 230
Query: 226 NEQ 228
            E+
Sbjct: 231 PEE 233

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  120 bits (301), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 86/243 (35%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 21  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 68
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 69  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 127
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I E N +   E   K PI+
Sbjct: 128 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTARE-GAKFPIK 185
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 245
Query: 226 NEQ 228
            E+
Sbjct: 246 PEE 248

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  120 bits (301), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 33/236 (13%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + +V+G GEFG V  G L          +  + VA+K LK     K    FL E ++M  
Sbjct: 49  IDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM-- 100
Query: 74  VGKHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------- 110
            G+ DH  I+   G   K + + +V E    G L S+LR+                    
Sbjct: 101 -GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YLS+   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIRW + 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  120 bits (301), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 86/243 (35%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 17  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 64
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 65  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I E N +   E + K PI+
Sbjct: 124 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGA-KFPIK 181
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 241
Query: 226 NEQ 228
            E+
Sbjct: 242 PEE 244

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  120 bits (301), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 86/243 (35%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 16  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 64  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 122
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I E N +   E + K PI+
Sbjct: 123 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGA-KFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 240
Query: 226 NEQ 228
            E+
Sbjct: 241 PEE 243

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 86/243 (35%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 58
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 59  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I E N +   E + K PI+
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGA-KFPIK 175
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 226 NEQ 228
            E+
Sbjct: 236 PEE 238

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 78/235 (33%), Positives = 116/235 (49%), Gaps = 33/235 (14%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           EV+G GEFG V +G L       A G+    VA+K LK     +   +FL E ++M    
Sbjct: 22  EVIGAGEFGEVCRGRLK------APGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF- 74
Query: 76  KHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLR---------------------EEYL 113
           +H +I+   G       + ++ E+   G L S+LR                       YL
Sbjct: 75  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 134
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE---KLPIRWLALE 170
           +    VHRDLA RNIL++S  V K+SDFGLS    E+N     E S    K+PIRW A E
Sbjct: 135 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           ++    +T+ SD WS+G+V+WE+++ G  PY  +    +++ +   YR+  P  C
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDC 248

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 123/244 (50%), Gaps = 38/244 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E + L + LG G+FG V  G   +          + +VAVK LK      +   FL+E
Sbjct: 10  PRESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGT--MSVQAFLEE 57
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE--------------- 111
            NLMK + +HD +V       K+E + ++ E+ A G L  +L+ +               
Sbjct: 58  ANLMKTL-QHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  Y+     +HRDL   N+L+S   + KI+DFGL+  I E N +   E + K PI
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGA-KFPI 174
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A E++    +T KS+VWSFG++L+EIVT G  PYP      ++  LS GYRM R  +
Sbjct: 175 KWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMEN 234
Query: 225 CNEQ 228
           C ++
Sbjct: 235 CPDE 238

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/243 (32%), Positives = 117/243 (48%), Gaps = 47/243 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V            A+     +VAVK +K  +   + + FL E
Sbjct: 180 PRESLKLEKKLGAGQFGEVWM----------ATYNKHTKVAVKTMKPGS--MSVEAFLAE 227
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
            N+MK + +HD +V       K+ + ++ E+ A G L  +L+ +                
Sbjct: 228 ANVMKTL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 286
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S+  V KI+DFGL+                K PI+
Sbjct: 287 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR------------VGAKFPIK 334
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 335 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 394
Query: 226 NEQ 228
            E+
Sbjct: 395 PEE 397

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 111/229 (48%), Gaps = 29/229 (12%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGK 76
           LG G FG V KG            +    VAVK+LK  A D    D+ L E N+M+ +  
Sbjct: 19  LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-D 70
Query: 77  HDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNN 116
           + +IV  IG C  +   LV+E   LG L  YL++                    +YL  +
Sbjct: 71  NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 117 KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI 176
             VHRDLA RN+LL + H  KISDFGLS+ +         +   K P++W A E +    
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 177 YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 239

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 19  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 66
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 67  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 125
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 126 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX--TAREGAKFPIK 183
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 184 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 243
Query: 226 NEQ 228
            E+
Sbjct: 244 PEE 246

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/233 (33%), Positives = 117/233 (50%), Gaps = 33/233 (14%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           V+G GEFG V  G L         G+  + VA+K LK     K    FL E ++M   G+
Sbjct: 50  VIGAGEFGEVCSGRLK------LPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM---GQ 100
Query: 77  HDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EY 112
            DH  +V   G   + + + +V+E+   G L ++LR+                      Y
Sbjct: 101 FDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRY 160
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L++   VHRDLA RNIL++S  V K+SDFGLS  I +           K+P+RW A E++
Sbjct: 161 LADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 173 VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
               +T+ SDVWS+G+V+WE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDC 273

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/243 (34%), Positives = 120/243 (49%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 7   PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 54
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 55  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 113
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HR+L   NIL+S     KI+DFGL+  I E N +   E + K PI+
Sbjct: 114 IAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGA-KFPIK 171
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 172 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 231
Query: 226 NEQ 228
            E+
Sbjct: 232 PEE 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 17  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 64
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 65  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 124 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX--TAREGAKFPIK 181
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 241
Query: 226 NEQ 228
            E+
Sbjct: 242 PEE 244

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 20  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 67
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 68  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 126
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 127 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX--TAREGAKFPIK 184
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 244
Query: 226 NEQ 228
            E+
Sbjct: 245 PEE 247

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 58
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 59  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX--TAREGAKFPIK 175
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 226 NEQ 228
            E+
Sbjct: 236 PEE 238

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 12  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 59
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 60  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 118
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 119 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX--TAREGAKFPIK 176
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 236
Query: 226 NEQ 228
            E+
Sbjct: 237 PEE 239

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 58
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 59  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX--TAREGAKFPIK 175
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 226 NEQ 228
            E+
Sbjct: 236 PEE 238

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 13  PRETLKLVERLGAGQFGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 60
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 61  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 119
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 120 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX--TAREGAKFPIK 177
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 237
Query: 226 NEQ 228
            E+
Sbjct: 238 PEE 240

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 120/237 (50%), Gaps = 37/237 (15%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G GEFG V  G L         G+  + VA+K LK+    K    FL E ++M   G
Sbjct: 39  QVIGAGEFGEVCSGHLK------LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM---G 89
Query: 76  KHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------E 111
           + DH  ++   G   K   + ++ E+   G L S+LR+                     +
Sbjct: 90  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPSEKLPIRWLA 168
           YL++   VHRDLA RNIL++S  V K+SDFGLS   ED      + +     K+PIRW A
Sbjct: 150 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL-GGKIPIRWTA 208
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            E++    +T+ SDVWS+G+V+WE+++ G  PY  +    +++ +   YR+  P  C
Sbjct: 209 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 265

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  117 bits (293), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 115/234 (49%), Gaps = 31/234 (13%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           EV+G GEFG V +G L       A G+    VA+K LK     +   +FL E ++M    
Sbjct: 20  EVIGAGEFGEVCRGRLK------APGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF- 72
Query: 76  KHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLR---------------------EEYL 113
           +H +I+   G       + ++ E+   G L S+LR                       YL
Sbjct: 73  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 132
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS--EKLPIRWLALES 171
           +    VHRDLA RNIL++S  V K+SDFGLS  + E +       S   K+PIRW A E+
Sbjct: 133 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +    +T+ SD WS+G+V+WE+++ G  PY  +    +++ +   YR+  P  C
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDC 246

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  117 bits (292), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 129/251 (51%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 70
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++  F+  EP E  PI W A ESL
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES-PIFWYAPESL 189
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 250 RLPRPDGCPDE 260

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score =  116 bits (291), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 65/140 (46%), Positives = 89/140 (63%), Gaps = 12/140 (8%)
Query: 88  YKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
           YKD L L  E+      Q     E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI
Sbjct: 184 YKDFLTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 241
Query: 148 YEQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           Y+  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +
Sbjct: 242 YKDPDYVRKGDA--RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 299
Query: 207 ----CRIVHYLSTGYRMERP 222
               CR    L  G RM  P
Sbjct: 300 DEEFCR---RLKEGTRMRAP 316

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score =  116 bits (291), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 65/140 (46%), Positives = 89/140 (63%), Gaps = 12/140 (8%)
Query: 88  YKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
           YKD L L  E+      Q     E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI
Sbjct: 193 YKDFLTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 250
Query: 148 YEQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           Y+  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +
Sbjct: 251 YKDPDYVRKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 308
Query: 207 ----CRIVHYLSTGYRMERP 222
               CR    L  G RM  P
Sbjct: 309 DEEFCR---RLKEGTRMRAP 325

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 65/140 (46%), Positives = 89/140 (63%), Gaps = 12/140 (8%)
Query: 88  YKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
           YKD L L  E+      Q     E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI
Sbjct: 186 YKDFLTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 148 YEQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           Y+  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +
Sbjct: 244 YKDPDYVRKGDA--RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301
Query: 207 ----CRIVHYLSTGYRMERP 222
               CR    L  G RM  P
Sbjct: 302 DEEFCR---RLKEGTRMRAP 318

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 65/140 (46%), Positives = 89/140 (63%), Gaps = 12/140 (8%)
Query: 88  YKDELRLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
           YKD L L  E+      Q     E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DI
Sbjct: 191 YKDFLTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 248
Query: 148 YEQ-NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
           Y+  +  + G+   +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +
Sbjct: 249 YKDPDYVRKGDA--RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 306
Query: 207 ----CRIVHYLSTGYRMERP 222
               CR    L  G RM  P
Sbjct: 307 DEEFCR---RLKEGTRMRAP 323

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 57/114 (50%), Positives = 78/114 (68%), Gaps = 4/114 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-NVFQNGEPSEKLPIRWLAL 169
           E+LS+ K +HRDLA RNILLS  +VVKI DFGL+ DIY+  +  + G+   +LP++W+A 
Sbjct: 213 EFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGD--TRLPLKWMAP 270
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR-IVHYLSTGYRMERP 222
           ES+   IY+ KSDVWS+GV+LWEI +LG +PYP + +       L  G RM  P
Sbjct: 271 ESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAP 324

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/243 (33%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+ G V  G   +G T+         VAVK LK  + +   D FL E
Sbjct: 11  PRETLKLVERLGAGQAGEVWMGYY-NGHTK---------VAVKSLKQGSMSP--DAFLAE 58
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 59  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I  ++         K PI+
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIK 175
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 226 NEQ 228
            E+
Sbjct: 236 PEE 238

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  115 bits (288), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 78/223 (34%), Positives = 113/223 (50%), Gaps = 43/223 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+  FG V KG L  GP  G   QA   VA+K LK  A+    ++F  E  L   + 
Sbjct: 15  EELGEDRFGKVYKGHLF-GPAPGEQTQA---VAIKTLKDKAEGPLREEFRHEAMLRARL- 69
Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYL-------------------------- 108
           +H ++V  +G   KD+ L ++  YC+ GDL  +L                          
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 109 ----------REEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                       EYLS++ VVH+DLATRN+L+     VKISD GL  ++Y  + ++    
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           S  LPIRW+A E+++   ++  SD+WS+GVVLWE+ + G  PY
Sbjct: 190 S-LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  115 bits (288), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 78/223 (34%), Positives = 113/223 (50%), Gaps = 43/223 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG+  FG V KG L  GP  G   QA   VA+K LK  A+    ++F  E  L   + 
Sbjct: 32  EELGEDRFGKVYKGHLF-GPAPGEQTQA---VAIKTLKDKAEGPLREEFRHEAMLRARL- 86
Query: 76  KHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYL-------------------------- 108
           +H ++V  +G   KD+ L ++  YC+ GDL  +L                          
Sbjct: 87  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 146
Query: 109 ----------REEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                       EYLS++ VVH+DLATRN+L+     VKISD GL  ++Y  + ++    
Sbjct: 147 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           S  LPIRW+A E+++   ++  SD+WS+GVVLWE+ + G  PY
Sbjct: 207 S-LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 119/237 (50%), Gaps = 37/237 (15%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G GEFG V  G L         G+  + VA+K LK+    K    FL E ++M   G
Sbjct: 13  QVIGAGEFGEVCSGHLK------LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM---G 63
Query: 76  KHDH--IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------E 111
           + DH  ++   G   K   + ++ E+   G L S+LR+                     +
Sbjct: 64  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPSEKLPIRWLA 168
           YL++   VHR LA RNIL++S  V K+SDFGLS   ED      + +     K+PIRW A
Sbjct: 124 YLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL-GGKIPIRWTA 182
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
            E++    +T+ SDVWS+G+V+WE+++ G  PY  +    +++ +   YR+  P  C
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 239

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 49  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 101
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 220
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 281 RLPRPDGCPDE 291

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 22  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 74
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 193
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 194 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 253
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 254 RLPRPDGCPDE 264

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 88
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 207
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 267
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 268 RLPRPDGCPDE 278

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 17  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 69
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 188
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 189 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 248
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 249 RLPRPDGCPDE 259

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 118/235 (50%), Gaps = 37/235 (15%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E + L + LG G+FGVV  G            +   +VAVKM+K  + ++  D+F +E  
Sbjct: 8   EEITLLKELGSGQFGVVKLG----------KWKGQYDVAVKMIKEGSMSE--DEFFQEAQ 55
Query: 70  LMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE----------------- 111
            M  +  H  +V F G C K+  + +V EY + G L +YLR                   
Sbjct: 56  TMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114
Query: 112 ----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               +L +++ +HRDLA RN L+     VK+SDFG++  + +     +     K P++W 
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWS 172
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           A E      Y++KSDVW+FG+++WE+ +LG  PY       +V  +S G+R+ RP
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP 227

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 16  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 68
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 187
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 188 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 247
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 248 RLPRPDGCPDE 258

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 88
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 207
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 267
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 268 RLPRPDGCPDE 278

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 70
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 189
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 250 RLPRPDGCPDE 260

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 70
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 189
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 250 RLPRPDGCPDE 260

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 24  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 76
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 195
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 196 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 255
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 256 RLPRPDGCPDE 266

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 25  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 77
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 196
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 197 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 256
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 257 RLPRPDGCPDE 267

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 73
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 192
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 252
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 253 RLPRPDGCPDE 263

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 23  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 75
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 194
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 195 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 254
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 255 RLPRPDGCPDE 265

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 129/251 (51%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 19  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 71
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL++                     EYL
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HR+LATRNIL+ + + VKI DFGL++ +  ++  ++  EP E  PI W A ESL
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES-PIFWYAPESL 190
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 191 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 250
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 251 RLPRPDGCPDE 261

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 127/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 73
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++EY   G L+ YL+                      EYL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 192
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 252
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 253 RLPRPDGCPDE 263

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 128/251 (50%), Gaps = 48/251 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   +    P +  +G+    VAVK L+ + +    D F +EI ++K + +H
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEV---VAVKKLQHSTEEHLRD-FEREIEILKSL-QH 73
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D+IV + G CY   +  L+L++E+   G L+ YL++                     EYL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
              + +HRDLATRNIL+ + + VKI DFGL++ +  ++   +  EP E  PI W A ESL
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-PIFWYAPESL 192
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCRIVHYLSTGY 217
             + ++  SDVWSFGVVL+E+ T               +G +    + +  ++  L    
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 252
Query: 218 RMERPASCNEQ 228
           R+ RP  C ++
Sbjct: 253 RLPRPDGCPDE 263

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 113/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 64  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDLA  NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  110 bits (274), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 113/240 (47%), Gaps = 37/240 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V  G          +     +VA+K LK    +   + FL+E
Sbjct: 7   PRESLQLIKRLGNGQFGEVWMG----------TWNGNTKVAIKTLKPGTMSP--ESFLEE 54
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
             +MK + KHD +V       ++ + +V EY   G L  +L++                 
Sbjct: 55  AQIMKKL-KHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQ 113
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     +HRDL + NIL+ +  + KI+DFGL+  I +           K PI+
Sbjct: 114 VAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEX--TARQGAKFPIK 171
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+VT G  PYP +    ++  +  GYRM  P  C
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC 231

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 116/244 (47%), Gaps = 42/244 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    PT   +G+    VAVK LKA+A  +    + +EI++++ +  H
Sbjct: 39  LGEGHFGKV--SLYCYDPTNDGTGEM---VAVKALKADAGPQHRSGWKQEIDILRTL-YH 92
Query: 78  DHIVSFIGCCYKD---ELRLVVEYCALGDLQSYLREE-------------------YLSN 115
           +HI+ + GCC       L+LV+EY  LG L+ YL                      YL  
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN 175
              +HRDLA RN+LL +  +VKI DFGL++ + E +           P+ W A E L   
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 176 IYTNKSDVWSFGVVLWEIVT-LGANPYP-------------HIPLCRIVHYLSTGYRMER 221
            +   SDVWSFGV L+E++T   ++  P              + + R+   L  G R+ R
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272
Query: 222 PASC 225
           P  C
Sbjct: 273 PDKC 276

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 118/244 (48%), Gaps = 42/244 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    PT   +G+    VAVK LKA+   +    + +EI++++ +  H
Sbjct: 22  LGEGHFGKV--SLYCYDPTNDGTGEM---VAVKALKADCGPQHRSGWKQEIDILRTL-YH 75
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLREE-------------------YLSN 115
           +HI+ + GCC    +  L+LV+EY  LG L+ YL                      YL +
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN 175
              +HR+LA RN+LL +  +VKI DFGL++ + E + +         P+ W A E L   
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 176 IYTNKSDVWSFGVVLWEIVT-LGANPYP-------------HIPLCRIVHYLSTGYRMER 221
            +   SDVWSFGV L+E++T   ++  P              + + R+   L  G R+ R
Sbjct: 196 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 255
Query: 222 PASC 225
           P  C
Sbjct: 256 PDKC 259

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 113/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V+EY + G L  +L+ E                
Sbjct: 64  AQVMKKL-RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 64  AQVMKKI-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 114/244 (46%), Gaps = 42/244 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    PT   +G+    VAVK LK     +    + +EI +++ +  H
Sbjct: 16  LGEGHFGKV--SLYCYDPTNDGTGEM---VAVKALKEGCGPQLRSGWQREIEILRTL-YH 69
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLREE-------------------YLSN 115
           +HIV + GCC    +  ++LV+EY  LG L+ YL                      YL  
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHA 129
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN 175
              +HR LA RN+LL +  +VKI DFGL++ + E + +         P+ W A E L   
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 176 IYTNKSDVWSFGVVLWEIVT-LGANPYPH-------------IPLCRIVHYLSTGYRMER 221
            +   SDVWSFGV L+E++T   +N  PH             + + R+   L  G R+ R
Sbjct: 190 KFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPR 249
Query: 222 PASC 225
           P  C
Sbjct: 250 PDRC 253

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 114/244 (46%), Gaps = 42/244 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    PT   +G+    VAVK LK     +    + +EI +++ +  H
Sbjct: 17  LGEGHFGKV--SLYCYDPTNDGTGEM---VAVKALKEGCGPQLRSGWQREIEILRTL-YH 70
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLREE-------------------YLSN 115
           +HIV + GCC    +  ++LV+EY  LG L+ YL                      YL  
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHA 130
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN 175
              +HR LA RN+LL +  +VKI DFGL++ + E + +         P+ W A E L   
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 176 IYTNKSDVWSFGVVLWEIVT-LGANPYPH-------------IPLCRIVHYLSTGYRMER 221
            +   SDVWSFGV L+E++T   +N  PH             + + R+   L  G R+ R
Sbjct: 191 KFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPR 250
Query: 222 PASC 225
           P  C
Sbjct: 251 PDRC 254

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 117/244 (47%), Gaps = 42/244 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    PT   +G+    VAVK LKA+   +    + +EI++++ +  H
Sbjct: 22  LGEGHFGKV--SLYCYDPTNDGTGEM---VAVKALKADCGPQHRSGWKQEIDILRTL-YH 75
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLREE-------------------YLSN 115
           +HI+ + GCC    +  L+LV+EY  LG L+ YL                      YL  
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN 175
              +HR+LA RN+LL +  +VKI DFGL++ + E + +         P+ W A E L   
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 176 IYTNKSDVWSFGVVLWEIVT-LGANPYP-------------HIPLCRIVHYLSTGYRMER 221
            +   SDVWSFGV L+E++T   ++  P              + + R+   L  G R+ R
Sbjct: 196 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 255
Query: 222 PASC 225
           P  C
Sbjct: 256 PDKC 259

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 37/236 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + +G G+FG+V  G   +            +VA+K ++  A ++  + F++E 
Sbjct: 6   PSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAMSE--EDFIEEA 53
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------- 111
            +M  +  H  +V   G C +   + LV E+   G L  YLR +                
Sbjct: 54  EVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 112
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL    V+HRDLA RN L+    V+K+SDFG++  + +           K P++W
Sbjct: 113 CEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 170
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P
Sbjct: 171 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 226

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 114/236 (48%), Gaps = 37/236 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + +G G+FG+V  G   +            +VA+K +K  + ++  D F++E 
Sbjct: 26  PSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIKEGSMSE--DDFIEEA 73
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------- 111
            +M  +  H  +V   G C +   + LV E+   G L  YLR +                
Sbjct: 74  EVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 132
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL    V+HRDLA RN L+    V+K+SDFG++  + +           K P++W
Sbjct: 133 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 190
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P
Sbjct: 191 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 246

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V+EY + G L  +L+ E                
Sbjct: 64  AQVMKKL-RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I +           K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX--TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 64  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 5   PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 52
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 53  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 111
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 112 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 169
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 170 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 229
Query: 226 NE 227
            E
Sbjct: 230 PE 231

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 229
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 230 AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 346
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406
Query: 226 NE 227
            E
Sbjct: 407 PE 408

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 312
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 313 AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 429
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489
Query: 226 NE 227
            E
Sbjct: 490 PE 491

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 229
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 230 AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 346
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406
Query: 226 NE 227
            E
Sbjct: 407 PE 408

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 9   PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 56
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 57  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 115
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 116 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 173
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 174 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 233
Query: 226 NE 227
            E
Sbjct: 234 PE 235

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 7   PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 54
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 55  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 113
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 114 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 171
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 231
Query: 226 NE 227
            E
Sbjct: 232 PE 233

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 64  AQVMKKL-RHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 110/242 (45%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 6   PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 53
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 54  AQVMKKL-RHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 112
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I +           K PI+
Sbjct: 113 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX--TARQGAKFPIK 170
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 171 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 230
Query: 226 NE 227
            E
Sbjct: 231 PE 232

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 37/236 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + +G G+FG+V  G   +            +VA+K ++  A ++  + F++E 
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAMSE--EDFIEEA 51
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------- 111
            +M  +  H  +V   G C +   + LV E+   G L  YLR +                
Sbjct: 52  EVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL    V+HRDLA RN L+    V+K+SDFG++  + +           K P++W
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 168
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 37/236 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + +G G+FG+V  G   +            +VA+K ++  A ++  + F++E 
Sbjct: 7   PSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAMSE--EDFIEEA 54
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------- 111
            +M  +  H  +V   G C +   + LV E+   G L  YLR +                
Sbjct: 55  EVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL    V+HRDLA RN L+    V+K+SDFG++  + +           K P++W
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 171
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 227

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 37/236 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + +G G+FG+V  G   +            +VA+K ++  A ++  + F++E 
Sbjct: 6   PSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAMSE--EDFIEEA 53
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------- 111
            +M  +  H  +V   G C +   + LV E+   G L  YLR +                
Sbjct: 54  EVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 112
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL    V+HRDLA RN L+    V+K+SDFG++  + +           K P++W
Sbjct: 113 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 170
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P
Sbjct: 171 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 226

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 37/236 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + +G G+FG+V  G   +            +VA+K ++  A ++  + F++E 
Sbjct: 9   PSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAMSE--EDFIEEA 56
Query: 69  NLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------- 111
            +M  +  H  +V   G C +   + LV E+   G L  YLR +                
Sbjct: 57  EVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 115
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL    V+HRDLA RN L+    V+K+SDFG++  + +           K P++W
Sbjct: 116 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 173
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P
Sbjct: 174 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  107 bits (266), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 13  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 60
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY   G L  +L+ E                
Sbjct: 61  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ 119
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 120 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 177
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 237
Query: 226 NE 227
            E
Sbjct: 238 PE 239

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 113/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V+EY + G L  +L+ E                
Sbjct: 64  AQVMKKL-RHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 16  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 63
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 64  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQ 122
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 123 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 180
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 240
Query: 226 NE 227
            E
Sbjct: 241 PE 242

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  107 bits (266), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 183 PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGNMSP--EAFLQE 230
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 231 AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 289
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL   I E N +       K PI+
Sbjct: 290 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLI-EDNEY-TARQGAKFPIK 347
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 348 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 407
Query: 226 NE 227
            E
Sbjct: 408 PE 409

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  106 bits (265), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 229
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 230 AQVMKKL-RHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIK 346
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406
Query: 226 NE 227
            E
Sbjct: 407 PE 408

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G          +      VA+K LK    +   + FL+E
Sbjct: 13  PRESLRLEVKLGQGCFGEVWMG----------TWNGTTRVAIKTLKPGTMSP--EAFLQE 60
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY   G L  +L+ E                
Sbjct: 61  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ 119
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I E N +       K PI+
Sbjct: 120 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEW-TARQGAKFPIK 177
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 237
Query: 226 NE 227
            E
Sbjct: 238 PE 239

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/247 (35%), Positives = 125/247 (50%), Gaps = 47/247 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    P    +G     VAVK L+ +   +  D F +EI ++K +   
Sbjct: 15  LGKGNFGSV--ELCRYDPLGDNTGAL---VAVKQLQHSGPDQQRD-FQREIQILKAL-HS 67
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D IV + G  Y   + ELRLV+EY   G L+ +L+                      EYL
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 127
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
            + + VHRDLA RNIL+ S   VKI+DFGL++ +  +++     EP +  PI W A ESL
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS-PIFWYAPESL 186
Query: 173 VSNIYTNKSDVWSFGVVLWEIVTL---GANPYPH----------IP-LCRIVHYLSTGYR 218
             NI++ +SDVWSFGVVL+E+ T      +P             +P LCR++  L  G R
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 246
Query: 219 MERPASC 225
           +  P +C
Sbjct: 247 LPAPPAC 253

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/247 (35%), Positives = 125/247 (50%), Gaps = 47/247 (19%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    P    +G     VAVK L+ +   +  D F +EI ++K +   
Sbjct: 19  LGKGNFGSVE--LCRYDPLGDNTGAL---VAVKQLQHSGPDQQRD-FQREIQILKAL-HS 71
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D IV + G  Y   +  LRLV+EY   G L+ +L+                      EYL
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 131
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
            + + VHRDLA RNIL+ S   VKI+DFGL++ +  +++ +   EP +  PI W A ESL
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-PIFWYAPESL 190
Query: 173 VSNIYTNKSDVWSFGVVLWEIVTL---GANPYPH----------IP-LCRIVHYLSTGYR 218
             NI++ +SDVWSFGVVL+E+ T      +P             +P LCR++  L  G R
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 250
Query: 219 MERPASC 225
           +  P +C
Sbjct: 251 LPAPPAC 257

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 109/203 (53%), Gaps = 33/203 (16%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    P    +G     VAVK L+ +   +  D F +EI ++K +   
Sbjct: 31  LGKGNFGSVE--LCRYDPLGDNTGAL---VAVKQLQHSGPDQQRD-FQREIQILKAL-HS 83
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D IV + G  Y   +  LRLV+EY   G L+ +L+                      EYL
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
            + + VHRDLA RNIL+ S   VKI+DFGL++ +  +++ +   EP +  PI W A ESL
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-PIFWYAPESL 202
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT 195
             NI++ +SDVWSFGVVL+E+ T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 109/203 (53%), Gaps = 33/203 (16%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    P    +G     VAVK L+ +   +  D F +EI ++K +   
Sbjct: 18  LGKGNFGSVE--LCRYDPLGDNTGAL---VAVKQLQHSGPDQQRD-FQREIQILKAL-HS 70
Query: 78  DHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE---------------------EYL 113
           D IV + G  Y   +  LRLV+EY   G L+ +L+                      EYL
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 130
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEKLPIRWLALESL 172
            + + VHRDLA RNIL+ S   VKI+DFGL++ +  +++ +   EP +  PI W A ESL
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-PIFWYAPESL 189
Query: 173 VSNIYTNKSDVWSFGVVLWEIVT 195
             NI++ +SDVWSFGVVL+E+ T
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 44/249 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    P    +G+   +VAVK LK  +         KEI +++++  H
Sbjct: 29  LGEGHFGKV--ELCRYDPEGDNTGE---QVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82
Query: 78  DHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE---------------------EYL 113
           ++IV + G C +D    ++L++E+   G L+ YL +                     +YL
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            + + VHRDLA RN+L+ S H VKI DFGL++ I         +     P+ W A E L+
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 174 SNIYTNKSDVWSFGVVLWEIVTL---GANP-----------YPHIPLCRIVHYLSTGYRM 219
            + +   SDVWSFGV L E++T     ++P           +  + + R+V+ L  G R+
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262
Query: 220 ERPASCNEQ 228
             P +C ++
Sbjct: 263 PCPPNCPDE 271

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 44/249 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G FG V   L    P    +G+   +VAVK LK  +         KEI +++++  H
Sbjct: 17  LGEGHFGKV--ELCRYDPEGDNTGE---QVAVKSLKPESGGNHIADLKKEIEILRNL-YH 70
Query: 78  DHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE---------------------EYL 113
           ++IV + G C +D    ++L++E+   G L+ YL +                     +YL
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 130
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            + + VHRDLA RN+L+ S H VKI DFGL++ I         +     P+ W A E L+
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 174 SNIYTNKSDVWSFGVVLWEIVTL---GANP-----------YPHIPLCRIVHYLSTGYRM 219
            + +   SDVWSFGV L E++T     ++P           +  + + R+V+ L  G R+
Sbjct: 191 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 250
Query: 220 ERPASCNEQ 228
             P +C ++
Sbjct: 251 PCPPNCPDE 259

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 69
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 70  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L   + VKI DFGL+    E++ +      E+L   
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSHQFEQLSGS 185
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +    SN Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 228

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 45/228 (19%)
Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           + P  LI GEVLG+G FG  +K           + +   EV V       D +T   FLK
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIK----------VTHRETGEVMVMKELIRFDEETQRTFLK 56
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+ +M+ + +H +++ FIG  YKD+ L  + EY   G L+  ++                
Sbjct: 57  EVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL +  ++HRDL + N L+     V ++DFGL+  + ++     G  S K P 
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 165 R-----------WLALESLVSNIYTNKSDVWSFGVVLWEIV-TLGANP 200
           R           W+A E +    Y  K DV+SFG+VL EI+  + A+P
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 122/247 (49%), Gaps = 48/247 (19%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINL 70
           L + E +G G FG V +           +     +VAVK+L + +  A+  ++FL+E+ +
Sbjct: 39  LNIKEKIGAGSFGTVHR-----------AEWHGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 71  MKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDL-----QSYLREE------------- 111
           MK + +H +IV F+G   +   L +V EY + G L     +S  RE+             
Sbjct: 88  MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 112 -----YLSNNK--VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                YL N    +VHRDL + N+L+   + VK+ DFGLS    + + F   + +   P 
Sbjct: 147 AKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTP- 203
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY---RMER 221
            W+A E L       KSDV+SFGV+LWE+ TL   P+ ++   ++V   + G+   R+E 
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATL-QQPWGNLNPAQVV--AAVGFKCKRLEI 260
Query: 222 PASCNEQ 228
           P + N Q
Sbjct: 261 PRNLNPQ 267

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 69
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E+ +++   +H +I+ F+G     +L +V ++C    L  +L                  
Sbjct: 70  EVGVLRKT-RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L   + VKI DFGL+    E++ +      E+L   
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSHQFEQLSGS 185
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +    SN Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 228

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 123/247 (49%), Gaps = 48/247 (19%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINL 70
           L + E +G G FG V +           +     +VAVK+L + +  A+  ++FL+E+ +
Sbjct: 39  LNIKEKIGAGSFGTVHR-----------AEWHGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 71  MKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDL-----QSYLREE------------- 111
           MK + +H +IV F+G   +   L +V EY + G L     +S  RE+             
Sbjct: 88  MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 112 -----YLSNNK--VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                YL N    +VHR+L + N+L+   + VK+ DFGLS    + + F + + +   P 
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTP- 203
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY---RMER 221
            W+A E L       KSDV+SFGV+LWE+ TL   P+ ++   ++V   + G+   R+E 
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATL-QQPWGNLNPAQVV--AAVGFKCKRLEI 260
Query: 222 PASCNEQ 228
           P + N Q
Sbjct: 261 PRNLNPQ 267

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 10  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 57
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 58  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 116
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L   + VKI DFGL+     ++ +      E+L   
Sbjct: 117 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 173
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +    SN Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 216

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 34  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 81
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 82  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+    E++ +      E+L   
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---EKSRWSGSHQFEQLSGS 197
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 240

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 53
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 54  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+    E++ +      E+L   
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---EKSRWSGSHQFEQLSGS 169
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 26  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 73
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 74  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+    E++ +      E+L   
Sbjct: 133 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---EKSRWSGSHQFEQLSGS 189
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 58
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 59  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+     ++ +      E+L   
Sbjct: 118 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 174
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 217

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 58
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 59  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+     ++ +      E+L   
Sbjct: 118 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 174
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 8   PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 55
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 56  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 114
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+     ++ +      E+L   
Sbjct: 115 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 171
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 214

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 34  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 81
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 82  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+     ++ +      E+L   
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 197
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 240

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 53
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 54  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+     ++ +      E+L   
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 169
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 212

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 33  PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 80
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G   K +L +V ++C    L  +L                  
Sbjct: 81  EVGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+     ++ +      E+L   
Sbjct: 140 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 196
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 239

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLK 66
           P  ++ +G+ +G G FG V KG            +   +VAVKML   A   +    F  
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKG------------KWHGDVAVKMLNVTAPTPQQLQAFKN 53
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR----------------- 109
           E+ +++   +H +I+ F+G     +L +V ++C    L  +L                  
Sbjct: 54  EVGVLRKT-RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 110 ----EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                +YL    ++HRDL + NI L     VKI DFGL+     ++ +      E+L   
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---VKSRWSGSHQFEQLSGS 169
Query: 164 IRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           I W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNI 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 40/218 (18%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLKEINL 70
           ++L   +G G FG V KG            +   +VAVK+LK  +   + +  F  E+ +
Sbjct: 38  VMLSTRIGSGSFGTVYKG------------KWHGDVAVKILKVVDPTPEQFQAFRNEVAV 85
Query: 71  MKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR--------------------- 109
           ++   +H +I+ F+G   KD L +V ++C    L  +L                      
Sbjct: 86  LRKT-RHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQG 144
Query: 110 EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
            +YL    ++HRD+ + NI L     VKI DFGL+      +  Q  E      + W+A 
Sbjct: 145 MDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTG-SVLWMAP 203
Query: 170 ESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           E +    +N ++ +SDV+S+G+VL+E++T G  PY HI
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSHI 240

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 44/247 (17%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQ-AAMEVAVKMLKANADAKTYDKFLKEI 68
           E LI  E LGQG F  + KG+  +    G  GQ    EV +K+L   A     + F +  
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREV---GDYGQLHETEVLLKVLDK-AHRNYSESFFEAA 63
Query: 69  NLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----------------- 110
           ++M  +  H H+V   G C+  DE  LV E+   G L +YL++                 
Sbjct: 64  SMMSKLS-HKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 111 ----EYLSNNKVVHRDLATRNILL--------SSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                +L  N ++H ++  +NILL         +P  +K+SD G+S  +  +++ Q    
Sbjct: 123 AWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---- 178
Query: 159 SEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY 217
            E++P  W+  E + +    N  +D WSFG  LWEI + G  P   +   R + +    +
Sbjct: 179 -ERIP--WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
Query: 218 RMERPAS 224
           ++  P +
Sbjct: 236 QLPAPKA 242

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 41/236 (17%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V   +      + A+GQ   EVA++ +      K  +
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAM------DVATGQ---EVAIRQMNLQQQPKK-E 62
Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E           
Sbjct: 63  LIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   E+L +N+V+HRD+ + NILL     VK++DFG    I  +   ++   G P 
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTP- 180
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E++  G  PY +    R ++ ++T
Sbjct: 181 -----YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIAT 230

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 41/236 (17%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V   +      + A+GQ   EVA++ +      K  +
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAM------DVATGQ---EVAIRQMNLQQQPKK-E 63
Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E           
Sbjct: 64  LIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 122
Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   E+L +N+V+HRD+ + NILL     VK++DFG    I  +   ++   G P 
Sbjct: 123 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTP- 181
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E++  G  PY +    R ++ ++T
Sbjct: 182 -----YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIAT 231

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 41/236 (17%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V   +      + A+GQ   EVA++ +      K  +
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAM------DVATGQ---EVAIRQMNLQQQPKK-E 62
Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E           
Sbjct: 63  LIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   E+L +N+V+HRD+ + NILL     VK++DFG    I  +   ++   G P 
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP- 180
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E++  G  PY +    R ++ ++T
Sbjct: 181 -----YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIAT 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 41/236 (17%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V   +      + A+GQ   EVA++ +      K  +
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAM------DVATGQ---EVAIRQMNLQQQPKK-E 62
Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E           
Sbjct: 63  LIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   E+L +N+V+HRD+ + NILL     VK++DFG    I  +   ++   G P 
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTP- 180
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E++  G  PY +    R ++ ++T
Sbjct: 181 -----YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIAT 230

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 110/247 (44%), Gaps = 44/247 (17%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQ-AAMEVAVKMLKANADAKTYDKFLKEI 68
           E LI  E LGQG F  + KG+  +    G  GQ    EV +K+L   A     + F +  
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREV---GDYGQLHETEVLLKVLDK-AHRNYSESFFEAA 63
Query: 69  NLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----------------- 110
           ++M  +  H H+V   G C   DE  LV E+   G L +YL++                 
Sbjct: 64  SMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 111 ----EYLSNNKVVHRDLATRNILL--------SSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                +L  N ++H ++  +NILL         +P  +K+SD G+S  +  +++ Q    
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---- 178
Query: 159 SEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY 217
            E++P  W+  E + +    N  +D WSFG  LWEI + G  P   +   R + +    +
Sbjct: 179 -ERIP--WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
Query: 218 RMERPAS 224
           ++  P +
Sbjct: 236 QLPAPKA 242

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 41/236 (17%)
Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD 62
           +S G P ++    E +GQG  G V   +      + A+GQ   EVA++ +      K  +
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAM------DVATGQ---EVAIRQMNLQQQPKK-E 63
Query: 63  KFLKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------- 110
             + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E           
Sbjct: 64  LIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 122
Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPS 159
                   E+L +N+V+HR++ + NILL     VK++DFG    I  +   ++   G P 
Sbjct: 123 CRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP- 181
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
                 W+A E +    Y  K D+WS G++  E++  G  PY +    R ++ ++T
Sbjct: 182 -----YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIAT 231

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 55/252 (21%)
Query: 12  LILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLKANAD---AKTYDKFLKE 67
           L L E++G G FG V +   +GD            EVAVK  + + D   ++T +   +E
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWIGD------------EVAVKAARHDPDEDISQTIENVRQE 56
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE--------------- 111
             L   + KH +I++  G C K+  L LV+E+   G L   L  +               
Sbjct: 57  AKLFAML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIA 115
Query: 112 ----YLSNNKVV---HRDLATRNILLS--------SPHVVKISDFGLSEDIYEQNVFQNG 156
               YL +  +V   HRDL + NIL+         S  ++KI+DFGL+ + +     +  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-----RTT 170
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
           + S      W+A E + +++++  SDVWS+GV+LWE++T G  P+  I    + + ++  
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAVAYGVAMN 229
Query: 217 -YRMERPASCNE 227
              +  P++C E
Sbjct: 230 KLALPIPSTCPE 241

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 52/232 (22%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           EV+G+G FGVV K           +   A +VA+K +++ ++ K +   L++++ +    
Sbjct: 15  EVVGRGAFGVVCK-----------AKWRAKDVAIKQIESESERKAFIVELRQLSRVN--- 60
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE------------------------- 110
            H +IV   G C  + + LV+EY   G L + L                           
Sbjct: 61  -HPNIVKLYGACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 111 -EYLSNNKVVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              +    ++HRDL   N+LL +   V+KI DFG + DI        G  +      W+A
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA------WMA 172
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI--PLCRIVHYLSTGYR 218
            E    + Y+ K DV+S+G++LWE++T    P+  I  P  RI+  +  G R
Sbjct: 173 PEVFEGSNYSEKCDVFSWGIILWEVITR-RKPFDEIGGPAFRIMWAVHNGTR 223

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 52/232 (22%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           EV+G+G FGVV K           +   A +VA+K +++ ++ K +   L++++ +    
Sbjct: 14  EVVGRGAFGVVCK-----------AKWRAKDVAIKQIESESERKAFIVELRQLSRVN--- 59
Query: 76  KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE------------------------- 110
            H +IV   G C  + + LV+EY   G L + L                           
Sbjct: 60  -HPNIVKLYGACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 111 -EYLSNNKVVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              +    ++HRDL   N+LL +   V+KI DFG + DI        G  +      W+A
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA------WMA 171
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI--PLCRIVHYLSTGYR 218
            E    + Y+ K DV+S+G++LWE++T    P+  I  P  RI+  +  G R
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITR-RKPFDEIGGPAFRIMWAVHNGTR 222

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 45/233 (19%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E   + E LG+G +G V K +  +      +GQ    VA+K +   +D +   + +KE
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKAIHKE------TGQI---VAIKQVPVESDLQ---EIIKE 74
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGD--------------------LQS 106
           I++M+      H+V + G  +K+ +L +V+EYC  G                     LQS
Sbjct: 75  ISIMQQCDS-PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 107 YLRE-EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKL 162
            L+  EYL   + +HRD+   NILL++    K++DFG++  + +    +N   G P    
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF--- 190
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
              W+A E +    Y   +D+WS G+   E+   G  PY  I   R +  + T
Sbjct: 191 ---WMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIHPMRAIFMIPT 239

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 57/225 (25%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L E++G G +G V KG          +GQ A   A+K++    D +  ++  +EIN++K 
Sbjct: 28  LVELVGNGTYGQVYKG------RHVKTGQLA---AIKVMDVTGDEE--EEIKQEINMLKK 76
Query: 74  VGKHDHIVSFIGCCYK-------DELRLVVEYCALGDLQ--------SYLREEY------ 112
              H +I ++ G   K       D+L LV+E+C  G +         + L+EE+      
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 113 --------LSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
                   L  +KV+HRD+  +N+LL+    VK+ DFG+S      +  +N F  G P  
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY- 194
Query: 161 KLPIRWLALESLVSN-----IYTNKSDVWSFGVVLWEIVTLGANP 200
                W+A E +  +      Y  KSD+WS G+   E+   GA P
Sbjct: 195 -----WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPP 233

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 45/210 (21%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD---KFLKEINLM 71
           G  +G+G FGVV KG + +             VAVK L A  D  T +   +F +EI +M
Sbjct: 36  GNKMGEGGFGVVYKGYVNN-----------TTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 72  KDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLR--------------------- 109
               +H+++V  +G     D+L LV  Y   G L   L                      
Sbjct: 85  AKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 110 --EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPIR 165
               +L  N  +HRD+ + NILL      KISDFGL+   + + Q V  +          
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVG---TTA 200
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           ++A E+L   I T KSD++SFGVVL EI+T
Sbjct: 201 YMAPEALRGEI-TPKSDIYSFGVVLLEIIT 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 94/210 (44%), Gaps = 45/210 (21%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD---KFLKEINLM 71
           G  +G+G FGVV KG + +             VAVK L A  D  T +   +F +EI +M
Sbjct: 36  GNKMGEGGFGVVYKGYVNN-----------TTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 72  KDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLR--------------------- 109
               +H+++V  +G     D+L LV  Y   G L   L                      
Sbjct: 85  AKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 110 --EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPIR 165
               +L  N  +HRD+ + NILL      KISDFGL+   + + Q V             
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVG---TTA 200
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           ++A E+L   I T KSD++SFGVVL EI+T
Sbjct: 201 YMAPEALRGEI-TPKSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 94/210 (44%), Gaps = 45/210 (21%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD---KFLKEINLM 71
           G  +G+G FGVV KG + +             VAVK L A  D  T +   +F +EI +M
Sbjct: 30  GNKMGEGGFGVVYKGYVNN-----------TTVAVKKLAAMVDITTEELKQQFDQEIKVM 78
Query: 72  KDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLR--------------------- 109
               +H+++V  +G     D+L LV  Y   G L   L                      
Sbjct: 79  AKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 137
Query: 110 --EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPIR 165
               +L  N  +HRD+ + NILL      KISDFGL+   + + Q V             
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVG---TTA 194
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           ++A E+L   I T KSD++SFGVVL EI+T
Sbjct: 195 YMAPEALRGEI-TPKSDIYSFGVVLLEIIT 223

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 42/208 (20%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           E LG G +  V KGL         +    + VA+K +K +++  T    ++EI+LMK++ 
Sbjct: 11  EKLGNGTYATVYKGL---------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL- 60
Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREEYLSN------------------- 115
           KH++IV      + +++L LV E+    DL+ Y+    + N                   
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 116 -------NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
                  NK++HRDL  +N+L++    +K+ DFGL+       +  N   SE + + + A
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF---GIPVNTFSSEVVTLWYRA 176
Query: 169 LESLV-SNIYTNKSDVWSFGVVLWEIVT 195
            + L+ S  Y+   D+WS G +L E++T
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 38/203 (18%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           ++G G FG V KG+L DG           +VA+K     +     +   +   L     +
Sbjct: 46  LIGHGVFGKVYKGVLRDGA----------KVALKRRTPESSQGIEEFETEIETL--SFCR 93
Query: 77  HDHIVSFIGCC-YKDELRLVVEYCALGDLQSYL--------------REE---------- 111
           H H+VS IG C  ++E+ L+ +Y   G+L+ +L              R E          
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           YL    ++HRD+ + NILL    V KI+DFG+S+   E +   +     K  + ++  E 
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ-THLXXVVKGTLGYIDPEY 212
Query: 172 LVSNIYTNKSDVWSFGVVLWEIV 194
            +    T KSDV+SFGVVL+E++
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 40/210 (19%)
Query: 9   PERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           PE L    E +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 20  PEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQE 70
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALG--------------DLQSYLRE-- 110
           I ++       ++  + G   KD +L +++EY   G               + + LRE  
Sbjct: 71  ITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 129
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF----- 184
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
            W+A E +  + Y +K+D+WS G+   E+ 
Sbjct: 185 -WMAPEVIKQSAYDSKADIWSLGITAIELA 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     E +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 5   PEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQE 55
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALG--------------DLQSYLRE-- 110
           I ++       ++  + G   KD +L +++EY   G               + + LRE  
Sbjct: 56  ITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 114
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 115 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF----- 169
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
            W+A E +  + Y +K+D+WS G+   E+ 
Sbjct: 170 -WMAPEVIKQSAYDSKADIWSLGITAIELA 198

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 97/235 (41%), Gaps = 55/235 (23%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L EV+G G   VV                   +VA+K +       + D+ LKEI  M  
Sbjct: 14  LQEVIGSGATAVV---------QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 64
Query: 74  VGKHDHIVSF-IGCCYKDELRLVVEYCALGD-----------------------LQSYLR 109
              H +IVS+      KDEL LV++  + G                        + + LR
Sbjct: 65  C-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 123
Query: 110 E-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE------DIYEQNVFQN--G 156
           E     EYL  N  +HRD+   NILL     V+I+DFG+S       DI    V +   G
Sbjct: 124 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 157 EPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
            P       W+A E +     Y  K+D+WSFG+   E+ T GA PY   P  +++
Sbjct: 184 TPC------WMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYPPMKVL 231

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     E +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 25  PEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQE 75
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALG--------------DLQSYLRE-- 110
           I ++       ++  + G   KD +L +++EY   G               + + LRE  
Sbjct: 76  ITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 134
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 135 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF----- 189
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
            W+A E +  + Y +K+D+WS G+   E+ 
Sbjct: 190 -WMAPEVIKQSAYDSKADIWSLGITAIELA 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     E +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 5   PEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQE 55
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALG--------------DLQSYLRE-- 110
           I ++       ++  + G   KD +L +++EY   G               + + LRE  
Sbjct: 56  ITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 114
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 115 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF----- 169
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
            W+A E +  + Y +K+D+WS G+   E+ 
Sbjct: 170 -WMAPEVIKQSAYDSKADIWSLGITAIELA 198

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 38/203 (18%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           ++G G FG V KG+L DG           +VA+K     +     +   +   L     +
Sbjct: 46  LIGHGVFGKVYKGVLRDGA----------KVALKRRTPESSQGIEEFETEIETL--SFCR 93
Query: 77  HDHIVSFIGCC-YKDELRLVVEYCALGDLQSYL--------------REE---------- 111
           H H+VS IG C  ++E+ L+ +Y   G+L+ +L              R E          
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           YL    ++HRD+ + NILL    V KI+DFG+S+   E     +     K  + ++  E 
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQ-THLXXVVKGTLGYIDPEY 212
Query: 172 LVSNIYTNKSDVWSFGVVLWEIV 194
            +    T KSDV+SFGVVL+E++
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 97/235 (41%), Gaps = 55/235 (23%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L EV+G G   VV                   +VA+K +       + D+ LKEI  M  
Sbjct: 19  LQEVIGSGATAVV---------QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 74  VGKHDHIVSF-IGCCYKDELRLVVEYCALGD-----------------------LQSYLR 109
              H +IVS+      KDEL LV++  + G                        + + LR
Sbjct: 70  C-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 110 E-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE------DIYEQNVFQN--G 156
           E     EYL  N  +HRD+   NILL     V+I+DFG+S       DI    V +   G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 157 EPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
            P       W+A E +     Y  K+D+WSFG+   E+ T GA PY   P  +++
Sbjct: 189 TPC------WMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYPPMKVL 236

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 51/229 (22%)
Query: 1   MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT 60
           + +S G P E L     +G+G  G+V         TE  +G+   +VAVK +      + 
Sbjct: 36  LVVSPGDPREYLANFIKIGEGSTGIVCIA------TEKHTGK---QVAVKKMDLRKQQRR 86
Query: 61  YDKFLKEINLMKDVGKHDHIVS-FIGCCYKDELRLVVEYC---ALGDLQSYLR--EE--- 111
            +    E+ +M+D   HD++V  +      DEL +V+E+    AL D+ ++ R  EE   
Sbjct: 87  -ELLFNEVVIMRDY-HHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA 144
Query: 112 -----------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                      YL N  V+HRD+ + +ILL+S   +K+SDFG    +           S+
Sbjct: 145 TVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-----------SK 193
Query: 161 KLPIR--------WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++P R        W+A E +    Y  + D+WS G+++ E++  G  PY
Sbjct: 194 EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPY 241

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E LG G FG V++ +  D            +VA+K  +     K  +++  EI +MK 
Sbjct: 18  MKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68
Query: 74  VGKHDHIVS-------FIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           +  H ++VS              D   L +EYC  GDL+ YL +                
Sbjct: 69  LN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 111 -------EYLSNNKVVHRDLATRNILLS-SPH--VVKISDFGLSEDIYEQNVFQNGEPSE 160
                   YL  N+++HRDL   NI+L   P   + KI D G ++++        GE   
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL------DQGELCT 181
Query: 161 KL--PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +    +++LA E L    YT   D WSFG + +E +T G  P+
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E LG G FG V++ +  D            +VA+K  +     K  +++  EI +MK 
Sbjct: 19  MKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKK 69
Query: 74  VGKHDHIVS-------FIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           +  H ++VS              D   L +EYC  GDL+ YL +                
Sbjct: 70  LN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 128
Query: 111 -------EYLSNNKVVHRDLATRNILLS-SPH--VVKISDFGLSEDIYEQNVFQNGEPSE 160
                   YL  N+++HRDL   NI+L   P   + KI D G ++++        GE   
Sbjct: 129 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL------DQGELCT 182
Query: 161 KL--PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +    +++LA E L    YT   D WSFG + +E +T G  P+
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPF 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 39/210 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     E +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 21  PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 71
Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------- 110
           I ++       ++  + G   K  +L +++EY   G     LR                 
Sbjct: 72  ITVLSQC-DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL 130
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 131 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF----- 185
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
            W+A E +  + Y +K+D+WS G+   E+ 
Sbjct: 186 -WMAPEVIQQSAYDSKADIWSLGITAIELA 214

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 91/209 (43%), Gaps = 43/209 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD---KFLKEINLM 71
           G   G+G FGVV KG + +             VAVK L A  D  T +   +F +EI + 
Sbjct: 27  GNKXGEGGFGVVYKGYVNN-----------TTVAVKKLAAMVDITTEELKQQFDQEIKVX 75
Query: 72  KDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLR--------------------- 109
               +H+++V  +G     D+L LV  Y   G L   L                      
Sbjct: 76  AKC-QHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAA 134
Query: 110 --EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-PIRW 166
               +L  N  +HRD+ + NILL      KISDFGL+     +   Q    S  +    +
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQXVXXSRIVGTTAY 192
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVT 195
            A E+L   I T KSD++SFGVVL EI+T
Sbjct: 193 XAPEALRGEI-TPKSDIYSFGVVLLEIIT 220

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 50/215 (23%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K           + + ++  A K++   ++ +  D ++ EI+++ 
Sbjct: 41  IIGE-LGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED-YMVEIDILA 89
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------- 110
               H +IV  +   Y ++ L +++E+CA G + + + E                     
Sbjct: 90  SCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
            YL +NK++HRDL   NIL +    +K++DFG+S      I  ++ F  G P       W
Sbjct: 149 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTP------YW 201
Query: 167 LALESLVSNI-----YTNKSDVWSFGVVLWEIVTL 196
           +A E ++        Y  K+DVWS G+ L E+  +
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 50/215 (23%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K           + + ++  A K++   ++ +  D ++ EI+++ 
Sbjct: 41  IIGE-LGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED-YMVEIDILA 89
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------- 110
               H +IV  +   Y ++ L +++E+CA G + + + E                     
Sbjct: 90  SCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
            YL +NK++HRDL   NIL +    +K++DFG+S      I  ++ F  G P       W
Sbjct: 149 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTP------YW 201
Query: 167 LALESLVSNI-----YTNKSDVWSFGVVLWEIVTL 196
           +A E ++        Y  K+DVWS G+ L E+  +
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 50/215 (23%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K           + + ++  A K++   ++ +  D ++ EI+++ 
Sbjct: 41  IIGE-LGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED-YMVEIDILA 89
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------- 110
               H +IV  +   Y ++ L +++E+CA G + + + E                     
Sbjct: 90  SCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
            YL +NK++HRDL   NIL +    +K++DFG+S      I  ++ F  G P       W
Sbjct: 149 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTP------YW 201
Query: 167 LALESLVSNI-----YTNKSDVWSFGVVLWEIVTL 196
           +A E ++        Y  K+DVWS G+ L E+  +
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 54/220 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKT-----YDKFLKEINLM 71
           +G+G FG+V KG L    +          VA+K ++  +++ +T     + +F +E+ +M
Sbjct: 27  IGKGGFGLVHKGRLVKDKSV---------VAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 72  KDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------- 110
            ++  H +IV   G  + +  R+V+E+   GDL   L +                     
Sbjct: 78  SNLN-HPNIVKLYGLMH-NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 111 EYLSNNK--VVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
           EY+ N    +VHRDL + NI L S     P   K++DFGLS+          G       
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGN------ 189
Query: 164 IRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPY 201
            +W+A E++ +    YT K+D +SF ++L+ I+T G  P+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPF 228

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 48/215 (22%)
Query: 18  LGQGEFGVVVKG-LLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDV 74
           +G+G+F  V +   L DG          + VA+K ++     DAK     +KEI+L+K +
Sbjct: 40  IGRGQFSEVYRAACLLDG----------VPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 75  GKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------- 110
             H +++ +     +D EL +V+E    GDL   ++                        
Sbjct: 90  N-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRW 166
            E++ + +V+HRD+   N+ +++  VVK+ D GL      +    +   G P       +
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY------Y 202
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E +  N Y  KSD+WS G +L+E+  L +  Y
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 1   MALSCGYPPERLILGEV--LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA 58
           M +  G P  RL+L     +G+G  G+V          E  SG+   +VAVKM+      
Sbjct: 36  MVVDQGDP--RLLLDSYVKIGEGSTGIVCLA------REKHSGR---QVAVKMMDLRKQQ 84
Query: 59  KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYC---ALGDLQSYLR--EE-- 111
           +  +    E+ +M+D    + +  +      +EL +++E+    AL D+ S +R  EE  
Sbjct: 85  RR-ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI 143
Query: 112 ------------YLSNNKVVHRDLATRNILLSSPHVVKISDFG----LSEDIYEQNVFQN 155
                       YL    V+HRD+ + +ILL+    VK+SDFG    +S+D+ ++     
Sbjct: 144 ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXL-V 202
Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           G P       W+A E +  ++Y  + D+WS G+++ E+V  G  PY
Sbjct: 203 GTPY------WMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPY 241

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 45/209 (21%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           +LG+G FG V KG L DG            VAVK LK         +F  E+ ++  +  
Sbjct: 45  ILGRGGFGKVYKGRLADGTL----------VAVKRLKEERXQGGELQFQTEVEMIS-MAV 93
Query: 77  HDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE------------------------ 111
           H +++   G C     RL+V  Y A G + S LRE                         
Sbjct: 94  HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 153
Query: 112 YLSNN---KVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPIRW 166
           YL ++   K++HRD+   NILL       + DFGL++  D  + +V      + +  I  
Sbjct: 154 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX----AVRGTIGH 209
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           +A E L +   + K+DV+ +GV+L E++T
Sbjct: 210 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 238

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 39/200 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG+G FG   K  L    T G   + A+++  K + A +D +   +  +EI+ ++ + 
Sbjct: 14  KTLGEGSFG---KVKLAYHTTTGQ--KVALKIINKKVLAKSDMQG--RIEREISYLR-LL 65
Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------EYLS 114
           +H HI+        KDE+ +V+EY    +L  Y+ +                    EY  
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLALESL 172
            +K+VHRDL   N+LL     VKI+DFGLS  + + N  +   G P+   P      E +
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP------EVI 178
Query: 173 VSNIYTN-KSDVWSFGVVLW 191
              +Y   + DVWS GV+L+
Sbjct: 179 SGKLYAGPEVDVWSCGVILY 198

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     + +G+G FG V KG+  D  T+         VA+K++         +   +E
Sbjct: 17  PEELFTKLDRIGKGSFGEVYKGI--DNHTKEV-------VAIKIIDLEEAEDEIEDIQQE 67
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGD--------------LQSYLRE-- 110
           I ++       +I  + G   K  +L +++EY   G               + + LRE  
Sbjct: 68  ITVLSQCDS-PYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL 126
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + + +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 127 KGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF----- 181
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
            W+A E +  + Y  K+D+WS G+   E+ 
Sbjct: 182 -WMAPEVIKQSAYDFKADIWSLGITAIELA 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 39/200 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG+G FG   K  L    T G   + A+++  K + A +D +   +  +EI+ ++ + 
Sbjct: 10  KTLGEGSFG---KVKLAYHTTTGQ--KVALKIINKKVLAKSDMQG--RIEREISYLR-LL 61
Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------EYLS 114
           +H HI+        KDE+ +V+EY    +L  Y+ +                    EY  
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLALESL 172
            +K+VHRDL   N+LL     VKI+DFGLS  + + N  +   G P+   P      E +
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP------EVI 174
Query: 173 VSNIYTN-KSDVWSFGVVLW 191
              +Y   + DVWS GV+L+
Sbjct: 175 SGKLYAGPEVDVWSCGVILY 194

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 39/200 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG+G FG   K  L    T G   + A+++  K + A +D +   +  +EI+ ++ + 
Sbjct: 19  KTLGEGSFG---KVKLAYHTTTGQ--KVALKIINKKVLAKSDMQG--RIEREISYLR-LL 70
Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------EYLS 114
           +H HI+        KDE+ +V+EY    +L  Y+ +                    EY  
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLALESL 172
            +K+VHRDL   N+LL     VKI+DFGLS  + + N  +   G P+   P      E +
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP------EVI 183
Query: 173 VSNIYTN-KSDVWSFGVVLW 191
              +Y   + DVWS GV+L+
Sbjct: 184 SGKLYAGPEVDVWSCGVILY 203

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 45/209 (21%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           +LG+G FG V KG L DG            VAVK LK         +F  E+ ++  +  
Sbjct: 37  ILGRGGFGKVYKGRLADGXL----------VAVKRLKEERTQGGELQFQTEVEMIS-MAV 85
Query: 77  HDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLREE------------------------ 111
           H +++   G C     RL+V  Y A G + S LRE                         
Sbjct: 86  HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 112 YLSNN---KVVHRDLATRNILLSSPHVVKISDFGLSE--DIYEQNVFQNGEPSEKLPIRW 166
           YL ++   K++HRD+   NILL       + DFGL++  D  + +V      + +  I  
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX----AVRGXIGH 201
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           +A E L +   + K+DV+ +GV+L E++T
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 230

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 39/200 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG+G FG   K  L    T G   + A+++  K + A +D +   +  +EI+ ++ + 
Sbjct: 20  KTLGEGSFG---KVKLAYHTTTGQ--KVALKIINKKVLAKSDMQG--RIEREISYLR-LL 71
Query: 76  KHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------EYLS 114
           +H HI+        KDE+ +V+EY    +L  Y+ +                    EY  
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLALESL 172
            +K+VHRDL   N+LL     VKI+DFGLS  + + N  +   G P+   P      E +
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP------EVI 184
Query: 173 VSNIYTN-KSDVWSFGVVLW 191
              +Y   + DVWS GV+L+
Sbjct: 185 SGKLYAGPEVDVWSCGVILY 204

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 54/220 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKT-----YDKFLKEINLM 71
           +G+G FG+V KG L    +          VA+K ++  +++ +T     + +F +E+ +M
Sbjct: 27  IGKGGFGLVHKGRLVKDKSV---------VAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 72  KDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------- 110
            ++  H +IV   G  + +  R+V+E+   GDL   L +                     
Sbjct: 78  SNLN-HPNIVKLYGLMH-NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 111 EYLSNNK--VVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
           EY+ N    +VHRDL + NI L S     P   K++DFG S+          G       
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGN------ 189
Query: 164 IRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPY 201
            +W+A E++ +    YT K+D +SF ++L+ I+T G  P+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPF 228

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 46/229 (20%)
Query: 1   MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADA 58
           +A   G   E   +G +LG+G F  V +           S    +EVA+KM+  KA   A
Sbjct: 2   LATCIGEKIEDFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKA 52
Query: 59  KTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLREE----- 111
               +   E+ +   + KH  I+      ++D   + LV+E C  G++  YL+       
Sbjct: 53  GMVQRVQNEVKIHCQL-KHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS 110
Query: 112 ----------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI---YEQNV 152
                           YL ++ ++HRDL   N+LL+    +KI+DFGL+  +   +E++ 
Sbjct: 111 ENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170
Query: 153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              G P+      +++ E    + +  +SDVWS G + + ++ +G  P+
Sbjct: 171 TLCGTPN------YISPEIATRSAHGLESDVWSLGCMFYTLL-IGRPPF 212

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAVK++ K   ++ +  K  +E+ +MK V  H +IV        ++ L LV+EY + G+
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL +   +KI+DFG 
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P       + A E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 160 SNEFTFGNKLDTFCGSPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 212
Query: 201 Y 201
           +
Sbjct: 213 F 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAVK++ K   ++ +  K  +E+ +MK V  H +IV        ++ L LV+EY + G+
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL +   +KI+DFG 
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P       + A E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 160 SNEFTFGNKLDTFCGSPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 212
Query: 201 Y 201
           +
Sbjct: 213 F 213

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 54/220 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKT-----YDKFLKEINLM 71
           +G+G FG+V KG L    +          VA+K ++  +++ +T     + +F +E+ +M
Sbjct: 27  IGKGGFGLVHKGRLVKDKSV---------VAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 72  KDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------- 110
            ++  H +IV   G  + +  R+V+E+   GDL   L +                     
Sbjct: 78  SNLN-HPNIVKLYGLMH-NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 111 EYLSNNK--VVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
           EY+ N    +VHRDL + NI L S     P   K++DF LS+          G       
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGN------ 189
Query: 164 IRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPY 201
            +W+A E++ +    YT K+D +SF ++L+ I+T G  P+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPF 228

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAVK++ K   ++ +  K  +E+ +MK V  H +IV        ++ L LV+EY + G+
Sbjct: 34  EVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKLFEVIETEKTLYLVMEYASGGE 92
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL +   +KI+DFG 
Sbjct: 93  VFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 152
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P    P      E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 153 SNEFTFGNKLDTFCGSPPYAAP------ELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 205
Query: 201 Y 201
           +
Sbjct: 206 F 206

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 44/215 (20%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT--YDKFLKEINL 70
           I+ E LG+G FG V               +   +VA+K +      K+  + +  +EI+ 
Sbjct: 12  IIRETLGEGSFGKV---------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 71  MKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE------------------- 110
           +K + +H HI+          ++ +V+EY   G+L  Y+ E                   
Sbjct: 63  LK-LLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
            EY   +K+VHRDL   N+LL     VKI+DFGLS  + + N  +   G P+      + 
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------YA 174
Query: 168 ALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANPY 201
           A E +   +Y   + DVWS G+VL+ ++ +G  P+
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLY-VMLVGRLPF 208

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKE 67
           PE   L  VLG+G +G V +     G   G     AM+V  K M+  NA    + K   E
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKI--FAMKVLKKAMIVRNAKDTAHTK--AE 71
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE--------------- 111
            N++++V KH  IV  I       +L L++EY + G+L   L  E               
Sbjct: 72  RNILEEV-KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQNGEPSEKLPIR 165
                +L    +++RDL   NI+L+    VK++DFGL  E I++  V      +    I 
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGT----IE 186
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L+ + +    D WS G ++++++T GA P+
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPF 221

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 44/213 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L  +LG+G +GVV         T   +G+    VA+K ++         + L+EI ++K 
Sbjct: 15  LKSLLGEGAYGVVCSA------THKPTGEI---VAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 74  VGKHDHIVSFIGCCYKDELR-----LVVEYCALGDLQSYLREEYLSNN------------ 116
             KH++I++       D         +++     DL   +  + LS++            
Sbjct: 66  F-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 117 -------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP-------SEKL 162
                   V+HRDL   N+L++S   +K+ DFGL+  I +++   N EP       +E +
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTGQQSGMTEXV 183
Query: 163 PIRWLALES--LVSNIYTNKSDVWSFGVVLWEI 193
             RW       L S  Y+   DVWS G +L E+
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAVK++ K   ++ +  K  +E+ +MK V  H +IV        ++ L LV+EY + G+
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL +   +KI+DFG 
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P       + A E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 160 SNEFTFGNKLDAFCGAPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 212
Query: 201 Y 201
           +
Sbjct: 213 F 213

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAV+++ K   ++ +  K  +E+ +MK V  H +IV        ++ L LV+EY + G+
Sbjct: 41  EVAVRIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL +   +KI+DFG 
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P       + A E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 160 SNEFTFGNKLDTFCGSPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 212
Query: 201 Y 201
           +
Sbjct: 213 F 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAV+++ K   ++ +  K  +E+ +MK V  H +IV        ++ L LV+EY + G+
Sbjct: 41  EVAVRIIDKTQLNSSSLQKLFREVRIMK-VLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL +   +KI+DFG 
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P       + A E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 160 SNEFTFGNKLDEFCGSPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 212
Query: 201 Y 201
           +
Sbjct: 213 F 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 99/210 (47%), Gaps = 40/210 (19%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K           + +     A K+++  ++ +  D ++ EI ++ 
Sbjct: 23  IVGE-LGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELED-YIVEIEILA 71
Query: 73  DVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------- 110
               H +IV  +G  Y D +L +++E+C  G + + + E                     
Sbjct: 72  TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
            +L + +++HRDL   N+L++    ++++DFG+S    + + +++ F  G P    P   
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAP-EV 188
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           +  E++    Y  K+D+WS G+ L E+  +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKE 67
           PE   L  VLG+G +G V +     G   G     AM+V  K M+  NA    + K   E
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKI--FAMKVLKKAMIVRNAKDTAHTK--AE 71
Query: 68  INLMKDVGKHDHIVSFI-GCCYKDELRLVVEYCALGDLQSYLREE--------------- 111
            N++++V KH  IV  I       +L L++EY + G+L   L  E               
Sbjct: 72  RNILEEV-KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQNGEPSEKLPIR 165
                +L    +++RDL   NI+L+    VK++DFGL  E I++  V      +    I 
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGT----IE 186
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L+ + +    D WS G ++++++T GA P+
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPF 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 99/210 (47%), Gaps = 40/210 (19%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I+GE LG G FG V K           + +     A K+++  ++ +  D ++ EI ++ 
Sbjct: 15  IVGE-LGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELED-YIVEIEILA 63
Query: 73  DVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------- 110
               H +IV  +G  Y D +L +++E+C  G + + + E                     
Sbjct: 64  TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 122
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSEKLPIRW 166
            +L + +++HRDL   N+L++    ++++DFG+S    + + +++ F  G P    P   
Sbjct: 123 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAP-EV 180
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           +  E++    Y  K+D+WS G+ L E+  +
Sbjct: 181 VMCETMKDTPYDYKADIWSLGITLIEMAQI 210

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 35/182 (19%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVA+K++ K   +  +  K  +E+ +MK +  H +IV        ++ L L++EY + G+
Sbjct: 42  EVAIKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y    ++VHRDL   N+LL +   +KI+DFG 
Sbjct: 101 VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 160
Query: 144 SEDIY---EQNVFQNGEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGAN 199
           S +     + + F    P       + A E      Y   + DVWS GV+L+ +V+ G+ 
Sbjct: 161 SNEFTVGGKLDAFCGAPP-------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSL 212
Query: 200 PY 201
           P+
Sbjct: 213 PF 214

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 44/213 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L  +LG+G +GVV         T   +G+    VA+K ++         + L+EI ++K 
Sbjct: 15  LKSLLGEGAYGVVCSA------THKPTGEI---VAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 74  VGKHDHIVSFIGCCYKDELR-----LVVEYCALGDLQSYLREEYLSNN------------ 116
             KH++I++       D         +++     DL   +  + LS++            
Sbjct: 66  F-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 117 -------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP-------SEKL 162
                   V+HRDL   N+L++S   +K+ DFGL+  I +++   N EP       +E +
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTGQQSGMTEYV 183
Query: 163 PIRWLALES--LVSNIYTNKSDVWSFGVVLWEI 193
             RW       L S  Y+   DVWS G +L E+
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 101/212 (47%), Gaps = 39/212 (18%)
Query: 10  ERLILGEVLGQGEFG--VVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           E+ +  + +G+G FG  ++VK       TE        E+ +  +     +K  ++  +E
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKS------TEDGRQYVIKEINISRM----SSKEREESRRE 73
Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDL---------------------- 104
           + ++ ++ KH +IV +     ++  L +V++YC  GDL                      
Sbjct: 74  VAVLANM-KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 105 QSYLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
           Q  L  +++ + K++HRD+ ++NI L+    V++ DFG++  +   +  +        P 
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPY 190
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
            +L+ E   +  Y NKSD+W+ G VL+E+ TL
Sbjct: 191 -YLSPEICENKPYNNKSDIWALGCVLYELCTL 221

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 35/182 (19%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVA+K++ K   +  +  K  +E+ +MK +  H +IV        ++ L L++EY + G+
Sbjct: 39  EVAIKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKLFEVIETEKTLYLIMEYASGGE 97
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y    ++VHRDL   N+LL +   +KI+DFG 
Sbjct: 98  VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 157
Query: 144 SEDIY---EQNVFQNGEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGAN 199
           S +     + + F    P       + A E      Y   + DVWS GV+L+ +V+ G+ 
Sbjct: 158 SNEFTVGGKLDTFCGSPP-------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSL 209
Query: 200 PY 201
           P+
Sbjct: 210 PF 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 42/168 (25%)
Query: 64  FLKEINLMKDVGKHDHIVSF---IGCCYKDELRLVVEYCALGDLQS----------YLRE 110
            + E+NL++++ KH +IV +   I       L +V+EYC  GDL S          YL E
Sbjct: 52  LVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 111 EYL-------------------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
           E++                     + V+HRDL   N+ L     VK+ DFGL+  +    
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 152 VFQN---GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
            F     G P       +++ E +    Y  KSD+WS G +L+E+  L
Sbjct: 171 SFAKAFVGTPY------YMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAVK++ K   +  +  K  +E+ +MK +  H +IV        ++ L LV+EY + G+
Sbjct: 42  EVAVKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKLFEVIETEKTLYLVMEYASGGE 100
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL     +KI+DFG 
Sbjct: 101 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGF 160
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P       + A E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 161 SNEFTVGNKLDTFCGSPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 213
Query: 201 Y 201
           +
Sbjct: 214 F 214

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 42/168 (25%)
Query: 64  FLKEINLMKDVGKHDHIVSF---IGCCYKDELRLVVEYCALGDLQS----------YLRE 110
            + E+NL++++ KH +IV +   I       L +V+EYC  GDL S          YL E
Sbjct: 52  LVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 111 EYL-------------------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
           E++                     + V+HRDL   N+ L     VK+ DFGL+  +    
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 152 VFQN---GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
            F     G P       +++ E +    Y  KSD+WS G +L+E+  L
Sbjct: 171 SFAKTFVGTPY------YMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 104/240 (43%), Gaps = 62/240 (25%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEI 68
           + L L E++G+G +G V KG L + P           VAVK+   AN      +K +  +
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDERP-----------VAVKVFSFANRQNFINEKNIYRV 61
Query: 69  NLMKDVGKHDHIVSFI------GCCYKDELRLVVEYCALGDLQSYLR---EEYLSNNK-- 117
            LM+    HD+I  FI          + E  LV+EY   G L  YL     +++S+ +  
Sbjct: 62  PLME----HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLA 117
Query: 118 -----------------------VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                                  + HRDL +RN+L+ +     ISDFGLS  +    + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 155 NGEP-----SEKLPIRWLALESL--VSNIYTNKS-----DVWSFGVVLWEIVTLGANPYP 202
            GE      SE   IR++A E L    N+   +S     D+++ G++ WEI     + +P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 44/213 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L  +LG+G +GVV         T   +G+    VA+K ++         + L+EI ++K 
Sbjct: 15  LKSLLGEGAYGVVCSA------THKPTGEI---VAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 74  VGKHDHIVSFIGCCYKDELR-----LVVEYCALGDLQSYLREEYLSNN------------ 116
             KH++I++       D         +++     DL   +  + LS++            
Sbjct: 66  F-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 117 -------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS-------EKL 162
                   V+HRDL   N+L++S   +K+ DFGL+  I +++   N EP+       E +
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTGQQSGMVEFV 183
Query: 163 PIRWLALES--LVSNIYTNKSDVWSFGVVLWEI 193
             RW       L S  Y+   DVWS G +L E+
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 34/174 (19%)
Query: 47  VAVKMLK--ANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYC--AL 101
           VA+K +        + +   +KE+  ++ + +H + + + GC  ++    LV+EYC  + 
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSA 140
Query: 102 GDL----QSYLRE--------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
            DL    +  L+E               YL ++ ++HRD+   NILLS P +VK+ DFG 
Sbjct: 141 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 200
Query: 144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIV 194
           +  +   N F  G P       W+A E +++     Y  K DVWS G+   E+ 
Sbjct: 201 ASIMAPANXFV-GTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 47/222 (21%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD---KFLKEIN 69
           ILG+ LG G FG V           G       +VAVK+L      ++ D   K  +EI 
Sbjct: 19  ILGDTLGVGTFGKV---------KVGKHELTGHKVAVKILNRQK-IRSLDVVGKIRREIQ 68
Query: 70  LMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE------------------ 110
            +K + +H HI+          ++ +V+EY + G+L  Y+ +                  
Sbjct: 69  NLK-LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRW 166
             +Y   + VVHRDL   N+LL +    KI+DFGLS  + +    +   G P+      +
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPN------Y 181
Query: 167 LALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANPY--PHIP 205
            A E +   +Y   + D+WS GV+L+ ++  G  P+   H+P
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVP 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E+L +GE++G+G FG V              G+   EVA++++    D +   K  K 
Sbjct: 31  PFEQLEIGELIGKGRFGQVY------------HGRWHGEVAIRLIDIERDNEDQLKAFKR 78
Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE--------------- 111
             +     +H+++V F+G C     L ++   C    L S +R+                
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 YL    ++H+DL ++N+   +  VV I+DFGL        V Q G   +KL I+
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNGKVV-ITDFGL---FSISGVLQAGRREDKLRIQ 194
Query: 166 --WLA------LESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH 211
             WL       +  L  +       ++  SDV++ G + +E+      P+   P   I+ 
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR-EWPFKTQPAEAIIW 253
Query: 212 YLSTGYR 218
            + TG +
Sbjct: 254 QMGTGMK 260

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 42/168 (25%)
Query: 64  FLKEINLMKDVGKHDHIVSF---IGCCYKDELRLVVEYCALGDLQS----------YLRE 110
            + E+NL++++ KH +IV +   I       L +V+EYC  GDL S          YL E
Sbjct: 52  LVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 111 EYL-------------------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
           E++                     + V+HRDL   N+ L     VK+ DFGL+  +    
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE 170
Query: 152 VFQN---GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
            F     G P       +++ E +    Y  KSD+WS G +L+E+  L
Sbjct: 171 DFAKEFVGTPY------YMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 45/221 (20%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINL 70
           +LG+ LG G FG V           G       +VAVK+L            K  +EI  
Sbjct: 14  VLGDTLGVGTFGKV---------KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN 64
Query: 71  MKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE------------------- 110
           +K + +H HI+          +  +V+EY + G+L  Y+ +                   
Sbjct: 65  LK-LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
            +Y   + VVHRDL   N+LL +    KI+DFGLS  + +    ++  G P+   P    
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAP---- 179
Query: 168 ALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANPY--PHIP 205
             E +   +Y   + D+WS GV+L+ ++  G  P+   H+P
Sbjct: 180 --EVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDEHVP 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 106/217 (48%), Gaps = 43/217 (19%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQ--AAMEVAVKMLKANADAKTYDKFLKEINLM 71
           +GE LG G+F +V K        +  +G+  AA  +  + L ++    + ++  +E+N++
Sbjct: 9   MGEELGSGQFAIVRKC------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE------------------- 111
           +++ +H +I++       K ++ L++E  + G+L  +L E+                   
Sbjct: 63  REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +K+ DFG++  I   N F+N  G P      
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE----- 176
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 177 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 211

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 46/214 (21%)
Query: 9   PERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK--ANADAKTYDKF 64
           PE+L   L E+ G G FG V               + +  VA+K +        + +   
Sbjct: 13  PEKLFSDLREI-GHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDI 62
Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYC--ALGDL----QSYLRE------- 110
           +KE+  ++ + +H + + + GC  ++    LV+EYC  +  DL    +  L+E       
Sbjct: 63  IKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                   YL ++ ++HRD+   NILLS P +VK+ DFG +  +   N F  G P     
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-GTPY---- 176
Query: 164 IRWLALESLVS---NIYTNKSDVWSFGVVLWEIV 194
             W+A E +++     Y  K DVWS G+   E+ 
Sbjct: 177 --WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 42/191 (21%)
Query: 45  MEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           MEV  + L      +  +   +E ++++ V  H HI++ I        + LV +    G+
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 104 LQSYLREE--------------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           L  YL E+                    +L  N +VHRDL   NILL     +++SDFG 
Sbjct: 187 LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246
Query: 144 SEDIYEQNVFQNGEPSEKL-----PIRWLALESLVSNI------YTNKSDVWSFGVVLWE 192
           S  +         EP EKL        +LA E L  ++      Y  + D+W+ GV+L+ 
Sbjct: 247 SCHL---------EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297
Query: 193 IVTLGANPYPH 203
           ++  G+ P+ H
Sbjct: 298 LLA-GSPPFWH 307

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 45/221 (20%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINL 70
           +LG+ LG G FG V           G       +VAVK+L            K  +EI  
Sbjct: 14  VLGDTLGVGTFGKV---------KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN 64
Query: 71  MKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE------------------- 110
           +K + +H HI+          +  +V+EY + G+L  Y+ +                   
Sbjct: 65  LK-LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
            +Y   + VVHRDL   N+LL +    KI+DFGLS  + +    +   G P+   P    
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP---- 179
Query: 168 ALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANPY--PHIP 205
             E +   +Y   + D+WS GV+L+ ++  G  P+   H+P
Sbjct: 180 --EVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDEHVP 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 40/217 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E  IL ++LG+G FG V   L     T       A++  V ++  + +    +K      
Sbjct: 17  EDFILHKMLGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK-----R 69
Query: 70  LMKDVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLRE----------------- 110
           ++    +H   ++ + C +  K+ L  V+EY   GDL  +++                  
Sbjct: 70  VLSLAWEHP-FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              ++L +  +V+RDL   NILL     +KI+DFG+ ++    +   N   G P      
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD----- 183
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E L+   Y +  D WSFGV+L+E++ +G +P+
Sbjct: 184 -YIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPF 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 106/217 (48%), Gaps = 43/217 (19%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQ--AAMEVAVKMLKANADAKTYDKFLKEINLM 71
           +GE LG G+F +V K        +  +G+  AA  +  + L ++    + ++  +E+N++
Sbjct: 16  MGEELGSGQFAIVRKC------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE------------------- 111
           +++ +H +I++       K ++ L++E  + G+L  +L E+                   
Sbjct: 70  REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +K+ DFG++  I   N F+N  G P      
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE----- 183
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 184 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 218

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 52/219 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEINLMKDVGK 76
           LG+G +G+V K +      +  +G+    VAVK +  A  ++    +  +EI ++ ++  
Sbjct: 17  LGKGAYGIVWKSI------DRRTGEV---VAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 77  HDHIVSFIGCCYKDELR---LVVEYCALGDLQSYLRE-------------------EYLS 114
           H++IV+ +     D  R   LV +Y    DL + +R                    +YL 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE-----QNV----------FQNGEP- 158
           +  ++HRD+   NILL++   VK++DFGLS           N+          F + +P 
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 159 -SEKLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIV 194
            ++ +  RW     ++  S  YT   D+WS G +L EI+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 103/223 (46%), Gaps = 48/223 (21%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 17  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 66
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-WLALE 170
           +    K++HRD+   NIL++S   +K+ DFG+S  + ++        +E +  R +++ E
Sbjct: 127 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA------NEFVGTRSYMSPE 176
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL 213
            L    Y+ +SD+WS G+ L E+  +G  P P + +  ++ Y+
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEM-AVGRYPRPPMAIFELLDYI 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 106/217 (48%), Gaps = 43/217 (19%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQ--AAMEVAVKMLKANADAKTYDKFLKEINLM 71
           +GE LG G+F +V K        +  +G+  AA  +  + L ++    + ++  +E+N++
Sbjct: 30  MGEELGSGQFAIVRKC------RQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE------------------- 111
           +++ +H +I++       K ++ L++E  + G+L  +L E+                   
Sbjct: 84  REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +K+ DFG++  I   N F+N  G P      
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE----- 197
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 198 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 232

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           + ++G++LG+G +G V + L  +     A      +   ++    A+ K      KEI L
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK------KEIQL 59
Query: 71  MKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE----------------- 110
           ++ + +H +++  +   Y +E   + +V+EYC  G +Q  L                   
Sbjct: 60  LRRL-RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP-I 164
                EYL +  +VH+D+   N+LL++   +KIS  G++E ++          S+  P  
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +   + + +      K D+WS GV L+ I T G  P+
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITT-GLYPF 213

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 39/218 (17%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANADAKTYDKFLKE 67
           P +  L +VLGQG FG V          +  SG  A ++ A+K+LK  A  K  D+   +
Sbjct: 23  PSQFELLKVLGQGSFGKVF-------LVKKISGSDARQLYAMKVLK-KATLKVRDRVRTK 74
Query: 68  I--NLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLREE------------ 111
           +  +++ +V  H  IV  +   ++ E  L L++++   GDL + L +E            
Sbjct: 75  MERDILVEVN-HPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                   +L +  +++RDL   NILL     +K++DFGLS++  +    +    S    
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EKKAYSFCGT 189
Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           + ++A E +    +T  +D WSFGV+++E++T G  P+
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPF 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 39/218 (17%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANADAKTYDKFLKE 67
           P +  L +VLGQG FG V          +  SG  A ++ A+K+LK  A  K  D+   +
Sbjct: 24  PSQFELLKVLGQGSFGKVF-------LVKKISGSDARQLYAMKVLK-KATLKVRDRVRTK 75
Query: 68  I--NLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLREE------------ 111
           +  +++ +V  H  IV  +   ++ E  L L++++   GDL + L +E            
Sbjct: 76  MERDILVEVN-HPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 133
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                   +L +  +++RDL   NILL     +K++DFGLS++  +    +    S    
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EKKAYSFCGT 190
Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           + ++A E +    +T  +D WSFGV+++E++T G  P+
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPF 227

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANADAKTYDKFLK- 66
           P +  L +VLGQG FG V          +  SG  A ++ A+K+LK  A  K  D+    
Sbjct: 23  PSQFELLKVLGQGSFGKVFL-------VKKISGSDARQLYAMKVLK-KATLKVRDRVRTK 74
Query: 67  -EINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLREE------------ 111
            E +++ +V  H  IV  +   ++ E  L L++++   GDL + L +E            
Sbjct: 75  MERDILVEVN-HPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                   +L +  +++RDL   NILL     +K++DFGLS++  +    +    S    
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EKKAYSFCGT 189
Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           + ++A E +    +T  +D WSFGV+++E++T G  P+
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPF 226

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 93  RLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE 149
           RL    C L   Q  L  +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E
Sbjct: 116 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 175
Query: 150 QNVFQN--GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++ +   G P+      +LA E LVS     Y    D WS GV+L+ I   G  P+
Sbjct: 176 TSLMRTLCGTPT------YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 225

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 93  RLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE 149
           RL    C L   Q  L  +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 150 QNVFQN--GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++ +   G P+      +LA E LVS     Y    D WS GV+L+ I   G  P+
Sbjct: 170 TSLMRTLCGTPT------YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 93  RLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE 149
           RL    C L   Q  L  +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 150 QNVFQN--GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++ +   G P+      +LA E LVS     Y    D WS GV+L+ I   G  P+
Sbjct: 170 TSLMRTLCGTPT------YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 93  RLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE 149
           RL    C L   Q  L  +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 150 QNVFQN--GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++ +   G P+      +LA E LVS     Y    D WS GV+L+ I   G  P+
Sbjct: 170 TSLMRTLCGTPT------YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 219

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 39/204 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDV 74
           E +G+G +GVV K          A       VA+K ++ +A D       ++EI+L+K++
Sbjct: 27  EKVGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 75  GKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------------Y 112
             H +IVS I   + +  L LV E+    DL+  L E                      +
Sbjct: 77  -HHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
              ++++HRDL  +N+L++S   +K++DFGL+       +       E + + + A + L
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAPDVL 191
Query: 173 V-SNIYTNKSDVWSFGVVLWEIVT 195
           + S  Y+   D+WS G +  E++T
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 93  RLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE 149
           RL    C L   Q  L  +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E
Sbjct: 109 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 168
Query: 150 QNVFQN--GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++ +   G P+      +LA E LVS     Y    D WS GV+L+ I   G  P+
Sbjct: 169 TSLMRTLCGTPT------YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKF 64
           G   ER  +  +LG+G FG V+K    D  T+        E AVK++ KA+A  K     
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLK--CKDRITQ-------QEYAVKVINKASAKNKDTSTI 68
Query: 65  LKEINLMKDVGKHDHIVSF------------IGCCYK-----DEL----RLVVEYCALGD 103
           L+E+ L+K +  H +I+              +G  Y      DE+    R      A   
Sbjct: 69  LREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 104 LQSYLREEYLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSE 160
            Q +    Y+  + +VHRDL   NILL S      +KI DFGLS         QN +  +
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-----QNTKMKD 182
Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++   +     ++   Y  K DVWS GV+L+ I+  G  P+
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILY-ILLSGTPPF 222

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +R + G  LG+G F    +  + D  T+       +  ++ +LK +      +K   EI 
Sbjct: 42  KRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKPHQK----EKMSTEIA 94
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------QSYLRE--- 110
           + K +  + H+V F G    D+   VV E C    L               + ++R+   
Sbjct: 95  IHKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ 153
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGEPSEKLPIR 165
             +YL NN+V+HRDL   N+ L+    VKI DFGL+  I    E+     G P+      
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPN------ 207
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    ++ + D+WS G +L+ ++ +G  P+
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLL-VGKPPF 242

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 48/224 (21%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDVG 75
           ++G+G +G+V+K    D      +G+    VA+K    + D K   K  ++EI L+K + 
Sbjct: 32  LVGEGSYGMVMKCRNKD------TGRI---VAIKKFLESDDDKMVKKIAMREIKLLKQL- 81
Query: 76  KHDHIVSFIGCCYKDE----LRLVVEYCALGDL------------QSYLRE-----EYLS 114
           +H+++V+ +  C K +    +   V++  L DL            Q YL +      +  
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 115 NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-ALESLV 173
           ++ ++HRD+   NIL+S   VVK+ DFG +  +       + E    +  RW  A E LV
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE----VATRWYRAPELLV 197
Query: 174 SNI-YTNKSDVWSFGVVLWEIVTLGANPYP---------HIPLC 207
            ++ Y    DVW+ G ++ E+  +G   +P         HI +C
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMF-MGEPLFPGDSDIDQLYHIMMC 240

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKF 64
           G   ER  +  +LG+G FG V+K    D  T+        E AVK++ KA+A  K     
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLK--CKDRITQ-------QEYAVKVINKASAKNKDTSTI 68
Query: 65  LKEINLMKDVGKHDHIVSF------------IGCCYK-----DEL----RLVVEYCALGD 103
           L+E+ L+K +  H +I+              +G  Y      DE+    R      A   
Sbjct: 69  LREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 104 LQSYLREEYLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSE 160
            Q +    Y+  + +VHRDL   NILL S      +KI DFGLS         QN +  +
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-----QNTKMKD 182
Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++   +     ++   Y  K DVWS GV+L+ I+  G  P+
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILY-ILLSGTPPF 222

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 39/204 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDV 74
           E +G+G +GVV K          A       VA+K ++ +A D       ++EI+L+K++
Sbjct: 27  EKVGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 75  GKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE---------------------Y 112
             H +IVS I   + +  L LV E+    DL+  L E                      +
Sbjct: 77  -HHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
              ++++HRDL  +N+L++S   +K++DFGL+       +       E + + + A + L
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAPDVL 191
Query: 173 V-SNIYTNKSDVWSFGVVLWEIVT 195
           + S  Y+   D+WS G +  E++T
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 38/202 (18%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDVGK 76
           +G+G +GVV K    D      +GQ    VA+K    + D     K  L+EI ++K + K
Sbjct: 11  IGEGSYGVVFKCRNRD------TGQI---VAIKKFLESEDDPVIKKIALREIRMLKQL-K 60
Query: 77  HDHIVSFIGCCY-KDELRLVVEYC---ALGDLQSYLRE-----------------EYLSN 115
           H ++V+ +     K  L LV EYC    L +L  Y R                   +   
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-ALESLVS 174
           +  +HRD+   NIL++   V+K+ DFG +  +   + + + E    +  RW  + E LV 
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE----VATRWYRSPELLVG 176
Query: 175 NI-YTNKSDVWSFGVVLWEIVT 195
           +  Y    DVW+ G V  E+++
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLS 198

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +R + G  LG+G F    +  + D  T+       +  ++ +LK +      +K   EI 
Sbjct: 42  KRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKPHQK----EKMSTEIA 94
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------QSYLRE--- 110
           + K +  + H+V F G    D+   VV E C    L               + ++R+   
Sbjct: 95  IHKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ 153
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGEPSEKLPIR 165
             +YL NN+V+HRDL   N+ L+    VKI DFGL+  I    E+     G P+      
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPN------ 207
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    ++ + D+WS G +L+ ++ +G  P+
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLL-VGKPPF 242

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 43/222 (19%)
Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKF 64
           G   ER  +  +LG+G FG V+K    D  T+        E AVK++ KA+A  K     
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLK--CKDRITQ-------QEYAVKVINKASAKNKDTSTI 68
Query: 65  LKEINLMKDVGKHDHIVSF------------IGCCYK-----DEL----RLVVEYCALGD 103
           L+E+ L+K +  H +I+              +G  Y      DE+    R      A   
Sbjct: 69  LREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 104 LQSYLREEYLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQ-NGEPS 159
            Q +    Y+  + +VHRDL   NILL S      +KI DFGLS        FQ N +  
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS------TCFQQNTKMK 181
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +++   +     ++   Y  K DVWS GV+L+ I+  G  P+
Sbjct: 182 DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILY-ILLSGTPPF 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 32/164 (19%)
Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------Q 105
           +K   EI++ + +  H H+V F G    ++   VV E C    L               +
Sbjct: 86  EKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 144
Query: 106 SYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGE 157
            YLR+     +YL  N+V+HRDL   N+ L+    VKI DFGL+  +    E+     G 
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           P+      ++A E L    ++ + DVWS G +++ ++ +G  P+
Sbjct: 205 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 241

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 33/181 (18%)
Query: 46  EVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGD 103
           EVAVK++ K   ++ +  K  +E+ + K V  H +IV        ++ L LV EY + G+
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIXK-VLNHPNIVKLFEVIETEKTLYLVXEYASGGE 99
Query: 104 LQSYL---------------RE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
           +  YL               R+     +Y     +VHRDL   N+LL +   +KI+DFG 
Sbjct: 100 VFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGF 159
Query: 144 SEDIYEQNVFQN--GEPSEKLPIRWLALESLVSNIYTN-KSDVWSFGVVLWEIVTLGANP 200
           S +    N      G P       + A E      Y   + DVWS GV+L+ +V+ G+ P
Sbjct: 160 SNEFTFGNKLDAFCGAPP------YAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLP 212
Query: 201 Y 201
           +
Sbjct: 213 F 213

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 32/164 (19%)
Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------Q 105
           +K   EI++ + +  H H+V F G    ++   VV E C    L               +
Sbjct: 84  EKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 142
Query: 106 SYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGE 157
            YLR+     +YL  N+V+HRDL   N+ L+    VKI DFGL+  +    E+     G 
Sbjct: 143 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 202
Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           P+      ++A E L    ++ + DVWS G +++ ++ +G  P+
Sbjct: 203 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 239

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           LGE+ G+G +G V K +         SGQ    +AVK +++  D K   + L +++++  
Sbjct: 27  LGEI-GRGAYGSVNKMV------HKPSGQI---MAVKRIRSTVDEKEQKQLLMDLDVVMR 76
Query: 74  VGKHDHIVSFIGCCYKD-ELRLVVE-------------YCALGDLQSYLREEYL------ 113
                +IV F G  +++ +  + +E             Y  L D+   + EE L      
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV---IPEEILGKITLA 133
Query: 114 ---------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                     N K++HRD+   NILL     +K+ DFG+S  + +               
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
                 S     Y  +SDVWS G+ L+E+ T G  PYP
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYP 230

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 39/208 (18%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 12  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREEYLS------------------- 114
             H +IV  +   + +++L LV E+ ++ DL+ ++    L+                   
Sbjct: 63  N-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 115 ---NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
              +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEI 177
Query: 172 LVS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           L+    Y+   D+WS G +  E+VT  A
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 32/164 (19%)
Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------Q 105
           +K   EI++ + +  H H+V F G    ++   VV E C    L               +
Sbjct: 60  EKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 118
Query: 106 SYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGE 157
            YLR+     +YL  N+V+HRDL   N+ L+    VKI DFGL+  +    E+     G 
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           P+      ++A E L    ++ + DVWS G +++ ++ +G  P+
Sbjct: 179 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 215

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 39/208 (18%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 11  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREEYLS------------------- 114
             H +IV  +   + +++L LV E+ ++ DL+ ++    L+                   
Sbjct: 62  N-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 115 ---NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
              +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEI 176
Query: 172 LVS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           L+    Y+   D+WS G +  E+VT  A
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 32/164 (19%)
Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------Q 105
           +K   EI++ + +  H H+V F G    ++   VV E C    L               +
Sbjct: 66  EKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 124
Query: 106 SYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGE 157
            YLR+     +YL  N+V+HRDL   N+ L+    VKI DFGL+  +    E+     G 
Sbjct: 125 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 184
Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           P+      ++A E L    ++ + DVWS G +++ ++ +G  P+
Sbjct: 185 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 221

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 37/217 (17%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK-- 66
           P    L +VLGQG FG V    L    T   SG      A+K+LK  A  K  D+     
Sbjct: 27  PSHFELLKVLGQGSFGKV---FLVRKVTRPDSGHL---YAMKVLK-KATLKVRDRVRTKM 79
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLREE------------- 111
           E +++ DV  H  +V  +   ++ E  L L++++   GDL + L +E             
Sbjct: 80  ERDILADVN-HPFVVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 137
Query: 112 -------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  +L +  +++RDL   NILL     +K++DFGLS++  +    +    S    +
Sbjct: 138 ELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDH---EKKAYSFCGTV 194
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +    +++ +D WS+GV+++E++T G+ P+
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLT-GSLPF 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 32/164 (19%)
Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------Q 105
           +K   EI++ + +  H H+V F G    ++   VV E C    L               +
Sbjct: 62  EKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 120
Query: 106 SYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGE 157
            YLR+     +YL  N+V+HRDL   N+ L+    VKI DFGL+  +    E+     G 
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           P+      ++A E L    ++ + DVWS G +++ ++ +G  P+
Sbjct: 181 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 32/164 (19%)
Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------Q 105
           +K   EI++ + +  H H+V F G    ++   VV E C    L               +
Sbjct: 62  EKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 120
Query: 106 SYLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGE 157
            YLR+     +YL  N+V+HRDL   N+ L+    VKI DFGL+  +    E+     G 
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           P+      ++A E L    ++ + DVWS G +++ ++ +G  P+
Sbjct: 181 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +R + G  LG+G F    +  + D  T+       +  ++ +LK +      +K   EI 
Sbjct: 26  KRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKPHQK----EKMSTEIA 78
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------QSYLRE--- 110
           + K +  + H+V F G    D+   VV E C    L               + ++R+   
Sbjct: 79  IHKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ 137
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGEPSEKLPIR 165
             +YL NN+V+HRDL   N+ L+    VKI DFGL+  I    E+     G P+      
Sbjct: 138 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN------ 191
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    ++ + D+WS G +L+ ++ +G  P+
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLL-VGKPPF 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +R + G  LG+G F    +  + D  T+       +  ++ +LK +      +K   EI 
Sbjct: 42  KRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSM-LLKPHQK----EKMSTEIA 94
Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDL---------------QSYLRE--- 110
           + K +  + H+V F G    D+   VV E C    L               + ++R+   
Sbjct: 95  IHKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ 153
Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY---EQNVFQNGEPSEKLPIR 165
             +YL NN+V+HRDL   N+ L+    VKI DFGL+  I    E+     G P+      
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN------ 207
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    ++ + D+WS G +L+ ++ +G  P+
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLL-VGKPPF 242

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 101/208 (48%), Gaps = 39/208 (18%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 12  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREEYLS------------------- 114
             H +IV  +   + +++L LV E+ ++ DL+ ++    L+                   
Sbjct: 63  N-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 115 ---NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
              +++V+HRDL   N+L+++   +K++DFGL+       V       E + + + A E 
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEI 177
Query: 172 LVS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           L+    Y+   D+WS G +  E+VT  A
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 101/208 (48%), Gaps = 39/208 (18%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 10  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREEYLS------------------- 114
             H +IV  +   + +++L LV E+ ++ DL+ ++    L+                   
Sbjct: 61  N-HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 115 ---NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
              +++V+HRDL   N+L+++   +K++DFGL+       V       E + + + A E 
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEI 175
Query: 172 LVS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           L+    Y+   D+WS G +  E+VT  A
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 93  RLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE 149
           RL    C L   Q  L  +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
Query: 150 QNVFQN--GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++ +   G P+      +LA E LVS     Y    D WS GV+L+ I   G  P+
Sbjct: 295 TSLMRTLCGTPT------YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 344

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 45/214 (21%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEV--AVKMLKANADAKTYDK--F 64
           P      +V+G+G FG V+            +   A EV  AVK+L+  A  K  ++   
Sbjct: 37  PSDFHFLKVIGKGSFGKVL-----------LARHKAEEVFYAVKVLQKKAILKKKEEKHI 85
Query: 65  LKEINLMKDVGKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE------------ 111
           + E N++    KH  +V         D+L  V++Y   G+L  +L+ E            
Sbjct: 86  MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 112 --------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSE 160
                   YL +  +V+RDL   NILL S   + ++DFGL ++  E N   +   G P  
Sbjct: 146 AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP-- 203
Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
                +LA E L    Y    D W  G VL+E++
Sbjct: 204 ----EYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 93  RLVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE 149
           RL    C L   Q  L  +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E
Sbjct: 249 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 308
Query: 150 QNVFQN--GEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++ +   G P+      +LA E LVS     Y    D WS GV+L+ I   G  P+
Sbjct: 309 TSLMRTLCGTPT------YLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPF 358

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 30/154 (19%)
Query: 70  LMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLRE----------------- 110
           LM  +  H  I+   G  ++D  ++ ++++Y   G+L S LR+                 
Sbjct: 58  LMLSIVTHPFIIRMWGT-FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
              EYL +  +++RDL   NILL     +KI+DFG ++ + +      G P       ++
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPD------YI 170
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E + +  Y    D WSFG++++E++  G  P+
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPF 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 8   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 59  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 16  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 67  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 126 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 182
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 50/83 (60%), Gaps = 4/83 (4%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           ++L +++VVHRDL  +NIL++S   +K++DFGL+  IY    FQ    S  + + + A E
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYS---FQMALTSVVVTLWYRAPE 189
Query: 171 SLVSNIYTNKSDVWSFGVVLWEI 193
            L+ + Y    D+WS G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 13  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 64  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 179
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E   L ++LG+G FG V   L     T       A++  V ++  + +    +K      
Sbjct: 18  EDFELHKMLGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK-----R 70
Query: 70  LMKDVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLRE----------------- 110
           ++    +H   ++ + C +  K+ L  V+EY   GDL  +++                  
Sbjct: 71  VLSLAWEHP-FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 129
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI-RW 166
              ++L +  +V+RDL   NILL     +KI+DFG+     ++N+  + + +E      +
Sbjct: 130 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC----KENMLGDAKTNEFCGTPDY 185
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +A E L+   Y +  D WSFGV+L+E++ +G +P+
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPF 219

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 62/265 (23%)
Query: 1   MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT 60
           MAL      +R    + LG+G+F  V K        +  + Q    VA+K +K    ++ 
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKA------RDKNTNQI---VAIKKIKLGHRSEA 51
Query: 61  YDKF----LKEINLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE----- 110
            D      L+EI L++++  H +I+  +    +K  + LV ++    DL+  +++     
Sbjct: 52  KDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVL 109
Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                           EYL  + ++HRDL   N+LL    V+K++DFGL++         
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF------- 162
Query: 155 NGEPSE----KLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP--- 205
            G P+     ++  RW     L+  + +Y    D+W+ G +L E++       P +P   
Sbjct: 163 -GSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR----VPFLPGDS 217
Query: 206 ----LCRIVHYLSTGYRMERPASCN 226
               L RI   L T    + P  C+
Sbjct: 218 DLDQLTRIFETLGTPTEEQWPDMCS 242

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 50/83 (60%), Gaps = 4/83 (4%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           ++L +++VVHRDL  +NIL++S   +K++DFGL+  IY    FQ    S  + + + A E
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYS---FQMALTSVVVTLWYRAPE 189
Query: 171 SLVSNIYTNKSDVWSFGVVLWEI 193
            L+ + Y    D+WS G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 12/116 (10%)
Query: 112 YLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEP-SEKLPIRWL 167
           YL  + +VHRDL   N+LL S     ++KI DFGLS       VF+N +   E+L   + 
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA------VFENQKKMKERLGTAYY 204
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERP 222
               ++   Y  K DVWS GV+L+ I+  G  P+       I+  +  G Y  + P
Sbjct: 205 IAPEVLRKKYDEKCDVWSIGVILF-ILLAGYPPFGGQTDQEILRKVEKGKYTFDSP 259

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 8   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 59  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 11  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 62  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 177
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 16  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 67  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 126 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 182
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 13  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 64  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 179
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 8   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 59  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 174
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 12  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 63  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 178
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 11  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 62  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 177
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 10  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 61  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 176
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 173 V-SNIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 12  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 63  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 178
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 12  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 63  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 178
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 10  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 61  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 176
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 42/209 (20%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 24  LGAGNGGVVTK--VQHRPS-------GLIMARKLIHLEIKPAIRNQIIRELQVLHECNS- 73
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLREE--------------------YL-SN 115
            +IV F G  Y D E+ + +E+   G L   L+E                     YL   
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLALESLV 173
           ++++HRD+   NIL++S   +K+ DFG+S  + +   N F            ++A E L 
Sbjct: 134 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMAPERLQ 186
Query: 174 SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
              Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 187 GTHYSVQSDIWSMGLSLVEL-AVGRYPIP 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 42/212 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           VLG+G +G+V  G          S Q  + +A+K +    D++      +EI L K + K
Sbjct: 29  VLGKGTYGIVYAG-------RDLSNQ--VRIAIKEI-PERDSRYSQPLHEEIALHKHL-K 77
Query: 77  HDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE-----------------------Y 112
           H +IV ++G   ++  +++ +E    G L + LR +                       Y
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 113 LSNNKVVHRDLATRNILLSS-PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           L +N++VHRD+   N+L+++   V+KISDFG S+ +   N       +    ++++A E 
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE---TFTGTLQYMAPEI 194
Query: 172 LVSNI--YTNKSDVWSFGVVLWEIVTLGANPY 201
           +      Y   +D+WS G  + E+ T G  P+
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMAT-GKPPF 225

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 10  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 61  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 176
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 50/83 (60%), Gaps = 4/83 (4%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           ++L +++VVHRDL  +NIL++S   +K++DFGL+  IY    FQ    S  + + + A E
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYS---FQMALTSVVVTLWYRAPE 189
Query: 171 SLVSNIYTNKSDVWSFGVVLWEI 193
            L+ + Y    D+WS G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 76  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 125
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 186 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 234
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIP 266

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 41/209 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY---DKFLKEINLMK 72
           E +G+G +GVV K          A  +   EV V + K   D +T       ++EI+L+K
Sbjct: 9   EKIGEGTYGVVYK----------ARNKLTGEV-VALXKIRLDTETEGVPSTAIREISLLK 57
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE----- 110
           ++  H +IV  +   + +++L LV E+                  L  ++SYL +     
Sbjct: 58  ELN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
            +  +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPE 173
Query: 171 SLVS-NIYTNKSDVWSFGVVLWEIVTLGA 198
            L+    Y+   D+WS G +  E+VT  A
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 41/209 (19%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY---DKFLKEINLMK 72
           E +G+G +GVV K          A  +   EV V + K   D +T       ++EI+L+K
Sbjct: 8   EKIGEGTYGVVYK----------ARNKLTGEV-VALXKIRLDTETEGVPSTAIREISLLK 56
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE----- 110
           ++  H +IV  +   + +++L LV E+                  L  ++SYL +     
Sbjct: 57  ELN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
            +  +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPE 172
Query: 171 SLVS-NIYTNKSDVWSFGVVLWEIVTLGA 198
            L+    Y+   D+WS G +  E+VT  A
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 8   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 59  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 174
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 8   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYC----------------ALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 59  N-HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 42/212 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           VLG+G +G+V  G          S Q  + +A+K +    D++      +EI L K + K
Sbjct: 15  VLGKGTYGIVYAG-------RDLSNQ--VRIAIKEI-PERDSRYSQPLHEEIALHKHL-K 63
Query: 77  HDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLREE-----------------------Y 112
           H +IV ++G   ++  +++ +E    G L + LR +                       Y
Sbjct: 64  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 123
Query: 113 LSNNKVVHRDLATRNILLSS-PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           L +N++VHRD+   N+L+++   V+KISDFG S+ +   N       +    ++++A E 
Sbjct: 124 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE---TFTGTLQYMAPEI 180
Query: 172 LVSNI--YTNKSDVWSFGVVLWEIVTLGANPY 201
           +      Y   +D+WS G  + E+ T G  P+
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMAT-GKPPF 211

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 14  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 63
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 124 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 172
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIP 204

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 49/214 (22%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKEINLMKDV 74
           E +G G +GVV             +GQ   +VA+K +    D  T  K  L+E+ ++K  
Sbjct: 61  ETIGNGAYGVVSSA------RRRLTGQ---QVAIKKIPNAFDVVTNAKRTLRELKILKHF 111
Query: 75  GKHDHIVSFIGCCYKDELRLVVEY-------CALGDLQSYLRE----------------- 110
            KHD+I++      KD LR  V Y         L  ++S L +                 
Sbjct: 112 -KHDNIIAI-----KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 165
Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  +Y+ + +V+HRDL   N+L++    +KI DFG++  +           +E + 
Sbjct: 166 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 164 IRWLALESLVSNI--YTNKSDVWSFGVVLWEIVT 195
            RW     L+ ++  YT   D+WS G +  E++ 
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 45/234 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+  L  D  T    GQ   E AVK++      +  DK   L+E+ L+K +
Sbjct: 56  VLGKGSFGEVI--LCKDKIT----GQ---ECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 75  GKHDHIVSF------------IGCCYK-----DELRLVVEYCALGDLQSYLRE-----EY 112
             H +I+              +G  Y      DE+     +  + D    +R+      Y
Sbjct: 107 -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 164
Query: 113 LSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
           +  NK+VHRDL   N+LL S      ++I DFGLS         ++     K+   +   
Sbjct: 165 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-----KIGTAYYIA 219
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERP 222
             ++   Y  K DVWS GV+L+ I+  G  P+       I+  +  G Y  E P
Sbjct: 220 PEVLHGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTFELP 272

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 45/234 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+  L  D  T    GQ   E AVK++      +  DK   L+E+ L+K +
Sbjct: 57  VLGKGSFGEVI--LCKDKIT----GQ---ECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 75  GKHDHIVSF------------IGCCYK-----DELRLVVEYCALGDLQSYLRE-----EY 112
             H +I+              +G  Y      DE+     +  + D    +R+      Y
Sbjct: 108 -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 165
Query: 113 LSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
           +  NK+VHRDL   N+LL S      ++I DFGLS         ++     K+   +   
Sbjct: 166 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-----KIGTAYYIA 220
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERP 222
             ++   Y  K DVWS GV+L+ I+  G  P+       I+  +  G Y  E P
Sbjct: 221 PEVLHGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTFELP 273

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 11  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 62  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL   N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 121 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 177
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 10  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 61  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL   N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 176
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 14  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 63
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 124 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 172
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIP 204

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 14  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 63
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 124 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 172
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIP 204

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 49/220 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKFLKEI 68
           +GE LG G+F +V K        E ++G   +E A K +K     A+    + ++  +E+
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE----------------- 111
           ++++ V  H+ I        + ++ L++E  + G+L  +L ++                 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 112 ---YLSNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
              YL   K+ H DL   NI+L       PH +K+ DFGL+ +I +   F+N  G P   
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPE-- 183
Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
               ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 184 ----FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 45/217 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           ++ +H ++++ +   Y  K ++ L++E  A G+L  +L E+                   
Sbjct: 70  EI-QHPNVIT-LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P      
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----- 182
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 49/220 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKFLKEI 68
           +GE LG G+F +V K        E ++G   +E A K +K     A+    + ++  +E+
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE----------------- 111
           ++++ V  H+ I        + ++ L++E  + G+L  +L ++                 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 112 ---YLSNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
              YL   K+ H DL   NI+L       PH +K+ DFGL+ +I +   F+N  G P   
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPE-- 183
Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
               ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 184 ----FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 218

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 43/216 (19%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE-------------------- 111
           ++ +H ++++       K ++ L++E  A G+L  +L E+                    
Sbjct: 70  EI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 112 YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P+      
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPA------ 182
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 49/220 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKFLKEI 68
           +GE LG G+F +V K        E ++G   +E A K +K     A+    + ++  +E+
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE----------------- 111
           ++++ V  H+ I        + ++ L++E  + G+L  +L ++                 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 112 ---YLSNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
              YL   K+ H DL   NI+L       PH +K+ DFGL+ +I +   F+N  G P   
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPE-- 183
Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
               ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 184 ----FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 218

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 9   EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------------CALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 60  N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL   N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 119 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 175
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 37/207 (17%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK-TYDKFLKEINLMKDV 74
           E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI+L+K++
Sbjct: 12  EKIGEGTYGVVYKA------RNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYC----------------ALGDLQSYLRE-----EY 112
             H +IV  +   + +++L LV E+                  L  ++SYL +      +
Sbjct: 63  N-HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +++V+HRDL  +N+L+++   +K++DFGL+       V       E + + + A E L
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYXHEVVTLWYRAPEIL 178
Query: 173 VS-NIYTNKSDVWSFGVVLWEIVTLGA 198
           +    Y+   D+WS G +  E+VT  A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 45/217 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           ++ +H ++++ +   Y  K ++ L++E  A G+L  +L E+                   
Sbjct: 70  EI-QHPNVIT-LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P      
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----- 182
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 45/234 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+  L  D  T    GQ   E AVK++      +  DK   L+E+ L+K +
Sbjct: 33  VLGKGSFGEVI--LCKDKIT----GQ---ECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 75  GKHDHIVSF------------IGCCYK-----DELRLVVEYCALGDLQSYLRE-----EY 112
             H +I+              +G  Y      DE+     +  + D    +R+      Y
Sbjct: 84  D-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 141
Query: 113 LSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
           +  NK+VHRDL   N+LL S      ++I DFGLS      +   + +  +K+   +   
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEASKKMKDKIGTAYYIA 196
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERP 222
             ++   Y  K DVWS GV+L+ I+  G  P+       I+  +  G Y  E P
Sbjct: 197 PEVLHGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTFELP 249

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+  L  D  T    GQ   E AVK++      +  DK   L+E+ L+K +
Sbjct: 39  VLGKGSFGEVI--LCKDKIT----GQ---ECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 75  GKHDHIVSF------------IGCCYK-----DELRLVVEYCALGDLQSYLRE-----EY 112
             H +I+              +G  Y      DE+     +  + D    +R+      Y
Sbjct: 90  D-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 147
Query: 113 LSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
           +  NK+VHRDL   N+LL S      ++I DFGLS         ++     K+   +   
Sbjct: 148 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-----KIGTAYYIA 202
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             ++   Y  K DVWS GV+L+ I+  G  P+
Sbjct: 203 PEVLHGTYDEKCDVWSTGVILY-ILLSGCPPF 233

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 14  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 63
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 124 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 172
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIP 204

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 14  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 63
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 124 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 172
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIP 204

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 45/217 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           ++ +H ++++ +   Y  K ++ L++E  A G+L  +L E+                   
Sbjct: 70  EI-QHPNVIT-LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P      
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----- 182
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 49/220 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKFLKEI 68
           +GE LG G+F +V K        E ++G   +E A K +K     A+    + ++  +E+
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE----------------- 111
           ++++ V  H+ I        + ++ L++E  + G+L  +L ++                 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 112 ---YLSNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
              YL   K+ H DL   NI+L       PH +K+ DFGL+ +I +   F+N  G P   
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPE-- 183
Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
               ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 184 ----FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 218

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 41  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 90
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 151 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-------SYMSP 199
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           E L    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIP 231

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 49/220 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKFLKEI 68
           +GE LG G+F +V K        E ++G   +E A K +K     A+    + ++  +E+
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE----------------- 111
           ++++ V  H+ I        + ++ L++E  + G+L  +L ++                 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 112 ---YLSNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
              YL   K+ H DL   NI+L       PH +K+ DFGL+ +I +   F+N  G P   
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPE-- 183
Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
               ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 184 ----FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 218

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 45/217 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           ++ +H ++++ +   Y  K ++ L++E  A G+L  +L E+                   
Sbjct: 70  EI-QHPNVIT-LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P      
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----- 182
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 45/217 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 15  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           ++ +H ++++ +   Y  K ++ L++E  A G+L  +L E+                   
Sbjct: 69  EI-QHPNVIT-LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P      
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----- 181
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 182 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 43/216 (19%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 15  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE-------------------- 111
           ++ +H ++++       K ++ L++E  A G+L  +L E+                    
Sbjct: 69  EI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 112 YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P       
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE------ 181
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 43/216 (19%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE-------------------- 111
           ++ +H ++++       K ++ L++E  A G+L  +L E+                    
Sbjct: 70  EI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 112 YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P       
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE------ 182
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 49/214 (22%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKEINLMKDV 74
           E +G G +GVV             +GQ   +VA+K +    D  T  K  L+E+ ++K  
Sbjct: 60  ETIGNGAYGVVSSA------RRRLTGQ---QVAIKKIPNAFDVVTNAKRTLRELKILKHF 110
Query: 75  GKHDHIVSFIGCCYKDELRLVVEY-------CALGDLQSYLRE----------------- 110
            KHD+I++      KD LR  V Y         L  ++S L +                 
Sbjct: 111 -KHDNIIAI-----KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 164
Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  +Y+ + +V+HRDL   N+L++    +KI DFG++  +           +E + 
Sbjct: 165 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 164 IRWLALESLVSNI--YTNKSDVWSFGVVLWEIVT 195
            RW     L+ ++  YT   D+WS G +  E++ 
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 43/216 (19%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE-------------------- 111
           ++ +H ++++       K ++ L++E  A G+L  +L E+                    
Sbjct: 70  EI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 112 YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P       
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE------ 182
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G +  V KG          S      VA+K ++   +       ++E++L+KD+ KH
Sbjct: 10  LGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KH 59
Query: 78  DHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSN 115
            +IV+     + ++ L LV EY    DL+ YL +                      Y   
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 116 NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-S 174
            KV+HRDL  +N+L++    +K++DFGL+     +++      +E + + +   + L+ S
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 175 NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL 213
             Y+ + D+W  G + +E+ T G   +P   +   +H++
Sbjct: 176 TDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLHFI 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 43/216 (19%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE-------------------- 111
           ++ +H ++++       K ++ L++E  A G+L  +L E+                    
Sbjct: 70  EI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 112 YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P       
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE------ 182
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 45/217 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGKFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           ++ +H ++++ +   Y  K ++ L++E  A G+L  +L E+                   
Sbjct: 70  EI-QHPNVIT-LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P      
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----- 182
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 43/216 (19%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE-------------------- 111
           ++ +H ++++       K ++ L++E  A G+L  +L E+                    
Sbjct: 70  EI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 112 YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P       
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE------ 182
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 51/212 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V         T  +SG+    VAVK +      +  +    E+ +M+D  +H
Sbjct: 82  IGEGSTGIVCIA------TVRSSGKL---VAVKKMDLRKQQRR-ELLFNEVVIMRDY-QH 130
Query: 78  DHIVSFIGC-CYKDELRLVVEYC---ALGDLQSYLR--EEY--------------LSNNK 117
           +++V         DEL +V+E+    AL D+ ++ R  EE               L    
Sbjct: 131 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--------WLAL 169
           V+HRD+ + +ILL+    VK+SDFG    +           S+++P R        W+A 
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWMAP 239
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 270

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 69/257 (26%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPT----EGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            +G+ +  GE  + V+ +L +G      E     +  E A+K L +N + K     ++E+
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEV 76
Query: 69  NLMKDVGKHDHIVSF-----IGCCYKD----ELRLVVEYCALGDLQSYLRE--------- 110
             MK +  H +IV F     IG    D    E  L+ E C  G L  +L++         
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSC 135
Query: 111 --------------EYLSNNK--VVHRDLATRNILLSSPHVVKISDFGLSEDI------- 147
                         +++   K  ++HRDL   N+LLS+   +K+ DFG +  I       
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 148 --------YEQNVFQNGEPSEKLPIRWLALESLVSNIYTN-----KSDVWSFGVVLWEIV 194
                    E+ + +N  P  + P         + ++Y+N     K D+W+ G +L+ ++
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTP--------EIIDLYSNFPIGEKQDIWALGCILY-LL 246
Query: 195 TLGANPYPHIPLCRIVH 211
               +P+      RIV+
Sbjct: 247 CFRQHPFEDGAKLRIVN 263

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 51/212 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V         T  +SG+    VAVK +      +  +    E+ +M+D  +H
Sbjct: 159 IGEGSTGIVCIA------TVRSSGKL---VAVKKMDLRKQQR-RELLFNEVVIMRDY-QH 207
Query: 78  DHIVSFIGC-CYKDELRLVVEYC---ALGDLQSYLR--EEY--------------LSNNK 117
           +++V         DEL +V+E+    AL D+ ++ R  EE               L    
Sbjct: 208 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--------WLAL 169
           V+HRD+ + +ILL+    VK+SDFG    +           S+++P R        W+A 
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWMAP 316
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 347

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 51/212 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V         T  +SG+    VAVK +      +  +    E+ +M+D  +H
Sbjct: 39  IGEGSTGIVCIA------TVRSSGKL---VAVKKMDLRKQQRR-ELLFNEVVIMRDY-QH 87
Query: 78  DHIVSFIGC-CYKDELRLVVEYC---ALGDLQSYLR--EE--------------YLSNNK 117
           +++V         DEL +V+E+    AL D+ ++ R  EE               L    
Sbjct: 88  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--------WLAL 169
           V+HRD+ + +ILL+    VK+SDFG    +           S+++P R        W+A 
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWMAP 196
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 227

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 37  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 87
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V    C   DE L   + Y   G+L  Y+R+                
Sbjct: 88  RDVMSRLD-HPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 147 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 205
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 51/212 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V         T  +SG+    VAVK +      +  +    E+ +M+D  +H
Sbjct: 37  IGEGSTGIVCIA------TVRSSGKL---VAVKKMDLRKQQRR-ELLFNEVVIMRDY-QH 85
Query: 78  DHIVSFIGC-CYKDELRLVVEYC---ALGDLQSYLR--EE--------------YLSNNK 117
           +++V         DEL +V+E+    AL D+ ++ R  EE               L    
Sbjct: 86  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--------WLAL 169
           V+HRD+ + +ILL+    VK+SDFG    +           S+++P R        W+A 
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWMAP 194
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 15/96 (15%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL----SEDIYEQNVF--------QNGEP 158
           E+L +  ++HRDL   NI  +   VVK+ DFGL     +D  EQ V           G+ 
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
             KL   +++ E +  N Y++K D++S G++L+E++
Sbjct: 192 GTKL---YMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 51/212 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V         T  +SG+    VAVK +      +  +    E+ +M+D  +H
Sbjct: 32  IGEGSTGIVCIA------TVRSSGKL---VAVKKMDLRKQQRR-ELLFNEVVIMRDY-QH 80
Query: 78  DHIVSFIGC-CYKDELRLVVEYC---ALGDLQSYLR--EE--------------YLSNNK 117
           +++V         DEL +V+E+    AL D+ ++ R  EE               L    
Sbjct: 81  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--------WLAL 169
           V+HRD+ + +ILL+    VK+SDFG    +           S+++P R        W+A 
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWMAP 189
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 51/212 (24%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G  G+V         T  +SG+    VAVK +      +  +    E+ +M+D  +H
Sbjct: 28  IGEGSTGIVCIA------TVRSSGKL---VAVKKMDLRKQQRR-ELLFNEVVIMRDY-QH 76
Query: 78  DHIVSFIGC-CYKDELRLVVEYC---ALGDLQSYLR--EE--------------YLSNNK 117
           +++V         DEL +V+E+    AL D+ ++ R  EE               L    
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 118 VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--------WLAL 169
           V+HRD+ + +ILL+    VK+SDFG    +           S+++P R        W+A 
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWMAP 185
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E +    Y  + D+WS G+++ E+V  G  PY
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 216

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 43/217 (19%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 34  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 85  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--PI 164
                Y  + +V+HRD+   N+LL S   +KI+DFG S       V       + L   +
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTL 196
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   GD+ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 55/221 (24%)
Query: 16  EVLGQGEFGVVV-KGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           +VLG G  G +V +G+  +            +VAVK +        +    +E+ L+++ 
Sbjct: 30  DVLGHGAEGTIVYRGMFDN-----------RDVAVKRILPEC----FSFADREVQLLRES 74
Query: 75  GKHDHIVSFIGCCYKDEL--RLVVEYCALGDLQSYLREE--------------------- 111
            +H +++ +  C  KD     + +E CA   LQ Y+ ++                     
Sbjct: 75  DEHPNVIRYF-CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 112 YLSNNKVVHRDLATRNILLSSPHV-----VKISDFGLSEDI-YEQNVF--QNGEPSEKLP 163
           +L +  +VHRDL   NIL+S P+        ISDFGL + +   ++ F  ++G P  +  
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE-- 190
Query: 164 IRWLALESLVSNIYTNKS---DVWSFGVVLWEIVTLGANPY 201
             W+A E L  +   N +   D++S G V + +++ G++P+
Sbjct: 191 -GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   GD+ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 43/216 (19%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G+F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE-------------------- 111
           ++ +H ++++       K ++ L+ E  A G+L  +L E+                    
Sbjct: 70  EI-QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 112 YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P       
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE------ 182
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 98/234 (41%), Gaps = 45/234 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+  L  D  T         E AVK++      +  DK   L+E+ L+K +
Sbjct: 33  VLGKGSFGEVI--LCKDKIT-------GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 75  GKHDHIVSF------------IGCCYK-----DELRLVVEYCALGDLQSYLRE-----EY 112
             H +I               +G  Y      DE+     +  + D    +R+      Y
Sbjct: 84  D-HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 141
Query: 113 LSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
              NK+VHRDL   N+LL S      ++I DFGLS      +   + +  +K+   +   
Sbjct: 142 XHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEASKKXKDKIGTAYYIA 196
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERP 222
             ++   Y  K DVWS GV+L+ I+  G  P+       I+  +  G Y  E P
Sbjct: 197 PEVLHGTYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKGKYTFELP 249

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 43/217 (19%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 62  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--PI 164
                Y  + +V+HRD+   N+LL S   +KI+DFG S       V       + L   +
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTL 173
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 104 LQSYLRE-EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
           ++ +LR  ++L  N +VHRDL   NIL++S   VK++DFGL+  IY    +Q       +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYS---YQMALAPVVV 173
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
            + + A E L+ + Y    D+WS G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 47/222 (21%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLK 66
           PE    G++LG+G F  VV         E A+ +   E A+K+L+     K        +
Sbjct: 9   PEDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTR 59
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E ++M  +  H   V        DE L   + Y   G+L  Y+R+               
Sbjct: 60  ERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 118
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ------NVFQNGEPS 159
                EYL    ++HRDL   NILL+    ++I+DFG ++ +  +      N F      
Sbjct: 119 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT--- 175
Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                ++++ E L        SD+W+ G +++++V  G  P+
Sbjct: 176 ----AQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 212

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 34  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 85  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 193
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 232

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 43/217 (19%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 60  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--PI 164
                Y  + +V+HRD+   N+LL S   +KI+DFG S       V       + L   +
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTL 171
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 207

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 104 LQSYLRE-EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
           ++ +LR  ++L  N +VHRDL   NIL++S   VK++DFGL+  IY    +Q       +
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYS---YQMALTPVVV 181
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
            + + A E L+ + Y    D+WS G +  E+
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 35/216 (16%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLK 66
           PE    G++LG+G F  VV         E A+ +   E A+K+L+     K        +
Sbjct: 8   PEDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTR 58
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E ++M  +  H   V        DE L   + Y   G+L  Y+R+               
Sbjct: 59  ERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 117
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          +
Sbjct: 118 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQ 176
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +++ E L        SD+W+ G +++++V  G  P+
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 211

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDV 74
           E +G+G +GVV K     G T           A+K ++    D       ++EI+++K++
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET----------FALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------CALGDLQSYLREEYL---------- 113
            KH +IV      + K  L LV E+             G L+S   + +L          
Sbjct: 58  -KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            + +V+HRDL  +N+L++    +KI+DFGL+       +       E + + + A + L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEVVTLWYRAPDVLM 173
Query: 174 -SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLST 215
            S  Y+   D+WS G +  E+V  GA  +P +     L RI   L T
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN-GAPLFPGVSEADQLMRIFRILGT 219

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTELC 167
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 45/217 (20%)
Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASG--QAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           GE LG G F VV K        E ++G   AA  +  +  K++    + +   +E++++K
Sbjct: 16  GEELGSGVFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           ++ +H ++++ +   Y  K ++ L++E  A G+L  +L E+                   
Sbjct: 70  EI-QHPNVIT-LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 112 -YLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N  G P      
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----- 182
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 183 -FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 217

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 35/216 (16%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLK 66
           PE    G++LG+G F  VV         E A+ +   E A+K+L+     K        +
Sbjct: 6   PEDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTR 56
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E ++M  +  H   V        DE L   + Y   G+L  Y+R+               
Sbjct: 57  ERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 115
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          +
Sbjct: 116 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQ 174
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +++ E L        SD+W+ G +++++V  G  P+
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 209

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 12  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 62
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 63  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 121
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 171
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 167
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 62  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP--- 163
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRAALC 170
Query: 164 --IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 35/216 (16%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLK 66
           PE    G++LG+G F  VV         E A+ +   E A+K+L+     K        +
Sbjct: 7   PEDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTR 57
Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E ++M  +  H   V        DE L   + Y   G+L  Y+R+               
Sbjct: 58  ERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQ 175
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +++ E L        SD+W+ G +++++V  G  P+
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 210

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G +G+V                  + VA+K +          + L+EI ++    +H
Sbjct: 51  IGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RH 100
Query: 78  DHIV---SFIGCCYKDELRLV--VEYCALGDLQSYLREEYLSNN---------------- 116
           ++I+     I     ++++ V  V +    DL   L+ ++LSN+                
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 117 ---KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
               V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW     ++
Sbjct: 161 HSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 174 SNI--YTNKSDVWSFGVVLWEIVT 195
            N   YT   D+WS G +L E+++
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 104 LQSYLRE-EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
           ++ +LR  ++L  N +VHRDL   NIL++S   VK++DFGL+  IY    +Q       +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYS---YQMALDPVVV 173
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
            + + A E L+ + Y    D+WS G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 64  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 172
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 211

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 62  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 170
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 49/206 (23%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG G  GVV K  +   P+        + +A K++         ++ ++E+ ++ +    
Sbjct: 33  LGAGNGGVVFK--VSHKPS-------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNS- 82
Query: 78  DHIVSFIGCCYKD-ELRLVVEYCALGDLQ-------------------------SYLREE 111
            +IV F G  Y D E+ + +E+   G L                          +YLRE+
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQNGEPSEKLPIRWLAL 169
           +    K++HRD+   NIL++S   +K+ DFG+S  + +   N F            +++ 
Sbjct: 143 H----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-------YMSP 191
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVT 195
           E L    Y+ +SD+WS G+ L E+  
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAV 217

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 60  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTDLC 168
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTDLC 167
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 25  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 76  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 134
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 184
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 36/187 (19%)
Query: 45  MEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALG 102
           ME AVK++  +    T     +EI ++   G+H +I++ +   Y D   + +V E    G
Sbjct: 48  MEFAVKIIDKSKRDPT-----EEIEILLRYGQHPNIIT-LKDVYDDGKYVYVVTELMKGG 101
Query: 103 DL------QSYLRE--------------EYLSNNKVVHRDLATRNILL----SSPHVVKI 138
           +L      Q +  E              EYL    VVHRDL   NIL      +P  ++I
Sbjct: 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161
Query: 139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA 198
            DFG ++ +  +N       +      ++A E L    Y    D+WS GV+L+ ++T G 
Sbjct: 162 CDFGFAKQLRAENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GY 217
Query: 199 NPYPHIP 205
            P+ + P
Sbjct: 218 TPFANGP 224

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +   N ++HRD+   NI++S+ + VK+ DFG++  I +         +     ++L+ E 
Sbjct: 148 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +    +SDV+S G VL+E++T G  P+
Sbjct: 208 ARGDSVDARSDVYSLGCVLYEVLT-GEPPF 236

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 112 YLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
           YL  + +VHRDL   N+LL S     ++KI DFGLS      +    G+  E+L   +  
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLS-----AHFEVGGKMKERLGTAYYI 190
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              ++   Y  K DVWS GV+L+ I+  G  P+
Sbjct: 191 APEVLRKKYDEKCDVWSCGVILY-ILLCGYPPF 222

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 64  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTDLC 172
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 211

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 46/225 (20%)
Query: 1   MALSCGYPPERLILGE-----VLGQGEFGVVVKGLLGDGPTEGASGQA-AMEVAVKMLKA 54
           M +S   P  R+ + E     +LG+G FG V+         E A+G+  AM++  K +  
Sbjct: 134 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIV 187
Query: 55  NADAKTYDKFLKEINLMKDVGKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE-- 111
             D   +   L E  ++++  +H  + +        D L  V+EY   G+L  +L  E  
Sbjct: 188 AKDEVAHT--LTENRVLQN-SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV 244
Query: 112 ------------------YLSNNK-VVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQN 151
                             YL + K VV+RDL   N++L     +KI+DFGL  E I +  
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 152 VFQN--GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
             +   G P       +LA E L  N Y    D W  GVV++E++
Sbjct: 305 TMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRXXLC 167
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTXLC 167
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTDLC 167
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 10  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 61  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRXXLC 169
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 208

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 243
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 244 ALGVLIYEMAA-GYPPF 259

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           +G+G +G+V                  + VA+K +          + L+EI ++    +H
Sbjct: 35  IGEGAYGMVCSAY---------DNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRF-RH 84
Query: 78  DHIV---SFIGCCYKDELR--LVVEYCALGDLQSYLREEYLSNN---------------- 116
           ++I+     I     ++++   +V+     DL   L+ ++LSN+                
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 117 ---KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
               V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW     ++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 174 SNI--YTNKSDVWSFGVVLWEIVT 195
            N   YT   D+WS G +L E+++
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 112 YLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
           YL  + +VHRDL   N+LL S     ++KI DFGLS      +    G+  E+L   +  
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLS-----AHFEVGGKMKERLGTAYYI 173
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              ++   Y  K DVWS GV+L+ I+  G  P+
Sbjct: 174 APEVLRKKYDEKCDVWSCGVILY-ILLCGYPPF 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 49/216 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
           +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+    ++
Sbjct: 15  IGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 73  DVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE----- 110
              +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E     
Sbjct: 66  SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIR 165
            Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +       + 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLCGTLD 174
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 209

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +   N ++HRD+   NIL+S+ + VK+ DFG++  I +         +     ++L+ E 
Sbjct: 131 FSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +    +SDV+S G VL+E++T G  P+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP--- 163
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRAALC 167
Query: 164 --IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 198
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +   N ++HRD+   NI++S+ + VK+ DFG++  I +         +     ++L+ E 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +    +SDV+S G VL+E++T G  P+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     +K++DFGL++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +   N ++HRD+   NI++S+ + VK+ DFG++  I +         +     ++L+ E 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +    +SDV+S G VL+E++T G  P+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +   N ++HRD+   NI++S+ + VK+ DFG++  I +         +     ++L+ E 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +    +SDV+S G VL+E++T G  P+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 46/225 (20%)
Query: 1   MALSCGYPPERLILGE-----VLGQGEFGVVVKGLLGDGPTEGASGQA-AMEVAVKMLKA 54
           M +S   P  R+ + E     +LG+G FG V+  L+     E A+G+  AM++  K +  
Sbjct: 137 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVI--LV----KEKATGRYYAMKILKKEVIV 190
Query: 55  NADAKTYDKFLKEINLMKDVGKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE-- 111
             D   +   L E  ++++  +H  + +        D L  V+EY   G+L  +L  E  
Sbjct: 191 AKDEVAHT--LTENRVLQN-SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV 247
Query: 112 ------------------YLSNNK-VVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQN 151
                             YL + K VV+RDL   N++L     +KI+DFGL  E I +  
Sbjct: 248 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 307
Query: 152 VFQN--GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
             +   G P       +LA E L  N Y    D W  GVV++E++
Sbjct: 308 TMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 346

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 7   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 57
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 58  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 116
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 117 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 166
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 205

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 58/221 (26%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAME-VAVKMLKANADAK-TYDKFLKEINLMKD 73
           E +G+G +G V K          A  +   E VA+K ++ + D +      L+EI L+K+
Sbjct: 8   EKIGEGTYGTVFK----------AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE 57
Query: 74  VGKHDHIVSFIGCCYKDE-LRLVVEYCAL----------GDLQSYLREEYL--------- 113
           + KH +IV      + D+ L LV E+C            GDL   + + +L         
Sbjct: 58  L-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 114 -SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +  V+HRDL  +N+L++    +K+++FGL+                 +P+R  + E +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-------------GIPVRCYSAEVV 163
Query: 173 V-----------SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
                       + +Y+   D+WS G +  E+   G   +P
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           +   N ++HRD+   NI++S+ + VK+ DFG++  I +         +     ++L+ E 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              +    +SDV+S G VL+E++T G  P+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 49/216 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
           +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+    ++
Sbjct: 15  IGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 73  DVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE----- 110
              +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E     
Sbjct: 66  SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIR 165
            Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +       + 
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRXXLCGTLD 174
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 209

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 200
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 58/221 (26%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAME-VAVKMLKANADAK-TYDKFLKEINLMKD 73
           E +G+G +G V K          A  +   E VA+K ++ + D +      L+EI L+K+
Sbjct: 8   EKIGEGTYGTVFK----------AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE 57
Query: 74  VGKHDHIVSFIGCCYKDE-LRLVVEYCAL----------GDLQSYLREEYL--------- 113
           + KH +IV      + D+ L LV E+C            GDL   + + +L         
Sbjct: 58  L-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 114 -SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
             +  V+HRDL  +N+L++    +K++DFGL+                 +P+R  + E +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLADFGLARAF-------------GIPVRCYSAEVV 163
Query: 173 V-----------SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
                       + +Y+   D+WS G +  E+       +P
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 64  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 172
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +    +  K D+WS GV+ +E + +G  P+
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFL-VGKPPF 211

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 163
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 164 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 217
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 218 ALGVLIYEMAA-GYPPF 233

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 57/225 (25%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
            ++ L E +G+G +G V +GL       G S      VAVK+  +  +      + +E  
Sbjct: 8   RQVALVECVGKGRYGEVWRGLW-----HGES------VAVKIFSSRDE----QSWFRETE 52
Query: 70  LMKDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLSNN------- 116
           +   V  +HD+I+ FI           +L L+  Y   G L  +L+ + L  +       
Sbjct: 53  IYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAV 112
Query: 117 --------------------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ--NVFQ 154
                                + HRD  +RN+L+ S     I+D GL+  ++ Q  +   
Sbjct: 113 SAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAV-MHSQGSDYLD 171
Query: 155 NGEPSEKLPIRWLALESLVSNIYTN------KSDVWSFGVVLWEI 193
            G        R++A E L   I T+       +D+W+FG+VLWEI
Sbjct: 172 IGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 56/234 (23%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+  I+  ++G+G +G V   L  D  TE      A++   +M +   D K   + L+EI
Sbjct: 25  PDNYIIKHLIGRGSYGYVY--LAYDKNTEK---NVAIKKVNRMFEDLIDCK---RILREI 76
Query: 69  NLMKDVGKHDHIVSFIGCCYKD------ELRLVVEYCALGDLQSYLR------------- 109
            ++  + K D+I+        D      EL +V+E  A  DL+   +             
Sbjct: 77  TILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTI 134
Query: 110 -------EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-------NVFQN 155
                  E ++  + ++HRDL   N LL+    VK+ DFGL+  I  +       ++ +N
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 156 GEP-----------SEKLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTL 196
            EP           +  +  RW     L+     YT   D+WS G +  E++ +
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 60  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS----------CHAPSSRRTTLS 168
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 83
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 84  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q    S     ++
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQY 201
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 235

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 155
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 156 PENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 209
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 210 ALGVLIYEMAA-GYPPF 225

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIIISKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 104 LQSYLRE-EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
           ++ +LR  ++L  N +VHRDL   NIL++S   VK++DFGL+  IY    +Q       +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYS---YQMALFPVVV 173
Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEI 193
            + + A E L+ + Y    D+WS G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 42/211 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+             G   +  AVK+LK +   +  D    + E  ++   
Sbjct: 27  VLGKGSFGKVM--------LSERKGTDEL-YAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 75  GKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE--------------------YL 113
           GK   +     C    D L  V+EY   GDL  ++++                     +L
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALE 170
            +  +++RDL   N++L S   +KI+DFG+  E+I++    +   G P       ++A E
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD------YIAPE 191
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +    Y    D W+FGV+L+E++  G  P+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLA-GQAPF 221

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 49/216 (22%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
           +G  LG+G+FG V               Q    +A+K+L KA  +    +  L+    ++
Sbjct: 9   IGRPLGKGKFGNVYLA---------REKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 73  DVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE----- 110
              +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E     
Sbjct: 60  SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 118
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIR 165
            Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +       + 
Sbjct: 119 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLCGTLD 168
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 203

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 42/211 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+             G   +  AVK+LK +   +  D    + E  ++   
Sbjct: 348 VLGKGSFGKVM--------LSERKGTDEL-YAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 75  GKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE--------------------YL 113
           GK   +     C    D L  V+EY   GDL  ++++                     +L
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLALE 170
            +  +++RDL   N++L S   +KI+DFG+  E+I++    +   G P       ++A E
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD------YIAPE 512
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +    Y    D W+FGV+L+E++  G  P+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLA-GQAPF 542

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 200
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 38/188 (20%)
Query: 45  MEVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCAL 101
           ME AVK++ K+  D        +EI ++   G+H +I++ +   Y D   + LV E    
Sbjct: 53  MEYAVKVIDKSKRDPS------EEIEILLRYGQHPNIIT-LKDVYDDGKHVYLVTELMRG 105
Query: 102 GDL------QSYLRE--------------EYLSNNKVVHRDLATRNILL----SSPHVVK 137
           G+L      Q +  E              EYL +  VVHRDL   NIL      +P  ++
Sbjct: 106 GELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLR 165
Query: 138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG 197
           I DFG ++ +  +N       +      ++A E L    Y    D+WS G++L+ ++  G
Sbjct: 166 ICDFGFAKQLRAENGLLM---TPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA-G 221
Query: 198 ANPYPHIP 205
             P+ + P
Sbjct: 222 YTPFANGP 229

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 79
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 80  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q    S     ++
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQY 197
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 231

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 38/216 (17%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L EV+G+G F VV + +         +GQ      V + K  +      + LK    +  
Sbjct: 28  LCEVIGKGAFSVVRRCI------NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 74  VGKHDHIVSFIGCCYKD-ELRLVVEYCALGDL-------------------QSYLRE--- 110
           + KH HIV  +     D  L +V E+    DL                     Y+R+   
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 111 --EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
              Y  +N ++HRD+   N+LL+S      VK+ DFG++  + E  +   G         
Sbjct: 142 ALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP---H 198
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +    Y    DVW  GV+L+ I+  G  P+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILF-ILLSGCLPF 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 158 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 216
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 15/96 (15%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL----SEDIYEQNVF--------QNGEP 158
           E+L +  ++HRDL   NI  +   VVK+ DFGL     +D  EQ V           G+ 
Sbjct: 178 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV 237
Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIV 194
             KL   +++ E +  N Y++K D++S G++L+E++
Sbjct: 238 GTKL---YMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 38/188 (20%)
Query: 45  MEVAVKML-KANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD--ELRLVVEYCAL 101
           ME AVK++ K+  D        +EI ++   G+H +I++ +   Y D   + LV E    
Sbjct: 53  MEYAVKVIDKSKRDPS------EEIEILLRYGQHPNIIT-LKDVYDDGKHVYLVTELMRG 105
Query: 102 GDL------QSYLRE--------------EYLSNNKVVHRDLATRNILL----SSPHVVK 137
           G+L      Q +  E              EYL +  VVHRDL   NIL      +P  ++
Sbjct: 106 GELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLR 165
Query: 138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG 197
           I DFG ++ +  +N       +      ++A E L    Y    D+WS G++L+ ++  G
Sbjct: 166 ICDFGFAKQLRAENGLLM---TPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA-G 221
Query: 198 ANPYPHIP 205
             P+ + P
Sbjct: 222 YTPFANGP 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 136 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 194
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 198
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 198
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 136 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 194
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 61/227 (26%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
            ++ L E +G+G +G V +G          S Q    VAVK+  +  D K++    +E  
Sbjct: 37  RQITLLECVGKGRYGEVWRG----------SWQGE-NVAVKIFSSR-DEKSW---FRETE 81
Query: 70  LMKDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLR-------------- 109
           L   V  +H++I+ FI           +L L+  Y  +G L  YL+              
Sbjct: 82  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL 141
Query: 110 -----------EEYLSNNK--VVHRDLATRNILLSSPHVVKISDFGL----SEDIYEQNV 152
                      E + +  K  + HRDL ++NIL+       I+D GL    S+   + +V
Sbjct: 142 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 201
Query: 153 FQNGEPSEKLPIRWLALESLVSNIYTN------KSDVWSFGVVLWEI 193
             N     K   R++A E L   I  +      + D+W+FG+VLWE+
Sbjct: 202 GNNPRVGTK---RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +        G P       +LA E ++S  Y    D W
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE------YLAPEIILSKGYNKAVDWW 243
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 244 ALGVLIYEMAA-GYPPF 259

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 146 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 204
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 200
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 143 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 201
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 144 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 202
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 135 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 193
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E +  RW    
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAP 200
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V                +   +A+K+L KA  +    +  L+  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA---------REKNSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 59  VEIQSHLRHPNILRLYGY-FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP--- 163
                Y  + KV+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 118 ANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRAALC 167
Query: 164 --IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 206

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDV 74
           E +G+G +GVV K     G T           A+K ++    D       ++EI+++K++
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET----------FALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------CALGDLQSYLREEYL---------- 113
            KH +IV      + K  L LV E+             G L+S   + +L          
Sbjct: 58  -KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            + +V+HRDL  +N+L++    +KI+DFGL+       +       E + + + A + L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEVVTLWYRAPDVLM 173
Query: 174 -SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLST 215
            S  Y+   D+WS G +  E+V  G   +P +     L RI   L T
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGT 219

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     +K++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 61/226 (26%)
Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           ++ L E +G+G +G V +G          S Q    VAVK+  ++ D K++    +E  L
Sbjct: 9   QITLLECVGKGRYGEVWRG----------SWQGE-NVAVKIF-SSRDEKSW---FRETEL 53
Query: 71  MKDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLR--------------- 109
              V  +H++I+ FI           +L L+  Y  +G L  YL+               
Sbjct: 54  YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS 113
Query: 110 ----------EEYLSNNK--VVHRDLATRNILLSSPHVVKISDFGL----SEDIYEQNVF 153
                     E + +  K  + HRDL ++NIL+       I+D GL    S+   + +V 
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 154 QNGEPSEKLPIRWLALESLVSNIYTN------KSDVWSFGVVLWEI 193
            N     K   R++A E L   I  +      + D+W+FG+VLWE+
Sbjct: 174 NNPRVGTK---RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 44/213 (20%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDV 74
           E LG+G F VV + +              +E A K++      A+ + K  +E  + + +
Sbjct: 35  EELGKGAFSVVRRCV---------HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 75  GKHDHIVSFIGCCYKDELRLVV----------------EYCALGDLQSYLRE-----EYL 113
            +H +IV       ++    +V                E+ +  D    +++      Y 
Sbjct: 86  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 114 SNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLA 168
            +N +VHR+L   N+LL+S      VK++DFGL+ ++ +   +    G P       +L+
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG------YLS 198
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E L  + Y+   D+W+ GV+L+ I+ +G  P+
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILY-ILLVGYPPF 230

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMKDV 74
           E +G+G +GVV K     G T           A+K ++    D       ++EI+++K++
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET----------FALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 75  GKHDHIVSFIGCCY-KDELRLVVEY----------CALGDLQSYLREEYL---------- 113
            KH +IV      + K  L LV E+             G L+S   + +L          
Sbjct: 58  -KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV 173
            + +V+HRDL  +N+L++    +KI+DFGL+       +       E + + + A + L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 174 -SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLST 215
            S  Y+   D+WS G +  E+V  G   +P +     L RI   L T
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGT 219

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+L+++   +KI DFGL+  I +      G  +E +  RW    
Sbjct: 158 KYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVATRWYRAP 216
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 44/215 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMK 72
           + E LG+G F VV + +              +E A K++      A+ + K  +E  + +
Sbjct: 9   VKEELGKGAFSVVRRCV---------HKTTGLEFAAKIINTKKLSARDFQKLEREARICR 59
Query: 73  DVGKHDHIVSFIGCCYKDELRLVV----------------EYCALGDLQSYLRE-----E 111
            + +H +IV       ++    +V                E+ +  D    +++      
Sbjct: 60  KL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 118
Query: 112 YLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRW 166
           Y  +N +VHR+L   N+LL+S      VK++DFGL+ ++ +   +    G P       +
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG------Y 172
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           L+ E L  + Y+   D+W+ GV+L+ I+ +G  P+
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILY-ILLVGYPPF 206

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G   E +  RW    
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYRAP 200
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  V+HRDL   N+LL++   +KI DFGL+  + + +    G   E +  RW    
Sbjct: 143 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYRAP 201
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G +L E+++
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     ++++DFGL++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 82
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G L  Y+R+                
Sbjct: 83  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q    S     ++
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQY 200
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L     +  SD+W+ G +++++V  G  P+
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P        LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA------LAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 44/213 (20%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDV 74
           E LG+G F VV + +              +E A K++      A+ + K  +E  + + +
Sbjct: 12  EELGKGAFSVVRRCV---------HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 75  GKHDHIVSFIGCCYKDELRLVV----------------EYCALGDLQSYLRE-----EYL 113
            +H +IV       ++    +V                E+ +  D    +++      Y 
Sbjct: 63  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 114 SNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWLA 168
            +N +VHR+L   N+LL+S      VK++DFGL+ ++ +   +    G P       +L+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG------YLS 175
Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E L  + Y+   D+W+ GV+L+ I+ +G  P+
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILY-ILLVGYPPF 207

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 48/213 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD-KFLKEINLMKDVGK 76
           +GQG FG V K           +GQ   +VA+K +    + + +    L+EI +++ + K
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQ---KVALKKVLMENEKEGFPITALREIKILQ-LLK 75
Query: 77  HDHIVSFIGCCY---------KDELRLVVEYC---------------ALGDLQSYLRE-- 110
           H+++V+ I  C          K  + LV ++C                L +++  ++   
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE---KLPI 164
               Y+  NK++HRD+   N+L++   V+K++DFGL+      ++ +N +P+    ++  
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRYXNRVVT 192
Query: 165 RWLALESLV--SNIYTNKSDVWSFGVVLWEIVT 195
            W     L+     Y    D+W  G ++ E+ T
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 44/215 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMK 72
           + E LG+G F VV + +              +E A K++      A+ + K  +E  + +
Sbjct: 10  VKEELGKGAFSVVRRCV---------HKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 73  DVGKHDHIVSFIGCCYKDELRLVV----------------EYCALGDLQSYLRE-----E 111
            + +H +IV       ++    +V                E+ +  D    +++      
Sbjct: 61  KL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 112 YLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRW 166
           Y  +N +VHR+L   N+LL+S      VK++DFGL+ ++ +   +    G P       +
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG------Y 173
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           L+ E L  + Y+   D+W+ GV+L+ I+ +G  P+
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILY-ILLVGYPPF 207

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++++   G  P+
Sbjct: 223 ALGVLIYQMAA-GYPPF 238

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 48/213 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD-KFLKEINLMKDVGK 76
           +GQG FG V K           +GQ   +VA+K +    + + +    L+EI +++ + K
Sbjct: 25  IGQGTFGEVFKA------RHRKTGQ---KVALKKVLMENEKEGFPITALREIKILQ-LLK 74
Query: 77  HDHIVSFIGCCY---------KDELRLVVEYC---------------ALGDLQSYLRE-- 110
           H+++V+ I  C          K  + LV ++C                L +++  ++   
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE---KLPI 164
               Y+  NK++HRD+   N+L++   V+K++DFGL+      ++ +N +P+    ++  
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRYXNRVVT 191
Query: 165 RWLALESLV--SNIYTNKSDVWSFGVVLWEIVT 195
            W     L+     Y    D+W  G ++ E+ T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 45/218 (20%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKE 67
           E   +G  LG+G+FG V               Q+   +A+K+L       A    +  +E
Sbjct: 12  EDFDIGRPLGKGKFGNVYLA---------RERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE 110
           + +   + +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E
Sbjct: 63  VEIQSHL-RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITE 120
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--P 163
                 Y  + +V+HRD+   N+LL S   +KI+DFG S       V       + L   
Sbjct: 121 LANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGT 173
Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGMPPF 210

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 51/221 (23%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY-----DKFLKEI 68
           +GE LG G+F +V K        E ++G   +E A K +K      +      ++  +E+
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTG---LEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 69  NLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREE---------------- 111
           ++++ V  H +I++       + ++ L++E  + G+L  +L ++                
Sbjct: 67  SILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 112 ----YLSNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVFQN--GEPSE 160
               YL   K+ H DL   NI+L       PH +K+ DFGL+ +I +   F+N  G P  
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPE- 183
Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                ++A E +       ++D+WS GV+ + I+  GA+P+
Sbjct: 184 -----FVAPEIVNYEPLGLEADMWSIGVITY-ILLSGASPF 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 50/221 (22%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
            I    LG G FG V          E +SG   +E  +K +  +      ++   EI ++
Sbjct: 24  FIFKRKLGSGAFGDV------HLVEERSSG---LERVIKTINKDRSQVPMEQIEAEIEVL 74
Query: 72  KDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDL---------------QSYLRE---- 110
           K +  H +I+  I   ++D   + +V+E C  G+L               + Y+ E    
Sbjct: 75  KSLD-HPNIIK-IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 111 -----EYLSNNKVVHRDLATRNILL--SSPHV-VKISDFGLSEDIYEQNVFQNGEPSEKL 162
                 Y  +  VVH+DL   NIL   +SPH  +KI DFGL+E      +F++ E S   
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE------LFKSDEHSTNA 186
Query: 163 P--IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                ++A E    ++ T K D+WS GVV++ ++T G  P+
Sbjct: 187 AGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLT-GCLPF 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 61/225 (27%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           + L E +G+G +G V +G          S Q    VAVK+  ++ D K++    +E  L 
Sbjct: 10  ITLLECVGKGRYGEVWRG----------SWQGE-NVAVKIF-SSRDEKSW---FRETELY 54
Query: 72  KDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLR---------------- 109
             V  +H++I+ FI           +L L+  Y  +G L  YL+                
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSI 114
Query: 110 ---------EEYLSNNK--VVHRDLATRNILLSSPHVVKISDFGL----SEDIYEQNVFQ 154
                    E + +  K  + HRDL ++NIL+       I+D GL    S+   + +V  
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 155 NGEPSEKLPIRWLALESLVSNIYTN------KSDVWSFGVVLWEI 193
           N     K   R++A E L   I  +      + D+W+FG+VLWE+
Sbjct: 175 NPRVGTK---RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 10  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 61  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI++FG S             PS +     
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHA----------PSSRRTTLC 169
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 208

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 48/213 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEINLMKDVGK 76
           +GQG FG V K           +GQ   +VA+K +L  N         L+EI +++ + K
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQ---KVALKKVLMENEKEGFPITALREIKILQ-LLK 75
Query: 77  HDHIVSFIGCCY---------KDELRLVVEYC---------------ALGDLQSYLRE-- 110
           H+++V+ I  C          K  + LV ++C                L +++  ++   
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE---KLPI 164
               Y+  NK++HRD+   N+L++   V+K++DFGL+      ++ +N +P+    ++  
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRYXNRVVT 192
Query: 165 RWLALESLV--SNIYTNKSDVWSFGVVLWEIVT 195
            W     L+     Y    D+W  G ++ E+ T
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 80
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 81  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q    +     ++
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANAFVGTAQY 198
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 48/213 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYD-KFLKEINLMKDVGK 76
           +GQG FG V K           +GQ   +VA+K +    + + +    L+EI +++ + K
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQ---KVALKKVLMENEKEGFPITALREIKILQ-LLK 75
Query: 77  HDHIVSFIGCCY---------KDELRLVVEYC---------------ALGDLQSYLRE-- 110
           H+++V+ I  C          K  + LV ++C                L +++  ++   
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE---KLPI 164
               Y+  NK++HRD+   N+L++   V+K++DFGL+      ++ +N +P+    ++  
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRYXNRVVT 192
Query: 165 RWLALESLV--SNIYTNKSDVWSFGVVLWEIVT 195
            W     L+     Y    D+W  G ++ E+ T
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLRE---------------- 110
             ++   +H +I+   G  + D  R  L++EY   G++   L++                
Sbjct: 64  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 172
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 211

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE- 110
             ++   +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E 
Sbjct: 62  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI++FG S             PS +     
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHA----------PSSRRTTLC 170
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 209

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 243
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 244 ALGVLIYEMAA-GYPPF 259

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 12/101 (11%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHV--VKISDFGLSEDIYEQNVFQNGE----PSEKLPIR 165
           YL N  + HRD+   N L S+     +K+ DFGLS++ Y+ N   NGE     ++     
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN---NGEYYGMTTKAGTPY 239
Query: 166 WLALESL--VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
           ++A E L   +  Y  K D WS GV+L  ++ +GA P+P +
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLL-HLLLMGAVPFPGV 279

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 49/220 (22%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +G  LG+G+FG V               Q+   +A+K+L KA  +    +  L+  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLRE---------------- 110
             ++   +H +I+   G  + D  R  L++EY   G++   L++                
Sbjct: 64  VEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
                Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +     
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRXXLX 172
Query: 163 -PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 211

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 51/221 (23%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKE 67
           E   +G  LG+G+FG V               Q+   +A+K+L       A    +  +E
Sbjct: 12  EDFDIGRPLGKGKFGNVYLA---------RERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 68  INLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALG----DLQ-----------SYLRE 110
           + +   + +H +I+   G  + D  R  L++EY  LG    +LQ           +Y+ E
Sbjct: 63  VEIQSHL-RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITE 120
Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--- 162
                 Y  + +V+HRD+   N+LL S   +KI+DFG S             PS +    
Sbjct: 121 LANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHA----------PSSRRTTL 170
Query: 163 --PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              + +L  E +   ++  K D+WS GV+ +E + +G  P+
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGMPPF 210

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 85/180 (47%), Gaps = 27/180 (15%)
Query: 45  MEVAVK--MLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCAL 101
           ++VA+K   +      +T  +F +E++    +  H +IVS I    +D+   LV+EY   
Sbjct: 37  IKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 102 GDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
             L  Y+                      ++  + ++VHRD+  +NIL+ S   +KI DF
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155
Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           G+++ + E ++ Q         +++ + E          +D++S G+VL+E++ +G  P+
Sbjct: 156 GIAKALSETSLTQTNHVLG--TVQYFSPEQAKGEATDECTDIYSIGIVLYEML-VGEPPF 212

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 82
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 83  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 200
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           EYL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE------YL 172
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L  N Y    D W  GVV++E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 35  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 85
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 86  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 145 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 203
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 83
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 84  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 201
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 235

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 82
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 83  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 200
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 82
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 83  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 200
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           EYL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +L
Sbjct: 122 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE------YL 175
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L  N Y    D W  GVV++E++
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMM 202

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           EYL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE------YL 172
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L  N Y    D W  GVV++E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 82
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 83  RDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 200
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 13/97 (13%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWL 167
           EYL   K++HRD+   N+L+     +KI+DFG+S +    +   +   G P+      ++
Sbjct: 151 EYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA------FM 204
Query: 168 ALESL--VSNIYTNKS-DVWSFGVVLWEIVTLGANPY 201
           A ESL     I++ K+ DVW+ GV L+  V  G  P+
Sbjct: 205 APESLSETRKIFSGKALDVWAMGVTLYCFV-FGQCPF 240

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 80
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 81  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 198
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 82
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 83  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 200
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 215
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 216 ALGVLIYEMAA-GYPPF 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 80
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 81  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 198
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 215
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 216 ALGVLIYEMAA-GYPPF 231

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 155 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE------YLAPEIILSKGYNKAVDWW 208
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 209 ALGVLIYEMAA-GYPPF 224

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE------YLAPEIILSKGYNKAVDWW 223
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 224 ALGVLIYEMAA-GYPPF 239

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 14  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 64
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 65  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 124 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 182
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY   G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+++     ++++DFG ++ +  +     G P       +LA E ++S  Y    D W
Sbjct: 169 PENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPEIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 87  CYKDE--LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLA 124
            +KD   L +V+EY A G++ S+LR                     EYL +  +++RDL 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVW 184
             N+L+     ++++DFG ++ +  +     G P       +LA   ++S  Y    D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE------YLAPAIILSKGYNKAVDWW 222
Query: 185 SFGVVLWEIVTLGANPY 201
           + GV+++E+   G  P+
Sbjct: 223 ALGVLIYEMAA-GYPPF 238

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 16/119 (13%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
           +YL  N +VHRDL   N+L  +P     + I+DFGLS+   EQN   +   G P      
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPG----- 172
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERP 222
            ++A E L    Y+   D WS GV+ + I+  G  P+      ++   +  G Y  E P
Sbjct: 173 -YVAPEVLAQKPYSKAVDCWSIGVITY-ILLCGYPPFYEETESKLFEKIKEGYYEFESP 229

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F  VV         E A+ +   E A+K+L+     K        +E
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 79
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 80  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 197
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 231

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           EYL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE------YL 172
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L  N Y    D W  GVV++E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           EYL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +L
Sbjct: 124 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE------YL 177
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L  N Y    D W  GVV++E++
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMM 204

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 42/211 (19%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V   +L D       G   +  A+K+LK +   +  D    + E  ++  +
Sbjct: 26  VLGKGSFGKV---MLAD-----RKGTEEL-YAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 75  GKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE--------------------YL 113
            K   +     C    D L  V+EY   GDL  ++++                     +L
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 114 SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLALE 170
               +++RDL   N++L S   +KI+DFG+ ++     V      G P       ++A E
Sbjct: 137 HKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPD------YIAPE 190
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            +    Y    D W++GV+L+E++  G  P+
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLA-GQPPF 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 36/186 (19%)
Query: 46  EVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGD 103
           E AVK++  +    T     +EI ++   G+H +I++ +   Y D   + +V E    G+
Sbjct: 49  EFAVKIIDKSKRDPT-----EEIEILLRYGQHPNIIT-LKDVYDDGKYVYVVTELXKGGE 102
Query: 104 L------QSYLRE--------------EYLSNNKVVHRDLATRNILL----SSPHVVKIS 139
           L      Q +  E              EYL    VVHRDL   NIL      +P  ++I 
Sbjct: 103 LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN 199
           DFG ++ +  +N       +      ++A E L    Y    D+WS GV+L+  +T G  
Sbjct: 163 DFGFAKQLRAENGLLX---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLT-GYT 218
Query: 200 PYPHIP 205
           P+ + P
Sbjct: 219 PFANGP 224

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           EYL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE------YL 172
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L  N Y    D W  GVV++E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWL 167
           EYL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE------YL 172
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIV 194
           A E L  N Y    D W  GVV++E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 112 YLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRW 166
           YL  N +VHRDL   N+L ++P     +KI+DFGLS+ +  Q + +   G P       +
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG------Y 216
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            A E L    Y  + D+WS G++ + I+  G  P+
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITY-ILLCGFEPF 250

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 50/216 (23%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT-YDKFLKEINL 70
           ++  + LG+G+F VV + +         S     E A K LK     +    + L EI +
Sbjct: 31  ILTSKELGRGKFAVVRQCI---------SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81
Query: 71  MKDVGKHDHIVSFIGCCYKD--ELRLVVEYCALGDLQSYLREE----------------- 111
           ++       +++ +   Y++  E+ L++EY A G++ S    E                 
Sbjct: 82  LELAKSCPRVIN-LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140
Query: 112 -----YLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                YL  N +VH DL  +NILLSS +    +KI DFG+S  I        G   E   
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--------GHACELRE 192
Query: 164 I----RWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           I     +LA E L  +  T  +D+W+ G++ + ++T
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
           +Y+ +  V+HRDL   N+ +++   V+KI DFGL+  I + +    G  SE L  +W   
Sbjct: 134 KYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR-IMDPHYSHKGHLSEGLVTKWYRS 192
Query: 170 ESLV--SNIYTNKSDVWSFGVVLWEIVT 195
             L+   N YT   D+W+ G +  E++T
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 42/171 (24%)
Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREEYLSNNK------ 117
           LKE+++++ V  H +I+        +    LV +    G+L  YL E+   + K      
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 117
Query: 118 --------------VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL- 162
                         +VHRDL   NILL     +K++DFG S  +         +P EKL 
Sbjct: 118 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---------DPGEKLR 168
Query: 163 ----PIRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYPH 203
                  +LA E +  ++      Y  + D+WS GV+++ ++  G+ P+ H
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWH 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 42/171 (24%)
Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREEYLSNNK------ 117
           LKE+++++ V  H +I+        +    LV +    G+L  YL E+   + K      
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 118 --------------VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL- 162
                         +VHRDL   NILL     +K++DFG S  +         +P EKL 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---------DPGEKLR 181
Query: 163 ----PIRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYPH 203
                  +LA E +  ++      Y  + D+WS GV+++ ++  G+ P+ H
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWH 231

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 42/171 (24%)
Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREEYLSNNK------ 117
           LKE+++++ V  H +I+        +    LV +    G+L  YL E+   + K      
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 118 --------------VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL- 162
                         +VHRDL   NILL     +K++DFG S  +         +P EKL 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---------DPGEKLR 181
Query: 163 ----PIRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYPH 203
                  +LA E +  ++      Y  + D+WS GV+++ ++  G+ P+ H
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWH 231

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEIXINKM 61
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 62  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L    + HRD+   N+LL     +KISDFGL+  ++  N  +         + ++A E L
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 173 VSN-IYTNKSDVWSFGVVL 190
                +    DVWS G+VL
Sbjct: 180 KRREFHAEPVDVWSCGIVL 198

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 49/85 (57%), Gaps = 6/85 (7%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE-KLPIRWLAL 169
           +Y+ + K++HRDL   NI L     VKI DFGL       ++  +G+ +  K  +R+++ 
Sbjct: 150 DYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLV-----TSLKNDGKRTRSKGTLRYMSP 204
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIV 194
           E + S  Y  + D+++ G++L E++
Sbjct: 205 EQISSQDYGKEVDLYALGLILAELL 229

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEIXINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L    + HRD+   N+LL     +KISDFGL+  ++  N  +         + ++A E L
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 173 VSN-IYTNKSDVWSFGVVL 190
                +    DVWS G+VL
Sbjct: 179 KRREFHAEPVDVWSCGIVL 197

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E L   ++V+RDL   NILL     ++ISD GL+  + E    +    +    + ++A E
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT----VGYMAPE 355
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            + +  YT   D W+ G +L+E++  G +P+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIA-GQSPF 385

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK--TYDKFLKE 67
           E    G++LG+G F   V         E A+ +   E A+K+L+     K        +E
Sbjct: 30  EDFKFGKILGEGSFSTTVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTRE 80
Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H   V        DE L   + Y   G+L  Y+R+                
Sbjct: 81  RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++  Q          ++
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTAQY 198
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++ E L        SD+W+ G +++++V  G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L E +G+G FG V +G                EVAVK+  +  +      + +E  + 
Sbjct: 44  IVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSSREER----SWFREAEIY 88
Query: 72  KDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLS----------- 114
           + V  +H++I+ FI    KD     +L LV +Y   G L  YL    ++           
Sbjct: 89  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST 148
Query: 115 ----------------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                              + HRDL ++NIL+       I+D GL+          +  P
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 159 SEKLPI-RWLALESLVSNIYT------NKSDVWSFGVVLWEIV 194
           + ++   R++A E L  +I         ++D+++ G+V WEI 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMK 72
           L E LG+G F VV +  +   PT+        E A K++      A+ + K  +E  + +
Sbjct: 35  LFEELGKGAFSVV-RRCVKKTPTQ--------EYAAKIINTKKLSARDHQKLEREARICR 85
Query: 73  DVGKHDHIVSFIGCCYKDELRLVV----------------EYCALGDLQSYLRE-----E 111
            + KH +IV       ++    +V                EY +  D    + +      
Sbjct: 86  -LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN 144
Query: 112 YLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIY-EQNVFQN--GEPSEKLPIR 165
           ++  + +VHRDL   N+LL+S      VK++DFGL+ ++  EQ  +    G P       
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPG------ 198
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +L+ E L  + Y    D+W+ GV+L+ I+ +G  P+
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILY-ILLVGYPPF 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E L   ++V+RDL   NILL     ++ISD GL+  + E    +    +    + ++A E
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT----VGYMAPE 355
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            + +  YT   D W+ G +L+E++  G +P+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIA-GQSPF 385

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 56/213 (26%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L +          + EVA+K +  +   K      +E+ +M+ V 
Sbjct: 46  KVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKRFKN-----RELQIMRIV- 89
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA--------------------LGDLQSY- 107
           KH ++V      Y     KDE  L LV+EY                      L  L  Y 
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 108 -LRE-EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            LR   Y+ +  + HRD+  +N+LL  P  V+K+ DFG ++      +   GEP+   + 
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNVSXIC 203
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIV 194
            R+     L+  +  YT   D+WS G V+ E++
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 55/229 (24%)
Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
           G     ++L E +G+G FG V +G                EVAVK+  +  +      + 
Sbjct: 2   GTIARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSSREER----SWF 46
Query: 66  KEINLMKDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLS----- 114
           +E  + + V  +H++I+ FI    KD     +L LV +Y   G L  YL    ++     
Sbjct: 47  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI 106
Query: 115 ----------------------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV 152
                                    + HRDL ++NIL+       I+D GL+        
Sbjct: 107 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 166
Query: 153 FQNGEPSEKLPI-RWLALESLVSNIYT------NKSDVWSFGVVLWEIV 194
             +  P+ ++   R++A E L  +I         ++D+++ G+V WEI 
Sbjct: 167 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L E +G+G FG V +G                EVAVK+  +  +      + +E  + 
Sbjct: 31  IVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSSREER----SWFREAEIY 75
Query: 72  KDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLS----------- 114
           + V  +H++I+ FI    KD     +L LV +Y   G L  YL    ++           
Sbjct: 76  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST 135
Query: 115 ----------------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                              + HRDL ++NIL+       I+D GL+          +  P
Sbjct: 136 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 195
Query: 159 SEKLPI-RWLALESLVSNIYT------NKSDVWSFGVVLWEIV 194
           + ++   R++A E L  +I         ++D+++ G+V WEI 
Sbjct: 196 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L    + HRD+   N+LL     +KISDFGL+  ++  N  +         + ++A E L
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 173 VSN-IYTNKSDVWSFGVVL 190
                +    DVWS G+VL
Sbjct: 179 KRREFHAEPVDVWSCGIVL 197

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L E +G+G FG V +G                EVAVK+  +  +      + +E  + 
Sbjct: 6   IVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSSREER----SWFREAEIY 50
Query: 72  KDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLS----------- 114
           + V  +H++I+ FI    KD     +L LV +Y   G L  YL    ++           
Sbjct: 51  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST 110
Query: 115 ----------------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                              + HRDL ++NIL+       I+D GL+          +  P
Sbjct: 111 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 170
Query: 159 SEKLPI-RWLALESLVSNIYT------NKSDVWSFGVVLWEIV 194
           + ++   R++A E L  +I         ++D+++ G+V WEI 
Sbjct: 171 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEIXINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 173
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL 197

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L E +G+G FG V +G                EVAVK+  +  +      + +E  + 
Sbjct: 11  IVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSSREER----SWFREAEIY 55
Query: 72  KDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLS----------- 114
           + V  +H++I+ FI    KD     +L LV +Y   G L  YL    ++           
Sbjct: 56  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST 115
Query: 115 ----------------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                              + HRDL ++NIL+       I+D GL+          +  P
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 175
Query: 159 SEKLPI-RWLALESLVSNIYT------NKSDVWSFGVVLWEIV 194
           + ++   R++A E L  +I         ++D+++ G+V WEI 
Sbjct: 176 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           ++L E +G+G FG V +G                EVAVK+  +  +      + +E  + 
Sbjct: 5   IVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSSREER----SWFREAEIY 49
Query: 72  KDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLS----------- 114
           + V  +H++I+ FI    KD     +L LV +Y   G L  YL    ++           
Sbjct: 50  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST 109
Query: 115 ----------------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                              + HRDL ++NIL+       I+D GL+          +  P
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 159 SEKLPI-RWLALESLVSNIYT------NKSDVWSFGVVLWEIV 194
           + ++   R++A E L  +I         ++D+++ G+V WEI 
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 33/182 (18%)
Query: 44  AMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCAL 101
           AM+V  K L    D +  D    E ++ +    H  +V  +  C++ E RL  V+EY   
Sbjct: 38  AMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNG 94
Query: 102 GDLQSYLREE--------------------YLSNNKVVHRDLATRNILLSSPHVVKISDF 141
           GDL  +++ +                    YL    +++RDL   N+LL S   +K++D+
Sbjct: 95  GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 142 GLSEDIYEQNVFQNGEPSEKL--PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN 199
           G+ ++       + G+ +        ++A E L    Y    D W+ GV+++E++  G +
Sbjct: 155 GMCKE-----GLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRS 208
Query: 200 PY 201
           P+
Sbjct: 209 PF 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L    + HRD+   N+LL     +KISDFGL+  ++  N  +         + ++A E L
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 173 VSN-IYTNKSDVWSFGVVL 190
                +    DVWS G+VL
Sbjct: 179 KRREFHAEPVDVWSCGIVL 197

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 33/182 (18%)
Query: 44  AMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCAL 101
           AM V  K L    D +  D    E ++ +    H  +V  +  C++ E RL  V+EY   
Sbjct: 81  AMRVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNG 137
Query: 102 GDLQSYLREE--------------------YLSNNKVVHRDLATRNILLSSPHVVKISDF 141
           GDL  +++ +                    YL    +++RDL   N+LL S   +K++D+
Sbjct: 138 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 142 GLSEDIYEQNVFQNGEPSEKL--PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN 199
           G+ ++       + G+ +        ++A E L    Y    D W+ GV+++E++  G +
Sbjct: 198 GMCKE-----GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRS 251
Query: 200 PY 201
           P+
Sbjct: 252 PF 253

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L    + HRD+   N+LL     +KISDFGL+  ++  N  +         + ++A E L
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 173 VSN-IYTNKSDVWSFGVVL 190
                +    DVWS G+VL
Sbjct: 179 KRREFHAEPVDVWSCGIVL 197

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/251 (22%), Positives = 99/251 (39%), Gaps = 63/251 (25%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+   +  ++G+G +G V          + A+   A++   +M +   D K   + L+EI
Sbjct: 27  PDNYEIKHLIGRGSYGYVYLAY-----DKNANKNVAIKKVNRMFEDLIDCK---RILREI 78
Query: 69  NLMKDVGKHDHIVSFIGCCYK------DELRLVVEYCALGDLQSYLR------------- 109
            ++  + K D+I+              DEL +V+E  A  DL+   +             
Sbjct: 79  TILNRL-KSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTI 136
Query: 110 -------EEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS------EDIY-------- 148
                  E+++  + ++HRDL   N LL+    VKI DFGL+      +DI+        
Sbjct: 137 LYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 149 -------EQNVFQNGEPSEKLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGA- 198
                    N     + +  +  RW     L+     YTN  D+WS G +  E++ +   
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256
Query: 199 ---NPYPHIPL 206
              NP    PL
Sbjct: 257 HINNPTNRFPL 267

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 41/205 (20%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQA-AMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           ++LG+G FG V+         E A+G+  AM++  K +    D   +   L E  ++++ 
Sbjct: 15  KLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQN- 65
Query: 75  GKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE--------------------YL 113
            +H  + +        D L  V+EY   G+L  +L  E                    YL
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 114 SNNK-VVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLAL 169
            + K VV+RDL   N++L     +KI+DFGL  E I +    +   G P       +LA 
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE------YLAP 179
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIV 194
           E L  N Y    D W  GVV++E++
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMM 204

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 41/205 (20%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQA-AMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           ++LG+G FG V+         E A+G+  AM++  K +    D   +   L E  ++++ 
Sbjct: 14  KLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQN- 64
Query: 75  GKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE--------------------YL 113
            +H  + +        D L  V+EY   G+L  +L  E                    YL
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 114 SNNK-VVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLAL 169
            + K VV+RDL   N++L     +KI+DFGL  E I +    +   G P       +LA 
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE------YLAP 178
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIV 194
           E L  N Y    D W  GVV++E++
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMM 203

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 33/182 (18%)
Query: 44  AMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCAL 101
           AM+V  K L    D +  D    E ++ +    H  +V  +  C++ E RL  V+EY   
Sbjct: 34  AMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNG 90
Query: 102 GDLQSYLREE--------------------YLSNNKVVHRDLATRNILLSSPHVVKISDF 141
           GDL  +++ +                    YL    +++RDL   N+LL S   +K++D+
Sbjct: 91  GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 150
Query: 142 GLSEDIYEQNVFQNGEPSEKL--PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN 199
           G+ ++       + G+ +        ++A E L    Y    D W+ GV+++E++  G +
Sbjct: 151 GMCKE-----GLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRS 204
Query: 200 PY 201
           P+
Sbjct: 205 PF 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 33/182 (18%)
Query: 44  AMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCAL 101
           AM+V  K L    D +  D    E ++ +    H  +V  +  C++ E RL  V+EY   
Sbjct: 49  AMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNG 105
Query: 102 GDLQSYLREE--------------------YLSNNKVVHRDLATRNILLSSPHVVKISDF 141
           GDL  +++ +                    YL    +++RDL   N+LL S   +K++D+
Sbjct: 106 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 142 GLSEDIYEQNVFQNGEPSEKL--PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN 199
           G+ ++       + G+ +        ++A E L    Y    D W+ GV+++E++  G +
Sbjct: 166 GMCKE-----GLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRS 219
Query: 200 PY 201
           P+
Sbjct: 220 PF 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 41/205 (20%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQA-AMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           ++LG+G FG V+         E A+G+  AM++  K +    D   +   L E  ++++ 
Sbjct: 16  KLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQN- 66
Query: 75  GKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLREE--------------------YL 113
            +H  + +        D L  V+EY   G+L  +L  E                    YL
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 114 SNNK-VVHRDLATRNILLSSPHVVKISDFGL-SEDIYEQNVFQN--GEPSEKLPIRWLAL 169
            + K VV+RDL   N++L     +KI+DFGL  E I +    +   G P       +LA 
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE------YLAP 180
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIV 194
           E L  N Y    D W  GVV++E++
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMM 205

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 44/212 (20%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK--FLKEINLMKDV 74
           VLG+G FG V+   + +      +G      AVK+LK +   +  D    + E  ++   
Sbjct: 30  VLGKGSFGKVMLARVKE------TGDL---YAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 75  GKHDHIVSFIGCCYK--DELRLVVEYCALGDLQSYLREE--------------------Y 112
             H  +     CC++  D L  V+E+   GDL  ++++                     +
Sbjct: 81  RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWLAL 169
           L +  +++RDL   N+LL      K++DFG+ ++     V      G P       ++A 
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD------YIAP 193
Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           E L   +Y    D W+ GV+L+E++  G  P+
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLC-GHAPF 224

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 45/216 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMK 72
           L E LG+G F VV + +      +  +GQ   E A K++      A+ + K  +E  + +
Sbjct: 8   LFEELGKGAFSVVRRCM------KIPTGQ---EYAAKIINTKKLSARDHQKLEREARICR 58
Query: 73  DVGKHDHIVSFIGCCYKDELR-LVVEYCALGDL-QSYLREEYLSN--------------- 115
            + KH +IV       ++    LV +    G+L +  +  EY S                
Sbjct: 59  -LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 116 ----NKVVHRDLATRNILLSSPH---VVKISDFGLSEDIY--EQNVFQ-NGEPSEKLPIR 165
               N +VHRDL   N+LL+S      VK++DFGL+ ++   +Q  F   G P       
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPG------ 171
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +L+ E L  + Y    D+W+ GV+L+ I+ +G  P+
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILY-ILLVGYPPF 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 62  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 174
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 45/216 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMK 72
           L E LG+G F VV + +      +  +GQ   E A K++      A+ + K  +E  + +
Sbjct: 8   LFEELGKGAFSVVRRCM------KIPTGQ---EYAAKIINTKKLSARDHQKLEREARICR 58
Query: 73  DVGKHDHIVSFIGCCYKDELR-LVVEYCALGDL-QSYLREEYLSN--------------- 115
            + KH +IV       ++    LV +    G+L +  +  EY S                
Sbjct: 59  -LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 116 ----NKVVHRDLATRNILLSSPH---VVKISDFGLSEDIY--EQNVFQ-NGEPSEKLPIR 165
               N +VHRDL   N+LL+S      VK++DFGL+ ++   +Q  F   G P       
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPG------ 171
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           +L+ E L  + Y    D+W+ GV+L+ I+ +G  P+
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILY-ILLVGYPPF 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 9   LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 59
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 60  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 172
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVL 196

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 173
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL 197

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 173
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL 197

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 57/216 (26%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G F +  K +         S QA    AVK++    +A T     KEI  +K    H
Sbjct: 19  LGEGSFSICRKCV------HKKSNQA---FAVKIISKRMEANTQ----KEITALKLCEGH 65
Query: 78  DHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE--------------------YLSN 115
            +IV  +   + D+L   LV+E    G+L   ++++                    ++ +
Sbjct: 66  PNIVK-LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 116 NKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR------- 165
             VVHRDL   N+L +  +    +KI DFG          F   +P +  P++       
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFG----------FARLKPPDNQPLKTPCFTLH 174
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           + A E L  N Y    D+WS GV+L+ +++ G  P+
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPF 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 62  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 174
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 173
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL 197

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 62  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 174
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 62  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 174
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 62  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 174
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 173
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL 197

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 173
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL 197

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 10  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 173
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL 197

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 42/189 (22%)
Query: 37  EGASGQAAMEV--------AVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY 88
           EGA+G+  + V        AVK++         +   KEI + K +  H+++V F G   
Sbjct: 16  EGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRR 74
Query: 89  KDELR-LVVEYCALGDLQSYLREE--------------------YLSNNKVVHRDLATRN 127
           +  ++ L +EYC+ G+L   +  +                    YL    + HRD+   N
Sbjct: 75  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 134
Query: 128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWLALESLVSN-IYTNKS 181
           +LL     +KISDFGL+       VF+       L      + ++A E L     +    
Sbjct: 135 LLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 182 DVWSFGVVL 190
           DVWS G+VL
Sbjct: 189 DVWSCGIVL 197

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI + K 
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 62  LN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L    + HRD+   N+LL     +KISDFGL+  ++  N  +         + ++A E L
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 173 VSN-IYTNKSDVWSFGVVL 190
                +    DVWS G+VL
Sbjct: 180 KRREFHAEPVDVWSCGIVL 198

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 47/207 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKEINLMKDVGK 76
           +G G +G V   +          G+   +VA+K L     ++ + K   +E+ L+K + +
Sbjct: 33  VGSGAYGAVCSAV---------DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-R 82
Query: 77  HDHIVSFIGCCYKDE-------LRLVVEYCALGDLQSYLREEYLSNNKV----------- 118
           H++++  +     DE         LV+ +    DL   ++ E L  +++           
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 119 --------VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
                   +HRDL   N+ ++    +KI DFGL+          + E    +  RW    
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-------DSEMXGXVVTRWYRAP 194
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVT 195
            ++ N   YT   D+WS G ++ E++T
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMIT 221

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 2   ALSCGYPPERLILGEVLGQGEFGVV---VKGLLGDGPTEGASGQAAMEVAVKMLKANADA 58
            ++C    E   L E LG+G F VV   VK L G          AAM +  K L A    
Sbjct: 3   TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAG-------QEYAAMIINTKKLSARDHQ 55
Query: 59  KTYD-----KFLKEINLMK------DVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSY 107
           K        + LK  N+++      + G H  I   +      E  +  EY +  D    
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC 115
Query: 108 LRE-----EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIY-EQNVFQN--G 156
           +++      +     VVHR+L   N+LL+S      VK++DFGL+ ++  EQ  +    G
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            P       +L+ E L  + Y    D+W+ GV+L+ I+ +G  P+
Sbjct: 176 TPG------YLSPEVLRKDPYGKPVDLWACGVILY-ILLVGYPPF 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 48/211 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G +GVV K           SGQ    +AVK ++A  +++   + L ++++       
Sbjct: 59  LGRGAYGVVEKM------RHVPSGQI---MAVKRIRATVNSQEQKRLLMDLDISMRTVDC 109
Query: 78  DHIVSFIGCCYKD----------ELRLVVEYCALGDLQSYLREEYL-------------- 113
              V+F G  +++          +  L   Y  + D    + E+ L              
Sbjct: 110 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 114 -SNNKVVHRDLATRNILLSSPHVVKISDFGLSE---DIYEQNVFQNGEPSEKLPIRWLAL 169
            S   V+HRD+   N+L+++   VK+ DFG+S    D   + +    +P       ++A 
Sbjct: 170 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKP-------YMAP 222
Query: 170 ESLVSNI----YTNKSDVWSFGVVLWEIVTL 196
           E +   +    Y+ KSD+WS G+ + E+  L
Sbjct: 223 ERINPELNQKGYSVKSDIWSLGITMIELAIL 253

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 63/227 (27%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           VLGQG FG VVK           +   +   A+K ++   +  +    L E+ L+  +  
Sbjct: 13  VLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEKLS--TILSEVMLLASLN- 60
Query: 77  HDHIVSFIGCCY--------------KDELRLVVEYCALGDLQSYLREE----------- 111
           H ++V +                   K  L + +EYC  G L   +  E           
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 112 ----------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-NVFQNGEPSE 160
                     Y+ +  ++HRDL   NI +     VKI DFGL+++++   ++ +    S+
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK--LDSQ 178
Query: 161 KLP------------IRWLALESLV-SNIYTNKSDVWSFGVVLWEIV 194
            LP              ++A E L  +  Y  K D++S G++ +E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVF-QNGEPSEKLPIRWL 167
           YL  + +VHRD+   NILL + +    +KI DFGLS      + F ++ +  ++L   + 
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS------SFFSKDYKLRDRLGTAYY 214
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
               ++   Y  K DVWS GV+++ I+  G  P+
Sbjct: 215 IAPEVLKKKYNEKCDVWSCGVIMY-ILLCGYPPF 247

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 48/211 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G +GVV K           SGQ    +AVK ++A  +++   + L ++++       
Sbjct: 15  LGRGAYGVVEKM------RHVPSGQI---MAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 78  DHIVSFIGCCYKD----------ELRLVVEYCALGDLQSYLREEYL-------------- 113
              V+F G  +++          +  L   Y  + D    + E+ L              
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 114 -SNNKVVHRDLATRNILLSSPHVVKISDFGLSE---DIYEQNVFQNGEPSEKLPIRWLAL 169
            S   V+HRD+   N+L+++   VK+ DFG+S    D   +++    +P       ++A 
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-------YMAP 178
Query: 170 ESLVSNI----YTNKSDVWSFGVVLWEIVTL 196
           E +   +    Y+ KSD+WS G+ + E+  L
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAIL 209

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 38/216 (17%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L EV+G+G F VV + +         +GQ      V + K  +      + LK    +  
Sbjct: 30  LCEVIGKGPFSVVRRCI------NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 83
Query: 74  VGKHDHIVSFIGCCYKD-ELRLVVEYCALGDL-------------------QSYLRE--- 110
           + KH HIV  +     D  L +V E+    DL                     Y+R+   
Sbjct: 84  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 143
Query: 111 --EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
              Y  +N ++HRD+    +LL+S      VK+  FG++  + E  +   G         
Sbjct: 144 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP---H 200
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +    Y    DVW  GV+L+ I+  G  P+
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILF-ILLSGCLPF 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 38/216 (17%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L EV+G+G F VV + +         +GQ      V + K  +      + LK    +  
Sbjct: 28  LCEVIGKGPFSVVRRCI------NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 74  VGKHDHIVSFIGCCYKD-ELRLVVEYCALGDL-------------------QSYLRE--- 110
           + KH HIV  +     D  L +V E+    DL                     Y+R+   
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 111 --EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
              Y  +N ++HRD+    +LL+S      VK+  FG++  + E  +   G         
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP---H 198
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E +    Y    DVW  GV+L+ I+  G  P+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILF-ILLSGCLPF 233

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/84 (28%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ + K+++RDL   NI L     VKI DFGL   +             K  +R+++ E
Sbjct: 136 DYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN----DGKRXRSKGTLRYMSPE 191
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIV 194
            + S  Y  + D+++ G++L E++
Sbjct: 192 QISSQDYGKEVDLYALGLILAELL 215

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 13/103 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDI-YEQNVFQNGEPSEKLPI-- 164
           ++L N  + HRDL   NIL   P+    VKI DFGL   I    +      P    P   
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 165 -RWLALE-----SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             ++A E     S  ++IY  + D+WS GV+L+ I+  G  P+
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPF 226

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 43/204 (21%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           L + LG+G +G V   L  +  TE A       VAVK++         +   KEI  +  
Sbjct: 11  LVQTLGEGAYGEV--QLAVNRVTEEA-------VAVKIVDMKRAVDCPENIKKEI-CINA 60
Query: 74  VGKHDHIVSFIGCCYKDELR-LVVEYCALGDLQSYLREE--------------------Y 112
           +  H+++V F G   +  ++ L +EYC+ G+L   +  +                    Y
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL-----PIRWL 167
           L    + HRD+   N+LL     +KISDFGL+       VF+       L      + ++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPYV 174
Query: 168 ALESLVSN-IYTNKSDVWSFGVVL 190
           A E L     +    DVWS G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           ++L ++ + HRD+   N+L +S     V+K++DFG +++       QN   +      ++
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-----TTQNALQTPCYTPYYV 196
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGFPPF 229

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 61/220 (27%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV-GK 76
           +G+G +G V  G                +VAVK+     +A     + +E  + + V  +
Sbjct: 45  IGKGRYGEVWMG-----------KWRGEKVAVKVFFTTEEAS----WFRETEIYQTVLMR 89
Query: 77  HDHIVSFIGCCYK-----DELRLVVEYCALGDLQSYLREEYLSNNK-------------- 117
           H++I+ FI    K      +L L+ +Y   G L  YL+   L                  
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCH 149
Query: 118 -------------VVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
                        + HRDL ++NIL+       I+D GL+     D  E ++  N     
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 161 KLPIRWLALESLVSNIYTNK------SDVWSFGVVLWEIV 194
           K   R++  E L  ++  N       +D++SFG++LWE+ 
Sbjct: 210 K---RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           ++L ++ + HRD+   N+L +S     V+K++DFG +++       QN   +      ++
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-----TTQNALQTPCYTPYYV 177
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGFPPF 210

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 73/245 (29%)
Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKE 67
           P+R  +  ++G G +G V          E         VA+K +L+   D     + L+E
Sbjct: 52  PDRYEIRHLIGTGSYGHVC---------EAYDKLEKRVVAIKKILRVFEDLIDCKRILRE 102
Query: 68  INLMKDVGKHDHIVSFIGCCYK------DELRLVVEYCALGDLQSYLRE----------- 110
           I ++  +  HDH+V  +           DEL +V+E  A  D +   R            
Sbjct: 103 IAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVYLTELHIKT 160
Query: 111 ---------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                    +Y+ +  ++HRDL   N L++    VK+ DFGL+  +   +  +NG  + +
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV---DYPENG--NSQ 215
Query: 162 LPI----------------------------RWLALESLV--SNIYTNKSDVWSFGVVLW 191
           LPI                            RW     L+     YT   DVWS G +  
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 192 EIVTL 196
           E++ +
Sbjct: 276 ELLNM 280

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 13/90 (14%)
Query: 118 VVHRDLATRNILLSSP---HVVKISDFGLSEDIY--EQNVFQ-NGEPSEKLPIRWLALES 171
           VVHRDL   N+LL+S      VK++DFGL+ ++   +Q  F   G P       +L+ E 
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPG------YLSPEV 177
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           L    Y    D+W+ GV+L+ I+ +G  P+
Sbjct: 178 LRKEAYGKPVDIWACGVILY-ILLVGYPPF 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 4/81 (4%)
Query: 112 YLSNNK-VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           Y+ N K + HRD+   NIL+     VK+SDFG SE + ++ +  +    E +P  + + E
Sbjct: 166 YIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNE 225
Query: 171 SLVSNIYTNKSDVWSFGVVLW 191
           S  +     K D+WS G+ L+
Sbjct: 226 SSYNGA---KVDIWSLGICLY 243

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 52/227 (22%)
Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           E +G GEFG V K +   DG         A++ + K L  + D +     L+E+     +
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCI------YAIKRSKKPLAGSVDEQNA---LREVYAHAVL 67
Query: 75  GKHDHIVSFIGCCYKDELRLVV-EYCALGDL----------QSYLRE------------- 110
           G+H H+V +     +D+  L+  EYC  G L           SY +E             
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN--VFQNGEPSEKLPI--- 164
             Y+ +  +VH D+   NI +S   +   +     ED +  N  +F+ G+      I   
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 165 -------RWLALESLVSNIYTN--KSDVWSFGVVLWEIVTLGANPYP 202
                  R+LA E L  N YT+  K+D+  F + L  +   GA P P
Sbjct: 188 QVEEGDSRFLANEVLQEN-YTHLPKADI--FALALTVVCAAGAEPLP 231

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 13/90 (14%)
Query: 118 VVHRDLATRNILLSSP---HVVKISDFGLSEDIY-EQNVFQN--GEPSEKLPIRWLALES 171
           VVHRDL   N+LL+S      VK++DFGL+ ++  EQ  +    G P       +L+ E 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG------YLSPEV 195
Query: 172 LVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           L  + Y    D+W+ GV+L+ I+ +G  P+
Sbjct: 196 LRKDPYGKPVDLWACGVILY-ILLVGYPPF 224

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 52/227 (22%)
Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           E +G GEFG V K +   DG         A++ + K L  + D +     L+E+     +
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCI------YAIKRSKKPLAGSVDEQNA---LREVYAHAVL 65
Query: 75  GKHDHIVSFIGCCYKDELRLVV-EYCALGDL----------QSYLRE------------- 110
           G+H H+V +     +D+  L+  EYC  G L           SY +E             
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN--VFQNGEPSEKLPI--- 164
             Y+ +  +VH D+   NI +S   +   +     ED +  N  +F+ G+      I   
Sbjct: 126 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 185
Query: 165 -------RWLALESLVSNIYTN--KSDVWSFGVVLWEIVTLGANPYP 202
                  R+LA E L  N YT+  K+D+  F + L  +   GA P P
Sbjct: 186 QVEEGDSRFLANEVLQEN-YTHLPKADI--FALALTVVCAAGAEPLP 229

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 52/227 (22%)
Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           E +G GEFG V K +   DG         A++ + K L  + D +     L+E+     +
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCI------YAIKRSKKPLAGSVDEQNA---LREVYAHAVL 63
Query: 75  GKHDHIVSFIGCCYKDELRLVV-EYCALGDL----------QSYLRE------------- 110
           G+H H+V +     +D+  L+  EYC  G L           SY +E             
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN--VFQNGEPSEKLPI--- 164
             Y+ +  +VH D+   NI +S   +   +     ED +  N  +F+ G+      I   
Sbjct: 124 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 183
Query: 165 -------RWLALESLVSNIYTN--KSDVWSFGVVLWEIVTLGANPYP 202
                  R+LA E L  N YT+  K+D+  F + L  +   GA P P
Sbjct: 184 QVEEGDSRFLANEVLQEN-YTHLPKADI--FALALTVVXAAGAEPLP 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 47/224 (20%)
Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA---DAKTYDKFL 65
           E   L +VLG G +G V             SG    ++ A+K+LK       AKT +   
Sbjct: 54  ENFELLKVLGTGAYGKVF-------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 66  KEINLMKDVGKHDHIVSF-IGCCYKDELRLVVEYCALGDLQSYLRE-------------- 110
            E  +++ + +   +V+       + +L L+++Y   G+L ++L +              
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                 E+L    +++RD+   NILL S   V ++DFGLS++          + +E+   
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-------ADETERAYD 219
Query: 165 RWLALESLVSNI-------YTNKSDVWSFGVVLWEIVTLGANPY 201
               +E +  +I       +    D WS GV+++E++T GA+P+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPF 262

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 52/227 (22%)
Query: 16  EVLGQGEFGVVVKGLLG-DGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
           E +G GEFG V K +   DG         A++ + K L  + D +     L+E+     +
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCI------YAIKRSKKPLAGSVDEQNA---LREVYAHAVL 65
Query: 75  GKHDHIVSFIGCCYKDELRLVV-EYCALGDL----------QSYLRE------------- 110
           G+H H+V +     +D+  L+  EYC  G L           SY +E             
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN--VFQNGE---------- 157
             Y+ +  +VH D+   NI +S   +   +     ED +  N  +F+ G+          
Sbjct: 126 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 185
Query: 158 PSEKLPIRWLALESLVSNIYTN--KSDVWSFGVVLWEIVTLGANPYP 202
             E+   R+LA E L  N YT+  K+D+  F + L  +   GA P P
Sbjct: 186 QVEEGDSRFLANEVLQEN-YTHLPKADI--FALALTVVCAAGAEPLP 229

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 27  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 72
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 73  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 132 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 185
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 26  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 71
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 184
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 224

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 48/224 (21%)
Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGA-SGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           +  E+LG+G +  V          +GA S Q   E AVK+++  A   +  +  +E+  +
Sbjct: 16  LTSELLGEGAYAKV----------QGAVSLQNGKEYAVKIIEKQA-GHSRSRVFREVETL 64
Query: 72  KDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLREE------------------ 111
                + +I+  I   ++D+ R  LV E    G + ++++++                  
Sbjct: 65  YQCQGNKNILELIEF-FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA 123
Query: 112 --YLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDIYEQNVFQN-GEPSEKLPI- 164
             +L    + HRDL   NIL  SP     VKI DF L   +   N       P    P  
Sbjct: 124 LDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCG 183
Query: 165 --RWLALESL-----VSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
              ++A E +      +  Y  + D+WS GVVL+ I+  G  P+
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLY-IMLSGYPPF 226

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 26  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 71
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 184
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 8/97 (8%)
Query: 107 YLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
           YL+E++     V+HRD+   NILL     +K+ DFG+S  + +        G  +   P 
Sbjct: 139 YLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           R    +    + Y  ++DVWS G+ L E+ T G  PY
Sbjct: 195 RIDPPDPTKPD-YDIRADVWSLGISLVELAT-GQFPY 229

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 30  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 75
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 76  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 134
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 135 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 188
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 38  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 83
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 84  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 143 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 196
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 236

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N     EP       ++
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TEPC--YTPYYV 184
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 185 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 217

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 38  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 83
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 84  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 143 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 196
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 236

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 60  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 105
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 218
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 258

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 45  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 90
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 91  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 149
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 150 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 203
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 34  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 79
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 80  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 138
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 139 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 192
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 232

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 37/180 (20%)
Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE------------ 110
            KE+ +M+ + +H  +V+ +   ++DE  + +VV+    GDL+ +L++            
Sbjct: 63  FKELQIMQGL-EHPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                   +YL N +++HRD+   NILL     V I+DF ++  +  +        ++  
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP- 179
Query: 163 PIRWLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPYPHIPLC----RIVHYLST 215
              ++A E   S     Y+   D WS GV  +E++  G  PY HI        IVH   T
Sbjct: 180 ---YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPY-HIRSSTSSKEIVHTFET 234

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 26  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 71
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 184
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 224

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 67/234 (28%)
Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P   L L E+  +G FG V K  L +             VAVK+     D +++     E
Sbjct: 13  PRGSLQLLEIKARGRFGCVWKAQLMND-----------FVAVKIFPLQ-DKQSWQS---E 57
Query: 68  INLMKDVG-KHDHIVSFI-----GCCYKDELRLVVEYCALGDLQSYLREEYLSNNK---- 117
             +    G KH++++ FI     G   + EL L+  +   G L  YL+   ++ N+    
Sbjct: 58  REIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHV 117
Query: 118 --------------------------VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
                                     + HRD  ++N+LL S     ++DFGL+       
Sbjct: 118 AETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVR----- 172
Query: 152 VFQNGEP-----SEKLPIRWLALESLVSNIYTNKS-----DVWSFGVVLWEIVT 195
            F+ G+P      +    R++A E L   I   +      D+++ G+VLWE+V+
Sbjct: 173 -FEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 43/214 (20%)
Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
             E LG G F  VV         E A+G+     AVK +   A          EI +++ 
Sbjct: 26  FKETLGTGAFSEVVLA------EEKATGKL---FAVKCIPKKALKGKESSIENEIAVLRK 76
Query: 74  VGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLREE--------------------Y 112
           + KH++IV+        + L LV++  + G+L   + E+                    Y
Sbjct: 77  I-KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 113 LSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
           L    +VHRDL   N+L  S      + ISDFGLS+   + +V     G P       ++
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPG------YV 189
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y+   D WS GV+ + I+  G  P+
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAY-ILLCGYPPF 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 39  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 84
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 85  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 143
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 144 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 197
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 237

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 31  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKL- 75
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 135
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 136 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 189
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 54  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKLD 99
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 100 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 158
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 159 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 212
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 252

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 62  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKL- 106
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 166
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 167 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 220
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 260

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +      K      +E+ +M+ + 
Sbjct: 26  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQGKAFKN-----RELQIMRKLD 71
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSXIC 184
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 224

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 60  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKL- 104
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 218
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 258

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAP 202
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 246

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 105 KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKL- 149
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 209
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 210 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 263
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 303

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/227 (22%), Positives = 90/227 (39%), Gaps = 63/227 (27%)
Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           VLGQG FG VVK           +   +   A+K ++   +  +    L E+ L+  +  
Sbjct: 13  VLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEKLS--TILSEVMLLASLN- 60
Query: 77  HDHIVSFIGCCY--------------KDELRLVVEYCALGDLQSYLREE----------- 111
           H ++V +                   K  L + +EYC    L   +  E           
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 112 ----------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ-NVFQNGEPSE 160
                     Y+ +  ++HRDL   NI +     VKI DFGL+++++   ++ +    S+
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK--LDSQ 178
Query: 161 KLP------------IRWLALESLV-SNIYTNKSDVWSFGVVLWEIV 194
            LP              ++A E L  +  Y  K D++S G++ +E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAP 193
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 237

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +  +   K      +E+ +M+ + 
Sbjct: 64  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQDKRFKN-----RELQIMRKL- 108
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 168
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 169 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 222
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 262

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAP 197
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 241

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 57/105 (54%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-AL 169
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW  A 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 170 ESLVSNIYTNKS-DVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
           E +++ ++ N++ D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 111 EYLSNNKVVHRDLATRNIL---LSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           +YL +  +VHRDL   N+L   L     + ISDFGLS+     +V     G P       
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG------ 183
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    Y+   D WS GV+ + I+  G  P+
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAY-ILLCGYPPF 218

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 200
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 201 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 233

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 111 EYLSNNKVVHRDLATRNIL---LSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           +YL +  +VHRDL   N+L   L     + ISDFGLS+     +V     G P       
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG------ 183
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    Y+   D WS GV+ + I+  G  P+
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAY-ILLCGYPPF 218

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +      K      +E+ +M+ + 
Sbjct: 26  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQGKAFKN-----RELQIMRKLD 71
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 184
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 224

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-WLAL 169
           E++ N  VV+RDL   NILL     V+ISD GL+ D      F   +P   +    ++A 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASVGTHGYMAP 359
Query: 170 ESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY 201
           E L   + Y + +D +S G +L++++  G +P+
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-WLAL 169
           E++ N  VV+RDL   NILL     V+ISD GL+ D      F   +P   +    ++A 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASVGTHGYMAP 359
Query: 170 ESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY 201
           E L   + Y + +D +S G +L++++  G +P+
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPF 391

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 137 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 192
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 193 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 225

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-WLAL 169
           E++ N  VV+RDL   NILL     V+ISD GL+ D      F   +P   +    ++A 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASVGTHGYMAP 359
Query: 170 ESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY 201
           E L   + Y + +D +S G +L++++  G +P+
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-WLAL 169
           E++ N  VV+RDL   NILL     V+ISD GL+ D      F   +P   +    ++A 
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASVGTHGYMAP 358
Query: 170 ESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY 201
           E L   + Y + +D +S G +L++++  G +P+
Sbjct: 359 EVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPF 390

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 136 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 191
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 192 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 13/103 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHV---VKISDFGLSEDI-YEQNVFQNGEPSEKLPI-- 164
           ++L N  + HRDL   NIL   P+    VKI DF L   I    +      P    P   
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 165 -RWLALE-----SLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             ++A E     S  ++IY  + D+WS GV+L+ I+  G  P+
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPF 226

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 135 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 190
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 191 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 223

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 56/221 (25%)
Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K +      K      +E+ +M+ + 
Sbjct: 26  KVIGNGSFGVVYQAKLCD------SGEL---VAIKKVLQGKAFKN-----RELQIMRKLD 71
Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCA-----------------------LGDLQ 105
            H +IV      Y     KDE  L LV++Y                         L   Q
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 106 SYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLP 163
            +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +        GEP+   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYIC 184
Query: 164 IRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 224

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALES 171
           YL    ++HRD+   NI+++    +K+ DFG +  +    +F     +    I + A E 
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGT----IEYCAPEV 200
Query: 172 LVSNIYTNKS-DVWSFGVVLWEIVTLGANPY 201
           L+ N Y     ++WS GV L+ +V    NP+
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLV-FEENPF 230

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 186
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 187 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 219

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 184
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 185 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGXVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E+L    +++RDL   N+LL     V+ISD GL+ ++        G         ++A E
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP---GFMAPE 359
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVT 195
            L+   Y    D ++ GV L+E++ 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 130 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 185
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 186 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 111 EYLSNNKVVHRDLATRNIL---LSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           +YL +  +VHRDL   N+L   L     + ISDFGLS+     +V     G P       
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG------ 183
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    Y+   D WS GV+ + I+  G  P+
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAY-ILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 111 EYLSNNKVVHRDLATRNIL---LSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           +YL +  +VHRDL   N+L   L     + ISDFGLS+     +V     G P       
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG------ 183
Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           ++A E L    Y+   D WS GV+ + I+  G  P+
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAY-ILLCGYPPF 218

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 186
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 187 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 219

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 181 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 236
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 237 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 269

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 49/87 (56%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-AL 169
           +Y+ +  VVHRDL   N+ ++    +KI DFGL+          + E +  +  RW  A 
Sbjct: 158 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA-------DAEMTGYVVTRWYRAP 210
Query: 170 ESLVSNIYTNKS-DVWSFGVVLWEIVT 195
           E ++S ++ N++ D+WS G ++ E++T
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
           +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +      ++
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYV 230
Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E L    Y    D+WS GV+++ I+  G  P+
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMY-ILLCGYPPF 263

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 48/211 (22%)
Query: 18  LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH 77
           LG+G +GVV K           SGQ     AVK ++A  +++   + L ++++       
Sbjct: 42  LGRGAYGVVEKX------RHVPSGQIX---AVKRIRATVNSQEQKRLLXDLDISXRTVDC 92
Query: 78  DHIVSFIGCCYKD----------ELRLVVEYCALGDLQSYLREEYL-------------- 113
              V+F G  +++          +  L   Y  + D    + E+ L              
Sbjct: 93  PFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 152
Query: 114 -SNNKVVHRDLATRNILLSSPHVVKISDFGLSE---DIYEQNVFQNGEPSEKLPIRWLAL 169
            S   V+HRD+   N+L+++   VK  DFG+S    D   +++    +P       + A 
Sbjct: 153 HSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKP-------YXAP 205
Query: 170 ESLVSNI----YTNKSDVWSFGVVLWEIVTL 196
           E +   +    Y+ KSD+WS G+   E+  L
Sbjct: 206 ERINPELNQKGYSVKSDIWSLGITXIELAIL 236

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 202
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 246

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E+L    +++RDL   N+LL     V+ISD GL+ ++        G         ++A E
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP---GFMAPE 359
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVT 195
            L+   Y    D ++ GV L+E++ 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E+L    +++RDL   N+LL     V+ISD GL+ ++        G         ++A E
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP---GFMAPE 359
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVT 195
            L+   Y    D ++ GV L+E++ 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 197
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 241

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 214
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 258

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 210
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 254

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 211
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 255

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 149 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 201
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 245

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 211
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 255

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 203
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 247

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E+L    +++RDL   N+LL     V+ISD GL+ ++        G         ++A E
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP---GFMAPE 359
Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVT 195
            L+   Y    D ++ GV L+E++ 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 203
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 247

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 193
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 237

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 203
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 247

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 198
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 242

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 210
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 254

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 193
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 138 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 190
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 234

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 196
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 240

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 197
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 241

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 187
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 231

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 197
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 241

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 188
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 193
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 237

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 49/87 (56%), Gaps = 9/87 (10%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL-AL 169
           +Y+ +  VVHRDL   N+ ++    +KI DFGL+          + E +  +  RW  A 
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA-------DAEMTGYVVTRWYRAP 192
Query: 170 ESLVSNIYTNKS-DVWSFGVVLWEIVT 195
           E ++S ++ N++ D+WS G ++ E++T
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 11/113 (9%)
Query: 94  LVVEYCALGDLQSYLREEYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNV 152
           L V Y  L   Q +    Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +     
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 175
Query: 153 FQNGEPS-EKLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
              GEP+   +  R+     L+  +  YT+  DVWS G VL E++ LG   +P
Sbjct: 176 ---GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 224

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL           + E +  +  RW    
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEMTGYVATRWYRAP 191
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 235

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 188
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 137 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 189
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 233

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E    +  RW    
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAP 211
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 255

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 187
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 231

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 47/215 (21%)
Query: 14  LGEVLGQGEFGVV-------------VKGLLGDG-PTEGASGQAAMEVAVK-MLKANADA 58
           +G  LG+G+FG V             +K L       EG   Q   E+ ++  L+     
Sbjct: 19  IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 78
Query: 59  KTYDKF--LKEINLM----------KDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQS 106
           + Y+ F   K I LM          K++ KH          + +EL   + YC       
Sbjct: 79  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC------- 131
Query: 107 YLREEYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                     KV+HRD+   N+L+     +KI+DFG S  ++  ++ +         + +
Sbjct: 132 -------HERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGT---LDY 179
Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           L  E +    +  K D+W  GV+ +E + +G  P+
Sbjct: 180 LPPEMIEGKTHDEKVDLWCAGVLCYEFL-VGMPPF 213

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           +Y+ +  ++HRDL   N+ ++    +KI DFGL+          + E +  +  RW    
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 187
Query: 171 SLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYP---HIPLCRIV 210
            ++ N   Y    D+WS G ++ E++T G   +P   HI   +++
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 231

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 3/83 (3%)
Query: 119 VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYT 178
            HRD+   NIL+S+     + DFG++    ++ + Q G     L   + A E    +  T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTL--YYXAPERFSESHAT 213
Query: 179 NKSDVWSFGVVLWEIVTLGANPY 201
            ++D+++   VL+E +T G+ PY
Sbjct: 214 YRADIYALTCVLYECLT-GSPPY 235

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	228
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-101
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-100
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-99
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-98
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-98
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-98
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-98
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-93
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-93
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-93
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-93
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-92
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-92
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-91
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-90
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-90
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-89
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-88
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-88
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-88
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-88
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-87
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-86
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-85
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-85
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-85
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-85
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-84
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-84
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-84
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-84
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-83
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-83
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-83
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-83
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-82
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-81
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-81
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-81
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-81
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-80
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-80
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-78
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-78
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-78
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-76
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-76
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-76
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-55
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-54
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-29
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-48
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-35
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-31
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-30
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-29
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-28
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-27
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-23
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-11
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-10
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-09
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-04

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  296 bits (759), Expect = e-101
 Identities = 95/259 (36%), Positives = 149/259 (57%), Gaps = 40/259 (15%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P ++L LG+ LG+G FG VV         +    + A+ VAVKMLK +A  K     + 
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 135

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR                
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ DI  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI 209
            + ++      +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP+  +
Sbjct: 256 IDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314

Query: 210 VHYLSTGYRMERPASCNEQ 228
              L  G+RM++PA+C  +
Sbjct: 315 FKLLKEGHRMDKPANCTNE 333

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  293 bits (753), Expect = e-100
 Identities = 95/259 (36%), Positives = 149/259 (57%), Gaps = 40/259 (15%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P ++L LG+ LG+G FG VV         +    + A+ VAVKMLK +A  K     + 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 89

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YLR                
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ DI  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI 209
            + ++      +LP++W+A E+L   +YT++SDVWSFGV++WEI TLG +PYP IP+  +
Sbjct: 210 IDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

Query: 210 VHYLSTGYRMERPASCNEQ 228
              L  G+RM++PA+C  +
Sbjct: 269 FKLLKEGHRMDKPANCTNE 287

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  291 bits (746), Expect = 4e-99
 Identities = 92/267 (34%), Positives = 134/267 (50%), Gaps = 50/267 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P E L  G+VLG G FG V+                +++VAVKMLK  AD+   +  + 
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMS 97

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+ +M  +G H++IV+ +G C     + L+ EYC  GDL +YLR                
Sbjct: 98  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 111 ----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG 142
                                       E+L     VHRDLA RN+L++   VVKI DFG
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217

Query: 143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           L+ DI   + +     + +LP++W+A ESL   IYT KSDVWS+G++LWEI +LG NPYP
Sbjct: 218 LARDIMSDSNYVVRG-NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276

Query: 203 HIPLCR-IVHYLSTGYRMERPASCNEQ 228
            IP+       +  G++M++P    E+
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEE 303

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  288 bits (740), Expect = 1e-98
 Identities = 90/261 (34%), Positives = 133/261 (50%), Gaps = 44/261 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++                  VAVKMLK  A    +   + 
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMS 79

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE-------------- 110
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                 E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199

Query: 149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR 208
           +   +       +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +  
Sbjct: 200 KDPDYVRKG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258

Query: 209 -IVHYLSTGYRMERPASCNEQ 228
                L  G RM  P     +
Sbjct: 259 EFCRRLKEGTRMRAPDYTTPE 279

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  287 bits (737), Expect = 3e-98
 Identities = 83/262 (31%), Positives = 129/262 (49%), Gaps = 45/262 (17%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P  RL  G+ LG G FG VV+              AAM VAVKMLK +A     +  + 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLI----KSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+ ++  +G H +IV+ +G C       ++ EYC  GDL ++LR                
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 111 -----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
                                   +L++   +HRDLA RNILL+   + KI DFGL+ DI
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC 207
              + +     + +LP++W+A ES+ + +YT +SDVWS+G+ LWE+ +LG++PYP +P+ 
Sbjct: 196 KNDSNYVVKG-NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 208 RIV-HYLSTGYRMERPASCNEQ 228
                 +  G+RM  P     +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAE 276

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  289 bits (742), Expect = 4e-98
 Identities = 94/259 (36%), Positives = 150/259 (57%), Gaps = 40/259 (15%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
            P +RL+LG+ LG+G FG VV         +        +VAVKMLK++A  K     + 
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIG--LDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 123

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+ +MK +GKH +I++ +G C +D  L ++VEY + G+L+ YL+                
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ DI+ 
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI 209
            + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+  +
Sbjct: 244 IDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302

Query: 210 VHYLSTGYRMERPASCNEQ 228
              L  G+RM++P++C  +
Sbjct: 303 FKLLKEGHRMDKPSNCTNE 321

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  286 bits (735), Expect = 6e-98
 Identities = 108/267 (40%), Positives = 146/267 (54%), Gaps = 51/267 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P + L+LG+ LG+GEFG VVK                  VAVKMLK NA        L 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLS 75

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E N++K V  H H++   G C +D  L L+VEY   G L+ +LRE               
Sbjct: 76  EFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                        +YL+  K+VHRDLA RNIL++    +KISDF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS D+YE++ +       ++P++W+A+ESL  +IYT +SDVWSFGV+LWEIVTLG NPY
Sbjct: 195 GLSRDVYEEDSYVKRSQG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

Query: 202 PHIPLCRIVHYLSTGYRMERPASCNEQ 228
           P IP  R+ + L TG+RMERP +C+E+
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEE 280

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  286 bits (735), Expect = 1e-97
 Identities = 86/258 (33%), Positives = 135/258 (52%), Gaps = 41/258 (15%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P   L  G+ LG G FG VV+        E A     ++VAVKMLK+ A A   +  + 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV----LKVAVKMLKSTAHADEKEALMS 98

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+ +M  +G+H++IV+ +G C     + ++ EYC  GDL ++LR                
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 111 -------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
                               +L++   +HRD+A RN+LL++ HV KI DFGL+ DI   +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

Query: 152 VFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR-IV 210
            +     + +LP++W+A ES+   +YT +SDVWS+G++LWEI +LG NPYP I +     
Sbjct: 219 NYIVKG-NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277

Query: 211 HYLSTGYRMERPASCNEQ 228
             +  GY+M +PA   + 
Sbjct: 278 KLVKDGYQMAQPAFAPKN 295

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  283 bits (726), Expect = 2e-96
 Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 52/260 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               +   +V+G+G FG V+K  +             M+ A+K +K  A    +  F  E
Sbjct: 23  DWNDIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGE 75

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
           + ++  +G H +I++ +G C     L L +EY   G+L  +LR+                
Sbjct: 76  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135

Query: 111 --------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS--EDIY 148
                               +YLS  + +HRDLA RNIL+   +V KI+DFGLS  +++Y
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195

Query: 149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR 208
            +     G    +LP+RW+A+ESL  ++YT  SDVWS+GV+LWEIV+LG  PY  +    
Sbjct: 196 VKK--TMG----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

Query: 209 IVHYLSTGYRMERPASCNEQ 228
           +   L  GYR+E+P +C+++
Sbjct: 250 LYEKLPQGYRLEKPLNCDDE 269

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  278 bits (713), Expect = 1e-94
 Identities = 86/252 (34%), Positives = 133/252 (52%), Gaps = 41/252 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFL 65
                LILG++LG+GEFG V++G L            +++VAVK +K  N+  +  ++FL
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGT------SLKVAVKTMKLDNSSQREIEEFL 84

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDE------LRLVVEYCALGDLQSYLRE--------- 110
            E   MKD   H +++  +G C +          +++ +   GDL +YL           
Sbjct: 85  SEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143

Query: 111 -----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF 153
                            EYLSN   +HRDLA RN +L     V ++DFGLS+ IY  + +
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203

Query: 154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL 213
           + G  + K+P++W+A+ESL   +YT+KSDVW+FGV +WEI T G  PYP +    +  YL
Sbjct: 204 RQGRIA-KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262

Query: 214 STGYRMERPASC 225
             G+R+++P  C
Sbjct: 263 LHGHRLKQPEDC 274

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  276 bits (709), Expect = 8e-94
 Identities = 80/250 (32%), Positives = 126/250 (50%), Gaps = 37/250 (14%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
              E++ +   LGQG FG+V +G+           +    VA+K +   A  +   +FL 
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E ++MK+     H+V  +G   + +   +++E    GDL+SYLR                
Sbjct: 78  EASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 111 ---------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
                           YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++ 
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
           G     LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++  
Sbjct: 197 GG-KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255

Query: 216 GYRMERPASC 225
           G  +++P +C
Sbjct: 256 GGLLDKPDNC 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  275 bits (706), Expect = 1e-93
 Identities = 87/240 (36%), Positives = 127/240 (52%), Gaps = 31/240 (12%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
             +   EV+G+G FG V  G L D           +  AVK L    D     +FL E  
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           +MKD   H +++S +G C + E    +V+ Y   GDL++++R                  
Sbjct: 79  IMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE-KLPIR 165
               +YL++ K VHRDLA RN +L     VK++DFGL+ D+Y++  +     +  KLP++
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P  C
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  276 bits (707), Expect = 3e-93
 Identities = 85/264 (32%), Positives = 119/264 (45%), Gaps = 51/264 (19%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           YP   +     +G+G FG V +             +    VAVKMLK  A A     F +
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQR 99

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E  LM +   + +IV  +G C   + + L+ EY A GDL  +LR                
Sbjct: 100 EAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 111 -----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF 141
                                         YLS  K VHRDLATRN L+    VVKI+DF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218

Query: 142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           GLS +IY  + ++       +PIRW+  ES+  N YT +SDVW++GVVLWEI + G  PY
Sbjct: 219 GLSRNIYSADYYKADGND-AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

Query: 202 PHIPLCRIVHYLSTGYRMERPASC 225
             +    +++Y+  G  +  P +C
Sbjct: 278 YGMAHEEVIYYVRDGNILACPENC 301

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  273 bits (700), Expect = 7e-93
 Identities = 82/240 (34%), Positives = 124/240 (51%), Gaps = 31/240 (12%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
                  V+G+G FGVV  G   D        Q  ++ A+K L    + +  + FL+E  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQ------AQNRIQCAIKSLSRITEMQQVEAFLREGL 74

Query: 70  LMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE----------------- 110
           LM+ +  H ++++ IG     E    +++ Y   GDL  ++R                  
Sbjct: 75  LMRGL-NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE-KLPIR 165
               EYL+  K VHRDLA RN +L     VK++DFGL+ DI ++  +   +    +LP++
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W ALESL +  +T KSDVWSFGV+LWE++T GA PY HI    + H+L+ G R+ +P  C
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYC 253

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  274 bits (702), Expect = 9e-93
 Identities = 89/253 (35%), Positives = 131/253 (51%), Gaps = 42/253 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT-YDKFL 65
            P ++  LG +LG+GEFG V +  L           + ++VAVKMLKA+  A +  ++FL
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQ------EDGSFVKVAVKMLKADIIASSDIEEFL 73

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDE-------LRLVVEYCALGDLQSYLRE-------- 110
           +E   MK+   H H+   +G   +           +++ +   GDL ++L          
Sbjct: 74  REAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 111 ------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV 152
                             EYLS+   +HRDLA RN +L+    V ++DFGLS  IY  + 
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192

Query: 153 FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY 212
           ++ G  S KLP++WLALESL  N+YT  SDVW+FGV +WEI+T G  PY  I    I +Y
Sbjct: 193 YRQGCAS-KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251

Query: 213 LSTGYRMERPASC 225
           L  G R+++P  C
Sbjct: 252 LIGGNRLKQPPEC 264

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  275 bits (706), Expect = 1e-92
 Identities = 86/242 (35%), Positives = 126/242 (52%), Gaps = 31/242 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               +   EV+G+G FG V  G L D           +  AVK L    D     +FL E
Sbjct: 87  SSLIVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTE 140

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE--------------- 110
             +MKD   H +++S +G C + E    +V+ Y   GDL++++R                
Sbjct: 141 GIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE-KLP 163
                 ++L++ K VHRDLA RN +L     VK++DFGL+ D+Y++        +  KLP
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA 223
           ++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +P 
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 319

Query: 224 SC 225
            C
Sbjct: 320 YC 321

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  271 bits (696), Expect = 7e-92
 Identities = 82/245 (33%), Positives = 123/245 (50%), Gaps = 28/245 (11%)

Query: 2   ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY 61
           AL            +VLG G FG V KGL           +  + VA+K L+     K  
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW-----IPEGEKVKIPVAIKELREATSPKAN 61

Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------- 110
            + L E  +M  V  + H+   +G C    ++L+ +    G L  Y+RE           
Sbjct: 62  KEILDEAYVMASV-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 120

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                      YL + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG- 179

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME 220
           K+PI+W+ALES++  IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239

Query: 221 RPASC 225
           +P  C
Sbjct: 240 QPPIC 244

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  267 bits (686), Expect = 7e-91
 Identities = 76/256 (29%), Positives = 115/256 (44%), Gaps = 43/256 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
                +   E LG+  FG V KG L         G+    VA+K LK  A+    ++F  
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRH 61

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE--------------- 110
           E  L     +H ++V  +G   KD+   ++  YC+ GDL  +L                 
Sbjct: 62  EAMLRAR-LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                EYLS++ VVH+DLATRN+L+     VKISD GL  ++Y 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI 209
            + ++    S  LPIRW+A E+++   ++  SD+WS+GVVLWE+ + G  PY       +
Sbjct: 181 ADYYKLLGNS-LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239

Query: 210 VHYLSTGYRMERPASC 225
           V  +     +  P  C
Sbjct: 240 VEMIRNRQVLPCPDDC 255

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  267 bits (685), Expect = 4e-90
 Identities = 82/250 (32%), Positives = 127/250 (50%), Gaps = 37/250 (14%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
            P + + L   LG G FG V +G +   P    +  + ++VAVK L      +    FL 
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLM 82

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE--------------- 110
           E  ++     H +IV  IG   +   R ++ E  A GDL+S+LRE               
Sbjct: 83  EALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 111 ------------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN 155
                       +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY  + ++ 
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201

Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
           G  +  LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++
Sbjct: 202 GGCA-MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260

Query: 216 GYRMERPASC 225
           G RM+ P +C
Sbjct: 261 GGRMDPPKNC 270

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  268 bits (687), Expect = 5e-90
 Identities = 82/250 (32%), Positives = 126/250 (50%), Gaps = 37/250 (14%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
            P + + L   LG G FG V +G +   P    +  + ++VAVK L      +    FL 
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLM 123

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE--------------- 110
           E  ++     H +IV  IG   +   R ++ E  A GDL+S+LRE               
Sbjct: 124 EALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 111 ------------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN 155
                       +YL  N  +HRD+A RN LL+ P    V KI DFG++ DIY    ++ 
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242

Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
           G  +  LP++W+  E+ +  I+T+K+D WSFGV+LWEI +LG  PYP      ++ ++++
Sbjct: 243 GGCA-MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301

Query: 216 GYRMERPASC 225
           G RM+ P +C
Sbjct: 302 GGRMDPPKNC 311

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  265 bits (680), Expect = 2e-89
 Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 28/239 (11%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               L   +VLG G FG V KG+              + V +K+++  +  +++      
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVW-----IPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
           +  +  +  H HIV  +G C    L+LV +Y  LG L  ++R+                 
Sbjct: 66  MLAIGSL-DHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL  + +VHR+LA RN+LL SP  V+++DFG+++ +   +       + K PI+W
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA-KTPIKW 183

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +ALES+    YT++SDVWS+GV +WE++T GA PY  + L  +   L  G R+ +P  C
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC 242

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  262 bits (672), Expect = 1e-88
 Identities = 83/256 (32%), Positives = 122/256 (47%), Gaps = 44/256 (17%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
                ++L   LG+G FG V      +        +  M VAVK LK +        F +
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLS----PTKDKMLVAVKALK-DPTLAARKDFQR 66

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E  L+ ++ +H+HIV F G C   + L +V EY   GDL  +LR                
Sbjct: 67  EAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                 YL++   VHRDLATRN L+ +  +VKI DFG+S D+Y 
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI 209
            + ++ G  +  LPIRW+  ES++   +T +SDVWSFGV+LWEI T G  P+  +    +
Sbjct: 186 TDYYRVGGHT-MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244

Query: 210 VHYLSTGYRMERPASC 225
           +  ++ G  +ERP  C
Sbjct: 245 IECITQGRVLERPRVC 260

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  263 bits (674), Expect = 2e-88
 Identities = 88/255 (34%), Positives = 121/255 (47%), Gaps = 43/255 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
                ++L   LG+G FG V      +        Q  M VAVK LK  +++   D F +
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLL----PEQDKMLVAVKALKEASESARQD-FQR 92

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE--------------- 110
           E  L+  + +H HIV F G C +    L+V EY   GDL  +LR                
Sbjct: 93  EAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151

Query: 111 --------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ 150
                                YL+    VHRDLATRN L+    VVKI DFG+S DIY  
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211

Query: 151 NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
           + ++ G  +  LPIRW+  ES++   +T +SDVWSFGVVLWEI T G  P+  +     +
Sbjct: 212 DYYRVGGRT-MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270

Query: 211 HYLSTGYRMERPASC 225
             ++ G  +ERP +C
Sbjct: 271 DCITQGRELERPRAC 285

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  263 bits (673), Expect = 2e-88
 Identities = 82/245 (33%), Positives = 123/245 (50%), Gaps = 28/245 (11%)

Query: 2   ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY 61
           AL            +VLG G FG V KGL           +  + VA+K L+     K  
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIP-----EGEKVKIPVAIKELREATSPKAN 61

Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------- 110
            + L E  +M  V  + H+   +G C    ++L+ +    G L  Y+RE           
Sbjct: 62  KEILDEAYVMASV-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 120

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                      YL + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG- 179

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME 220
           K+PI+W+ALES++  IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239

Query: 221 RPASC 225
           +P  C
Sbjct: 240 QPPIC 244

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  262 bits (672), Expect = 2e-88
 Identities = 77/255 (30%), Positives = 113/255 (44%), Gaps = 42/255 (16%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +    L     LG+G FG V      D   +G        VAVK LKA+A  +    + +
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCY-DPTNDGTG----EMVAVKALKADAGPQHRSGWKQ 82

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE------------- 110
           EI++++ +  H+HI+ + GCC       L+LV+EY  LG L+ YL               
Sbjct: 83  EIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ 141

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL     +HRDLA RN+LL +  +VKI DFGL++ + E + +         P+
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG--------------ANPYPHIPLCRIV 210
            W A E L    +   SDVWSFGV L+E++T                      + + R+ 
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 211 HYLSTGYRMERPASC 225
             L  G R+ RP  C
Sbjct: 262 ELLERGERLPRPDKC 276

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  259 bits (663), Expect = 3e-87
 Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 44/256 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               L     LG+G FG V          +        +VAVK LK  +         KE
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRY-----DPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE-------------- 110
           I +++++  H++IV + G C +D    ++L++E+   G L+ YL +              
Sbjct: 74  IEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  +YL + + VHRDLA RN+L+ S H VKI DFGL++ I     +   +     P
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLG--------------ANPYPHIPLCRI 209
           + W A E L+ + +   SDVWSFGV L E++T                   +  + + R+
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252

Query: 210 VHYLSTGYRMERPASC 225
           V+ L  G R+  P +C
Sbjct: 253 VNTLKEGKRLPCPPNC 268

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  256 bits (656), Expect = 2e-86
 Identities = 87/242 (35%), Positives = 126/242 (52%), Gaps = 45/242 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + L L + +G+GEFG V+ G                +VAVK +K +A A+    FL E
Sbjct: 19  NMKELKLLQTIGKGEFGDVMLGDYRG-----------NKVAVKCIKNDATAQ---AFLAE 64

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE--------------- 110
            ++M  + +H ++V  +G   +++  L +V EY A G L  YLR                
Sbjct: 65  ASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++         G    KLP
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTG----KLP 177

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA 223
           ++W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P 
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 237

Query: 224 SC 225
            C
Sbjct: 238 GC 239

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  254 bits (651), Expect = 1e-85
 Identities = 74/239 (30%), Positives = 119/239 (49%), Gaps = 30/239 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             E ++L  +LG+G FG V +G+  +           + VAVK  K +      +KF+ E
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSE 63

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
             +MK++  H HIV  IG   ++   +++E    G+L  YL                   
Sbjct: 64  AVIMKNL-DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL +   VHRD+A RNIL++SP  VK+ DFGLS  I +++ ++      +LPI+W
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPIKW 180

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           ++ ES+    +T  SDVW F V +WEI++ G  P+  +    ++  L  G R+ +P  C
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  254 bits (651), Expect = 1e-85
 Identities = 77/239 (32%), Positives = 122/239 (51%), Gaps = 30/239 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             ER+ LG  +G+G+FG V +G+             A+ VA+K  K        +KFL+E
Sbjct: 13  QRERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQE 66

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
              M+    H HIV  IG   ++ + +++E C LG+L+S+L+                  
Sbjct: 67  ALTMRQF-DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++      KLPI+W
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKW 183

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +A ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  252 bits (647), Expect = 7e-85
 Identities = 78/257 (30%), Positives = 120/257 (46%), Gaps = 46/257 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               L   + LG+G FG V          +         VAVK L+ + +    D F +E
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRY-----DPLQDNTGEVVAVKKLQHSTEEHLRD-FERE 61

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE-------------- 110
           I ++K + +HD+IV + G CY      L+L++EY   G L+ YL++              
Sbjct: 62  IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  EYL   + +HRDLATRNIL+ + + VKI DFGL++ + +   F   +   + P
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCR 208
           I W A ESL  + ++  SDVWSFGVVL+E+ T               +G +    + +  
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

Query: 209 IVHYLSTGYRMERPASC 225
           ++  L    R+ RP  C
Sbjct: 241 LIELLKNNGRLPRPDGC 257

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  254 bits (650), Expect = 7e-85
 Identities = 77/257 (29%), Positives = 120/257 (46%), Gaps = 46/257 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               L   + LG+G FG V          +         VAVK L+ + +    D F +E
Sbjct: 39  EERHLKFLQQLGKGNFGSVEMCRY-----DPLQDNTGEVVAVKKLQHSTEEHLRD-FERE 92

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE-------------- 110
           I ++K + +HD+IV + G CY      L+L++EY   G L+ YL++              
Sbjct: 93  IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  EYL   + +HRDLATRNIL+ + + VKI DFGL++ + +   +   +   + P
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVT---------------LGANPYPHIPLCR 208
           I W A ESL  + ++  SDVWSFGVVL+E+ T               +G +    + +  
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

Query: 209 IVHYLSTGYRMERPASC 225
           ++  L    R+ RP  C
Sbjct: 272 LIELLKNNGRLPRPDGC 288

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  253 bits (649), Expect = 1e-84
 Identities = 76/240 (31%), Positives = 114/240 (47%), Gaps = 29/240 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
              R+ + +++G G+ G V  G L         GQ  + VA+K LKA    +    FL E
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLR------VPGQRDVPVAIKALKAGYTERQRRDFLSE 100

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M     H +I+   G   +     +V EY   G L ++LR                 
Sbjct: 101 ASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 YLS+   VHRDLA RN+L+ S  V K+SDFGLS  + +           K+PIR
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +++ SDVWSFGVV+WE++  G  PY ++    ++  +  GYR+  P  C
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC 279

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  252 bits (645), Expect = 1e-84
 Identities = 87/245 (35%), Positives = 122/245 (49%), Gaps = 45/245 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               + +   LG G++G V +G+                VAVK LK +      ++FLKE
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLT---------VAVKTLKEDTMEV--EEFLKE 59

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
             +MK++ KH ++V  +G C ++    ++ E+   G+L  YLRE                
Sbjct: 60  AAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
                 EYL     +HRDLA RN L+   H+VK++DFGLS     D Y  +         
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------GA 172

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME 220
           K PI+W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRME
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232

Query: 221 RPASC 225
           RP  C
Sbjct: 233 RPEGC 237

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  253 bits (647), Expect = 2e-84
 Identities = 82/258 (31%), Positives = 118/258 (45%), Gaps = 47/258 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +    L     LG+G FG V          +         VAVK L+ +   +  D F +
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRY-----DPLGDNTGALVAVKQLQHSGPDQQRD-FQR 73

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE---LRLVVEYCALGDLQSYLRE------------- 110
           EI ++K +   D IV + G  Y      LRLV+EY   G L+ +L+              
Sbjct: 74  EIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEPSEK 161
                   EYL + + VHRDLA RNIL+ S   VKI+DFGL++ +  +++ +   EP  +
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG-Q 191

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY--------------PHIPLC 207
            PI W A ESL  NI++ +SDVWSFGVVL+E+ T                        L 
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

Query: 208 RIVHYLSTGYRMERPASC 225
           R++  L  G R+  P +C
Sbjct: 252 RLLELLEEGQRLPAPPAC 269

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  262 bits (670), Expect = 4e-84
 Identities = 78/239 (32%), Positives = 123/239 (51%), Gaps = 30/239 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             ER+ LG  +G+G+FG V +G+             AM VA+K  K        +KFL+E
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMS------PENPAMAVAIKTCKNCTSDSVREKFLQE 441

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
              M+    H HIV  IG   ++ + +++E C LG+L+S+L+                  
Sbjct: 442 ALTMRQF-DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++  +   KLPI+W
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKW 558

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           +A ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  252 bits (646), Expect = 1e-83
 Identities = 80/243 (32%), Positives = 124/243 (51%), Gaps = 33/243 (13%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             E L+LGE +G+G FG V  G L    T          VAVK  +         KFL+E
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTL---------VAVKSCRETLPPDLKAKFLQE 162

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
             ++K    H +IV  IG C + + + +V+E    GD  ++LR                 
Sbjct: 163 ARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL +   +HRDLA RN L++  +V+KISDFG+S +  +     +G    ++P++
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG-GLRQVPVK 280

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+L    Y+++SDVWSFG++LWE  +LGA+PYP++   +   ++  G R+  P  C
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC 340

Query: 226 NEQ 228
            + 
Sbjct: 341 PDA 343

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  254 bits (651), Expect = 2e-83
 Identities = 86/242 (35%), Positives = 126/242 (52%), Gaps = 45/242 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + L L + +G+GEFG V+ G                 VAVK +K +A A+    FL E
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATAQ---AFLAE 236

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE--------------- 110
            ++M  + +H ++V  +G   +++  L +V EY A G L  YLR                
Sbjct: 237 ASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++          + + KLP
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS------TQDTGKLP 349

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA 223
           ++W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P 
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 409

Query: 224 SC 225
            C
Sbjct: 410 GC 411

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  248 bits (635), Expect = 3e-83
 Identities = 80/240 (33%), Positives = 111/240 (46%), Gaps = 37/240 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G                +VAVK LK  + +   D FL E
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY----------NGHTKVAVKSLKQGSMSP--DAFLAE 58

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 59  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIK 175

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  249 bits (638), Expect = 5e-83
 Identities = 87/243 (35%), Positives = 126/243 (51%), Gaps = 34/243 (13%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
            P  +   +V+G GEFG V KG+L     + +SG+  + VA+K LKA    K    FL E
Sbjct: 42  HPSCVTRQKVIGAGEFGEVYKGML-----KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE---------------- 110
             +M     H +I+   G   K +  +++ EY   G L  +LRE                
Sbjct: 97  AGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPSEKL 162
                +YL+N   VHRDLA RNIL++S  V K+SDFGLS   ED  E     +G    K+
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG---KI 212

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
           PIRW A E++    +T+ SDVWSFG+V+WE++T G  PY  +    ++  ++ G+R+  P
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272

Query: 223 ASC 225
             C
Sbjct: 273 MDC 275

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  245 bits (628), Expect = 3e-82
 Identities = 74/240 (30%), Positives = 118/240 (49%), Gaps = 37/240 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             E + L + LG G+FGVV  G            +   +VAVKM+K  + ++  D+F +E
Sbjct: 6   KREEITLLKELGSGQFGVVKLGKW----------KGQYDVAVKMIKEGSMSE--DEFFQE 53

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
              M  +  H  +V F G C K+  + +V EY + G L +YLR                 
Sbjct: 54  AQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 +L +++ +HRDLA RN L+     VK+SDFG++  + +     +     K P++
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVK 170

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E      Y++KSDVW+FG+++WE+ +LG  PY       +V  +S G+R+ RP   
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA 230

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  242 bits (621), Expect = 3e-81
 Identities = 69/240 (28%), Positives = 113/240 (47%), Gaps = 37/240 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
            P  L   + +G G+FG+V  G                +VA+K ++  A ++  + F++E
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGYW----------LNKDKVAIKTIREGAMSE--EDFIEE 53

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
             +M  +  H  +V   G C +   + LV E+   G L  YLR                 
Sbjct: 54  AEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 YL    V+HRDLA RN L+    V+K+SDFG++  + +     +     K P++
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVK 170

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P   
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 230

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  242 bits (621), Expect = 6e-81
 Identities = 82/240 (34%), Positives = 115/240 (47%), Gaps = 30/240 (12%)

Query: 8   PPERLILGE-VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY-DKFL 65
             + L L +  LG G FG V KG                 VAVK+LK  A+     D+ L
Sbjct: 14  DRKLLTLEDKELGSGNFGTVKKGYYQMKKVV-------KTVAVKILKNEANDPALKDELL 66

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------- 110
            E N+M+ +  + +IV  IG C  +   LV+E   LG L  YL++               
Sbjct: 67  AEANVMQQL-DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL  +  VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E +    +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 245

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  242 bits (620), Expect = 7e-81
 Identities = 77/240 (32%), Positives = 123/240 (51%), Gaps = 37/240 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
            P+ L   + LG G+FGVV  G            +   +VA+KM+K  + ++  D+F++E
Sbjct: 22  DPKDLTFLKELGTGQFGVVKYGKW----------RGQYDVAIKMIKEGSMSE--DEFIEE 69

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
             +M ++  H+ +V   G C K   + ++ EY A G L +YLRE                
Sbjct: 70  AKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL + + +HRDLA RN L++   VVK+SDFGLS  + +     +     K P+R
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVR 186

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W   E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  242 bits (620), Expect = 8e-81
 Identities = 71/240 (29%), Positives = 119/240 (49%), Gaps = 30/240 (12%)

Query: 8   PPERLILGEV-LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
             + L++ ++ LG G FG V +G+      +       ++VA+K+LK   +    ++ ++
Sbjct: 7   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMR 59

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E  +M  +  + +IV  IG C  + L LV+E    G L  +L                  
Sbjct: 60  EAQIMHQL-DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL     VHRDLA RN+LL + H  KISDFGLS+ +   + +     + K P++
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E +    ++++SDVWS+GV +WE ++ G  PY  +    ++ ++  G RME P  C
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  242 bits (619), Expect = 1e-80
 Identities = 76/242 (31%), Positives = 115/242 (47%), Gaps = 31/242 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFL 65
             + L L E LG G FGVV +G         A     + VAVK LK +     +  D F+
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFI 69

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------- 110
           +E+N M  +  H +++   G      +++V E   LG L   LR+               
Sbjct: 70  REVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     +   K+P 
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYRMERPA 223
            W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G R+ RP 
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248

Query: 224 SC 225
            C
Sbjct: 249 DC 250

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  244 bits (625), Expect = 2e-80
 Identities = 77/240 (32%), Positives = 116/240 (48%), Gaps = 29/240 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               + + +V+G GEFG V  G L          +  + VA+K LK     K    FL E
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGE 96

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M     H +I+   G   K + + +V EY   G L S+LR+                
Sbjct: 97  ASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YLS+   VHRDLA RNIL++S  V K+SDFGL   + +           K+PIR
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W + E++    +T+ SDVWS+G+VLWE+++ G  PY  +    ++  +  GYR+  P  C
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  241 bits (618), Expect = 4e-78
 Identities = 87/245 (35%), Positives = 121/245 (49%), Gaps = 45/245 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               + +   LG G++G V +G+                VAVK LK   D    ++FLKE
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLT---------VAVKTLKE--DTMEVEEFLKE 266

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
             +MK++ KH ++V  +G C ++    ++ E+   G+L  YLRE                
Sbjct: 267 AAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS----EDIYEQNVFQNGEPSE 160
                 EYL     +HR+LA RN L+   H+VK++DFGLS     D Y            
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA------HAGA 379

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME 220
           K PI+W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRME
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439

Query: 221 RPASC 225
           RP  C
Sbjct: 440 RPEGC 444

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  240 bits (614), Expect = 6e-78
 Identities = 80/242 (33%), Positives = 117/242 (48%), Gaps = 41/242 (16%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L + LG G+FG V      +  T+         VAVK +K  + +   + FL E
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATY-NKHTK---------VAVKTMKPGSMSV--EAFLAE 233

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            N+MK + +HD +V       K+ + ++ E+ A G L  +L+                  
Sbjct: 234 ANVMKTL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE--KLP 163
                 ++     +HRDL   NIL+S+  V KI+DFGL+  I +          E  K P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFP 348

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA 223
           I+W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP 
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 408

Query: 224 SC 225
           +C
Sbjct: 409 NC 410

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  234 bits (600), Expect = 7e-78
 Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 42/249 (16%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             E LI  E LGQG F  + KG+  +            EV +K+L   A     + F + 
Sbjct: 6   RNEDLIFNESLGQGTFTKIFKGVRRE--VGDYGQLHETEVLLKVLD-KAHRNYSESFFEA 62

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
            ++M  +  H H+V   G C   +   LV E+   G L +YL++                
Sbjct: 63  ASMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121

Query: 111 -----EYLSNNKVVHRDLATRNILLSS--------PHVVKISDFGLSEDIYEQNVFQNGE 157
                 +L  N ++H ++  +NILL          P  +K+SD G+S  +  ++      
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ 175

Query: 158 PSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
              +  I W+  E +         +D WSFG  LWEI + G  P   +   R + +    
Sbjct: 176 -ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234

Query: 217 YRMERPASC 225
           +++  P + 
Sbjct: 235 HQLPAPKAA 243

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  239 bits (610), Expect = 1e-76
 Identities = 74/240 (30%), Positives = 107/240 (44%), Gaps = 37/240 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G                 VA+K LK    +   + FL+E
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTW----------NGTTRVAIKTLKPGTMSP--EAFLQE 312

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
             +MK + +H+ +V       ++ + +V EY + G L  +L+                  
Sbjct: 313 AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I +           K PI+
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIK 429

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  236 bits (604), Expect = 2e-76
 Identities = 74/240 (30%), Positives = 107/240 (44%), Gaps = 37/240 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G                 VA+K LK    +   + FL+E
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTW----------NGTTRVAIKTLKPGTMSP--EAFLQE 229

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
             +MK + +H+ +V       ++ + +V EY + G L  +L+                  
Sbjct: 230 AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I +           K PI+
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIK 346

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  240 bits (613), Expect = 4e-76
 Identities = 70/240 (29%), Positives = 118/240 (49%), Gaps = 30/240 (12%)

Query: 8   PPERLILGE-VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
             + L++ +  LG G FG V +G+      +       ++VA+K+LK   +    ++ ++
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMR 385

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E  +M  +  + +IV  IG C  + L LV+E    G L  +L                  
Sbjct: 386 EAQIMHQL-DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL     VHR+LA RN+LL + H  KISDFGLS+ +   + +     + K P++
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E +    ++++SDVWS+GV +WE ++ G  PY  +    ++ ++  G RME P  C
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 564

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  190 bits (485), Expect = 3e-60
 Identities = 68/255 (26%), Positives = 109/255 (42%), Gaps = 45/255 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
            P  LI GEVLG+G FG  +K    +      +G+    + +K L    D +T   FLKE
Sbjct: 8   RPSDLIHGEVLGKGCFGQAIKVTHRE------TGEV---MVMKELI-RFDEETQRTFLKE 57

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
           + +M+ + +H +++ FIG  YKD+ L  + EY   G L+  ++                 
Sbjct: 58  VKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI- 164
                 YL +  ++HRDL + N L+     V ++DFGL+  + ++     G  S K P  
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 165 ----------RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY-L 213
                      W+A E +    Y  K DV+SFG+VL EI+        ++P        +
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236

Query: 214 STGYRMERPASCNEQ 228
                   P +C   
Sbjct: 237 RGFLDRYCPPNCPPS 251

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  182 bits (464), Expect = 2e-57
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 45/251 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLK 66
           P  ++ +G+ +G G FG V KG                +VAVKML       +    F  
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKN 69

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E+ +++   +H +I+ F+G     +L +V ++C    L  +L                  
Sbjct: 70  EVGVLRKT-RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL    ++HRDL + NI L   + VKI DFGL+     +    +        I 
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSIL 187

Query: 166 WLALESL---VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI-PLCRIVHYLSTGYRM-- 219
           W+A E +    SN Y+ +SDV++FG+VL+E++T G  PY +I    +I+  +  G     
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIEMVGRGSLSPD 246

Query: 220 --ERPASCNEQ 228
             +  ++C ++
Sbjct: 247 LSKVRSNCPKR 257

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  177 bits (450), Expect = 2e-55
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 53/256 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD---AKTYDKF 64
               L L E++G G FG V +                 EVAVK  + + D   ++T +  
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIG-----------DEVAVKAARHDPDEDISQTIENV 53

Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------- 110
            +E  L   + KH +I++  G C K+  L LV+E+   G L   L               
Sbjct: 54  RQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAV 112

Query: 111 ------EYLSNNK---VVHRDLATRNILLSSP--------HVVKISDFGLSEDIYEQNVF 153
                  YL +     ++HRDL + NIL+            ++KI+DFGL+ + +     
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----- 167

Query: 154 QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY- 212
           +  + S      W+A E + +++++  SDVWS+GV+LWE++T G  P+  I    + +  
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAVAYGV 226

Query: 213 LSTGYRMERPASCNEQ 228
                 +  P++C E 
Sbjct: 227 AMNKLALPIPSTCPEP 242

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  176 bits (447), Expect = 5e-54
 Identities = 55/119 (46%), Positives = 77/119 (64%), Gaps = 2/119 (1%)

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY+   +       +LP++W+A E
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPE 265

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRMERPASCNEQ 228
           ++   +YT +SDVWSFGV+LWEI +LGA+PYP + +       L  G RM  P     +
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 324

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  111 bits (280), Expect = 2e-29
 Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 22/181 (12%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           +P +RL LG+ LG+G FG V++                  VAVKMLK  A    +   + 
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMS 74

Query: 67  EINLMKDVGKHDHIVSFIGCCYK--DELRLVVEYCALGDLQSYLREEYLSNNKV------ 118
           E+ ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR +             
Sbjct: 75  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134

Query: 119 ----------VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
                     +  DL  R   ++S      S F   + + +    +  E   K  +    
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194

Query: 169 L 169
           L
Sbjct: 195 L 195

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  168 bits (427), Expect = 1e-51
 Identities = 70/249 (28%), Positives = 109/249 (43%), Gaps = 44/249 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLK 66
           P   L + E +G G FG V +                 +VAVK+L   +  A+  ++FL+
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWHG-----------SDVAVKILMEQDFHAERVNEFLR 83

Query: 67  EINLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE--------------- 110
           E+ +MK + +H +IV F+G   +   L +V EY + G L   L +               
Sbjct: 84  EVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142

Query: 111 --------EYL--SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                    YL   N  +VHR+L + N+L+   + VK+ DFGLS       +        
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG- 201

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY-LSTGYRM 219
                W+A E L       KSDV+SFGV+LWE+ T    P+ ++   ++V        R+
Sbjct: 202 --TPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRL 258

Query: 220 ERPASCNEQ 228
           E P + N Q
Sbjct: 259 EIPRNLNPQ 267

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  166 bits (422), Expect = 1e-50
 Identities = 51/249 (20%), Positives = 95/249 (38%), Gaps = 49/249 (19%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLK 66
           P E+L +GE++G+G FG V  G                EVA++++     +      F +
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKR 78

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           E+   +   +H+++V F+G C     L ++   C    L S +R+               
Sbjct: 79  EVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP- 163
                  YL    ++H+DL ++N+   +   V I+DFGL          +  +       
Sbjct: 138 EIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 164 -IRWLALE---------SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL 213
            +  LA E               ++  SDV++ G + +E+      P+   P   I+  +
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQPAEAIIWQM 255

Query: 214 STGYRMERP 222
            TG +    
Sbjct: 256 GTGMKPNLS 264

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  160 bits (406), Expect = 1e-48
 Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 57/260 (21%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD------AKTY 61
               +   + +G+G FG+V KG L    +          VA+K L            + +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSV---------VAIKSLILGDSEGETEMIEKF 67

Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------- 110
            +F +E+ +M ++  H +IV   G    +  R+V+E+   GDL   L +           
Sbjct: 68  QEFQREVFIMSNL-NHPNIVKLYGLM-HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125

Query: 111 ----------EYL--SNNKVVHRDLATRNILLSS-----PHVVKISDFGLSEDIYEQNVF 153
                     EY+   N  +VHRDL + NI L S     P   K++DFGLS+        
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG 185

Query: 154 QNGEPSEKLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH 211
             G        +W+A E++      YT K+D +SF ++L+ I+T G  P+      +I  
Sbjct: 186 LLGNF------QWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGKIKF 238

Query: 212 Y---LSTGYRMERPASCNEQ 228
                  G R   P  C  +
Sbjct: 239 INMIREEGLRPTIPEDCPPR 258

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  159 bits (405), Expect = 3e-48
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 52/250 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + + + EV+G+G FGVV K             +   +VA+K ++          F+ E
Sbjct: 6   DYKEIEVEEVVGRGAFGVVCKAKW--------RAK---DVAIKQIE---SESERKAFIVE 51

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
           +  +  V  H +IV   G C  + + LV+EY   G L + L                   
Sbjct: 52  LRQLSRV-NHPNIVKLYGAC-LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 111 ------EYL---SNNKVVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                  YL       ++HRDL   N+LL +   V+KI DFG + DI        G    
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA-- 167

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI--PLCRIVHYLSTGYR 218
                W+A E    + Y+ K DV+S+G++LWE++T    P+  I  P  RI+  +  G R
Sbjct: 168 ----AWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNGTR 222

Query: 219 MERPASCNEQ 228
                +  + 
Sbjct: 223 PPLIKNLPKP 232

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (398), Expect = 1e-47
 Identities = 45/253 (17%), Positives = 83/253 (32%), Gaps = 53/253 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA-NADAKTYDKFLK 66
             ++L     L +   G + KG           G    ++ VK+LK  +   +    F +
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW--------QGN---DIVVKVLKVRDWSTRKSRDFNE 56

Query: 67  EINLMKDVGKHDHIVSFIGCCYK---DELRLVVEYCALGDLQSYLRE------------- 110
           E   ++    H +++  +G C         L+  +   G L + L E             
Sbjct: 57  ECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115

Query: 111 ---------EYL--SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
                     +L      +    L +R++++      +IS   +         F    P 
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK--------FSFQSPG 167

Query: 160 EKLPIRWLA---LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY-LST 215
                 W+A   L+    +     +D+WSF V+LWE+VT    P+  +    I       
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGMKVALE 226

Query: 216 GYRMERPASCNEQ 228
           G R   P   +  
Sbjct: 227 GLRPTIPPGISPH 239

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  134 bits (339), Expect = 3e-38
 Identities = 48/249 (19%), Positives = 91/249 (36%), Gaps = 66/249 (26%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             +++ + + +G+G +G V  G                +VAVK+     +A        E
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKWRG-----------EKVAVKVFFTTEEA--SWFRETE 81

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLRE------------ 110
           I     + +H++I+ FI    K      +L L+ +Y   G L  YL+             
Sbjct: 82  IYQTVLM-RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLA 140

Query: 111 -------EYL--------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
                   +L            + HRDL ++NIL+       I+D GL+        F +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------KFIS 194

Query: 156 GEPSEKLP-------IRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYP 202
                 +P        R++  E L  ++          +D++SFG++LWE+         
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGG 253

Query: 203 HIPLCRIVH 211
            +   ++ +
Sbjct: 254 IVEEYQLPY 262

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  130 bits (330), Expect = 3e-37
 Identities = 52/243 (21%), Positives = 86/243 (35%), Gaps = 56/243 (23%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
                + L E +G+G +G V +G                 VAVK+  +  +      + +
Sbjct: 5   TVARDITLLECVGKGRYGEVWRGSWQG-----------ENVAVKIFSSRDEKS----WFR 49

Query: 67  EINLMKDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLRE---------- 110
           E  L   V  +H++I+ FI           +L L+  Y  +G L  YL+           
Sbjct: 50  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR 109

Query: 111 ---------EYL--------SNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNV 152
                     +L            + HRDL ++NIL+       I+D GL+       N 
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

Query: 153 FQNGEPSEKLPIRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYPHIPL 206
              G        R++A E L   I         + D+W+FG+VLWE+          +  
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVED 228

Query: 207 CRI 209
            + 
Sbjct: 229 YKP 231

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  131 bits (331), Expect = 5e-37
 Identities = 53/242 (21%), Positives = 88/242 (36%), Gaps = 65/242 (26%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
              ++L E +G+G FG V +G                EVAVK+  +    +       EI
Sbjct: 41  ARTIVLQESIGKGRFGEVWRGKWRG-----------EEVAVKIFSS--REERSWFREAEI 87

Query: 69  NLMKDVGKHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLRE------------- 110
                + +H++I+ FI    KD     +L LV +Y   G L  YL               
Sbjct: 88  YQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL 146

Query: 111 ------EYL--------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG 156
                  +L            + HRDL ++NIL+       I+D GL+          + 
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------RHDSA 200

Query: 157 EPSEKLP-------IRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYPH 203
             +  +         R++A E L  +I         ++D+++ G+V WEI    +    H
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

Query: 204 IP 205
             
Sbjct: 261 ED 262

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  127 bits (320), Expect = 1e-35
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 54/227 (23%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               L L EV  +G FG V K  L          +    VAVK+           +   E
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQLL--------NE---YVAVKIFPIQDKQ--SWQNEYE 68

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREEYLS-------- 114
           +  +  + KH++I+ FIG   +      +L L+  +   G L  +L+   +S        
Sbjct: 69  VYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127

Query: 115 ---------------------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF 153
                                   + HRD+ ++N+LL +     I+DFGL+   +E    
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA-LKFEAGKS 186

Query: 154 QNGEPSEKLPIRWLALESLVSNI-----YTNKSDVWSFGVVLWEIVT 195
                 +    R++A E L   I        + D+++ G+VLWE+ +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  126 bits (318), Expect = 4e-35
 Identities = 59/243 (24%), Positives = 90/243 (37%), Gaps = 64/243 (26%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + L L E++G+G +G V KG L          +    VAVK+            F+ E
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLD--------ER---PVAVKVFSFAN----RQNFINE 55

Query: 68  INLMKDVG-KHDHIVSFIGCCYKD------ELRLVVEYCALGDLQSYLRE---------- 110
            N+ +    +HD+I  FI    +       E  LV+EY   G L  YL            
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR 115

Query: 111 ---------EYL---------SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNV 152
                     YL             + HRDL +RN+L+ +     ISDFGLS      N 
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS-MRLTGNR 174

Query: 153 FQNGEPSEKLP------IRWLALESLVSNI-------YTNKSDVWSFGVVLWEIVTLGAN 199
                  +         IR++A E L   +          + D+++ G++ WEI     +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 200 PYP 202
            +P
Sbjct: 235 LFP 237

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (299), Expect = 1e-32
 Identities = 50/223 (22%), Positives = 76/223 (34%), Gaps = 46/223 (20%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKML-KANADAKTYDKF 64
           +  +       LG G +G V K     DG             AVK         K   + 
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDG----------RLYAVKRSMSPFRGPKDRARK 103

Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE------------- 110
           L E+   + VG+H   V       +   L L  E C    LQ +                
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGY 162

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSE 160
                    +L +  +VH D+   NI L      K+ DFGL  ++      +   G+P  
Sbjct: 163 LRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP-- 220

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
               R++A E L+   Y   +DV+S G+ + E+        PH
Sbjct: 221 ----RYMAPE-LLQGSYGTAADVFSLGLTILEVAC--NMELPH 256

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (295), Expect = 6e-32
 Identities = 46/223 (20%), Positives = 77/223 (34%), Gaps = 56/223 (25%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +L ++LGQG    V +G          +G      A+K+    +  +  D  ++E  ++K
Sbjct: 12  LLSDILGQGATANVFRG------RHKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLK 62

Query: 73  DVGKHDHIVSFIGC---CYKDELRLVVEYCALGDLQSYLRE------------------- 110
            +  H +IV               L++E+C  G L + L E                   
Sbjct: 63  KL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPH----VVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                +L  N +VHR++   NI+         V K++DFG +         ++ E    L
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------RELEDDEQFVSL 175

Query: 163 --------P--IRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                   P       L       Y    D+WS GV  +   T
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (302), Expect = 1e-31
 Identities = 59/227 (25%), Positives = 90/227 (39%), Gaps = 54/227 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
            + E LG G FG V++           +G+   +VA+K  +     K  +++  EI +MK
Sbjct: 17  EMKERLGTGGFGYVLRW------IHQDTGE---QVAIKQCRQELSPKNRERWCLEIQIMK 67

Query: 73  DVGKHDHIV-------SFIGCCYKDELRLVVEYCALGDLQSYLRE--------------- 110
            +  H ++V               D   L +EYC  GDL+ YL +               
Sbjct: 68  KL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPS 159
                    YL  N+++HRDL   NI+L       + KI D G +           GE  
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA------KELDQGELC 180

Query: 160 EKL---PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            +      ++LA E L    YT   D WSFG + +E +T G  P+  
Sbjct: 181 TEFVGTL-QYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLP 225

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  116 bits (292), Expect = 2e-31
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 48/220 (21%)

Query: 8   PPERLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVK--MLKANADAKTYDKF 64
                 + + +G+G+F  V +   L DG          + VA+K   +    DAK     
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDG----------VPVALKKVQIFDLMDAKARADC 79

Query: 65  LKEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------- 110
           +KEI+L+K +  H +++ +       +EL +V+E    GDL   ++              
Sbjct: 80  IKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138

Query: 111 -----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---G 156
                      E++ + +V+HRD+   N+ +++  VVK+ D GL      +    +   G
Sbjct: 139 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 198

Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
            P       +++ E +  N Y  KSD+WS G +L+E+  L
Sbjct: 199 TPY------YMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  116 bits (293), Expect = 2e-31
 Identities = 46/210 (21%), Positives = 92/210 (43%), Gaps = 43/210 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMK 72
             + +G+G FG  +             G+   +  +K +  +   +K  ++  +E+ ++ 
Sbjct: 28  RLQKIGEGSFGKAILVK------STEDGR---QYVIKEINISRMSSKEREESRREVAVLA 78

Query: 73  DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------------- 110
           ++ KH +IV +         L +V++YC  GDL   +                       
Sbjct: 79  NM-KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRW 166
            +++ + K++HRD+ ++NI L+    V++ DFG++  +           G P       +
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY------Y 191

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           L+ E   +  Y NKSD+W+ G VL+E+ TL
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTL 221

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  116 bits (292), Expect = 2e-31
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 48/209 (22%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           ++G G FG V KG+L DG           +VA+K       ++  ++F  EI  +    +
Sbjct: 46  LIGHGVFGKVYKGVLRDG----------AKVALKRRTPE-SSQGIEEFETEIETLSFC-R 93

Query: 77  HDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------------E 111
           H H+VS IG C  ++E+ L+ +Y   G+L+ +L                           
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE-----KLPIRW 166
           YL    ++HRD+ + NILL    V KI+DFG+S+           + +      K  + +
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKK------GTELDQTHLSTVVKGTLGY 207

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           +  E  +    T KSDV+SFGVVL+E++ 
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  117 bits (294), Expect = 3e-31
 Identities = 46/223 (20%), Positives = 77/223 (34%), Gaps = 56/223 (25%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +L ++LGQG    V +G          +G      A+K+    +  +  D  ++E  ++K
Sbjct: 12  LLSDILGQGATANVFRG------RHKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLK 62

Query: 73  DVGKHDHIVS---FIGCCYKDELRLVVEYCALGDLQSYLRE------------------- 110
            +  H +IV               L++E+C  G L + L E                   
Sbjct: 63  KL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 111 ----EYLSNNKVVHRDLATRNILLSS----PHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                +L  N +VHR++   NI+         V K++DFG +         ++ E    L
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------RELEDDEQFVSL 175

Query: 163 --------P--IRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                   P       L       Y    D+WS GV  +   T
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  116 bits (292), Expect = 1e-30
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 61/227 (26%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEINLM 71
              +VLG G  G +V   + D            +VAVK +L        +    +E+ L+
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDN----------RDVAVKRILPEC-----FSFADREVQLL 71

Query: 72  KDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE------------------- 110
           ++  +H +++ +  C  KD     + +E CA   LQ Y+ +                   
Sbjct: 72  RESDEHPNVIRYF-CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTS 129

Query: 111 --EYLSNNKVVHRDLATRNILLSSPH-----VVKISDFGLSEDIY-EQNVFQN-----GE 157
              +L +  +VHRDL   NIL+S P+        ISDFGL + +   ++ F       G 
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 158 PSEKLPIRWLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPY 201
                   W+A E L  +     T   D++S G V + +++ G++P+
Sbjct: 190 EG------WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  110 bits (277), Expect = 2e-29
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 45/205 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
           + E LG+G F VV +           +G    E A K++      A+ + K  +E  + +
Sbjct: 10  VKEELGKGAFSVVRRC------VHKTTGL---EFAAKIINTKKLSARDFQKLEREARICR 60

Query: 73  DVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL------QSYLRE-------------- 110
            + +H +IV       ++E    LV +    G+L      + +  E              
Sbjct: 61  KL-QHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 118

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
            Y  +N +VHR+L   N+LL+S      VK++DFGL+ ++ +   +    G P       
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG------ 172

Query: 166 WLALESLVSNIYTNKSDVWSFGVVL 190
           +L+ E L  + Y+   D+W+ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (276), Expect = 2e-29
 Identities = 51/236 (21%), Positives = 83/236 (35%), Gaps = 66/236 (27%)

Query: 15  GEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEINLMK 72
            E +G GEFG V K +   DG             A+K  K   A +      L+E+    
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDG----------CIYAIKRSKKPLAGSVDEQNALREVYAHA 65

Query: 73  DVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------- 110
            +G+H H+V +     +D+ + +  EYC  G L   + E                     
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 111 ---EYLSNNKVVHRDLATRNILLS-------------------SPHVVKISDFGLSEDIY 148
               Y+ +  +VH D+   NI +S                   +  + KI D G    I 
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 149 EQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPH 203
              V + G+       R+LA E L  N  +  K+D+++  + +         P P 
Sbjct: 186 SPQVEE-GDS------RFLANEVLQENYTHLPKADIFALALTVVCAAGAE--PLPR 232

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  110 bits (276), Expect = 2e-29
 Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 47/227 (20%)

Query: 8   PPERLI-LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFL 65
              R +     +G+G F  V KGL      +  +     EVA   +           +F 
Sbjct: 23  NDGRFLKFDIEIGRGSFKTVYKGL------DTETTV---EVAWCELQDRKLTKSERQRFK 73

Query: 66  KEINLMKDVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSYLRE---------- 110
           +E  ++K + +H +IV F          K  + LV E    G L++YL+           
Sbjct: 74  EEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR 132

Query: 111 ----------EYL--SNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQNGE 157
                     ++L      ++HRDL   NI ++ P   VKI D GL+          +  
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-----ASFA 187

Query: 158 PSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
            +      ++A E +    Y    DV++FG+ + E+ T    PY   
Sbjct: 188 KAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSEC 232

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  109 bits (275), Expect = 4e-29
 Identities = 43/226 (19%), Positives = 86/226 (38%), Gaps = 55/226 (24%)

Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
            + LG+G FGVV +                   A+K ++        +K ++E+  +  +
Sbjct: 10  IQCLGRGGFGVVFEA------KNKVDDC---NYAIKRIRLPNRELAREKVMREVKALAKL 60

Query: 75  GKHDHIVSFIGCCYKDE-------------LRLVVEYCALGDLQSYLRE----------- 110
            +H  IV +     +               L + ++ C   +L+ ++             
Sbjct: 61  -EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                       E+L +  ++HRDL   NI  +   VVK+ DFGL   + +    Q    
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 159 SEKLPIR---------WLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                 R         +++ E +  N Y++K D++S G++L+E++ 
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (278), Expect = 5e-29
 Identities = 47/232 (20%), Positives = 84/232 (36%), Gaps = 58/232 (25%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLM 71
            + + +G G    V + L           Q     A+K +    AD +T D +  EI  +
Sbjct: 59  SILKQIGSGGSSKVFQVL-------NEKKQ---IYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 72  KDV-GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------- 110
             +    D I+           + +V+E C   DL S+L++                   
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP-----I 164
              +  + +VH DL   N L+    ++K+ DFG++      N  Q    S         +
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIA------NQMQPDTTSVVKDSQVGAV 220

Query: 165 RWLALESLVS-----------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
            ++  E++             +  + KSDVWS G +L+ +   G  P+  I 
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII 271

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  109 bits (275), Expect = 1e-28
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 45/205 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
           + E LG+G F VV +           +G    E A K++      A+ + K  +E  + +
Sbjct: 33  VKEELGKGAFSVVRRC------VHKTTGL---EFAAKIINTKKLSARDFQKLEREARICR 83

Query: 73  DVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL------QSYLRE-------------- 110
            + +H +IV       ++E    LV +    G+L      + +  E              
Sbjct: 84  KL-QHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 141

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
            Y  +N +VHR+L   N+LL+S      VK++DFGL+ ++ +   +    G P       
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG------ 195

Query: 166 WLALESLVSNIYTNKSDVWSFGVVL 190
           +L+ E L  + Y+   D+W+ GV+L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  108 bits (272), Expect = 2e-28
 Identities = 47/232 (20%), Positives = 83/232 (35%), Gaps = 58/232 (25%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLM 71
            + + +G G    V + L           Q     A+K +    AD +T D +  EI  +
Sbjct: 31  SILKQIGSGGSSKVFQVL-------NEKKQ---IYAIKYVNLEEADNQTLDSYRNEIAYL 80

Query: 72  KDV-GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------- 110
             +    D I+           + +V+E C   DL S+L++                   
Sbjct: 81  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 139

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR---- 165
              +  + +VH DL   N L+    ++K+ DFG++      N  Q    S     +    
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIA------NQMQPDTTSVVKDSQVGTV 192

Query: 166 -WLALESLVSNI-----------YTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
            ++  E++                + KSDVWS G +L+ +   G  P+  I 
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII 243

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  107 bits (269), Expect = 2e-28
 Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 52/223 (23%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           E   +   +G G +G   K          + G+    +  K L   +         + E+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKI------RRKSDGK---ILVWKELDYGSMTEAEKQMLVSEV 56

Query: 69  NLMKDVGKHDHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE--------------- 110
           NL++++ KH +IV +           L +V+EYC  GDL S + +               
Sbjct: 57  NLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115

Query: 111 ---------EYL-----SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN- 155
                    +         + V+HRDL   N+ L     VK+ DFGL+  +     F   
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175

Query: 156 --GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
             G P       +++ E +    Y  KSD+WS G +L+E+  L
Sbjct: 176 FVGTPY------YMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  108 bits (271), Expect = 3e-28
 Identities = 47/232 (20%), Positives = 83/232 (35%), Gaps = 60/232 (25%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLM 71
            + + +G G    V + L           Q     A+K +    AD +T D +  EI  +
Sbjct: 12  SILKQIGSGGSSKVFQVL-------NEKKQ---IYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 72  KDV-GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------- 110
             +    D I+           + +V+E C   DL S+L++                   
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 120

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL------P 163
              +  + +VH DL   N L+    ++K+ DFG++      N  Q    S          
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIA------NQMQPDTTSVVKDSQVGTV 173

Query: 164 IRWLALESLV-----------SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
             ++  E++             +  + KSDVWS G +L+ +   G  P+  I
Sbjct: 174 N-YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQI 223

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  107 bits (270), Expect = 3e-28
 Identities = 58/231 (25%), Positives = 87/231 (37%), Gaps = 73/231 (31%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT---YDKF 64
                + G  +G+G FGVV KG + +             VAVK L A  D  T     +F
Sbjct: 29  ERPISVGGNKMGEGGFGVVYKGYVNNT-----------TVAVKKLAAMVDITTEELKQQF 77

Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------- 110
            +EI +M    +H+++V  +G     +   +V  Y   G L   L               
Sbjct: 78  DQEIKVMAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                      +L  N  +HRD+ + NILL      KISDFGL+                
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS----------EKF 186

Query: 161 KLPIRWLALESLVSN----------------IYTNKSDVWSFGVVLWEIVT 195
                    ++++++                  T KSD++SFGVVL EI+T
Sbjct: 187 A--------QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  106 bits (267), Expect = 4e-28
 Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 62/228 (27%)

Query: 15  GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV 74
            E++G G FG V K            G+      +K +K        +K  +E+  +  +
Sbjct: 16  IELIGSGGFGQVFKA------KHRIDGK---TYVIKRVK-----YNNEKAEREVKALAKL 61

Query: 75  GKHDHIVSFIGC-----------------CYKDELRLVVEYCALGDLQSYLRE------- 110
             H +IV + GC                      L + +E+C  G L+ ++ +       
Sbjct: 62  -DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 111 ---------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
                          +Y+ + K+++RDL   NI L     VKI DFGL   +        
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 156 --GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
             G         +++ E + S  Y  + D+++ G++L E++ +    +
Sbjct: 181 SKGTLR------YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  106 bits (266), Expect = 7e-28
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 43/222 (19%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P ++    E +GQG  G V          + A+GQ   EVA++ +      K  +  + E
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTA------MDVATGQ---EVAIRQMNLQQQPK-KELIINE 67

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDLQSYLRE---------------- 110
           I +M++  K+ +IV+++      DEL +V+EY A G L   + E                
Sbjct: 68  ILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEKLP 163
              E+L +N+V+HRD+ + NILL     VK++DFG    ++ +  +++    G P     
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY---- 181

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
             W+A E +    Y  K D+WS G++  E++  G  PY +  
Sbjct: 182 --WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNEN 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 7e-28
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 51/213 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-------KANADAKTYDKFL 65
           I+ + LG G  G V          E  + +   +VA++++        +  +A       
Sbjct: 138 IMSKTLGSGACGEVKLA------FERKTCK---KVAIRIISKRKFAIGSAREADPALNVE 188

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDL------QSYLRE--------- 110
            EI ++K +  H  I+        ++  +V+E    G+L         L+E         
Sbjct: 189 TEIEILKKL-NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSE 160
                +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E ++ +   G P+ 
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT- 306

Query: 161 KLPIRWLA---LESLVSNIYTNKSDVWSFGVVL 190
                +LA   L S+ +  Y    D WS GV+L
Sbjct: 307 -----YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (267), Expect = 8e-28
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 43/222 (19%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P   L     +G+G  G+V          E  SG+   +VAVKM+      +  +    E
Sbjct: 43  PRLLLDSYVKIGEGSTGIVCLA------REKHSGR---QVAVKMMDLRKQQR-RELLFNE 92

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALGDL-----QSYLRE----------- 110
           + +M+D  +H ++V         +EL +++E+   G L     Q  L E           
Sbjct: 93  VVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL 151

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEKLP 163
               YL    V+HRD+ + +ILL+    VK+SDFG    +S+D+ ++     G P     
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPY---- 206

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
             W+A E +  ++Y  + D+WS G+++ E+V  G  PY    
Sbjct: 207 --WMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDS 245

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  105 bits (265), Expect = 8e-28
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 46/209 (22%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEI 68
           ER  +  +LG+G FG V+K        +  + Q   E AVK++ KA+A  K     L+E+
Sbjct: 22  ERYNIVCMLGKGSFGEVLKC------KDRITQQ---EYAVKVINKASAKNKDTSTILREV 72

Query: 69  NLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL------QSYLRE---------- 110
            L+K +  H +I+       +D     +V E    G+L      +    E          
Sbjct: 73  ELLKKL-DHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEK 161
                Y+  + +VHRDL   NILL S      +KI DFGLS    +    ++  G     
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-- 188

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVL 190
               ++A E L    Y  K DVWS GV+L
Sbjct: 189 ----YIAPEVLRGT-YDEKCDVWSAGVIL 212

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  108 bits (271), Expect = 9e-28
 Identities = 55/246 (22%), Positives = 89/246 (36%), Gaps = 80/246 (32%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEINLM 71
           +  ++LG G  G VV      G            VAVK ML         D  L EI L+
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQG----------RPVAVKRMLIDF-----CDIALMEIKLL 62

Query: 72  KDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE------------------- 110
            +   H +++ +  C    +  L + +E C   +LQ  +                     
Sbjct: 63  TESDDHPNVIRYY-CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHV-------------VKISDFGLSEDIYE 149
                    +L + K++HRDL  +NIL+S+                + ISDFGL      
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC----- 175

Query: 150 QNVFQNGEPSEKLPIR-------WLALESLVSNI-------YTNKSDVWSFGVVLWEIVT 195
                +G+ S +  +        W A E L  +         T   D++S G V + I++
Sbjct: 176 -KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

Query: 196 LGANPY 201
            G +P+
Sbjct: 235 KGKHPF 240

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  105 bits (264), Expect = 2e-27
 Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 46/205 (22%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I  EVLG G F  V          +  +G+     A+K +K +  A        EI ++K
Sbjct: 12  IFMEVLGSGAFSEVFLV------KQRLTGK---LFALKCIKKSP-AFRDSSLENEIAVLK 61

Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDL------QSYLRE-------------- 110
            + KH++IV+     Y       LV++  + G+L      +    E              
Sbjct: 62  KI-KHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
           +YL  N +VHRDL   N+L  +P     + I+DFGLS  + +  +     G P       
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPG------ 172

Query: 166 WLALESLVSNIYTNKSDVWSFGVVL 190
           ++A E L    Y+   D WS GV+ 
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVIT 197

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 3e-27
 Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 55/235 (23%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P     L E++G G +G V KG          +GQ     A+K++    D +  ++  +E
Sbjct: 22  PAGIFELVELVGNGTYGQVYKG------RHVKTGQ---LAAIKVMDVTGDEE--EEIKQE 70

Query: 68  INLMKDVGKHDHIVSFIGCCYK-------DELRLVVEYCALGDLQ--------------- 105
           IN++K    H +I ++ G   K       D+L LV+E+C  G +                
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130

Query: 106 -SY-LRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--- 155
            +Y  RE      +L  +KV+HRD+  +N+LL+    VK+ DFG+S  +      +N   
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190

Query: 156 GEPSEKLPIRWLALE-----SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
           G P       W+A E           Y  KSD+WS G+   E+   GA P   + 
Sbjct: 191 GTP------YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMH 238

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  105 bits (264), Expect = 3e-27
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 57/215 (26%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGK 76
           +LG+G FG V KG L DG            VAVK LK         +F  E+ ++     
Sbjct: 37  ILGRGGFGKVYKGRLADG----------TLVAVKRLKEERTQGGELQFQTEVEMISMA-V 85

Query: 77  HDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------------E 111
           H +++   G C     RL+V  Y A G + S LRE                         
Sbjct: 86  HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145

Query: 112 YL---SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR--- 165
           YL    + K++HRD+   NILL       + DFGL++ +            +   +    
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----------DYKDTHVTTAV 195

Query: 166 -----WLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                 +A E L +   + K+DV+ +GV+L E++T
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (263), Expect = 3e-27
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 51/213 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-------KANADAKTYDKFL 65
           I+ + LG G  G V          E  + +   +VA+K++        +  +A       
Sbjct: 13  IMSKTLGSGACGEVKLA------FERKTCK---KVAIKIISKRKFAIGSAREADPALNVE 63

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDL------QSYLRE--------- 110
            EI ++K +  H  I+        ++  +V+E    G+L         L+E         
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSE 160
                +YL  N ++HRDL   N+LLSS     ++KI+DFG S+ + E ++ +   G P+ 
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT- 181

Query: 161 KLPIRWLALESLVSNI---YTNKSDVWSFGVVL 190
                +LA E LVS     Y    D WS GV+L
Sbjct: 182 -----YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (261), Expect = 5e-27
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 40/221 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E     E +G+G FG V KG+      +  + +    VA+K++         +   +E
Sbjct: 20  PEELFTKLEKIGKGSFGEVFKGI------DNRTQK---VVAIKIIDLEEAEDEIEDIQQE 70

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------- 110
           I ++       ++  + G   KD +L +++EY   G     L                  
Sbjct: 71  ITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 129

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              +YL + K +HRD+   N+LLS    VK++DFG++  + +  + +N   G P      
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP------ 183

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
            W+A E +  + Y +K+D+WS G+   E+   G  P+  + 
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELH 223

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  103 bits (260), Expect = 6e-27
 Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 48/229 (20%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           Y  +      VLG+G +G+V  G          +      +A+K +    D++      +
Sbjct: 19  YEYDENGDRVVLGKGTYGIVYAGRDLS------NQV---RIAIKEIPER-DSRYSQPLHE 68

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------- 110
           EI L K + KH +IV ++G   ++  +++ +E    G L + LR                
Sbjct: 69  EIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQN---GEP 158
                   +YL +N++VHRD+   N+L+++   V+KISDFG S+ +   N       G  
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187

Query: 159 SEKLPIRWLALE--SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
                 +++A E        Y   +D+WS G  + E+ T G  P+  + 
Sbjct: 188 ------QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELG 229

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (262), Expect = 7e-27
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 46/221 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             +       LG G  GVV K      P+        + +A K++         ++ ++E
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVS--HKPSG-------LVMARKLIHLEIKPAIRNQIIRE 81

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------- 110
           + ++ +     +IV F G  Y D E+ + +E+   G L   L++                
Sbjct: 82  LQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140

Query: 111 ----EYL-SNNKVVHRDLATRNILLSSPHVVKISDFG----LSEDIYEQNVFQNGEPSEK 161
                YL   +K++HRD+   NIL++S   +K+ DFG    L + +    V   G  S  
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRS-- 195

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
               +++ E L    Y+ +SD+WS G+ L E+   G  P P
Sbjct: 196 ----YMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIP 231

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (260), Expect = 7e-27
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 45/223 (20%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E   + E LG+G +G V K           +GQ    VA+K +   +D     + +KE
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKA------IHKETGQ---IVAIKQVPVESD---LQEIIKE 74

Query: 68  INLMKDVGKHDHIVSFIGCCYK-DELRLVVEYCALG---DL----QSYLRE--------- 110
           I++M+      H+V + G  +K  +L +V+EYC  G   D+       L E         
Sbjct: 75  ISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKL 162
                EYL   + +HRD+   NILL++    K++DFG++  + +    +N   G P    
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF--- 190

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
              W+A E +    Y   +D+WS G+   E+   G  PY  I 
Sbjct: 191 ---WMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIH 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  103 bits (260), Expect = 1e-26
 Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 44/207 (21%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLM 71
           +  + LG+G+F VV +          ++GQ   E A K L K         + L EI ++
Sbjct: 32  LTSKELGRGKFAVVRQC------ISKSTGQ---EYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 72  KDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDL--------QSYLRE------------ 110
           +       +++         E+ L++EY A G++           + E            
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 111 --EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQN--GEPSEKLP 163
              YL  N +VH DL  +NILLSS      +KI DFG+S  I      +   G P     
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE---- 198

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVL 190
             +LA E L  +  T  +D+W+ G++ 
Sbjct: 199 --YLAPEILNYDPITTATDMWNIGIIA 223

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  104 bits (260), Expect = 1e-26
 Identities = 38/221 (17%), Positives = 80/221 (36%), Gaps = 41/221 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               +     +G+G FG V +        +  +G    + AVK ++            +E
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHRMK------DKQTGF---QCAVKKVRLEVFRV------EE 100

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE---------------- 110
           +     +     IV   G   +   + + +E    G L   +++                
Sbjct: 101 LVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159

Query: 111 ----EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYEQNVFQNGEPSEKLP-- 163
               EYL   +++H D+   N+LLSS      + DFG +  +    + ++    + +P  
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI 204
              +A E ++      K D+WS   ++  ++  G +P+   
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQY 259

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  103 bits (258), Expect = 1e-26
 Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 42/208 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KAN-ADAKTYDKFLKEINLM 71
            G  LG+G F    +       ++  + +     A K++ K+        +K   EI++ 
Sbjct: 19  RGRFLGKGGFAKCFEI------SDADTKE---VFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           + +  H H+V F G     D + +V+E C    L    +                     
Sbjct: 70  RSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWL 167
           +YL  N+V+HRDL   N+ L+    VKI DFGL+  +      +    G P+      ++
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------YI 182

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           A E L    ++ + DVWS G +++ ++ 
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLV 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  103 bits (259), Expect = 1e-26
 Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 42/208 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KAN-ADAKTYDKFLKEINLM 71
            G  LG+G F    +       ++  + +     A K++ K+        +K   EI++ 
Sbjct: 45  RGRFLGKGGFAKCFEI------SDADTKE---VFAGKIVPKSLLLKPHQREKMSMEISIH 95

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           + +  H H+V F G     D + +V+E C    L    +                     
Sbjct: 96  RSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWL 167
           +YL  N+V+HRDL   N+ L+    VKI DFGL+  +      +    G P+      ++
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------YI 208

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           A E L    ++ + DVWS G +++ ++ 
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLV 236

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  102 bits (257), Expect = 2e-26
 Identities = 46/227 (20%), Positives = 80/227 (35%), Gaps = 61/227 (26%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
              VLGQG FG VVK             +     A+K ++   +       L E+ L+  
Sbjct: 10  EIAVLGQGAFGQVVKA------RNALDSR---YYAIKKIRHTEEKL--STILSEVMLLAS 58

Query: 74  VGKHDHIVSFIGC--------------CYKDELRLVVEYCALGDLQSYLRE--------- 110
           +  H ++V +                   K  L + +EYC  G L   +           
Sbjct: 59  L-NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117

Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEP 158
                        Y+ +  ++HRDL   NI +     VKI DFGL+++++        + 
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 159 SEKLPIR-----------WLALESLVSNI--YTNKSDVWSFGVVLWE 192
                             ++A E ++     Y  K D++S G++ +E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFE 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  105 bits (263), Expect = 2e-26
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 46/205 (22%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
             + LG G +G V+         +  +     E A+K++ K +    +  K L+E+ ++K
Sbjct: 41  RVKKLGSGAYGEVLLC------RDKVTHV---ERAIKIIRKTSVSTSSNSKLLEEVAVLK 91

Query: 73  DVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLRE-------------------- 110
            +  H +I+      ++D+    LV+E    G+L   +                      
Sbjct: 92  LLD-HPNIMKLYDF-FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
            YL  + +VHRDL   N+LL S     ++KI DFGLS     Q   +   G         
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY------ 203

Query: 166 WLALESLVSNIYTNKSDVWSFGVVL 190
           ++A E L    Y  K DVWS GV+L
Sbjct: 204 YIAPEVLRKK-YDEKCDVWSIGVIL 227

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  102 bits (256), Expect = 3e-26
 Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 54/215 (25%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK--------MLKANADAKTYDKFL 65
             E+LG+G   VV +           + +   E AVK           A    +  +  L
Sbjct: 21  PKEILGRGVSSVVRRC------IHKPTCK---EYAVKIIDVTGGGSFSAEEVQELREATL 71

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL------QSYLRE------- 110
           KE+++++ V  H +I+      Y+      LV +    G+L      +  L E       
Sbjct: 72  KEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
                    L    +VHRDL   NILL     +K++DFG S  +      +   G PS  
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS-- 188

Query: 162 LPIRWLALESLVSNI------YTNKSDVWSFGVVL 190
               +LA E +  ++      Y  + D+WS GV++
Sbjct: 189 ----YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  103 bits (259), Expect = 3e-26
 Identities = 45/211 (21%), Positives = 86/211 (40%), Gaps = 55/211 (26%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +  +VLG G  G V++           + +   + A+KML+    A+      +E+ L  
Sbjct: 65  VTSQVLGLGINGKVLQI------FNKRTQE---KFALKMLQDCPKAR------REVELHW 109

Query: 73  DVGKHDHIVSFIGCCYKDELR------LVVEYCALGDL---------QSY--------LR 109
              +  HIV  +   Y++         +V+E    G+L         Q++        ++
Sbjct: 110 RASQCPHIVRIVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 168

Query: 110 E-----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPS 159
                 +YL +  + HRD+   N+L +S     ++K++DFG +++    N        P 
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVL 190
                 ++A E L    Y    D+WS GV++
Sbjct: 229 ------YVAPEVLGPEKYDKSCDMWSLGVIM 253

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  102 bits (256), Expect = 3e-26
 Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 42/206 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQ--AAMEVAVKMLKANADAKTYDKFLKEINLM 71
           +GE LG G+F +V K        E ++G   AA  +  +  +A+    + ++  +E++++
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 72  KDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDL------QSYLRE-------------- 110
           + V  H ++++       + ++ L++E  + G+L      +  L E              
Sbjct: 70  RQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 111 EYLSNNKVVHRDLATRNILLSSPH----VVKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL   K+ H DL   NI+L   +     +K+ DFGL+ +I +   F+N  G P      
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE----- 183

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVL 190
            ++A E +       ++D+WS GV+ 
Sbjct: 184 -FVAPEIVNYEPLGLEADMWSIGVIT 208

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (255), Expect = 3e-26
 Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 48/228 (21%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E   +   LG G FG V K           +G      A K+++  ++ +  + ++ E
Sbjct: 17  PNEVWEIVGELGDGAFGKVYKA------KNKETGA---LAAAKVIETKSEEE-LEDYIVE 66

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------- 110
           I ++     H +IV  +G  Y D +L +++E+C  G + + + E                
Sbjct: 67  IEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKL 162
                 +L + +++HRDL   N+L++    ++++DFG+S    +    ++   G P    
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY--- 182

Query: 163 PIRWLA-----LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
              W+A      E++    Y  K+D+WS G+ L E+      P+  + 
Sbjct: 183 ---WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELN 226

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (261), Expect = 3e-26
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 46/206 (22%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
           L E LG+G F VV +        +  +GQ   E A  ++      A+ + K  +E  + +
Sbjct: 15  LFEELGKGAFSVVRRC------VKVLAGQ---EYAAMIINTKKLSARDHQKLEREARICR 65

Query: 73  DVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL------QSYLRE-------------- 110
            + KH +IV        +E    L+ +    G+L      + Y  E              
Sbjct: 66  LL-KHPNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDI-YEQNVFQN--GEPSEKLPI 164
            +     VVHR+L   N+LL+S      VK++DFGL+ ++  EQ  +    G P      
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG----- 178

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVL 190
            +L+ E L  + Y    D+W+ GV+L
Sbjct: 179 -YLSPEVLRKDPYGKPVDLWACGVIL 203

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  102 bits (256), Expect = 4e-26
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 53/214 (24%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK----ANADAKTYDKFLKEI 68
            L EV+G+G F VV +           +GQ   + AVK++      ++   + +   +E 
Sbjct: 27  ELCEVIGKGPFSVVRRC------INRETGQ---QFAVKIVDVAKFTSSPGLSTEDLKREA 77

Query: 69  NLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL-------------------QSY 107
           ++   + KH HIV  +   Y  +  L +V E+    DL                     Y
Sbjct: 78  SICHML-KHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135

Query: 108 LRE-----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYE-QNVFQN--G 156
           +R+      Y  +N ++HRD+    +LL+S      VK+  FG++  + E   V     G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195

Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVL 190
            P       ++A E +    Y    DVW  GV+L
Sbjct: 196 TPH------FMAPEVVKREPYGKPVDVWGCGVIL 223

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (255), Expect = 5e-26
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 48/209 (22%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKM-----LKANADAKTYDKFLKEI 68
            GE LG G+F VV K        E ++G    + A K       K++    + +   +E+
Sbjct: 15  TGEELGSGQFAVVKKC------REKSTGL---QYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 69  NLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDL------QSYLRE----------- 110
           +++K++ +H ++++       K ++ L++E  A G+L      +  L E           
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124

Query: 111 ---EYLSNNKVVHRDLATRNILLSSP----HVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
               YL + ++ H DL   NI+L         +KI DFGL+  I   N F+N  G P   
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE-- 182

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVL 190
               ++A E +       ++D+WS GV+ 
Sbjct: 183 ----FVAPEIVNYEPLGLEADMWSIGVIT 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (256), Expect = 5e-26
 Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 49/212 (23%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKM-------LKANADAKTYDKFLK 66
             +V+G+G   VV +          A+G    E AVK+       L      +  +   +
Sbjct: 98  PKDVIGRGVSSVVRRC------VHRATGH---EFAVKIMEVTAERLSPEQLEEVREATRR 148

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDL------QSYLRE-------- 110
           E ++++ V  H HI++ I   Y+      LV +    G+L      +  L E        
Sbjct: 149 ETHILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR 207

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPS--- 159
                  +L  N +VHRDL   NILL     +++SDFG S  +      +   G P    
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 160 -EKLPIRWLALESLVSNIYTNKSDVWSFGVVL 190
            E L              Y  + D+W+ GV+L
Sbjct: 268 PEILKCSMDETHPG----YGKEVDLWACGVIL 295

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (256), Expect = 6e-26
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 42/206 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQ--AAMEVAVKMLKANADAKTYDKFLKEINLM 71
           +GE LG G+F +V K        E ++G   AA  +  +  +A+      ++  +E++++
Sbjct: 16  IGEELGSGQFAIVKKC------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69

Query: 72  KDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDL------QSYLRE-------------- 110
           + V  H +I++       + ++ L++E  + G+L      +  L E              
Sbjct: 70  RQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 111 EYLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
            YL   K+ H DL   NI+L   ++    +K+ DFGL+ +I +   F+N  G P      
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE----- 183

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVL 190
            ++A E +       ++D+WS GV+ 
Sbjct: 184 -FVAPEIVNYEPLGLEADMWSIGVIT 208

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  103 bits (258), Expect = 7e-26
 Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 46/205 (22%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLMK 72
           +  +LG+G FG V+K        +  + Q   E AVK++ KA+A  K     L+E+ L+K
Sbjct: 26  IVCMLGKGSFGEVLKC------KDRITQQ---EYAVKVINKASAKNKDTSTILREVELLK 76

Query: 73  DVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLRE-------------------- 110
            +  H +I+       +D     +V E    G+L   + +                    
Sbjct: 77  KLD-HPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
            Y+  + +VHRDL   NILL S      +KI DFGLS    +    ++  G         
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY------ 188

Query: 166 WLALESLVSNIYTNKSDVWSFGVVL 190
           ++A E L    Y  K DVWS GV+L
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVIL 212

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (253), Expect = 8e-26
 Identities = 40/203 (19%), Positives = 83/203 (40%), Gaps = 44/203 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E LG+GEFG+V +        E +S +       K +K     +      KEI+++  
Sbjct: 9   IAEDLGRGEFGIVHRC------VETSSKK---TYMAKFVKVKGTDQ--VLVKKEISILNI 57

Query: 74  VGKHDHIVSFIGCC-YKDELRLVVEYCALGDL----------------QSYLRE-----E 111
              H +I+         +EL ++ E+ +  D+                 SY+ +     +
Sbjct: 58  AR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 112 YLSNNKVVHRDLATRNILLSSP--HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
           +L ++ + H D+   NI+  +     +KI +FG +  +   + F+     P       + 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE------YY 170

Query: 168 ALESLVSNIYTNKSDVWSFGVVL 190
           A E    ++ +  +D+WS G ++
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  100 bits (252), Expect = 8e-26
 Identities = 53/209 (25%), Positives = 79/209 (37%), Gaps = 49/209 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           I    LG G FG V          E +SG    E  +K +  +      ++   EI ++K
Sbjct: 25  IFKRKLGSGAFGDVHLV------EERSSGL---ERVIKTINKDRSQVPMEQIEAEIEVLK 75

Query: 73  DVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL----------QSYLRE---------- 110
            +  H +I+      ++D   + +V+E C  G+L             L E          
Sbjct: 76  SLD-HPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEK 161
                Y  +  VVH+DL   NIL         +KI DFGL+E         N  G     
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL-- 191

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVL 190
               ++A E    +  T K D+WS GVV+
Sbjct: 192 ----YMAPEVFKRD-VTFKCDIWSAGVVM 215

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  100 bits (251), Expect = 9e-26
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 48/209 (22%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKM-----LKANADAKTYDKFLKEI 68
           +GE LG G+F +V K        +  +G+   E A K      L ++    + ++  +E+
Sbjct: 9   MGEELGSGQFAIVRKC------RQKGTGK---EYAAKFIKKRRLSSSRRGVSREEIEREV 59

Query: 69  NLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDL------QSYLRE----------- 110
           N+++++ +H +I++       K ++ L++E  + G+L      +  L E           
Sbjct: 60  NILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 118

Query: 111 ---EYLSNNKVVHRDLATRNILLSSP----HVVKISDFGLSEDIYEQNVFQN--GEPSEK 161
               YL + ++ H DL   NI+L         +K+ DFG++  I   N F+N  G P   
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE-- 176

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVL 190
               ++A E +       ++D+WS GV+ 
Sbjct: 177 ----FVAPEIVNYEPLGLEADMWSIGVIT 201

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  101 bits (253), Expect = 1e-25
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 47/205 (22%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
            +   LG+G   +V +        +  + +     A+K+LK   D         EI ++ 
Sbjct: 56  EVESELGRGATSIVYRC------KQKGTQK---PYALKVLKKTVDK---KIVRTEIGVLL 103

Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDL------QSYLRE-------------- 110
            +  H +I+      +    E+ LV+E    G+L      + Y  E              
Sbjct: 104 RL-SHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAV 161

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
            YL  N +VHRDL   N+L ++P     +KI+DFGLS+ +  Q + +   G P       
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG------ 215

Query: 166 WLALESLVSNIYTNKSDVWSFGVVL 190
           + A E L    Y  + D+WS G++ 
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 1e-25
 Identities = 59/206 (28%), Positives = 87/206 (42%), Gaps = 47/206 (22%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKT-YDKFLKEINLM 71
              VLG+G FG V+         +  +GQ   E AVK++ K     KT  +  L+E+ L+
Sbjct: 30  GQRVLGKGSFGEVILC------KDKITGQ---ECAVKVISKRQVKQKTDKESLLREVQLL 80

Query: 72  KDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLRE------------------- 110
           K +  H +I+      ++D+    LV E    G+L   +                     
Sbjct: 81  KQLD-HPNIMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138

Query: 111 -EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
             Y+  NK+VHRDL   N+LL S      ++I DFGLS         ++  G        
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY----- 193

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVL 190
            ++A E L    Y  K DVWS GV+L
Sbjct: 194 -YIAPEVLHGT-YDEKCDVWSTGVIL 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 99.6 bits (249), Expect = 2e-25
 Identities = 47/206 (22%), Positives = 79/206 (38%), Gaps = 48/206 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLM 71
            L   +G+G +G V          +  +       A K + K   +    D+F +EI +M
Sbjct: 12  TLENTIGRGSWGEVKIA------VQKGTRI---RRAAKKIPKYFVEDV--DRFKQEIEIM 60

Query: 72  KDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDL------QSYLRE------------- 110
           K +  H +I+      ++D   + LV+E C  G+L      +   RE             
Sbjct: 61  KSL-DHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 111 -EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPSEKLPI 164
             Y     V HRDL   N L  +      +K+ DFGL+       + +   G P      
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY----- 173

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVL 190
            +++ + L    Y  + D WS GV++
Sbjct: 174 -YVSPQVLEGL-YGPECDEWSAGVMM 197

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.6 bits (249), Expect = 2e-25
 Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 54/241 (22%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + L     LG+G +GVV K      P+    GQ    +AVK ++A  +++   + L +
Sbjct: 5   KADDLEPIMELGRGAYGVVEKMR--HVPS----GQ---IMAVKRIRATVNSQEQKRLLMD 55

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSY---------LREEYL---- 113
           +++          V+F G  +++ ++ + +E       + Y         + E+ L    
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 114 -----------SNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPS 159
                      S   V+HRD+   N+L+++   VK+ DFG+S    D   +++   G   
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-GCKP 174

Query: 160 EKLPIRWLALE----SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-----LCRIV 210
                 ++A E     L    Y+ KSD+WS G+ + E+      PY         L ++V
Sbjct: 175 ------YMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQLKQVV 227

Query: 211 H 211
            
Sbjct: 228 E 228

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (250), Expect = 2e-25
 Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 55/241 (22%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            E L     +G+G +G V K +    P+    GQ    +AVK +++  D K   + L ++
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMV--HKPS----GQ---IMAVKRIRSTVDEKEQKQLLMDL 71

Query: 69  NLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSY----------LREEYL---- 113
           +++       +IV F G  +++ +  + +E  +    + Y          + EE L    
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 114 -----------SNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPS 159
                       N K++HRD+   NILL     +K+ DFG+S    D   +     G   
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-GCRP 190

Query: 160 EKLPIRWLALE----SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-----LCRIV 210
                 ++A E    S     Y  +SDVWS G+ L+E+ T G  PYP        L ++V
Sbjct: 191 ------YMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWNSVFDQLTQVV 243

Query: 211 H 211
            
Sbjct: 244 K 244

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 99.7 bits (249), Expect = 4e-25
 Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 56/211 (26%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +  +VLG G  G V++           +GQ   + A+K+L  +  A+      +E++   
Sbjct: 32  LSKQVLGLGVNGKVLEC------FHRRTGQ---KCALKLLYDSPKAR------QEVDHHW 76

Query: 73  DVGKHDHIVSFIGCCYKDELR------LVVEYCALGDL---------QSY--------LR 109
                 HIV  +   Y++         +++E    G+L         Q++        +R
Sbjct: 77  QASGGPHIVCILDV-YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 110 E-----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN--GEPS 159
           +     ++L ++ + HRD+   N+L +S     V+K++DFG +     QN  Q     P 
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPY 194

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVL 190
                 ++A E L    Y    D+WS GV++
Sbjct: 195 ------YVAPEVLGPEKYDKSCDMWSLGVIM 219

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.7 bits (249), Expect = 4e-25
 Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 50/206 (24%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E +G G + V  +          A+     E AVK++      K+     +EI ++  
Sbjct: 26  VKEDIGVGSYSVCKRC------IHKATNM---EFAVKIID-----KSKRDPTEEIEILLR 71

Query: 74  VGKHDHIVSFIGCCYKDELR--LVVEYCALGDL------QSYLRE--------------E 111
            G+H +I++     Y D     +V E    G+L      Q +  E              E
Sbjct: 72  YGQHPNIITLKDV-YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 112 YLSNNKVVHRDLATRNILLSSPH----VVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
           YL    VVHRDL   NIL          ++I DFG ++ +  +N          +     
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN----- 185

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVL 190
            ++A E L    Y    D+WS GV+L
Sbjct: 186 -FVAPEVLERQGYDAACDIWSLGVLL 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 98.4 bits (246), Expect = 5e-25
 Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 43/209 (20%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KAN-ADAKTYDKFLKEINLM 71
           +G +LG+G F  V +           +G    EVA+KM+ K     A    +   E+ + 
Sbjct: 15  VGNLLGKGSFAGVYRA------ESIHTGL---EVAIKMIDKKAMYKAGMVQRVQNEVKIH 65

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
             + KH  I+         + + LV+E C  G++  YL+                     
Sbjct: 66  CQL-KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRW 166
             YL ++ ++HRDL   N+LL+    +KI+DFGL+  +   +       G P+      +
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN------Y 178

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           ++ E    + +  +SDVWS G + + ++ 
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLI 207

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.0 bits (247), Expect = 5e-25
 Identities = 48/238 (20%), Positives = 87/238 (36%), Gaps = 52/238 (21%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
              L     +G G  G V K       T          +AVK ++ + + +   + L ++
Sbjct: 24  INDLENLGEMGSGTCGQVWKMR--FRKT-------GHVIAVKQMRRSGNKEENKRILMDL 74

Query: 69  NLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------------- 110
           +++       +IV   G    + ++ + +E       +   R                  
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134

Query: 111 ---EYL-SNNKVVHRDLATRNILLSSPHVVKISDFGLS---EDIYEQNVFQNGEPSEKLP 163
               YL   + V+HRD+   NILL     +K+ DFG+S    D   ++    G  +    
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-GCAA---- 189

Query: 164 IRWLALE-----SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-----LCRIVH 211
             ++A E           Y  ++DVWS G+ L E+ T G  PY +       L +++ 
Sbjct: 190 --YMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVLTKVLQ 244

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 99.4 bits (248), Expect = 7e-25
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 44/224 (19%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL-- 65
           P +       +G G FG V          +  + +    VA+K +  +            
Sbjct: 52  PEKLFSDLREIGHGSFGAVYFA------RDVRNSE---VVAIKKMSYSGKQSNEKWQDII 102

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCA--LGDLQSY-------------LR 109
           KE+  ++ + +H + + + GC  ++    LV+EYC     DL                  
Sbjct: 103 KEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161

Query: 110 E-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL ++ ++HRD+   NILLS P +VK+ DFG +  +   N F  G P      
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-GTP------ 214

Query: 165 RWLALE---SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
            W+A E   ++    Y  K DVWS G+   E+      P  ++ 
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN 257

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.4 bits (248), Expect = 8e-25
 Identities = 42/203 (20%), Positives = 80/203 (39%), Gaps = 43/203 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E LG G FGVV +        E A+G+       K +              EI++M  
Sbjct: 55  ILEELGSGAFGVVHRC------VEKATGR---VFVAKFINTPY-PLDKYTVKNEISIMNQ 104

Query: 74  VGKHDHIVSFIGCC-YKDELRLVVEYCALGDL----------------QSYLRE-----E 111
           +  H  +++       K E+ L++E+ + G+L                 +Y+R+     +
Sbjct: 105 L-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163

Query: 112 YLSNNKVVHRDLATRNILLSSP--HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
           ++  + +VH D+   NI+  +     VKI DFGL+  +    + +             + 
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE------FA 217

Query: 168 ALESLVSNIYTNKSDVWSFGVVL 190
           A E +        +D+W+ GV+ 
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLG 240

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 98.8 bits (246), Expect = 2e-24
 Identities = 46/230 (20%), Positives = 79/230 (34%), Gaps = 43/230 (18%)

Query: 8   PPERLILGEVLGQGE--FGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKF 64
                 L  V+G+G      V        PT    G+    V V+ +       +     
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLAR--YKPT----GE---YVTVRRINLEACSNEMVTFL 73

Query: 65  LKEINLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQ-----------------S 106
             E+++ K    H +IV +       +EL +V  + A G  +                  
Sbjct: 74  QGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY 132

Query: 107 YLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
            L+      +Y+ +   VHR +   +IL+S    V +S    +  +      Q       
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 162 LPIR----WLALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
                   WL+ E L  N+  Y  KSD++S G+   E+   G  P+  +P
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMP 241

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.4 bits (248), Expect = 2e-24
 Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 57/217 (26%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK------------ANADAKT 60
                LG G +G V+         E        E A+K++K                 K 
Sbjct: 39  FKVRKLGSGAYGEVLLC------KEKNGHS---EKAIKVIKKSQFDKGRYSDDNKNIEKF 89

Query: 61  YDKFLKEINLMKDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLRE-------- 110
           +++   EI+L+K +  H +I+      ++D+    LV E+   G+L   +          
Sbjct: 90  HEEIYNEISLLKSLD-HPNIIKLFDV-FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147

Query: 111 ------------EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQN 155
                        YL  + +VHRD+   NILL + +    +KI DFGLS    +    ++
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207

Query: 156 --GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVL 190
             G         ++A E L    Y  K DVWS GV++
Sbjct: 208 RLGTAY------YIAPEVLKKK-YNEKCDVWSCGVIM 237

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.0 bits (242), Expect = 3e-24
 Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 51/215 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLM 71
           +  +VLG+G    V             + Q   E AVK++ K     +   +  +E+ ++
Sbjct: 16  LQEDVLGEGAHARVQTC------INLITSQ---EYAVKIIEKQPGHIR--SRVFREVEML 64

Query: 72  KDVGKHDHIVSFIGCCYKDELR--LVVEYCALGDLQSYLRE------------------- 110
                H +++  I   +++E R  LV E    G + S++ +                   
Sbjct: 65  YQCQGHRNVLELIE-FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123

Query: 111 -EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKL---- 162
            ++L N  + HRDL   NIL   P+    VKI DF L   I            E L    
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 163 ------P-IRWLALESLVSNIYTNKSDVWSFGVVL 190
                 P +  +   S  ++IY  + D+WS GV+L
Sbjct: 184 SAEYMAPEV--VEAFSEEASIYDKRCDLWSLGVIL 216

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 96.6 bits (241), Expect = 4e-24
 Identities = 66/236 (27%), Positives = 93/236 (39%), Gaps = 55/236 (23%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             +   L EV+G G   VV        P +        +VA+K +       + D+ LKE
Sbjct: 13  NRDDYELQEVIGSGATAVVQAAY--CAPKK-------EKVAIKRINLEKCQTSMDELLKE 63

Query: 68  INLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALG---DLQSY---------------- 107
           I  M     H +IVS+        EL LV++  + G   D+  +                
Sbjct: 64  IQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 108 ----LRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--- 155
               LRE     EYL  N  +HRD+   NILL     V+I+DFG+S  +           
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 156 -----GEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP 205
                G P       W+A E +     Y  K+D+WSFG+   E+ T GA PY   P
Sbjct: 183 RKTFVGTP------CWMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYP 231

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.4 bits (242), Expect = 4e-24
 Identities = 31/229 (13%), Positives = 76/229 (33%), Gaps = 54/229 (23%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            + + +  +LG+G F  V +   GD        +   +  +K+ K  A+   +    + +
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDA----KNKQKFVLKVQK-PANPWEFYIGTQLM 118

Query: 69  NLMKDVGKHDHIVSFIGC-CYKDELRLVVEYCALGDLQSYLRE----------------- 110
             +K        + F     +++   LV E  + G L + +                   
Sbjct: 119 ERLKPS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHV-----------VKISDFGLSEDIYEQN 151
                   E + + +++H D+   N +L +  +           + + D G S D+    
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM---K 234

Query: 152 VFQNGEPSEKLPIRW-----LALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           +F  G        +        +E L +  +  + D +     ++ ++ 
Sbjct: 235 LFPKG---TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.8 bits (246), Expect = 4e-24
 Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 43/203 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E LG G FGVV +       TE A+G      A K +         +   KEI  M  
Sbjct: 161 IHEELGTGAFGVVHRV------TERATGN---NFAAKFVMT-PHESDKETVRKEIQTMSV 210

Query: 74  VGKHDHIVSFIGCC-YKDELRLVVEYCALGDL-------QSYLRE--------------E 111
           + +H  +V+        +E+ ++ E+ + G+L        + + E               
Sbjct: 211 L-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 112 YLSNNKVVHRDLATRNILLSS--PHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
           ++  N  VH DL   NI+ ++   + +K+ DFGL+  +  +   +   G         + 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE------FA 323

Query: 168 ALESLVSNIYTNKSDVWSFGVVL 190
           A E          +D+WS GV+ 
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLS 346

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.6 bits (241), Expect = 4e-24
 Identities = 50/206 (24%), Positives = 77/206 (37%), Gaps = 48/206 (23%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +  + LG+G F +  K           S Q     AVK++      +      KEI  +K
Sbjct: 14  LKDKPLGEGSFSICRKC------VHKKSNQ---AFAVKII----SKRMEANTQKEITALK 60

Query: 73  DVGKHDHIVSFIGCCYKDELR--LVVEYCALGDL------QSYLRE-------------- 110
               H +IV      + D+L   LV+E    G+L      + +  E              
Sbjct: 61  LCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119

Query: 111 EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQN-VFQN--GEPSEKLPI 164
            ++ +  VVHRDL   N+L +  +    +KI DFG +      N   +            
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH----- 174

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVL 190
            + A E L  N Y    D+WS GV+L
Sbjct: 175 -YAAPELLNQNGYDESCDLWSLGVIL 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.8 bits (239), Expect = 1e-23
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 61/218 (27%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINLM 71
            L + +G+G F  V             +G+   EVA+K++ K   +  +  K  +E+ +M
Sbjct: 18  RLLKTIGKGNFAKVKLA------RHILTGR---EVAIKIIDKTQLNPTSLQKLFREVRIM 68

Query: 72  KDVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSYLRE---------------- 110
           K +  H +IV      +     +  L L++EY + G++  YL                  
Sbjct: 69  KIL-NHPNIVKL----FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE--------P 158
               +Y    ++VHRDL   N+LL +   +KI+DFG S      N F  G         P
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAP 177

Query: 159 SEKLPIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVT 195
               P      E      Y   + DVWS GV+L+ +V+
Sbjct: 178 PYAAP------ELFQGKKYDGPEVDVWSLGVILYTLVS 209

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 95.1 bits (237), Expect = 1e-23
 Identities = 37/228 (16%), Positives = 73/228 (32%), Gaps = 55/228 (24%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +  +  + LG+G F  V              G      A+K +  + + +  ++  +E +
Sbjct: 29  KHYLFIQKLGEGGFSYVDLV------EGLHDGH---FYALKRILCH-EQQDREEAQREAD 78

Query: 70  LMKDVGKHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLRE-------------- 110
           + +    H +I+  +  C ++     E  L++ +   G L + +                
Sbjct: 79  MHRLFN-HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS------------EDIY 148
                     E +      HRDL   NILL       + D G                  
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL 196
           +    Q    S + P  +         +   ++DVWS G VL+ ++  
Sbjct: 198 QDWAAQRCTISYRAPELF---SVQSHCVIDERTDVWSLGCVLYAMMFG 242

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.9 bits (239), Expect = 1e-23
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 43/205 (20%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLM 71
           +   E+LG G FG V K        E A+G    ++A K++K     K  ++   EI++M
Sbjct: 91  VSKTEILGGGRFGQVHKC------EETATGL---KLAAKIIKTRG-MKDKEEVKNEISVM 140

Query: 72  KDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDL----------------QSYLRE---- 110
             +  H +++        K+++ LV+EY   G+L                  ++++    
Sbjct: 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199

Query: 111 -EYLSNNKVVHRDLATRNILLSSP--HVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIR 165
             ++    ++H DL   NIL  +     +KI DFGL+     +   +   G P       
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE------ 253

Query: 166 WLALESLVSNIYTNKSDVWSFGVVL 190
           +LA E +  +  +  +D+WS GV+ 
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIA 278

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 93.9 bits (234), Expect = 3e-23
 Identities = 40/208 (19%), Positives = 75/208 (36%), Gaps = 70/208 (33%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +  +VLG G  G V++           + +   + A+KML+    A+      +E+ L  
Sbjct: 21  VTSQVLGLGINGKVLQI------FNKRTQE---KFALKMLQDCPKAR------REVELHW 65

Query: 73  DVGKHDHIVSFIG-----CCYKDELRLVVEYCALGDL--------QSYLRE--------- 110
              +  HIV  +         +  L +V+E    G+L             E         
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                +YL +  + HRD+   N+L +S     ++K++DFG +++   +            
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK----------- 174

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVL 190
                         Y    D+WS GV++
Sbjct: 175 --------------YDKSCDMWSLGVIM 188

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 93.4 bits (233), Expect = 4e-23
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 44/208 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLM 71
           +G  LG+G+FG V          E  S      +A+K+L       A    +  +E+ + 
Sbjct: 13  IGRPLGKGKFGNVYLA------REKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQ 63

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
             + +H +I+   G  +    + L++EY  LG +   L++                    
Sbjct: 64  SHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWL 167
            Y  + +V+HRD+   N+LL S   +KI+DFG S  ++  +  +    G         +L
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLD------YL 174

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
             E +   ++  K D+WS GV+ +E + 
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLV 202

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 92.3 bits (230), Expect = 9e-23
 Identities = 53/209 (25%), Positives = 81/209 (38%), Gaps = 51/209 (24%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
            L + LG+G +G V             + +    VAVK++         +   KEI + K
Sbjct: 10  DLVQTLGEGAYGEVQLA------VNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINK 60

Query: 73  DVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSY------LRE----------- 110
            +  H+++V F    Y      +   L +EYC+ G+L         + E           
Sbjct: 61  ML-NHENVVKF----YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 115

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-- 165
               YL    + HRD+   N+LL     +KISDFGL+       VF+       L     
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCG 169

Query: 166 ---WLALESLVSNIYT-NKSDVWSFGVVL 190
              ++A E L    +     DVWS G+VL
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 92.3 bits (230), Expect = 1e-22
 Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 44/208 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLM 71
           +G  LG+G+FG V          E  +      +A+K+L  +         +  +EI + 
Sbjct: 18  IGRPLGKGKFGNVYLA------REKQNKF---IMALKVLFKSQLEKEGVEHQLRREIEIQ 68

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
             + +H +I+      + +  + L++E+   G+L   L++                    
Sbjct: 69  SHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPIRWL 167
            Y    KV+HRD+   N+L+     +KI+DFG S  ++  ++ +    G         +L
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLD------YL 179

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
             E +    +  K D+W  GV+ +E + 
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLV 207

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.0 bits (229), Expect = 3e-22
 Identities = 53/209 (25%), Positives = 81/209 (38%), Gaps = 51/209 (24%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
            L + LG+G +G V             + +    VAVK++         +   KEI + K
Sbjct: 10  DLVQTLGEGAYGEVQLA------VNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINK 60

Query: 73  DVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSY------LRE----------- 110
            +  H+++V F    Y      +   L +EYC+ G+L         + E           
Sbjct: 61  ML-NHENVVKF----YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 115

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-- 165
               YL    + HRD+   N+LL     +KISDFGL+       VF+       L     
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCG 169

Query: 166 ---WLALESLVSNIYT-NKSDVWSFGVVL 190
              ++A E L    +     DVWS G+VL
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 89.0 bits (221), Expect = 4e-21
 Identities = 48/237 (20%), Positives = 85/237 (35%), Gaps = 67/237 (28%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           RL +  VL +G F  V +        +  SG+   E A+K L +N + +     ++E+  
Sbjct: 29  RLRVRRVLAEGGFAFVYEA------QDVGSGR---EYALKRLLSN-EEEKNRAIIQEVCF 78

Query: 71  MKDVGKHDHIVSFIGCCYKDELR--------LVVEYCALGDLQSYLRE------------ 110
           MK +  H +IV F       +          L++     G L  +L++            
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138

Query: 111 -----------EYLSNNK--VVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                      +++   K  ++HRDL   N+LLS+   +K+ DFG +          +  
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA------TTISHYP 192

Query: 158 PSEKLPIRWLALE-----------------SLVSN-IYTNKSDVWSFGVVLWEIVTL 196
                  R   +E                  L SN     K D+W+ G +L+ +   
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.7 bits (213), Expect = 3e-20
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 62/219 (28%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDKFLKEINL 70
           +LG+ LG G FG V  G          +G    +VAVK+L  +         K  +EI  
Sbjct: 14  VLGDTLGVGTFGKVKIG------EHQLTGH---KVAVKILNRQKIRSLDVVGKIKREIQN 64

Query: 71  MKDVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSY------LRE--------- 110
           +K   +H HI+      Y       +  +V+EY + G+L  Y      + E         
Sbjct: 65  LKLF-RHPHIIKL----YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ 119

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE-------- 157
                +Y   + VVHRDL   N+LL +    KI+DFGLS      N+  +GE        
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGS 173

Query: 158 PSEKLPIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVT 195
           P+      + A E +   +Y   + D+WS GV+L+ ++ 
Sbjct: 174 PN------YAAPEVISGRLYAGPEVDIWSCGVILYALLC 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.2 bits (209), Expect = 1e-19
 Identities = 46/219 (21%), Positives = 88/219 (40%), Gaps = 54/219 (24%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML---KANADAKTYDKFLKEIN 69
           ++G++LG+G +G V +        +  +       AVK+L   K            KEI 
Sbjct: 8   LMGDLLGEGSYGKVKEV------LDSETLC---RRAVKILKKKKLRRIPNGEANVKKEIQ 58

Query: 70  LMKDVGKHDHIVSF---IGCCYKDELRLVVEYCALGDL-------QSYLRE--------- 110
           L++ + +H +++     +    K ++ +V+EYC  G         +              
Sbjct: 59  LLRRL-RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--- 162
                EYL +  +VH+D+   N+LL++   +KIS  G++               +     
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA------EALHPFAADDTCRTS 171

Query: 163 ---PIRWLALESLVSNI--YT-NKSDVWSFGVVLWEIVT 195
              P  +   E + + +  ++  K D+WS GV L+ I T
Sbjct: 172 QGSP-AFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITT 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.9 bits (208), Expect = 2e-19
 Identities = 49/231 (21%), Positives = 84/231 (36%), Gaps = 69/231 (29%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-------------------- 52
            L + +G+G +GVV                     A+K+L                    
Sbjct: 16  TLKDEIGKGSYGVVKLA------YNENDNT---YYAMKVLSKKKLIRQAGFPRRPPPRGT 66

Query: 53  -----KANADAKTYDKFLKEINLMKDVGKHDHIVSF---IGCCYKDELRLVVEYCALGDL 104
                         ++  +EI ++K +  H ++V     +    +D L +V E    G +
Sbjct: 67  RPAPGGCIQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125

Query: 105 QSY-----LRE--------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE 145
                   L E              EYL   K++HRD+   N+L+     +KI+DFG+S 
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 146 DIYEQNVFQN---GEPSEKLPIRWLALESLVSN--IYT-NKSDVWSFGVVL 190
           +    +   +   G P+      ++A ESL     I++    DVW+ GV L
Sbjct: 186 EFKGSDALLSNTVGTPA------FMAPESLSETRKIFSGKALDVWAMGVTL 230

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 65/231 (28%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINL 70
           ILG+ LG G FG V  G          +G    +VAVK+L            K  +EI  
Sbjct: 19  ILGDTLGVGTFGKVKVG------KHELTGH---KVAVKILNRQKIRSLDVVGKIRREIQN 69

Query: 71  MKDVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSY------LRE--------- 110
           +K   +H HI+      Y       ++ +V+EY + G+L  Y      L E         
Sbjct: 70  LKLF-RHPHIIKL----YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ 124

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE-------- 157
                +Y   + VVHRDL   N+LL +    KI+DFGLS      N+  +GE        
Sbjct: 125 ILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGS 178

Query: 158 PSEKLPIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANPY--PHIP 205
           P+      + A E +   +Y   + D+WS GV+L+ ++  G  P+   H+P
Sbjct: 179 PN------YAAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVP 222

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 83.9 bits (207), Expect = 3e-19
 Identities = 35/249 (14%), Positives = 68/249 (27%), Gaps = 68/249 (27%)

Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDK 63
           G  P  L+ G VLGQ +    ++       T+  +G+      V +        +    +
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEA------TDQETGE---SFEVHVPYFTERPPSNAIKQ 119

Query: 64  FLKEINLMK---------------------DVGKHDHIVSFIGCCYKDELRLVVEYCAL- 101
             +E+  ++                     D+ K       I     +    V+    L 
Sbjct: 120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 179

Query: 102 -----------GDLQSYLRE--------------------EYLSNNKVVHRDLATRNILL 130
                        L S+                         L +  +VH  L   +I+L
Sbjct: 180 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 239

Query: 131 SSPHVVKISDFGLSEDIYEQNVFQNGE----PSEKLPIRWLALESLVSNIYTNKSDVWSF 186
                V ++ F        + V         P  +     ++       + T   D W+ 
Sbjct: 240 DQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299

Query: 187 GVVLWEIVT 195
           G+V++ I  
Sbjct: 300 GLVIYWIWC 308

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 83.6 bits (207), Expect = 3e-19
 Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 63/228 (27%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-------ANADAKTYDKFL 65
                LG G FG V          +    +   EV VK +K          +     K  
Sbjct: 27  STMSPLGSGAFGFVWTA------VDKEKNK---EVVVKFIKKEKVLEDCWIEDPKLGKVT 77

Query: 66  KEINLMKDVGKHDHIVSFIGCCY-----KDELRLVVEYCALG-DLQSYLRE--------- 110
            EI ++  V +H +I+            +   +LV+E    G DL +++           
Sbjct: 78  LEIAILSRV-EHANIIKV----LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA 132

Query: 111 -----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
                       YL    ++HRD+   NI+++    +K+ DFG +         + G   
Sbjct: 133 SYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA------AYLERG--- 183

Query: 160 EKLP-----IRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANPY 201
           +        I + A E L+ N Y   + ++WS GV L+ +V    NP+
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-EENPF 230

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 83.6 bits (206), Expect = 4e-19
 Identities = 30/254 (11%), Positives = 62/254 (24%), Gaps = 76/254 (29%)

Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDK 63
                +L L E L  G+  VV          +    +   + A+K+    A       ++
Sbjct: 58  SQGERKLKLVEPLRVGDRSVVFLV------RDVERLE---DFALKVFTMGAENSRSELER 108

Query: 64  FLKEINLMK--------------------DVGKHDHIVSFIGCCYKDELRLVVEYCAL-- 101
             +                          D         F       +   V  Y  L  
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 102 ---GDLQSYLRE---------------------------EYLSNNKVVHRDLATRNILLS 131
               DL+                                  L +  +VH      N+ + 
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM 228

Query: 132 SPHVVKISDFGLSEDIYEQNVFQNGEPSEKL--PIRWLALESLVSN--IYTNKSDVWSFG 187
               + + D            ++ G        P+ +   E L ++   +T+  + W  G
Sbjct: 229 PDGRLMLGDVSAL--------WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 188 VVLWEIVTLGANPY 201
           + ++ +      P+
Sbjct: 281 LSIYRVWC-LFLPF 293

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.4 bits (204), Expect = 7e-19
 Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 49/219 (22%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKM-----LKANADAKTYDKFLKEI 68
           +G +LG G FG V  G         +       VA+K      +    +     +   E+
Sbjct: 47  VGPLLGSGGFGSVYSG------IRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEV 97

Query: 69  NLMKDVG-KHDHIVSFIGCC-YKDELRLVVEYCA-LGDLQSYLRE--------------- 110
            L+K V      ++  +      D   L++E    + DL  ++ E               
Sbjct: 98  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157

Query: 111 -----EYLSNNKVVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKL 162
                 +  N  V+HRD+   NIL+  +   +K+ DFG    + +  V+ +  G      
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 216

Query: 163 PIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANP 200
           P      E +  + Y    + VWS G++L+++V  G  P
Sbjct: 217 P------EWIRYHRYHGRSAAVWSLGILLYDMVC-GDIP 248

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 83.2 bits (205), Expect = 8e-19
 Identities = 37/256 (14%), Positives = 65/256 (25%), Gaps = 68/256 (26%)

Query: 6   GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDK 63
           G  P  L+ G VLGQ +    ++       T+  +G+      V +        +    +
Sbjct: 74  GERPRTLVRGTVLGQEDPYAYLEA------TDQETGE---SFEVHVPYFTERPPSNAIKQ 124

Query: 64  FLKEINLMK---------------------DVGKHDHIVSFIGCCYKDELRLVVEY---- 98
             +E+  ++                     D+ K       I     +    V+      
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 99  ----CALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILL 130
                 L      L                            L +  +VH  L   +I+L
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 244

Query: 131 SSPHVVKISDFGLSEDIYEQNVFQNGEPS---EKLPIRWLALESLVSNIYTNKSDVWSFG 187
                V ++ F          V   G      E    R L        + T   D W+ G
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304

Query: 188 VVLWEIVTLGANPYPH 203
           + ++ I      P   
Sbjct: 305 LAIYWIWC-ADLPNTD 319

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.2 bits (201), Expect = 2e-18
 Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 55/223 (24%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKM-----LKANADAKTYDKFLKEI 68
           LG +LG+G FG V  G                +VA+K+     +   +          E+
Sbjct: 35  LGPLLGKGGFGTVFAG------HRLTDRL---QVAIKVIPRNRVLGWSPLSDSVTCPLEV 85

Query: 69  NLMKDV---GKHDHIVS---FIGCCYKDELRLVVEYCALG-DLQSYLRE----------- 110
            L+  V   G H  ++    +     ++   LV+E      DL  Y+ E           
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFE--TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143

Query: 111 ---------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQN--GEP 158
                    ++  +  VVHRD+   NIL+       K+ DFG    +     + +  G  
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTR 202

Query: 159 SEKLPIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANP 200
               P      E +  + Y    + VWS G++L+++V  G  P
Sbjct: 203 VYSPP------EWISRHQYHALPATVWSLGILLYDMVC-GDIP 238

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.2 bits (201), Expect = 2e-18
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 67/221 (30%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINL 70
           I+ E LG+G FG V         T   + Q   +VA+K +       +  + +  +EI+ 
Sbjct: 12  IIRETLGEGSFGKVKLA------THYKTQQ---KVALKFISRQLLKKSDMHMRVEREISY 62

Query: 71  MKDVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSY------LRE--------- 110
           +K + +H HI+      Y       ++ +V+EY   G+L  Y      + E         
Sbjct: 63  LKLL-RHPHIIKL----YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQ 116

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EY   +K+VHRDL   N+LL     VKI+DFGLS      N+  +G         
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS------NIMTDGN-------- 162

Query: 166 WL----------ALESLVSNIYT-NKSDVWSFGVVLWEIVT 195
           +L          A E +   +Y   + DVWS G+VL+ ++ 
Sbjct: 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 81.5 bits (201), Expect = 2e-18
 Identities = 32/168 (19%), Positives = 61/168 (36%), Gaps = 32/168 (19%)

Query: 57  DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE------ 110
                D    +I  M      + +        K  L + ++ C   +L+ ++        
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 111 -----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF 153
                            E+L +  ++HRDL   NI  +   VVK+ DFGL   + +    
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220

Query: 154 QNGEPSEKLPIR---------WLALESLVSNIYTNKSDVWSFGVVLWE 192
           Q                    +++ E +  N Y++K D++S G++L+E
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.5 bits (199), Expect = 4e-18
 Identities = 55/226 (24%), Positives = 86/226 (38%), Gaps = 57/226 (25%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
              + +G G FGV           +  + +    VAVK +     A   +   +EI   +
Sbjct: 23  DFVKDIGSGNFGVARLM------RDKLTKE---LVAVKYI--ERGAAIDENVQREIINHR 71

Query: 73  DVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSY------LRE----------- 110
            + +H +IV F             L +++EY + G+L           E           
Sbjct: 72  SL-RHPNIVRF----KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126

Query: 111 ---EYLSNNKVVHRDLATRNILL--SSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKL 162
               Y  + ++ HRDL   N LL  S    +KI DFG S      +       G P+   
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPA--- 182

Query: 163 PIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANPY--PHIP 205
              ++A E L+   Y    +DVWS GV L+ ++  GA P+  P  P
Sbjct: 183 ---YIAPEVLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 224

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 80.2 bits (198), Expect = 7e-18
 Identities = 39/237 (16%), Positives = 77/237 (32%), Gaps = 79/237 (33%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK----------------ANAD 57
           +   L QG+F  ++         +    +     A+K  +                  + 
Sbjct: 35  IIRTLNQGKFNKIILC------EK--DNK---FYALKKYEKSLLEKKRDFTKSNNDKISI 83

Query: 58  AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------ 110
              YD F  E+ ++ D+ K+++ ++  G     DE+ ++ EY     +  +         
Sbjct: 84  KSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142

Query: 111 ----------------------EYL-SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI 147
                                  Y+ +   + HRD+   NIL+     VK+SDFG S   
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES--- 199

Query: 148 YEQNVFQNGE-------PSEKLPIRWLALESLVSNIYTN--KSDVWSFGVVLWEIVT 195
                  + +               ++  E   +    N  K D+WS G+ L+ +  
Sbjct: 200 ---EYMVDKKIKGSRGTYE------FMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 51/227 (22%)

Query: 1   MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT 60
           MAL      +R    + LG+G+F  V K        +  + Q    VA+K +K    ++ 
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKA------RDKNTNQI---VAIKKIKLGHRSEA 51

Query: 61  YDKF----LKEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----- 110
            D      L+EI L++++  H +I+  +     K  + LV ++    DL+  +++     
Sbjct: 52  KDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVL 109

Query: 111 ----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ 154
                           EYL  + ++HRDL   N+LL    V+K++DFGL+        F 
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA------KSF- 162

Query: 155 NGEPSEKLP----IRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
            G P+         RW  A E L  + +Y    D+W+ G +L E++ 
Sbjct: 163 -GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 72.6 bits (179), Expect = 2e-15
 Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 48/209 (22%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDV 74
             +G+G +GVV K           +GQ    VA+K    + D     K  L+EI ++K +
Sbjct: 9   GKIGEGSYGVVFKC------RNRDTGQ---IVAIKKFLESEDDPVIKKIALREIRMLKQL 59

Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------------EY 112
            KH ++V+ +     K  L LV EYC    +   L                        +
Sbjct: 60  -KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL----PIRWL- 167
              +  +HRD+   NIL++   V+K+ DFG +  +          PS+        RW  
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL--------TGPSDYYDDEVATRWYR 169

Query: 168 ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
           + E LV    Y    DVW+ G V  E+++
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 71.9 bits (177), Expect = 4e-15
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 48/209 (22%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF-LKEINLMKDV 74
            ++G+G +G+V+K           +G+    VA+K    + D K   K  ++EI L+K +
Sbjct: 31  GLVGEGSYGMVMKC------RNKDTGRI---VAIKKFLESDDDKMVKKIAMREIKLLKQL 81

Query: 75  GKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------------EY 112
            +H+++V+ +  C  K    LV E+     +   L                        +
Sbjct: 82  -RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP----IRWL- 167
             ++ ++HRD+   NIL+S   VVK+ DFG +  +          P E        RW  
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--------AAPGEVYDDEVATRWYR 191

Query: 168 ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
           A E LV    Y    DVW+ G ++ E+  
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFM 220

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.0 bits (175), Expect = 6e-15
 Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 58/216 (26%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
           E +G+G +G V K           + +    VA+K ++ + D    +      L+EI L+
Sbjct: 8   EKIGEGTYGTVFKA------KNRETHEI---VALKRVRLDDDD---EGVPSSALREICLL 55

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH +IV      +   +L LV E+C   DL+ Y                       
Sbjct: 56  KEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS------EDIYEQNVFQNGEPSEKLP 163
             +  +  V+HRDL  +N+L++    +K+++FGL+         Y   V           
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT--------- 164

Query: 164 IRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVTLG 197
             W    + L  + +Y+   D+WS G +  E+   G
Sbjct: 165 -LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 70.3 bits (173), Expect = 1e-14
 Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 60/220 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
             +G G +G V K        +  SG     VA+K ++               ++E+ L+
Sbjct: 15  AEIGVGAYGTVYKA------RDPHSGHF---VALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 72  KD--VGKHDHIVSFIGCCYKDELR------LVVEYCALGDLQSYLRE------------- 110
           +     +H ++V  +  C            LV E+    DL++YL +             
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 111 ---------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-----SEDIYEQNVFQNG 156
                    ++L  N +VHRDL   NIL++S   VK++DFGL      +      V    
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT-- 182

Query: 157 EPSEKLPIRWL-ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                    W  A E L+ + Y    D+WS G +  E+  
Sbjct: 183 --------LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 64/218 (29%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +       ++        EVA+K +  +   K      +E+ +M+ V 
Sbjct: 46  KVIGNGSFGVVFQAK--LVESD--------EVAIKKVLQDKRFK-----NRELQIMRIV- 89

Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCALGDLQSYLRE------------------ 110
           KH ++V      Y     KDE  L LV+EY     +    R                   
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 111 ------EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYEQNVFQNGEP--SEK 161
                  Y+ +  + HRD+  +N+LL  P  V+K+ DFG ++      +   GEP  S  
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNVSY- 201

Query: 162 LPI--RWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             I  R+  A E +  +  YT   D+WS G V+ E++ 
Sbjct: 202 --ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 69.7 bits (171), Expect = 4e-14
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 57/215 (26%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G G FGVV +  L D      SG+    VA+K  K   D +   K  +E+ +M+ + 
Sbjct: 60  KVIGNGSFGVVYQAKLCD------SGE---LVAIK--KVLQDKR--FK-NRELQIMRKL- 104

Query: 76  KHDHIVSFIGCCY-----KDE--LRLVVEYCALGDLQSYLREEYLSNNK----------- 117
            H +IV      Y     KDE  L LV++Y     +    R    +              
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 118 -------------VVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPS-EKL 162
                        + HRD+  +N+LL     V+K+ DFG ++          GEP+   +
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYI 217

Query: 163 PIRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             R+  A E +  +  YT+  DVWS G VL E++ 
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 68.8 bits (169), Expect = 6e-14
 Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 59/214 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
           + LG+G +  V KG          +      VA+K ++   +    +      ++E++L+
Sbjct: 8   DKLGEGTYATVYKG------KSKLTDNL---VALKEIRLEHE----EGAPCTAIREVSLL 54

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           KD+ KH +IV+     + +  L LV EY    DL+ YL +                    
Sbjct: 55  KDL-KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRG 112

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS------EDIYEQNVFQNGEPSEKLP 163
             Y    KV+HRDL  +N+L++    +K++DFGL+         Y+  V           
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT--------- 163

Query: 164 IRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             W    + L+ S  Y+ + D+W  G + +E+ T
Sbjct: 164 -LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 68.0 bits (167), Expect = 8e-14
 Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 56/216 (25%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI----- 68
            G++LG+G F  VV         E A+ +   E A+K+L+     K +     ++     
Sbjct: 34  FGKILGEGSFSTVVLA------RELATSR---EYAIKILE-----KRHIIKENKVPYVTR 79

Query: 69  --NLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE-------------- 110
             ++M  +  H   V      ++D+ +L   + Y   G+L  Y+R+              
Sbjct: 80  ERDVMSRL-DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN-----GEPS 159
                 EYL    ++HRDL   NILL+    ++I+DFG ++ +  ++         G   
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                 +++ E L        SD+W+ G +++++V 
Sbjct: 198 ------YVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.4 bits (168), Expect = 9e-14
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 62/222 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
             +GQG FG V K           +GQ    VA+K +    +    + F    L+EI ++
Sbjct: 23  AKIGQGTFGEVFKAR------HRKTGQK---VALKKVLMENEK---EGFPITALREIKIL 70

Query: 72  KDVGKHDHIVSFIGCC---------YKDELRLVVEYCALGDLQSYLRE------------ 110
           + + KH+++V+ I  C          K  + LV ++C   DL   L              
Sbjct: 71  QLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128

Query: 111 ---------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                     Y+  NK++HRD+   N+L++   V+K++DFGL+        F   + S+ 
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA------RAFSLAKNSQP 182

Query: 162 LPI------RWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
                     W    E L+    Y    D+W  G ++ E+ T
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.0 bits (167), Expect = 1e-13
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 59/214 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
           E +G+G +GVV K     G            VA+K ++ +A+    +      ++EI+L+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRI----------VALKRIRLDAED---EGIPSTAIREISLL 73

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           K++  H +IVS I   + +  L LV E+    DL+  L E                    
Sbjct: 74  KEL-HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS------EDIYEQNVFQNGEPSEKLP 163
             +   ++++HRDL  +N+L++S   +K++DFGL+         Y   V           
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT--------- 182

Query: 164 IRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             W  A + L+ S  Y+   D+WS G +  E++T
Sbjct: 183 -LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 49/234 (20%), Positives = 85/234 (36%), Gaps = 75/234 (32%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
             G  +G+G +G V K    DG  +        + A+K ++    + +     +EI L++
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDK-------DYALKQIEGTGISMSA---CREIALLR 73

Query: 73  DVGKHDHIVSFIGCCYKDELR---LVVEYCALGDLQSYLRE------------------- 110
           ++ KH +++S          R   L+ +Y    DL   ++                    
Sbjct: 74  EL-KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPH----VVKISDFGLSEDIYEQNVFQNG 156
                      YL  N V+HRDL   NIL+         VKI+D G +       +F + 
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------RLFNS- 184

Query: 157 EPSEKLPIRWLALESLV--------------SNIYTNKSDVWSFGVVLWEIVTL 196
                 P++ LA    V              +  YT   D+W+ G +  E++T 
Sbjct: 185 ------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.9 bits (164), Expect = 3e-13
 Identities = 43/210 (20%), Positives = 85/210 (40%), Gaps = 41/210 (19%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            +   L   LG+G++  V + +  +        +   +V VK+LK     K   K  +EI
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAI--NITN----NE---KVVVKILK-PVKKK---KIKREI 81

Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR---LVVEYCALGDL------------QSYLRE--- 110
            +++++    +I++          R   LV E+    D             + Y+ E   
Sbjct: 82  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 141

Query: 111 --EYLSNNKVVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
             +Y  +  ++HRD+   N+++      +++ D+GL+E  Y      N   +     R+ 
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVAS----RYF 196

Query: 168 -ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
              E LV   +Y    D+WS G +L  ++ 
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIF 226

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.4 bits (163), Expect = 3e-13
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 59/214 (27%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
           E +G+G +GVV K        +   G+     A+K ++   +    +      ++EI+++
Sbjct: 8   EKIGEGTYGVVYKA-------QNNYGET---FALKKIRLEKED---EGIPSTTIREISIL 54

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH +IV      + K  L LV E+    DL+  L                      
Sbjct: 55  KEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS------EDIYEQNVFQNGEPSEKLP 163
             Y  + +V+HRDL  +N+L++    +KI+DFGL+         Y   +           
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--------- 163

Query: 164 IRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             W  A + L+ S  Y+   D+WS G +  E+V 
Sbjct: 164 -LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 46/160 (28%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
           E LG G +  V KG          +G     VA+K +K +++    +      ++EI+LM
Sbjct: 11  EKLGNGTYATVYKG------LNKTTGVY---VALKEVKLDSE----EGTPSTAIREISLM 57

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           K++ KH++IV      + +++L LV E+    DL+ Y+                      
Sbjct: 58  KEL-KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS 144
                  +   NK++HRDL  +N+L++    +K+ DFGL+
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 65.3 bits (160), Expect = 7e-13
 Identities = 45/218 (20%), Positives = 86/218 (39%), Gaps = 62/218 (28%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
             LG+G +G V K        +  + +    VA+K ++   +    +      ++E++L+
Sbjct: 40  TKLGEGTYGEVYKA------IDTVTNET---VAIKRIRLEHEE---EGVPGTAIREVSLL 87

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
           K++ +H +I+      +    L L+ EY    DL+ Y+ +                    
Sbjct: 88  KEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 111 EYLSNNKVVHRDLATRNILLSSPH-----VVKISDFGLS------EDIYEQNVFQNGEPS 159
            +  + + +HRDL  +N+LLS        V+KI DFGL+         +   +       
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT----- 200

Query: 160 EKLPIRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
                 W    E L+ S  Y+   D+WS   +  E++ 
Sbjct: 201 -----LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.3 bits (160), Expect = 1e-12
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 52/224 (23%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA---NADAKTYDKFL 65
                L  +LG+G +GVV        PT          VA+K ++       A    + L
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSAT--HKPTG-------EIVAIKKIEPFDKPLFAL---RTL 57

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELR------LVVEYCALGDLQSYLREEYLSNN--- 116
           +EI ++K   KH++I++       D         ++ E     DL   +  + LS++   
Sbjct: 58  REIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQ 115

Query: 117 ----------------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                            V+HRDL   N+L++S   +K+ DFGL+  I +++   N EP+ 
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTG 174

Query: 161 KLPI-------RWL-ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
           +          RW  A E +++   Y+   DVWS G +L E+  
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 64.9 bits (158), Expect = 1e-12
 Identities = 47/252 (18%), Positives = 73/252 (28%), Gaps = 90/252 (35%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK----ANADAKTYDKFLKE-- 67
           L   +GQG +GVV          E  +       A+K++        + K  ++   E  
Sbjct: 30  LKGAIGQGSYGVVRVA------IENQTRA---IRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 68  ---------INLMKDV---GKHDHIV--------------------------------SF 83
                    I  + +V    ++  +V                                  
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 84  IGCCYKDELRLVVEYCALGDLQSYLRE--------------EYLSNNKVVHRDLATRNIL 129
                 +E      +     L    RE               YL N  + HRD+   N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200

Query: 130 LSSPH--VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR-------WLALESLVSNI--YT 178
            S+     +K+ DFGLS        F      E   +        ++A E L +    Y 
Sbjct: 201 FSTNKSFEIKLVDFGLS------KEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254

Query: 179 NKSDVWSFGVVL 190
            K D WS GV+L
Sbjct: 255 PKCDAWSAGVLL 266

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 44/210 (20%), Positives = 88/210 (41%), Gaps = 48/210 (22%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           +V+G+G FG VVK    D             VA+KM++     + + +  +EI +++ + 
Sbjct: 103 KVIGKGSFGQVVKAY--DHKVH-------QHVALKMVRNEK--RFHRQAAEEIRILEHLR 151

Query: 76  KHD-----HIVSFIGC-CYKDELRLVVEYCA----------------LGDLQSYLRE--- 110
           K D     +++  +    +++ + +  E  +                L  ++ +      
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211

Query: 111 --EYLSNNKVVHRDLATRNILLSSPH--VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
             + L  N+++H DL   NILL       +K+ DFG S        +++      +  R+
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------CYEHQRVYTYIQSRF 264

Query: 167 L-ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
             A E ++   Y    D+WS G +L E++T
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 45/215 (20%)

Query: 7   YPPERLILGEVLGQGEFGVV--VKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYD 62
              ++    + LG G FG V  VK           SG      A+K+L        K  +
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVK--------HKESGNH---YAMKILDKQKVVKLKQIE 86

Query: 63  KFLKEINLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE---------- 110
             L E  +++ V     +V      +KD   L  V+EY A G++ S+LR           
Sbjct: 87  HTLNEKRILQAV-NFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                     EYL +  +++RDL   N+L+     ++++DFG ++ +  +     G P  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE- 203

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                 LA E ++S  Y    D W+ GV+++E+  
Sbjct: 204 -----ALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.0 bits (154), Expect = 5e-12
 Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 62/220 (28%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF----LKEINLM 71
             +G+G +G V K    D    G        VA+K ++        +      ++E+ ++
Sbjct: 17  AEIGEGAYGKVFKAR--DLKNGGRF------VALKRVRVQTGE---EGMPLSTIREVAVL 65

Query: 72  KD--VGKHDHIVSFIGCCYKDELR------LVVEYCALGDLQSYLRE------------- 110
           +     +H ++V     C            LV E+    DL +YL +             
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124

Query: 111 ---------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL-----SEDIYEQNVFQNG 156
                    ++L +++VVHRDL  +NIL++S   +K++DFGL      +      V    
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT-- 182

Query: 157 EPSEKLPIRWL-ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                    W  A E L+ + Y    D+WS G +  E+  
Sbjct: 183 --------LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.2 bits (154), Expect = 6e-12
 Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 60/233 (25%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-----DAKTYDK 63
             +  L + LG+G +G+V K +  D  T          VAVK +  +A     DA+   +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSI--DRRTG-------EVVAVKKI-FDAFQNSTDAQ---R 54

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCYKDELR---LVVEYCALGDLQSYLREEYLSNN---- 116
             +EI ++ ++  H++IV+ +     D  R   LV +Y    DL + +R   L       
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY 113

Query: 117 ---------------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                           ++HRD+   NILL++   VK++DFGLS          N  P   
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 162 LPI-----------------RWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
                               RW  A E L+ S  YT   D+WS G +L EI+ 
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 62.8 bits (153), Expect = 7e-12
 Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 43/214 (20%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKE 67
            +R    + +G G  G+V      D   E         VA+K L      +T+ K   +E
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAY--DAILE-------RNVAIKKLSRPFQNQTHAKRAYRE 74

Query: 68  INLMKDVGKHDHIVS----FIGCCYKDELR---LVVEYCALGDLQSYLREE--------- 111
           + LMK V  H +I+     F      +E +   +V+E     +L   ++ E         
Sbjct: 75  LVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYL 132

Query: 112 ---------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                    +L +  ++HRDL   NI++ S   +KI DFGL+     +    +   +  +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMTPYV 187

Query: 163 PIRWL-ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
             R+  A E ++   Y    D+WS G ++ E++ 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 63.3 bits (154), Expect = 7e-12
 Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 43/214 (20%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKE 67
            +R    + +G G  G+V      D   +         VA+K L      +T+ K   +E
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAY--DAVLD-------RNVAIKKLSRPFQNQTHAKRAYRE 111

Query: 68  INLMKDVGKHDHIVS----FIGCCYKDELR---LVVEYCALGDLQSYLREE--------- 111
           + LMK V  H +I+S    F      +E +   LV+E     +L   ++ E         
Sbjct: 112 LVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYL 169

Query: 112 ---------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                    +L +  ++HRDL   NI++ S   +KI DFGL+     +    +   +  +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMTPYV 224

Query: 163 PIRWL-ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
             R+  A E ++   Y    D+WS G ++ E+V 
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 63.0 bits (153), Expect = 9e-12
 Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 47/214 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           ++G+G FG V           G       ++ A+K L        +     L E  ++  
Sbjct: 196 IIGRGGFGEVY----------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245

Query: 74  VGKHDH--IVSFIGCCY--KDELRLVVEYCALGDLQSYLRE------------------- 110
           V   D   IV  +   +   D+L  +++    GDL  +L +                   
Sbjct: 246 VSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN-GEPSEKLPIRWLA 168
            E++ N  VV+RDL   NILL     V+ISD GL+ D  ++    + G         ++A
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG------YMA 358

Query: 169 LESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY 201
            E L   + Y + +D +S G +L++++  G +P+
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPF 391

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 61.5 bits (150), Expect = 2e-11
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 46/214 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           +LG+G FG V    L       A  +   +  A+K LK +        +  + E  ++  
Sbjct: 24  MLGKGSFGKV---FL-------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
             +H  +     C +  K+ L  V+EY   GDL  +++                      
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           +L +  +V+RDL   NILL     +KI+DFG+  E++          G P       ++A
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD------YIA 186

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            E L+   Y +  D WSFGV+L+E++  G +P+ 
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFH 219

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 46/214 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           VLG+G FG V   +L       +  +   E+ AVK+LK +        +  + E  ++  
Sbjct: 348 VLGKGSFGKV---ML-------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
            GK   +      C+   D L  V+EY   GDL  ++++                     
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           +L +  +++RDL   N++L S   +KI+DFG+  E+I++    +   G P       ++A
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD------YIA 510

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            E +    Y    D W+FGV+L+E++  G  P+ 
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFE 543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 60.3 bits (147), Expect = 4e-11
 Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 55/193 (28%)

Query: 46  EVAVKMLKAN--ADAKTYDKFLKEI---------NLMK--DVGKHDHIVSFIGCCYKDEL 92
           +VA+K +        +T  +F +E+         N++   DV + D         Y    
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY------Y---- 87

Query: 93  RLVVEYCALGDLQSYLREEY-LS-------------------NNKVVHRDLATRNILLSS 132
            LV+EY     L  Y+     LS                   + ++VHRD+  +NIL+ S
Sbjct: 88  -LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146

Query: 133 PHVVKISDFGLSEDIYEQNVFQN----GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGV 188
              +KI DFG+++ + E ++ Q     G         + + E          +D++S G+
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVLGTVQ------YFSPEQAKGEATDECTDIYSIGI 200

Query: 189 VLWEIVTLGANPY 201
           VL+E++  G  P+
Sbjct: 201 VLYEMLV-GEPPF 212

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 54/213 (25%)

Query: 17  VLGQGEFGVV--VKGLLGDGPTEGASGQA-AMEVAVK--MLKANADAKTYDKFLKEINLM 71
           V+G+G FG V  V+          ++ +  AM++  K  M+K +  A       +E ++M
Sbjct: 76  VIGRGAFGEVQLVR--------HKSTRKVYAMKLLSKFEMIKRSDSAFF----WEERDIM 123

Query: 72  KDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE------------------- 110
                   +V  +   ++D+  L  V+EY   GDL + +                     
Sbjct: 124 AFA-NSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 181

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN----GEPSEKLPIRW 166
           + + +   +HRD+   N+LL     +K++DFG    + ++ + +     G P       +
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD------Y 235

Query: 167 LALESLVS----NIYTNKSDVWSFGVVLWEIVT 195
           ++ E L S      Y  + D WS GV L+E++ 
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 46/214 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           VLG+G FG V   +L       +  +   E+ AVK+LK +        +  + E  ++  
Sbjct: 27  VLGKGSFGKV---ML-------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
            GK   +      C+   D L  V+EY   GDL  ++++                     
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           +L +  +++RDL   N++L S   +KI+DFG+  E+I++    +   G P       ++A
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD------YIA 189

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            E +    Y    D W+FGV+L+E++  G  P+ 
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFE 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 60.4 bits (147), Expect = 4e-11
 Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 45/217 (20%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA---NADAKTYDKFL 65
             R      +G+G +G+V      D   +       + VA+K +         +   + L
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAY--DNLNK-------VRVAIKKISPFEHQTYCQ---RTL 73

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELR------LVVEYCALGDLQSYLREEYLSNN--- 116
           +EI ++    +H++I+          +       +V +     DL   L+ ++LSN+   
Sbjct: 74  REIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC 131

Query: 117 ----------------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                            V+HRDL   N+LL++   +KI DFGL+  + + +    G  +E
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTE 190

Query: 161 KLPIRWL-ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
            +  RW  A E +++   YT   D+WS G +L E+++
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 60.3 bits (147), Expect = 5e-11
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 45/213 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQA-AMEVAVK-MLKANADAKTYDKFLKEINLMKDV 74
           VLGQG FG V    L    +   + Q  AM+V  K  LK     +T      E +++ +V
Sbjct: 31  VLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRT----KMERDILVEV 83

Query: 75  GKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE--------------------Y 112
             H  IV      +  + +L L++++   GDL + L +E                    +
Sbjct: 84  -NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 113 LSNNKVVHRDLATRNILLSSP-HVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           L +  +++RDL   NILL    H +K++DFGLS E I  +    +  G         ++A
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVE------YMA 194

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E +    +T  +D WSFGV+++E++T G  P+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPF 226

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 60.2 bits (147), Expect = 5e-11
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 45/215 (20%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KAN--ADAKTYDKFLKEINLMKD 73
           VLG+G +G V         T   +G+     A+K+L KA    +AK       E N++++
Sbjct: 24  VLGKGGYGKV---FQVRKVTGANTGKI---FAMKVLKKAMIVRNAKDTAHTKAERNILEE 77

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
           V KH  IV  I   +    +L L++EY + G+L   L  E                    
Sbjct: 78  V-KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135

Query: 112 YLSNNKVVHRDLATRNILLSSP-HVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWL 167
           +L    +++RDL   NI+L+   H VK++DFGL  E I++  V     G         ++
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIE------YM 188

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           A E L+ + +    D WS G ++++++T GA P+ 
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLT-GAPPFT 222

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 60.5 bits (147), Expect = 5e-11
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 50/216 (23%)

Query: 17  VLGQGEFGVV--VKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMK 72
           +LG+G FG V  VK        E A+G+     A+K+LK             L E  +++
Sbjct: 155 LLGKGTFGKVILVK--------EKATGRY---YAMKILKKEVIVAKDEVAHTLTENRVLQ 203

Query: 73  DVGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE------------------- 111
           +  +H  + +     +   D L  V+EY   G+L  +L  E                   
Sbjct: 204 NS-RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 112 -YL-SNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRW 166
            YL S   VV+RDL   N++L     +KI+DFGL  E I +    +   G P       +
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE------Y 315

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           LA E L  N Y    D W  GVV++E++  G  P+ 
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFY 350

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 60.6 bits (147), Expect = 6e-11
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 48/214 (22%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           VLG+G FG V               +A  ++ A K L+       K     L E  +++ 
Sbjct: 191 VLGKGGFGEVC----------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLRE--------------------- 110
           V     +VS +   Y  KD L LV+     GDL+ ++                       
Sbjct: 241 V-NSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSEKLPIRWL 167
            E L   ++V+RDL   NILL     ++ISD GL+  + E    +   G         ++
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG------YM 352

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
           A E + +  YT   D W+ G +L+E++  G +P+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIA-GQSPF 385

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 60.1 bits (146), Expect = 7e-11
 Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 46/215 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           V+G+G +  V   LL          +    + A++++K     D +  D    E ++ + 
Sbjct: 59  VIGRGSYAKV---LL-------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
              H  +V     C+  +  L  V+EY   GDL  +++ +                    
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           YL    +++RDL   N+LL S   +K++D+G+  E +   +      G P+      ++A
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------YIA 221

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            E L    Y    D W+ GV+++E++  G +P+  
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI 255

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 59.6 bits (145), Expect = 8e-11
 Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 46/215 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           V+G+G +  V   LL          +    + A+K++K     D +  D    E ++ + 
Sbjct: 16  VIGRGSYAKV---LL-------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
              H  +V     C+  +  L  V+EY   GDL  +++ +                    
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           YL    +++RDL   N+LL S   +K++D+G+  E +   +      G P+      ++A
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------YIA 178

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            E L    Y    D W+ GV+++E++  G +P+  
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI 212

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 58/222 (26%)

Query: 17  VLGQGEFGVV--VKGLLGDGPTEGASGQA-AMEVAVK--MLKANADAKTYDKFLKEINLM 71
           V+G+G FG V  VK           + +  AM++  K  MLK    A       +E +++
Sbjct: 81  VIGRGAFGEVAVVK--------LKNADKVFAMKILNKWEMLKRAETACF----REERDVL 128

Query: 72  KDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE------------------- 110
            +      I +     ++D+  L LV++Y   GDL + L +                   
Sbjct: 129 VNG-DSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN---GEPSEKLPI 164
             + +     VHRD+   NIL+     ++++DFG   + + +  V  +   G P      
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD----- 241

Query: 165 RWLALESLVSNI-----YTNKSDVWSFGVVLWEIVTLGANPY 201
            +++ E L +       Y  + D WS GV ++E++  G  P+
Sbjct: 242 -YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY-GETPF 281

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 51/217 (23%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           VLG+G FG V               +A  ++ A K L        K Y   + E  ++  
Sbjct: 192 VLGRGGFGEVF----------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLRE--------------------- 110
           V     IVS +   +  K +L LV+     GD++ ++                       
Sbjct: 242 V-HSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN---GEPSEKLPI 164
              E+L    +++RDL   N+LL     V+ISD GL+ ++           G P      
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG----- 354

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            ++A E L+   Y    D ++ GV L+E++     P+
Sbjct: 355 -FMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPF 389

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 47/226 (20%), Positives = 79/226 (34%), Gaps = 56/226 (24%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKF--- 64
                +   +  G +G V                  + VA+K +    +D +T +     
Sbjct: 21  QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 65  ------LKEINLMKDVGKHDHIVS----FIGCCYKD--ELRLVVEYCALGDL-------Q 105
                 L+EI L+     H +I+     F+        +L LV E     DL       +
Sbjct: 71  FLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR 128

Query: 106 SYLREE--------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQN 151
             +  +               L    VVHRDL   NILL+  + + I DF L+     + 
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-----RE 183

Query: 152 VFQNGEPSEKLPIRWL-ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
              +   +  +  RW  A E ++    +T   D+WS G V+ E+  
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 46/215 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           VLG+G FG V   +L       A  +   ++ AVK+LK +        +  + E  ++  
Sbjct: 30  VLGKGSFGKV---ML-------ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDL---------------QSYLRE-----E 111
              H  +     CC+   D L  V+E+   GDL               + Y  E      
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           +L +  +++RDL   N+LL      K++DFG+  E I          G P       ++A
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD------YIA 192

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            E L   +Y    D W+ GV+L+E++  G  P+  
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEA 226

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 47/217 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KAN--ADAKTYDKFLKEINLMKD 73
           VLG G +G V    L    +   +G+     A+K+L KA     AKT +    E  +++ 
Sbjct: 61  VLGTGAYGKV---FLVRKISGHDTGKL---YAMKVLKKATIVQKAKTTEHTRTERQVLEH 114

Query: 74  VGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLREE-------------------- 111
           + +   +V+     ++ E +L  +++Y   G+L ++L +                     
Sbjct: 115 IRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 173

Query: 112 YLSNNKVVHRDLATRNILLSSP-HVVKISDFGLS-EDIYEQNVFQN---GEPSEKLPIRW 166
           +L    +++RD+   NILL S  H V ++DFGLS E + ++        G         +
Sbjct: 174 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE------Y 226

Query: 167 LALESLVSNIY-TNKS-DVWSFGVVLWEIVTLGANPY 201
           +A + +       +K+ D WS GV+++E++T GA+P+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPF 262

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 47/218 (21%), Positives = 79/218 (36%), Gaps = 57/218 (26%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
            + GQG FG V  G          +G     VA+K  K   D +  ++ L+ +  +  + 
Sbjct: 29  RMAGQGTFGTVQLGKEKS------TGM---SVAIK--KVIQDPRFRNRELQIMQDLAVL- 76

Query: 76  KHDHIVSFIGCCY------KDE--LRLVVEYCALGDLQSYLREEYLSNNK---------- 117
            H +IV      Y      + +  L +V+EY     L    R  Y               
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 118 ----------------VVHRDLATRNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPS- 159
                           V HRD+   N+L+  +   +K+ DFG ++           EP+ 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSPSEPNV 189

Query: 160 EKLPIRWL-ALESLV-SNIYTNKSDVWSFGVVLWEIVT 195
             +  R+  A E +  +  YT   D+WS G +  E++ 
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 50/212 (23%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
            ++G+G FG VVK    D   +         VA+K++K        ++   E+ L++ + 
Sbjct: 60  SLIGKGSFGQVVKAY--DRVEQ-------EWVAIKIIKNKK--AFLNQAQIEVRLLELMN 108

Query: 76  KHD-----HIVSFIGC-CYKDELRLVVEYCA----------------LGDLQSYLRE--- 110
           KHD     +IV       +++ L LV E  +                L   + + ++   
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168

Query: 111 --EYLSNNK--VVHRDLATRNILLSSP--HVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
              +L+  +  ++H DL   NILL +P    +KI DFG S               + +  
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-------CQLGQRIYQYIQS 221

Query: 165 RWL-ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           R+  + E L+   Y    D+WS G +L E+ T
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 47/214 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           +LG+G FG V   +L          +A     A+K+L+             + E  ++++
Sbjct: 12  LLGKGTFGKV---IL-------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
             +H  + +     +   D L  V+EY   G+L  +L  E                    
Sbjct: 62  T-RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           YL +  VV+RD+   N++L     +KI+DFGL  E I +    +   G P       +LA
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE------YLA 173

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            E L  N Y    D W  GVV++E++  G  P+ 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFY 206

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 57.9 bits (141), Expect = 3e-10
 Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 57/214 (26%)

Query: 14  LGEVLGQGEFGVV--VKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI--- 68
           +   LG G FG V  ++           +G+     A+K+LK     K     LK++   
Sbjct: 10  ILRTLGTGSFGRVHLIR--------SRHNGRY---YAMKVLK-----KEIVVRLKQVEHT 53

Query: 69  ----NLMKDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE------------ 110
                ++  V  H  I+      ++D  ++  +++Y   G+L S LR+            
Sbjct: 54  NDERLMLSIV-THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY 111

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQNGEPSEK 161
                   EYL +  +++RDL   NILL     +KI+DFG +            G P   
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-CGTPD-- 168

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
               ++A E + +  Y    D WSFG++++E++ 
Sbjct: 169 ----YIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 50/250 (20%), Positives = 83/250 (33%), Gaps = 71/250 (28%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-----DAKTYDK 63
           P+R  +  ++G G +G V +    D        +    VA+K +         D K    
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAY--DKLE----KR---VVAIKKI-LRVFEDLIDCKR--- 98

Query: 64  FLKEINLMKDVGKHDHIVSFI------GCCYKDELRLVVEYCALGDLQSYLR-EEYLSN- 115
            L+EI ++  +  HDH+V  +           DEL +V+E     D +   R   YL+  
Sbjct: 99  ILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTEL 156

Query: 116 ------------------NKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                               ++HRDL   N L++    VK+ DFGL+  +       +  
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

Query: 158 PSEKLPIRWLALES-------------------------LVSNIYTNKSDVWSFGVVLWE 192
           P          +                           L+   YT   DVWS G +  E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276

Query: 193 IVTLGANPYP 202
           ++ +      
Sbjct: 277 LLNMIKENVA 286

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 57.6 bits (140), Expect = 3e-10
 Identities = 37/183 (20%), Positives = 74/183 (40%), Gaps = 33/183 (18%)

Query: 46  EVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSF--IGCCYKDELRLVVEYCAL 101
            VA+K++     +D     +  +E      + +  H+V     G     +L + +     
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGE-IDGQLYVDMRLING 118

Query: 102 GDLQSYLREEY-LS-------------------NNKVVHRDLATRNILLSSPHVVKISDF 141
            DL + LR +  L+                        HRD+   NIL+S+     + DF
Sbjct: 119 VDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178

Query: 142 GLSEDIYEQNVFQNGEP--SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN 199
           G++    ++ + Q G    +    + ++A E    +  T ++D+++   VL+E +T G+ 
Sbjct: 179 GIASATTDEKLTQLGNTVGT----LYYMAPERFSESHATYRADIYALTCVLYECLT-GSP 233

Query: 200 PYP 202
           PY 
Sbjct: 234 PYQ 236

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 57.7 bits (140), Expect = 4e-10
 Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 54/226 (23%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML--KANADAKTYDKFLK 66
             R +  + LG G  G+V   +  D        +    VA+K +        K     L+
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAV--DNDC----DK---RVAIKKIVLTDPQSVK---HALR 57

Query: 67  EINLMKDVGKHDHIVS---------------FIGCCYKDELRLVVEYCALGDLQSYLREE 111
           EI +++ +  HD+IV                       + + +V EY    DL + L + 
Sbjct: 58  EIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG 115

Query: 112 YLSNN-------------------KVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQN 151
            L                       V+HRDL   N+ +++   V+KI DFGL+  I + +
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR-IMDPH 174

Query: 152 VFQNGEPSEKLPIRWL-ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
               G  SE L  +W  +   L+S N YT   D+W+ G +  E++T
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 57.8 bits (140), Expect = 4e-10
 Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 59/218 (27%)

Query: 17  VLGQGEFGVV--VKGLLGDGPTEGASGQA-AMEVAVK--MLKANADAKTYDKFLKEINLM 71
           V+G+G F  V  VK           +GQ  AM++  K  MLK    +       +E +++
Sbjct: 68  VIGRGAFSEVAVVK--------MKQTGQVYAMKIMNKWDMLKRGEVSCF----REERDVL 115

Query: 72  KDVGKHDHIVSFIGCCYKDELRL--VVEYCALGDLQSYLRE------------------- 110
            +      I       ++DE  L  V+EY   GDL + L +                   
Sbjct: 116 VNG-DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN---GEPSEKLPI 164
             + +     VHRD+   NILL     ++++DFG   +   +  V      G P      
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD----- 228

Query: 165 RWLALESL-------VSNIYTNKSDVWSFGVVLWEIVT 195
            +L+ E L        +  Y  + D W+ GV  +E+  
Sbjct: 229 -YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.8 bits (140), Expect = 5e-10
 Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 66/251 (26%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-----DAKTYDK 63
           P+  I+  ++G+G +G V      D  TE         VA+K +         D K   +
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAY--DKNTE-------KNVAIKKV-NRMFEDLIDCK---R 71

Query: 64  FLKEINLMKDVGKHDHIVSFI------GCCYKDELRLVVEYCALGDLQSYLREE------ 111
            L+EI ++  + K D+I+              DEL +V+E     DL+   +        
Sbjct: 72  ILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEE 129

Query: 112 --------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGE 157
                         ++  + ++HRDL   N LL+    VK+ DFGL+  I  +       
Sbjct: 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 158 PSEKLPIRWLALES--------------------LVSNIYTNKSDVWSFGVVLWEIVTLG 197
             E+        ++                    L+   YT   D+WS G +  E++ + 
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 198 ANPYPHIPLCR 208
            +         
Sbjct: 250 QSHINDPTNRF 260

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 47/216 (21%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKE 67
           PER      +G G +G V      D  T        + VAVK L     +  + K   +E
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF--DTKT-------GLRVAVKKLSRPFQSIIHAKRTYRE 78

Query: 68  INLMKDVGKHDHIVS----FIGCCYKDELR---LVVEYCALGDLQSYLREEYLSNN---- 116
           + L+K + KH++++     F      +E     LV       DL + ++ + L+++    
Sbjct: 79  LRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF 136

Query: 117 ---------------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                           ++HRDL   N+ ++    +KI DFGL+            E +  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-------ADEMTGY 189

Query: 162 LPIRWL-ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
           +  RW  A E +++   Y    D+WS G ++ E++T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 56.9 bits (138), Expect = 6e-10
 Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 46/215 (21%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKE 67
           P+  +    +G G +G V   +  D  +         +VA+K L     ++ + K   +E
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAI--DKRSG-------EKVAIKKLSRPFQSEIFAKRAYRE 73

Query: 68  INLMKDVGKHDHIVS----FIGCCYKDELR---LVVEYCALGDLQSYLREE--------- 111
           + L+K + +H++++     F             LV+ +    DLQ  +  +         
Sbjct: 74  LLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYL 131

Query: 112 ---------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                    Y+ +  VVHRDL   N+ ++    +KI DFGL+          + E +  +
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA-------DAEMTGYV 184

Query: 163 PIRWL-ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
             RW  A E ++S   Y    D+WS G ++ E++T
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 56.9 bits (138), Expect = 8e-10
 Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 47/216 (21%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKE 67
                  + +G G +G V   +  DG T         +VA+K L     ++ + K   +E
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAV--DGRTG-------AKVAIKKLYRPFQSELFAKRAYRE 74

Query: 68  INLMKDVGKHDHIVS----FIGCCYKDELR---LVVEYCALGDLQSYLREEYLSNN---- 116
           + L+K + +H++++     F      D+     LV+ +    DL   ++ E L  +    
Sbjct: 75  LRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQF 132

Query: 117 ---------------KVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEK 161
                           ++HRDL   N+ ++    +KI DFGL+          + E +  
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-------DSEMTGY 185

Query: 162 LPIRWL-ALESLVS-NIYTNKSDVWSFGVVLWEIVT 195
           +  RW  A E +++   YT   D+WS G ++ E++T
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.9 bits (138), Expect = 8e-10
 Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 46/213 (21%)

Query: 17  VLGQGEFGVVVKGLLGDGPTEGASGQAAMEV-AVKMLKANA--DAKTYDKFLKEINLMKD 73
           V+G+G FG V   LL       A  +A     AVK+L+  A    K     + E N++  
Sbjct: 45  VIGKGSFGKV---LL-------ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94

Query: 74  VGKHDHIVSFIGCCY--KDELRLVVEYCALGDLQSYLREE-------------------- 111
             KH  +V      +   D+L  V++Y   G+L  +L+ E                    
Sbjct: 95  NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153

Query: 112 YLSNNKVVHRDLATRNILLSSPHVVKISDFGLS-EDIYEQNVFQN--GEPSEKLPIRWLA 168
           YL +  +V+RDL   NILL S   + ++DFGL  E+I   +      G P       +LA
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE------YLA 207

Query: 169 LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
            E L    Y    D W  G VL+E++  G  P+
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPF 239

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 56.8 bits (137), Expect = 1e-09
 Identities = 37/244 (15%), Positives = 65/244 (26%), Gaps = 94/244 (38%)

Query: 14  LGEVLGQGEFGVVVKG----LLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +   +  G  G +       + G              V +K L  + DA+     + E  
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGR------------PVVLKGLVHSGDAEAQAMAMAERQ 131

Query: 70  LMKDVGKHDHIVS-----------FIGCCYKDELRLVVEYCALGDLQSYLRE-------- 110
            + +V  H  IV                 Y     +V+EY     L+    +        
Sbjct: 132 FLAEV-VHPSIVQIFNFVEHTDRHGDPVGY-----IVMEYVGGQSLKRSKGQKLPVAEAI 185

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-----------Y- 148
                      YL +  +V+ DL   NI+L +   +K+ D G    I           + 
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLYGTPGFQ 244

Query: 149 --EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY----- 201
             E        P                   T  +D+++ G  L  +             
Sbjct: 245 APEI---VRTGP-------------------TVATDIYTVGRTLAALTL-DLPTRNGRYV 281

Query: 202 PHIP 205
             +P
Sbjct: 282 DGLP 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 55.7 bits (135), Expect = 1e-09
 Identities = 46/191 (24%), Positives = 81/191 (42%), Gaps = 45/191 (23%)

Query: 46  EVAVKMLKAN--ADAKTYDKFLKEINLMKDVGK--HDHIVSF--IGCCYKDELR---LVV 96
           +VAVK+L+A+   D   Y +F +E    ++     H  IV+    G           +V+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREA---QNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95

Query: 97  EYCALGDLQSYLREEY-LS-------------------NNKVVHRDLATRNILLSSPHVV 136
           EY     L+  +  E  ++                    N ++HRD+   NI++S+ + V
Sbjct: 96  EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 155

Query: 137 KISDFGLSEDIYEQNVFQN------GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVL 190
           K+ DFG++  I +            G         +L+ E    +    +SDV+S G VL
Sbjct: 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQ------YLSPEQARGDSVDARSDVYSLGCVL 209

Query: 191 WEIVTLGANPY 201
           +E++T G  P+
Sbjct: 210 YEVLT-GEPPF 219

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 54.4 bits (131), Expect = 5e-09
 Identities = 50/254 (19%), Positives = 89/254 (35%), Gaps = 89/254 (35%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            ++  LG+ LG G FG+V +    D  +    G+     A+K  K   D +      +E+
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVF--DIES----GK---RFALK--KVLQDPRYK---NREL 51

Query: 69  NLMKDVGKHDHIVSFIGCCY---------------------------------------K 89
           ++MK +  H +I+  +   Y                                        
Sbjct: 52  DIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110

Query: 90  DELRLVVEYCALGDLQSYLREEYLSNNK------------------------VVHRDLAT 125
             L +++EY     L   L+    S                           + HRD+  
Sbjct: 111 KYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKP 169

Query: 126 RNILL-SSPHVVKISDFGLSEDIYEQNVFQNGEPS-EKLPIRWL-ALESLV-SNIYTNKS 181
           +N+L+ S  + +K+ DFG ++           EPS   +  R+  A E ++ +  YT   
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAK------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223

Query: 182 DVWSFGVVLWEIVT 195
           D+WS G V  E++ 
Sbjct: 224 DLWSIGCVFGELIL 237

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 54.3 bits (131), Expect = 6e-09
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 36/164 (21%)

Query: 65  LKEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE------------ 110
            KE+ +M+ + +H  +V+ +   ++DE  + +VV+    GDL+ +L++            
Sbjct: 63  FKELQIMQGL-EHPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEPSE 160
                   +YL N +++HRD+   NILL     V I+DF ++  +  +       G    
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP- 179

Query: 161 KLPIRWLA---LESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY 201
                ++A     S     Y+   D WS GV  +E++  G  PY
Sbjct: 180 -----YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPY 217

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.2 bits (128), Expect = 1e-08
 Identities = 39/225 (17%), Positives = 79/225 (35%), Gaps = 64/225 (28%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKEINLMKDV 74
             LG G F  V      D             VA+K+++ +   K Y +    EI L++ V
Sbjct: 25  RKLGWGHFSTVWLAK--DMVNN-------THVAMKIVRGD---KVYTEAAEDEIKLLQRV 72

Query: 75  GKHD----------HIVSFIGC-CYKDELR----LVVE----------------YCALGD 103
              D          HI+  +    +K        +V E                   L  
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132

Query: 104 LQSYLRE-----EYL-SNNKVVHRDLATRNILLSSPH------VVKISDFGLSEDIYEQN 151
           ++   ++     +Y+     ++H D+   N+L+           +KI+D G +       
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------- 185

Query: 152 VFQNGEPSEKLPIRWL-ALESLVSNIYTNKSDVWSFGVVLWEIVT 195
            + +   +  +  R   + E L+   +   +D+WS   +++E++T
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.2 bits (118), Expect = 3e-07
 Identities = 43/236 (18%), Positives = 75/236 (31%), Gaps = 82/236 (34%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
             LG+G FG VV+ L  D     +      +VA+K+++     K  +    EIN++K + 
Sbjct: 25  GNLGEGTFGKVVECL--DHARGKS------QVALKIIRNV--GKYREAARLEINVLKKIK 74

Query: 76  KHD-----HIVSFIGC-CYKDELRLVVEYCA----------------LGDLQSYLRE--- 110
           + D       V       +   + +  E                   L  ++    +   
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHV-------------------VKISDFG----LSE 145
              +L  N++ H DL   NIL  +                      ++++DFG      E
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194

Query: 146 DIYEQNVFQNGEPSEKLPI------RWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                             I      R    E ++   +    DVWS G +L+E   
Sbjct: 195 HHT--------------TIVATRHYR--PPEVILELGWAQPCDVWSIGCILFEYYR 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.2 bits (118), Expect = 3e-07
 Identities = 49/227 (21%), Positives = 78/227 (34%), Gaps = 60/227 (26%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
             +G G FG V+         +          AVK+++     K       E +++K + 
Sbjct: 41  RKMGDGTFGRVLLCQ--HIDNK-------KYYAVKVVRNI--KKYTRSAKIEADILKKIQ 89

Query: 76  KHD----HIVSFIGC-CYKDELRLVVEYCA----------------LGDLQSYLRE---- 110
             D    +IV + G   Y D + L+ E                   + D++ Y  E    
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149

Query: 111 -EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE-KL------ 162
             YL    + H DL   NILL  P+  K           ++      + +  KL      
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 163 --------PI------RWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
                    I      R  A E +++  +   SD+WSFG VL E+ T
Sbjct: 210 TFKSDYHGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYT 254

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.6 bits (116), Expect = 5e-07
 Identities = 29/167 (17%), Positives = 58/167 (34%), Gaps = 38/167 (22%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK------ 66
            L     +   G++ +       T  +  Q   + ++K+   +        F +      
Sbjct: 45  KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQ-KFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 67  EINLMKDVGKHDH--IVSFIGC-CYKDELR-LVVEYCALG-DLQSYLRE----------- 110
           ++N  K +       I + +G   ++D+ R LV+    LG  LQS L             
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSV 161

Query: 111 -----------EYLSNNKVVHRDLATRNILL--SSPHVVKISDFGLS 144
                      E+L  N+ VH ++   NI +       V ++ +G +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.0 bits (115), Expect = 7e-07
 Identities = 42/238 (17%), Positives = 73/238 (30%), Gaps = 86/238 (36%)

Query: 16  EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG 75
           + LG+G FG VV+ +  D    G        VAVK++K     +  +    EI +++ + 
Sbjct: 20  DTLGEGAFGKVVECI--DHKAGG------RHVAVKIVKNVD--RYCEAARSEIQVLEHLN 69

Query: 76  KHD-----HIVSFIGC-CYKDELRLVVEYCA----------------LGDLQSYLRE--- 110
             D       V  +    +   + +V E                   L  ++    +   
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHV-------------------VKISDFGLS--EDI 147
              +L +NK+ H DL   NIL                         +K+ DFG +  +D 
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 148 YEQNVFQN----------GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVT 195
           +   +                                  ++   DVWS G +L E   
Sbjct: 190 HHSTLVSTRHYRAPEVILALG------------------WSQPCDVWSIGCILIEYYL 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 47.4 bits (113), Expect = 1e-06
 Identities = 20/218 (9%), Positives = 41/218 (18%), Gaps = 78/218 (35%)

Query: 14  LGEVLGQGEFGVVVKG---LLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEI 68
           L    G        +     L              +VA+  +            + L   
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDR------------QVALTFVDPQGVLPDDVLQETLSRT 82

Query: 69  NLMKDVGKHDHIVSFI------GCCYKDELRLVVEYCALGDLQSYLRE------------ 110
             +  +     +   +               +V E+   G LQ                 
Sbjct: 83  LRLSRID-KPGVARVLDVVHTRAGGL-----VVAEWIRGGSLQEVADTSPSPVGAIRAMQ 136

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                 +      V         + +S    V ++      D                  
Sbjct: 137 SLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------- 179

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
                          + D+   G  L+ ++     P P
Sbjct: 180 -------------NPQDDIRGIGASLYALLV-NRWPLP 203

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 30/161 (18%), Positives = 54/161 (33%), Gaps = 40/161 (24%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
              +G+ +G G FG +  G          + +    VA+K+    + A        E   
Sbjct: 10  NFRVGKKIGCGNFGELRLG------KNLYTNE---YVAIKLEPMKSRAPQLHL---EYRF 57

Query: 71  MKDVGKHDHIVSFIGCCYKDELRLVV------------EYCA----------LGDLQSYL 108
            K +G  D I          +   +V            + C           +   Q   
Sbjct: 58  YKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAI-QLIS 116

Query: 109 REEYLSNNKVVHRDLATRNILL-----SSPHVVKISDFGLS 144
           R EY+ +  +++RD+   N L+      +  V+ I DF L+
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 32/170 (18%), Positives = 58/170 (34%), Gaps = 44/170 (25%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-----AKTYDKFLKE 67
            +G  +GQG FG +             S  +     VK+  ++        K Y +  K 
Sbjct: 38  KVGLPIGQGGFGCIYLAD----MNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93

Query: 68  INLMKDVGKHDHIVSFI------GCCYKDELR---LVVEYCALG-DLQSYLRE------- 110
             + K +         +      G   K+      ++++    G DLQ            
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANAKRFSR 151

Query: 111 --------------EYLSNNKVVHRDLATRNILLS--SPHVVKISDFGLS 144
                         EY+  ++ VH D+   N+LL+  +P  V + D+GL+
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.7 bits (101), Expect = 4e-05
 Identities = 29/162 (17%), Positives = 56/162 (34%), Gaps = 40/162 (24%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
               +G  +G+G FGV+ +G      T   + Q   +VA+K     +DA        E  
Sbjct: 10  VHYKVGRRIGEGSFGVIFEG------TNLLNNQ---QVAIKFEPRRSDAPQLRD---EYR 57

Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV------------EYCA----------LGDLQSY 107
             K +     I +      +    ++V            + C               Q  
Sbjct: 58  TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAK-QML 116

Query: 108 LREEYLSNNKVVHRDLATRNILL-----SSPHVVKISDFGLS 144
            R + +    +V+RD+   N L+      + +++ + DFG+ 
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 35/181 (19%), Positives = 65/181 (35%), Gaps = 38/181 (20%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
            +  LG  +G G FG +  G      T   + +   EVA+K+             L E  
Sbjct: 7   NKFRLGRKIGSGSFGEIYLG------TNIQTNE---EVAIKLENVKTKHPQL---LYESK 54

Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV------------EYCA----------LGDLQSY 107
           + + +     I +      + +  ++V             +C+          L D Q  
Sbjct: 55  IYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD-QMI 113

Query: 108 LREEYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
            R E++ +   +HRD+   N L+      + V I DFGL++   + +  Q+    E   +
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173

Query: 165 R 165
            
Sbjct: 174 T 174

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 6e-05
 Identities = 38/160 (23%), Positives = 62/160 (38%), Gaps = 38/160 (23%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
            R  LG  +G G FG +  G      T+ A+G+   EVA+K+               E  
Sbjct: 9   NRYRLGRKIGSGSFGDIYLG------TDIAAGE---EVAIKLECVKTKHPQL---HIESK 56

Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVV------------EYCA----------LGDLQSY 107
           + K +     I +   C  + +  ++V             +C+          L D Q  
Sbjct: 57  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD-QMI 115

Query: 108 LREEYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLS 144
            R EY+ +   +HRD+   N L+      ++V I DFGL+
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 34/208 (16%), Positives = 63/208 (30%), Gaps = 77/208 (37%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-------K 59
            P E+L   E +G+G FG V + +    P           VA+K++             K
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIADHTP-----------VAIKIIAIEGPDLVNGSHQK 65

Query: 60  TYDKFLKEINLMKDVG--------KHDHIVSFIGCC------------------------ 87
           T+++ L EI + K++         + +  +                              
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 88  -------YKDELRLVVEYCALGDLQSYLREEYLS--------------------NNKVVH 120
                    D+L +V+E+   G     +R +  S                    + +  H
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEH 185

Query: 121 RDLATRNILLSSPHVVKISDFGLSEDIY 148
           RDL   N+LL    + K+      +   
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSST 213

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 38/174 (21%), Positives = 62/174 (35%), Gaps = 55/174 (31%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +LG+ +G G FG++                   + A  ++K   + +       E+   +
Sbjct: 40  VLGKKIGSGGFGLIY---------LAFPTNKPEKDARHVVKV--EYQENGPLFSELKFYQ 88

Query: 73  DVGKHDHIVSFIGCCYKDELR-------------------LVVEYCALG-DLQSYLRE-- 110
            V K D I  +I     D L                    +V+E   LG DLQ    +  
Sbjct: 89  RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQNG 146

Query: 111 ------------------EYLSNNKVVHRDLATRNILL--SSPHVVKISDFGLS 144
                             EY+  N+ VH D+   N+LL   +P  V ++D+GLS
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	228
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.03
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.65
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.06
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.88
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.83
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.26
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.23
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.57
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.51
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.11
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.5
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	92.32
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	88.89
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	87.0
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.96
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	85.44
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	83.85
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	83.81
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	83.58
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.63
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.59
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	80.92

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.3e-53  Score=342.51  Aligned_cols=217  Identities=37%  Similarity=0.683  Sum_probs=184.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.|+.++|++.+.||+|+||+||+|++.+..    ...++..||||.++.. .....+.+.+|+++|+++ +||||++++
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~HpnIV~l~   81 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDA-SDNARKDFHREAELLTNL-QHEHIVKFY   81 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSC-CHHHHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcc----cCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhC-CCCCCccEE
Confidence            4689999999999999999999999876532    3346678999999754 445567899999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH---------------------------------hcccCCCCcccCCCCCCEee
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE---------------------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                      +++..+ .+++||||+++|+|.+++..                                 .|||+++|+||||||+|||+
T Consensus        82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl  161 (299)
T 4asz_A           82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV  161 (299)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence            998764 58999999999999998842                                 59999999999999999999


Q ss_pred             cCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy3166         131 SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV  210 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~  210 (228)
                      +.++.+||+|||+++......... ......||+.|||||++.+..|+.++|||||||++|||+|.|..||.+.+..++.
T Consensus       162 ~~~~~~Ki~DFGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  240 (299)
T 4asz_A          162 GENLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  240 (299)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCEE-ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             CCCCcEEECCcccceecCCCCcee-ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999998654433221 1223467889999999999999999999999999999998789999999999999


Q ss_pred             HHHHcCCCCCCCCCCCCC
Q psy3166         211 HYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       211 ~~~~~~~~~~~p~~~~~~  228 (228)
                      ..+.++.+++.|+.||++
T Consensus       241 ~~i~~~~~~~~p~~~~~~  258 (299)
T 4asz_A          241 ECITQGRVLQRPRTCPQE  258 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHH
T ss_pred             HHHHcCCCCCCCccchHH
Confidence            999999999999999863

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.9e-53  Score=341.48  Aligned_cols=218  Identities=35%  Similarity=0.611  Sum_probs=184.7

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ..++.+++++.+.||+|+||+||+|.+.+..    +..+++.||||.++........+.+.+|+.+|+++ +||||++++
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~   95 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLL   95 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcc
Confidence            3578899999999999999999999975432    34556789999997665445567899999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++..+ .+++||||+++|+|.++|..                                    .|||+++|+||||||+|
T Consensus        96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N  175 (308)
T 4gt4_A           96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN  175 (308)
T ss_dssp             EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence            998764 48999999999999999831                                    69999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      ||++.++.+||+|||+++.+...... .......||+.|||||++....|+.++|||||||++|||+|.|..||.+.+..
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             eEECCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999866443322 22334678899999999999999999999999999999998789999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~~  228 (228)
                      ++.+.+.++.+++.|+.||++
T Consensus       255 ~~~~~i~~~~~~~~p~~~~~~  275 (308)
T 4gt4_A          255 DVVEMIRNRQVLPCPDDCPAW  275 (308)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHH
T ss_pred             HHHHHHHcCCCCCCcccchHH
Confidence            999999999999999999863

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-52  Score=340.47  Aligned_cols=217  Identities=40%  Similarity=0.676  Sum_probs=179.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.|+.++|.+.++||+|+||+||+|++++..    +..++..||||.++.. .....+.+.+|+++|+++ +||||++++
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l-~HpnIV~l~  109 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLL----PEQDKMLVAVKALKEA-SESARQDFQREAELLTML-QHQHIVRFF  109 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSC----C---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcc----cCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhC-CCCCCCcEE
Confidence            4578899999999999999999999876532    3456678999999754 445567899999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH-----------------------------------hcccCCCCcccCCCCCCE
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE-----------------------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~-----------------------------------~~lh~~~i~H~~lk~~ni  128 (228)
                      +++..+ .+++||||+++|+|.+++..                                   .|||+++|+||||||+||
T Consensus       110 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NI  189 (329)
T 4aoj_A          110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC  189 (329)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             EEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhE
Confidence            998764 48999999999999998741                                   699999999999999999


Q ss_pred             eecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         129 LLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      |++.++.+||+|||+++.+...... .......||+.|||||++.+..|+.++|||||||++|||+|.|..||.+.+..+
T Consensus       190 Ll~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          190 LVGQGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             EEETTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             EECCCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999865443221 122345788999999999999999999999999999999987899999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCC
Q psy3166         209 IVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       209 ~~~~~~~~~~~~~p~~~~~~  228 (228)
                      +...+.++.+++.|+.||++
T Consensus       269 ~~~~i~~g~~~~~p~~~~~~  288 (329)
T 4aoj_A          269 AIDCITQGRELERPRACPPE  288 (329)
T ss_dssp             HHHHHHHTCCCCCCTTCCHH
T ss_pred             HHHHHHcCCCCCCcccccHH
Confidence            99999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5e-53  Score=340.70  Aligned_cols=208  Identities=25%  Similarity=0.418  Sum_probs=178.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ..+++|++.+.||+|+||+||+|+         +..+++.||+|.+++..  .....+.+.+|+++|+++ +||||++++
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~---------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~   98 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY   98 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred             CCccccEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            445789999999999999999998         44566789999986431  112346788999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++.+++ +|+|||||+||+|.+++..                    +|||+++|+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGl  178 (311)
T 4aw0_A           99 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT  178 (311)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence            9998755 8999999999999999875                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.+..... .....+.+||+.|||||++.+..|+.++||||+||++|+|++ |..||.+.+..++.+++.++ .++.|+
T Consensus       179 a~~~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~-~~~~p~  255 (311)
T 4aw0_A          179 AKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAKIIKL-EYDFPE  255 (311)
T ss_dssp             CEECCTTTT-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT-CCCCCT
T ss_pred             ceecCCCCC-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCc
Confidence            986643321 122345789999999999999999999999999999999999 99999999999999999887 677787


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .+++
T Consensus       256 ~~s~  259 (311)
T 4aw0_A          256 KFFP  259 (311)
T ss_dssp             TCCH
T ss_pred             ccCH
Confidence            7764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-52  Score=343.96  Aligned_cols=205  Identities=22%  Similarity=0.394  Sum_probs=172.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      -++|++++.||+|+||+||+|+         +..+++.||+|.++.. ......+++.+|+++|+++ +||||+++++++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~   92 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVK---------STEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESF   92 (350)
T ss_dssp             CCCEEEEEEC------CEEEEE---------ETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEE---------ECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEE
Confidence            4689999999999999999998         4455668999999755 3455667899999999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ..+. +|+|||||+||+|.+++..                      .|||++||+||||||+|||++.+|.+||+|||++
T Consensus        93 ~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  172 (350)
T 4b9d_A           93 EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA  172 (350)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence            7654 8999999999999999853                      6999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +.+......   .....||+.|||||++.+..|+.++||||+||++|+|+| |..||.+.+..+++.++.++..++.|..
T Consensus       173 ~~~~~~~~~---~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~~~  248 (350)
T 4b9d_A          173 RVLNSTVEL---ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLKIISGSFPPVSLH  248 (350)
T ss_dssp             SCCCHHHHH---HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             eeecCCccc---ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCCcc
Confidence            865433211   123468899999999999999999999999999999999 9999999999999999999888888877


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +|+
T Consensus       249 ~s~  251 (350)
T 4b9d_A          249 YSY  251 (350)
T ss_dssp             SCH
T ss_pred             CCH
Confidence            765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.9e-52  Score=341.64  Aligned_cols=219  Identities=41%  Similarity=0.781  Sum_probs=186.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.||.++|++.+.||+|+||+||+|.+.+..    ...+.+.||+|.++..........+.+|+.+|+++.+||||++++
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~----~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCC----cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            7899999999999999999999999976643    334556799999987766666778999999999996679999999


Q ss_pred             eEEEcC--ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCC
Q psy3166          85 GCCYKD--ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        85 ~~~~~~--~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      +++...  .+++|||||++|+|.++|+.                                    .|||+++|+||||||+
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~  214 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  214 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence            998653  48999999999999999842                                    5999999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      |||++.++.+||+|||+++.+....... ......||+.|||||++.+..|+.++|||||||++|||+|.|..||.+...
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCce-eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999998664432221 122356788999999999999999999999999999999879999999764


Q ss_pred             -HHHHHHHHcCCCCCCCCCCCCC
Q psy3166         207 -CRIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       207 -~~~~~~~~~~~~~~~p~~~~~~  228 (228)
                       ..+...+..+.+++.|+.||+|
T Consensus       294 ~~~~~~~i~~g~~~~~p~~~~~~  316 (353)
T 4ase_A          294 DEEFCRRLKEGTRMRAPDYTTPE  316 (353)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHH
T ss_pred             HHHHHHHHHcCCCCCCCccCCHH
Confidence             4567788999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-52  Score=338.05  Aligned_cols=210  Identities=26%  Similarity=0.381  Sum_probs=172.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +++++|++.+.||+|+||+||+|+...      +..+++.||+|.+++.. ......++.+|+++|+++ +||||+++++
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~   93 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKIS------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHY   93 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECS------STTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEcc------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEE
Confidence            567899999999999999999998533      34466789999986442 112234577899999999 9999999999


Q ss_pred             EEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ++.++ .+|+|||||+||+|.+++..                    .|||+++|+||||||+|||++.+|.+||+|||++
T Consensus        94 ~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           94 AFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             EEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             EEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            98765 48999999999999999875                    6999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +......   .......||+.|||||++.+..|+.++||||+||++|+|+| |..||.+.+..++..++.++ .++.|+.
T Consensus       174 ~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  248 (304)
T 3ubd_A          174 KESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTMILKA-KLGMPQF  248 (304)
T ss_dssp             EC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTT
T ss_pred             eeccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHh-CCCCCCCcCHHHHHHHHHcC-CCCCCCc
Confidence            7543322   12335689999999999999999999999999999999999 99999999999999998887 6778888


Q ss_pred             CCCC
Q psy3166         225 CNEQ  228 (228)
Q Consensus       225 ~~~~  228 (228)
                      +|+|
T Consensus       249 ~s~~  252 (304)
T 3ubd_A          249 LSPE  252 (304)
T ss_dssp             SCHH
T ss_pred             CCHH
Confidence            7753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4e-51  Score=334.08  Aligned_cols=202  Identities=25%  Similarity=0.409  Sum_probs=172.8

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +++-+.++|++.+.||+|+||+||+|+         +..+++.||+|+++.... ...+.+.+|+.+|+++ +||||+++
T Consensus        68 ~~~dp~~~y~~~~~iG~G~fG~V~~a~---------~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l-~HpnIV~l  136 (346)
T 4fih_A           68 DPGDPRSYLDNFIKIGEGSTGIVCIAT---------VRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDY-QHENVVEM  136 (346)
T ss_dssp             CSSCGGGTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHC-CCTTBCCE
T ss_pred             CCCChhHhcEEeEEeecCcCeEEEEEE---------ECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhC-CCCCCCcE
Confidence            345566789999999999999999998         445566899999864422 1234678999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++++..+ .+|+|||||++|+|.+++..                   .|||+++|+||||||+|||++.+|.+||+|||+
T Consensus       137 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGl  216 (346)
T 4fih_A          137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF  216 (346)
T ss_dssp             EEEEEETTEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcC
Confidence            9998765 48999999999999998865                   699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ++.+.....   ......||+.|||||++.+..|+.++||||+||++|+|++ |..||.+.+..+++..+..+..+.
T Consensus       217 a~~~~~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~  289 (346)
T 4fih_A          217 CAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPR  289 (346)
T ss_dssp             CEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCC
T ss_pred             ceecCCCCC---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCC
Confidence            986544321   2345789999999999998899999999999999999999 999999999888888888775443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.3e-51  Score=323.31  Aligned_cols=208  Identities=26%  Similarity=0.440  Sum_probs=159.8

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCce
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHI   80 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni   80 (228)
                      ++.|-..++|++.+.||+|+||+||+|+         +..+++.||+|.+++..  ......++.+|+++|+++ +||||
T Consensus         6 l~~G~~ig~Y~i~~~lG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnI   75 (275)
T 3hyh_A            6 LADGAHIGNYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHI   75 (275)
T ss_dssp             --------CCEEEEEEEC---CCEEEEE---------CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTB
T ss_pred             CCCCCEeeCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCC
Confidence            3445566799999999999999999998         55566789999987542  223346788999999999 99999


Q ss_pred             EEeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          81 VSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        81 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +++++++...+ +++||||+ +|+|.+++..                    +|||+++|+||||||+|||++.++.+||+
T Consensus        76 v~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~  154 (275)
T 3hyh_A           76 IKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIA  154 (275)
T ss_dssp             CCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred             CeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEe
Confidence            99999987754 88999999 6799998765                    69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      |||+++......    ......||+.|+|||++.+..+ +.++||||+||++|+|+| |..||.+.+..++.+++.++ .
T Consensus       155 DFGla~~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt-g~~PF~~~~~~~~~~~i~~~-~  228 (275)
T 3hyh_A          155 DFGLSNIMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKNISNG-V  228 (275)
T ss_dssp             CSSCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT-C
T ss_pred             ecCCCeecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcC-C
Confidence            999997654322    2234678999999999998776 579999999999999999 99999999888888888887 6


Q ss_pred             CCCCCCCCC
Q psy3166         219 MERPASCNE  227 (228)
Q Consensus       219 ~~~p~~~~~  227 (228)
                      ++.|..+++
T Consensus       229 ~~~p~~~s~  237 (275)
T 3hyh_A          229 YTLPKFLSP  237 (275)
T ss_dssp             CCCCTTSCH
T ss_pred             CCCCCCCCH
Confidence            677877764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=326.53  Aligned_cols=209  Identities=30%  Similarity=0.540  Sum_probs=170.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .|.|+.+++++.+.||+|+||+||+|++++            .||||.++.. ......+.+.+|+.+|+++ +||||++
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~   96 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILL   96 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCC
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEee
Confidence            488999999999999999999999998532            3899998754 3455667899999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++..+.+++|||||++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+||
T Consensus        97 l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A           97 FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             EEEEECSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCC
T ss_pred             EEEEEECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeec
Confidence            9999888889999999999999999854                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeeccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYLSTGY  217 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~~~~~  217 (228)
                      |+++........ .......||+.|||||++..   ..|+.++|||||||++|||+| |..||.+.++.+. ...+..+.
T Consensus       177 Gla~~~~~~~~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~~~~~~~~~~~~~~~~  254 (307)
T 3omv_A          177 GLATVKSRWSGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSHINNRDQIIFMVGRGY  254 (307)
T ss_dssp             SSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHHHHTTC
T ss_pred             cCceecccCCcc-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH-CCCCCCCCChHHHHHHHHhcCC
Confidence            999755332211 12234678999999999863   358999999999999999999 9999998766544 55566665


Q ss_pred             CCC----CCCCCCC
Q psy3166         218 RME----RPASCNE  227 (228)
Q Consensus       218 ~~~----~p~~~~~  227 (228)
                      +.|    .|.+||+
T Consensus       255 ~~p~~~~~~~~~~~  268 (307)
T 3omv_A          255 ASPDLSKLYKNCPK  268 (307)
T ss_dssp             CCCCSTTSCTTSCH
T ss_pred             CCCCcccccccchH
Confidence            554    3456654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=336.03  Aligned_cols=208  Identities=25%  Similarity=0.394  Sum_probs=176.2

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +++-|.++|++.+.||+|+||+||+|+         +..+++.||+|+++.... ...+.+.+|+.+|+++ +||||+++
T Consensus       145 ~~~dp~~~y~~~~~iG~G~fG~V~~a~---------~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l-~HpnIV~l  213 (423)
T 4fie_A          145 DPGDPRSYLDNFIKIGEGSTGIVCIAT---------VRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDY-QHENVVEM  213 (423)
T ss_dssp             CSSCGGGTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHC-CCTTBCCE
T ss_pred             CCCChhHhcEeeeEeccCcCcEEEEEE---------ECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhC-CCCCCCce
Confidence            456677889999999999999999998         445566899999875432 2235678999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++++..+ .+|+|||||+||+|.+++..                   .|||++||+||||||+|||++.+|.+||+|||+
T Consensus       214 ~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGl  293 (423)
T 4fie_A          214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF  293 (423)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCcc
Confidence            9998765 48999999999999998865                   699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--C
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME--R  221 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~--~  221 (228)
                      ++.+.....   .....+||+.|||||++.+..|+.++|||||||++|+|++ |..||.+.+..+++..+..+..+.  .
T Consensus       294 a~~~~~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~~  369 (423)
T 4fie_A          294 CAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPRLKN  369 (423)
T ss_dssp             CEECCSSCC---CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             ceECCCCCc---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCcc
Confidence            986544321   2345688999999999999999999999999999999999 999999999888888888775443  3


Q ss_pred             CCCCC
Q psy3166         222 PASCN  226 (228)
Q Consensus       222 p~~~~  226 (228)
                      +..++
T Consensus       370 ~~~~s  374 (423)
T 4fie_A          370 LHKVS  374 (423)
T ss_dssp             TTSSC
T ss_pred             cccCC
Confidence            34444

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.7e-50  Score=325.91  Aligned_cols=203  Identities=20%  Similarity=0.310  Sum_probs=167.4

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ..+.|++.++||+|+||+||+|+         ++.+++.||+|.++....      ..+|+.+|+++ +||||+++++++
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~---------~~~~g~~vAiK~i~~~~~------~~~E~~il~~l-~HpnIV~l~~~~  119 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMK---------DKQTGFQCAVKKVRLEVF------RVEELVACAGL-SSPRIVPLYGAV  119 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEETTTC------CTHHHHTTTTC-CCTTBCCEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEE---------ECCCCCEEEEEEECHHHh------HHHHHHHHHhC-CCCCCCcEEEEE
Confidence            45678999999999999999998         445666899999975422      23699999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC-cEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~dfg~~~  145 (228)
                      ..+. +|+||||++||+|.+++..                    .|||+++|+||||||+|||++.+| .+||+|||+++
T Consensus       120 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             EECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            7654 8899999999999999875                    699999999999999999999987 69999999998


Q ss_pred             ccccccccc--CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CC
Q psy3166         146 DIYEQNVFQ--NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM--ER  221 (228)
Q Consensus       146 ~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~--~~  221 (228)
                      .+.......  .......||+.|||||++.+..|+.++||||+||++|+|+| |..||.+.+..++..++..+..+  +.
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  278 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASEPPPIREI  278 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSTTTCCSCCHHHHHHSCCGGGGS
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHHcCCCCchhc
Confidence            664432211  11234579999999999999999999999999999999999 99999998888888888776443  35


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |+.+|+
T Consensus       279 ~~~~s~  284 (336)
T 4g3f_A          279 PPSCAP  284 (336)
T ss_dssp             CTTSCH
T ss_pred             CccCCH
Confidence            677764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-48  Score=311.44  Aligned_cols=198  Identities=26%  Similarity=0.412  Sum_probs=162.2

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-   89 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-   89 (228)
                      |++.++||+|+||+||+|++         ..++..||+|.+... ......+++.+|+++|+++ +||||+++++++.. 
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLD---------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWEST   97 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEE---------CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeec
Confidence            48889999999999999984         445567999998644 3455567899999999999 99999999998854 


Q ss_pred             ----CceEEEEecCCCCcHHHHHHH--------------------hcccCCC--CcccCCCCCCEeecC-CCcEEEeecc
Q psy3166          90 ----DELRLVVEYCALGDLQSYLRE--------------------EYLSNNK--VVHRDLATRNILLSS-PHVVKISDFG  142 (228)
Q Consensus        90 ----~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~--i~H~~lk~~nil~~~-~~~~kl~dfg  142 (228)
                          +.+++||||+++|+|.+++..                    .|||+++  |+||||||+|||++. ++.+||+|||
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence                237899999999999999865                    6999998  999999999999985 7899999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCC-
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLSTGYRME-  220 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~~~~~~~-  220 (228)
                      +++.....     ......||+.|||||++.+ .|+.++|||||||++|+|+| |..||.+... ..+.+.+..+.+++ 
T Consensus       178 la~~~~~~-----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~  250 (290)
T 3fpq_A          178 LATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVKPAS  250 (290)
T ss_dssp             GGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred             CCEeCCCC-----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHH-CCCCCCCCCcHHHHHHHHHcCCCCCC
Confidence            99743221     1234678999999998865 59999999999999999999 9999987544 45567777776553 


Q ss_pred             CCCCCC
Q psy3166         221 RPASCN  226 (228)
Q Consensus       221 ~p~~~~  226 (228)
                      .|..++
T Consensus       251 ~~~~~~  256 (290)
T 3fpq_A          251 FDKVAI  256 (290)
T ss_dssp             GGGCCC
T ss_pred             CCccCC
Confidence            344444

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.6e-48  Score=312.51  Aligned_cols=194  Identities=23%  Similarity=0.425  Sum_probs=149.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|++         +.+++.||+|.++........+++.+|+++|+++ +||||+++++++..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~   74 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKN---------KVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLE   74 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEE---------TTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe
Confidence            4799999999999999999984         4455679999998666666667899999999999 99999999998854


Q ss_pred             Cc-------------eEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecCC
Q psy3166          90 DE-------------LRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSSP  133 (228)
Q Consensus        90 ~~-------------~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~~  133 (228)
                      .+             +|++||||++|+|.+++..                       +|||+++|+||||||+|||++.+
T Consensus        75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred             cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC
Confidence            22             6899999999999998763                       69999999999999999999999


Q ss_pred             CcEEEeeccCccccccccccc---------CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQ---------NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      +.+||+|||+++.+.......         .......||+.|||||++.+..|+.++|||||||++|||++    ||.+.
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~----Pf~~~  230 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----PFSTQ  230 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS----CCSSH
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc----CCCCc
Confidence            999999999998664432111         11234578999999999999999999999999999999996    88653


Q ss_pred             CH-HHHHHHHHcCC
Q psy3166         205 PL-CRIVHYLSTGY  217 (228)
Q Consensus       205 ~~-~~~~~~~~~~~  217 (228)
                      .. ...+..+....
T Consensus       231 ~~~~~~~~~~~~~~  244 (299)
T 4g31_A          231 MERVRTLTDVRNLK  244 (299)
T ss_dssp             HHHHHHHHHHHTTC
T ss_pred             cHHHHHHHHHhcCC
Confidence            22 22344444443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=309.42  Aligned_cols=195  Identities=23%  Similarity=0.384  Sum_probs=162.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++++.||+|+||+||+|+         +..+++.||||+++... ......++.+|+++|+++ +||||+++++++.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~---------~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  123 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSAR---------RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILR  123 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECC
T ss_pred             CCeEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeee
Confidence            689999999999999999998         44566789999997553 344556788999999999 9999999999874


Q ss_pred             c-------CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          89 K-------DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        89 ~-------~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      .       +.+|+||||+. |+|.+++..                    .|||++||+||||||+|||++.++.+||+||
T Consensus       124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             cccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeec
Confidence            3       34899999995 689888754                    6999999999999999999999999999999


Q ss_pred             cCcccccccccc-cCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         142 GLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       142 g~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |+++.+...... ........||+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+.++.+.+.
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~-G~~pF~g~~~~~~l~~I~~~  278 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFPGKNYVHQLQLIMMV  278 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHHHH
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHH-CCCCCCCCCHHHHHHHHHHh
Confidence            999866443221 2233457899999999998865 46899999999999999999 99999999988888877654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.2e-45  Score=320.53  Aligned_cols=205  Identities=24%  Similarity=0.314  Sum_probs=164.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHH---HHHHHHhcCCCCce
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLK---EINLMKDVGKHDHI   80 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~~h~ni   80 (228)
                      .+..++|++.+.||+|+||+||+|+         ++.+++.||+|.+++...  ........+   ++.+++.+ +||||
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~---------~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~I  254 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFI  254 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTB
T ss_pred             CCchHHeEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCE
Confidence            3566799999999999999999998         445667899999864310  011122333   45666677 89999


Q ss_pred             EEeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          81 VSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        81 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +++++++.+.. +|+||||++||+|.+++..                    .|||++||+||||||+|||++.+|.+||+
T Consensus       255 V~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~  334 (689)
T 3v5w_A          255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS  334 (689)
T ss_dssp             CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             eEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEec
Confidence            99999998754 8999999999999999875                    69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIP---LCRIVHYLST  215 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~---~~~~~~~~~~  215 (228)
                      |||+++.+....     ..+.+||+.|||||++.. ..|+.++||||+||++|+|++ |..||.+.+   ..++...+..
T Consensus       335 DFGlA~~~~~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLt-G~~PF~~~~~~~~~~i~~~i~~  408 (689)
T 3v5w_A          335 DLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLT  408 (689)
T ss_dssp             CCTTCEECSSCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCGGGCCCHHHHHHHHHH
T ss_pred             ccceeeecCCCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcC
Confidence            999998654332     335689999999999974 579999999999999999999 999997643   3345555555


Q ss_pred             CCCCCCCCCCCC
Q psy3166         216 GYRMERPASCNE  227 (228)
Q Consensus       216 ~~~~~~p~~~~~  227 (228)
                      . .++.|..+++
T Consensus       409 ~-~~~~p~~~S~  419 (689)
T 3v5w_A          409 M-AVELPDSFSP  419 (689)
T ss_dssp             C-CCCCCTTSCH
T ss_pred             C-CCCCCccCCH
Confidence            5 6677777764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-44  Score=296.57  Aligned_cols=194  Identities=18%  Similarity=0.293  Sum_probs=154.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|+.+.      +..+++.||+|.+......   .++.+|+++|+.+.+||||+++++++..
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~---~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQL------QVGPEEKIALKHLIPTSHP---IRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEB------TTSCEEEEEEEEECTTSCH---HHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcc------cCCCCCEEEEEEEccccCH---HHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            679999999999999999998532      2345678999998755333   4577899999999789999999999876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH-----------------hcccCCCCcccCCCCCCEeecCC-CcEEEeeccCccccccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE-----------------EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYEQ  150 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~-----------------~~lh~~~i~H~~lk~~nil~~~~-~~~kl~dfg~~~~~~~~  150 (228)
                      . .+++||||+++|+|.+++..                 .|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             CCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            4 48899999999999998754                 79999999999999999999876 89999999999754332


Q ss_pred             ccc-------------------------cCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-
Q psy3166         151 NVF-------------------------QNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPH-  203 (228)
Q Consensus       151 ~~~-------------------------~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~-  203 (228)
                      ...                         .....+..||+.|+|||++.+. .|+.++||||+||++|+|++ |..||.. 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~-G~~Pf~~~  250 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKA  250 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TCSSSSCC
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH-CCCCCCCC
Confidence            110                         0112345789999999999865 48999999999999999999 9999855 


Q ss_pred             CCHHHHHHHH
Q psy3166         204 IPLCRIVHYL  213 (228)
Q Consensus       204 ~~~~~~~~~~  213 (228)
                      .+..+.+.++
T Consensus       251 ~~~~~~l~~I  260 (361)
T 4f9c_A          251 SDDLTALAQI  260 (361)
T ss_dssp             SSHHHHHHHH
T ss_pred             CCHHHHHHHH
Confidence            4444444443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.7e-44  Score=311.49  Aligned_cols=191  Identities=21%  Similarity=0.344  Sum_probs=166.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|+         ++.+++.||+|.+... .....+.+.+|+++|+.+ +||||+++++++..
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~---------~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  225 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVL-RHPTLVNLHDAFED  225 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEE---------ECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE
Confidence            689999999999999999998         4456668999998754 334456788999999999 99999999999877


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCC--CcEEEeeccCcc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSP--HVVKISDFGLSE  145 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~--~~~kl~dfg~~~  145 (228)
                      +. ++++|||+.||+|.+++..                     .|||+++|+||||||+|||++.+  +.+||+|||+++
T Consensus       226 ~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~  305 (573)
T 3uto_A          226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA  305 (573)
T ss_dssp             SSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred             CCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecccee
Confidence            54 8899999999999998742                     69999999999999999999854  899999999998


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      .+......    ....||+.|+|||++.+..|+.++||||+||++|+|++ |..||.+.+..+++..+.++
T Consensus       306 ~~~~~~~~----~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~-G~~Pf~~~~~~~~~~~i~~~  371 (573)
T 3uto_A          306 HLDPKQSV----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSC  371 (573)
T ss_dssp             ECCTTSEE----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTT
T ss_pred             EccCCCce----eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHhC
Confidence            76443221    23568999999999999999999999999999999999 99999999999999888876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-44  Score=292.00  Aligned_cols=177  Identities=29%  Similarity=0.421  Sum_probs=139.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|.+.+.||+|+||+||+|++.           ++.||||.++....  .......|+..+.++ +||||+++++++..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~   68 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREE--RSWFREAEIYQTVML-RHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGH--HHHHHHHHHHTSTTC-CCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccch--hhHHHHHHHHHHhcC-CCCCCCcEEEEEEe
Confidence            57999999999999999999863           34699999875421  112233566666788 99999999999865


Q ss_pred             C-----ceEEEEecCCCCcHHHHHHH-------------------hcccCC--------CCcccCCCCCCEeecCCCcEE
Q psy3166          90 D-----ELRLVVEYCALGDLQSYLRE-------------------EYLSNN--------KVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        90 ~-----~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~--------~i~H~~lk~~nil~~~~~~~k  137 (228)
                      +     .+++||||+++|+|.++++.                   .|||++        +|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             cCCCceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence            3     37899999999999999875                   589976        999999999999999999999


Q ss_pred             EeeccCcccccccccc-cCCCCCCCCcceeecccccccC------CCCchhhHHHHHHHHHHHHhCCCCCC
Q psy3166         138 ISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSN------IYTNKSDVWSFGVVLWEIVTLGANPY  201 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Diwslg~~~~~l~t~g~~pf  201 (228)
                      |+|||+++........ ........||+.|||||++.+.      .++.++|||||||++|||+| |..||
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~  218 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIG  218 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH-CCCCC
Confidence            9999999765443222 1122345789999999998754      25678999999999999999 86554

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-41  Score=282.63  Aligned_cols=220  Identities=43%  Similarity=0.846  Sum_probs=185.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.++.++|++.+.||+|+||.||+|.+.....  .....+..||+|.++..........+.+|+.+++++.+||||++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            56788999999999999999999998654321  1234566799999987666666778999999999997899999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++..+ .+++||||+++|+|.+++..                                    .|||+++|+||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            998764 48999999999999988742                                    58999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      ||++.++.+||+|||++..+...... .......++..|+|||++.+..++.++|+|||||++|+|++.|..||.+.+..
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999765433221 11223456778999999998889999999999999999998799999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ++...+..+.+++.|..|++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~  332 (370)
T 2psq_A          313 ELFKLLKEGHRMDKPANCTN  332 (370)
T ss_dssp             GHHHHHHTTCCCCCCTTSCH
T ss_pred             HHHHHHhcCCCCCCCCCCCH
Confidence            99999999999999988875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.1e-42  Score=278.64  Aligned_cols=216  Identities=35%  Similarity=0.616  Sum_probs=181.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ..+..++|++.+.||+|+||.||+|.+..+.      ..+..||+|.++..........+.+|+.+++++ +||||++++
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~  116 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPG------QRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLE  116 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTT------SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCC------CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEE
Confidence            4577889999999999999999999875432      344569999998766666677899999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++..+. .++||||+.+++|.+++..                     .|||+++|+||||||+||+++.++.+||+|||
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             EEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence            9987644 7899999999999999853                     69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++..+..............+|..|+|||++.+..++.++||||||+++|+|++.|..||.+.+..++...+..+.+++.|
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  276 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP  276 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC
Confidence            99765443221111223445678999999988889999999999999999997799999999999999999999899999


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       277 ~~~~~  281 (325)
T 3kul_A          277 MGCPH  281 (325)
T ss_dssp             TTCCH
T ss_pred             CCcCH
Confidence            88875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.5e-42  Score=286.49  Aligned_cols=213  Identities=37%  Similarity=0.679  Sum_probs=181.5

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+..         ++..||+|.++..........+.+|+++|+++ +||||+++
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~  177 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRL  177 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCE
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEE
Confidence            467888999999999999999999998543         34579999988665555566788999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+ ..++||||+++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+||
T Consensus       178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred             EEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcC
Confidence            9998764 48999999999999998764                     5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++....... .........++..|+|||++....++.++|+|||||++|+|+|.|..||.+.+..++.+.+..+.+++.
T Consensus       258 G~s~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  336 (377)
T 3cbl_A          258 GMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC  336 (377)
T ss_dssp             GGCEECTTSE-EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred             CCceecCCCc-eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9987543321 111112233466799999998888999999999999999999879999999999999999999999999


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..||+
T Consensus       337 ~~~~~~  342 (377)
T 3cbl_A          337 PELCPD  342 (377)
T ss_dssp             CTTCCH
T ss_pred             CCCCCH
Confidence            999885

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=282.68  Aligned_cols=207  Identities=22%  Similarity=0.352  Sum_probs=167.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+..         .++..||+|.+++..  .........+|..+++.+.+||||+++
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l   89 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVK---------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL   89 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEc---------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeE
Confidence            356789999999999999999999843         445679999987542  122345677899999998789999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++.... +++||||+++|+|.+++..                    .|||++||+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcccc
Confidence            99987754 8899999999999988764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++......   .......||+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+..+ .+..|
T Consensus       170 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p  244 (353)
T 3txo_A          170 MCKEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILND-EVVYP  244 (353)
T ss_dssp             TCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCC
T ss_pred             ceeecccCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence            987432221   12234578899999999988889999999999999999999 99999999999998888887 55566


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      ..++
T Consensus       245 ~~~~  248 (353)
T 3txo_A          245 TWLH  248 (353)
T ss_dssp             TTSC
T ss_pred             CCCC
Confidence            5554

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-41  Score=278.77  Aligned_cols=206  Identities=24%  Similarity=0.362  Sum_probs=171.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +..++|++.+.||+|+||+||+|+.         ..+++.||+|.+++..  .......+.+|+.+|+.+ +||||++++
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~   71 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK   71 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceE
Confidence            4568999999999999999999984         3455679999986431  112235678899999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++.... +++||||+++|+|.+++..                    .|||++||+||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccc
Confidence            9987654 8899999999999988764                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++......   .......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+.+..+ .+..|.
T Consensus       152 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~  226 (337)
T 1o6l_A          152 CKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPR  226 (337)
T ss_dssp             CBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCT
T ss_pred             hhhcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCC
Confidence            87532221   12234578889999999998889999999999999999999 99999998888888777765 556666


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .+++
T Consensus       227 ~~s~  230 (337)
T 1o6l_A          227 TLSP  230 (337)
T ss_dssp             TSCH
T ss_pred             CCCH
Confidence            6654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.2e-41  Score=275.05  Aligned_cols=204  Identities=26%  Similarity=0.442  Sum_probs=172.5

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ..++|++.+.||+|+||.||+|++         ..++..||+|.+... ......+++.+|+.+|+++ +||||++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~   82 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARH---------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEV   82 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence            356899999999999999999984         445567999998654 3455567788999999999 89999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.... .++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             EEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            87654 8899999999999998754                    69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      .......    .....||+.|+|||++.+..+. .++|+||+||++|+|++ |..||.+.+..++...+..+ ....|..
T Consensus       163 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~p~~  236 (328)
T 3fe3_A          163 EFTVGGK----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERVLRG-KYRIPFY  236 (328)
T ss_dssp             GGSSSCG----GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTT
T ss_pred             ecCCCCc----cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCC
Confidence            5543321    2345688899999999887765 78999999999999999 99999999988888888877 5566665


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +++
T Consensus       237 ~s~  239 (328)
T 3fe3_A          237 MST  239 (328)
T ss_dssp             SCH
T ss_pred             CCH
Confidence            553

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.9e-41  Score=278.54  Aligned_cols=208  Identities=24%  Similarity=0.351  Sum_probs=172.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+         +..+++.||+|.++....  ......+..|..++..+.+||||+++
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~---------~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l   86 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSE---------RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL   86 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEE---------ETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEE---------ECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeE
Confidence            3567899999999999999999998         445667899999875311  12235677899999988789999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++... .+++||||+++|+|.+++..                    .|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            9998774 48899999999999998764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++......   .......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+.+..+ .+..|
T Consensus       167 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p  241 (353)
T 2i0e_A          167 MCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEH-NVAYP  241 (353)
T ss_dssp             TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCC
T ss_pred             cccccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc-CCCCCCCCCHHHHHHHHHhC-CCCCC
Confidence            987432221   12334678999999999998889999999999999999999 99999999888888888876 56667


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+++
T Consensus       242 ~~~s~  246 (353)
T 2i0e_A          242 KSMSK  246 (353)
T ss_dssp             TTSCH
T ss_pred             CCCCH
Confidence            66654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-41  Score=277.20  Aligned_cols=208  Identities=25%  Similarity=0.376  Sum_probs=171.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+.         ..+++.||+|.++....  .........|..++..+.+||||+++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l   83 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEF---------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM   83 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcE
Confidence            46778999999999999999999984         44566799999875311  11234567899999887799999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++.... +++||||+++|+|.+++..                    .|||++||+||||||+||+++.++.+||+|||
T Consensus        84 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeECh
Confidence            99987654 8899999999999998764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++......   .......||+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+..+ .+..|
T Consensus       164 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~~p  238 (345)
T 1xjd_A          164 MCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMD-NPFYP  238 (345)
T ss_dssp             TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCC
T ss_pred             hhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhC-CCCCC
Confidence            987532221   12234678899999999998889999999999999999999 99999999988888888877 55666


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+++
T Consensus       239 ~~~s~  243 (345)
T 1xjd_A          239 RWLEK  243 (345)
T ss_dssp             TTSCH
T ss_pred             cccCH
Confidence            66553

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5e-41  Score=268.63  Aligned_cols=215  Identities=36%  Similarity=0.691  Sum_probs=173.0

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+.+..++|++.+.||+|+||.||+|....+.      ..+..||+|.++........+.+.+|+.+++++ +||||+++
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~   81 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKL   81 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCC------CCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceE
Confidence            35688899999999999999999999864422      344569999987665666677889999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+..++|||++++++|.+++..                     .|||+++|+|+||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           82 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             EEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEEccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence            999877789999999999999998763                     69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++..........  .....++..|+|||.+....++.++|+||||+++|+|++.|..||.+.+..++...+..+.+++.|
T Consensus       162 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (281)
T 1mp8_A          162 LSRYMEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  239 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             cccccCcccccc--cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence            987654332111  122345678999999988889999999999999999996599999999888899999999888888


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       240 ~~~~~  244 (281)
T 1mp8_A          240 PNCPP  244 (281)
T ss_dssp             TTCCH
T ss_pred             CCCCH
Confidence            88875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=280.57  Aligned_cols=217  Identities=37%  Similarity=0.700  Sum_probs=181.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.++.++|++.+.||+|+||+||+|.+.+..    +..++..||+|.++..........+.+|+.+++++ +||||++++
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~  140 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCI  140 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            3577899999999999999999999976533    33466789999997665666667888999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH---------------------------hcccCCCCcccCCCCCCEeecCCC--
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE---------------------------EYLSNNKVVHRDLATRNILLSSPH--  134 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------------~~lh~~~i~H~~lk~~nil~~~~~--  134 (228)
                      +++..+ ..++||||+++|+|.+++..                           .|||+++|+||||||+|||++.++  
T Consensus       141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  220 (367)
T 3l9p_A          141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG  220 (367)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred             EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence            998764 47899999999999998763                           589999999999999999999554  


Q ss_pred             -cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         135 -VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       135 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                       .+||+|||+++.+...... .......+|..|+|||++.+..++.++|+|||||++|+|++.|..||.+.+..++...+
T Consensus       221 ~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i  299 (367)
T 3l9p_A          221 RVAKIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  299 (367)
T ss_dssp             CCEEECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECCCcccccccccccc-ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             5999999998755433221 11223456778999999998889999999999999999997799999999999999999


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      ..+.+++.|..+|+
T Consensus       300 ~~~~~~~~~~~~~~  313 (367)
T 3l9p_A          300 TSGGRMDPPKNCPG  313 (367)
T ss_dssp             HTTCCCCCCTTCCH
T ss_pred             HcCCCCCCCccCCH
Confidence            99988888888875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.9e-41  Score=280.75  Aligned_cols=210  Identities=22%  Similarity=0.383  Sum_probs=166.8

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      +..+..++|++.+.||+|+||+||+|+.         ..+++.||+|.+++..  .......+.+|..++.++.+||||+
T Consensus        46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~---------~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv  116 (396)
T 4dc2_A           46 SSSLGLQDFDLLRVIGRGSYAKVLLVRL---------KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV  116 (396)
T ss_dssp             ---CCGGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBC
T ss_pred             ccCCChhHcEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcC
Confidence            3457778999999999999999999984         4455679999987542  2223345778999998887899999


Q ss_pred             EeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          82 SFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        82 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++++.... +++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|
T Consensus       117 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             eeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEee
Confidence            9999987754 8899999999999988764                    699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---------HHHHHH
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP---------LCRIVH  211 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~---------~~~~~~  211 (228)
                      ||+++......   .......||+.|+|||++.+..++.++|+|||||++|+|++ |..||....         ...+.+
T Consensus       197 FGla~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~-G~~Pf~~~~~~~~~~~~~~~~~~~  272 (396)
T 4dc2_A          197 YGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQ  272 (396)
T ss_dssp             CTTCBCCCCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSTTTTC------CCHHHHHH
T ss_pred             cceeeecccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh-CCCCCcccccccccchhhHHHHHH
Confidence            99987432221   12345678999999999999999999999999999999999 999996431         223444


Q ss_pred             HHHcCCCCCCCCCCCC
Q psy3166         212 YLSTGYRMERPASCNE  227 (228)
Q Consensus       212 ~~~~~~~~~~p~~~~~  227 (228)
                      .+..+ .+..|..+++
T Consensus       273 ~i~~~-~~~~p~~~s~  287 (396)
T 4dc2_A          273 VILEK-QIRIPRSLSV  287 (396)
T ss_dssp             HHHHC-CCCCCTTSCH
T ss_pred             HHhcc-ccCCCCcCCH
Confidence            45544 6667766653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.5e-41  Score=287.66  Aligned_cols=210  Identities=38%  Similarity=0.664  Sum_probs=181.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||+||+|.+..          +..||+|.++....  ..+.+.+|+.+|+++ +||||+++
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~~iv~l  248 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGSM--SVEAFLAEANVMKTL-QHDKLVKL  248 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTSB--CHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCCc--cHHHHHHHHHHHhhC-CCCCEeeE
Confidence            467899999999999999999999998643          23599999975432  346788999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+..++||||+++|+|.+++..                      .|||+++|+||||||+|||++.++.+||+||
T Consensus       249 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          249 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             EEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred             EEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeC
Confidence            999887779999999999999999863                      5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |+++........  ......++..|+|||++....++.++||||||+++|+|+|.|..||.+.+..++.+.+..+.+++.
T Consensus       329 G~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~  406 (454)
T 1qcf_A          329 GLARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR  406 (454)
T ss_dssp             TGGGGBCCHHHH--TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC
T ss_pred             CCceEcCCCcee--ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999765432211  112344567899999999888999999999999999999889999999999999999999999999


Q ss_pred             CCCCCCC
Q psy3166         222 PASCNEQ  228 (228)
Q Consensus       222 p~~~~~~  228 (228)
                      |..||++
T Consensus       407 ~~~~~~~  413 (454)
T 1qcf_A          407 PENCPEE  413 (454)
T ss_dssp             CTTSCHH
T ss_pred             CCCCCHH
Confidence            9998853

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-41  Score=274.39  Aligned_cols=203  Identities=25%  Similarity=0.399  Sum_probs=170.3

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+.         ..+++.||+|.++....  ....+.+.+|..+++.+ +||||+++
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~   71 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRM   71 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceE
Confidence            45678999999999999999999984         34456799999864321  12235677899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++.... +++||||+++|+|.+++..                    .|||++||+||||||+||+++.++.+||+|||
T Consensus        72 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg  151 (318)
T 1fot_A           72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG  151 (318)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecC
Confidence            99987654 8899999999999998864                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++.....      .....||+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+..+++..+ .+..|
T Consensus       152 ~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~p  223 (318)
T 1fot_A          152 FAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNA-ELRFP  223 (318)
T ss_dssp             SCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHC-CCCCC
T ss_pred             cceecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCC
Confidence            99754321      234577889999999998889999999999999999999 99999998888888887776 45566


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      ..++
T Consensus       224 ~~~~  227 (318)
T 1fot_A          224 PFFN  227 (318)
T ss_dssp             TTSC
T ss_pred             CCCC
Confidence            5554

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=274.90  Aligned_cols=221  Identities=43%  Similarity=0.839  Sum_probs=187.1

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|...+....  ....+..||+|.++.........++.+|+++++++.+||||+++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTT--CTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEcccccc--ccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            4678889999999999999999999987553321  22455679999998776666677899999999999889999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      ++++..+ ..++||||+++++|.+++..                                    .|||+++|+||||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            9998765 48999999999999998742                                    5899999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ||+++.++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++.|..||.+.+.
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999998755433221 1223345677899999999888999999999999999999879999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCC
Q psy3166         207 CRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       207 ~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .++.+.+..+.+++.|..+++
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~  320 (382)
T 3tt0_A          300 EELFKLLKEGHRMDKPSNCTN  320 (382)
T ss_dssp             HHHHHHHHTTCCCCCCSSCCH
T ss_pred             HHHHHHHHcCCCCCCCccCCH
Confidence            999999999989988888875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=293.98  Aligned_cols=216  Identities=32%  Similarity=0.657  Sum_probs=177.4

Q ss_pred             CCCCCCceeeee-eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGE-VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~-~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.+..+++.+.+ .||+|+||.||+|.+...       ..+..||+|.++........+.+.+|+++|+++ +||||+++
T Consensus       330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l  401 (613)
T 2ozo_A          330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRL  401 (613)
T ss_dssp             SBCCTTSEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             eeccccceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeE
Confidence            345667777776 899999999999986432       234569999998664444567889999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+.+++||||+++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+|||
T Consensus       402 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          402 IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             EEEEESSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             EEEeccCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            999988889999999999999998743                     69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++.+..............++..|+|||++....++.++|||||||++|||++.|..||.+.+..++.+.+..+.+++.|
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p  561 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP  561 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99765433221111222344567999999998889999999999999999997799999999999999999999999999


Q ss_pred             CCCCCC
Q psy3166         223 ASCNEQ  228 (228)
Q Consensus       223 ~~~~~~  228 (228)
                      .+||++
T Consensus       562 ~~~~~~  567 (613)
T 2ozo_A          562 PECPPE  567 (613)
T ss_dssp             TTCCHH
T ss_pred             CcCCHH
Confidence            999853

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-40  Score=271.68  Aligned_cols=208  Identities=23%  Similarity=0.384  Sum_probs=169.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||.||+|+.         ..+++.||+|.+++..  .......+.+|..+++++.+||||+++
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l   75 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRL---------KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL   75 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEE---------CCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeE
Confidence            46678999999999999999999984         4455679999987542  344456778899999988789999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++.... +++||||+++|+|.+++..                    .|||+++|+||||||+||+++.++.+||+|||
T Consensus        76 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG  155 (345)
T 3a8x_A           76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG  155 (345)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecc
Confidence            99987644 8899999999999988764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------CHHHHHHHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI---------PLCRIVHYL  213 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~---------~~~~~~~~~  213 (228)
                      +++......   .......||..|+|||++.+..++.++|+||+||++|+|++ |..||...         ....+.+.+
T Consensus       156 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~i  231 (345)
T 3a8x_A          156 MCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVI  231 (345)
T ss_dssp             GCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTTTC-------CHHHHHHHH
T ss_pred             ccccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh-CCCCcCCcccccccccccHHHHHHHH
Confidence            987532221   12334678899999999998889999999999999999999 99999752         223344555


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      ..+ ++..|..+++
T Consensus       232 ~~~-~~~~p~~~s~  244 (345)
T 3a8x_A          232 LEK-QIRIPRSLSV  244 (345)
T ss_dssp             HHC-CCCCCTTSCH
T ss_pred             HcC-CCCCCCCCCH
Confidence            554 5666666553

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.5e-41  Score=278.08  Aligned_cols=217  Identities=35%  Similarity=0.634  Sum_probs=169.8

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ...+..++|++.+.||+|+||.||+|+....      ...+..||+|.++..........+.+|+.+++++ +||||+++
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~  111 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLP------SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRL  111 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCT------TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecC------CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeE
Confidence            3457778999999999999999999985421      2345569999998765666667899999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++... ..++||||+++++|.+++..                     .|||+++|+||||||+||+++.++.+||+||
T Consensus       112 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcC
Confidence            9998764 48899999999999999864                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.................++..|+|||++....++.++|+||||+++|+|++.|..||...+..++.+.+..+.+++.
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~  271 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP  271 (373)
T ss_dssp             ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99876543321111111223456799999999888999999999999999999779999999999999999998888888


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       272 ~~~~~~  277 (373)
T 2qol_A          272 PMDCPA  277 (373)
T ss_dssp             CTTCBH
T ss_pred             CccccH
Confidence            877764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.3e-40  Score=263.75  Aligned_cols=215  Identities=35%  Similarity=0.670  Sum_probs=181.2

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+++..++|++.+.||+|+||.||+|++...      ..++..||+|.++........+.+.+|+.+++++ +||||+++
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~   78 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNH------KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKL   78 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECT------TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCE
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCC------CCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceE
Confidence            4688999999999999999999999986542      2345569999998766666677889999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+..+++||++++++|.+++..                     .|||+++|+|+||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           79 IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEEECSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEcCCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence            999888888999999999999998864                     59999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++.........  ......++..|+|||.+.+..++.++|+||||+++|+|++.|..||......+....+..+.+++.|
T Consensus       159 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (281)
T 3cc6_A          159 LSRYIEDEDYY--KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP  236 (281)
T ss_dssp             GGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred             CCccccccccc--ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence            98755332211  1223455678999999988889999999999999999997699999998888888888888888888


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       237 ~~~~~  241 (281)
T 3cc6_A          237 DLCPP  241 (281)
T ss_dssp             TTCCH
T ss_pred             CCCCH
Confidence            87764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.3e-40  Score=269.59  Aligned_cols=212  Identities=26%  Similarity=0.384  Sum_probs=165.5

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCce
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHI   80 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni   80 (228)
                      +..+..++|++.+.||+|+||.||+++...      +..++..||+|.++...   .......+.+|+.+|+++ +||||
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i   83 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVT------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFI   83 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECS------STTTTCEEEEEEECCC--------------HHHHHHHC-CCTTB
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEec------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCc
Confidence            346788999999999999999999998532      23456679999987542   122345577899999999 99999


Q ss_pred             EEeeeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          81 VSFIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        81 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +++++++..+ ..++||||+++++|.+++..                    .|||++||+||||||+||+++.++.+||+
T Consensus        84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             CCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred             cceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEE
Confidence            9999998764 48999999999999988764                    69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      |||++........   ......||..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+..+.+.++ .+
T Consensus       164 Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~-~~  238 (327)
T 3a62_A          164 DFGLCKESIHDGT---VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDKILKC-KL  238 (327)
T ss_dssp             CCSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHT-CC
T ss_pred             eCCcccccccCCc---cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhC-CC
Confidence            9999874432211   1223567889999999998889999999999999999999 99999998888888887776 55


Q ss_pred             CCCCCCCC
Q psy3166         220 ERPASCNE  227 (228)
Q Consensus       220 ~~p~~~~~  227 (228)
                      ..|..+++
T Consensus       239 ~~p~~~~~  246 (327)
T 3a62_A          239 NLPPYLTQ  246 (327)
T ss_dssp             CCCTTSCH
T ss_pred             CCCCCCCH
Confidence            66666553

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-40  Score=275.06  Aligned_cols=203  Identities=24%  Similarity=0.382  Sum_probs=172.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ...++|++.+.||+|+||.||+|+.         ..++..||+|.++...  .......+.+|+.+|+++ +||||++++
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~  107 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKH---------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE  107 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEE---------CCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            4568999999999999999999984         3455679999986432  112245678899999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++.... +++||||+++++|.+++..                    .|||++||+||||||+||+++.++.+||+|||+
T Consensus       108 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~  187 (350)
T 1rdq_E          108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccc
Confidence            9987654 8899999999999998864                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.....      .....||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+.+..+ .+..|.
T Consensus       188 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~  259 (350)
T 1rdq_E          188 AKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSG-KVRFPS  259 (350)
T ss_dssp             CEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCT
T ss_pred             ceeccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhh-CCCCCCCCCHHHHHHHHHcC-CCCCCC
Confidence            8754322      234567889999999998889999999999999999999 99999999888888888887 566776


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .+++
T Consensus       260 ~~~~  263 (350)
T 1rdq_E          260 HFSS  263 (350)
T ss_dssp             TCCH
T ss_pred             CCCH
Confidence            6654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-40  Score=270.37  Aligned_cols=218  Identities=39%  Similarity=0.691  Sum_probs=183.5

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ++.++.++|++.+.||+|+||.||+|+..+..    ...++..||+|.++..........+.+|+.+++++ +||||+++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~  115 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKL  115 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcC----CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEE
Confidence            45788899999999999999999999875432    22455779999998766666667889999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------------------------------hcccCCCC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------------------------------EYLSNNKV  118 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------------------------------~~lh~~~i  118 (228)
                      ++++..+ ..+++|||+++++|.+++..                                            .|||+++|
T Consensus       116 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i  195 (343)
T 1luf_A          116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  195 (343)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            9998764 48899999999999988742                                            58999999


Q ss_pred             cccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCC
Q psy3166         119 VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA  198 (228)
Q Consensus       119 ~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~  198 (228)
                      +|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++.|.
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence            99999999999999999999999998755433221 12233566788999999998889999999999999999997799


Q ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         199 NPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .||.+.+..++...+..+..++.|..+|+
T Consensus       275 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (343)
T 1luf_A          275 QPYYGMAHEEVIYYVRDGNILACPENCPL  303 (343)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CcCCCCChHHHHHHHhCCCcCCCCCCCCH
Confidence            99999999999999999988888888875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-40  Score=283.46  Aligned_cols=209  Identities=36%  Similarity=0.616  Sum_probs=175.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+.++          ..||+|.++....  ..+.+.+|+++|+++ +||||+++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----------~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hp~iv~~  244 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGTM--SPEAFLQEAQVMKKL-RHEKLVQL  244 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTT----------EEEEEEECCTTSS--CHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCC----------ceEEEEEeccCCC--CHHHHHHHHHHHHhC-CCCCEeeE
Confidence            4678999999999999999999999986432          3499999976532  235788999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+..++||||+++|+|.+++..                      .|||+++|+||||||+|||++.++.+||+||
T Consensus       245 ~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             EEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCC
Confidence            999888789999999999999999853                      5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.........  ......++..|+|||++....++.++|+||||+++|+|++.|..||.+.+..++...+..+.+++.
T Consensus       325 G~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~  402 (452)
T 1fmk_A          325 GLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  402 (452)
T ss_dssp             CTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             ccceecCCCcee--cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999765432211  112344567899999999888999999999999999999878999999999999999999999999


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..||+
T Consensus       403 ~~~~~~  408 (452)
T 1fmk_A          403 PPECPE  408 (452)
T ss_dssp             CTTSCH
T ss_pred             CCCCCH
Confidence            998885

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-40  Score=275.18  Aligned_cols=206  Identities=27%  Similarity=0.405  Sum_probs=162.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHH-HhcCCCCceEE
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLM-KDVGKHDHIVS   82 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l-~~l~~h~ni~~   82 (228)
                      .+..++|++.+.||+|+||+||+|+..         .++..||+|.+++..  .......+.+|..++ +.+ +||||++
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~  103 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHK---------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVG  103 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEET---------TTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCC
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCC
Confidence            356789999999999999999999843         445679999987542  222334566777764 556 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++.... +++||||+++|+|.+++..                    .|||++||+||||||+|||++.++.+||+||
T Consensus       104 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeC
Confidence            999987754 8899999999999988764                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |+++......   .......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++.+.+..+ ....
T Consensus       184 G~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~  258 (373)
T 2r5t_A          184 GLCKENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNK-PLQL  258 (373)
T ss_dssp             CBCGGGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSBHHHHHHHHHHS-CCCC
T ss_pred             ccccccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-ccCC
Confidence            9987533221   12334678889999999998889999999999999999999 99999999888888888776 5555


Q ss_pred             CCCCC
Q psy3166         222 PASCN  226 (228)
Q Consensus       222 p~~~~  226 (228)
                      |..++
T Consensus       259 ~~~~~  263 (373)
T 2r5t_A          259 KPNIT  263 (373)
T ss_dssp             CSSSC
T ss_pred             CCCCC
Confidence            65554

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-40  Score=268.32  Aligned_cols=218  Identities=38%  Similarity=0.666  Sum_probs=175.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+.+..++|++.+.||+|+||.||+|....+.     ...+..||+|.++..........+.+|+.+++++ +||||+++
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~  111 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRL  111 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCC-----CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcE
Confidence            45788999999999999999999999865432     2234569999998766666667889999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++... ..++|||++++++|.+++..                     .|||+++|+|+||||+||+++.++.+||+||
T Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence            9998764 48899999999999998864                     5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.................++..|+|||.+....++.++|+||||+++|+|++.|..||.+.+..++...+..+.+++.
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  271 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  271 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence            99876543322111122234567899999998888999999999999999999779999999999999999999988888


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       272 ~~~~~~  277 (333)
T 1mqb_A          272 PMDCPS  277 (333)
T ss_dssp             CTTCBH
T ss_pred             cccCCH
Confidence            887764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-40  Score=266.39  Aligned_cols=208  Identities=34%  Similarity=0.542  Sum_probs=166.6

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .+.++.++|++.+.||+|+||+||+|++.           +..||+|.+.... .......+.+|+.+++++ +||||++
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~   98 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVL   98 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEee
Confidence            35688999999999999999999999752           3459999987553 345556788999999999 8999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH-----------------------hcccCCC--CcccCCCCCCEeecCCCcE
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE-----------------------EYLSNNK--VVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~--i~H~~lk~~nil~~~~~~~  136 (228)
                      +++++... ..++||||+++++|.+++..                       .|||+++  |+||||||+||+++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~  178 (309)
T 3p86_A           99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTV  178 (309)
T ss_dssp             EEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCE
T ss_pred             EEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcE
Confidence            99998764 48899999999999998753                       5999999  9999999999999999999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS-T  215 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~-~  215 (228)
                      ||+|||++.......   .......||..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+. .
T Consensus       179 kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  254 (309)
T 3p86_A          179 KVCDFGLSRLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFK  254 (309)
T ss_dssp             EECCCC--------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHH-CCCTTTTSCHHHHHHHHHHS
T ss_pred             EECCCCCCccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence            999999986433221   11234567888999999998889999999999999999999 999999998888876654 5


Q ss_pred             CCCCCCCCCCCC
Q psy3166         216 GYRMERPASCNE  227 (228)
Q Consensus       216 ~~~~~~p~~~~~  227 (228)
                      ..+.+.|..+|+
T Consensus       255 ~~~~~~~~~~~~  266 (309)
T 3p86_A          255 CKRLEIPRNLNP  266 (309)
T ss_dssp             CCCCCCCTTSCH
T ss_pred             CCCCCCCccCCH
Confidence            666777887765

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=264.30  Aligned_cols=216  Identities=33%  Similarity=0.658  Sum_probs=182.7

Q ss_pred             cCCCCCCceeeee-eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGE-VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~-~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .+.++.++|.+.+ .||+|+||.||+|.+...       ..+..||+|.++........+.+.+|+++++++ +||||++
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~   74 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVR   74 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeE
Confidence            3567888998887 999999999999975332       234569999998766666677889999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++..+..+++||++++++|.+++..                     .|||+++|+|+||||+||+++.++.++|+||
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             EEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEecCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcc
Confidence            9999977789999999999999998742                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.................++..|+|||++.+..++.++|+||||+++|+|++.|..||.+.+..++...+..+.+++.
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~  234 (287)
T 1u59_A          155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC  234 (287)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred             cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC
Confidence            99876544332222233345678899999998888999999999999999999769999999988889999999988888


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       235 ~~~~~~  240 (287)
T 1u59_A          235 PPECPP  240 (287)
T ss_dssp             CTTCCH
T ss_pred             CCCcCH
Confidence            888875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-40  Score=281.65  Aligned_cols=204  Identities=42%  Similarity=0.772  Sum_probs=176.1

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+.           +..||+|.++...   ..+.+.+|+.+|+++ +||||+++
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~  251 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQL  251 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT---TSHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch---HHHHHHHHHHHHHhc-cCCCEEEE
Confidence            47789999999999999999999999753           2369999997653   335788999999999 99999999


Q ss_pred             eeEEEcC--ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          84 IGCCYKD--ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        84 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++++...  .+++||||+++|+|.+++..                      .|||+++|+||||||+|||++.++.+||+
T Consensus       252 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~  331 (450)
T 1k9a_A          252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS  331 (450)
T ss_dssp             EEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEe
Confidence            9997654  48999999999999998864                      59999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      |||+++......      ....++..|+|||++....++.++|+||||+++|+|+|.|..||.+.+..++...+.++.++
T Consensus       332 DfG~a~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~  405 (450)
T 1k9a_A          332 DFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  405 (450)
T ss_dssp             CCTTCEECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC
T ss_pred             eCCCcccccccc------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            999987432211      12245677999999998889999999999999999998799999999999999999999999


Q ss_pred             CCCCCCCCC
Q psy3166         220 ERPASCNEQ  228 (228)
Q Consensus       220 ~~p~~~~~~  228 (228)
                      +.|..||++
T Consensus       406 ~~p~~~~~~  414 (450)
T 1k9a_A          406 DAPDGCPPA  414 (450)
T ss_dssp             CCCTTCCHH
T ss_pred             CCCCcCCHH
Confidence            999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.8e-40  Score=269.96  Aligned_cols=214  Identities=37%  Similarity=0.702  Sum_probs=173.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||+|++..+..     ....+||+|.+...........+.+|+.+++++ +||||++++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   85 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGI   85 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCc-----eEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEE
Confidence            567899999999999999999998654321     223457889886554445557788999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..+..++++|++.+|+|.+++..                     .|||+++|+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           86 CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EESSSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EecCCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence            998889999999999999998764                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+....... ......+|..|+|||.+.+..++.++|+|||||++|+|++.|..||.+.+..++...+..+.+++.|..+
T Consensus       166 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3poz_A          166 LLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             HHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             EccCCcccc-cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccC
Confidence            654332211 1223445778999999999899999999999999999998799999999999999999999888888777


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      ++
T Consensus       245 ~~  246 (327)
T 3poz_A          245 TI  246 (327)
T ss_dssp             CH
T ss_pred             CH
Confidence            64

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.7e-41  Score=282.13  Aligned_cols=198  Identities=23%  Similarity=0.339  Sum_probs=164.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--HHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--KTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+..         .++..||+|.+++....  .....+.+|+.+++.+ +||||+++
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l  134 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQL  134 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEEC---------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeE
Confidence            466789999999999999999999844         44567999998642110  1113467899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++++.... +++||||+++|+|.+++..                   .|||++||+||||||+|||++.++.+||+|||+
T Consensus       135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence            99987755 8899999999999998764                   699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI----YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ++.+......  ......||+.|+|||++....    ++.++|+|||||++|+|++ |..||.+.+..++..++.++
T Consensus       215 a~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~  288 (410)
T 3v8s_A          215 CMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIMNH  288 (410)
T ss_dssp             CEECCTTSEE--ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTH
T ss_pred             eEeeccCCcc--cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh-CCCCCCCCChhhHHHHHHhc
Confidence            9765433221  123467899999999998655    7789999999999999999 99999999888888887764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.1e-40  Score=273.41  Aligned_cols=220  Identities=41%  Similarity=0.771  Sum_probs=181.4

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .+|.++.++|++.+.||+|+||.||+|++.+..    +..+++.||+|.++..........+.+|++++.++.+||||++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            357799999999999999999999999865532    4456778999999876666666789999999999988999999


Q ss_pred             eeeEEEcC-c-eEEEEecCCCCcHHHHHHH--------------------------------------------------
Q psy3166          83 FIGCCYKD-E-LRLVVEYCALGDLQSYLRE--------------------------------------------------  110 (228)
Q Consensus        83 ~~~~~~~~-~-~~lv~e~~~~~~L~~~l~~--------------------------------------------------  110 (228)
                      +++++... . .+++|||+++|+|.+++..                                                  
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            99998763 3 8899999999999887631                                                  


Q ss_pred             ------------------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccccccccc
Q psy3166         111 ------------------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ  154 (228)
Q Consensus       111 ------------------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (228)
                                                          .|||+++|+||||||+||+++.++.+||+|||++..+.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                                                58999999999999999999999999999999987553332211


Q ss_pred             CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCC
Q psy3166         155 NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       155 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~~~~~~~~~~~~p~~~~~  227 (228)
                       ......+|..|+|||++.+..++.++||||||+++|+|+|.|..||.+.... .+...+..+.+++.|..+++
T Consensus       251 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (359)
T 3vhe_A          251 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP  323 (359)
T ss_dssp             -EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCH
T ss_pred             -hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCH
Confidence             1223456778999999998889999999999999999997699999987654 44666777878888877764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-40  Score=285.04  Aligned_cols=210  Identities=40%  Similarity=0.774  Sum_probs=180.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|++.         .++..||+|.++....  ..+.+.+|+.+|+++ +||||+++
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l  281 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEI-KHPNLVQL  281 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEG---------GGTEEEEEEECCSSSS--CHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEc---------CCCeEEEEEEecCccc--chHHHHHHHHHHHhc-CCCCEeeE
Confidence            46788899999999999999999999853         3456799999976532  246788999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++... .+++||||+++|+|.+++..                      .|||+++|+||||||+|||++.++.+||+|
T Consensus       282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~D  361 (495)
T 1opk_A          282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVAD  361 (495)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEee
Confidence            9998764 48999999999999999864                      599999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||+++.+......  ......++..|+|||++....++.++||||||+++|+|++.|..||.+.+..++.+.+..+.+++
T Consensus       362 FG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  439 (495)
T 1opk_A          362 FGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME  439 (495)
T ss_dssp             TTCEECCTTCCEE--CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             cccceeccCCcee--ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9998765332211  12234456789999999888899999999999999999987999999999999999999999999


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .|..||+
T Consensus       440 ~~~~~~~  446 (495)
T 1opk_A          440 RPEGCPE  446 (495)
T ss_dssp             CCTTCCH
T ss_pred             CCCCCCH
Confidence            9999885

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.4e-40  Score=264.68  Aligned_cols=218  Identities=50%  Similarity=0.895  Sum_probs=183.5

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|......    ...++..||+|.++..........+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~   91 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKL   91 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeE
Confidence            46788999999999999999999999853321    23455679999998766666677889999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------------------------------hcccCCCC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------------------------------EYLSNNKV  118 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------------------------------~~lh~~~i  118 (228)
                      ++++..+ ..+++|||+++++|.+++..                                            .|||+++|
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  171 (314)
T 2ivs_A           92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL  171 (314)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            9998764 48899999999999988741                                            58999999


Q ss_pred             cccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCC
Q psy3166         119 VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA  198 (228)
Q Consensus       119 ~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~  198 (228)
                      +|+||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++|+||+|+++|+|++.|.
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE-CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccce-eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987554332211 1233456778999999988889999999999999999997799


Q ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         199 NPYPHIPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .||.+.+..++.+.+..+.+++.|..+|+
T Consensus       251 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (314)
T 2ivs_A          251 NPYPGIPPERLFNLLKTGHRMERPDNCSE  279 (314)
T ss_dssp             CSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             CCCCCCCHHHHHHHhhcCCcCCCCccCCH
Confidence            99999998888888999888888888775

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.9e-40  Score=263.95  Aligned_cols=198  Identities=30%  Similarity=0.511  Sum_probs=165.6

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.+-+.++|++.+.||+|+||+||+|.         +..++..||+|.+...... ..+.+.+|+.+++++ +||||+++
T Consensus        14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~iv~~   82 (297)
T 3fxz_A           14 SVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQP-KKELIINEILVMREN-KNPNIVNY   82 (297)
T ss_dssp             BSSCGGGTBCCCEEEEEETTEEEEEEE---------BTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             CcCChhhceeeeeeeccCCCeEEEEEE---------ECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcC-CCCCCCeE
Confidence            456677899999999999999999998         4445667999998644222 235678999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++++..+ ..++||||+.+++|.+++..                   .|||++||+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  162 (297)
T 3fxz_A           83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  162 (297)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEECCEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCC
Confidence            9988764 48899999999999998764                   699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +........   ......||..|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+..+....+...
T Consensus       163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  231 (297)
T 3fxz_A          163 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATN  231 (297)
T ss_dssp             CEECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHH
T ss_pred             ceecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Confidence            875543321   2234578889999999998899999999999999999999 99999998776665554443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.7e-40  Score=263.05  Aligned_cols=216  Identities=36%  Similarity=0.628  Sum_probs=171.1

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +..+..++|++.+.||+|+||.||+|++...     +..++..||+|.+... .....+.+.+|+.+++++ +||||+++
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~   76 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSL-QHDNIVKY   76 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTT-----CSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecc-----cCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCEeeE
Confidence            3467889999999999999999999986432     3456678999998754 345557788999999999 89999999


Q ss_pred             eeEEEc---CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          84 IGCCYK---DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        84 ~~~~~~---~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++++..   ..+++||||+++++|.+++..                     .|||+++|+|+||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~  156 (295)
T 3ugc_A           77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG  156 (295)
T ss_dssp             EEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEc
Confidence            998854   348899999999999998864                     69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC------------  207 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~------------  207 (228)
                      |||++.................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......            
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T 3ugc_A          157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQGQ  235 (295)
T ss_dssp             CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH-TTCTTCSHHHHHHHHHCTTCCTH
T ss_pred             cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh-cccccCCChHHHHhhhcCccccc
Confidence            99999765443322222333456677999999998889999999999999999999 99988764321            


Q ss_pred             ----HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 ----RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 ----~~~~~~~~~~~~~~p~~~~~  227 (228)
                          .+...+..+.+++.|..||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~  259 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPD  259 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCH
Confidence                34556777878888888875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4e-40  Score=268.74  Aligned_cols=217  Identities=34%  Similarity=0.628  Sum_probs=177.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      --+..++|++.+.||+|+||+||+|++..+..     ....+||+|.+...........+.+|+.+++++ +||||++++
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~   81 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGE-----SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLL   81 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTC-----SCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEE
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCc-----eEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEE
Confidence            35678899999999999999999998654331     223457888775443222334566899999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++..+..++||||+.+++|.+++..                     .|||+++|+||||||+||+++.++.+||+|||+
T Consensus        82 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           82 GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEECBSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEEcCCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence            99888889999999999999998753                     699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.+...... .......++..|+|||.+....++.++|+||||+++|+|++.|..||.+....++...+..+.+++.|.
T Consensus       162 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (325)
T 3kex_A          162 ADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ  240 (325)
T ss_dssp             GGGSCCCTTC-CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT
T ss_pred             ccccCccccc-ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC
Confidence            9765433211 112334566789999999988899999999999999999987999999998888999999998888888


Q ss_pred             CCCCC
Q psy3166         224 SCNEQ  228 (228)
Q Consensus       224 ~~~~~  228 (228)
                      .++++
T Consensus       241 ~~~~~  245 (325)
T 3kex_A          241 ICTID  245 (325)
T ss_dssp             TBCTT
T ss_pred             cCcHH
Confidence            88764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.7e-40  Score=290.44  Aligned_cols=214  Identities=39%  Similarity=0.674  Sum_probs=175.3

Q ss_pred             CCCCCceeeee-eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGE-VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~-~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .++.+.+.+.. .||+|+||+||+|.+..       ..++..||+|.++... .......+.+|+++|+++ +||||+++
T Consensus       364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l  435 (635)
T 4fl3_A          364 YLDRKLLTLEDKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRM  435 (635)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             cccchhccccCCEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeE
Confidence            44555565544 89999999999996432       3355679999987542 334457789999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++++..+..++||||+.+|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||+
T Consensus       436 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          436 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             EEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             EEEEecCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence            999988889999999999999999864                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.+..............++..|+|||++....++.++|||||||++|+|++.|..||.+.+..++.+.+..+.+++.|.
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  595 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA  595 (635)
T ss_dssp             HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            87654433222222334556789999999988899999999999999999977999999999999999999999999999


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      +||+
T Consensus       596 ~~~~  599 (635)
T 4fl3_A          596 GCPR  599 (635)
T ss_dssp             TCCH
T ss_pred             CCCH
Confidence            9885

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.3e-39  Score=265.11  Aligned_cols=221  Identities=43%  Similarity=0.848  Sum_probs=183.8

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+.....  ....++..||+|.++..........+.+|+.+++++.+||||+++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            467899999999999999999999998754321  123456679999998766666677889999999999889999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATR  126 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~  126 (228)
                      ++++..+ ..++|||++++++|.+++..                                    .|||+++|+|+||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            9998764 48899999999999988741                                    5899999999999999


Q ss_pred             CEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         127 NILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++|+||||+++|+|++.|..||.+.+.
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEE-CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEEcCCCCEEEcccccccccccccccc-ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999999999999999987554332211 122345567899999998888999999999999999999879999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCC
Q psy3166         207 CRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       207 ~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .++...+..+.+++.|..+|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~  286 (334)
T 2pvf_A          266 EELFKLLKEGHRMDKPANCTN  286 (334)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCH
T ss_pred             HHHHHHHhcCCCCCCCccCCH
Confidence            999989999888888888764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.9e-40  Score=279.39  Aligned_cols=197  Identities=24%  Similarity=0.362  Sum_probs=163.2

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--HHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--KTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+..         .+++.||+|.+++....  .....+.+|..++..+ +||||+++
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l  139 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTL  139 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEc---------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEE
Confidence            356789999999999999999999843         45567999998643111  1112367899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+. +++||||+++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+||
T Consensus       140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcch
Confidence            99987754 8899999999999999864                     5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      |+++.+.......  .....||+.|+|||++.     ...++.++|||||||++|+|++ |..||.+.+..++..++..
T Consensus       220 Gla~~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~  295 (437)
T 4aw2_A          220 GSCLKLMEDGTVQ--SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMN  295 (437)
T ss_dssp             TTCEECCTTSCEE--CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHT
T ss_pred             hhhhhcccCCCcc--cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhh
Confidence            9997554332211  22357899999999987     4568999999999999999999 9999999988888877765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-39  Score=259.09  Aligned_cols=209  Identities=33%  Similarity=0.646  Sum_probs=176.6

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+.+          +..||+|.+......  .+++.+|+.+++++ +||||+++
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~   70 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMS--EEDFIEEAEVMMKL-SHPKLVQL   70 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSBC--HHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEecC----------CCeEEEEEecccccC--HHHHHHHHHHHHhC-CCCCEeeE
Confidence            578999999999999999999999998533          235999998755322  25688999999999 89999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+ ..+++|||+++++|.+++..                     .|||+++|+|+||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  150 (269)
T 4hcu_A           71 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF  150 (269)
T ss_dssp             EEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCT
T ss_pred             EEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccc
Confidence            9998764 48899999999999998853                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.........  ......++..|+|||.+....++.++|+||+|+++|+|++.|..||...+..++...+..+.++..
T Consensus       151 g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (269)
T 4hcu_A          151 GMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  228 (269)
T ss_dssp             TGGGGBCCHHHH--STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccccc--cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence            998755433211  122345567899999998888999999999999999999878999999999999999999888888


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+++
T Consensus       229 ~~~~~~  234 (269)
T 4hcu_A          229 PRLAST  234 (269)
T ss_dssp             CTTSCH
T ss_pred             CCcCCH
Confidence            877654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-39  Score=261.74  Aligned_cols=199  Identities=24%  Similarity=0.367  Sum_probs=160.6

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      -.++|++.+.||+|+||.||+|+.         ..++..||+|.+...  ........+.+|+.+++++ +||||+++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~   78 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAED---------TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMID   78 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEE---------TTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEE---------CCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEE
Confidence            347899999999999999999984         345567999988543  3445567889999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ++..+. .+++|||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||++
T Consensus        79 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           79 VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             eeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            987655 7899999999999998764                    6999999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      ..+......  ......||..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+..........+
T Consensus       159 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  230 (294)
T 4eqm_A          159 KALSETSLT--QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDSVP  230 (294)
T ss_dssp             TTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH-SSCSSCSSCHHHHHHHHHSSCCC
T ss_pred             ccccccccc--ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhccCC
Confidence            755433211  1223467889999999998889999999999999999999 99999998877665554444333

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=272.43  Aligned_cols=206  Identities=25%  Similarity=0.401  Sum_probs=166.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..+..++|++.+.||+|+||.||+|..         ..++..||+|.+....  .......+.+|+.+|+.+ +||||++
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~---------~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~   79 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQK---------NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVN   79 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCC
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCc
Confidence            457778999999999999999999984         3455679999986431  112245678999999999 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++.... +++||||+.+|+|.+++..                    .|||++||+||||||+|||++.++.+||+||
T Consensus        80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             EEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEecc
Confidence            999987654 8899999999999988764                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeeccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHc
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHI---PLCRIVHYLST  215 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Diwslg~~~~~l~t~g~~pf~~~---~~~~~~~~~~~  215 (228)
                      |++..+....    ......||..|+|||++..   ..++.++|+|||||++|+|++ |..||...   ...++...+..
T Consensus       160 G~a~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~  234 (384)
T 4fr4_A          160 NIAAMLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPYHIRSSTSSKEIVHTFET  234 (384)
T ss_dssp             TTCEECCTTC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCCTTSCHHHHHHHHHH
T ss_pred             ceeeeccCCC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh-CCCCCCCCCCccHHHHHHHHhh
Confidence            9997553321    2234678899999999874   358899999999999999999 99999753   33444555554


Q ss_pred             CCCCCCCCCCC
Q psy3166         216 GYRMERPASCN  226 (228)
Q Consensus       216 ~~~~~~p~~~~  226 (228)
                      . .++.|..++
T Consensus       235 ~-~~~~p~~~s  244 (384)
T 4fr4_A          235 T-VVTYPSAWS  244 (384)
T ss_dssp             C-CCCCCTTSC
T ss_pred             c-ccCCCCcCC
Confidence            4 555666554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=277.18  Aligned_cols=197  Identities=21%  Similarity=0.304  Sum_probs=163.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+.         +.+++.||+|.+++...  ......+.+|..++..+ +||||+++
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~---------~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l  126 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKM---------KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQL  126 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeE
Confidence            46678999999999999999999984         34556799999864311  11223467899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++.... +++||||+++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+||
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeec
Confidence            99987755 8899999999999998864                     5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-------SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-------~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      |+++.+......  ......||+.|+|||++.       ...++.++|+|||||++|+|++ |..||.+.+..++..++.
T Consensus       207 Gla~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          207 GSCLKLRADGTV--RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY-GQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             TTCEECCTTSCE--ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHH
T ss_pred             hhheeccCCCcc--ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence            999765433211  122357899999999987       3458899999999999999999 999999998888877766


Q ss_pred             c
Q psy3166         215 T  215 (228)
Q Consensus       215 ~  215 (228)
                      .
T Consensus       284 ~  284 (412)
T 2vd5_A          284 H  284 (412)
T ss_dssp             T
T ss_pred             h
Confidence            5

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.2e-40  Score=285.26  Aligned_cols=209  Identities=36%  Similarity=0.616  Sum_probs=180.2

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+.++          ..||+|.++....  ..+.+.+|+++|+++ +||||+++
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----------~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~~  327 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGTM--SPEAFLQEAQVMKKL-RHEKLVQL  327 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETTT----------EEEEEEEECTTSS--CHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECCC----------ceEEEEEeCCCCC--CHHHHHHHHHHHHhC-CCCCEeeE
Confidence            4778999999999999999999999986432          3499999976532  235788999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++.....++||||+.+|+|.+++..                      .|||+++|+||||||+|||++.++.+||+||
T Consensus       328 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             EEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             EEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccc
Confidence            999888789999999999999998853                      5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++..+......  ......++..|+|||++....++.++||||||+++|+|++.|..||.+....++.+.+..+.+++.
T Consensus       408 G~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~  485 (535)
T 2h8h_A          408 GLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  485 (535)
T ss_dssp             TSTTTCCCHHHH--TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             ccceecCCCcee--cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999765432111  122345567899999999888999999999999999999878999999999999999999999999


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..||+
T Consensus       486 ~~~~~~  491 (535)
T 2h8h_A          486 PPECPE  491 (535)
T ss_dssp             CTTCCH
T ss_pred             CCCCCH
Confidence            998875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.4e-39  Score=263.43  Aligned_cols=219  Identities=36%  Similarity=0.685  Sum_probs=182.8

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      -+|.+..++|++.+.||+|+||.||+|.+....    ...++..||+|.+...........+.+|+.+++++ +||||++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~   92 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVR   92 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCC
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCcc----CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEee
Confidence            357788899999999999999999999854311    22456679999998666666667789999999999 9999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH------------------------------hcccCCCCcccCCCCCCEeec
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE------------------------------EYLSNNKVVHRDLATRNILLS  131 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------------~~lh~~~i~H~~lk~~nil~~  131 (228)
                      +++++..+ ..+++||++++++|.+++..                              .|||++||+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred             eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence            99998764 48899999999999988752                              589999999999999999999


Q ss_pred             CCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         132 SPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      .++.+||+|||++.......... ......++..|+|||++.+..++.++|+||+|+++|+|++.|..||.+.+..++..
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEE-GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             CCCeEEECcCccccccccccccc-cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            99999999999987654432221 11233456789999999888899999999999999999986889999999888888


Q ss_pred             HHHcCCCCCCCCCCCC
Q psy3166         212 YLSTGYRMERPASCNE  227 (228)
Q Consensus       212 ~~~~~~~~~~p~~~~~  227 (228)
                      .+..+..++.|..+|+
T Consensus       252 ~~~~~~~~~~~~~~~~  267 (322)
T 1p4o_A          252 FVMEGGLLDKPDNCPD  267 (322)
T ss_dssp             HHHTTCCCCCCTTCCH
T ss_pred             HHHcCCcCCCCCCCCH
Confidence            8888878888887774

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-39  Score=262.02  Aligned_cols=215  Identities=38%  Similarity=0.670  Sum_probs=177.6

Q ss_pred             CCCCCCceeeee-eeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGE-VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~-~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      +.++.++|++.+ .||+|+||.||+|.+.       +..++..||+|.++.... ....+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~   82 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR   82 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEE-------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCC
T ss_pred             eeecchhhhhccCccccccCeeeEeeeec-------CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEE
Confidence            357788999998 9999999999999642       234556799999875532 23356788999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++++..+..+++||++++++|.+++..                    .|||+++|+|+||||+||+++.++.++|+|||
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           83 MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             EEEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEECCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence            9999977789999999999999998764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++.................++..|+|||.+.+..++.++|+||||+++|+|++.|..||.+.+..++...+..+.+++.|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP  242 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            98765443322222223445678999999988888999999999999999997799999999999999999999888888


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       243 ~~~~~  247 (291)
T 1xbb_A          243 AGCPR  247 (291)
T ss_dssp             TTCCH
T ss_pred             CCCCH
Confidence            88875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.5e-39  Score=266.84  Aligned_cols=193  Identities=24%  Similarity=0.400  Sum_probs=164.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----HHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----KTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .++|++.+.||+|+||+||+|+.         ..++..||+|.++.....     ...+.+.+|+.+|+++ +||||+++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~---------~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l   80 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCRE---------KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITL   80 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEE---------CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcE
Confidence            46799999999999999999984         345567999998754321     1246788999999999 89999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC----cEEE
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH----VVKI  138 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~----~~kl  138 (228)
                      ++++.... +++||||+++++|.+++..                    .|||++||+||||||+||+++.++    .+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             EEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            99987754 8899999999999998754                    699999999999999999998776    7999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +|||++..+....    ......||+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++...+..+
T Consensus       161 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~  233 (361)
T 2yab_A          161 IDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANITAV  233 (361)
T ss_dssp             CCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTT
T ss_pred             EecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence            9999997654322    1234568899999999998889999999999999999999 99999999888888888776

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.7e-40  Score=290.55  Aligned_cols=208  Identities=24%  Similarity=0.354  Sum_probs=172.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|+.         ..+++.||+|.+++..  ..........|..++..+.+||||+.+
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~---------~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l  407 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSER---------KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL  407 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEE---------SSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEE---------CCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            35678999999999999999999984         3455679999987431  112235677899999998789999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++... .+++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||
T Consensus       408 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecc
Confidence            9988764 48899999999999998865                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++......   .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+.++ .+..|
T Consensus       488 la~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  562 (674)
T 3pfq_A          488 MCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEH-NVAYP  562 (674)
T ss_dssp             TCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHSS-CCCCC
T ss_pred             eeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc-CCCCCCCCCHHHHHHHHHhC-CCCCC
Confidence            987533221   12334678999999999998899999999999999999999 99999999999999998887 56777


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+++
T Consensus       563 ~~~s~  567 (674)
T 3pfq_A          563 KSMSK  567 (674)
T ss_dssp             TTSCH
T ss_pred             ccCCH
Confidence            76654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=265.05  Aligned_cols=214  Identities=37%  Similarity=0.703  Sum_probs=173.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||+|.+..+..     ....+||+|.+...........+.+|+.+++++ +||||++++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~   85 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGI   85 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTC-----SCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCc-----eEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEE
Confidence            567899999999999999999998654432     223356888876554444557788999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..+..+++++++.+++|.+++..                     .|||+++|+||||||+||+++.++.+||+|||++.
T Consensus        86 ~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           86 CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EESSSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             EecCCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            998889999999999999998764                     69999999999999999999999999999999997


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+...... .......++..|+|||.+.+..++.++|+|||||++|+|++.|..||.+.+..++...+..+.+++.|..+
T Consensus       166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3lzb_A          166 LLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             EccCcccc-ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            65433211 11223445678999999999899999999999999999998799999999999999999999888888877


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      |+
T Consensus       245 ~~  246 (327)
T 3lzb_A          245 TI  246 (327)
T ss_dssp             CH
T ss_pred             CH
Confidence            64

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.8e-40  Score=277.89  Aligned_cols=207  Identities=24%  Similarity=0.362  Sum_probs=162.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||.||+|+.         ..++..||+|.++..  ........+.+|+.+++++ +||||+++
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l  213 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKE---------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTAL  213 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEE---------cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeE
Confidence            35567899999999999999999984         445567999998743  1223345677899999999 89999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccC-CCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSN-NKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~-~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++.... +++||||+++++|.+++..                    .|||+ +||+||||||+|||++.++.+||+||
T Consensus       214 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DF  293 (446)
T 4ejn_A          214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF  293 (446)
T ss_dssp             EEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCC
T ss_pred             EEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccC
Confidence            99987654 8899999999999988754                    69998 99999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |+++......   .......||..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++...+... .+..
T Consensus       294 G~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~~  368 (446)
T 4ejn_A          294 GLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-EIRF  368 (446)
T ss_dssp             CCCCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCC
T ss_pred             CCceeccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHHhC-CCCC
Confidence            9987533221   11234678899999999998899999999999999999999 99999998888887777665 4556


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+++
T Consensus       369 p~~~~~  374 (446)
T 4ejn_A          369 PRTLGP  374 (446)
T ss_dssp             CTTSCH
T ss_pred             CccCCH
Confidence            666553

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.8e-39  Score=258.06  Aligned_cols=211  Identities=38%  Similarity=0.643  Sum_probs=178.9

Q ss_pred             CccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           2 ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         2 ~~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .-+|.++.++|++.+.||+|+||.||+|...+          +..||+|.++....  ..+.+.+|+++++++ +||||+
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~   71 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSM--SPDAFLAEANLMKQL-QHQRLV   71 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSS--CHHHHHHHHHHHHHC-CCTTBC
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcC----------CcEEEEEEecCCcc--cHHHHHHHHHHHHhC-CCcCcc
Confidence            34688999999999999999999999998533          23599999875532  235788999999999 999999


Q ss_pred             EeeeEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          82 SFIGCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++++++..+..+++||++++++|.+++..                      .|||++||+|+||||+||+++.++.++|+
T Consensus        72 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~  151 (279)
T 1qpc_A           72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA  151 (279)
T ss_dssp             CEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             eEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEEC
Confidence            99999888889999999999999998642                      69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      |||++.........  ......++..|+|||.+.+..++.++|+||||+++|+|++.|..||.+.+..++.+.+..+.++
T Consensus       152 Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  229 (279)
T 1qpc_A          152 DFGLARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM  229 (279)
T ss_dssp             CCTTCEECSSSCEE--CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCcccccccCcccc--cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC
Confidence            99998765433211  1223445667999999988888999999999999999998689999999999999999999888


Q ss_pred             CCCCCCCC
Q psy3166         220 ERPASCNE  227 (228)
Q Consensus       220 ~~p~~~~~  227 (228)
                      ..|..+|+
T Consensus       230 ~~~~~~~~  237 (279)
T 1qpc_A          230 VRPDNCPE  237 (279)
T ss_dssp             CCCTTCCH
T ss_pred             CCcccccH
Confidence            88888774

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-39  Score=258.49  Aligned_cols=209  Identities=38%  Similarity=0.701  Sum_probs=174.1

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +|.++.++|++.+.||+|+||.||++.+.+          +..||+|.++.....  ...+.+|+.+++++ +||||+++
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~   84 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMS--EDEFIEEAKVMMNL-SHEKLVQL   84 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTSBC--HHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCCCC--HHHHHHHHHHHhcC-CCCCEeeE
Confidence            578999999999999999999999997543          235999999755322  25678999999999 89999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++.... .+++||++++++|.+++..                     .|||+++|+|+||||+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df  164 (283)
T 3gen_A           85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF  164 (283)
T ss_dssp             EEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECST
T ss_pred             EEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccc
Confidence            99987644 8899999999999998754                     5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.........  ......++..|+|||.+.+..++.++|+||+|+++|+|+|.|..||...+..+....+..+.+...
T Consensus       165 g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  242 (283)
T 3gen_A          165 GLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR  242 (283)
T ss_dssp             TGGGGBCCHHHH--STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccccc--cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC
Confidence            998755433211  122345567899999999888999999999999999999769999999999999999999988888


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       243 ~~~~~~  248 (283)
T 3gen_A          243 PHLASE  248 (283)
T ss_dssp             CTTCCH
T ss_pred             CCcCCH
Confidence            877664

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.5e-39  Score=270.77  Aligned_cols=194  Identities=25%  Similarity=0.355  Sum_probs=163.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|.         +..++..||+|.+..... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~---------~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~   80 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCV---------KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSIS   80 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEE---------ETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEE---------ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEE
Confidence            689999999999999999998         445566899999876533 33456788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeec---CCCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLS---SPHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~---~~~~~kl~dfg~~  144 (228)
                      .+. .++||||+.+|+|.+++..                    .|||++||+||||||+|||++   .++.+||+|||++
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            754 7899999999999988754                    699999999999999999998   4578999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ........   ......||+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++.+.+..+.
T Consensus       161 ~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~  229 (444)
T 3soa_A          161 IEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV-GYPPFWDEDQHRLYQQIKAGA  229 (444)
T ss_dssp             BCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTC
T ss_pred             EEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Confidence            75543221   1224578899999999998889999999999999999999 999999999888888888763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.2e-39  Score=264.53  Aligned_cols=192  Identities=26%  Similarity=0.459  Sum_probs=163.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|..         ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~   98 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVH---------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ   98 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEE
Confidence            4799999999999999999984         3455679999987543 344556788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC---CcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~---~~~kl~dfg~~  144 (228)
                      ... .++||||+++++|.+++..                    .|||+++|+||||||+||+++.+   +.+||+|||++
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            755 7899999999999887753                    69999999999999999999864   46999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ........    .....||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..++...+..+
T Consensus       179 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~  245 (362)
T 2bdw_A          179 IEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAG  245 (362)
T ss_dssp             BCCTTCCS----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred             eEecCCcc----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhC
Confidence            75543221    223567889999999998889999999999999999999 99999999888888888776

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=266.10  Aligned_cols=220  Identities=42%  Similarity=0.809  Sum_probs=176.0

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..|.++.++|++.+.||+|+||.||+|......    ...++..||+|.++..........+.+|+.+++++.+||||++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  113 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN  113 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            357889999999999999999999999864432    2345667999999765444455678899999999988999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------------------------------hcccCCCC
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------------------------------EYLSNNKV  118 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------------------------------~~lh~~~i  118 (228)
                      +++++... ..++||||+++++|.+++..                                           .|||++||
T Consensus       114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  193 (344)
T 1rjb_A          114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC  193 (344)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            99998764 48899999999999988741                                           58999999


Q ss_pred             cccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCC
Q psy3166         119 VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA  198 (228)
Q Consensus       119 ~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~  198 (228)
                      +|+||||+||+++.++.+||+|||++..+....... ......++..|+|||.+.+..++.++|+||||+++|+|+|.|.
T Consensus       194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             ccCCCChhhEEEcCCCcEEeCCCccCcccccCccce-eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999987554332111 1122345677999999988889999999999999999997699


Q ss_pred             CCCCCCCHHHH-HHHHHcCCCCCCCCCCCC
Q psy3166         199 NPYPHIPLCRI-VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       199 ~pf~~~~~~~~-~~~~~~~~~~~~p~~~~~  227 (228)
                      .||.+.+..+. ...+..+.+++.|..+|+
T Consensus       273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (344)
T 1rjb_A          273 NPYPGIPVDANFYKLIQNGFKMDQPFYATE  302 (344)
T ss_dssp             CSSTTCCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCcccCCcHHHHHHHHhcCCCCCCCCCCCH
Confidence            99988765544 555777778888877764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.9e-39  Score=283.29  Aligned_cols=214  Identities=36%  Similarity=0.696  Sum_probs=180.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+..++|++.+.||+|+||.||+|.+....      ..+..||+|.++........+.+.+|+.+++++ +||||++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~  457 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE------NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLI  457 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSS------SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCC------CccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            4567789999999999999999999875432      234569999987665666667899999999999 999999999


Q ss_pred             eEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++..+..++||||+++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+|||+
T Consensus       458 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             EEECSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             EEEecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC
Confidence            99877789999999999999998863                     699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      +..........  .....++..|+|||++....++.++|+||||+++|+|++.|..||.+.+..++...+..+.+++.|.
T Consensus       538 a~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  615 (656)
T 2j0j_A          538 SRYMEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  615 (656)
T ss_dssp             CCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT
T ss_pred             CeecCCCccee--ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            97654332111  1223456789999999888899999999999999999966999999999999999999999999998


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .||+
T Consensus       616 ~~~~  619 (656)
T 2j0j_A          616 NCPP  619 (656)
T ss_dssp             TCCH
T ss_pred             cccH
Confidence            8875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.8e-39  Score=260.94  Aligned_cols=215  Identities=40%  Similarity=0.758  Sum_probs=163.2

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ..++.++|++.+.||+|+||.||+|.+..+.      .....||+|.++... .......+.+|+.+++++ +||||+++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~   90 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQED------GSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKL   90 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccC------CcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehh
Confidence            3578899999999999999999999854432      122369999987542 234457788999999999 99999999


Q ss_pred             eeEEEcCc-------eEEEEecCCCCcHHHHHHH--------------------------hcccCCCCcccCCCCCCEee
Q psy3166          84 IGCCYKDE-------LRLVVEYCALGDLQSYLRE--------------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        84 ~~~~~~~~-------~~lv~e~~~~~~L~~~l~~--------------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                      ++++....       .+++|||+.+++|.+++..                          .|||++||+||||||+||++
T Consensus        91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli  170 (323)
T 3qup_A           91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML  170 (323)
T ss_dssp             CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence            99986543       3899999999999988742                          59999999999999999999


Q ss_pred             cCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy3166         131 SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV  210 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~  210 (228)
                      +.++.+||+|||++......... .......++..|+|||.+.+..++.++|+|||||++|+|++.|..||.+.+..++.
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  249 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY  249 (323)
T ss_dssp             CTTSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             cCCCCEEEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence            99999999999998765433221 11223455678999999998889999999999999999998789999999999999


Q ss_pred             HHHHcCCCCCCCCCCCC
Q psy3166         211 HYLSTGYRMERPASCNE  227 (228)
Q Consensus       211 ~~~~~~~~~~~p~~~~~  227 (228)
                      ..+..+.+++.|..+|+
T Consensus       250 ~~~~~~~~~~~~~~~~~  266 (323)
T 3qup_A          250 NYLIGGNRLKQPPECME  266 (323)
T ss_dssp             HHHHTTCCCCCCTTCCH
T ss_pred             HHHhcCCCCCCCCccCH
Confidence            99998888888887764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.4e-39  Score=278.73  Aligned_cols=208  Identities=23%  Similarity=0.298  Sum_probs=169.5

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .++..++|++.+.||+|+||.||+|+.         ..+++.||+|.+++...  ......+.+|+.+|+++ +||||++
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~---------~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~  249 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQM---------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVS  249 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEee
Confidence            356778999999999999999999984         34556799999864321  12235678899999999 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      +++++.... +++||||+++|+|.+++..                        .|||++||+||||||+|||++.+|.+|
T Consensus       250 l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEE
Confidence            999987654 8899999999999988753                        699999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI----PLCRIVHYL  213 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~----~~~~~~~~~  213 (228)
                      |+|||++..+.....   ......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.    ...++.+.+
T Consensus       330 L~DFGla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt-G~~PF~~~~~~~~~~~~~~~i  405 (543)
T 3c4z_A          330 ISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRV  405 (543)
T ss_dssp             ECCCTTCEECCTTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCTTCCCCHHHHHHHH
T ss_pred             EeecceeeeccCCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh-CCCCCCCCccchhHHHHHHHH
Confidence            999999976543321   1223578899999999999889999999999999999999 99999875    335566666


Q ss_pred             HcCCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCNE  227 (228)
Q Consensus       214 ~~~~~~~~p~~~~~  227 (228)
                      ... .+..|..+|+
T Consensus       406 ~~~-~~~~p~~~s~  418 (543)
T 3c4z_A          406 LEQ-AVTYPDKFSP  418 (543)
T ss_dssp             HHC-CCCCCTTSCH
T ss_pred             hhc-ccCCCcccCH
Confidence            655 5566666653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.6e-39  Score=254.10  Aligned_cols=208  Identities=36%  Similarity=0.654  Sum_probs=175.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+..++|++.+.||+|+||.||+|.+.+          +..||+|.++.....  ...+.+|+++++++ +||||++++
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~   69 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSMS--EDEFFQEAQTMMKL-SHPKLVKFY   69 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTBC--HHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCCc--HHHHHHHHHHHHhC-CCCCEeeEE
Confidence            56788999999999999999999997543          235999998765322  35678999999999 899999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +++..+ ..+++||++++++|.+++..                     .|||+++|+|+||||+||+++.++.++|+|||
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             EEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCc
Confidence            998765 48899999999999998764                     59999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++..........  .....++..|+|||.+.+..++.++|+||+|+++|+|++.|..||...+..+....+..+.++..|
T Consensus       150 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (268)
T 3sxs_A          150 MTRYVLDDQYVS--SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP  227 (268)
T ss_dssp             CEEECCTTCEEE--CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             cceecchhhhhc--ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC
Confidence            987554432221  123445677999999988888999999999999999997799999999999999999998888888


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       228 ~~~~~  232 (268)
T 3sxs_A          228 HLASD  232 (268)
T ss_dssp             TTSCH
T ss_pred             CcChH
Confidence            77664

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-38  Score=258.51  Aligned_cols=219  Identities=38%  Similarity=0.751  Sum_probs=178.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+....    +..++..||+|.++........+.+.+|+.+++++.+||||+++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccChhhhhHHHhhCccCCcceEEEEEeecc----ccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence            46788999999999999999999999854321    34566789999998766666667889999999999889999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------------------------hcccCCCCcccCCC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------------------------EYLSNNKVVHRDLA  124 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------------------------~~lh~~~i~H~~lk  124 (228)
                      ++++... ..+++||++++++|.+++..                                      .|||+++|+|+|||
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  172 (313)
T 1t46_A           93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (313)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            9998764 48899999999999988742                                      58999999999999


Q ss_pred             CCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       125 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      |+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+|++.|..||.+.
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSE-ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cceEEEcCCCCEEEccccccccccccccce-eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999987554332211 1123445677999999988889999999999999999997799999887


Q ss_pred             CHHH-HHHHHHcCCCCCCCCCCCC
Q psy3166         205 PLCR-IVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       205 ~~~~-~~~~~~~~~~~~~p~~~~~  227 (228)
                      ...+ +...+..+.+...|..+|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~  275 (313)
T 1t46_A          252 PVDSKFYKMIKEGFRMLSPEHAPA  275 (313)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCH
T ss_pred             cchhHHHHHhccCCCCCCcccCCH
Confidence            6544 4555666777777776664

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.6e-39  Score=260.90  Aligned_cols=200  Identities=26%  Similarity=0.374  Sum_probs=157.7

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.-.++|++.+.||+|+||.||+|+.         ..++..||+|.++...  .......+.+|+.+++++ +||||+++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~   77 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARD---------LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAV   77 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCE
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEE---------CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceE
Confidence            34457899999999999999999984         4456679999987542  344556788999999999 99999999


Q ss_pred             eeEEEcCc-----eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          84 IGCCYKDE-----LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        84 ~~~~~~~~-----~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      ++++....     .++||||+++++|.+++..                    .|||+++|+|+||||+||+++.++.+||
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEE
T ss_pred             EEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEE
Confidence            99875432     4899999999999998764                    6999999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +|||++..+..............|+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+...+....
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~  234 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVRE  234 (311)
T ss_dssp             CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHC
T ss_pred             eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcC
Confidence            999998765443222222234567889999999998889999999999999999999 99999998887775554444

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=268.90  Aligned_cols=210  Identities=40%  Similarity=0.764  Sum_probs=165.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-   89 (228)
                      .|++.+.||+|+||+||+|.+...      ......||+|.++.........++.+|+.+++++ +||||+++++++.. 
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS  162 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEET------TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECC------CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC
Confidence            467889999999999999986432      1234568999987655555667899999999999 99999999998754 


Q ss_pred             -CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 -DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 -~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                       +..++||||+++++|.+++..                     .|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence             357899999999999999863                     6999999999999999999999999999999998755


Q ss_pred             cccccc-cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         148 YEQNVF-QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       148 ~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ...... ........++..|+|||.+....++.++|+||||+++|+|++.|..||...+..++...+..+.++..|..||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~  322 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  322 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCC
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            332211 1112234556789999999988899999999999999999996788999888888888889998888888887


Q ss_pred             C
Q psy3166         227 E  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       323 ~  323 (373)
T 3c1x_A          323 D  323 (373)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.7e-39  Score=259.53  Aligned_cols=219  Identities=41%  Similarity=0.778  Sum_probs=179.2

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+.+..    +..++..||+|.++..........+.+|+.+++++.+||||+++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            46788899999999999999999999865432    34566789999998766666667889999999999789999999


Q ss_pred             eeEEEcC--ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCC
Q psy3166          84 IGCCYKD--ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLAT  125 (228)
Q Consensus        84 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~  125 (228)
                      ++++...  ..+++|||+++++|.+++..                                    .|||+++|+|+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp  176 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA  176 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence            9988653  38899999999999988742                                    589999999999999


Q ss_pred             CCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         126 RNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++|+||||+++|+|+|.|..||.+..
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccce-eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999999987553322111 11223456779999999988899999999999999999976999998866


Q ss_pred             HH-HHHHHHHcCCCCCCCCCCCC
Q psy3166         206 LC-RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       206 ~~-~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .. .+...+..+.+++.|..+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~  278 (316)
T 2xir_A          256 IDEEFCRRLKEGTRMRAPDYTTP  278 (316)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCH
T ss_pred             hhHHHHHHhccCccCCCCCCCCH
Confidence            44 45667777878888877764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-38  Score=255.44  Aligned_cols=213  Identities=40%  Similarity=0.767  Sum_probs=173.3

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ...+|++.+.||+|+||.||+|.+...      ......+|+|.+.........+.+.+|+.+++++ +||||+++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   95 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGIC   95 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEE
T ss_pred             cceehhhcceeeecCCceEEEEEEecC------CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEE
Confidence            345788999999999999999986442      2234468999988766666677889999999999 999999999986


Q ss_pred             Ec--CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          88 YK--DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        88 ~~--~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ..  +..+++||++.+++|.+++..                     .|||+++|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A           96 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             CCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             EcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccc
Confidence            54  347899999999999998853                     5999999999999999999999999999999998


Q ss_pred             ccccccccc-cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         145 EDIYEQNVF-QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       145 ~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ..+...... ........++..|+|||.+.+..++.++|+||+|+++|+|++.|..||......+....+..+.+...|.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  255 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence            765443221 1223345567789999999988899999999999999999986678888888888888888888888888


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .+|+
T Consensus       256 ~~~~  259 (298)
T 3f66_A          256 YCPD  259 (298)
T ss_dssp             TCCH
T ss_pred             cCCH
Confidence            7764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-38  Score=260.60  Aligned_cols=219  Identities=39%  Similarity=0.778  Sum_probs=177.8

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|....+.    .......||+|.++..........+.+|+.+++++.+||||+++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLG----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCS----SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCC----cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            46788999999999999999999999876543    12334569999998766666667889999999999789999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------------------hcccCCCCcccCCCCCCE
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------------------~~lh~~~i~H~~lk~~ni  128 (228)
                      ++++..+ ..++|||++++|+|.+++..                                  .|||+++|+|+||||+||
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV  195 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence            9998764 48899999999999988742                                  589999999999999999


Q ss_pred             eecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         129 LLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      +++.++.+||+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+|+|.|..||.+.....
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSE-ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             EECCCCeEEECcccccccccccccee-ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            99999999999999987554332111 11234456789999999888899999999999999999976899998866544


Q ss_pred             H-HHHHHcCCCCCCCCCCCC
Q psy3166         209 I-VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       209 ~-~~~~~~~~~~~~p~~~~~  227 (228)
                      . ...+..+.+++.|..+|+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~  294 (333)
T 2i1m_A          275 KFYKLVKDGYQMAQPAFAPK  294 (333)
T ss_dssp             HHHHHHHHTCCCCCCTTCCH
T ss_pred             HHHHHHhcCCCCCCCCCCCH
Confidence            4 455666777777777664

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.7e-38  Score=250.83  Aligned_cols=206  Identities=22%  Similarity=0.390  Sum_probs=170.6

Q ss_pred             CCccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCc
Q psy3166           1 MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDH   79 (228)
Q Consensus         1 ~~~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~n   79 (228)
                      |.-.++++.++|++.+.||+|+||.||+|++.           +..||+|.++... .......+.+|+.+++++ +|||
T Consensus         1 m~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~   68 (271)
T 3kmu_A            1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPN   68 (271)
T ss_dssp             ---CCCCCGGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTT
T ss_pred             CCCcCCCCHHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCc
Confidence            45678999999999999999999999999853           3459999987553 445567789999999999 9999


Q ss_pred             eEEeeeEEEcC---ceEEEEecCCCCcHHHHHHH----------------------hcccCCC--CcccCCCCCCEeecC
Q psy3166          80 IVSFIGCCYKD---ELRLVVEYCALGDLQSYLRE----------------------EYLSNNK--VVHRDLATRNILLSS  132 (228)
Q Consensus        80 i~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~--i~H~~lk~~nil~~~  132 (228)
                      |+++++++...   ..+++|||+++++|.+++..                      .|||+++  ++|+||||+||+++.
T Consensus        69 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~  148 (271)
T 3kmu_A           69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE  148 (271)
T ss_dssp             EECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT
T ss_pred             hhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC
Confidence            99999998764   47899999999999999864                      6999999  999999999999999


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYT---NKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~---~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ++.+++.||++.....        .....+|..|+|||.+.+..++   .++|+||||+++|+|++ |..||.+.+..+.
T Consensus       149 ~~~~~l~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~  219 (271)
T 3kmu_A          149 DMTARISMADVKFSFQ--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEI  219 (271)
T ss_dssp             TSCEEEEGGGSCCTTS--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH-CSCTTTTSCHHHH
T ss_pred             CcceeEEeccceeeec--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCccccChHHH
Confidence            9999999988765321        1235667889999998865544   37999999999999999 9999999888877


Q ss_pred             HHH-HHcCCCCCCCCCCCC
Q psy3166         210 VHY-LSTGYRMERPASCNE  227 (228)
Q Consensus       210 ~~~-~~~~~~~~~p~~~~~  227 (228)
                      ... ...+.+++.|..+|+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          220 GMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             HHHHHHSCCCCCCCTTCCH
T ss_pred             HHHHHhcCCCCCCCCCCCH
Confidence            555 556777788888775

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=259.84  Aligned_cols=193  Identities=21%  Similarity=0.373  Sum_probs=163.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|..         ..++..||+|.++...  .....+.+|+.+++.+ +||||+++++++.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~   71 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVE---------TSSKKTYMAKFVKVKG--TDQVLVKKEISILNIA-RHRNILHLHESFE   71 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHS-CCTTBCCEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEE---------CCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhC-CCCCCCeEeEEEe
Confidence            37899999999999999999984         4455679999987542  3345678999999999 9999999999987


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC--CCcEEEeeccCc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS--PHVVKISDFGLS  144 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~--~~~~kl~dfg~~  144 (228)
                      .. ..+++|||+++++|.+++..                     .|||++||+||||||+||+++.  ++.+||+|||++
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a  151 (321)
T 1tki_A           72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             ETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             cCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence            64 48899999999999998753                     6999999999999999999987  789999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      ..+......    ....+++.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..++...+..+..
T Consensus       152 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~  220 (321)
T 1tki_A          152 RQLKPGDNF----RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEY  220 (321)
T ss_dssp             EECCTTCEE----EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCC
T ss_pred             eECCCCCcc----ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHcCCC
Confidence            765433211    12456788999999988888999999999999999999 9999999988888888777643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-38  Score=260.47  Aligned_cols=216  Identities=37%  Similarity=0.699  Sum_probs=173.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .++.++|++.+.||+|+||.||+|++.+..    +..++..||+|.+..........++.+|+.+++++ +||||+++++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  100 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG  100 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEE
Confidence            478899999999999999999999864432    33456679999997665666667889999999999 9999999999


Q ss_pred             EEEcC-ceEEEEecCCCCcHHHHHHH---------------------------hcccCCCCcccCCCCCCEeecC---CC
Q psy3166          86 CCYKD-ELRLVVEYCALGDLQSYLRE---------------------------EYLSNNKVVHRDLATRNILLSS---PH  134 (228)
Q Consensus        86 ~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------------~~lh~~~i~H~~lk~~nil~~~---~~  134 (228)
                      ++... ..+++||++++++|.+++..                           .|||+++|+|+||||+||+++.   +.
T Consensus       101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence            98764 47899999999999998863                           5899999999999999999984   44


Q ss_pred             cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         135 VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      .++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+|+|.|..||......++...+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccc-cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            69999999986543322111 12234557789999999888899999999999999999977999999998888899999


Q ss_pred             cCCCCCCCCCCCC
Q psy3166         215 TGYRMERPASCNE  227 (228)
Q Consensus       215 ~~~~~~~p~~~~~  227 (228)
                      .+.+++.|..+|+
T Consensus       260 ~~~~~~~~~~~~~  272 (327)
T 2yfx_A          260 SGGRMDPPKNCPG  272 (327)
T ss_dssp             TTCCCCCCTTCCH
T ss_pred             cCCCCCCCCCCCH
Confidence            9888888887764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.9e-39  Score=256.73  Aligned_cols=210  Identities=41%  Similarity=0.777  Sum_probs=178.5

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.+..++|++.+.||+|+||.||+|.+         ..++..||+|.+.....  ..+.+.+|+.+++++ +||||+++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~   74 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVW---------KKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEI-KHPNLVQL   74 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEE---------GGGTEEEEEEEECSCST--HHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEe---------cCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhC-CCCCEeeE
Confidence            4678899999999999999999999984         44566799999875533  346788999999999 89999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++..+ ..++|||++.+++|.+++..                      .|||+++|+|+||||+||+++.++.++|+|
T Consensus        75 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~D  154 (288)
T 3kfa_A           75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD  154 (288)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEcc
Confidence            9998764 48899999999999998864                      589999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||++..........  .....++..|+|||.+.+..++.++|+||+|+++|+|++.|..||.+.+..++...+....+++
T Consensus       155 fg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (288)
T 3kfa_A          155 FGLSRLMTGDTYTA--HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME  232 (288)
T ss_dssp             CCGGGTSCSSSSEE--ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             CccceeccCCcccc--ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC
Confidence            99987554332111  1223445679999999988899999999999999999987899999999888999999998888


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .|..+|+
T Consensus       233 ~~~~~~~  239 (288)
T 3kfa_A          233 RPEGCPE  239 (288)
T ss_dssp             CCTTCCH
T ss_pred             CCCCCCH
Confidence            8888875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-39  Score=267.02  Aligned_cols=202  Identities=28%  Similarity=0.435  Sum_probs=159.1

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--HHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--KTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ..++|++.+.||+|+||+||+|.+         ..++..||+|.+......  .....+.+|+.+++.+ +||||+++++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~   76 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATH---------YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYD   76 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence            346899999999999999999984         445567999998643111  1124678999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ++.... .++||||+ +|+|.+++..                    .|||++||+||||||+||+++.++.+||+|||++
T Consensus        77 ~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s  155 (336)
T 3h4j_B           77 VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS  155 (336)
T ss_dssp             EEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred             EEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccc
Confidence            987654 88999999 6788888754                    6999999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ........    .....||+.|+|||++.+..+ ++++|+||+||++|+|++ |..||.+....++...+..+ ....|.
T Consensus       156 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~  229 (336)
T 3h4j_B          156 NIMTDGNF----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV-GRLPFDDEFIPNLFKKVNSC-VYVMPD  229 (336)
T ss_dssp             BTTTTSBT----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH-SSCSSBCSSSTTCBCCCCSS-CCCCCT
T ss_pred             eeccCCcc----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcC-CCCCcc
Confidence            75543321    234567889999999987765 689999999999999999 99999876554444333333 333444


Q ss_pred             CCC
Q psy3166         224 SCN  226 (228)
Q Consensus       224 ~~~  226 (228)
                      .++
T Consensus       230 ~~s  232 (336)
T 3h4j_B          230 FLS  232 (336)
T ss_dssp             TSC
T ss_pred             cCC
Confidence            443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=259.41  Aligned_cols=187  Identities=33%  Similarity=0.557  Sum_probs=156.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||+||+|.+.         .++..||+|.+... .......+.+|+.+++++ +||||+++++
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~   74 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHR---------ETGEVMVMKELIRF-DEETQRTFLKEVKVMRCL-EHPNVLKFIG   74 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEEC---------CCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhC-CCcCcccEEE
Confidence            467899999999999999999999853         34557999987543 455567889999999999 8999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++..+. .++||||+.+++|.+++..                     .|||+++|+|+||||+||+++.++.+||+|||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             EEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence            987654 8899999999999998864                     699999999999999999999999999999999


Q ss_pred             cccccccccccC-----------CCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         144 SEDIYEQNVFQN-----------GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       144 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      +..+........           ......||..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~~~~~~  225 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDY  225 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-TCCSSTTT
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc-CCCCCcch
Confidence            875533221110           1114568889999999999889999999999999999999 99988764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-38  Score=250.89  Aligned_cols=209  Identities=33%  Similarity=0.646  Sum_probs=175.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.++.++|++.+.||+|+||.||+|.+.+          +..||+|.++.....  .+.+.+|+.+++++ +||||+++
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~   68 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMS--EEDFIEEAEVMMKL-SHPKLVQL   68 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTBC--HHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCCC--HHHHHHHHHHHHhC-CCCCEeeE
Confidence            477899999999999999999999998532          235999998765322  25688999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+ ..+++||++++++|.+++..                     .|||+++++|+||||+||+++.++.++|+||
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~df  148 (267)
T 3t9t_A           69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF  148 (267)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCT
T ss_pred             EEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccc
Confidence            9998764 48899999999999998864                     5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++.........  ......++..|+|||++....++.++|+||+|+++|+|++.|..||...+..++.+.+..+.++..
T Consensus       149 g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~  226 (267)
T 3t9t_A          149 GMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  226 (267)
T ss_dssp             TGGGGBCCHHHH--STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccccc--ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence            998755332211  122345567899999998888999999999999999999868999999998999999999888887


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |..+|+
T Consensus       227 ~~~~~~  232 (267)
T 3t9t_A          227 PRLAST  232 (267)
T ss_dssp             CTTSCH
T ss_pred             CccCcH
Confidence            877654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-38  Score=259.37  Aligned_cols=214  Identities=36%  Similarity=0.621  Sum_probs=172.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..+.|++.+.||+|+||.||++.+...     +..++..||+|.++..........+.+|+.+++++ +||||++++++
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  101 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPT-----NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGC  101 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSC-----C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccC-----CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEE
Confidence            3444459999999999999999876432     44577789999998776666677899999999999 89999999999


Q ss_pred             EEcC---ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD---ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~---~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +...   .+++|||++++++|.+++..                   .|||+++|+|+||||+||+++.++.++|+|||++
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence            8763   37899999999999998754                   6999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------------HH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC---------------RI  209 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~---------------~~  209 (228)
                      .................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......               ++
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh-CCCcccccchhhhhhhcccccchhHHHH
Confidence            765443322222334556778999999988888999999999999999999 99999764322               34


Q ss_pred             HHHHHcCCCCCCCCCCCC
Q psy3166         210 VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       210 ~~~~~~~~~~~~p~~~~~  227 (228)
                      ...+..+.+++.|..+|+
T Consensus       261 ~~~~~~~~~~~~~~~~~~  278 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPA  278 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCH
T ss_pred             HHHHhcccCCCCCccccH
Confidence            455677778888888774

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.4e-38  Score=254.57  Aligned_cols=214  Identities=39%  Similarity=0.773  Sum_probs=170.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      .+..++|++.+.||+|+||.||+|....      +..++..||+|.++... .......+.+|+.+++++ +||||++++
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  102 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLL  102 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEEC------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCC
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEec------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeee
Confidence            4778899999999999999999998644      23456679999987553 445567788999999999 899999999


Q ss_pred             eEEEcC------ceEEEEecCCCCcHHHHHHH--------------------------hcccCCCCcccCCCCCCEeecC
Q psy3166          85 GCCYKD------ELRLVVEYCALGDLQSYLRE--------------------------EYLSNNKVVHRDLATRNILLSS  132 (228)
Q Consensus        85 ~~~~~~------~~~lv~e~~~~~~L~~~l~~--------------------------~~lh~~~i~H~~lk~~nil~~~  132 (228)
                      +++...      ..+++||++++++|.+++..                          .|||+++|+|+||||+||+++.
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence            988653      25899999999999998731                          6999999999999999999999


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ++.+||+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++.|..||.+....++...
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             TSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCcEEEeecCcceeccccccc-CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            999999999998755433211 1122345567899999999888999999999999999999878899999999999999


Q ss_pred             HHcCCCCCCCCCCCC
Q psy3166         213 LSTGYRMERPASCNE  227 (228)
Q Consensus       213 ~~~~~~~~~p~~~~~  227 (228)
                      +..+.+++.|..+|+
T Consensus       262 ~~~~~~~~~~~~~~~  276 (313)
T 3brb_A          262 LLHGHRLKQPEDCLD  276 (313)
T ss_dssp             HHTTCCCCCBTTCCH
T ss_pred             HHcCCCCCCCccccH
Confidence            999988888888774

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.7e-39  Score=277.21  Aligned_cols=206  Identities=24%  Similarity=0.338  Sum_probs=166.6

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||.||+|+..         .++..||+|.+....  .......+.+|+.+|+++ +||||+++
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l  249 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSL  249 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeE
Confidence            367789999999999999999999843         455679999986431  111235678899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++.... +++||||+++|+|.+++..                      .|||++||+||||||+|||++.++.+||+|
T Consensus       250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEe
Confidence            99987654 8899999999999988753                      699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLSTG  216 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~----~~~~~~~~~~~  216 (228)
                      ||++..+.....    .....||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+..    ..++.+.+...
T Consensus       330 FGla~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLlt-G~~PF~~~~~~~~~~~i~~~i~~~  404 (576)
T 2acx_A          330 LGLAVHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLVKEV  404 (576)
T ss_dssp             CTTCEECCTTCC----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHH-SSCSSSCSSSCCCHHHHHHHHHHC
T ss_pred             cccceecccCcc----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCcccccchhHHHHHHHhhcc
Confidence            999976543321    123578899999999998889999999999999999999 999998753    23445555544


Q ss_pred             CCCCCCCCCCC
Q psy3166         217 YRMERPASCNE  227 (228)
Q Consensus       217 ~~~~~p~~~~~  227 (228)
                       +...|..+++
T Consensus       405 -~~~~p~~~s~  414 (576)
T 2acx_A          405 -PEEYSERFSP  414 (576)
T ss_dssp             -CCCCCTTSCH
T ss_pred             -cccCCccCCH
Confidence             5555655543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-38  Score=256.65  Aligned_cols=215  Identities=33%  Similarity=0.589  Sum_probs=171.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||.||+|++...     +..++..||+|.++..........+.+|+.+++++ +||||+++++
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~   90 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKG   90 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTT-----SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccc-----cCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeee
Confidence            35567799999999999999999986432     34567789999997654444456788999999999 9999999999


Q ss_pred             EEEcC---ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          86 CCYKD---ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        86 ~~~~~---~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++...   .++++||++++++|.+++..                     .|||+++|+|+||||+||+++.++.++|+||
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence            98753   37899999999999999843                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------CH
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI---------------PL  206 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~---------------~~  206 (228)
                      |++.................++..|+|||.+.+..++.++|+||+|+++|+|++ |..|+...               ..
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHH-ccCCCcchhhHHhhccCCcccccCH
Confidence            998766444322223344567778999999988888999999999999999999 98875332               22


Q ss_pred             HHHHHHHHcCCCCCCCCCCCC
Q psy3166         207 CRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       207 ~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ..+...+..+.+.+.|..+|+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~  270 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPD  270 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCH
T ss_pred             HHHHHHHhccCCCCCCCCCCH
Confidence            344666777888888887764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=250.90  Aligned_cols=210  Identities=39%  Similarity=0.734  Sum_probs=173.9

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      .|.+.+.||+|+||.||+|.+..+      ...+..+|+|.++........+.+.+|+.+++++ +||||+++++++...
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   94 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPP   94 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS------SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS
T ss_pred             EEccCceeccCCCceEEEEEEecC------CCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecC
Confidence            445679999999999999986442      2344569999998666666677889999999999 999999999998653


Q ss_pred             c--eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          91 E--LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        91 ~--~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .  .+++||++.+++|.+++..                     .|||++||+|+||||+||+++.++.+||+|||++..+
T Consensus        95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            3  4899999999999998764                     6999999999999999999999999999999999755


Q ss_pred             cccccc-cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         148 YEQNVF-QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       148 ~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ...... ........++..|+|||.+.+..++.++|+||||+++|+|++.|.+||...+..++...+..+.+++.|..+|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP  254 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccch
Confidence            443221 1223345667889999999988899999999999999999995566678888888888899988888888776


Q ss_pred             C
Q psy3166         227 E  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       255 ~  255 (298)
T 3pls_A          255 D  255 (298)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-38  Score=258.20  Aligned_cols=193  Identities=30%  Similarity=0.506  Sum_probs=145.3

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ..++|++.+.||+|+||.||+|.         +..++..||+|.++..........+.+|+.+++++ +||||+++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   72 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGL---------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVI   72 (317)
T ss_dssp             ----------------CEEEEEE---------CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEE---------ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEE
Confidence            45799999999999999999998         44456679999987554333345678999999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ..++ .++||||+. ++|.+++..                          .|||++||+||||||+||+++.++.+||+|
T Consensus        73 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           73 HTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             CCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             EECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECc
Confidence            7654 889999997 588887643                          599999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ||++.......   .......+|..|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.+
T Consensus       152 fg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~  223 (317)
T 2pmi_A          152 FGLARAFGIPV---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGTNDEEQLKLIFD  223 (317)
T ss_dssp             CSSCEETTSCC---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             CccceecCCCc---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence            99987553221   112335678889999998764 58999999999999999999 9999999888877766543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-38  Score=256.45  Aligned_cols=193  Identities=25%  Similarity=0.387  Sum_probs=162.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----HHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----KTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .++|++.+.||+|+||.||+|+.         ..++..||+|.++.....     .....+.+|+.+|+++ +||||+++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~   79 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCRE---------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITL   79 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEE---------TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             ccceEeceEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcE
Confidence            35799999999999999999984         345567999998654221     1346788999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC----cEEE
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH----VVKI  138 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~----~~kl  138 (228)
                      ++++.... .++||||+++++|.+++..                    .|||+++|+||||||+||+++.++    .+||
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           80 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence            99987654 8899999999999998753                    699999999999999999998877    8999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +|||++..+....    ......||..|+|||++....++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus       160 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~  232 (326)
T 2y0a_A          160 IDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANVSAV  232 (326)
T ss_dssp             CCCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHT
T ss_pred             EECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHHhc
Confidence            9999987553322    1234567889999999988889999999999999999999 99999998888777776655

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-38  Score=264.03  Aligned_cols=195  Identities=28%  Similarity=0.452  Sum_probs=151.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|.+         ..++..||+|.+... .......+..+|+.+++++.+||||+++++++.
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSID---------RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             TTEEEEEC-------CEEEEEE---------TTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEE---------CCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            6899999999999999999984         445567999998644 344556778899999999956999999999986


Q ss_pred             cC---ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KD---ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~---~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..   .+++||||+. ++|.+++..                   .|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            43   4899999997 588887654                   699999999999999999999999999999999875


Q ss_pred             ccccccc------------------cCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         147 IYEQNVF------------------QNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       147 ~~~~~~~------------------~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      +......                  ........||..|+|||++.+ ..++.++||||+||++|+|++ |..||.+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  237 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSSTM  237 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHH
Confidence            4321100                  011233578889999999886 568999999999999999999 99999999888


Q ss_pred             HHHHHHHc
Q psy3166         208 RIVHYLST  215 (228)
Q Consensus       208 ~~~~~~~~  215 (228)
                      +.+.++..
T Consensus       238 ~~~~~i~~  245 (388)
T 3oz6_A          238 NQLERIIG  245 (388)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            77776654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-38  Score=271.57  Aligned_cols=205  Identities=29%  Similarity=0.461  Sum_probs=169.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +..++|++.+.||+|+||.||+|+.         ..++..||+|.++....  ......+.+|+.+++.+ +||||++++
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~   82 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKH---------ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLY   82 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEE---------TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEE
Confidence            4567999999999999999999984         44556799999864311  11235678999999999 999999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++... .+++||||+++++|.+++..                    .|||+++|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~  162 (476)
T 2y94_A           83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL  162 (476)
T ss_dssp             EEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccc
Confidence            998764 48899999999999998753                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +........    .....||+.|+|||++.+..+ +.++|+||+||++|+|++ |..||.+.+..++..++..+ ....|
T Consensus       163 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  236 (476)
T 2y94_A          163 SNMMSDGEF----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFKKICDG-IFYTP  236 (476)
T ss_dssp             CEECCTTCC----BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSSCCSSSHHHHHHHHTT-CCCCC
T ss_pred             hhhcccccc----ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC-CcCCC
Confidence            876543221    224567889999999987765 689999999999999999 99999998888888888877 45566


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+++
T Consensus       237 ~~~s~  241 (476)
T 2y94_A          237 QYLNP  241 (476)
T ss_dssp             TTCCH
T ss_pred             ccCCH
Confidence            66553

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.5e-38  Score=261.58  Aligned_cols=201  Identities=21%  Similarity=0.290  Sum_probs=163.4

Q ss_pred             cCCCCCCceeeeeeeeee--cCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCce
Q psy3166           4 SCGYPPERLILGEVLGQG--EFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHI   80 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g--~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni   80 (228)
                      +.-...++|++.+.||+|  +||.||+|+..         .++..||+|.++... .......+.+|+.+++++ +||||
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni   88 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYK---------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNI   88 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTB
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEc---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCC
Confidence            344677899999999999  99999999843         455679999987553 344556788899999999 99999


Q ss_pred             EEeeeEEEcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          81 VSFIGCCYKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        81 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      +++++++..+. +++||||+++++|.+++..                      .|||+++|+||||||+|||++.++.+|
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B           89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            99999987654 8899999999999998754                      699999999999999999999999999


Q ss_pred             EeeccCcccccccccc----cCCCCCCCCcceeeccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         138 ISDFGLSEDIYEQNVF----QNGEPSEKLPIRWLALESLVS--NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      |+|||.+.........    ........||..|+|||++.+  ..++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  247 (389)
T 3gni_B          169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLL  247 (389)
T ss_dssp             ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTCCSTTHHH
T ss_pred             EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence            9999987644332211    112223467888999999987  568999999999999999999 999999877666654


Q ss_pred             HHHc
Q psy3166         212 YLST  215 (228)
Q Consensus       212 ~~~~  215 (228)
                      .+..
T Consensus       248 ~~~~  251 (389)
T 3gni_B          248 EKLN  251 (389)
T ss_dssp             HC--
T ss_pred             HHhc
Confidence            4433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.3e-38  Score=252.70  Aligned_cols=207  Identities=24%  Similarity=0.465  Sum_probs=173.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      -+.++|++.+.||+|+||.||+|+.         ..++..||+|.+...........+.+|+.+++++ +||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   88 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGID---------NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGS   88 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEE---------CCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEE
Confidence            3456799999999999999999984         3345579999987654444457788999999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      +..+ ..+++||++++++|.+++..                   .|||++||+|+||||+||+++.++.++|+|||++..
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  168 (303)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeeccccee
Confidence            8764 47899999999999998753                   699999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      +.....   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+.++..+..+|
T Consensus       169 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (303)
T 3a7i_A          169 LTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELHPMKVLFLIPKNNPPTLEGNYS  244 (303)
T ss_dssp             CBTTBC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCCSSCC
T ss_pred             cCcccc---ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc-CCCCCCCcCHHHHHHHhhcCCCCCCccccC
Confidence            543321   1234567888999999998889999999999999999999 999999988888887887777777776665


Q ss_pred             C
Q psy3166         227 E  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       245 ~  245 (303)
T 3a7i_A          245 K  245 (303)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.6e-38  Score=269.66  Aligned_cols=191  Identities=24%  Similarity=0.323  Sum_probs=154.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|.         +..+++.||+|++.... ......++.+|+.+|+.+ +||||+++++++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~---------~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  131 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFT  131 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEE---------ETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEC
T ss_pred             CCeEEEEEeecCCCeEEEEEE---------ECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEc
Confidence            689999999999999999998         44556689999987542 344566788999999999 9999999999985


Q ss_pred             cC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          89 KD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        89 ~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ..       .+++||||+.++ +.+.+..                  .|||++||+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~~~~~~~~~lv~E~~~~~-l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          132 PQKTLEEFQDVYLVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             SCCSTTTCCEEEEEEECCSEE-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             cCCccccCCeEEEEEeCCCCC-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            43       368999999764 5544321                  799999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ++......    ......||..|+|||++.+..++.++||||+||++|+|++ |..||.+.+..+.+..+.+.
T Consensus       211 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pF~g~~~~~~~~~i~~~  278 (464)
T 3ttj_A          211 ARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQ  278 (464)
T ss_dssp             C-----CC----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred             eeecCCCc----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Confidence            97553321    1234567888999999999899999999999999999999 99999998887777666553

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.5e-39  Score=260.88  Aligned_cols=187  Identities=28%  Similarity=0.418  Sum_probs=151.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||+||+|+..         .++..||+|.+.........+.+.+|+.+++.+ +||||+++++++.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~   75 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRR   75 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence            379999999999999999999843         445579999987554333345678999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .+. .++||||+++++|.+++..                    .|||++||+||||||+||+++.++.+||+|||++..+
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             CSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            755 7899999999999877543                    6999999999999999999999999999999999755


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      ..... ........||..|+|||++.+..+ +.++|+||+||++|+|++ |..||......
T Consensus       156 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  214 (323)
T 3tki_A          156 RYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDS  214 (323)
T ss_dssp             EETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSCTT
T ss_pred             ccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCchH
Confidence            33221 112234578889999999987765 678999999999999999 99999876553

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.3e-38  Score=256.78  Aligned_cols=213  Identities=37%  Similarity=0.589  Sum_probs=174.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||+|++...     +..++..||+|.+... .....+.+.+|+++++++ +||||++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   92 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHS-GPDQQRDFQREIQILKAL-HSDFIVKYRGV   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhc-CCCceeEEEEE
Confidence            6778999999999999999999985432     3456678999998755 344556788999999999 99999999998


Q ss_pred             EEc---CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          87 CYK---DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        87 ~~~---~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      +..   ...++||||+++++|.+++..                     .|||+++|+|+||||+||+++.++.+||+|||
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             EECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             EecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence            763   337899999999999998764                     59999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------------H
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL---------------C  207 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~---------------~  207 (228)
                      ++.................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....               .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHh-CCCCCccccchhhhhcccccccccHH
Confidence            99765443322223344567788999999988888999999999999999999 9999865433               3


Q ss_pred             HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ++...+..+.+++.|..+|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~  271 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPA  271 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCH
T ss_pred             HHHHHhhcccCCCCCCcccH
Confidence            44566777778888877774

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=259.94  Aligned_cols=192  Identities=19%  Similarity=0.327  Sum_probs=161.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|...         .++..||+|.+.... ......+.+|+.+|+++ +||||+++++++.
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~  118 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPY-PLDKYTVKNEISIMNQL-HHPKLINLHDAFE  118 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEEC---------CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEE
Confidence            468999999999999999999843         445579999987542 33445788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC--CCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS--PHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~--~~~~kl~dfg~~  144 (228)
                      ... .++||||+.+++|.+++..                     .|||++||+||||||+||+++.  .+.+||+|||++
T Consensus       119 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             CSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccc
Confidence            654 8899999999999988643                     6999999999999999999974  468999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ..+......    ....+|..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+..+
T Consensus       199 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~  265 (387)
T 1kob_A          199 TKLNPDEIV----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRC  265 (387)
T ss_dssp             EECCTTSCE----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHC
T ss_pred             eecCCCcce----eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Confidence            765433211    12357888999999998889999999999999999999 99999998888888777765

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.5e-38  Score=254.32  Aligned_cols=191  Identities=28%  Similarity=0.461  Sum_probs=153.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||+||+|+..+          +..||+|.++.... ......+.+|+++++++ +||||+++++++
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   88 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ----------GRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVI   88 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT----------SCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC----------CCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEE
Confidence            4799999999999999999998532          34699999875432 22346778999999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .... .++||||+++ +|.+++..                     .|||++||+||||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence            7644 8899999975 77776543                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ......   .......+|..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+....+..
T Consensus       168 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  234 (311)
T 3niz_A          168 AFGIPV---RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDDDQLPKIFS  234 (311)
T ss_dssp             ETTSCC---C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSTTTHHHHHHH
T ss_pred             ecCCCc---ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence            553221   11223466788999999876 458999999999999999999 9999999877777666554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4e-38  Score=251.28  Aligned_cols=203  Identities=42%  Similarity=0.772  Sum_probs=167.8

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.+..++|++.+.||+|+||.||++...           +..||+|.++...   ..+.+.+|+.+++++ +||||+++
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~~iv~~   79 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQL   79 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC-----HHHHHTHHHHTTC-CCTTBCCE
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh---HHHHHHHHHHHHHhC-CCCCEeeE
Confidence            56788999999999999999999998753           3469999987553   345788999999999 99999999


Q ss_pred             eeEEEc--CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          84 IGCCYK--DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++++..  +..+++||++++++|.+++..                      .|||+++++|+||||+||+++.++.++|+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~  159 (278)
T 1byg_A           80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS  159 (278)
T ss_dssp             EEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEe
Confidence            998654  348999999999999988754                      58999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      |||++.......      ....++..|+|||.+.+..++.++|+||||+++|+|++.|..||...+..++...+..+.++
T Consensus       160 Dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~  233 (278)
T 1byg_A          160 DFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  233 (278)
T ss_dssp             CCCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred             eccccccccccc------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            999986443221      12345667999999988889999999999999999997699999999888888899998888


Q ss_pred             CCCCCCCC
Q psy3166         220 ERPASCNE  227 (228)
Q Consensus       220 ~~p~~~~~  227 (228)
                      +.|..+|+
T Consensus       234 ~~~~~~~~  241 (278)
T 1byg_A          234 DAPDGCPP  241 (278)
T ss_dssp             CCCTTCCH
T ss_pred             CCcccCCH
Confidence            88888775

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.1e-38  Score=259.04  Aligned_cols=192  Identities=26%  Similarity=0.432  Sum_probs=156.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ++|++.+.||+|+||+||+|+.         ..+++.||+|.++...    .....+.+.+|+.+++++ +||||+++++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~   93 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCIN---------RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLE   93 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEE
Confidence            5799999999999999999984         3455679999985321    111246788999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCC---cEE
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPH---VVK  137 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~---~~k  137 (228)
                      ++..+. +++||||+++++|.+++..                        .|||+++|+||||||+||+++.++   .+|
T Consensus        94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred             EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEE
Confidence            987654 7899999999999876642                        699999999999999999998655   499


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |+|||++.........   .....||..|+|||++.+..++.++|+||+||++|+|++ |..||.+. ..++...+.++
T Consensus       174 l~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~-~~~~~~~i~~~  247 (351)
T 3c0i_A          174 LGGFGVAIQLGESGLV---AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS-GCLPFYGT-KERLFEGIIKG  247 (351)
T ss_dssp             ECCCTTCEECCTTSCB---CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCSS-HHHHHHHHHHT
T ss_pred             EecCcceeEecCCCee---ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH-CCCCCCCc-HHHHHHHHHcC
Confidence            9999999765443211   234568899999999998889999999999999999999 99999885 34556666555

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.4e-38  Score=252.92  Aligned_cols=216  Identities=35%  Similarity=0.660  Sum_probs=166.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ..+..++|++.+.||+|+||.||+|.+....      .....||+|.++...  .....+.+.+|+.+++++ +||||++
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~   85 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIR   85 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCccc
Confidence            3467789999999999999999999864322      233458999987542  234456788999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++.....++++|++++++|.+++..                     .|||+++++|+||||+||+++.++.+||+||
T Consensus        86 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           86 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             EEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             EEEEEccCCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccc
Confidence            9999988889999999999999998754                     5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYRME  220 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~-~~~~~  220 (228)
                      |++.................++..|+|||.+.+..++.++|+||||+++|+|++.|..||.+.+..++...+.. +.+++
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  245 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC
Confidence            99876543322211222345667899999998888899999999999999999769999999988888777655 44556


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .|..+|+
T Consensus       246 ~~~~~~~  252 (291)
T 1u46_A          246 RPEDCPQ  252 (291)
T ss_dssp             CCTTCCH
T ss_pred             CCcCcCH
Confidence            6666664

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-38  Score=258.54  Aligned_cols=212  Identities=38%  Similarity=0.728  Sum_probs=169.8

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.+..++|++.+.||+|+||.||+|+...+.       ....+|+|.++..........+.+|+.+++++.+||||++++
T Consensus        20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   92 (327)
T 1fvr_A           20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL   92 (327)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred             ccccHHHccceeeeecCCCceEEEEEEccCC-------cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhc
Confidence            3477789999999999999999999854322       111359998875544444567889999999998899999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++.... .+++||++++++|.+++..                                    .|||+++|+|+||||+|
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N  172 (327)
T 1fvr_A           93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  172 (327)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence            9987654 7899999999999998742                                    58999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      |+++.++.+||+|||++......    .......++..|+|||.+....++.++|+||||+++|+|++.|..||.+.+..
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~  248 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  248 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             EEEcCCCeEEEcccCcCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence            99999999999999998633221    11122345667999999988888999999999999999997699999999988


Q ss_pred             HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ++...+..+.+++.|..+|+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~  268 (327)
T 1fvr_A          249 ELYEKLPQGYRLEKPLNCDD  268 (327)
T ss_dssp             HHHHHGGGTCCCCCCTTBCH
T ss_pred             HHHHHhhcCCCCCCCCCCCH
Confidence            88888888888888877764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-37  Score=249.50  Aligned_cols=202  Identities=32%  Similarity=0.558  Sum_probs=157.0

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ++.++.++|++.+.||+|+||.||+|...+            .+|+|.++... .....+.+.+|+.+++++ +||||++
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~   84 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILL   84 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCC
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEE
Confidence            467999999999999999999999997422            38999987553 445567788999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++......+++||++.+++|.+++..                     .|||+++|+|+||||+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           85 FMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             EEEEECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             EEeeccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccc
Confidence            9998777779999999999999988742                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYLSTGY  217 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~~~~~  217 (228)
                      |++......... .......|+..|+|||.+.   ...++.++|+||||+++|+|++ |..||.+....+. ...+..+.
T Consensus       165 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  242 (289)
T 3og7_A          165 GLATEKSRWSGS-HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIEMVGRGS  242 (289)
T ss_dssp             C-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH-SSCTTSSCCCHHHHHHHHHHTS
T ss_pred             eecccccccccc-ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH-CCCCccccchHHHHHHHhcccc
Confidence            998654322111 1122346788899999986   5568889999999999999999 9999988655544 55555554


Q ss_pred             CCC
Q psy3166         218 RME  220 (228)
Q Consensus       218 ~~~  220 (228)
                      ..+
T Consensus       243 ~~~  245 (289)
T 3og7_A          243 LSP  245 (289)
T ss_dssp             CCC
T ss_pred             cCc
Confidence            443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.2e-38  Score=249.33  Aligned_cols=204  Identities=25%  Similarity=0.420  Sum_probs=165.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      ....++|++.+.||+|+||.||+|...         .++..||+|.+.....  ......+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~   74 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRL   74 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEc---------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcch
Confidence            345679999999999999999999843         3445799999864321  11235678899999999 89999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++.... .+++|||+++++|.+++..                    .|||++||+|+||||+||+++.++.++|+|||
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCC
T ss_pred             hheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecc
Confidence            99987755 7899999999999988764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++......     ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+... ..+.|
T Consensus       155 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~  227 (279)
T 3fdn_A          155 WSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRV-EFTFP  227 (279)
T ss_dssp             EESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHT-CCCCC
T ss_pred             ccccCCcc-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH-CCCCCCCCcHHHHHHHHHhC-CCCCC
Confidence            87543222     1223466788999999998888999999999999999999 99999998888887777765 55556


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      ..++
T Consensus       228 ~~~~  231 (279)
T 3fdn_A          228 DFVT  231 (279)
T ss_dssp             TTSC
T ss_pred             CcCC
Confidence            5554

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=256.74  Aligned_cols=198  Identities=24%  Similarity=0.398  Sum_probs=160.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||+||+|...         .++..||+|.++..........+.+|+++++++ +||||+++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   74 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFA   74 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEE
Confidence            345689999999999999999999853         345579999987553333456678999999999 8999999999


Q ss_pred             EEEcC---ceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEee----cCCCc
Q psy3166          86 CCYKD---ELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILL----SSPHV  135 (228)
Q Consensus        86 ~~~~~---~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~----~~~~~  135 (228)
                      ++...   ..++||||+++++|.+++..                       .|||+++|+||||||+||++    +.++.
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  154 (319)
T 4euu_A           75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV  154 (319)
T ss_dssp             EEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEE
T ss_pred             EeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCce
Confidence            88653   47899999999999998763                       59999999999999999998    67778


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV--------SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-  206 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--------~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-  206 (228)
                      +||+|||++..+.....    .....+|..|+|||++.        +..++.++|+|||||++|+|++ |..||..... 
T Consensus       155 ~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  229 (319)
T 4euu_A          155 YKLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGP  229 (319)
T ss_dssp             EEECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH-SSCSEECTTCG
T ss_pred             EEEccCCCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcc
Confidence            99999999976544321    22356788999999886        4568899999999999999999 9999975433 


Q ss_pred             ---HHHHHHHHcCCC
Q psy3166         207 ---CRIVHYLSTGYR  218 (228)
Q Consensus       207 ---~~~~~~~~~~~~  218 (228)
                         .++...+..+.+
T Consensus       230 ~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          230 RRNKEVMYKIITGKP  244 (319)
T ss_dssp             GGCHHHHHHHHHHCC
T ss_pred             chhHHHHHHHhcCCC
Confidence               455556655543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.6e-37  Score=247.02  Aligned_cols=205  Identities=24%  Similarity=0.395  Sum_probs=170.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ...++|++.+.||+|+||.||++...         .++..||+|.+...  ......+.+.+|+.+++++ +||||++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~   81 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH   81 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEEC---------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeee
Confidence            45679999999999999999999843         34457999998654  2345567788999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++..+. .+++||++.+++|.+++..                    .|||+++++|+||||+||+++.++.+||+|||+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccC
Confidence            9987755 7899999999999988754                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      +........   ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+....+..+ ....|.
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~  236 (294)
T 2rku_A          162 ATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKN-EYSIPK  236 (294)
T ss_dssp             CEECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT-CCCCCT
T ss_pred             ceecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc-cCCCcc
Confidence            875432211   1223567788999999988888999999999999999999 99999998888777777665 455566


Q ss_pred             CCC
Q psy3166         224 SCN  226 (228)
Q Consensus       224 ~~~  226 (228)
                      .++
T Consensus       237 ~~~  239 (294)
T 2rku_A          237 HIN  239 (294)
T ss_dssp             TSC
T ss_pred             ccC
Confidence            554

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-37  Score=248.99  Aligned_cols=191  Identities=26%  Similarity=0.454  Sum_probs=153.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|..         ..++..||+|.++... .......+.+|+.+++++ +||||+++++++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   71 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKN---------RETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLH   71 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEE---------CCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEE
Confidence            6899999999999999999984         3445679999987543 333446788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+. .++|||++.+ ++.+++..                     .|||++||+||||||+||+++.++.+||+|||++..
T Consensus        72 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           72 SDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            654 7899999976 55544332                     699999999999999999999999999999999975


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHc
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANP-YPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~p-f~~~~~~~~~~~~~~  215 (228)
                      .....   .......+|..|+|||++.+.. ++.++|+||+||++|+|++ |..| |.+.+..+....+..
T Consensus       151 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-~~~p~~~~~~~~~~~~~i~~  217 (292)
T 3o0g_A          151 FGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_dssp             CCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT-TSCCSCCCSSHHHHHHHHHH
T ss_pred             cCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH-cCCCCcCCCCHHHHHHHHHH
Confidence            53221   1223456788899999998665 7999999999999999998 6555 677777776666544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-37  Score=257.81  Aligned_cols=186  Identities=28%  Similarity=0.401  Sum_probs=144.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.....++|++.+.||+|+||+||+++.         ..++..||+|.+......  ...+.+|+.+++++ +||||+++
T Consensus        14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~~   81 (361)
T 3uc3_A           14 PIMHDSDRYDFVKDIGSGNFGVARLMRD---------KLTKELVAVKYIERGAAI--DENVQREIINHRSL-RHPNIVRF   81 (361)
T ss_dssp             CCCCCTTTEEEEEEESSSTTSSEEEEEE---------TTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             cCCCCCCcEEEEEEeccCCCEEEEEEEE---------CCCCcEEEEEEEecCccc--cHHHHHHHHHHHhC-CCCCCCcE
Confidence            3445678999999999999999999984         445567999998754322  24577899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCc--EEEee
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHV--VKISD  140 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~--~kl~d  140 (228)
                      ++++.... .++||||+.+++|.+++..                    .|||++||+||||||+||+++.++.  +||+|
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~D  161 (361)
T 3uc3_A           82 KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD  161 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred             EEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEee
Confidence            99987654 8899999999999998754                    6999999999999999999987664  99999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNK-SDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ||+++......    ......||..|+|||++.+..++.+ +|+||+||++|+|++ |..||.+...
T Consensus       162 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~  223 (361)
T 3uc3_A          162 FGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE  223 (361)
T ss_dssp             CCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH-SSCSCC----
T ss_pred             cCccccccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh-CCCCCCCCcc
Confidence            99986432221    1233567889999999988777655 899999999999999 9999987544

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.6e-37  Score=252.35  Aligned_cols=205  Identities=24%  Similarity=0.400  Sum_probs=169.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ...++|++.+.||+|+||.||++...         .++..||+|.+....  .....+.+.+|+.+++++ +||||++++
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~  107 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH  107 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            34578999999999999999999843         345579999986542  345567788999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++.... .+++|||+.+++|.+++..                    .|||+++|+|+||||+||+++.++.+||+|||+
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence            9987755 7899999999999988754                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      +.......   .......++..|+|||++.+..++.++|+||||+++|+|++ |..||......+....+..+ ....|.
T Consensus       188 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~  262 (335)
T 2owb_A          188 ATKVEYDG---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKN-EYSIPK  262 (335)
T ss_dssp             CEECCSTT---CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHT-CCCCCT
T ss_pred             ceecccCc---ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHhcC-CCCCCc
Confidence            87553221   11233567888999999988889999999999999999999 99999998887777776665 445565


Q ss_pred             CCC
Q psy3166         224 SCN  226 (228)
Q Consensus       224 ~~~  226 (228)
                      .++
T Consensus       263 ~~~  265 (335)
T 2owb_A          263 HIN  265 (335)
T ss_dssp             TSC
T ss_pred             cCC
Confidence            554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.6e-37  Score=251.87  Aligned_cols=196  Identities=26%  Similarity=0.419  Sum_probs=163.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ..|...+.||+|+||.||+|+..         .++..||+|.+..... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  113 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDY-QHFNVVEMYKSYLV  113 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTC-CCTTBCCEEEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccch-hHHHHHHHHHHHHHhC-CCCCcceEEEEEEE
Confidence            45788899999999999999843         3455799999875432 2345678999999999 99999999998876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE  149 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~  149 (228)
                      . ..+++|||+++++|.+++..                   .|||+++|+||||||+||+++.++.+||+|||++..+..
T Consensus       114 ~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          114 GEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             TTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence            4 58899999999999998753                   699999999999999999999999999999999875543


Q ss_pred             cccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ...   ......||..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+.....+.
T Consensus       194 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  260 (321)
T 2c30_A          194 DVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPK  260 (321)
T ss_dssp             SSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCC
T ss_pred             Ccc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC
Confidence            211   1234578889999999998889999999999999999999 999999988887777777664443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=252.10  Aligned_cols=196  Identities=24%  Similarity=0.395  Sum_probs=154.8

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-------------------------HHH
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-------------------------KTY   61 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~   61 (228)
                      +..++|++.+.||+|+||.||+|+.         ..++..||+|.+......                         ...
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYN---------ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI   80 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEE---------TTTTEEEEEEEEECC-------------------------------
T ss_pred             eeecceEEEeEEeecCCEEEEEEEE---------CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchH
Confidence            4457999999999999999999984         445567999998654211                         113


Q ss_pred             HHHHHHHHHHHhcCCCCceEEeeeEEEc---CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCc
Q psy3166          62 DKFLKEINLMKDVGKHDHIVSFIGCCYK---DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVV  119 (228)
Q Consensus        62 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~  119 (228)
                      +.+.+|+++++++ +||||+++++++..   +..+++|||+++++|.+++..                   .|||+++|+
T Consensus        81 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  159 (298)
T 2zv2_A           81 EQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKII  159 (298)
T ss_dssp             CHHHHHHHHHHTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4678999999999 99999999999875   347899999998887654211                   799999999


Q ss_pred             ccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCC---CCchhhHHHHHHHHHHHHhC
Q psy3166         120 HRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI---YTNKSDVWSFGVVLWEIVTL  196 (228)
Q Consensus       120 H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~---~~~~~Diwslg~~~~~l~t~  196 (228)
                      ||||||+||+++.++.+||+|||++..+......   .....||..|+|||.+.+..   ++.++|+|||||++|+|++ 
T Consensus       160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~-  235 (298)
T 2zv2_A          160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF-  235 (298)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE---ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH-
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCcccccccccc---ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH-
Confidence            9999999999999999999999998765433211   12356788999999987654   3678999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHcC
Q psy3166         197 GANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       197 g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |..||.+....++...+...
T Consensus       236 g~~pf~~~~~~~~~~~~~~~  255 (298)
T 2zv2_A          236 GQCPFMDERIMCLHSKIKSQ  255 (298)
T ss_dssp             SSCSSCCSSHHHHHHHHHHC
T ss_pred             CCCCCCCccHHHHHHHHhcc
Confidence            99999998877776666554

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-37  Score=254.86  Aligned_cols=200  Identities=26%  Similarity=0.419  Sum_probs=151.3

Q ss_pred             CCccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHH----HHHHHHHHHHHHHhcCC
Q psy3166           1 MALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK----TYDKFLKEINLMKDVGK   76 (228)
Q Consensus         1 ~~~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~~   76 (228)
                      ||+..+...++|++.+.||+|+||.||+|.         +..++..||+|.++......    ....+.+|+.+++++ +
T Consensus         1 m~l~~~~~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~   70 (346)
T 1ua2_A            1 MALDVKSRAKRYEKLDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-S   70 (346)
T ss_dssp             ------------CEEEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHC-C
T ss_pred             CchhhHHHhcccEEEeEEeecCCEEEEEEE---------ECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-C
Confidence            677788888999999999999999999998         44455679999987542211    123577899999999 9


Q ss_pred             CCceEEeeeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCC
Q psy3166          77 HDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPH  134 (228)
Q Consensus        77 h~ni~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~  134 (228)
                      ||||+++++++... ..++|||++.+ +|.+++..                     .|||+++|+||||||+||+++.++
T Consensus        71 h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~  149 (346)
T 1ua2_A           71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG  149 (346)
T ss_dssp             CTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred             CCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC
Confidence            99999999998664 58899999976 78777653                     699999999999999999999999


Q ss_pred             cEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         135 VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      .+||+|||++..+....   .......+|..|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..+.+.++
T Consensus       150 ~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~~~~~~~~~~~~~~i  225 (346)
T 1ua2_A          150 VLKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRI  225 (346)
T ss_dssp             CEEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             CEEEEecccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence            99999999987553321   112335678889999998754 58899999999999999999 99999998887776665


Q ss_pred             Hc
Q psy3166         214 ST  215 (228)
Q Consensus       214 ~~  215 (228)
                      .+
T Consensus       226 ~~  227 (346)
T 1ua2_A          226 FE  227 (346)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=257.61  Aligned_cols=196  Identities=27%  Similarity=0.467  Sum_probs=152.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++..........+.+|+.+++++ +||||+++++++..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~   71 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT   71 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee
Confidence            68999999999999999999843         345579999987543222222445799999999 99999999999876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      . ..++||||+. ++|.+++..                     .|||++||+||||||+||+++.++.+||+|||++...
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           72 EKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             CCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            5 4889999997 488887653                     6999999999999999999999999999999998644


Q ss_pred             cccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ....   .......++..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+....+.+....+
T Consensus       151 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~  220 (324)
T 3mtl_A          151 SIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLHFIFRILGTP  220 (324)
T ss_dssp             ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Confidence            3221   11223466888999999876 568999999999999999999 999999998888877766543333

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=250.61  Aligned_cols=199  Identities=32%  Similarity=0.556  Sum_probs=160.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .++.++|++.+.||+|+||.||+|.+.           +..||+|.+...   ...+.+.+|+.+++++ +||||+++++
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~   68 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE---SERKAFIVELRQLSRV-NHPNIVKLYG   68 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST---THHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh---hHHHHHHHHHHHHhcC-CCCCcCeEEE
Confidence            578899999999999999999999753           245999998643   2346788999999999 9999999999


Q ss_pred             EEEcCceEEEEecCCCCcHHHHHHH-----------------------hcccC---CCCcccCCCCCCEeecCCCc-EEE
Q psy3166          86 CCYKDELRLVVEYCALGDLQSYLRE-----------------------EYLSN---NKVVHRDLATRNILLSSPHV-VKI  138 (228)
Q Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~---~~i~H~~lk~~nil~~~~~~-~kl  138 (228)
                      ++. +..++||||+++++|.+++..                       .|||+   ++|+||||||+||+++.++. +||
T Consensus        69 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl  147 (307)
T 2eva_A           69 ACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI  147 (307)
T ss_dssp             BCT-TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred             EEc-CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence            765 558899999999999998763                       58999   89999999999999998876 899


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL--CRIVHYLSTG  216 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~--~~~~~~~~~~  216 (228)
                      +|||++......      .....|+..|+|||++.+..++.++|+||||+++|+|++ |..||.....  ..+...+..+
T Consensus       148 ~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  220 (307)
T 2eva_A          148 CDFGTACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNG  220 (307)
T ss_dssp             CCCCC------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH-TCCTTTTTCSSHHHHHHHHHTT
T ss_pred             cccccccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH-CCCCchhhCccHHHHHHHHhcC
Confidence            999998644322      122457788999999998889999999999999999999 9999986533  3455667777


Q ss_pred             CCCCCCCCCCC
Q psy3166         217 YRMERPASCNE  227 (228)
Q Consensus       217 ~~~~~p~~~~~  227 (228)
                      .+++.+..+|+
T Consensus       221 ~~~~~~~~~~~  231 (307)
T 2eva_A          221 TRPPLIKNLPK  231 (307)
T ss_dssp             CCCCCBTTCCH
T ss_pred             CCCCcccccCH
Confidence            78888777764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-37  Score=246.58  Aligned_cols=204  Identities=22%  Similarity=0.371  Sum_probs=168.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||.||+|..         ..++..||+|.+.....  ......+.+|+.+++++ +||||+++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~   79 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLARE---------KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRM   79 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEE---------cCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeE
Confidence            46678999999999999999999984         33456799999864311  11235678899999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++.... .+++||++++++|.+++..                    .|||+++|+|+||||+||+++.++.++|+|||
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           80 YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccc
Confidence            99987654 7899999999999988764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      ++......     ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+... ..+.|
T Consensus       160 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~-~~~~~  232 (284)
T 2vgo_A          160 WSVHAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV-GMPPFDSPSHTETHRRIVNV-DLKFP  232 (284)
T ss_dssp             TCEECSSS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT-CCCCC
T ss_pred             ccccCccc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH-CCCCCCCCCHhHHHHHHhcc-ccCCC
Confidence            88644321     1223567888999999998889999999999999999999 99999998888777777665 45566


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      ..++
T Consensus       233 ~~~~  236 (284)
T 2vgo_A          233 PFLS  236 (284)
T ss_dssp             TTSC
T ss_pred             CcCC
Confidence            5554

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-36  Score=242.79  Aligned_cols=193  Identities=25%  Similarity=0.455  Sum_probs=162.8

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|...         .++..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   74 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI   74 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEc---------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEE
Confidence            478999999999999999999843         445579999986543 445557788999999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCc---EEEeeccC
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHV---VKISDFGL  143 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~---~kl~dfg~  143 (228)
                      ..+. .+++||++++++|.+++..                    .|||+++|+|+||||+||+++.++.   +||+|||.
T Consensus        75 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           75 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7655 7899999999999887654                    6999999999999999999986554   99999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +........    .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+..+
T Consensus       155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  222 (284)
T 3kk8_A          155 AIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAG  222 (284)
T ss_dssp             CEECCSSCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred             eEEcccCcc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH-CCCCCCCCchhHHHHHHHhc
Confidence            865433221    123567889999999998889999999999999999999 99999998888887777665

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-37  Score=253.99  Aligned_cols=181  Identities=22%  Similarity=0.430  Sum_probs=148.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++........+.+.+|+.+|+++ +||||+++++++..
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~   75 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLE   75 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEET---------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEE
T ss_pred             hcCceeeEecCCCCeEEEEEEEc---------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE
Confidence            57999999999999999999843         345579999997655455567889999999999 99999999998743


Q ss_pred             Cc----------------------------------------------------------eEEEEecCCCCcHHHHHHH-
Q psy3166          90 DE----------------------------------------------------------LRLVVEYCALGDLQSYLRE-  110 (228)
Q Consensus        90 ~~----------------------------------------------------------~~lv~e~~~~~~L~~~l~~-  110 (228)
                      ..                                                          .+++|||+++++|.+++.. 
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  155 (332)
T 3qd2_B           76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR  155 (332)
T ss_dssp             CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred             eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence            21                                                          6899999999999998753 


Q ss_pred             ----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc---------cCCCCC
Q psy3166         111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF---------QNGEPS  159 (228)
Q Consensus       111 ----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~  159 (228)
                                            .|||+++|+||||||+||+++.++.+||+|||++..+......         ......
T Consensus       156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             CSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             cCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence                                  6999999999999999999999999999999998765443211         011234


Q ss_pred             CCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy3166         160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPY  201 (228)
Q Consensus       160 ~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf  201 (228)
                      ..||..|+|||.+.+..++.++|+||+||++|+|++ |..|+
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~~~~~  276 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-SFSTQ  276 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS-CCCCH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHH-cCCCh
Confidence            568889999999998889999999999999999998 76654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.4e-38  Score=249.66  Aligned_cols=206  Identities=24%  Similarity=0.397  Sum_probs=169.6

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ..++|++.+.||+|+||.||++...         .+++.||+|.+.... .....+.+.+|+.+++++ +||||++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   73 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDR   73 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEE
Confidence            3579999999999999999999843         345579999987543 445567788999999999 99999999998


Q ss_pred             EEc---CceEEEEecCCCCcHHHHHHH------------------------hcccCCC-----CcccCCCCCCEeecCCC
Q psy3166          87 CYK---DELRLVVEYCALGDLQSYLRE------------------------EYLSNNK-----VVHRDLATRNILLSSPH  134 (228)
Q Consensus        87 ~~~---~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~-----i~H~~lk~~nil~~~~~  134 (228)
                      +..   ...+++|||+++++|.+++..                        .|||+++     |+|+||||+||+++.++
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             EEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS
T ss_pred             EecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC
Confidence            753   348899999999999998753                        5899999     99999999999999999


Q ss_pred             cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         135 VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      .+||+|||++..........   ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++...+.
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~  229 (279)
T 2w5a_A          154 NVKLGDFGLARILNHDTSFA---KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIR  229 (279)
T ss_dssp             CEEECCCCHHHHC---CHHH---HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred             CEEEecCchheeeccccccc---cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCcccCHHHHHHHHh
Confidence            99999999886543321110   11245667999999988889999999999999999999 999999998888888899


Q ss_pred             cCCCCCCCCCCCC
Q psy3166         215 TGYRMERPASCNE  227 (228)
Q Consensus       215 ~~~~~~~p~~~~~  227 (228)
                      .+..++.|..+|+
T Consensus       230 ~~~~~~~~~~~~~  242 (279)
T 2w5a_A          230 EGKFRRIPYRYSD  242 (279)
T ss_dssp             HTCCCCCCTTSCH
T ss_pred             hcccccCCcccCH
Confidence            9888788877764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.1e-37  Score=247.10  Aligned_cols=204  Identities=31%  Similarity=0.551  Sum_probs=162.3

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH---HHH---HHHHHHHHHHHhcCCCCc
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA---KTY---DKFLKEINLMKDVGKHDH   79 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~---~~~~~e~~~l~~l~~h~n   79 (228)
                      .+..++|++.+.||+|+||.||+|++.         .++..||+|.+......   ...   +.+.+|+.+++++ +|||
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~   84 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLV---------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPN   84 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEET---------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTT
T ss_pred             hhhhccceehhccccCCceeEEEEEEc---------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCC
Confidence            467899999999999999999999853         34557999998644221   111   5688999999999 9999


Q ss_pred             eEEeeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCC--CcccCCCCCCEeecCCCc-
Q psy3166          80 IVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNK--VVHRDLATRNILLSSPHV-  135 (228)
Q Consensus        80 i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~--i~H~~lk~~nil~~~~~~-  135 (228)
                      |+++++++.... +++|||+++++|.+++..                     .|||+++  |+|+||||+||+++.++. 
T Consensus        85 i~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           85 IVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             BCCEEEEETTTT-EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTT
T ss_pred             chhhheeecCCC-eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCC
Confidence            999999875544 799999999999888743                     6999999  999999999999987765 


Q ss_pred             ----EEEeeccCcccccccccccCCCCCCCCcceeecccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         136 ----VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV--SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       136 ----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                          +||+|||++......      .....++..|+|||++.  ...++.++|+||+||++|+|++ |..||...+..+.
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  236 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGKI  236 (287)
T ss_dssp             CSCCEEECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH-SSCTTTTCCCCHH
T ss_pred             CceeEEeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc-CCCCCccccccHH
Confidence                999999998743221      22356778899999984  4457889999999999999999 9999988655433


Q ss_pred             --HHH-HHcCCCCCCCCCCCC
Q psy3166         210 --VHY-LSTGYRMERPASCNE  227 (228)
Q Consensus       210 --~~~-~~~~~~~~~p~~~~~  227 (228)
                        ... ...+.++..|..+|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~  257 (287)
T 4f0f_A          237 KFINMIREEGLRPTIPEDCPP  257 (287)
T ss_dssp             HHHHHHHHSCCCCCCCTTSCH
T ss_pred             HHHHHHhccCCCCCCCcccCH
Confidence              333 445666777887764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.6e-37  Score=254.37  Aligned_cols=194  Identities=22%  Similarity=0.359  Sum_probs=161.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|+.         ..++..||+|.+...........+.+|+.+++++ +||||+++++++..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~   96 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYD---------NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRA   96 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECC
T ss_pred             ccEEEEEEeecCCCeEEEEEEE---------CCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEec
Confidence            6899999999999999999984         4455679999997665566667889999999999 99999999998854


Q ss_pred             C------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          90 D------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        90 ~------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .      ..+++||++. ++|.+++..                   .|||++||+||||||+||+++.++.+||+|||++
T Consensus        97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A           97 PTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             SSTTTCCCEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CCccccceEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence            2      3789999996 488887754                   6999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .................||..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+.+..+..
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  246 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHILG  246 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH-SSCSSCCSSGGGHHHHHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH-CCCCCCCCChHHHHHHHHH
Confidence            765443322222344578889999998764 458999999999999999999 9999999887777666543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-37  Score=249.36  Aligned_cols=190  Identities=26%  Similarity=0.431  Sum_probs=152.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|+..          ++..||+|.+...... .....+.+|+++++++ +||||+++++++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   70 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIH   70 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEc
Confidence            68999999999999999999852          3346999998654322 2235677999999999 9999999999987


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .. ..+++||++.+ +|.+++..                     .|||++||+||||||+||+++.++.+||+|||++..
T Consensus        71 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           71 TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             CSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             cCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            64 48899999975 88877653                     699999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .....   .......+|..|+|||++.+. .++.++|+||+||++|+|++ |..||.+.+..+...++.+
T Consensus       150 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  215 (288)
T 1ob3_A          150 FGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFR  215 (288)
T ss_dssp             HCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             cCccc---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            43221   112234567889999998754 58999999999999999999 9999999887776665543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.5e-37  Score=265.26  Aligned_cols=193  Identities=28%  Similarity=0.426  Sum_probs=159.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH------------HHHHHHHHHHHHHHhcCC
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA------------KTYDKFLKEINLMKDVGK   76 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~~   76 (228)
                      .++|++.+.||+|+||+||+|..         ..++..||+|.++.....            .....+.+|+.+|+++ +
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  104 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKE---------KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-D  104 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEE---------TTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-C
T ss_pred             ccceEEEeEecccCCeEEEEEEE---------CCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-C
Confidence            46899999999999999999984         344557999998754211            2345788999999999 9


Q ss_pred             CCceEEeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC-
Q psy3166          77 HDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH-  134 (228)
Q Consensus        77 h~ni~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~-  134 (228)
                      ||||+++++++.... +++||||+++|+|.+++..                    .|||+++|+||||||+||+++.++ 
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC
Confidence            999999999987755 7899999999999988754                    699999999999999999998765 


Q ss_pred             --cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         135 --VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       135 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                        .+||+|||++..+....    ......||+.|+|||++. ..++.++|+||+||++|+|++ |..||.+.+..++...
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  258 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKK  258 (504)
T ss_dssp             CSSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             CccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence              69999999997554332    123456888999999876 458999999999999999999 9999999999999888


Q ss_pred             HHcCC
Q psy3166         213 LSTGY  217 (228)
Q Consensus       213 ~~~~~  217 (228)
                      +.++.
T Consensus       259 i~~~~  263 (504)
T 3q5i_A          259 VEKGK  263 (504)
T ss_dssp             HHHCC
T ss_pred             HHcCC
Confidence            88874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-37  Score=254.23  Aligned_cols=186  Identities=19%  Similarity=0.299  Sum_probs=154.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +-.++|++.+.||+|+||.||+|.         +..++..||+|.+......   ..+.+|+.+++++.+||||++++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~   73 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGK---------NLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYF   73 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEE---------ETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEE---------ECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEE
Confidence            345789999999999999999998         3445668999998654322   3467899999999899999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCc-----EEEe
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHV-----VKIS  139 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~-----~kl~  139 (228)
                      +..+. .++|||++ +++|.+++..                     .|||+++|+||||||+||+++.++.     +||+
T Consensus        74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           74 GPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             EecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            87655 78999999 9999998763                     6999999999999999999998876     9999


Q ss_pred             eccCccccccccccc----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         140 DFGLSEDIYEQNVFQ----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       140 dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      |||++..+.......    .......||..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~Pf~~~~~  222 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR-GSLPWQGLKA  222 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCC
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc-CCCCcccccc
Confidence            999997654332111    11235678899999999999889999999999999999999 9999988543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-37  Score=253.69  Aligned_cols=197  Identities=23%  Similarity=0.414  Sum_probs=150.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      +.+...++|++.+.||+|+||.||+|+         +..++..||+|.++.... ......+.+|+.+++++ +||||++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~   97 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAI---------DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIE   97 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCC
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEE---------ECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcce
Confidence            445677899999999999999999997         444566899999975532 22345677899999999 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeec-----CCCcE
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLS-----SPHVV  136 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~-----~~~~~  136 (228)
                      +++++..+. .++||||+.+ +|.+++..                    .|||+++|+||||||+||+++     ..+.+
T Consensus        98 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~  176 (329)
T 3gbz_A           98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL  176 (329)
T ss_dssp             EEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred             EEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceE
Confidence            999987654 8899999975 99888764                    699999999999999999995     45569


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ||+|||++..+....   .......+|..|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       177 kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  252 (329)
T 3gbz_A          177 KIGDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFE  252 (329)
T ss_dssp             EECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred             EECcCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH-CCCCcCCCCHHHHHHHHHH
Confidence            999999987553221   112234567889999999864 48999999999999999999 9999999888777666544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-37  Score=255.97  Aligned_cols=190  Identities=26%  Similarity=0.445  Sum_probs=155.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|..         ..++..||+|.++....     ...+|++++.++.+||||+++++++..
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~   87 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIH---------KATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDD   87 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence            5799999999999999999984         44566899999975532     234688889888789999999999877


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC----CcEEEeeccCc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP----HVVKISDFGLS  144 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~----~~~kl~dfg~~  144 (228)
                      +. .++||||+.+|+|.+++..                    .|||++||+||||||+||++...    +.+||+|||++
T Consensus        88 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           88 GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            55 7899999999999998754                    69999999999999999998542    35999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHcCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH---IPLCRIVHYLSTGY  217 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~---~~~~~~~~~~~~~~  217 (228)
                      ........   ......+|..|+|||++.+..++.++|+|||||++|+|++ |..||.+   .+..++...+..+.
T Consensus       168 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~i~~~~  239 (342)
T 2qr7_A          168 KQLRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GYTPFANGPDDTPEEILARIGSGK  239 (342)
T ss_dssp             EECBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-SSCSSCSSTTSCHHHHHHHHHHCC
T ss_pred             ccCcCCCC---ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc-CCCCCCCCCcCCHHHHHHHHccCC
Confidence            76543321   1234567888999999988778899999999999999999 9999986   34556777777763

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=256.08  Aligned_cols=188  Identities=16%  Similarity=0.208  Sum_probs=149.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC--CCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG--KHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--~h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||+||+|.+....    +..++..||+|.++...    ...+..|+++++++.  .|+||+.+
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            356688999999999999999999654322    34566679999987542    235667777777772  28999999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH-------------------------hcccCCCCcccCCCCCCEeecC-----
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE-------------------------EYLSNNKVVHRDLATRNILLSS-----  132 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~-------------------------~~lh~~~i~H~~lk~~nil~~~-----  132 (228)
                      ++++.. +..++||||+++|+|.+++..                         .|||+++|+||||||+|||++.     
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence            998876 458999999999999999862                         5999999999999999999988     


Q ss_pred             ------CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         133 ------PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       133 ------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                            ++.+||+|||++..+...... .......||..|+|||++.+..++.++|+|||||++|+|++ |..||..
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  287 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF-GTYMKVK  287 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCCCEE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh-CCCcccc
Confidence                  899999999999754321111 11234568889999999998889999999999999999999 9988753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-37  Score=245.61  Aligned_cols=204  Identities=32%  Similarity=0.593  Sum_probs=159.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC---HHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD---AKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .++.++|++.+.||+|+||.||+|.+.           +..||+|.++....   ....+.+.+|+.+++.+ +||||++
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~   70 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIA   70 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEee
Confidence            567889999999999999999999853           34599999865422   22346788999999999 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH-------------------hcccCCC---CcccCCCCCCEeecC-------
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------EYLSNNK---VVHRDLATRNILLSS-------  132 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~---i~H~~lk~~nil~~~-------  132 (228)
                      +++++..+. .+++|||+++++|.+++..                   .|||+++   |+|+||||+||+++.       
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~  150 (271)
T 3dtc_A           71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL  150 (271)
T ss_dssp             EEEEECCC--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred             EEEEEecCCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccc
Confidence            999987654 8899999999999988743                   6999999   889999999999986       


Q ss_pred             -CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         133 -PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       133 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                       ++.++|+|||++.......     .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+...
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~  224 (271)
T 3dtc_A          151 SNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAVAY  224 (271)
T ss_dssp             SSCCEEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH-CCCTTTTSCHHHHHH
T ss_pred             cCcceEEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence             6789999999987543322     123467888999999998889999999999999999999 999999988877766


Q ss_pred             HHHc-CCCCCCCCCCCC
Q psy3166         212 YLST-GYRMERPASCNE  227 (228)
Q Consensus       212 ~~~~-~~~~~~p~~~~~  227 (228)
                      .+.. ..+.+.|..+|+
T Consensus       225 ~~~~~~~~~~~~~~~~~  241 (271)
T 3dtc_A          225 GVAMNKLALPIPSTCPE  241 (271)
T ss_dssp             HHHTSCCCCCCCTTCCH
T ss_pred             hhhcCCCCCCCCcccCH
Confidence            5444 445567777764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.6e-38  Score=251.83  Aligned_cols=207  Identities=29%  Similarity=0.436  Sum_probs=144.7

Q ss_pred             CccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           2 ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         2 ~~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .++|.+..++|++.+.||+|+||.||+|.         +..++..||+|.+...........+.+|+.+++++ +||||+
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~   76 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAY---------CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIV   76 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEE---------C----CEEEEECCC----------------CCCCC-CCTTBC
T ss_pred             ccccccchhhhhhhheeccccceEEEEEE---------ECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEe
Confidence            46788999999999999999999999997         33455679999987554344456778999999999 999999


Q ss_pred             EeeeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------------hcccCCCCcccCCCCCCEeecC
Q psy3166          82 SFIGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------------EYLSNNKVVHRDLATRNILLSS  132 (228)
Q Consensus        82 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------------~~lh~~~i~H~~lk~~nil~~~  132 (228)
                      ++++++... ..+++||++++++|.+++..                            .|||+++++|+||||+||+++.
T Consensus        77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~  156 (303)
T 2vwi_A           77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE  156 (303)
T ss_dssp             CEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT
T ss_pred             eEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC
Confidence            999998764 58899999999999998752                            5899999999999999999999


Q ss_pred             CCcEEEeeccCcccccccccc--cCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVF--QNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      ++.++|+|||++.........  ........++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+.
T Consensus       157 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~  235 (303)
T 2vwi_A          157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYPPMKV  235 (303)
T ss_dssp             TCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGH
T ss_pred             CCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh-CCCCCccCchhhH
Confidence            999999999988654332111  111223467788999999875 468899999999999999999 9999999877766


Q ss_pred             HHHHHcCCCC
Q psy3166         210 VHYLSTGYRM  219 (228)
Q Consensus       210 ~~~~~~~~~~  219 (228)
                      .........+
T Consensus       236 ~~~~~~~~~~  245 (303)
T 2vwi_A          236 LMLTLQNDPP  245 (303)
T ss_dssp             HHHHHTSSCC
T ss_pred             HHHHhccCCC
Confidence            5555554343

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6e-37  Score=249.51  Aligned_cols=192  Identities=23%  Similarity=0.407  Sum_probs=162.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----HHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----KTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++.....     .....+.+|+.+++++ +||||++++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~   81 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLH   81 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEEC---------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEE
Confidence            57999999999999999999843         44557999998654221     1346788999999999 899999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC----cEEEe
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH----VVKIS  139 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~----~~kl~  139 (228)
                      +++.... .+++||++++++|.+++..                    .|||+++|+|+||||+||+++.++    .++|+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence            9987654 8899999999999998864                    699999999999999999999877    79999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |||++........    .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+
T Consensus       162 Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~  233 (321)
T 2a2a_A          162 DFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANITSV  233 (321)
T ss_dssp             CCTTCEECCTTCC----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTT
T ss_pred             cCccceecCcccc----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhc
Confidence            9999875543221    223567889999999998889999999999999999999 99999998888887777765

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.4e-37  Score=245.65  Aligned_cols=192  Identities=23%  Similarity=0.393  Sum_probs=160.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|....         ++..+|+|.+..... .....+.+|+++++++ +||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~   76 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSL-DHPNIIRLYETFE   76 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhcc-chHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence            3679999999999999999998543         445699999865422 2246788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEee---cCCCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILL---SSPHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~---~~~~~~kl~dfg~~  144 (228)
                      .+. .++||||+++++|.+++..                    .|||+++|+|+||||+||++   +.++.++|+|||++
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             cCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            755 7899999999999888754                    69999999999999999999   77889999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ..+....    ......++..|+|||.+.+. ++.++|+||+|+++|+|++ |..||...+..+....+.++.
T Consensus       157 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  223 (277)
T 3f3z_A          157 ARFKPGK----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC-GYPPFSAPTDSEVMLKIREGT  223 (277)
T ss_dssp             EECCTTS----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred             eeccCcc----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCC
Confidence            7554332    12235678889999988654 8899999999999999999 999999998888888877763

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-37  Score=254.95  Aligned_cols=197  Identities=22%  Similarity=0.308  Sum_probs=154.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|..         ..++..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~   93 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVF   93 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hhheeEeeeeEecCCEEEEEEEE---------CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEee
Confidence            36899999999999999999984         4455679999987542 344556788999999999 999999999998


Q ss_pred             EcC-------ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          88 YKD-------ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        88 ~~~-------~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ...       ..++|||++.+ +|.+++..                  .|||++||+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A           94 TPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CSCCSTTTCCEEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccccccccccceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence            653       47899999965 67776542                  69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      ++.......    ......+|..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+....+.+....+.
T Consensus       173 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~  246 (371)
T 2xrw_A          173 LARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQLGTPC  246 (371)
T ss_dssp             C--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHC-CCCCC
T ss_pred             ccccccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            987543321    1223567788999999998889999999999999999999 9999999888877777766544443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1e-36  Score=251.70  Aligned_cols=189  Identities=23%  Similarity=0.290  Sum_probs=159.1

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC----CCCceEEee
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG----KHDHIVSFI   84 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~----~h~ni~~~~   84 (228)
                      .++|++.+.||+|+||.||+|+..         .++..||+|.++..  .........|+.+++.+.    .||||++++
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHI---------DNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEEC---------CCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            478999999999999999999853         34557999998643  344456778999999984    399999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC---------
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS---------  132 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~---------  132 (228)
                      +++... ..++|||++ +++|.+++..                      .|||+++|+||||||+|||++.         
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence            988764 488999999 8899998764                      6999999999999999999975         


Q ss_pred             ----------------CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhC
Q psy3166         133 ----------------PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTL  196 (228)
Q Consensus       133 ----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~  196 (228)
                                      ++.+||+|||++......      .....||..|+|||++.+..++.++|+|||||++|+|++ 
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-  254 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT-  254 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH-
Confidence                            788999999998743221      234567889999999999899999999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHcC
Q psy3166         197 GANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       197 g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |..||.+.+..+....+...
T Consensus       255 g~~pf~~~~~~~~~~~~~~~  274 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESI  274 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHh
Confidence            99999998888877776654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=255.19  Aligned_cols=190  Identities=23%  Similarity=0.378  Sum_probs=153.7

Q ss_pred             ceee--eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          11 RLIL--GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        11 ~~~~--~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .|.+  .+.||+|+||.||+|..         ..++..||+|.++... ....+.+.+|+++++++ +||||+++++++.
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~---------~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  156 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEE---------TATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQL-DHANLIQLYDAFE  156 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEE---------TTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEE---------cCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhC-CCCCCCeEEEEEE
Confidence            3444  67899999999999984         3345579999987542 34456788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEee--cCCCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILL--SSPHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~--~~~~~~kl~dfg~~  144 (228)
                      ... .++||||+++++|.+++..                     .|||+++|+||||||+|||+  +.++.+||+|||++
T Consensus       157 ~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             CSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            654 8899999999999887753                     69999999999999999999  45679999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ..+.....    .....||..|+|||++....++.++|+|||||++|+|++ |..||.+.+..+....+..+
T Consensus       237 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~  303 (373)
T 2x4f_A          237 RRYKPREK----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDNDAETLNNILAC  303 (373)
T ss_dssp             EECCTTCB----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHT
T ss_pred             eecCCccc----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence            76543321    223467889999999988889999999999999999999 99999999888887777665

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.5e-37  Score=247.41  Aligned_cols=209  Identities=20%  Similarity=0.257  Sum_probs=156.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +...++|++.+.||+|+||.||+|..         ..++..||+|.++...  .......+.+|+.+++++ +||||+++
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~   99 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAED---------TVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPI   99 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEE---------cCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEE
Confidence            56678999999999999999999984         3455679999987542  344457788999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+. .+++||++++++|.+++..                    .|||+++|+|+||||+||+++.++.++|+|||
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             EEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence            99987644 7899999999999998764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--C
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM--E  220 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~--~  220 (228)
                      ++........  .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.....+...+......  .
T Consensus       180 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (309)
T 2h34_A          180 IASATTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPRPST  256 (309)
T ss_dssp             C------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH-SSCSSCSCHHHHHHHHHHSCCCCGGG
T ss_pred             cCcccccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH-CCCCCCCchHHHHHHHhccCCCCccc
Confidence            9865433221  11223467888999999988889999999999999999999 99999987666555555544332  2


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .+.++|+
T Consensus       257 ~~~~~~~  263 (309)
T 2h34_A          257 VRPGIPV  263 (309)
T ss_dssp             TSTTCCT
T ss_pred             cCCCCCH
Confidence            3455554

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.2e-37  Score=251.29  Aligned_cols=198  Identities=25%  Similarity=0.450  Sum_probs=161.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|+.         ..++..||+|.+....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  123 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCY  123 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEE---------ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence            5699999999999999999983         4455679999987542  233456788999999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..+. .++||||+. |++.+++..                     .|||+++|+||||||+||+++.++.+||+|||++.
T Consensus       124 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          124 LREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS  202 (348)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence            7654 789999997 577776642                     69999999999999999999999999999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER-  221 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~-  221 (228)
                      ....       .....||..|+|||++.   ...++.++|+|||||++|+|++ |..||...+..+....+..+..+.. 
T Consensus       203 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  274 (348)
T 1u5q_A          203 IMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPALQ  274 (348)
T ss_dssp             SSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred             ecCC-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC
Confidence            5432       12356788999999985   4568899999999999999999 9999999888777666666555443 


Q ss_pred             CCCCC
Q psy3166         222 PASCN  226 (228)
Q Consensus       222 p~~~~  226 (228)
                      +..+|
T Consensus       275 ~~~~~  279 (348)
T 1u5q_A          275 SGHWS  279 (348)
T ss_dssp             CTTSC
T ss_pred             CCCCC
Confidence            33443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=253.32  Aligned_cols=191  Identities=24%  Similarity=0.327  Sum_probs=145.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|+..         .+++.||+|.++...   ..+.+.+|+.+++++ +||||+++++++..
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  119 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQK---------GTQKPYALKVLKKTV---DKKIVRTEIGVLLRL-SHPNIIKLKEIFET  119 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEC-------------CHHHHHC-CCTTBCCEEEEEEC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccch---hHHHHHHHHHHHHhC-CCCCCcceeeeEec
Confidence            56999999999999999999854         344579999987543   234577899999999 99999999999876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecC---CCcEEEeeccCcc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSS---PHVVKISDFGLSE  145 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~---~~~~kl~dfg~~~  145 (228)
                      .. .+++|||+++++|.+++..                    .|||+++|+||||||+||+++.   ++.+||+|||++.
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            54 7899999999999998753                    6999999999999999999975   7899999999987


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR-IVHYLSTGYR  218 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~-~~~~~~~~~~  218 (228)
                      ......    ......||..|+|||++.+..++.++|+|||||++|+|++ |..||......+ +...+.++..
T Consensus       200 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~i~~~~~  268 (349)
T 2w4o_A          200 IVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQFMFRRILNCEY  268 (349)
T ss_dssp             -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCTTCHHHHHHHHHTTCC
T ss_pred             ccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCcccHHHHHHHHhCCC
Confidence            543321    1223567889999999998889999999999999999999 999998766554 5666666533

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.8e-37  Score=244.89  Aligned_cols=191  Identities=26%  Similarity=0.416  Sum_probs=155.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|...         .++..+|+|.+...........+.+|+++++++ +||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~   91 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEER---------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED   91 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEc---------cCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec
Confidence            67999999999999999999843         345579999987654333456788999999999 99999999999876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeec---CCCcEEEeec
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLS---SPHVVKISDF  141 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~---~~~~~kl~df  141 (228)
                      .. .++|||++++++|.+++..                        .|||+++|+|+||||+||+++   .++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            44 7899999999999988742                        599999999999999999994   4678999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |++..+.....    .....++..|+|||.+. ..++.++|+||+|+++|+|++ |..||.+.+..++.......
T Consensus       172 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~  240 (285)
T 3is5_A          172 GLAELFKSDEH----STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQKATYK  240 (285)
T ss_dssp             CCCCC--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC
T ss_pred             ecceecCCccc----CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh-CCCCCCCCCHHHHHhhhccC
Confidence            99875433221    22356788899999875 458899999999999999999 99999998888777666554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.2e-37  Score=263.69  Aligned_cols=193  Identities=31%  Similarity=0.460  Sum_probs=159.8

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||+||+|+.         ..++..||+|.+.... .......+.+|+.+|+++ +||||+++++++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~   90 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKD---------RITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEIL   90 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEE---------TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEE---------CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEE
Confidence            36899999999999999999984         3445679999985331 112246788999999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecC---CCcEEEeeccC
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSS---PHVVKISDFGL  143 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~---~~~~kl~dfg~  143 (228)
                      .... +++||||+.+++|.+++..                    .|||++||+||||||+||+++.   ++.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           91 EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            7754 7899999999999888754                    6999999999999999999954   56799999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      +..+....    ......||+.|+|||++.+ .++.++|+||+||++|+|++ |..||.+.+..++...+..+.
T Consensus       171 a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~  238 (486)
T 3mwu_A          171 STCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGK  238 (486)
T ss_dssp             TTTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTC
T ss_pred             CeECCCCC----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence            87554332    1234568899999999875 48999999999999999999 999999999888888887764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=249.86  Aligned_cols=195  Identities=25%  Similarity=0.379  Sum_probs=154.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC----HHHHHHHHHHHHHHHhcC--CCCce
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD----AKTYDKFLKEINLMKDVG--KHDHI   80 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~--~h~ni   80 (228)
                      +-.++|++.+.||+|+||+||+|+         +..+++.||+|.++....    ........+|+.+++++.  +||||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni   76 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV   76 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEE---------CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred             ccccceEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence            445799999999999999999998         445566899999863321    111234556777777662  59999


Q ss_pred             EEeeeEEEcCc------eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC
Q psy3166          81 VSFIGCCYKDE------LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS  132 (228)
Q Consensus        81 ~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~  132 (228)
                      +++++++....      .+++||++. ++|.+++..                      .|||+++|+||||||+||+++.
T Consensus        77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS  155 (308)
T ss_dssp             CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred             EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence            99999986532      689999996 599888654                      6999999999999999999999


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ++.+||+|||++.......    ......+|..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+...+
T Consensus       156 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  230 (308)
T 3g33_A          156 GGTVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGK  230 (308)
T ss_dssp             TSCEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTT-SSCSCCCSSHHHHHHH
T ss_pred             CCCEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            9999999999987543321    1223466888999999998889999999999999999999 9999999888887776


Q ss_pred             HHcC
Q psy3166         213 LSTG  216 (228)
Q Consensus       213 ~~~~  216 (228)
                      +.+.
T Consensus       231 i~~~  234 (308)
T 3g33_A          231 IFDL  234 (308)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.8e-37  Score=257.95  Aligned_cols=178  Identities=26%  Similarity=0.421  Sum_probs=143.2

Q ss_pred             CCceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|.+. +.||+|+||+||+|+.         ..++..||+|.++..      ..+.+|+.++.++.+||||+++++++
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~---------~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~  124 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVY  124 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEE---------CCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEE
Confidence            3567776 7999999999999984         445567999998633      34567888887776999999999987


Q ss_pred             Ec-----CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC---CCcEE
Q psy3166          88 YK-----DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS---PHVVK  137 (228)
Q Consensus        88 ~~-----~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~---~~~~k  137 (228)
                      ..     ..+++||||+.+|+|.+++..                      .|||+++|+||||||+|||++.   ++.+|
T Consensus       125 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             EEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred             eecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEE
Confidence            53     337899999999999998753                      6999999999999999999997   78999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      |+|||+++......    ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       205 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  268 (400)
T 1nxk_A          205 LTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHG  268 (400)
T ss_dssp             ECCCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH-SSCSCCCCTT
T ss_pred             EEecccccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcc
Confidence            99999987543321    1224567888999999988889999999999999999999 9999987654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-37  Score=254.96  Aligned_cols=189  Identities=22%  Similarity=0.393  Sum_probs=152.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|..         ..++..||+|.+... .......++.+|+.+|+++ +||||+++++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~   93 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVD---------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVF   93 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEE---------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEE
T ss_pred             cceEEEeEEeeecCCeEEEEEEE---------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeE
Confidence            46899999999999999999984         445567999998654 3344556788999999999 899999999998


Q ss_pred             EcC-------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          88 YKD-------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        88 ~~~-------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ...       .++++||++ +++|.+++..                   .|||++||+||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A           94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEee
Confidence            653       358999999 7899888764                   6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      |++......      .....+|..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+.+..+.+
T Consensus       173 g~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i~~  240 (367)
T 1cm8_A          173 GLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIMK  240 (367)
T ss_dssp             TTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred             ecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            998754221      223567888999999886 678999999999999999999 9999999887766665543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.2e-37  Score=251.41  Aligned_cols=196  Identities=30%  Similarity=0.506  Sum_probs=157.5

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ++|++.+.||+|+||.||+|..         ..++..||+|.+....    .......+.+|+.+++++ +||||+++++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~   95 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIE---------NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYE   95 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             hheeecceeeecCCeEEEEEEE---------CCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeeh
Confidence            5799999999999999999984         3445579999986431    233456788999999999 8999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHH----------------------------------------------H--------
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLR----------------------------------------------E--------  110 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~----------------------------------------------~--------  110 (228)
                      ++.... .++||||+++++|.+++.                                              +        
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            987755 789999999999988762                                              0        


Q ss_pred             ------hcccCCCCcccCCCCCCEeecCCC--cEEEeeccCccccccccc-ccCCCCCCCCcceeeccccccc--CCCCc
Q psy3166         111 ------EYLSNNKVVHRDLATRNILLSSPH--VVKISDFGLSEDIYEQNV-FQNGEPSEKLPIRWLALESLVS--NIYTN  179 (228)
Q Consensus       111 ------~~lh~~~i~H~~lk~~nil~~~~~--~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~~Pe~~~~--~~~~~  179 (228)
                            .|||+++|+|+||||+||+++.++  .+||+|||++..+..... .........++..|+|||.+.+  ..++.
T Consensus       176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence                  699999999999999999998766  899999999875533211 1112234567889999999875  56889


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         180 KSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       180 ~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ++|+|||||++|+|++ |..||.+.+..+...++..+
T Consensus       256 ~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLM-GAVPFPGVNDADTISQVLNK  291 (345)
T ss_dssp             HHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHH-CCCCCCCCChHHHHHHHHhc
Confidence            9999999999999999 99999998888887776655

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.6e-37  Score=263.43  Aligned_cols=193  Identities=28%  Similarity=0.431  Sum_probs=156.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|+.         ..++..||+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  106 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRD---------KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFE  106 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEE---------TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEE---------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEE
Confidence            3699999999999999999984         3445579999987542 122345678999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecC---CCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSS---PHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~---~~~~kl~dfg~~  144 (228)
                      ... .++||||+++|+|.+++..                    .|||++||+||||||+||+++.   ++.+||+|||++
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            754 7899999999999887654                    6999999999999999999976   456999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      ..+....    ......||+.|+|||++. ..++.++|+||+||++|+|++ |..||.+.+..++...+..+..
T Consensus       187 ~~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~  254 (494)
T 3lij_A          187 AVFENQK----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVEKGKY  254 (494)
T ss_dssp             EECBTTB----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCC
T ss_pred             eECCCCc----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence            7654332    123456888999999876 458999999999999999999 9999999999999888887643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=257.31  Aligned_cols=210  Identities=25%  Similarity=0.337  Sum_probs=161.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +..++|++.+.||+|+||.||+|+...      ...++..||+|.++...   .......+.+|+++++++.+||||+++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~  124 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL  124 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEE
Confidence            455799999999999999999998633      23456689999986431   111224456799999999779999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++... ..++||||+++++|.+++..                    .|||+++|+||||||+|||++.++.+||+|||
T Consensus       125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          125 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             EEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence            9988765 48899999999999998764                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLSTG  216 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Diwslg~~~~~l~t~g~~pf~~~~----~~~~~~~~~~~  216 (228)
                      +++.+......  ......||..|+|||++.+.  .++.++|+|||||++|+|++ |..||....    ..++...+...
T Consensus       205 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  281 (355)
T 1vzo_A          205 LSKEFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRILKS  281 (355)
T ss_dssp             EEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             CCeecccCCCC--cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH-CCCCCccCCccchHHHHHHHHhcc
Confidence            98754332211  11234678889999999853  47889999999999999999 999997532    23444444444


Q ss_pred             CCCCCCCCCC
Q psy3166         217 YRMERPASCN  226 (228)
Q Consensus       217 ~~~~~p~~~~  226 (228)
                       .++.|..++
T Consensus       282 -~~~~~~~~~  290 (355)
T 1vzo_A          282 -EPPYPQEMS  290 (355)
T ss_dssp             -CCCCCTTSC
T ss_pred             -CCCCCcccC
Confidence             555565554

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-37  Score=253.00  Aligned_cols=190  Identities=26%  Similarity=0.431  Sum_probs=161.7

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||.||+|...         .++..||+|.++..........+.+|+.+++++ +||||+++++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   98 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYG   98 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEEC---------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeE
Confidence            356789999999999999999999853         345579999998766666677889999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCC-CCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNN-KVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~-~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++..+. .++||||+++++|.+++..                    .|||++ +|+|+||||+||+++.++.++|+|||+
T Consensus        99 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A           99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence            987654 7899999999999998764                    589986 999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      +..+....     .....++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..++..
T Consensus       179 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~  240 (360)
T 3eqc_A          179 SGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELEL  240 (360)
T ss_dssp             CHHHHHHC---------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH-TSCCSSCCCHHHHHH
T ss_pred             Cccccccc-----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence            86543321     223467788999999998889999999999999999999 999999987766543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=251.05  Aligned_cols=214  Identities=36%  Similarity=0.637  Sum_probs=171.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||.||+|++...     +..++..||+|.+.... ....+.+.+|+.+++++ +||||+++++
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~  109 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSL-QHDNIVKYKG  109 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTT-----SSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccc-----cCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhC-CCCCeeeEEE
Confidence            46677899999999999999999985321     33466789999987653 34456788999999999 9999999999


Q ss_pred             EEEcC---ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          86 CCYKD---ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        86 ~~~~~---~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++...   ..++|||++++++|.+++..                     .|||+++|+|+||||+||+++.++.+||+||
T Consensus       110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df  189 (326)
T 2w1i_A          110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF  189 (326)
T ss_dssp             EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence            87543   47899999999999998764                     5899999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------------
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL---------------  206 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~---------------  206 (228)
                      |++.................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....               
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHH-TTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCHHHHHHhhccccchhhh
Confidence            998765443322222233456677999999988888999999999999999999 9988865311               


Q ss_pred             -HHHHHHHHcCCCCCCCCCCCC
Q psy3166         207 -CRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       207 -~~~~~~~~~~~~~~~p~~~~~  227 (228)
                       .++.+.+..+.+++.|..+|+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~  290 (326)
T 2w1i_A          269 VFHLIELLKNNGRLPRPDGCPD  290 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCH
T ss_pred             HHHHHHHhhcCCCCCCCCcccH
Confidence             133455666777888888875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.1e-37  Score=250.68  Aligned_cols=183  Identities=27%  Similarity=0.403  Sum_probs=150.6

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      -+..++|++.+.||+|+||+||+|++.           +..||+|.++...  ........|+.+++++ +||||+++++
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~~~~   85 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD--KQSWQNEYEVYSLPGM-KHENILQFIG   85 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc--hHHHHHHHHHHHHhcC-CCCCchhhcc
Confidence            367889999999999999999999753           3469999986542  2234556689999999 9999999999


Q ss_pred             EEEcCc-----eEEEEecCCCCcHHHHHHH-------------------hcccCC----------CCcccCCCCCCEeec
Q psy3166          86 CCYKDE-----LRLVVEYCALGDLQSYLRE-------------------EYLSNN----------KVVHRDLATRNILLS  131 (228)
Q Consensus        86 ~~~~~~-----~~lv~e~~~~~~L~~~l~~-------------------~~lh~~----------~i~H~~lk~~nil~~  131 (228)
                      ++....     +++||||+++|+|.+++..                   .|||++          +|+||||||+||+++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~  165 (322)
T 3soc_A           86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK  165 (322)
T ss_dssp             EEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred             eeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence            986532     6899999999999999865                   689999          999999999999999


Q ss_pred             CCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         132 SPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-----IYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      .++.+||+|||++..+...... .......||..|+|||++.+.     .++.++|||||||++|+|+| |..||.+.
T Consensus       166 ~~~~~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~  241 (322)
T 3soc_A          166 NNLTACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTAADGP  241 (322)
T ss_dssp             TTCCEEECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TBTTSSSC
T ss_pred             CCCeEEEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh-CCCCCCCC
Confidence            9999999999999765443221 122335688999999998863     34567899999999999999 99999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=246.36  Aligned_cols=191  Identities=26%  Similarity=0.430  Sum_probs=154.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|...         .++..||+|.+..... ......+.+|+.+++++ +||||+++++++.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~   72 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNR---------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFR   72 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheee
Confidence            68999999999999999999843         3455799998865533 34456778999999999 8999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      ... .++|||++.+++|.+++..                    .|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           73 RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            654 7899999999988887653                    6999999999999999999999999999999998755


Q ss_pred             cccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ......   .....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..+....+.
T Consensus       153 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~  216 (311)
T 4agu_A          153 TGPSDY---YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GVPLWPGKSDVDQLYLIR  216 (311)
T ss_dssp             C---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred             cCcccc---cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence            432211   123467788999999876 568999999999999999999 999999988776655443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-36  Score=244.08  Aligned_cols=207  Identities=23%  Similarity=0.387  Sum_probs=147.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHH-HHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN-LMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~~h~ni~~   82 (228)
                      |+.+..++|++.+.||+|+||.||+|+.         ..+++.||+|.++.............|.. .++.+ +||||++
T Consensus         1 S~~i~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~   70 (290)
T 3fme_A            1 SMEVKADDLEPIMELGRGAYGVVEKMRH---------VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVT   70 (290)
T ss_dssp             -CCCCGGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCC
T ss_pred             CCcccHHhhhhHHhcCCCCCeEEEEEEe---------cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEE
Confidence            5678899999999999999999999984         44566799999976644444444444444 46666 9999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH------------------------hcccCC-CCcccCCCCCCEeecCCCcE
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE------------------------EYLSNN-KVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~-~i~H~~lk~~nil~~~~~~~  136 (228)
                      +++++... ..+++||++++ +|.+++..                        .|||++ ||+|+||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~  149 (290)
T 3fme_A           71 FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV  149 (290)
T ss_dssp             EEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCE
T ss_pred             EeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCE
Confidence            99998764 48899999975 77766542                        699998 99999999999999999999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeeccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL----VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI-PLCRIVH  211 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~----~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~-~~~~~~~  211 (228)
                      ||+|||++........    .....++..|+|||.+    ....++.++|+||+|+++|+|++ |..||... ...+...
T Consensus       150 kl~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~  224 (290)
T 3fme_A          150 KMCDFGISGYLVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQLK  224 (290)
T ss_dssp             EBCCC-------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH-TSCSSCCCSCHHHHHH
T ss_pred             EEeecCCccccccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH-CCCCccccCchHHHHH
Confidence            9999999875533221    1224577889999996    45568899999999999999999 99999873 3333344


Q ss_pred             HHHcCCCCCCC-CCCC
Q psy3166         212 YLSTGYRMERP-ASCN  226 (228)
Q Consensus       212 ~~~~~~~~~~p-~~~~  226 (228)
                      .......+..| ..+|
T Consensus       225 ~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          225 QVVEEPSPQLPADKFS  240 (290)
T ss_dssp             HHHHSCCCCCCTTTSC
T ss_pred             HHhccCCCCcccccCC
Confidence            44443344333 3444

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.4e-37  Score=249.27  Aligned_cols=190  Identities=26%  Similarity=0.403  Sum_probs=136.9

Q ss_pred             Cceeee---eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          10 ERLILG---EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        10 ~~~~~~---~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++|++.   +.||+|+||.||+|..         ..++..||+|.++..    ......+|+.+++++.+||||++++++
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~   74 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVH---------KKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEV   74 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEE---------TTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEE---------CCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEE
Confidence            356665   7899999999999984         345567999998643    234567899999999669999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC---cEEEeecc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH---VVKISDFG  142 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~---~~kl~dfg  142 (228)
                      +..+. .++||||+++++|.+++..                    .|||+++|+||||||+||+++.++   .+||+|||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             EEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            87754 7899999999999998864                    699999999999999999998765   89999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-------CRIVHYLST  215 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-------~~~~~~~~~  215 (228)
                      ++........   ......+|..|+|||++.+..++.++|+||+||++|+|++ |..||.+.+.       .++..++..
T Consensus       155 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          155 FARLKPPDNQ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             TCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHH-SSCTTC-------CCCHHHHHHHHTT
T ss_pred             cceecCCCCC---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCccccccccHHHHHHHHHc
Confidence            9875433221   1223456888999999998889999999999999999999 9999987433       345555655


Q ss_pred             C
Q psy3166         216 G  216 (228)
Q Consensus       216 ~  216 (228)
                      +
T Consensus       231 ~  231 (325)
T 3kn6_A          231 G  231 (325)
T ss_dssp             T
T ss_pred             C
Confidence            5

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-37  Score=244.50  Aligned_cols=209  Identities=28%  Similarity=0.503  Sum_probs=161.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ..+..++|++.+.||+|+||.||+|+...+...  .......||+|.+.... ....+.+.+|+.+++++ +||||++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~   78 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDY--GQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKL-SHKHLVLNY   78 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGG--GCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTS-CCTTBCCEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEeccccc--ccccchhhhhhhccccc-HHHHHHHHHHHHHHHhC-CCCCEeEEE
Confidence            357889999999999999999999986543210  01123469999986542 33456788999999999 899999999


Q ss_pred             eEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCc-------
Q psy3166          85 GCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHV-------  135 (228)
Q Consensus        85 ~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~-------  135 (228)
                      +++..+ ..++||||+.+++|.+++..                     .|||+++|+||||||+||+++.++.       
T Consensus        79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           79 GVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             EEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             EEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence            998764 47899999999999998864                     6999999999999999999998776       


Q ss_pred             -EEEeeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         136 -VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       136 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                       +||+|||++........       ..++..|+|||.+.+ ..++.++|+||||+++|+|++.|..||...+........
T Consensus       159 ~~kl~Dfg~~~~~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~  231 (289)
T 4fvq_A          159 FIKLSDPGISITVLPKDI-------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY  231 (289)
T ss_dssp             EEEECCCCSCTTTSCHHH-------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             eeeeccCcccccccCccc-------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence             99999999864433211       234556999999987 668999999999999999999455667776665555544


Q ss_pred             HcCCCCCCCCCCC
Q psy3166         214 STGYRMERPASCN  226 (228)
Q Consensus       214 ~~~~~~~~p~~~~  226 (228)
                      ...  ...|..++
T Consensus       232 ~~~--~~~~~~~~  242 (289)
T 4fvq_A          232 EDR--HQLPAPKA  242 (289)
T ss_dssp             HTT--CCCCCCSS
T ss_pred             hcc--CCCCCCCC
Confidence            443  33344444

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-36  Score=244.22  Aligned_cols=192  Identities=27%  Similarity=0.412  Sum_probs=158.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|+.         ..+++.||+|.++.... .....+.+|+.+++++ +||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   76 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQ---------RLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKI-KHENIVTLEDIYE   76 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEECC-------HHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEE---------CCCCCEEEEEEEecccc-cchHHHHHHHHHHHhC-CCCCeeehhhhcc
Confidence            36899999999999999999984         33455799999875432 2235678999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEee---cCCCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILL---SSPHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~---~~~~~~kl~dfg~~  144 (228)
                      .+. .+++||++++++|.+++..                    .|||+++|+|+||||+||++   +.++.++|+|||++
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             cCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence            654 7899999999999988754                    69999999999999999999   67889999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      .......     .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..++...+.++.
T Consensus       157 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~  223 (304)
T 2jam_A          157 KMEQNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYEETESKLFEKIKEGY  223 (304)
T ss_dssp             CCCCCBT-----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHCC
T ss_pred             eecCCCc-----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCC
Confidence            6432211     112346778999999998889999999999999999999 999999988888888877764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-36  Score=252.66  Aligned_cols=204  Identities=24%  Similarity=0.396  Sum_probs=154.9

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCC-CCceEEeee
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGK-HDHIVSFIG   85 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~-h~ni~~~~~   85 (228)
                      ..++|++.+.||+|+||+||++....          +..||+|.+... ........+.+|+.+|+++.+ ||||+++++
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~  123 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD  123 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT----------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC----------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEE
Confidence            34569999999999999999997422          446999998654 345556788999999999953 699999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ++..+. +++||| +.+++|.+++..                    .|||+++|+||||||+|||++ ++.+||+|||++
T Consensus       124 ~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          124 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             EEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             EEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            887654 789999 568899998764                    699999999999999999995 588999999999


Q ss_pred             ccccccccccCCCCCCCCcceeeccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVS-----------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHY  212 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~  212 (228)
                      ..+...... .......||+.|+|||++..           ..++.++|||||||++|+|++ |..||..... ...+..
T Consensus       202 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~~  279 (390)
T 2zmd_A          202 NQMQPDTTS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHA  279 (390)
T ss_dssp             CCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHH
T ss_pred             ccccCCCcc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH-CCCcchhhhHHHHHHHH
Confidence            765432211 11234568899999999865           358889999999999999999 9999987543 233444


Q ss_pred             HHc-CCCCCCCCCC
Q psy3166         213 LST-GYRMERPASC  225 (228)
Q Consensus       213 ~~~-~~~~~~p~~~  225 (228)
                      +.. ....+.|..+
T Consensus       280 ~~~~~~~~~~~~~~  293 (390)
T 2zmd_A          280 IIDPNHEIEFPDIP  293 (390)
T ss_dssp             HHCTTSCCCCCCCS
T ss_pred             HhCccccCCCCccc
Confidence            443 3334445444

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.9e-37  Score=262.62  Aligned_cols=193  Identities=29%  Similarity=0.457  Sum_probs=161.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .++|++.+.||+|+||.||+|+.         ..++..||+|.+.....  ......+.+|+.+++++ +||||++++++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~   94 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKD---------KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEF   94 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEE---------CCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEE
Confidence            46899999999999999999984         34556799999864421  23356788999999999 99999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeec---CCCcEEEeecc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLS---SPHVVKISDFG  142 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~---~~~~~kl~dfg  142 (228)
                      +.... .++|||++.+++|.+++..                    .|||+++|+||||||+||+++   .++.+||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A           95 FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            87754 7899999999999988754                    699999999999999999994   57899999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ++..+......    ....||+.|+|||++.+ .++.++|+||+||++|+|++ |..||.+.+..++...+.++.
T Consensus       175 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~  243 (484)
T 3nyv_A          175 LSTHFEASKKM----KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVEKGK  243 (484)
T ss_dssp             HHHHBCCCCSH----HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred             eeEEccccccc----ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCC
Confidence            98755333211    12457888999998876 58999999999999999999 999999999999988888764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-36  Score=242.51  Aligned_cols=204  Identities=28%  Similarity=0.455  Sum_probs=160.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +..++|++.+.||+|+||.||+|...         .++..||+|.+.....  ......+.+|+.+++++ +||||++++
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~   77 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQ---------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLY   77 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEEC---------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEE
Confidence            45679999999999999999999843         3455799999864311  12235678999999999 899999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++.... .+++||++++++|.+++..                    .|||+++++|+||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             EEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence            9987654 7899999999999998754                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +........    .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..++.+.+..+ ....|
T Consensus       158 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~  231 (276)
T 2h6d_A          158 SNMMSDGEF----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKIRGG-VFYIP  231 (276)
T ss_dssp             GGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCC
T ss_pred             ccccCCCcc----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-cccCc
Confidence            875433211    123456788999999987765 578999999999999999 99999998888777777766 45556


Q ss_pred             CCCC
Q psy3166         223 ASCN  226 (228)
Q Consensus       223 ~~~~  226 (228)
                      ..++
T Consensus       232 ~~~~  235 (276)
T 2h6d_A          232 EYLN  235 (276)
T ss_dssp             TTSC
T ss_pred             hhcC
Confidence            6554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=246.63  Aligned_cols=206  Identities=25%  Similarity=0.433  Sum_probs=141.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      |-..++|++.+.||+|+||.||+|..         ..++..||+|.+.....  ......+.+|+.+++++ +||||+++
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~   76 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAES---------IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILEL   76 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCE
T ss_pred             ccccccceeeeeecCCCceEEEEEEE---------ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeE
Confidence            55667999999999999999999984         33455799999864321  11235678999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++.... .+++||++++++|.+++..                     .|||+++|+|+||||+||+++.++.++|+||
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~df  156 (278)
T 3cok_A           77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADF  156 (278)
T ss_dssp             EEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCC
T ss_pred             EEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEee
Confidence            99987755 7899999999999998764                     5999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |++........   ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+... ..+.
T Consensus       157 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~  231 (278)
T 3cok_A          157 GLATQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI-GRPPFDTDTVKNTLNKVVLA-DYEM  231 (278)
T ss_dssp             TTCEECC-------------------------------CTHHHHHHHHHHHHHH-SSCSSCCCSCC-----CCSS-CCCC
T ss_pred             cceeeccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCChhHHHHHHHHhhc-ccCC
Confidence            99875432211   1123456788999999988888999999999999999999 99999886655554443332 2334


Q ss_pred             CCCCC
Q psy3166         222 PASCN  226 (228)
Q Consensus       222 p~~~~  226 (228)
                      |..++
T Consensus       232 ~~~~~  236 (278)
T 3cok_A          232 PSFLS  236 (278)
T ss_dssp             CTTSC
T ss_pred             ccccC
Confidence            44443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-36  Score=249.49  Aligned_cols=197  Identities=24%  Similarity=0.389  Sum_probs=157.8

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      -..++|++.+.||+|+||.||+|+.         ..++..||+|.+..... ......+.+|+.+++++ +||||+++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   83 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARH---------RKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIE   83 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEE---------TTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             ccccceeEEEEEecCCCcEEEEEEE---------CCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhh
Confidence            3567999999999999999999984         34455799998864422 22235677899999999 8999999999


Q ss_pred             EEEc---------CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          86 CCYK---------DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        86 ~~~~---------~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      ++..         +..++||||+.+ +|.+.+..                     .|||++||+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           84 ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             EEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred             eeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC
Confidence            8764         237899999975 66665432                     6999999999999999999999999


Q ss_pred             EEEeeccCcccccccccc-cCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         136 VKISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +||+|||++..+...... ........+|..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  241 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI  241 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence            999999998765432211 122234567889999999876 457999999999999999999 99999998887776665


Q ss_pred             Hc
Q psy3166         214 ST  215 (228)
Q Consensus       214 ~~  215 (228)
                      ..
T Consensus       242 ~~  243 (351)
T 3mi9_A          242 SQ  243 (351)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-36  Score=253.18  Aligned_cols=188  Identities=22%  Similarity=0.393  Sum_probs=149.4

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ....++|++.+.||+|+||+||+|+.         ..++..||+|.+......     ..+|+++++.+ +||||+++++
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l-~hpnIv~l~~   67 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFD---------IESGKRFALKKVLQDPRY-----KNRELDIMKVL-DHVNIIKLVD   67 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEE---------TTTCCEEEEEEEECCTTS-----CCHHHHHHTTC-CCTTBCCEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEE---------CCCCCEEEEEEEecCcch-----HHHHHHHHHHc-CCCCccchhh
Confidence            45678999999999999999999984         345567999998654221     23699999999 9999999999


Q ss_pred             EEEcC---------------------------------------ceEEEEecCCCCcHHHHHHH----------------
Q psy3166          86 CCYKD---------------------------------------ELRLVVEYCALGDLQSYLRE----------------  110 (228)
Q Consensus        86 ~~~~~---------------------------------------~~~lv~e~~~~~~L~~~l~~----------------  110 (228)
                      ++...                                       .+++||||+++ +|.+.+..                
T Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i  146 (383)
T 3eb0_A           68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIY  146 (383)
T ss_dssp             EEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred             eeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHH
Confidence            87431                                       16799999974 77666542                


Q ss_pred             --------hcccCCCCcccCCCCCCEeec-CCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCch
Q psy3166         111 --------EYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNK  180 (228)
Q Consensus       111 --------~~lh~~~i~H~~lk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~  180 (228)
                              .|||++||+||||||+||+++ .++.+||+|||++..+....    ......++..|+|||.+.+. .++.+
T Consensus       147 ~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          147 IYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             HHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcc
Confidence                    699999999999999999998 58899999999997553332    12234567789999998765 48999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         181 SDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       181 ~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      +|+||+||++|+|++ |..||.+.+..+.+..+.
T Consensus       223 ~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~  255 (383)
T 3eb0_A          223 IDLWSIGCVFGELIL-GKPLFSGETSIDQLVRII  255 (383)
T ss_dssp             HHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred             hhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Confidence            999999999999999 999999988877766544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=248.36  Aligned_cols=207  Identities=24%  Similarity=0.400  Sum_probs=155.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCC-CceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKH-DHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h-~ni~~~   83 (228)
                      .+..++|++.+.||+|+||.||++...          ++..||+|.+... ........+.+|+.+|+++.+| |||+++
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   74 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   74 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEE
Confidence            356789999999999999999999742          2446999998754 3445567788999999999433 999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+. .++||| +.+++|.+++..                    .|||+++|+||||||+|||++ ++.+||+|||
T Consensus        75 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           75 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             EEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             eeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecc
Confidence            99987755 789999 567899998764                    699999999999999999997 6889999999


Q ss_pred             CcccccccccccCCCCCCCCcceeeccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-----------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIV  210 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~  210 (228)
                      ++..+...... .......||..|+|||++..           ..++.++|||||||++|+|++ |..||...... ...
T Consensus       153 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  230 (343)
T 3dbq_A          153 IANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKL  230 (343)
T ss_dssp             SSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHHH
T ss_pred             cccccCccccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh-CCCcchhhhhHHHHH
Confidence            99765433211 11224567889999999864           568889999999999999999 99999875433 223


Q ss_pred             HH-HHcCCCCCCCCCCC
Q psy3166         211 HY-LSTGYRMERPASCN  226 (228)
Q Consensus       211 ~~-~~~~~~~~~p~~~~  226 (228)
                      .. +....+.+.|..++
T Consensus       231 ~~~~~~~~~~~~~~~~~  247 (343)
T 3dbq_A          231 HAIIDPNHEIEFPDIPE  247 (343)
T ss_dssp             HHHHCTTSCCCCCCCSC
T ss_pred             HHHhcCCcccCCcccCC
Confidence            33 33344445555444

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.8e-38  Score=261.47  Aligned_cols=186  Identities=16%  Similarity=0.140  Sum_probs=145.0

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcC--CCC
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVG--KHD   78 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~--~h~   78 (228)
                      ..++.+.++|++.+.||+|+||.||+|++         ..++..||+|.++..  ......+.+.+|+.+++.+.  +||
T Consensus        66 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hp  136 (377)
T 3byv_A           66 SELGERPRTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ  136 (377)
T ss_dssp             ESSSCCCEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSH
T ss_pred             eecCCCCceEEEcceeecCCCEEEEEEEE---------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCH
Confidence            34567788999999999999999999984         345567999998743  22334567889995444442  899


Q ss_pred             ceEEee-------eEEEcC------------------ceEEEEecCCCCcHHHHHHH-----------------------
Q psy3166          79 HIVSFI-------GCCYKD------------------ELRLVVEYCALGDLQSYLRE-----------------------  110 (228)
Q Consensus        79 ni~~~~-------~~~~~~------------------~~~lv~e~~~~~~L~~~l~~-----------------------  110 (228)
                      ||++++       +++...                  ..+++|||+ +|+|.+++..                       
T Consensus       137 niv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi  215 (377)
T 3byv_A          137 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV  215 (377)
T ss_dssp             HHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHH
Confidence            999988       544432                  278999999 6799988752                       


Q ss_pred             ----hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-----------
Q psy3166         111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-----------  175 (228)
Q Consensus       111 ----~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----------  175 (228)
                          .|||+++|+||||||+|||++.++.+||+|||++......      .....| ..|+|||++.+.           
T Consensus       216 ~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~  288 (377)
T 3byv_A          216 IRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVS-RGFEPPELEARRATISYHRDRRT  288 (377)
T ss_dssp             HHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE------EECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred             HHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCc------ccCCCC-cCccChhhhcccccccccccccc
Confidence                5999999999999999999999999999999998743221      122345 679999999877           


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         176 IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       176 ~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      .++.++|+|||||++|+|++ |..||.+...
T Consensus       289 ~~~~~~DvwSlG~il~ellt-g~~Pf~~~~~  318 (377)
T 3byv_A          289 LMTFSFDAWALGLVIYWIWC-ADLPITKDAA  318 (377)
T ss_dssp             ECCHHHHHHHHHHHHHHHHH-SSCCC-----
T ss_pred             cCChhhhHHHHHHHHHHHHH-CCCCCccccc
Confidence            79999999999999999999 9999987553

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=258.29  Aligned_cols=198  Identities=24%  Similarity=0.396  Sum_probs=159.6

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ...++|++.+.||+|+||.||+|++.         .++..||+|.++..........+.+|+++++++ +||||++++++
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~   75 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAI   75 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEe
Confidence            45679999999999999999999853         445579999987553333456678999999999 99999999998


Q ss_pred             EEcC---ceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEee----cCCCcE
Q psy3166          87 CYKD---ELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILL----SSPHVV  136 (228)
Q Consensus        87 ~~~~---~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~----~~~~~~  136 (228)
                      +...   ..++||||+++++|.+++..                       .|||+++|+||||||+||++    +.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             EECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             eccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence            8653   47899999999999988653                       69999999999999999998    667789


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeeccccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS--------NIYTNKSDVWSFGVVLWEIVTLGANPYPHI----  204 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~----  204 (228)
                      ||+|||++........    .....|+..|+|||++..        ..++.++|+|||||++|+|++ |..||...    
T Consensus       156 kL~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t-g~~Pf~~~~~~~  230 (396)
T 4eut_A          156 KLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPR  230 (396)
T ss_dssp             EECCGGGCEECCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH-SSCSEECTTCTT
T ss_pred             EEecCCCceEccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCccc
Confidence            9999999976544322    223567888999998864        456789999999999999999 99999753    


Q ss_pred             CHHHHHHHHHcCCCC
Q psy3166         205 PLCRIVHYLSTGYRM  219 (228)
Q Consensus       205 ~~~~~~~~~~~~~~~  219 (228)
                      ...++...+..+.++
T Consensus       231 ~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          231 RNKEVMYKIITGKPS  245 (396)
T ss_dssp             TCHHHHHHHHHSCCT
T ss_pred             chHHHHHHHhcCCCc
Confidence            234566666666443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.5e-36  Score=239.30  Aligned_cols=192  Identities=24%  Similarity=0.421  Sum_probs=158.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----HHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----KTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++.....     ...+.+.+|+.+++++ +||||++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~   74 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK---------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLH   74 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEc---------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehh
Confidence            57999999999999999999853         34457999998654211     1356788999999999 899999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC----cEEEe
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH----VVKIS  139 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~----~~kl~  139 (228)
                      +++.... .+++||++++++|.+++..                    .|||+++++|+||||+||+++.++    .++|+
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           75 DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             heecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence            9987654 7899999999999998864                    689999999999999999998876    89999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |||++........    .....++..|+|||.+....++.++|+||||+++|+|++ |..||.+.+..+....+...
T Consensus       155 dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  226 (283)
T 3bhy_A          155 DFGIAHKIEAGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGETKQETLTNISAV  226 (283)
T ss_dssp             CCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT
T ss_pred             ecccceeccCCCc----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH-CCCCCCCcchHHHHHHhHhc
Confidence            9999875533221    123457788999999988889999999999999999999 99999998888777776665

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.7e-37  Score=259.54  Aligned_cols=194  Identities=27%  Similarity=0.447  Sum_probs=148.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-------CHHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-------DAKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .++|++.+.||+|+||.||+|..         ..++..||+|.+....       .......+.+|+.+|+++ +||||+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  203 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFE---------RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCII  203 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBC
T ss_pred             hccEEEEeEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEe
Confidence            46899999999999999999984         3455679999986431       111123477899999999 999999


Q ss_pred             EeeeEEEcCceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC---cEEE
Q psy3166          82 SFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH---VVKI  138 (228)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~---~~kl  138 (228)
                      ++++++..+..++||||+++++|.+++..                    .|||+++|+||||||+|||++.++   .+||
T Consensus       204 ~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          204 KIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             CCCEEEESSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             eEEEEEecCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence            99999888889999999999999876532                    699999999999999999997544   5999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeeccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIVHYLS  214 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~~~~~  214 (228)
                      +|||+++.+.....    .....||..|+|||++.+   ..++.++|+|||||++|+|++ |..||...... .+...+.
T Consensus       284 ~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~i~  358 (419)
T 3i6u_A          284 TDFGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSLKDQIT  358 (419)
T ss_dssp             CCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH-SSCSSCCCSSSCCHHHHHH
T ss_pred             eecccceecCCCcc----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCcchHHHHHHHh
Confidence            99999976543221    223567889999999863   457889999999999999999 99999875443 3445555


Q ss_pred             cCC
Q psy3166         215 TGY  217 (228)
Q Consensus       215 ~~~  217 (228)
                      .+.
T Consensus       359 ~~~  361 (419)
T 3i6u_A          359 SGK  361 (419)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            553

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-35  Score=237.43  Aligned_cols=197  Identities=26%  Similarity=0.421  Sum_probs=158.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ....+.|++.+.||+|+||.||+|...         .++..||+|.+... ........+.+|+.+++++ +||||++++
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~   91 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFY   91 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEec---------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeee
Confidence            355667899999999999999999843         34557999998654 3445567788999999999 999999999


Q ss_pred             eEEEc-----CceEEEEecCCCCcHHHHHHH--------------------hcccCCC--CcccCCCCCCEeec-CCCcE
Q psy3166          85 GCCYK-----DELRLVVEYCALGDLQSYLRE--------------------EYLSNNK--VVHRDLATRNILLS-SPHVV  136 (228)
Q Consensus        85 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~--i~H~~lk~~nil~~-~~~~~  136 (228)
                      +++..     ..+++||||+++++|.+++..                    .|||+++  |+|+||||+||+++ .++.+
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~  171 (290)
T 1t4h_A           92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV  171 (290)
T ss_dssp             EEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCE
T ss_pred             eeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCE
Confidence            98754     227899999999999998864                    6999999  99999999999998 78899


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLST  215 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~~  215 (228)
                      +|+|||++.......     .....++..|+|||.+.+ .++.++|+||+|+++|+|++ |..||..... ......+..
T Consensus       172 kl~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  244 (290)
T 1t4h_A          172 KIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTS  244 (290)
T ss_dssp             EECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTT
T ss_pred             EEeeCCCcccccccc-----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHh-CCCCCCCcCcHHHHHHHHhc
Confidence            999999986432221     123457788999998764 58999999999999999999 9999988544 444555666


Q ss_pred             CCCC
Q psy3166         216 GYRM  219 (228)
Q Consensus       216 ~~~~  219 (228)
                      +.++
T Consensus       245 ~~~~  248 (290)
T 1t4h_A          245 GVKP  248 (290)
T ss_dssp             TCCC
T ss_pred             cCCc
Confidence            5444

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8e-36  Score=241.47  Aligned_cols=205  Identities=25%  Similarity=0.427  Sum_probs=154.0

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC--CCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ..++|++.+.||+|+||.||+|...         .++..||+|.++..  ........+.+|+.+++++ +||||+++++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~   99 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYA   99 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEET---------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEc---------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEE
Confidence            4568999999999999999999843         34457999998743  2445567788999999999 9999999999


Q ss_pred             EEEcC-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          86 CCYKD-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        86 ~~~~~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++..+ ..+++||++.+++|.+++..                        .|||+++++|+||||+||+++.++.++|+|
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             EEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEe
Confidence            98765 47899999999999988753                        589999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI--PLCRIVHYLSTGYR  218 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~--~~~~~~~~~~~~~~  218 (228)
                      ||++........   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.  ...++...+..+..
T Consensus       180 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  255 (310)
T 2wqm_A          180 LGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCDY  255 (310)
T ss_dssp             C---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTC---CCHHHHHHHHHTTCS
T ss_pred             ccceeeecCCCc---cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchhHHHHHHHhhcccC
Confidence            999875433221   1123456778999999998889999999999999999999 99999764  33455666766655


Q ss_pred             CCCC-CCCC
Q psy3166         219 MERP-ASCN  226 (228)
Q Consensus       219 ~~~p-~~~~  226 (228)
                      ++.+ ..+|
T Consensus       256 ~~~~~~~~~  264 (310)
T 2wqm_A          256 PPLPSDHYS  264 (310)
T ss_dssp             CCCCTTTSC
T ss_pred             CCCcccccC
Confidence            5443 4444

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-36  Score=251.70  Aligned_cols=191  Identities=18%  Similarity=0.287  Sum_probs=148.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHH----------HHHHHHHHHHHhcCC
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTY----------DKFLKEINLMKDVGK   76 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~~   76 (228)
                      +..++|++.+.||+|+||.||+|.+..+.    ....+..||+|.+.........          ....+|+..++.+ +
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~  106 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-K  106 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSS----CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-S
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCcc----ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-c
Confidence            44569999999999999999999876543    2234567999998654311100          1233455566667 7


Q ss_pred             CCceEEeeeEEEcC-----ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEee
Q psy3166          77 HDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        77 h~ni~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                      ||||+++++++...     ..++||||+ +++|.+++..                     .|||+++|+||||||+|||+
T Consensus       107 h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill  185 (364)
T 3op5_A          107 YLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL  185 (364)
T ss_dssp             CCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE
Confidence            99999999987652     278999999 9999998764                     69999999999999999999


Q ss_pred             c--CCCcEEEeeccCccccccccccc----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         131 S--SPHVVKISDFGLSEDIYEQNVFQ----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       131 ~--~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      +  .++.+||+|||+++.+.......    .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~Pf~~~  264 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT-GHLPWEDN  264 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCTTGGG
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCcccc
Confidence            9  78999999999997654432211    11234558889999999998889999999999999999999 99999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2e-35  Score=237.65  Aligned_cols=196  Identities=27%  Similarity=0.408  Sum_probs=162.4

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----C----HHHHHHHHHHHHHHHhcCCCCc
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----D----AKTYDKFLKEINLMKDVGKHDH   79 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~~e~~~l~~l~~h~n   79 (228)
                      -.++|++.+.||+|+||.||+|..         ..++..||+|.++...    .    ......+.+|+.+++++.+|||
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~   85 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIH---------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN   85 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             hhhccceeeeecCCCceEEEEEEE---------cCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357999999999999999999984         4455679999986442    1    1234567899999999966999


Q ss_pred             eEEeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          80 IVSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        80 i~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      |+++++++..+. .++|||++++++|.+++..                    .|||++|++|+||||+||+++.++.++|
T Consensus        86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEE
Confidence            999999987655 7899999999999998764                    6999999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV------SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~------~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      +|||++..+.....    .....++..|+|||++.      ...++.++|+||||+++|+|++ |..||...+..+....
T Consensus       166 ~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          166 TDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             CCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             ecccchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH-CCCCCcCccHHHHHHH
Confidence            99999875533221    22356788899999885      3457889999999999999999 9999999888877777


Q ss_pred             HHcCC
Q psy3166         213 LSTGY  217 (228)
Q Consensus       213 ~~~~~  217 (228)
                      +..+.
T Consensus       241 ~~~~~  245 (298)
T 1phk_A          241 IMSGN  245 (298)
T ss_dssp             HHHTC
T ss_pred             HhcCC
Confidence            76653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.3e-36  Score=247.04  Aligned_cols=194  Identities=25%  Similarity=0.391  Sum_probs=155.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ...++|++.+.||+|+||.||+|+..         .++..||+|.+.... .......+.+|+.+++++ +||||+++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   91 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNK---------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLE   91 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEET---------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEEC---------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEE
Confidence            35679999999999999999999843         445579999986543 344456678999999999 8999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      ++.... .++|||++.+++|.+++..                    .|||++||+|+||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A           92 VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             EEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence            987655 7899999999888876532                    6999999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ..+......   .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.+..+....+.
T Consensus       172 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~  238 (331)
T 4aaa_A          172 RTLAAPGEV---YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIM  238 (331)
T ss_dssp             ---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred             eeecCCccc---cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Confidence            754332211   1234567789999998865 68899999999999999999 999999988776655443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-36  Score=242.94  Aligned_cols=198  Identities=29%  Similarity=0.510  Sum_probs=155.9

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      ..+.++|++.+.||+|+||.||+|++.         .++..||+|.+......  ...+.+|+.+++++.+||||+++++
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEEC---------CCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeee
Confidence            456789999999999999999999853         34457999998654322  3567889999999978999999999


Q ss_pred             EEEc-------CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcE
Q psy3166          86 CCYK-------DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        86 ~~~~-------~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~  136 (228)
                      ++..       +..+++||++.+++|.+++..                      .|||++||+|+||||+||+++.++.+
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCE
Confidence            9864       347899999999999998764                      58999999999999999999999999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      ||+|||++.......   .......++..|+|||.+.     ...++.++|+|||||++|+|++ |..||.+....+...
T Consensus       169 kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~  244 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALF  244 (326)
T ss_dssp             EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred             EEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Confidence            999999987543221   1122346788899999987     4568899999999999999999 999999988776666


Q ss_pred             HHHcCCC
Q psy3166         212 YLSTGYR  218 (228)
Q Consensus       212 ~~~~~~~  218 (228)
                      .+.....
T Consensus       245 ~~~~~~~  251 (326)
T 2x7f_A          245 LIPRNPA  251 (326)
T ss_dssp             HHHHSCC
T ss_pred             HhhcCcc
Confidence            6555433

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.7e-36  Score=239.69  Aligned_cols=198  Identities=24%  Similarity=0.321  Sum_probs=159.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|...         .++..||+|.++... .......+.+|+..+.++.+||||+++++++.
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~   81 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKR---------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA   81 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEc---------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            68999999999999999999843         345579999987542 23345678899999999889999999999987


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCC----------
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSP----------  133 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~----------  133 (228)
                      .+ ..+++||++++++|.+++..                        .|||+++|+|+||||+||+++.+          
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence            64 47899999999999998753                        59999999999999999999844          


Q ss_pred             ---------CcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         134 ---------HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       134 ---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                               ..++|+|||.+......       ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..|+..
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~~  233 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG-AEPLPRN  233 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT-CCCCCSS
T ss_pred             ccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc-CCCCCcc
Confidence                     47999999998754322       234578889999999866 45689999999999999998 8877654


Q ss_pred             CCHHHHHHHHHcCCCCCCCCCCCC
Q psy3166         204 IPLCRIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~p~~~~~  227 (228)
                      .   .....+..+..+..|..+|+
T Consensus       234 ~---~~~~~~~~~~~~~~~~~~~~  254 (289)
T 1x8b_A          234 G---DQWHEIRQGRLPRIPQVLSQ  254 (289)
T ss_dssp             S---HHHHHHHTTCCCCCSSCCCH
T ss_pred             h---hHHHHHHcCCCCCCCcccCH
Confidence            3   34556677777777777664

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.7e-36  Score=247.47  Aligned_cols=193  Identities=27%  Similarity=0.367  Sum_probs=156.7

Q ss_pred             Cceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|.+. +.||+|+||.||+|+.         ..++..||+|.++... .......+.+|+.+++++.+||||+++++++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCIS---------KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            357776 8999999999999984         3445679999987542 2233467889999999997789999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC---CCcEEEeec
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS---PHVVKISDF  141 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~---~~~~kl~df  141 (228)
                      .... .++||||+.+++|.+++..                      .|||++||+||||||+||+++.   ++.+||+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            7654 7899999999998877532                      6999999999999999999987   789999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |++..+.....    .....++..|+|||++....++.++|+||||+++|+|++ |..||.+.+..+....+...
T Consensus       179 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  248 (327)
T 3lm5_A          179 GMSRKIGHACE----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQETYLNISQV  248 (327)
T ss_dssp             GGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred             ccccccCCccc----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhc
Confidence            99875533221    123567889999999998889999999999999999999 99999998888777666554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.9e-36  Score=244.55  Aligned_cols=186  Identities=25%  Similarity=0.433  Sum_probs=146.4

Q ss_pred             CCceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++. +.||+|+||.||+|.         +..++..||+|.++.... .....+.+|++++.++.+||||+++++++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~   80 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCI---------NLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFF   80 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEE---------CSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEE---------EcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            4678885 789999999999997         444566799999875532 23467889999999965899999999998


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCc---EEEeeccC
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHV---VKISDFGL  143 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~---~kl~dfg~  143 (228)
                      ..+ ..++|||++++++|.+++..                    .|||+++|+||||||+||+++.++.   +||+|||+
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            764 48899999999999998864                    6999999999999999999998765   99999999


Q ss_pred             cccccccccc----cCCCCCCCCcceeeccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         144 SEDIYEQNVF----QNGEPSEKLPIRWLALESLVS-----NIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       144 ~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +.........    ........|+..|+|||++..     ..++.++|+|||||++|+|++ |..||.+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  230 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS-GYPPFVGRC  230 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH-CCCCCcccc
Confidence            8654322111    111223457889999999875     457889999999999999999 999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.3e-36  Score=240.93  Aligned_cols=186  Identities=19%  Similarity=0.277  Sum_probs=153.9

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+-.++|++.+.||+|+||.||+|..         ..++..||+|.+......   ..+.+|+.+++++.+|+|++.+++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~   73 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTN---------LLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYY   73 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEE---------CCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEe
Confidence            45578999999999999999999983         445567999998644322   346789999999988999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCc-----EEE
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHV-----VKI  138 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~-----~kl  138 (228)
                      ++..+. .+++||++ +++|.+++..                     .|||+++|+||||||+||+++.++.     +||
T Consensus        74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           74 FGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             ecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            887654 78999999 9999999874                     5999999999999999999987665     999


Q ss_pred             eeccCccccccccccc----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         139 SDFGLSEDIYEQNVFQ----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +|||++..........    .......||..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  222 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLK  222 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCC
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc-CCCCcchhh
Confidence            9999987654332111    12334568889999999998889999999999999999999 999998843

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-36  Score=251.57  Aligned_cols=188  Identities=23%  Similarity=0.423  Sum_probs=141.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|.         +..++..||+|.+... .......++.+|+.+++.+ +||||+++++++.
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~   98 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFT   98 (367)
T ss_dssp             TTEEEEEECC----CCEEEEE---------ETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEC
T ss_pred             CceEEeeEEeecCCeEEEEEE---------ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEe
Confidence            789999999999999999997         4445668999998754 2344556788999999999 8999999999885


Q ss_pred             c-------CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          89 K-------DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        89 ~-------~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      .       ...++++|++ +++|.+++..                   .|||++||+||||||+||+++.++.+||+|||
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X           99 PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             SCSSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             cCCccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence            4       3378999998 6777766542                   69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ++......      .....+|..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+.+..+.+
T Consensus       178 ~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i~~  244 (367)
T 2fst_X          178 LARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILR  244 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            98754321      223466778999999886 568999999999999999999 9999999887766665544

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-35  Score=244.85  Aligned_cols=194  Identities=27%  Similarity=0.456  Sum_probs=160.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-------HHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-------AKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      ++|++.+.||+|+||.||+|+..         .++..||||.+.....       ......+.+|+.+++++.+||||++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             hhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            47999999999999999999853         3445799999865421       1224567889999999978999999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++... ..++||||+.+++|.+++..                    .|||++||+|+||||+||+++.++.++|+||
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEec
Confidence            99998764 48899999999999998764                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN------IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      |++..+....    ......||..|+|||++.+.      .++.++|+|||||++|+|++ |..||.+....+....+..
T Consensus       245 G~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~  319 (365)
T 2y7j_A          245 GFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRMIME  319 (365)
T ss_dssp             TTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred             CcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHh
Confidence            9987554322    12345778899999988632      47889999999999999999 9999999887777777766


Q ss_pred             CC
Q psy3166         216 GY  217 (228)
Q Consensus       216 ~~  217 (228)
                      +.
T Consensus       320 ~~  321 (365)
T 2y7j_A          320 GQ  321 (365)
T ss_dssp             TC
T ss_pred             CC
Confidence            53

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=240.18  Aligned_cols=194  Identities=29%  Similarity=0.548  Sum_probs=155.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .+.++|++.+.||+|+||.||+|...         .++..||+|.+.....   ...+.+|+.+++++ +||||++++++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~   92 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQIVAIKQVPVESD---LQEIIKEISIMQQC-DSPHVVKYYGS   92 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEET---------TTCCEEEEEEEETTSC---CHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEEC---------CCCCEEEEEecCchHH---HHHHHHHHHHHHhC-CCCCCccEEEE
Confidence            46788999999999999999999843         3455799999875432   24678899999999 99999999998


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+ ..+++||++.+++|.+++..                     .|||++|++|+||||+||+++.++.++|+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  172 (314)
T 3com_A           93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA  172 (314)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccc
Confidence            8764 47899999999999998762                     5999999999999999999999999999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ........   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+....
T Consensus       173 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  241 (314)
T 3com_A          173 GQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIHPMRAIFMIPTNP  241 (314)
T ss_dssp             EECBTTBS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSC
T ss_pred             hhhhhhcc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCC
Confidence            75533211   1234567888999999998889999999999999999999 999999887766655555543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.5e-36  Score=252.25  Aligned_cols=189  Identities=23%  Similarity=0.318  Sum_probs=156.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC-----CCCceEEe
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG-----KHDHIVSF   83 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~~   83 (228)
                      ..+|++.+.||+|+||.||+|..         ..++..||+|.++..  ......+.+|+.+++.+.     +|+||+.+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~---------~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYD---------HKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEE---------TTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             cCcEEEEEEcccCccEEEEEEEE---------CCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            45799999999999999999984         445667999998754  334456778888888762     56799999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCc--EEE
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHV--VKI  138 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~--~kl  138 (228)
                      ++.+... .++++||++. ++|.+++..                      .|||+++|+||||||+|||++.++.  +||
T Consensus       165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEE
T ss_pred             EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEE
Confidence            9998764 4889999995 588887654                      6999999999999999999999886  999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      +|||++......      .....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.+.
T Consensus       244 ~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~l~~i~~~  314 (429)
T 3kvw_A          244 IDFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT-GYPLLPGEDEGDQLACMIEL  314 (429)
T ss_dssp             CCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred             eecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Confidence            999998643221      223567888999999999889999999999999999999 99999998888777665543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-36  Score=253.01  Aligned_cols=181  Identities=26%  Similarity=0.459  Sum_probs=144.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||+||+|+.         ..++..||+|+++... ......++.+|+.+|+++ +||||+++++++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~   94 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYD---------KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLI   94 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEE---------CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEE
Confidence            47999999999999999999984         4456689999997542 344557789999999999 899999999988


Q ss_pred             EcC------ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          88 YKD------ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        88 ~~~------~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ...      .+++|||++. ++|.+++..                    .|||++||+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A           95 IPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             CCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccC
Confidence            653      4899999985 599888764                    6999999999999999999999999999999


Q ss_pred             cCcccccccccc-------------------cCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy3166         142 GLSEDIYEQNVF-------------------QNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPY  201 (228)
Q Consensus       142 g~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t~g~~pf  201 (228)
                      |+++........                   ........||..|+|||++. ...++.++||||+||++|+|++ |..||
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~-g~~p~  252 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN-MLQSH  252 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT-TCTTT
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh-ccccc
Confidence            999765432211                   01124567788899999864 5568999999999999999996 54443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.2e-36  Score=241.50  Aligned_cols=198  Identities=25%  Similarity=0.477  Sum_probs=158.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .+.++|++.+.||+|+||.||+|...         .++..||+|.+.... ......+.+|+.+++++ +||||++++++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   84 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKS-EEELEDYIVEIEILATC-DHPYIVKLLGA   84 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEET---------TTCCEEEEEEEC-----CCHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEc---------CCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcC-CCCCEeeeeee
Confidence            34578999999999999999999854         344579999986542 23346788999999999 99999999999


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +..+ ..+++||++++++|.+++..                     .|||+++++|+||||+||+++.++.++|+|||++
T Consensus        85 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             EECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             eeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            8764 48899999999999988653                     6999999999999999999999999999999987


Q ss_pred             ccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      .......   .......++..|+|||.+.     ...++.++|+||||+++|+|++ |..||...+..+....+..+..+
T Consensus       165 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  240 (302)
T 2j7t_A          165 AKNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSDPP  240 (302)
T ss_dssp             HHHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             ccccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc-CCCCCccCCHHHHHHHHhccCCc
Confidence            5332211   1112346778899999884     5568899999999999999999 99999998887777776666444

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8e-36  Score=240.75  Aligned_cols=204  Identities=26%  Similarity=0.498  Sum_probs=162.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++|++.+.||+|+||.||++.         +..++..||+|.++...   .......+.+|+.+++++ +||||++++++
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   74 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVL---------DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDV   74 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEE---------BTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             cceeEeeEEecCCCeEEEEEE---------ECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEE
Confidence            689999999999999999998         44455679999986432   112346788999999999 89999999998


Q ss_pred             EEc---CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          87 CYK---DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        87 ~~~---~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +..   ...+++||++.++ |.+++..                      .|||+++|+|+||||+||+++.++.++|+||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecc
Confidence            743   3488999999876 5555442                      6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      |++......... .......++..|+|||++.+..  ++.++|+||||+++|+|++ |..||.+.+..++.+.+.++ ..
T Consensus       154 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~~~-~~  230 (305)
T 2wtk_C          154 GVAEALHPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT-GLYPFEGDNIYKLFENIGKG-SY  230 (305)
T ss_dssp             TTCEECCTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHC-CC
T ss_pred             ccccccCccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHHhcC-CC
Confidence            998754322111 1112345788899999987643  3779999999999999999 99999998888888888777 55


Q ss_pred             CCCCCCCC
Q psy3166         220 ERPASCNE  227 (228)
Q Consensus       220 ~~p~~~~~  227 (228)
                      +.|..+++
T Consensus       231 ~~~~~~~~  238 (305)
T 2wtk_C          231 AIPGDCGP  238 (305)
T ss_dssp             CCCSSSCH
T ss_pred             CCCCccCH
Confidence            66666653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-35  Score=243.55  Aligned_cols=193  Identities=25%  Similarity=0.391  Sum_probs=156.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|..         ..++..||+|.++..........+.+|+.+++++ +||||+++++++.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   79 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATH---------KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQR   79 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEE---------CCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeec
Confidence            47899999999999999999984         3455679999997655566667788999999999 9999999999875


Q ss_pred             c------CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          89 K------DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        89 ~------~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .      ...+++||++. ++|.+++..                   .|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           80 PDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CSCSTTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccccCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            4      34789999996 588887654                   699999999999999999999999999999999


Q ss_pred             ccccccccccc-------CCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         144 SEDIYEQNVFQ-------NGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       144 ~~~~~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      +..+.......       .......||..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+..+....+
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Confidence            87554321110       01223467888999998764 668999999999999999999 99999998776554443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.8e-36  Score=238.19  Aligned_cols=186  Identities=28%  Similarity=0.423  Sum_probs=153.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|...         .++..||+|.++..........+.+|+.+++.+ +||||+++++++..
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   76 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE   76 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEEC---------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc
Confidence            58999999999999999999843         345579999987554334456788999999999 99999999999876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      +. .+++||++++++|.+++..                    .|||+++++|+||||+||+++.++.++|+|||.+..+.
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            54 7899999999898877542                    69999999999999999999999999999999987543


Q ss_pred             ccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      .... ........++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||......
T Consensus       157 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~  214 (276)
T 2yex_A          157 YNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDS  214 (276)
T ss_dssp             ETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH-SSCCCSCSCTT
T ss_pred             CCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Confidence            3221 111234567888999999987665 678999999999999999 99999886543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-36  Score=255.49  Aligned_cols=176  Identities=27%  Similarity=0.468  Sum_probs=132.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||+||+|++         ..++..||+|.+... .......++.+|+.+|+++ +||||+++++++
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  121 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYD---------KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIV  121 (458)
T ss_dssp             CTTEEECCC-------CEEEEEE---------CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEE---------CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEE
Confidence            37899999999999999999984         445567999998654 2344557788999999999 999999999988


Q ss_pred             Ec------CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          88 YK------DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        88 ~~------~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ..      ..+++|||++ +++|.+++..                    .|||+++|+||||||+|||++.++.+||+||
T Consensus       122 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          122 IPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             CCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccc
Confidence            43      2479999988 5688887653                    6999999999999999999999999999999


Q ss_pred             cCcccccccccc------------------------cCCCCCCCCcceeecccccc-cCCCCchhhHHHHHHHHHHHHh
Q psy3166         142 GLSEDIYEQNVF------------------------QNGEPSEKLPIRWLALESLV-SNIYTNKSDVWSFGVVLWEIVT  195 (228)
Q Consensus       142 g~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Diwslg~~~~~l~t  195 (228)
                      |+++........                        ........||..|+|||++. ...++.++|||||||++|||++
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            999765322110                        01123456688899999864 5669999999999999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=239.97  Aligned_cols=178  Identities=25%  Similarity=0.288  Sum_probs=143.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|+..         .++..||+|++.... ..........|+..+.++.+||||+++++++.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSK---------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET---------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEEC---------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            57999999999999999999853         345579999876542 34445566777777777769999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+. .++|||++ +++|.+++..                     .|||+++|+||||||+|||++.++.+||+|||++..
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            654 78999999 6688887653                     699999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      .....    ......||..|+|||++.+ .++.++|+|||||++|+|++ |..|+.+
T Consensus       207 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~-g~~~~~~  257 (311)
T 3p1a_A          207 LGTAG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC-NMELPHG  257 (311)
T ss_dssp             CC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHH-TCCCCSS
T ss_pred             cccCC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHh-CCCCCCC
Confidence            53322    1223567889999998876 68999999999999999999 8655544

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=241.18  Aligned_cols=195  Identities=25%  Similarity=0.401  Sum_probs=150.1

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|..         ..+++.||+|.+... .......+.+|+.+++++ +||||+++++++.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   78 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVD---------NDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRL-DHDNIVKVFEILG   78 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEE---------TTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred             CCceeEEEEeccCCCeEEEEEEE---------CCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEecc
Confidence            57899999999999999999984         445567999998754 345567788999999999 9999999998863


Q ss_pred             c---------------CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeec-CC
Q psy3166          89 K---------------DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLS-SP  133 (228)
Q Consensus        89 ~---------------~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~-~~  133 (228)
                      .               ...+++||++. ++|.+++..                   .|||++||+|+||||+||+++ .+
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED  157 (320)
T ss_dssp             TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred             ccccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence            2               34789999997 589887653                   699999999999999999997 46


Q ss_pred             CcEEEeeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         134 HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      +.+||+|||++.................++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+..+.
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTLFAGAHELEQMQL  236 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence            79999999998755332111112223345677999998875 568999999999999999999 9999999887777666


Q ss_pred             HHcC
Q psy3166         213 LSTG  216 (228)
Q Consensus       213 ~~~~  216 (228)
                      +...
T Consensus       237 ~~~~  240 (320)
T 2i6l_A          237 ILES  240 (320)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            5543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.4e-35  Score=239.65  Aligned_cols=177  Identities=22%  Similarity=0.375  Sum_probs=148.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|+.         ..++..||+|.++...    ...+.+|+.+++++.+||||+++++++.
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~  101 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAIN---------ITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVK  101 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEE---------CCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence            47899999999999999999984         3445579999987432    3567899999999966999999999987


Q ss_pred             c---CceEEEEecCCCCcHHHHHHH-----------------hcccCCCCcccCCCCCCEeecCCC-cEEEeeccCcccc
Q psy3166          89 K---DELRLVVEYCALGDLQSYLRE-----------------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDI  147 (228)
Q Consensus        89 ~---~~~~lv~e~~~~~~L~~~l~~-----------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~dfg~~~~~  147 (228)
                      .   ...+++||++.+++|.+++..                 .|||++||+||||||+||+++.++ .+||+|||++...
T Consensus       102 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          102 DPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             CTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             cCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            5   347899999999999887643                 699999999999999999999776 8999999999755


Q ss_pred             cccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      .....    .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||..
T Consensus       182 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~  233 (330)
T 3nsz_A          182 HPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFH  233 (330)
T ss_dssp             CTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSC
T ss_pred             CCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh-CCCCccc
Confidence            43321    223567788999999886 568999999999999999999 9999854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-36  Score=247.30  Aligned_cols=182  Identities=32%  Similarity=0.509  Sum_probs=150.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||.||+|+..+          +..||+|.+...........+.+|+.+++++ +||||++++++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~   95 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLAD----------GTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGF   95 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCSS----------SCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEecC----------CCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEE
Confidence            567899999999999999999996432          3469999987653333233678999999999 89999999999


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH------------------------hcccCC---CCcccCCCCCCEeecCCCcEEE
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE------------------------EYLSNN---KVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~---~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      +... ..+++|||+.+++|.+++..                        .|||++   +|+|+||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            8764 47899999999999998763                        589999   9999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      +|||++.........  ......||..|+|||.+.+..++.++|+||+|+++|+|++ |..||.
T Consensus       176 ~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~  236 (326)
T 3uim_A          176 GDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD  236 (326)
T ss_dssp             CCCSSCEECCSSSSC--EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH-CCCSBC
T ss_pred             ccCccccccCccccc--ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh-CCCccc
Confidence            999998755332211  1223457889999999988889999999999999999999 999995

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.4e-35  Score=246.14  Aligned_cols=188  Identities=22%  Similarity=0.392  Sum_probs=153.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|.         +..++..||+|.++... .......+.+|+.+++++ +||||+++++++.
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  111 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAI---------DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFT  111 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEC
T ss_pred             ccEEEEeEEecCCCeEEEEEE---------ECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhhee
Confidence            689999999999999999998         44456689999987543 344456788999999999 8999999999986


Q ss_pred             cCc-------eEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          89 KDE-------LRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        89 ~~~-------~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ...       .+++||++. ++|.+++..                  .|||++||+||||||+||+++.++.+||+|||+
T Consensus       112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             ccCCcccceeEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            543       389999996 577776432                  699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +......      .....+|..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+.+..+.+
T Consensus       191 a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~  256 (371)
T 4exu_A          191 ARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILK  256 (371)
T ss_dssp             C--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence            8744222      223566788999999886 678999999999999999999 9999999887777666543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=246.05  Aligned_cols=210  Identities=25%  Similarity=0.449  Sum_probs=164.5

Q ss_pred             ccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           3 LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         3 ~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      -.|.++.++|++.+.||+|+||.||+|.+.+            .+|+|.++.... ....+.+.+|+.+++++ +||||+
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv   92 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVV   92 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEe
Confidence            3578999999999999999999999998532            389998864421 22224566799999999 999999


Q ss_pred             EeeeEEEcC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          82 SFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        82 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++++++... ..+++||++.+++|.+++..                     .|||+++|+|+||||+||+++ ++.++|+
T Consensus        93 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B           93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             CCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEEC
T ss_pred             EEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEe
Confidence            999998765 48899999999999998753                     699999999999999999998 6899999


Q ss_pred             eccCccccccccc--ccCCCCCCCCcceeeccccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         140 DFGLSEDIYEQNV--FQNGEPSEKLPIRWLALESLVS---------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       140 dfg~~~~~~~~~~--~~~~~~~~~~~~~~~~Pe~~~~---------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      |||++........  .........|+..|+|||++..         ..++.++|+||||+++|+|++ |..||...+..+
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~  250 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQPAEA  250 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH-SSCSSSSCCHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence            9998764422111  1112223457788999999874         347889999999999999999 999999999888


Q ss_pred             HHHHHHcCCCCCCC-CCCCC
Q psy3166         209 IVHYLSTGYRMERP-ASCNE  227 (228)
Q Consensus       209 ~~~~~~~~~~~~~p-~~~~~  227 (228)
                      +...+..+.++..+ .++|+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~  270 (319)
T 2y4i_B          251 IIWQMGTGMKPNLSQIGMGK  270 (319)
T ss_dssp             HHHHHHTTCCCCCCCSSCCT
T ss_pred             HHHHhccCCCCCCCcCCCCH
Confidence            88888888776654 35554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-35  Score=249.07  Aligned_cols=184  Identities=28%  Similarity=0.404  Sum_probs=145.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      .+|++.+.||+|+||+||+|++.         .++..||+|.+.....     ...+|+++|+++ +||||+++++++..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vaiK~~~~~~~-----~~~~E~~il~~l-~hpniv~l~~~~~~  118 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR-----FKNRELQIMRKL-DHCNIVRLRYFFYS  118 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECCTT-----SCCHHHHHHHTC-CCTTBCCEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccch-----hHHHHHHHHHHc-CCCCccceeeEEec
Confidence            36999999999999999999853         3455799999865422     123699999999 99999999998753


Q ss_pred             -----Cc--eEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCC-CcEE
Q psy3166          90 -----DE--LRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSP-HVVK  137 (228)
Q Consensus        90 -----~~--~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~-~~~k  137 (228)
                           +.  +++||||+++ ++.+.+..                        .|||+++|+||||||+|||++.+ +.+|
T Consensus       119 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             EETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEE
T ss_pred             cCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEE
Confidence                 11  5689999976 55544321                        69999999999999999999965 6789


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      |+|||+++.+....    ......+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus       198 l~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~l~~i~  270 (420)
T 1j1b_A          198 LCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEII  270 (420)
T ss_dssp             ECCCTTCEECCTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred             eccchhhhhcccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence            99999997553321    12234667889999998764 68999999999999999999 999999987766555443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=247.72  Aligned_cols=188  Identities=22%  Similarity=0.284  Sum_probs=144.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHH----------HHHHHHHHHHHHhcCC
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT----------YDKFLKEINLMKDVGK   76 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~~   76 (228)
                      +..++|++.+.||+|+||.||+|.....      ..++..+|+|..........          ...+.+|+..++.+ +
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~  106 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNK------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-D  106 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSS------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-S
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCC------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-c
Confidence            4567899999999999999999986542      23556799999875532211          12355788888999 9


Q ss_pred             CCceEEeeeEEEc----C-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeec
Q psy3166          77 HDHIVSFIGCCYK----D-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLS  131 (228)
Q Consensus        77 h~ni~~~~~~~~~----~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~  131 (228)
                      ||||+++++++..    . ..+++||++ +++|.+++..                    .|||+++|+||||||+||+++
T Consensus       107 h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          107 YLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG  185 (345)
T ss_dssp             CCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             ccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc
Confidence            9999999998765    2 378999999 9999998653                    699999999999999999999


Q ss_pred             CCC--cEEEeeccCccccccccccc----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         132 SPH--VVKISDFGLSEDIYEQNVFQ----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       132 ~~~--~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      .++  .+||+|||+++.+.......    .......|+..|+|||++.+..++.++|+|||||++|+|++ |..||.+
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~  262 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC-GKLPWEQ  262 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCTTGG
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCccc
Confidence            877  99999999997654332111    11134567889999999998889999999999999999999 9999965

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=248.93  Aligned_cols=181  Identities=27%  Similarity=0.455  Sum_probs=149.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-------HHHHHHHHHHHHHHhcCCCCceE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-------KTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .++|++.+.||+|+||.||+|+         +..++..||+|.++.....       .....+.+|+.+++++ +||||+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv   92 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAV---------DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANII   92 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEE---------ETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBC
T ss_pred             ccceEEEeEEEecCCEEEEEEE---------ECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEe
Confidence            3689999999999999999998         4445667999998754211       1223466799999999 999999


Q ss_pred             EeeeEEEcCc-eEEEEecCCCC-cHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          82 SFIGCCYKDE-LRLVVEYCALG-DLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        82 ~~~~~~~~~~-~~lv~e~~~~~-~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      ++++++.... .+++||++.+| +|.+++..                    .|||+++|+||||||+||+++.++.+||+
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~  172 (335)
T 3dls_A           93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLI  172 (335)
T ss_dssp             CEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEe
Confidence            9999987755 78999998666 99988764                    69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      |||++..+.....    .....||..|+|||++.+..+ +.++|+|||||++|+|++ |..||...
T Consensus       173 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  233 (335)
T 3dls_A          173 DFGSAAYLERGKL----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-EENPFCEL  233 (335)
T ss_dssp             CCTTCEECCTTCC----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSCSSG
T ss_pred             ecccceECCCCCc----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh-CCCchhhH
Confidence            9999876543321    123457889999999987776 788999999999999999 99999763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.9e-36  Score=239.03  Aligned_cols=204  Identities=27%  Similarity=0.438  Sum_probs=156.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|.....||+|+||.||+|...         .++..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   89 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDL---------SNQVRIAIKEIPERDS-RYSQPLHEEIALHKHL-KHKNIVQYLGSFS   89 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEET---------TTCCEEEEEEEECCCC----HHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEEC---------CCCeEEEEEEccCCch-HHHHHHHHHHHHHHhC-CCCCEeeEeeEEE
Confidence            334444559999999999999843         3455799999875532 3346788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecC-CCcEEEeeccC
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSS-PHVVKISDFGL  143 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~dfg~  143 (228)
                      ... .+++||++++++|.+++..                       .|||+++|+|+||||+||+++. ++.++|+|||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~  169 (295)
T 2clq_A           90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT  169 (295)
T ss_dssp             ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred             eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence            654 7899999999999988753                       5899999999999999999997 89999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI--YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI--VHYLSTGYRM  219 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~--~~~~~~~~~~  219 (228)
                      +........   ......++..|+|||++....  ++.++|+||||+++|+|++ |..||........  ........++
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  245 (295)
T 2clq_A          170 SKRLAGINP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGEPQAAMFKVGMFKVHP  245 (295)
T ss_dssp             CEESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH-TSCTTGGGSSHHHHHHHHHHHCCCC
T ss_pred             ccccCCCCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH-CCCCccCCCchhHHHHhhccccccc
Confidence            875433211   122356788899999987643  7889999999999999999 9999976543322  2233345566


Q ss_pred             CCCCCCCC
Q psy3166         220 ERPASCNE  227 (228)
Q Consensus       220 ~~p~~~~~  227 (228)
                      +.|..+|+
T Consensus       246 ~~~~~~~~  253 (295)
T 2clq_A          246 EIPESMSA  253 (295)
T ss_dssp             CCCTTSCH
T ss_pred             cccccCCH
Confidence            66766653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-35  Score=240.79  Aligned_cols=186  Identities=27%  Similarity=0.498  Sum_probs=134.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHH-HHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN-LMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~~h~ni~~   82 (228)
                      .|.++.++|++.+.||+|+||.||+|..         ..++..||+|.++.........++..|+. +++.+ +||||++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~   85 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVH---------KPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQ   85 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEE---------TTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCC
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEE---------cCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEee
Confidence            4678899999999999999999999984         34556799999987655555566677777 55555 9999999


Q ss_pred             eeeEEEcCc-eEEEEecCCCCcHHHHHHH-------------------------hcccCC-CCcccCCCCCCEeecCCCc
Q psy3166          83 FIGCCYKDE-LRLVVEYCALGDLQSYLRE-------------------------EYLSNN-KVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        83 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~-------------------------~~lh~~-~i~H~~lk~~nil~~~~~~  135 (228)
                      +++++.... .+++||++.+ +|.+++..                         .|||++ +|+|+||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~  164 (327)
T 3aln_A           86 FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN  164 (327)
T ss_dssp             EEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE
T ss_pred             eeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC
Confidence            999987654 7899999975 77666541                         589999 9999999999999999999


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeeccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL----VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~----~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +||+|||++..+.....    .....++..|+|||++    ....++.++|+||||+++|+|++ |..||.+..
T Consensus       165 ~kl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  233 (327)
T 3aln_A          165 IKLCDFGISGQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWN  233 (327)
T ss_dssp             EEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHH-SCCCSSCC-
T ss_pred             EEEccCCCceecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH-CCCCCCCcc
Confidence            99999999875533221    1223577889999998    35568899999999999999999 999998754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=240.94  Aligned_cols=190  Identities=25%  Similarity=0.428  Sum_probs=136.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+...+|++.+.||+|+||.||+|.+         ..++..||+|.+... .......+.+|+.+++++.+||||+++++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~   93 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQD---------VGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCS   93 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEE---------TTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             eccCceEEEEEEEccCCceEEEEEEE---------CCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccc
Confidence            35567899999999999999999984         334557999988654 34445678899999999956999999999


Q ss_pred             EEEc-------C--ceEEEEecCCCCcHHHHHHH-----------------------hcccCCC--CcccCCCCCCEeec
Q psy3166          86 CCYK-------D--ELRLVVEYCALGDLQSYLRE-----------------------EYLSNNK--VVHRDLATRNILLS  131 (228)
Q Consensus        86 ~~~~-------~--~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~--i~H~~lk~~nil~~  131 (228)
                      ++..       .  .++++||++. |+|.+++..                       .|||+++  |+|+||||+||+++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~  172 (337)
T 3ll6_A           94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS  172 (337)
T ss_dssp             EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred             cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence            8842       1  2689999995 688887653                       6999999  99999999999999


Q ss_pred             CCCcEEEeeccCccccccccccc---------CCCCCCCCcceeeccccc---ccCCCCchhhHHHHHHHHHHHHhCCCC
Q psy3166         132 SPHVVKISDFGLSEDIYEQNVFQ---------NGEPSEKLPIRWLALESL---VSNIYTNKSDVWSFGVVLWEIVTLGAN  199 (228)
Q Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~Pe~~---~~~~~~~~~Diwslg~~~~~l~t~g~~  199 (228)
                      .++.+||+|||++..........         .......++..|+|||++   ....++.++|+||||+++|+|++ |..
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~  251 (337)
T 3ll6_A          173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-RQH  251 (337)
T ss_dssp             TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHH-SSC
T ss_pred             CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHh-CCC
Confidence            99999999999987654332111         011134578889999998   45568899999999999999999 999


Q ss_pred             CCCCCCHH
Q psy3166         200 PYPHIPLC  207 (228)
Q Consensus       200 pf~~~~~~  207 (228)
                      ||......
T Consensus       252 p~~~~~~~  259 (337)
T 3ll6_A          252 PFEDGAKL  259 (337)
T ss_dssp             CC------
T ss_pred             CCcchhHH
Confidence            99875443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=242.06  Aligned_cols=183  Identities=33%  Similarity=0.514  Sum_probs=140.0

Q ss_pred             CccCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHH--HHhcCCCCc
Q psy3166           2 ALSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL--MKDVGKHDH   79 (228)
Q Consensus         2 ~~~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~~h~n   79 (228)
                      +..++++.++|++.+.||+|+||.||+|+.           ++..||+|.++...    ...+..|.++  +..+ +|||
T Consensus         5 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~-~h~~   68 (336)
T 3g2f_A            5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN----RQNFINEKNIYRVPLM-EHDN   68 (336)
T ss_dssp             ----CCCTTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTC-CCTT
T ss_pred             ccCCCcChHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc----hhhHHHHHHHHHHHhc-cCcc
Confidence            345689999999999999999999999974           23469999986442    2233344444  4446 9999


Q ss_pred             eEEeeeEEEc----C--ceEEEEecCCCCcHHHHHHH-------------------hcccCC---------CCcccCCCC
Q psy3166          80 IVSFIGCCYK----D--ELRLVVEYCALGDLQSYLRE-------------------EYLSNN---------KVVHRDLAT  125 (228)
Q Consensus        80 i~~~~~~~~~----~--~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~---------~i~H~~lk~  125 (228)
                      |+++++.+..    +  .+++||||+++|+|.+++..                   .|||++         +|+||||||
T Consensus        69 i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp  148 (336)
T 3g2f_A           69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS  148 (336)
T ss_dssp             BCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSG
T ss_pred             hhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeeccccc
Confidence            9999975432    1  36899999999999999864                   699999         999999999


Q ss_pred             CCEeecCCCcEEEeeccCcccccccccc-----cCCCCCCCCcceeeccccccc-------CCCCchhhHHHHHHHHHHH
Q psy3166         126 RNILLSSPHVVKISDFGLSEDIYEQNVF-----QNGEPSEKLPIRWLALESLVS-------NIYTNKSDVWSFGVVLWEI  193 (228)
Q Consensus       126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Diwslg~~~~~l  193 (228)
                      +|||++.++.+||+|||++..+......     ........||..|+|||++.+       ..++.++|||||||++|+|
T Consensus       149 ~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~el  228 (336)
T 3g2f_A          149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI  228 (336)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHH
Confidence            9999999999999999999765432211     112224568899999999876       3456789999999999999


Q ss_pred             HhCCCCCC
Q psy3166         194 VTLGANPY  201 (228)
Q Consensus       194 ~t~g~~pf  201 (228)
                      ++ |..||
T Consensus       229 l~-g~~p~  235 (336)
T 3g2f_A          229 FM-RCTDL  235 (336)
T ss_dssp             HT-TBGGG
T ss_pred             Hh-cCCcC
Confidence            99 86554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.9e-36  Score=245.48  Aligned_cols=193  Identities=27%  Similarity=0.447  Sum_probs=151.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-------HHHHHHHHHHHHHHHhcCCCCceE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-------AKTYDKFLKEINLMKDVGKHDHIV   81 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~~h~ni~   81 (228)
                      .++|++.+.||+|+||.||+|..         ..++..||+|.+.....       ......+.+|+++++++ +||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~   78 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFE---------RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCII   78 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBC
T ss_pred             hhceeEeeEEecCCCEEEEEEEE---------cCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCc
Confidence            36899999999999999999984         44556799999864321       11223577899999999 999999


Q ss_pred             EeeeEEEcCceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC---cEEE
Q psy3166          82 SFIGCCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH---VVKI  138 (228)
Q Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~---~~kl  138 (228)
                      ++++++.....++|||++++++|.+++..                    .|||+++|+|+||||+||+++.++   .+||
T Consensus        79 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           79 KIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             CEEEEEESSSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             eEeeEEcCCceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEE
Confidence            99999988889999999999999887643                    699999999999999999998765   4999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIVHYLS  214 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~~~~~  214 (228)
                      +|||++.........    ....++..|+|||++.   ...++.++|+|||||++|+|++ |..||...... .+...+.
T Consensus       159 ~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~  233 (322)
T 2ycf_A          159 TDFGHSKILGETSLM----RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSLKDQIT  233 (322)
T ss_dssp             CCCTTCEECCCCHHH----HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH-SSCSSCSTTCSSCHHHHHH
T ss_pred             ccCccceeccccccc----ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchHHHHHHHHH
Confidence            999998755332211    1134567899999874   4568899999999999999999 99999875433 3444455


Q ss_pred             cC
Q psy3166         215 TG  216 (228)
Q Consensus       215 ~~  216 (228)
                      .+
T Consensus       234 ~~  235 (322)
T 2ycf_A          234 SG  235 (322)
T ss_dssp             HT
T ss_pred             hC
Confidence            44

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.6e-36  Score=244.83  Aligned_cols=186  Identities=32%  Similarity=0.495  Sum_probs=152.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ...++|++.+.||+|+||.||+|++++          +..||+|.+..... ...+.+.+|+.+++++ +||||++++++
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~  103 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESS-QGIEEFETEIETLSFC-RHPHLVSLIGF  103 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTT----------CCEEEEEECCSCCS-SHHHHHHHHHHGGGSC-CCTTBCCEEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECC----------CCEEEEEEecccCh-HHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence            345789999999999999999998432          34699998875532 3456788999999999 99999999999


Q ss_pred             EEcC-ceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          87 CYKD-ELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        87 ~~~~-~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +... ..++||||+++++|.+++..                        .|||+++|+|+||||+||+++.++.+||+||
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeec
Confidence            8664 48899999999999876521                        6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      |++........ ........|+..|+|||++.+..++.++|+||||+++|+|++ |..||.+..+
T Consensus       184 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~p~~~~~~  246 (321)
T 2qkw_B          184 GISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC-ARSAIVQSLP  246 (321)
T ss_dssp             TTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHH-CCTTCSCSSS
T ss_pred             ccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHh-CCCcccccCc
Confidence            99875432211 111223456788999999988889999999999999999999 9999976543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.4e-35  Score=242.00  Aligned_cols=188  Identities=27%  Similarity=0.362  Sum_probs=153.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC-----ceEEe
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD-----HIVSF   83 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~-----ni~~~   83 (228)
                      .++|++.+.||+|+||+||+|+.         ..++..||+|.++..  ......+..|+.+++.+.+|+     +++.+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYD---------RVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEE---------cCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            36899999999999999999984         445567999998743  334456778888888885465     49999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH----------------------hccc--CCCCcccCCCCCCEeec--CCCcE
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE----------------------EYLS--NNKVVHRDLATRNILLS--SPHVV  136 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh--~~~i~H~~lk~~nil~~--~~~~~  136 (228)
                      .+++.. +..++|||++. ++|.+++..                      .|||  +.+|+||||||+|||+.  .++.+
T Consensus       122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcE
Confidence            988766 45889999995 599888754                      5788  57999999999999995  47789


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ||+|||++......      .....+|..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+.+..+..
T Consensus       201 kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             EECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred             EEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            99999998754322      234567888999999998889999999999999999999 9999999888877776655

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.4e-36  Score=243.64  Aligned_cols=209  Identities=19%  Similarity=0.280  Sum_probs=156.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .++.++|++.+.||+|+||.||++..         ..++..||+|.+... .......+.+|+.+++++ +||||+++++
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   93 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEG---------LHDGHFYALKRILCH-EQQDREEAQREADMHRLF-NHPNILRLVA   93 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEE---------TTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTC-CCTTBCCCCE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEe---------cCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhc-CCCCeeeEEE
Confidence            46778999999999999999999984         344567999988654 344567788999999999 9999999999


Q ss_pred             EEEc-----CceEEEEecCCCCcHHHHHHH------------------------hcccCCCCcccCCCCCCEeecCCCcE
Q psy3166          86 CCYK-----DELRLVVEYCALGDLQSYLRE------------------------EYLSNNKVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        86 ~~~~-----~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~i~H~~lk~~nil~~~~~~~  136 (228)
                      ++..     ...+++||++.+++|.+++..                        .|||+++|+|+||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~  173 (317)
T 2buj_A           94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP  173 (317)
T ss_dssp             EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred             EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCE
Confidence            8752     247899999999999988753                        59999999999999999999999999


Q ss_pred             EEeeccCccccccccccc------CCCCCCCCcceeecccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCC--
Q psy3166         137 KISDFGLSEDIYEQNVFQ------NGEPSEKLPIRWLALESLVSNI---YTNKSDVWSFGVVLWEIVTLGANPYPHIP--  205 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~~Pe~~~~~~---~~~~~Diwslg~~~~~l~t~g~~pf~~~~--  205 (228)
                      +|+|||++..........      .......++..|+|||.+....   ++.++|+||||+++|+|++ |..||....  
T Consensus       174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~  252 (317)
T 2buj_A          174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF-GEGPYDMVFQK  252 (317)
T ss_dssp             EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH-SSCTTHHHHHT
T ss_pred             EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh-CCCChhhhhcc
Confidence            999999876432211000      0001123467899999987543   6889999999999999999 999996421  


Q ss_pred             HHHHHHHHHcCCCCCCCCCCC
Q psy3166         206 LCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       206 ~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      ...+...+....+.+.+..+|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~  273 (317)
T 2buj_A          253 GDSVALAVQNQLSIPQSPRHS  273 (317)
T ss_dssp             TSCHHHHHHCC--CCCCTTSC
T ss_pred             cchhhHHhhccCCCCccccCC
Confidence            122333344444444444444

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.1e-36  Score=247.47  Aligned_cols=185  Identities=14%  Similarity=0.176  Sum_probs=139.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHHHHHHHHhcC-CCCce
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLKEINLMKDVG-KHDHI   80 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-~h~ni   80 (228)
                      .++.+..+|++.+.||+|+||+||+|.+         ..++..||+|.++....  ......+.+|+.+++.+. +||||
T Consensus        56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~i  126 (371)
T 3q60_A           56 LLSQGERKLKLVEPLRVGDRSVVFLVRD---------VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE  126 (371)
T ss_dssp             TTTCCEEEEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----
T ss_pred             cCCCCceeeeeeeeccCCCCEEEEEEEE---------CCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhh
Confidence            3566777899999999999999999984         34556799999986542  334556778876666663 59998


Q ss_pred             EEee-------eEEEc------------------CceEEEEecCCCCcHHHHHHH-------------------------
Q psy3166          81 VSFI-------GCCYK------------------DELRLVVEYCALGDLQSYLRE-------------------------  110 (228)
Q Consensus        81 ~~~~-------~~~~~------------------~~~~lv~e~~~~~~L~~~l~~-------------------------  110 (228)
                      ++++       +++..                  ..+++||||+. ++|.+++..                         
T Consensus       127 v~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~  205 (371)
T 3q60_A          127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIR  205 (371)
T ss_dssp             -----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHH
Confidence            8855       33321                  22789999998 799988753                         


Q ss_pred             --hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeeccccccc--CCCCchhhHHHH
Q psy3166         111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS--NIYTNKSDVWSF  186 (228)
Q Consensus       111 --~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Diwsl  186 (228)
                        .|||+++|+||||||+|||++.++.+||+|||++........      ...++..|+|||++.+  ..++.++|+|||
T Consensus       206 aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          206 LAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP------ASSVPVTYAPREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             HHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE------GGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred             HHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc------CccCCcCCcChhhccCCCCCcCccccHHHH
Confidence              589999999999999999999999999999999875432211      2344578999999987  678999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCC
Q psy3166         187 GVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       187 g~~~~~l~t~g~~pf~~~~  205 (228)
                      ||++|+|++ |..||.+..
T Consensus       280 G~il~ellt-g~~Pf~~~~  297 (371)
T 3q60_A          280 GLSIYRVWC-LFLPFGLVT  297 (371)
T ss_dssp             HHHHHHHHH-SSCSTTBCC
T ss_pred             HHHHHHHHh-CCCCCCCcC
Confidence            999999999 999998763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.2e-35  Score=235.02  Aligned_cols=182  Identities=27%  Similarity=0.497  Sum_probs=145.8

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHh--cCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD--VGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~~h~ni~~~   83 (228)
                      .+-.++|++.+.||+|+||.||+|++           ++..||+|.+...    ....+.+|.+++..  + +||||+++
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l-~h~niv~~   67 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR----DEKSWFRETELYNTVML-RHENILGF   67 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG----GHHHHHHHHHHHHHTCC-CCTTBCCE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc----cchhhHHHHHHHHHhhc-cCcCeeeE
Confidence            34568999999999999999999975           2346999998643    22445567777666  6 89999999


Q ss_pred             eeEEEc-----CceEEEEecCCCCcHHHHHHH-------------------hccc--------CCCCcccCCCCCCEeec
Q psy3166          84 IGCCYK-----DELRLVVEYCALGDLQSYLRE-------------------EYLS--------NNKVVHRDLATRNILLS  131 (228)
Q Consensus        84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-------------------~~lh--------~~~i~H~~lk~~nil~~  131 (228)
                      ++++..     ...+++|||+++|+|.+++..                   .|||        +++|+||||||+||+++
T Consensus        68 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~  147 (301)
T 3q4u_A           68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK  147 (301)
T ss_dssp             EEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred             EEeeccccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence            988643     237899999999999998764                   6999        99999999999999999


Q ss_pred             CCCcEEEeeccCcccccccccc-cCCCCCCCCcceeecccccccC------CCCchhhHHHHHHHHHHHHhCC-------
Q psy3166         132 SPHVVKISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSN------IYTNKSDVWSFGVVLWEIVTLG-------  197 (228)
Q Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Diwslg~~~~~l~t~g-------  197 (228)
                      .++.+||+|||++......... ........||..|+|||++.+.      .++.++|+|||||++|+|++ |       
T Consensus       148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~  226 (301)
T 3q4u_A          148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIV  226 (301)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBC
T ss_pred             CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh-hhcCcccc
Confidence            9999999999998755443221 1223345788999999999866      34468999999999999999 9       


Q ss_pred             ---CCCCCCC
Q psy3166         198 ---ANPYPHI  204 (228)
Q Consensus       198 ---~~pf~~~  204 (228)
                         ..||...
T Consensus       227 ~~~~~pf~~~  236 (301)
T 3q4u_A          227 EDYKPPFYDV  236 (301)
T ss_dssp             CCCCCTTTTT
T ss_pred             cccccccccc
Confidence               8888653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-35  Score=244.97  Aligned_cols=185  Identities=26%  Similarity=0.402  Sum_probs=145.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      .+|++.+.||+|+||+||+|+...         ++ .+|+|++......     ..+|+++++.+ +||||+++++++..
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~~-----~~~E~~il~~l-~h~niv~l~~~~~~  103 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKRF-----KNRELQIMRIV-KHPNVVDLKAFFYS  103 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTTS-----CCHHHHHHHTC-CCTTBCCEEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcch-----HHHHHHHHHhC-CCCCcceEEEEEEe
Confidence            479999999999999999998533         22 3888887543221     13699999999 99999999998854


Q ss_pred             Cc-------eEEEEecCCCCcHHHHHH------------------H-----hcccCCCCcccCCCCCCEeec-CCCcEEE
Q psy3166          90 DE-------LRLVVEYCALGDLQSYLR------------------E-----EYLSNNKVVHRDLATRNILLS-SPHVVKI  138 (228)
Q Consensus        90 ~~-------~~lv~e~~~~~~L~~~l~------------------~-----~~lh~~~i~H~~lk~~nil~~-~~~~~kl  138 (228)
                      ..       +++||||++++.+.....                  +     .|||++||+||||||+|||++ .++.+||
T Consensus       104 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL  183 (394)
T 4e7w_A          104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL  183 (394)
T ss_dssp             ESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             cCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE
Confidence            21       679999997753332211                  0     699999999999999999999 7899999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +|||+++.+....    ......+|..|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+.+..+.+
T Consensus       184 ~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~l~~i~~  256 (394)
T 4e7w_A          184 IDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVEIIK  256 (394)
T ss_dssp             CCCTTCEECCTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred             eeCCCcccccCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            9999997553322    12235668889999998765 58999999999999999999 9999999887766555443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-34  Score=234.86  Aligned_cols=188  Identities=23%  Similarity=0.353  Sum_probs=154.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC------ceEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD------HIVS   82 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~------ni~~   82 (228)
                      .++|++.+.||+|+||.||+|...        ...+..||+|.++..  ......+.+|+.+++.+ +|+      ++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~   81 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHL-NTTDPNSTFRCVQ   81 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHH-HHHCTTCTTCBCC
T ss_pred             cCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecC--CchhHHHHHHHHHHHHh-hhcCCCCceeeEe
Confidence            479999999999999999999742        234567999998643  34456778899999888 554      5999


Q ss_pred             eeeEEEcC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC-------
Q psy3166          83 FIGCCYKD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS-------  132 (228)
Q Consensus        83 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~-------  132 (228)
                      +++++... ..++|||++ +++|.+++..                      .|||+++|+||||||+||+++.       
T Consensus        82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence            99988664 488999999 8899988764                      5999999999999999999987       


Q ss_pred             ------------CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy3166         133 ------------PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANP  200 (228)
Q Consensus       133 ------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~p  200 (228)
                                  ++.+||+|||++......      .....+|..|+|||++.+..++.++|+|||||++|+|++ |..|
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p  233 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL-GFTV  233 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCS
T ss_pred             CCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh-CCCC
Confidence                        667999999998743221      234567889999999998889999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHc
Q psy3166         201 YPHIPLCRIVHYLST  215 (228)
Q Consensus       201 f~~~~~~~~~~~~~~  215 (228)
                      |...+..+....+..
T Consensus       234 f~~~~~~~~~~~~~~  248 (339)
T 1z57_A          234 FPTHDSKEHLAMMER  248 (339)
T ss_dssp             CCCSCHHHHHHHHHH
T ss_pred             CCCCChHHHHHHHHH
Confidence            999888776655544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.2e-35  Score=238.60  Aligned_cols=193  Identities=24%  Similarity=0.397  Sum_probs=153.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-HHHHHHHHHHHHHHhcC--CCCceEEeee
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-KTYDKFLKEINLMKDVG--KHDHIVSFIG   85 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~--~h~ni~~~~~   85 (228)
                      .++|++.+.||+|+||.||+|+...        ..+..||+|.++..... .....+.+|+.+++.+.  +||||+++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~   81 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD   81 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeee
Confidence            3789999999999999999998521        33457999998643211 11123456777666553  7999999999


Q ss_pred             EEE-----c-CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          86 CCY-----K-DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        86 ~~~-----~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      ++.     . ...+++||++. ++|.+++..                      .|||++||+|+||||+||+++.++.+|
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           82 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEE
Confidence            875     2 33789999997 599888754                      589999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      |+|||++........    .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+..
T Consensus       161 l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~  233 (326)
T 1blx_A          161 LADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD  233 (326)
T ss_dssp             ECSCCSCCCCCGGGG----GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             EecCcccccccCCCC----ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHH
Confidence            999999875433221    223566788999999998889999999999999999999 9999999888777666554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.8e-35  Score=233.33  Aligned_cols=193  Identities=31%  Similarity=0.461  Sum_probs=158.2

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|...         .++..||+|.+.... .......+.+|+++++++ +||||+++++++
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   90 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEIL   90 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEc---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEE
Confidence            368999999999999999999843         345579999986442 223346788999999999 999999999998


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCC---CcEEEeeccC
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSP---HVVKISDFGL  143 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~---~~~kl~dfg~  143 (228)
                      .... .+++||++++++|.+++..                    .|||+++++|+||||+||+++.+   +.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           91 EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             eCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            7654 7899999999999887653                    69999999999999999999764   4799999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      +........    .....++..|+|||.+.+. ++.++|+||||+++|+|++ |..||.+.+..++...+..+.
T Consensus       171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  238 (287)
T 2wei_A          171 STCFQQNTK----MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGK  238 (287)
T ss_dssp             GGTBCCCSS----CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred             ceeecCCCc----cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Confidence            875433211    1223467789999988754 8899999999999999999 999999998888888877764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.4e-35  Score=235.36  Aligned_cols=181  Identities=24%  Similarity=0.343  Sum_probs=145.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE-
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC-   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~-   87 (228)
                      .++|++.+.||+|+||.||+|+.         ..+++.||+|.+......   ..+.+|+.+++++ +|++++..+..+ 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~~~~~i~~~~~~~   74 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTKH---PQLHIESKIYKMM-QGGVGIPTIRWCG   74 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEEESCSSC---CHHHHHHHHHHHH-TTSTTCCCEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEE---------cCCCcEEEEEEecCCcch---hHHHHHHHHHHHh-hcCCCCCcccccc
Confidence            47899999999999999999983         445568999998654322   3577899999999 666555444444 


Q ss_pred             Ec-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeec---CCCcEEEeecc
Q psy3166          88 YK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLS---SPHVVKISDFG  142 (228)
Q Consensus        88 ~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~---~~~~~kl~dfg  142 (228)
                      .. +..+++||++ +++|.+++..                     .|||+++|+|+||||+||+++   .++.+||+|||
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           75 AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             CCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            33 3478999999 8999998863                     699999999999999999994   78899999999


Q ss_pred             Cccccccccccc----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         143 LSEDIYEQNVFQ----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       143 ~~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      ++..........    .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~  218 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGL  218 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSC
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCc
Confidence            987654432211    11234577889999999998889999999999999999999 99999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.7e-35  Score=240.76  Aligned_cols=188  Identities=23%  Similarity=0.396  Sum_probs=152.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|+.         ..++..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   92 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAID---------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVF   92 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEE
T ss_pred             CceEEEeeeEecCCCeEEEEEEE---------CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheE
Confidence            37899999999999999999984         4456689999987543 344456788999999999 899999999998


Q ss_pred             EcCc-------eEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          88 YKDE-------LRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        88 ~~~~-------~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ....       .+++||++. ++|.+++..                  .|||++||+|+||||+||+++.++.+||+|||
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A           93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CSCSSGGGCCCCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             ecccccccceeEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence            6542       489999996 477654321                  79999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      ++......      .....++..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+.+..+.
T Consensus       172 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~~i~  237 (353)
T 3coi_A          172 LARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQIL  237 (353)
T ss_dssp             CTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSSBSSCHHHHHHHHH
T ss_pred             cccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence            98753221      223466788999999886 568899999999999999999 999999988766655543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.2e-35  Score=245.33  Aligned_cols=184  Identities=25%  Similarity=0.388  Sum_probs=134.0

Q ss_pred             Cceee-eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLIL-GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~-~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      +.|++ .+.||+|+||+||+|+...+       .++..||+|.+......   ..+.+|+.+|+++ +||||+++++++.
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~hpniv~~~~~~~   88 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGIS---MSACREIALLREL-KHPNVISLQKVFL   88 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSCC---HHHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCCC---HHHHHHHHHHHhc-CCCCeeeEeeEEe
Confidence            34666 45899999999999986432       23456999999755332   3567899999999 8999999999985


Q ss_pred             c---CceEEEEecCCCCcHHHHHHH-----------------------------hcccCCCCcccCCCCCCEee----cC
Q psy3166          89 K---DELRLVVEYCALGDLQSYLRE-----------------------------EYLSNNKVVHRDLATRNILL----SS  132 (228)
Q Consensus        89 ~---~~~~lv~e~~~~~~L~~~l~~-----------------------------~~lh~~~i~H~~lk~~nil~----~~  132 (228)
                      .   ..+++||||+.+ +|.+++..                             .|||+++|+||||||+|||+    +.
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             ETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred             cCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence            4   348899999964 77666531                             69999999999999999999    66


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ++.+||+|||++..+..............||..|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  241 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE  241 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH-SSCTTCCCC-
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh-CCCCCCCccc
Confidence            7899999999997654322211223345678889999999874 48999999999999999999 9999977543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.1e-35  Score=240.10  Aligned_cols=190  Identities=25%  Similarity=0.388  Sum_probs=139.8

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ..++|++.+.||+|+||.||+|+..         .++..||+|.+......  .....++++.+..+ +||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~h~niv~~~~~~   88 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEK---------STGMSVAIKKVIQDPRF--RNRELQIMQDLAVL-HHPNIVQLQSYF   88 (360)
T ss_dssp             HHTTEEEC----------CEEEEET---------TTCCEEEEEEEECCTTC--CCHHHHHHHHHHHH-CCTTBCCEEEEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEecCccc--cHHHHHHHHHHHhc-CCCCcccHHHhh
Confidence            3468999999999999999999843         34557999988644221  23456778888888 999999999988


Q ss_pred             Ec-Cc-------eEEEEecCCCCcHHHHHHH------------------------hccc--CCCCcccCCCCCCEeecC-
Q psy3166          88 YK-DE-------LRLVVEYCALGDLQSYLRE------------------------EYLS--NNKVVHRDLATRNILLSS-  132 (228)
Q Consensus        88 ~~-~~-------~~lv~e~~~~~~L~~~l~~------------------------~~lh--~~~i~H~~lk~~nil~~~-  132 (228)
                      .. +.       .+++|||+.+ +|.+.+..                        .|||  +++|+||||||+||+++. 
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence            54 11       6799999976 44433221                        5788  999999999999999997 


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH  211 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~  211 (228)
                      ++.+||+|||++..+....    ......+|..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~  242 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLH  242 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred             CCcEEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCcCCCChHHHHH
Confidence            8999999999987554332    122356788899999987554 8999999999999999999 999999988877766


Q ss_pred             HHHc
Q psy3166         212 YLST  215 (228)
Q Consensus       212 ~~~~  215 (228)
                      .+.+
T Consensus       243 ~~~~  246 (360)
T 3e3p_A          243 EIVR  246 (360)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-34  Score=232.70  Aligned_cols=182  Identities=24%  Similarity=0.337  Sum_probs=142.8

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE-
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC-   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~-   87 (228)
                      .++|++.+.||+|+||.||+|+.         ..++..||+|.+.....   ...+.+|+.+++++ +|++++..+..+ 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~~~~~i~~~~~~~   74 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTK---HPQLHIESKIYKMM-QGGVGIPTIRWCG   74 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEC------CCCHHHHHHHHHHH-TTSTTCCCEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEE---------cCCCceEEEEeeccccc---chHHHHHHHHHHHh-cCCCCCCeeeeec
Confidence            47899999999999999999983         44556799998654322   23467899999999 665555554444 


Q ss_pred             Ec-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEee---cCCCcEEEeecc
Q psy3166          88 YK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILL---SSPHVVKISDFG  142 (228)
Q Consensus        88 ~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~---~~~~~~kl~dfg  142 (228)
                      .. +..+++||++ +++|.+++..                     .|||+++|+||||||+||++   +.++.+||+|||
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           75 AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             CCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            43 3478999999 9999998863                     69999999999999999999   778899999999


Q ss_pred             Cccccccccccc----CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         143 LSEDIYEQNVFQ----NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       143 ~~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      ++..........    .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  219 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLK  219 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCC
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc-CCCCCcccc
Confidence            987654432211    12234677889999999998889999999999999999999 999998753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-34  Score=232.00  Aligned_cols=191  Identities=26%  Similarity=0.469  Sum_probs=146.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|+.         ..++..||+|.++..  ......+.+|+.+++++ +||||+++++++..
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   73 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARN---------ALDSRYYAIKKIRHT--EEKLSTILSEVMLLASL-NHQYVVRYYAAWLE   73 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE
T ss_pred             ccchhhheeccCCcEEEEEEEE---------cCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHh
Confidence            5799999999999999999984         334557999998643  34456788999999999 99999999998743


Q ss_pred             --------------CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCC
Q psy3166          90 --------------DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPH  134 (228)
Q Consensus        90 --------------~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~  134 (228)
                                    +..+++||++++++|.+++..                     .|||+++|+|+||||+||+++.++
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred             hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC
Confidence                          237899999999999998863                     699999999999999999999999


Q ss_pred             cEEEeeccCcccccccccc-----------cCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         135 VVKISDFGLSEDIYEQNVF-----------QNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      .++|+|||++.........           ........++..|+|||++.+. .++.++|+||+||++|+|++    ||.
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~----p~~  229 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY----PFS  229 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS----CCS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh----ccC
Confidence            9999999998754322100           0112234567789999998854 68899999999999999997    555


Q ss_pred             C-CCHHHHHHHHHcC
Q psy3166         203 H-IPLCRIVHYLSTG  216 (228)
Q Consensus       203 ~-~~~~~~~~~~~~~  216 (228)
                      . .+..++...+...
T Consensus       230 ~~~~~~~~~~~~~~~  244 (303)
T 1zy4_A          230 TGMERVNILKKLRSV  244 (303)
T ss_dssp             SHHHHHHHHHHHHST
T ss_pred             CchhHHHHHHhcccc
Confidence            4 2333445555543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.2e-35  Score=240.11  Aligned_cols=192  Identities=23%  Similarity=0.353  Sum_probs=148.9

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----------CHHHHHHHHHHHHHHHhcCC
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----------DAKTYDKFLKEINLMKDVGK   76 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~e~~~l~~l~~   76 (228)
                      ...++|++.+.||+|+||.||+|....          +..||+|.+....          .....+.+.+|+.+++++ +
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~   87 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE----------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-H   87 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT----------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-C
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC----------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-C
Confidence            345799999999999999999997422          4569999885432          122346788999999999 9


Q ss_pred             CCceEEeeeEEEc------CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEe
Q psy3166          77 HDHIVSFIGCCYK------DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNIL  129 (228)
Q Consensus        77 h~ni~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil  129 (228)
                      ||||+++++++..      ..+++|||++. ++|.+++..                     .|||+++|+|+||||+||+
T Consensus        88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL  166 (362)
T ss_dssp             CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence            9999999998743      13789999997 577776643                     6999999999999999999


Q ss_pred             ecCCCcEEEeeccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         130 LSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       130 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      ++.++.+||+|||++.......    ......++..|+|||++.+ ..++.++|+||+||++|+|++ |..||.+.+..+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  241 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKALFRGSTFYN  241 (362)
T ss_dssp             ECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred             EcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh-CCCCCCCCCHHH
Confidence            9999999999999986433321    1223466788999999876 668999999999999999999 999999988777


Q ss_pred             HHHHHHc
Q psy3166         209 IVHYLST  215 (228)
Q Consensus       209 ~~~~~~~  215 (228)
                      ..+.+..
T Consensus       242 ~~~~i~~  248 (362)
T 3pg1_A          242 QLNKIVE  248 (362)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            7666543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-34  Score=241.61  Aligned_cols=178  Identities=25%  Similarity=0.367  Sum_probs=146.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC-------CCCceE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG-------KHDHIV   81 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-------~h~ni~   81 (228)
                      .++|++.+.||+|+||+||+|+.         ..++..||+|.++..  ......+.+|+.+++++.       +|+||+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWD---------IQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             CCeEEEEEEeeecCCeeEEEEEe---------cCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            36899999999999999999973         445668999998744  344567889999999983       178899


Q ss_pred             EeeeEEE----c-CceEEEEecCCCCcHHHHHHH----------------------hcccCC-CCcccCCCCCCEeecCC
Q psy3166          82 SFIGCCY----K-DELRLVVEYCALGDLQSYLRE----------------------EYLSNN-KVVHRDLATRNILLSSP  133 (228)
Q Consensus        82 ~~~~~~~----~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~-~i~H~~lk~~nil~~~~  133 (228)
                      ++++++.    . ...++|||++ ++++.+++..                      .|||++ ||+||||||+|||++.+
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred             eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence            9999876    2 2478999999 5566655432                      699998 99999999999999876


Q ss_pred             C-------------------------------------------------cEEEeeccCcccccccccccCCCCCCCCcc
Q psy3166         134 H-------------------------------------------------VVKISDFGLSEDIYEQNVFQNGEPSEKLPI  164 (228)
Q Consensus       134 ~-------------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  164 (228)
                      +                                                 .+||+|||++......      .....+|.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~  257 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTR  257 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCG
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCC
Confidence            5                                                 7999999998754322      23456788


Q ss_pred             eeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       165 ~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      .|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus       258 ~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  297 (397)
T 1wak_A          258 QYRSLEVLIGSGYNTPADIWSTACMAFELAT-GDYLFEPHS  297 (397)
T ss_dssp             GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred             cccCChhhcCCCCCcHHHHHHHHHHHHHHhh-CCCCCCCCc
Confidence            9999999998889999999999999999999 999998755

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-35  Score=244.36  Aligned_cols=196  Identities=22%  Similarity=0.401  Sum_probs=159.1

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH----------------HHHHHHHHHHHHH
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA----------------KTYDKFLKEINLM   71 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~e~~~l   71 (228)
                      ..++|++.+.||+|+||.||+|..           ++..||+|.+......                .....+.+|+.++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   97 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII   97 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHH
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHH
Confidence            347999999999999999999984           4457999998643110                0116788999999


Q ss_pred             HhcCCCCceEEeeeEEEcCc-eEEEEecCCCCcHHHH------HHH----------------------hcccC-CCCccc
Q psy3166          72 KDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSY------LRE----------------------EYLSN-NKVVHR  121 (228)
Q Consensus        72 ~~l~~h~ni~~~~~~~~~~~-~~lv~e~~~~~~L~~~------l~~----------------------~~lh~-~~i~H~  121 (228)
                      +++ +||||+++++++.... .++|||++++++|.++      +..                      .|||+ +||+|+
T Consensus        98 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~  176 (348)
T 2pml_X           98 TDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR  176 (348)
T ss_dssp             TTC-CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred             HhC-CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence            999 8999999999987754 7899999999888776      321                      69998 999999


Q ss_pred             CCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCc-hhhHHHHHHHHHHHHhCCCC
Q psy3166         122 DLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTN-KSDVWSFGVVLWEIVTLGAN  199 (228)
Q Consensus       122 ~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~-~~Diwslg~~~~~l~t~g~~  199 (228)
                      ||||+||+++.++.++|+|||.+.......     .....++..|+|||.+.+. .++. ++|+||||+++|+|++ |..
T Consensus       177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~  250 (348)
T 2pml_X          177 DVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY-NVV  250 (348)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECBTTE-----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH-SSC
T ss_pred             CCChHhEEEcCCCcEEEecccccccccccc-----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh-CCC
Confidence            999999999999999999999987543321     1235677889999999877 5666 8999999999999999 999


Q ss_pred             CCCCCCH-HHHHHHHHcCCCCCCC
Q psy3166         200 PYPHIPL-CRIVHYLSTGYRMERP  222 (228)
Q Consensus       200 pf~~~~~-~~~~~~~~~~~~~~~p  222 (228)
                      ||...+. .++.+.+..+ .++.|
T Consensus       251 pf~~~~~~~~~~~~i~~~-~~~~~  273 (348)
T 2pml_X          251 PFSLKISLVELFNNIRTK-NIEYP  273 (348)
T ss_dssp             SSCCSSCSHHHHHHHTSC-CCCCC
T ss_pred             CCCCCCcHHHHHHHHhcc-CcCCc
Confidence            9998776 6777777766 44444

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-34  Score=247.44  Aligned_cols=184  Identities=21%  Similarity=0.301  Sum_probs=148.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|.+         ..++..||||.+......   .++..|+.+++.+.+++++..+..++.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~   73 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTN---------IQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGV   73 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEE---------TTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEE---------CCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            47899999999999999999984         344557999987654322   346789999999955567766666555


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEee---cCCCcEEEeeccC
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILL---SSPHVVKISDFGL  143 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~---~~~~~~kl~dfg~  143 (228)
                      .. ..+++|||+ +++|.+++..                     .|||+++|+||||||+|||+   +.++.+||+|||+
T Consensus        74 ~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl  152 (483)
T 3sv0_A           74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (483)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence            44 478999999 8999998863                     69999999999999999999   5788999999999


Q ss_pred             cccccccccc----cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         144 SEDIYEQNVF----QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       144 ~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      ++.+......    ........||..|++||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  218 (483)
T 3sv0_A          153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (483)
T ss_dssp             CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred             ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccccc
Confidence            9765443221    112235678889999999999899999999999999999999 9999988543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.3e-34  Score=233.49  Aligned_cols=188  Identities=23%  Similarity=0.337  Sum_probs=152.3

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCc------eEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDH------IVS   82 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~n------i~~   82 (228)
                      .++|++.+.||+|+||.||+|....+        .+..||+|.++..  ......+.+|+.+++++ +|++      ++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~   86 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNV--GKYREAARLEINVLKKI-KEKDKENKFLCVL   86 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSC--HHHHHHHHHHHHHHHHH-HHHCTTSCSCBCC
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEccc--ccchhHHHHHHHHHHHH-hhcCCCCceeEEE
Confidence            47899999999999999999985332        2256999998743  34456778899999988 6554      888


Q ss_pred             eeeEEEc-CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEee---------
Q psy3166          83 FIGCCYK-DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILL---------  130 (228)
Q Consensus        83 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~---------  130 (228)
                      +.+++.. +..+++||++ ++++.+++..                      .|||+++|+||||||+||++         
T Consensus        87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence            8887765 4588999999 5677666543                      69999999999999999999         


Q ss_pred             ----------cCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy3166         131 ----------SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANP  200 (228)
Q Consensus       131 ----------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~p  200 (228)
                                +.++.+||+|||++.....      ......||..|+|||++.+..++.++|+|||||++|+|++ |..|
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p  238 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR-GFTL  238 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCS
T ss_pred             cccccccccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh-CCCC
Confidence                      5678999999999874322      1234567889999999998889999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHc
Q psy3166         201 YPHIPLCRIVHYLST  215 (228)
Q Consensus       201 f~~~~~~~~~~~~~~  215 (228)
                      |.+.+..+....+.+
T Consensus       239 f~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          239 FQTHENREHLVMMEK  253 (355)
T ss_dssp             CCCSSHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHH
Confidence            999888776655544

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-35  Score=239.74  Aligned_cols=188  Identities=16%  Similarity=0.237  Sum_probs=148.0

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEE-----
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVS-----   82 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~-----   82 (228)
                      ..++|++.+.||+|+||.||+|+...+... .....+..||+|.+...      ..+.+|+++++++ +||||++     
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~  111 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD------GRLFNEQNFFQRA-AKPLQVNKWKKL  111 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc------chHHHHHHHHHHh-cccchhhhhhhh
Confidence            358999999999999999999987553210 01113557999998754      3467899999999 8999887     


Q ss_pred             ----------eeeEEEc--CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCE
Q psy3166          83 ----------FIGCCYK--DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNI  128 (228)
Q Consensus        83 ----------~~~~~~~--~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~ni  128 (228)
                                +++++..  ...++||||+ +++|.+++..                      .|||+++|+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      4555543  4478999999 9999999864                      599999999999999999


Q ss_pred             eecCCC--cEEEeeccCcccccccccc----cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         129 LLSSPH--VVKISDFGLSEDIYEQNVF----QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       129 l~~~~~--~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      +++.++  .+||+|||++..+......    ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~  269 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY-GFLPWT  269 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCTTG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCcc
Confidence            999988  8999999999765443211    112234577889999999998889999999999999999999 999998


Q ss_pred             CCC
Q psy3166         203 HIP  205 (228)
Q Consensus       203 ~~~  205 (228)
                      ...
T Consensus       270 ~~~  272 (352)
T 2jii_A          270 NCL  272 (352)
T ss_dssp             GGT
T ss_pred             cCC
Confidence            753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-34  Score=233.01  Aligned_cols=207  Identities=23%  Similarity=0.394  Sum_probs=154.5

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCC-CCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGK-HDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~-h~ni~~~   83 (228)
                      .+..++|++.+.||+|+||.||++....          +..||+|.+... ........+.+|+.+++++.+ ||||+++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTT----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCC----------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence            3567889999999999999999997422          446999998654 345556788899999999943 6999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+. .+++|| +.+++|.+++..                    .|||+++|+|+||||+||+++. +.+||+|||
T Consensus        94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           94 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             EEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             EEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecc
Confidence            99887655 788999 568899998764                    6999999999999999999964 899999999


Q ss_pred             CcccccccccccCCCCCCCCcceeeccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHH
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-----------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC-RIV  210 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~-~~~  210 (228)
                      ++..+...... .......++..|+|||.+..           ..++.++|+||||+++|+|++ |..||...... ...
T Consensus       172 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~  249 (313)
T 3cek_A          172 IANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKL  249 (313)
T ss_dssp             SSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHHH
T ss_pred             ccccccCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh-CCCchhhHHHHHHHH
Confidence            98755432211 11223467889999999875           367889999999999999999 99999875432 233


Q ss_pred             HH-HHcCCCCCCCCCCC
Q psy3166         211 HY-LSTGYRMERPASCN  226 (228)
Q Consensus       211 ~~-~~~~~~~~~p~~~~  226 (228)
                      .. +....+.+.|..++
T Consensus       250 ~~~~~~~~~~~~~~~~~  266 (313)
T 3cek_A          250 HAIIDPNHEIEFPDIPE  266 (313)
T ss_dssp             HHHHCTTSCCCCCCCSC
T ss_pred             HHHHhcccccCCcccch
Confidence            33 33344445555544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.8e-34  Score=232.12  Aligned_cols=201  Identities=22%  Similarity=0.325  Sum_probs=142.0

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHH-HHHHhcCCCCceEEee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI-NLMKDVGKHDHIVSFI   84 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~~h~ni~~~~   84 (228)
                      .+..++|++.+.||+|+||.||+|...         .++..||+|.+..........+...|. .+++.+ +||||++++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~   90 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCF   90 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEET---------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEe---------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEE
Confidence            456679999999999999999999853         345579999997665544444444444 456666 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCC-CCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNN-KVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~-~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++.... .+++||++ ++.+......                     .|||++ +|+|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           91 GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             EEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence            9987654 78999999 4455444331                     699995 9999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHc
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPH-IPLCRIVHYLST  215 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~-~~~~~~~~~~~~  215 (228)
                      |++..+.....    .....++..|+|||.+.     ...++.++|+||||+++|+|++ |..||.. ....+....+..
T Consensus       170 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  244 (318)
T 2dyl_A          170 GISGRLVDDKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVLTKVLQ  244 (318)
T ss_dssp             TTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHHHHHHHH
T ss_pred             CCchhccCCcc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccHHHHHHHhc
Confidence            99865433221    12345677899999985     4457889999999999999999 9999987 445566777766


Q ss_pred             CCCCCCC
Q psy3166         216 GYRMERP  222 (228)
Q Consensus       216 ~~~~~~p  222 (228)
                      +.++..|
T Consensus       245 ~~~~~~~  251 (318)
T 2dyl_A          245 EEPPLLP  251 (318)
T ss_dssp             SCCCCCC
T ss_pred             cCCCCCC
Confidence            6565554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-34  Score=231.56  Aligned_cols=174  Identities=26%  Similarity=0.481  Sum_probs=146.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||.||+|...         .++..||+|.++...     ..+.+|+++++++ +||||+++++++..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~i~~~~~~~~~   75 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHR---------IDGKTYVIKRVKYNN-----EKAEREVKALAKL-DHVNIVHYNGCWDG   75 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEET---------TTCCEEEEEEEECCS-----GGGHHHHHHHHHC-CCTTBCCEEEEEEE
T ss_pred             cccceeeeeccCCceEEEEEEEc---------CCCeEEEEEEecccc-----HHHHHHHHHHHhC-CCCCEEEEeeeEec
Confidence            57999999999999999999853         344579999987543     2456899999999 99999999998743


Q ss_pred             -----------------CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEee
Q psy3166          90 -----------------DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILL  130 (228)
Q Consensus        90 -----------------~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~  130 (228)
                                       ...+++|||+++++|.+++..                      .|||+++|+|+||||+||++
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~  155 (284)
T 2a19_B           76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL  155 (284)
T ss_dssp             EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence                             227899999999999998853                      59999999999999999999


Q ss_pred             cCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         131 SSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      +.++.++|+|||++.......    ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~~  223 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-VCDTAFE  223 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS-CCSSHHH
T ss_pred             cCCCCEEECcchhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh-cCCcchh
Confidence            999999999999987554322    1223457788999999998889999999999999999999 8887643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-34  Score=233.14  Aligned_cols=181  Identities=34%  Similarity=0.473  Sum_probs=146.9

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .|...+.||+|+||.||+|...           +..||+|.+....   .....+.+.+|+.+++++ +||||+++++++
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~   99 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFS   99 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEE
Confidence            3455689999999999999742           3359999986432   233456788999999999 999999999998


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ... ..+++||++++++|.+++..                       .|||+++|+|+||||+||+++.++.++|+|||+
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~  179 (307)
T 2nru_A          100 SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL  179 (307)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence            764 48899999999999998762                       589999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      +......... .......|+..|+|||.+.+ .++.++|+||||+++|+|++ |..||.....
T Consensus       180 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~  239 (307)
T 2nru_A          180 ARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT-GLPAVDEHRE  239 (307)
T ss_dssp             CEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH-CCCSBCTTBS
T ss_pred             cccccccccc-ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH-CCCCcccCcc
Confidence            8754332111 11223467889999998765 47889999999999999999 9999987543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-34  Score=232.14  Aligned_cols=180  Identities=27%  Similarity=0.489  Sum_probs=140.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhc-CCCCceEEeeeEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV-GKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~h~ni~~~~~~~   87 (228)
                      .++|++.+.||+|+||.||+|...           +..||+|.+....    .....+|.+++..+ .+||||+++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            368999999999999999999753           3469999986432    12334455554443 2899999999987


Q ss_pred             EcC-----ceEEEEecCCCCcHHHHHHH-------------------hcccCC--------CCcccCCCCCCEeecCCCc
Q psy3166          88 YKD-----ELRLVVEYCALGDLQSYLRE-------------------EYLSNN--------KVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        88 ~~~-----~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~--------~i~H~~lk~~nil~~~~~~  135 (228)
                      ...     ..++||||+++++|.+++..                   .|||++        +|+||||||+||+++.++.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence            653     47899999999999999864                   689998        9999999999999999999


Q ss_pred             EEEeeccCcccccccccc-cCCCCCCCCcceeecccccccCCCCch------hhHHHHHHHHHHHHhCC----------C
Q psy3166         136 VKISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSNIYTNK------SDVWSFGVVLWEIVTLG----------A  198 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~------~Diwslg~~~~~l~t~g----------~  198 (228)
                      +||+|||++..+...... ........||..|+|||++.+......      +|+|||||++|+|++ |          .
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~~~~~~~~~~  259 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQ  259 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh-ccCccccccccc
Confidence            999999998755433211 111224578889999999987665554      999999999999999 9          7


Q ss_pred             CCCCCC
Q psy3166         199 NPYPHI  204 (228)
Q Consensus       199 ~pf~~~  204 (228)
                      .||...
T Consensus       260 ~p~~~~  265 (337)
T 3mdy_A          260 LPYHDL  265 (337)
T ss_dssp             CTTTTT
T ss_pred             ccHhhh
Confidence            787653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.6e-34  Score=234.90  Aligned_cols=180  Identities=22%  Similarity=0.346  Sum_probs=145.8

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC----------C
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG----------K   76 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~----------~   76 (228)
                      +..++|++.+.||+|+||.||+|..         ..++..||+|.+...  ......+.+|+.+++++.          .
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~   84 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKD---------MVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMG   84 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEe---------cCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccc
Confidence            4457999999999999999999984         445567999998743  334466788999999883          1


Q ss_pred             CCceEEeeeEEEcC-----ceEEEEecCCCCcHHHHHHH----------------------hcccCC-CCcccCCCCCCE
Q psy3166          77 HDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLRE----------------------EYLSNN-KVVHRDLATRNI  128 (228)
Q Consensus        77 h~ni~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~-~i~H~~lk~~ni  128 (228)
                      ||||+++++++...     ..+++||++ +++|.+++..                      .|||++ ||+||||||+||
T Consensus        85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI  163 (373)
T 1q8y_A           85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV  163 (373)
T ss_dssp             HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred             cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence            89999999988642     377999999 8899988754                      599998 999999999999


Q ss_pred             eec------CCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         129 LLS------SPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       129 l~~------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      +++      ..+.+||+|||++......      .....+|..|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~  236 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFE  236 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC-
T ss_pred             EEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh-CCCCCC
Confidence            995      3448999999998754322      223567889999999998889999999999999999999 999998


Q ss_pred             CCC
Q psy3166         203 HIP  205 (228)
Q Consensus       203 ~~~  205 (228)
                      +.+
T Consensus       237 ~~~  239 (373)
T 1q8y_A          237 PDE  239 (373)
T ss_dssp             ---
T ss_pred             CCc
Confidence            754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-33  Score=230.32  Aligned_cols=179  Identities=30%  Similarity=0.510  Sum_probs=145.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhc-CCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDV-GKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||.||+|.+.           ++.||+|.++..    ....+.+|.+++..+ .+||||+++++++.
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            68999999999999999999752           456999998643    234567888888873 28999999999987


Q ss_pred             cC-----ceEEEEecCCCCcHHHHHHH-------------------hccc--------CCCCcccCCCCCCEeecCCCcE
Q psy3166          89 KD-----ELRLVVEYCALGDLQSYLRE-------------------EYLS--------NNKVVHRDLATRNILLSSPHVV  136 (228)
Q Consensus        89 ~~-----~~~lv~e~~~~~~L~~~l~~-------------------~~lh--------~~~i~H~~lk~~nil~~~~~~~  136 (228)
                      ..     ..+++|||+++++|.+++..                   .|||        +++|+|+||||+||+++.++.+
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            64     57899999999999999865                   5899        8999999999999999999999


Q ss_pred             EEeeccCcccccccccc-cCCCCCCCCcceeecccccccCC------CCchhhHHHHHHHHHHHHhCC----------CC
Q psy3166         137 KISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLG----------AN  199 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~------~~~~~Diwslg~~~~~l~t~g----------~~  199 (228)
                      ||+|||++......... ........++..|+|||.+.+..      ++.++|+||||+++|+|++ |          ..
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~~~~~~~  265 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL  265 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCC
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh-ccCcCCccccccc
Confidence            99999998755433211 11223456888999999987653      2368999999999999999 8          78


Q ss_pred             CCCCC
Q psy3166         200 PYPHI  204 (228)
Q Consensus       200 pf~~~  204 (228)
                      ||...
T Consensus       266 p~~~~  270 (342)
T 1b6c_B          266 PYYDL  270 (342)
T ss_dssp             TTTTT
T ss_pred             Ccccc
Confidence            98764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.4e-34  Score=250.63  Aligned_cols=184  Identities=31%  Similarity=0.493  Sum_probs=151.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +...++|++.+.||+|+||.||+|.         +..++..||+|.++..........+.+|+.+++++ +||||+++++
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~---------~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~   79 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWI---------HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSARE   79 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCC---------CTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEE
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEE---------ECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceee
Confidence            4556899999999999999999987         44455679999998766666677899999999999 9999999998


Q ss_pred             EEEc-------CceEEEEecCCCCcHHHHHHH-----------------------hcccCCCCcccCCCCCCEeecCCCc
Q psy3166          86 CCYK-------DELRLVVEYCALGDLQSYLRE-----------------------EYLSNNKVVHRDLATRNILLSSPHV  135 (228)
Q Consensus        86 ~~~~-------~~~~lv~e~~~~~~L~~~l~~-----------------------~~lh~~~i~H~~lk~~nil~~~~~~  135 (228)
                      ++..       +..++||||+++++|.+++..                       .|||++||+|+||||+||+++.++.
T Consensus        80 v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~  159 (676)
T 3qa8_A           80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ  159 (676)
T ss_dssp             CCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS
T ss_pred             eecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC
Confidence            8643       347899999999999998763                       5999999999999999999997654


Q ss_pred             ---EEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         136 ---VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       136 ---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                         ++|+|||++........    .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.
T Consensus       160 ~~~vKL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt-G~~Pf~~~  226 (676)
T 3qa8_A          160 RLIHKIIDLGYAKELDQGEL----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPN  226 (676)
T ss_dssp             SCEEEECSCCCCCBTTSCCC----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS-SCSSCCSS
T ss_pred             ceeEEEcccccccccccccc----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH-CCCCCCcc
Confidence               99999999876543321    233567888999999998889999999999999999999 99999764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.4e-34  Score=232.49  Aligned_cols=180  Identities=25%  Similarity=0.426  Sum_probs=122.7

Q ss_pred             CCceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++. +.||+|+||.||+|+..         .+++.||+|.+...  .    ...+|+..+.+..+||||+++++++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~--~----~~~~e~~~~~~~~~h~~i~~~~~~~   91 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHR---------RTGQKCALKLLYDS--P----KARQEVDHHWQASGGPHIVCILDVY   91 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESS--H----HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEEC---------CCCCEEEEEEecCc--H----HHHHHHHHHHHhcCCCChHHHHHHH
Confidence            3688885 57999999999999843         44567999998643  1    2233444433444999999999987


Q ss_pred             Ec----C-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC---CCcEE
Q psy3166          88 YK----D-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS---PHVVK  137 (228)
Q Consensus        88 ~~----~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~---~~~~k  137 (228)
                      ..    + ..++||||+.+++|.+++..                      .|||+++|+||||||+||+++.   ++.+|
T Consensus        92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k  171 (336)
T 3fhr_A           92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK  171 (336)
T ss_dssp             EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred             hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence            54    2 27899999999999998864                      6999999999999999999986   45699


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI  209 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~  209 (228)
                      |+|||++.......     .....++..|+|||++....++.++|+||||+++|+|++ |..||.+......
T Consensus       172 l~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~  237 (336)
T 3fhr_A          172 LTDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAI  237 (336)
T ss_dssp             ECCCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHH-SSCCC--------
T ss_pred             Eeccccceeccccc-----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCccchhh
Confidence            99999987543221     223466788999999988888899999999999999999 9999987665443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.3e-33  Score=236.40  Aligned_cols=183  Identities=27%  Similarity=0.387  Sum_probs=139.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +.|.+.+.||+|+||+||.+..          .++..||+|.+....    ...+.+|+.+++++.+||||+++++++..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~----------~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   80 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS----------FQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETT   80 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE----------SSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEE----------ECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            4456678999999999976432          234579999986432    34567899999987689999999998876


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------------hcccCCCCcccCCCCCCEeecCC--------
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------------EYLSNNKVVHRDLATRNILLSSP--------  133 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------------~~lh~~~i~H~~lk~~nil~~~~--------  133 (228)
                      +. .+++||++. |+|.+++..                           .|||+++|+||||||+||+++.+        
T Consensus        81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred             CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc
Confidence            55 789999995 599887642                           59999999999999999999754        


Q ss_pred             -----CcEEEeeccCcccccccccc-cCCCCCCCCcceeeccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCC
Q psy3166         134 -----HVVKISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVS-------NIYTNKSDVWSFGVVLWEIVTLGANP  200 (228)
Q Consensus       134 -----~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Diwslg~~~~~l~t~g~~p  200 (228)
                           +.+||+|||++..+...... ........||..|+|||++.+       ..++.++|||||||++|+|++.|..|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence                 48999999999765433211 111223567889999999875       56889999999999999999768999


Q ss_pred             CCCCCHH
Q psy3166         201 YPHIPLC  207 (228)
Q Consensus       201 f~~~~~~  207 (228)
                      |.+....
T Consensus       240 f~~~~~~  246 (434)
T 2rio_A          240 FGDKYSR  246 (434)
T ss_dssp             TCSTTTH
T ss_pred             CCCchhh
Confidence            9875443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=237.82  Aligned_cols=186  Identities=25%  Similarity=0.348  Sum_probs=139.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +...+|++.+.||+|+||+|+...          ..+++.||||.+.....    ..+.+|+++|+++.+||||++++++
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~----------~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~   86 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRG----------MFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCT   86 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEE----------ESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             EccEEEecCCeeecCcCEEEEEEE----------EeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEE
Confidence            455679999999999999865322          12345699999865422    1245799999999789999999998


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC-----CCcEEEe
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS-----PHVVKIS  139 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~-----~~~~kl~  139 (228)
                      +.... .+++||++. |+|.+++..                     .|||+++|+||||||+||+++.     ...+||+
T Consensus        87 ~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           87 EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             EEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             EecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence            87655 789999996 599888754                     6999999999999999999953     2368899


Q ss_pred             eccCcccccccccccCCCCCCCCcceeeccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      |||+++.+..............||..|+|||++..   ..++.++||||+||++|+|++.|..||......
T Consensus       166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~  236 (432)
T 3p23_A          166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR  236 (432)
T ss_dssp             CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH
T ss_pred             cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH
Confidence            99998765433221122334568889999999873   457789999999999999998788999765443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.5e-34  Score=253.36  Aligned_cols=176  Identities=20%  Similarity=0.218  Sum_probs=145.4

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||.||+|.+..        .+++.||+|.+...........+.+|+.+++++ +||||+++++++.
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~  149 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVE  149 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEe
Confidence            3789999999999999999998532        135679999987665566667888999999999 9999999999986


Q ss_pred             cC-c-----eEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          89 KD-E-----LRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        89 ~~-~-----~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      .. .     .++||||+++++|.+++..                  .|||++||+||||||+||+++.+ .+||+|||++
T Consensus       150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EECTTSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             ecCCCCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence            53 2     5899999999998876542                  69999999999999999999875 8999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      +.....       ....||..|++||++.+. ++.++|||||||++|+|++ |..||.+
T Consensus       229 ~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~-g~~~~~~  278 (681)
T 2pzi_A          229 SRINSF-------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTL-DLPTRNG  278 (681)
T ss_dssp             EETTCC-------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHS-CCCEETT
T ss_pred             hhcccC-------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHh-CCCCCcc
Confidence            754322       345678899999988765 4889999999999999998 9888765

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.8e-33  Score=223.84  Aligned_cols=156  Identities=13%  Similarity=0.080  Sum_probs=134.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||.||+|++         ..+++.||+|.+....  .......+.+|+..+.++ +||||+++++++
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~  100 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALD---------TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVV  100 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEE---------TTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEe---------cCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEE
Confidence            6799999999999999999984         4455679999997553  245557788999999999 999999999998


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      ..+ ..++||||+.+++|.+++..                  .|||++||+||||||+||+++.++.+||++++      
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EECCcEEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            765 48899999999999998754                  69999999999999999999999999987443      


Q ss_pred             ccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                                       |++|       ++.++|+|||||++|+|++ |..||.+.+.
T Consensus       175 -----------------~~~~-------~~~~~Di~slG~il~ellt-g~~Pf~~~~~  207 (286)
T 3uqc_A          175 -----------------TMPD-------ANPQDDIRGIGASLYALLV-NRWPLPEAGV  207 (286)
T ss_dssp             -----------------CCTT-------CCHHHHHHHHHHHHHHHHH-SEECSCCCSB
T ss_pred             -----------------ccCC-------CCchhHHHHHHHHHHHHHH-CCCCCCcCCc
Confidence                             2332       6889999999999999999 9999988654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.3e-34  Score=231.67  Aligned_cols=183  Identities=23%  Similarity=0.383  Sum_probs=148.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----HHHHHHHHHHHHHHhcC-CCCce
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----KTYDKFLKEINLMKDVG-KHDHI   80 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~-~h~ni   80 (228)
                      .-.++|++.+.||+|+||.||+|+.         ..++..||+|.++.....     .....+.+|+.+++++. .||||
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIR---------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEE---------TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            4567899999999999999999984         345567999998654211     11234567999999995 26999


Q ss_pred             EEeeeEEEcCc-eEEEEecCCC-CcHHHHHHH--------------------hcccCCCCcccCCCCCCEeec-CCCcEE
Q psy3166          81 VSFIGCCYKDE-LRLVVEYCAL-GDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLS-SPHVVK  137 (228)
Q Consensus        81 ~~~~~~~~~~~-~~lv~e~~~~-~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~-~~~~~k  137 (228)
                      +++++++.... .++++|++.+ ++|.+++..                    .|||+++|+||||||+||+++ .++.+|
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEE
Confidence            99999987654 7899999865 899988764                    699999999999999999999 678999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      |+|||++.......     .....++..|+|||.+....+ +.++|+||||+++|+|++ |..||...
T Consensus       191 L~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~  252 (320)
T 3a99_A          191 LIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHD  252 (320)
T ss_dssp             ECCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH
T ss_pred             EeeCcccccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH-CCCCCCCh
Confidence            99999987553321     223567888999999887665 678899999999999999 99999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=228.05  Aligned_cols=181  Identities=26%  Similarity=0.411  Sum_probs=141.7

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----HHHHHHHHHHHHHHhcC---CCCc
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----KTYDKFLKEINLMKDVG---KHDH   79 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~---~h~n   79 (228)
                      -.++|++.+.||+|+||.||+|.         +..++..||+|.++.....     .....+.+|+.+++++.   +|||
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGH---------RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEE---------CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhceEEeeEEEcCCCEEEEEEE---------EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            35689999999999999999997         4445567999998654221     11233557888888874   6999


Q ss_pred             eEEeeeEEEc-CceEEEEec-CCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeec-CCCcE
Q psy3166          80 IVSFIGCCYK-DELRLVVEY-CALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLS-SPHVV  136 (228)
Q Consensus        80 i~~~~~~~~~-~~~~lv~e~-~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~-~~~~~  136 (228)
                      |+++++++.. +..++++|+ +.+++|.+++..                    .|||+++|+|+||||+||+++ .++.+
T Consensus       100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred             eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence            9999998865 457899999 788999998764                    699999999999999999999 78999


Q ss_pred             EEeeccCcccccccccccCCCCCCCCcceeecccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q psy3166         137 KISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYT-NKSDVWSFGVVLWEIVTLGANPYPH  203 (228)
Q Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Diwslg~~~~~l~t~g~~pf~~  203 (228)
                      +|+|||++.......     .....++..|+|||++.+..+. .++|+||||+++|+|++ |..||..
T Consensus       180 kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~  241 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-GDIPFER  241 (312)
T ss_dssp             EECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCS
T ss_pred             EEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH-CCCCCCC
Confidence            999999987554322     2234577889999998876664 58999999999999999 9999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=1.3e-32  Score=231.36  Aligned_cols=185  Identities=16%  Similarity=0.135  Sum_probs=136.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH--HHHHHHHHHHHHHHhcCCC-Cce-
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA--KTYDKFLKEINLMKDVGKH-DHI-   80 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~h-~ni-   80 (228)
                      ++.+..+|++.+.||+|+||+||+|.+         ..++..||||.++.....  ...+.+.+|+.+++.+ .| .|. 
T Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~---------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~  142 (413)
T 3dzo_A           73 LGERPRTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQK  142 (413)
T ss_dssp             SSSCCEEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHH
T ss_pred             CCCCceeEEEecccccCCCEEEEEEEe---------cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHH
Confidence            456677899999999999999999984         344557999998744222  2346788899999988 55 211 


Q ss_pred             --------------EEe------eeEEEc------CceEEEEecCCCCcHHHHHHH------------------------
Q psy3166          81 --------------VSF------IGCCYK------DELRLVVEYCALGDLQSYLRE------------------------  110 (228)
Q Consensus        81 --------------~~~------~~~~~~------~~~~lv~e~~~~~~L~~~l~~------------------------  110 (228)
                                    +.+      ...+..      ...+++|+.+ +++|.+++..                        
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~  221 (413)
T 3dzo_A          143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI  221 (413)
T ss_dssp             HHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHH
Confidence                          111      111111      1255666655 6788887731                        


Q ss_pred             ---hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeeccccc----------ccCCC
Q psy3166         111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL----------VSNIY  177 (228)
Q Consensus       111 ---~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~----------~~~~~  177 (228)
                         .|||+++|+||||||+|||++.++.+||+|||++......      .....| ..|+|||++          ....+
T Consensus       222 ~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  294 (413)
T 3dzo_A          222 RLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLM  294 (413)
T ss_dssp             HHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred             HHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCC
Confidence               6999999999999999999999999999999998754332      123455 789999998          44457


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         178 TNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       178 ~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      +.++|+|||||++|+|++ |..||......+
T Consensus       295 ~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  324 (413)
T 3dzo_A          295 TFAFDTWTLGLAIYWIWC-ADLPNTDDAALG  324 (413)
T ss_dssp             CHHHHHHHHHHHHHHHHH-SSCCCCTTGGGS
T ss_pred             CchhhHHHHHHHHHHHHH-CCCCCCCcchhh
Confidence            889999999999999999 999998865443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=1.2e-33  Score=231.41  Aligned_cols=176  Identities=22%  Similarity=0.286  Sum_probs=139.3

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-------CHHHHHHHHHHHHHHHhcC----
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-------DAKTYDKFLKEINLMKDVG----   75 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~----   75 (228)
                      ++.++|++.+.||+|+||+||+|++           ++..||+|.++...       .......+.+|+.+++.+.    
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~   85 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG   85 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGG
T ss_pred             cccccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhc
Confidence            5668899999999999999999984           23579999987542       1223467788999998884    


Q ss_pred             ----CCCceEEeeeEEE-------------------------------cCceEEEEecCCCCcHHHHHHH----------
Q psy3166          76 ----KHDHIVSFIGCCY-------------------------------KDELRLVVEYCALGDLQSYLRE----------  110 (228)
Q Consensus        76 ----~h~ni~~~~~~~~-------------------------------~~~~~lv~e~~~~~~L~~~l~~----------  110 (228)
                          .||||+++.+++.                               .+..++||||+++|++.+.+..          
T Consensus        86 ~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~  165 (336)
T 2vuw_A           86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKS  165 (336)
T ss_dssp             CSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHH
T ss_pred             cccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHH
Confidence                3777777776542                               3568999999998865544321          


Q ss_pred             ---------hccc-CCCCcccCCCCCCEeecCCC--------------------cEEEeeccCcccccccccccCCCCCC
Q psy3166         111 ---------EYLS-NNKVVHRDLATRNILLSSPH--------------------VVKISDFGLSEDIYEQNVFQNGEPSE  160 (228)
Q Consensus       111 ---------~~lh-~~~i~H~~lk~~nil~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (228)
                               .||| +++|+||||||+|||++.++                    .+||+|||+++.....        ..
T Consensus       166 i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~  237 (336)
T 2vuw_A          166 ILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IV  237 (336)
T ss_dssp             HHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EE
T ss_pred             HHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cE
Confidence                     6999 99999999999999999887                    8999999999755322        23


Q ss_pred             CCcceeecccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCC
Q psy3166         161 KLPIRWLALESLVSNIYTNKSDVWSFGVV-LWEIVTLGANPYPH  203 (228)
Q Consensus       161 ~~~~~~~~Pe~~~~~~~~~~~Diwslg~~-~~~l~t~g~~pf~~  203 (228)
                      .||..|+|||++.+.. +.++||||++++ .+++++ |..||..
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~-g~~p~~~  279 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG-EYHPYSN  279 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT-SCCTHHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCccccc-ccCCCcc
Confidence            6778899999998766 889999998776 777887 9999855

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=2.8e-31  Score=214.00  Aligned_cols=160  Identities=26%  Similarity=0.446  Sum_probs=130.0

Q ss_pred             CCCCCceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           6 GYPPERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         6 ~~~~~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.-.++|.+. +.||+|+||.||+|..         ..++..||+|.++..      ....+|+.++.++.+||||++++
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~   77 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIV   77 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEE
T ss_pred             cccccchhhcCcccccCCCeEEEEEEE---------cCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHH
Confidence            3445678777 7899999999999984         345567999998643      34567898886666999999999


Q ss_pred             eEEEc-----CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC---CC
Q psy3166          85 GCCYK-----DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS---PH  134 (228)
Q Consensus        85 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~---~~  134 (228)
                      +++..     ...++||||+++++|.+++..                      .|||+++|+||||||+||+++.   ++
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  157 (299)
T 3m2w_A           78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA  157 (299)
T ss_dssp             EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC
T ss_pred             hhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC
Confidence            98754     337899999999999998864                      6999999999999999999998   78


Q ss_pred             cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         135 VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      .++|+|||++....                         +..++.++|+||+||++|+|++ |..||.+...
T Consensus       158 ~~kl~Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~  203 (299)
T 3m2w_A          158 ILKLTDFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHG  203 (299)
T ss_dssp             CEEECCCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHH-SSCSCCC---
T ss_pred             cEEEeccccccccc-------------------------cccCCchhhHHHHHHHHHHHHH-CCCCCCCCcc
Confidence            89999999875321                         1236778999999999999999 9999976543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=8.9e-31  Score=227.94  Aligned_cols=152  Identities=13%  Similarity=0.043  Sum_probs=108.9

Q ss_pred             CcccceeeeeeccccCC---------CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc-eEEEEecCCCCcHHHHHH
Q psy3166          40 SGQAAMEVAVKMLKANA---------DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-LRLVVEYCALGDLQSYLR  109 (228)
Q Consensus        40 ~~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~  109 (228)
                      ....+..||+|.+....         .....+.+.+|+++|+++.+|+||+++++++.++. .|+||||++|++|.+++.
T Consensus       255 r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~  334 (569)
T 4azs_A          255 RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA  334 (569)
T ss_dssp             EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH
T ss_pred             cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence            34466779999986441         12234568899999999988999999999998754 899999999999999987


Q ss_pred             H-----------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeeccccc
Q psy3166         110 E-----------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL  172 (228)
Q Consensus       110 ~-----------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  172 (228)
                      .                 .|+|++||+||||||+|||++.+|.+||+|||+++.......   ...+..||+.|++||++
T Consensus       335 ~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~---~~~t~vGTp~YmAPE~l  411 (569)
T 4azs_A          335 AGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS---WPTNLVQSFFVFVNELF  411 (569)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C---CSHHHHHHHHHHHHHHC
T ss_pred             hCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc---cccCceechhhccHHHh
Confidence            5                 699999999999999999999999999999999875533221   12235678999999998


Q ss_pred             ccCCCCchhhHHHHHHHHHHHHh
Q psy3166         173 VSNIYTNKSDVWSFGVVLWEIVT  195 (228)
Q Consensus       173 ~~~~~~~~~Diwslg~~~~~l~t  195 (228)
                      .+. +..++|+|++|++.+++.+
T Consensus       412 ~g~-~~~~~d~~s~g~~~~~l~~  433 (569)
T 4azs_A          412 AEN-KSWNGFWRSAPVHPFNLPQ  433 (569)
T ss_dssp             ------------------CCCCT
T ss_pred             CCC-CCCcccccccccchhhhcc
Confidence            764 5667999999998776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=2.2e-26  Score=199.30  Aligned_cols=174  Identities=19%  Similarity=0.141  Sum_probs=123.9

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CH-----HHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DA-----KTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      -.+.||+|+||+||+|...+           ..+++|......  ..     ...+++.+|+++|+++ +||||+.+..+
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~-----------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~  407 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLD-----------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIF  407 (540)
T ss_dssp             --------CCEEEEEEECSS-----------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEE
T ss_pred             CCCEEeeCCCEEEEEEEECC-----------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEE
Confidence            35799999999999985322           247777754321  11     1234578999999999 99999944333


Q ss_pred             E-EcCceEEEEecCCCCcHHHHHHH------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccccccccc
Q psy3166          87 C-YKDELRLVVEYCALGDLQSYLRE------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVF  153 (228)
Q Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (228)
                      + ..+..++||||+++++|.+++..            .|||+++|+||||||+|||++.  .+||+|||+++........
T Consensus       408 ~~~~~~~~lVmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          408 DVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEETTTTEEEEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEeCCccEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            3 44568999999999999988653            7999999999999999999998  9999999999865432110


Q ss_pred             c----CCCCCCCCcceeeccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         154 Q----NGEPSEKLPIRWLALESLVS--NIYTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       154 ~----~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      .    .......||+.|+|||++..  ..|+...|+|+..+-..+... ++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~-~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE-RRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH-TCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH-hccccC
Confidence            0    00123467888999999986  557778899999987777776 666653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=1.6e-23  Score=167.42  Aligned_cols=117  Identities=20%  Similarity=0.250  Sum_probs=92.8

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----------------HHHHHHHHHHHHHHhcC
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----------------KTYDKFLKEINLMKDVG   75 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~   75 (228)
                      .+.+.||+|+||.||+|.+          .++..||+|.++.....                 .....+.+|+.+++++ 
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-  161 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-  161 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-
T ss_pred             EecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-
Confidence            3449999999999999985          23457999998643211                 1345688999999999 


Q ss_pred             CCCceEEeeeEEEcCceEEEEecCCCCcHHHHHHH--------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          76 KHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        76 ~h~ni~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +|   +.+.+++..+..++||||+++++|.+ +..              .|||++||+||||||+|||++ ++.+||+||
T Consensus       162 ~~---~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          162 QG---LAVPKVYAWEGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             TT---SSSCCEEEEETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             cC---CCcCeEEeccceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            44   55555555567899999999988876 211              799999999999999999999 999999999


Q ss_pred             cCcc
Q psy3166         142 GLSE  145 (228)
Q Consensus       142 g~~~  145 (228)
                      |++.
T Consensus       237 G~a~  240 (282)
T 1zar_A          237 PQSV  240 (282)
T ss_dssp             TTCE
T ss_pred             CCCe
Confidence            9886

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=1e-18  Score=137.76  Aligned_cols=121  Identities=21%  Similarity=0.191  Sum_probs=89.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCccccee--eeeeccccCCCH-----------------------HHHHHHH
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAME--VAVKMLKANADA-----------------------KTYDKFL   65 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~-----------------------~~~~~~~   65 (228)
                      -|++...||+|+||.||+|..         ..++..  ||+|.++.....                       .....+.
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~---------~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  118 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADG---------VFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE  118 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEE---------EETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEE---------cCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence            468999999999999999974         234456  999986543110                       1123577


Q ss_pred             HHHHHHHhcCCCCce--EEeeeEEEcCceEEEEecCCC-C----cHHHHHHH-----------------hccc-CCCCcc
Q psy3166          66 KEINLMKDVGKHDHI--VSFIGCCYKDELRLVVEYCAL-G----DLQSYLRE-----------------EYLS-NNKVVH  120 (228)
Q Consensus        66 ~e~~~l~~l~~h~ni--~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~-----------------~~lh-~~~i~H  120 (228)
                      +|+.+|.++ .|+++  ...+.   .+..++||||+.+ |    +|.+....                 .+|| +.||+|
T Consensus       119 ~E~~~l~~l-~~~~i~~p~~~~---~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givH  194 (258)
T 1zth_A          119 KEFRNLERA-KEAGVSVPQPYT---YMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVH  194 (258)
T ss_dssp             HHHHHHHHH-HHTTCCCCCEEE---EETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred             HHHHHHHHH-HhCCCCCCeEEE---cCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            899999999 66653  33332   2467899999942 3    66655321                 6899 999999


Q ss_pred             cCCCCCCEeecCCCcEEEeeccCccc
Q psy3166         121 RDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus       121 ~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      |||||+|||++.  .++|+|||++..
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             CCCCHHHEEEcC--cEEEEECccccc
Confidence            999999999998  899999999863

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=2.1e-16  Score=130.37  Aligned_cols=122  Identities=14%  Similarity=0.139  Sum_probs=84.8

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC----------------CHH-----HHHHHHHHHH
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA----------------DAK-----TYDKFLKEIN   69 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~-----~~~~~~~e~~   69 (228)
                      -|++...||+|++|.||+|...          .++.||+|+++...                ...     ......+|..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            4889999999999999999743          24469999865320                000     1112345778


Q ss_pred             HHHhcCCCCceEEeeeEEEcCceEEEEecCCCCcHHHHHH---------H-----hcccCCCCcccCCCCCCEeecCCC-
Q psy3166          70 LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLR---------E-----EYLSNNKVVHRDLATRNILLSSPH-  134 (228)
Q Consensus        70 ~l~~l~~h~ni~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---------~-----~~lh~~~i~H~~lk~~nil~~~~~-  134 (228)
                      .|.++ .+..+. +...+.....++||||+.|++|.+...         +     .++|+.||+||||||.|||++.++ 
T Consensus       166 nL~rL-~~~gv~-vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          166 FMKAL-YEEGFP-VPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             HHHHH-HHTTCS-CCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             HHHHH-HhcCCC-CCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            88887 443332 222222334579999998877754321         1     689999999999999999998766 


Q ss_pred             ---------cEEEeeccCc
Q psy3166         135 ---------VVKISDFGLS  144 (228)
Q Consensus       135 ---------~~kl~dfg~~  144 (228)
                               .+.|+||+-+
T Consensus       244 ~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTC
T ss_pred             cccccccccceEEEEeCCc
Confidence                     3889999965

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.03  E-value=2.9e-10  Score=89.18  Aligned_cols=124  Identities=15%  Similarity=0.018  Sum_probs=90.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ..|++...++.|+.+.||++...           +..+++|....... .....+.+|..+++.+..+..+.+++++...
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~   81 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence            36888888998999999997632           23589999764211 1123467899999999667778888887665


Q ss_pred             C-ceEEEEecCCCCcHHHHH----------HH-----hcccC--------------------------------------
Q psy3166          90 D-ELRLVVEYCALGDLQSYL----------RE-----EYLSN--------------------------------------  115 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l----------~~-----~~lh~--------------------------------------  115 (228)
                      . ..+++||+++|.++.+.+          ..     ..||+                                      
T Consensus        82 ~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           82 DGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             CCceEEEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            4 478999999998887641          11     34444                                      


Q ss_pred             ---------------------CCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         116 ---------------------NKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       116 ---------------------~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                                           ..++|+|+++.||+++..+.+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 347899999999999875556799998653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.89  E-value=3.8e-09  Score=82.27  Aligned_cols=121  Identities=13%  Similarity=0.017  Sum_probs=80.3

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCc-eEEeeeEEEc
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDH-IVSFIGCCYK   89 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~n-i~~~~~~~~~   89 (228)
                      .+.+....+.|..+.||++...+          +..+++|......    ...+.+|..+++.+..+.- +.+++.+...
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~----------g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~   86 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQG----------RPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE   86 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTT----------SCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCC----------CCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence            45554444456668999985322          2348999875431    1345679999998844422 5567776654


Q ss_pred             -CceEEEEecCCCCcHH-------HHHHH-----hcccCC----------------------------------------
Q psy3166          90 -DELRLVVEYCALGDLQ-------SYLRE-----EYLSNN----------------------------------------  116 (228)
Q Consensus        90 -~~~~lv~e~~~~~~L~-------~~l~~-----~~lh~~----------------------------------------  116 (228)
                       +..+++||+++|.++.       .....     ..+|+.                                        
T Consensus        87 ~~~~~~v~e~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           87 AGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSCEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCCCEEEEEecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence             3478999999987774       11111     233432                                        


Q ss_pred             ------------------CCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         117 ------------------KVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       117 ------------------~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                                        .++|+|++|.||+++.++.+.|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                              28999999999999876666799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.65  E-value=6.5e-08  Score=79.26  Aligned_cols=80  Identities=10%  Similarity=0.087  Sum_probs=51.8

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccc--cCCCHHHHHHHHHHHHHHHhcCC-CCceEEeeeEEEcC
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK--ANADAKTYDKFLKEINLMKDVGK-HDHIVSFIGCCYKD   90 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~~-h~ni~~~~~~~~~~   90 (228)
                      -.+.|+.|.++.||+....+           ..+++|...  ..........+.+|..+++.+.. +..+.+++..+...
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-----------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-----------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-----------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             eEEEcCCcccceEEEEEECC-----------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            45678899999999976422           248888875  33222223467789999999943 34577777766543


Q ss_pred             ----ceEEEEecCCCCcH
Q psy3166          91 ----ELRLVVEYCALGDL  104 (228)
Q Consensus        91 ----~~~lv~e~~~~~~L  104 (228)
                          ..++|||+++|.++
T Consensus       111 ~~~g~~~~vme~v~G~~l  128 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVL  128 (359)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCeEEEEEecCCeec
Confidence                37899999987655

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.06  E-value=3.1e-06  Score=67.56  Aligned_cols=74  Identities=15%  Similarity=0.080  Sum_probs=48.2

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCc--eEEeeeEEEcCc-
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDH--IVSFIGCCYKDE-   91 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~n--i~~~~~~~~~~~-   91 (228)
                      .+.++.|....||+..              ..+++|....   ......+.+|..+|+.+..+..  +..++.....+. 
T Consensus        25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~   87 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN--------------RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET   87 (304)
T ss_dssp             CCEEEECSSEEEEEST--------------TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS
T ss_pred             eEecCCCCcceEEEEC--------------CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC
Confidence            3568999999999852              1388887542   2344677889999988844432  333333322222 


Q ss_pred             ---eEEEEecCCCCcHH
Q psy3166          92 ---LRLVVEYCALGDLQ  105 (228)
Q Consensus        92 ---~~lv~e~~~~~~L~  105 (228)
                         .|+||++++|.++.
T Consensus        88 ~~~~~~vm~~i~G~~l~  104 (304)
T 3sg8_A           88 YQMSFAGFTKIKGVPLT  104 (304)
T ss_dssp             CSCSCEEEECCCCEECC
T ss_pred             CCcceEEEcccCCeECC
Confidence               47899999887664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.88  E-value=0.00017  Score=56.22  Aligned_cols=78  Identities=12%  Similarity=-0.017  Sum_probs=50.0

Q ss_pred             eeeeecCc-eEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc-CceEE
Q psy3166          17 VLGQGEFG-VVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK-DELRL   94 (228)
Q Consensus        17 ~ig~g~~~-~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~-~~~~l   94 (228)
                      .+..|..+ .||+.....         .+..+.+|.-...    ....+.+|...|+.+..+--+.+++.++.. +..++
T Consensus        31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l   97 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL   97 (272)
T ss_dssp             EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence            34445554 588765322         2234788875422    234567899999988655456667766654 44789


Q ss_pred             EEecCCCCcHHHH
Q psy3166          95 VVEYCALGDLQSY  107 (228)
Q Consensus        95 v~e~~~~~~L~~~  107 (228)
                      |||+++|.++.+.
T Consensus        98 vme~l~G~~~~~~  110 (272)
T 4gkh_A           98 LTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECCCSEEHHHH
T ss_pred             EEEeeCCcccccc
Confidence            9999998776553

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.53  E-value=0.00018  Score=59.48  Aligned_cols=78  Identities=15%  Similarity=0.101  Sum_probs=47.4

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC------HHHHHHHHHHHHHHHhcCCC-C-ceEEeee
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD------AKTYDKFLKEINLMKDVGKH-D-HIVSFIG   85 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~~h-~-ni~~~~~   85 (228)
                      -.+.||.|..+.||++....         .+..+++|.......      .....+...|.++|+.+..+ + .+..++.
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~  104 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY  104 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred             EEEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence            45689999999999986322         223589997643211      01123456788888877332 3 3445544


Q ss_pred             EEEcCceEEEEecCCC
Q psy3166          86 CCYKDELRLVVEYCAL  101 (228)
Q Consensus        86 ~~~~~~~~lv~e~~~~  101 (228)
                      + ..+..++|||++++
T Consensus       105 ~-d~~~~~lvmE~l~g  119 (397)
T 2olc_A          105 S-DTEMAVTVMEDLSH  119 (397)
T ss_dssp             E-ETTTTEEEECCCTT
T ss_pred             E-cCCccEEEEEeCCC
Confidence            3 44557899999976

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.26  E-value=0.00083  Score=52.95  Aligned_cols=80  Identities=19%  Similarity=0.136  Sum_probs=51.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCC--ceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHD--HIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~--ni~~~~~~~   87 (228)
                      ....-.+.+|.|..+.||+.+..++          +.|.+|...... ......+..|...|+.|....  .+.+++.  
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG----------~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~--   81 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADG----------TPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAG--   81 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTS----------CEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEE--
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCC----------CEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEe--
Confidence            4556678899999999999876443          358889764332 112235678999998884331  2333333  


Q ss_pred             EcCceEEEEecCCCCc
Q psy3166          88 YKDELRLVVEYCALGD  103 (228)
Q Consensus        88 ~~~~~~lv~e~~~~~~  103 (228)
                       .+.-+++||++.++.
T Consensus        82 -~~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           82 -WDDRTLAMEWVDERP   96 (288)
T ss_dssp             -EETTEEEEECCCCCC
T ss_pred             -ccCceEEEEeecccC
Confidence             234578899986543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.23  E-value=0.0038  Score=49.69  Aligned_cols=75  Identities=16%  Similarity=0.065  Sum_probs=49.9

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCC-C-ceEEeeeEEE--cC
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH-D-HIVSFIGCCY--KD   90 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h-~-ni~~~~~~~~--~~   90 (228)
                      .+.++.|....||+.   +           ..+++|+..   .......+.+|..+|..+..+ + .+..+..+..  .+
T Consensus        24 v~~l~~G~~n~v~~v---g-----------~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g   86 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---N-----------GDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG   86 (306)
T ss_dssp             EEEEEECSSEEEEEE---T-----------TTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS
T ss_pred             eeecCCCcceeEEEE---C-----------CEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC
Confidence            356788888899985   1           138888743   233456788999999999544 2 2445444443  23


Q ss_pred             ceEEEEecCCCCcHHH
Q psy3166          91 ELRLVVEYCALGDLQS  106 (228)
Q Consensus        91 ~~~lv~e~~~~~~L~~  106 (228)
                      ..+++|++++|.++.+
T Consensus        87 ~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           87 NPFVGYRKVQGQILGE  102 (306)
T ss_dssp             CEEEEEECCCSEECHH
T ss_pred             ceEEEEeccCCeECch
Confidence            3789999998877654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.57  E-value=0.0072  Score=50.24  Aligned_cols=30  Identities=20%  Similarity=0.356  Sum_probs=25.8

Q ss_pred             CCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         115 NNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       115 ~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ...++|+|+++.||+++.++ +.++||+.+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~  260 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSF  260 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence            34578999999999998776 9999999765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.51  E-value=0.0075  Score=48.22  Aligned_cols=75  Identities=17%  Similarity=0.044  Sum_probs=52.1

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCC--CceEEeeeEEEc-C
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH--DHIVSFIGCCYK-D   90 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h--~ni~~~~~~~~~-~   90 (228)
                      -.+.|+.|....+|+....           +..+++|.....    ....+..|...|+.|...  ..+++++..... +
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-----------~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g  104 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-----------VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG  104 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-----------SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred             eeEEeCCccceeeeEEEEC-----------CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence            4567899999999997632           224888876532    245677898888887433  466777666544 4


Q ss_pred             ceEEEEecCCCCc
Q psy3166          91 ELRLVVEYCALGD  103 (228)
Q Consensus        91 ~~~lv~e~~~~~~  103 (228)
                      ..+++||++++..
T Consensus       105 ~~~lvme~l~G~~  117 (312)
T 3jr1_A          105 HSFLLLEALNKSK  117 (312)
T ss_dssp             EEEEEEECCCCCC
T ss_pred             ceEEEEEeccCCC
Confidence            4789999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.11  E-value=0.0025  Score=51.62  Aligned_cols=89  Identities=6%  Similarity=-0.046  Sum_probs=50.1

Q ss_pred             eeeeeee-eeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCC--CceEEeeeE
Q psy3166          12 LILGEVL-GQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKH--DHIVSFIGC   86 (228)
Q Consensus        12 ~~~~~~i-g~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h--~ni~~~~~~   86 (228)
                      ....+.| +.|..+.+|+........   ....+..+++|......  .......+.+|..+++.+..+  -.+.+++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~---~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~   98 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQD---GRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWI   98 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEET---TEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred             eEEEEECCCCCccceEEEEEEecccC---CCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            3445677 788888999875320000   00013458888764321  000013456788888887444  346666666


Q ss_pred             EEcC----ceEEEEecCCCCc
Q psy3166          87 CYKD----ELRLVVEYCALGD  103 (228)
Q Consensus        87 ~~~~----~~~lv~e~~~~~~  103 (228)
                      ....    ..+++||+++|.+
T Consensus        99 ~~~~~~~g~~~~v~e~l~G~~  119 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEGVV  119 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCCBC
T ss_pred             ccCCCccCCceEEEEecCCCC
Confidence            5443    3578999997643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.04  E-value=0.053  Score=44.50  Aligned_cols=89  Identities=16%  Similarity=0.163  Sum_probs=47.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.+.+++ +.+..|-...+|++...++...  ....+..+.+|+.-...  .......+|..+++.+..+.-..++++.
T Consensus        48 ~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~  122 (379)
T 3feg_A           48 VQPEELRV-YPVSGGLSNLLFRCSLPDHLPS--VGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGV  122 (379)
T ss_dssp             CCGGGCCC-EEC-----CCEEEEECCTTSCC--CSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred             CCcCceEE-EEcCCcccccEEEEEeCCCccc--cCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            45566664 4566677788999875431100  01123468888753221  1223455899988887555445666655


Q ss_pred             EEcCceEEEEecCCCCc
Q psy3166          87 CYKDELRLVVEYCALGD  103 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~  103 (228)
                      +..   -+|||+++|.+
T Consensus       123 ~~~---g~v~e~i~G~~  136 (379)
T 3feg_A          123 FPE---GRLEQYIPSRP  136 (379)
T ss_dssp             ETT---EEEEECCSEEE
T ss_pred             cCC---ccEEEEecCcc
Confidence            433   28889987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.50  E-value=0.036  Score=43.68  Aligned_cols=75  Identities=11%  Similarity=0.086  Sum_probs=42.9

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCc
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDE   91 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   91 (228)
                      +.-.+.|+.|....+|+.    .           .+.+|+.......  .....+|..+++.+..+.-..+++.. ..+.
T Consensus        20 ~~~i~~l~gG~tN~~~~~----~-----------~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~-~~~~   81 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA----G-----------DLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV-DPAT   81 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE----T-----------TEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE-CTTT
T ss_pred             ccceeEcCCcccccccee----e-----------eEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE-ECCC
Confidence            333788888999999986    1           2788876543111  11223577777766333322444443 2334


Q ss_pred             eEEEEecC-CCCcH
Q psy3166          92 LRLVVEYC-ALGDL  104 (228)
Q Consensus        92 ~~lv~e~~-~~~~L  104 (228)
                      -++++|++ ++.++
T Consensus        82 ~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           82 GVMVTRYIAGAQTM   95 (301)
T ss_dssp             CCEEEECCTTCEEC
T ss_pred             CEEEEeecCCCccC
Confidence            57889999 55433

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=92.32  E-value=0.062  Score=42.78  Aligned_cols=31  Identities=23%  Similarity=0.348  Sum_probs=27.2

Q ss_pred             CCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         115 NNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       115 ~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ...++|+|+.+.||+++.++.+.++||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3678999999999999877889999999764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=88.89  E-value=0.12  Score=40.79  Aligned_cols=30  Identities=23%  Similarity=0.379  Sum_probs=25.1

Q ss_pred             CCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         116 NKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+++|+|+.+.||+++.++.+-++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            358899999999999876656799998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=87.00  E-value=0.25  Score=39.27  Aligned_cols=30  Identities=30%  Similarity=0.399  Sum_probs=25.7

Q ss_pred             CCCcccCCCCCCEeecCC----CcEEEeeccCcc
Q psy3166         116 NKVVHRDLATRNILLSSP----HVVKISDFGLSE  145 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~----~~~kl~dfg~~~  145 (228)
                      ..++|+|+.+.||+++.+    +.+.++||+.+.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            468999999999999874    678999999764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.96  E-value=0.079  Score=44.68  Aligned_cols=63  Identities=10%  Similarity=0.065  Sum_probs=17.0

Q ss_pred             eeeeeeeeecCceEEEeeecCCCCCCCCcccceeeee------eccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166          13 ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAV------KMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus        13 ~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vav------K~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+.+.||   ||+||+|.+...         ..+||+      |..+... .......+.+|..+++.+ +|||+++.+.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~  211 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHN  211 (463)
T ss_dssp             CSTTTSS---BCCC------------------CCBGGGC------------------------------------CBCCC
T ss_pred             cccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcc
Confidence            3455666   999999986432         225788      6554322 223334577788888888 9999999987


Q ss_pred             EEE
Q psy3166          86 CCY   88 (228)
Q Consensus        86 ~~~   88 (228)
                      +..
T Consensus       212 f~~  214 (463)
T 3cxl_A          212 FKV  214 (463)
T ss_dssp             EEE
T ss_pred             eEE
Confidence            653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=85.44  E-value=0.35  Score=39.09  Aligned_cols=89  Identities=9%  Similarity=0.066  Sum_probs=43.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.+..+ ...|+.|....+|+....++... .....+..+.+|+.....  ........|..+++.+..+..+.+++..
T Consensus        31 ~~~~~~~-~~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~  106 (369)
T 3c5i_A           31 FTEDNLR-VKQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNT  106 (369)
T ss_dssp             CCGGGEE-EEEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred             CCcCceE-EEEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEe
Confidence            4444443 35677788889998764321000 000012357888764321  1111234678888777444334455543


Q ss_pred             EEcCceEEEEecCCCC
Q psy3166          87 CYKDELRLVVEYCALG  102 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~  102 (228)
                      +   .-++++++++|.
T Consensus       107 ~---~~~~v~e~i~G~  119 (369)
T 3c5i_A          107 F---NGGRIEEWLYGD  119 (369)
T ss_dssp             E---TTEEEEECCCSE
T ss_pred             c---CCcEEEEEecCC
Confidence            3   236788888764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=83.85  E-value=0.45  Score=37.59  Aligned_cols=28  Identities=21%  Similarity=0.127  Sum_probs=23.8

Q ss_pred             CCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         116 NKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       116 ~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..++|+|+++.||+++ + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            3478999999999998 4 78999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=83.81  E-value=0.5  Score=39.75  Aligned_cols=73  Identities=7%  Similarity=-0.007  Sum_probs=41.9

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEE
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL   94 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~l   94 (228)
                      .+.|+.|-...+|++...+         .+..+.+|+.......  .....+|..++..|..+.-..++++.+. +  .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~-~--G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT-N--GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET-T--EE
T ss_pred             EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C--eE
Confidence            4567778888999986432         1235788876432111  0112478889988855554566666552 2  24


Q ss_pred             EEecCCC
Q psy3166          95 VVEYCAL  101 (228)
Q Consensus        95 v~e~~~~  101 (228)
                      |+||++|
T Consensus       179 v~e~I~G  185 (458)
T 2qg7_A          179 IEEFMDG  185 (458)
T ss_dssp             EEECCCS
T ss_pred             EEEeeCC
Confidence            7888765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=83.58  E-value=0.38  Score=40.01  Aligned_cols=79  Identities=9%  Similarity=0.009  Sum_probs=45.0

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcCceEE
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRL   94 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~l   94 (228)
                      .+.|+.|-...+|++...+....  ....+..+.+|+......   ...+..|..+++.+..+....++++.+..   .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---EE
T ss_pred             EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---CE
Confidence            35677788889999875432110  011234588888743211   12344688888887545444555554322   26


Q ss_pred             EEecCCC
Q psy3166          95 VVEYCAL  101 (228)
Q Consensus        95 v~e~~~~  101 (228)
                      |++|++|
T Consensus       150 v~e~l~G  156 (429)
T 1nw1_A          150 LEEYIPS  156 (429)
T ss_dssp             EECCCCE
T ss_pred             EEEEeCC
Confidence            7777764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.59  E-value=0.66  Score=38.13  Aligned_cols=28  Identities=32%  Similarity=0.427  Sum_probs=23.9

Q ss_pred             CcccCCCCCCEeec------CCCcEEEeeccCcc
Q psy3166         118 VVHRDLATRNILLS------SPHVVKISDFGLSE  145 (228)
Q Consensus       118 i~H~~lk~~nil~~------~~~~~kl~dfg~~~  145 (228)
                      ++|+|+.+.|||+.      ..+.+.++||.++.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            57999999999993      45679999999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=80.92  E-value=0.52  Score=37.75  Aligned_cols=29  Identities=21%  Similarity=0.373  Sum_probs=25.6

Q ss_pred             CCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         117 KVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       117 ~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .++|+|+.+.|++++.++.+.++||+.+.
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            47899999999999877889999998764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	228
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-48
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-45
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-44
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-41
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-37
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-36
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-34
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-33
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-28
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-26
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-25
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-24
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-20
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-18
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-10

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 8e-51
 Identities = 81/243 (33%), Positives = 113/243 (46%), Gaps = 37/243 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L E LG G+FG V  G                +VAVK LK  + +   D FL E
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYNGH----------TKVAVKSLKQGSMSP--DAFLAE 58

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
            NLMK + +H  +V       ++ + ++ EY   G L  +L+                  
Sbjct: 59  ANLMKQL-QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 ++     +HRDL   NIL+S     KI+DFGL+  I +           K PI+
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIK 175

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T KSDVWSFG++L EIVT G  PYP +    ++  L  GYRM RP +C
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235

Query: 226 NEQ 228
            E+
Sbjct: 236 PEE 238

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-50
 Identities = 71/243 (29%), Positives = 120/243 (49%), Gaps = 30/243 (12%)

Query: 8   PPERLILGEV-LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
             + L++ ++ LG G FG V +G+      +       ++VA+K+LK   +    ++ ++
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMR 58

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E  +M  +  + +IV  IG C  + L LV+E    G L  +L                  
Sbjct: 59  EAQIMHQL-DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL     VHRDLA RN+LL + H  KISDFGLS+ +   + +     + K P++
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E +    ++++SDVWS+GV +WE ++ G  PY  +    ++ ++  G RME P  C
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237

Query: 226 NEQ 228
             +
Sbjct: 238 PPE 240

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-49
 Identities = 93/266 (34%), Positives = 135/266 (50%), Gaps = 50/266 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L  G+VLG G FG V+          G     +++VAVKMLK  AD+   +  + E
Sbjct: 35  PRENLEFGKVLGSGAFGKVMNATAYGISKTGV----SIQVAVKMLKEKADSSEREALMSE 90

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
           + +M  +G H++IV+ +G C     + L+ EYC  GDL +YLR                 
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 111 ---------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL 143
                                      E+L     VHRDLA RN+L++   VVKI DFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
           + DI   + +     + +LP++W+A ESL   IYT KSDVWS+G++LWEI +LG NPYP 
Sbjct: 211 ARDIMSDSNYVV-RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269

Query: 204 IPLCRIVH-YLSTGYRMERPASCNEQ 228
           IP+    +  +  G++M++P    E+
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEE 295

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-49
 Identities = 90/247 (36%), Positives = 132/247 (53%), Gaps = 33/247 (13%)

Query: 8   PPERLIL--GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFL 65
            P  LI+   EV+G+G FG V  G L D   +       +  AVK L    D     +FL
Sbjct: 23  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK------IHCAVKSLNRITDIGEVSQFL 76

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLREE------------ 111
            E  +MKD   H +++S +G C + E    +V+ Y   GDL++++R E            
Sbjct: 77  TEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135

Query: 112 ---------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQ-NGEPSEK 161
                    +L++ K VHRDLA RN +L     VK++DFGL+ D+Y++     + +   K
Sbjct: 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 162 LPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER 221
           LP++W+ALESL +  +T KSDVWSFGV+LWE++T GA PYP +    I  YL  G R+ +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255

Query: 222 PASCNEQ 228
           P  C + 
Sbjct: 256 PEYCPDP 262

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 7e-49
 Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 30/243 (12%)

Query: 8   PPERLILGE-VLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFL 65
             + L L +  LG G FG V KG                 VAVK+LK  A D    D+ L
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVV-------KTVAVKILKNEANDPALKDELL 56

Query: 66  KEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE--------------- 110
            E N+M+ +  + +IV  IG C  +   LV+E   LG L  YL++               
Sbjct: 57  AEANVMQQL-DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL  +  VHRDLA RN+LL + H  KISDFGLS+ +     +   +   K P++
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E +    +++KSDVWSFGV++WE  + G  PY  +    +   L  G RM  PA C
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235

Query: 226 NEQ 228
             +
Sbjct: 236 PRE 238

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 9e-49
 Identities = 76/242 (31%), Positives = 120/242 (49%), Gaps = 30/242 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             ER+ LG  +G+G+FG V +G+                VA+K  K        +KFL+E
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPAL------AVAIKTCKNCTSDSVREKFLQE 58

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE----------------- 110
              M+    H HIV  IG   ++ + +++E C LG+L+S+L+                  
Sbjct: 59  ALTMRQF-DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL + + VHRD+A RN+L+SS   VK+ DFGLS  + +   ++      KLPI+W
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKW 175

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
           +A ES+    +T+ SDVW FGV +WEI+  G  P+  +    ++  +  G R+  P +C 
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235

Query: 227 EQ 228
             
Sbjct: 236 PT 237

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 3e-48
 Identities = 76/243 (31%), Positives = 109/243 (44%), Gaps = 37/243 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P E L L   LGQG FG V  G                 VA+K LK    +   + FL+E
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGTMSP--EAFLQE 62

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE---------------- 111
             +MK + +H+ +V       ++ + +V EY + G L  +L+ E                
Sbjct: 63  AQVMKKL-RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121

Query: 112 ------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 Y+     VHRDL   NIL+    V K++DFGL+  I +           K PI+
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIK 179

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E+ +   +T KSDVWSFG++L E+ T G  PYP +    ++  +  GYRM  P  C
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239

Query: 226 NEQ 228
            E 
Sbjct: 240 PES 242

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-48
 Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 41/247 (16%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLK 66
           P  ++ +G+ +G G FG V KG                +VAVKML   A   +    F  
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKN 53

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E+ +++   +H +I+ F+G     +L +V ++C    L  +L                  
Sbjct: 54  EVGVLRKT-RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL    ++HRDL + NI L     VKI DFGL+      +     E      I 
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSIL 171

Query: 166 WLALESLV---SNIYTNKSDVWSFGVVLWEIVTLGANPYPHI-PLCRIVHYLSTGYRMER 221
           W+A E +     N Y+ +SDV++FG+VL+E++T G  PY +I    +I+  +  GY    
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMVGRGYLSPD 230

Query: 222 PASCNEQ 228
            +     
Sbjct: 231 LSKVRSN 237

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-48
 Identities = 93/258 (36%), Positives = 148/258 (57%), Gaps = 40/258 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P +RL+LG+ LG+G FG VV         +        +VAVKMLK++A  K     + E
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
           + +MK +GKH +I++ +G C     L ++VEY + G+L+ YL+                 
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 111 --------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ 150
                               EYL++ K +HRDLA RN+L++  +V+KI+DFGL+ DI+  
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 151 NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
           + ++    + +LP++W+A E+L   IYT++SDVWSFGV+LWEI TLG +PYP +P+  + 
Sbjct: 189 DYYKKT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 211 HYLSTGYRMERPASCNEQ 228
             L  G+RM++P++C  +
Sbjct: 248 KLLKEGHRMDKPSNCTNE 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 7e-48
 Identities = 81/258 (31%), Positives = 128/258 (49%), Gaps = 48/258 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               +   +V+G+G FG V+K  +             M+ A+K +K  A    +  F  E
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGE 60

Query: 68  INLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE---------------- 110
           + ++  +G H +I++ +G C ++  L L +EY   G+L  +LR+                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 111 --------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQ 150
                               +YLS  + +HRDLA RNIL+   +V KI+DFGLS      
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 151 NVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV 210
                G    +LP+RW+A+ESL  ++YT  SDVWS+GV+LWEIV+LG  PY  +    + 
Sbjct: 181 VKKTMG----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 211 HYLSTGYRMERPASCNEQ 228
             L  GYR+E+P +C+++
Sbjct: 237 EKLPQGYRLEKPLNCDDE 254

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-47
 Identities = 84/245 (34%), Positives = 123/245 (50%), Gaps = 45/245 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             + L L + +G+GEFG V+ G                +VAVK +K +A A+    FL E
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDYRG-----------NKVAVKCIKNDATAQ---AFLAE 50

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE--------------- 110
            ++M  + +H ++V  +G   +++  L +V EY A G L  YLR                
Sbjct: 51  ASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 109

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  EYL  N  VHRDLA RN+L+S  +V K+SDFGL+++                P
Sbjct: 110 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P 163

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA 223
           ++W A E+L    ++ KSDVWSFG++LWEI + G  PYP IPL  +V  +  GY+M+ P 
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223

Query: 224 SCNEQ 228
            C   
Sbjct: 224 GCPPA 228

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 7e-47
 Identities = 80/236 (33%), Positives = 121/236 (51%), Gaps = 28/236 (11%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
             +VLG G FG V KGL      +       + VA+K L+     K   + L E  +M  
Sbjct: 13  KIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 74  VGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EY 112
           V  + H+   +G C    ++L+ +    G L  Y+RE                      Y
Sbjct: 68  V-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 113 LSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESL 172
           L + ++VHRDLA RN+L+ +P  VKI+DFGL++ +  +    + E   K+PI+W+ALES+
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMALESI 185

Query: 173 VSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
           +  IYT++SDVWS+GV +WE++T G+ PY  IP   I   L  G R+ +P  C   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 8e-47
 Identities = 77/242 (31%), Positives = 125/242 (51%), Gaps = 37/242 (15%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P+ L   + LG G+FGVV  G                +VA+KM+K  + ++  D+F++E 
Sbjct: 3   PKDLTFLKELGTGQFGVVKYGKWRGQ----------YDVAIKMIKEGSMSE--DEFIEEA 50

Query: 69  NLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----------------- 110
            +M ++  H+ +V   G C  +  + ++ EY A G L +YLRE                 
Sbjct: 51  KVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL + + +HRDLA RN L++   VVK+SDFGLS  + +     +     K P+RW
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRW 167

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
              E L+ + +++KSD+W+FGV++WEI +LG  PY          +++ G R+ RP   +
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227

Query: 227 EQ 228
           E+
Sbjct: 228 EK 229

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 3e-46
 Identities = 82/243 (33%), Positives = 119/243 (48%), Gaps = 28/243 (11%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
            P  +   +V+G GEFG V KG+L        SG+  + VA+K LKA    K    FL E
Sbjct: 5   HPSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
             +M     H +I+   G       + ++ EY   G L  +LRE                
Sbjct: 60  AGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                +YL+N   VHRDLA RNIL++S  V K+SDFGLS  + +           K+PIR
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC 225
           W A E++    +T+ SDVWSFG+V+WE++T G  PY  +    ++  ++ G+R+  P  C
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238

Query: 226 NEQ 228
              
Sbjct: 239 PSA 241

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-46
 Identities = 69/242 (28%), Positives = 115/242 (47%), Gaps = 37/242 (15%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
           P  L   + +G G+FG+V  G   +            +VA+K ++  A ++  + F++E 
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYWLNK----------DKVAIKTIREGAMSE--EDFIEEA 51

Query: 69  NLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----------------- 110
            +M  +  H  +V   G C  +  + LV E+   G L  YLR                  
Sbjct: 52  EVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                YL    V+HRDLA RN L+    V+K+SDFG++  + +     +     K P++W
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS--TGTKFPVKW 168

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
            + E    + Y++KSDVWSFGV++WE+ + G  PY +     +V  +STG+R+ +P   +
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228

Query: 227 EQ 228
             
Sbjct: 229 TH 230

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 5e-45
 Identities = 77/250 (30%), Positives = 120/250 (48%), Gaps = 31/250 (12%)

Query: 3   LSCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKT 60
           L+C    + L L E LG G FGVV +G       +       + VAVK LK +  +  + 
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT------VSVAVKCLKPDVLSQPEA 54

Query: 61  YDKFLKEINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLREE--------- 111
            D F++E+N M  +  H +++   G      +++V E   LG L   LR+          
Sbjct: 55  MDDFIREVNAMHSL-DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 113

Query: 112 ------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
                       YL + + +HRDLA RN+LL++  +VKI DFGL   + + +     +  
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST-GYR 218
            K+P  W A ESL +  +++ SD W FGV LWE+ T G  P+  +   +I+H +   G R
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233

Query: 219 MERPASCNEQ 228
           + RP  C + 
Sbjct: 234 LPRPEDCPQD 243

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  149 bits (377), Expect = 1e-44
 Identities = 73/245 (29%), Positives = 118/245 (48%), Gaps = 31/245 (12%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               + + +V+G GEFG V  G L         G+  + VA+K LK+    K    FL E
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKL------PGKREIFVAIKTLKSGYTEKQRRDFLSE 77

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
            ++M     H +++   G       + ++ E+   G L S+LR+                
Sbjct: 78  ASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE--QNVFQNGEPSEKLP 163
                +YL++   VHRDLA RNIL++S  V K+SDFGLS  + +   +         K+P
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA 223
           IRW A E++    +T+ SDVWS+G+V+WE+++ G  PY  +    +++ +   YR+  P 
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 224 SCNEQ 228
            C   
Sbjct: 257 DCPSA 261

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (371), Expect = 6e-44
 Identities = 87/244 (35%), Positives = 124/244 (50%), Gaps = 37/244 (15%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
               + +   LG G++G V +G+             ++ VAVK LK   D    ++FLKE
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKE--DTMEVEEFLKE 63

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
             +MK++ KH ++V  +G C  +    ++ E+   G+L  YLRE                
Sbjct: 64  AAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                 EYL     +HRDLA RN L+   H+VK++DFGLS  +       +     K PI
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPI 180

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS 224
           +W A ESL  N ++ KSDVW+FGV+LWEI T G +PYP I L ++   L   YRMERP  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240

Query: 225 CNEQ 228
           C E+
Sbjct: 241 CPEK 244

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 8e-44
 Identities = 82/266 (30%), Positives = 117/266 (43%), Gaps = 49/266 (18%)

Query: 7   YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLK 66
           YP   +     +G+G FG V +             +    VAVKMLK  A A     F +
Sbjct: 10  YPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 67  EINLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE---------------- 110
           E  LM +    + +     C     + L+ EY A GDL  +LR                 
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 111 ----------------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG 142
                                        YLS  K VHRDLATRN L+    VVKI+DFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185

Query: 143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
           LS +IY  + ++    ++ +PIRW+  ES+  N YT +SDVW++GVVLWEI + G  PY 
Sbjct: 186 LSRNIYSADYYKADG-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244

Query: 203 HIPLCRIVHYLSTGYRMERPASCNEQ 228
            +    +++Y+  G  +  P +C  +
Sbjct: 245 GMAHEEVIYYVRDGNILACPENCPLE 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-43
 Identities = 83/261 (31%), Positives = 129/261 (49%), Gaps = 45/261 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P  RL  G+ LG G FG VV+              AAM VAVKMLK +A     +  + E
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKS----DAAMTVAVKMLKPSAHLTEREALMSE 76

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
           + ++  +G H +IV+ +G C       ++ EYC  GDL ++LR                 
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 111 ----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY 148
                                  +L++   +HRDLA RNILL+   + KI DFGL+ DI 
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 149 EQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR 208
             + +     + +LP++W+A ES+ + +YT +SDVWS+G+ LWE+ +LG++PYP +P+  
Sbjct: 197 NDSNYVVKGNA-RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 209 IVH-YLSTGYRMERPASCNEQ 228
             +  +  G+RM  P     +
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAE 276

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 9e-42
 Identities = 81/252 (32%), Positives = 126/252 (50%), Gaps = 37/252 (14%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
             E++ +   LGQG FG+V +G+   G  +         VA+K +   A  +   +FL E
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVA-KGVVKDEPET---RVAIKTVNEAASMRERIEFLNE 73

Query: 68  INLMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE---------------- 110
            ++MK+     H+V  +G         +++E    GDL+SYLR                 
Sbjct: 74  ASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 111 --------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG 156
                          YL+ NK VHRDLA RN +++    VKI DFG++ DIYE + ++ G
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 157 EPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                LP+RW++ ESL   ++T  SDVWSFGVVLWEI TL   PY  +   +++ ++  G
Sbjct: 193 GKG-LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251

Query: 217 YRMERPASCNEQ 228
             +++P +C + 
Sbjct: 252 GLLDKPDNCPDM 263

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 7e-41
 Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 38/217 (17%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            +       LG G  GVV K       +   SG     +A K++         ++ ++E+
Sbjct: 5   DDDFEKISELGAGNGGVVFKV------SHKPSGL---VMARKLIHLEIKPAIRNQIIREL 55

Query: 69  NLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE----------------- 110
            ++ +     +IV F G  Y   E+ + +E+   G L   L++                 
Sbjct: 56  QVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114

Query: 111 ---EYL-SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               YL   +K++HRD+   NIL++S   +K+ DFG+S  + +         S      +
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFVGTRSY 169

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
           ++ E L    Y+ +SD+WS G+ L E+   G  P P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPP 205

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-39
 Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 37/247 (14%)

Query: 4   SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK 63
           S G P ++    E +GQG  G V          + A+GQ   EVA++ +      K  + 
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTA------MDVATGQ---EVAIRQMNLQQQPKK-EL 63

Query: 64  FLKEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------ 110
            + EI +M++  K+ +IV+++      DEL +V+EY A G L   + E            
Sbjct: 64  IINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC 122

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  E+L +N+V+HRD+ + NILL     VK++DFG    I  +   ++   +    
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGT 179

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG--YRMER 221
             W+A E +    Y  K D+WS G++  E++  G  PY +    R ++ ++T     ++ 
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQN 238

Query: 222 PASCNEQ 228
           P   +  
Sbjct: 239 PEKLSAI 245

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 8e-39
 Identities = 92/260 (35%), Positives = 137/260 (52%), Gaps = 44/260 (16%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P +RL LG+ LG+G FG V++     G  + A+ +    VAVKMLK  A    +   + E
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCR---TVAVKMLKEGATHSEHRALMSE 66

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE--LRLVVEYCALGDLQSYLRE--------------- 110
           + ++  +G H ++V+ +G C K    L ++VE+C  G+L +YLR                
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 111 ---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYE 149
                                E+L++ K +HRDLA RNILLS  +VVKI DFGL+ DIY+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR- 208
              +       +LP++W+A E++   +YT +SDVWSFGV+LWEI +LGA+PYP + +   
Sbjct: 187 DPDYVRKG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 209 IVHYLSTGYRMERPASCNEQ 228
               L  G RM  P     +
Sbjct: 246 FCRRLKEGTRMRAPDYTTPE 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-38
 Identities = 51/253 (20%), Positives = 92/253 (36%), Gaps = 47/253 (18%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKE 67
            E   +   +G G +G   K          + G+    +  K L   +         + E
Sbjct: 3   AEDYEVLYTIGTGSYGRCQKI------RRKSDGK---ILVWKELDYGSMTEAEKQMLVSE 53

Query: 68  INLMKDVGKHDHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE-------------- 110
           +NL++++ KH +IV +           L +V+EYC  GDL S + +              
Sbjct: 54  VNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 112

Query: 111 ----------EYL-----SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN 155
                     +         + V+HRDL   N+ L     VK+ DFGL+  +     F  
Sbjct: 113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 172

Query: 156 GEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST 215
              +      +++ E +    Y  KSD+WS G +L+E+      P+       +   +  
Sbjct: 173 ---AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIRE 228

Query: 216 GYRMERPASCNEQ 228
           G     P   +++
Sbjct: 229 GKFRRIPYRYSDE 241

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-38
 Identities = 54/250 (21%), Positives = 103/250 (41%), Gaps = 44/250 (17%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKE 67
           P +   +   LG G FG V K    +              A K++      +  + ++ E
Sbjct: 10  PEDFWEIIGELGDGAFGKVYKAQNKETSVL---------AAAKVIDTK-SEEELEDYMVE 59

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
           I+++     H +IV  +   Y ++ L +++E+CA G + + + E                
Sbjct: 60  IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 118

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                 YL +NK++HRDL   NIL +    +K++DFG+S         ++   S      
Sbjct: 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD---SFIGTPY 175

Query: 166 WLALESLVSN-----IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG--YR 218
           W+A E ++        Y  K+DVWS G+ L E+      P+  +   R++  ++      
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKIAKSEPPT 234

Query: 219 MERPASCNEQ 228
           + +P+  +  
Sbjct: 235 LAQPSRWSSN 244

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 3e-37
 Identities = 51/242 (21%), Positives = 91/242 (37%), Gaps = 40/242 (16%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKE 67
           E   +G  LG+G+FG V                    +A+K+L       A    +  +E
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFI---------LALKVLFKAQLEKAGVEHQLRRE 56

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
           + +   + +H +I+   G  +    + L++EY  LG +   L++                
Sbjct: 57  VEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 115

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                Y  + +V+HRD+   N+LL S   +KI+DFG S              +    + +
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----TLCGTLDY 170

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
           L  E +   ++  K D+WS GV+ +E +  G  P+           +S       P    
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRV-EFTFPDFVT 228

Query: 227 EQ 228
           E 
Sbjct: 229 EG 230

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  126 bits (317), Expect = 4e-36
 Identities = 56/245 (22%), Positives = 96/245 (39%), Gaps = 42/245 (17%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK--------ANADAKTY 61
           E     E+LG+G   VV +           + +   E AVK++         A    +  
Sbjct: 3   ENYEPKEILGRGVSSVVRRC------IHKPTCK---EYAVKIIDVTGGGSFSAEEVQELR 53

Query: 62  DKFLKEINLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDLQSYLRE---------- 110
           +  LKE+++++ V  H +I+        +    LV +    G+L  YL E          
Sbjct: 54  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 113

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQN--GEP 158
                       L    +VHRDL   NILL     +K++DFG S  +      +   G P
Sbjct: 114 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 159 SEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-Y 217
           S   P       +     Y  + D+WS GV+++ ++  G+ P+ H     ++  + +G Y
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRMIMSGNY 232

Query: 218 RMERP 222
           +   P
Sbjct: 233 QFGSP 237

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (316), Expect = 1e-35
 Identities = 51/241 (21%), Positives = 94/241 (39%), Gaps = 44/241 (18%)

Query: 8   PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFL 65
           P +       +G G FG V          +  + +    VA+K +  +     + +   +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFA------RDVRNSE---VVAIKKMSYSGKQSNEKWQDII 63

Query: 66  KEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------- 110
           KE+  ++ + +H + + + GC   +    LV+EYC                         
Sbjct: 64  KEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                  YL ++ ++HRD+   NILLS P +VK+ DFG +  +   N F  G P      
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-GTP------ 175

Query: 165 RWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER 221
            W+A E +++     Y  K DVWS G+   E+      P  ++     +++++       
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPAL 234

Query: 222 P 222
            
Sbjct: 235 Q 235

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 4e-35
 Identities = 41/218 (18%), Positives = 92/218 (42%), Gaps = 41/218 (18%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E+ ++ E LG+GEFG+V +        E +S +       K +K     +      KEI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRC------VETSSKK---TYMAKFVKVKGTDQ--VLVKKEIS 53

Query: 70  LMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------ 110
           ++    +H +I+         +EL ++ E+ +  D+   +                    
Sbjct: 54  ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPH--VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
              ++L ++ + H D+   NI+  +     +KI +FG +  +   + F+    +      
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA----PE 168

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
           + A E    ++ +  +D+WS G +++ +++ G NP+  
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLA 205

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-34
 Identities = 55/242 (22%), Positives = 98/242 (40%), Gaps = 37/242 (15%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKE 67
           E  IL ++LG+G FG V             + Q     A+K LK +        +  + E
Sbjct: 2   EDFILHKMLGKGSFGKVFLA------EFKKTNQ---FFAIKALKKDVVLMDDDVECTMVE 52

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
             ++    +H  +         K+ L  V+EY   GDL  +++                 
Sbjct: 53  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 112

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               ++L +  +V+RDL   NILL     +KI+DFG+ ++    +   N   +      +
Sbjct: 113 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---TFCGTPDY 169

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
           +A E L+   Y +  D WSFGV+L+E++  G +P+       + H +        P    
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMD-NPFYPRWLE 227

Query: 227 EQ 228
           ++
Sbjct: 228 KE 229

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 3e-34
 Identities = 52/242 (21%), Positives = 86/242 (35%), Gaps = 34/242 (14%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           E   L + LG+G +G V             + +    VAVK++         +   KEI 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLA------VNRVTEE---AVAVKIVDMKRAVDCPENIKKEIC 55

Query: 70  LMKDVGKHDHIVSFIGCC-YKDELRLVVEYCALGDLQSYLRE------------------ 110
           + K +  H+++V F G     +   L +EYC+ G+L   +                    
Sbjct: 56  INKML-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 114

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
              YL    + HRD+   N+LL     +KISDFGL+      N  +         + ++A
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVA 173

Query: 169 LESLVSN-IYTNKSDVWSFGVVLWEIVTLGAN-PYPHIPLCRIVHYLSTGYRMERPASCN 226
            E L     +    DVWS G+VL  ++        P         +      +      +
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 227 EQ 228
             
Sbjct: 234 SA 235

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  122 bits (306), Expect = 8e-34
 Identities = 45/218 (20%), Positives = 85/218 (38%), Gaps = 40/218 (18%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +   + E LG G FGVV +       TE A+G      A K +         +   KEI 
Sbjct: 26  DHYDIHEELGTGAFGVVHRV------TERATGN---NFAAKFVM-TPHESDKETVRKEIQ 75

Query: 70  LMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------ 110
            M  + +H  +V+        +E+ ++ E+ + G+L   + +                  
Sbjct: 76  TMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPH--VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
               ++  N  VH DL   NI+ ++     +K+ DFGL+  +  +   +           
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK----VTTGTAE 190

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
           + A E          +D+WS GV+ + +++ G +P+  
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGG 227

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-33
 Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 55/234 (23%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
             ++L E +G+G FG V +G           G+   EVAVK+  +  +      + +E  
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--------RGE---EVAVKIFSSREE----RSWFREAE 47

Query: 70  LMKDVG-KHDHIVSFIGCCYKD-----ELRLVVEYCALGDLQSYLREE------------ 111
           + + V  +H++I+ FI    KD     +L LV +Y   G L  YL               
Sbjct: 48  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL 107

Query: 112 ---------------YLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNG 156
                                + HRDL ++NIL+       I+D GL+          + 
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167

Query: 157 EPSEKL-PIRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYPH 203
            P+ ++   R++A E L  +I         ++D+++ G+V WEI    +    H
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  120 bits (303), Expect = 3e-33
 Identities = 42/214 (19%), Positives = 84/214 (39%), Gaps = 40/214 (18%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKD 73
           + E LG G FGVV +        E A+G+       K +              EI++M  
Sbjct: 33  ILEELGSGAFGVVHRC------VEKATGR---VFVAKFIN-TPYPLDKYTVKNEISIMNQ 82

Query: 74  VGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------------E 111
           +  H  +++       K E+ L++E+ + G+L   +                       +
Sbjct: 83  L-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141

Query: 112 YLSNNKVVHRDLATRNILLSSPH--VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLAL 169
           ++  + +VH D+   NI+  +     VKI DFGL+  +    + +           + A 
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATAEFAAP 197

Query: 170 ESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
           E +        +D+W+ GV+ + +++ G +P+  
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAG 230

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 5e-33
 Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLK 66
           PE    G++LG+G F  VV         E A+ +   E A+K+L+              +
Sbjct: 7   PEDFKFGKILGEGSFSTVVLA------RELATSR---EYAIKILEKRHIIKENKVPYVTR 57

Query: 67  EINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------- 110
           E ++M  +  H   V         ++L   + Y   G+L  Y+R+               
Sbjct: 58  ERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                EYL    ++HRDL   NILL+    ++I+DFG +  +      Q    S     +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-KVLSPESKQARANSFVGTAQ 175

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
           +++ E L        SD+W+ G +++++V  G  P+  
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRA 212

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 4e-32
 Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 51/243 (20%)

Query: 12  LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKEINL 70
           L     +G+G F  V KGL  +           +EVA   L           +F +E  +
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTET---------TVEVAWCELQDRKLTKSERQRFKEEAEM 61

Query: 71  MKDVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSYLRE--------------- 110
           +K + +H +IV F          K  + LV E    G L++YL+                
Sbjct: 62  LKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120

Query: 111 -----EYL--SNNKVVHRDLATRNILLSSPH-VVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                ++L      ++HRDL   NI ++ P   VKI D GL+         +    ++ +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-------TLKRASFAKAV 173

Query: 163 --PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH-IPLCRIVHYLSTGYRM 219
                ++A E +    Y    DV++FG+ + E+ T    PY       +I   +++G + 
Sbjct: 174 IGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVKP 231

Query: 220 ERP 222
              
Sbjct: 232 ASF 234

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 4e-32
 Identities = 50/240 (20%), Positives = 95/240 (39%), Gaps = 50/240 (20%)

Query: 13  ILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMK 72
           +  +VLG G  G V++           + +   + A+KML+         K  +E+ L  
Sbjct: 15  VTSQVLGLGINGKVLQI------FNKRTQE---KFALKMLQDC------PKARREVELHW 59

Query: 73  DVGKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSYLRE----------------- 110
              +  HIV  +         +  L +V+E    G+L S +++                 
Sbjct: 60  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                +YL +  + HRD+   N+L +S     ++K++DFG +++    N       +   
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT--- 176

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
              ++A E L    Y    D+WS GV+++ ++  G  P+       I   + T  RM + 
Sbjct: 177 -PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTRIRMGQY 234

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 6e-31
 Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 40/238 (16%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
           +     +VLG G F  V+         +  + +    VA+K +   A          EI 
Sbjct: 9   DIYDFRDVLGTGAFSEVILA------EDKRTQK---LVAIKCIAKKALEGKEGSMENEIA 59

Query: 70  LMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------ 110
           ++  + KH +IV+          L L+++  + G+L   + E                  
Sbjct: 60  VLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118

Query: 111 --EYLSNNKVVHRDLATRNILLSSPH---VVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
             +YL +  +VHRDL   N+L  S      + ISDFGLS+     +V      +      
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT----PG 174

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG-YRMERP 222
           ++A E L    Y+   D WS GV+ + ++  G  P+      ++   +    Y  + P
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQILKAEYEFDSP 231

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  112 bits (282), Expect = 2e-30
 Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 41/216 (18%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLM 71
           +  ++G+G FG V      D      +G+     A+K L        +     L E  ++
Sbjct: 8   VHRIIGRGGFGEVYGCRKAD------TGK---MYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 72  K--DVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------------ 110
                G    IV      +  D+L  +++    GDL  +L +                  
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLA 168
             E++ N  VV+RDL   NILL     V+ISD GL+ D  ++    +          ++A
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMA 173

Query: 169 LESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPH 203
            E L   + Y + +D +S G +L++++  G +P+  
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQ 208

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (278), Expect = 5e-30
 Identities = 54/238 (22%), Positives = 95/238 (39%), Gaps = 41/238 (17%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLM 71
           +   LG G FG V             +G+     A+K+LK       K  +    E  ++
Sbjct: 8   ILRTLGTGSFGRVHLI------RSRHNGR---YYAMKVLKKEIVVRLKQVEHTNDERLML 58

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------------- 110
             V  H  I+   G      ++ ++++Y   G+L S LR+                    
Sbjct: 59  SIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 111 EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
           EYL +  +++RDL   NILL     +KI+DFG ++ + +      G P       ++A E
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP------DYIAPE 171

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
            + +  Y    D WSFG++++E++  G  P+      +    +     +  P   NE 
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNA-ELRFPPFFNED 227

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  110 bits (275), Expect = 7e-30
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 38/220 (17%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKE 67
           +R  LGE+LG G    V          +    +   +VAVK+L+A+   D   Y +F +E
Sbjct: 7   DRYELGEILGFGGMSEVHLA------RDLRLHR---DVAVKVLRADLARDPSFYLRFRRE 57

Query: 68  INLMKDVGKHDHIVSFIGCCYKDE-----LRLVVEYCALGDLQSYLRE------------ 110
                 +  H  IV+       +        +V+EY     L+  +              
Sbjct: 58  AQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 116

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                    +   N ++HRD+   NI++S+ + VK+ DFG++  I +         +   
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
             ++L+ E    +    +SDV+S G VL+E++T G  P+ 
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFT 215

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 9e-30
 Identities = 45/220 (20%), Positives = 84/220 (38%), Gaps = 36/220 (16%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
             R      +G+G +G+V          +  +      VA+K +          + L+EI
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSA------YDNVNKV---RVAIKKISPFEHQTYCQRTLREI 57

Query: 69  NLMKDVGKHDHIVSFIGCCYKDELR-----LVVEYCALGDLQSYLREEYLS--------- 114
            ++    +H++I+          +       +V +    DL   L+ ++LS         
Sbjct: 58  KILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 116

Query: 115 ----------NNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                     +  V+HRDL   N+LL++   +KI DFGL+      +             
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 165 RWLALESLV-SNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
            + A E ++ S  YT   D+WS G +L E+++     +P 
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPG 215

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-29
 Identities = 52/237 (21%), Positives = 96/237 (40%), Gaps = 31/237 (13%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK---ANADAKTYDKFLK 66
           E   L +VLG G +G V       G   G         A+K+LK       AKT +    
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGK------LYAMKVLKKATIVQKAKTTEHTRT 77

Query: 67  EINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE--------------- 110
           E  +++ + +   +V+       + +L L+++Y   G+L ++L +               
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137

Query: 111 -----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIR 165
                E+L    +++RD+   NILL S   V ++DFGLS++       +  +    +   
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 166 WLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
              +     + +    D WS GV+++E++T GA+P+           +S       P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRILKSEP 253

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 3e-28
 Identities = 55/237 (23%), Positives = 106/237 (44%), Gaps = 45/237 (18%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKF 64
           +    GE LG G+F VV K        E ++G    + A K +K     ++    + +  
Sbjct: 10  DYYDTGEELGSGQFAVVKKC------REKSTGL---QYAAKFIKKRRTKSSRRGVSREDI 60

Query: 65  LKEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE------------- 110
            +E++++K++ +H ++++       K ++ L++E  A G+L  +L E             
Sbjct: 61  EREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHV----VKISDFGLSEDIYEQNVFQNGEPS 159
                   YL + ++ H DL   NI+L   +V    +KI DFGL+  I   N F+N    
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---- 175

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG 216
                 ++A E +       ++D+WS GV+ + +++ GA+P+        +  +S  
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANVSAV 231

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 7e-28
 Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 43/225 (19%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVK-MLKANADAKTYDKFLKEI 68
            +      +GQG FG V K           +GQ   +VA+K +L  N         L+EI
Sbjct: 10  SKYEKLAKIGQGTFGEVFKA------RHRKTGQ---KVALKKVLMENEKEGFPITALREI 60

Query: 69  NLMKDVGKHDHIVSFIGCC---------YKDELRLVVEYCALGDLQSYLRE--------- 110
            +++ + KH+++V+ I  C          K  + LV ++C                    
Sbjct: 61  KILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 119

Query: 111 -----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI-YEQNVFQNGEP 158
                       Y+  NK++HRD+   N+L++   V+K++DFGL+      +N   N   
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 159 SEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYP 202
           +  + + +   E L+    Y    D+W  G ++ E+ T  +    
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQ 223

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (259), Expect = 2e-27
 Identities = 41/256 (16%), Positives = 90/256 (35%), Gaps = 50/256 (19%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEIN 69
               +G  +G+G FGV+ +G      T   + Q   +VA+K     +DA    +   E  
Sbjct: 5   VHYKVGRRIGEGSFGVIFEG------TNLLNNQ---QVAIKFEPRRSDAP---QLRDEYR 52

Query: 70  LMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE------------------- 110
             K +     I +      +    ++V       L+  L                     
Sbjct: 53  TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112

Query: 111 --EYLSNNKVVHRDLATRNILLSSPHV-----VKISDFGLS----EDIYEQNVFQNGEPS 159
             + +    +V+RD+   N L+  P+      + + DFG+     + + +Q++    + +
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP-------LCRIVHY 212
                R++++ + +    + + D+ + G V    +  G+ P+  +          RI   
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKAATNKQKYERIGEK 231

Query: 213 LSTGYRMERPASCNEQ 228
             +    E  A   E+
Sbjct: 232 KQSTPLRELCAGFPEE 247

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 3e-26
 Identities = 54/246 (21%), Positives = 93/246 (37%), Gaps = 45/246 (18%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK----ANADAKTYDKFL 65
           E+L   + LG+G+F  V K    +      + Q    VA+K +K    + A        L
Sbjct: 1   EKL---DFLGEGQFATVYKARDKN------TNQ---IVAIKKIKLGHRSEAKDGINRTAL 48

Query: 66  KEINLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE-------------- 110
           +EI L++++  H +I+  +     K  + LV ++                          
Sbjct: 49  REIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML 107

Query: 111 ------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPI 164
                 EYL  + ++HRDL   N+LL    V+K++DFGL++     N     +       
Sbjct: 108 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRW 165

Query: 165 RWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP----HIPLCRIVHYLSTGYRME 220
                    + +Y    D+W+ G +L E++       P       L RI   L T    +
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQ 224

Query: 221 RPASCN 226
            P  C+
Sbjct: 225 WPDMCS 230

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (250), Expect = 3e-26
 Identities = 41/240 (17%), Positives = 79/240 (32%), Gaps = 40/240 (16%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           R  LG  +G G FG +  G      T+ A+G+   EVA+K+         + +   E  +
Sbjct: 8   RYRLGRKIGSGSFGDIYLG------TDIAAGE---EVAIKLECVKTK---HPQLHIESKI 55

Query: 71  MKDVGKHDHIVSFIGCCYKDELRLVV-EYCALGDLQSYLRE------------------- 110
            K +     I +   C  + +  ++V E         +                      
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115

Query: 111 -EYLSNNKVVHRDLATRNILLSSP---HVVKISDFG----LSEDIYEQNVFQNGEPSEKL 162
            EY+ +   +HRD+   N L+      ++V I DFG      +    Q++      +   
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP 222
             R+ ++ + +    + + D+ S G VL                 +   Y     +    
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (251), Expect = 5e-26
 Identities = 40/243 (16%), Positives = 84/243 (34%), Gaps = 41/243 (16%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEI 68
            +   L   LG+G++  V +           + +   +V VK+LK         K  +EI
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEA------INITNNE---KVVVKILKP----VKKKKIKREI 80

Query: 69  NLMKDVGKHDHIVSFIGCCY---KDELRLVVEYCALGDLQSYLRE--------------- 110
            +++++    +I++              LV E+    D +   +                
Sbjct: 81  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 140

Query: 111 --EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
             +Y  +  ++HRD+   N+++      +++ D+GL+E  +    +     S        
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS---RYFKG 197

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLSTGYRMERPA 223
               +   +Y    D+WS G +L  ++      +        L RI   L T    +   
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 224 SCN 226
             N
Sbjct: 258 KYN 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =   99 bits (248), Expect = 6e-26
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 42/240 (17%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEI 68
           E+    E +G+G +GVV K     G             A+K ++    D       ++EI
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG----------ETFALKKIRLEKEDEGIPSTTIREI 51

Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE------------------ 110
           +++K++ KH +IV      +  +  ++V      DL+  L                    
Sbjct: 52  SILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               Y  + +V+HRDL  +N+L++    +KI+DFGL+               E + + + 
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT---HEIVTLWYR 167

Query: 168 ALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIP----LCRIVHYLSTGYRMERP 222
           A + L+ +  Y+   D+WS G +  E+V  G   +P +     L RI   L T      P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 7e-26
 Identities = 45/223 (20%), Positives = 84/223 (37%), Gaps = 45/223 (20%)

Query: 11  RLILGEVLGQGEFGVVVKGL-LGDGPTEGASGQAAMEVAVKMLK-----ANADAKTYDKF 64
           +  +G +LG G FG V  G+ + D           + VA+K ++        +     + 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDN----------LPVAIKHVEKDRISDWGELPNGTRV 54

Query: 65  LKEINLMKDV-GKHDHIVSFIGCCY-KDELRLVVEYCA-LGDLQSYLRE----------- 110
             E+ L+K V      ++  +      D   L++E    + DL  ++ E           
Sbjct: 55  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114

Query: 111 ---------EYLSNNKVVHRDLATRNILLS-SPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                     +  N  V+HRD+   NIL+  +   +K+ DFG    + +           
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
             P  W+         +   + VWS G++L+++V  G  P+ H
Sbjct: 175 YSPPEWIRYHR----YHGRSAAVWSLGILLYDMVC-GDIPFEH 212

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 1e-25
 Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 34/215 (15%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEI 68
           ++    E +G+G +G V K           + +    VA+K ++  + D       L+EI
Sbjct: 2   QKYEKLEKIGEGTYGTVFKA------KNRETHE---IVALKRVRLDDDDEGVPSSALREI 52

Query: 69  NLMKDVGKHDHIVSFIGCCYKD-ELRLVVEYCALGDL---------------QSYLRE-- 110
            L+K++ KH +IV      + D +L LV E+C                    +S+L +  
Sbjct: 53  CLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
               +  +  V+HRDL  +N+L++    +K+++FGL+         +             
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRP 169

Query: 168 ALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
                 + +Y+   D+WS G +  E+   G   +P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 1e-25
 Identities = 53/245 (21%), Positives = 103/245 (42%), Gaps = 42/245 (17%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKEI 68
           E     E +G+G +GVV K           +G+    VA+K ++ + + +      ++EI
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGE---VVALKKIRLDTETEGVPSTAIREI 52

Query: 69  NLMKDVGKHDHIVSFIGCCYKDELRLVVEYCALGDLQSYLRE------------------ 110
           +L+K++  H +IV  +   + +    +V      DL+ ++                    
Sbjct: 53  SLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
                +  +++V+HRDL  +N+L+++   +K++DFGL+               E + + +
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWY 168

Query: 167 LALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYP----HIPLCRIVHYLSTGYRMER 221
            A E L+   Y +   D+WS G +  E+VT     +P       L RI   L T   +  
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 222 PASCN 226
           P   +
Sbjct: 228 PGVTS 232

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 3e-25
 Identities = 45/224 (20%), Positives = 89/224 (39%), Gaps = 43/224 (19%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLK-ANADAKTYDKFLKEI 68
           ++      +G+G +G V K    D    G        VA+K ++    +       ++E+
Sbjct: 7   QQYECVAEIGEGAYGKVFKAR--DLKNGG------RFVALKRVRVQTGEEGMPLSTIREV 58

Query: 69  NLMKDVG--KHDHIVSFIGCC------YKDELRLVVEYCALGDLQSYLRE---------- 110
            +++ +   +H ++V     C       + +L LV E+          +           
Sbjct: 59  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118

Query: 111 -----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPS 159
                      ++L +++VVHRDL  +NIL++S   +K++DFGL+     Q        S
Sbjct: 119 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT----S 174

Query: 160 EKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
             + + + A E L+ + Y    D+WS G +  E+       +  
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRG 217

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 5e-25
 Identities = 51/238 (21%), Positives = 94/238 (39%), Gaps = 38/238 (15%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKEINLM 71
             ++LG+G FG V+         E A+G+     A+K+L+             + E  ++
Sbjct: 9   YLKLLGKGTFGKVILV------REKATGR---YYAMKILRKEVIIAKDEVAHTVTESRVL 59

Query: 72  KDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLREEYL----------------- 113
           ++  +H  + +        D L  V+EY   G+L  +L  E +                 
Sbjct: 60  QNT-RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118

Query: 114 ---SNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALE 170
               +  VV+RD+   N++L     +KI+DFGL ++                   +LA E
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG---TPEYLAPE 175

Query: 171 SLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCNEQ 228
            L  N Y    D W  GVV++E++  G  P+ +    R+   +     +  P + + +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPRTLSPE 231

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 96.4 bits (239), Expect = 3e-24
 Identities = 53/242 (21%), Positives = 98/242 (40%), Gaps = 41/242 (16%)

Query: 10  ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN--ADAKTYDKFLKE 67
           ++    + LG G FG V+            SG      A+K+L        K  +  L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLV------KHKESGN---HYAMKILDKQKVVKLKQIEHTLNE 91

Query: 68  INLMKDVGKHDHIVSFIGCCY-KDELRLVVEYCALGDLQSYLRE---------------- 110
             +++ V     +V           L +V+EY A G++ S+LR                 
Sbjct: 92  KRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150

Query: 111 ----EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRW 166
               EYL +  +++RDL   N+L+     ++++DFG ++ +  +     G P        
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP------EA 204

Query: 167 LALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN 226
           LA E ++S  Y    D W+ GV+++E+   G  P+      +I   + +G ++  P+  +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSG-KVRFPSHFS 262

Query: 227 EQ 228
             
Sbjct: 263 SD 264

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.2 bits (236), Expect = 9e-24
 Identities = 51/233 (21%), Positives = 85/233 (36%), Gaps = 55/233 (23%)

Query: 6   GYPPERLI-----LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKT 60
           G  P+R         +V+G G FGVV +  L D      SG+    VA+K +      + 
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD------SGE---LVAIKKVL-----QD 56

Query: 61  YDKFLKEINLMKDVGKHDHIVSFIGCCYKDE-------LRLVVEYCALGDLQSYLRE--- 110
                +E+ +M+ +  H +IV      Y          L LV++Y      +        
Sbjct: 57  KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115

Query: 111 --------------------EYLSNNKVVHRDLATRNILLSSP-HVVKISDFGLSEDIYE 149
                                Y+ +  + HRD+  +N+LL     V+K+ DFG ++ +  
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 150 QNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
                +                  +  YT+  DVWS G VL E++  G   +P
Sbjct: 176 GEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFP 224

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 1e-20
 Identities = 43/220 (19%), Positives = 81/220 (36%), Gaps = 42/220 (19%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKE 67
           PER      +G G +G V          +  +G     VAVK L +         +  +E
Sbjct: 17  PERYQNLSPVGSGAYGSVCAA------FDTKTGL---RVAVKKLSRPFQSIIHAKRTYRE 67

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELR------LVVEYCALGDLQSYLRE----------- 110
           + L+K + KH++++  +                +V +    DL + ++            
Sbjct: 68  LRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126

Query: 111 --------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKL 162
                   +Y+ +  ++HRDL   N+ ++    +KI DFGL+    ++            
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----- 181

Query: 163 PIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
                    L    Y    D+WS G ++ E++T G   +P
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFP 220

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (208), Expect = 5e-20
 Identities = 43/223 (19%), Positives = 81/223 (36%), Gaps = 46/223 (20%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDK-FLKE 67
                  + +G G +G V          +G +G    +VA+K L     ++ + K   +E
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSA------VDGRTGA---KVAIKKLYRPFQSELFAKRAYRE 67

Query: 68  INLMKDVGKHDHIVSFIGCCYKDELR-------LVVEYCALGDLQSYLRE---------- 110
           + L+K + +H++++  +     DE         LV+ +   G     L +          
Sbjct: 68  LRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ 124

Query: 111 ----------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSE 160
                      Y+    ++HRDL   N+ ++    +KI DFGL+     +          
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT--- 181

Query: 161 KLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
                      L    YT   D+WS G ++ E++T G   +  
Sbjct: 182 --RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKG 221

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.2 bits (194), Expect = 5e-18
 Identities = 46/220 (20%), Positives = 83/220 (37%), Gaps = 40/220 (18%)

Query: 9   PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKML-KANADAKTYDKFLKE 67
            +R    + +G G  G+V          +    +    VA+K L +   +     +  +E
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAA------YDAVLDR---NVAIKKLSRPFQNQTHAKRAYRE 66

Query: 68  INLMKDVGKHDHIVSFIGCC-------YKDELRLVVEYCALGDLQSYLRE---------- 110
           + LMK V  H +I+S +             ++ LV+E       Q    E          
Sbjct: 67  LVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 125

Query: 111 -------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLP 163
                  ++L +  ++HRDL   NI++ S   +KI DFGL+       +      +    
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT---- 181

Query: 164 IRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPH 203
             + A E ++   Y    D+WS G ++ E+V      +P 
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPG 220

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.7 bits (169), Expect = 1e-14
 Identities = 38/235 (16%), Positives = 75/235 (31%), Gaps = 61/235 (25%)

Query: 11  RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINL 70
           R IL   LG G F  V          +  +      VA+K+++ +      +    EI L
Sbjct: 14  RYILVRKLGWGHFSTVWLA------KDMVNNT---HVAMKIVRGDKVYT--EAAEDEIKL 62

Query: 71  MKDV----------GKHDHIVSFIGCCY-----KDELRLVVEYCALGDLQSYLREEYLS- 114
           ++ V             +HI+  +            + +V E      L    + E+   
Sbjct: 63  LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122

Query: 115 ---------------------NNKVVHRDLATRNILLSSP------HVVKISDFGLSEDI 147
                                   ++H D+   N+L+           +KI+D G +   
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182

Query: 148 YEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYP 202
            E                + + E L+   +   +D+WS   +++E++T G   + 
Sbjct: 183 DEHYTNSIQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 56.7 bits (136), Expect = 1e-10
 Identities = 30/198 (15%), Positives = 61/198 (30%), Gaps = 43/198 (21%)

Query: 14  LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKF--------L 65
           +G+++G+G+   V                   E  VK  K    +    K          
Sbjct: 4   IGKLMGEGKESAVFNCYSEKF----------GECVVKFHKVGHTSFKKVKEKRDYGDLHF 53

Query: 66  KEINLMKDVGKHDHIVSFIGCC-----YKDELRLVVEYCALGDL--------QSYLRE-- 110
             + +     +   +    G         +   +++E     +L           L    
Sbjct: 54  SVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMIL 113

Query: 111 ---EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWL 167
                  +  +VH DL+  N+L+S   +  I DF  S ++ E+   +  E   +  I + 
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 168 ALESLVSNIYTNKSDVWS 185
           +        Y  + D+ S
Sbjct: 173 SRT------YRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	228
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.95
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.34
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.24
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.35

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=325.85  Aligned_cols=216  Identities=33%  Similarity=0.668  Sum_probs=187.3

Q ss_pred             CCCCCCceeeeee-eeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEV-LGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~-ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +-++.++|.+.+. ||+|+||+||+|.++..       ..+..||||.++........+.+.+|+++|+++ +||||+++
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l   74 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRL   74 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeE
Confidence            3467789999985 99999999999986442       233469999998776666678899999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+.+++||||+++|+|.+++..                     .|||+++|+||||||+||+++.++.+||+|||
T Consensus        75 ~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          75 IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             EEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             eeeeccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence            999988889999999999999998743                     69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++.+..............||..|+|||++....++.++|||||||++|||+|.|..||.+.+..++...+.++.+++.|
T Consensus       155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p  234 (285)
T d1u59a_         155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP  234 (285)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC
T ss_pred             hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99876554433333445667889999999998889999999999999999998799999999999999999999999999


Q ss_pred             CCCCCC
Q psy3166         223 ASCNEQ  228 (228)
Q Consensus       223 ~~~~~~  228 (228)
                      +.||++
T Consensus       235 ~~~~~~  240 (285)
T d1u59a_         235 PECPPE  240 (285)
T ss_dssp             TTCCHH
T ss_pred             CcCCHH
Confidence            999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-50  Score=316.52  Aligned_cols=216  Identities=36%  Similarity=0.684  Sum_probs=177.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.|+.++|++.+.||+|+||+||+|++..+      .+....||+|.++........+.+.+|+.+|+++ +||||+++
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l   73 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKL   73 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecC------CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeE
Confidence            3889999999999999999999999986543      2344568999987666666677899999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++..+.+++||||+++|++.+++..                     .|||+++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          74 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             EEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEEecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence            999988889999999999999987654                     69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++.+......  ......||+.|+|||++....++.++|||||||++|||+|.|..||.+.+..++..++.++.+++.|
T Consensus       154 ~a~~~~~~~~~--~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~  231 (273)
T d1mp8a_         154 LSRYMEDSTYY--KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  231 (273)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             hheeccCCcce--eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99765433221  1233567888999999999999999999999999999998799999999999999999999999999


Q ss_pred             CCCCCC
Q psy3166         223 ASCNEQ  228 (228)
Q Consensus       223 ~~~~~~  228 (228)
                      ++||++
T Consensus       232 ~~~~~~  237 (273)
T d1mp8a_         232 PNCPPT  237 (273)
T ss_dssp             TTCCHH
T ss_pred             CCCCHH
Confidence            999863

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-49  Score=318.87  Aligned_cols=217  Identities=34%  Similarity=0.606  Sum_probs=174.6

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +..++.++|++.+.||+|+||+||+|+++.+.      +....||+|.+.........+.+.+|+++|+++ +||||+++
T Consensus        20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l   92 (299)
T d1jpaa_          20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHL   92 (299)
T ss_dssp             SCBCCGGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             chhhChhhcEEeeEEeeCCCeEEEEEEEeCCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccE
Confidence            34678899999999999999999999865432      223458999987766666677899999999999 99999999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++.. +.+++||||+++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+||
T Consensus        93 ~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_          93 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCc
Confidence            999876 458999999999999998764                     6999999999999999999999999999999


Q ss_pred             cCccccccccccc--CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Q psy3166         142 GLSEDIYEQNVFQ--NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM  219 (228)
Q Consensus       142 g~~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~  219 (228)
                      |+++.+.......  .......+|..|+|||.+....++.++|||||||++|||+|.|..||.+.+..++...+.++.++
T Consensus       173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~  252 (299)
T d1jpaa_         173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL  252 (299)
T ss_dssp             -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             ccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9998664432211  12223456888999999998899999999999999999998789999999999999999999999


Q ss_pred             CCCCCCCC
Q psy3166         220 ERPASCNE  227 (228)
Q Consensus       220 ~~p~~~~~  227 (228)
                      +.|..||+
T Consensus       253 ~~~~~~~~  260 (299)
T d1jpaa_         253 PPPMDCPS  260 (299)
T ss_dssp             CCCTTCCH
T ss_pred             CCCccchH
Confidence            99998885

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-50  Score=317.68  Aligned_cols=213  Identities=39%  Similarity=0.684  Sum_probs=178.1

Q ss_pred             CCCceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           8 PPERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         8 ~~~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      +.+.+.+. +.||+|+||+||+|.++..       .+++.||+|.++... .....+.+.+|+.+|+++ +||||+++++
T Consensus         4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g   75 (277)
T d1xbba_           4 DRKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIG   75 (277)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             chhhCeecCCCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEE
Confidence            44556665 4699999999999986432       345679999987543 334456789999999999 9999999999


Q ss_pred             EEEcCceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          86 CCYKDELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ++..+..++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~~~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~  155 (277)
T d1xbba_          76 ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK  155 (277)
T ss_dssp             EEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EeccCCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhh
Confidence            9988889999999999999999875                    69999999999999999999999999999999998


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+..............||+.|+|||++....++.++|||||||++|||+|.|..||.+.+..++...+.++.+++.|.+|
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~  235 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC  235 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             hccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            66544333333344677889999999998889999999999999999998789999999999999999999999999999


Q ss_pred             CCC
Q psy3166         226 NEQ  228 (228)
Q Consensus       226 ~~~  228 (228)
                      |++
T Consensus       236 ~~~  238 (277)
T d1xbba_         236 PRE  238 (277)
T ss_dssp             CHH
T ss_pred             CHH
Confidence            863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-50  Score=314.84  Aligned_cols=202  Identities=26%  Similarity=0.436  Sum_probs=173.2

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .++|++.+.||+|+||+||+|+.         +.+++.||+|.+.+..  .......+.+|+++++++ +||||++++++
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~   74 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLARE---------KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGY   74 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEE---------CCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEE
Confidence            46999999999999999999984         4455679999986431  112345678999999999 99999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..++ +++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          75 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence            88754 8899999999999998865                    69999999999999999999999999999999997


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      ......     .....||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..++.+++.++ .++.|+.+
T Consensus       155 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  227 (263)
T d2j4za1         155 HAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRV-EFTFPDFV  227 (263)
T ss_dssp             CCCCCC-----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT-CCCCCTTS
T ss_pred             ecCCCc-----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCccC
Confidence            543321     234578999999999999899999999999999999999 99999999988888888887 66778777


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      |+
T Consensus       228 s~  229 (263)
T d2j4za1         228 TE  229 (263)
T ss_dssp             CH
T ss_pred             CH
Confidence            65

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-50  Score=316.85  Aligned_cols=210  Identities=39%  Similarity=0.654  Sum_probs=181.3

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +|.|+.++|++.+.||+|+||+||+|++++          +..||||.++.....  .+.+.+|+++|+++ +||||+++
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l-~HpnIv~~   73 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSMS--PDAFLAEANLMKQL-QHQRLVRL   73 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSSC--HHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCcCC--HHHHHHHHHHHHhC-CCCCEeEE
Confidence            588999999999999999999999998643          235999999755322  35789999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+..++||||+++|+|.+++..                      .|||+++|+||||||+|||++.++.+||+||
T Consensus        74 ~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          74 YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             EEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence            999888889999999999999886542                      6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |+++.+......  ......++..|+|||++....++.++|||||||++|||+|.|.+||...+..++.+.+..+.+++.
T Consensus       154 Gla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~  231 (272)
T d1qpca_         154 GLARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR  231 (272)
T ss_dssp             TTCEECSSSCEE--CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             cceEEccCCccc--cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            999866443221  223456778899999998888999999999999999999956778888888899999999999999


Q ss_pred             CCCCCCC
Q psy3166         222 PASCNEQ  228 (228)
Q Consensus       222 p~~~~~~  228 (228)
                      |..||++
T Consensus       232 p~~~~~~  238 (272)
T d1qpca_         232 PDNCPEE  238 (272)
T ss_dssp             CTTCCHH
T ss_pred             cccChHH
Confidence            9998863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=316.60  Aligned_cols=207  Identities=24%  Similarity=0.398  Sum_probs=168.4

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ..++|++.+.||+|+||+||+|+.         +.+++.||+|.++... .....+.+.+|+++|+++ +||||++++++
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~   71 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRR---------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDR   71 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEE
T ss_pred             CchhCEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEE
Confidence            468999999999999999999984         4455679999987653 455567788999999999 99999999998


Q ss_pred             EEc---CceEEEEecCCCCcHHHHHHH------------------------hcccCCC-----CcccCCCCCCEeecCCC
Q psy3166          87 CYK---DELRLVVEYCALGDLQSYLRE------------------------EYLSNNK-----VVHRDLATRNILLSSPH  134 (228)
Q Consensus        87 ~~~---~~~~lv~e~~~~~~L~~~l~~------------------------~~lh~~~-----i~H~~lk~~nil~~~~~  134 (228)
                      +.+   +.+++||||+++|+|.+++..                        +|||+++     |+||||||+|||++.++
T Consensus        72 ~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~  151 (269)
T d2java1          72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ  151 (269)
T ss_dssp             EEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred             EEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence            864   348899999999999998753                        6999876     99999999999999999


Q ss_pred             cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         135 VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      .+||+|||+++.+......   .....||+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+..++..++.
T Consensus       152 ~vkl~DFG~a~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~t-g~~Pf~~~~~~~~~~~i~  227 (269)
T d2java1         152 NVKLGDFGLARILNHDTSF---AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIR  227 (269)
T ss_dssp             CEEECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred             cEEEeeccceeecccCCCc---cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhh-CCCCCCCCCHHHHHHHHH
Confidence            9999999999865443221   234677889999999998899999999999999999999 999999999999999999


Q ss_pred             cCCCCCCCCCCCCC
Q psy3166         215 TGYRMERPASCNEQ  228 (228)
Q Consensus       215 ~~~~~~~p~~~~~~  228 (228)
                      ++..++.|..+|+|
T Consensus       228 ~~~~~~~~~~~s~~  241 (269)
T d2java1         228 EGKFRRIPYRYSDE  241 (269)
T ss_dssp             HTCCCCCCTTSCHH
T ss_pred             cCCCCCCCcccCHH
Confidence            99888888888753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-50  Score=319.17  Aligned_cols=209  Identities=25%  Similarity=0.406  Sum_probs=174.1

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .+.+++|++.+.||+|+||+||+|+.         ..+++.||+|.++...  .....+.+.+|+++|+++ +||||+++
T Consensus         4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l   73 (288)
T d1uu3a_           4 KKRPEDFKFGKILGEGSFSTVVLARE---------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKL   73 (288)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCE
T ss_pred             CCCCCCCEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEE
Confidence            45678999999999999999999984         4455679999986431  112345688999999999 99999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++.+++ +++||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||
T Consensus        74 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccc
Confidence            99987754 8899999999999998765                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERP  222 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p  222 (228)
                      +++.+...... .......||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..++.+++.++ .++.|
T Consensus       154 ~a~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~-~~~~p  230 (288)
T d1uu3a_         154 TAKVLSPESKQ-ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKL-EYDFP  230 (288)
T ss_dssp             TCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHTT-CCCCC
T ss_pred             cceecccCCcc-cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh-CCCCCCCcCHHHHHHHHHcC-CCCCC
Confidence            99866433211 12234578999999999999999999999999999999999 99999999888888888887 56778


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      +.+++
T Consensus       231 ~~~s~  235 (288)
T d1uu3a_         231 EKFFP  235 (288)
T ss_dssp             TTCCH
T ss_pred             ccCCH
Confidence            77765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=323.11  Aligned_cols=220  Identities=42%  Similarity=0.805  Sum_probs=179.6

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.||+++|++.+.||+|+||+||+|++....    .......||+|.+...........+.+|+.+|+++.+||||+++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCC----cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence            47899999999999999999999999976543    22344569999987654455556788999999998789999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------------------------------hcccCCCCc
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------------------------------EYLSNNKVV  119 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------------------------------~~lh~~~i~  119 (228)
                      ++++... .+++||||+++|+|.+++..                                           .|||+++|+
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~Ii  186 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV  186 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            9998764 48999999999999998741                                           699999999


Q ss_pred             ccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q psy3166         120 HRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGAN  199 (228)
Q Consensus       120 H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~  199 (228)
                      ||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||+|.|..
T Consensus       187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             eccCchhccccccCCeEEEeeccccccccCCCcee-eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence            99999999999999999999999997654432211 11234568889999999999999999999999999999976899


Q ss_pred             CCCCCCHHHH-HHHHHcCCCCCCCCCCCCC
Q psy3166         200 PYPHIPLCRI-VHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       200 pf~~~~~~~~-~~~~~~~~~~~~p~~~~~~  228 (228)
                      ||.+.+..+. .+.+..+.+++.|..||++
T Consensus       266 Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~  295 (325)
T d1rjba_         266 PYPGIPVDANFYKLIQNGFKMDQPFYATEE  295 (325)
T ss_dssp             SSTTCCCSHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCcCCHH
Confidence            9998766544 5567888899999998863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-49  Score=317.59  Aligned_cols=211  Identities=41%  Similarity=0.770  Sum_probs=179.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.|+.++|++.+.||+|+||+||+|++         ..++..||+|.++.+..  ..+++.+|+++|+++ +||||+++
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l-~HpnIv~~   78 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVW---------KKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEI-KHPNLVQL   78 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEE---------GGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEE---------CCCCeEEEEEEECCccc--hHHHHHHHHHHHHhC-CCCCEecC
Confidence            4788999999999999999999999984         45566899999875533  245788999999999 99999999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++.. +.++++|||+++|+|.+++..                      +|||+++|+||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~D  158 (287)
T d1opja_          79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD  158 (287)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             CccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcc
Confidence            999876 458899999999999998764                      699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||+++.........  .....|+..|+|||++....++.++|||||||++|||++.|.+||.+.+..++.+.+..+.+++
T Consensus       159 FG~a~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~  236 (287)
T d1opja_         159 FGLSRLMTGDTYTA--HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME  236 (287)
T ss_dssp             CCCTTTCCSSSSEE--ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             ccceeecCCCCcee--eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC
Confidence            99998654432221  1223467789999999999999999999999999999994556677788888888899999999


Q ss_pred             CCCCCCCC
Q psy3166         221 RPASCNEQ  228 (228)
Q Consensus       221 ~p~~~~~~  228 (228)
                      .|+.+|++
T Consensus       237 ~~~~~~~~  244 (287)
T d1opja_         237 RPEGCPEK  244 (287)
T ss_dssp             CCTTCCHH
T ss_pred             CCccchHH
Confidence            99998863

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=311.69  Aligned_cols=216  Identities=38%  Similarity=0.675  Sum_probs=175.6

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .|++++|++.+.||+|+||+||+|.++.+.     ......||||.++..........+.+|+++|+++ +||||+++++
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g   76 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEG   76 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCC-----CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeE
Confidence            478899999999999999999999976543     2334569999998776666667889999999999 9999999999


Q ss_pred             EEEc-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          86 CCYK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        86 ~~~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++.. +..+++||++.++++.+++..                     .|||+++|+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          77 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence            9876 458899999999999887654                     699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++.+..............||..|+|||++....++.++|||||||++|||++.|.+||...+..++.+.+..+.+++.|.
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~  236 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  236 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch
Confidence            98664433222223345678899999999999999999999999999999995667778788888999999999999999


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .||+
T Consensus       237 ~~~~  240 (283)
T d1mqba_         237 DCPS  240 (283)
T ss_dssp             TCBH
T ss_pred             hhHH
Confidence            8875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-49  Score=319.60  Aligned_cols=206  Identities=24%  Similarity=0.367  Sum_probs=177.0

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |..++|++.+.||+|+||+||+|+         ++.+++.||+|++++..  ......++.+|+.+|+++ +||||++++
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~---------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~   71 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK   71 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEE
Confidence            456799999999999999999998         44566689999987441  112246688999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      +++.... +++||||+++|+|.+++..                    +|||++||+||||||+|||++.+|.+||+|||+
T Consensus        72 ~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccc
Confidence            9998765 8899999999999998775                    699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPA  223 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~  223 (228)
                      ++......   .......||+.|+|||++.+..|+.++|+||+||++|+|++ |..||.+.+..++.+.+..+ .++.|.
T Consensus       152 a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~i~~~-~~~~p~  226 (337)
T d1o6la_         152 CKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPR  226 (337)
T ss_dssp             CBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCT
T ss_pred             ccccccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH-CCCCCCCcCHHHHHHHHhcC-CCCCCc
Confidence            98553322   12334678999999999999999999999999999999999 99999999999888888887 678888


Q ss_pred             CCCC
Q psy3166         224 SCNE  227 (228)
Q Consensus       224 ~~~~  227 (228)
                      .+++
T Consensus       227 ~~s~  230 (337)
T d1o6la_         227 TLSP  230 (337)
T ss_dssp             TSCH
T ss_pred             cCCH
Confidence            8765

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=311.54  Aligned_cols=209  Identities=29%  Similarity=0.488  Sum_probs=173.2

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +.+-|.++|++.+.||+|+||+||+|+         +..+++.||+|.++..... ..+.+.+|+.+|+++ +||||+++
T Consensus        14 ~~~dp~~~Y~~~~~iG~G~fg~Vy~a~---------~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~HpnIv~~   82 (293)
T d1yhwa1          14 SVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQP-KKELIINEILVMREN-KNPNIVNY   82 (293)
T ss_dssp             BSSCTTTTBCSCEECCCSSSCEEEEEE---------BTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             CCCCcccccEEEEEEecCcCcEEEEEE---------ECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhC-CCCCEeeE
Confidence            345567899999999999999999998         4556678999998754322 246788999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++++..+ .+++||||+++|+|.+++..                   .|||++||+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEECCEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchh
Confidence            9998765 48899999999999998764                   699999999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CC
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRM--ER  221 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~--~~  221 (228)
                      ++.+.....   ......||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..+....+.....+  +.
T Consensus       163 a~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T d1yhwa1         163 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQN  238 (293)
T ss_dssp             CEECCSTTC---CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSCCCSS
T ss_pred             heeeccccc---cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence            986543321   2234678999999999999999999999999999999999 99999998877776665554333  34


Q ss_pred             CCCCCC
Q psy3166         222 PASCNE  227 (228)
Q Consensus       222 p~~~~~  227 (228)
                      |+.+++
T Consensus       239 ~~~~s~  244 (293)
T d1yhwa1         239 PEKLSA  244 (293)
T ss_dssp             GGGSCH
T ss_pred             cccCCH
Confidence            555543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=308.23  Aligned_cols=207  Identities=33%  Similarity=0.658  Sum_probs=169.4

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      |++++|++.+.||+|+||+||+|++.++          ..||||.++.+...  .+.+.+|+++++++ +||||++++++
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~----------~~vAvK~i~~~~~~--~~~~~~E~~~l~~l-~HpnIv~~~g~   68 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNK----------DKVAIKTIREGAMS--EEDFIEEAEVMMKL-SHPKLVQLYGV   68 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTT----------EEEEEEECCSSSSC--HHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCC----------CEEEEEEECCCcCc--HHHHHHHHHHHHhc-CCCCcccccce
Confidence            6789999999999999999999986432          35999998765332  35788999999999 99999999999


Q ss_pred             EEc-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +.. +..++||||+++|+|.+++..                     .|+|+++|+||||||+|||++.++.+||+|||++
T Consensus        69 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             eccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchh
Confidence            875 458999999999999998754                     6999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +.+......  ......||..|+|||++.+..++.++|||||||++|||+|.|.+||...+..++.+.+..+.+++.|..
T Consensus       149 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~  226 (263)
T d1sm2a_         149 RFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL  226 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTT
T ss_pred             eeccCCCce--eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence            765443221  122356778899999999999999999999999999999967888888888899999999999999998


Q ss_pred             CCCC
Q psy3166         225 CNEQ  228 (228)
Q Consensus       225 ~~~~  228 (228)
                      ||++
T Consensus       227 ~~~~  230 (263)
T d1sm2a_         227 ASTH  230 (263)
T ss_dssp             SCHH
T ss_pred             cCHH
Confidence            8753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-48  Score=312.14  Aligned_cols=219  Identities=39%  Similarity=0.692  Sum_probs=187.5

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +|.+|.++|++.+.||+|+||+||+|++++..    +..++..||||+++.........++.+|+++|+++ +||||+++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~   81 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKL   81 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccc
Confidence            57899999999999999999999999976533    34566789999998766666677899999999999 99999999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------------------------------hcccCCCC
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------------------------------EYLSNNKV  118 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------------------------------~~lh~~~i  118 (228)
                      ++++... ..+++||++++|+|.+++..                                            .|||+++|
T Consensus        82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i  161 (301)
T d1lufa_          82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  161 (301)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence            9998764 58899999999999998752                                            59999999


Q ss_pred             cccCCCCCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCC
Q psy3166         119 VHRDLATRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGA  198 (228)
Q Consensus       119 ~H~~lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~  198 (228)
                      +||||||+|||++.++.+||+|||+++.+....... ......++..|+|||.+.+..++.++|||||||++|||++.+.
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCcccc-ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            999999999999999999999999997654432221 2234567788999999999999999999999999999999346


Q ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q psy3166         199 NPYPHIPLCRIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~  228 (228)
                      .||.+.+..++...+.++.++++|+++|++
T Consensus       241 ~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~  270 (301)
T d1lufa_         241 QPYYGMAHEEVIYYVRDGNILACPENCPLE  270 (301)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence            789999999999999999999999999863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=309.68  Aligned_cols=209  Identities=31%  Similarity=0.547  Sum_probs=168.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .|.|+.++|++.+.||+|+||+||+|++++            .||||.++... .....+.+.+|+.+|+++ +||||++
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~   68 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILL   68 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCC
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEee
Confidence            488999999999999999999999997422            39999987543 344567889999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++..+.+++||||+++|+|.+++..                     .|||+++|+||||||+|||++.++.+||+||
T Consensus        69 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          69 FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             EEEEECSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred             eeEEEeccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccc
Confidence            9999888889999999999999999864                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeeccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRI-VHYLSTGY  217 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~-~~~~~~~~  217 (228)
                      |+++........ .......||+.|+|||++..   ..|+.++|||||||++|||+| |..||.+.+..+. ...+.++.
T Consensus       149 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~  226 (276)
T d1uwha_         149 GLATVKSRWSGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMVGRGY  226 (276)
T ss_dssp             CCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHHHHHTS
T ss_pred             cceeeccccCCc-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH-CCCCCCCCChHHHHHHHHhcCC
Confidence            999765432211 12234678899999999864   358899999999999999999 9999998766544 55566665


Q ss_pred             CCC----CCCCCCC
Q psy3166         218 RME----RPASCNE  227 (228)
Q Consensus       218 ~~~----~p~~~~~  227 (228)
                      +.+    .|.+||+
T Consensus       227 ~~p~~~~~~~~~~~  240 (276)
T d1uwha_         227 LSPDLSKVRSNCPK  240 (276)
T ss_dssp             CCCCGGGSCTTCCH
T ss_pred             CCCcchhccccchH
Confidence            554    3556654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-48  Score=314.95  Aligned_cols=201  Identities=25%  Similarity=0.402  Sum_probs=173.1

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .++|++.+.||+|+||+||+|+.         +.+++.||+|++++..  .....+.+.+|+.+|+++ +||||++++++
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~   72 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGT   72 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeee
Confidence            46899999999999999999984         4455679999986431  112346788999999999 99999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..+. +++||||+.||+|.+++..                    .|||+++|+||||||+|||++.+|.+||+|||+++
T Consensus        73 ~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          73 FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccce
Confidence            87754 8899999999999888764                    69999999999999999999999999999999997


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .....      .....||+.|+|||++.+..|+.++||||+||++|+|++ |..||.+.+..++.+++.++ ..+.|..+
T Consensus       153 ~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  224 (316)
T d1fota_         153 YVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNA-ELRFPPFF  224 (316)
T ss_dssp             ECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHC-CCCCCTTS
T ss_pred             Eeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHh-CCCCCCCcCHHHHHHHHHcC-CCCCCCCC
Confidence            65332      234678999999999998889999999999999999999 99999999999999998887 56677776


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      |+
T Consensus       225 s~  226 (316)
T d1fota_         225 NE  226 (316)
T ss_dssp             CH
T ss_pred             CH
Confidence            64

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=312.38  Aligned_cols=204  Identities=26%  Similarity=0.470  Sum_probs=169.0

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .+.|++.+.||+|+||+||+|++         ..++..||+|.++.... ...+.+.+|+++|+++ +||||+++++++.
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~   79 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQN---------KETSVLAAAKVIDTKSE-EELEDYMVEIDILASC-DHPNIVKLLDAFY   79 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEE---------CCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence            35689999999999999999984         44556799999875532 3346788999999999 9999999999987


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      .+ .+++||||+++|+|.+++.+                     .|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhc
Confidence            64 48899999999999998654                     699999999999999999999999999999999875


Q ss_pred             ccccccccCCCCCCCCcceeecccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLV-----SNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME-  220 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~-  220 (228)
                      .......   .....||+.|+|||++.     ...|+.++||||+||++|+|+| |..||.+.+..+++.++.++.++. 
T Consensus       160 ~~~~~~~---~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt-g~~Pf~~~~~~~~~~~i~~~~~~~~  235 (288)
T d2jfla1         160 NTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKIAKSEPPTL  235 (288)
T ss_dssp             CHHHHHH---HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred             cCCCccc---ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            5432211   22457888999999984     4458899999999999999999 999999999888988888876543 


Q ss_pred             -CCCCCCC
Q psy3166         221 -RPASCNE  227 (228)
Q Consensus       221 -~p~~~~~  227 (228)
                       .|..+|+
T Consensus       236 ~~~~~~s~  243 (288)
T d2jfla1         236 AQPSRWSS  243 (288)
T ss_dssp             SSGGGSCH
T ss_pred             CccccCCH
Confidence             3455553

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-48  Score=308.67  Aligned_cols=220  Identities=41%  Similarity=0.776  Sum_probs=176.0

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.|+.++|++.+.||+|+||+||+|++....    +..+++.||+|.++..........+.+|...+.++.+|+||+.+
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTT----SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCC----cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            46799999999999999999999999976643    34566789999998766666667788999999998789999999


Q ss_pred             eeEEEcC--ceEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCC
Q psy3166          84 IGCCYKD--ELRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLAT  125 (228)
Q Consensus        84 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~  125 (228)
                      ++++...  .++++|||+++|+|.+++..                                    .|||+++|+||||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp  162 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA  162 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence            9987653  47899999999999998742                                    699999999999999


Q ss_pred             CCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         126 RNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      +|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+|.+..||.+.+
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999765433222 123346788999999999999999999999999999999984567898865


Q ss_pred             HH-HHHHHHHcCCCCCCCCCCCCC
Q psy3166         206 LC-RIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       206 ~~-~~~~~~~~~~~~~~p~~~~~~  228 (228)
                      .. .+...+.++.+++.|..+|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~  265 (299)
T d1ywna1         242 IDEEFCRRLKEGTRMRAPDYTTPE  265 (299)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHH
T ss_pred             HHHHHHHHHhcCCCCCCCccCCHH
Confidence            54 456778889999999988763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-48  Score=302.63  Aligned_cols=206  Identities=38%  Similarity=0.707  Sum_probs=178.8

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +++++|++.+.||+|+||+||+|++++          +..||||.++.+...  .+.+.+|+.+++++ +||||++++++
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l-~HpnIv~~~g~   67 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMS--EDEFIEEAKVMMNL-SHEKLVQLYGV   67 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETT----------TEEEEEEEEESSSSC--HHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECC----------CCEEEEEEECcCcCC--HHHHHHHHHHHHhc-CCCceeeEEEE
Confidence            578999999999999999999998643          346999999765332  35788999999999 99999999999


Q ss_pred             EEc-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCc
Q psy3166          87 CYK-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLS  144 (228)
Q Consensus        87 ~~~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~  144 (228)
                      +.. +.+++||||+++|+|.+++..                     .|||++||+||||||+||+++.++.+||+|||++
T Consensus        68 ~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a  147 (258)
T d1k2pa_          68 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS  147 (258)
T ss_dssp             ECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhh
Confidence            876 458999999999999888543                     6999999999999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPAS  224 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  224 (228)
                      +.+......  ......+|..|+|||.+....++.++|||||||++|||+|.|..||.+.+..++.+++.++.+++.|..
T Consensus       148 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~  225 (258)
T d1k2pa_         148 RYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL  225 (258)
T ss_dssp             CBCSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             eeccCCCce--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            765443221  223356788899999999889999999999999999999878999999999999999999999999998


Q ss_pred             CCC
Q psy3166         225 CNE  227 (228)
Q Consensus       225 ~~~  227 (228)
                      +|+
T Consensus       226 ~~~  228 (258)
T d1k2pa_         226 ASE  228 (258)
T ss_dssp             CCH
T ss_pred             ccH
Confidence            885

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=307.24  Aligned_cols=210  Identities=36%  Similarity=0.612  Sum_probs=175.9

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +|.|+.++|++.+.||+|+||+||+|+++++          ..||+|.++.....  .+.+.+|+.+++++ +||||+++
T Consensus        11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~----------~~vAiK~l~~~~~~--~~~~~~E~~~l~~l-~h~nIv~~   77 (285)
T d1fmka3          11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT----------TRVAIKTLKPGTMS--PEAFLQEAQVMKKL-RHEKLVQL   77 (285)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTT----------EEEEEEECCTTSSC--HHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC----------CEEEEEEECcccCC--HHHHHHHHHHHHhc-ccCCEeEE
Confidence            6899999999999999999999999986443          25999999755332  36788999999999 99999999


Q ss_pred             eeEEEcCceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          84 IGCCYKDELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      ++++..+++++||||+++|+|.+++..                      .|||+++|+||||||+|||++.++.+||+||
T Consensus        78 ~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df  157 (285)
T d1fmka3          78 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  157 (285)
T ss_dssp             EEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence            999988889999999999999887643                      6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER  221 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (228)
                      |+++........  ......+|..|+|||++....++.++|||||||++|||+|.|.+||......+++..+.++.+++.
T Consensus       158 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~  235 (285)
T d1fmka3         158 GLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  235 (285)
T ss_dssp             CTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             chhhhccCCCce--eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            999765433221  123356788999999999999999999999999999999966777888888889999999999999


Q ss_pred             CCCCCCC
Q psy3166         222 PASCNEQ  228 (228)
Q Consensus       222 p~~~~~~  228 (228)
                      |..||++
T Consensus       236 ~~~~~~~  242 (285)
T d1fmka3         236 PPECPES  242 (285)
T ss_dssp             CTTSCHH
T ss_pred             CcccCHH
Confidence            9998853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=307.42  Aligned_cols=187  Identities=28%  Similarity=0.408  Sum_probs=154.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||+||+|++         ..+++.||+|.++........+.+.+|+.+|+++ +||||+++++++.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~   73 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVN---------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRR   73 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeec
Confidence            36899999999999999999984         4455679999987654444456788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .++ +++||||+++|+|.+++..                    +|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        74 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          74 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             ETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence            755 7899999999999988653                    6999999999999999999999999999999999866


Q ss_pred             cccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      ...... .......||+.|+|||++.+..+ +.++||||+||++|+|++ |..||......
T Consensus       154 ~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~-G~~pf~~~~~~  212 (271)
T d1nvra_         154 RYNNRE-RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDS  212 (271)
T ss_dssp             EETTEE-CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSSTT
T ss_pred             ccCCcc-ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh-CCCCCCCCChH
Confidence            433221 22345678999999999988776 567999999999999999 99999876544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-48  Score=310.99  Aligned_cols=214  Identities=37%  Similarity=0.701  Sum_probs=177.7

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      +..++|++.+.||+|+||+||+|++..+.     .....+||+|.++.....+..+.+.+|+.+|+++ +||||++++++
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~   79 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGI   79 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCC-----CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence            56678999999999999999999875432     1233468999887655555567899999999999 99999999999


Q ss_pred             EEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +..+..++++|++.+++|.+++..                     .|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          80 CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EESSSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             EecCCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence            999889999999999999887664                     69999999999999999999999999999999998


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+....... ......||..|+|||++.+..++.++|||||||++|||+|.|..||.+.+..++...+.++.+++.|..|
T Consensus       160 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~  238 (317)
T d1xkka_         160 LLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  238 (317)
T ss_dssp             HTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTB
T ss_pred             ecccccccc-cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            654332211 1223457889999999999999999999999999999998789999999999999999999999999998


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      |+
T Consensus       239 ~~  240 (317)
T d1xkka_         239 TI  240 (317)
T ss_dssp             CH
T ss_pred             CH
Confidence            85

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-47  Score=308.52  Aligned_cols=194  Identities=25%  Similarity=0.356  Sum_probs=150.9

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|+.         ..+++.||+|.+...........+.+|+.+|+++ +||||+++++++..
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~   78 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAED---------KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES   78 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEE---------TTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEE---------CCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE
Confidence            5699999999999999999984         4455679999997654333445678999999999 99999999999877


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeec---CCCcEEEeeccCcc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLS---SPHVVKISDFGLSE  145 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~---~~~~~kl~dfg~~~  145 (228)
                      +. +++||||+++|+|.+++..                    .|||+++|+||||||+||++.   .++.+||+|||+++
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            55 8899999999999999865                    699999999999999999995   47899999999997


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYR  218 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~  218 (228)
                      .......    .....||+.|+|||++.+..|+.++||||+||++|+|++ |..||.+....++...+.++..
T Consensus       159 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~~  226 (307)
T d1a06a_         159 MEDPGSV----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQILKAEY  226 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHTTCC
T ss_pred             EccCCCe----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHhccCC
Confidence            5543321    234578899999999999999999999999999999999 9999999998888888887643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=310.51  Aligned_cols=187  Identities=26%  Similarity=0.443  Sum_probs=161.6

Q ss_pred             CCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeee
Q psy3166           6 GYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIG   85 (228)
Q Consensus         6 ~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~   85 (228)
                      .+..++|++.+.||+|+||+||+|+         +..++..||+|.++.........++.+|+.+|+++ +||||+++++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~   71 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYG   71 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEE---------ETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEE
Confidence            4667899999999999999999998         44566789999997665555567889999999999 9999999999


Q ss_pred             EEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCC-CCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          86 CCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNN-KVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        86 ~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~-~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      ++.... +++||||+++|+|.+++.+                    +|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGl  151 (322)
T d1s9ja_          72 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  151 (322)
T ss_dssp             EEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCC
Confidence            997755 8999999999999998865                    699974 999999999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCR  208 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~  208 (228)
                      ++.+....     .....||..|+|||++.+..|+.++||||+||++|||++ |..||.+.+..+
T Consensus       152 a~~~~~~~-----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~-G~~Pf~~~~~~~  210 (322)
T d1s9ja_         152 SGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKE  210 (322)
T ss_dssp             CHHHHHHT-----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHH-SSCCSSCCCTTH
T ss_pred             ccccCCCc-----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHH
Confidence            98654332     234678999999999999999999999999999999999 999998866543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=303.57  Aligned_cols=216  Identities=35%  Similarity=0.660  Sum_probs=171.7

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEE
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVS   82 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~   82 (228)
                      .-|..++|++.+.||+|+||.||+|+.....      .....||+|.++...  .....+.+.+|+.+|+++ +||||++
T Consensus         3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~   75 (273)
T d1u46a_           3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIR   75 (273)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred             eEEchHHeEEEEEEecCCCeEEEEEEEECCC------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEE
Confidence            3477899999999999999999999865432      234469999987542  234456789999999999 9999999


Q ss_pred             eeeEEEcCceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          83 FIGCCYKDELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++++..+.+++||||+++|++.+++..                     .|||+++|+||||||+||+++.++.+||+||
T Consensus        76 ~~g~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          76 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             EEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             EEEEEeecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence            9999988889999999999999987653                     6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS-TGYRME  220 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~-~~~~~~  220 (228)
                      |+++.+..............++..|+|||.+.+..++.++||||||+++|||+|.|..||.+.+..++.+.+. .+.+++
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  235 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            9998764443222223334567789999999998899999999999999999987899999999999988764 567888


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .|+.+|+
T Consensus       236 ~~~~~~~  242 (273)
T d1u46a_         236 RPEDCPQ  242 (273)
T ss_dssp             CCTTCCH
T ss_pred             CcccccH
Confidence            8988875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=306.58  Aligned_cols=204  Identities=26%  Similarity=0.382  Sum_probs=172.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ++|++.+.||+|+||+||+|+         +..+++.||+|.+++..  .....+.+..|..++.+..+||||+++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~---------~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEE---------ECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            689999999999999999998         45566789999986431  1122345667777776433999999999999


Q ss_pred             EcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+. +|+||||+++|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence            8755 8899999999999999865                    699999999999999999999999999999999975


Q ss_pred             ccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASCN  226 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  226 (228)
                      .....   .......||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..++..++..+ .+..|..+|
T Consensus       153 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s  227 (320)
T d1xjda_         153 NMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMD-NPFYPRWLE  227 (320)
T ss_dssp             CCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTTSC
T ss_pred             ccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCccCC
Confidence            54332   22334678999999999999999999999999999999999 99999999999999888887 677888776


Q ss_pred             C
Q psy3166         227 E  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       228 ~  228 (320)
T d1xjda_         228 K  228 (320)
T ss_dssp             H
T ss_pred             H
Confidence            5

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-47  Score=311.63  Aligned_cols=201  Identities=24%  Similarity=0.390  Sum_probs=172.7

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .++|++++.||+|+||+||+|++         +.++..||+|.+++..  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~---------~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~  109 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKH---------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFS  109 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccc
Confidence            47899999999999999999984         4455679999986431  112345788999999999 99999999999


Q ss_pred             EEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          87 CYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        87 ~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      +.... .++|||++.+|+|.+++..                    .|||+++|+||||||+|||++.++.+||+|||+++
T Consensus       110 ~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence            87755 7899999999999998764                    69999999999999999999999999999999998


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMERPASC  225 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  225 (228)
                      .+...      .....||+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+..++..++..+ .+..|..+
T Consensus       190 ~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  261 (350)
T d1rdqe_         190 RVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSG-KVRFPSHF  261 (350)
T ss_dssp             ECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTTC
T ss_pred             ecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh-CCCCCCCcCHHHHHHHHhcC-CCCCCccC
Confidence            65322      234678899999999999999999999999999999999 99999999888888888887 56677777


Q ss_pred             CC
Q psy3166         226 NE  227 (228)
Q Consensus       226 ~~  227 (228)
                      ++
T Consensus       262 s~  263 (350)
T d1rdqe_         262 SS  263 (350)
T ss_dssp             CH
T ss_pred             CH
Confidence            64

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-47  Score=303.87  Aligned_cols=218  Identities=36%  Similarity=0.698  Sum_probs=187.0

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.|++++|++.+.||+|+||+||+|.+....    ....+..||||+++..........+.+|+++++++ +||||+++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~   88 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRL   88 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeee
Confidence            37799999999999999999999999865422    22345679999998766666667899999999999 99999999


Q ss_pred             eeEEEc-CceEEEEecCCCCcHHHHHHH------------------------------hcccCCCCcccCCCCCCEeecC
Q psy3166          84 IGCCYK-DELRLVVEYCALGDLQSYLRE------------------------------EYLSNNKVVHRDLATRNILLSS  132 (228)
Q Consensus        84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~------------------------------~~lh~~~i~H~~lk~~nil~~~  132 (228)
                      ++++.. +..++||||+++|+|.+++..                              .|||+++|+||||||+|||++.
T Consensus        89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred             eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC
Confidence            999875 458999999999999998652                              5999999999999999999999


Q ss_pred             CCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         133 PHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ++++||+|||+++.+........ .....+++.|++||.+....++.++|+|||||++|||+|.+..||.+.+..++.+.
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~-~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~  247 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  247 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEG-GGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CceEEEeecccceeccCCcceee-ccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999986654432221 23346788999999999999999999999999999999944799999999999999


Q ss_pred             HHcCCCCCCCCCCCC
Q psy3166         213 LSTGYRMERPASCNE  227 (228)
Q Consensus       213 ~~~~~~~~~p~~~~~  227 (228)
                      +.++.+++.|..||+
T Consensus       248 i~~~~~~~~p~~~~~  262 (308)
T d1p4oa_         248 VMEGGLLDKPDNCPD  262 (308)
T ss_dssp             HHTTCCCCCCTTCCH
T ss_pred             HHhCCCCCCcccchH
Confidence            999999999999885

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=301.47  Aligned_cols=220  Identities=43%  Similarity=0.843  Sum_probs=184.0

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.||.++|++.+.||+|+||.||+|+..++...  .......||+|.++.+........+.+|...++++.+||||++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            779999999999999999999999987665421  223445799999987777777788899999999997899999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++..+. +++||||+.+|+|.+++..                                    +|||+++|+||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            9987654 8999999999999998842                                    59999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      ||++.++.+||+|||++......... .......++..|+|||.+....|+.++||||||+++|+|++.|..||.+.+..
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999999999866544322 22344667888999999999999999999999999999998689999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNE  227 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~  227 (228)
                      ++.+.+..+.+++.|..+|+
T Consensus       245 ~~~~~i~~~~~~~~p~~~~~  264 (299)
T d1fgka_         245 ELFKLLKEGHRMDKPSNCTN  264 (299)
T ss_dssp             HHHHHHHTTCCCCCCSSCCH
T ss_pred             HHHHHHHcCCCCCCCccchH
Confidence            99999999999999998875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=296.52  Aligned_cols=205  Identities=25%  Similarity=0.387  Sum_probs=164.6

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccC-CCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKAN-ADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      -..+.+.|++.+.||+|+||+||+|++         ..++..||+|.+... ......+.+.+|+++|+++ +||||+++
T Consensus         4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~---------~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~   73 (270)
T d1t4ha_           4 MSNDGRFLKFDIEIGRGSFKTVYKGLD---------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF   73 (270)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred             cCCCCCEEEeeeEEecCcCcEEEEEEE---------CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeE
Confidence            344555568999999999999999984         445567999998654 3455567889999999999 89999999


Q ss_pred             eeEEEc-----CceEEEEecCCCCcHHHHHHH--------------------hcccCCC--CcccCCCCCCEeec-CCCc
Q psy3166          84 IGCCYK-----DELRLVVEYCALGDLQSYLRE--------------------EYLSNNK--VVHRDLATRNILLS-SPHV  135 (228)
Q Consensus        84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~--i~H~~lk~~nil~~-~~~~  135 (228)
                      ++++..     ..+++||||+++|+|.+++.+                    +|||+++  |+||||||+|||++ .++.
T Consensus        74 ~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~  153 (270)
T d1t4ha_          74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS  153 (270)
T ss_dssp             EEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC
T ss_pred             EEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC
Confidence            998753     237899999999999999865                    6999998  99999999999997 4789


Q ss_pred             EEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH
Q psy3166         136 VKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL-CRIVHYLS  214 (228)
Q Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~-~~~~~~~~  214 (228)
                      +||+|||+++.....     ......||+.|+|||++.+ .++.++||||+||++|+|++ |..||.+..+ .++.+.+.
T Consensus       154 ~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~-g~~Pf~~~~~~~~~~~~i~  226 (270)
T d1t4ha_         154 VKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVT  226 (270)
T ss_dssp             EEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHT
T ss_pred             EEEeecCcceeccCC-----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHH-CCCCCCCcccHHHHHHHHH
Confidence            999999999743222     1224578999999998865 59999999999999999999 9999987554 45567777


Q ss_pred             cCCCCC-CCCCCC
Q psy3166         215 TGYRME-RPASCN  226 (228)
Q Consensus       215 ~~~~~~-~p~~~~  226 (228)
                      .+.+++ .+..++
T Consensus       227 ~~~~~~~~~~~~~  239 (270)
T d1t4ha_         227 SGVKPASFDKVAI  239 (270)
T ss_dssp             TTCCCGGGGGCCC
T ss_pred             cCCCCcccCccCC
Confidence            775553 344444

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-46  Score=302.45  Aligned_cols=200  Identities=24%  Similarity=0.425  Sum_probs=166.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      +.|+.++.||+|+||+||+|+         +..++..||||.++...  .....+.+.+|+.+|+++ +||||+++++++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~   84 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCY   84 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEE---------ECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEE
Confidence            359999999999999999998         44556689999987553  234456788999999999 999999999998


Q ss_pred             EcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccc
Q psy3166          88 YKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSED  146 (228)
Q Consensus        88 ~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~  146 (228)
                      ..+ .+++||||+.+|++..++..                    .|||++||+||||||+|||++.++.+||+|||++..
T Consensus        85 ~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          85 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence            765 48899999999998766543                    699999999999999999999999999999999975


Q ss_pred             ccccccccCCCCCCCCcceeeccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-C
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVS---NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRMER-P  222 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~~-p  222 (228)
                      ...       .....||+.|+|||++.+   ..|+.++|||||||++|+|++ |..||.+.+..+...++..+..++. +
T Consensus       165 ~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  236 (309)
T d1u5ra_         165 MAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPALQS  236 (309)
T ss_dssp             SSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             cCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence            432       234578999999999863   358899999999999999999 9999999888888887777656554 4


Q ss_pred             CCCCC
Q psy3166         223 ASCNE  227 (228)
Q Consensus       223 ~~~~~  227 (228)
                      ..+|+
T Consensus       237 ~~~s~  241 (309)
T d1u5ra_         237 GHWSE  241 (309)
T ss_dssp             TTSCH
T ss_pred             CCCCH
Confidence            44543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-46  Score=305.80  Aligned_cols=193  Identities=19%  Similarity=0.320  Sum_probs=165.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||+||+|+         +..+++.||+|.++... ......+.+|+.+|+++ +||||+++++++.
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   96 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQL-HHPKLINLHDAFE   96 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEE
Confidence            3579999999999999999998         44456679999987553 33456788999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeec--CCCcEEEeeccCc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLS--SPHVVKISDFGLS  144 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~--~~~~~kl~dfg~~  144 (228)
                      .+. +++||||+++|+|.+++..                     .|||++||+||||||+|||++  .++.+||+|||++
T Consensus        97 ~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla  176 (352)
T d1koba_          97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA  176 (352)
T ss_dssp             CSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             ECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccc
Confidence            654 8899999999999887543                     699999999999999999998  5689999999999


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ..+.....    .....||+.|+|||++.+..++.++||||+||++|+|+| |..||.+.+..++++++.++.
T Consensus       177 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  244 (352)
T d1koba_         177 TKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCD  244 (352)
T ss_dssp             EECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCC
T ss_pred             eecCCCCc----eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence            86644322    123467888999999999999999999999999999999 999999999999988888764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=296.04  Aligned_cols=203  Identities=42%  Similarity=0.770  Sum_probs=171.3

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      |.|+.++|++.+.||+|+||.||+|++++           ..||+|.++.+.   ..+.+.+|+.+++++ +||||++++
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-----------~~vAvK~i~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~   66 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYRG-----------NKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQLL   66 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETT-----------EEEEEEECCCCC-----HHHHHTHHHHTTC-CCTTBCCEE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEECC-----------eEEEEEEECcHH---HHHHHHHHHHHHHhC-CCCCEeeEE
Confidence            88999999999999999999999998632           359999997553   235688999999999 999999999


Q ss_pred             eEEEc--CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          85 GCCYK--DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        85 ~~~~~--~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      +++..  +.+++||||+++|+|.+++..                      .|||+++|+||||||+||+++.++.+|++|
T Consensus        67 g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~d  146 (262)
T d1byga_          67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD  146 (262)
T ss_dssp             EEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecc
Confidence            98864  348999999999999999754                      699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      ||+++......      ....++..|+|||++.+..++.++|||||||++|||+|.|..||...+..++...+.++.+++
T Consensus       147 fg~s~~~~~~~------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~  220 (262)
T d1byga_         147 FGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD  220 (262)
T ss_dssp             CCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC
T ss_pred             cccceecCCCC------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99987543321      223456679999999988999999999999999999987899999999999999999999999


Q ss_pred             CCCCCCCC
Q psy3166         221 RPASCNEQ  228 (228)
Q Consensus       221 ~p~~~~~~  228 (228)
                      .|+.+|++
T Consensus       221 ~~~~~~~~  228 (262)
T d1byga_         221 APDGCPPA  228 (262)
T ss_dssp             CCTTCCHH
T ss_pred             CCccCCHH
Confidence            99988753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.1e-46  Score=304.70  Aligned_cols=192  Identities=22%  Similarity=0.340  Sum_probs=165.3

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|+         +..++..||+|.+... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~---------~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~   94 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVL-RHPTLVNLHDAFED   94 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEE---------ETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEE
Confidence            589999999999999999998         4456678999998755 334456788999999999 99999999999876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC--CCcEEEeeccCcc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS--PHVVKISDFGLSE  145 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~--~~~~kl~dfg~~~  145 (228)
                      + .+++||||+++|+|.+++..                     .|||++||+||||||+|||++.  ++.+||+|||+++
T Consensus        95 ~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          95 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            5 48899999999999998843                     6999999999999999999964  6789999999998


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      .+.....    .....||+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..+++.++..+.
T Consensus       175 ~~~~~~~----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~  241 (350)
T d1koaa2         175 HLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCD  241 (350)
T ss_dssp             ECCTTSC----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTC
T ss_pred             ecccccc----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence            6544322    123567889999999999999999999999999999999 999999999988888887763

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=294.81  Aligned_cols=193  Identities=25%  Similarity=0.385  Sum_probs=165.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-----CHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-----DAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ++|++.+.||+|+||+||+|+.         ..+++.||+|.+++..     .....+.+.+|+.+|+++ +||||++++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~   79 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCRE---------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLH   79 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEE
Confidence            5699999999999999999984         4455679999986432     112356788999999999 999999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC----cEEEe
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH----VVKIS  139 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~----~~kl~  139 (228)
                      +++.... +++||||+++|+|.+++.+                    +|||+++|+||||||+||+++.++    .+|++
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEec
Confidence            9987755 8899999999999999865                    699999999999999999998766    59999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      |||++........    .....+|+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+..++...+..+.
T Consensus       160 DfG~a~~~~~~~~----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~  232 (293)
T d1jksa_         160 DFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANVSAVN  232 (293)
T ss_dssp             CCTTCEECTTSCB----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHTTC
T ss_pred             chhhhhhcCCCcc----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Confidence            9999876543321    234567889999999998889999999999999999999 999999999999988888773

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=298.08  Aligned_cols=219  Identities=38%  Similarity=0.748  Sum_probs=185.7

Q ss_pred             cCCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           4 SCGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         4 ~~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .|.||.++|++.+.||+|+||.||+|++....    +..++..||||+++..........+.+|+.+++++.+||||+++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccc----cCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            47899999999999999999999999876533    34567789999998776777777899999999999779999999


Q ss_pred             eeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------------------------hcccCCCCcccCCC
Q psy3166          84 IGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------------------------EYLSNNKVVHRDLA  124 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------------------------~~lh~~~i~H~~lk  124 (228)
                      ++++.... .+++|||+++|+|.+++..                                      .|||+++++|||||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK  172 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence            99987654 8999999999999998752                                      59999999999999


Q ss_pred             CCCEeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         125 TRNILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       125 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      |+||+++.++.++++|||+++.......... .....+|+.|+|||++....++.++|||||||++|+|+|.|.+||...
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEE-CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccccccccCcccccccchheeccCCCcceE-eeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999986644332221 234577889999999998899999999999999999998678888887


Q ss_pred             CHHHH-HHHHHcCCCCCCCCCCCC
Q psy3166         205 PLCRI-VHYLSTGYRMERPASCNE  227 (228)
Q Consensus       205 ~~~~~-~~~~~~~~~~~~p~~~~~  227 (228)
                      +..+. .+.+..+.+++.|..+|+
T Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~~  275 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRMLSPEHAPA  275 (311)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCH
T ss_pred             CHHHHHHHHHhcCCCCCCcccccH
Confidence            66555 556788889999988775

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=302.20  Aligned_cols=213  Identities=38%  Similarity=0.727  Sum_probs=174.8

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      +.|+.++|++.+.||+|+||+||+|+++++.       ....||||.++........+.+.+|+.+|+++.+||||++++
T Consensus         5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~   77 (309)
T d1fvra_           5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL   77 (309)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred             CccCHHHcEEEEEEeeCCCcEEEEEEECCCC-------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEE
Confidence            3578899999999999999999999865432       122478888765544445667899999999986799999999


Q ss_pred             eEEEcCc-eEEEEecCCCCcHHHHHHH------------------------------------hcccCCCCcccCCCCCC
Q psy3166          85 GCCYKDE-LRLVVEYCALGDLQSYLRE------------------------------------EYLSNNKVVHRDLATRN  127 (228)
Q Consensus        85 ~~~~~~~-~~lv~e~~~~~~L~~~l~~------------------------------------~~lh~~~i~H~~lk~~n  127 (228)
                      +++.... +++||||+++|+|.+++..                                    .|+|+++|+||||||+|
T Consensus        78 ~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~N  157 (309)
T d1fvra_          78 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  157 (309)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccce
Confidence            9987654 8999999999999998742                                    59999999999999999


Q ss_pred             EeecCCCcEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         128 ILLSSPHVVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      ||++.++.+||+|||+++......    ......||..|+|||.+....++.++|||||||++|||++.+..||.+.+..
T Consensus       158 IL~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~  233 (309)
T d1fvra_         158 ILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  233 (309)
T ss_dssp             EEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             EEEcCCCceEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999987443321    1223457788999999998889999999999999999999445789999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCCC
Q psy3166         208 RIVHYLSTGYRMERPASCNEQ  228 (228)
Q Consensus       208 ~~~~~~~~~~~~~~p~~~~~~  228 (228)
                      ++...+.++.+++.|.+||++
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~  254 (309)
T d1fvra_         234 ELYEKLPQGYRLEKPLNCDDE  254 (309)
T ss_dssp             HHHHHGGGTCCCCCCTTBCHH
T ss_pred             HHHHHHHhcCCCCCCccCCHH
Confidence            999999999999999998863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.4e-45  Score=291.74  Aligned_cols=197  Identities=26%  Similarity=0.388  Sum_probs=158.6

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC--CHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA--DAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      .++|++.+.||+|+||+||+|+         +..+++.||+|.++...  ......++.+|+++|+++ +||||++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~   75 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDT   75 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccce
Confidence            3689999999999999999998         44566789999997553  345566789999999999 99999999998


Q ss_pred             EEcC-----ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          87 CYKD-----ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        87 ~~~~-----~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +...     ..|+||||+++++|.+++..                    .|||++||+||||||+|||++.++..+++||
T Consensus        76 ~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          76 GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred             eeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehh
Confidence            7642     27899999999999988764                    6999999999999999999999999999999


Q ss_pred             cCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         142 GLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      |.+.................||+.|+|||++.+..++.++||||+||++|+|+| |..||.+.+..++..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~~~~~  229 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVRE  229 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHC
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh-CCCCCCCcCHHHHHHHHHhc
Confidence            988755433322233445678899999999998889999999999999999999 99999998888886665554

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.1e-45  Score=302.05  Aligned_cols=205  Identities=23%  Similarity=0.309  Sum_probs=161.5

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--HHHHHHHHH---HHHHHHhcCCCCceE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--AKTYDKFLK---EINLMKDVGKHDHIV   81 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~~h~ni~   81 (228)
                      +..++|++.+.||+|+||+||+|+.         ..+++.||+|.++....  ......+.+   ++++++.+ +||||+
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~---------~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv   70 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIV   70 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBC
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEE
Confidence            3567999999999999999999984         44566799999864311  111122333   46677777 899999


Q ss_pred             EeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEee
Q psy3166          82 SFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISD  140 (228)
Q Consensus        82 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~d  140 (228)
                      ++++++...+ +++||||+++|+|.+++..                    .|||+++|+||||||+|||++.+|.+||+|
T Consensus        71 ~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~D  150 (364)
T d1omwa3          71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD  150 (364)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECC
T ss_pred             EEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEee
Confidence            9999987754 8999999999999999865                    699999999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHcCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVH--YLSTGY  217 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~--~~~~~~  217 (228)
                      ||+++.+....     .....||+.|+|||++.. ..|+.++||||+||++|+|+| |..||.+.+..+...  +.....
T Consensus       151 FGla~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~  224 (364)
T d1omwa3         151 LGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTM  224 (364)
T ss_dssp             CTTCEECSSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCSSCSSCHHHHHHHSSSC
T ss_pred             eceeeecCCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC
Confidence            99998654332     234678999999999975 468999999999999999999 999998865543332  223334


Q ss_pred             CCCCCCCCCC
Q psy3166         218 RMERPASCNE  227 (228)
Q Consensus       218 ~~~~p~~~~~  227 (228)
                      .++.|.++|+
T Consensus       225 ~~~~~~~~s~  234 (364)
T d1omwa3         225 AVELPDSFSP  234 (364)
T ss_dssp             CCCCCSSSCH
T ss_pred             CCCCCCCCCH
Confidence            5566777764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-44  Score=286.85  Aligned_cols=195  Identities=27%  Similarity=0.420  Sum_probs=164.5

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC--------HHHHHHHHHHHHHHHhcCCCCce
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD--------AKTYDKFLKEINLMKDVGKHDHI   80 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~~h~ni   80 (228)
                      .++|++.+.||+|+||+||+|+         +..+++.||+|+++....        ....+++.+|+.+++++..||||
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~---------~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   72 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   72 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             cccCEEceEEecCcCeEEEEEE---------ECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence            3799999999999999999998         444567899999865421        12234688999999999559999


Q ss_pred             EEeeeEEEcCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          81 VSFIGCCYKDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        81 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +++++++.++. +++||||+++|+|.+++..                    .|||++||+||||||+||+++.++.+||+
T Consensus        73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEc
Confidence            99999998755 8899999999999999865                    69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeeccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS------NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL  213 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~------~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~  213 (228)
                      |||+++.+....    ......||..|++||.+.+      ..++.++||||+||++|+|++ |..||.+.+..++.+++
T Consensus       153 DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~-g~~Pf~~~~~~~~~~~i  227 (277)
T d1phka_         153 DFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRMI  227 (277)
T ss_dssp             CCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred             cchheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc-CCCCCCCCCHHHHHHHH
Confidence            999998664432    1234678889999998863      346789999999999999999 99999999988888887


Q ss_pred             HcCC
Q psy3166         214 STGY  217 (228)
Q Consensus       214 ~~~~  217 (228)
                      .++.
T Consensus       228 ~~~~  231 (277)
T d1phka_         228 MSGN  231 (277)
T ss_dssp             HHTC
T ss_pred             HhCC
Confidence            7763

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-45  Score=294.22  Aligned_cols=192  Identities=20%  Similarity=0.372  Sum_probs=163.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||+||+|+         +..+++.||+|.++...  .....+.+|+++|+++ +||||+++++++.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~---------~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   71 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIA-RHRNILHLHESFE   71 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHS-CCTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhC-CCCCCCeEEEEEE
Confidence            3689999999999999999998         45566789999997653  2235678999999999 9999999999987


Q ss_pred             c-CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCC--CcEEEeeccCc
Q psy3166          89 K-DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSP--HVVKISDFGLS  144 (228)
Q Consensus        89 ~-~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~--~~~kl~dfg~~  144 (228)
                      . +.+|+||||++||+|.+++..                     .|||++||+||||||+|||++.+  ..+||+|||++
T Consensus        72 ~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~  151 (321)
T d1tkia_          72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             ETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchh
Confidence            6 458999999999999998864                     69999999999999999999854  58999999998


Q ss_pred             ccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy3166         145 EDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGY  217 (228)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~  217 (228)
                      ........    .....+++.|++||...+..++.++|+||+||++|+|++ |..||.+.+..++..++.++.
T Consensus       152 ~~~~~~~~----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~-G~~Pf~~~~~~~~~~~i~~~~  219 (321)
T d1tkia_         152 RQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAE  219 (321)
T ss_dssp             EECCTTCE----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC
T ss_pred             hccccCCc----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence            76533221    123456778999999998889999999999999999999 999999999998988888763

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-44  Score=288.76  Aligned_cols=214  Identities=41%  Similarity=0.776  Sum_probs=169.9

Q ss_pred             CCCCcee--eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEee
Q psy3166           7 YPPERLI--LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFI   84 (228)
Q Consensus         7 ~~~~~~~--~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~   84 (228)
                      ++++.+.  +.++||+|+||+||+|++..+.      ++...||||.++........+++.+|+++|+++ +||||++++
T Consensus        22 ~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~   94 (311)
T d1r0pa_          22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLL   94 (311)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCC
T ss_pred             eChHHceeccceEEeecCCeEEEEEEEECCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEe
Confidence            4445554  3689999999999999875432      234468999998666677778899999999999 999999999


Q ss_pred             eEEEc--CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          85 GCCYK--DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        85 ~~~~~--~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                      +++..  +..++||||+++++|.+++..                     .|+|+.+|+||||||+|||++.++.+||+||
T Consensus        95 g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DF  174 (311)
T d1r0pa_          95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF  174 (311)
T ss_dssp             EEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSS
T ss_pred             EEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecc
Confidence            98764  347899999999999998763                     6999999999999999999999999999999


Q ss_pred             cCccccccccccc-CCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy3166         142 GLSEDIYEQNVFQ-NGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTGYRME  220 (228)
Q Consensus       142 g~~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~~~~~  220 (228)
                      |+++......... .......||..|+|||.+....++.++||||||+++|||+|.|.+|+...+..++...+..+.+++
T Consensus       175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~  254 (311)
T d1r0pa_         175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL  254 (311)
T ss_dssp             GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC
T ss_pred             cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9998664432221 223345678899999999988999999999999999999994444455566667788899999999


Q ss_pred             CCCCCCC
Q psy3166         221 RPASCNE  227 (228)
Q Consensus       221 ~p~~~~~  227 (228)
                      .|..||+
T Consensus       255 ~p~~~~~  261 (311)
T d1r0pa_         255 QPEYCPD  261 (311)
T ss_dssp             CCTTCCH
T ss_pred             CcccCcH
Confidence            9998875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=283.72  Aligned_cols=189  Identities=24%  Similarity=0.367  Sum_probs=152.3

Q ss_pred             eeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHH----HHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          14 LGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAK----TYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        14 ~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      .+++||+|+||+||+|+         +..+++.||+|+++......    ....+.+|+.+|+++ +||||+++++++..
T Consensus         2 ~l~~lG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~   71 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH   71 (299)
T ss_dssp             EEEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC
T ss_pred             cceEeccCcCeEEEEEE---------ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc
Confidence            46899999999999998         45566789999987543221    224678999999999 99999999999876


Q ss_pred             C-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCccccc
Q psy3166          90 D-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDIY  148 (228)
Q Consensus        90 ~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~~  148 (228)
                      + .+++||||+.++++......                    +|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          72 KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             CCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC
Confidence            4 48999999988776655432                    69999999999999999999999999999999987554


Q ss_pred             ccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy3166         149 EQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLSTG  216 (228)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~~  216 (228)
                      ....   ......||..|+|||++... .|+.++||||+||++|+|++ |..||.+.+..+.+.++.+.
T Consensus       152 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~l~~i~~~  216 (299)
T d1ua2a_         152 SPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFET  216 (299)
T ss_dssp             SCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred             CCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh-CcCCCCCCCHHHHHHHHHHh
Confidence            4321   12345678889999998754 57999999999999999999 99999999888887776653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=287.42  Aligned_cols=182  Identities=26%  Similarity=0.421  Sum_probs=150.8

Q ss_pred             CCceeee-eeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           9 PERLILG-EVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         9 ~~~~~~~-~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      .++|++. +.||+|+||+||+|+         +..+++.||+|.++..      ..+.+|+.++.++.+||||+++++++
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~   74 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIF---------NKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVY   74 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEE---------ECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            4689877 469999999999998         4445667999998643      34568999987776899999999988


Q ss_pred             Ec-----CceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecC---CCcEE
Q psy3166          88 YK-----DELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSS---PHVVK  137 (228)
Q Consensus        88 ~~-----~~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~---~~~~k  137 (228)
                      .+     ..+++|||||+||+|.+++..                      +|||++||+||||||+|||++.   .+.+|
T Consensus        75 ~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             EEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEE
T ss_pred             eecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccc
Confidence            54     337899999999999999864                      6999999999999999999985   46799


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIV  210 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~  210 (228)
                      |+|||+++......    ......||+.|+|||++.+..|+.++||||+||++|+|+| |..||.+.+..+..
T Consensus       155 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt-g~~Pf~~~~~~~~~  222 (335)
T d2ozaa1         155 LTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAIS  222 (335)
T ss_dssp             ECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT-SSCSCEETTCC---
T ss_pred             ccccceeeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh-CCCCCCCCCHHHHH
Confidence            99999997654432    2234678999999999998889999999999999999999 99999876554443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=278.53  Aligned_cols=191  Identities=25%  Similarity=0.438  Sum_probs=154.1

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|++         ..+++.||+|.++.... ....+++.+|+++|+++ +||||+++++++.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~   71 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARN---------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIH   71 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccc
Confidence            6999999999999999999984         44556799999965432 22346788999999999 9999999999997


Q ss_pred             cC-ceEEEEecCCCCcHHHHHHH----------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          89 KD-ELRLVVEYCALGDLQSYLRE----------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        89 ~~-~~~lv~e~~~~~~L~~~l~~----------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .+ .+++||||+.++ +.+++..                      +|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        72 ~~~~~~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          72 TENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             ETTEEEEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             cccceeEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcce
Confidence            75 489999999664 4444322                      69999999999999999999999999999999997


Q ss_pred             cccccccccCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .......   ......||+.|+|||.+.... ++.++|+||+||++|+|++ |..||.+.+..+...++.+
T Consensus       151 ~~~~~~~---~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~-G~~Pf~~~~~~~~~~~i~~  217 (298)
T d1gz8a_         151 AFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFR  217 (298)
T ss_dssp             HHCCCSB---CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             eccCCcc---cceeecccceeeehhhhccccCCCccccccccchhhhHHhh-CCCCCCCCCHHHHHHHHHH
Confidence            6543322   223456788999999887665 5789999999999999999 9999999888777665443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=280.38  Aligned_cols=192  Identities=22%  Similarity=0.336  Sum_probs=156.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++++.||+|+||+||+|+.         ..+++.||||.++........+++.+|+++|+++ +||||+++++++..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~   77 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYD---------NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRA   77 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEE---------TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECC
T ss_pred             CCeEEEEEEeeccCeEEEEEEE---------CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEee
Confidence            4699999999999999999984         4455679999998665666677889999999999 99999999998854


Q ss_pred             C-----ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166          90 D-----ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus        90 ~-----~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      .     ..+++++++.+|+|.+++..                   +|||++||+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          78 PTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             SSTTTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            3     23555667779999999864                   69999999999999999999999999999999997


Q ss_pred             cccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         146 DIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      ................||..|+|||++.. ..++.++|+||+||++|+|++ |..||.+.+..+....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~-g~~pf~~~~~~~~~~~  224 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNH  224 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh-CCCCCCCCCHHHHHHH
Confidence            65544333333345678889999999854 457899999999999999999 9999998876655444

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=278.74  Aligned_cols=193  Identities=22%  Similarity=0.333  Sum_probs=153.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcC--CCCceEEeeeE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVG--KHDHIVSFIGC   86 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--~h~ni~~~~~~   86 (228)
                      ++|++++.||+|+||+||+|++..        ..++.||+|.++.... ......+.+|+.+|+.+.  +||||++++++
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~   78 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   78 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeee
Confidence            689999999999999999998532        2245689999864421 112234557777776652  79999999998


Q ss_pred             EEc------CceEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecCCCcEEEe
Q psy3166          87 CYK------DELRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSSPHVVKIS  139 (228)
Q Consensus        87 ~~~------~~~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~  139 (228)
                      +..      ..++++||++.++++......                     +|||+++|+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             EEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeec
Confidence            753      237899999988766443221                     69999999999999999999999999999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      |||+++......    ......||+.|+|||++.+..|+.++||||+||++|+|++ |..||.+.+..+.+.++.+
T Consensus       159 dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  229 (305)
T d1blxa_         159 DFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD  229 (305)
T ss_dssp             SCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             chhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH-CCCCCCCCCHHHHHHHHHH
Confidence            999987543322    2235678899999999999999999999999999999999 9999999988887776654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-43  Score=282.02  Aligned_cols=212  Identities=24%  Similarity=0.310  Sum_probs=165.1

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC---CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA---DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      +..++|++.+.||+|+||+||+|+...      ++.+++.||+|.++...   .....+++.+|+.+|+++.+||||+++
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~   94 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL   94 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECc------cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEe
Confidence            445789999999999999999998533      34567789999986431   122235677899999999555899999


Q ss_pred             eeEEEcC-ceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeecc
Q psy3166          84 IGCCYKD-ELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFG  142 (228)
Q Consensus        84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg  142 (228)
                      ++++... ..+++|||+.+|+|.+++..                    .|+|+++|+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_          95 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeecc
Confidence            9998764 48899999999999998765                    69999999999999999999999999999999


Q ss_pred             CcccccccccccCCCCCCCCcceeecccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCC
Q psy3166         143 LSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN--IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYL---STGY  217 (228)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~---~~~~  217 (228)
                      +++.+.......  .....|+..|++||.+...  .++.++||||+||++|+|++ |..||.+....+...++   ....
T Consensus       175 ~a~~~~~~~~~~--~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt-G~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         175 LSKEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             EEEECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             chhhhccccccc--ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcccC
Confidence            987654332221  2235677789999998754  36789999999999999999 99999886544333332   2233


Q ss_pred             CCCCCCCCCC
Q psy3166         218 RMERPASCNE  227 (228)
Q Consensus       218 ~~~~p~~~~~  227 (228)
                      .++.|..+++
T Consensus       252 ~~~~~~~~s~  261 (322)
T d1vzoa_         252 EPPYPQEMSA  261 (322)
T ss_dssp             CCCCCTTSCH
T ss_pred             CCCCcccCCH
Confidence            6677777664

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.2e-42  Score=272.08  Aligned_cols=191  Identities=25%  Similarity=0.378  Sum_probs=153.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-HHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-AKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|+++          +++.||+|.++.... .....++.+|+.+|+++ +||||+++++++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~   70 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIH   70 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecc
Confidence            69999999999999999999853          234699999875432 22246788999999999 9999999999988


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      .++ .++++|++.++.+..+...                    +|||+++|+||||||+|||++.++.+|++|||.+...
T Consensus        71 ~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          71 TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             CSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             cCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            755 7889999987766655432                    6999999999999999999999999999999998765


Q ss_pred             cccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      .....   ......+++.|++||.+.+. .++.++|+||+||++|+|++ |..||.+.+..+.+.++.+
T Consensus       151 ~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~-G~~pf~~~~~~~~~~~i~~  215 (286)
T d1ob3a_         151 GIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFR  215 (286)
T ss_dssp             CC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             ccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH-CCCCCCCCCHHHHHHHHHH
Confidence            43321   12334567789999998755 46899999999999999999 9999999888777666544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=273.08  Aligned_cols=180  Identities=24%  Similarity=0.393  Sum_probs=145.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCH-----HHHHHHHHHHHHHHhcC-CCCceEEe
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADA-----KTYDKFLKEINLMKDVG-KHDHIVSF   83 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~-~h~ni~~~   83 (228)
                      ++|++.+.||+|+||+||+|+.         ..+++.||+|.++.....     ....++.+|+.+|+++. .||||+++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~   74 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIR---------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL   74 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence            5799999999999999999984         445567999998643111     11234568999999994 38999999


Q ss_pred             eeEEEcCc-eEEEEecCCC-CcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecC-CCcEEEee
Q psy3166          84 IGCCYKDE-LRLVVEYCAL-GDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSS-PHVVKISD  140 (228)
Q Consensus        84 ~~~~~~~~-~~lv~e~~~~-~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~-~~~~kl~d  140 (228)
                      ++++...+ .++|||++.+ +++.+++..                    .|||+++|+||||||+|||++. ++.+||+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          75 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence            99987754 8899999865 678777654                    6999999999999999999985 47999999


Q ss_pred             ccCcccccccccccCCCCCCCCcceeecccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy3166         141 FGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIY-TNKSDVWSFGVVLWEIVTLGANPYPHI  204 (228)
Q Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Diwslg~~~~~l~t~g~~pf~~~  204 (228)
                      ||++......     ......||..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.
T Consensus       155 FG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~  213 (273)
T d1xwsa_         155 FGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHD  213 (273)
T ss_dssp             CTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH
T ss_pred             cccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh-CCCCCCCc
Confidence            9999754332     2234678999999999987765 567899999999999999 99999763

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=273.73  Aligned_cols=201  Identities=22%  Similarity=0.325  Sum_probs=158.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      .=-+.++|++.+.||+|+||+||+|++         ..+++.||||++.... ......++.+|+.+|+++ +|||++++
T Consensus         5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~   74 (318)
T d3blha1           5 FCDEVSKYEKLAKIGQGTFGEVFKARH---------RKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNL   74 (318)
T ss_dssp             TSCBGGGEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             CCCccCCEEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccce
Confidence            334568999999999999999999984         4455679999986442 223346678999999999 99999999


Q ss_pred             eeEEEc---------CceEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCC
Q psy3166          84 IGCCYK---------DELRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPH  134 (228)
Q Consensus        84 ~~~~~~---------~~~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~  134 (228)
                      ++++..         +.++++||++.++++......                    .|||++||+||||||+|||++.++
T Consensus        75 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~  154 (318)
T d3blha1          75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG  154 (318)
T ss_dssp             EEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred             EeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC
Confidence            998743         237899999987766543221                    699999999999999999999999


Q ss_pred             cEEEeeccCcccccccccc-cCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy3166         135 VVKISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHY  212 (228)
Q Consensus       135 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~  212 (228)
                      .+||+|||++..+...... ........||..|+|||++... .++.++|+||+||++|+|++ |..||.+.+..+..+.
T Consensus       155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~-g~~pf~~~~~~~~~~~  233 (318)
T d3blha1         155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL  233 (318)
T ss_dssp             CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred             cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh-CCCCCCCCCHHHHHHH
Confidence            9999999999765543222 2223345789999999998755 68999999999999999999 9999999888777666


Q ss_pred             HHcC
Q psy3166         213 LSTG  216 (228)
Q Consensus       213 ~~~~  216 (228)
                      +...
T Consensus       234 i~~~  237 (318)
T d3blha1         234 ISQL  237 (318)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            5553

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=272.53  Aligned_cols=192  Identities=21%  Similarity=0.376  Sum_probs=153.1

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      |.+ .++|++.+.||+|+||+||+|++         ..+++.||+|.++... .....+++.+|+++|+++ +||||+++
T Consensus        14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l   82 (346)
T d1cm8a_          14 WEV-RAVYRDLQPVGSGAYGAVCSAVD---------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGL   82 (346)
T ss_dssp             ECC-BSSEEEEEEC------CEEEEEE---------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCC
T ss_pred             eec-CCcEEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEE
Confidence            344 47999999999999999999984         4456679999997553 445567889999999999 99999999


Q ss_pred             eeEEEcC-------ceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEE
Q psy3166          84 IGCCYKD-------ELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        84 ~~~~~~~-------~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      ++++...       .+++||||+ +.+|.+.++.                   .|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          83 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEeccCccccccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccc
Confidence            9998653       368999999 5677776543                   699999999999999999999999999


Q ss_pred             EeeccCcccccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         138 ISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ++|||++......      .....+|..|+|||++.+. .++.++|+||+||++|+|++ |..||.+.+....+.++..
T Consensus       162 l~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~  233 (346)
T d1cm8a_         162 ILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIMK  233 (346)
T ss_dssp             ECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred             cccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHH-CcCCCCCCChHHHHHHHHh
Confidence            9999999754322      2345678899999998764 46889999999999999999 9999999877666554433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-40  Score=264.81  Aligned_cols=184  Identities=18%  Similarity=0.272  Sum_probs=150.9

Q ss_pred             CCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166           9 PERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus         9 ~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      .++|++.+.||+|+||+||+|+         +..+++.||+|.++.....   ..+.+|++.++.+.+|+|++.+++++.
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~---------~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~   71 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQ   71 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEE---------ETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEee
Confidence            4789999999999999999998         4456678999988654322   245678899999966799999998887


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC-----CCcEEEeec
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS-----PHVVKISDF  141 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~-----~~~~kl~df  141 (228)
                      .+. .++|||++ +++|.+++..                     .|||++||+||||||+||+++.     .+.+||+||
T Consensus        72 ~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          72 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             cCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence            654 78999998 7899888764                     6999999999999999999974     568999999


Q ss_pred             cCccccccccc----ccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy3166         142 GLSEDIYEQNV----FQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPL  206 (228)
Q Consensus       142 g~~~~~~~~~~----~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~  206 (228)
                      |+++.+.....    .........||+.|+|||++.+..++.++|+||||+++|+|+| |..||.+...
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~  218 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKA  218 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCS
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh-CCCcCCCccc
Confidence            99986543221    1122345678999999999999899999999999999999999 9999986543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=259.69  Aligned_cols=192  Identities=24%  Similarity=0.391  Sum_probs=156.0

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++++.||+|+||+||+|++         ..+++.||+|+++... ......++.+|+.+|+++ +||||+++++++.
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~   71 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKN---------RETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLH   71 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEE---------CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccc
Confidence            6899999999999999999984         4455679999986543 334567889999999999 9999999999987


Q ss_pred             cCc-eEEEEecCCCCcHHHHHHH--------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccCcccc
Q psy3166          89 KDE-LRLVVEYCALGDLQSYLRE--------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGLSEDI  147 (228)
Q Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~--------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~~~  147 (228)
                      ... .+++++++.++++..++..                    .|||+++|+||||||+|||++.++.+||+|||.++..
T Consensus        72 ~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          72 SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             CSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcc
Confidence            755 7889999988888776553                    6999999999999999999999999999999999765


Q ss_pred             cccccccCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Q psy3166         148 YEQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPY-PHIPLCRIVHYLST  215 (228)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~pf-~~~~~~~~~~~~~~  215 (228)
                      ......   .....++..|++||.+.... ++.++|+||+||++|+|++ |..|| .+.+..+..+++..
T Consensus       152 ~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~-g~~p~~~~~~~~~~~~~~~~  217 (292)
T d1unla_         152 GIPVRC---YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_dssp             CSCCSC---CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT-TSCCSCCCSSHHHHHHHHHH
T ss_pred             cCCCcc---ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhh-CCCCCCCCCCHHHHHHHHHh
Confidence            443221   22234556789999887654 6899999999999999999 88775 55666666666544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-40  Score=267.74  Aligned_cols=184  Identities=26%  Similarity=0.375  Sum_probs=147.4

Q ss_pred             ceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEcC
Q psy3166          11 RLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYKD   90 (228)
Q Consensus        11 ~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   90 (228)
                      +|+..++||+|+||+||+|++         ..+++.||+|.++.....     ..+|+++|+++ +||||+++++++...
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l-~h~niv~~~~~~~~~   85 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKL---------CDSGELVAIKKVLQDKRF-----KNRELQIMRKL-DHCNIVRLRYFFYSS   85 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSSS-----CCHHHHHHHHC-CCTTBCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEE---------CCCCCEEEEEEECccchH-----HHHHHHHHHhc-CCCCCCcEEEEEEec
Confidence            688999999999999999984         445667999998754321     23699999999 999999999988532


Q ss_pred             -------ceEEEEecCCCCcHHHHHH---H--------------------hcccCCCCcccCCCCCCEeecCCC-cEEEe
Q psy3166          91 -------ELRLVVEYCALGDLQSYLR---E--------------------EYLSNNKVVHRDLATRNILLSSPH-VVKIS  139 (228)
Q Consensus        91 -------~~~lv~e~~~~~~L~~~l~---~--------------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~  139 (228)
                             .+++||||++++.+.....   .                    +|||++||+||||||+|||++.++ .+||+
T Consensus        86 ~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             --CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEEC
T ss_pred             CccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEe
Confidence                   2679999997654332211   1                    699999999999999999999875 89999


Q ss_pred             eccCcccccccccccCCCCCCCCcceeeccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy3166         140 DFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVS-NIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLS  214 (228)
Q Consensus       140 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~  214 (228)
                      |||++..+....    ......|+..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+.+..+.
T Consensus       166 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~-g~~pf~~~~~~~~l~~i~  236 (350)
T d1q5ka_         166 DFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEII  236 (350)
T ss_dssp             CCTTCEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHH
T ss_pred             cccchhhccCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehhh-CCCCCCCCCHHHHHHHHH
Confidence            999987654332    1234567788999998875 468999999999999999999 999999988777666554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-40  Score=264.69  Aligned_cols=178  Identities=29%  Similarity=0.427  Sum_probs=138.7

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|.+.+.||+|+||.||+|++.           +..||||.++...  ........|+..++++ +||||+++++++..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~   68 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccc--hhHHHHHHHHHHHhhC-CCCcCcceEEEEEe
Confidence            57999999999999999999852           3469999986442  1112223455555677 89999999999865


Q ss_pred             C-----ceEEEEecCCCCcHHHHHHH-------------------hccc--------CCCCcccCCCCCCEeecCCCcEE
Q psy3166          90 D-----ELRLVVEYCALGDLQSYLRE-------------------EYLS--------NNKVVHRDLATRNILLSSPHVVK  137 (228)
Q Consensus        90 ~-----~~~lv~e~~~~~~L~~~l~~-------------------~~lh--------~~~i~H~~lk~~nil~~~~~~~k  137 (228)
                      .     .+++||||+++|+|.+++++                   .|+|        +++|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             CCCcceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            3     37899999999999999875                   3555        57999999999999999999999


Q ss_pred             EeeccCcccccccccc-cCCCCCCCCcceeecccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCC
Q psy3166         138 ISDFGLSEDIYEQNVF-QNGEPSEKLPIRWLALESLVSNI------YTNKSDVWSFGVVLWEIVTLGANPYP  202 (228)
Q Consensus       138 l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~------~~~~~Diwslg~~~~~l~t~g~~pf~  202 (228)
                      |+|||+++........ ........||+.|+|||++....      ++.++|||||||++|||+| |..||.
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~~  219 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGG  219 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh-CCCCCC
Confidence            9999999866543322 12233467899999999987542      5678999999999999999 877663

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-40  Score=271.08  Aligned_cols=190  Identities=24%  Similarity=0.319  Sum_probs=148.6

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEeeeEEE
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSFIGCCY   88 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   88 (228)
                      ++|++.+.||+|+||+||+|+         +..++..||||+++... ......++.+|+.+|+++ +||||+++++++.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~---------d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~   86 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFT   86 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEE---------ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEC
T ss_pred             CCeEEEEEeecCcCeEEEEEE---------ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe
Confidence            579999999999999999998         45566789999997553 344556788999999999 9999999999985


Q ss_pred             c-------CceEEEEecCCCCcHHHHHHH------------------hcccCCCCcccCCCCCCEeecCCCcEEEeeccC
Q psy3166          89 K-------DELRLVVEYCALGDLQSYLRE------------------EYLSNNKVVHRDLATRNILLSSPHVVKISDFGL  143 (228)
Q Consensus        89 ~-------~~~~lv~e~~~~~~L~~~l~~------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl~dfg~  143 (228)
                      .       ..+|+||||+.++.+.. +..                  .|||++||+||||||+|||++.++.++++|||+
T Consensus        87 ~~~~~~~~~~~~iv~Ey~~~~l~~~-~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          87 PQKTLEEFQDVYLVMELMDANLCQV-IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             SCCSTTTCCEEEEEEECCSEEHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             cccccccCceeEEEEeccchHHHHh-hhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence            3       34789999997654443 322                  799999999999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         144 SEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      ++......    ......+|..|+|||++.+..+++++|+||+||++++|++ |..||.+.+......++..
T Consensus       166 ~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~-g~~pF~~~~~~~~~~~i~~  232 (355)
T d2b1pa1         166 ARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIE  232 (355)
T ss_dssp             -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred             hhcccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhh-CCCCCCCCCHHHHHHHHHH
Confidence            87543322    1233566788999999999899999999999999999999 9999999887766665544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-40  Score=268.11  Aligned_cols=193  Identities=22%  Similarity=0.385  Sum_probs=156.4

Q ss_pred             CCCCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCC-CHHHHHHHHHHHHHHHhcCCCCceEEe
Q psy3166           5 CGYPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANA-DAKTYDKFLKEINLMKDVGKHDHIVSF   83 (228)
Q Consensus         5 ~~~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~   83 (228)
                      |+++ ++|++.+.||+|+||+||+|+         +..+++.||||+++... ......++.+|+++|+++ +|||++++
T Consensus        14 ~~~~-~rY~i~~~LG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~   82 (348)
T d2gfsa1          14 WEVP-ERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGL   82 (348)
T ss_dssp             EEEE-TTEEEEEECGGGTTSSEEEEE---------ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCC
T ss_pred             ccCC-CCeEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeE
Confidence            4554 789999999999999999998         44566789999997553 344556788999999999 99999999


Q ss_pred             eeEEEc------CceEEEEecCCCCcHHHHHHH-------------------hcccCCCCcccCCCCCCEeecCCCcEEE
Q psy3166          84 IGCCYK------DELRLVVEYCALGDLQSYLRE-------------------EYLSNNKVVHRDLATRNILLSSPHVVKI  138 (228)
Q Consensus        84 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~-------------------~~lh~~~i~H~~lk~~nil~~~~~~~kl  138 (228)
                      ++++..      ...+++++++.+|+|.+++..                   .|||++||+||||||+|||++.++.+|+
T Consensus        83 ~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl  162 (348)
T d2gfsa1          83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI  162 (348)
T ss_dssp             SEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccc
Confidence            998753      235677788889999998753                   6999999999999999999999999999


Q ss_pred             eeccCcccccccccccCCCCCCCCcceeecccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy3166         139 SDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNI-YTNKSDVWSFGVVLWEIVTLGANPYPHIPLCRIVHYLST  215 (228)
Q Consensus       139 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~~~~~~~~~  215 (228)
                      +|||++......      .....|+..|+|||...+.. ++.++|+||+||++|+|++ |..||.+.+.......+..
T Consensus       163 ~dfg~a~~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~-g~~pF~~~~~~~~~~~i~~  233 (348)
T d2gfsa1         163 LDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILR  233 (348)
T ss_dssp             CCC----CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred             cccchhcccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence            999998644222      23456778899999877654 6889999999999999999 9999999887777666544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-39  Score=260.55  Aligned_cols=184  Identities=22%  Similarity=0.313  Sum_probs=143.8

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      ++|++.+.||+|+||+||+|++         ..+++.||||.+......   ..+..|+++++++.+|++|+.+..++..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~   74 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE   74 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEE---------CCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEec
Confidence            5799999999999999999984         445567999988754322   3467899999999545556666665555


Q ss_pred             Cc-eEEEEecCCCCcHHHHHHH---------------------hcccCCCCcccCCCCCCEeecC---CCcEEEeeccCc
Q psy3166          90 DE-LRLVVEYCALGDLQSYLRE---------------------EYLSNNKVVHRDLATRNILLSS---PHVVKISDFGLS  144 (228)
Q Consensus        90 ~~-~~lv~e~~~~~~L~~~l~~---------------------~~lh~~~i~H~~lk~~nil~~~---~~~~kl~dfg~~  144 (228)
                      +. .++|||++ ++++.+.+..                     +|||++||+||||||+|||+..   +..++++|||++
T Consensus        75 ~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          75 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             CCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence            44 77899998 5566665442                     6999999999999999999864   457999999999


Q ss_pred             ccccccccc----cCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy3166         145 EDIYEQNVF----QNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIPLC  207 (228)
Q Consensus       145 ~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~~~  207 (228)
                      +.+......    ........||+.|+|||++.+..++.++|||||||++|+|+| |..||......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t-g~~P~~~~~~~  219 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAA  219 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH-SSCTTCCCC--
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh-CCCcccccchH
Confidence            866543221    112335678999999999999899999999999999999999 99999886554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.2e-39  Score=262.99  Aligned_cols=180  Identities=22%  Similarity=0.363  Sum_probs=149.0

Q ss_pred             CCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEE
Q psy3166           8 PPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCC   87 (228)
Q Consensus         8 ~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   87 (228)
                      ..++|++++.||+|+||+||+|+         +..+++.||+|+++...    ..++.+|+++|+.+.+||||+++++++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~   99 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIV   99 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEE
Confidence            34789999999999999999998         45566789999987542    356788999999996699999999998


Q ss_pred             Ec---CceEEEEecCCCCcHHHHHHH-----------------hcccCCCCcccCCCCCCEeecCCC-cEEEeeccCccc
Q psy3166          88 YK---DELRLVVEYCALGDLQSYLRE-----------------EYLSNNKVVHRDLATRNILLSSPH-VVKISDFGLSED  146 (228)
Q Consensus        88 ~~---~~~~lv~e~~~~~~L~~~l~~-----------------~~lh~~~i~H~~lk~~nil~~~~~-~~kl~dfg~~~~  146 (228)
                      ..   ..+++||||+.+++|.+..+.                 +|||++||+||||||+|||++.++ .+||+|||++..
T Consensus       100 ~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         100 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             ECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence            64   348899999999998765322                 799999999999999999998754 699999999975


Q ss_pred             ccccccccCCCCCCCCcceeecccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         147 IYEQNVFQNGEPSEKLPIRWLALESLVSN-IYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      .....    ......+|..|+|||.+.+. .++.++|+||+||++|+|++ |..||....
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~-g~~pf~~~~  234 (328)
T d3bqca1         180 YHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGH  234 (328)
T ss_dssp             CCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCS
T ss_pred             ccCCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc-CCCCCCCCc
Confidence            54332    12345678889999998765 47999999999999999999 999997644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-33  Score=229.02  Aligned_cols=178  Identities=22%  Similarity=0.379  Sum_probs=135.4

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcC----------CCCc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVG----------KHDH   79 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~n   79 (228)
                      ++|++.+.||+|+||+||+|+         +..+++.||||+++..  ....+.+.+|+.+++++.          .|+|
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~---------~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~   81 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH   81 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CcEEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence            469999999999999999998         4456678999999754  233456778999888872          3578


Q ss_pred             eEEeeeEEEc---CceEEEEecCCCCc-HHHHHHH----------------------hcccC-CCCcccCCCCCCEeecC
Q psy3166          80 IVSFIGCCYK---DELRLVVEYCALGD-LQSYLRE----------------------EYLSN-NKVVHRDLATRNILLSS  132 (228)
Q Consensus        80 i~~~~~~~~~---~~~~lv~e~~~~~~-L~~~l~~----------------------~~lh~-~~i~H~~lk~~nil~~~  132 (228)
                      |+++++++..   ...+++++++..+. .......                      .|||+ .||+||||||+|||++.
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence            9999988754   23556666654333 2222111                      58997 89999999999999986


Q ss_pred             CC------cEEEeeccCcccccccccccCCCCCCCCcceeecccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3166         133 PH------VVKISDFGLSEDIYEQNVFQNGEPSEKLPIRWLALESLVSNIYTNKSDVWSFGVVLWEIVTLGANPYPHIP  205 (228)
Q Consensus       133 ~~------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Diwslg~~~~~l~t~g~~pf~~~~  205 (228)
                      ++      .++++|||.+......      .....||..|+|||++....++.++|+||+||++++|++ |..||....
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pF~~~~  233 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDE  233 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC----
T ss_pred             cCcccccceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHH-CCCCCCCCc
Confidence            54      4999999998744322      234678889999999999899999999999999999999 999997643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=3.9e-22  Score=148.73  Aligned_cols=121  Identities=19%  Similarity=0.221  Sum_probs=89.0

Q ss_pred             eeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCC-----------------HHHHHHHHHHHHHHHhc
Q psy3166          12 LILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANAD-----------------AKTYDKFLKEINLMKDV   74 (228)
Q Consensus        12 ~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~e~~~l~~l   74 (228)
                      +.+.+.||+|+||+||+|+..          ++..||+|.++.+..                 ........+|...+.++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   71 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL   71 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             chhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence            468899999999999999743          234699998653210                 01123345688899999


Q ss_pred             CCCCceEEeeeEEEcCceEEEEecCCCCcHHH--------HHHH-----hcccCCCCcccCCCCCCEeecCCCcEEEeec
Q psy3166          75 GKHDHIVSFIGCCYKDELRLVVEYCALGDLQS--------YLRE-----EYLSNNKVVHRDLATRNILLSSPHVVKISDF  141 (228)
Q Consensus        75 ~~h~ni~~~~~~~~~~~~~lv~e~~~~~~L~~--------~l~~-----~~lh~~~i~H~~lk~~nil~~~~~~~kl~df  141 (228)
                       .|++++..++..   ..+++||++.+..+.+        .+.+     .|||++||+||||||+|||++.++ ++|+||
T Consensus        72 -~~~~v~~~~~~~---~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDF  146 (191)
T d1zara2          72 -QGLAVPKVYAWE---GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDF  146 (191)
T ss_dssp             -TTSSSCCEEEEE---TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred             -cCCCcceEEEec---CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEEC
Confidence             899988876542   3478999997754432        2222     799999999999999999999654 899999


Q ss_pred             cCcccc
Q psy3166         142 GLSEDI  147 (228)
Q Consensus       142 g~~~~~  147 (228)
                      |.+...
T Consensus       147 G~a~~~  152 (191)
T d1zara2         147 PQSVEV  152 (191)
T ss_dssp             TTCEET
T ss_pred             CCcccC
Confidence            988643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.95  E-value=9.1e-06  Score=61.34  Aligned_cols=85  Identities=11%  Similarity=-0.097  Sum_probs=51.2

Q ss_pred             CceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeEEEc
Q psy3166          10 ERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGCCYK   89 (228)
Q Consensus        10 ~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   89 (228)
                      +.|++.+..+-++.+.||+....+           ..+.+|........ ....+.+|...+..+..+--+.+++.+...
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~~~-----------~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~   81 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVGEN-----------ENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEECSS-----------CEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEEeCC-----------CeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence            355655554444456899865222           23778876543211 112456788888777555445666665544


Q ss_pred             -CceEEEEecCCCCcHHH
Q psy3166          90 -DELRLVVEYCALGDLQS  106 (228)
Q Consensus        90 -~~~~lv~e~~~~~~L~~  106 (228)
                       +..++||++++|.++.+
T Consensus        82 ~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             TTEEEEEEECCSSEEHHH
T ss_pred             CCceEEEEEecccccccc
Confidence             44789999998877644

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.34  E-value=0.00021  Score=57.23  Aligned_cols=79  Identities=14%  Similarity=0.073  Sum_probs=46.9

Q ss_pred             eeeeeeecCceEEEeeecCCCCCCCCcccceeeeeecccc------CCCHHHHHHHHHHHHHHHhcCCC--CceEEeeeE
Q psy3166          15 GEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKA------NADAKTYDKFLKEINLMKDVGKH--DHIVSFIGC   86 (228)
Q Consensus        15 ~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~~e~~~l~~l~~h--~ni~~~~~~   86 (228)
                      .+.||.|....||+.....         .++.+++|+-..      ...+....+...|...|..+..+  ..+++++.+
T Consensus        31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~  101 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  101 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence            4578999999999986432         233578886431      11111223455688888776443  345555543


Q ss_pred             EEcCceEEEEecCCCCc
Q psy3166          87 CYKDELRLVVEYCALGD  103 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~~  103 (228)
                       ..+..+++||++.+..
T Consensus       102 -d~~~~~lvmE~L~~~~  117 (392)
T d2pula1         102 -DTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             -ETTTTEEEECCCTTSE
T ss_pred             -cCCCCEEEEeccCCcc
Confidence             4455778999997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.24  E-value=0.00095  Score=49.47  Aligned_cols=74  Identities=14%  Similarity=0.013  Sum_probs=43.3

Q ss_pred             eeeeecC-ceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCC-CceEEeeeEEEc-CceE
Q psy3166          17 VLGQGEF-GVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKH-DHIVSFIGCCYK-DELR   93 (228)
Q Consensus        17 ~ig~g~~-~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h-~ni~~~~~~~~~-~~~~   93 (228)
                      .+..|.. +.||+....+++          .+.+|.......    ..+..|...++.+..+ -.+.+++.+... +..+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~----------~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~   82 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRP----------VLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   82 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSC----------CEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             EcCCcccCCeEEEEEeCCCC----------EEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence            4455554 578987643332          377787653321    2345677777766333 235555655554 3478


Q ss_pred             EEEecCCCCcH
Q psy3166          94 LVVEYCALGDL  104 (228)
Q Consensus        94 lv~e~~~~~~L  104 (228)
                      ++|++++|.++
T Consensus        83 ~v~~~i~G~~~   93 (255)
T d1nd4a_          83 LLLGEVPGQDL   93 (255)
T ss_dssp             EEEECCSSEET
T ss_pred             EEEEeeecccc
Confidence            99999987554

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.86  E-value=0.013  Score=46.24  Aligned_cols=87  Identities=11%  Similarity=0.082  Sum_probs=53.2

Q ss_pred             CCCCceeeeeeeeeecCceEEEeeecCCCCCCCCcccceeeeeeccccCCCHHHHHHHHHHHHHHHhcCCCCceEEeeeE
Q psy3166           7 YPPERLILGEVLGQGEFGVVVKGLLGDGPTEGASGQAAMEVAVKMLKANADAKTYDKFLKEINLMKDVGKHDHIVSFIGC   86 (228)
Q Consensus         7 ~~~~~~~~~~~ig~g~~~~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   86 (228)
                      ++.+++++. .|+-|-...+|++...++...  .+.....|.+++.-.....   ....+|..+++.+..+.-..+++++
T Consensus        40 ~~~~~l~v~-~l~GGltN~~y~v~~~~~~~~--~~~~~~~vllRi~g~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~  113 (395)
T d1nw1a_          40 VPLEHLRIS-RIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPETE---SHLVAESVIFTLLSERHLGPKLYGI  113 (395)
T ss_dssp             CCGGGEEEE-EECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCCCH---HHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred             CCccceEEE-EcCCccccceEEEEeCCCCcc--ccCCCCcEEEEecCCcchh---hHHHHHHHHHHHHHhCCCCCeEEEE
Confidence            566666664 677788889999886654321  1122334666665422222   3445788899888666556677665


Q ss_pred             EEcCceEEEEecCCCC
Q psy3166          87 CYKDELRLVVEYCALG  102 (228)
Q Consensus        87 ~~~~~~~lv~e~~~~~  102 (228)
                      +..   .+|+||++|.
T Consensus       114 ~~~---g~I~efi~g~  126 (395)
T d1nw1a_         114 FSG---GRLEEYIPSR  126 (395)
T ss_dssp             ETT---EEEECCCCEE
T ss_pred             cCC---ceEEEEeccc
Confidence            532   5677887653

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.35  E-value=0.071  Score=40.30  Aligned_cols=31  Identities=23%  Similarity=0.357  Sum_probs=26.7

Q ss_pred             CCCCcccCCCCCCEeecCCCcEEEeeccCcc
Q psy3166         115 NNKVVHRDLATRNILLSSPHVVKISDFGLSE  145 (228)
Q Consensus       115 ~~~i~H~~lk~~nil~~~~~~~kl~dfg~~~  145 (228)
                      ..|++|+|+.++|++++.+...-++||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3578999999999999988777899999763